data_2mf6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mf6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 tttt . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.31 136.97 52.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 122.564 1.173 . . . . 0.0 111.747 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.14 129.03 24.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.909 2.484 . . . . 0.0 107.564 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.83 -31.25 70.97 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -53.44 116.53 2.5 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.731 0.777 . . . . 0.0 110.947 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.45 -128.85 4.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 10' ' ' TRP . 14.8 ttmt -146.23 152.34 39.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 55.9 m95 -138.35 162.73 33.66 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 110.879 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -141.3 144.64 34.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.54 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 14' ' ' LEU . 4.2 t30 -106.92 147.28 30.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.84 0.856 . . . . 0.0 111.591 -174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -27.79 58.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.868 1.267 . . . . 0.0 113.94 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 35.1 tp -71.09 -15.99 62.55 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.425 1.49 . . . . 0.0 113.476 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.68 -9.81 44.77 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.871 2.177 . . . . 0.0 114.068 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -71.93 146.73 47.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.685 1.243 . . . . 0.0 110.839 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -122.72 148.36 45.41 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.15 -0.969 . . . . 0.0 111.711 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -135.06 139.81 45.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -126.4 132.68 51.48 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.76 126.71 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.77 -91.0 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.637 1.211 . . . . 0.0 111.97 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 134.61 30.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.519 -0.989 . . . . 0.0 110.387 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.01 133.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.959 0.787 . . . . 0.0 111.241 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.36 158.09 36.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.372 1.069 . . . . 0.0 110.874 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.6 m -57.65 -24.58 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.865 -1.147 . . . . 0.0 113.963 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.409 -0.807 . . . . 0.0 110.766 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.31 -5.01 33.42 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.769 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.23 154.24 39.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.942 1.871 . . . . 0.0 111.608 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.04 154.22 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -116.83 156.28 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.604 1.162 . . . . 0.0 109.557 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.72 -176.57 38.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.651 1.139 . . . . 0.0 115.288 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 p -134.26 123.29 24.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.279 -1.461 . . . . 0.0 107.724 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -124.38 132.14 53.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.169 -1.832 . . . . 0.0 113.76 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.15 131.37 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.735 0.778 . . . . 0.0 108.965 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -106.92 138.27 43.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.087 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.32 24.63 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.81 136.96 45.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 124.083 0.953 . . . . 0.0 111.921 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.46 163.13 37.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.172 -0.955 . . . . 0.0 111.012 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.88 -27.13 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.25 80.47 10.13 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 127.281 2.232 . . . . 0.0 109.881 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.92 13.21 0.23 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.736 3.624 . . . . 0.0 117.986 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.31 -28.86 1.53 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.41 53.53 0.17 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.147 1.473 . . . . 0.0 112.28 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.55 130.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.756 -1.215 . . . . 0.0 111.096 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.09 172.32 11.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 128.272 2.629 . . . . 0.0 108.818 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . 0.289 5.5 mp -66.69 131.91 46.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.7 m -99.39 117.72 63.46 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.421 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.93 138.72 78.48 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.782 1.655 . . . . 0.0 110.525 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.53 148.49 46.24 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.165 0.916 . . . . 0.0 110.688 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.32 148.89 33.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.554 2.342 . . . . 0.0 108.64 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.49 -159.03 32.05 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.254 -1.529 . . . . 0.0 109.312 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 mt -145.48 146.65 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.717 0.892 . . . . 0.0 111.5 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -132.29 154.35 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.28 1.038 . . . . 0.0 113.071 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -92.16 157.93 16.45 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.381 1.086 . . . . 0.0 109.098 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 23.53 0.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.726 1.61 . . . . 0.0 111.918 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.46 -52.34 4.55 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.465 2.306 . . . . 0.0 111.93 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.78 174.46 3.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -71.77 -44.84 63.33 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.446 -0.784 . . . . 0.0 111.773 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.59 69.08 81.52 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.688 1.195 . . . . 0.0 110.229 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.22 168.64 17.12 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.903 3.068 . . . . 0.0 118.08 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.5 p -86.06 157.45 20.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.365 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -150.59 174.32 13.11 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 123.989 1.852 . . . . 0.0 112.533 174.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.82 149.62 9.38 Favored Glycine 0 N--CA 1.408 -3.186 0 CA-C-N 108.674 -3.875 . . . . 0.0 120.168 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.31 153.21 23.21 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.4 150.01 23.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.362 1.865 . . . . 0.0 109.985 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.84 117.01 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -101.99 110.86 22.94 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.87 -174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.331 50.5 m95 -70.08 154.79 41.5 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.156 1.931 . . . . 0.0 115.436 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 71' ' ' LYS . 9.9 mmpt? -107.52 -44.18 4.35 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.332 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -91.8 -8.54 46.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 t -152.47 136.61 16.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.359 2.264 . . . . 0.0 107.728 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -72.52 112.35 8.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.658 1.572 . . . . 0.0 110.441 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.1 p -165.98 169.99 14.11 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.011 1.724 . . . . 0.0 111.562 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -148.14 141.62 25.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 122.855 1.312 . . . . 0.0 111.241 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -137.11 124.06 21.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 110.945 -2.843 . . . . 0.0 110.198 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -101.3 154.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.426 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -127.23 142.31 51.51 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.163 0.985 . . . . 0.0 108.521 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 120.76 7.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.69 -166.12 28.17 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.552 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.85 146.15 50.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 124.671 0.865 . . . . 0.0 113.296 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 50.4 t -97.4 113.23 24.86 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.219 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HB2' HD12 ' D' ' 106' ' ' ILE . 18.1 m-85 -103.77 169.64 8.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.298 1.839 . . . . 0.0 111.743 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -125.44 112.14 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.01 161.59 8.19 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.801 0.441 . . . . 0.0 110.535 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -30.36 -57.11 0.2 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.397 1.879 . . . . 0.0 115.975 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.26 -15.51 63.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.01 1.724 . . . . 0.0 115.022 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.94 27.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.702 1.144 . . . . 0.0 114.77 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -78.93 144.32 34.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.739 1.616 . . . . 0.0 111.79 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -101.42 141.73 33.86 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.728 1.211 . . . . 0.0 111.708 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.8 m -144.02 160.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.777 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -119.45 116.92 27.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -107.28 111.92 24.52 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -133.28 172.0 13.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.125 1.441 . . . . 0.0 111.563 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.438 ' HG3' HG23 ' D' ' 113' ' ' THR . 90.8 mmm -124.78 169.22 12.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.431 -1.258 . . . . 0.0 107.794 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -139.94 162.03 36.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.045 1.402 . . . . 0.0 112.319 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.67 119.17 9.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.25 141.27 38.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 123.649 1.69 . . . . 0.0 110.42 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -125.62 113.91 18.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 110.172 -3.195 . . . . 0.0 109.746 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -77.09 156.94 31.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.982 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.87 82.87 2.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.427 HG11 ' H ' ' A' ' 105' ' ' ASP . 1.6 t -65.8 173.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.684 1.194 . . . . 0.0 111.978 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -117.87 -7.58 10.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.427 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -140.96 148.1 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.869 1.319 . . . . 0.0 110.33 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' D' ' 84' ' ' PHE . 15.7 tt -63.3 -26.28 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.862 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.04 -2.83 33.38 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 117.912 -1.493 . . . . 0.0 115.219 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.55 3.67 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.843 1.321 . . . . 0.0 113.459 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -35.38 61.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.959 -1.088 . . . . 0.0 111.577 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -50.13 -46.34 53.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.163 0.985 . . . . 0.0 113.402 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -14.71 42.65 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.372 -0.83 . . . . 0.0 112.728 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.81 -9.16 58.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.445 HG23 ' HG3' ' D' ' 96' ' ' MET . 61.9 m -95.24 155.97 16.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -154.05 124.15 6.87 Favored 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 126.822 2.049 . . . . 0.0 111.156 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.37 156.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 121.792 2.087 . . . . 0.0 110.203 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.18 -177.56 31.4 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 124.397 1.061 . . . . 0.0 115.023 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -123.67 152.23 42.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.114 0.966 . . . . 0.0 110.984 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -150.4 148.2 28.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.899 0.88 . . . . 0.0 110.67 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.3 mt -132.27 122.94 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.082 -1.011 . . . . 0.0 109.294 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -113.87 153.94 28.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.013 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.0 p -135.73 164.27 28.28 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.307 1.043 . . . . 0.0 110.796 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -57.74 117.7 4.51 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.444 1.098 . . . . 0.0 110.41 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.57 0 O-C-N 122.228 -0.295 . . . . 0.0 110.606 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttt . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 131.36 56.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.752 1.263 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.77 127.58 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.908 2.083 . . . . 0.0 106.042 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.22 -28.87 62.42 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 124.414 1.071 . . . . 0.0 112.755 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -53.5 115.84 2.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.93 0.892 . . . . 0.0 110.508 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.72 -132.63 5.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.482 1.515 . . . . 0.0 109.392 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' D' ' 10' ' ' TRP . 16.0 ttmt -144.24 152.51 40.93 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . 0.43 ' H ' ' HG2' ' D' ' 9' ' ' LYS . 55.6 m95 -139.94 162.72 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.544 1.938 . . . . 0.0 111.476 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -139.9 146.95 39.9 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.354 1.062 . . . . 0.0 109.102 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -108.85 148.25 30.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.64 0.776 . . . . 0.0 111.546 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -25.37 59.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.692 1.197 . . . . 0.0 114.108 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 34.9 tp -73.3 -15.85 61.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.596 1.559 . . . . 0.0 113.269 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.04 -12.84 45.14 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.479 1.99 . . . . 0.0 113.89 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -67.96 145.63 54.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.94 1.37 . . . . 0.0 111.166 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -120.95 149.31 42.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.182 -0.949 . . . . 0.0 111.692 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -135.31 142.46 45.84 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.912 -0.493 . . . . 0.0 112.209 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -128.59 132.35 48.19 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.871 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.01 127.6 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.577 1.173 . . . . 0.0 112.307 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.27 134.6 29.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.851 -0.794 . . . . 0.0 110.632 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.02 131.91 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.679 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.71 156.45 38.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.778 1.231 . . . . 0.0 110.275 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 72.8 m -57.29 -23.04 45.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.09 -28.15 68.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.501 -0.75 . . . . 0.0 110.841 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.74 -4.35 34.39 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 125.302 1.429 . . . . 0.0 112.771 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.85 158.98 30.43 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.843 1.322 . . . . 0.0 113.32 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.09 166.36 33.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.71 0.767 . . . . 0.0 112.05 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -128.61 160.07 33.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.552 1.141 . . . . 0.0 108.801 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.93 -175.48 39.52 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 119.974 -1.108 . . . . 0.0 115.465 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 8.7 p -134.75 124.03 24.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.084 1.354 . . . . 0.0 107.927 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -125.3 131.24 53.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.638 -172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.4 HG13 HD11 ' D' ' 46' ' ' LEU . 2.5 mp -123.37 129.67 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.926 0.87 . . . . 0.0 109.015 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.25 137.84 42.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.255 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.53 -6.92 26.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.4 136.87 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.056 0.931 . . . . 0.0 112.175 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.27 161.96 39.9 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.855 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.3 -25.45 54.84 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.715 -0.616 . . . . 0.0 110.555 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -146.85 79.81 9.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 127.277 2.231 . . . . 0.0 109.791 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.91 13.13 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.834 3.689 . . . . 0.0 117.992 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.48 -28.64 1.57 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 118.241 2.056 . . . . 0.0 118.241 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.71 54.77 0.17 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.203 1.502 . . . . 0.0 112.076 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.68 130.54 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.76 -1.213 . . . . 0.0 111.068 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 173.06 10.95 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.274 2.629 . . . . 0.0 108.894 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.4 HD11 HG13 ' D' ' 34' ' ' ILE 0.296 5.4 mp -67.72 131.11 44.96 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 61.1 m -98.31 117.98 64.08 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.762 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.26 137.86 78.06 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.694 1.596 . . . . 0.0 110.264 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -121.9 155.67 34.97 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.446 1.091 . . . . 0.0 110.662 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.62 149.03 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.319 1.848 . . . . 0.0 109.026 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.32 -157.42 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 O-C-N 121.158 -0.964 . . . . 0.0 111.021 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.56 147.06 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.03 0.919 . . . . 0.0 111.568 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.12 153.59 51.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.37 1.081 . . . . 0.0 112.969 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.37 157.55 17.56 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.389 1.09 . . . . 0.0 108.539 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 24.33 0.56 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.728 1.611 . . . . 0.0 111.358 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -93.48 -51.57 4.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.602 2.361 . . . . 0.0 111.318 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 172.26 8.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -69.11 -43.47 74.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 0.0 111.075 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.85 71.59 69.68 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.947 1.299 . . . . 0.0 110.851 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -69.86 169.29 19.38 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.076 3.184 . . . . 0.0 118.817 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 36.2 p -86.65 156.23 20.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.018 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' D' ' 83' ' ' CYS . 0.0 OUTLIER -152.62 173.99 14.52 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 123.981 1.848 . . . . 0.0 112.633 174.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.0 148.89 9.17 Favored Glycine 0 N--CA 1.412 -2.941 0 CA-C-N 109.213 -3.63 . . . . 0.0 119.748 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -159.59 153.09 22.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.55 151.3 23.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.601 1.96 . . . . 0.0 110.006 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.47 117.38 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.42 111.83 24.29 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.136 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.328 51.1 m95 -70.68 153.11 43.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 124.105 1.907 . . . . 0.0 115.61 -172.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' D' ' 71' ' ' LYS . 9.9 mmpt? -105.76 -43.46 4.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.188 -174.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -92.09 -8.65 45.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -152.58 136.51 16.32 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.204 2.202 . . . . 0.0 107.473 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.83 111.52 7.16 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.691 1.587 . . . . 0.0 110.368 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 93.0 p -165.07 170.73 14.72 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.778 1.631 . . . . 0.0 111.569 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -148.35 142.21 25.74 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.519 1.152 . . . . 0.0 111.586 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.13 123.65 20.9 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 111.25 -2.705 . . . . 0.0 110.357 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 m -100.8 154.04 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -127.21 142.08 51.57 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.01 0.924 . . . . 0.0 108.719 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 119.96 7.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.79 -166.75 27.4 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.132 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -133.56 147.07 51.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 125.051 1.089 . . . . 0.0 112.819 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . 0.405 ' HB2' ' CZ ' ' D' ' 64' ' ' PHE . 44.1 t -97.28 125.35 41.79 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 116.19 -1.862 . . . . 0.0 108.011 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.412 ' HB2' HD12 ' A' ' 106' ' ' ILE . 13.1 m-85 -114.51 172.03 7.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.921 1.689 . . . . 0.0 110.819 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mt -127.87 111.87 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.51 158.73 9.27 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -25.97 -55.16 0.06 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.212 2.205 . . . . 0.0 116.005 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -9.02 58.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.137 2.175 . . . . 0.0 116.001 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.8 51.1 3.51 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 120.082 1.31 . . . . 0.0 109.981 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -124.07 136.35 54.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.795 1.638 . . . . 0.0 109.119 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -101.06 139.82 36.22 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.903 1.335 . . . . 0.0 110.689 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.3 161.05 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.704 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.73 116.78 25.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -106.78 111.13 23.52 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -133.07 172.18 12.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 123.51 1.624 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.445 ' HG3' HG23 ' A' ' 113' ' ' THR . 90.4 mmm -124.92 169.06 12.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -139.26 162.22 35.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.56 1.648 . . . . 0.0 112.55 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 119.81 9.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.699 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.29 141.75 38.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.599 1.812 . . . . 0.0 110.442 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -126.0 113.87 17.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 109.999 -3.273 . . . . 0.0 109.895 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 2.6 t -77.84 158.19 29.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.286 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 56.6 m -105.22 77.62 1.32 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.68 0.752 . . . . 0.0 109.74 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 t -63.55 166.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.106 1.363 . . . . 0.0 112.595 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -112.44 -4.36 14.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.64 147.4 35.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.58 1.181 . . . . 0.0 110.373 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 84' ' ' PHE . 16.0 tt -63.36 -26.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.854 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.49 -3.03 30.66 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 117.659 -1.634 . . . . 0.0 115.432 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.26 3.49 10.34 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.806 1.303 . . . . 0.0 113.636 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.96 60.71 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.819 -1.176 . . . . 0.0 111.816 174.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -49.46 -46.83 48.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 -15.65 41.82 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.29 -0.881 . . . . 0.0 112.789 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 -7.76 53.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 96' ' ' MET . 57.2 m -96.54 154.88 17.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.021 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.19 124.3 7.47 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.627 1.971 . . . . 0.0 111.195 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.52 156.23 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 121.699 2.045 . . . . 0.0 110.047 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -178.6 31.68 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.834 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.51 152.62 40.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.168 0.987 . . . . 0.0 110.83 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -150.61 147.36 27.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.937 0.875 . . . . 0.0 110.837 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.64 120.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.239 -0.913 . . . . 0.0 108.985 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -110.46 154.31 23.8 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.067 0.855 . . . . 0.0 111.539 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -136.68 161.95 34.51 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.378 1.071 . . . . 0.0 110.055 174.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -56.66 128.26 35.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.724 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.408 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 tttt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 132.22 56.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.453 1.101 . . . . 0.0 111.391 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.27 127.64 19.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.847 2.059 . . . . 0.0 106.439 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.66 -30.82 64.6 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.84 117.3 2.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.929 0.892 . . . . 0.0 110.733 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.28 -130.49 4.83 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.755 1.645 . . . . 0.0 109.662 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' B' ' 10' ' ' TRP . 15.1 ttmt -145.25 152.83 40.58 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . 0.424 ' H ' ' HG2' ' B' ' 9' ' ' LYS . 58.0 m95 -138.76 162.73 33.99 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.753 2.021 . . . . 0.0 111.275 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -143.51 145.0 32.21 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.903 0.881 . . . . 0.0 109.195 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -109.7 146.55 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.887 0.875 . . . . 0.0 111.83 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -25.87 53.38 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.21 -16.54 61.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.479 1.512 . . . . 0.0 113.075 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 -12.94 29.98 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.964 2.221 . . . . 0.0 114.033 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -69.0 142.96 54.49 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.836 -1.391 . . . . 0.0 111.993 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.42 143.31 45.72 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.829 -1.169 . . . . 0.0 110.657 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -133.24 139.23 46.84 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.946 -0.471 . . . . 0.0 112.053 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -126.51 132.6 51.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.871 0.868 . . . . 0.0 108.74 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.9 mt -129.05 127.2 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -91.06 0.07 OUTLIER Glycine 0 CA--C 1.528 0.9 0 O-C-N 124.87 1.356 . . . . 0.0 112.096 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.32 135.35 32.12 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.863 -0.787 . . . . 0.0 110.865 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.94 133.61 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.223 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.9 158.26 36.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.358 1.063 . . . . 0.0 110.993 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 64.7 m -57.87 -24.31 57.01 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.753 -1.217 . . . . 0.0 114.021 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -66.15 -29.25 69.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.453 -0.779 . . . . 0.0 110.729 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.19 34.63 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 117.918 -1.49 . . . . 0.0 112.933 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.85 154.15 39.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.798 1.799 . . . . 0.0 111.535 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.35 154.16 31.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -116.78 156.43 27.23 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 109.573 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.62 -176.18 38.1 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.691 1.162 . . . . 0.0 115.02 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -134.87 123.97 24.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 113.259 -1.471 . . . . 0.0 107.298 -174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -124.72 131.29 53.47 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.724 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.418 HG13 HD11 ' B' ' 46' ' ' LEU . 2.4 mp -123.72 129.57 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 122.09 0.948 . . . . 0.0 108.597 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.02 141.23 36.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.251 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.97 21.6 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.96 136.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.201 1.0 . . . . 0.0 111.797 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.94 162.2 39.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.241 -0.912 . . . . 0.0 110.999 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.02 -27.45 60.1 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.445 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.09 80.36 10.33 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.214 2.205 . . . . 0.0 109.758 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.64 12.94 0.23 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.722 3.615 . . . . 0.0 118.073 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.0 -28.97 1.38 Allowed Glycine 0 CA--C 1.54 1.621 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -163.25 53.29 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.152 1.476 . . . . 0.0 112.361 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.74 130.54 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 120.782 -1.199 . . . . 0.0 111.358 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 173.5 10.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.049 2.54 . . . . 0.0 108.945 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.418 HD11 HG13 ' B' ' 34' ' ' ILE 0.292 5.4 mp -67.71 131.51 45.72 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.6 m -99.22 117.69 63.67 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.418 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -54.61 138.85 75.92 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.665 1.577 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.5 148.47 46.22 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.248 0.967 . . . . 0.0 110.641 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.66 148.85 33.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.402 2.281 . . . . 0.0 108.646 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.52 -159.09 32.12 Favored Glycine 0 N--CA 1.443 -0.898 0 O-C-N 120.319 -1.488 . . . . 0.0 109.464 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 mt -145.41 147.58 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.784 0.834 . . . . 0.0 111.473 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -133.15 153.99 51.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 122.409 1.099 . . . . 0.0 113.859 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -91.9 157.09 17.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.549 1.166 . . . . 0.0 108.892 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.38 25.09 0.47 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.018 1.727 . . . . 0.0 111.55 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -93.64 -52.16 4.6 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.601 2.36 . . . . 0.0 112.123 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.97 171.86 8.77 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.7 t -69.65 -42.22 74.51 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.747 0.819 . . . . 0.0 111.161 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 69.32 72.68 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.499 1.12 . . . . 0.0 110.931 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.88 169.14 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.003 3.136 . . . . 0.0 118.454 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -86.44 157.24 19.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.063 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' B' ' 83' ' ' CYS . 0.0 OUTLIER -153.21 174.28 14.47 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 124.18 1.943 . . . . 0.0 112.353 174.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.28 149.11 9.22 Favored Glycine 0 N--CA 1.411 -2.992 0 CA-C-N 109.065 -3.698 . . . . 0.0 120.046 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -159.12 153.48 23.99 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.47 149.94 23.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.984 1.714 . . . . 0.0 109.984 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 117.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 173.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -102.11 110.81 22.87 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.799 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.334 49.9 m95 -70.08 155.54 40.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.958 1.837 . . . . 0.0 115.396 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' B' ' 71' ' ' LYS . 9.8 mmpt? -108.54 -44.26 4.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.355 -1.748 . . . . 0.0 114.143 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -91.18 -8.74 47.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.23 1.012 . . . . 0.0 113.691 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -152.38 137.05 16.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.31 2.244 . . . . 0.0 107.36 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.64 111.77 8.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.497 1.498 . . . . 0.0 110.715 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 93.3 p -165.31 169.92 15.28 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.077 1.751 . . . . 0.0 111.635 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.68 141.87 26.13 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.21 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -137.62 123.82 20.48 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.216 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.95 154.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.536 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.24 141.93 51.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 108.676 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.62 119.86 7.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.55 -167.4 29.12 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.412 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -133.56 146.37 50.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.078 -1.061 . . . . 0.0 112.618 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' B' ' 64' ' ' PHE . 41.4 t -97.37 122.0 39.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.087 173.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -111.37 172.49 6.85 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.714 1.606 . . . . 0.0 110.669 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mt -128.41 113.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.97 162.47 6.96 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -30.12 -52.53 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.744 2.017 . . . . 0.0 115.772 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -78.35 -0.7 30.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.393 2.277 . . . . 0.0 116.978 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 50.94 6.87 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.439 -1.413 . . . . 0.0 110.505 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -119.91 141.89 49.2 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.514 2.326 . . . . 0.0 105.432 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -111.38 138.5 47.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.265 1.426 . . . . 0.0 110.99 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.6 m -144.3 161.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.686 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -121.04 118.2 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -108.03 111.55 23.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -133.46 171.91 13.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.066 1.412 . . . . 0.0 111.971 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.444 ' HG3' HG23 ' C' ' 113' ' ' THR . 90.6 mmm -124.63 169.32 12.05 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -139.67 162.02 36.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.489 1.614 . . . . 0.0 112.644 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.58 119.65 9.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.017 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 141.54 38.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 123.677 1.703 . . . . 0.0 110.578 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -126.26 114.0 17.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 110.121 -3.218 . . . . 0.0 110.162 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -78.23 156.65 29.64 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.616 1.198 . . . . 0.0 110.824 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.73 82.45 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.404 ' CG2' ' HB1' ' B' ' 112' ' ' ALA . 1.6 t -66.32 172.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.94 1.296 . . . . 0.0 111.815 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -119.2 -2.77 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.25 146.4 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.346 1.07 . . . . 0.0 111.06 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' C' ' 84' ' ' PHE . 14.8 tt -63.57 -26.88 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.958 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.63 -3.62 34.86 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.979 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.16 3.55 10.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.712 1.256 . . . . 0.0 113.271 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -36.13 62.12 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.041 -1.037 . . . . 0.0 111.575 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -48.68 -46.79 40.9 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 -16.06 38.71 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.267 -0.895 . . . . 0.0 112.673 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . 0.404 ' HB1' ' CG2' ' B' ' 103' ' ' VAL . . . -72.25 -8.34 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.429 HG23 ' HG3' ' C' ' 96' ' ' MET . 57.6 m -96.38 156.65 16.25 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.697 0.399 . . . . 0.0 110.227 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ttm-85 -154.27 124.52 6.89 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 126.933 2.093 . . . . 0.0 111.366 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 p -105.63 156.18 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 121.832 2.105 . . . . 0.0 110.166 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.88 -178.0 31.52 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.232 0.958 . . . . 0.0 114.83 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -123.02 152.72 40.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.285 1.034 . . . . 0.0 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -150.61 146.25 26.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.008 0.908 . . . . 0.0 111.331 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.64 119.14 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.082 -1.011 . . . . 0.0 108.67 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.63 154.45 21.97 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.281 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 20.3 p -138.02 164.16 29.78 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.379 1.072 . . . . 0.0 109.645 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.99 123.72 16.14 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.547 0.837 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.039 174.74 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 tttt . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 131.49 56.92 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.924 1.345 . . . . 0.0 110.077 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.61 127.52 22.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' C' ' 64' ' ' PHE . 2.7 mt -73.41 -27.56 61.52 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.414 1.071 . . . . 0.0 112.844 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -53.61 117.28 3.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.861 0.838 . . . . 0.0 110.368 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.98 -130.27 4.79 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.719 1.628 . . . . 0.0 109.525 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' C' ' 10' ' ' TRP . 19.7 ttmt -142.46 151.13 41.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.808 1.29 . . . . 0.0 113.288 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' C' ' 9' ' ' LYS . 50.0 m95 -136.18 162.69 32.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 112.469 -2.15 . . . . 0.0 110.816 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -142.84 142.51 31.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.65 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' C' ' 14' ' ' LEU . 4.2 t30 -108.36 148.06 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.918 0.887 . . . . 0.0 112.529 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -27.9 61.74 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.316 1.446 . . . . 0.0 114.365 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.414 ' H ' ' ND2' ' C' ' 12' ' ' ASN . 33.9 tp -72.34 -15.9 61.87 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.393 1.477 . . . . 0.0 113.176 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -14.34 29.51 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.153 2.311 . . . . 0.0 113.645 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.636 1.218 . . . . 0.0 111.29 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -118.49 144.48 45.98 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.264 -0.897 . . . . 0.0 111.061 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -133.79 141.46 47.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.998 0.428 . . . . 0.0 111.63 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 5.9 m -129.73 132.12 46.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.79 127.37 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.57 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.867 1.354 . . . . 0.0 112.18 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.41 135.12 30.05 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.605 -0.938 . . . . 0.0 110.649 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.71 131.67 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.807 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.46 156.37 39.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.791 1.237 . . . . 0.0 110.229 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -57.29 -23.05 46.0 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -66.05 -28.49 68.88 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.531 -0.731 . . . . 0.0 110.797 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.83 -3.94 34.11 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.167 1.365 . . . . 0.0 112.724 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -77.05 158.76 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.71 1.255 . . . . 0.0 113.316 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.02 166.32 33.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.485 0.659 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.7 160.16 33.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.709 1.203 . . . . 0.0 108.702 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.22 -175.5 39.72 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 119.961 -1.114 . . . . 0.0 115.435 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 9.0 p -134.7 123.96 24.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.811 1.244 . . . . 0.0 107.702 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -125.09 130.56 52.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.612 -171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.413 HG13 HD11 ' C' ' 46' ' ' LEU . 2.3 mp -122.9 129.48 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 CA-C-O 121.932 0.872 . . . . 0.0 108.833 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -104.99 140.31 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.996 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.56 -6.39 22.87 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.64 136.93 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.025 0.93 . . . . 0.0 111.645 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.76 162.21 39.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.985 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.98 -27.49 60.18 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -145.78 80.42 10.57 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.989 2.116 . . . . 0.0 109.766 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.85 13.44 0.22 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.835 3.69 . . . . 0.0 118.044 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.71 -28.62 1.7 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.21 53.39 0.18 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.093 1.447 . . . . 0.0 112.037 -174.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -56.84 130.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.914 -1.116 . . . . 0.0 111.087 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.53 172.27 11.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.109 2.564 . . . . 0.0 109.115 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.413 HD11 HG13 ' C' ' 34' ' ' ILE 0.299 5.4 mp -66.95 130.45 43.2 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 59.4 m -98.08 118.15 64.07 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.977 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -55.0 138.65 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.643 1.562 . . . . 0.0 110.061 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -122.53 155.72 35.65 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.331 1.019 . . . . 0.0 110.852 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.38 149.08 25.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.014 1.726 . . . . 0.0 108.799 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.58 29.78 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 119.353 0.979 . . . . 0.0 111.033 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.42 147.0 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.057 0.932 . . . . 0.0 111.938 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.57 154.0 51.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.221 1.008 . . . . 0.0 113.225 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -90.67 159.06 16.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.435 1.112 . . . . 0.0 108.765 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 25.05 0.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.689 1.596 . . . . 0.0 111.57 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -93.36 -51.87 4.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.831 2.453 . . . . 0.0 111.328 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 171.96 10.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -71.08 -41.95 70.01 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.665 0.745 . . . . 0.0 110.955 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.56 67.76 80.32 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.405 1.082 . . . . 0.0 111.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -69.69 170.23 16.99 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.902 3.068 . . . . 0.0 118.268 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 41.7 p -86.63 156.42 20.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.903 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.0 OUTLIER -153.58 173.7 15.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.728 1.728 . . . . 0.0 112.762 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.51 148.49 9.12 Favored Glycine 0 N--CA 1.412 -2.927 0 CA-C-N 109.351 -3.568 . . . . 0.0 119.528 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -159.47 153.18 22.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -87.85 150.94 23.22 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.333 1.853 . . . . 0.0 110.021 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.78 117.13 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -102.39 111.47 23.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.969 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.33 49.9 m95 -70.45 154.7 41.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 124.199 1.952 . . . . 0.0 115.448 -172.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' C' ' 71' ' ' LYS . 9.9 mmpt? -107.54 -43.79 4.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.221 -1.809 . . . . 0.0 114.145 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.79 -8.42 46.77 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.57 136.7 16.48 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.286 2.235 . . . . 0.0 107.448 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -72.53 111.21 7.5 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.556 1.525 . . . . 0.0 110.829 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -165.1 170.07 15.45 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 125.879 1.672 . . . . 0.0 111.441 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -147.8 141.92 26.06 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 122.901 1.334 . . . . 0.0 111.264 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -137.04 124.36 21.91 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 110.88 -2.873 . . . . 0.0 110.387 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 m -101.81 154.31 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.555 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.19 142.32 51.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.102 0.961 . . . . 0.0 108.419 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.09 120.16 7.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.3 -167.31 28.75 Favored Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.11 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.58 146.67 51.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 125.171 1.159 . . . . 0.0 112.656 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 44.7 t -97.23 125.56 41.85 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 115.66 -2.114 . . . . 0.0 108.009 174.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' B' ' 106' ' ' ILE . 13.8 m-85 -114.4 171.27 7.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.928 1.691 . . . . 0.0 110.614 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.03 110.77 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.26 157.67 13.04 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -23.45 -57.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.978 2.111 . . . . 0.0 116.53 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.0 -14.18 62.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.91 20.95 10.66 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.031 0.824 . . . . 0.0 113.68 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -91.09 142.28 27.93 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.849 1.325 . . . . 0.0 110.296 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -101.47 139.46 37.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.281 1.032 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 22.8 m -142.17 161.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.179 1.392 . . . . 0.0 110.057 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 14.8 mt -119.26 116.92 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -107.43 110.76 22.79 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -132.34 171.51 13.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 123.24 1.495 . . . . 0.0 111.862 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.429 ' HG3' HG23 ' B' ' 113' ' ' THR . 91.2 mmm -124.68 169.07 12.32 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -139.36 162.33 35.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 123.378 1.561 . . . . 0.0 112.658 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.76 119.48 9.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.069 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.74 38.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.465 1.602 . . . . 0.0 110.403 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -126.14 113.9 17.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 110.346 -3.116 . . . . 0.0 109.762 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -77.11 156.48 31.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.032 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 52.6 m -103.05 83.14 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.52 172.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.472 1.109 . . . . 0.0 111.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -118.04 -5.21 10.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.93 148.01 37.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.73 1.252 . . . . 0.0 110.202 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.61 -25.73 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.02 -1.446 . . . . 0.0 112.909 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.15 -1.75 36.05 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.579 -1.123 . . . . 0.0 115.393 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.25 3.09 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.287 1.044 . . . . 0.0 113.54 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.91 60.52 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.2 -0.938 . . . . 0.0 111.556 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -50.28 -46.35 55.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.137 0.975 . . . . 0.0 113.565 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -15.12 41.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.158 -0.964 . . . . 0.0 112.577 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.54 -8.12 54.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' THR . . . . . 0.444 HG23 ' HG3' ' B' ' 96' ' ' MET . 62.2 m -96.63 155.12 16.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.675 0.39 . . . . 0.0 110.044 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttm-85 -153.04 124.02 7.43 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 126.931 2.092 . . . . 0.0 111.208 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.09 156.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 121.77 2.077 . . . . 0.0 110.091 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -177.54 31.46 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.206 0.941 . . . . 0.0 114.962 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -123.85 152.41 42.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.276 1.03 . . . . 0.0 110.908 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -150.43 147.0 27.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.936 0.895 . . . . 0.0 111.187 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.97 121.77 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -112.93 153.47 27.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.683 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.7 p -134.13 162.55 31.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.106 0.962 . . . . 0.0 110.317 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -55.5 121.77 9.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.948 0.899 . . . . 0.0 109.691 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.921 178.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -124.09 129.2 50.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.077 0.941 . . . . 0.0 110.963 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -139.61 127.5 22.11 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.248 -1.532 . . . . 0.0 114.279 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.448 HD21 ' CE2' ' A' ' 64' ' ' PHE . 21.1 mt -55.51 -32.84 63.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -54.83 122.02 9.87 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.724 1.249 . . . . 0.0 110.932 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.25 -108.31 0.87 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.512 2.006 . . . . 0.0 111.696 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.12 144.0 20.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -140.76 162.79 34.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.327 1.851 . . . . 0.0 110.632 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -141.71 151.44 42.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.237 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 120' ' ' PHE . 4.6 t30 -116.42 146.31 42.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.376 1.071 . . . . 0.0 112.521 -173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.49 -23.67 64.69 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 tp -71.58 -15.7 62.28 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.703 -1.248 . . . . 0.0 112.115 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.82 -14.35 24.34 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 128.382 2.896 . . . . 0.0 113.686 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p -63.31 144.27 57.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.456 1.128 . . . . 0.0 112.987 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.509 HD22 HD12 ' A' ' 34' ' ' ILE . 6.2 p30 -115.66 140.34 49.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -130.71 139.81 50.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.545 0.688 . . . . 0.0 111.084 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.7 m -129.0 131.52 47.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.21 127.02 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.51 -88.4 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.299 1.0 . . . . 0.0 111.553 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.24 42.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.863 0.839 . . . . 0.0 112.426 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 t -98.14 123.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.017 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.22 156.0 38.51 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 m -55.21 -22.01 16.14 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -72.32 -37.78 68.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.359 0.664 . . . . 0.0 111.237 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.31 -2.66 18.64 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 117.336 -1.813 . . . . 0.0 113.422 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.26 137.44 53.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.928 1.691 . . . . 0.0 107.079 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.25 148.19 25.61 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.16 163.58 15.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.192 0.997 . . . . 0.0 109.374 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.35 -168.0 34.59 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 120.947 -1.095 . . . . 0.0 113.165 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -141.54 129.69 22.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.965 1.364 . . . . 0.0 110.831 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.64 141.02 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.019 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.509 HD12 HD22 ' A' ' 17' ' ' ASN . 7.9 mt -131.93 128.75 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.375 1.083 . . . . 0.0 108.53 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.3 m -105.65 133.76 49.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.615 -1.175 . . . . 0.0 113.073 -173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.26 -17.87 23.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.74 142.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.831 1.252 . . . . 0.0 111.83 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.98 153.81 40.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.028 -1.045 . . . . 0.0 111.268 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.54 -24.25 66.35 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -147.88 76.56 10.53 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 128.518 2.727 . . . . 0.0 112.053 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.03 169.56 18.97 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.169 2.579 . . . . 0.0 112.431 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.88 -29.55 1.55 Allowed Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.473 1.035 . . . . 0.0 113.078 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.06 2.89 3.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.559 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -31.83 112.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.151 1.78 . . . . 0.0 114.354 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 157.78 41.59 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.556 1.543 . . . . 0.0 110.879 -176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.72 115.51 1.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.021 2.928 . . . . 0.0 111.623 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 t -103.48 117.06 60.97 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.454 1.102 . . . . 0.0 109.933 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 144.22 82.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.27 2.647 . . . . 0.0 112.552 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.71 155.08 45.64 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.673 0.789 . . . . 0.0 111.863 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -159.75 147.61 17.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.164 1.785 . . . . 0.0 112.296 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.17 -151.55 21.91 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 120.786 1.63 . . . . 0.0 110.954 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.24 137.86 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 113.135 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -120.95 141.03 51.05 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.15 -50.47 71.72 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.503 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.92 14.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 127.395 2.278 . . . . 0.0 116.852 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.76 -47.08 6.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.515 2.726 . . . . 0.0 115.103 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.76 -174.11 2.46 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.319 1.012 . . . . 0.0 111.63 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -83.43 -36.72 24.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -124.41 56.67 12.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.667 1.187 . . . . 0.0 110.497 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.02 164.04 37.16 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.884 3.056 . . . . 0.0 116.309 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.5 p -82.21 167.79 18.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.95 1.3 . . . . 0.0 111.383 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -159.13 162.29 36.43 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.818 -1.176 . . . . 0.0 112.961 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.86 139.24 5.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 118.731 -1.7 . . . . 0.0 117.053 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -163.0 151.73 14.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 m -88.29 148.98 24.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.562 1.945 . . . . 0.0 110.549 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -126.02 117.72 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -97.33 105.4 17.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.147 0.579 . . . . 0.0 112.376 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -74.76 147.99 40.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -110.7 -45.71 3.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.165 -1.38 . . . . 0.0 114.647 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -80.86 -11.3 59.61 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -152.53 133.24 13.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.789 2.436 . . . . 0.0 105.838 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.26 118.52 14.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.695 1.134 . . . . 0.0 111.2 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -178.52 167.15 1.82 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-O 123.625 1.679 . . . . 0.0 110.895 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 t -144.69 144.71 31.36 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.123 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -140.7 131.71 26.19 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 110.15 -3.205 . . . . 0.0 110.312 -172.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.7 143.63 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.06 143.74 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 116.78 9.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.98 -176.13 24.37 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 119.389 -1.386 . . . . 0.0 115.625 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -123.17 147.8 46.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.702 -1.249 . . . . 0.0 111.059 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 39.0 t -96.88 120.81 37.91 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.651 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.24 166.9 11.34 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.731 1.213 . . . . 0.0 114.089 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.01 110.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.01 154.18 16.08 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -33.63 -41.97 0.1 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.619 1.968 . . . . 0.0 115.97 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -13.96 60.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 50.36 2.83 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.44 137.61 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.449 1.9 . . . . 0.0 109.492 174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -101.28 148.24 25.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.004 2.121 . . . . 0.0 112.164 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -152.09 155.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.606 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.04 105.92 10.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HE3' HD13 ' A' ' 119' ' ' ILE . 3.0 mmtt -98.33 119.33 36.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 p -130.35 162.5 28.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.346 1.546 . . . . 0.0 112.632 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.96 162.78 14.49 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -136.84 161.38 36.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.134 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.57 121.57 10.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 113.248 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.76 142.23 38.1 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.923 1.344 . . . . 0.0 112.241 -175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -127.99 113.95 16.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 111.798 -2.455 . . . . 0.0 112.524 -174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.25 0.4 OUTLIER -71.95 165.68 23.71 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 125.269 1.606 . . . . 0.0 110.549 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -113.26 79.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.19 175.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 121.524 -0.735 . . . . 0.0 110.529 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -22.89 15.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.08 150.32 43.32 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 123.156 1.455 . . . . 0.0 112.678 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.3 -27.57 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.141 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.87 9.32 24.85 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.959 0.79 . . . . 0.0 113.934 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -120.59 -0.41 10.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.328 1.051 . . . . 0.0 112.187 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -32.0 70.53 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.646 -1.284 . . . . 0.0 113.408 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.86 -44.91 59.67 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.911 1.684 . . . . 0.0 112.652 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -93.26 -10.63 34.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.332 1.053 . . . . 0.0 113.002 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.42 9.34 1.75 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.372 -0.83 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.9 m -117.45 139.3 51.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.853 0.861 . . . . 0.0 113.195 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.51 116.18 12.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 127.414 2.286 . . . . 0.0 111.281 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.68 152.91 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.725 1.148 . . . . 0.0 110.177 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.32 -174.24 31.97 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.56 154.66 44.91 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.705 -0.879 . . . . 0.0 112.195 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -146.71 152.63 39.15 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.815 1.246 . . . . 0.0 109.736 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.9 mt -136.46 119.01 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 12' ' ' ASN . 21.1 m-85 -109.68 149.38 29.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.331 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -134.74 163.32 30.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -56.82 119.91 7.0 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.845 0.858 . . . . 0.0 110.964 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 123' ' ' LEU . 10.4 tt . . . . . 0 C--O 1.241 0.609 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 22.5 p -136.48 130.41 32.53 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.693 0.758 . . . . 0.0 111.501 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -139.77 129.51 24.57 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.4 -1.437 . . . . 0.0 114.56 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . 0.458 HD21 ' CE2' ' D' ' 64' ' ' PHE . 20.7 mt -56.89 -32.16 65.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -55.58 119.71 6.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.968 1.366 . . . . 0.0 111.744 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.94 -116.5 1.99 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.203 1.859 . . . . 0.0 110.819 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.7 146.43 30.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -174.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -141.57 161.92 36.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.232 1.413 . . . . 0.0 111.077 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.2 148.14 37.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -113.03 147.64 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.362 1.065 . . . . 0.0 112.599 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.74 -23.47 64.96 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.08 -14.47 61.4 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.477 1.511 . . . . 0.0 112.257 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.11 -12.92 34.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.857 2.646 . . . . 0.0 113.913 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.47 148.68 50.09 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.584 1.192 . . . . 0.0 112.824 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . 0.526 HD22 HD12 ' D' ' 34' ' ' ILE . 5.8 p30 -121.66 143.08 49.54 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.58 0.752 . . . . 0.0 110.543 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -132.07 139.88 48.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.605 0.717 . . . . 0.0 111.849 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -127.74 132.78 49.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.74 123.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.42 -79.95 0.24 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.346 1.029 . . . . 0.0 111.78 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.24 42.09 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.848 -0.795 . . . . 0.0 112.084 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -100.53 125.25 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.616 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -69.46 156.7 38.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 20.1 m -55.88 -21.7 21.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -70.75 -35.73 72.78 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.688 0.676 . . . . 0.0 111.283 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.95 -1.39 21.27 Favored Glycine 0 N--CA 1.469 0.9 0 C-N-CA 124.52 1.057 . . . . 0.0 112.95 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.89 149.81 44.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 110.717 173.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.15 163.86 39.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.034 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -125.81 167.69 14.85 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.4 -166.49 33.12 Favored Glycine 0 N--CA 1.467 0.74 0 O-C-N 120.031 -1.668 . . . . 0.0 113.201 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -140.32 132.1 27.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.772 1.273 . . . . 0.0 111.539 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.5 139.1 50.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.463 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.526 HD12 HD22 ' D' ' 17' ' ' ASN . 7.8 mt -129.97 131.48 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.84 0.829 . . . . 0.0 108.789 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 7.7 m -109.32 134.78 51.37 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 -19.22 21.55 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.38 141.54 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.892 1.277 . . . . 0.0 112.161 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.38 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.947 -1.096 . . . . 0.0 111.333 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.99 -24.08 66.7 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -147.91 76.72 10.45 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 128.536 2.734 . . . . 0.0 112.041 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.25 169.35 19.73 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.181 2.587 . . . . 0.0 112.517 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.87 -29.18 1.56 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.574 1.083 . . . . 0.0 113.123 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.29 2.87 3.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.736 -1.126 . . . . 0.0 113.533 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 50.8 mt -32.36 113.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 114.242 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.73 157.96 41.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.55 1.54 . . . . 0.0 110.747 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 tp -47.48 115.36 1.1 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.712 2.805 . . . . 0.0 111.074 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.25 117.15 60.93 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.853 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.02 143.03 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.867 2.378 . . . . 0.0 112.272 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -128.48 163.76 24.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.87 0.868 . . . . 0.0 112.209 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -169.07 149.01 4.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.249 1.42 . . . . 0.0 113.842 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 -150.96 21.56 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 120.883 1.674 . . . . 0.0 111.315 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.32 135.35 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.965 0.906 . . . . 0.0 111.705 -174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -120.16 140.18 51.5 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 110.113 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.21 -50.0 74.86 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.436 -0.79 . . . . 0.0 111.525 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.09 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.67 2.388 . . . . 0.0 116.634 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.94 -46.64 7.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.386 2.675 . . . . 0.0 115.053 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.25 -175.43 3.67 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.26 0.975 . . . . 0.0 112.512 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 40.8 t -81.67 -35.28 30.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.561 0.745 . . . . 0.0 111.576 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.29 58.56 31.44 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 125.041 1.336 . . . . 0.0 111.033 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.91 163.34 38.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.742 2.962 . . . . 0.0 117.317 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -81.63 168.08 18.53 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.197 1.399 . . . . 0.0 111.569 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . 0.458 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -159.12 162.26 36.44 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.736 -1.227 . . . . 0.0 112.967 174.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.0 139.08 5.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 118.873 -1.632 . . . . 0.0 116.871 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.89 153.12 16.26 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -89.11 151.61 22.12 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 127.601 2.36 . . . . 0.0 110.325 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 32.1 t -129.25 119.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -99.2 105.15 17.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.242 0.617 . . . . 0.0 112.004 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -74.34 147.27 42.38 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -110.1 -45.12 3.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.099 -1.409 . . . . 0.0 114.554 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.67 -11.16 59.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.55 132.91 13.68 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.881 2.473 . . . . 0.0 105.671 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.3 118.49 15.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.808 1.185 . . . . 0.0 111.193 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.79 166.55 1.68 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.94 1.696 . . . . 0.0 111.116 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 t -143.96 144.63 31.78 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.217 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 133.25 29.25 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 109.975 -3.284 . . . . 0.0 109.797 -172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.85 143.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.682 0.614 . . . . 0.0 109.548 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -116.3 143.91 44.92 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.7 116.55 8.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.45 -175.72 23.53 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.669 -1.253 . . . . 0.0 115.757 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.42 147.41 47.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.438 -1.381 . . . . 0.0 110.776 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.16 123.61 40.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.872 1.358 . . . . 0.0 110.624 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -116.65 163.02 16.75 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -130.16 110.4 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.96 157.44 9.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -36.22 -40.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.445 1.898 . . . . 0.0 115.578 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -78.2 -10.23 59.55 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.14 51.03 4.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.057 0.836 . . . . 0.0 111.633 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.5 147.08 46.78 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 129.107 2.963 . . . . 0.0 107.401 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -112.73 152.63 28.85 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 120.267 1.394 . . . . 0.0 111.279 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -153.37 158.3 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.516 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 mt -121.17 108.13 13.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . 0.474 ' HE3' HD13 ' D' ' 119' ' ' ILE . 2.8 mmtt -100.76 117.67 35.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -129.28 163.08 26.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.608 1.671 . . . . 0.0 112.88 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.12 162.54 14.8 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 170.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -136.55 161.51 35.68 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.879 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.59 121.94 10.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.298 -1.774 . . . . 0.0 113.05 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 141.76 38.52 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.859 1.314 . . . . 0.0 112.556 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -126.98 114.06 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 111.731 -2.486 . . . . 0.0 112.303 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.63 165.62 23.57 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 125.039 1.462 . . . . 0.0 110.557 173.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 8.3 t -113.53 77.11 1.02 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.82 176.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.23 -22.81 15.45 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.95 150.0 41.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 123.088 1.423 . . . . 0.0 112.914 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.57 -28.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.442 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 9.01 21.35 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.202 0.906 . . . . 0.0 113.961 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.45 -1.81 10.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.556 1.142 . . . . 0.0 111.878 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -31.45 70.27 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.394 -1.441 . . . . 0.0 113.279 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.62 -46.23 58.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.579 1.552 . . . . 0.0 112.52 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -91.73 -10.94 38.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.27 1.028 . . . . 0.0 112.832 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 8.75 2.08 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.605 -0.684 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 19.5 m -116.42 139.22 50.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.986 0.914 . . . . 0.0 113.28 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.54 116.21 12.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.4 2.28 . . . . 0.0 111.151 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.66 152.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.825 1.193 . . . . 0.0 110.394 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.51 -173.83 31.67 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -127.77 154.92 44.83 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.679 -0.895 . . . . 0.0 112.266 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -147.41 151.19 36.07 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.457 1.103 . . . . 0.0 109.746 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . 0.474 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -135.69 119.18 24.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -111.12 151.72 27.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.566 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -137.4 167.64 21.22 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -61.69 125.61 24.41 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.586 -1.321 . . . . 0.0 113.246 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.164 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 24.9 p -139.68 127.96 22.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.623 0.769 . . . . 0.0 110.226 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -139.74 127.7 22.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.417 -1.427 . . . . 0.0 114.567 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.459 HD21 ' CE2' ' B' ' 64' ' ' PHE . 20.7 mt -55.62 -32.34 63.06 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -54.47 118.81 4.45 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.323 1.535 . . . . 0.0 111.732 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.14 -106.87 0.66 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.883 1.706 . . . . 0.0 111.302 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.27 146.58 21.51 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -140.71 162.84 34.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.548 1.539 . . . . 0.0 110.578 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -139.36 152.22 46.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -117.5 146.86 43.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 111.864 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -60.89 -22.12 63.99 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.7 tp -73.45 -14.19 61.2 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.959 1.304 . . . . 0.0 112.238 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.69 -13.32 35.39 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 128.069 2.747 . . . . 0.0 113.743 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 3.4 p -64.1 148.62 49.44 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.293 -1.122 . . . . 0.0 112.73 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.512 HD22 HD12 ' B' ' 34' ' ' ILE . 5.7 p30 -122.42 140.42 52.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.471 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -128.71 139.19 52.34 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.976 0.893 . . . . 0.0 111.793 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.93 131.93 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.016 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.39 126.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.4 -86.8 0.13 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.529 1.143 . . . . 0.0 111.531 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.36 154.15 42.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.916 0.865 . . . . 0.0 112.607 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.6 123.57 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.214 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -68.12 155.89 38.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.112 0.415 . . . . 0.0 109.916 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 20.3 m -54.99 -22.29 14.75 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -72.25 -37.42 69.11 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.636 0.653 . . . . 0.0 111.178 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -2.52 19.41 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-O 117.378 -1.79 . . . . 0.0 113.471 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.37 137.52 52.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.078 1.751 . . . . 0.0 107.112 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.31 147.75 25.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.05 162.66 16.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.39 1.076 . . . . 0.0 109.62 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.36 -167.48 33.21 Favored Glycine 0 CA--C 1.523 0.538 0 O-C-N 120.972 -1.08 . . . . 0.0 113.407 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -140.66 131.6 26.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.785 1.279 . . . . 0.0 110.952 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -114.42 138.73 50.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.792 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.512 HD12 HD22 ' B' ' 17' ' ' ASN . 7.6 mt -129.97 132.45 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 16.9 m -110.46 134.75 52.06 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.88 -18.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.59 141.71 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.88 1.272 . . . . 0.0 111.93 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.77 154.19 41.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.994 -1.066 . . . . 0.0 110.959 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.74 -24.55 66.24 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -148.12 76.61 10.29 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.577 2.751 . . . . 0.0 111.979 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.05 169.75 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.152 2.568 . . . . 0.0 112.566 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.82 -29.46 1.56 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.502 1.048 . . . . 0.0 113.158 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.02 2.73 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.512 1.125 . . . . 0.0 113.535 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 52.2 mt -31.9 113.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 126.164 1.786 . . . . 0.0 114.429 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.37 158.54 39.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.455 1.502 . . . . 0.0 110.84 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 tp -48.62 115.41 1.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.672 2.789 . . . . 0.0 111.139 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -103.65 117.79 59.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.944 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.27 144.4 82.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.197 2.598 . . . . 0.0 112.782 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.49 155.51 44.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.831 0.852 . . . . 0.0 111.84 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -160.37 147.65 16.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.183 1.793 . . . . 0.0 112.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.23 -151.53 21.87 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 120.789 1.631 . . . . 0.0 111.051 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.15 137.95 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.855 0.862 . . . . 0.0 113.176 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -121.0 141.1 51.05 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.098 -1.001 . . . . 0.0 110.706 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.81 -50.33 72.74 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.21 -0.931 . . . . 0.0 111.617 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 41.68 16.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 127.504 2.322 . . . . 0.0 116.907 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . 0.255 6.7 ptp180 -93.67 -46.19 7.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.948 2.499 . . . . 0.0 115.095 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 -175.33 4.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.318 1.011 . . . . 0.0 112.802 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -33.1 29.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.384 1.074 . . . . 0.0 111.45 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.03 57.51 30.59 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 124.849 1.26 . . . . 0.0 111.005 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.58 163.34 38.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.366 2.711 . . . . 0.0 117.078 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p -81.79 168.58 17.87 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -159.92 161.97 34.4 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.783 -1.198 . . . . 0.0 113.134 174.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.81 139.28 5.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 118.83 -1.652 . . . . 0.0 117.065 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -163.43 151.86 13.79 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.57 150.89 23.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.513 1.925 . . . . 0.0 110.771 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -127.85 117.75 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -97.63 104.24 16.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.254 0.622 . . . . 0.0 112.264 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.254 32.6 m95 -74.04 147.24 43.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -109.91 -46.05 3.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.461 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.89 -11.28 59.61 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -152.51 133.35 14.03 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.964 2.505 . . . . 0.0 106.055 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.46 118.58 15.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.028 1.285 . . . . 0.0 110.617 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -178.74 166.72 1.71 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.978 1.711 . . . . 0.0 110.952 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -144.38 144.79 31.59 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.273 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -140.53 132.95 28.46 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 110.341 -3.118 . . . . 0.0 110.043 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.05 143.33 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.04 143.85 44.55 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.719 0.637 . . . . 0.0 109.478 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.29 116.85 9.17 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.65 24.92 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.337 -1.411 . . . . 0.0 115.222 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -122.85 148.01 45.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.807 1.534 . . . . 0.0 110.426 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 t -97.04 124.54 41.06 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.255 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.09 164.57 14.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.6 mt -131.75 107.91 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -59.29 154.74 15.85 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -35.11 -41.17 0.14 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -11.91 59.88 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.34 52.63 3.34 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 122.199 0.888 . . . . 0.0 111.863 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.16 148.18 45.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 129.135 2.974 . . . . 0.0 105.023 173.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -114.13 150.81 33.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.362 1.465 . . . . 0.0 110.326 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.77 159.93 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.439 1.095 . . . . 0.0 110.398 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 mt -121.9 108.6 13.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . 0.455 ' HE3' HD13 ' B' ' 119' ' ' ILE . 2.6 mmtt -101.46 117.64 35.34 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 172.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -130.0 162.67 28.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.303 1.525 . . . . 0.0 112.463 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.22 163.03 14.35 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -137.04 161.42 36.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.075 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.59 121.6 10.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.303 -1.771 . . . . 0.0 113.203 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.69 142.34 37.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.947 1.356 . . . . 0.0 112.258 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -128.0 113.98 16.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 111.504 -2.589 . . . . 0.0 112.28 -174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.23 165.61 24.07 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 125.147 1.53 . . . . 0.0 110.19 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.9 t -113.69 77.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -66.28 177.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -100.83 -22.45 14.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.88 148.72 43.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 123.047 1.404 . . . . 0.0 112.648 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.24 -27.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.267 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.92 8.49 22.29 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.135 0.874 . . . . 0.0 113.782 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -120.89 -0.46 10.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.39 1.076 . . . . 0.0 112.535 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -31.78 69.86 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 120.785 -1.197 . . . . 0.0 113.466 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -50.25 -46.56 54.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.628 1.571 . . . . 0.0 112.406 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.13 -10.39 39.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.045 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.03 2.03 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.575 -0.703 . . . . 0.0 111.845 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 21.5 m -116.45 139.13 50.78 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.948 0.899 . . . . 0.0 113.158 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.27 116.15 13.17 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.589 2.356 . . . . 0.0 111.163 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.7 152.69 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.699 1.136 . . . . 0.0 110.235 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.19 -174.39 32.02 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.787 -0.831 . . . . 0.0 112.133 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -147.32 150.7 35.26 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.697 1.199 . . . . 0.0 109.571 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.455 HD13 ' HE3' ' B' ' 94' ' ' LYS . 12.4 mt -135.24 119.8 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -110.39 152.11 26.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.171 0.92 . . . . 0.0 109.535 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -136.67 165.79 25.08 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -56.87 136.14 55.77 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.786 -1.196 . . . . 0.0 113.179 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 25.1 p -143.09 125.95 16.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.726 0.81 . . . . 0.0 109.503 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -139.56 129.39 24.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.232 -1.543 . . . . 0.0 114.503 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' C' ' 64' ' ' PHE . 20.2 mt -56.38 -29.75 61.84 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -56.89 121.62 10.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 123.324 1.535 . . . . 0.0 111.643 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.13 -112.02 1.23 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.424 1.964 . . . . 0.0 110.582 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -149.12 147.73 28.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.744 0.818 . . . . 0.0 113.142 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -141.86 162.51 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.293 1.437 . . . . 0.0 110.474 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -140.76 150.76 43.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -115.02 146.42 41.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.103 0.961 . . . . 0.0 112.669 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.89 -21.31 63.2 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.69 -16.21 61.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.297 1.439 . . . . 0.0 112.19 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.45 -13.58 27.92 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.869 2.652 . . . . 0.0 113.984 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.88 149.17 50.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.688 1.244 . . . . 0.0 112.981 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.525 HD22 HD12 ' C' ' 34' ' ' ILE . 5.9 p30 -122.05 142.75 50.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.688 0.795 . . . . 0.0 110.754 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -131.4 139.51 49.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.447 0.641 . . . . 0.0 112.202 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -126.93 132.76 50.79 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.93 123.22 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -77.14 0.43 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.148 0.905 . . . . 0.0 111.908 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.82 157.44 42.93 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.77 0.795 . . . . 0.0 112.176 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 t -101.77 125.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.815 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -69.83 156.58 38.83 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -55.89 -21.69 21.58 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -70.38 -36.11 73.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.251 0.62 . . . . 0.0 111.337 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.04 -0.98 21.16 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 124.614 1.102 . . . . 0.0 112.899 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.67 149.74 43.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.696 0.799 . . . . 0.0 110.73 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -156.21 163.74 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.835 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 168.38 13.87 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.99 -166.86 34.03 Favored Glycine 0 N--CA 1.465 0.633 0 O-C-N 120.073 -1.642 . . . . 0.0 113.212 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -140.64 132.24 27.14 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 123.024 1.393 . . . . 0.0 111.454 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -117.04 138.5 51.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.872 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.525 HD12 HD22 ' C' ' 17' ' ' ASN . 7.5 mt -129.36 131.16 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m -109.53 134.93 51.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.322 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.63 -17.39 22.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.23 141.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.7 1.2 . . . . 0.0 112.099 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.66 154.51 41.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.39 -24.47 65.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -148.0 76.59 10.41 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 128.573 2.749 . . . . 0.0 111.965 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.11 169.39 19.48 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.231 2.62 . . . . 0.0 112.411 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.86 -29.33 1.56 Allowed Glycine 0 N--CA 1.474 1.206 0 C-N-CA 124.57 1.081 . . . . 0.0 113.138 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 2.93 3.32 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 117.656 -1.164 . . . . 0.0 113.529 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 52.4 mt -32.3 113.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.075 1.75 . . . . 0.0 114.311 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.03 158.1 41.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.72 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 tp -47.56 115.42 1.13 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.764 2.826 . . . . 0.0 111.132 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.2 117.23 60.79 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.998 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.13 142.92 85.92 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.877 2.385 . . . . 0.0 112.269 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.66 163.62 24.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.865 0.866 . . . . 0.0 112.311 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 27.4 tp -169.26 148.93 4.02 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 113.936 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.63 -151.07 21.78 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 120.928 1.695 . . . . 0.0 111.414 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.39 135.47 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.806 0.843 . . . . 0.0 111.543 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -119.73 140.68 50.32 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.765 1.226 . . . . 0.0 109.921 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.0 -50.34 72.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.487 -0.758 . . . . 0.0 111.388 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.68 15.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.64 2.376 . . . . 0.0 116.456 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.67 -45.83 7.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.281 2.633 . . . . 0.0 114.895 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -173.97 3.53 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 124.434 1.084 . . . . 0.0 112.765 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 48.4 t -81.02 -37.9 28.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.062 . . . . 0.0 111.027 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.28 58.47 30.77 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 125.111 1.364 . . . . 0.0 111.392 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.68 163.1 40.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.771 2.981 . . . . 0.0 116.953 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -81.5 167.9 18.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.636 1.574 . . . . 0.0 111.657 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . 0.451 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.28 161.81 35.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.662 -1.274 . . . . 0.0 113.064 174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.49 139.21 5.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 118.78 -1.676 . . . . 0.0 116.608 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -162.73 153.72 17.27 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -89.73 151.72 21.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.616 2.366 . . . . 0.0 110.49 174.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 t -129.38 118.42 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -98.53 104.89 16.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 111.976 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -74.33 147.05 42.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.47 -45.98 3.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.337 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -80.51 -11.3 59.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.2 t -152.56 133.22 13.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.915 2.486 . . . . 0.0 105.961 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.04 118.49 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.802 1.183 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.83 166.48 1.66 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.916 1.686 . . . . 0.0 111.085 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -144.02 144.8 31.82 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.102 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -140.4 132.89 28.58 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 109.971 -3.286 . . . . 0.0 109.972 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 144.93 19.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -116.64 144.36 44.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.9 117.16 8.99 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -176.44 24.52 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 119.48 -1.343 . . . . 0.0 115.155 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -123.15 147.51 46.73 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 125.795 1.527 . . . . 0.0 110.527 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 5.4 t -97.09 123.64 40.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.027 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -116.51 164.65 14.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.09 111.55 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -60.89 154.75 21.38 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -34.7 -41.61 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.334 1.854 . . . . 0.0 115.849 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -13.88 60.96 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.55 46.26 4.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.478 1.037 . . . . 0.0 113.097 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.48 151.56 34.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.521 2.728 . . . . 0.0 106.172 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -115.25 150.05 36.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.865 1.666 . . . . 0.0 110.987 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.88 158.95 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.233 1.413 . . . . 0.0 110.762 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mt -121.67 109.91 15.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.682 -2.711 . . . . 0.0 103.682 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . 0.464 ' HE3' HD13 ' C' ' 119' ' ' ILE . 2.9 mmtt -102.35 116.69 33.16 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -129.08 163.13 26.13 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.429 1.585 . . . . 0.0 112.741 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.5 162.88 14.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -136.96 161.6 35.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.952 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.85 121.65 9.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.142 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 142.05 38.08 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.706 1.241 . . . . 0.0 112.319 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -127.54 113.99 16.85 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 111.762 -2.472 . . . . 0.0 112.364 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.255 0.4 OUTLIER -71.79 165.96 23.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.583 173.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -114.22 79.53 1.27 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.53 177.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.59 -0.694 . . . . 0.0 110.52 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.43 -22.79 15.37 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.6 150.01 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.116 1.436 . . . . 0.0 113.134 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.92 -27.25 41.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.145 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.17 9.06 28.21 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.256 0.932 . . . . 0.0 113.738 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -119.49 -1.39 10.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.48 1.112 . . . . 0.0 111.852 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.78 -31.58 70.94 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.385 -1.447 . . . . 0.0 113.142 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -50.44 -45.81 56.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.694 1.597 . . . . 0.0 112.523 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.86 -10.36 36.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.367 1.067 . . . . 0.0 113.026 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.41 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.779 -0.576 . . . . 0.0 111.851 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 22.2 m -116.93 139.56 50.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.887 0.875 . . . . 0.0 113.089 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -136.44 116.18 13.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.624 2.37 . . . . 0.0 111.3 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -99.7 152.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.832 1.196 . . . . 0.0 110.239 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.43 -174.18 32.02 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -127.28 155.33 43.68 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.703 -0.881 . . . . 0.0 112.227 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -147.62 151.23 35.86 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.505 1.122 . . . . 0.0 109.702 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . 0.464 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.5 mt -135.61 118.98 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -109.99 151.08 27.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.527 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.9 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.3 127.71 33.51 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.079 -1.013 . . . . 0.0 111.228 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mttm . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 130.21 56.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -139.64 130.1 25.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 110.876 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.62 -27.99 61.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -65.02 110.93 2.65 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.22 5.25 0.23 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 118.738 2.255 . . . . 0.0 118.738 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt 68.86 143.92 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.733 2.413 . . . . 0.0 115.642 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -139.14 159.25 42.59 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.278 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -138.45 147.06 42.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.699 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -111.47 145.63 38.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.726 0.81 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.06 -25.02 57.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.453 1.501 . . . . 0.0 113.944 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.08 -16.39 61.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.344 1.858 . . . . 0.0 111.838 174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.27 -9.69 28.84 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.443 2.449 . . . . 0.0 114.28 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -64.46 144.97 56.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.009 1.404 . . . . 0.0 112.121 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -122.97 134.05 54.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -128.12 136.59 51.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.911 0.862 . . . . 0.0 111.671 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -126.97 130.31 49.83 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.846 0.831 . . . . 0.0 109.252 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.59 131.02 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.72 -103.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.807 0 O-C-N 125.692 1.87 . . . . 0.0 110.569 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.48 138.58 52.35 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.596 0.758 . . . . 0.0 111.127 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.88 133.47 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.95 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -69.73 158.06 36.12 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.8 m -54.36 -29.02 46.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -67.68 -33.82 75.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.894 0.77 . . . . 0.0 111.323 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.73 -7.55 22.08 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.624 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.76 151.63 45.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.097 1.448 . . . . 0.0 108.415 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.0 161.59 42.41 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.286 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.53 163.82 20.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.368 -1.742 . . . . 0.0 107.121 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.97 -168.13 35.17 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.508 1.06 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -138.19 146.15 42.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 112.776 -1.712 . . . . 0.0 111.746 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -126.06 141.02 52.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.347 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 145.54 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 139.35 53.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 112.387 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.64 -15.14 17.86 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.48 140.37 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.709 1.203 . . . . 0.0 111.079 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.28 169.39 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.727 -1.233 . . . . 0.0 112.027 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' CG ' HH12 ' A' ' 114' ' ' ARG . 25.7 m-20 -70.65 -43.27 69.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 173.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -128.41 84.34 63.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.529 2.332 . . . . 0.0 107.588 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.76 36.96 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.262 3.308 . . . . 0.0 114.731 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.95 -3.31 90.64 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 119.845 -1.784 . . . . 0.0 115.999 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 -3.33 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.92 1.36 . . . . 0.0 114.342 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.1 mt -20.03 108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 164.87 24.87 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.019 1.727 . . . . 0.0 109.513 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tt -50.74 136.85 21.24 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.643 1.977 . . . . 0.0 114.025 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -119.95 125.94 27.12 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 113.176 -1.829 . . . . 0.0 111.937 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.29 141.99 98.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.596 2.198 . . . . 0.0 111.715 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 142.74 50.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.619 1.199 . . . . 0.0 109.701 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.25 149.24 34.54 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.093 2.557 . . . . 0.0 109.073 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.03 -156.22 27.72 Favored Glycine 0 N--CA 1.452 -0.259 0 O-C-N 120.128 -1.608 . . . . 0.0 109.857 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mt -146.96 146.86 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.244 1.017 . . . . 0.0 111.527 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.48 153.59 43.33 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.343 1.457 . . . . 0.0 112.537 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.5 153.52 40.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.195 -1.566 . . . . 0.0 112.28 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -139.53 20.8 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -93.42 -57.8 2.48 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.271 1.029 . . . . 0.0 112.944 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.79 20.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.185 0.594 . . . . 0.0 112.323 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -81.57 -20.28 40.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 45.28 0.78 Allowed Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.984 1.314 . . . . 0.0 113.253 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.38 -176.76 3.1 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.222 3.281 . . . . 0.0 115.568 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.289 2.8 t -97.02 164.33 12.57 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.884 1.326 . . . . 0.0 112.931 174.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -158.54 168.95 25.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.633 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.04 151.85 21.03 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 120.516 2.967 . . . . 0.0 120.516 -172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -163.52 153.73 15.55 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -92.67 149.88 21.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.601 1.561 . . . . 0.0 108.839 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.87 127.82 68.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -104.32 110.53 22.79 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.434 -0.792 . . . . 0.0 110.935 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -75.91 129.9 37.65 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.587 1.184 . . . . 0.0 112.329 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -90.93 -38.08 13.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.261 -1.336 . . . . 0.0 114.506 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -83.77 -19.7 34.62 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 117.28 5.09 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.28 118.94 6.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.959 1.254 . . . . 0.0 111.711 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -175.64 167.42 3.19 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 126.644 1.978 . . . . 0.0 110.42 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 t -139.79 141.77 36.74 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.427 ' HG1' ' CD1' ' A' ' 99' ' ' LEU . 2.4 m -141.09 122.97 15.39 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.902 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.04 156.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.386 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -132.41 141.87 49.04 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 121.43 9.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.57 173.52 44.95 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 34.4 tt0 -106.71 144.47 33.32 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.429 0.723 . . . . 0.0 111.508 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.0 p -97.65 121.48 39.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.503 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.1 170.59 8.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.491 1.139 . . . . 0.0 111.665 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.9 mt -127.09 116.58 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -58.78 156.03 11.88 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -17.57 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -82.68 -12.9 57.26 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.94 5.67 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.831 1.205 . . . . 0.0 112.796 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.09 152.0 35.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.497 174.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -103.13 146.54 28.25 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.847 1.259 . . . . 0.0 110.207 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.75 164.68 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.052 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.92 118.38 26.15 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -107.09 113.39 26.81 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 p -131.21 172.5 12.06 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.365 1.555 . . . . 0.0 111.346 -174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.447 ' HG3' HG23 ' D' ' 113' ' ' THR . 87.8 mmm -127.8 170.3 12.92 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.706 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -139.76 164.0 31.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.749 1.261 . . . . 0.0 112.208 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.72 121.67 13.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.326 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' CD1' ' HG1' ' A' ' 77' ' ' THR . 0.4 OUTLIER -107.05 138.3 43.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 124.193 1.949 . . . . 0.0 109.934 -177.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.63 114.14 18.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 109.652 -3.431 . . . . 0.0 110.057 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -72.61 167.73 20.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.424 1.702 . . . . 0.0 112.207 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -114.97 87.96 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.05 -170.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.767 1.227 . . . . 0.0 108.428 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -121.61 -28.28 4.59 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.85 -1.156 . . . . 0.0 113.814 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.9 144.96 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.573 1.178 . . . . 0.0 110.986 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.3 tt -61.63 -20.69 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.144 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.86 2.95 47.39 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.387 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.45 7.51 8.34 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.567 1.184 . . . . 0.0 112.9 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.62 -36.07 75.6 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.517 -1.989 . . . . 0.0 111.463 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -48.22 -45.67 34.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.487 1.115 . . . . 0.0 113.401 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.59 -12.47 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.656 1.183 . . . . 0.0 113.576 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.96 1.69 22.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.443 HG23 ' HG3' ' D' ' 96' ' ' MET . 27.0 m -111.66 140.26 46.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.966 0.906 . . . . 0.0 111.499 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.464 HH12 ' CG ' ' A' ' 39' ' ' ASP . 7.6 mtt180 -144.3 130.25 19.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.958 1.303 . . . . 0.0 111.433 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.41 151.45 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 121.038 1.745 . . . . 0.0 110.98 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.97 179.53 27.59 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -120.15 151.56 38.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.121 0.968 . . . . 0.0 110.706 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -149.78 149.52 30.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.233 1.016 . . . . 0.0 110.777 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.9 mt -130.4 133.74 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.08 -1.012 . . . . 0.0 108.289 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -123.92 149.02 46.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.94 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.8 p -132.66 159.76 38.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.71 1.204 . . . . 0.0 110.866 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.24 125.58 24.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 111.122 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.24 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mttm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -149.16 136.5 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.992 1.269 . . . . 0.0 111.632 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 31.3 p -139.45 133.56 31.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.169 2.187 . . . . 0.0 111.549 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.72 -26.42 60.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -65.4 112.1 3.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -4.96 0.36 Allowed Glycine 0 N--CA 1.476 1.316 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 74.68 144.05 0.08 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.418 2.287 . . . . 0.0 114.007 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -139.41 162.16 35.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.134 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -142.49 148.8 38.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.09 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -113.43 146.08 40.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.977 0.911 . . . . 0.0 110.803 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -56.92 -25.39 57.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.967 1.307 . . . . 0.0 113.921 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.19 -15.62 61.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.362 1.865 . . . . 0.0 112.134 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.84 -8.37 31.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 127.304 2.383 . . . . 0.0 114.294 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -64.56 143.97 57.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.14 1.47 . . . . 0.0 112.512 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -121.4 132.07 54.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.901 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -126.74 137.67 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 111.969 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.6 m -128.75 130.39 47.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.244 1.021 . . . . 0.0 109.786 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.26 130.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.4 -97.09 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 125.825 1.953 . . . . 0.0 111.146 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.41 138.16 46.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 110.959 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.07 134.03 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.008 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -69.75 157.84 36.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.499 0.72 . . . . 0.0 111.793 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 64.4 m -54.51 -28.75 47.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -67.81 -32.87 73.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.794 0.724 . . . . 0.0 111.369 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.23 -6.07 23.34 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 124.777 1.179 . . . . 0.0 112.715 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.16 156.99 38.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.456 1.128 . . . . 0.0 110.541 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.59 166.53 33.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 123.186 1.47 . . . . 0.0 110.891 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -129.75 164.72 23.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 112.0 -2.364 . . . . 0.0 105.905 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.13 -167.1 35.05 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 75.1 p -139.23 146.74 40.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.186 -1.507 . . . . 0.0 112.134 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -126.87 141.14 51.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.179 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.406 ' CD1' HD11 ' D' ' 46' ' ' LEU . 4.4 mp -125.89 144.77 34.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -120.85 138.84 53.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.055 0.942 . . . . 0.0 112.522 -173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.76 -15.98 18.28 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.81 140.81 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.577 1.151 . . . . 0.0 111.337 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.66 169.06 23.65 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 120.477 -1.389 . . . . 0.0 111.905 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' D' ' 114' ' ' ARG . 31.2 m-20 -70.29 -43.26 70.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.059 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -128.4 83.93 64.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.522 2.329 . . . . 0.0 107.69 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.9 37.44 0.29 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.323 3.348 . . . . 0.0 114.684 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.5 -2.83 90.66 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 119.893 -1.754 . . . . 0.0 116.063 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.828 1.314 . . . . 0.0 114.401 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mt -19.53 107.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 164.35 25.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.994 1.717 . . . . 0.0 109.494 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.406 HD11 ' CD1' ' D' ' 34' ' ' ILE . 4.4 tt -49.99 136.19 19.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.664 1.986 . . . . 0.0 113.95 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -119.3 125.96 27.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 113.21 -1.813 . . . . 0.0 111.991 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.21 140.67 95.89 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.229 1.953 . . . . 0.0 111.269 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.45 149.78 41.84 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 124.892 1.37 . . . . 0.0 109.359 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 149.34 26.27 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.074 2.15 . . . . 0.0 108.869 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.94 -154.2 25.33 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 120.898 -1.126 . . . . 0.0 111.347 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -146.92 146.02 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.286 1.035 . . . . 0.0 112.033 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.79 153.81 41.9 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.457 1.503 . . . . 0.0 112.325 174.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -73.17 159.17 33.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 119.954 -1.716 . . . . 0.0 112.344 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -145.46 21.75 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -93.46 -58.07 2.4 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.039 0.936 . . . . 0.0 112.453 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.47 169.81 16.69 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.962 0.789 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 26.1 m -90.41 -13.77 34.27 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -136.22 39.75 0.46 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.724 1.209 . . . . 0.0 113.768 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.76 -176.99 3.57 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.792 2.328 . . . . 0.0 114.359 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.305 2.5 t -97.06 164.36 12.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.742 1.258 . . . . 0.0 112.074 174.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.57 168.35 27.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.391 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 151.61 20.51 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 120.742 3.057 . . . . 0.0 120.742 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -163.49 152.78 14.63 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -90.84 150.79 21.41 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.932 1.693 . . . . 0.0 108.776 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.09 128.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.44 110.26 22.53 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -75.74 129.82 37.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.823 1.297 . . . . 0.0 112.608 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -91.51 -37.63 13.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.944 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -83.79 -19.54 34.85 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -152.42 119.01 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.38 119.05 7.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.304 1.411 . . . . 0.0 111.758 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -175.29 166.43 3.38 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 126.531 1.933 . . . . 0.0 110.384 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 141.59 38.07 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.195 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' THR . . . . . 0.426 ' HG1' ' CD1' ' D' ' 99' ' ' LEU . 2.6 m -141.11 123.34 15.68 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 111.364 -2.653 . . . . 0.0 109.947 -172.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.05 156.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.649 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.54 141.92 49.82 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.21 121.26 9.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -174.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.66 173.68 44.49 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 118.665 -1.731 . . . . 0.0 117.19 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 34.6 tt0 -106.63 144.51 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.99 0.9 . . . . 0.0 111.274 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 p -97.66 118.22 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.924 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.27 170.56 8.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.901 0.858 . . . . 0.0 111.911 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 49.9 mt -128.97 114.81 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -58.61 155.85 11.75 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -29.62 2.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -72.07 -17.7 61.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.337 1.455 . . . . 0.0 113.833 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.89 54.38 2.64 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.55 46.8 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 129.51 3.124 . . . . 0.0 108.794 173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -109.54 146.96 33.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.523 1.154 . . . . 0.0 109.971 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 23.3 m -148.44 164.03 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.34 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.29 118.36 25.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -106.76 112.94 26.15 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -130.52 172.12 12.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.553 1.644 . . . . 0.0 111.155 -174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.443 ' HG3' HG23 ' A' ' 113' ' ' THR . 86.5 mmm -127.19 169.99 12.89 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.753 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -139.69 164.01 31.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.657 1.218 . . . . 0.0 111.913 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.09 122.3 13.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.212 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . 0.426 ' CD1' ' HG1' ' D' ' 77' ' ' THR . 0.4 OUTLIER -107.05 139.46 41.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 124.105 1.907 . . . . 0.0 110.11 -177.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.84 114.58 18.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 109.717 -3.402 . . . . 0.0 110.626 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -73.08 167.83 20.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 125.492 1.745 . . . . 0.0 112.429 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -114.7 83.71 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.46 -172.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.904 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -119.05 -30.22 5.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.529 -1.357 . . . . 0.0 112.411 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.06 143.92 43.98 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 111.564 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.61 -22.27 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.666 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.39 1.16 51.98 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 117.635 -1.647 . . . . 0.0 114.445 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.08 7.46 9.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.841 1.321 . . . . 0.0 113.002 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.06 -36.18 74.61 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.696 -1.877 . . . . 0.0 111.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -48.25 -46.03 35.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.377 1.071 . . . . 0.0 113.201 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -90.32 -12.65 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.441 1.096 . . . . 0.0 113.508 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.28 1.0 23.12 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 96' ' ' MET . 24.2 m -111.12 140.85 45.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.231 1.012 . . . . 0.0 111.669 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' D' ' 39' ' ' ASP . 7.3 mtt180 -144.75 130.95 19.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.61 152.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.085 1.766 . . . . 0.0 110.966 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.29 28.79 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -120.13 150.8 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.026 0.93 . . . . 0.0 110.407 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -149.18 148.07 29.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.768 0.794 . . . . 0.0 110.357 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -128.46 133.71 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -123.22 147.45 46.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.559 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 46.9 p -129.81 156.75 43.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.757 1.223 . . . . 0.0 110.009 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -57.75 127.79 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.761 0.825 . . . . 0.0 110.496 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 mttm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 44.4 t -139.31 133.9 31.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 109.421 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.2 p -139.56 131.72 28.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.748 2.019 . . . . 0.0 110.081 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.45 -25.72 60.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -65.68 111.6 3.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -5.38 0.37 Allowed Glycine 0 N--CA 1.478 1.472 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt 75.34 144.32 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.657 2.383 . . . . 0.0 114.037 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -140.55 162.39 35.46 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.849 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -141.11 149.96 42.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.688 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -112.03 146.26 38.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.618 0.767 . . . . 0.0 110.512 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -57.26 -23.81 50.66 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.499 1.52 . . . . 0.0 113.626 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 24.5 tp -74.52 -16.17 60.84 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.511 1.924 . . . . 0.0 111.932 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.5 -7.68 32.19 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 127.421 2.439 . . . . 0.0 114.272 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -64.41 144.39 57.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.278 1.539 . . . . 0.0 113.14 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -122.85 132.26 54.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.177 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -126.49 136.64 52.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.887 0.851 . . . . 0.0 111.739 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -126.69 130.56 50.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.601 0.715 . . . . 0.0 109.607 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.04 130.14 72.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.61 -98.16 0.09 OUTLIER Glycine 0 CA--C 1.527 0.829 0 O-C-N 125.559 1.787 . . . . 0.0 111.229 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.16 138.21 46.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.709 0.804 . . . . 0.0 110.984 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 p -92.35 133.47 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.018 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -69.27 158.02 35.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.237 0.615 . . . . 0.0 111.344 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 63.9 m -54.4 -29.02 47.46 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -67.76 -33.9 75.76 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.801 . . . . 0.0 111.39 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.83 21.63 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.697 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.52 151.72 45.68 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.116 1.458 . . . . 0.0 108.426 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.27 42.9 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.107 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.3 163.71 20.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.111 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.93 -168.34 35.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-O 122.741 1.19 . . . . 0.0 110.976 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -137.96 146.97 43.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.505 -1.847 . . . . 0.0 111.73 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -126.61 141.13 51.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.228 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.414 ' CD1' HD11 ' B' ' 46' ' ' LEU . 4.5 mp -126.18 144.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -120.89 139.42 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.941 0.896 . . . . 0.0 112.645 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.09 -16.21 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.96 140.65 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.612 1.165 . . . . 0.0 111.116 -176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.72 169.11 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.844 -1.16 . . . . 0.0 112.103 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.449 ' CG ' HH12 ' B' ' 114' ' ' ARG . 27.9 m-20 -70.19 -43.39 70.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.987 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -128.72 83.95 64.63 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.651 2.381 . . . . 0.0 107.66 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.71 37.48 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.263 3.308 . . . . 0.0 114.753 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.69 -2.98 90.72 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 119.839 -1.788 . . . . 0.0 116.041 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.07 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -19.7 107.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.73 24.78 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.98 1.712 . . . . 0.0 109.54 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' B' ' 34' ' ' ILE . 5.0 tt -50.77 137.21 20.73 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 126.556 1.942 . . . . 0.0 113.929 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -120.15 126.24 26.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.094 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.26 141.84 98.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.679 2.253 . . . . 0.0 111.813 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.74 143.13 50.02 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 124.562 1.163 . . . . 0.0 109.614 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.32 149.25 34.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.978 2.511 . . . . 0.0 108.878 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.17 -155.95 27.39 Favored Glycine 0 N--CA 1.453 -0.222 0 O-C-N 120.337 -1.477 . . . . 0.0 109.853 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mt -147.2 147.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.316 1.047 . . . . 0.0 111.618 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.62 154.0 42.94 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.048 1.339 . . . . 0.0 112.431 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -74.06 153.5 39.61 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.223 -1.548 . . . . 0.0 112.063 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -138.6 20.98 2.71 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -93.56 -57.07 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.791 0.836 . . . . 0.0 112.941 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 170.2 16.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.675 0.75 . . . . 0.0 112.972 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.8 m -80.77 -24.53 38.57 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.94 44.97 0.78 Allowed Pre-proline 0 CA--C 1.569 1.685 0 C-N-CA 125.319 1.448 . . . . 0.0 113.156 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.78 -176.23 3.07 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.201 2.6 . . . . 0.0 114.882 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.299 2.9 t -97.26 164.15 12.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.788 1.28 . . . . 0.0 112.508 174.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.56 168.61 26.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.893 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.44 151.53 20.32 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 120.825 3.09 . . . . 0.0 120.825 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -163.09 153.49 16.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -92.15 149.65 21.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.566 1.546 . . . . 0.0 108.849 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.61 128.18 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -104.75 110.61 23.02 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.369 -0.832 . . . . 0.0 110.778 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -76.25 130.67 38.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 122.784 1.278 . . . . 0.0 112.645 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -92.41 -37.81 12.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.737 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -84.1 -19.49 34.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.5 117.32 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.96 118.93 6.84 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.897 1.226 . . . . 0.0 111.76 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -175.56 167.23 3.25 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 126.599 1.96 . . . . 0.0 110.27 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -139.38 142.14 37.55 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.249 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' THR . . . . . 0.41 ' HG1' ' CD1' ' B' ' 99' ' ' LEU . 2.3 m -141.15 123.32 15.63 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 111.462 -2.608 . . . . 0.0 109.588 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 m -99.17 156.53 3.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.512 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.29 141.85 49.14 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.55 121.34 9.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.66 172.52 43.68 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 118.628 -1.748 . . . . 0.0 116.947 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 34.9 tt0 -105.02 144.85 31.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.654 0.74 . . . . 0.0 111.224 -176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 p -97.56 122.89 41.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.106 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -116.98 169.61 9.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.963 0.887 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -126.37 116.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.91 155.55 13.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -21.26 0.8 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 118.104 2.631 . . . . 0.0 118.104 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.43 -12.23 59.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 47.5 4.79 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.259 0.933 . . . . 0.0 112.416 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.69 150.81 42.22 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.257 2.223 . . . . 0.0 110.462 174.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -103.44 145.75 29.53 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.967 1.307 . . . . 0.0 110.228 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.83 164.19 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.865 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.98 118.29 25.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -106.77 113.47 26.98 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.0 p -130.85 172.69 11.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.543 1.64 . . . . 0.0 111.161 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.431 ' HG3' HG23 ' C' ' 113' ' ' THR . 87.7 mmm -127.63 170.12 13.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.554 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -139.82 163.36 32.84 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.573 1.178 . . . . 0.0 111.752 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.13 122.02 14.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.19 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.41 ' CD1' ' HG1' ' B' ' 77' ' ' THR . 0.4 OUTLIER -107.0 138.38 43.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 124.356 2.027 . . . . 0.0 110.108 -177.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.71 114.11 18.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 109.475 -3.511 . . . . 0.0 109.922 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -73.08 167.94 20.09 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 125.508 1.755 . . . . 0.0 112.125 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.4 t -114.87 87.87 2.74 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.04 -171.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.838 1.255 . . . . 0.0 108.243 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.05 -30.52 4.35 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.823 -1.173 . . . . 0.0 112.226 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -112.76 143.2 44.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.255 1.026 . . . . 0.0 111.76 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 14.2 tt -60.37 -22.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.08 -0.963 . . . . 0.0 113.161 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.61 54.48 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 117.701 -1.611 . . . . 0.0 114.55 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.67 7.2 9.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.922 1.289 . . . . 0.0 113.118 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.68 -36.11 73.68 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 119.76 -1.837 . . . . 0.0 111.296 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -48.27 -45.92 35.2 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.429 1.092 . . . . 0.0 113.479 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.36 -12.32 37.98 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.463 1.105 . . . . 0.0 113.345 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.61 1.1 23.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.446 HG23 ' HG3' ' C' ' 96' ' ' MET . 25.4 m -110.86 140.35 45.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.297 1.039 . . . . 0.0 111.938 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.449 HH12 ' CG ' ' B' ' 39' ' ' ASP . 7.5 mtt180 -144.6 130.7 19.47 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.658 1.183 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.39 152.25 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 121.111 1.778 . . . . 0.0 111.209 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.35 179.49 27.95 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -120.48 150.61 40.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.241 1.017 . . . . 0.0 110.344 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.41 148.27 29.26 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.033 0.921 . . . . 0.0 110.41 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 62.7 mt -129.58 133.31 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -122.88 148.01 45.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.985 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.7 p -131.28 159.15 38.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.768 1.227 . . . . 0.0 110.432 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 5.0 mmt-85 -59.14 134.52 57.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.731 0.812 . . . . 0.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.659 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 53.5 mttm . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -141.58 135.92 30.54 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.921 1.237 . . . . 0.0 110.777 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 22.4 p -139.48 131.68 28.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.536 1.935 . . . . 0.0 110.844 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -73.54 -24.76 60.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -67.58 112.33 4.67 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.58 -3.22 0.43 Allowed Glycine 0 N--CA 1.481 1.636 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt 74.05 144.5 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.908 2.483 . . . . 0.0 114.446 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -139.54 162.55 34.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.121 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.81 147.38 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.449 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -110.68 145.92 37.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.826 0.85 . . . . 0.0 110.348 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -57.46 -23.39 49.54 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.627 1.571 . . . . 0.0 113.69 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.6 tp -75.04 -16.37 60.59 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.613 1.965 . . . . 0.0 111.895 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.07 -7.86 31.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 127.417 2.436 . . . . 0.0 114.364 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -65.1 145.25 56.54 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.285 1.543 . . . . 0.0 112.656 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -123.84 132.01 53.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.143 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -125.93 137.9 53.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 111.738 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 33.9 m -128.39 129.84 46.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.721 0.772 . . . . 0.0 109.438 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.9 129.73 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.76 -96.59 0.1 OUTLIER Glycine 0 CA--C 1.527 0.786 0 O-C-N 125.638 1.836 . . . . 0.0 111.179 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.92 45.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.758 0.823 . . . . 0.0 110.962 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.97 133.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.011 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -69.49 157.91 36.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.543 0.737 . . . . 0.0 111.831 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 64.3 m -54.58 -28.89 49.42 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -67.78 -32.88 73.77 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.834 0.743 . . . . 0.0 111.303 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.17 -6.06 23.44 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 124.761 1.172 . . . . 0.0 112.763 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.04 157.09 38.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.434 1.112 . . . . 0.0 110.426 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.6 166.55 33.01 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.95 1.357 . . . . 0.0 110.872 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -129.74 165.04 22.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 112.164 -2.289 . . . . 0.0 105.84 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.44 -167.03 35.11 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 122.448 1.027 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.2 p -139.01 147.36 42.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.972 -1.614 . . . . 0.0 112.187 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -127.48 141.26 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' C' ' 46' ' ' LEU . 4.3 mp -125.94 145.65 33.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 2.9 m -122.11 138.95 54.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -13.45 18.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.63 140.16 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.672 1.189 . . . . 0.0 111.429 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.12 169.56 22.11 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.575 -1.328 . . . . 0.0 112.192 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' C' ' 114' ' ' ARG . 30.2 m-20 -70.93 -42.9 69.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.142 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -128.31 84.57 62.84 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.685 2.394 . . . . 0.0 107.506 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.84 36.52 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.168 3.245 . . . . 0.0 114.675 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.88 -3.01 90.58 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 119.909 -1.744 . . . . 0.0 115.99 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.11 -4.11 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.83 1.315 . . . . 0.0 114.47 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mt -19.33 108.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.77 164.09 26.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.073 1.749 . . . . 0.0 109.593 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' C' ' 34' ' ' ILE . 4.4 tt -49.98 136.57 18.44 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.652 1.981 . . . . 0.0 113.943 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -120.07 126.11 27.0 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.18 140.06 93.14 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.636 2.224 . . . . 0.0 111.377 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.09 149.48 42.12 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 124.772 1.295 . . . . 0.0 109.64 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.79 149.44 26.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.98 2.112 . . . . 0.0 108.601 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.95 -154.05 25.21 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 119.163 0.892 . . . . 0.0 111.543 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -147.16 145.95 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.317 1.047 . . . . 0.0 111.923 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.98 153.29 43.01 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.349 1.459 . . . . 0.0 112.321 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -72.77 157.92 36.57 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.94 -1.725 . . . . 0.0 112.298 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -143.88 21.14 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -93.52 -57.26 2.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.931 0.892 . . . . 0.0 112.364 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.18 169.03 17.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.611 0.764 . . . . 0.0 112.179 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -85.38 -19.81 30.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 40.35 0.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 125.085 1.354 . . . . 0.0 113.335 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.95 -177.06 3.63 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.857 2.371 . . . . 0.0 114.531 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.308 2.3 t -96.57 164.09 12.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.711 1.243 . . . . 0.0 112.121 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -158.44 168.25 27.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.653 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.58 151.46 20.14 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 120.61 3.004 . . . . 0.0 120.61 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.19 153.21 15.73 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -91.53 150.44 21.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.996 1.719 . . . . 0.0 108.804 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.49 128.7 68.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -105.46 110.62 23.03 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.817 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.47 130.95 39.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.736 1.255 . . . . 0.0 112.413 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -92.37 -38.35 12.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.964 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -82.94 -19.33 37.43 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.44 119.92 6.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.27 118.89 7.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.369 1.44 . . . . 0.0 111.35 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 6.4 m -175.56 166.38 3.22 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.695 1.998 . . . . 0.0 110.539 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 142.09 38.06 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 122.324 1.059 . . . . 0.0 111.397 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' THR . . . . . 0.407 ' HG1' ' CD1' ' C' ' 99' ' ' LEU . 2.4 m -141.25 124.19 16.25 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 111.284 -2.689 . . . . 0.0 109.831 -172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -100.17 155.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.421 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -131.43 141.76 49.88 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.44 121.46 9.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.55 44.13 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.54 -1.791 . . . . 0.0 116.703 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 35.0 tt0 -105.81 144.89 31.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.379 1.085 . . . . 0.0 111.132 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 30.1 p -97.43 123.23 41.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.356 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.76 170.43 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.733 0.778 . . . . 0.0 112.257 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 49.7 mt -127.28 115.77 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -58.85 154.95 14.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -19.16 0.51 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 176.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -82.31 -9.61 59.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.174 0.99 . . . . 0.0 113.247 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.83 49.75 5.24 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.193 0.901 . . . . 0.0 112.359 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.31 152.88 42.55 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 127.716 2.406 . . . . 0.0 109.506 173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -107.54 145.71 32.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.14 1.376 . . . . 0.0 110.005 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 25.9 m -148.15 165.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.178 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.89 118.63 25.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -106.97 112.62 25.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 3.0 p -129.94 172.87 11.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.533 1.635 . . . . 0.0 111.374 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.446 ' HG3' HG23 ' B' ' 113' ' ' THR . 88.0 mmm -128.31 170.56 12.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -140.43 163.6 32.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.741 1.257 . . . . 0.0 111.804 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.39 122.2 14.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.389 174.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . 0.407 ' CD1' ' HG1' ' C' ' 77' ' ' THR . 0.4 OUTLIER -107.08 139.17 41.93 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 124.122 1.915 . . . . 0.0 110.026 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.27 18.42 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 109.75 -3.386 . . . . 0.0 110.132 -173.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -72.35 168.25 18.77 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.342 1.651 . . . . 0.0 112.41 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -115.43 82.68 1.79 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.97 -172.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.791 1.237 . . . . 0.0 108.916 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -119.73 -28.52 5.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.661 -1.274 . . . . 0.0 112.847 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -116.55 143.28 45.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 122.419 1.104 . . . . 0.0 111.624 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.79 -20.52 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.731 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.4 2.37 57.86 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 118.335 -1.259 . . . . 0.0 114.086 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.04 7.62 8.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.79 1.236 . . . . 0.0 112.994 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.8 -36.07 75.98 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 119.734 -1.853 . . . . 0.0 111.524 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -48.1 -46.02 33.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.602 1.161 . . . . 0.0 113.248 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -90.22 -12.41 38.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.101 . . . . 0.0 113.763 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 1.36 23.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' THR . . . . . 0.431 HG23 ' HG3' ' B' ' 96' ' ' MET . 26.2 m -111.25 140.63 45.65 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.21 1.004 . . . . 0.0 111.385 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . 0.471 HH12 ' CG ' ' C' ' 39' ' ' ASP . 7.4 mtt180 -144.81 130.93 19.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.911 1.284 . . . . 0.0 111.195 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.63 152.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.972 1.715 . . . . 0.0 111.145 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.12 28.3 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -119.9 150.72 40.02 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.146 0.978 . . . . 0.0 110.145 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.52 147.23 27.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.856 0.836 . . . . 0.0 110.406 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.56 132.78 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.87 147.74 45.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.569 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 63.3 p -131.54 158.09 41.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.831 1.252 . . . . 0.0 109.971 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -60.46 136.72 58.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.757 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 CA--C 1.536 0.419 0 O-C-N 121.456 -0.778 . . . . 0.0 111.387 174.737 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -131.04 147.03 52.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.1 p -139.84 130.71 26.08 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.278 -1.514 . . . . 0.0 112.646 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.7 -27.45 68.71 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -50.49 118.43 3.04 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 123.575 1.655 . . . . 0.0 112.189 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.11 -119.12 2.58 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.84 2.162 . . . . 0.0 110.017 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -145.01 149.73 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.546 1.138 . . . . 0.0 113.273 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -145.83 159.18 43.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.296 1.438 . . . . 0.0 110.068 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -134.87 150.2 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.4 HD22 ' ND2' ' A' ' 118' ' ' ASN . 61.0 t-20 -107.96 143.51 36.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.461 1.104 . . . . 0.0 111.265 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.3 -24.03 64.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.39 1.076 . . . . 0.0 112.632 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.485 HD22 HD22 ' A' ' 118' ' ' ASN . 50.0 tp -74.09 -14.34 60.97 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.983 1.313 . . . . 0.0 112.639 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.61 -14.29 32.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 127.049 2.262 . . . . 0.0 113.889 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.61 153.85 22.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.298 1.523 . . . . 0.0 112.741 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.52 146.81 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.149 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -141.29 147.12 37.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -129.89 134.04 47.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.339 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.18 123.72 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.93 -87.06 0.11 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 124.434 1.084 . . . . 0.0 111.567 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.5 42.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.06 0.933 . . . . 0.0 112.145 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.16 125.55 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 113.166 -1.834 . . . . 0.0 108.038 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -71.36 162.81 28.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.995 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -54.91 -23.67 19.93 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -74.75 -32.52 62.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.905 -1.122 . . . . 0.0 113.217 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 -5.4 26.4 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 117.603 -1.665 . . . . 0.0 112.586 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 0.0 OUTLIER -67.06 142.46 57.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.71 156.91 32.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -125.2 168.61 13.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.622 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.52 -167.36 35.64 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.32 0.956 . . . . 0.0 113.838 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.9 p -138.61 133.63 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.758 -1.221 . . . . 0.0 111.308 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -113.65 131.92 55.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.59 129.24 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.251 61.2 m -104.66 142.65 34.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.638 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.24 -10.2 20.57 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -138.99 146.16 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.266 1.026 . . . . 0.0 112.647 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.1 26.4 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.319 -0.863 . . . . 0.0 110.881 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -31.14 63.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -141.1 69.73 28.27 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.454 1.902 . . . . 0.0 113.897 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.53 72.1 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 124.339 3.359 . . . . 0.0 114.183 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.69 2.28 13.64 Favored Glycine 0 N--CA 1.477 1.408 0 O-C-N 120.712 -1.242 . . . . 0.0 114.597 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.14 27.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.805 1.242 . . . . 0.0 112.623 -174.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.56 130.71 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.929 0.871 . . . . 0.0 110.76 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.25 0.5 OUTLIER -140.52 170.2 16.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.616 1.566 . . . . 0.0 110.055 177.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.1 tp -57.53 115.4 2.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.865 2.866 . . . . 0.0 111.0 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.2 m -100.55 120.09 56.97 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.23 142.38 87.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.434 2.089 . . . . 0.0 111.699 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.46 152.98 47.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.802 0.841 . . . . 0.0 111.624 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.59 148.79 16.34 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 110.463 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.48 -152.01 22.66 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 120.883 1.674 . . . . 0.0 110.195 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.2 140.01 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.304 0.642 . . . . 0.0 111.279 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.21 136.41 52.79 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.396 -0.815 . . . . 0.0 111.932 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -68.76 149.79 48.61 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.935 0.874 . . . . 0.0 111.321 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.3 23.98 1.15 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.995 1.318 . . . . 0.0 111.436 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -92.97 -58.2 2.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.361 1.864 . . . . 0.0 111.357 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.05 -178.15 3.21 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.616 1.197 . . . . 0.0 114.169 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -65.73 -57.81 7.15 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.215 1.006 . . . . 0.0 111.845 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -141.52 65.39 20.88 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.917 0.887 . . . . 0.0 110.129 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.34 -174.15 1.53 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.27 2.647 . . . . 0.0 114.546 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.484 ' HG1' ' HB3' ' D' ' 100' ' ' ARG 0.275 4.5 t -96.15 160.72 14.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 123.158 1.456 . . . . 0.0 112.796 174.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.9 167.34 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.469 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.55 147.37 12.91 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.19 156.91 27.38 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -92.9 149.68 21.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.661 1.984 . . . . 0.0 109.535 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.22 117.04 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -92.36 105.5 17.68 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.752 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.266 42.9 m95 -74.3 130.96 40.7 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -89.47 -40.26 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -92.17 -9.46 42.28 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.42 128.37 10.31 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 128.187 2.595 . . . . 0.0 104.865 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.76 118.7 12.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.363 1.078 . . . . 0.0 110.739 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 m -177.07 159.65 1.68 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.001 1.721 . . . . 0.0 110.475 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.63 141.64 35.07 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.033 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.57 126.68 19.65 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.553 -3.022 . . . . 0.0 108.558 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.754 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -124.61 142.56 51.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 116.67 5.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.31 169.21 39.73 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 118.737 -1.697 . . . . 0.0 116.408 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 29.0 tt0 -101.84 148.13 25.68 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.274 1.035 . . . . 0.0 111.723 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 132.82 36.31 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.271 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -121.62 158.09 29.37 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 110.18 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.81 158.58 7.94 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.547 1.139 . . . . 0.0 110.087 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -48.08 -33.77 8.65 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -75.33 -15.26 60.5 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.6 47.15 3.04 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.248 0.928 . . . . 0.0 111.729 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HZ3' ' HB3' ' A' ' 90' ' ' LYS . 4.9 mtpm? -119.8 154.18 34.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.431 1.492 . . . . 0.0 109.639 174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -109.03 151.82 25.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.814 1.645 . . . . 0.0 111.26 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -152.83 156.3 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.189 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 mt -123.42 104.11 8.89 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HE3' HD13 ' A' ' 119' ' ' ILE . 1.2 mmtt -95.04 127.84 41.41 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -139.77 163.07 33.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.792 1.282 . . . . 0.0 112.768 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 19.9 mtp -121.34 160.47 23.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -133.51 162.57 31.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.154 -1.839 . . . . 0.0 113.057 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.81 126.55 23.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.508 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.3 140.79 39.64 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 125.14 1.525 . . . . 0.0 109.972 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HB3' ' HG1' ' D' ' 63' ' ' THR . 0.6 OUTLIER -129.09 118.23 22.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.57 -173.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.8 p -84.99 172.07 11.61 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.7 m -110.71 70.89 0.73 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 107.7 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.46 169.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.048 1.339 . . . . 0.0 109.667 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.34 -11.1 14.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -135.36 152.76 51.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.064 1.412 . . . . 0.0 111.942 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.8 tt -67.43 -20.77 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.376 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.83 4.3 45.83 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.674 -0.641 . . . . 0.0 114.401 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -125.75 1.64 7.45 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.25 -34.58 72.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.987 0.915 . . . . 0.0 113.028 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -48.32 -38.85 20.06 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -97.43 -12.92 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.04 1.336 . . . . 0.0 114.032 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.76 38.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.4 m -108.34 144.94 35.2 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-O 122.352 1.072 . . . . 0.0 109.583 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -141.0 151.84 44.44 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.524 1.529 . . . . 0.0 108.311 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.62 153.19 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.57 1.148 . . . . 0.0 109.411 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.38 32.22 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.141 0.877 . . . . 0.0 111.776 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 17.3 p90 -132.41 159.99 37.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.139 -0.624 . . . . 0.0 112.076 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.485 HD22 HD22 ' A' ' 14' ' ' LEU . 4.6 m120 -150.42 157.35 42.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.542 1.163 . . . . 0.0 109.784 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.483 HD13 ' HE3' ' A' ' 94' ' ' LYS . 8.6 mt -131.93 129.45 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.85 151.97 38.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 124.334 1.022 . . . . 0.0 108.772 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 p -139.84 164.77 29.09 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -57.04 129.62 42.51 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.496 0.718 . . . . 0.0 110.94 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.499 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 27.5 p -137.67 143.37 41.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.656 1.583 . . . . 0.0 108.888 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 85.2 p -139.98 131.95 27.77 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.346 -1.471 . . . . 0.0 113.552 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.31 -24.04 67.68 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -53.95 118.43 3.99 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.545 1.64 . . . . 0.0 112.092 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.46 -120.73 2.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.261 1.886 . . . . 0.0 109.554 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 113.301 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -147.8 159.89 43.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.18 147.88 46.18 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -105.79 143.57 33.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.652 1.181 . . . . 0.0 111.945 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.79 -24.56 62.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.562 1.145 . . . . 0.0 112.92 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.492 HD22 HD22 ' D' ' 118' ' ' ASN . 45.4 tp -74.84 -13.81 60.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.694 1.197 . . . . 0.0 112.666 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -13.81 36.72 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.973 2.225 . . . . 0.0 113.619 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.2 152.27 25.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.298 1.523 . . . . 0.0 112.439 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.95 146.44 50.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.854 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -141.19 147.29 38.14 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -129.76 134.95 47.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.035 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.08 123.62 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.86 0.12 Allowed Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.128 0.893 . . . . 0.0 111.757 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.09 151.63 38.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.747 -0.855 . . . . 0.0 111.969 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.66 126.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.596 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -70.87 162.8 28.62 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -56.52 -24.92 49.88 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -73.02 -30.95 64.14 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.825 -1.172 . . . . 0.0 112.52 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.11 -1.25 25.49 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.214 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.51 155.61 39.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.152 1.476 . . . . 0.0 112.417 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.47 166.06 34.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.316 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' THR . . . . . 0.515 HG21 ' CD1' ' D' ' 50' ' ' LEU . 3.0 p -125.44 -179.92 4.83 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.81 -167.33 39.49 Favored Glycine 0 N--CA 1.469 0.878 0 O-C-N 119.46 -2.025 . . . . 0.0 113.755 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -137.92 132.31 32.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.101 0.953 . . . . 0.0 112.133 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -112.2 136.13 51.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 mt -125.78 129.53 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 70.4 m -104.74 143.33 33.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.736 -173.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.88 21.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -141.48 145.67 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.359 1.063 . . . . 0.0 112.504 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.05 167.99 26.67 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.111 -0.993 . . . . 0.0 110.896 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -30.98 63.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.9 69.7 29.45 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.448 1.899 . . . . 0.0 113.966 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.53 71.5 2.49 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.324 3.349 . . . . 0.0 114.266 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.17 14.49 Favored Glycine 0 N--CA 1.477 1.389 0 O-C-N 120.734 -1.229 . . . . 0.0 114.595 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.03 28.02 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.721 1.208 . . . . 0.0 112.626 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.69 130.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.946 0.879 . . . . 0.0 110.686 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.09 169.98 16.59 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.683 1.593 . . . . 0.0 109.753 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.17 115.37 2.62 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.249 3.02 . . . . 0.0 111.151 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -100.93 119.48 58.08 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.12 141.17 87.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.365 2.044 . . . . 0.0 111.647 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -125.38 157.15 37.5 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.738 0.815 . . . . 0.0 111.777 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . 0.515 ' CD1' HG21 ' D' ' 30' ' ' THR . 12.5 tp -163.67 149.04 10.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.356 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -148.25 15.26 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 120.298 1.408 . . . . 0.0 110.729 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mt -146.42 139.49 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.179 0.992 . . . . 0.0 110.317 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.91 136.83 54.59 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.224 -0.922 . . . . 0.0 111.549 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -68.58 150.38 48.08 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.659 -1.276 . . . . 0.0 111.782 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -147.26 24.66 1.13 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 111.751 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 15.5 mmt-85 -93.12 -58.19 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.085 1.754 . . . . 0.0 111.448 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 179.89 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -63.68 -55.28 24.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.246 1.018 . . . . 0.0 111.431 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.07 67.83 15.5 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.516 0.726 . . . . 0.0 112.447 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.23 -173.59 1.65 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.166 2.577 . . . . 0.0 115.5 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.511 ' HG1' ' HB3' ' A' ' 100' ' ' ARG 0.273 3.9 t -96.88 161.56 13.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 123.038 1.399 . . . . 0.0 112.997 174.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -151.46 167.99 26.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.352 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.84 147.53 13.1 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.994 2.358 . . . . 0.0 118.994 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.74 156.0 24.66 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.03 149.43 21.23 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.595 1.958 . . . . 0.0 109.594 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.62 117.73 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -93.21 106.38 18.35 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.49 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.268 42.6 m95 -74.26 131.98 41.7 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -172.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -90.48 -39.47 12.59 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.83 -9.51 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.35 129.01 10.79 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.553 2.741 . . . . 0.0 105.374 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.28 118.82 12.65 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.07 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 4.7 m -177.03 159.99 1.73 Allowed 'General case' 0 C--O 1.244 0.779 0 C-N-CA 125.875 1.67 . . . . 0.0 110.34 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.64 141.29 35.1 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.065 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.5 126.26 19.27 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.834 -2.894 . . . . 0.0 108.845 -172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.12 151.5 5.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.808 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 142.28 51.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.84 116.42 5.83 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.2 168.98 39.56 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 118.605 -1.76 . . . . 0.0 116.388 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 28.8 tt0 -101.89 148.31 25.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.782 0.801 . . . . 0.0 111.521 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 49.1 t -95.21 131.72 40.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.716 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -117.59 159.93 22.09 Favored 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 123.685 0.794 . . . . 0.0 112.867 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -124.13 110.37 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.68 158.19 8.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.958 1.303 . . . . 0.0 109.678 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -47.52 -34.27 7.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.96 -18.23 61.4 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 36.4 4.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.705 1.145 . . . . 0.0 112.802 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.41 ' NZ ' ' HB3' ' D' ' 90' ' ' LYS . 8.4 mtpm? -109.14 157.14 19.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.727 1.211 . . . . 0.0 110.189 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -109.21 153.55 23.64 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 119.919 -1.738 . . . . 0.0 111.511 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -153.18 154.57 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.177 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 mt -118.9 106.44 12.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 172.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . 0.485 ' HE3' HD13 ' D' ' 119' ' ' ILE . 1.1 mptt -97.7 125.94 42.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 172.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -138.78 162.91 33.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.75 1.262 . . . . 0.0 112.419 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 18.4 mtp -121.17 160.72 23.2 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -133.92 162.27 32.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.066 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -137.78 126.76 24.17 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.536 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.24 142.06 37.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 125.074 1.484 . . . . 0.0 109.827 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . 0.484 ' HB3' ' HG1' ' A' ' 63' ' ' THR . 0.6 OUTLIER -129.82 117.85 20.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 111.801 -2.454 . . . . 0.0 111.729 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -84.49 171.12 12.82 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 23.4 m -109.09 71.91 0.79 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.79 171.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.838 1.255 . . . . 0.0 109.613 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.64 -4.26 12.81 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.8 150.97 46.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.739 1.257 . . . . 0.0 110.807 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.4 tt -68.33 -21.5 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.183 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.38 3.99 44.38 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.943 0.783 . . . . 0.0 114.294 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.31 1.22 7.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.037 0.935 . . . . 0.0 113.423 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.5 -34.59 71.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 113.034 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -48.21 -39.48 21.23 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -96.78 -12.93 23.02 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.967 1.307 . . . . 0.0 114.189 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.29 -4.62 37.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 6.7 m -108.8 145.42 35.24 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.621 0.724 . . . . 0.0 109.369 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -141.2 151.7 44.0 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.936 1.694 . . . . 0.0 108.854 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.17 153.73 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 109.715 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.78 -176.24 32.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.687 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 18.4 p90 -132.51 160.01 37.76 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.162 -0.61 . . . . 0.0 111.881 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . 0.492 HD22 HD22 ' D' ' 14' ' ' LEU . 4.7 m120 -150.33 157.2 42.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.73 1.252 . . . . 0.0 109.866 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . 0.485 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.0 mt -133.02 130.33 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.66 152.52 41.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.19 0.931 . . . . 0.0 109.417 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 45.2 p -140.66 167.38 22.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -57.4 125.58 23.48 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.326 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 28.8 p -137.97 140.94 40.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.107 1.763 . . . . 0.0 107.479 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -139.86 131.17 26.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 119.839 -1.788 . . . . 0.0 113.463 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.56 -26.11 68.41 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -52.14 118.09 3.25 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.704 1.716 . . . . 0.0 112.433 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.44 -118.0 2.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.507 2.004 . . . . 0.0 110.306 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -144.75 148.52 34.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.502 1.121 . . . . 0.0 113.621 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -144.87 159.05 43.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.177 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -136.65 148.41 47.41 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -105.81 143.55 33.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.812 1.245 . . . . 0.0 112.215 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.89 -22.33 62.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.731 1.212 . . . . 0.0 112.918 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.491 HD22 HD22 ' B' ' 118' ' ' ASN . 50.2 tp -76.68 -14.5 59.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.838 1.255 . . . . 0.0 112.497 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 -12.83 34.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.707 2.099 . . . . 0.0 113.769 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 153.77 28.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.105 1.431 . . . . 0.0 112.554 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.45 147.56 50.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.628 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -142.03 146.87 36.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m -128.55 135.36 49.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.064 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.7 124.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.19 -86.41 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 O-C-N 124.362 1.039 . . . . 0.0 111.502 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.83 152.59 42.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 122.068 0.937 . . . . 0.0 112.11 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -99.84 125.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 113.124 -1.853 . . . . 0.0 108.288 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -71.38 162.83 28.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 110.94 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -55.09 -23.52 21.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -74.83 -31.82 61.78 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.849 -1.157 . . . . 0.0 113.304 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.78 -5.47 27.61 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.874 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.48 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 0.0 OUTLIER -67.03 142.77 57.08 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.15 156.73 31.41 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -125.01 168.87 12.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.556 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.35 -167.1 35.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 122.461 1.034 . . . . 0.0 113.778 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 12.3 p -138.56 132.33 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.606 -1.297 . . . . 0.0 111.15 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.11 136.36 50.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.222 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mt -126.8 129.37 71.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.252 63.7 m -104.67 143.2 33.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.925 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.44 -8.46 21.09 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 m -140.35 145.74 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.267 1.027 . . . . 0.0 112.601 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.94 167.78 27.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.216 -0.928 . . . . 0.0 111.0 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.94 -31.52 64.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.75 69.83 30.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 126.562 1.945 . . . . 0.0 113.902 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 71.36 2.48 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 124.426 3.417 . . . . 0.0 114.259 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.0 2.17 14.68 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 120.753 -1.217 . . . . 0.0 114.571 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.11 27.9 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.594 1.157 . . . . 0.0 112.561 -174.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 86.4 mt -50.45 130.59 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.816 0.817 . . . . 0.0 110.658 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.59 170.42 15.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.636 1.574 . . . . 0.0 109.833 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.61 115.4 2.75 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.133 2.973 . . . . 0.0 111.068 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m -100.9 119.97 56.79 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.06 142.53 85.68 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.622 2.215 . . . . 0.0 111.853 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.98 153.07 47.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.741 0.816 . . . . 0.0 111.725 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.64 148.77 16.24 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.426 1.49 . . . . 0.0 110.348 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.42 -152.38 23.12 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 120.857 1.662 . . . . 0.0 110.158 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -143.0 139.59 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.78 136.36 53.05 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.508 -0.745 . . . . 0.0 112.081 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -69.25 150.93 46.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.988 0.899 . . . . 0.0 111.358 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.26 18.96 1.22 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.056 1.342 . . . . 0.0 111.865 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 mmt-85 -87.84 -58.19 2.66 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.315 1.846 . . . . 0.0 111.467 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 178.5 4.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.6 t -64.42 -53.37 49.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.602 1.161 . . . . 0.0 111.85 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -143.95 66.51 14.86 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.785 0.834 . . . . 0.0 113.057 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.83 -174.23 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.912 2.408 . . . . 0.0 115.316 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.486 ' HG1' ' HB3' ' C' ' 100' ' ' ARG 0.262 4.2 t -96.35 161.27 14.0 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.689 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -151.49 168.48 24.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.207 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.41 147.16 12.27 Favored Glycine 0 CA--C 1.539 1.58 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -160.05 157.63 29.01 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.45 150.11 20.7 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.516 1.926 . . . . 0.0 109.575 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.51 117.12 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -92.41 105.58 17.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.613 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.267 42.9 m95 -74.12 130.79 40.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -89.32 -40.34 12.85 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -91.9 -9.56 42.77 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.37 128.08 10.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.52 2.728 . . . . 0.0 105.326 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.08 118.88 12.54 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.823 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -177.08 159.95 1.71 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.958 1.703 . . . . 0.0 110.317 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -141.11 141.54 34.18 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.87 126.93 19.47 Favored 'General case' 0 N--CA 1.407 -2.625 0 CA-C-N 110.593 -3.003 . . . . 0.0 108.657 -172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.842 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -124.56 142.72 51.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.41 116.92 5.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.84 168.96 39.94 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 118.816 -1.659 . . . . 0.0 116.546 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 28.8 tt0 -101.81 148.4 25.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.76 0.79 . . . . 0.0 111.356 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 49.8 t -95.2 133.04 39.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.133 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -118.41 158.17 25.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 mt -121.97 108.43 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.14 158.62 8.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.126 0.97 . . . . 0.0 110.466 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -46.95 -32.15 3.65 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.05 -12.22 59.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.65 51.32 3.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.8 156.74 30.05 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 129.658 3.183 . . . . 0.0 108.548 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -118.02 155.31 30.53 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 119.948 -1.72 . . . . 0.0 111.465 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -155.54 155.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -120.12 107.07 12.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . 0.477 ' HE3' HD13 ' B' ' 119' ' ' ILE . 1.0 OUTLIER -98.29 126.14 43.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -139.32 163.08 33.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.688 1.233 . . . . 0.0 112.551 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 19.7 mtp -120.79 160.68 22.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.82 162.63 31.48 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.133 -1.849 . . . . 0.0 113.175 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.73 126.38 23.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.568 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.24 141.0 39.23 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 125.05 1.468 . . . . 0.0 109.84 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . 0.513 ' HB3' ' HG1' ' C' ' 63' ' ' THR . 0.8 OUTLIER -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 111.728 -2.487 . . . . 0.0 111.669 -173.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -84.93 171.81 11.86 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 32.6 m -110.08 71.73 0.77 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.72 170.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.333 1.453 . . . . 0.0 110.012 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.39 -4.52 13.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.05 151.85 47.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.662 1.22 . . . . 0.0 111.067 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 15.7 tt -68.52 -22.29 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.072 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.73 4.53 36.19 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.753 0.692 . . . . 0.0 114.391 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.65 1.38 7.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.65 -34.38 71.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.294 1.038 . . . . 0.0 113.284 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -48.34 -39.51 22.3 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -96.44 -13.35 23.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.902 1.281 . . . . 0.0 114.125 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.06 -5.77 43.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -107.54 145.03 33.71 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 121.822 0.82 . . . . 0.0 109.279 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -140.61 151.31 44.56 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 125.966 1.706 . . . . 0.0 108.751 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.88 154.21 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 119.582 1.083 . . . . 0.0 109.656 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.84 -176.14 32.62 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.093 0.854 . . . . 0.0 111.739 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 17.9 p90 -132.73 160.08 37.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.137 -0.625 . . . . 0.0 112.087 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . 0.491 HD22 HD22 ' B' ' 14' ' ' LEU . 5.3 m120 -150.43 157.07 42.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.665 1.221 . . . . 0.0 110.02 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.477 HD13 ' HE3' ' B' ' 94' ' ' LYS . 8.6 mt -132.65 130.0 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.9 153.36 39.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 124.285 0.991 . . . . 0.0 109.408 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.4 p -141.74 165.67 26.85 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.16 121.79 11.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.803 1.241 . . . . 0.0 111.872 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.219 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 p -133.72 143.63 48.61 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -140.04 129.22 23.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 119.581 -1.949 . . . . 0.0 114.248 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.07 -27.32 69.31 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -52.11 114.49 1.34 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 123.035 1.398 . . . . 0.0 111.915 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.96 -109.44 0.74 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.669 1.604 . . . . 0.0 110.979 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -152.0 144.26 23.98 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.87 160.48 39.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.256 1.022 . . . . 0.0 110.699 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.21 148.0 50.81 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -109.3 143.62 38.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.945 0.898 . . . . 0.0 111.859 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -59.6 -25.72 64.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.628 1.171 . . . . 0.0 112.969 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.492 HD22 HD22 ' C' ' 118' ' ' ASN . 48.9 tp -73.58 -14.2 61.15 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.838 -1.164 . . . . 0.0 112.357 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.28 -12.19 36.79 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.82 2.152 . . . . 0.0 113.685 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.86 155.01 28.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 123.393 1.568 . . . . 0.0 112.427 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.39 146.3 51.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.015 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -142.31 144.18 33.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.035 0.922 . . . . 0.0 113.348 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -127.52 134.11 49.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.246 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 95.9 mt -132.64 124.39 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.46 -85.71 0.1 Allowed Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.241 0.963 . . . . 0.0 111.701 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.6 152.33 39.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.846 -0.796 . . . . 0.0 112.283 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.98 126.23 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 113.474 -1.694 . . . . 0.0 108.652 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -71.29 163.23 28.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.541 0.686 . . . . 0.0 111.78 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -56.78 -24.82 53.15 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -73.04 -31.26 64.32 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.736 -1.228 . . . . 0.0 112.524 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.79 -2.26 24.51 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.257 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.44 155.47 40.08 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.016 1.408 . . . . 0.0 112.459 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.89 166.08 34.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.43 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.525 HG21 ' CD1' ' C' ' 50' ' ' LEU . 3.0 p -125.66 -179.34 4.61 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 173.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.0 -166.91 39.22 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 119.208 -2.182 . . . . 0.0 113.222 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 12.4 p -137.13 131.94 33.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.797 0.808 . . . . 0.0 112.199 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -111.39 137.78 48.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.8 129.85 70.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.254 64.9 m -104.8 144.07 32.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.462 -173.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.97 -6.26 21.42 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -141.68 144.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 112.57 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.59 168.03 26.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 110.966 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -31.29 63.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 172.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -140.41 69.94 32.69 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.626 1.97 . . . . 0.0 113.977 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.53 71.56 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.405 3.403 . . . . 0.0 114.195 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.05 1.94 14.64 Favored Glycine 0 N--CA 1.477 1.409 0 O-C-N 120.686 -1.259 . . . . 0.0 114.616 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.91 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.583 1.153 . . . . 0.0 112.554 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.56 130.86 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.898 0.856 . . . . 0.0 110.612 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.15 169.93 16.68 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.773 1.629 . . . . 0.0 109.803 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.8 115.44 2.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 129.264 3.025 . . . . 0.0 111.153 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 57.0 m -100.98 119.47 58.04 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.88 141.75 85.13 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.174 1.916 . . . . 0.0 111.526 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.47 157.02 39.75 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.664 0.786 . . . . 0.0 111.805 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . 0.525 ' CD1' HG21 ' C' ' 30' ' ' THR . 12.6 tp -164.19 148.98 10.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.521 1.528 . . . . 0.0 112.455 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.09 -147.97 14.74 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 120.357 1.435 . . . . 0.0 110.699 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mt -146.84 139.47 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 110.162 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.66 136.66 54.61 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 121.188 -0.945 . . . . 0.0 111.428 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -68.36 150.6 47.99 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.626 -1.296 . . . . 0.0 111.64 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -146.86 25.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.011 1.324 . . . . 0.0 111.717 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 mmt-85 -93.42 -58.2 2.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.173 1.789 . . . . 0.0 111.705 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.25 179.65 4.39 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.594 1.184 . . . . 0.0 113.992 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -63.71 -57.9 8.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.725 0.81 . . . . 0.0 110.795 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.75 66.64 27.63 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.606 0.763 . . . . 0.0 112.065 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -173.31 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.29 2.66 . . . . 0.0 115.245 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.513 ' HG1' ' HB3' ' B' ' 100' ' ' ARG 0.276 4.0 t -96.54 161.51 13.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 123.055 1.407 . . . . 0.0 113.011 174.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -151.75 167.57 27.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.469 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.5 147.79 13.71 Favored Glycine 0 CA--C 1.542 1.771 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.68 156.54 25.64 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -93.57 150.05 20.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.546 1.938 . . . . 0.0 109.618 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.03 117.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -92.74 107.14 18.99 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.347 -0.846 . . . . 0.0 110.42 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.268 43.1 m95 -75.3 131.8 40.56 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -89.95 -40.53 12.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -92.21 -9.23 43.0 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -152.37 127.79 9.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.605 2.762 . . . . 0.0 105.172 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.37 118.84 12.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.2 m -177.2 160.2 1.7 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 126.127 1.771 . . . . 0.0 110.424 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -140.98 141.57 34.38 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.054 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.43 127.32 20.63 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 110.642 -2.981 . . . . 0.0 108.824 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.13 151.19 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.69 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.8 142.42 51.12 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.5 117.16 5.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -173.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 169.0 39.61 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.257 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 28.8 tt0 -101.75 148.66 25.01 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 111.354 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.48 132.67 41.8 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.107 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -117.95 160.28 21.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.01 110.18 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 172.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.79 156.96 10.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 109.912 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -46.76 -34.9 5.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.62 -15.95 61.24 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.62 35.62 5.6 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.365 1.459 . . . . 0.0 113.232 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' C' ' 90' ' ' LYS . 4.6 mtpm? -104.47 163.04 12.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.16 1.384 . . . . 0.0 107.854 173.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -118.49 152.57 35.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.997 1.719 . . . . 0.0 111.182 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -153.34 156.04 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.229 1.411 . . . . 0.0 111.168 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 mt -119.91 108.67 14.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' C' ' 119' ' ' ILE . 1.0 OUTLIER -99.6 126.07 45.53 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 172.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -139.34 162.55 34.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.667 1.223 . . . . 0.0 112.677 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 18.9 mtp -120.3 160.98 21.91 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -133.86 162.76 31.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.995 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 tp -137.81 126.73 24.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.467 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.22 38.84 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 124.881 1.363 . . . . 0.0 109.944 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . 0.486 ' HB3' ' HG1' ' B' ' 63' ' ' THR . 0.5 OUTLIER -129.42 118.92 22.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 111.615 -2.539 . . . . 0.0 111.771 -173.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 96.2 p -85.96 171.68 11.26 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -110.34 71.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.5 171.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.081 1.352 . . . . 0.0 109.529 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -114.07 -5.68 13.1 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.54 151.49 47.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.703 1.24 . . . . 0.0 110.98 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.3 tt -67.79 -22.11 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.932 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.5 3.84 38.84 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.85 -0.972 . . . . 0.0 114.33 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -125.58 1.27 7.57 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.289 1.036 . . . . 0.0 113.747 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.66 -34.39 71.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.148 0.979 . . . . 0.0 112.973 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.54 -39.0 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -96.95 -12.62 23.16 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.028 1.331 . . . . 0.0 114.237 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.57 -4.61 38.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 6.8 m -108.65 144.99 35.67 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.305 1.05 . . . . 0.0 109.672 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -141.31 151.68 43.81 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.547 1.539 . . . . 0.0 108.262 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.23 153.41 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.87 -175.88 32.37 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 123.998 0.808 . . . . 0.0 111.807 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 18.4 p90 -133.09 160.52 36.96 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.086 -0.656 . . . . 0.0 112.26 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . 0.492 HD22 HD22 ' C' ' 14' ' ' LEU . 4.9 m120 -150.65 157.56 43.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.719 1.247 . . . . 0.0 110.276 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' C' ' 94' ' ' LYS . 8.8 mt -133.13 130.87 58.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -124.32 150.93 44.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -139.59 167.59 21.76 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.399 -0.813 . . . . 0.0 109.061 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -57.59 117.33 4.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.222 1.009 . . . . 0.0 111.572 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.045 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 t -116.33 123.44 47.64 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -141.11 134.78 30.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.892 -1.13 . . . . 0.0 112.232 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.65 -18.09 61.07 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -56.15 115.89 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.606 1.162 . . . . 0.0 111.317 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.91 -122.23 3.29 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.926 1.727 . . . . 0.0 111.269 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.45 143.6 26.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -140.35 162.68 34.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.28 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -137.77 146.31 43.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.359 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.403 HD21 ' HB3' ' A' ' 14' ' ' LEU . 6.3 t30 -108.0 145.31 34.09 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.948 0.899 . . . . 0.0 110.581 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.81 -29.45 54.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.963 1.305 . . . . 0.0 114.248 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 12' ' ' ASN . 30.3 tp -70.99 -13.83 62.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.975 1.71 . . . . 0.0 113.402 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.38 22.95 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.31 2.386 . . . . 0.0 113.868 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 156.04 34.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.042 1.421 . . . . 0.0 113.578 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.29 136.14 51.54 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.407 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -130.1 143.26 50.69 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.393 -0.817 . . . . 0.0 112.09 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 m -132.07 133.08 43.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.514 0.726 . . . . 0.0 109.589 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.91 121.75 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -58.19 9.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.311 1.007 . . . . 0.0 112.425 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.32 153.27 3.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.164 1.386 . . . . 0.0 110.557 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.48 130.96 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 124.582 1.176 . . . . 0.0 111.293 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -75.1 168.85 19.18 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 m -55.62 -27.95 52.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -81.77 -35.77 29.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.059 0.845 . . . . 0.0 110.422 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.54 -6.02 9.2 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 117.151 -1.916 . . . . 0.0 114.489 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.9 141.81 56.26 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 119.7 1.75 . . . . 0.0 108.101 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.24 151.0 22.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.85 165.32 11.94 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.42 -165.45 32.09 Favored Glycine 0 C--O 1.237 0.322 0 O-C-N 120.683 -1.261 . . . . 0.0 111.707 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -141.36 143.35 33.94 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 122.227 1.013 . . . . 0.0 112.983 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -118.65 123.9 46.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.246 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.15 126.68 72.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.3 m -105.65 150.51 25.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.3 -11.88 14.82 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.39 146.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.363 1.465 . . . . 0.0 112.091 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.17 42.18 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.292 -1.505 . . . . 0.0 113.265 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -71.57 -21.54 61.87 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.693 0.397 . . . . 0.0 110.598 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -148.47 83.46 7.03 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.828 2.451 . . . . 0.0 109.944 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 28.33 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.545 3.497 . . . . 0.0 115.834 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.12 -5.67 49.17 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 0.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.003 -1.475 . . . . 0.0 114.165 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -20.57 114.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.865 1.666 . . . . 0.0 115.451 -173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 168.18 18.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.351 2.26 . . . . 0.0 107.923 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -53.69 138.25 35.53 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.148 1.379 . . . . 0.0 112.856 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -115.55 121.56 34.32 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.22 144.82 89.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.435 2.757 . . . . 0.0 111.622 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.49 154.86 48.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 111.378 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.81 148.56 20.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.237 1.815 . . . . 0.0 109.916 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.25 -153.4 23.88 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 121.748 2.067 . . . . 0.0 111.775 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -142.17 142.4 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.04 143.98 51.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.35 0.66 . . . . 0.0 111.816 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -79.35 151.43 31.0 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.603 1.192 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -145.94 25.46 1.28 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.43 1.492 . . . . 0.0 111.744 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -93.52 -50.22 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.219 2.208 . . . . 0.0 112.107 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.95 178.19 7.66 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.797 0.808 . . . . 0.0 112.81 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 p -77.82 -41.77 35.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 113.676 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -131.66 56.46 24.26 Favored Pre-proline 0 CA--C 1.554 1.103 0 C-N-CA 125.367 1.467 . . . . 0.0 112.174 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.06 172.06 12.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.975 1.783 . . . . 0.0 115.71 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.51 174.08 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.229 173.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -166.69 165.34 16.54 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.252 -1.794 . . . . 0.0 113.592 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.68 148.32 13.67 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 118.589 2.195 . . . . 0.0 118.589 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -164.13 154.98 15.47 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 152.4 22.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.906 1.683 . . . . 0.0 110.326 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -133.23 116.91 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -99.49 110.13 22.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -76.95 136.81 38.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -38.34 12.54 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.545 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -86.54 -15.67 39.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -152.55 122.23 6.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.195 1.798 . . . . 0.0 107.145 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.65 118.48 5.71 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.175 1.352 . . . . 0.0 110.114 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.9 p -175.18 168.34 3.39 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.04 1.736 . . . . 0.0 110.616 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -147.78 145.33 28.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.254 1.502 . . . . 0.0 111.326 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.02 130.35 31.27 Favored 'General case' 0 N--CA 1.407 -2.621 0 CA-C-N 110.03 -3.259 . . . . 0.0 108.515 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.35 140.79 31.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 O-C-N 123.874 0.734 . . . . 0.0 109.573 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -115.09 147.43 40.21 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.422 0.452 . . . . 0.0 110.561 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 118.25 10.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.39 -172.71 31.21 Favored Glycine 0 CA--C 1.502 -0.768 0 C-N-CA 119.493 -1.336 . . . . 0.0 115.749 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -123.3 149.9 44.24 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 125.101 1.118 . . . . 0.0 113.103 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.49 112.86 24.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.576 -2.556 . . . . 0.0 106.31 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 10.5 m-85 -108.41 155.97 19.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 118.893 0.77 . . . . 0.0 112.625 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -128.9 113.04 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.79 161.65 4.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.812 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -41.63 -48.29 4.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.553 1.541 . . . . 0.0 113.599 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.36 -29.97 70.26 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.23 24.53 5.38 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.124 1.345 . . . . 0.0 114.142 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -92.92 160.5 14.87 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.647 1.223 . . . . 0.0 108.128 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.01 147.67 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.363 1.465 . . . . 0.0 111.405 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -148.27 159.62 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.104 1.362 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.1 mt -122.47 106.43 11.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' HE3' HD13 ' A' ' 119' ' ' ILE . 3.9 mmtt -98.87 123.99 43.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -139.34 168.4 19.91 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.54 1.638 . . . . 0.0 113.652 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -118.71 163.15 17.26 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -136.9 162.23 33.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.632 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -145.52 120.82 10.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.78 -1.554 . . . . 0.0 111.676 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.74 137.57 45.52 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 125.152 1.532 . . . . 0.0 112.897 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -118.95 113.85 21.65 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 111.121 -2.763 . . . . 0.0 110.88 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.282 49.2 m -73.6 168.09 20.01 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.364 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 p -110.4 85.88 2.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.09 -164.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -131.49 -26.07 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.574 -1.329 . . . . 0.0 114.042 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.35 148.89 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.81 1.767 . . . . 0.0 111.916 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.2 -22.49 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.343 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.86 2.69 54.04 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 117.969 -1.462 . . . . 0.0 113.634 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -120.36 1.9 10.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.72 -27.84 66.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.606 -1.934 . . . . 0.0 112.395 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 43.7 p-90 -46.08 -49.49 16.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.302 1.041 . . . . 0.0 113.042 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -89.29 -11.42 43.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.93 0.892 . . . . 0.0 112.703 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.34 -3.03 34.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.237 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -107.72 138.46 43.92 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.746 0.819 . . . . 0.0 112.585 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 114' ' ' ARG . 18.4 mtt85 -141.35 130.37 23.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 110.821 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.45 158.25 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.933 1.242 . . . . 0.0 111.308 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.63 -177.51 36.54 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 14.7 p90 -126.69 155.56 42.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.913 -0.757 . . . . 0.0 111.858 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -148.13 155.73 41.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.539 1.161 . . . . 0.0 110.915 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.479 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.1 mt -139.32 120.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.06 153.92 27.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.466 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -142.14 165.99 25.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 123.5 14.84 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.287 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.25 123.49 47.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -143.02 136.26 28.23 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.41 -17.87 61.21 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -55.86 118.81 4.93 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.434 1.111 . . . . 0.0 111.704 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.2 -114.83 1.72 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 125.612 1.577 . . . . 0.0 111.239 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.83 141.37 21.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -139.18 162.8 34.08 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.559 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -142.52 147.92 36.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.92 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . 0.415 HD21 ' HB3' ' D' ' 14' ' ' LEU . 5.5 t30 -108.15 145.66 33.84 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.897 0.879 . . . . 0.0 110.487 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.63 -27.02 57.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.819 1.248 . . . . 0.0 113.9 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' D' ' 12' ' ' ASN . 30.5 tp -71.41 -14.62 62.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.753 1.621 . . . . 0.0 113.384 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.14 -13.45 21.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.309 2.385 . . . . 0.0 113.975 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.39 154.55 41.08 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.094 1.447 . . . . 0.0 112.619 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.65 135.13 51.82 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.309 0.644 . . . . 0.0 110.764 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -128.77 144.42 51.16 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.472 -0.768 . . . . 0.0 111.987 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -133.77 131.48 39.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.964 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.81 122.3 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.64 -60.52 6.12 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 124.542 1.151 . . . . 0.0 112.24 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.1 156.08 8.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.538 1.135 . . . . 0.0 110.872 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.23 129.84 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.481 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -75.35 168.21 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.082 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -56.43 -26.8 54.72 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -80.16 -32.76 38.78 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.095 0.861 . . . . 0.0 110.606 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 -6.15 10.3 Favored Glycine 0 C--O 1.221 -0.703 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.486 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.59 149.77 46.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.218 1.407 . . . . 0.0 113.265 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.17 165.56 31.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.769 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 161.96 26.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -172.06 -165.26 28.93 Favored Glycine 0 N--CA 1.464 0.552 0 O-C-N 119.983 -1.698 . . . . 0.0 111.96 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 70.6 p -139.89 141.43 36.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.464 1.126 . . . . 0.0 113.337 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -119.52 122.43 41.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.094 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.75 127.23 71.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 58.2 m -105.6 150.87 25.02 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.79 -12.31 14.62 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.49 146.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.312 1.445 . . . . 0.0 111.935 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.88 161.59 41.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.362 -1.462 . . . . 0.0 113.353 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -72.09 -21.48 61.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.717 0.407 . . . . 0.0 110.747 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.27 83.29 7.23 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 127.857 2.463 . . . . 0.0 109.915 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.76 28.0 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 124.489 3.459 . . . . 0.0 115.951 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.91 -5.65 47.83 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 1.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.136 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -21.53 115.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 168.3 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.401 2.28 . . . . 0.0 107.894 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.01 139.03 35.75 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.325 1.45 . . . . 0.0 112.837 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -116.8 121.59 32.65 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.87 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.21 143.34 93.68 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.452 2.768 . . . . 0.0 111.474 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.63 161.68 33.29 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.998 0.919 . . . . 0.0 111.885 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 tp -166.78 148.4 6.19 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.231 1.412 . . . . 0.0 112.011 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 -152.91 23.54 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 121.171 1.805 . . . . 0.0 111.804 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.56 142.65 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.672 0.789 . . . . 0.0 112.689 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 144.6 51.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.851 1.26 . . . . 0.0 111.183 174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.56 149.49 29.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.942 0.877 . . . . 0.0 109.522 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -143.46 24.53 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.573 1.549 . . . . 0.0 111.648 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.48 -49.68 5.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.748 2.019 . . . . 0.0 111.536 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.23 178.45 8.06 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.087 0.867 . . . . 0.0 112.371 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 13.2 p -77.39 -42.27 36.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.603 1.961 . . . . 0.0 113.907 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -131.28 54.06 13.5 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.237 1.415 . . . . 0.0 112.05 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.25 173.59 9.35 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.571 2.181 . . . . 0.0 115.989 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.67 6.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.72 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -166.7 164.27 16.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.868 -1.515 . . . . 0.0 113.724 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.7 147.84 13.31 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 118.158 2.023 . . . . 0.0 118.158 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -164.05 154.03 14.7 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.7 152.7 21.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.209 1.804 . . . . 0.0 110.06 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -133.59 116.91 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -100.11 110.06 22.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.428 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -76.44 138.62 40.45 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -37.72 11.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.152 -1.386 . . . . 0.0 114.688 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -87.23 -15.7 37.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -152.54 121.68 6.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 126.553 1.941 . . . . 0.0 107.277 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -57.98 118.49 5.44 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.957 1.253 . . . . 0.0 110.179 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 66.1 p -174.75 169.34 3.55 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.992 1.717 . . . . 0.0 110.65 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -148.09 145.71 28.53 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-O 123.501 1.619 . . . . 0.0 111.081 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.77 130.22 31.61 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 109.847 -3.342 . . . . 0.0 108.459 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.69 141.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -115.09 147.73 39.82 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 0.0 110.562 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.29 117.92 9.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.66 -171.9 29.44 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 119.398 -1.382 . . . . 0.0 115.566 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . 0.526 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.4 OUTLIER -127.31 149.95 49.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.528 1.156 . . . . 0.0 113.309 -174.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.63 112.63 24.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.83 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.526 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 11.9 m-85 -111.22 153.09 26.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 119.458 1.026 . . . . 0.0 113.066 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.75 109.94 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 163.16 3.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.475 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -41.63 -42.3 2.46 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -12.67 60.03 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.57 44.71 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.086 1.327 . . . . 0.0 114.898 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -67.76 159.51 30.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.254 1.527 . . . . 0.0 110.705 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -120.11 145.49 46.85 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.858 1.663 . . . . 0.0 111.892 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.31 158.29 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.751 1.22 . . . . 0.0 110.706 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -121.57 106.65 11.57 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . 0.488 ' HE3' HD13 ' D' ' 119' ' ' ILE . 4.2 mmtt -99.34 123.98 44.06 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -139.35 168.22 20.31 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.577 1.656 . . . . 0.0 113.677 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.29 163.39 16.77 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 171.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -137.0 162.45 33.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.254 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -145.82 121.07 10.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.611 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.14 44.49 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 125.062 1.477 . . . . 0.0 112.917 -174.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.45 113.85 21.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 111.177 -2.738 . . . . 0.0 110.943 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.284 49.8 m -73.42 168.3 19.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.279 1.612 . . . . 0.0 111.337 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.9 86.02 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.07 -165.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -130.77 -26.28 2.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 149.23 40.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.859 1.79 . . . . 0.0 111.93 176.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.39 -22.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.213 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.92 4.06 54.72 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.99 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 6.7 m-20 -120.99 2.67 10.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.34 -27.86 67.7 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.587 -1.946 . . . . 0.0 112.046 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . 0.451 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.3 p-90 -45.69 -49.46 14.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.347 1.059 . . . . 0.0 113.107 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -89.61 -11.32 42.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.039 0.936 . . . . 0.0 112.558 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.61 -2.62 33.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.695 0.398 . . . . 0.0 111.437 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -107.9 138.59 43.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.638 0.775 . . . . 0.0 112.78 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' D' ' 114' ' ' ARG . 18.8 mtt85 -141.43 130.18 22.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.856 1.262 . . . . 0.0 111.032 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.32 158.26 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.891 1.223 . . . . 0.0 111.331 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.15 -177.9 36.48 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 14.7 p90 -126.07 155.33 41.74 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.913 -0.757 . . . . 0.0 111.477 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -148.03 154.69 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.072 0.939 . . . . 0.0 110.45 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . 0.488 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -137.31 120.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -111.84 153.26 26.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.348 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -138.38 164.86 28.25 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 121.4 7.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.071 0.948 . . . . 0.0 110.956 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' D' ' 123' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.235 0.306 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.51 123.35 48.3 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -173.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -142.91 135.48 27.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.396 1.078 . . . . 0.0 113.528 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.48 -17.83 61.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -55.94 115.87 2.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.46 1.104 . . . . 0.0 111.407 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.34 -119.72 2.7 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.953 1.739 . . . . 0.0 110.887 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.21 143.79 27.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -142.13 162.78 34.6 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.249 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -142.1 146.84 35.84 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.976 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' B' ' 14' ' ' LEU . 6.6 t30 -107.08 146.25 31.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.15 0.98 . . . . 0.0 110.386 -174.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.8 -27.77 52.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.862 1.265 . . . . 0.0 114.329 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' B' ' 12' ' ' ASN . 30.0 tp -72.14 -14.58 61.86 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.759 1.624 . . . . 0.0 113.225 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.03 -12.28 24.47 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.257 2.36 . . . . 0.0 114.077 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.53 153.58 41.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.154 1.477 . . . . 0.0 113.74 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.8 134.05 52.9 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 174.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -128.06 145.21 51.07 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.544 -0.722 . . . . 0.0 112.408 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -133.33 133.28 42.32 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.43 0.692 . . . . 0.0 109.673 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -132.87 122.18 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.65 -58.85 7.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.226 0.954 . . . . 0.0 112.378 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.64 153.55 4.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.121 1.368 . . . . 0.0 110.626 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.52 131.4 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 124.492 1.12 . . . . 0.0 111.371 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -75.52 168.79 19.34 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -55.61 -27.89 52.13 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -81.83 -35.55 29.3 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.059 0.845 . . . . 0.0 110.44 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 -6.33 9.27 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 117.22 -1.878 . . . . 0.0 114.663 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.07 141.57 57.45 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.48 1.64 . . . . 0.0 108.461 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.22 151.13 22.63 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.95 165.19 12.07 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.15 -164.93 31.14 Favored Glycine 0 C--O 1.237 0.33 0 O-C-N 120.547 -1.346 . . . . 0.0 111.568 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -141.45 142.76 33.64 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.287 1.041 . . . . 0.0 113.011 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -117.58 125.26 50.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.229 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.09 125.93 73.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 30.6 m -106.34 144.98 32.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.88 -13.42 16.96 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.8 146.8 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.182 1.393 . . . . 0.0 112.113 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.66 161.42 42.17 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.301 -1.499 . . . . 0.0 113.264 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.85 -21.52 61.66 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.31 83.05 7.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.858 2.463 . . . . 0.0 110.084 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.8 29.15 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 124.645 3.563 . . . . 0.0 115.895 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.88 -5.49 52.38 Favored Glycine 0 N--CA 1.478 1.434 0 N-CA-C 118.194 2.038 . . . . 0.0 118.194 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.92 2.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.163 1.482 . . . . 0.0 114.148 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -21.27 111.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.15 167.63 16.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.334 2.254 . . . . 0.0 108.181 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.78 138.54 35.46 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.398 1.479 . . . . 0.0 112.846 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -115.55 121.82 33.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.056 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.42 144.75 90.89 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.426 2.751 . . . . 0.0 111.455 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.47 154.36 48.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.148 0.979 . . . . 0.0 111.287 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -156.87 148.79 22.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.066 1.746 . . . . 0.0 109.944 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.19 -153.5 24.05 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 121.933 2.151 . . . . 0.0 111.66 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -142.39 142.43 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 143.45 50.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.192 0.597 . . . . 0.0 111.694 173.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -78.48 152.87 31.82 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.424 1.107 . . . . 0.0 109.549 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -147.29 25.45 1.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.568 1.547 . . . . 0.0 111.68 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -93.46 -49.21 6.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.985 2.114 . . . . 0.0 112.078 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 178.32 8.12 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.3 p -75.47 -43.06 51.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.042 1.737 . . . . 0.0 113.635 174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.2 54.21 13.37 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.25 1.42 . . . . 0.0 112.192 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -67.43 171.82 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.035 1.824 . . . . 0.0 115.79 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 174.58 7.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.129 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.77 164.61 16.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.529 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.4 147.8 12.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.43 154.75 16.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -88.38 150.72 23.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.22 1.808 . . . . 0.0 110.528 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.58 116.92 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -99.32 110.14 22.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.748 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -76.79 136.77 38.99 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.76 -37.93 12.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.667 -174.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -87.28 -15.11 39.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 21.8 t -152.58 122.66 7.07 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.42 1.888 . . . . 0.0 107.309 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.85 118.53 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.932 1.242 . . . . 0.0 110.078 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -174.92 168.98 3.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.19 1.796 . . . . 0.0 110.542 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.79 145.47 28.79 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.243 1.497 . . . . 0.0 111.181 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.31 130.21 30.46 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 110.095 -3.23 . . . . 0.0 108.588 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 m -113.47 140.84 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.892 0.745 . . . . 0.0 109.68 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -115.04 147.29 40.33 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 123.463 0.477 . . . . 0.0 110.452 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 117.99 10.21 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.55 -173.16 30.91 Favored Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 119.728 -1.225 . . . . 0.0 115.645 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . 0.523 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.1 OUTLIER -124.77 149.92 46.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.579 1.18 . . . . 0.0 112.895 -175.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.44 112.66 24.4 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 111.358 -2.656 . . . . 0.0 105.488 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 11.5 m-85 -110.71 155.78 21.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 119.265 0.939 . . . . 0.0 112.666 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.34 117.99 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.95 162.79 10.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.195 0.998 . . . . 0.0 110.578 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -42.7 -44.85 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.595 1.558 . . . . 0.0 114.795 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -24.34 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.787 1.235 . . . . 0.0 113.541 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.46 5.45 26.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.446 1.498 . . . . 0.0 115.094 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -72.57 162.22 29.77 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 119.274 1.537 . . . . 0.0 110.809 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.45 142.51 51.26 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.527 1.531 . . . . 0.0 112.162 -173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.11 159.26 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 125.355 1.462 . . . . 0.0 110.701 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.4 107.18 11.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . 0.474 ' HE3' HD13 ' B' ' 119' ' ' ILE . 3.8 mmtt -99.78 124.5 45.12 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 172.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.5 p -139.71 168.49 19.69 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.637 1.684 . . . . 0.0 113.662 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -118.85 163.18 17.27 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -136.96 162.83 32.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 0.0 111.647 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.19 121.06 9.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.741 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 138.33 44.18 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 125.198 1.561 . . . . 0.0 113.138 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.69 113.89 21.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.357 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.273 49.4 m -73.49 168.08 19.99 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.886 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.3 p -110.24 84.34 1.91 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.28 -167.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -127.2 -26.45 3.09 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.042 -1.036 . . . . 0.0 112.9 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.11 145.93 40.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 123.252 1.501 . . . . 0.0 112.521 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.13 -23.77 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.851 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.78 0.14 62.45 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 117.543 -1.698 . . . . 0.0 114.075 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 1.0 OUTLIER -117.55 1.07 12.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.808 1.304 . . . . 0.0 114.104 -178.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.59 -27.87 66.66 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 119.562 -1.961 . . . . 0.0 112.278 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.409 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 46.4 p-90 -46.38 -49.18 18.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.275 1.03 . . . . 0.0 113.157 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -88.86 -12.69 41.13 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.783 0.833 . . . . 0.0 112.367 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.26 -1.7 24.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.815 0.446 . . . . 0.0 111.577 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -109.13 137.7 46.62 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.614 0.765 . . . . 0.0 113.042 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.467 ' HG3' HH11 ' B' ' 114' ' ' ARG . 19.5 mtt85 -140.69 130.21 24.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.633 1.173 . . . . 0.0 110.676 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.88 158.88 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.044 1.293 . . . . 0.0 111.236 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.73 -177.33 36.47 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 14.4 p90 -126.87 156.03 42.03 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.819 -0.812 . . . . 0.0 111.937 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -148.46 155.34 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.554 1.168 . . . . 0.0 110.856 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.474 HD13 ' HE3' ' B' ' 94' ' ' LYS . 10.5 mt -138.26 119.83 17.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.21 152.52 27.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.467 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 21.5 p -139.13 164.2 30.41 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.57 128.99 31.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.291 1.036 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.093 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.39 123.74 48.32 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -143.22 137.9 29.29 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.245 -1.535 . . . . 0.0 113.564 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.43 -18.95 61.08 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -56.29 115.91 2.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.387 1.075 . . . . 0.0 111.615 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.53 -119.63 2.5 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.838 1.685 . . . . 0.0 111.139 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 142.27 24.8 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -140.87 162.8 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.785 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -142.83 145.13 32.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.635 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' C' ' 14' ' ' LEU . 6.2 t30 -105.89 146.97 29.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.186 0.995 . . . . 0.0 110.582 -174.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.18 -26.48 64.83 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.418 ' HB3' HD21 ' C' ' 12' ' ' ASN . 30.3 tp -71.44 -14.63 62.21 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.697 1.599 . . . . 0.0 112.983 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.69 -13.23 22.7 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.071 2.272 . . . . 0.0 113.99 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 154.3 37.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.958 1.379 . . . . 0.0 113.835 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 136.59 53.22 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -130.27 145.37 51.75 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.561 -0.712 . . . . 0.0 112.004 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -134.29 132.46 39.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.259 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.22 120.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.46 -56.9 12.85 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.535 1.147 . . . . 0.0 112.658 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.53 155.63 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.494 1.518 . . . . 0.0 110.648 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.41 129.72 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.611 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -75.18 167.93 20.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -56.38 -27.06 55.1 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -79.53 -33.77 41.7 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.083 0.856 . . . . 0.0 110.647 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.09 9.53 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 124.123 0.868 . . . . 0.0 114.373 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.02 149.96 46.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.218 1.407 . . . . 0.0 113.019 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.22 166.05 30.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.55 0.74 . . . . 0.0 110.84 175.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.8 p -125.57 162.34 25.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.99 -165.55 29.32 Favored Glycine 0 N--CA 1.464 0.542 0 O-C-N 119.955 -1.716 . . . . 0.0 111.986 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.9 p -140.37 140.74 35.59 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.522 1.153 . . . . 0.0 113.116 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -118.63 124.87 48.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.906 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.98 127.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 45.0 m -108.3 145.67 34.06 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.39 -11.6 17.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.91 146.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.102 1.361 . . . . 0.0 111.918 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.38 161.24 42.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.498 -1.376 . . . . 0.0 113.355 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.42 -22.54 61.84 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.603 0.361 . . . . 0.0 110.589 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -147.69 83.57 7.46 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.767 2.427 . . . . 0.0 110.111 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.82 28.27 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 124.548 3.499 . . . . 0.0 115.895 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.75 48.92 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.9 2.3 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.071 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 60.8 mt -22.0 112.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.46 168.21 16.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.449 2.3 . . . . 0.0 108.131 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -53.96 139.1 35.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.463 1.505 . . . . 0.0 112.724 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -116.39 121.16 33.79 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.195 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.15 143.18 93.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.391 2.727 . . . . 0.0 111.56 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.43 161.71 32.99 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.912 0.885 . . . . 0.0 111.694 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 tp -166.56 148.73 6.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.131 1.373 . . . . 0.0 111.87 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.39 -153.04 23.73 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 121.563 1.983 . . . . 0.0 111.986 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.73 142.38 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 112.554 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 144.91 51.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.005 1.322 . . . . 0.0 111.01 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.72 151.13 29.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.771 0.796 . . . . 0.0 109.393 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -143.99 23.95 1.68 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.381 1.472 . . . . 0.0 111.686 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.36 -50.35 5.5 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.894 2.078 . . . . 0.0 111.84 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.36 178.18 7.88 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.822 0.701 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 13.5 p -75.14 -42.48 56.14 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.751 1.62 . . . . 0.0 113.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -132.37 53.54 11.45 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -66.55 172.42 9.26 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 121.804 1.669 . . . . 0.0 115.716 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 174.52 7.12 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.138 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.73 164.24 16.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.558 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.8 147.58 12.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 118.151 2.02 . . . . 0.0 118.151 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -163.52 154.22 16.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.67 152.73 21.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.372 1.869 . . . . 0.0 110.136 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.67 116.84 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -100.26 109.55 21.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.426 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -76.23 138.66 40.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -37.69 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -87.31 -15.49 37.85 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.7 t -152.5 122.41 7.01 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.377 1.871 . . . . 0.0 107.236 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -58.32 118.57 5.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.002 1.274 . . . . 0.0 110.274 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 70.3 p -175.42 168.59 3.25 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.101 1.76 . . . . 0.0 110.553 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.2 t -147.84 146.01 28.94 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-O 123.489 1.614 . . . . 0.0 111.028 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.36 130.15 30.25 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 109.872 -3.331 . . . . 0.0 108.79 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -112.51 142.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -115.5 148.07 39.92 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.885 0.74 . . . . 0.0 110.597 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 117.91 9.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.64 -172.72 30.46 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.547 -1.311 . . . . 0.0 115.687 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.1 OUTLIER -125.86 149.64 48.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.606 1.193 . . . . 0.0 113.028 -174.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.38 112.55 24.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.409 -2.632 . . . . 0.0 105.437 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 12.7 m-85 -110.67 154.43 23.84 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.283 0.947 . . . . 0.0 112.72 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.84 115.34 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.99 162.09 11.96 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.806 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -42.82 -41.86 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.015 1.726 . . . . 0.0 115.577 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.35 -3.24 42.09 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.92 5.2 64.48 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.603 1.573 . . . . 0.0 115.19 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -71.72 162.27 29.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 1.242 . . . . 0.0 110.195 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -123.34 141.46 51.96 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.658 1.583 . . . . 0.0 111.235 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.15 159.44 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 125.368 1.467 . . . . 0.0 110.867 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.23 107.79 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 172.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . 0.479 ' HE3' HD13 ' C' ' 119' ' ' ILE . 3.7 mmtt -100.56 123.97 45.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -138.92 168.1 20.58 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 123.645 1.688 . . . . 0.0 113.866 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -118.29 163.79 16.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -136.97 162.87 32.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.395 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.27 121.19 9.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.683 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.13 44.51 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 125.216 1.572 . . . . 0.0 113.044 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -119.78 113.93 21.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 111.372 -2.649 . . . . 0.0 111.12 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.279 50.2 m -73.49 168.1 19.95 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 125.365 1.666 . . . . 0.0 111.664 174.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.59 86.78 2.38 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.75 -165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -130.0 -25.42 2.52 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.947 -1.095 . . . . 0.0 113.251 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.03 147.16 39.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.366 1.555 . . . . 0.0 112.259 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 18.8 tt -62.93 -23.25 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.892 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.61 60.17 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.767 -1.574 . . . . 0.0 114.075 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . 0.416 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.5 OUTLIER -118.8 0.95 11.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.738 1.269 . . . . 0.0 113.833 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.4 -27.91 66.42 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.629 -1.92 . . . . 0.0 112.368 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . 0.416 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 46.1 p-90 -46.1 -49.13 16.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.229 1.012 . . . . 0.0 113.379 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -89.06 -12.32 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.607 0.763 . . . . 0.0 112.67 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.57 -2.09 27.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.693 0.397 . . . . 0.0 111.409 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 2.0 m -108.55 138.71 44.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.55 0.74 . . . . 0.0 112.742 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' C' ' 114' ' ' ARG . 19.4 mtt85 -141.25 130.55 23.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.943 1.297 . . . . 0.0 110.831 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.17 158.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.272 . . . . 0.0 111.213 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.06 -177.45 36.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 13.4 p90 -126.68 155.82 42.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.851 -0.793 . . . . 0.0 111.861 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -148.47 154.58 40.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.386 1.089 . . . . 0.0 111.089 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . 0.479 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.0 mt -137.17 120.97 22.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.21 152.62 28.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.943 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.5 p -138.44 163.04 32.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.72 135.01 36.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.312 0.645 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 123.06 1.41 . . . . 0.0 111.186 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.28 150.09 38.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.367 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 p -139.33 127.44 22.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.205 1.002 . . . . 0.0 112.311 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.403 HD21 ' CE2' ' A' ' 64' ' ' PHE . 73.9 mt -69.24 -34.44 74.83 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -47.57 110.97 0.36 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.021 1.328 . . . . 0.0 111.077 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.38 -130.17 4.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 125.312 1.434 . . . . 0.0 109.584 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -146.14 144.87 30.24 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.073 0.949 . . . . 0.0 112.721 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -136.64 162.9 31.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.188 1.395 . . . . 0.0 111.391 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -140.62 150.95 44.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.11 0.964 . . . . 0.0 109.567 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.66 143.54 47.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.385 1.074 . . . . 0.0 110.348 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -60.52 -22.16 63.28 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.45 1.5 . . . . 0.0 113.338 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.52 -15.61 61.78 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.629 1.172 . . . . 0.0 111.094 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.76 -16.43 18.73 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.639 3.019 . . . . 0.0 113.395 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.42 148.87 40.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.065 1.412 . . . . 0.0 112.955 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.46 136.52 54.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.779 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -127.46 143.26 51.22 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.535 0.684 . . . . 0.0 112.154 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -131.34 130.98 43.39 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.979 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.59 126.03 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.52 -85.55 0.13 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.48 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.03 145.79 30.73 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.86 0.838 . . . . 0.0 111.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.17 129.65 50.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.16 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -75.65 168.96 19.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.995 0.902 . . . . 0.0 112.386 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -58.7 -26.34 63.77 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.89 -40.65 75.53 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.374 -0.829 . . . . 0.0 110.822 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.05 -7.34 12.89 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 117.558 -1.69 . . . . 0.0 112.694 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HB2' HD21 ' D' ' 50' ' ' LEU . 4.7 pt-20 -67.18 146.69 53.96 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.693 1.597 . . . . 0.0 107.469 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.79 166.05 34.67 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.229 175.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 p -124.75 177.76 5.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.8 -167.51 39.76 Favored Glycine 0 CA--C 1.521 0.439 0 O-C-N 120.372 -1.455 . . . . 0.0 112.262 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.4 p -139.8 137.73 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.93 1.347 . . . . 0.0 111.947 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -111.46 138.77 47.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.161 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.5 mt -130.01 128.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.6 m -105.15 144.09 32.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -172.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.6 -13.25 17.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.79 143.15 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.352 1.061 . . . . 0.0 112.715 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.49 43.84 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.407 -0.808 . . . . 0.0 111.74 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.77 -28.52 64.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.765 -0.584 . . . . 0.0 109.499 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -140.64 75.35 26.21 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.966 2.507 . . . . 0.0 110.836 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.14 61.06 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.365 1 C-N-CA 125.627 4.218 . . . . 0.0 115.028 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.44 13.41 39.56 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 120.163 -1.586 . . . . 0.0 116.795 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -172.32 -29.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.037 1.335 . . . . 0.0 113.298 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 47.6 mt 4.48 91.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.449 2.3 . . . . 0.0 116.533 -172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 159.13 18.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 111.563 -2.562 . . . . 0.0 109.337 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tt -46.74 126.82 9.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.848 2.059 . . . . 0.0 113.131 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.8 p -103.8 120.25 51.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 122.966 0.506 . . . . 0.0 111.898 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 144.01 84.62 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.327 2.684 . . . . 0.0 112.872 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.38 154.67 44.71 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.916 0.886 . . . . 0.0 112.418 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -159.75 149.21 18.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.794 2.038 . . . . 0.0 110.112 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.8 -147.69 16.44 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 121.583 1.992 . . . . 0.0 109.961 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.563 ' CG2' HD21 ' D' ' 69' ' ' ASN . 2.8 mt -145.74 141.06 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.688 0.795 . . . . 0.0 112.707 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 139.96 52.68 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.794 -1.191 . . . . 0.0 113.147 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -76.97 158.09 30.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.049 -1.657 . . . . 0.0 113.638 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -158.48 21.63 0.23 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.432 1.493 . . . . 0.0 112.51 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -87.23 -54.62 4.21 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.516 1.126 . . . . 0.0 109.999 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.33 173.11 10.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.748 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.38 -34.74 31.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.786 0.834 . . . . 0.0 112.504 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.22 47.6 2.86 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.993 1.317 . . . . 0.0 112.065 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.9 176.07 10.36 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.16 2.573 . . . . 0.0 115.341 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.329 0.0 OUTLIER -100.13 171.07 8.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 123.21 1.481 . . . . 0.0 112.194 173.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.403 ' CE2' HD21 ' A' ' 6' ' ' LEU . 1.2 p90 -160.64 167.25 27.38 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.401 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.66 144.99 9.52 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 118.482 2.153 . . . . 0.0 118.482 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.25 158.57 30.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -95.35 152.41 18.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.583 1.553 . . . . 0.0 108.823 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.67 118.84 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.523 HD21 ' CG2' ' D' ' 52' ' ' ILE . 5.9 t-20 -92.83 116.21 28.82 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.314 46.2 m95 -80.49 134.64 35.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.413 1.577 . . . . 0.0 114.431 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -89.56 -40.63 12.5 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -88.78 -15.87 33.55 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -151.43 130.29 12.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 129.389 3.076 . . . . 0.0 106.102 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -68.67 118.62 11.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.032 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -173.85 161.76 3.84 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 127.342 2.257 . . . . 0.0 108.802 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 140.15 30.94 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 123.105 1.431 . . . . 0.0 111.151 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -139.08 129.29 25.39 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 110.34 -3.118 . . . . 0.0 110.555 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -106.88 154.84 7.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.039 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.76 142.36 51.33 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.68 121.23 9.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.16 176.15 42.15 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 118.799 -1.667 . . . . 0.0 116.866 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -112.33 149.95 31.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.831 1.301 . . . . 0.0 112.929 -174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 19.6 t -97.18 130.37 44.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.806 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.75 166.03 13.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.94 0.876 . . . . 0.0 111.749 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mt -128.77 109.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -59.57 159.65 8.11 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -28.45 -51.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -11.39 60.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.205 1.802 . . . . 0.0 115.706 -174.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.07 51.77 3.27 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 120.383 1.447 . . . . 0.0 110.235 -173.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.21 136.64 53.07 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.521 2.328 . . . . 0.0 107.755 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -101.34 144.09 30.59 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.628 1.171 . . . . 0.0 109.974 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.9 162.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.652 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.1 116.87 25.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -104.92 120.51 41.62 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 p -137.25 166.91 22.64 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 123.358 1.551 . . . . 0.0 113.723 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.25 165.9 12.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 172.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -141.1 159.6 41.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.238 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.42 126.17 15.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.913 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.18 143.64 40.0 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 125.379 1.674 . . . . 0.0 112.381 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.69 114.34 17.87 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 111.416 -2.629 . . . . 0.0 111.736 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.252 44.6 m -67.12 175.45 2.59 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 125.635 1.834 . . . . 0.0 113.083 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.4 p -117.93 67.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 107.948 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.63 167.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 120.921 -1.112 . . . . 0.0 111.709 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -102.78 -32.35 9.86 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -109.03 148.77 30.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.82 1.295 . . . . 0.0 111.407 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.0 tt -63.32 -30.78 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 113.426 -1.716 . . . . 0.0 109.979 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.88 5.75 3.32 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.801 -1.555 . . . . 0.0 113.726 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.495 ' CG ' ' HZ1' ' A' ' 111' ' ' LYS . 36.7 m-20 -121.41 1.92 10.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.809 1.305 . . . . 0.0 113.69 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -33.48 75.38 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.402 -0.811 . . . . 0.0 111.713 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -46.88 -40.99 15.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HZ1' ' CG ' ' A' ' 108' ' ' ASP . 15.6 pttp -99.34 -6.72 27.38 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.359 1.063 . . . . 0.0 113.463 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.95 0.32 21.51 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.9 m -110.36 138.44 46.74 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.74 0.816 . . . . 0.0 112.072 176.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -140.59 124.79 17.55 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 125.184 1.394 . . . . 0.0 110.723 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.56 158.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.13 1.372 . . . . 0.0 111.317 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.02 -178.46 37.59 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.027 0.822 . . . . 0.0 113.326 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -124.98 156.74 37.6 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.755 -0.85 . . . . 0.0 111.705 175.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -147.7 157.91 43.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.416 1.103 . . . . 0.0 109.664 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.2 mt -133.37 138.36 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -125.72 149.14 48.75 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.285 1.041 . . . . 0.0 111.264 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 p -133.05 161.09 35.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.661 1.184 . . . . 0.0 110.352 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.09 113.16 2.96 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.614 0.765 . . . . 0.0 112.233 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt . . . . . 0 N--CA 1.462 0.14 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 173.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.3 144.84 43.71 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.255 1.022 . . . . 0.0 109.62 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -139.7 127.85 22.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.8 -33.01 71.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -48.83 113.46 0.79 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.511 1.124 . . . . 0.0 110.531 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.3 -132.5 5.85 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -147.23 143.67 28.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -136.09 162.55 32.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.221 1.408 . . . . 0.0 111.96 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.7 151.79 48.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.229 1.012 . . . . 0.0 109.231 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -119.89 143.79 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.232 1.013 . . . . 0.0 110.681 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -58.41 -25.31 62.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.462 1.505 . . . . 0.0 113.66 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 tp -70.25 -15.47 62.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.588 1.155 . . . . 0.0 111.711 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.23 -12.21 28.73 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 128.238 2.828 . . . . 0.0 113.515 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.65 149.65 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.265 1.507 . . . . 0.0 113.33 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -125.53 137.37 53.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.921 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -128.14 144.36 51.11 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -131.66 131.17 42.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.206 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 80.8 mt -131.13 124.52 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -86.42 0.08 OUTLIER Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.208 0.943 . . . . 0.0 111.733 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.24 145.28 31.22 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.803 -0.822 . . . . 0.0 110.676 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -99.72 130.37 48.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.053 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.99 166.7 23.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 112.382 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -26.02 63.98 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -67.89 -39.25 83.69 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.273 -0.892 . . . . 0.0 111.129 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.53 -6.55 11.53 Favored Glycine 0 C--O 1.221 -0.698 0 C-N-CA 124.728 1.156 . . . . 0.0 113.402 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' D' ' 28' ' ' GLU . 13.0 pt-20 -70.89 152.99 43.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.151 1.781 . . . . 0.0 112.258 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.38 30.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.252 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p -123.53 -177.13 3.63 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.71 -167.13 40.16 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 119.41 -2.056 . . . . 0.0 112.622 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 52.1 p -139.55 137.68 35.63 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.56 0.695 . . . . 0.0 112.346 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -112.83 138.71 49.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.377 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.72 128.42 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 54.6 m -105.74 144.82 31.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.1 -13.62 17.42 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.73 142.76 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.245 1.018 . . . . 0.0 112.607 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.55 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.153 -0.967 . . . . 0.0 111.474 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -70.5 -29.15 65.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.15 75.3 29.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 127.893 2.477 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.12 61.25 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.358 1 C-N-CA 125.629 4.22 . . . . 0.0 115.13 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.61 13.58 38.96 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 120.099 -1.626 . . . . 0.0 116.844 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -172.51 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.158 1.383 . . . . 0.0 113.401 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . 0.321 49.2 mt 4.55 91.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.627 2.371 . . . . 0.0 116.365 -172.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.58 159.31 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.584 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tt -46.82 126.15 8.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.674 1.99 . . . . 0.0 112.88 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.03 120.53 52.02 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.158 0.583 . . . . 0.0 111.634 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.06 143.78 82.18 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.166 2.577 . . . . 0.0 112.438 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.75 160.33 32.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.953 0.901 . . . . 0.0 112.598 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 28' ' ' GLU . 15.3 tp -169.01 149.01 4.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 0.0 112.642 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 -144.1 10.45 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 121.091 1.769 . . . . 0.0 109.774 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . 0.523 ' CG2' HD21 ' A' ' 69' ' ' ASN . 2.9 mt -147.53 139.37 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.769 0.827 . . . . 0.0 111.592 -175.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 138.45 54.05 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.163 1.385 . . . . 0.0 112.612 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -76.7 157.52 31.69 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 119.9 -1.75 . . . . 0.0 113.172 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -156.96 19.39 0.31 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 0.0 112.5 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -84.96 -54.11 4.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.766 1.227 . . . . 0.0 110.085 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 172.67 11.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.911 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -31.77 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.28 1.032 . . . . 0.0 113.378 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -130.17 50.58 6.18 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 125.118 1.367 . . . . 0.0 112.589 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.24 175.96 10.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.989 2.46 . . . . 0.0 116.274 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.335 0.0 OUTLIER -100.82 170.17 8.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.104 1.431 . . . . 0.0 111.808 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -161.01 167.29 26.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.82 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.32 145.43 10.0 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 118.431 2.133 . . . . 0.0 118.431 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.88 158.69 28.68 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -95.02 152.42 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.569 1.948 . . . . 0.0 108.472 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.58 117.78 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . 0.563 HD21 ' CG2' ' A' ' 52' ' ' ILE . 7.2 t-20 -92.85 117.21 29.78 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.407 -0.808 . . . . 0.0 109.927 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.3 46.3 m95 -80.46 137.39 36.47 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.543 1.64 . . . . 0.0 114.246 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -92.67 -39.45 11.28 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.3 -14.94 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -152.27 131.59 12.85 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 129.319 3.048 . . . . 0.0 106.241 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.4 118.64 12.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 10.8 m -173.53 161.82 4.09 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 127.222 2.209 . . . . 0.0 108.978 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.8 t -143.28 140.31 30.56 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.114 1.435 . . . . 0.0 110.842 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.05 128.79 24.74 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 110.509 -3.041 . . . . 0.0 110.451 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.12 154.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.038 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -127.64 141.8 51.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.1 121.69 10.44 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.78 174.46 42.15 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 118.748 -1.691 . . . . 0.0 116.786 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.51 146.65 38.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.021 1.071 . . . . 0.0 111.967 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 48.9 t -97.62 134.23 41.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.138 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.31 164.93 17.05 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.203 1.001 . . . . 0.0 111.366 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.98 105.33 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -63.38 154.22 32.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -22.42 -51.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.072 2.549 . . . . 0.0 117.39 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -76.08 -7.2 54.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.253 1.821 . . . . 0.0 115.784 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.38 51.38 3.52 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.925 0.784 . . . . 0.0 111.231 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 135.96 54.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 108.784 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.29 144.6 29.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.17 0.986 . . . . 0.0 109.572 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.51 159.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.818 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mt -117.72 117.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -105.47 119.06 38.14 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -136.95 167.09 22.16 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.258 1.504 . . . . 0.0 113.639 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.13 166.51 12.15 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -141.58 160.09 40.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.101 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.83 126.6 15.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.771 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.03 144.45 38.59 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 125.51 1.756 . . . . 0.0 112.082 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -127.45 114.36 17.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.677 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 42.5 m -67.01 175.33 2.58 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 125.803 1.939 . . . . 0.0 113.0 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.9 p -117.74 66.64 0.75 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.11 1.364 . . . . 0.0 108.251 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.69 167.47 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.988 -1.07 . . . . 0.0 111.999 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -101.52 -32.26 10.48 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.0 149.89 31.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 122.709 1.242 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.96 -29.01 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.21 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.51 6.13 4.88 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.501 1.048 . . . . 0.0 113.586 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . 0.498 ' CG ' ' HZ1' ' D' ' 111' ' ' LYS . 36.9 m-20 -122.2 2.26 9.77 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.509 1.155 . . . . 0.0 113.712 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.74 -34.02 76.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.312 -0.868 . . . . 0.0 112.14 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -46.19 -41.43 12.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.28 1.032 . . . . 0.0 113.728 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . 0.498 ' HZ1' ' CG ' ' D' ' 108' ' ' ASP . 15.5 pttp -99.48 -6.79 26.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.215 1.006 . . . . 0.0 113.365 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.65 -0.21 22.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -109.33 138.8 45.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.477 0.711 . . . . 0.0 111.792 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -140.76 124.79 17.31 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 125.56 1.544 . . . . 0.0 111.247 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.6 158.89 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.08 1.352 . . . . 0.0 111.166 176.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.17 -179.53 38.43 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.939 0.781 . . . . 0.0 113.441 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.77 156.37 36.19 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.759 -0.848 . . . . 0.0 111.571 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -147.72 157.36 43.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.09 0.948 . . . . 0.0 109.855 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.58 136.65 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -124.45 151.25 44.77 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 18.7 p -134.65 160.81 36.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.746 1.218 . . . . 0.0 110.186 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 129.43 41.36 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.53 -0.731 . . . . 0.0 110.855 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.306 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.23 142.01 50.89 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 109.478 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -139.66 127.88 22.55 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.23 -31.53 70.16 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -48.96 113.25 0.75 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.332 1.053 . . . . 0.0 111.028 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.32 -131.11 5.24 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.63 1.586 . . . . 0.0 109.452 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -146.38 143.21 28.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.46 1.104 . . . . 0.0 113.293 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -135.56 162.75 31.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.297 1.439 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -141.27 150.55 42.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.97 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -122.12 143.78 49.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.389 1.076 . . . . 0.0 111.025 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -58.88 -25.34 63.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.608 1.563 . . . . 0.0 113.458 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.9 tp -70.68 -15.63 62.73 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.371 1.081 . . . . 0.0 111.619 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.32 -13.98 23.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 128.415 2.912 . . . . 0.0 113.47 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 148.57 44.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 123.113 1.435 . . . . 0.0 113.252 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -122.7 136.08 54.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.671 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -131.05 131.19 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -130.2 124.39 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.32 -84.34 0.11 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.537 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.79 32.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.76 -0.847 . . . . 0.0 110.85 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.66 130.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.294 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -75.94 168.77 19.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.942 0.877 . . . . 0.0 112.207 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 81.5 p -58.59 -26.08 63.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -70.1 -40.58 74.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.324 -0.86 . . . . 0.0 110.981 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.85 -7.17 13.32 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.523 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.33 146.75 53.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.649 1.58 . . . . 0.0 107.416 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 166.22 34.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.108 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.6 p -125.39 176.85 6.51 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.66 -167.54 39.46 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 120.321 -1.487 . . . . 0.0 112.302 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 48.5 p -139.76 137.52 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.607 1.194 . . . . 0.0 112.016 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -110.88 139.0 46.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.23 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 27.5 mt -130.59 128.02 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 42.7 m -105.21 144.25 32.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.64 -13.72 17.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.24 143.46 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.328 1.051 . . . . 0.0 112.701 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.03 43.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.424 -0.798 . . . . 0.0 111.464 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -71.21 -28.82 64.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.24 75.66 27.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.926 2.49 . . . . 0.0 111.038 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.22 61.86 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.409 1 C-N-CA 125.583 4.188 . . . . 0.0 115.02 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.97 13.56 37.74 Favored Glycine 0 N--CA 1.481 1.659 0 O-C-N 120.269 -1.519 . . . . 0.0 116.862 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -172.36 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.174 1.39 . . . . 0.0 113.297 -174.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . 0.324 50.3 mt 5.35 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.616 2.366 . . . . 0.0 116.323 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.63 159.19 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 111.607 -2.542 . . . . 0.0 109.32 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tt -46.84 127.97 10.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.768 2.027 . . . . 0.0 112.926 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -104.96 120.65 49.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.083 0.553 . . . . 0.0 111.846 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.33 144.38 82.72 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.034 2.489 . . . . 0.0 112.947 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.47 154.37 45.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 112.633 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -159.97 149.14 17.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.531 1.932 . . . . 0.0 109.949 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.72 -147.22 15.32 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 121.389 1.904 . . . . 0.0 109.879 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . 0.548 ' CG2' HD21 ' C' ' 69' ' ' ASN . 2.8 mt -145.67 141.0 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.523 0.729 . . . . 0.0 112.655 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.94 136.84 52.84 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.978 -1.076 . . . . 0.0 113.363 174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -74.01 158.32 34.55 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.96 -1.713 . . . . 0.0 113.557 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -159.58 23.93 0.19 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.483 1.513 . . . . 0.0 111.855 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -90.37 -53.08 4.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.677 1.191 . . . . 0.0 110.331 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.44 174.28 9.13 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.65 1.219 . . . . 0.0 113.36 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.27 -29.69 22.9 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -129.34 49.52 4.78 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.681 1.192 . . . . 0.0 112.627 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.59 175.1 10.65 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.901 2.401 . . . . 0.0 116.169 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.33 0.0 OUTLIER -101.03 169.83 8.68 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 123.048 1.404 . . . . 0.0 111.97 173.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -160.66 167.5 26.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.543 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.71 144.44 9.09 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.96 158.66 31.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.8 m -94.87 152.22 18.57 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.753 1.621 . . . . 0.0 108.802 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.55 118.23 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.56 HD21 ' CG2' ' C' ' 52' ' ' ILE . 7.6 t-20 -92.71 116.53 29.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.733 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.299 46.1 m95 -80.22 136.59 36.5 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 123.465 1.603 . . . . 0.0 114.326 -173.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -91.54 -39.83 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -89.29 -15.42 33.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -151.43 130.23 12.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.202 3.001 . . . . 0.0 105.904 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.66 118.57 11.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.0 m -173.58 161.61 4.02 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 127.253 2.221 . . . . 0.0 109.082 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 140.4 30.48 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.033 1.397 . . . . 0.0 110.694 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.33 129.41 25.15 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 110.549 -3.023 . . . . 0.0 110.558 -171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.44 155.46 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.092 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -128.48 142.22 51.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.41 121.18 9.89 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.18 175.05 41.76 Favored Glycine 0 CA--C 1.504 -0.629 0 C-N-CA 118.708 -1.711 . . . . 0.0 116.627 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -112.85 144.56 42.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.79 1.281 . . . . 0.0 112.083 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 t -97.84 127.22 43.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.873 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -115.31 166.8 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.33 1.052 . . . . 0.0 111.561 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 mt -127.41 108.13 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -62.33 156.76 21.46 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -26.77 -48.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.336 2.254 . . . . 0.0 116.854 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.59 -2.25 41.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 49.26 5.77 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.651 1.114 . . . . 0.0 112.118 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.31 136.94 54.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.873 1.669 . . . . 0.0 108.043 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -101.26 144.23 30.37 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.357 1.063 . . . . 0.0 109.607 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.01 159.93 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.006 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 9.1 mt -118.08 118.42 31.85 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -107.09 118.08 35.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -136.0 166.65 22.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 123.488 1.613 . . . . 0.0 113.712 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -116.83 165.75 12.95 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 p-90 -141.13 160.23 40.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.276 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.92 126.76 15.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.956 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.38 143.16 41.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 125.37 1.669 . . . . 0.0 112.3 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.08 114.23 18.13 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 111.176 -2.738 . . . . 0.0 111.713 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 43.5 m -67.2 175.24 2.73 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 125.778 1.924 . . . . 0.0 112.911 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -117.7 67.66 0.75 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.082 1.353 . . . . 0.0 108.041 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.43 168.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 121.027 -1.046 . . . . 0.0 111.804 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -103.51 -31.35 10.0 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.09 148.63 30.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.838 1.304 . . . . 0.0 111.669 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.405 ' CD1' HG21 ' C' ' 92' ' ' VAL . 14.8 tt -64.42 -29.48 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.653 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.53 5.25 5.78 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.276 0.941 . . . . 0.0 113.254 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.49 ' CG ' ' HZ1' ' B' ' 111' ' ' LYS . 35.1 m-20 -120.92 1.24 10.41 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.387 1.075 . . . . 0.0 113.639 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.12 -32.88 73.51 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.057 0.932 . . . . 0.0 112.435 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -46.93 -41.45 16.08 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.49 ' HZ1' ' CG ' ' B' ' 108' ' ' ASP . 15.5 pttp -98.86 -6.67 28.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.456 1.103 . . . . 0.0 113.419 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.91 0.09 22.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.3 m -109.35 138.41 45.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.596 0.758 . . . . 0.0 112.124 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.98 123.49 15.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.404 1.482 . . . . 0.0 111.433 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.48 158.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.834 1.254 . . . . 0.0 111.062 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.35 -178.21 37.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.86 0.743 . . . . 0.0 113.462 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 0.0 OUTLIER -125.14 156.31 38.55 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.781 -0.835 . . . . 0.0 111.797 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -147.45 155.3 41.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.136 0.97 . . . . 0.0 110.003 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.72 132.07 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -119.9 152.38 37.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.118 0.961 . . . . 0.0 110.821 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 160.38 37.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.447 1.099 . . . . 0.0 109.476 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 122.32 13.78 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.109 174.881 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 29.6 p -116.29 141.41 48.19 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.073 0.858 . . . . 0.0 108.865 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -139.64 127.69 22.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.994 -1.066 . . . . 0.0 113.07 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.07 -31.7 71.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -48.27 113.85 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.964 1.306 . . . . 0.0 110.931 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -131.12 5.44 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 125.99 1.757 . . . . 0.0 109.111 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -145.47 146.97 31.69 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -136.59 162.65 32.54 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.993 1.317 . . . . 0.0 111.457 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -136.34 153.25 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.685 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -123.47 143.61 50.05 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.173 0.989 . . . . 0.0 111.093 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.9 -25.9 61.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.907 1.683 . . . . 0.0 113.353 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.25 -15.29 62.43 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.816 1.246 . . . . 0.0 111.788 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.27 -14.49 23.2 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 128.479 2.942 . . . . 0.0 113.513 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 149.4 42.61 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 123.14 1.448 . . . . 0.0 113.088 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -123.34 136.21 54.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.325 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -128.34 139.82 52.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m -127.73 131.63 49.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.688 0.795 . . . . 0.0 109.003 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.9 125.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.71 -85.85 0.09 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.615 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.05 33.84 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.726 -0.867 . . . . 0.0 110.909 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.83 129.05 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.222 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -74.51 166.23 23.87 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.972 0.891 . . . . 0.0 112.356 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -58.78 -25.9 63.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -67.91 -39.12 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.216 -0.927 . . . . 0.0 110.919 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.14 -6.34 12.03 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 124.782 1.182 . . . . 0.0 113.322 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.24 152.76 43.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.071 1.749 . . . . 0.0 112.15 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.38 166.49 30.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.884 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 21.6 p -123.37 -177.47 3.71 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.89 -166.87 39.84 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 119.322 -2.111 . . . . 0.0 112.703 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 59.0 p -139.69 136.89 34.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.257 1.027 . . . . 0.0 112.578 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -111.84 138.4 48.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.38 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.42 127.62 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 55.9 m -105.09 143.65 32.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.61 -13.08 18.72 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.8 143.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.179 0.992 . . . . 0.0 112.907 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.17 161.12 43.31 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.106 -0.996 . . . . 0.0 111.45 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -71.36 -28.81 64.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -140.09 75.38 29.26 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.914 2.486 . . . . 0.0 110.978 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.92 61.41 3.83 Favored 'Trans proline' 0 CA--C 1.551 1.373 1 C-N-CA 125.589 4.192 . . . . 0.0 115.134 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.7 13.56 38.65 Favored Glycine 0 N--CA 1.481 1.645 0 O-C-N 120.141 -1.599 . . . . 0.0 116.817 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -172.58 -29.43 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.21 1.404 . . . . 0.0 113.401 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . 0.325 48.8 mt 5.05 90.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.662 2.385 . . . . 0.0 116.33 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.9 159.24 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.794 -2.457 . . . . 0.0 109.352 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tt -46.76 128.02 10.32 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.624 1.97 . . . . 0.0 112.878 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -104.82 120.46 50.05 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.978 0.511 . . . . 0.0 111.682 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.89 143.0 83.57 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.949 2.432 . . . . 0.0 112.445 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.1 160.29 31.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.021 0.928 . . . . 0.0 112.78 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 tp -169.0 149.19 4.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.479 1.512 . . . . 0.0 112.466 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.26 -144.17 10.54 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 121.122 1.783 . . . . 0.0 109.765 -174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.56 ' CG2' HD21 ' B' ' 69' ' ' ASN . 3.0 mt -147.99 139.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.745 -175.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.77 138.94 53.88 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.613 1.165 . . . . 0.0 112.727 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -76.64 157.82 31.56 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.023 -1.673 . . . . 0.0 113.277 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -157.67 20.3 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.285 1.434 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -86.77 -53.73 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.926 1.29 . . . . 0.0 110.247 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.52 172.46 11.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.814 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.95 -29.31 25.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.857 0.863 . . . . 0.0 113.034 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -130.69 51.86 8.38 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 125.085 1.354 . . . . 0.0 112.726 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 175.72 10.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.935 2.423 . . . . 0.0 116.139 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.333 0.0 OUTLIER -100.77 170.78 8.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.202 1.477 . . . . 0.0 111.742 173.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -161.57 167.07 25.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.684 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.25 144.86 9.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -173.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.36 158.47 29.7 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -94.99 152.64 18.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.336 1.854 . . . . 0.0 108.718 173.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.85 117.8 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . 0.548 HD21 ' CG2' ' B' ' 52' ' ' ILE . 7.3 t-20 -92.78 117.26 29.82 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.235 -0.916 . . . . 0.0 109.866 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.301 46.4 m95 -80.63 137.55 36.36 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 123.456 1.598 . . . . 0.0 114.123 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -92.78 -39.79 11.03 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -89.13 -15.47 33.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -151.22 130.4 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 129.307 3.043 . . . . 0.0 106.299 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -69.03 118.55 12.08 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 10.7 m -174.0 161.37 3.67 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.238 2.215 . . . . 0.0 108.968 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -142.56 140.58 31.8 Favored 'General case' 0 CA--C 1.483 -1.635 0 CA-C-O 123.347 1.546 . . . . 0.0 111.057 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.15 129.97 26.21 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 110.339 -3.119 . . . . 0.0 110.21 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.15 154.84 7.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.974 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.37 142.34 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.49 121.0 9.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.94 41.17 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 118.708 -1.71 . . . . 0.0 116.625 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -112.49 146.5 38.35 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 125.101 1.118 . . . . 0.0 111.805 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.63 135.13 39.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.312 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -123.54 165.9 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.055 0.942 . . . . 0.0 111.118 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.62 108.27 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.01 157.12 25.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -24.85 -48.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.634 2.374 . . . . 0.0 117.339 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -80.39 -3.38 49.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.905 2.082 . . . . 0.0 116.449 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.46 48.11 5.75 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 120.295 1.407 . . . . 0.0 111.963 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 135.62 54.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.198 1.799 . . . . 0.0 109.077 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -101.3 145.97 28.17 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.713 1.244 . . . . 0.0 109.729 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.2 m -150.13 157.07 6.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.934 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.49 115.39 26.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -103.74 119.35 38.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.2 p -136.57 167.31 21.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 123.398 1.57 . . . . 0.0 113.889 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.83 166.11 12.86 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -141.23 160.15 40.71 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.121 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.81 125.79 14.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.131 -1.849 . . . . 0.0 112.008 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.52 143.19 39.5 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.065 1.478 . . . . 0.0 112.218 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -126.66 114.19 17.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.516 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -66.75 175.35 2.44 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 126.083 2.114 . . . . 0.0 112.926 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.7 p -118.19 68.98 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.34 1.456 . . . . 0.0 107.675 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.8 171.53 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.889 -1.132 . . . . 0.0 111.539 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -106.7 -32.28 8.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -108.22 148.77 29.47 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.833 1.302 . . . . 0.0 111.588 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -64.07 -29.04 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.888 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 5.56 6.11 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.706 1.146 . . . . 0.0 113.516 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . 0.49 ' CG ' ' HZ1' ' C' ' 111' ' ' LYS . 34.8 m-20 -121.39 1.51 10.17 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.333 1.066 . . . . 0.0 113.694 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -33.07 73.73 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.035 0.922 . . . . 0.0 112.553 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -46.7 -41.43 14.98 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . 0.49 ' HZ1' ' CG ' ' C' ' 108' ' ' ASP . 15.7 pttp -99.34 -6.57 27.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.318 1.047 . . . . 0.0 113.356 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.35 -0.17 21.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 5.9 m -109.9 138.38 46.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.599 0.76 . . . . 0.0 111.636 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.59 124.47 17.26 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 125.65 1.58 . . . . 0.0 111.01 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -99.57 158.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.245 1.418 . . . . 0.0 111.35 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.65 -178.84 38.34 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.809 0.718 . . . . 0.0 113.407 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.41 157.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.733 -0.863 . . . . 0.0 111.911 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -148.39 155.59 41.44 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.967 0.889 . . . . 0.0 109.864 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -132.19 133.28 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -120.76 151.7 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 111.665 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.8 p -135.42 163.15 30.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.024 1.33 . . . . 0.0 109.876 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 115.94 5.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.86 -1.15 . . . . 0.0 111.732 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 tp . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.594 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 p -116.61 137.61 52.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.003 0.921 . . . . 0.0 109.823 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 p -139.77 133.09 29.94 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.196 -1.565 . . . . 0.0 114.348 -174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.13 -32.01 69.47 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -52.35 116.18 2.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.774 1.273 . . . . 0.0 111.83 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.1 -114.47 1.25 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 125.94 1.733 . . . . 0.0 110.209 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -153.16 147.44 25.78 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -140.65 162.75 34.64 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.493 1.517 . . . . 0.0 111.35 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -138.63 147.94 43.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.29 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.28 146.99 38.46 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.709 0.803 . . . . 0.0 110.619 -175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -56.67 -28.6 61.05 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.6 tp -72.29 -15.62 61.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.053 1.741 . . . . 0.0 112.02 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.39 -14.29 25.42 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.048 2.261 . . . . 0.0 113.441 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.7 p -68.51 155.05 40.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.412 1.606 . . . . 0.0 113.134 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -127.02 138.28 53.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.608 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -124.09 136.03 53.96 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.56 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -126.79 130.51 50.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.9 mt -134.43 127.46 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.83 -89.59 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.077 0.861 . . . . 0.0 112.558 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.92 139.65 32.58 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.837 -0.801 . . . . 0.0 111.641 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.8 t -89.61 129.47 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.357 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.56 166.04 15.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.894 0.854 . . . . 0.0 111.589 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.1 p -57.15 -27.81 62.19 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -74.71 -32.83 62.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.698 0.681 . . . . 0.0 111.722 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.67 -7.43 26.05 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.959 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 9.6 pt-20 -66.3 144.27 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.772 1.286 . . . . 0.0 108.487 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -158.18 145.82 18.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.802 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.57 162.01 14.34 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.02 -170.04 36.9 Favored Glycine 0 C--O 1.239 0.416 0 O-C-N 121.187 -0.946 . . . . 0.0 112.664 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -140.15 139.03 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.407 1.098 . . . . 0.0 112.17 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -114.42 138.72 50.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 108.389 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 mt -130.83 126.87 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.5 m -105.05 144.34 31.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.74 -21.96 17.82 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.98 143.26 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.48 1.112 . . . . 0.0 113.27 -174.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.55 159.43 39.7 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.528 -0.732 . . . . 0.0 110.219 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.54 -23.72 58.84 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.95 -0.469 . . . . 0.0 110.909 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -146.43 68.72 12.34 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.221 2.208 . . . . 0.0 111.069 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.71 -79.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 125.08 3.853 . . . . 0.0 116.853 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.87 -48.65 0.01 OUTLIER Glycine 0 CA--C 1.546 1.996 0 C-N-CA 129.561 3.458 . . . . 0.0 120.565 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.84 -5.12 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.25 2.22 . . . . 0.0 113.118 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.347 64.5 mt -8.89 85.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 124.316 2.007 . . . . 0.0 115.009 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.2 151.13 21.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 111.63 -2.532 . . . . 0.0 108.465 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.34 127.19 8.76 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.934 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.32 118.52 57.59 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 123.961 0.788 . . . . 0.0 111.252 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.92 144.07 69.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.727 2.284 . . . . 0.0 112.177 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.5 158.23 35.01 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.765 0.826 . . . . 0.0 111.267 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -159.89 148.97 17.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.319 1.847 . . . . 0.0 110.425 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.9 -157.22 28.95 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 121.062 1.756 . . . . 0.0 110.069 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.7 134.94 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.45 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 136.61 53.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.543 1.137 . . . . 0.0 110.772 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -73.29 151.88 41.18 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.004 0.907 . . . . 0.0 109.746 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.9 26.46 1.37 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.619 -1.301 . . . . 0.0 111.633 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.47 -50.29 5.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 110.717 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 173.29 10.34 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.231 0.957 . . . . 0.0 112.987 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.7 m -83.93 -31.64 25.52 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.762 1.225 . . . . 0.0 113.366 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -128.51 54.94 15.09 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.243 1.417 . . . . 0.0 111.381 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.66 165.18 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.042 2.495 . . . . 0.0 117.553 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.3 p -81.11 164.27 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.115 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.78 163.47 36.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.215 -0.928 . . . . 0.0 113.021 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.89 140.1 6.12 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -159.68 157.55 29.76 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -95.84 151.55 19.3 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.302 1.441 . . . . 0.0 110.651 174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.44 118.13 48.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -93.72 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 109.554 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.301 43.8 m95 -83.07 135.48 34.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.82 -44.02 9.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.953 2.101 . . . . 0.0 116.321 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -91.02 -9.56 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -152.79 126.8 9.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.507 2.323 . . . . 0.0 107.06 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -69.25 118.48 12.19 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.965 1.257 . . . . 0.0 110.503 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -177.23 164.23 2.16 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 126.329 1.851 . . . . 0.0 109.193 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -144.18 143.84 31.27 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.542 1.639 . . . . 0.0 111.549 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.31 125.17 21.12 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 110.33 -3.123 . . . . 0.0 109.691 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.67 152.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -126.33 142.17 51.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 118.14 7.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -174.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.1 -164.94 14.67 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -130.3 150.0 51.74 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.485 0.756 . . . . 0.0 112.216 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.5 t -94.86 124.93 39.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.7 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.46 163.48 15.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.242 1.017 . . . . 0.0 111.966 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.87 110.72 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.16 161.22 9.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.249 0.619 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.37 -51.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -69.24 -33.46 73.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.8 42.44 0.73 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.906 1.241 . . . . 0.0 111.734 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -110.44 142.64 41.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.302 1.441 . . . . 0.0 109.85 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -101.58 140.33 36.01 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.856 1.262 . . . . 0.0 111.613 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' D' ' 106' ' ' ILE . 20.1 m -143.62 160.32 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.372 1.069 . . . . 0.0 108.681 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.69 119.25 33.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 119.51 39.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -137.7 172.27 13.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 123.131 1.443 . . . . 0.0 111.992 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 87.9 mmm -126.02 168.9 13.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.588 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -141.49 164.06 31.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.168 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.15 119.67 7.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.056 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 140.11 41.06 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.181 1.467 . . . . 0.0 112.11 -173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -120.16 120.97 37.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 110.804 -2.907 . . . . 0.0 111.237 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -88.7 163.52 15.73 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 125.496 1.748 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -113.81 70.85 0.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.83 -167.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 111.001 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.44 -15.16 3.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.738 -1.851 . . . . 0.0 114.776 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.77 150.23 43.07 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.87 1.319 . . . . 0.0 110.315 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.4 ' CD1' HG21 ' D' ' 92' ' ' VAL . 16.6 tt -62.85 -28.38 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.708 174.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.82 6.89 10.58 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.244 -1.309 . . . . 0.0 113.472 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.491 ' CG ' ' HZ1' ' A' ' 111' ' ' LYS . 38.0 m-20 -121.08 -1.36 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.85 1.325 . . . . 0.0 113.632 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -59.08 -34.75 72.34 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.623 -1.298 . . . . 0.0 112.158 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.73 -39.56 18.07 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.724 1.21 . . . . 0.0 114.16 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' HZ1' ' CG ' ' A' ' 108' ' ' ASP . 12.2 pttp -99.32 -7.65 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.285 1.434 . . . . 0.0 114.011 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 1.8 9.6 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.163 -0.961 . . . . 0.0 113.016 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.416 HG23 ' HG3' ' D' ' 96' ' ' MET . 34.0 m -116.97 145.23 43.77 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.865 0.866 . . . . 0.0 111.537 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.52 129.05 18.06 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 125.759 1.624 . . . . 0.0 110.659 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.71 155.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 120.483 1.492 . . . . 0.0 109.367 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -175.31 28.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.542 1.067 . . . . 0.0 113.08 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 21.4 p90 -125.97 153.01 44.92 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.064 0.945 . . . . 0.0 110.782 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -144.85 152.97 41.1 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.695 1.198 . . . . 0.0 109.865 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.1 mt -135.06 122.17 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -110.6 149.18 30.78 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.521 0.677 . . . . 0.0 110.427 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.5 p -134.16 162.83 31.06 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.081 -1.012 . . . . 0.0 109.662 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -56.87 114.82 2.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.451 0.701 . . . . 0.0 109.928 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.417 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 24.5 p -122.43 135.22 54.64 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.373 1.469 . . . . 0.0 110.236 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -139.91 134.4 31.55 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.389 -1.445 . . . . 0.0 114.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' D' ' 64' ' ' PHE . 43.1 mt -58.6 -32.94 69.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -51.5 117.32 2.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 123.35 1.547 . . . . 0.0 112.098 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.52 -116.72 1.75 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.687 1.613 . . . . 0.0 110.351 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -151.92 147.15 26.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -141.27 162.78 34.65 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.83 1.652 . . . . 0.0 111.927 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -139.73 148.08 41.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.938 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.05 146.98 38.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.781 0.832 . . . . 0.0 110.585 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -57.9 -26.38 62.09 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.16 -16.91 61.98 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.451 1.5 . . . . 0.0 111.74 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.04 -13.74 23.99 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 127.136 2.303 . . . . 0.0 113.627 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -69.77 155.66 40.2 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.308 1.554 . . . . 0.0 112.841 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -127.81 138.35 52.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.044 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -124.11 136.64 54.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.261 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -126.67 131.25 51.45 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.2 127.12 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.03 -89.93 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.91 141.32 32.98 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.608 -0.937 . . . . 0.0 111.219 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -91.4 130.07 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.83 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 165.09 18.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.908 0.861 . . . . 0.0 111.885 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 28.7 p -57.37 -26.96 61.85 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -73.58 -31.97 63.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.849 0.75 . . . . 0.0 111.722 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.99 25.32 Favored Glycine 0 N--CA 1.462 0.389 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.344 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.3 156.81 38.77 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.582 1.191 . . . . 0.0 112.872 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.35 160.25 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.389 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' THR . . . . . 0.493 HG21 ' CD1' ' D' ' 50' ' ' LEU . 0.9 OUTLIER -120.45 156.98 30.33 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 173.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.78 -167.82 28.04 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 120.11 -1.619 . . . . 0.0 112.527 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -140.0 137.74 34.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 122.351 1.072 . . . . 0.0 112.474 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -114.62 139.14 49.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.476 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mt -130.79 127.23 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 86.7 m -105.1 144.17 32.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.64 -21.41 18.24 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 143.75 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 112.974 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.49 39.25 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.722 -0.611 . . . . 0.0 110.238 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.68 -23.46 58.63 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 121.984 -0.447 . . . . 0.0 110.935 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -146.6 68.7 12.12 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.263 2.225 . . . . 0.0 111.087 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -56.79 -78.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 125.05 3.833 . . . . 0.0 116.89 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.66 -48.74 0.01 OUTLIER Glycine 0 CA--C 1.545 1.931 0 C-N-CA 129.651 3.501 . . . . 0.0 120.587 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.68 -5.15 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 127.176 2.19 . . . . 0.0 113.03 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . 0.345 64.9 mt -8.92 86.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 124.337 2.018 . . . . 0.0 115.068 -172.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.29 151.47 21.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.55 174.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 tt -46.51 126.87 8.72 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.295 -2.23 . . . . 0.0 111.772 174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.7 p -102.85 118.68 57.72 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 123.844 0.715 . . . . 0.0 111.381 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.84 144.15 67.88 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.66 2.24 . . . . 0.0 111.962 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.44 162.75 24.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.551 0.74 . . . . 0.0 111.516 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . 0.495 ' CD2' ' HB2' ' A' ' 28' ' ' GLU . 15.9 tp -164.22 149.02 10.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.894 1.678 . . . . 0.0 112.129 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -154.62 25.65 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 120.933 1.697 . . . . 0.0 110.498 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -144.35 133.42 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.359 1.076 . . . . 0.0 110.929 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 136.71 54.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.28 1.432 . . . . 0.0 110.497 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -73.8 151.26 40.63 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.28 -0.887 . . . . 0.0 109.971 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -144.62 26.47 1.42 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.696 -1.252 . . . . 0.0 111.58 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.42 -49.28 6.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 111.289 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 172.8 12.6 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -80.01 -30.66 39.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.781 1.232 . . . . 0.0 113.11 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -133.29 57.68 28.8 Favored Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -71.76 164.25 36.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 N-CA-C 117.494 2.075 . . . . 0.0 117.494 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -81.21 164.1 22.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.944 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -158.35 163.56 37.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.871 0.844 . . . . 0.0 112.758 175.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.43 140.09 6.08 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -159.56 157.91 30.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -96.11 151.38 19.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.91 1.684 . . . . 0.0 110.648 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.47 118.74 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -94.93 113.29 25.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.966 0.906 . . . . 0.0 109.523 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.297 43.8 m95 -82.53 136.01 34.96 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -173.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -92.41 -43.25 9.32 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.899 2.08 . . . . 0.0 116.417 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -91.37 -9.72 43.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.77 127.41 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.422 2.289 . . . . 0.0 107.171 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -69.52 118.48 12.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.009 1.277 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -177.34 163.91 2.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.31 1.844 . . . . 0.0 109.039 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.5 t -144.0 143.78 31.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.893 1.806 . . . . 0.0 111.721 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 110.224 -3.171 . . . . 0.0 109.869 -172.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.1 153.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -127.12 141.97 51.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.36 118.37 7.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -164.95 14.61 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 116.401 1.32 . . . . 0.0 116.401 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -131.09 149.75 52.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.245 0.615 . . . . 0.0 112.024 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 37.9 t -97.25 122.28 40.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.211 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.35 163.46 13.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.138 0.975 . . . . 0.0 112.008 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.79 107.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 160.84 5.36 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.251 0.548 . . . . 0.0 110.103 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.09 -49.97 0.14 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -25.87 61.06 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.83 51.51 1.17 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.881 0.764 . . . . 0.0 111.286 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -120.16 147.73 44.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 128.261 2.624 . . . . 0.0 105.346 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -113.7 137.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.804 1.242 . . . . 0.0 110.135 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 106' ' ' ILE . 26.0 m -139.71 161.86 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 110.05 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.01 120.05 36.64 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 118.41 36.7 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -137.11 171.84 13.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 123.303 1.525 . . . . 0.0 112.151 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.422 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 88.5 mmm -125.95 168.88 13.29 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -141.07 163.72 32.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.312 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -148.11 120.1 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.84 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 140.33 40.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 123.23 1.49 . . . . 0.0 112.044 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.08 119.86 34.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 110.89 -2.868 . . . . 0.0 110.758 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -86.15 162.97 18.11 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 125.257 1.598 . . . . 0.0 112.044 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 3.8 t -112.83 73.17 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.14 -166.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.452 0.701 . . . . 0.0 110.709 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.11 -14.54 3.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 119.907 -1.746 . . . . 0.0 114.569 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -123.46 149.49 45.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 123.086 1.422 . . . . 0.0 110.516 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 92' ' ' VAL . 17.2 tt -62.01 -29.37 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.111 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.0 5.92 11.66 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.45 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . 0.478 ' CG ' ' HZ1' ' D' ' 111' ' ' LYS . 34.7 m-20 -120.41 -1.77 10.13 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.01 1.405 . . . . 0.0 113.575 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.82 -34.99 70.26 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.652 -1.28 . . . . 0.0 112.745 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -47.51 -39.8 17.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.079 1.352 . . . . 0.0 113.912 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . 0.478 ' HZ1' ' CG ' ' D' ' 108' ' ' ASP . 12.5 pttp -99.21 -6.8 27.49 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.322 1.449 . . . . 0.0 114.114 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.75 1.46 10.35 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.88 -1.137 . . . . 0.0 113.126 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 96' ' ' MET . 34.7 m -117.29 145.24 44.1 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.574 0.75 . . . . 0.0 111.604 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.17 129.05 18.42 Favored 'General case' 0 C--O 1.214 -0.81 0 C-N-CA 125.53 1.532 . . . . 0.0 110.681 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.74 155.15 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 120.531 1.514 . . . . 0.0 109.504 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.21 -175.53 29.24 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.628 1.109 . . . . 0.0 113.002 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 21.7 p90 -125.87 153.48 44.09 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.039 0.936 . . . . 0.0 110.68 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.33 153.24 41.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.675 1.19 . . . . 0.0 109.706 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 80.9 mt -135.37 123.93 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.52 149.51 32.57 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 111.064 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -133.56 164.93 26.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.939 0.896 . . . . 0.0 109.82 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -60.93 121.14 11.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.104 -0.997 . . . . 0.0 109.979 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 CA--C 1.55 0.954 0 O-C-N 121.765 -0.584 . . . . 0.0 110.14 174.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.59 134.94 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.322 1.849 . . . . 0.0 109.619 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -139.75 135.71 33.39 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.414 -1.429 . . . . 0.0 114.193 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' B' ' 64' ' ' PHE . 40.7 mt -60.46 -30.57 69.76 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -53.5 116.81 2.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.713 1.244 . . . . 0.0 111.582 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.65 -116.11 1.54 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.474 1.512 . . . . 0.0 110.369 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -152.68 145.3 24.22 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -139.63 162.15 35.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 111.553 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -141.51 145.57 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.607 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.21 148.85 30.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.062 0.945 . . . . 0.0 110.744 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -57.47 -28.91 63.8 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.18 -14.87 61.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.367 1.867 . . . . 0.0 111.91 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.78 -14.02 29.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 127.048 2.261 . . . . 0.0 113.461 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 54.1 p -69.35 155.83 39.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.233 1.516 . . . . 0.0 112.683 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -127.95 139.58 52.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.935 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -125.69 134.83 51.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.563 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -124.97 131.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.0 mt -135.01 127.83 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.6 -89.6 0.11 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.048 0.842 . . . . 0.0 112.52 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.4 140.5 32.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.714 -0.874 . . . . 0.0 111.554 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.3 t -90.96 129.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.402 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.73 165.8 16.55 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.576 0.703 . . . . 0.0 111.533 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 27.5 p -56.98 -27.42 61.37 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -74.89 -32.79 61.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.785 0.721 . . . . 0.0 111.877 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.62 -7.32 26.16 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.164 -1.353 . . . . 0.0 112.856 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.498 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 9.7 pt-20 -66.11 144.58 56.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.857 1.328 . . . . 0.0 108.464 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.44 146.16 18.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.783 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.69 162.25 14.15 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.894 0.877 . . . . 0.0 108.76 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.84 36.86 Favored Glycine 0 C--O 1.238 0.372 0 O-C-N 121.245 -0.909 . . . . 0.0 112.608 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 43.9 p -140.17 139.24 35.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.335 1.064 . . . . 0.0 112.292 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -114.38 139.09 49.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.477 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -131.2 127.1 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 86.5 m -105.0 145.47 30.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.45 -22.37 17.17 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.61 143.44 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.553 1.141 . . . . 0.0 113.093 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.62 159.5 39.68 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.387 -0.82 . . . . 0.0 110.083 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.46 -23.49 58.9 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.017 -0.427 . . . . 0.0 111.083 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.78 68.62 11.84 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 127.256 2.223 . . . . 0.0 110.945 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -56.85 -78.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 125.083 3.856 . . . . 0.0 116.776 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.82 -48.46 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 C-N-CA 129.582 3.468 . . . . 0.0 120.568 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.98 -5.29 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.283 2.233 . . . . 0.0 113.114 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . 0.349 65.7 mt -8.58 85.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 124.354 2.026 . . . . 0.0 115.147 -172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.89 151.11 21.21 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.501 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -46.34 127.3 8.86 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.777 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.46 118.72 56.98 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 123.951 0.782 . . . . 0.0 111.405 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.85 144.12 68.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.58 158.44 34.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.728 0.811 . . . . 0.0 111.22 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.4 tp -160.03 148.94 17.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.409 1.884 . . . . 0.0 110.453 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.86 -157.28 29.01 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 121.018 1.735 . . . . 0.0 110.236 -174.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.62 135.0 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.64 0.733 . . . . 0.0 111.491 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.56 136.71 53.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.723 1.209 . . . . 0.0 110.843 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -73.48 152.49 40.7 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.993 0.902 . . . . 0.0 109.756 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.86 25.82 1.42 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.537 -1.352 . . . . 0.0 111.773 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -93.23 -49.21 6.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.918 1.287 . . . . 0.0 111.238 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.23 172.53 12.69 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.557 1.161 . . . . 0.0 114.042 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.67 -28.6 36.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.492 1.117 . . . . 0.0 113.028 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -135.11 57.09 18.72 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.665 1.186 . . . . 0.0 111.52 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.77 163.95 37.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.598 2.865 . . . . 0.0 117.73 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 69.6 p -80.89 163.74 23.15 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.761 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -158.76 162.84 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.346 -0.846 . . . . 0.0 112.811 175.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.76 140.03 6.08 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -159.59 158.17 31.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.37 151.46 19.52 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.477 1.511 . . . . 0.0 110.632 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -127.38 118.06 48.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -93.74 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.01 0.924 . . . . 0.0 109.501 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.298 43.8 m95 -83.06 135.05 34.98 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.44 -43.86 9.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.179 2.192 . . . . 0.0 116.361 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -91.14 -9.66 44.71 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -152.74 126.32 8.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.479 2.312 . . . . 0.0 106.912 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.12 118.49 12.09 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.046 1.294 . . . . 0.0 110.515 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -177.48 163.57 1.98 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 109.176 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -143.63 144.25 31.82 Favored 'General case' 0 CA--C 1.482 -1.673 0 CA-C-O 123.376 1.56 . . . . 0.0 111.648 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 125.67 21.32 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 110.441 -3.072 . . . . 0.0 109.656 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.03 153.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -126.99 142.03 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 118.06 6.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.09 -165.01 14.76 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -130.83 149.61 52.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.928 1.016 . . . . 0.0 111.75 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.23 125.84 42.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.464 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -113.07 165.44 12.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.267 1.027 . . . . 0.0 112.213 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 22.7 mt -130.56 110.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.91 162.08 4.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.258 0.623 . . . . 0.0 109.567 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -33.33 -48.94 0.26 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -13.44 60.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.64 43.45 4.22 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.225 0.92 . . . . 0.0 112.23 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -113.36 142.67 45.59 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 127.389 2.276 . . . . 0.0 109.324 174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -106.8 141.68 37.64 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.004 1.321 . . . . 0.0 111.271 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 24.8 m -144.55 160.37 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.589 1.156 . . . . 0.0 110.14 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.71 119.43 35.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 118.59 37.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 4.5 p -137.38 172.05 13.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.169 1.461 . . . . 0.0 112.189 -174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 88.4 mmm -125.92 168.87 13.3 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.12 163.99 31.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.583 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.16 119.77 8.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.983 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 139.63 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 124.964 1.415 . . . . 0.0 112.176 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -119.38 120.35 36.63 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 110.684 -2.962 . . . . 0.0 110.676 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -87.79 163.35 16.5 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 125.319 1.637 . . . . 0.0 111.405 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -113.13 72.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.58 -167.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.312 0.645 . . . . 0.0 110.269 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.03 -20.28 3.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.092 -1.63 . . . . 0.0 113.66 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -115.38 148.3 39.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.991 1.377 . . . . 0.0 110.96 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' C' ' 84' ' ' PHE . 16.9 tt -62.85 -28.4 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.516 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.75 5.83 15.31 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 118.003 -1.443 . . . . 0.0 113.831 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' B' ' 111' ' ' LYS . 32.4 m-20 -121.27 -0.93 9.79 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.95 1.375 . . . . 0.0 113.432 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.5 -35.86 70.79 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.737 -1.227 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -47.22 -40.25 15.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.195 1.398 . . . . 0.0 113.802 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' B' ' 108' ' ' ASP . 12.3 pttp -99.04 -7.07 27.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.241 1.416 . . . . 0.0 113.943 177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.58 13.05 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.627 -1.295 . . . . 0.0 113.165 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.427 HG23 ' HG3' ' C' ' 96' ' ' MET . 33.1 m -115.09 145.47 42.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.869 0.868 . . . . 0.0 111.757 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.78 129.86 18.51 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 125.876 1.671 . . . . 0.0 110.42 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.66 155.13 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 120.421 1.464 . . . . 0.0 109.353 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.68 -175.07 28.19 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.673 1.13 . . . . 0.0 113.517 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 21.1 p90 -126.29 152.84 45.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.13 0.972 . . . . 0.0 110.71 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -145.15 151.57 38.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.528 1.131 . . . . 0.0 110.304 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.86 119.74 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -108.69 152.28 25.03 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.933 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -136.91 162.15 34.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.23 1.012 . . . . 0.0 109.566 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -54.55 125.79 21.07 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.51 -0.744 . . . . 0.0 109.668 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.598 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -119.27 133.41 55.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.279 1.832 . . . . 0.0 109.228 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 78.9 p -139.83 133.21 30.01 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.243 -1.536 . . . . 0.0 114.148 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' C' ' 64' ' ' PHE . 40.8 mt -58.23 -32.82 68.68 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -51.76 116.3 2.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.903 1.335 . . . . 0.0 111.729 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.95 -114.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 125.66 1.6 . . . . 0.0 109.829 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -152.9 148.22 26.89 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -141.12 162.67 34.93 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.267 1.427 . . . . 0.0 112.315 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -135.45 147.3 48.89 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.859 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.67 146.81 36.81 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.591 0.756 . . . . 0.0 110.475 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -57.1 -27.46 61.79 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 34.9 tp -72.64 -16.25 61.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.126 1.77 . . . . 0.0 111.986 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.56 -13.81 25.15 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.128 2.299 . . . . 0.0 113.662 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 44.1 p -69.16 156.31 38.92 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.489 1.645 . . . . 0.0 113.128 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -128.86 138.93 52.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.848 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -124.08 136.87 54.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.26 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -126.68 130.72 50.96 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.97 126.87 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.83 -89.59 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.898 0.749 . . . . 0.0 112.63 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.42 32.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.619 -0.93 . . . . 0.0 111.206 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.33 130.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.08 165.33 18.29 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.589 0.709 . . . . 0.0 111.782 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 30.6 p -57.78 -26.76 62.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -73.65 -32.04 63.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.975 0.807 . . . . 0.0 111.733 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.08 -4.55 25.48 Favored Glycine 0 N--CA 1.463 0.462 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.392 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.73 156.49 39.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.432 1.116 . . . . 0.0 112.766 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.81 159.93 33.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.258 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.5 HG21 ' CD1' ' C' ' 50' ' ' LEU . 1.0 OUTLIER -120.34 157.11 29.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 173.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.08 -167.33 27.6 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 120.054 -1.654 . . . . 0.0 112.627 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 54.0 p -139.79 138.14 35.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.514 1.149 . . . . 0.0 112.783 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.9 139.45 49.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.371 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.16 127.06 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.05 145.03 31.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.98 -20.12 18.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.49 142.89 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.548 1.139 . . . . 0.0 113.197 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.42 159.37 39.8 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.326 -0.859 . . . . 0.0 110.215 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.38 -23.42 58.99 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 110.99 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.71 68.88 12.07 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 127.239 2.216 . . . . 0.0 111.029 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.92 -78.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 125.054 3.836 . . . . 0.0 116.86 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.51 -48.85 0.01 OUTLIER Glycine 0 CA--C 1.546 1.982 0 C-N-CA 129.65 3.5 . . . . 0.0 120.591 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.49 -5.08 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.307 2.243 . . . . 0.0 113.167 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . 0.345 65.6 mt -9.02 85.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 124.465 2.078 . . . . 0.0 115.301 -172.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.88 151.36 20.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.525 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -46.48 127.08 8.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 112.181 -2.282 . . . . 0.0 111.777 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.25 118.71 57.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 123.85 0.718 . . . . 0.0 111.376 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.74 144.29 66.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.755 2.303 . . . . 0.0 111.869 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.63 162.73 25.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.545 0.738 . . . . 0.0 111.702 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . 0.5 ' CD1' HG21 ' C' ' 30' ' ' THR . 15.6 tp -164.46 148.97 9.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.778 1.631 . . . . 0.0 112.166 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.73 25.79 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 120.866 1.666 . . . . 0.0 110.488 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -143.76 135.18 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.209 1.004 . . . . 0.0 110.984 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.58 136.55 52.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.311 1.444 . . . . 0.0 110.34 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -73.72 151.44 40.7 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.889 0.852 . . . . 0.0 110.172 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -144.56 25.68 1.48 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.573 -1.329 . . . . 0.0 112.017 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -93.51 -49.96 5.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.28 1.432 . . . . 0.0 111.239 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.64 173.11 11.48 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.691 1.245 . . . . 0.0 113.659 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -83.0 -26.47 31.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.107 1.363 . . . . 0.0 113.46 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -134.91 55.74 14.77 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 125.438 1.495 . . . . 0.0 112.2 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.28 163.72 37.66 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.794 2.329 . . . . 0.0 117.878 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 68.2 p -80.86 164.18 22.84 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.033 173.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.21 163.33 36.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.874 0.845 . . . . 0.0 113.118 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.74 140.81 6.53 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 117.816 1.886 . . . . 0.0 117.816 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -160.3 158.55 30.0 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -96.63 152.02 19.05 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.118 1.767 . . . . 0.0 110.709 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.34 118.12 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -94.22 113.14 25.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.017 0.927 . . . . 0.0 109.447 -174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.295 43.6 m95 -82.46 135.43 35.13 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -172.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -91.56 -44.07 9.29 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.956 2.102 . . . . 0.0 116.226 -173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -90.89 -9.49 46.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.0 t -152.74 126.84 9.09 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 127.448 2.299 . . . . 0.0 107.065 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -69.19 118.48 12.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.0 1.273 . . . . 0.0 110.407 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -177.34 163.59 2.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.393 1.877 . . . . 0.0 109.142 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -143.69 143.89 31.62 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 124.067 1.889 . . . . 0.0 111.613 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.44 125.71 21.65 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 109.99 -3.277 . . . . 0.0 109.86 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.33 153.58 4.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.79 142.15 51.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.72 118.94 7.26 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -174.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.88 -164.29 14.16 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.06 149.46 52.41 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.541 0.789 . . . . 0.0 111.812 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 41.4 t -97.21 123.26 40.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.318 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.403 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.1 m-85 -112.34 164.71 12.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.264 1.025 . . . . 0.0 112.203 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -128.11 111.78 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.85 160.18 6.11 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -33.42 -47.74 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -10.06 59.13 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.07 5.79 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.524 1.056 . . . . 0.0 112.644 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -112.99 143.21 44.68 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 128.208 2.603 . . . . 0.0 108.959 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -109.45 143.93 38.38 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.489 1.495 . . . . 0.0 110.865 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.95 162.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.581 1.152 . . . . 0.0 109.606 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.63 121.02 39.16 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.84 119.07 38.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.7 p -137.31 172.54 12.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.083 1.42 . . . . 0.0 112.371 -174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.427 ' HG3' HG23 ' B' ' 113' ' ' THR . 88.7 mmm -126.97 169.22 13.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -141.15 164.37 30.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.389 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.27 120.01 8.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.949 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.19 140.2 40.43 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 125.022 1.451 . . . . 0.0 112.231 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.25 120.74 36.98 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 111.208 -2.724 . . . . 0.0 111.129 -174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 38.4 t -88.56 163.18 15.99 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 125.176 1.548 . . . . 0.0 111.351 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -113.0 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.96 -165.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.439 0.695 . . . . 0.0 110.453 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.36 -15.65 3.19 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.074 -1.641 . . . . 0.0 114.054 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.58 148.89 43.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.13 1.443 . . . . 0.0 110.798 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.18 -28.34 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.932 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.28 5.84 18.35 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-O 118.121 -1.377 . . . . 0.0 113.866 173.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . 0.483 ' CG ' ' HZ1' ' C' ' 111' ' ' LYS . 35.3 m-20 -121.17 -1.43 9.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.587 1.194 . . . . 0.0 113.481 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.07 -35.71 71.76 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.738 -1.226 . . . . 0.0 112.581 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -47.1 -39.8 13.98 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.018 1.327 . . . . 0.0 113.903 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . 0.483 ' HZ1' ' CG ' ' C' ' 108' ' ' ASP . 12.2 pttp -99.28 -7.21 26.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.16 2.04 9.89 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.537 -1.352 . . . . 0.0 113.09 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' THR . . . . . 0.41 HG23 ' HG3' ' B' ' 96' ' ' MET . 35.8 m -116.96 145.08 43.87 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.977 0.911 . . . . 0.0 111.618 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.23 129.37 18.65 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 125.68 1.592 . . . . 0.0 110.62 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.66 155.08 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 120.558 1.526 . . . . 0.0 109.246 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -175.82 28.83 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.681 1.134 . . . . 0.0 113.441 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 21.1 p90 -125.45 152.95 44.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.541 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.61 152.66 40.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.75 1.22 . . . . 0.0 110.151 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.16 121.5 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -109.02 152.69 24.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -141.02 164.08 31.24 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.136 0.975 . . . . 0.0 110.676 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.39 114.38 2.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.097 0.959 . . . . 0.0 111.24 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.714 174.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 134.2 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.219 1.408 . . . . 0.0 111.273 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.43 127.54 13.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.022 1.329 . . . . 0.0 109.234 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -73.74 -27.7 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.77 116.1 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.86 1.264 . . . . 0.0 111.204 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.33 -123.52 2.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.411 1.482 . . . . 0.0 110.97 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -147.62 144.65 28.56 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -142.67 159.15 42.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.369 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -141.33 146.95 37.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.409 HD22 ' HB2' ' A' ' 16' ' ' SER . 25.2 p30 -114.21 159.37 20.2 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -55.99 -26.06 46.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.146 2.578 . . . . 0.0 115.164 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.1 tp -76.27 -11.97 60.0 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.608 1.163 . . . . 0.0 111.974 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.89 47.28 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 127.145 2.307 . . . . 0.0 112.931 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.409 ' HB2' HD22 ' A' ' 12' ' ' ASN . 15.8 m -69.21 154.91 41.28 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.596 1.189 . . . . 0.0 111.598 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -128.99 150.56 50.35 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.736 -1.227 . . . . 0.0 110.273 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -134.47 145.4 48.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.339 0.59 . . . . 0.0 112.159 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -129.2 134.75 48.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.767 0.827 . . . . 0.0 109.231 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.31 125.05 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -78.68 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 O-C-N 124.335 1.022 . . . . 0.0 111.199 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.85 30.92 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.83 -0.806 . . . . 0.0 112.407 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.61 132.17 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.337 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -76.52 168.73 19.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.941 0.877 . . . . 0.0 112.521 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 p -56.07 -27.4 53.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -75.64 -34.0 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.539 0.609 . . . . 0.0 112.272 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.65 -10.38 14.26 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.985 -1.453 . . . . 0.0 113.501 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 140.02 58.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.358 2.263 . . . . 0.0 108.991 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.86 147.57 24.34 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 p -107.39 169.31 8.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.566 1.147 . . . . 0.0 109.78 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.04 -168.2 37.18 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.377 -1.452 . . . . 0.0 114.905 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -140.53 129.56 23.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.375 1.084 . . . . 0.0 111.975 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.29 137.79 48.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.12 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.5 mt -127.22 127.43 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.264 73.7 m -105.06 133.0 50.57 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 125.051 1.34 . . . . 0.0 112.986 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.51 27.63 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.46 146.79 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.016 1.327 . . . . 0.0 112.092 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.02 161.69 42.23 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.817 -1.177 . . . . 0.0 111.407 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.98 -29.07 55.36 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 122.037 -0.414 . . . . 0.0 110.353 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -143.02 78.95 14.88 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 127.338 2.255 . . . . 0.0 110.215 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.15 21.28 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.336 1 C-N-CA 125.474 4.116 . . . . 0.0 117.415 -174.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.6 -7.13 5.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 119.289 2.476 . . . . 0.0 119.289 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.93 43.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.686 1.743 . . . . 0.0 111.38 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.5 mt -51.21 125.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.34 -1.475 . . . . 0.0 111.272 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.63 30.4 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.692 1.597 . . . . 0.0 110.389 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -46.71 115.37 1.03 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.971 2.909 . . . . 0.0 110.738 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 t -102.76 119.36 55.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.493 0.717 . . . . 0.0 109.554 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -55.86 142.66 83.79 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.261 2.641 . . . . 0.0 111.431 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.54 154.81 47.42 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 124.017 0.823 . . . . 0.0 111.017 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -156.54 148.75 23.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.736 1.614 . . . . 0.0 110.574 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.21 -157.55 29.43 Favored Glycine 0 C--N 1.333 0.405 0 O-C-N 119.738 -1.851 . . . . 0.0 110.641 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.7 142.01 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.681 0.792 . . . . 0.0 112.836 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.44 136.91 47.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.0 151.12 44.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.671 1.225 . . . . 0.0 112.105 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -151.33 26.95 0.68 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.352 1.861 . . . . 0.0 110.019 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.41 -57.04 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.881 1.672 . . . . 0.0 110.065 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.26 7.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.301 0.64 . . . . 0.0 112.08 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 p -95.19 -17.95 21.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 117.329 -1.32 . . . . 0.0 113.754 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -131.6 45.4 1.71 Allowed Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.895 1.278 . . . . 0.0 112.364 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 171.38 17.28 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.7 2.266 . . . . 0.0 115.452 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.485 ' HG1' ' HB3' ' D' ' 100' ' ' ARG 0.298 0.1 OUTLIER -98.81 163.81 12.47 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.747 1.737 . . . . 0.0 111.199 173.156 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -158.34 166.11 33.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.911 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.6 145.12 10.12 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 118.999 2.359 . . . . 0.0 118.999 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -161.41 153.65 19.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -90.15 149.18 22.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.548 1.939 . . . . 0.0 110.314 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -128.17 118.53 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.67 101.81 12.38 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.449 -0.782 . . . . 0.0 110.429 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -58.69 129.43 42.08 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.49 -32.29 16.42 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -99.8 -11.96 20.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.35 138.01 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.944 2.098 . . . . 0.0 106.728 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -73.45 118.62 16.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.59 1.186 . . . . 0.0 111.254 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.67 159.77 2.37 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.591 1.556 . . . . 0.0 109.604 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -136.58 134.66 37.66 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.4 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.02 138.0 54.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.78 155.2 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -130.96 143.99 51.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.078 0.951 . . . . 0.0 108.844 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.47 118.98 8.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.32 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.73 176.68 44.83 Favored Glycine 0 C--O 1.215 -1.077 0 N-CA-C 118.196 2.038 . . . . 0.0 118.196 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.619 ' NE2' ' H ' ' D' ' 103' ' ' VAL . 0.0 OUTLIER -101.71 150.5 23.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.47 115.14 27.21 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.445 1.716 . . . . 0.0 107.086 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 82' ' ' GLN . 25.5 m-85 -105.64 159.21 16.14 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.761 1.164 . . . . 0.0 113.266 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 mt -120.02 109.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 113.519 -1.673 . . . . 0.0 106.9 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.86 161.41 4.91 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -22.71 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 177.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -10.31 48.88 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.689 0.796 . . . . 0.0 112.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.75 6.44 56.24 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.487 1.042 . . . . 0.0 114.851 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -73.82 165.51 24.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.773 1.286 . . . . 0.0 110.153 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.62 143.42 49.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.738 1.615 . . . . 0.0 111.473 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.51 153.17 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.09 0.956 . . . . 0.0 110.891 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.5 mt -116.46 103.59 10.59 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HE3' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -97.06 114.45 26.09 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -133.26 164.54 26.85 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.216 1.484 . . . . 0.0 112.227 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.43 ' HG3' HG23 ' D' ' 113' ' ' THR . 92.9 mmm -115.29 167.87 10.47 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -139.07 163.87 31.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 0.0 113.423 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 124.66 15.02 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.05 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.15 131.97 53.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.634 1.683 . . . . 0.0 109.036 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.499 ' HB3' ' HG1' ' D' ' 63' ' ' THR . 3.2 tpt85 -114.79 113.67 24.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 111.036 -2.802 . . . . 0.0 109.232 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.271 1.0 OUTLIER -68.26 165.98 17.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.447 . . . . 0.0 111.688 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.1 t -107.3 86.95 2.39 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 121.465 1.939 . . . . 0.0 107.775 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.606 ' H ' ' NE2' ' D' ' 82' ' ' GLN . 8.1 p -86.66 157.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 129.294 3.038 . . . . 0.0 110.96 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -96.84 -34.14 11.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.47 148.84 32.28 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.777 0.799 . . . . 0.0 112.685 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.37 -29.58 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.851 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.63 5.26 38.92 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.4 0.03 8.82 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.333 1.567 . . . . 0.0 113.6 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -28.8 69.32 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.49 -1.381 . . . . 0.0 113.77 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.675 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 62.5 p-90 -49.64 -44.39 47.45 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.946 0.898 . . . . 0.0 113.223 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.675 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -87.63 -12.72 44.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.252 -0.905 . . . . 0.0 113.223 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 -0.69 26.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.513 -0.742 . . . . 0.0 112.247 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.424 HG23 ' HG3' ' D' ' 96' ' ' MET . 35.2 m -110.22 139.84 44.96 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.348 1.059 . . . . 0.0 111.054 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.23 132.96 22.39 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.737 1.215 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -112.31 154.66 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 120.275 1.398 . . . . 0.0 110.961 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -174.45 27.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.938 0.78 . . . . 0.0 114.728 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 9.7 p90 -128.43 156.65 42.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.209 1.004 . . . . 0.0 112.209 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -152.16 150.23 29.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.243 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.478 HD13 ' HE3' ' A' ' 94' ' ' LYS . 9.0 mt -126.66 121.13 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.67 149.49 34.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.6 p -138.8 165.02 28.1 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.62 117.0 2.79 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.649 0.78 . . . . 0.0 110.546 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 123' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.23 0.068 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 t -133.04 142.81 48.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.669 0.787 . . . . 0.0 110.964 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.02 135.88 33.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.155 1.782 . . . . 0.0 108.801 174.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.51 -24.78 60.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.045 1.293 . . . . 0.0 113.858 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 115.73 1.7 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.94 1.296 . . . . 0.0 111.08 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.91 -125.72 3.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.982 1.277 . . . . 0.0 110.382 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -147.48 145.81 29.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -143.51 159.85 41.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -140.26 149.21 42.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.88 160.15 19.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -56.24 -26.07 50.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.127 2.571 . . . . 0.0 114.912 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -76.48 -11.04 59.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.793 1.237 . . . . 0.0 112.074 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.17 -15.21 56.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.832 2.158 . . . . 0.0 112.994 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -69.76 154.75 41.54 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.64 1.21 . . . . 0.0 111.643 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.02 151.23 49.94 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.576 -1.327 . . . . 0.0 110.677 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -134.3 146.78 50.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -130.27 134.85 47.53 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.662 0.785 . . . . 0.0 109.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.75 124.18 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.91 -75.86 0.39 Allowed Glycine 0 CA--C 1.527 0.827 0 O-C-N 124.339 1.024 . . . . 0.0 111.394 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.85 156.99 42.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.561 0.695 . . . . 0.0 111.931 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.5 131.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.052 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -77.99 168.57 19.69 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.833 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 61.8 p -57.08 -26.65 60.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -75.04 -30.2 60.99 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.253 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.02 -8.24 18.86 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 124.666 1.127 . . . . 0.0 114.154 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.49 147.72 51.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.51 2.324 . . . . 0.0 113.683 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -156.56 161.61 39.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.023 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -119.2 172.72 7.39 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.4 -167.26 35.43 Favored Glycine 0 N--CA 1.467 0.756 0 O-C-N 119.349 -2.095 . . . . 0.0 114.143 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -139.52 129.24 24.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.482 1.134 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -111.86 138.04 49.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.268 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 80.7 mt -127.16 127.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' THR . . . . . 0.403 ' HG1' ' HZ3' ' D' ' 70' ' ' TRP 0.264 90.5 m -105.1 133.82 49.23 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.816 1.246 . . . . 0.0 112.849 -172.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.65 -16.51 26.9 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 m -135.5 147.05 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.065 1.346 . . . . 0.0 112.167 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.4 161.04 42.71 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.806 -1.184 . . . . 0.0 111.74 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -76.22 -28.76 57.31 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.881 -0.512 . . . . 0.0 110.587 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -143.18 78.95 14.66 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.278 2.231 . . . . 0.0 110.311 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 21.09 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.316 1 C-N-CA 125.44 4.093 . . . . 0.0 117.403 -174.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.46 -7.04 5.17 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.15 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.136 1.774 . . . . 0.0 111.392 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -51.05 126.31 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.303 -1.498 . . . . 0.0 111.288 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.73 164.66 31.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.606 1.562 . . . . 0.0 110.426 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 13.4 tp -46.55 115.36 1.01 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.918 2.887 . . . . 0.0 110.562 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.8 t -103.2 118.63 57.44 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 123.607 0.763 . . . . 0.0 109.221 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.89 141.71 85.26 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.015 2.476 . . . . 0.0 111.094 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -129.76 162.18 29.02 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.199 0.999 . . . . 0.0 111.428 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 18.7 tp -165.5 148.83 8.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.703 1.201 . . . . 0.0 112.104 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.72 25.77 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 121.227 1.83 . . . . 0.0 110.456 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -145.19 141.83 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.878 0.987 . . . . 0.0 111.591 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 133.62 43.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.988 1.315 . . . . 0.0 114.515 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -67.31 147.31 53.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.443 1.116 . . . . 0.0 112.208 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -146.06 27.76 1.15 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.614 1.965 . . . . 0.0 110.127 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.12 -57.28 2.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.629 1.572 . . . . 0.0 110.133 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 175.31 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.527 0.731 . . . . 0.0 112.5 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 p -91.76 -20.59 21.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.673 1.189 . . . . 0.0 113.706 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -133.29 46.14 1.94 Allowed Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 125.227 1.411 . . . . 0.0 112.989 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.76 170.51 19.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.692 2.261 . . . . 0.0 116.006 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.499 ' HG1' ' HB3' ' A' ' 100' ' ' ARG 0.296 0.0 OUTLIER -97.89 161.98 13.47 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 124.023 1.868 . . . . 0.0 111.465 173.092 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.09 166.37 33.48 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.369 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.86 145.52 10.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 118.656 2.223 . . . . 0.0 118.656 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -161.91 152.98 18.04 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -89.44 151.15 22.17 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.62 1.968 . . . . 0.0 110.268 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 70.9 t -130.28 119.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -103.0 102.11 12.14 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 110.426 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . 0.403 ' HZ3' ' HG1' ' D' ' 35' ' ' THR . 84.4 m95 -58.43 129.8 43.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 124.071 1.891 . . . . 0.0 115.216 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.22 -31.58 16.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.57 -11.95 19.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 138.34 18.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.999 2.12 . . . . 0.0 106.484 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.85 118.69 17.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 43.1 t -175.66 160.04 2.41 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.486 1.514 . . . . 0.0 109.558 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.39 134.71 38.08 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.594 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.97 138.58 54.64 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.371 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.69 155.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -131.29 143.65 50.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.081 0.953 . . . . 0.0 108.657 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.61 118.25 8.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.444 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.05 44.4 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 118.185 2.034 . . . . 0.0 118.185 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . 0.606 ' NE2' ' H ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -101.76 150.42 23.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.943 1.025 . . . . 0.0 113.491 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 12.6 p -97.51 118.41 33.95 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.193 -1.821 . . . . 0.0 106.633 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.414 ' CZ ' ' CB ' ' D' ' 82' ' ' GLN . 20.4 m-85 -110.01 155.35 21.94 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.662 1.119 . . . . 0.0 113.849 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.55 110.33 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.477 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -58.81 162.02 4.39 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -23.38 1.3 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -4.57 57.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.68 0.792 . . . . 0.0 112.692 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.86 61.85 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.035 1.302 . . . . 0.0 114.977 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -77.32 165.92 23.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.927 1.363 . . . . 0.0 110.505 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -122.06 145.12 48.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.02 1.328 . . . . 0.0 111.212 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.5 154.19 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.381 1.072 . . . . 0.0 110.64 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.98 103.81 10.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . 0.494 ' HE3' HD13 ' D' ' 119' ' ' ILE . 0.6 OUTLIER -96.85 114.27 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -133.05 164.59 26.68 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 123.003 1.383 . . . . 0.0 112.382 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.424 ' HG3' HG23 ' A' ' 113' ' ' THR . 92.3 mmm -115.19 167.86 10.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -139.06 164.0 30.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.412 1.101 . . . . 0.0 113.43 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.1 124.95 15.09 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.922 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.22 132.01 53.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 123.7 1.714 . . . . 0.0 108.964 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . 0.485 ' HB3' ' HG1' ' A' ' 63' ' ' THR . 2.8 tpt85 -114.7 113.6 24.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 111.067 -2.788 . . . . 0.0 108.985 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.266 1.0 OUTLIER -67.37 165.92 15.51 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 116.875 -1.536 . . . . 0.0 111.888 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 29.7 t -107.81 87.3 2.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 121.775 2.079 . . . . 0.0 107.611 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . 0.619 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 8.0 p -88.09 154.86 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 129.215 3.006 . . . . 0.0 110.993 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -93.5 -33.06 13.93 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.83 150.35 35.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.96 -28.83 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.485 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.3 5.75 48.44 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.838 1.208 . . . . 0.0 115.606 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.3 0.42 8.94 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.273 1.536 . . . . 0.0 113.374 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -29.37 69.34 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.387 -1.446 . . . . 0.0 114.226 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . 0.684 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 62.4 p-90 -49.37 -44.75 45.15 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.973 0.909 . . . . 0.0 113.085 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . 0.684 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.0 OUTLIER -87.31 -12.64 45.9 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.04 0.936 . . . . 0.0 113.279 176.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.99 1.12 21.83 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.457 -0.777 . . . . 0.0 112.402 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' THR . . . . . 0.43 HG23 ' HG3' ' A' ' 96' ' ' MET . 33.9 m -111.56 139.7 46.78 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.33 1.052 . . . . 0.0 111.118 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.12 133.35 23.06 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.641 1.176 . . . . 0.0 110.942 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.33 154.74 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 120.4 1.455 . . . . 0.0 110.978 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -173.94 27.33 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.006 0.812 . . . . 0.0 114.744 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 10.0 p90 -128.67 156.39 43.53 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.282 1.033 . . . . 0.0 112.241 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -152.18 149.78 29.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.393 1.077 . . . . 0.0 112.144 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . 0.494 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.4 mt -126.47 123.4 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.675 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 148.39 40.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -139.74 167.29 22.44 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 120.74 7.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.675 1.19 . . . . 0.0 112.495 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 118.778 -0.63 . . . . 0.0 109.942 177.599 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tmmt? . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.33 144.0 51.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 111.533 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.06 134.97 32.12 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.827 1.651 . . . . 0.0 109.064 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -73.46 -25.8 60.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.978 1.263 . . . . 0.0 113.683 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.54 115.69 1.45 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 111.069 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.95 -125.6 3.14 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 125.252 1.406 . . . . 0.0 110.334 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -149.58 144.12 26.0 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -142.31 159.44 42.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.577 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 t -138.96 150.36 45.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -114.84 158.89 21.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.825 1.298 . . . . 0.0 114.347 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -54.53 -26.45 31.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.054 2.542 . . . . 0.0 114.879 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -12.06 60.07 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.897 1.279 . . . . 0.0 112.302 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.16 -15.7 50.67 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.132 2.301 . . . . 0.0 112.991 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -69.81 155.26 40.82 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.718 1.247 . . . . 0.0 111.706 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 150.2 50.72 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.639 -1.288 . . . . 0.0 110.511 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -133.63 147.06 51.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.371 0.605 . . . . 0.0 112.626 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -130.67 134.49 46.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.651 0.78 . . . . 0.0 109.469 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 92.9 mt -132.35 125.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -78.89 0.22 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 124.506 1.129 . . . . 0.0 111.208 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.31 152.7 33.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.629 0.728 . . . . 0.0 112.305 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.64 131.94 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.362 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -76.93 168.4 20.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 0.0 112.472 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 62.8 p -55.79 -27.51 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.58 -33.33 60.59 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.596 0.634 . . . . 0.0 112.327 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.86 -10.05 15.87 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 117.961 -1.466 . . . . 0.0 113.682 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.12 139.89 58.82 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.453 2.301 . . . . 0.0 108.861 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.79 148.54 25.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.0 p -108.94 168.4 9.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.809 1.244 . . . . 0.0 109.633 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 -168.58 37.31 Favored Glycine 0 N--CA 1.466 0.692 0 O-C-N 120.27 -1.519 . . . . 0.0 114.983 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -140.5 130.03 24.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.394 1.092 . . . . 0.0 111.765 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -111.46 138.37 48.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.191 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 78.7 mt -127.66 127.77 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.263 82.4 m -105.16 134.02 48.97 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.792 1.237 . . . . 0.0 112.913 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 -15.44 27.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 146.54 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.936 1.294 . . . . 0.0 111.972 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.31 42.7 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.735 -1.228 . . . . 0.0 111.489 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.48 -29.21 56.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.058 -0.401 . . . . 0.0 110.408 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -142.84 79.18 15.02 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.336 2.254 . . . . 0.0 110.292 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.17 20.55 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.377 1 C-N-CA 125.389 4.06 . . . . 0.0 117.406 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.67 -8.16 5.19 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.99 43.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.702 1.751 . . . . 0.0 111.335 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 70.3 mt -51.12 125.65 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.346 -1.471 . . . . 0.0 111.35 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.17 164.48 31.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.595 1.558 . . . . 0.0 110.449 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -46.49 115.41 1.02 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 129.005 2.922 . . . . 0.0 110.753 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.1 t -103.17 119.83 54.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.544 0.738 . . . . 0.0 109.268 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.03 142.55 85.45 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.363 2.708 . . . . 0.0 111.385 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.38 154.92 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.119 0.887 . . . . 0.0 110.89 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.73 148.72 22.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.621 1.568 . . . . 0.0 110.364 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.0 -158.07 29.97 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 121.25 1.841 . . . . 0.0 110.691 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.64 141.95 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.571 0.748 . . . . 0.0 112.749 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.57 135.01 45.65 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -69.45 149.13 48.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.8 1.286 . . . . 0.0 112.249 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -148.8 27.1 0.89 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.475 1.91 . . . . 0.0 109.841 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.71 -56.55 2.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.522 1.529 . . . . 0.0 109.721 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.89 173.64 10.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.784 0.802 . . . . 0.0 112.88 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -88.85 -23.27 22.84 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 113.505 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -131.88 48.31 3.52 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.255 1.422 . . . . 0.0 113.315 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.82 171.64 17.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.328 2.019 . . . . 0.0 115.58 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.493 ' HG1' ' HB3' ' C' ' 100' ' ' ARG 0.294 0.1 OUTLIER -98.14 163.07 12.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 123.775 1.75 . . . . 0.0 111.368 173.147 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -157.92 165.74 34.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.049 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 145.6 10.63 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 118.988 2.355 . . . . 0.0 118.988 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -161.59 153.94 19.91 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -89.92 149.46 22.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.651 1.98 . . . . 0.0 110.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -128.52 118.73 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -101.81 101.83 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.477 -0.764 . . . . 0.0 110.587 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.9 129.43 42.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 123.853 1.787 . . . . 0.0 115.311 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.62 -32.25 16.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -100.07 -11.92 20.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.5 t -152.46 138.0 17.74 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.807 2.043 . . . . 0.0 106.432 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.8 118.58 16.92 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.618 1.199 . . . . 0.0 111.406 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -175.34 159.99 2.56 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.624 1.57 . . . . 0.0 109.625 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.64 134.47 37.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.293 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.83 137.67 54.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.45 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -109.04 155.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -131.69 144.61 51.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.88 118.49 7.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.705 0.628 . . . . 0.0 109.965 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.8 176.42 44.26 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 118.201 2.041 . . . . 0.0 118.201 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . 0.614 ' NE2' ' H ' ' C' ' 103' ' ' VAL . 0.0 OUTLIER -101.77 150.33 23.26 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 125.021 1.071 . . . . 0.0 113.82 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 10.4 p -97.51 117.43 31.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.621 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.413 ' CZ ' ' CB ' ' B' ' 82' ' ' GLN . 17.6 m-85 -108.81 155.15 21.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 119.804 1.184 . . . . 0.0 113.864 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.19 109.57 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.751 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -58.71 164.94 2.48 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.829 0.706 . . . . 0.0 109.594 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.98 -29.93 3.86 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -8.04 56.38 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.405 1.082 . . . . 0.0 113.27 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.95 10.71 58.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.764 1.173 . . . . 0.0 115.534 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -76.6 168.44 20.07 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.06 1.43 . . . . 0.0 108.895 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -124.58 145.06 49.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.192 1.36 . . . . 0.0 110.687 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.12 153.76 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.197 0.999 . . . . 0.0 111.453 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -117.57 103.32 9.95 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . 0.483 ' HE3' HD13 ' B' ' 119' ' ' ILE . 0.6 OUTLIER -96.8 113.97 25.56 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 173.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -132.8 164.66 26.34 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.099 1.428 . . . . 0.0 112.385 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.433 ' HG3' HG23 ' C' ' 113' ' ' THR . 93.1 mmm -115.73 168.09 10.34 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -139.26 164.14 30.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.637 1.208 . . . . 0.0 113.419 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.73 125.05 15.53 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.088 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.2 131.55 54.05 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 125.412 1.695 . . . . 0.0 109.27 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . 0.492 ' HB3' ' HG1' ' C' ' 63' ' ' THR . 3.5 tpt85 -114.82 113.65 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 110.847 -2.888 . . . . 0.0 108.947 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.261 0.9 OUTLIER -69.02 164.4 22.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.318 1.447 . . . . 0.0 111.994 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.5 t -105.45 87.95 2.73 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 121.462 1.937 . . . . 0.0 107.703 173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.601 ' H ' ' NE2' ' C' ' 82' ' ' GLN . 7.5 p -88.04 156.04 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 129.215 3.006 . . . . 0.0 111.065 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -95.81 -33.31 12.3 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.28 148.46 34.13 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.64 0.733 . . . . 0.0 112.698 -174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 4.8 tt -62.4 -29.79 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.588 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.88 40.66 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.764 1.173 . . . . 0.0 115.888 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.94 -0.36 9.01 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.319 1.559 . . . . 0.0 113.631 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -28.86 69.22 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.48 -1.387 . . . . 0.0 113.792 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.674 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 62.2 p-90 -49.44 -44.28 45.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.092 0.957 . . . . 0.0 113.311 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.674 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.0 OUTLIER -87.99 -12.56 44.12 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.139 -0.975 . . . . 0.0 113.294 176.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -0.54 25.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.424 0.69 . . . . 0.0 112.342 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.412 HG23 ' HG3' ' C' ' 96' ' ' MET . 35.5 m -110.1 139.85 44.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.289 1.036 . . . . 0.0 110.799 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.27 132.6 21.93 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.901 1.28 . . . . 0.0 111.167 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.82 154.59 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 120.213 1.37 . . . . 0.0 110.936 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.04 -174.7 28.08 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.008 0.813 . . . . 0.0 114.733 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 9.8 p90 -128.16 156.59 42.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.222 1.009 . . . . 0.0 112.272 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -152.6 148.88 27.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.299 1.04 . . . . 0.0 112.249 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.483 HD13 ' HE3' ' B' ' 94' ' ' LYS . 9.5 mt -125.31 122.74 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.424 175.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.9 148.68 38.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 28.3 p -140.35 167.78 21.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.32 123.47 16.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.888 -1.132 . . . . 0.0 113.016 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.204 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 45.3 t -132.08 143.63 50.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.828 0.851 . . . . 0.0 111.874 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 135.4 32.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.674 1.99 . . . . 0.0 109.216 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.2 mt -73.41 -24.7 60.31 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.605 1.548 . . . . 0.0 114.283 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -50.79 117.36 2.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.712 1.205 . . . . 0.0 111.237 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.98 -126.38 3.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.239 1.399 . . . . 0.0 110.295 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -147.02 143.42 28.38 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -141.43 158.58 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.682 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -139.07 148.8 43.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -113.46 161.03 17.82 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.909 1.338 . . . . 0.0 114.499 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -57.69 -25.57 60.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.494 2.718 . . . . 0.0 114.899 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.06 -11.02 59.75 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 111.759 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.23 -16.27 53.51 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.945 2.212 . . . . 0.0 112.943 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -69.29 154.58 41.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.598 1.189 . . . . 0.0 111.592 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.1 150.74 50.36 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.613 -1.305 . . . . 0.0 110.558 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.62 145.4 48.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.362 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -129.66 134.06 47.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.52 124.14 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.95 -74.75 0.48 Allowed Glycine 0 CA--C 1.528 0.866 0 O-C-N 124.26 0.975 . . . . 0.0 111.461 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.42 43.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.943 -0.74 . . . . 0.0 111.989 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.52 130.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.192 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -77.13 168.51 19.96 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.877 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 60.2 p -56.64 -26.99 57.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.12 -29.95 60.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.976 0.807 . . . . 0.0 112.395 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.83 -7.87 19.46 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 124.585 1.088 . . . . 0.0 114.339 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.47 148.12 49.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.599 2.36 . . . . 0.0 113.132 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.93 161.51 39.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.982 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -118.83 172.67 7.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.3 -167.58 35.84 Favored Glycine 0 N--CA 1.469 0.848 0 O-C-N 119.334 -2.104 . . . . 0.0 114.409 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 6.3 p -138.57 129.6 26.85 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.756 1.265 . . . . 0.0 112.446 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -112.05 137.64 49.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.302 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -127.31 127.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.261 90.3 m -105.03 134.46 48.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.842 1.257 . . . . 0.0 112.699 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.87 -15.73 26.07 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.88 146.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 161.19 42.71 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.795 -1.19 . . . . 0.0 111.566 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.51 -29.38 56.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.538 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -142.66 79.15 15.37 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.386 2.275 . . . . 0.0 110.377 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.28 21.04 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.386 1 C-N-CA 125.464 4.109 . . . . 0.0 117.356 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.24 -7.56 5.45 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.52 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.139 1.776 . . . . 0.0 111.439 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.12 126.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.418 -1.426 . . . . 0.0 111.379 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.4 164.67 30.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.614 1.565 . . . . 0.0 110.412 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -46.55 115.38 1.02 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 129.06 2.944 . . . . 0.0 110.545 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -102.96 119.06 56.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.547 0.739 . . . . 0.0 109.399 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.97 141.06 86.68 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.157 2.571 . . . . 0.0 111.278 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pp -129.57 162.29 28.56 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.045 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 tp -165.36 148.82 8.19 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.991 1.717 . . . . 0.0 112.243 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.87 25.96 Favored Glycine 0 N--CA 1.448 -0.544 0 O-C-N 119.795 -1.816 . . . . 0.0 110.606 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.49 142.25 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.838 0.964 . . . . 0.0 111.739 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 135.32 44.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.155 1.382 . . . . 0.0 114.384 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.88 149.58 47.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.482 1.134 . . . . 0.0 112.373 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -148.72 25.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.577 1.951 . . . . 0.0 110.065 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.88 -56.44 2.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.599 1.56 . . . . 0.0 110.347 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 173.92 8.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.773 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 3.9 p -92.25 -19.14 22.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.87 1.268 . . . . 0.0 113.674 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -133.61 46.31 1.98 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.924 1.29 . . . . 0.0 112.682 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.75 170.64 19.56 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.023 2.482 . . . . 0.0 116.19 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.492 ' HG1' ' HB3' ' B' ' 100' ' ' ARG 0.292 0.0 OUTLIER -97.07 162.59 13.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 123.751 1.738 . . . . 0.0 111.282 173.088 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.55 166.11 33.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.267 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.87 145.71 10.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.95 153.49 18.6 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -89.65 150.99 22.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.765 2.026 . . . . 0.0 110.228 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 78.3 t -130.25 119.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -102.83 101.72 11.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -58.43 129.78 43.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.352 1.548 . . . . 0.0 115.137 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.06 -31.8 16.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.38 -11.98 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 32.4 t -152.4 138.09 17.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.827 2.051 . . . . 0.0 106.213 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -74.25 118.61 17.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.591 1.186 . . . . 0.0 111.253 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.03 159.83 2.68 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.557 1.543 . . . . 0.0 109.543 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -135.98 134.66 38.82 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.386 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.24 138.53 54.61 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.408 0.623 . . . . 0.0 111.497 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.59 155.33 11.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -131.14 143.68 50.82 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.942 0.897 . . . . 0.0 108.77 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.35 118.45 8.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.26 176.64 43.86 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . 0.601 ' NE2' ' H ' ' B' ' 103' ' ' VAL . 0.0 OUTLIER -101.67 150.35 23.2 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.928 1.016 . . . . 0.0 113.517 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 11.6 p -97.52 116.97 30.75 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 125.611 1.819 . . . . 0.0 107.34 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.417 ' CZ ' ' CB ' ' C' ' 82' ' ' GLN . 17.5 m-85 -108.66 156.62 19.35 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.552 1.168 . . . . 0.0 113.604 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 9.7 mt -117.37 110.24 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.174 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -58.69 160.5 5.58 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -24.79 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -9.31 52.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.984 0.914 . . . . 0.0 113.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.18 14.97 49.88 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.673 1.13 . . . . 0.0 115.402 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -82.64 166.29 19.3 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.078 1.439 . . . . 0.0 109.075 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -122.39 145.37 48.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.605 1.548 . . . . 0.0 110.767 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.24 153.09 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.712 1.205 . . . . 0.0 111.106 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.25 103.65 10.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' C' ' 119' ' ' ILE . 0.5 OUTLIER -97.13 112.73 24.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 173.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.68 163.82 27.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.093 1.425 . . . . 0.0 112.383 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.412 ' HG3' HG23 ' B' ' 113' ' ' THR . 93.4 mmm -114.95 168.23 10.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -139.45 163.84 31.45 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.428 1.109 . . . . 0.0 113.376 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.87 124.66 15.06 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.123 175.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.2 131.95 53.59 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 123.769 1.747 . . . . 0.0 108.841 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . 0.493 ' HB3' ' HG1' ' B' ' 63' ' ' THR . 3.2 tpt85 -114.84 113.57 24.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 110.942 -2.844 . . . . 0.0 109.05 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.19 164.83 19.61 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 116.867 -1.54 . . . . 0.0 111.912 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 88.12 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 121.742 2.065 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . 0.614 ' H ' ' NE2' ' B' ' 82' ' ' GLN . 6.6 p -88.45 155.82 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 129.265 3.026 . . . . 0.0 111.138 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -95.08 -32.77 12.95 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -114.02 149.35 35.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.573 0.701 . . . . 0.0 112.671 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 4.8 tt -62.53 -30.22 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.795 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.65 5.28 38.94 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.598 1.094 . . . . 0.0 115.777 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -123.09 0.08 9.01 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.361 1.581 . . . . 0.0 113.735 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.92 69.17 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.365 -1.459 . . . . 0.0 113.806 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . 0.683 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 62.5 p-90 -49.65 -44.24 47.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.87 0.868 . . . . 0.0 113.214 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . 0.683 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.0 OUTLIER -88.16 -12.6 43.49 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.097 -1.002 . . . . 0.0 113.347 176.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 1.48 18.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.708 0.803 . . . . 0.0 112.577 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' THR . . . . . 0.433 HG23 ' HG3' ' B' ' 96' ' ' MET . 33.9 m -112.68 139.61 48.15 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.436 1.094 . . . . 0.0 111.207 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -144.26 133.01 22.41 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.656 1.183 . . . . 0.0 110.94 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.13 154.79 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.364 1.438 . . . . 0.0 110.897 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.39 -174.29 27.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.908 0.766 . . . . 0.0 114.76 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.41 156.72 42.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.219 1.008 . . . . 0.0 112.294 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -152.23 148.67 27.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 112.298 173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' C' ' 94' ' ' LYS . 9.4 mt -124.94 122.2 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.522 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 148.87 37.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.843 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 45.6 p -138.84 167.43 22.04 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.69 122.54 13.05 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.4 -0.813 . . . . 0.0 111.735 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.309 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.14 154.67 51.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.72 1.208 . . . . 0.0 108.382 173.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.91 129.92 24.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.009 -1.057 . . . . 0.0 111.597 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.1 -25.17 67.98 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -54.56 120.25 6.41 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 123.355 1.55 . . . . 0.0 112.562 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.9 -110.92 1.04 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.979 2.228 . . . . 0.0 110.242 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -152.99 152.1 31.02 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.73 -0.865 . . . . 0.0 113.271 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -140.16 156.33 46.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.801 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.62 146.64 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.394 177.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -116.72 143.33 45.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 111.238 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.04 -24.99 57.81 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.58 1.552 . . . . 0.0 113.825 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.5 tp -67.31 -15.94 63.98 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 120.735 -1.228 . . . . 0.0 111.821 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.09 -9.46 42.98 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 127.645 2.545 . . . . 0.0 113.242 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.4 147.99 52.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.228 -1.16 . . . . 0.0 111.925 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -126.62 151.42 48.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.198 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.41 147.33 33.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -127.97 134.98 49.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.787 0.835 . . . . 0.0 110.291 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.67 121.01 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.13 -65.17 2.7 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.671 1.232 . . . . 0.0 113.291 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.68 137.71 4.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -84.45 137.67 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.76 163.5 27.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.826 0.451 . . . . 0.0 111.348 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -23.69 50.39 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -27.35 63.79 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.137 -0.977 . . . . 0.0 111.165 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.11 48.78 Favored Glycine 0 C--O 1.224 -0.512 0 CA-C-O 117.577 -1.68 . . . . 0.0 112.958 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -70.99 144.6 50.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.779 1.289 . . . . 0.0 108.547 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -156.03 155.77 33.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.682 0.753 . . . . 0.0 112.307 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.75 158.71 36.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.395 1.878 . . . . 0.0 108.267 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.32 -170.67 34.92 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.97 -1.081 . . . . 0.0 114.747 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.6 p -137.53 126.23 23.84 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -126.52 133.14 51.21 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.05 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -121.48 135.61 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 50.1 m -115.77 131.0 57.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.36 3.86 50.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.34 162.28 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 128.116 2.566 . . . . 0.0 108.444 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.46 10.51 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.893 -1.754 . . . . 0.0 111.842 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.64 -24.69 61.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.287 0.235 . . . . 0.0 110.603 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.35 84.01 4.43 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 175.95 8.72 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.815 3.01 . . . . 0.0 112.905 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.51 -33.03 2.83 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.738 1.161 . . . . 0.0 111.981 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -132.77 20.71 4.2 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.16 127.87 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 122.025 0.916 . . . . 0.0 109.233 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.0 177.12 8.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.655 1.982 . . . . 0.0 107.538 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.0 146.1 3.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.185 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -124.55 113.17 27.43 Favored Pre-proline 0 N--CA 1.426 -1.629 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.674 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.75 134.63 65.69 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.237 1.958 . . . . 0.0 109.668 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.32 151.26 46.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.429 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.3 149.13 37.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.853 2.461 . . . . 0.0 108.012 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.2 -160.79 34.57 Favored Glycine 0 N--CA 1.452 -0.267 0 O-C-N 120.75 -1.219 . . . . 0.0 111.019 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mt -144.58 145.57 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 111.942 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.474 HE22 ' HB2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.662 -1.274 . . . . 0.0 113.108 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -86.81 141.85 28.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.654 1.216 . . . . 0.0 111.191 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HB2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -139.52 29.64 2.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.029 1.332 . . . . 0.0 112.138 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -93.06 -55.05 3.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.644 2.377 . . . . 0.0 111.405 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -179.9 5.9 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -81.77 -39.27 24.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.192 1.397 . . . . 0.0 112.888 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -132.61 46.4 2.13 Favored Pre-proline 0 CA--C 1.568 1.636 0 O-C-N 125.416 1.698 . . . . 0.0 111.473 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.55 177.02 5.84 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.359 2.039 . . . . 0.0 114.676 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.326 0.1 OUTLIER -100.95 169.62 8.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 122.54 1.162 . . . . 0.0 111.603 174.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -162.63 164.18 26.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.393 -173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.39 147.78 13.73 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.836 2.294 . . . . 0.0 118.836 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -161.0 150.5 17.0 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -89.1 147.84 24.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.906 1.682 . . . . 0.0 108.21 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.8 t -129.21 119.72 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -102.87 102.05 12.13 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.372 -173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -69.18 125.36 26.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 121.249 1.84 . . . . 0.0 115.684 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -81.3 -37.35 28.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.435 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.08 -22.29 36.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.603 1.161 . . . . 0.0 113.65 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.43 124.07 7.84 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.59 1.556 . . . . 0.0 108.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -60.78 115.27 3.54 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.595 1.089 . . . . 0.0 111.722 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 p -172.52 158.78 4.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.974 2.109 . . . . 0.0 110.03 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -143.47 142.5 31.2 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-O 123.175 1.464 . . . . 0.0 110.427 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.443 ' HG1' ' CD1' ' A' ' 99' ' ' LEU . 3.1 m -141.8 128.74 20.67 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 109.965 -3.289 . . . . 0.0 109.838 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.54 154.05 6.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.773 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -128.99 141.66 51.18 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.82 118.25 5.66 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.36 -175.44 34.34 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.658 -1.258 . . . . 0.0 115.388 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -126.97 147.2 50.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.235 1.017 . . . . 0.0 112.196 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.41 127.25 43.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.44 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 166.34 13.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.531 0.681 . . . . 0.0 112.461 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.6 mt -127.33 109.03 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.552 -1.658 . . . . 0.0 107.098 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.97 162.34 4.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.392 0.677 . . . . 0.0 110.162 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.42 -32.3 1.32 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.32 -21.09 53.99 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.88 19.98 11.25 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.851 1.215 . . . . 0.0 114.572 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -90.66 153.24 20.44 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.1 1.36 . . . . 0.0 111.559 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.14 134.92 43.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.634 1.574 . . . . 0.0 110.257 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.16 160.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 122.13 0.967 . . . . 0.0 108.819 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.1 mt -124.15 119.06 28.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -106.59 117.77 34.93 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.3 167.27 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.974 1.369 . . . . 0.0 112.554 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -119.36 170.49 9.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -140.55 159.06 43.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.446 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -134.38 121.98 21.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.406 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.443 ' CD1' ' HG1' ' A' ' 77' ' ' THR 0.254 0.5 OUTLIER -107.46 135.89 48.18 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 124.961 1.413 . . . . 0.0 112.055 -176.415 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.98 113.9 23.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 111.857 -2.429 . . . . 0.0 110.167 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -69.82 166.8 18.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.384 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -112.41 85.44 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.44 -161.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.33 -13.64 1.02 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.709 -1.869 . . . . 0.0 114.281 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.06 151.1 49.06 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.298 1.047 . . . . 0.0 111.931 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.9 tt -59.27 -25.49 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.117 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.65 -1.87 19.05 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.193 1.378 . . . . 0.0 114.761 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.0 7.11 6.6 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.138 0.969 . . . . 0.0 112.346 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.57 -32.14 73.66 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 119.443 -2.036 . . . . 0.0 112.866 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -47.67 -40.82 20.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.789 1.235 . . . . 0.0 114.036 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -95.19 -11.61 27.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.403 1.081 . . . . 0.0 113.503 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.17 -0.8 20.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.975 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.61 143.72 42.02 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.432 1.11 . . . . 0.0 111.056 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -142.06 153.78 44.45 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.471 1.509 . . . . 0.0 109.572 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.98 151.19 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.395 1.078 . . . . 0.0 109.903 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.44 -176.69 29.77 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 121.453 0.474 . . . . 0.0 112.104 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 33.6 p90 -124.92 152.03 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.507 0.723 . . . . 0.0 109.98 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -144.53 152.41 40.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.938 0.875 . . . . 0.0 109.301 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt -128.92 135.13 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.93 148.07 45.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -132.01 158.64 40.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.099 0.96 . . . . 0.0 110.655 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.05 118.8 6.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.646 0.779 . . . . 0.0 111.641 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 C--O 1.238 0.496 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.771 174.706 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? . . . . . 0 C--O 1.225 -0.185 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -143.67 143.54 31.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.633 1.973 . . . . 0.0 107.8 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.83 128.78 23.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.59 -1.319 . . . . 0.0 112.269 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.4 -25.59 68.35 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -53.0 119.27 4.47 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.204 1.478 . . . . 0.0 112.459 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.82 -110.69 1.02 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.841 2.162 . . . . 0.0 110.865 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -152.59 151.86 31.14 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -141.33 158.76 43.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.709 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -133.86 149.04 51.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.57 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -116.19 143.33 45.65 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.904 0.881 . . . . 0.0 110.737 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -58.74 -23.16 59.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.015 1.326 . . . . 0.0 113.475 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.85 -15.94 63.86 Favored 'General case' 0 CA--C 1.555 1.16 0 O-C-N 120.543 -1.348 . . . . 0.0 111.398 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.34 -9.38 42.02 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.65 2.548 . . . . 0.0 113.372 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -66.42 148.25 52.14 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 121.213 -1.169 . . . . 0.0 111.792 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -127.02 151.16 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.196 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 147.35 33.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -127.53 135.96 51.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.761 0.824 . . . . 0.0 109.947 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.68 119.96 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.68 -64.39 3.34 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.58 1.175 . . . . 0.0 113.25 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.56 141.36 4.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.213 1.405 . . . . 0.0 110.214 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.17 136.36 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 122.505 0.322 . . . . 0.0 110.239 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.45 163.59 27.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.275 0.63 . . . . 0.0 111.186 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -21.98 54.05 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -25.45 62.37 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.161 -0.962 . . . . 0.0 111.221 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.89 51.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.248 1.404 . . . . 0.0 113.247 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 150.76 44.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.017 0.927 . . . . 0.0 110.42 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.52 166.34 33.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.347 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.28 160.82 36.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.444 1.898 . . . . 0.0 106.775 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.44 -170.78 35.91 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.418 -1.426 . . . . 0.0 114.599 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 35.2 p -138.22 126.62 23.21 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.408 0.623 . . . . 0.0 109.341 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -126.96 133.42 50.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.935 -172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.46 136.28 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 43.4 m -116.77 130.24 56.6 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 3.24 53.63 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.44 162.22 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 128.085 2.554 . . . . 0.0 108.141 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.38 10.2 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.015 -1.678 . . . . 0.0 111.738 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.52 -24.05 61.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.311 0.244 . . . . 0.0 110.652 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -154.14 83.43 4.21 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 127.277 2.231 . . . . 0.0 109.254 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.69 176.04 8.74 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.553 2.835 . . . . 0.0 112.805 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.02 -33.21 2.86 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.765 1.174 . . . . 0.0 112.33 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -132.59 20.62 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.93 1.292 . . . . 0.0 112.403 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -54.18 127.7 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.236 1.017 . . . . 0.0 109.247 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.01 177.21 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.49 1.916 . . . . 0.0 107.273 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.99 146.65 3.23 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.218 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -125.0 112.98 26.72 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 112.118 -2.31 . . . . 0.0 110.506 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -56.09 132.52 52.45 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.17 1.914 . . . . 0.0 109.263 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.32 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.274 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.42 149.22 31.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.866 2.466 . . . . 0.0 108.066 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.66 -160.24 32.58 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 121.287 -0.883 . . . . 0.0 112.781 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -144.94 145.06 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.384 1.074 . . . . 0.0 112.374 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . 0.511 HE22 ' HB2' ' D' ' 57' ' ' LYS . 0.3 OUTLIER -132.01 150.97 52.01 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.626 -1.296 . . . . 0.0 112.843 175.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.38 141.66 28.47 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.696 0.76 . . . . 0.0 110.399 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . 0.511 ' HB2' HE22 ' D' ' 53' ' ' GLN . 1.0 OUTLIER -138.96 29.84 2.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.983 1.313 . . . . 0.0 112.517 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -92.93 -55.21 3.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.01 2.524 . . . . 0.0 111.399 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -78.95 -39.78 33.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.821 1.648 . . . . 0.0 113.037 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.34 50.14 4.7 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 125.244 1.417 . . . . 0.0 111.429 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 176.78 6.39 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.351 2.7 . . . . 0.0 115.223 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -102.23 168.79 9.13 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.732 1.253 . . . . 0.0 111.435 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -162.22 163.48 28.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.881 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.18 148.05 14.85 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 118.646 2.218 . . . . 0.0 118.646 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -161.63 149.86 15.3 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.93 149.09 23.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.259 1.823 . . . . 0.0 108.238 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.62 121.47 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -104.88 102.31 11.85 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.988 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -68.92 124.47 23.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -80.14 -36.81 34.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.623 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -82.6 -22.01 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 113.591 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 35.2 t -152.55 124.63 8.04 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.544 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -60.86 115.44 3.69 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.897 1.226 . . . . 0.0 111.509 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 9.4 p -172.74 158.94 4.14 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.129 2.172 . . . . 0.0 110.125 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -143.62 142.42 31.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 123.036 1.398 . . . . 0.0 110.296 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' THR . . . . . 0.437 ' HG1' ' CD1' ' D' ' 99' ' ' LEU . 3.0 m -141.8 128.54 20.42 Favored 'General case' 0 N--CA 1.402 -2.825 0 CA-C-N 110.173 -3.194 . . . . 0.0 109.971 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.95 154.41 5.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.773 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -129.65 141.35 50.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.58 118.22 5.74 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.95 -175.25 34.66 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.49 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -127.61 144.91 51.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.704 0.885 . . . . 0.0 112.421 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 36.8 t -97.81 123.63 41.85 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.623 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -115.69 167.26 11.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 118.45 0.568 . . . . 0.0 111.692 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 30.6 mt -126.21 107.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 O-C-N 125.293 1.62 . . . . 0.0 106.741 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -58.99 160.56 5.86 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -44.22 -31.74 1.08 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 118.193 2.664 . . . . 0.0 118.193 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -76.3 -21.94 55.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.26 1.85 29.67 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.111 1.339 . . . . 0.0 115.592 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -74.09 153.66 39.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.257 1.423 . . . . 0.0 112.578 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.38 135.44 42.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.265 1.826 . . . . 0.0 109.964 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 20.6 m -141.97 160.08 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.029 0.931 . . . . 0.0 109.663 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -122.69 118.64 28.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -106.76 117.74 34.84 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 167.95 20.41 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.05 1.405 . . . . 0.0 112.69 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -120.06 170.57 9.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 p-90 -140.57 159.51 42.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.561 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.93 121.86 21.12 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.526 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . 0.437 ' CD1' ' HG1' ' D' ' 77' ' ' THR . 0.5 OUTLIER -107.37 136.01 47.89 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 125.061 1.476 . . . . 0.0 111.767 -176.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -117.12 113.82 22.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.288 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 71.3 m -69.55 167.04 17.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.404 174.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 2.0 p -112.37 86.11 2.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.99 -160.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -140.36 -13.19 1.03 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 119.561 -1.962 . . . . 0.0 114.093 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.57 152.13 48.66 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.565 1.174 . . . . 0.0 112.356 174.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.82 -24.87 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.982 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.93 -1.13 23.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.245 1.402 . . . . 0.0 114.935 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -127.12 6.34 6.49 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.119 0.968 . . . . 0.0 111.916 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.16 -31.79 73.15 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 119.327 -2.108 . . . . 0.0 113.067 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -47.33 -41.61 19.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.343 1.057 . . . . 0.0 113.768 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -94.89 -11.47 28.65 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.403 1.081 . . . . 0.0 113.131 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.02 -1.13 21.35 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.311 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -111.21 143.8 41.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.318 1.056 . . . . 0.0 111.129 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -142.16 153.65 44.23 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.328 1.451 . . . . 0.0 109.486 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.88 151.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.464 1.106 . . . . 0.0 109.724 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.59 -177.23 30.5 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.505 0.503 . . . . 0.0 112.169 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 32.7 p90 -124.28 152.21 43.3 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.901 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -145.16 151.6 38.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.554 0.742 . . . . 0.0 109.46 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 59.7 mt -128.47 136.03 61.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -123.98 148.5 46.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.667 0.387 . . . . 0.0 111.061 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 12.7 p -132.24 161.63 32.96 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.694 1.198 . . . . 0.0 111.176 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -61.51 122.26 14.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.056 0.943 . . . . 0.0 111.784 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.282 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p -143.11 144.21 32.14 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 124.967 1.417 . . . . 0.0 108.529 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.73 127.72 22.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.566 -0.709 . . . . 0.0 112.569 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.85 -25.3 67.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.61 119.49 5.36 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 123.042 1.401 . . . . 0.0 111.984 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.35 -111.2 1.06 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.01 2.243 . . . . 0.0 110.447 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -153.65 152.56 30.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.34 158.18 43.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.884 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.1 146.88 45.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.683 1.193 . . . . 0.0 108.35 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -116.28 143.33 45.66 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 111.188 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -57.8 -24.15 55.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.204 1.401 . . . . 0.0 113.645 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.18 -15.59 63.64 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.644 -1.285 . . . . 0.0 111.735 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.42 43.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.732 2.587 . . . . 0.0 113.418 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.61 147.7 52.92 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.196 -1.179 . . . . 0.0 111.633 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -127.1 152.01 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.12 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.96 147.38 33.86 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -126.89 135.39 50.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.99 120.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.23 -64.85 3.02 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.662 1.226 . . . . 0.0 113.201 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.51 139.8 3.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.241 1.416 . . . . 0.0 110.163 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -86.3 137.36 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.403 0.281 . . . . 0.0 110.576 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.26 163.37 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.678 0.391 . . . . 0.0 111.246 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -23.83 50.11 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -27.11 63.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.3 -0.875 . . . . 0.0 111.285 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.84 -2.12 48.5 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.218 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.18 144.51 51.93 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.524 1.162 . . . . 0.0 108.542 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.79 156.12 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 112.157 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.5 158.33 38.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.341 1.856 . . . . 0.0 108.201 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.33 -170.5 34.73 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 120.973 -1.079 . . . . 0.0 114.758 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 35.9 p -137.19 126.51 24.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.065 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -126.74 133.31 50.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.72 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.41 136.24 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 42.7 m -116.39 130.54 56.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.29 2.7 53.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.302 1.049 . . . . 0.0 113.828 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.09 161.66 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.348 2.259 . . . . 0.0 108.373 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.61 166.67 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 119.971 -1.706 . . . . 0.0 111.909 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.0 -24.65 62.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 122.461 -0.149 . . . . 0.0 110.674 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.3 83.73 4.51 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.152 2.181 . . . . 0.0 109.22 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.54 175.92 8.82 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.842 3.028 . . . . 0.0 112.9 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.41 -33.21 2.81 Favored Glycine 0 N--CA 1.476 1.324 0 C-N-CA 124.715 1.15 . . . . 0.0 112.219 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -132.62 20.75 4.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.005 1.322 . . . . 0.0 112.359 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.25 127.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.08 0.943 . . . . 0.0 109.141 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.19 176.46 8.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.758 2.023 . . . . 0.0 107.57 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.49 146.3 3.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.258 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -125.02 113.26 26.62 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 112.07 -2.332 . . . . 0.0 110.57 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -56.4 134.68 65.79 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.135 1.89 . . . . 0.0 109.65 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.04 151.22 45.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.486 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.32 149.19 37.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.821 2.449 . . . . 0.0 107.839 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 -161.28 35.11 Favored Glycine 0 N--CA 1.451 -0.326 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mt -144.56 144.91 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.961 0.904 . . . . 0.0 111.799 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' B' ' 57' ' ' LYS . 0.1 OUTLIER -133.18 148.26 52.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.301 1.04 . . . . 0.0 113.323 175.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -84.65 141.31 30.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.099 0.952 . . . . 0.0 111.069 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . 0.496 ' HB2' HE22 ' B' ' 53' ' ' GLN . 0.9 OUTLIER -139.05 30.72 2.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.95 1.3 . . . . 0.0 112.222 178.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -93.33 -55.38 3.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.94 2.496 . . . . 0.0 111.72 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.97 179.51 6.17 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.0 m -82.98 -35.53 25.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.842 1.257 . . . . 0.0 113.264 174.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -135.04 49.01 3.29 Favored Pre-proline 0 CA--C 1.562 1.434 0 O-C-N 125.377 1.673 . . . . 0.0 111.4 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.44 177.5 5.98 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.079 2.52 . . . . 0.0 115.272 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.347 0.1 OUTLIER -102.13 168.06 9.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.027 1.394 . . . . 0.0 111.749 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -161.41 163.03 30.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.84 -173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.66 147.26 13.02 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 118.81 2.284 . . . . 0.0 118.81 -173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.9 m -89.28 147.95 23.83 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.066 1.746 . . . . 0.0 108.338 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.34 119.8 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -102.67 102.09 12.26 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.352 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -69.07 125.64 27.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.278 1.854 . . . . 0.0 115.707 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.36 -37.46 28.21 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.514 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.83 -22.14 37.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.516 1.127 . . . . 0.0 113.647 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -152.42 124.79 8.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.722 1.609 . . . . 0.0 108.699 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.97 116.29 4.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.803 1.183 . . . . 0.0 111.173 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 9.2 p -173.01 158.79 3.83 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.059 2.143 . . . . 0.0 109.856 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -143.36 142.6 31.34 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-O 123.117 1.437 . . . . 0.0 110.531 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' THR . . . . . 0.443 ' HG1' ' CD1' ' B' ' 99' ' ' LEU . 3.0 m -142.12 128.46 19.97 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 110.084 -3.234 . . . . 0.0 109.927 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.33 153.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.741 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.11 142.29 50.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.29 118.61 5.59 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.72 -176.75 35.11 Favored Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -127.68 143.22 51.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.36 0.682 . . . . 0.0 112.169 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.52 124.84 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.07 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -116.01 168.27 10.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.239 1.019 . . . . 0.0 111.794 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.2 mt -124.79 109.54 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.286 174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -58.62 157.33 9.36 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -42.31 -30.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.91 -19.38 54.79 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.81 8.57 27.88 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 125.073 1.32 . . . . 0.0 115.583 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -87.48 152.94 21.82 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.931 1.366 . . . . 0.0 112.585 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -100.96 134.83 43.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.565 1.546 . . . . 0.0 110.016 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 m -144.14 145.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 38.0 mt -118.89 92.42 3.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.47 1.129 . . . . 0.0 111.227 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -83.4 113.13 20.53 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.074 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -135.29 168.48 19.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.559 1.647 . . . . 0.0 112.801 -174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -120.12 170.44 9.3 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 124.608 1.163 . . . . 0.0 107.901 172.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -141.11 159.05 43.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.427 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -134.41 122.15 22.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.404 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.443 ' CD1' ' HG1' ' B' ' 77' ' ' THR 0.262 0.4 OUTLIER -107.53 134.64 50.25 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 125.047 1.467 . . . . 0.0 112.216 -176.098 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -115.55 114.06 24.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 112.001 -2.363 . . . . 0.0 110.048 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.259 72.9 m -70.09 167.97 16.56 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.266 1.604 . . . . 0.0 111.465 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -113.29 85.38 2.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 -160.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -140.52 -13.21 1.0 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 119.569 -1.957 . . . . 0.0 114.223 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.17 151.17 49.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.509 1.147 . . . . 0.0 112.003 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 2.2 tt -58.57 -25.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.407 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.64 -2.36 28.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.038 1.304 . . . . 0.0 114.626 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.33 5.87 7.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.214 1.006 . . . . 0.0 112.137 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.5 -32.12 73.63 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 119.55 -1.969 . . . . 0.0 112.668 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -48.0 -41.25 24.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.726 1.21 . . . . 0.0 113.718 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -94.37 -11.43 29.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.349 1.059 . . . . 0.0 113.494 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.1 -0.91 20.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.105 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -111.6 143.65 42.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.168 0.985 . . . . 0.0 111.244 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -142.38 153.48 43.82 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.316 1.446 . . . . 0.0 109.524 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.26 150.64 33.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.689 1.131 . . . . 0.0 109.517 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.99 -177.02 29.71 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.375 0.512 . . . . 0.0 112.184 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 34.9 p90 -124.42 151.77 44.09 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -144.17 151.22 39.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.998 0.904 . . . . 0.0 109.22 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.19 134.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -122.25 149.83 43.15 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.042 0.448 . . . . 0.0 111.038 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 5.3 p -130.86 159.82 36.24 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.94 1.296 . . . . 0.0 110.647 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -58.69 123.81 17.62 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.5 0.72 . . . . 0.0 111.495 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 CA--C 1.527 0.064 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.561 177.277 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? . . . . . 0 CA--C 1.515 -0.376 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 26.6 p -148.37 145.02 27.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.595 1.184 . . . . 0.0 109.788 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.74 127.92 22.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.53 -25.64 68.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.34 118.39 4.07 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.863 1.316 . . . . 0.0 112.08 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.55 -112.17 1.17 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.955 2.217 . . . . 0.0 110.667 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -150.58 151.77 33.09 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -142.0 157.44 44.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.577 -2.101 . . . . 0.0 111.226 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 147.95 50.58 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -115.87 143.41 45.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.929 0.892 . . . . 0.0 110.879 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.1 -24.21 52.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.332 1.453 . . . . 0.0 113.638 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.85 -15.07 63.45 Favored 'General case' 0 CA--C 1.556 1.182 0 O-C-N 120.773 -1.204 . . . . 0.0 111.819 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.39 -9.35 45.37 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.723 2.582 . . . . 0.0 113.324 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -66.62 147.02 53.85 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.202 -1.175 . . . . 0.0 111.618 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -126.52 152.04 47.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.8 147.41 34.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -127.39 135.85 51.05 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.842 0.857 . . . . 0.0 110.22 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -128.31 119.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.51 -63.99 3.75 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.605 1.191 . . . . 0.0 113.308 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.23 143.16 4.22 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.51 1.524 . . . . 0.0 110.265 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.93 135.66 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.735 0.414 . . . . 0.0 110.274 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.7 163.38 28.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.337 0.655 . . . . 0.0 111.287 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -22.02 53.68 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -25.56 62.29 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.23 -0.919 . . . . 0.0 111.253 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.59 51.4 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.273 1.416 . . . . 0.0 113.225 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.1 150.37 43.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 110.333 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.14 166.32 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.795 0.807 . . . . 0.0 111.122 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.49 160.72 37.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.529 1.932 . . . . 0.0 106.844 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.64 -170.9 36.2 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.327 -1.483 . . . . 0.0 114.822 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -137.61 126.63 24.27 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.565 0.698 . . . . 0.0 109.383 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -126.73 133.45 50.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.466 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.49 136.29 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 130.55 56.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.14 5.08 50.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.2 161.25 17.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.149 2.179 . . . . 0.0 108.261 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.31 166.96 12.34 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.786 -1.821 . . . . 0.0 111.757 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.78 -23.72 61.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.162 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -153.41 84.08 4.39 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 127.211 2.205 . . . . 0.0 109.373 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.69 176.02 8.77 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.557 2.838 . . . . 0.0 112.805 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.04 -33.14 2.87 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.776 1.179 . . . . 0.0 112.284 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -132.64 20.57 4.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.026 1.33 . . . . 0.0 112.328 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 44.8 mt -54.11 127.82 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.249 1.023 . . . . 0.0 109.234 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.13 177.24 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.486 1.914 . . . . 0.0 107.296 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.0 146.82 3.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.118 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -125.23 113.08 26.13 Favored Pre-proline 0 N--CA 1.426 -1.651 0 CA-C-N 112.042 -2.345 . . . . 0.0 110.398 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -56.01 132.25 50.84 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.03 1.82 . . . . 0.0 109.223 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.65 154.93 36.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.323 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.6 149.23 31.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.827 2.451 . . . . 0.0 108.142 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.72 -160.04 32.41 Favored Glycine 0 CA--C 1.517 0.186 0 O-C-N 121.383 -0.823 . . . . 0.0 112.71 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.36 144.95 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.319 1.047 . . . . 0.0 112.149 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' C' ' 57' ' ' LYS . 0.4 OUTLIER -131.87 152.04 51.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.857 1.263 . . . . 0.0 112.909 175.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -88.93 140.87 29.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.05 0.929 . . . . 0.0 111.038 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . 0.499 ' HB2' HE22 ' C' ' 53' ' ' GLN . 0.9 OUTLIER -138.17 30.15 2.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.735 1.214 . . . . 0.0 112.237 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -93.37 -55.48 3.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.98 2.512 . . . . 0.0 111.714 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -179.76 5.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -83.94 -35.76 23.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.671 1.188 . . . . 0.0 112.95 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -134.34 48.06 2.87 Favored Pre-proline 0 CA--C 1.564 1.49 0 O-C-N 125.388 1.68 . . . . 0.0 111.823 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.09 176.42 6.28 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.148 2.565 . . . . 0.0 115.518 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.337 0.2 OUTLIER -101.05 169.91 8.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.674 1.226 . . . . 0.0 111.414 174.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.86 163.31 26.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.733 -173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 147.88 14.19 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -161.66 149.81 15.2 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.58 149.21 23.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.245 1.818 . . . . 0.0 108.221 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.63 121.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -104.32 102.19 11.88 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.198 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -68.44 124.35 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.854 1.661 . . . . 0.0 115.427 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -80.07 -37.55 33.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.641 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.78 -22.23 37.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 113.692 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.6 t -152.51 124.61 8.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.75 1.62 . . . . 0.0 108.66 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.68 116.52 4.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.587 1.085 . . . . 0.0 111.132 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 8.6 p -173.29 158.36 3.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.15 2.18 . . . . 0.0 110.02 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -142.69 142.01 31.93 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-O 123.181 1.467 . . . . 0.0 110.488 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' THR . . . . . 0.443 ' HG1' ' CD1' ' C' ' 99' ' ' LEU . 3.1 m -141.86 128.05 19.76 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 110.015 -3.266 . . . . 0.0 110.091 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.66 154.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.785 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.47 141.99 50.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.27 118.69 5.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.07 -176.12 34.78 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -128.9 143.1 50.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 124.484 0.755 . . . . 0.0 112.319 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.56 122.69 40.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.527 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.0 167.81 10.34 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.551 0.691 . . . . 0.0 111.638 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.71 108.34 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.082 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.56 160.93 4.98 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.05 -31.09 0.84 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -79.99 -15.08 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.03 5.6 40.72 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.884 1.23 . . . . 0.0 115.682 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 152.63 28.53 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.017 1.408 . . . . 0.0 112.543 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -100.72 135.96 41.33 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.496 1.518 . . . . 0.0 109.131 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.56 147.36 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.265 1.026 . . . . 0.0 111.36 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 40.7 mt -119.97 92.38 3.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.682 1.23 . . . . 0.0 111.772 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -83.59 112.57 20.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.903 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.5 p -134.36 168.95 17.98 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.607 1.194 . . . . 0.0 112.831 -174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -120.94 170.7 9.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 38.9 p-90 -140.53 159.83 41.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.385 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 tp -135.16 122.1 21.19 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . 0.443 ' CD1' ' HG1' ' C' ' 77' ' ' THR . 0.4 OUTLIER -107.43 134.98 49.68 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.927 1.392 . . . . 0.0 111.863 -176.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.16 114.09 23.98 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 111.974 -2.375 . . . . 0.0 110.078 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 71.4 m -69.74 168.09 15.74 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 125.299 1.624 . . . . 0.0 111.681 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -112.94 85.64 2.21 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.53 -160.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -141.45 -11.61 0.92 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 119.518 -1.989 . . . . 0.0 114.406 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.46 150.47 50.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.284 1.04 . . . . 0.0 111.723 174.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 2.2 tt -58.13 -25.44 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.4 -2.81 28.97 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.97 1.272 . . . . 0.0 114.611 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.42 6.17 7.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.164 0.986 . . . . 0.0 112.309 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.47 -32.69 74.2 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.757 -1.84 . . . . 0.0 112.741 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -48.28 -41.77 28.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.684 1.194 . . . . 0.0 113.697 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -93.93 -11.67 30.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.242 1.017 . . . . 0.0 113.329 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.61 -1.23 20.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.077 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.35 143.71 41.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.002 0.906 . . . . 0.0 111.373 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -142.56 153.33 43.45 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.463 1.505 . . . . 0.0 109.504 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.04 151.1 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 109.358 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.03 -177.77 30.47 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 121.813 0.674 . . . . 0.0 112.244 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 34.8 p90 -123.84 151.33 43.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.4 0.68 . . . . 0.0 109.419 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -144.18 151.4 39.46 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.995 0.902 . . . . 0.0 108.83 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.67 133.71 67.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -120.81 149.71 42.14 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.134 0.492 . . . . 0.0 111.093 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 33.2 p -134.6 163.48 29.64 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 110.907 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.48 123.76 20.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.062 0.945 . . . . 0.0 113.132 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.3 157.55 24.79 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 p -139.38 127.19 22.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.349 -0.844 . . . . 0.0 113.102 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.39 -27.05 64.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.017 0.527 . . . . 0.0 111.777 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -62.91 120.77 11.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.67 24.86 1.49 Allowed Glycine 0 N--CA 1.476 1.309 0 N-CA-C 118.001 1.96 . . . . 0.0 118.001 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 tttt 69.3 145.96 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.894 2.478 . . . . 0.0 116.911 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -140.99 158.91 43.28 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.334 1.454 . . . . 0.0 112.538 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -132.45 142.85 49.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.853 1.261 . . . . 0.0 108.622 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.75 143.69 44.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.47 1.108 . . . . 0.0 110.128 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -57.06 -30.37 64.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.52 -11.73 61.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.311 1.444 . . . . 0.0 112.586 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.92 -11.19 37.88 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 127.503 2.477 . . . . 0.0 113.519 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -61.06 145.67 50.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 122.781 1.277 . . . . 0.0 112.326 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -122.81 139.99 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -132.71 145.27 50.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.94 0.876 . . . . 0.0 112.416 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 m -128.78 125.54 38.05 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.2 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.77 127.67 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.34 -88.86 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 O-C-N 125.647 1.842 . . . . 0.0 111.08 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.82 143.52 36.86 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.084 -0.657 . . . . 0.0 110.733 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.03 131.92 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.656 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -72.52 159.14 34.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.079 0.943 . . . . 0.0 112.919 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.0 m -54.47 -28.46 44.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.774 1.23 . . . . 0.0 114.212 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -71.11 -34.91 71.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.085 0.554 . . . . 0.0 112.472 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.81 -8.81 12.75 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.531 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 155.27 40.43 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.459 1.63 . . . . 0.0 108.271 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.47 166.12 32.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.975 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.5 148.04 52.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.24 26.34 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 122.554 1.086 . . . . 0.0 113.298 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.9 p -139.49 139.45 36.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.021 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.71 129.52 55.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.929 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -118.28 128.51 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 m -106.11 143.55 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.404 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 -15.63 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.03 142.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 113.154 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.56 168.91 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.39 -38.78 26.0 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.33 74.37 77.46 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.323 1.849 . . . . 0.0 109.227 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.64 6.5 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.165 3.243 . . . . 0.0 117.348 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.66 -21.29 0.8 Allowed Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.04 42.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.709 1.255 . . . . 0.0 111.945 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.59 134.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.835 0.826 . . . . 0.0 111.518 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 0.6 OUTLIER -152.48 171.82 17.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 0.0 111.22 176.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.2 tp -46.69 117.4 1.63 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 129.496 3.119 . . . . 0.0 112.438 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.7 m -111.79 114.05 52.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.899 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.18 145.15 66.88 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.324 2.683 . . . . 0.0 112.82 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.34 51.99 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.526 1.13 . . . . 0.0 111.864 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.75 149.85 39.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.188 2.995 . . . . 0.0 109.282 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.99 -155.33 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -144.82 139.56 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.996 0.903 . . . . 0.0 112.637 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.54 155.74 31.61 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.355 -0.841 . . . . 0.0 111.06 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.24 164.02 21.47 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.767 -1.208 . . . . 0.0 110.723 172.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.94 25.32 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.402 1.081 . . . . 0.0 112.924 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.84 -55.36 3.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.07 2.148 . . . . 0.0 110.454 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 173.19 12.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.711 1.243 . . . . 0.0 113.217 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -43.61 60.58 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.789 2.036 . . . . 0.0 112.176 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -131.41 53.75 12.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.952 1.301 . . . . 0.0 110.309 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.57 176.71 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.161 1.907 . . . . 0.0 116.272 -174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -88.34 161.85 16.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.504 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.37 164.48 29.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.249 -0.907 . . . . 0.0 112.46 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.84 149.47 15.7 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 120.397 2.919 . . . . 0.0 120.397 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -164.29 154.38 14.5 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -90.04 150.57 22.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.047 2.139 . . . . 0.0 109.332 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -129.97 120.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.59 106.01 18.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.653 -174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.12 131.88 46.72 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 121.234 1.834 . . . . 0.0 112.766 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.07 -38.22 12.33 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -90.38 -10.74 42.8 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -152.44 132.5 13.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 127.705 2.402 . . . . 0.0 106.847 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -69.85 118.49 12.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.546 1.066 . . . . 0.0 110.173 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -173.53 170.26 4.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.481 1.912 . . . . 0.0 109.769 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.89 137.95 31.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.979 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.29 165.99 12.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.327 1.06 . . . . 0.0 108.617 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 149.9 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.01 142.11 51.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.46 120.3 9.93 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 179.79 39.46 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 118.935 -1.602 . . . . 0.0 117.079 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.49 147.93 36.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 112.176 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.4 t -97.48 129.0 44.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.866 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -124.1 169.18 11.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.729 1.252 . . . . 0.0 113.72 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.8 mt -131.49 107.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 112.642 -2.072 . . . . 0.0 106.85 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -58.86 157.28 9.96 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.46 -55.13 0.05 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.148 2.179 . . . . 0.0 116.449 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.93 -19.85 62.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.39 1.876 . . . . 0.0 115.976 -173.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.73 53.65 1.19 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -125.59 136.03 52.84 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 126.834 2.053 . . . . 0.0 108.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.34 142.65 32.43 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 111.094 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' D' ' 106' ' ' ILE . 15.1 m -147.23 166.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.188 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.34 122.34 33.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -109.37 116.18 31.35 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.86 160.11 39.85 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.194 1.473 . . . . 0.0 112.15 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -108.25 167.75 9.8 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 172.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -141.32 160.81 39.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.649 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -143.84 127.43 17.02 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.783 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.85 144.65 39.55 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 125.172 1.545 . . . . 0.0 110.818 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.27 116.01 19.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 112.209 -2.268 . . . . 0.0 112.115 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -89.43 158.68 17.64 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 113.396 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -103.68 80.76 1.82 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.7 m -66.8 -173.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.996 0.518 . . . . 0.0 109.658 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.16 -20.83 9.68 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.984 -1.698 . . . . 0.0 114.783 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -124.66 152.42 43.68 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.791 1.282 . . . . 0.0 111.459 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' D' ' 92' ' ' VAL . 10.3 tt -62.44 -27.5 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.181 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.99 23.62 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.291 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -120.08 -0.91 10.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.037 1.419 . . . . 0.0 113.937 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.76 -32.4 69.24 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.968 . . . . 0.0 112.947 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -45.53 -44.6 12.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.609 1.164 . . . . 0.0 113.892 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -93.42 -12.86 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.86 0.864 . . . . 0.0 113.111 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.65 5.57 8.98 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.0 m -113.83 135.5 53.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.909 0.884 . . . . 0.0 111.824 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.67 126.49 22.29 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.61 154.92 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 120.524 1.511 . . . . 0.0 112.235 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.55 30.02 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.606 1.098 . . . . 0.0 113.177 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 24.4 p90 -129.28 153.67 47.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.771 0.828 . . . . 0.0 109.995 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -148.62 149.1 30.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.131 0.972 . . . . 0.0 109.716 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.32 130.63 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.39 -0.819 . . . . 0.0 109.28 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -118.52 153.86 33.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.255 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -137.51 165.1 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.202 1.001 . . . . 0.0 110.447 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -60.83 116.7 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 110.783 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.53 0.183 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 178.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . 0.414 ' SG ' ' SG ' ' D' ' 83' ' ' CYS . 10.1 p -131.32 142.95 50.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 124.147 0.979 . . . . 0.0 108.388 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 21.1 p -132.63 127.47 35.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -68.21 -26.56 65.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.292 1.037 . . . . 0.0 112.425 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 t -62.57 121.02 12.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.34 40.55 0.62 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 mttt 56.53 150.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 129.087 2.955 . . . . 0.0 118.371 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -142.55 161.97 36.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.567 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -131.76 148.17 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.305 1.442 . . . . 0.0 107.552 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.42 143.41 45.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 109.988 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -56.4 -28.86 60.57 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.23 -12.48 61.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.938 1.695 . . . . 0.0 113.018 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.8 -8.44 36.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.142 2.306 . . . . 0.0 113.775 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -63.59 147.0 52.64 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.827 1.313 . . . . 0.0 112.066 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -124.66 137.83 54.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -130.33 147.18 52.01 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.112 0.958 . . . . 0.0 113.121 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 14.6 m -131.31 125.25 32.28 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.14 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.94 126.55 73.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 -88.05 0.1 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 126.09 2.119 . . . . 0.0 111.073 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.36 142.59 35.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.246 0.618 . . . . 0.0 110.661 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.09 133.02 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.722 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -71.92 160.07 33.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.206 1.003 . . . . 0.0 113.316 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 15.8 m -53.76 -27.33 28.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.249 1.419 . . . . 0.0 114.455 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.99 -34.03 68.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.282 0.633 . . . . 0.0 112.625 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.74 -9.83 12.57 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.981 1.277 . . . . 0.0 113.432 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.3 157.42 37.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.907 1.354 . . . . 0.0 110.634 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.82 166.3 33.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.332 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -131.03 147.68 52.66 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.46 -168.67 24.73 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.859 1.255 . . . . 0.0 112.904 -174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 9.5 p -140.06 139.53 35.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.396 -1.402 . . . . 0.0 112.202 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -118.52 132.92 56.21 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.861 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 60.3 mt -121.47 129.31 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 55.1 m -107.36 143.42 35.68 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.538 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.63 -15.73 18.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.73 142.62 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.012 0.925 . . . . 0.0 112.933 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.35 169.19 22.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.216 -0.928 . . . . 0.0 110.967 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -38.77 25.35 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.15 74.41 77.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.573 1.949 . . . . 0.0 109.375 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.75 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.13 3.22 . . . . 0.0 117.332 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.52 -21.35 0.77 Allowed Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.531 2.172 . . . . 0.0 118.531 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.06 42.38 0.08 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 111.929 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -50.29 133.56 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.397 -0.815 . . . . 0.0 111.748 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . 0.259 0.6 OUTLIER -151.81 171.54 17.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 111.377 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 12.3 tp -46.62 118.38 1.99 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.096 2.958 . . . . 0.0 112.116 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 69.6 m -113.08 112.52 49.86 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.256 1.022 . . . . 0.0 108.581 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -54.47 145.71 56.13 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.143 2.562 . . . . 0.0 112.593 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 143.96 51.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.43 1.092 . . . . 0.0 111.525 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -144.34 151.42 39.31 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 129.021 2.928 . . . . 0.0 109.446 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.55 -155.39 26.43 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -145.07 139.1 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.446 -0.877 . . . . 0.0 112.333 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.42 155.05 32.72 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.176 0.99 . . . . 0.0 110.79 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.15 163.98 22.7 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.43 -1.419 . . . . 0.0 110.81 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.16 26.43 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.231 1.013 . . . . 0.0 112.865 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.4 -56.69 2.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.019 2.128 . . . . 0.0 110.622 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.37 171.86 14.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.376 1.084 . . . . 0.0 113.356 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -43.82 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.2 1.4 . . . . 0.0 111.032 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -132.37 57.67 30.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 111.283 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.61 177.21 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 N-CA-C 116.767 1.795 . . . . 0.0 116.767 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -88.88 162.22 16.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.588 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.63 165.56 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.715 -1.241 . . . . 0.0 112.38 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.91 149.47 15.12 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.7 156.9 18.57 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -92.98 151.07 20.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.23 2.212 . . . . 0.0 108.967 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.41 121.97 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -97.77 106.73 19.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.414 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -67.16 131.7 46.32 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.807 1.639 . . . . 0.0 112.73 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.87 -38.13 12.5 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -90.42 -10.94 41.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.5 132.27 13.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.045 2.538 . . . . 0.0 107.068 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -69.54 118.61 12.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.298 0.954 . . . . 0.0 110.39 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 72.5 p -173.97 170.05 3.93 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 109.886 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -140.9 137.78 33.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.445 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.25 165.53 12.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.205 1.002 . . . . 0.0 108.478 173.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.91 150.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.95 142.03 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.33 120.52 10.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.46 -179.86 39.46 Favored Glycine 0 CA--C 1.497 -1.033 0 N-CA-C 117.274 1.67 . . . . 0.0 117.274 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.98 145.34 41.68 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.692 0.878 . . . . 0.0 112.236 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . 0.414 ' SG ' ' SG ' ' D' ' 4' ' ' CYS . 28.1 t -97.76 125.25 42.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.439 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.19 169.84 9.87 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.456 1.122 . . . . 0.0 113.618 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.8 mt -130.6 107.24 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.056 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.15 155.31 14.25 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.477 0.711 . . . . 0.0 109.097 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -24.15 -56.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 127.091 2.157 . . . . 0.0 116.704 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.23 -17.83 63.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.43 47.89 1.62 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.501 1.046 . . . . 0.0 110.632 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -119.78 139.61 52.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.477 1.511 . . . . 0.0 110.025 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -101.39 143.69 31.12 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 111.108 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 106' ' ' ILE . 15.2 m -148.09 164.28 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.928 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.34 120.52 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -108.75 115.15 29.55 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -136.57 161.58 35.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 123.319 1.533 . . . . 0.0 111.667 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.01 168.53 9.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -142.11 161.28 38.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.306 173.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -144.29 127.06 16.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.808 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.62 144.71 39.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.554 1.159 . . . . 0.0 110.898 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.11 114.59 17.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.011 -2.359 . . . . 0.0 112.13 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 85.7 p -86.97 158.6 19.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 124.813 1.32 . . . . 0.0 113.462 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -103.68 81.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.85 -173.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.039 0.535 . . . . 0.0 109.838 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -115.83 -21.0 9.79 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.119 -1.613 . . . . 0.0 114.789 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -123.85 151.3 43.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.486 1.136 . . . . 0.0 111.702 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . 0.423 ' CD1' HG21 ' A' ' 92' ' ' VAL . 10.8 tt -61.93 -27.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.055 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.77 4.32 22.68 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.356 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -120.13 -0.19 10.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.905 1.353 . . . . 0.0 113.935 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -60.08 -31.38 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.358 -0.839 . . . . 0.0 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -46.54 -44.21 17.66 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.53 1.132 . . . . 0.0 113.97 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -93.63 -12.79 28.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.011 0.924 . . . . 0.0 113.161 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.64 5.11 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 14.5 m -113.08 135.6 53.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.862 0.865 . . . . 0.0 111.726 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.57 126.25 22.14 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.611 -1.185 . . . . 0.0 110.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.91 154.82 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.298 1.408 . . . . 0.0 111.821 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.86 -175.87 30.27 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.687 1.137 . . . . 0.0 113.096 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -126.47 153.43 45.09 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.623 0.769 . . . . 0.0 109.517 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -148.08 148.24 30.43 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.036 0.934 . . . . 0.0 109.271 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 64.9 mt -128.2 131.5 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.031 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -117.74 156.76 27.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.222 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -137.53 160.95 37.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.591 1.156 . . . . 0.0 110.195 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.18 129.54 42.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.891 -0.506 . . . . 0.0 109.735 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.764 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . 0.407 ' SG ' ' SG ' ' B' ' 83' ' ' CYS . 25.0 p -130.15 147.49 51.89 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.323 1.049 . . . . 0.0 108.275 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -137.64 127.46 25.5 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.549 0.74 . . . . 0.0 112.43 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.09 120.08 10.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.75 43.18 0.5 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt 53.6 148.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.388 3.075 . . . . 0.0 119.175 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -140.83 160.1 40.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.929 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 142.26 47.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.121 1.368 . . . . 0.0 108.514 175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.32 143.5 42.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.966 1.306 . . . . 0.0 110.041 -174.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -56.35 -29.36 61.27 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.9 -12.16 61.38 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.747 1.619 . . . . 0.0 112.836 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.45 -8.13 40.48 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 127.062 2.268 . . . . 0.0 113.635 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.9 t -64.43 145.04 56.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.787 1.294 . . . . 0.0 111.511 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -121.94 141.46 51.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -133.08 147.17 52.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.304 1.049 . . . . 0.0 112.795 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -129.58 125.26 35.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.544 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.56 127.44 75.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.05 -88.45 0.1 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 125.874 1.984 . . . . 0.0 110.987 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.98 145.13 37.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.202 -0.587 . . . . 0.0 110.824 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.02 131.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.729 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -72.79 159.54 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.029 0.919 . . . . 0.0 112.808 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -54.47 -27.87 40.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -71.84 -34.81 69.59 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.148 0.579 . . . . 0.0 112.448 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.82 -9.16 12.63 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.503 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 155.3 40.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.379 1.59 . . . . 0.0 108.225 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.39 166.12 32.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.882 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.14 147.92 52.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.54 26.77 Favored Glycine 0 C--O 1.236 0.24 0 O-C-N 121.623 -0.673 . . . . 0.0 112.81 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 10.7 p -139.89 138.53 35.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.836 -1.182 . . . . 0.0 112.092 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -117.14 132.39 56.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.811 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.13 129.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 45.2 m -107.14 143.56 35.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.742 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.44 -13.59 18.65 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.44 142.06 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.948 0.899 . . . . 0.0 112.806 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.28 168.68 23.33 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.219 -0.926 . . . . 0.0 111.036 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -39.15 25.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -126.85 74.64 75.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.428 1.891 . . . . 0.0 109.321 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.82 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.175 3.25 . . . . 0.0 117.34 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.79 -20.96 0.75 Allowed Glycine 0 CA--C 1.537 1.433 0 N-CA-C 118.523 2.169 . . . . 0.0 118.523 -174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.2 42.34 0.08 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 111.861 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -50.06 134.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.336 -0.852 . . . . 0.0 111.454 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -152.3 171.85 17.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.425 1.49 . . . . 0.0 111.109 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 12.1 tp -46.69 119.34 2.41 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.469 3.108 . . . . 0.0 112.143 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 68.2 m -114.3 113.59 45.92 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.095 0.958 . . . . 0.0 108.579 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -55.28 144.76 69.9 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.622 2.881 . . . . 0.0 112.814 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.04 52.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.613 1.165 . . . . 0.0 111.892 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.41 150.7 40.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.167 2.987 . . . . 0.0 109.266 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.08 -155.43 26.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -144.8 139.48 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.668 -0.766 . . . . 0.0 112.421 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.78 155.15 31.66 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.255 1.022 . . . . 0.0 110.993 172.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.95 163.9 22.97 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.499 -1.375 . . . . 0.0 110.588 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.97 26.38 0.32 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 113.213 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -56.36 2.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.282 2.233 . . . . 0.0 111.022 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.75 171.83 14.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.955 0.883 . . . . 0.0 113.331 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -41.43 66.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.45 1.1 . . . . 0.0 110.91 173.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -132.87 57.9 31.71 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 125.383 1.473 . . . . 0.0 111.07 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.32 176.62 9.71 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.053 1.835 . . . . 0.0 116.654 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -87.71 163.79 16.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.718 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -163.44 164.44 24.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 149.14 15.03 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 119.941 2.736 . . . . 0.0 119.941 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -164.12 154.29 14.8 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -90.06 150.92 21.88 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.927 2.091 . . . . 0.0 109.133 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 74.1 t -130.28 120.72 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -95.76 105.91 17.97 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.612 -1.185 . . . . 0.0 110.793 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -67.1 132.14 47.24 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.165 1.802 . . . . 0.0 112.742 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.46 -38.2 12.1 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.58 -10.4 43.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -152.5 133.28 14.0 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.002 2.521 . . . . 0.0 107.265 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -70.66 118.47 13.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.273 0.942 . . . . 0.0 109.823 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 75.5 p -173.62 170.2 4.12 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.639 1.976 . . . . 0.0 109.928 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.76 137.9 31.92 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.142 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.34 166.12 12.0 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 150.49 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -129.07 141.61 51.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.08 120.3 10.17 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.37 -179.35 38.47 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.915 -1.612 . . . . 0.0 117.106 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -114.31 145.7 41.44 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 125.178 1.163 . . . . 0.0 112.098 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . 0.407 ' SG ' ' SG ' ' B' ' 4' ' ' CYS . 34.6 t -97.76 125.94 42.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.291 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.7 170.89 9.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.76 1.267 . . . . 0.0 113.573 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 mt -131.63 110.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.49 -2.141 . . . . 0.0 106.506 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.5 156.55 19.22 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.59 -53.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -73.63 -8.96 58.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.435 1.894 . . . . 0.0 116.101 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.16 50.87 3.12 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 120.008 1.276 . . . . 0.0 110.684 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -122.87 135.97 54.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.434 1.894 . . . . 0.0 109.746 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -101.83 143.03 32.24 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.308 1.443 . . . . 0.0 112.066 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' C' ' 106' ' ' ILE . 15.3 m -148.56 161.95 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.803 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 mt -122.16 120.21 33.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -108.24 114.47 28.37 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.05 161.06 36.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.306 1.527 . . . . 0.0 112.137 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -109.3 168.06 9.66 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -141.69 160.69 39.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.508 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.46 127.7 17.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.559 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.03 144.59 39.92 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 124.826 1.329 . . . . 0.0 110.987 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -128.23 116.91 20.61 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 112.125 -2.307 . . . . 0.0 112.279 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -90.71 158.66 16.77 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 124.73 1.269 . . . . 0.0 113.627 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.1 m -103.21 80.34 1.83 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -66.76 -174.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -115.66 -22.65 9.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 119.934 -1.729 . . . . 0.0 114.537 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -118.63 148.82 42.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.766 1.269 . . . . 0.0 110.734 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' C' ' 92' ' ' VAL . 10.7 tt -61.05 -28.23 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.77 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.95 4.05 25.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.221 -1.322 . . . . 0.0 115.457 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.83 -1.39 11.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.102 1.451 . . . . 0.0 113.815 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.77 -31.54 68.47 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.341 -0.85 . . . . 0.0 112.824 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -46.43 -44.57 17.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 114.107 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -92.88 -12.78 30.1 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.951 0.9 . . . . 0.0 113.263 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 4.95 10.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 16.2 m -113.12 135.08 54.19 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.915 0.886 . . . . 0.0 111.668 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.48 126.66 22.84 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.541 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.94 154.77 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 120.427 1.467 . . . . 0.0 112.041 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.94 -175.32 30.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.698 1.142 . . . . 0.0 113.056 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 24.2 p90 -128.21 154.63 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.678 0.791 . . . . 0.0 109.965 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -149.71 147.26 27.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.853 0.861 . . . . 0.0 109.831 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 129.54 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.399 -0.813 . . . . 0.0 109.146 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -116.86 155.41 29.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.437 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 32.8 p -137.31 160.42 39.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 110.458 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -59.65 128.58 37.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.79 0.836 . . . . 0.0 111.395 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.334 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' C' ' 83' ' ' CYS . 13.1 p -133.54 147.39 51.58 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.838 1.255 . . . . 0.0 108.453 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -137.21 127.51 26.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -68.87 -26.76 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.959 0.904 . . . . 0.0 112.571 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -61.47 120.8 11.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.35 45.2 0.53 Allowed Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.938 1.535 . . . . 0.0 116.938 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt 52.87 149.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -141.83 161.02 38.99 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.427 -1.715 . . . . 0.0 112.139 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.05 144.35 49.97 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.271 1.428 . . . . 0.0 108.519 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.81 143.42 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.105 1.362 . . . . 0.0 109.476 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -55.75 -29.51 59.7 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.76 -12.23 61.43 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.77 1.628 . . . . 0.0 113.007 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.63 -9.09 40.77 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.284 2.373 . . . . 0.0 113.611 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.5 t -63.09 145.91 54.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.82 1.31 . . . . 0.0 111.804 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -122.36 141.09 51.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.17 147.24 52.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.999 0.904 . . . . 0.0 112.823 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.4 m -130.35 125.69 35.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.766 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.47 126.42 74.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.19 -88.71 0.08 OUTLIER Glycine 0 CA--C 1.526 0.77 0 O-C-N 126.036 2.085 . . . . 0.0 111.036 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.37 143.69 35.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.228 0.611 . . . . 0.0 110.862 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.16 132.74 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.739 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -71.77 160.04 33.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.247 1.023 . . . . 0.0 113.304 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 16.0 m -53.84 -27.23 28.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.151 1.381 . . . . 0.0 114.505 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.93 -34.17 68.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.231 0.612 . . . . 0.0 112.588 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.76 -9.88 12.52 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.967 1.27 . . . . 0.0 113.468 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.25 157.59 37.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.967 1.384 . . . . 0.0 110.563 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 166.3 33.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.326 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 148.04 52.66 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.65 -169.12 25.59 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 122.478 1.044 . . . . 0.0 112.746 -174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 10.2 p -139.66 138.96 36.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.686 -1.257 . . . . 0.0 112.032 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -117.19 135.09 54.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.854 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 60.6 mt -123.57 130.17 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 42.1 m -107.92 143.84 36.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.779 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.71 -13.5 18.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.74 141.43 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 112.737 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.84 168.36 23.95 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.204 -0.935 . . . . 0.0 110.992 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.62 -39.27 27.75 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.61 74.62 74.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.469 1.908 . . . . 0.0 109.291 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.8 6.8 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.147 3.232 . . . . 0.0 117.406 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.68 -21.28 0.8 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.14 42.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.732 1.266 . . . . 0.0 111.832 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 54.2 mt -49.95 134.62 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.382 -0.824 . . . . 0.0 111.518 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -152.85 171.6 18.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.222 1.409 . . . . 0.0 111.254 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.3 tp -46.63 118.43 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 129.263 3.025 . . . . 0.0 112.136 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -113.5 112.79 48.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.542 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.5 145.69 56.6 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.173 2.582 . . . . 0.0 112.565 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.2 143.89 51.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.078 0.951 . . . . 0.0 111.329 175.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -143.93 151.53 39.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.339 3.056 . . . . 0.0 109.606 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.85 -155.66 26.72 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -144.87 139.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 114.484 -0.858 . . . . 0.0 112.282 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.19 155.54 31.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.162 0.985 . . . . 0.0 110.739 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.85 163.6 22.2 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.392 -1.442 . . . . 0.0 110.886 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.74 25.09 0.33 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.113 0.965 . . . . 0.0 113.1 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.39 -57.52 2.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.191 2.196 . . . . 0.0 111.08 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.8 172.07 12.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -43.25 64.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.006 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -129.96 57.78 33.33 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 125.223 1.409 . . . . 0.0 111.054 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.37 176.83 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.976 1.784 . . . . 0.0 116.691 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 11.4 p -87.98 162.81 16.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.955 1.702 . . . . 0.0 109.637 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -162.02 165.33 27.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.174 -0.954 . . . . 0.0 112.665 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.64 149.38 15.06 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.14 155.4 15.9 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -91.6 150.78 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.985 2.114 . . . . 0.0 109.151 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.04 121.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -97.78 106.16 18.42 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.59 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -66.58 131.69 46.56 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.779 1.627 . . . . 0.0 112.901 -173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.92 -37.99 12.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.56 -10.71 42.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 26.7 t -152.43 132.55 13.5 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.043 2.537 . . . . 0.0 107.216 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -70.24 118.53 13.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.303 0.956 . . . . 0.0 109.947 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 77.3 p -173.49 170.3 4.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.492 1.917 . . . . 0.0 110.026 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.82 137.88 31.81 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.019 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.22 165.8 12.31 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.329 1.061 . . . . 0.0 108.578 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.42 150.89 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -128.95 142.0 51.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.35 120.3 10.0 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.6 -179.73 38.85 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.79 144.83 42.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.084 0.945 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' C' ' 4' ' ' CYS . 34.2 t -97.85 123.13 41.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.549 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.89 170.42 8.83 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.585 1.183 . . . . 0.0 113.652 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -130.23 111.61 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.928 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.62 157.23 17.96 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -25.85 -53.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.195 2.198 . . . . 0.0 116.856 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.48 -8.61 56.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.78 47.16 4.31 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 120.399 1.454 . . . . 0.0 110.947 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -119.11 141.67 48.59 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.339 2.256 . . . . 0.0 108.209 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -108.41 145.49 34.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.598 1.159 . . . . 0.0 112.168 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' B' ' 106' ' ' ILE . 18.6 m -149.66 165.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.215 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 59.6 mt -124.3 121.59 35.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -109.81 114.19 27.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -136.06 160.76 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.32 1.533 . . . . 0.0 112.033 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.04 168.16 9.57 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -141.6 161.1 38.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.278 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -144.08 127.09 16.45 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.265 -1.788 . . . . 0.0 110.505 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tt -110.5 144.65 39.0 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.577 1.173 . . . . 0.0 110.779 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -128.86 117.21 20.66 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 112.315 -2.22 . . . . 0.0 112.199 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -90.5 158.96 16.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 124.847 1.342 . . . . 0.0 113.848 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -103.07 80.01 1.81 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.84 -175.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.099 0.56 . . . . 0.0 109.924 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -114.47 -23.27 9.42 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.379 -1.451 . . . . 0.0 114.571 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -119.13 149.78 41.13 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.709 1.242 . . . . 0.0 110.455 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . 0.425 ' CD1' HG21 ' B' ' 92' ' ' VAL . 11.5 tt -61.25 -29.06 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.295 174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.91 3.75 19.13 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.324 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.75 -1.19 11.13 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.963 1.381 . . . . 0.0 113.894 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -58.9 -31.74 68.89 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.273 -0.892 . . . . 0.0 112.74 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -46.54 -44.19 17.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.765 1.226 . . . . 0.0 113.95 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -93.14 -12.88 29.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.979 0.912 . . . . 0.0 113.232 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.35 10.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 16.8 m -113.25 135.3 53.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.032 0.933 . . . . 0.0 111.449 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -138.82 125.36 20.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 117.597 -1.192 . . . . 0.0 110.552 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.53 154.85 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.211 1.368 . . . . 0.0 111.851 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.61 -175.47 30.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.714 1.149 . . . . 0.0 113.081 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.48 153.51 46.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.702 0.801 . . . . 0.0 109.81 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -148.63 147.2 28.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.165 0.986 . . . . 0.0 109.707 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -128.32 132.08 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -119.5 156.41 30.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.111 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 38.7 p -139.1 163.68 31.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.697 1.199 . . . . 0.0 110.662 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -60.79 124.66 21.08 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.419 -0.801 . . . . 0.0 111.517 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.667 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -138.76 153.94 48.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.009 0.818 . . . . 0.0 110.603 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -139.46 126.37 20.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.48 -31.41 72.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -66.3 101.38 0.73 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.75 -8.19 0.11 Allowed Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.1 tttt 75.63 139.09 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.041 2.536 . . . . 0.0 113.721 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -137.73 162.75 33.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.074 1.35 . . . . 0.0 111.617 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -141.05 148.47 40.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.661 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -108.88 151.99 25.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.796 0.838 . . . . 0.0 112.294 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.94 -25.76 66.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.27 -15.98 61.4 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.346 1.858 . . . . 0.0 110.946 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.24 -6.34 34.28 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 127.192 2.329 . . . . 0.0 114.517 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 p -70.56 148.14 48.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.928 1.864 . . . . 0.0 112.219 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -119.11 139.09 52.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.868 -1.145 . . . . 0.0 109.433 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -127.8 136.16 51.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.692 0.758 . . . . 0.0 110.63 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.05 132.21 52.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.65 126.71 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -87.54 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 O-C-N 125.67 1.856 . . . . 0.0 110.611 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.88 29.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.193 -0.592 . . . . 0.0 111.5 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.49 126.55 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.045 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.19 159.3 29.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 112.277 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 t -53.07 -30.15 34.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -63.46 -39.59 94.86 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.006 -1.059 . . . . 0.0 110.97 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.56 -6.75 10.54 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 116.854 -2.081 . . . . 0.0 114.118 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.36 152.8 44.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.812 1.806 . . . . 0.0 109.705 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -152.03 145.27 24.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.304 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.53 155.67 22.91 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.834 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -169.16 30.96 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 122.928 1.293 . . . . 0.0 112.991 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -134.69 129.22 34.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.413 -1.394 . . . . 0.0 111.646 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -123.25 120.64 33.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.991 0.901 . . . . 0.0 111.607 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.99 132.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.9 144.79 42.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.47 -13.99 21.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 143.11 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.572 1.149 . . . . 0.0 112.409 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.23 43.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.467 -1.396 . . . . 0.0 111.505 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 114' ' ' ARG . 8.5 m-20 -70.12 -25.82 63.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.54 83.71 14.71 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.568 1.947 . . . . 0.0 109.747 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.68 177.48 7.49 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.176 2.584 . . . . 0.0 110.47 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.11 -27.35 3.3 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 113.301 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -142.57 23.14 1.97 Allowed 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.72 1.608 . . . . 0.0 110.531 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.21 105.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 123.182 1.468 . . . . 0.0 111.481 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 171.02 7.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.079 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.58 126.63 24.51 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 127.645 2.378 . . . . 0.0 111.62 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -104.09 119.54 53.92 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.646 174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -55.23 149.96 42.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.51 2.14 . . . . 0.0 111.562 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.22 149.46 47.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.324 1.05 . . . . 0.0 110.287 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.86 149.13 29.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.369 2.267 . . . . 0.0 109.159 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.33 -156.87 28.35 Favored Glycine 0 C--O 1.228 -0.236 0 O-C-N 120.355 -1.466 . . . . 0.0 111.058 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -145.99 148.8 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 125.41 1.3 . . . . 0.0 111.704 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 152.81 50.76 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.515 -1.366 . . . . 0.0 112.997 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -101.19 147.12 26.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 14.12 1.77 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.391 1.477 . . . . 0.0 113.533 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -92.56 -42.35 9.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.823 1.649 . . . . 0.0 112.147 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.32 4.62 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.96 0.788 . . . . 0.0 112.64 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 t -70.12 -49.18 53.3 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.582 1.153 . . . . 0.0 112.538 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.34 65.33 72.25 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.07 0.948 . . . . 0.0 111.763 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.15 173.53 5.99 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.537 3.491 . . . . 0.0 116.921 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER -100.36 169.38 9.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 123.443 1.592 . . . . 0.0 110.725 173.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -162.17 162.5 28.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.071 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.87 143.17 8.45 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 118.579 2.192 . . . . 0.0 118.579 -172.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.16 152.33 20.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -89.81 152.23 21.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.032 1.733 . . . . 0.0 109.263 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.71 120.65 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.45 117.97 35.46 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -82.29 136.31 35.06 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.065 -1.647 . . . . 0.0 114.55 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -97.08 -44.38 7.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.836 -1.074 . . . . 0.0 113.836 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -74.83 -19.28 60.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.368 0.667 . . . . 0.0 112.54 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.41 132.81 13.72 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.703 2.801 . . . . 0.0 107.34 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.45 118.88 20.32 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.284 1.402 . . . . 0.0 111.855 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 76.3 p -176.71 164.5 2.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.926 2.09 . . . . 0.0 107.379 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.6 135.67 17.66 Favored 'General case' 0 CA--C 1.47 -2.103 0 CA-C-O 122.202 1.001 . . . . 0.0 108.781 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -135.34 130.28 34.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 111.066 -2.788 . . . . 0.0 111.492 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.92 154.1 5.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 120.742 0.306 . . . . 0.0 110.212 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -127.99 144.2 51.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.84 117.06 4.55 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.16 -177.72 34.51 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.98 138.56 54.65 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.806 0.812 . . . . 0.0 111.178 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.6 t -97.97 112.76 24.57 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.154 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -112.01 168.58 9.48 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.793 1.282 . . . . 0.0 110.148 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.74 113.75 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 112.841 -1.981 . . . . 0.0 107.571 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.09 157.95 14.7 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -44.63 -28.63 0.62 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 118.156 2.651 . . . . 0.0 118.156 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -5.69 55.77 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.17 41.07 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.635 1.112 . . . . 0.0 113.416 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.27 144.53 25.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.522 2.329 . . . . 0.0 109.983 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.26 141.92 33.43 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.587 1.155 . . . . 0.0 109.616 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.6 160.66 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 125.121 1.513 . . . . 0.0 110.36 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 mt -124.43 118.17 26.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -106.39 113.2 26.58 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 p -132.86 165.1 25.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.58 1.657 . . . . 0.0 111.598 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.56 168.52 10.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.037 173.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -141.54 158.08 44.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.272 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.68 127.26 28.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.867 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.5 137.24 45.89 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 124.788 1.305 . . . . 0.0 111.726 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.8 113.84 20.75 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.783 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 m -77.66 164.76 25.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 125.215 1.572 . . . . 0.0 111.755 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.6 m -108.61 85.16 2.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.01 178.2 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -116.25 6.43 13.83 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.35 144.88 33.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.427 174.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.72 -31.11 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.166 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.14 6.67 13.11 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.366 1.46 . . . . 0.0 115.072 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -120.9 3.0 10.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.202 1.001 . . . . 0.0 112.831 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -33.41 75.37 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.966 -1.084 . . . . 0.0 113.196 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -45.7 -41.04 10.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.12 0.968 . . . . 0.0 113.441 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -98.14 -9.02 26.47 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.242 1.017 . . . . 0.0 113.601 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.95 -0.8 19.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -112.58 141.76 45.96 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.568 0.699 . . . . 0.0 111.861 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 39' ' ' ASP . 34.3 mtp180 -138.69 147.96 43.4 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.22 1.408 . . . . 0.0 109.898 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.75 149.51 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.955 1.707 . . . . 0.0 109.836 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.26 -175.26 27.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 123.799 0.714 . . . . 0.0 111.86 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 28.3 p90 -130.69 157.4 42.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.142 0.577 . . . . 0.0 110.282 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -148.81 145.94 27.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.042 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.6 mt -124.81 126.07 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.07 149.65 37.17 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.398 -0.814 . . . . 0.0 109.625 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 p -133.38 157.29 45.9 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.776 -0.578 . . . . 0.0 109.59 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 121.52 9.26 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.894 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p -150.14 145.46 26.32 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.508 1.13 . . . . 0.0 110.538 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -139.79 127.15 21.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.21 -27.98 68.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.84 101.2 1.04 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.42 -9.74 0.09 OUTLIER Glycine 0 N--CA 1.484 1.899 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 75.82 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.913 2.485 . . . . 0.0 113.649 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.18 162.73 32.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.846 1.307 . . . . 0.0 111.66 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -139.71 149.7 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.097 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.12 152.73 25.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.675 0.79 . . . . 0.0 111.584 -175.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.59 -26.66 67.21 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.0 tp -72.45 -16.04 61.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.5 1.92 . . . . 0.0 111.237 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.57 -5.59 35.32 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.194 2.33 . . . . 0.0 114.363 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 66.4 p -71.27 149.61 46.02 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.926 1.863 . . . . 0.0 112.252 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -121.99 139.05 54.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.914 -1.116 . . . . 0.0 109.808 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -127.37 136.76 52.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.88 0.848 . . . . 0.0 111.018 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.01 131.72 52.15 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 86.6 mt -127.64 126.74 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.84 -87.49 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 125.023 1.452 . . . . 0.0 110.704 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.61 139.33 31.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.287 -0.537 . . . . 0.0 111.328 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.06 125.46 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.908 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -65.26 159.1 24.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.172 0.589 . . . . 0.0 112.236 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 17.7 t -54.2 -28.58 41.74 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -63.37 -37.21 86.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.982 -1.074 . . . . 0.0 110.983 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.1 -4.87 15.95 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.484 1.516 . . . . 0.0 113.753 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.26 155.42 38.28 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.925 1.363 . . . . 0.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -152.51 154.53 35.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.698 1.237 . . . . 0.0 112.72 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.18 156.05 30.55 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.164 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.06 -168.62 30.45 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.844 1.247 . . . . 0.0 113.394 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -133.9 130.5 37.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.589 -1.306 . . . . 0.0 111.763 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -124.05 121.04 34.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.982 0.896 . . . . 0.0 111.515 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.3 133.45 66.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.99 145.72 41.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.6 -15.97 20.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 143.55 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.441 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.71 158.3 43.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.678 -1.264 . . . . 0.0 111.615 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . 0.485 ' CG ' HH12 ' D' ' 114' ' ' ARG . 9.2 m-20 -69.96 -26.06 63.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.98 83.42 14.05 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.384 1.874 . . . . 0.0 109.441 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.72 177.48 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.091 2.527 . . . . 0.0 110.546 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.9 -27.24 3.35 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 121.346 -0.847 . . . . 0.0 113.324 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 23.32 2.0 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.799 1.64 . . . . 0.0 110.687 -177.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 62.9 mt -57.21 106.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 123.195 1.474 . . . . 0.0 111.296 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.22 170.79 8.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.954 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.78 126.31 21.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 127.409 2.284 . . . . 0.0 111.628 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -104.53 119.87 52.35 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.015 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.97 150.4 38.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.354 2.036 . . . . 0.0 111.456 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.85 152.66 50.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 110.059 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.52 149.29 26.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.759 2.024 . . . . 0.0 109.691 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.26 -155.29 26.43 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 119.257 0.935 . . . . 0.0 113.948 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -146.84 148.8 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.717 1.207 . . . . 0.0 111.838 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.04 152.34 49.97 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.482 -1.386 . . . . 0.0 112.794 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -100.2 146.97 26.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 16.17 1.84 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 113.335 -175.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -91.93 -42.12 10.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 174.39 5.34 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -71.8 -47.55 52.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 0.0 112.669 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.5 64.68 73.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 124.644 1.178 . . . . 0.0 112.673 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.43 173.61 8.5 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.654 3.569 . . . . 0.0 116.639 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.303 0.5 OUTLIER -99.15 168.62 9.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.533 1.635 . . . . 0.0 111.086 173.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.54 161.78 27.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.927 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.98 143.6 8.95 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.6 151.64 18.91 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -89.16 154.0 20.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.357 1.863 . . . . 0.0 109.52 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.25 121.04 45.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.84 117.25 33.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -174.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.83 135.16 35.46 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.24 -1.538 . . . . 0.0 114.676 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -95.62 -44.28 7.55 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -74.66 -19.59 60.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.455 0.702 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.39 132.19 13.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.553 2.741 . . . . 0.0 107.491 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -75.98 118.9 19.24 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.444 1.475 . . . . 0.0 112.107 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -176.59 164.12 2.47 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 127.004 2.122 . . . . 0.0 107.196 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.29 135.18 17.65 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-O 122.505 1.145 . . . . 0.0 108.897 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 4.9 m -135.02 130.16 35.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.576 -169.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -103.38 154.58 5.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 120.623 0.249 . . . . 0.0 110.421 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -128.43 144.0 51.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.44 116.91 4.65 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.98 -177.0 33.71 Favored Glycine 0 CA--C 1.503 -0.707 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.73 137.98 54.31 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.66 0.859 . . . . 0.0 110.734 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.92 112.82 24.6 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.266 -1.35 . . . . 0.0 108.771 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.43 169.16 8.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.762 1.225 . . . . 0.0 110.031 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.08 110.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.916 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -60.19 157.3 13.55 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -43.59 -30.17 0.57 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.64 -0.76 48.64 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.76 43.35 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.511 -0.743 . . . . 0.0 113.13 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.85 146.14 23.99 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.748 2.019 . . . . 0.0 109.545 175.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -101.27 142.24 32.98 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.806 1.242 . . . . 0.0 108.795 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 21.9 m -146.26 159.13 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 125.07 1.481 . . . . 0.0 110.7 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 42.4 mt -121.64 117.01 25.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.17 112.28 25.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -132.27 165.62 23.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.613 1.673 . . . . 0.0 111.752 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.19 168.07 10.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 114.729 -1.123 . . . . 0.0 107.977 173.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -141.32 158.34 44.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.243 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.97 127.02 27.88 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.54 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 137.22 46.06 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.767 1.292 . . . . 0.0 111.46 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.72 113.83 20.78 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 113.131 -1.85 . . . . 0.0 110.855 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -77.58 164.9 24.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.829 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -109.25 84.82 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.24 -178.28 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -119.1 6.44 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.94 145.15 34.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.225 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.34 -30.61 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.15 7.08 18.09 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.609 1.576 . . . . 0.0 115.207 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.63 3.21 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.25 1.025 . . . . 0.0 112.888 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.63 -33.04 74.73 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.119 -0.988 . . . . 0.0 112.655 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -45.41 -41.38 9.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 113.636 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -98.3 -8.95 26.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.312 1.045 . . . . 0.0 113.672 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.64 -1.46 21.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 3.7 m -111.85 141.69 45.16 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.748 0.704 . . . . 0.0 111.895 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . 0.485 HH12 ' CG ' ' D' ' 39' ' ' ASP . 35.4 mtp180 -138.35 148.05 44.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.335 1.454 . . . . 0.0 109.961 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.95 149.59 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 120.804 1.638 . . . . 0.0 109.83 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.51 -175.21 27.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.743 0.687 . . . . 0.0 111.877 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 29.1 p90 -130.77 156.78 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.125 0.57 . . . . 0.0 110.051 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -148.28 145.81 28.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.388 0.675 . . . . 0.0 109.922 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.3 mt -124.32 126.45 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -114.84 150.28 35.77 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.069 0.938 . . . . 0.0 110.076 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 61.9 p -133.64 158.81 42.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.683 0.793 . . . . 0.0 110.352 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 126.58 28.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.282 0.633 . . . . 0.0 109.381 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p -147.01 149.27 32.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 124.58 1.175 . . . . 0.0 111.207 -174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.5 p -139.74 127.02 21.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.71 -28.16 67.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.43 101.97 1.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.36 -14.3 0.13 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 118.592 2.197 . . . . 0.0 118.592 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 tttt 80.7 143.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 128.502 2.721 . . . . 0.0 112.776 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -137.56 162.74 32.94 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 111.536 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.01 154.07 51.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.092 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -114.41 150.79 34.14 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.848 0.859 . . . . 0.0 111.409 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.05 -25.18 66.92 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.77 -16.29 61.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.852 2.061 . . . . 0.0 111.011 173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.07 -6.52 32.53 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.279 2.371 . . . . 0.0 114.603 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 45.4 p -71.49 147.15 48.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.776 1.788 . . . . 0.0 111.907 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.31 139.76 50.85 Favored 'General case' 0 CA--C 1.522 -0.103 0 O-C-N 120.829 -1.169 . . . . 0.0 109.823 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -127.96 135.17 49.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -123.85 130.7 53.03 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -126.12 126.83 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.88 -88.02 0.1 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 125.506 1.754 . . . . 0.0 110.678 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.55 141.22 32.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.069 -0.665 . . . . 0.0 111.966 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.61 126.14 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.256 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.9 158.93 29.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.879 0.472 . . . . 0.0 112.176 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -53.07 -30.05 33.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -63.5 -39.21 93.84 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.924 -1.11 . . . . 0.0 111.005 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.42 -7.22 10.54 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 116.882 -2.066 . . . . 0.0 114.159 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.04 152.74 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.73 1.765 . . . . 0.0 109.757 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -152.18 145.83 24.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.927 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.89 156.31 22.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.941 174.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.63 -169.11 30.75 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-O 122.588 1.104 . . . . 0.0 113.345 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 10.8 p -133.3 129.84 38.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.583 -1.309 . . . . 0.0 112.008 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -122.87 121.26 35.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 122.012 0.91 . . . . 0.0 111.066 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -121.07 132.62 70.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.6 146.93 40.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.69 -16.64 18.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.57 144.42 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 112.387 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.5 158.22 42.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.625 -1.297 . . . . 0.0 111.383 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.484 ' CG ' HH12 ' B' ' 114' ' ' ARG . 8.6 m-20 -69.7 -26.57 64.42 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -140.71 83.44 14.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.689 1.996 . . . . 0.0 109.586 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.58 177.46 7.45 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.19 2.593 . . . . 0.0 110.532 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.98 -27.04 3.36 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.285 -0.885 . . . . 0.0 113.382 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -142.68 23.64 1.92 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.879 1.672 . . . . 0.0 110.666 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.62 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.986 1.374 . . . . 0.0 111.35 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 170.03 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.944 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 126.24 18.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.397 2.279 . . . . 0.0 112.184 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.4 m -104.88 120.62 49.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.985 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -55.33 150.23 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.732 2.288 . . . . 0.0 111.818 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.23 149.61 47.28 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.985 0.914 . . . . 0.0 110.302 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.74 149.34 29.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.342 2.257 . . . . 0.0 108.884 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.53 -156.94 28.36 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 120.246 1.385 . . . . 0.0 111.358 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.4 148.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 125.21 1.182 . . . . 0.0 111.612 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 153.92 51.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.748 -1.22 . . . . 0.0 113.061 175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -101.83 147.51 26.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 16.71 1.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.37 1.468 . . . . 0.0 113.394 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -92.85 -40.2 10.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.165 1.786 . . . . 0.0 111.899 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.55 174.31 8.44 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.087 0.867 . . . . 0.0 111.979 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -70.36 -50.15 41.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.126 1.37 . . . . 0.0 112.688 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.43 63.74 70.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.108 0.963 . . . . 0.0 112.107 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -66.73 172.95 8.71 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.446 3.43 . . . . 0.0 116.407 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.306 0.4 OUTLIER -98.9 167.85 10.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.662 1.22 . . . . 0.0 110.823 173.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.83 162.26 29.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.866 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.62 143.8 9.05 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -160.08 153.37 22.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -91.29 151.54 20.85 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.218 1.807 . . . . 0.0 109.485 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.67 120.82 51.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.57 117.42 34.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -82.04 136.4 35.23 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.98 -1.7 . . . . 0.0 114.402 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -97.06 -44.22 7.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.896 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -75.12 -19.29 59.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.833 0.853 . . . . 0.0 112.495 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.44 133.35 14.1 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.832 2.853 . . . . 0.0 107.412 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -77.93 118.91 20.69 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.17 1.35 . . . . 0.0 111.895 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.6 p -176.69 164.32 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.957 2.103 . . . . 0.0 107.18 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.32 135.69 18.01 Favored 'General case' 0 CA--C 1.473 -1.991 0 CA-C-O 122.244 1.021 . . . . 0.0 108.668 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . 0.251 5.2 m -135.88 130.06 33.25 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.337 -169.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.94 154.87 5.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -129.16 143.82 50.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 117.45 4.75 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.35 -177.71 34.68 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 115.951 1.14 . . . . 0.0 115.951 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.22 138.28 54.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.374 0.691 . . . . 0.0 110.456 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.8 112.82 24.57 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.32 168.95 8.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.699 1.238 . . . . 0.0 109.973 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -123.24 109.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.497 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -58.66 158.26 8.14 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -43.56 -35.91 1.88 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.727 2.491 . . . . 0.0 117.727 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -20.51 61.44 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.92 19.73 12.53 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.734 1.159 . . . . 0.0 113.434 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 149.62 26.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.169 1.788 . . . . 0.0 109.097 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -101.36 145.45 28.9 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.401 1.481 . . . . 0.0 110.128 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 23.3 m -147.77 160.21 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.234 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 mt -121.86 117.24 26.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.41 111.37 23.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.0 p -130.93 166.33 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.127 1.917 . . . . 0.0 111.907 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -119.64 168.19 11.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.109 172.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -141.95 157.81 44.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.086 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -135.1 127.29 30.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 136.51 47.28 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 124.882 1.364 . . . . 0.0 111.583 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.15 113.88 21.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.871 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 23.2 m -78.15 164.91 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 124.925 1.391 . . . . 0.0 111.814 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 71.8 m -108.9 87.23 2.44 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 103.009 -2.959 . . . . 0.0 103.009 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.08 -174.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -122.5 7.49 9.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.57 145.68 31.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.293 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.94 -30.72 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.114 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.14 17.03 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.279 1.419 . . . . 0.0 114.902 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.93 3.37 10.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.389 1.095 . . . . 0.0 112.86 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.17 -32.84 74.33 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.228 -0.92 . . . . 0.0 113.261 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -45.29 -41.83 9.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.307 1.043 . . . . 0.0 113.694 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -97.29 -9.65 27.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -0.81 19.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.09 141.91 45.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.358 0.663 . . . . 0.0 111.545 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.484 HH12 ' CG ' ' B' ' 39' ' ' ASP . 35.2 mtp180 -138.4 148.37 44.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.624 1.57 . . . . 0.0 110.114 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.33 149.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 120.594 1.543 . . . . 0.0 109.727 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.69 27.36 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 124.04 0.828 . . . . 0.0 111.694 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 28.6 p90 -129.93 157.11 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.062 0.545 . . . . 0.0 110.096 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -148.68 145.0 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.81 129.1 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -116.88 149.79 39.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.752 0.786 . . . . 0.0 110.944 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 81.6 p -135.18 158.44 44.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.957 0.903 . . . . 0.0 110.014 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 129.53 41.67 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.218 -0.926 . . . . 0.0 110.762 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.705 175.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 23.8 p -147.88 147.43 29.74 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.815 0.697 . . . . 0.0 111.386 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.4 p -139.63 126.82 21.19 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -67.69 -29.1 68.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -67.58 102.14 1.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.31 0.11 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 73.2 140.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.637 2.375 . . . . 0.0 113.997 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -137.81 162.73 33.19 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.969 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.9 t -139.45 148.06 42.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.553 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -108.12 152.94 23.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.661 0.784 . . . . 0.0 111.553 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.0 -26.14 65.75 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.6 tp -72.41 -16.15 61.84 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.581 1.953 . . . . 0.0 110.956 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.4 -6.66 34.08 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 127.497 2.475 . . . . 0.0 114.451 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 73.2 p -70.67 148.45 48.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.87 1.835 . . . . 0.0 112.114 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.3 139.62 52.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 120.867 -1.146 . . . . 0.0 109.962 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -128.1 135.81 50.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.44 130.82 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.84 126.29 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.01 -87.64 0.09 OUTLIER Glycine 0 CA--C 1.526 0.74 0 O-C-N 125.41 1.694 . . . . 0.0 110.769 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.53 141.04 32.01 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.233 -0.569 . . . . 0.0 111.387 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.77 125.07 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.155 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -64.93 158.28 25.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.236 0.615 . . . . 0.0 112.252 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 17.6 t -53.74 -28.39 34.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -63.47 -37.15 86.2 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.805 -1.184 . . . . 0.0 111.005 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.31 -4.86 15.47 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.673 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 154.13 38.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.023 1.412 . . . . 0.0 111.287 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -151.71 154.39 36.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.934 0.873 . . . . 0.0 112.278 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -118.34 156.2 29.33 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.538 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -168.79 30.46 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 122.157 0.865 . . . . 0.0 113.52 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -133.45 130.08 38.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.778 -1.211 . . . . 0.0 112.018 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -125.09 120.96 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.627 1.203 . . . . 0.0 111.416 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -119.93 132.66 69.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.2 146.1 42.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.52 -13.89 22.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.34 144.44 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.737 1.215 . . . . 0.0 113.357 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.82 158.55 43.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.282 -1.511 . . . . 0.0 111.645 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . 0.487 ' CG ' HH12 ' C' ' 114' ' ' ARG . 8.3 m-20 -70.46 -26.01 63.44 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -140.84 83.09 14.66 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.552 1.941 . . . . 0.0 109.709 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.6 177.4 7.53 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.089 2.526 . . . . 0.0 110.605 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.27 -27.58 3.26 Favored Glycine 0 N--CA 1.476 1.348 0 O-C-N 121.345 -0.847 . . . . 0.0 113.412 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.99 23.12 2.07 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.893 1.677 . . . . 0.0 110.589 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.95 106.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 122.946 1.355 . . . . 0.0 111.631 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.1 t -113.63 169.56 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.005 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.36 126.89 20.54 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.507 2.323 . . . . 0.0 111.707 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.09 120.09 50.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.336 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.78 149.78 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.461 2.107 . . . . 0.0 111.432 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.66 153.05 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 109.917 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.65 149.31 26.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.859 2.064 . . . . 0.0 109.72 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.6 -155.64 26.96 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 119.207 0.912 . . . . 0.0 113.863 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -146.41 148.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.846 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 153.04 50.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.304 -1.497 . . . . 0.0 112.869 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -101.11 147.46 26.2 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 16.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.019 1.328 . . . . 0.0 113.493 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -92.95 -40.0 10.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.737 1.615 . . . . 0.0 112.06 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.57 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.825 0.85 . . . . 0.0 113.048 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 34.3 t -69.2 -48.47 61.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.429 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.61 64.82 69.61 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.241 1.017 . . . . 0.0 112.614 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -66.22 173.29 7.59 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.497 3.465 . . . . 0.0 116.931 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.305 0.5 OUTLIER -99.18 168.28 10.15 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.504 1.621 . . . . 0.0 111.13 173.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -162.24 162.0 28.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.937 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.63 143.83 9.08 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 118.075 1.99 . . . . 0.0 118.075 -172.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -160.42 152.42 20.18 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -90.01 154.36 19.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.367 1.867 . . . . 0.0 109.242 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -132.64 121.09 44.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.29 115.83 30.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 117.972 0.351 . . . . 0.0 110.12 -174.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.02 135.88 36.47 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -96.38 -44.25 7.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.929 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -74.91 -19.67 60.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.789 0.836 . . . . 0.0 112.563 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -152.35 133.1 14.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.83 2.852 . . . . 0.0 107.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -77.78 118.93 20.6 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.39 1.45 . . . . 0.0 111.974 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 78.7 p -176.51 164.64 2.57 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 126.868 2.067 . . . . 0.0 107.201 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.64 135.45 17.45 Favored 'General case' 0 CA--C 1.475 -1.942 0 CA-C-O 122.593 1.187 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.0 m -135.55 130.07 34.0 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 110.761 -2.927 . . . . 0.0 111.706 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.28 154.81 5.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.676 0.274 . . . . 0.0 110.328 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -128.87 144.0 51.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.81 116.88 4.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.45 -176.98 33.14 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.09 137.82 54.52 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.417 0.716 . . . . 0.0 110.575 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.88 112.85 24.61 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 117.232 -1.366 . . . . 0.0 108.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.17 168.94 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.123 1.369 . . . . 0.0 109.973 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -124.32 109.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.989 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.88 160.17 10.08 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -44.56 -31.92 1.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.02 -25.55 58.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.63 -3.74 19.66 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.909 1.242 . . . . 0.0 114.18 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 145.44 55.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.605 1.962 . . . . 0.0 111.684 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -101.14 140.75 35.0 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.668 1.987 . . . . 0.0 109.902 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 m -144.78 160.1 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.608 1.163 . . . . 0.0 110.954 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 mt -120.7 116.98 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -106.13 110.69 23.02 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -130.94 166.03 21.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 123.625 1.679 . . . . 0.0 112.029 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -119.17 168.72 10.59 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -142.21 158.18 44.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.136 172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.66 127.27 28.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.609 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.58 137.31 45.84 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 124.704 1.253 . . . . 0.0 111.449 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.98 113.87 20.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.798 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -77.89 165.85 23.61 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.891 1.369 . . . . 0.0 111.985 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 69.5 m -109.89 87.24 2.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.33 -172.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.284 -0.885 . . . . 0.0 108.658 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -124.88 7.86 8.08 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.94 145.98 30.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.031 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.29 -31.22 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.559 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.03 6.22 14.64 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.187 1.375 . . . . 0.0 115.471 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -120.61 3.27 10.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.615 1.207 . . . . 0.0 113.089 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.51 -32.63 74.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.296 -0.877 . . . . 0.0 112.948 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -45.64 -41.4 10.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -97.56 -9.83 26.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.159 0.984 . . . . 0.0 113.557 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -0.47 17.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.097 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.64 141.92 45.85 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.433 0.693 . . . . 0.0 111.547 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . 0.487 HH12 ' CG ' ' C' ' 39' ' ' ASP . 35.0 mtp180 -138.65 148.02 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.522 1.529 . . . . 0.0 109.79 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.78 149.32 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 120.655 1.57 . . . . 0.0 109.664 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.69 -176.26 28.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.753 0.692 . . . . 0.0 111.572 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 28.7 p90 -129.7 156.71 43.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.069 0.548 . . . . 0.0 110.336 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -148.12 145.17 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.963 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.55 129.37 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.98 149.85 40.25 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.411 -0.806 . . . . 0.0 110.265 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.9 p -132.11 158.93 40.37 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.377 -0.827 . . . . 0.0 110.215 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 125.85 25.3 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 122.115 -0.366 . . . . 0.0 110.089 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.578 -177.101 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 pttt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.22 147.18 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.419 1.104 . . . . 0.0 109.152 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.406 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 69.6 m -139.27 126.71 21.6 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.764 -1.21 . . . . 0.0 111.568 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.08 -25.3 62.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.68 122.15 9.29 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.163 1.458 . . . . 0.0 110.598 174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.63 -118.02 2.38 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.805 2.145 . . . . 0.0 109.154 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -141.53 156.1 45.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.533 1.133 . . . . 0.0 113.37 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.68 160.85 39.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.901 -1.954 . . . . 0.0 111.201 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -139.86 142.24 36.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.84 147.29 31.11 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.713 0.805 . . . . 0.0 112.227 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.0 tp -72.92 -15.59 61.57 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.16 1.384 . . . . 0.0 111.8 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.76 -16.63 21.01 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.547 2.499 . . . . 0.0 113.593 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -61.28 146.57 47.46 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.517 1.151 . . . . 0.0 113.076 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -121.4 139.25 53.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.646 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -131.66 145.63 51.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 111.585 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -129.87 132.73 46.53 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.223 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.58 126.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.39 -95.03 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 O-C-N 124.22 0.95 . . . . 0.0 112.274 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.58 126.89 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.436 -1.038 . . . . 0.0 110.529 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.44 139.3 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.01 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -75.14 166.44 23.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.108 0.963 . . . . 0.0 112.959 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.4 t -56.42 -34.51 66.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.982 1.313 . . . . 0.0 113.358 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -68.91 -35.59 77.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.593 -1.317 . . . . 0.0 111.54 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.68 -6.48 9.71 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.83 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.19 142.62 56.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.439 1.496 . . . . 0.0 111.98 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -155.53 147.47 23.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.731 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 163.73 13.28 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.87 -166.87 29.54 Favored Glycine 0 C--O 1.238 0.378 0 O-C-N 121.335 -0.853 . . . . 0.0 111.895 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -140.01 128.65 23.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.937 -1.132 . . . . 0.0 111.788 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -103.82 137.57 41.65 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.231 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mt -128.64 126.17 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 37' ' ' VAL . 15.3 m -104.99 140.75 37.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.733 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.28 -2.42 33.76 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.477 ' H ' HG21 ' A' ' 35' ' ' THR . 30.4 m -138.54 163.43 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.616 1.966 . . . . 0.0 111.446 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.37 16.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.834 -1.791 . . . . 0.0 112.857 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -69.46 -47.04 65.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -124.86 79.41 64.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.18 2.992 . . . . 0.0 110.202 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.24 25.42 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 124.825 3.683 . . . . 0.0 116.591 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.36 0.75 63.02 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.107 -1.621 . . . . 0.0 115.799 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.76 30.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -49.03 131.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.034 -1.666 . . . . 0.0 112.399 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.17 165.26 27.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.886 2.074 . . . . 0.0 108.707 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.24 131.04 19.91 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.78 1.632 . . . . 0.0 111.656 174.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 p -108.5 122.66 39.63 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.163 0.506 . . . . 0.0 112.206 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.56 145.36 89.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.151 2.567 . . . . 0.0 111.997 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -133.78 156.6 47.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.553 0.741 . . . . 0.0 112.45 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -158.86 149.06 19.51 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.448 2.299 . . . . 0.0 109.366 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.35 -153.76 23.5 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 120.461 1.482 . . . . 0.0 110.345 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -146.39 138.17 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.493 1.117 . . . . 0.0 112.026 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -122.19 141.27 51.64 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.899 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -57.06 -52.39 65.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.635 0.374 . . . . 0.0 111.152 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HE3' ' OG ' ' A' ' 5' ' ' SER . 16.7 tptm 52.58 -0.76 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.339 2.256 . . . . 0.0 116.363 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -75.08 -56.29 4.89 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.747 2.019 . . . . 0.0 113.408 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.26 173.35 12.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.81 0.814 . . . . 0.0 110.933 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -73.42 -28.93 62.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.471 1.108 . . . . 0.0 113.749 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -141.81 46.47 0.82 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.296 1.439 . . . . 0.0 112.15 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.39 -177.45 3.46 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.127 2.551 . . . . 0.0 114.245 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.3 p -84.91 167.77 15.64 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.143 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.86 159.38 15.89 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.484 1.114 . . . . 0.0 111.277 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.91 148.18 14.71 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.62 162.82 35.3 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -100.59 146.88 26.58 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 127.127 2.171 . . . . 0.0 109.413 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.34 117.0 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -98.65 106.56 18.84 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.893 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.329 52.4 m95 -67.93 158.87 31.75 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 121.56 1.982 . . . . 0.0 115.197 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -39.26 4.02 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -90.44 -11.99 38.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -152.42 143.6 23.19 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.076 2.55 . . . . 0.0 106.393 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.61 118.53 15.65 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.042 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -171.45 164.85 7.0 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.504 1.522 . . . . 0.0 111.644 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -146.99 138.76 24.33 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 123.867 1.794 . . . . 0.0 110.468 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.35 127.26 27.57 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 109.579 -3.464 . . . . 0.0 109.715 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.23 155.87 6.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.011 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.97 139.94 52.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 113.9 5.26 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.38 176.42 29.84 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.04 -1.076 . . . . 0.0 115.509 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 9.7 tt0 -118.05 146.69 43.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.178 -1.511 . . . . 0.0 108.934 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.8 t -97.09 129.61 44.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.368 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -125.72 167.87 14.55 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.867 1.318 . . . . 0.0 112.333 177.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.5 119.02 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 112.668 -2.06 . . . . 0.0 106.7 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -58.44 154.14 14.44 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.47 -23.58 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -7.34 58.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.554 1.142 . . . . 0.0 113.998 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.56 36.93 8.33 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.995 0.809 . . . . 0.0 113.981 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.73 151.91 35.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.868 1.267 . . . . 0.0 110.85 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -101.33 146.33 27.71 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 111.059 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.416 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.9 m -148.17 160.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.329 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.5 mt -121.43 115.64 23.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -105.71 110.65 23.03 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -126.02 166.61 16.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.886 1.327 . . . . 0.0 110.528 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.97 170.9 8.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -144.64 159.24 43.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.215 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -137.72 123.24 19.66 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.451 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 137.79 44.96 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 125.569 1.793 . . . . 0.0 113.185 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -120.16 119.36 33.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.934 2.021 . . . . 0.0 111.762 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -86.25 160.11 19.26 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.309 1.006 . . . . 0.0 110.815 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m -103.43 82.17 2.01 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.16 -12.84 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.41 -29.47 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.3 137.12 51.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.025 1.284 . . . . 0.0 112.383 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.409 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.8 tt -62.5 -25.6 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.31 -3.76 33.42 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.628 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.402 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -124.69 3.16 8.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.396 1.078 . . . . 0.0 113.879 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -34.85 60.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.364 -0.835 . . . . 0.0 112.377 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.614 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 55.6 p-90 -49.95 -44.94 50.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.767 1.227 . . . . 0.0 113.542 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.614 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -89.58 -10.78 44.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.387 -0.82 . . . . 0.0 112.429 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.35 -0.05 24.17 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -118.61 146.25 44.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.19 0.596 . . . . 0.0 111.765 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.56 151.66 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.789 1.636 . . . . 0.0 110.498 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.32 148.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.224 1.375 . . . . 0.0 111.556 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.02 -176.8 27.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 122.55 1.083 . . . . 0.0 112.638 175.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -122.15 152.68 39.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.86 0.864 . . . . 0.0 108.812 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -149.63 132.82 16.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.104 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -124.95 121.32 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.585 -0.697 . . . . 0.0 110.725 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -110.38 151.55 27.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.776 -1.557 . . . . 0.0 110.396 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -133.54 160.25 38.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.281 1.032 . . . . 0.0 109.491 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -57.97 110.47 0.93 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.188 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 N--CA 1.466 0.344 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 p -116.32 144.43 44.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.054 0.942 . . . . 0.0 108.763 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 59.5 m -139.56 126.91 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.405 -1.434 . . . . 0.0 113.178 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.08 -26.99 64.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.5 121.38 7.59 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.009 1.385 . . . . 0.0 110.47 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.38 -117.9 2.25 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.844 2.164 . . . . 0.0 109.512 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -143.87 152.37 41.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.219 1.008 . . . . 0.0 113.337 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -142.16 158.05 44.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.255 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -136.46 144.95 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.661 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.12 146.58 35.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.553 0.741 . . . . 0.0 112.299 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.13 -23.3 67.38 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.63 -14.69 61.66 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.027 1.331 . . . . 0.0 112.047 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -14.55 31.61 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.564 2.507 . . . . 0.0 113.563 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.34 149.59 41.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.759 1.266 . . . . 0.0 113.059 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -125.12 142.18 51.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.028 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -133.02 143.87 49.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.407 0.622 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -128.38 131.93 48.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.224 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.72 127.14 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -95.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.451 1.094 . . . . 0.0 112.358 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -137.87 127.09 24.49 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.46 -1.024 . . . . 0.0 110.797 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.86 139.96 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.233 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.68 164.1 25.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.974 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.9 t -54.58 -34.22 61.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.178 1.391 . . . . 0.0 114.166 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -66.94 -35.66 80.47 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.288 -1.507 . . . . 0.0 111.545 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.1 -6.21 9.44 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 124.408 1.004 . . . . 0.0 114.313 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.12 147.56 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.17 162.86 40.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.577 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.72 168.15 14.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.14 -164.9 29.9 Favored Glycine 0 C--O 1.238 0.396 0 O-C-N 120.184 -1.573 . . . . 0.0 112.082 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -140.54 128.0 21.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.133 0.968 . . . . 0.0 112.058 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -104.71 138.45 40.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.86 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.49 126.56 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' THR . . . . . 0.475 HG21 ' H ' ' D' ' 37' ' ' VAL . 16.4 m -105.06 141.15 37.14 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.703 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.08 -2.75 33.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.475 ' H ' HG21 ' D' ' 35' ' ' THR . 26.8 m -138.2 163.85 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.41 1.884 . . . . 0.0 111.142 -174.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.32 167.78 15.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.917 -1.74 . . . . 0.0 112.655 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -69.88 -46.56 65.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.284 1.034 . . . . 0.0 108.261 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -125.37 79.16 67.02 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.985 2.914 . . . . 0.0 110.121 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.85 24.47 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.937 3.758 . . . . 0.0 116.59 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.67 60.35 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.182 -1.574 . . . . 0.0 115.915 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.34 29.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mt -48.99 131.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.019 -1.676 . . . . 0.0 112.417 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 164.89 28.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.877 2.071 . . . . 0.0 108.821 174.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.01 130.66 18.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.656 1.582 . . . . 0.0 111.456 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -107.98 122.73 39.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 121.388 0.613 . . . . 0.0 112.408 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.22 144.76 89.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.919 2.412 . . . . 0.0 111.582 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -131.41 164.11 26.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.62 0.768 . . . . 0.0 112.305 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 149.03 8.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.226 1.811 . . . . 0.0 109.483 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.48 -156.28 27.71 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 120.858 1.663 . . . . 0.0 112.952 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -146.13 137.11 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.246 1.018 . . . . 0.0 111.486 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -122.13 140.9 52.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.478 1.511 . . . . 0.0 108.578 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' D' ' 58' ' ' ARG . 14.0 m170 -57.14 -50.96 71.19 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.068 -0.395 . . . . 0.0 111.353 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 tptm 51.61 2.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.507 2.323 . . . . 0.0 116.156 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' D' ' 54' ' ' HIS . 27.2 mtt180 -78.81 -56.32 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.129 2.171 . . . . 0.0 113.568 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.65 173.62 12.4 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.467 1.104 . . . . 0.0 111.371 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -74.03 -27.06 60.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.682 -1.151 . . . . 0.0 113.969 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -143.01 48.53 1.01 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 125.2 1.4 . . . . 0.0 112.754 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.8 -177.65 3.49 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.221 2.614 . . . . 0.0 114.939 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -85.51 168.3 14.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.492 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.37 159.84 15.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 111.148 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.13 148.5 15.19 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -159.85 162.66 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -100.6 149.6 23.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.238 2.215 . . . . 0.0 109.01 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -129.1 117.81 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -100.17 107.45 19.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.746 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.336 50.9 m95 -68.68 158.24 34.55 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.102 1.774 . . . . 0.0 115.334 -172.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.35 4.26 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.09 -12.03 36.85 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -152.31 143.9 23.48 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.104 2.562 . . . . 0.0 106.305 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.84 118.53 15.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.101 0.864 . . . . 0.0 110.413 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 90.3 p -171.73 165.19 6.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.352 1.461 . . . . 0.0 111.903 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -146.9 139.2 24.75 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.459 1.6 . . . . 0.0 110.447 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.31 25.94 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 109.631 -3.44 . . . . 0.0 109.856 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.03 155.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.232 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.38 140.24 51.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.76 114.45 5.31 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 178.69 29.28 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.946 -1.121 . . . . 0.0 115.8 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . 0.444 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 12.2 tt0 -120.08 144.91 47.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.456 -1.372 . . . . 0.0 109.17 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 41.4 t -97.31 128.74 44.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.542 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 0.4 OUTLIER -121.61 168.87 11.27 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.792 1.282 . . . . 0.0 111.299 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.28 118.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 112.823 -1.99 . . . . 0.0 106.994 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -58.67 154.87 13.65 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.38 -25.28 0.98 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -6.28 59.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.296 1.039 . . . . 0.0 113.746 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 27.25 20.88 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.544 1.545 . . . . 0.0 114.185 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' D' ' 90' ' ' LYS . 7.1 mtpm? -106.35 153.12 22.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 111.884 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -101.42 145.92 28.3 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 123.328 1.537 . . . . 0.0 110.871 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 106' ' ' ILE . 17.6 m -148.57 159.56 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.643 175.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.2 115.28 23.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -105.9 109.84 21.92 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -125.25 167.33 15.02 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.941 1.353 . . . . 0.0 111.163 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.99 171.14 8.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 159.23 43.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.297 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tp -137.93 123.23 19.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.265 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.7 138.51 43.8 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 125.521 1.763 . . . . 0.0 113.005 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -120.97 117.77 28.14 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 125.898 1.999 . . . . 0.0 111.858 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -83.93 159.99 21.17 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 124.688 1.243 . . . . 0.0 110.977 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -104.22 82.97 2.01 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.0 -12.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 63.93 -28.22 0.09 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.71 136.5 53.32 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.93 1.241 . . . . 0.0 112.301 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . 0.416 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.3 tt -62.09 -25.15 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.04 -4.09 33.34 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.546 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -124.94 3.07 8.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.494 1.117 . . . . 0.0 113.769 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -34.83 57.75 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.333 -0.854 . . . . 0.0 113.053 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . 0.629 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 56.3 p-90 -49.72 -45.69 49.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.7 1.2 . . . . 0.0 113.287 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . 0.629 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.3 OUTLIER -89.06 -11.3 44.49 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.451 -0.781 . . . . 0.0 112.451 177.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.3 23.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 7.6 m -118.24 145.99 44.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.288 0.635 . . . . 0.0 111.884 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.77 151.86 40.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.85 1.66 . . . . 0.0 110.773 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.04 148.68 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 120.13 1.332 . . . . 0.0 111.675 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.21 -177.19 28.23 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 122.465 1.036 . . . . 0.0 112.912 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -120.96 152.88 38.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.778 0.831 . . . . 0.0 109.053 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -149.5 133.41 17.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.225 -174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 48.8 mt -126.09 122.63 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.259 1.028 . . . . 0.0 110.714 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -112.55 148.77 33.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.465 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 16.4 p -133.43 160.3 37.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.424 1.09 . . . . 0.0 109.844 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -55.88 115.62 2.49 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.132 0.573 . . . . 0.0 109.778 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . 0.425 ' C ' ' CD2' ' D' ' 123' ' ' LEU . 3.6 tt . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 120.142 0.02 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 p -116.46 144.43 44.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.207 1.003 . . . . 0.0 109.736 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 m -139.5 126.81 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.433 -1.417 . . . . 0.0 113.012 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.06 -27.77 62.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -53.17 116.62 2.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.764 1.226 . . . . 0.0 110.385 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.6 -121.14 2.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.974 1.749 . . . . 0.0 109.793 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -143.08 153.4 42.88 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.919 1.288 . . . . 0.0 113.224 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -143.31 160.23 40.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.707 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -138.28 145.14 40.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.677 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -112.11 146.17 38.48 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.478 0.711 . . . . 0.0 112.34 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.13 -24.38 67.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.06 -14.4 62.31 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 112.029 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.96 -13.78 31.7 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.805 2.621 . . . . 0.0 113.738 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -63.64 149.47 46.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.842 1.306 . . . . 0.0 112.865 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -125.38 140.68 52.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.011 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -131.89 145.58 51.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.745 0.784 . . . . 0.0 112.408 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -129.22 133.63 47.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.015 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.03 127.56 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -93.75 0.07 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.922 0.764 . . . . 0.0 112.124 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.46 127.01 21.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.266 -1.138 . . . . 0.0 110.351 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.23 139.12 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.88 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -75.36 167.07 22.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.781 0.832 . . . . 0.0 112.914 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -56.81 -34.37 67.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.01 1.324 . . . . 0.0 113.352 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -68.78 -36.19 77.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.281 -1.512 . . . . 0.0 111.476 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.77 -6.68 9.61 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.786 -1.563 . . . . 0.0 114.858 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -65.99 142.61 57.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.448 1.499 . . . . 0.0 112.45 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.75 147.94 23.56 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.553 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.32 163.09 14.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 174.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.26 -166.86 29.0 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 121.296 -0.877 . . . . 0.0 111.867 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -140.62 128.73 22.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.967 -1.117 . . . . 0.0 111.88 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -103.82 137.92 41.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.101 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.25 126.17 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.482 HG21 ' H ' ' B' ' 37' ' ' VAL . 15.4 m -105.11 141.37 36.78 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.853 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.67 -2.27 33.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.482 ' H ' HG21 ' B' ' 35' ' ' THR . 26.9 m -138.5 163.29 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.534 1.933 . . . . 0.0 111.223 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.21 167.7 15.91 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.006 -1.684 . . . . 0.0 112.879 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -70.71 -44.86 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 108.493 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -126.61 79.04 72.02 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 129.035 2.934 . . . . 0.0 109.843 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.08 24.82 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.786 3.658 . . . . 0.0 116.602 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.84 0.63 61.32 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.157 -1.589 . . . . 0.0 115.877 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.45 29.96 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 30.5 mt -49.13 130.94 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 119.899 -1.75 . . . . 0.0 112.445 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.72 165.21 28.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.76 2.024 . . . . 0.0 108.59 174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.48 131.44 20.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.843 1.657 . . . . 0.0 111.806 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 7.3 p -109.54 122.61 38.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.183 0.516 . . . . 0.0 111.53 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.3 145.3 88.07 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.211 2.607 . . . . 0.0 111.92 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.83 156.21 48.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.587 0.755 . . . . 0.0 112.441 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -158.38 149.11 20.41 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.506 2.322 . . . . 0.0 109.483 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.11 -153.79 23.65 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 120.612 1.551 . . . . 0.0 110.254 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -146.13 138.48 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.51 1.124 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.73 140.59 52.71 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.082 -1.011 . . . . 0.0 108.681 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -56.47 -52.2 65.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.844 0.458 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tptm 52.87 0.28 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.488 2.315 . . . . 0.0 116.284 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -77.29 -56.3 4.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.137 2.175 . . . . 0.0 113.745 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.73 173.46 12.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 124.288 0.992 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -74.21 -26.26 60.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 117.206 -1.378 . . . . 0.0 113.903 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -143.67 48.74 0.98 Allowed Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 125.465 1.506 . . . . 0.0 112.709 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 -178.62 3.96 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.11 2.54 . . . . 0.0 114.848 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 70.4 p -84.54 167.77 16.02 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.24 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.84 159.83 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.452 1.101 . . . . 0.0 111.285 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.37 148.11 14.35 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -159.66 163.11 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -101.1 147.48 26.18 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.67 1.988 . . . . 0.0 109.303 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.58 117.05 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -98.45 107.03 19.39 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.662 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.331 52.5 m95 -68.31 158.77 32.72 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.594 1.997 . . . . 0.0 114.982 -173.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -38.89 4.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -174.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -90.96 -12.01 37.27 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -152.31 143.24 23.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.038 2.535 . . . . 0.0 106.433 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -72.9 118.39 15.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.081 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -170.92 164.94 7.75 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.742 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.61 138.92 24.94 Favored 'General case' 0 CA--C 1.48 -1.73 0 CA-C-O 123.473 1.606 . . . . 0.0 110.493 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.74 127.36 27.02 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 110.042 -3.254 . . . . 0.0 109.54 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -105.18 155.75 6.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.145 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.21 140.43 51.91 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.01 114.23 5.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.406 0.622 . . . . 0.0 109.327 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.34 178.26 29.64 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 120.072 -1.061 . . . . 0.0 115.587 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 10.8 tt0 -119.83 144.91 47.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.301 -1.449 . . . . 0.0 109.157 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.21 128.73 44.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.724 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 0.4 OUTLIER -121.81 168.82 11.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.913 1.34 . . . . 0.0 110.977 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.3 118.94 57.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.636 -2.075 . . . . 0.0 106.627 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.31 153.56 15.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.48 -26.15 0.53 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.14 -9.44 59.19 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 31.37 10.58 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.521 1.057 . . . . 0.0 114.531 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.26 152.71 24.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.999 1.319 . . . . 0.0 110.85 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -101.43 146.05 28.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.495 1.518 . . . . 0.0 110.99 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.415 HG21 ' CD1' ' C' ' 106' ' ' ILE . 17.8 m -147.62 159.72 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.956 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 67.1 mt -119.44 115.27 23.73 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -105.88 110.65 23.01 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -126.56 167.11 16.1 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.007 1.384 . . . . 0.0 110.81 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 170.85 8.92 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -144.72 158.97 43.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.494 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -137.51 123.21 19.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.416 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.53 137.76 44.99 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 125.66 1.85 . . . . 0.0 113.299 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -120.93 117.1 26.46 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 125.937 2.023 . . . . 0.0 111.94 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 160.43 21.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.541 1.151 . . . . 0.0 111.137 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 3.6 m -104.33 83.35 2.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.46 -12.69 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 t30 64.07 -29.85 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.47 136.16 52.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.152 0.977 . . . . 0.0 112.515 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 2.5 tt -62.42 -26.58 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.12 -3.61 24.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.453 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 5.0 m-20 -124.64 3.34 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.53 1.132 . . . . 0.0 113.874 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -35.76 58.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.226 -0.922 . . . . 0.0 112.306 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.624 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 54.9 p-90 -49.6 -45.24 47.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.378 1.071 . . . . 0.0 113.686 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.624 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -89.39 -11.04 44.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.621 0.768 . . . . 0.0 112.686 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.47 -0.32 25.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.427 -0.797 . . . . 0.0 113.078 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -118.02 146.19 44.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.769 0.713 . . . . 0.0 111.738 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.24 151.75 39.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.785 1.634 . . . . 0.0 110.415 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.19 148.37 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.01 -176.86 27.7 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 122.536 1.076 . . . . 0.0 112.79 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -121.52 153.43 37.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.565 -0.817 . . . . 0.0 108.985 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.1 133.72 16.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.015 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 51.8 mt -126.18 122.64 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.755 0.788 . . . . 0.0 110.637 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.7 148.71 32.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.164 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 19.0 p -135.7 162.94 31.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.261 1.024 . . . . 0.0 110.189 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -59.93 115.83 3.69 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.526 -0.734 . . . . 0.0 111.062 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.413 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 p -116.41 141.84 47.64 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 122.112 0.958 . . . . 0.0 108.977 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' SER . . . . . 0.401 ' OG ' ' HE3' ' C' ' 57' ' ' LYS . 65.0 m -139.39 126.54 21.21 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.368 -1.457 . . . . 0.0 113.026 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.55 -29.63 64.96 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -52.0 118.38 3.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.591 1.186 . . . . 0.0 110.243 174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.53 -122.53 2.94 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.315 1.912 . . . . 0.0 109.336 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -143.03 152.96 42.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.48 1.112 . . . . 0.0 113.113 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -143.59 155.85 44.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.091 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -133.43 145.14 49.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.395 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -109.42 147.43 32.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -65.06 -19.09 65.82 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 -14.91 60.51 Favored 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.963 -1.086 . . . . 0.0 111.273 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.59 -14.07 32.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.222 2.344 . . . . 0.0 113.659 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 149.73 44.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.411 -1.052 . . . . 0.0 112.377 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -125.35 142.82 51.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.956 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -132.41 146.1 51.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 112.507 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -129.64 133.34 47.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.547 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.65 127.23 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.85 -93.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.135 0.897 . . . . 0.0 112.282 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.31 128.29 23.66 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.364 -1.08 . . . . 0.0 110.469 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.21 139.24 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.315 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -77.55 164.03 25.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.98 0.912 . . . . 0.0 112.584 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -54.35 -33.82 59.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.232 1.413 . . . . 0.0 114.217 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.26 -35.45 79.56 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.384 -1.447 . . . . 0.0 111.543 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.41 -6.26 9.24 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 124.369 0.985 . . . . 0.0 114.506 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.9 147.25 47.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -154.8 161.94 41.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.96 0.886 . . . . 0.0 110.728 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 167.72 14.1 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.31 30.28 Favored Glycine 0 C--O 1.238 0.344 0 O-C-N 120.391 -1.443 . . . . 0.0 112.096 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 33.9 p -140.33 129.0 22.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.155 0.978 . . . . 0.0 111.715 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -105.43 138.23 41.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.179 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.22 126.64 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' THR . . . . . 0.477 HG21 ' H ' ' C' ' 37' ' ' VAL . 16.6 m -105.11 141.15 37.18 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.909 -173.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.39 -1.88 34.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.477 ' H ' HG21 ' C' ' 35' ' ' THR . 26.9 m -139.24 163.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.533 1.933 . . . . 0.0 111.31 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.24 167.46 16.07 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 119.894 -1.754 . . . . 0.0 112.871 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -70.16 -45.42 66.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.286 1.034 . . . . 0.0 108.463 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -126.33 78.85 71.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 129.002 2.921 . . . . 0.0 110.114 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.85 24.2 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.909 3.739 . . . . 0.0 116.591 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 0.65 59.7 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.224 -1.548 . . . . 0.0 115.885 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.38 30.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.09 131.4 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.965 -1.709 . . . . 0.0 112.462 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.3 165.44 27.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.775 2.03 . . . . 0.0 108.664 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tt -49.51 131.22 20.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.558 1.543 . . . . 0.0 111.65 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.1 p -109.02 123.04 38.06 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.33 144.61 90.77 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.01 2.473 . . . . 0.0 111.542 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -131.15 164.32 25.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.788 0.835 . . . . 0.0 112.708 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.64 148.93 7.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.064 1.746 . . . . 0.0 109.656 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.34 -156.17 27.55 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 120.898 1.681 . . . . 0.0 112.629 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -146.16 137.05 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 123.37 1.557 . . . . 0.0 112.006 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.02 141.65 51.13 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.086 -1.634 . . . . 0.0 108.38 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.15 -50.79 71.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.881 0.31 . . . . 0.0 111.345 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . 0.401 ' HE3' ' OG ' ' C' ' 5' ' ' SER . 16.4 tptm 51.85 2.79 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.351 2.26 . . . . 0.0 115.979 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -79.74 -56.73 4.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.598 1.959 . . . . 0.0 113.546 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.63 174.7 11.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.853 0.721 . . . . 0.0 111.339 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -75.73 -26.68 57.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.583 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.63 48.9 1.13 Allowed Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 125.216 1.407 . . . . 0.0 112.705 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -83.12 -178.3 3.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.805 2.337 . . . . 0.0 115.007 -174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 82.4 p -84.63 168.1 15.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.619 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -166.08 160.29 16.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.457 1.103 . . . . 0.0 111.372 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.3 148.12 14.4 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 119.119 2.408 . . . . 0.0 119.119 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -159.76 162.17 34.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -100.25 150.1 22.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.007 2.123 . . . . 0.0 108.966 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 49.5 t -129.28 117.9 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.96 107.18 19.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.761 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.337 51.3 m95 -67.79 158.11 33.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.247 1.84 . . . . 0.0 115.387 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.16 4.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.2 -12.08 36.38 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 8.3 t -152.32 143.86 23.45 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 128.155 2.582 . . . . 0.0 106.329 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.94 118.55 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.457 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p -171.83 165.13 6.51 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.573 1.549 . . . . 0.0 111.767 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.56 138.97 25.05 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 123.635 1.683 . . . . 0.0 110.606 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.52 26.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-N 109.785 -3.37 . . . . 0.0 109.712 -172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.05 155.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.145 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -128.31 140.06 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.08 115.02 5.34 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.13 177.87 30.52 Favored Glycine 0 CA--C 1.501 -0.792 0 C-N-CA 119.894 -1.146 . . . . 0.0 115.508 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 10.6 tt0 -119.22 145.27 46.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.545 -1.327 . . . . 0.0 108.917 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.27 129.23 44.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.404 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 0.3 OUTLIER -124.8 171.94 9.73 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.009 1.385 . . . . 0.0 111.649 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.81 115.76 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 112.363 -2.199 . . . . 0.0 106.604 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.82 152.42 19.22 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -45.27 -22.89 0.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.57 -10.5 55.82 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.46 43.06 6.3 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.731 1.158 . . . . 0.0 113.495 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -116.05 147.25 41.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.256 1.423 . . . . 0.0 108.382 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -101.26 141.19 34.51 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.969 1.707 . . . . 0.0 109.966 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.93 161.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.29 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.13 116.34 25.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -106.53 110.53 22.77 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 172.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 9.1 p -126.4 165.37 19.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.661 1.22 . . . . 0.0 110.935 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.16 170.66 8.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 172.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -144.37 159.44 42.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.487 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tp -137.79 123.14 19.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.436 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.63 138.41 43.91 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 125.295 1.622 . . . . 0.0 113.065 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -121.43 117.43 26.87 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 125.895 1.997 . . . . 0.0 111.823 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 15.7 m -83.53 159.76 21.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.729 1.268 . . . . 0.0 111.285 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -103.9 83.0 2.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.24 -12.56 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.48 -29.06 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.1 136.54 52.82 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.8 1.286 . . . . 0.0 112.436 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . 0.415 ' CD1' HG21 ' B' ' 92' ' ' VAL . 2.3 tt -62.3 -25.21 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.574 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.61 -3.96 36.57 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.591 -1.116 . . . . 0.0 114.61 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 4.7 m-20 -124.29 2.72 8.49 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.455 1.102 . . . . 0.0 113.92 -177.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -35.67 57.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.381 -0.824 . . . . 0.0 112.361 176.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 57.2 p-90 -49.67 -45.77 49.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.595 1.158 . . . . 0.0 113.311 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . 0.61 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.3 OUTLIER -88.88 -11.03 45.76 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.436 -0.79 . . . . 0.0 112.544 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -0.24 25.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -117.87 146.03 44.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.316 0.647 . . . . 0.0 111.65 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.61 152.06 40.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.745 1.618 . . . . 0.0 110.654 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.21 148.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 120.186 1.357 . . . . 0.0 111.802 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.96 -176.98 27.8 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-O 122.442 1.023 . . . . 0.0 112.809 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -121.55 153.49 37.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.719 0.808 . . . . 0.0 108.834 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.28 132.44 15.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.229 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 mt -124.8 118.04 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.903 0.858 . . . . 0.0 111.068 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.59 150.71 25.15 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.564 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 3.9 p -136.53 159.83 40.61 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.514 1.126 . . . . 0.0 109.859 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -55.36 124.34 16.8 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.742 -0.599 . . . . 0.0 109.813 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.916 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.04 133.5 53.64 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -139.54 128.53 23.62 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.811 -1.805 . . . . 0.0 110.695 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.8 mt -68.06 -23.22 64.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -51.58 113.63 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 112.004 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.95 -121.41 2.47 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.788 1.185 . . . . 0.0 110.954 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -151.88 146.28 25.54 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -143.34 163.24 33.58 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.223 1.409 . . . . 0.0 112.065 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -142.76 154.89 44.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.682 -1.151 . . . . 0.0 109.149 174.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 146.35 49.65 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.095 0.861 . . . . 0.0 112.515 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.24 -25.1 13.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.653 2.381 . . . . 0.0 115.012 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.07 -18.78 62.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.371 1.069 . . . . 0.0 112.848 174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.84 -15.76 21.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.828 2.633 . . . . 0.0 113.261 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.4 p -65.99 145.54 55.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 123.297 1.522 . . . . 0.0 113.086 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.98 144.93 46.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.737 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -141.8 147.34 37.11 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 173.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -137.44 135.23 36.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.428 0.691 . . . . 0.0 109.759 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.324 0.65 . . . . 0.0 109.903 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -92.68 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.57 32.25 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.701 -0.882 . . . . 0.0 112.235 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.67 129.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.244 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -70.31 165.84 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.228 0.33 . . . . 0.0 111.62 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -59.78 -24.11 63.82 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.429 -1.42 . . . . 0.0 114.822 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.37 -27.09 46.8 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.895 0.77 . . . . 0.0 112.027 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.27 -6.16 30.31 Favored Glycine 0 N--CA 1.468 0.805 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.539 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 10.0 pt-20 -63.78 138.62 58.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 162.58 38.94 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.395 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 p -129.34 176.9 7.58 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.35 -166.0 37.75 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.566 -1.334 . . . . 0.0 114.095 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -136.76 130.92 32.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.605 1.193 . . . . 0.0 111.781 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -114.52 141.28 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.658 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.4 mt -131.54 133.14 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -107.69 140.56 40.54 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.731 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.33 -11.15 19.65 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.21 141.66 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 111.183 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.26 33.05 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.977 -0.452 . . . . 0.0 110.135 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -77.35 -34.75 55.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.75 83.84 40.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.764 1.626 . . . . 0.0 110.138 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.78 36.05 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.998 3.799 . . . . 0.0 115.075 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.29 -7.21 63.05 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 179.58 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.624 1.97 . . . . 0.0 110.858 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.52 125.56 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 119.988 -1.695 . . . . 0.0 111.05 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.27 165.24 28.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 111.585 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 tp -46.98 115.94 1.22 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 130.781 3.632 . . . . 0.0 113.028 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.6 p -105.9 122.99 40.61 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.456 0.702 . . . . 0.0 111.234 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.62 136.58 74.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.836 2.357 . . . . 0.0 111.318 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.69 155.03 37.27 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.07 0.856 . . . . 0.0 111.694 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -162.37 149.01 13.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.92 1.688 . . . . 0.0 109.349 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.97 -150.01 20.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.296 1.407 . . . . 0.0 109.658 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -144.0 141.48 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.49 0.716 . . . . 0.0 111.271 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 137.53 51.91 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.333 -0.854 . . . . 0.0 110.599 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -68.52 155.07 40.65 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.397 -0.814 . . . . 0.0 111.843 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -146.2 13.98 1.28 Allowed 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.273 -1.517 . . . . 0.0 114.489 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -87.89 -49.11 7.3 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.825 0.739 . . . . 0.0 112.465 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.07 175.06 9.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -78.93 -38.56 36.91 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.798 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -136.31 52.0 5.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.591 1.156 . . . . 0.0 112.567 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.87 173.83 13.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.738 1.625 . . . . 0.0 113.834 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.331 0.6 OUTLIER -95.41 167.38 11.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.571 173.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.56 166.54 31.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.722 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.49 146.61 12.43 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -159.13 152.67 22.79 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.41 151.75 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.286 1.835 . . . . 0.0 109.287 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.16 118.44 40.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.13 116.55 26.4 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.748 -0.595 . . . . 0.0 110.126 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.81 142.35 44.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.385 1.088 . . . . 0.0 110.573 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.69 -39.78 5.27 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.246 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.83 -13.12 54.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.268 1.427 . . . . 0.0 114.439 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.3 t -152.35 132.36 13.42 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.423 2.689 . . . . 0.0 106.06 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.02 117.67 16.09 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.081 1.309 . . . . 0.0 110.416 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -173.65 164.03 4.36 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 126.549 1.94 . . . . 0.0 110.057 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.86 142.6 38.6 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.19 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.38 152.07 51.6 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.79 150.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.748 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.42 143.95 51.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 127.38 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.61 178.47 45.51 Favored Glycine 0 C--O 1.217 -0.915 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -101.21 147.9 25.73 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.856 0.974 . . . . 0.0 112.835 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 21.7 p -97.74 120.53 38.29 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.754 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 82' ' ' GLN 0.299 2.7 m-85 -112.91 162.25 16.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -132.41 109.66 15.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -59.38 162.13 5.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.335 0.654 . . . . 0.0 109.448 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -21.67 2.27 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -8.18 54.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.562 0.745 . . . . 0.0 113.003 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.17 51.96 4.78 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -121.33 146.82 46.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.816 2.446 . . . . 0.0 104.938 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -112.41 150.19 31.47 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.857 1.263 . . . . 0.0 112.182 -172.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.418 ' CG1' ' HD3' ' A' ' 94' ' ' LYS . 1.7 t -148.14 161.33 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.786 1.279 . . . . 0.0 110.681 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.4 mt -125.51 110.49 13.94 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 101.241 -3.614 . . . . 0.0 101.241 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HE3' HD13 ' A' ' 119' ' ' ILE . 7.5 mmmt -102.71 122.35 44.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -138.84 163.76 31.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.477 1.608 . . . . 0.0 114.264 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -112.89 165.24 12.5 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -140.89 159.48 42.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.071 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.21 124.1 14.3 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.833 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.0 tp -107.69 141.7 38.81 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 125.692 1.87 . . . . 0.0 110.689 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -124.41 114.03 18.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 110.298 -3.137 . . . . 0.0 109.455 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.251 18.5 m -70.88 164.51 25.19 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.74 1.9 . . . . 0.0 113.094 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -101.44 84.36 2.59 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.38 164.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 127.463 2.305 . . . . 0.0 109.296 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -114.59 -23.19 9.4 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.51 138.29 51.19 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.719 0.771 . . . . 0.0 111.113 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.77 -17.23 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.68 7.75 74.23 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.361 -1.8 . . . . 0.0 115.759 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.87 4.99 15.01 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.853 1.827 . . . . 0.0 112.704 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -62.27 -30.67 71.29 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.054 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.409 ' CD1' HD13 ' C' ' 14' ' ' LEU . 54.7 p-90 -48.97 -40.12 29.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 113.21 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -96.92 -6.25 36.12 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 114.022 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.94 7.0 7.92 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.2 m -122.1 140.46 52.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.757 0.789 . . . . 0.0 113.043 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 119.56 6.48 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.558 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.93 150.19 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.44 1.896 . . . . 0.0 111.51 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.41 -171.48 22.71 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.707 0.67 . . . . 0.0 112.768 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 20.1 p90 -131.38 157.31 43.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.071 -0.664 . . . . 0.0 111.448 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -147.69 160.13 43.03 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.363 1.065 . . . . 0.0 109.15 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.491 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.1 mt -138.71 119.03 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.74 148.44 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.529 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -134.98 165.31 25.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.66 124.4 20.9 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.893 0.877 . . . . 0.0 111.526 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 tt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.05 136.26 41.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -139.31 133.49 31.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.662 -1.274 . . . . 0.0 110.696 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.13 -23.2 63.94 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -51.02 114.38 1.16 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.1 1.429 . . . . 0.0 111.592 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.76 -120.54 2.42 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.67 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -152.81 149.74 28.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -147.0 163.21 36.96 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.56 1.544 . . . . 0.0 112.057 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -141.47 154.48 45.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.062 0.945 . . . . 0.0 108.935 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -123.08 145.83 48.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.855 0.862 . . . . 0.0 112.296 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.43 -24.57 13.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.527 2.331 . . . . 0.0 114.816 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' B' ' 110' ' ' TRP . 33.4 tp -70.81 -19.18 62.7 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.976 -1.078 . . . . 0.0 112.858 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.62 -15.69 19.51 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 127.796 2.617 . . . . 0.0 113.392 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -66.42 144.9 56.23 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 123.289 1.518 . . . . 0.0 112.991 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.87 146.07 45.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.698 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -141.99 147.59 37.18 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 18.9 m -136.24 135.25 38.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.517 0.727 . . . . 0.0 110.529 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 92.7 mt -136.94 128.34 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.339 0.656 . . . . 0.0 109.497 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.08 -90.61 0.06 OUTLIER Glycine 0 CA--C 1.533 1.194 0 O-C-N 123.573 0.546 . . . . 0.0 112.557 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.48 141.8 29.82 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.644 -0.915 . . . . 0.0 111.914 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.15 130.01 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.518 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -68.19 164.96 19.3 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.503 0.502 . . . . 0.0 111.795 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -60.47 -23.77 64.74 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.178 -1.576 . . . . 0.0 114.739 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -76.12 -24.77 54.96 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.877 0.762 . . . . 0.0 112.025 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.82 -5.45 32.59 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 124.093 0.854 . . . . 0.0 114.255 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.49 153.27 44.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.966 0.883 . . . . 0.0 112.167 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.45 166.52 33.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.107 176.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -127.09 -177.67 4.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.39 -165.99 39.22 Favored Glycine 0 N--CA 1.469 0.89 0 O-C-N 119.534 -1.979 . . . . 0.0 114.217 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -136.79 130.13 31.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.144 0.973 . . . . 0.0 112.325 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -114.59 141.38 47.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.74 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.9 133.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -108.28 140.66 41.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.749 1.22 . . . . 0.0 111.861 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.46 -11.93 18.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.84 141.08 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 124.093 0.957 . . . . 0.0 111.26 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.9 34.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.057 -0.402 . . . . 0.0 110.185 -174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.91 -34.55 57.69 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -134.92 83.82 39.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.641 1.576 . . . . 0.0 110.244 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 36.09 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 125.009 3.806 . . . . 0.0 115.197 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.12 63.32 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.77 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.538 1.935 . . . . 0.0 110.849 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.21 125.84 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 119.989 -1.695 . . . . 0.0 111.254 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.79 165.91 27.45 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.988 1.315 . . . . 0.0 111.856 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 tp -47.86 115.62 1.22 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.589 3.556 . . . . 0.0 112.782 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -105.69 122.69 41.79 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.469 0.708 . . . . 0.0 110.615 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.92 135.87 71.63 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.492 2.128 . . . . 0.0 110.837 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -121.11 161.02 22.48 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.043 0.84 . . . . 0.0 111.246 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 28' ' ' GLU . 17.7 tp -169.05 149.33 4.25 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.668 1.587 . . . . 0.0 112.182 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.81 -146.96 13.51 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -147.01 139.76 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.965 0.906 . . . . 0.0 110.296 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.79 53.37 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.157 -0.964 . . . . 0.0 110.871 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -70.57 153.52 42.81 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.766 -1.209 . . . . 0.0 111.304 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -143.91 17.23 1.78 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -93.31 -49.0 6.16 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.656 0.782 . . . . 0.0 112.642 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.7 177.25 5.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -81.58 -38.29 26.33 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.596 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.77 51.98 4.69 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.469 1.108 . . . . 0.0 111.875 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.71 175.21 11.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.707 1.605 . . . . 0.0 113.726 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.328 0.7 OUTLIER -96.47 165.91 11.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.018 1.389 . . . . 0.0 112.353 173.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.77 165.96 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.948 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 146.57 12.43 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -159.02 152.42 22.68 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.82 151.75 19.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.872 2.069 . . . . 0.0 109.034 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.87 119.45 45.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.07 118.31 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.322 -0.861 . . . . 0.0 110.601 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -76.52 141.89 41.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.539 1.162 . . . . 0.0 110.498 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.55 -39.65 5.34 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.239 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.67 -13.3 54.48 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 114.268 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 43.2 t -152.34 133.32 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 128.554 2.741 . . . . 0.0 106.211 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -75.3 117.73 17.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.148 1.34 . . . . 0.0 110.347 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -173.72 164.02 4.31 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 109.72 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -138.88 142.59 38.57 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.073 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.96 152.23 51.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.533 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.12 149.53 29.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.768 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.75 126.86 12.05 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.29 178.36 45.28 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.34 147.25 26.53 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 124.63 0.841 . . . . 0.0 112.337 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.83 115.7 28.59 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.445 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' D' ' 82' ' ' GLN 0.275 3.3 m-85 -110.15 162.95 14.09 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -132.74 112.21 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.71 161.95 11.56 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.671 0.788 . . . . 0.0 109.011 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -20.52 0.85 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.09 -2.22 55.71 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.81 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.33 51.57 6.03 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -173.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.23 138.9 54.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.91 2.084 . . . . 0.0 107.185 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -106.69 149.42 27.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.781 1.632 . . . . 0.0 112.261 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . 0.418 ' CG1' ' HD3' ' D' ' 94' ' ' LYS . 1.8 t -150.53 161.64 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 122.729 1.252 . . . . 0.0 110.247 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 mt -125.9 111.27 14.61 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . 0.484 ' HE3' HD13 ' D' ' 119' ' ' ILE . 6.8 mmmt -103.97 120.62 41.42 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -137.35 162.96 32.16 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.792 1.758 . . . . 0.0 114.101 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.45 164.8 12.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -140.54 159.72 41.58 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.887 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.45 124.01 14.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.85 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.51 141.96 38.13 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 125.616 1.822 . . . . 0.0 110.693 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -124.2 114.13 19.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.216 -3.175 . . . . 0.0 109.417 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.263 19.2 m -71.45 163.93 26.78 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.682 1.864 . . . . 0.0 112.762 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -100.25 85.7 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.89 164.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 127.048 2.139 . . . . 0.0 109.065 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.87 -23.84 8.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.44 137.96 51.18 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.601 0.715 . . . . 0.0 111.142 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.1 tt -59.06 -17.74 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 7.31 73.23 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.356 1.932 . . . . 0.0 116.016 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.49 4.66 15.31 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 119.967 1.884 . . . . 0.0 112.969 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -61.35 -31.17 71.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.972 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD13 ' B' ' 14' ' ' LEU . 55.1 p-90 -49.0 -39.58 27.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.117 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -97.72 -5.96 33.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.733 1.213 . . . . 0.0 114.057 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.89 6.74 8.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 18.3 m -121.65 140.18 52.6 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 122.076 0.941 . . . . 0.0 113.251 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.36 121.05 7.51 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.008 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 9.7 p -100.87 150.29 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.732 2.013 . . . . 0.0 111.418 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.42 -171.49 22.73 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.663 0.649 . . . . 0.0 112.502 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -131.67 157.19 44.38 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.02 -0.694 . . . . 0.0 111.517 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -147.9 159.55 43.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.524 1.13 . . . . 0.0 109.095 174.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . 0.484 HD13 ' HE3' ' D' ' 94' ' ' LYS . 7.3 mt -137.83 118.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.61 146.5 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 14.7 p -132.89 163.57 28.84 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.158 0.98 . . . . 0.0 108.64 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.87 124.18 17.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.942 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.301 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.38 138.78 51.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -139.49 133.32 30.74 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.524 -1.36 . . . . 0.0 111.16 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.45 -23.63 65.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -49.75 112.09 0.6 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.226 1.41 . . . . 0.0 112.308 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.57 -116.0 1.53 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.995 1.284 . . . . 0.0 111.907 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -153.39 147.87 26.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -145.24 163.36 34.67 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.674 1.589 . . . . 0.0 111.987 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -145.47 152.95 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.709 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.53 145.67 48.68 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.73 0.812 . . . . 0.0 112.537 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.63 -26.16 12.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.817 2.447 . . . . 0.0 114.834 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' D' ' 110' ' ' TRP . 32.6 tp -70.21 -19.85 63.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.316 1.046 . . . . 0.0 112.968 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.64 22.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 127.535 2.493 . . . . 0.0 113.574 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -67.83 145.57 54.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.338 1.569 . . . . 0.0 112.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 145.54 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.87 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -142.27 147.75 36.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -137.08 135.81 37.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.67 0.788 . . . . 0.0 109.994 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.1 mt -135.54 127.58 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.391 0.677 . . . . 0.0 110.337 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -75.92 0.57 Allowed Glycine 0 CA--C 1.532 1.1 0 O-C-N 123.922 0.764 . . . . 0.0 113.544 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.06 24.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.808 0.804 . . . . 0.0 112.084 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.89 130.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.91 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.4 166.79 20.95 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.24 0.337 . . . . 0.0 111.804 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 88.1 p -60.52 -24.69 65.55 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.451 -1.406 . . . . 0.0 114.771 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -78.24 -27.12 47.57 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.964 0.802 . . . . 0.0 111.849 173.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.66 30.37 Favored Glycine 0 N--CA 1.468 0.797 0 CA-C-O 117.82 -1.545 . . . . 0.0 113.571 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 10.0 pt-20 -64.17 138.9 58.67 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 173.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.84 162.21 39.71 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.43 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.5 p -129.0 177.27 7.24 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.48 -166.19 37.97 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 120.695 -1.253 . . . . 0.0 114.273 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p -136.63 131.03 33.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.635 1.207 . . . . 0.0 111.696 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -114.36 141.36 47.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.095 -1.412 . . . . 0.0 108.39 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.92 134.51 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -110.03 140.18 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.592 1.157 . . . . 0.0 111.611 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.13 -11.7 19.37 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -137.52 141.17 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.097 0.959 . . . . 0.0 111.325 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.24 32.97 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.999 -0.438 . . . . 0.0 110.21 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -77.14 -34.46 56.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -135.02 83.7 39.18 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.795 1.638 . . . . 0.0 110.244 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.62 36.19 0.26 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.849 3.699 . . . . 0.0 115.129 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.47 -6.98 63.29 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.72 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.591 1.956 . . . . 0.0 110.973 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.58 125.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.137 -1.602 . . . . 0.0 110.922 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.25 165.74 27.5 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.007 1.323 . . . . 0.0 111.688 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tp -46.78 115.99 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.803 3.641 . . . . 0.0 112.995 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -106.19 123.17 39.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.519 0.728 . . . . 0.0 111.199 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 136.73 76.25 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.871 2.381 . . . . 0.0 111.329 174.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.87 155.59 36.34 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 124.023 0.827 . . . . 0.0 111.656 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -162.98 148.84 12.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.834 1.654 . . . . 0.0 109.364 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.19 -149.64 19.69 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.231 1.378 . . . . 0.0 109.672 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -144.64 140.72 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.511 0.725 . . . . 0.0 111.372 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 137.81 52.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.354 -0.841 . . . . 0.0 111.044 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -69.35 154.75 41.53 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.236 0.925 . . . . 0.0 111.152 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -145.22 16.45 1.52 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -92.24 -47.56 7.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.463 0.705 . . . . 0.0 112.685 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.11 175.28 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -76.74 -41.37 45.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.243 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -138.7 54.69 6.95 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.762 1.225 . . . . 0.0 111.843 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.63 174.54 12.68 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.711 1.608 . . . . 0.0 113.699 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.322 0.5 OUTLIER -96.21 166.57 11.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 123.057 1.408 . . . . 0.0 112.039 173.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.02 166.85 32.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.898 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.04 146.33 11.91 Favored Glycine 0 CA--C 1.544 1.901 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -158.92 153.46 24.35 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.23 -1.747 . . . . 0.0 115.66 -174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 151.94 19.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.273 1.829 . . . . 0.0 109.386 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.34 118.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.34 116.62 26.68 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.866 -0.521 . . . . 0.0 110.039 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.67 143.09 44.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.517 1.151 . . . . 0.0 110.565 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -109.46 -39.72 5.1 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.226 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.79 -13.35 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.273 1.429 . . . . 0.0 114.408 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.5 t -152.31 132.52 13.58 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 128.408 2.683 . . . . 0.0 106.059 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -74.8 118.33 17.64 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.189 1.359 . . . . 0.0 110.394 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -174.44 163.81 3.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.661 1.985 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.33 142.33 39.72 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.089 173.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.71 152.32 50.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.648 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.53 150.2 29.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.788 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.67 143.01 51.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 127.34 12.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.83 178.54 44.8 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.12 147.78 25.83 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.663 0.86 . . . . 0.0 112.704 178.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 6.8 p -97.9 115.85 28.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.267 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' B' ' 82' ' ' GLN 0.288 2.9 m-85 -110.24 161.56 15.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.39 112.09 18.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.45 162.76 12.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.642 0.777 . . . . 0.0 109.495 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -23.08 1.03 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.77 -4.66 56.5 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.774 0.83 . . . . 0.0 113.121 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 53.81 5.33 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 122.059 0.81 . . . . 0.0 111.346 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -122.96 140.66 52.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.245 2.618 . . . . 0.0 104.604 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -111.59 148.04 34.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.195 1.798 . . . . 0.0 112.08 -172.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.405 ' CG1' ' HD3' ' B' ' 94' ' ' LYS . 1.9 t -149.12 160.99 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 122.408 1.099 . . . . 0.0 110.546 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 mt -124.91 112.41 16.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 101.697 -3.445 . . . . 0.0 101.697 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . 0.485 ' HE3' HD13 ' B' ' 119' ' ' ILE . 6.3 mmmt -104.96 120.08 40.57 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -137.28 162.8 32.54 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.663 1.697 . . . . 0.0 114.105 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.11 164.88 12.66 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -140.47 159.25 42.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.382 -1.735 . . . . 0.0 111.968 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -142.82 123.99 14.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.997 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.65 141.6 38.9 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 125.779 1.925 . . . . 0.0 110.826 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.9 tpt85 -123.89 114.09 19.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 110.069 -3.241 . . . . 0.0 109.338 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.264 21.6 m -71.48 164.69 25.35 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.639 1.837 . . . . 0.0 112.722 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 59.8 m -101.25 84.55 2.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 127.547 2.339 . . . . 0.0 109.295 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.87 -22.57 9.56 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.057 0.844 . . . . 0.0 113.246 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.48 137.56 51.93 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.757 0.789 . . . . 0.0 111.096 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.76 -17.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.01 6.86 76.58 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.068 -1.962 . . . . 0.0 115.774 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.68 4.38 15.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.802 1.801 . . . . 0.0 112.798 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -30.55 70.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.412 ' CD1' HD13 ' D' ' 14' ' ' LEU . 54.8 p-90 -48.59 -41.15 29.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.269 1.028 . . . . 0.0 113.248 174.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -96.26 -6.22 38.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.577 1.151 . . . . 0.0 113.807 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.02 6.79 8.54 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 16.2 m -121.43 140.23 52.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.06 119.53 6.44 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.549 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -100.51 149.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.472 1.909 . . . . 0.0 111.255 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -171.77 22.8 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.594 0.616 . . . . 0.0 112.801 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -131.5 157.04 44.6 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.084 -0.656 . . . . 0.0 111.544 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -147.71 159.89 43.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.705 1.202 . . . . 0.0 109.277 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.485 HD13 ' HE3' ' B' ' 94' ' ' LYS . 7.3 mt -138.75 119.33 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.44 147.37 34.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 15.0 p -134.85 164.95 26.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.818 0.847 . . . . 0.0 109.131 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -60.22 119.07 7.19 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.54 1.136 . . . . 0.0 111.627 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.441 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.68 138.28 45.78 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 15.4 m -139.35 131.1 27.45 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.568 -1.333 . . . . 0.0 110.95 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.74 -24.05 64.41 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -49.21 114.61 1.05 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.025 1.33 . . . . 0.0 111.747 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.23 -120.46 2.47 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.919 1.247 . . . . 0.0 110.675 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -151.29 147.57 27.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -145.33 163.16 35.38 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.295 1.438 . . . . 0.0 112.234 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -143.65 153.78 42.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.516 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.29 146.26 48.03 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.724 0.809 . . . . 0.0 112.599 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.1 -26.24 15.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.44 2.296 . . . . 0.0 114.74 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 110' ' ' TRP . 32.9 tp -70.19 -20.25 63.13 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.098 -1.001 . . . . 0.0 113.032 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 -13.21 21.94 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.471 2.462 . . . . 0.0 113.607 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 86.8 p -67.57 145.85 54.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.436 1.618 . . . . 0.0 112.852 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.63 144.9 46.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.628 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -141.75 147.44 37.38 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 35.3 m -137.86 136.38 37.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.512 0.725 . . . . 0.0 109.676 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.69 127.91 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.66 0.784 . . . . 0.0 110.721 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.01 -77.93 0.42 Allowed Glycine 0 CA--C 1.532 1.132 0 O-C-N 123.643 0.59 . . . . 0.0 113.909 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.39 145.13 22.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.051 0.925 . . . . 0.0 112.102 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.54 130.06 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.816 0.846 . . . . 0.0 109.776 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.06 164.89 19.17 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.579 0.55 . . . . 0.0 111.783 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 82.1 p -60.58 -25.15 65.99 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.223 -1.548 . . . . 0.0 114.598 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -74.76 -24.95 58.77 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.833 0.742 . . . . 0.0 111.928 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.58 -5.14 32.95 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.09 0.853 . . . . 0.0 114.286 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.0 152.92 44.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.172 0.986 . . . . 0.0 112.133 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.05 166.49 33.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.117 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -127.04 -177.49 4.06 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.01 -165.6 38.92 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 119.486 -2.009 . . . . 0.0 113.947 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 11.3 p -136.67 130.48 32.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.453 1.12 . . . . 0.0 112.369 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.71 141.4 47.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.68 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 mt -130.69 134.19 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 2.9 m -109.97 140.42 43.98 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.447 1.099 . . . . 0.0 111.562 -173.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.35 18.84 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.92 140.92 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 123.772 0.829 . . . . 0.0 111.294 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.86 165.4 35.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.01 -0.431 . . . . 0.0 110.131 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -76.58 -34.75 58.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -134.7 83.78 40.86 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.691 1.596 . . . . 0.0 110.154 173.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.89 36.21 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.917 3.745 . . . . 0.0 115.149 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.13 63.32 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 179.71 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.576 1.95 . . . . 0.0 110.883 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.59 125.68 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.074 -1.641 . . . . 0.0 111.145 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.59 165.05 29.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.958 1.303 . . . . 0.0 111.806 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.28 115.55 1.14 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 130.766 3.626 . . . . 0.0 112.823 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 11.2 p -105.77 122.42 42.61 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.439 0.696 . . . . 0.0 110.74 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.6 135.29 68.63 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.559 2.173 . . . . 0.0 110.755 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.8 161.07 22.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.72 0.808 . . . . 0.0 111.181 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' B' ' 28' ' ' GLU . 17.9 tp -168.98 149.35 4.31 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.544 1.538 . . . . 0.0 112.257 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -147.16 13.92 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 120.185 1.357 . . . . 0.0 109.711 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -146.87 139.85 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.892 0.877 . . . . 0.0 110.24 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.82 53.37 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.86 154.09 42.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.685 -1.259 . . . . 0.0 111.148 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -144.63 14.67 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -89.78 -47.85 7.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.575 0.75 . . . . 0.0 112.389 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.61 172.23 13.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 31.2 t -74.85 -39.86 61.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.18 0.992 . . . . 0.0 112.617 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -138.45 53.47 5.73 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 112.866 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.1 176.04 10.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.461 1.44 . . . . 0.0 113.814 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.7 OUTLIER -97.29 166.0 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.071 1.415 . . . . 0.0 112.492 173.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -156.49 166.4 33.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.146 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.8 146.73 12.48 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -159.16 153.41 23.81 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -93.85 151.82 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.139 2.176 . . . . 0.0 109.002 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -130.9 119.71 45.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.09 118.29 27.56 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.2 -0.938 . . . . 0.0 110.542 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.66 141.55 40.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.121 0.962 . . . . 0.0 110.214 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.94 -40.05 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.225 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.3 -13.12 55.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.326 1.451 . . . . 0.0 114.348 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 43.3 t -152.39 132.98 13.88 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 128.436 2.694 . . . . 0.0 106.175 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.61 117.96 17.02 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.093 1.315 . . . . 0.0 110.244 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 13.9 m -174.18 163.82 3.93 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.545 1.938 . . . . 0.0 109.871 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -139.0 142.48 38.3 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.291 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.01 152.2 51.29 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.679 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.13 149.89 29.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.182 -1.827 . . . . 0.0 107.889 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.06 143.6 51.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 127.07 11.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -174.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.96 178.4 44.98 Favored Glycine 0 CA--C 1.499 -0.943 0 N-CA-C 117.421 1.728 . . . . 0.0 117.421 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . 0.469 ' HB3' ' CE1' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.27 147.17 26.6 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.668 0.864 . . . . 0.0 112.125 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 4.4 p -97.8 115.62 28.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.205 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' C' ' 82' ' ' GLN 0.268 3.5 m-85 -110.67 162.57 14.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.15 112.74 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -62.74 163.48 9.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 0.0 109.416 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.19 -28.16 2.83 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.42 -7.39 58.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.188 0.995 . . . . 0.0 113.104 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.69 53.82 3.89 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -121.72 140.32 52.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.708 2.403 . . . . 0.0 106.012 174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -111.42 147.49 35.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.72 1.608 . . . . 0.0 112.251 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . 0.415 ' CG1' ' HD3' ' C' ' 94' ' ' LYS . 1.8 t -150.11 161.11 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.583 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.48 112.94 17.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . 0.473 ' HE3' HD13 ' C' ' 119' ' ' ILE . 6.6 mmmt -105.46 118.87 37.68 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 174.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.47 161.82 34.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 124.005 1.86 . . . . 0.0 114.043 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.21 165.66 11.74 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -140.91 159.49 42.1 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.037 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.27 124.03 14.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.868 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.65 142.07 38.17 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 125.579 1.799 . . . . 0.0 110.68 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 -124.43 114.22 19.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 110.272 -3.149 . . . . 0.0 109.403 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.254 18.5 m -71.4 164.86 24.96 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 125.638 1.836 . . . . 0.0 112.897 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.4 m -102.4 82.58 2.19 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.2 165.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 127.905 2.482 . . . . 0.0 108.971 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -115.65 -23.5 8.7 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.6 139.49 50.05 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.986 0.898 . . . . 0.0 111.34 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.36 -16.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.73 7.2 74.11 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 117.222 -1.877 . . . . 0.0 115.601 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -115.01 4.87 14.83 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.939 1.87 . . . . 0.0 112.725 174.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.8 -31.12 70.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.204 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD13 ' A' ' 14' ' ' LEU . 54.5 p-90 -49.3 -40.35 34.55 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 113.188 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -96.63 -5.61 38.59 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 113.927 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.51 7.2 8.6 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 18.0 m -122.03 140.67 52.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.767 0.794 . . . . 0.0 113.017 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.07 120.53 6.89 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.308 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -100.95 149.79 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.576 1.95 . . . . 0.0 111.303 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.5 -171.28 22.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.617 0.627 . . . . 0.0 112.653 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -132.06 156.95 45.39 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.106 -0.644 . . . . 0.0 111.569 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -147.79 159.82 43.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.619 1.168 . . . . 0.0 109.256 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . 0.473 HD13 ' HE3' ' C' ' 94' ' ' LYS . 7.2 mt -138.56 119.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.21 147.29 34.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.2 p -135.34 164.62 27.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.716 0.806 . . . . 0.0 109.169 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -59.85 119.92 8.6 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.494 1.518 . . . . 0.0 113.175 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 mttt . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.4 131.7 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.477 1.511 . . . . 0.0 108.284 173.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.08 130.79 22.77 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.62 -26.6 60.86 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -45.39 109.73 0.19 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.866 1.666 . . . . 0.0 111.642 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.28 -125.98 2.93 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.231 0.92 . . . . 0.0 111.003 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -154.6 143.66 21.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -141.04 160.52 39.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.361 1.464 . . . . 0.0 110.983 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 t -136.59 151.65 49.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.58 1.152 . . . . 0.0 108.481 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.92 143.98 45.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 110.919 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -55.51 -23.06 24.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.451 1.901 . . . . 0.0 114.498 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 -18.56 62.57 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.577 -1.327 . . . . 0.0 111.305 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.81 -14.19 19.8 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 128.337 2.875 . . . . 0.0 113.487 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.2 p -71.05 144.7 50.29 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.988 -1.301 . . . . 0.0 112.332 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -120.48 141.77 49.88 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.209 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -130.88 143.52 50.79 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.146 0.974 . . . . 0.0 112.992 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.8 m -131.47 132.02 43.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.562 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.04 126.84 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.62 -89.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.775 0 O-C-N 125.125 1.516 . . . . 0.0 111.118 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.08 152.62 43.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.969 0.89 . . . . 0.0 111.815 176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.78 124.89 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.771 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.83 160.81 28.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.877 0.37 . . . . 0.0 111.961 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -53.97 -22.88 11.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.28 -36.53 77.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.317 0.647 . . . . 0.0 111.225 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -8.04 17.43 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 124.851 1.215 . . . . 0.0 112.534 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 155.33 40.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 108.789 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.82 163.84 34.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.515 177.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -129.16 162.7 27.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.52 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.81 -166.51 27.98 Favored Glycine 0 C--O 1.237 0.29 0 O-C-N 121.219 -0.926 . . . . 0.0 112.369 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 138.54 39.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 122.578 1.18 . . . . 0.0 111.732 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -114.51 140.66 48.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.234 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mt -133.57 126.48 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.3 m -104.99 148.73 26.41 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.86 -18.22 15.83 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.97 138.44 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 111.511 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.1 18.99 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.179 -0.95 . . . . 0.0 112.44 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HZ1' ' C' ' 111' ' ' LYS . 21.5 p-10 -71.25 -26.43 62.9 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.825 -0.547 . . . . 0.0 110.495 173.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -143.77 81.03 12.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.677 2.391 . . . . 0.0 110.346 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.66 33.43 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 124.94 3.76 . . . . 0.0 116.066 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.66 6.38 83.52 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 119.75 -1.844 . . . . 0.0 115.629 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -176.55 11.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.257 59.5 mt -33.5 108.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -173.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -102.38 174.8 5.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.418 -2.173 . . . . 0.0 111.089 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.69 137.14 47.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.379 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 p -114.12 125.9 28.73 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.189 0.596 . . . . 0.0 111.198 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -57.81 144.27 93.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.283 1.989 . . . . 0.0 112.131 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.66 144.24 51.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.153 0.981 . . . . 0.0 110.818 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.88 149.01 30.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.455 2.302 . . . . 0.0 108.621 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.11 -149.04 15.11 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 120.333 -1.479 . . . . 0.0 111.155 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -145.12 138.39 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.872 0.869 . . . . 0.0 112.137 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.49 131.99 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.738 0.815 . . . . 0.0 110.817 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -64.4 156.1 30.38 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.794 -1.191 . . . . 0.0 111.273 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -146.75 13.34 1.16 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.798 1.239 . . . . 0.0 113.279 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -78.69 -58.14 3.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.109 2.564 . . . . 0.0 111.304 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.74 13.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.5 m -78.55 -29.2 46.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.062 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.53 58.98 33.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.933 1.293 . . . . 0.0 112.384 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.96 175.72 9.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.344 2.03 . . . . 0.0 116.001 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -88.92 160.05 17.36 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.572 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -161.09 156.69 24.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.156 -0.965 . . . . 0.0 113.145 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 149.39 17.2 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 119.7 2.64 . . . . 0.0 119.7 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.06 159.69 36.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.8 150.36 20.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.265 1.826 . . . . 0.0 108.398 173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.93 125.98 63.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -104.04 112.4 25.38 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.495 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.355 56.4 m95 -74.47 154.89 38.52 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.86 -50.25 2.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.139 1.776 . . . . 0.0 115.396 -172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -75.58 -15.51 60.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.544 0.737 . . . . 0.0 112.934 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 t -149.26 145.02 26.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.186 2.594 . . . . 0.0 107.295 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.56 116.83 21.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.852 1.31 . . . . 0.0 110.216 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.2 p -168.42 172.06 8.61 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 126.194 1.798 . . . . 0.0 111.045 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.95 142.01 25.98 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.337 1.541 . . . . 0.0 110.711 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.77 132.04 30.04 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.644 -3.435 . . . . 0.0 109.848 -172.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 m -109.54 157.46 9.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.78 137.28 43.26 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 119.96 10.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.48 0.712 . . . . 0.0 110.369 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.38 -173.21 24.62 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -124.0 145.67 49.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 124.968 1.04 . . . . 0.0 111.056 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.6 p -97.8 113.1 24.81 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.443 1.089 . . . . 0.0 112.095 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -102.65 166.94 10.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.883 0.473 . . . . 0.0 111.715 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.3 mt -126.47 110.54 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -58.7 160.73 5.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.218 1.007 . . . . 0.0 108.735 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -49.66 -25.27 2.74 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.79 -13.85 49.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.021 0.929 . . . . 0.0 113.276 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.22 58.24 2.0 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -130.12 148.26 51.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.388 2.675 . . . . 0.0 107.359 172.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -109.58 138.57 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 110.601 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.6 m -141.3 164.17 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 109.518 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 mt -123.31 118.53 27.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -107.57 115.87 30.93 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -133.02 169.43 16.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.886 1.803 . . . . 0.0 112.245 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -121.37 171.17 8.95 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.0 p-90 -146.38 162.75 37.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.13 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -145.59 125.62 13.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.385 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.9 144.65 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 125.115 1.509 . . . . 0.0 114.588 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -128.64 123.5 33.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.035 -2.348 . . . . 0.0 113.755 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.88 156.24 18.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.674 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -103.08 64.15 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.589 -0.695 . . . . 0.0 109.84 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -49.12 153.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.139 1.376 . . . . 0.0 113.003 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.79 -29.76 32.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.13 144.69 43.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.728 1.252 . . . . 0.0 112.641 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.419 ' CD1' HG21 ' D' ' 92' ' ' VAL . 14.0 tt -65.25 -24.24 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.788 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.0 1.18 41.6 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-O 118.106 -1.386 . . . . 0.0 113.54 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.508 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 14.8 m-20 -121.35 6.28 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.804 1.242 . . . . 0.0 114.025 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -33.52 67.9 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 119.755 -1.841 . . . . 0.0 111.705 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.508 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 44.1 p-90 -45.67 -50.34 13.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.826 1.251 . . . . 0.0 113.981 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.584 ' HZ1' ' HA ' ' C' ' 39' ' ' ASP . 4.5 ptmm? -87.83 -11.62 47.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.92 0.888 . . . . 0.0 113.342 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.68 -5.92 54.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.361 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.4 m -103.6 143.7 32.4 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 125.11 1.506 . . . . 0.0 112.174 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -144.05 129.91 19.37 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 124.694 1.198 . . . . 0.0 111.013 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.85 154.8 8.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 120.248 1.385 . . . . 0.0 110.524 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.78 -177.24 32.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.326 0.488 . . . . 0.0 113.259 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 22.8 p90 -125.1 152.58 44.18 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.9 -0.765 . . . . 0.0 111.096 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -148.13 144.04 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.77 128.13 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -115.45 152.75 32.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.975 0.417 . . . . 0.0 110.518 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.8 p -134.69 160.54 37.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.439 1.096 . . . . 0.0 110.054 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -56.81 122.09 11.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.818 0.847 . . . . 0.0 111.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.099 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 83.2 mttt . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -116.31 135.31 53.99 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 2.2 t -139.6 136.84 34.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.774 1.23 . . . . 0.0 108.943 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 38.5 mt -73.63 -24.27 60.0 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -48.34 109.8 0.27 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.319 1.448 . . . . 0.0 112.07 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.48 -124.16 2.56 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 124.679 1.133 . . . . 0.0 110.813 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -151.72 144.28 24.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -142.28 157.49 44.77 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.111 1.365 . . . . 0.0 110.968 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -137.16 150.36 47.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 108.492 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -116.02 143.54 45.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.096 0.958 . . . . 0.0 111.042 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.62 -24.73 8.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.79 2.036 . . . . 0.0 114.975 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.61 -18.53 62.88 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.282 -1.511 . . . . 0.0 111.643 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.29 -14.88 18.32 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 128.592 2.996 . . . . 0.0 113.543 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 82.5 p -71.34 144.11 50.02 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.011 -1.288 . . . . 0.0 112.455 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -118.73 142.98 47.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.631 0.773 . . . . 0.0 110.403 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -132.19 143.09 49.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.918 0.866 . . . . 0.0 112.538 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 20.5 m -131.44 132.03 44.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.163 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 70.3 mt -130.01 124.51 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -85.74 0.09 OUTLIER Glycine 0 CA--C 1.527 0.794 0 O-C-N 124.934 1.397 . . . . 0.0 111.224 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.32 155.82 44.55 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 122.045 0.926 . . . . 0.0 111.997 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.98 126.34 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.909 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -79.27 161.61 26.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.75 -23.2 16.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -69.63 -34.3 73.85 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.727 -0.608 . . . . 0.0 111.329 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.4 -6.27 18.93 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 124.918 1.247 . . . . 0.0 112.789 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.68 157.13 38.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 122.122 0.963 . . . . 0.0 111.783 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.06 166.53 32.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.482 1.134 . . . . 0.0 110.126 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -132.33 160.87 35.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.552 -1.658 . . . . 0.0 106.717 173.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.64 -166.65 28.97 Favored Glycine 0 C--O 1.24 0.488 0 CA-C-O 122.479 1.044 . . . . 0.0 112.333 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 40.0 p -137.84 140.33 40.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.502 -1.349 . . . . 0.0 112.001 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -117.15 141.12 48.67 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.994 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -133.31 126.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 90.7 m -104.99 147.92 27.28 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.29 16.26 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.96 138.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.105 0.962 . . . . 0.0 111.37 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.67 170.37 18.3 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.286 -0.884 . . . . 0.0 112.229 -173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . 0.589 ' HA ' ' HZ1' ' B' ' 111' ' ' LYS . 21.9 p-10 -71.59 -26.8 62.75 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.826 -0.546 . . . . 0.0 110.443 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.65 81.24 12.25 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.77 2.428 . . . . 0.0 110.241 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.43 32.56 0.12 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.79 3.66 . . . . 0.0 116.321 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.72 6.14 83.34 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 119.726 -1.859 . . . . 0.0 115.696 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.19 11.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . 0.257 59.6 mt -33.16 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -101.52 173.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.545 -2.116 . . . . 0.0 111.102 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.79 138.06 52.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -114.83 125.61 28.84 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.281 0.633 . . . . 0.0 111.051 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -58.27 143.49 97.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.251 1.967 . . . . 0.0 112.062 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.76 151.02 48.79 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 110.741 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.34 149.16 22.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.774 2.03 . . . . 0.0 108.256 -175.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.73 -148.52 17.72 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 119.462 1.028 . . . . 0.0 112.676 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -144.26 138.71 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.167 0.987 . . . . 0.0 112.395 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 129.44 45.48 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.856 -1.153 . . . . 0.0 110.828 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -62.65 155.32 26.55 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.762 -1.211 . . . . 0.0 111.835 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -146.43 12.52 1.19 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.862 1.265 . . . . 0.0 113.131 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -78.61 -58.17 3.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.35 2.66 . . . . 0.0 111.036 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.36 172.01 12.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.07 0.856 . . . . 0.0 112.603 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -83.39 -25.92 30.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.158 0.983 . . . . 0.0 112.428 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.53 55.33 15.74 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.168 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.69 178.35 7.09 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.984 1.789 . . . . 0.0 115.703 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -89.96 157.07 18.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.5 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.934 -1.104 . . . . 0.0 112.883 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.59 149.19 16.29 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 119.925 2.73 . . . . 0.0 119.925 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.6 158.62 34.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -94.98 151.61 19.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.336 1.854 . . . . 0.0 108.543 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.75 127.85 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -105.73 112.35 25.38 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.332 -0.842 . . . . 0.0 111.288 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.351 56.4 m95 -73.79 155.07 39.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.548 1.642 . . . . 0.0 115.353 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mmpm? -112.97 -49.4 2.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.022 1.729 . . . . 0.0 115.366 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.27 -15.63 59.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 45.7 t -149.52 144.69 26.43 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.228 2.611 . . . . 0.0 106.952 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -81.77 116.82 21.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.753 1.263 . . . . 0.0 110.115 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 92.9 p -168.67 171.35 8.8 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.231 1.813 . . . . 0.0 111.167 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.15 142.25 27.12 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.947 1.356 . . . . 0.0 110.994 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -139.01 131.85 29.24 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-N 109.906 -3.316 . . . . 0.0 110.098 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 m -109.12 156.8 9.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.941 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -133.71 137.29 45.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.58 119.76 10.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.554 0.741 . . . . 0.0 110.357 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.66 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -121.23 144.83 48.39 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.179 1.164 . . . . 0.0 110.551 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -97.65 113.07 24.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.427 1.08 . . . . 0.0 111.148 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -103.91 166.79 10.19 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.58 0.627 . . . . 0.0 111.868 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.71 112.08 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -58.71 164.52 2.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.997 0.919 . . . . 0.0 109.795 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -51.83 -27.0 11.09 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -10.25 58.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.889 0.876 . . . . 0.0 113.099 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.49 39.39 6.32 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.833 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -113.94 147.24 38.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.608 1.563 . . . . 0.0 109.711 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -101.53 139.37 37.28 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.217 1.407 . . . . 0.0 110.647 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 106' ' ' ILE . 22.3 m -141.66 161.04 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.213 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.7 117.34 27.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 174.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -106.58 115.64 30.55 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -132.43 170.1 15.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.936 1.826 . . . . 0.0 111.89 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -121.79 171.23 9.04 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -146.15 162.65 37.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.105 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 tt -145.68 125.71 13.67 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.16 -1.382 . . . . 0.0 113.211 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.08 144.67 38.33 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 125.218 1.574 . . . . 0.0 114.337 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -128.55 123.57 33.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.774 -174.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.95 158.66 16.61 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.98 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -105.37 62.58 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.717 -0.614 . . . . 0.0 110.102 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -48.75 152.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.268 1.427 . . . . 0.0 113.452 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -80.84 -29.69 35.83 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.44 144.7 43.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.772 1.272 . . . . 0.0 113.161 -174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . 0.42 ' CD1' HG21 ' A' ' 92' ' ' VAL . 12.1 tt -64.82 -24.58 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.991 174.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.21 1.07 43.8 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.054 -1.415 . . . . 0.0 113.72 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . 0.503 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 13.6 m-20 -121.06 5.41 10.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.506 1.122 . . . . 0.0 113.931 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -33.93 65.79 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.877 -1.764 . . . . 0.0 111.492 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . 0.503 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.7 p-90 -45.59 -50.36 13.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . 0.571 ' HZ1' ' HA ' ' B' ' 39' ' ' ASP . 4.5 ptmm? -87.86 -11.69 47.07 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.292 -0.88 . . . . 0.0 113.231 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.64 -5.57 53.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.213 -172.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 15.2 m -103.34 143.86 32.12 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.981 1.425 . . . . 0.0 112.38 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -144.51 130.2 19.13 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.815 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.92 154.85 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 120.355 1.434 . . . . 0.0 110.733 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -177.64 33.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.402 0.525 . . . . 0.0 113.453 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.1 p90 -124.88 152.29 44.21 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.842 -0.799 . . . . 0.0 111.088 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.15 143.62 27.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.547 0.739 . . . . 0.0 109.061 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -127.55 131.52 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -120.25 151.5 39.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.446 0.641 . . . . 0.0 111.884 174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 36.8 p -131.07 163.8 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.548 1.139 . . . . 0.0 110.129 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -61.5 115.88 4.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.161 1.385 . . . . 0.0 111.781 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.464 0.258 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 174.688 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 51.2 t -117.96 134.56 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -139.61 136.48 34.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.464 1.106 . . . . 0.0 108.704 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 34.5 mt -73.63 -25.89 60.51 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -46.81 109.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.52 1.528 . . . . 0.0 111.705 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.29 -124.94 2.64 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.524 1.059 . . . . 0.0 111.164 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -153.52 142.26 20.99 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -140.42 158.5 43.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.573 1.549 . . . . 0.0 110.959 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t -137.2 151.19 48.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 108.783 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -117.76 143.67 46.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.148 0.979 . . . . 0.0 110.8 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -55.75 -22.99 26.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.441 1.896 . . . . 0.0 114.442 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.86 -18.06 62.71 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.601 -1.312 . . . . 0.0 111.098 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.21 18.82 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.585 2.993 . . . . 0.0 113.52 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -70.8 145.08 50.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.798 1.299 . . . . 0.0 112.372 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -119.51 140.42 50.53 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.788 0.835 . . . . 0.0 110.321 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -130.54 140.61 50.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.806 0.813 . . . . 0.0 112.728 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.4 m -129.56 131.82 46.66 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.97 125.93 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.31 -88.27 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 125.0 1.437 . . . . 0.0 111.122 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 155.28 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.09 0.947 . . . . 0.0 112.087 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.17 124.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.899 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -77.81 161.3 27.76 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.896 0.379 . . . . 0.0 111.963 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m -54.39 -22.7 13.12 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -69.62 -36.28 76.02 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.241 0.616 . . . . 0.0 111.197 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -8.22 17.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.909 1.243 . . . . 0.0 112.554 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.53 154.5 40.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.579 1.18 . . . . 0.0 109.025 174.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.39 163.56 35.41 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.314 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.56 162.94 26.1 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.436 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.01 -166.22 27.7 Favored Glycine 0 C--O 1.237 0.341 0 O-C-N 121.406 -0.809 . . . . 0.0 112.589 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 37.5 p -136.93 137.12 39.22 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 113.795 -1.202 . . . . 0.0 111.791 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.7 140.62 48.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.238 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.7 mt -133.79 126.77 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -104.95 149.33 25.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -173.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.78 15.38 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.34 138.6 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.77 1.228 . . . . 0.0 111.443 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.2 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.216 -0.928 . . . . 0.0 112.1 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HZ1' ' D' ' 111' ' ' LYS . 22.4 p-10 -71.38 -26.84 62.96 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.948 -0.47 . . . . 0.0 110.296 173.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -143.51 81.15 12.47 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.604 2.362 . . . . 0.0 110.293 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -65.94 30.16 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.763 3.642 . . . . 0.0 116.242 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 6.73 76.74 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 119.829 -1.795 . . . . 0.0 116.176 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -176.76 11.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . 0.256 61.5 mt -33.66 109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -102.87 173.97 6.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.838 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tt -70.94 137.86 49.55 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 171.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.2 p -114.85 126.33 28.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.184 0.593 . . . . 0.0 111.188 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -57.85 143.88 94.83 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.416 2.077 . . . . 0.0 112.134 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 144.49 51.13 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.209 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.88 149.07 30.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.565 2.346 . . . . 0.0 108.714 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.26 -149.41 15.88 Favored Glycine 0 CA--C 1.523 0.541 0 O-C-N 120.424 -1.422 . . . . 0.0 111.111 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -144.08 139.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.891 0.877 . . . . 0.0 112.17 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.62 130.72 49.48 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.151 -0.968 . . . . 0.0 110.619 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -63.22 156.06 26.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.683 -1.261 . . . . 0.0 111.577 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -146.16 12.06 1.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.666 1.187 . . . . 0.0 113.106 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -77.56 -57.87 3.58 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.257 2.623 . . . . 0.0 110.861 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.7 171.84 11.31 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.602 1.189 . . . . 0.0 112.911 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 71.3 m -79.19 -29.68 43.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.002 0.921 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.29 56.55 19.03 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 111.631 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.15 178.31 7.31 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 121.908 1.738 . . . . 0.0 115.773 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 p -90.02 156.64 18.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.36 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.68 156.54 31.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.224 -0.923 . . . . 0.0 112.742 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.98 149.77 17.89 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 120.07 2.788 . . . . 0.0 120.07 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -158.25 159.25 35.81 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.09 150.59 20.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.885 1.674 . . . . 0.0 108.478 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -129.02 125.72 63.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -103.72 112.37 25.28 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.507 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.355 57.5 m95 -74.11 154.94 38.93 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.81 -49.42 2.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 115.438 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.42 -15.16 59.99 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -150.44 144.64 25.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.984 2.514 . . . . 0.0 107.278 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.62 116.95 21.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.691 1.234 . . . . 0.0 109.975 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -168.56 171.52 8.82 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.284 1.834 . . . . 0.0 111.208 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.89 142.03 26.07 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 123.202 1.477 . . . . 0.0 110.456 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.51 132.73 31.66 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.629 -3.441 . . . . 0.0 109.577 -173.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.08 157.37 10.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.925 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.22 137.29 44.27 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.05 119.85 10.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.588 0.755 . . . . 0.0 110.018 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 -176.3 27.5 Favored Glycine 0 N--CA 1.463 0.492 0 N-CA-C 116.649 1.42 . . . . 0.0 116.649 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.06 144.56 48.48 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 124.874 0.984 . . . . 0.0 110.41 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 25.7 p -97.63 113.0 24.64 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.452 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.14 166.45 10.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.779 0.718 . . . . 0.0 112.057 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.26 112.42 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -58.59 161.38 4.66 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.264 1.026 . . . . 0.0 108.999 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -48.79 -30.05 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -15.01 57.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.403 1.081 . . . . 0.0 113.221 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.48 54.09 2.47 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -126.99 146.27 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.339 2.256 . . . . 0.0 108.407 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -106.27 138.32 42.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.932 1.693 . . . . 0.0 110.969 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.6 m -141.67 162.24 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.21 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.52 117.68 27.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -106.96 115.48 30.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -132.66 170.0 15.84 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 123.517 1.627 . . . . 0.0 111.952 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -121.8 170.88 9.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -145.84 162.83 36.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.215 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -145.67 125.68 13.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.375 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 144.31 38.61 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 125.037 1.46 . . . . 0.0 114.625 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.26 123.93 35.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 112.023 -2.353 . . . . 0.0 113.777 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 156.55 17.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.137 0.975 . . . . 0.0 111.716 176.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -102.83 63.5 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.146 0.498 . . . . 0.0 109.75 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -49.61 151.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.855 1.262 . . . . 0.0 112.675 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.99 -30.73 39.74 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.05 144.92 42.33 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.49 1.138 . . . . 0.0 113.145 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' C' ' 92' ' ' VAL . 12.7 tt -65.74 -23.41 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.559 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.7 1.43 53.02 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 118.24 -1.311 . . . . 0.0 113.693 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.502 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 13.5 m-20 -121.14 5.63 10.31 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -33.71 66.67 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 119.878 -1.764 . . . . 0.0 111.699 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 44.4 p-90 -45.29 -50.22 12.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.024 1.329 . . . . 0.0 114.264 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . 0.589 ' HZ1' ' HA ' ' D' ' 39' ' ' ASP . 4.1 ptmm? -88.12 -11.41 47.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.82 -6.26 55.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.214 -1.374 . . . . 0.0 114.476 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 15.2 m -102.96 143.75 32.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 125.228 1.58 . . . . 0.0 112.148 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.9 mtt85 -144.34 129.38 18.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.626 1.17 . . . . 0.0 111.061 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.42 154.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.178 1.354 . . . . 0.0 110.867 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.92 -177.64 33.2 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.291 0.472 . . . . 0.0 113.579 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 23.9 p90 -125.13 152.25 44.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.683 -0.892 . . . . 0.0 110.97 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -148.27 143.42 26.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.62 0.768 . . . . 0.0 109.209 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.51 128.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.83 153.51 31.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.108 0.48 . . . . 0.0 111.43 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 42.2 p -136.14 160.74 37.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.285 1.034 . . . . 0.0 111.331 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -58.93 118.24 5.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.042 0.937 . . . . 0.0 111.735 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.632 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 118.528 -0.748 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 43.9 t -116.31 136.2 53.21 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -139.75 136.09 33.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.49 -26.15 60.77 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -46.54 109.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.256 1.422 . . . . 0.0 112.139 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.34 -126.9 3.32 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.389 0.995 . . . . 0.0 111.161 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -150.31 144.65 25.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -142.61 158.44 43.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.161 1.384 . . . . 0.0 111.034 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 148.82 45.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.705 1.202 . . . . 0.0 108.391 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -115.93 143.62 45.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.9 0.88 . . . . 0.0 110.769 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -53.45 -24.85 13.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.827 2.051 . . . . 0.0 114.549 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.08 -18.39 63.26 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.192 -1.567 . . . . 0.0 111.565 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.42 -15.0 17.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 128.587 2.994 . . . . 0.0 113.452 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 87.9 p -71.66 144.73 49.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.574 1.187 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.89 142.67 49.47 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.4 -0.813 . . . . 0.0 110.681 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -131.3 144.12 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.28 1.038 . . . . 0.0 112.769 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 17.5 m -132.04 131.55 42.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.232 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 66.8 mt -128.66 124.64 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.53 -84.87 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 125.026 1.454 . . . . 0.0 111.102 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.86 157.42 44.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.068 0.937 . . . . 0.0 112.067 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -109.91 125.81 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.918 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -79.25 161.46 26.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.841 0.456 . . . . 0.0 112.01 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.64 -23.46 17.27 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -69.23 -34.54 74.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.203 0.601 . . . . 0.0 111.413 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.41 -6.35 18.87 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.994 1.283 . . . . 0.0 112.878 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.81 157.78 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.423 1.106 . . . . 0.0 112.07 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 166.35 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.205 174.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -132.08 160.34 36.24 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.06 -166.53 28.26 Favored Glycine 0 C--O 1.239 0.419 0 CA-C-O 122.439 1.021 . . . . 0.0 112.423 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -137.43 140.16 41.11 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.458 -1.371 . . . . 0.0 111.97 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.95 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mt -133.48 126.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -104.99 148.89 26.24 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.36 -18.17 15.53 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.07 138.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.83 1.252 . . . . 0.0 111.475 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 169.98 19.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.365 -0.834 . . . . 0.0 112.369 -173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . 0.584 ' HA ' ' HZ1' ' A' ' 111' ' ' LYS . 21.5 p-10 -71.49 -25.53 62.3 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.836 -0.54 . . . . 0.0 110.534 173.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -145.09 81.2 10.68 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.621 2.369 . . . . 0.0 110.256 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.18 30.99 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 124.686 3.591 . . . . 0.0 116.243 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.35 6.49 79.68 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 119.816 -1.803 . . . . 0.0 116.1 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.46 10.51 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . 0.259 59.8 mt -32.64 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.66 173.59 6.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.042 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.28 137.72 50.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.3 p -114.46 126.14 28.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.96 144.31 94.54 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.058 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 150.95 49.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.015 0.926 . . . . 0.0 110.57 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.28 149.23 22.5 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.95 2.1 . . . . 0.0 108.512 -175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.62 -148.44 17.56 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.498 1.045 . . . . 0.0 112.419 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -144.58 138.67 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 124.29 1.036 . . . . 0.0 112.424 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 130.08 47.5 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.816 -1.178 . . . . 0.0 110.561 174.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -62.12 156.26 22.08 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.716 -1.24 . . . . 0.0 111.868 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -147.57 12.87 1.04 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.835 1.254 . . . . 0.0 113.284 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -78.96 -58.16 3.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 128.22 2.608 . . . . 0.0 111.184 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.2 170.28 14.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.853 0.861 . . . . 0.0 112.622 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 73.9 m -81.22 -25.91 36.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.927 173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.93 56.4 16.79 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 125.228 1.411 . . . . 0.0 112.707 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.38 178.95 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.103 1.869 . . . . 0.0 115.84 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -89.54 157.48 18.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.98 1.312 . . . . 0.0 112.728 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -158.75 156.12 29.24 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.232 -0.917 . . . . 0.0 112.862 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.03 149.64 17.59 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.63 158.95 34.81 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -95.27 151.36 19.31 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.272 1.829 . . . . 0.0 108.56 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.7 124.01 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -102.12 112.47 25.15 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.956 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.354 55.4 m95 -73.91 154.87 39.21 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.98 -48.73 2.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.178 1.791 . . . . 0.0 115.529 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.67 -15.12 59.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -150.91 144.82 25.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.07 2.548 . . . . 0.0 107.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.8 117.17 22.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.607 1.094 . . . . 0.0 109.748 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 93.2 p -168.95 171.24 8.47 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.581 1.952 . . . . 0.0 110.942 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -147.59 142.27 26.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-O 123.039 1.399 . . . . 0.0 110.924 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.52 132.03 30.54 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 109.897 -3.319 . . . . 0.0 110.051 -172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -108.95 157.19 9.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.959 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -133.99 137.35 44.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.93 119.53 10.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 0.0 109.82 -174.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.24 -174.68 25.42 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.1 144.52 48.88 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.464 0.743 . . . . 0.0 110.781 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.69 113.0 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 124.139 0.899 . . . . 0.0 110.982 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.75 167.71 9.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.469 0.652 . . . . 0.0 111.557 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.79 113.97 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -58.78 161.2 5.0 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.871 0.868 . . . . 0.0 109.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -51.31 -20.95 1.89 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.72 -11.04 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.535 0.734 . . . . 0.0 112.665 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.94 49.02 3.93 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -122.81 145.82 48.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.639 1.976 . . . . 0.0 109.409 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -102.9 139.17 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.857 1.263 . . . . 0.0 111.024 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.6 m -141.77 163.97 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.97 1.308 . . . . 0.0 109.433 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.52 119.02 28.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -108.14 115.41 30.07 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -132.59 170.06 15.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.978 1.847 . . . . 0.0 112.274 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.11 170.98 9.32 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -146.15 162.69 37.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.233 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -145.64 125.67 13.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.194 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.14 144.69 38.4 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.974 1.421 . . . . 0.0 114.333 -174.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.28 123.1 33.24 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 111.943 -2.389 . . . . 0.0 113.701 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.7 156.22 18.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.699 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -102.97 61.55 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.864 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -48.06 151.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.144 1.377 . . . . 0.0 113.008 174.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -80.17 -31.05 38.89 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.89 145.15 42.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.534 1.159 . . . . 0.0 112.992 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' B' ' 92' ' ' VAL . 13.1 tt -64.84 -24.16 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.707 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 1.73 46.66 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.945 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . 0.502 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 13.2 m-20 -121.32 5.89 10.2 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -33.33 67.92 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 119.896 -1.752 . . . . 0.0 111.7 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 43.9 p-90 -45.59 -49.92 13.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.79 1.236 . . . . 0.0 114.299 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . 0.571 ' HZ1' ' HA ' ' A' ' 39' ' ' ASP . 4.1 ptmm? -88.33 -11.01 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.32 56.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -102.83 143.85 31.92 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 125.134 1.521 . . . . 0.0 112.265 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -144.54 130.03 18.93 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.64 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.25 154.18 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 120.417 1.462 . . . . 0.0 110.644 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -177.84 33.38 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.466 0.555 . . . . 0.0 113.442 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -124.76 152.43 43.84 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.665 -0.903 . . . . 0.0 111.135 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -148.14 143.71 27.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.666 0.787 . . . . 0.0 109.305 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.73 129.16 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.93 152.65 34.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.282 0.563 . . . . 0.0 111.612 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.2 p -135.18 161.86 34.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.447 1.099 . . . . 0.0 110.643 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -57.5 117.29 4.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.621 1.168 . . . . 0.0 112.505 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.466 0.374 0 O-C-N 121.655 -0.653 . . . . 0.0 109.817 176.391 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 154.03 31.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.014 0.926 . . . . 0.0 109.408 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.6 p -139.66 127.58 22.15 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.137 -0.977 . . . . 0.0 112.999 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.95 -31.56 72.85 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.594 1.543 . . . . 0.0 113.375 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -66.5 113.68 4.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.26 0.21 0.3 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 119.03 2.372 . . . . 0.0 119.03 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt 73.14 144.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 129.405 3.082 . . . . 0.0 114.362 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -140.27 161.97 36.4 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.321 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -141.44 147.17 37.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.434 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.42 143.42 40.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.729 0.812 . . . . 0.0 110.195 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -56.64 -23.87 44.35 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.478 1.911 . . . . 0.0 113.593 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.61 -18.97 62.18 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.666 1.586 . . . . 0.0 111.499 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.45 -14.79 25.1 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 127.493 2.473 . . . . 0.0 113.582 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 p -67.99 140.3 56.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.361 1.581 . . . . 0.0 112.123 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.47 142.86 46.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -136.48 146.64 46.52 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.297 1.046 . . . . 0.0 112.843 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -134.2 132.17 39.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.313 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.0 mt -133.02 127.14 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.96 -84.52 0.19 Allowed Glycine 0 CA--C 1.526 0.762 0 O-C-N 125.187 1.554 . . . . 0.0 111.475 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 145.49 29.39 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.869 0.842 . . . . 0.0 112.238 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.57 128.9 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.718 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.14 161.88 20.93 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.519 0.676 . . . . 0.0 111.851 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 p -57.97 -20.9 41.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -78.22 -31.56 49.42 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.211 0.914 . . . . 0.0 111.532 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.29 -5.78 23.3 Favored Glycine 0 N--CA 1.466 0.655 0 CA-C-O 117.352 -1.805 . . . . 0.0 114.626 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 145.83 53.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.711 1.755 . . . . 0.0 109.056 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -155.1 140.2 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.05 12.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 -168.94 35.27 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.873 1.263 . . . . 0.0 111.304 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.3 p -133.0 130.26 39.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 123.339 1.543 . . . . 0.0 110.928 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -111.64 136.83 50.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.033 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 mt -132.6 130.27 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.5 145.98 33.91 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.32 -15.19 18.9 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -133.49 140.99 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.626 1.17 . . . . 0.0 112.937 -174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.47 162.53 38.1 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 120.76 -1.212 . . . . 0.0 111.0 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.95 -39.5 79.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.476 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -131.81 84.66 53.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 127.184 2.194 . . . . 0.0 108.082 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.11 175.56 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.423 2.082 . . . . 0.0 111.522 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.58 -31.96 3.29 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.608 1.099 . . . . 0.0 112.543 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.02 28.29 2.12 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.406 1.083 . . . . 0.0 112.164 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -58.25 134.11 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.796 0.807 . . . . 0.0 109.587 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 174.06 11.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.399 1.48 . . . . 0.0 108.984 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.28 132.48 39.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.112 1.765 . . . . 0.0 113.055 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -114.51 125.49 29.11 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.057 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HD3' ' HE3' ' A' ' 71' ' ' LYS . 4.9 Cg_exo -58.51 146.96 88.78 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.235 1.957 . . . . 0.0 110.846 173.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.46 151.66 51.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.26 0.624 . . . . 0.0 110.871 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tp -156.75 149.05 23.21 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.003 1.721 . . . . 0.0 110.872 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.56 -154.26 25.0 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 121.541 1.973 . . . . 0.0 109.833 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 mt -146.7 140.94 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 112.132 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.28 138.24 50.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.792 1.237 . . . . 0.0 110.766 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -70.52 155.56 40.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.837 0.827 . . . . 0.0 110.415 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -138.61 -5.6 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -77.67 -35.09 52.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.85 167.12 12.69 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 m -76.96 -37.99 54.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.298 1.439 . . . . 0.0 114.659 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -139.33 49.92 2.33 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 125.026 1.33 . . . . 0.0 111.877 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.76 -179.04 4.98 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.408 2.739 . . . . 0.0 115.35 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.5 p -87.44 161.31 17.91 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.892 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.51 155.75 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.487 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.82 19.92 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 119.715 2.646 . . . . 0.0 119.715 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -159.72 159.73 33.2 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -97.64 148.72 23.02 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.952 2.501 . . . . 0.0 108.685 173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.52 125.33 63.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -103.68 107.06 17.75 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.555 -174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -72.06 149.19 45.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 123.411 1.577 . . . . 0.0 114.731 -173.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HE3' ' HD3' ' A' ' 48' ' ' PRO . 27.9 mttt -108.54 -45.39 3.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -78.85 -17.23 55.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.287 1.035 . . . . 0.0 112.804 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 128.66 10.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 129.269 3.028 . . . . 0.0 105.397 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.12 119.01 11.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.332 0.969 . . . . 0.0 112.088 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.465 ' HG ' HD21 ' A' ' 99' ' ' LEU . 48.2 t -170.72 167.52 7.71 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.773 1.629 . . . . 0.0 110.919 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -146.13 140.9 27.02 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 124.001 1.857 . . . . 0.0 110.484 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.433 ' HG1' ' CD1' ' A' ' 99' ' ' LEU . 1.5 m -137.24 126.38 24.53 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-N 109.303 -3.589 . . . . 0.0 109.949 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -102.09 161.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.39 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -136.7 137.95 40.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.92 118.14 9.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.14 -179.41 26.84 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.058 -1.068 . . . . 0.0 115.535 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -121.57 148.89 43.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 125.223 1.19 . . . . 0.0 111.264 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.1 t -97.13 127.64 43.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 125.094 1.496 . . . . 0.0 109.911 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -117.7 161.4 19.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.16 0.984 . . . . 0.0 113.517 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.1 mt -127.18 112.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.54 160.56 6.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.104 0.562 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -43.05 -37.26 1.89 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.12 -14.94 60.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.448 1.499 . . . . 0.0 114.773 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 46.82 4.15 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.587 0.613 . . . . 0.0 113.016 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.79 160.23 20.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.966 2.106 . . . . 0.0 108.037 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -116.0 144.77 43.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.075 1.762 . . . . 0.0 111.713 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.72 159.36 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.601 1.191 . . . . 0.0 109.592 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.14 102.29 7.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HE3' HD13 ' A' ' 119' ' ' ILE . 2.3 mmtt -96.23 121.42 37.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.4 p -134.01 162.86 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.627 1.204 . . . . 0.0 111.373 -174.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.38 168.16 9.85 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -142.11 163.8 31.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.786 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.97 123.98 12.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.801 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.465 HD21 ' HG ' ' A' ' 75' ' ' SER . 0.3 OUTLIER -110.32 144.87 38.4 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 125.088 1.493 . . . . 0.0 114.025 -174.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -124.52 114.89 20.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.983 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -73.7 162.59 29.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.889 0.876 . . . . 0.0 111.557 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.6 p -99.88 45.69 0.98 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.0 -1.063 . . . . 0.0 111.492 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.4 137.23 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.98 1.712 . . . . 0.0 113.145 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -20.58 61.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -174.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.62 150.93 51.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.16 1.457 . . . . 0.0 113.549 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.0 tt -64.15 -23.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.109 -0.994 . . . . 0.0 113.084 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.47 3.75 58.18 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.071 0.843 . . . . 0.0 113.552 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.7 -0.65 9.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.195 0.998 . . . . 0.0 112.451 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -31.76 69.18 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.208 -0.932 . . . . 0.0 112.85 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -48.18 -41.61 27.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.096 1.358 . . . . 0.0 113.714 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -96.39 -8.59 32.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 -0.9 18.94 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.2 m -113.39 140.97 47.61 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.588 0.755 . . . . 0.0 112.632 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -144.21 131.67 20.97 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.787 1.235 . . . . 0.0 111.738 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.66 156.55 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 110.53 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -175.43 30.89 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.516 0.579 . . . . 0.0 113.225 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -125.14 153.15 43.45 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.795 -0.826 . . . . 0.0 112.112 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 132.13 14.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.746 0.784 . . . . 0.0 110.052 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.481 HD13 ' HE3' ' A' ' 94' ' ' LYS . 15.5 mt -118.93 138.45 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.56 139.97 53.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.821 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.3 p -129.32 154.09 47.2 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -53.01 117.86 3.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.336 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.329 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' D' ' 83' ' ' CYS . 6.2 p -134.58 148.53 50.47 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.27 1.828 . . . . 0.0 107.732 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 65.3 p -139.29 131.12 27.57 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.285 -1.51 . . . . 0.0 114.148 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 50.7 mt -65.04 -31.88 73.33 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.259 1.391 . . . . 0.0 113.924 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -66.33 115.64 6.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.38 8.16 0.29 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 118.296 2.079 . . . . 0.0 118.296 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 66.55 148.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.272 2.629 . . . . 0.0 114.927 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -143.43 161.08 39.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.474 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -140.5 145.7 37.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.545 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -109.54 143.61 38.97 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.178 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.16 -23.34 46.77 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.405 1.882 . . . . 0.0 113.543 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.0 tp -72.4 -19.06 61.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.006 1.722 . . . . 0.0 111.27 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.47 -14.59 22.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.121 2.296 . . . . 0.0 113.622 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -67.52 138.34 56.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.458 1.629 . . . . 0.0 112.202 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.85 141.3 46.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -135.03 147.15 49.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.246 1.022 . . . . 0.0 113.179 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.1 m -134.49 131.96 38.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.068 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -133.13 126.32 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.08 -84.59 0.16 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 125.292 1.62 . . . . 0.0 111.583 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.05 29.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.713 0.757 . . . . 0.0 111.853 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.56 128.8 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.901 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.52 161.54 19.95 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.636 0.731 . . . . 0.0 111.595 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.8 p -58.2 -21.38 47.44 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -75.92 -30.3 58.68 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.176 0.898 . . . . 0.0 111.666 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.77 -4.21 25.98 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.778 1.18 . . . . 0.0 115.061 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.56 150.85 45.67 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.399 1.08 . . . . 0.0 110.926 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -156.46 162.84 39.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.164 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.86 171.97 12.17 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 173.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.21 -167.84 37.3 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 119.947 -1.721 . . . . 0.0 111.628 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 44.0 p -132.95 128.84 37.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.89 1.329 . . . . 0.0 110.823 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -111.65 136.06 51.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.12 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 30.6 mt -132.11 132.39 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.26 145.5 38.65 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 -15.41 19.2 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.55 140.7 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.324 1.05 . . . . 0.0 113.068 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.01 162.4 37.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.132 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.77 -38.85 80.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.628 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -131.89 84.5 53.75 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.987 2.115 . . . . 0.0 108.013 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 175.09 9.58 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.09 1.86 . . . . 0.0 111.417 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.23 -31.45 3.3 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.567 1.079 . . . . 0.0 112.502 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.37 28.13 2.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.341 1.056 . . . . 0.0 112.16 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.9 134.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.929 0.871 . . . . 0.0 109.608 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.18 174.08 11.19 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.314 1.445 . . . . 0.0 108.862 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.53 132.69 40.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 126.248 1.819 . . . . 0.0 113.093 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -114.67 125.67 28.83 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.067 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' PRO . . . . . 0.456 ' HD3' ' HE3' ' D' ' 71' ' ' LYS . 4.8 Cg_exo -58.72 146.92 90.43 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.164 1.909 . . . . 0.0 110.748 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.13 157.41 43.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.441 0.697 . . . . 0.0 111.234 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.89 148.85 15.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.822 1.649 . . . . 0.0 110.381 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -157.7 28.96 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 121.35 1.886 . . . . 0.0 111.999 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.41 138.7 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.094 0.957 . . . . 0.0 111.903 -174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.98 138.17 50.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.537 1.535 . . . . 0.0 110.733 174.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -71.09 154.94 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.408 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -136.8 -6.38 1.91 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -78.61 -35.91 44.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.25 168.57 13.8 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -74.82 -42.55 57.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.244 1.018 . . . . 0.0 113.556 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -137.45 53.07 6.06 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.07 1.348 . . . . 0.0 112.037 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.91 -179.73 5.48 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.264 1.976 . . . . 0.0 115.248 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 34.8 p -87.97 161.91 17.16 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.762 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -159.53 155.97 27.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.57 149.69 19.59 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 119.517 2.567 . . . . 0.0 119.517 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.13 158.07 29.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -96.47 149.22 21.97 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.827 2.451 . . . . 0.0 108.989 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.89 124.87 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -104.23 107.31 18.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.053 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.7 149.6 45.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 123.381 1.562 . . . . 0.0 114.397 -173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' LYS . . . . . 0.456 ' HE3' ' HD3' ' D' ' 48' ' ' PRO . 27.2 mttt -108.56 -45.06 3.93 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -173.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -79.22 -16.88 55.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.395 1.078 . . . . 0.0 112.917 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -152.26 129.25 11.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.299 3.04 . . . . 0.0 105.453 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.91 118.95 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.355 0.98 . . . . 0.0 111.584 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' SER . . . . . 0.478 ' HG ' HD21 ' D' ' 99' ' ' LEU . 45.5 t -170.5 167.54 8.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 110.776 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -145.9 141.06 27.44 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.832 1.777 . . . . 0.0 110.892 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' THR . . . . . 0.44 ' HG1' ' CD1' ' D' ' 99' ' ' LEU . 1.5 m -137.46 125.25 22.48 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 109.469 -3.514 . . . . 0.0 110.456 -172.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -101.04 161.06 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.355 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.29 138.38 39.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.26 118.16 9.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 109.223 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.23 -178.59 26.18 Favored Glycine 0 CA--C 1.5 -0.85 0 C-N-CA 120.006 -1.092 . . . . 0.0 115.816 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.26 145.58 48.09 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 125.09 1.112 . . . . 0.0 111.263 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' D' ' 4' ' ' CYS . 17.0 t -97.6 118.37 33.95 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.939 1.4 . . . . 0.0 110.653 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.06 163.78 13.02 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -127.94 113.64 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.31 154.99 26.18 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -36.51 -38.98 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -72.37 -29.68 64.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.655 1.582 . . . . 0.0 114.467 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.38 58.72 0.73 Allowed Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.122 1.344 . . . . 0.0 110.949 -173.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -123.72 163.46 21.07 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.414 2.686 . . . . 0.0 107.31 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -124.81 145.74 49.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 121.77 2.077 . . . . 0.0 112.725 -172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.16 159.48 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.679 1.191 . . . . 0.0 110.643 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 19.1 mt -123.22 104.15 8.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' LYS . . . . . 0.46 ' HE3' HD13 ' D' ' 119' ' ' ILE . 1.7 mmtt -98.29 119.05 36.29 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -133.19 161.93 33.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.534 1.159 . . . . 0.0 111.257 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.24 168.45 9.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -142.14 164.25 30.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.477 1.132 . . . . 0.0 111.727 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 124.14 11.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.685 -1.598 . . . . 0.0 113.569 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' LEU . . . . . 0.478 HD21 ' HG ' ' D' ' 75' ' ' SER . 0.3 OUTLIER -110.62 144.81 38.95 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 125.332 1.645 . . . . 0.0 114.078 -174.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -124.63 115.02 20.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.896 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 31.5 m -74.52 161.32 29.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.937 0.895 . . . . 0.0 111.844 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 58.8 p -99.0 45.55 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.85 -1.157 . . . . 0.0 111.356 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.22 137.96 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 112.964 -174.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -19.74 60.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.04 151.75 50.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.862 1.315 . . . . 0.0 113.783 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.89 -24.37 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.367 -0.833 . . . . 0.0 113.171 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.16 3.5 52.09 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.212 0.911 . . . . 0.0 113.6 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.9 -0.78 8.96 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.139 0.976 . . . . 0.0 112.454 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -31.85 68.46 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.408 -0.808 . . . . 0.0 112.747 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -48.3 -41.68 28.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.255 1.422 . . . . 0.0 113.703 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -96.66 -8.6 31.16 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -1.46 20.87 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -112.95 140.83 47.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.531 0.733 . . . . 0.0 112.687 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -144.12 131.34 20.72 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.788 1.235 . . . . 0.0 111.658 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.49 156.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 110.492 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.24 -175.26 31.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.541 0.591 . . . . 0.0 113.434 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -125.06 152.59 44.1 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.734 -0.862 . . . . 0.0 112.004 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.34 12.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.851 0.834 . . . . 0.0 110.166 -175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' ILE . . . . . 0.46 HD13 ' HE3' ' D' ' 94' ' ' LYS . 16.4 mt -116.02 138.29 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.08 141.88 51.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -130.36 154.32 47.8 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -52.83 112.94 0.93 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.246 1.018 . . . . 0.0 110.145 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.51 -0.571 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 174.442 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' B' ' 83' ' ' CYS . 25.3 p -116.86 147.77 41.87 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.331 1.852 . . . . 0.0 109.54 -174.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -139.48 129.66 25.25 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.78 -33.22 75.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.13 1.332 . . . . 0.0 114.105 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -65.27 115.55 5.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.82 5.2 0.32 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 68.76 146.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 128.59 2.756 . . . . 0.0 115.483 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -141.97 159.14 42.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.411 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -136.45 143.82 44.09 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.591 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -108.97 143.54 38.11 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.611 0.764 . . . . 0.0 110.571 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -55.62 -25.09 36.9 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.194 1.798 . . . . 0.0 113.332 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.13 -18.92 62.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.633 1.573 . . . . 0.0 111.846 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.94 -16.06 23.27 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.381 2.42 . . . . 0.0 113.414 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 61.5 p -67.29 141.11 57.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.019 1.39 . . . . 0.0 111.89 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.67 141.09 48.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -134.56 147.14 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.569 1.176 . . . . 0.0 112.505 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -134.76 131.17 37.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.57 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 93.9 mt -132.59 126.2 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -84.75 0.17 Allowed Glycine 0 CA--C 1.526 0.769 0 O-C-N 125.348 1.655 . . . . 0.0 111.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.23 146.54 30.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 112.265 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 28.2 t -89.94 128.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.497 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.28 162.18 17.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.527 0.68 . . . . 0.0 111.847 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.2 p -58.0 -20.92 42.24 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -78.35 -31.4 48.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.176 0.898 . . . . 0.0 111.719 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.97 -5.75 23.87 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-O 117.479 -1.734 . . . . 0.0 114.687 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.6 145.34 54.03 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.531 1.665 . . . . 0.0 108.914 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.76 140.1 17.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.18 12.04 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.43 -168.72 34.93 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-O 122.82 1.233 . . . . 0.0 111.132 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -133.59 131.1 39.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.32 -1.44 . . . . 0.0 110.789 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -112.25 137.06 50.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.898 -1.956 . . . . 0.0 108.116 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 27.0 mt -132.96 129.72 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.75 145.73 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.23 -14.75 19.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.93 140.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.559 1.143 . . . . 0.0 112.745 -174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.36 162.85 37.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 110.862 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.48 -38.96 77.9 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.433 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -132.15 84.6 52.28 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.202 2.201 . . . . 0.0 107.995 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.01 175.49 9.06 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.375 2.05 . . . . 0.0 111.486 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.35 -31.41 3.44 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.584 1.088 . . . . 0.0 112.654 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -140.28 28.25 2.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.395 1.078 . . . . 0.0 112.15 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.03 134.41 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.92 0.867 . . . . 0.0 109.562 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.31 173.63 11.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.347 1.459 . . . . 0.0 109.039 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.97 132.93 38.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.15 1.78 . . . . 0.0 113.211 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -115.26 125.86 28.42 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.082 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.455 ' HD3' ' HE3' ' B' ' 71' ' ' LYS . 6.7 Cg_exo -58.42 146.51 89.9 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 0.0 110.811 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.4 151.48 51.5 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.289 0.635 . . . . 0.0 110.7 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 tp -156.78 149.08 23.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.028 1.731 . . . . 0.0 110.845 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.59 25.49 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 121.555 1.979 . . . . 0.0 109.511 -173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mt -146.2 140.23 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.371 1.068 . . . . 0.0 112.403 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.35 137.35 49.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.465 1.106 . . . . 0.0 110.657 174.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -69.91 156.13 39.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 109.992 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -138.81 -5.66 1.51 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -79.15 -36.9 39.72 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.47 166.64 15.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.749 0.656 . . . . 0.0 112.524 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.7 m -79.41 -34.28 41.93 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -139.78 51.88 3.35 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 125.147 1.379 . . . . 0.0 112.351 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.3 -179.5 5.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.734 2.29 . . . . 0.0 115.806 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -87.23 161.55 17.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.941 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.84 155.67 26.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.575 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.68 19.44 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 119.705 2.642 . . . . 0.0 119.705 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -160.07 159.05 31.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -96.52 149.44 21.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.844 2.457 . . . . 0.0 108.783 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.88 125.74 63.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -104.05 106.63 17.2 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 118.223 -0.894 . . . . 0.0 112.373 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -71.8 149.43 45.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.288 1.518 . . . . 0.0 114.591 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . 0.455 ' HE3' ' HD3' ' B' ' 48' ' ' PRO . 28.2 mttt -108.58 -45.24 3.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -79.14 -16.97 55.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 112.857 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 129.17 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.242 3.017 . . . . 0.0 105.455 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.73 119.0 11.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.472 1.033 . . . . 0.0 111.791 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 39.4 t -170.43 167.38 8.25 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.993 1.717 . . . . 0.0 110.738 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -146.12 140.83 26.98 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-O 124.03 1.871 . . . . 0.0 110.453 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' THR . . . . . 0.438 ' HG1' ' CD1' ' B' ' 99' ' ' LEU . 1.5 m -137.52 126.18 23.78 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 109.335 -3.575 . . . . 0.0 110.052 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.8 161.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.328 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.91 138.58 40.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.3 119.43 10.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.668 0.787 . . . . 0.0 109.148 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.81 -178.84 27.85 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.202 -0.999 . . . . 0.0 115.579 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -121.51 145.9 47.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 125.211 1.183 . . . . 0.0 111.058 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' B' ' 4' ' ' CYS . 17.2 t -97.36 121.94 39.83 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.651 1.219 . . . . 0.0 110.012 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -111.98 163.57 14.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.916 1.286 . . . . 0.0 112.648 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 mt -128.08 119.09 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.13 163.63 5.98 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.362 0.601 . . . . 0.0 109.839 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -47.0 -36.84 8.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.85 -25.09 60.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.308 1.443 . . . . 0.0 113.444 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.06 11.37 22.51 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.02 -1.433 . . . . 0.0 115.785 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -81.58 167.21 19.51 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.426 1.613 . . . . 0.0 111.143 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.77 148.19 43.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.065 1.757 . . . . 0.0 112.185 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.99 160.6 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 122.358 1.075 . . . . 0.0 110.61 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -123.49 103.58 8.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' LYS . . . . . 0.466 ' HE3' HD13 ' B' ' 119' ' ' ILE . 2.0 mmtt -98.14 118.71 35.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -132.41 163.3 29.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.583 1.182 . . . . 0.0 111.534 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -113.15 168.45 9.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -142.57 164.0 31.31 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.184 0.992 . . . . 0.0 111.771 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.38 123.73 11.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.678 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.438 ' CD1' ' HG1' ' B' ' 77' ' ' THR . 0.3 OUTLIER -110.06 144.78 38.14 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 125.197 1.56 . . . . 0.0 114.173 -174.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.4 115.4 20.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 111.822 -2.445 . . . . 0.0 114.298 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 38.4 m -75.81 161.33 29.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.156 0.982 . . . . 0.0 111.134 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.5 p -98.28 45.29 1.02 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.42 137.73 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.91 1.684 . . . . 0.0 112.979 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -20.3 60.86 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -173.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.21 153.13 50.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.84 1.305 . . . . 0.0 113.666 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 16.0 tt -65.03 -22.81 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.76 2.78 58.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.363 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.5 -0.79 9.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.558 1.143 . . . . 0.0 112.436 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -32.07 67.05 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.28 -0.887 . . . . 0.0 112.892 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 57.0 p-90 -48.65 -41.52 31.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.076 1.35 . . . . 0.0 113.764 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -96.65 -8.33 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.91 -1.21 18.7 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.2 m -113.15 140.97 47.46 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.772 0.829 . . . . 0.0 112.807 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -144.13 131.56 20.95 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.708 1.203 . . . . 0.0 111.547 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.54 156.73 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 123.976 0.91 . . . . 0.0 110.73 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.35 -175.91 31.85 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.509 0.576 . . . . 0.0 113.358 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 27.8 p90 -124.56 152.57 43.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.781 -0.834 . . . . 0.0 111.956 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.6 12.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.953 0.883 . . . . 0.0 110.072 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.466 HD13 ' HE3' ' B' ' 94' ' ' LYS . 15.2 mt -116.7 138.74 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -125.19 142.41 51.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.851 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 26.9 p -132.29 158.86 40.76 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -57.55 119.68 6.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.455 1.102 . . . . 0.0 113.255 -173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 tt . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' C' ' 83' ' ' CYS 0.254 16.1 p -116.02 142.94 46.14 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 124.559 1.144 . . . . 0.0 108.343 -173.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 33.1 p -134.83 132.4 38.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.826 1.25 . . . . 0.0 113.858 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.31 -30.03 68.92 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -67.78 111.81 4.5 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.45 -10.32 0.29 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 118.597 2.199 . . . . 0.0 118.597 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt 81.19 146.48 0.08 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 130.513 3.525 . . . . 0.0 113.261 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -140.47 161.45 37.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.227 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -139.09 144.22 38.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.686 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -107.89 143.61 36.27 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.712 0.805 . . . . 0.0 110.275 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.08 -23.91 50.16 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.697 1.599 . . . . 0.0 113.276 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.14 -18.96 62.49 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.729 1.612 . . . . 0.0 111.415 174.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.9 -16.36 23.23 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.363 2.411 . . . . 0.0 113.537 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 51.7 p -66.55 141.04 57.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.215 1.508 . . . . 0.0 112.128 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.75 139.41 51.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.58 147.11 51.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.22 1.009 . . . . 0.0 113.021 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -134.85 131.9 37.96 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.891 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.99 125.6 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.99 -82.0 0.23 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 125.342 1.651 . . . . 0.0 111.379 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.72 151.11 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.681 0.753 . . . . 0.0 112.027 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.63 128.02 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.846 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -65.02 161.09 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.618 0.723 . . . . 0.0 111.675 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 11.7 p -58.03 -20.57 39.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -76.81 -29.91 56.18 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.313 0.96 . . . . 0.0 111.621 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.26 -3.69 26.76 Favored Glycine 0 N--CA 1.468 0.772 0 C-N-CA 124.761 1.172 . . . . 0.0 115.112 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.14 150.31 45.55 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.371 1.069 . . . . 0.0 110.797 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.86 162.73 40.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.041 174.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 172.4 11.62 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.37 -167.08 36.2 Favored Glycine 0 C--O 1.237 0.302 0 O-C-N 120.004 -1.685 . . . . 0.0 111.861 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 34.8 p -133.78 128.57 35.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 123.172 1.463 . . . . 0.0 111.1 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.02 137.21 50.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.14 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.27 133.25 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.92 146.96 40.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.91 -14.06 19.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.16 142.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.746 1.218 . . . . 0.0 112.609 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.42 38.95 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.035 -1.041 . . . . 0.0 110.992 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.95 -39.01 79.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.362 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -132.12 84.69 52.16 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.089 2.156 . . . . 0.0 107.988 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 175.4 9.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.328 2.018 . . . . 0.0 111.506 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.83 -31.37 3.37 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.523 1.059 . . . . 0.0 112.58 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -140.19 28.6 2.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.486 1.114 . . . . 0.0 112.135 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.83 134.54 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.786 0.803 . . . . 0.0 109.462 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.97 174.66 10.65 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.273 1.429 . . . . 0.0 108.888 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.86 133.09 42.75 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.26 1.824 . . . . 0.0 112.963 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 49.0 m -115.37 125.75 28.51 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.153 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . 0.427 ' HD3' ' HE3' ' C' ' 71' ' ' LYS . 5.6 Cg_exo -58.04 146.7 86.43 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.142 1.895 . . . . 0.0 110.92 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.83 157.53 42.63 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.229 0.612 . . . . 0.0 111.187 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 148.89 15.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.835 1.654 . . . . 0.0 110.244 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.83 -157.9 29.15 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 121.57 1.986 . . . . 0.0 111.875 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.26 138.25 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.17 0.988 . . . . 0.0 111.933 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.17 139.29 51.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.687 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.46 154.64 40.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.486 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -137.28 -6.21 1.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -78.42 -37.2 44.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.31 165.8 16.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.344 0.592 . . . . 0.0 112.538 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 24.8 m -79.05 -34.26 43.95 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -140.2 52.74 3.7 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.897 1.279 . . . . 0.0 112.244 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.79 -179.09 5.11 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.851 2.367 . . . . 0.0 115.95 -174.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -86.5 162.38 18.1 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.792 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -160.22 156.49 26.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.736 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.4 148.98 17.96 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.64 158.77 32.16 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.91 149.78 21.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.825 2.45 . . . . 0.0 108.894 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.58 124.13 58.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.53 107.66 18.59 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.231 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -71.87 149.1 45.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.127 1.441 . . . . 0.0 114.557 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.427 ' HE3' ' HD3' ' C' ' 48' ' ' PRO . 26.5 mttt -108.21 -45.15 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.415 2.005 . . . . 0.0 116.415 -173.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -78.9 -16.93 56.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.204 1.002 . . . . 0.0 112.958 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -152.05 131.57 13.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 129.517 3.127 . . . . 0.0 105.032 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.41 119.04 13.98 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.163 0.892 . . . . 0.0 111.627 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' SER . . . . . 0.474 ' HG ' HD21 ' C' ' 99' ' ' LEU . 48.5 t -170.53 167.59 8.01 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.767 1.627 . . . . 0.0 110.819 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -145.81 141.14 27.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 123.927 1.823 . . . . 0.0 110.763 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' THR . . . . . 0.445 ' HG1' ' CD1' ' C' ' 99' ' ' LEU . 1.5 m -137.59 125.93 23.29 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 109.454 -3.521 . . . . 0.0 110.43 -172.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -102.01 160.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.15 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -136.96 138.36 40.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.4 119.29 9.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.716 0.807 . . . . 0.0 108.875 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.51 -177.88 26.6 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 119.931 -1.128 . . . . 0.0 115.709 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -122.09 145.85 47.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.004 1.061 . . . . 0.0 111.191 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' C' ' 4' ' ' CYS . 14.6 t -97.4 121.73 39.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.803 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.8 162.23 16.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.415 1.086 . . . . 0.0 113.276 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.5 mt -127.86 111.7 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -62.23 162.19 10.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.424 0.69 . . . . 0.0 110.052 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -42.97 -39.53 2.64 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.36 -25.55 63.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.051 1.34 . . . . 0.0 113.784 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.54 10.01 22.33 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.87 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -78.77 164.24 24.7 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.333 1.566 . . . . 0.0 110.862 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.62 148.18 41.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.019 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.91 162.92 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.904 1.281 . . . . 0.0 110.425 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 19.4 mt -126.24 104.21 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' C' ' 119' ' ' ILE . 1.9 mmtt -98.79 118.26 35.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -131.96 163.13 29.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.462 1.125 . . . . 0.0 111.572 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.92 168.82 9.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -143.09 164.29 30.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.199 1.0 . . . . 0.0 111.832 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.4 123.77 11.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.973 -1.467 . . . . 0.0 113.705 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' LEU . . . . . 0.474 HD21 ' HG ' ' C' ' 75' ' ' SER . 0.3 OUTLIER -110.23 144.72 38.49 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.248 1.419 . . . . 0.0 114.068 -174.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.48 114.91 20.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 112.168 -2.287 . . . . 0.0 114.185 -174.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -74.86 161.32 29.66 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.852 0.861 . . . . 0.0 111.938 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 55.4 p -98.27 45.33 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.307 1.043 . . . . 0.0 111.48 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.31 136.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.744 1.618 . . . . 0.0 113.453 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -20.52 61.85 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -174.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.53 151.35 51.09 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.819 1.295 . . . . 0.0 113.597 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 tt -64.28 -21.92 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.56 3.27 64.06 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -122.81 -0.58 9.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.316 1.046 . . . . 0.0 112.621 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -31.55 68.51 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.72 0.808 . . . . 0.0 112.83 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -49.02 -41.16 33.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.009 1.323 . . . . 0.0 113.706 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -96.78 -8.54 30.93 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.01 18.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.3 m -113.41 140.44 48.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.52 0.728 . . . . 0.0 112.66 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -143.69 131.24 21.14 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.639 1.176 . . . . 0.0 111.645 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.37 156.49 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.034 0.933 . . . . 0.0 110.64 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.95 -175.8 31.33 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.352 0.501 . . . . 0.0 113.261 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.21 152.93 42.33 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.786 -0.832 . . . . 0.0 112.053 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.17 128.81 11.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.966 0.889 . . . . 0.0 110.132 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' ILE . . . . . 0.487 HD13 ' HE3' ' C' ' 94' ' ' LYS . 15.3 mt -115.37 140.87 34.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -127.27 141.32 51.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.772 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 18.2 p -131.69 161.17 33.4 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -59.15 119.76 7.93 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.706 0.802 . . . . 0.0 112.546 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 172.332 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' -3' ' ' GLN . 10.7 mm-40 . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 118.797 -0.621 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 18.5 p -86.87 -42.92 12.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.547 1.139 . . . . 0.0 111.972 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.63 137.11 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 142.9 101.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 129.702 3.201 . . . . 0.0 111.615 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 51.86 25.83 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -146.66 124.46 11.91 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.396 1.078 . . . . 0.0 113.228 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.31 136.97 52.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 122.564 1.173 . . . . 0.0 111.747 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.14 129.03 24.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.909 2.484 . . . . 0.0 107.564 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.83 -31.25 70.97 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -53.44 116.53 2.5 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.731 0.777 . . . . 0.0 110.947 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.45 -128.85 4.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 10' ' ' TRP . 14.8 ttmt -146.23 152.34 39.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 55.9 m95 -138.35 162.73 33.66 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 110.879 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -141.3 144.64 34.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.54 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 14' ' ' LEU . 4.2 t30 -106.92 147.28 30.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.84 0.856 . . . . 0.0 111.591 -174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -27.79 58.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.868 1.267 . . . . 0.0 113.94 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 35.1 tp -71.09 -15.99 62.55 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.425 1.49 . . . . 0.0 113.476 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.68 -9.81 44.77 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.871 2.177 . . . . 0.0 114.068 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -71.93 146.73 47.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.685 1.243 . . . . 0.0 110.839 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -122.72 148.36 45.41 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.15 -0.969 . . . . 0.0 111.711 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -135.06 139.81 45.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -126.4 132.68 51.48 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.76 126.71 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.77 -91.0 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.637 1.211 . . . . 0.0 111.97 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 134.61 30.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.519 -0.989 . . . . 0.0 110.387 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.01 133.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.959 0.787 . . . . 0.0 111.241 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.36 158.09 36.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.372 1.069 . . . . 0.0 110.874 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.6 m -57.65 -24.58 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.865 -1.147 . . . . 0.0 113.963 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.409 -0.807 . . . . 0.0 110.766 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.31 -5.01 33.42 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.769 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.23 154.24 39.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.942 1.871 . . . . 0.0 111.608 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.04 154.22 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -116.83 156.28 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.604 1.162 . . . . 0.0 109.557 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.72 -176.57 38.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.651 1.139 . . . . 0.0 115.288 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 p -134.26 123.29 24.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.279 -1.461 . . . . 0.0 107.724 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -124.38 132.14 53.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.169 -1.832 . . . . 0.0 113.76 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.15 131.37 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.735 0.778 . . . . 0.0 108.965 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -106.92 138.27 43.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.087 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.32 24.63 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.81 136.96 45.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 124.083 0.953 . . . . 0.0 111.921 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.46 163.13 37.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.172 -0.955 . . . . 0.0 111.012 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.88 -27.13 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.25 80.47 10.13 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 127.281 2.232 . . . . 0.0 109.881 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.92 13.21 0.23 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.736 3.624 . . . . 0.0 117.986 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.31 -28.86 1.53 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.41 53.53 0.17 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.147 1.473 . . . . 0.0 112.28 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.55 130.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.756 -1.215 . . . . 0.0 111.096 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.09 172.32 11.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 128.272 2.629 . . . . 0.0 108.818 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . 0.289 5.5 mp -66.69 131.91 46.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.7 m -99.39 117.72 63.46 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.421 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.93 138.72 78.48 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.782 1.655 . . . . 0.0 110.525 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.53 148.49 46.24 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.165 0.916 . . . . 0.0 110.688 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.32 148.89 33.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.554 2.342 . . . . 0.0 108.64 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.49 -159.03 32.05 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.254 -1.529 . . . . 0.0 109.312 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 mt -145.48 146.65 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.717 0.892 . . . . 0.0 111.5 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -132.29 154.35 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.28 1.038 . . . . 0.0 113.071 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -92.16 157.93 16.45 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.381 1.086 . . . . 0.0 109.098 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 23.53 0.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.726 1.61 . . . . 0.0 111.918 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.46 -52.34 4.55 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.465 2.306 . . . . 0.0 111.93 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.78 174.46 3.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -71.77 -44.84 63.33 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.446 -0.784 . . . . 0.0 111.773 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.59 69.08 81.52 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.688 1.195 . . . . 0.0 110.229 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.22 168.64 17.12 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.903 3.068 . . . . 0.0 118.08 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.5 p -86.06 157.45 20.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.365 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -150.59 174.32 13.11 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 123.989 1.852 . . . . 0.0 112.533 174.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.82 149.62 9.38 Favored Glycine 0 N--CA 1.408 -3.186 0 CA-C-N 108.674 -3.875 . . . . 0.0 120.168 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.31 153.21 23.21 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.4 150.01 23.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.362 1.865 . . . . 0.0 109.985 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.84 117.01 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -101.99 110.86 22.94 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.87 -174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.331 50.5 m95 -70.08 154.79 41.5 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.156 1.931 . . . . 0.0 115.436 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 71' ' ' LYS . 9.9 mmpt? -107.52 -44.18 4.35 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.332 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -91.8 -8.54 46.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 t -152.47 136.61 16.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.359 2.264 . . . . 0.0 107.728 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -72.52 112.35 8.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.658 1.572 . . . . 0.0 110.441 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.1 p -165.98 169.99 14.11 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.011 1.724 . . . . 0.0 111.562 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -148.14 141.62 25.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 122.855 1.312 . . . . 0.0 111.241 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -137.11 124.06 21.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 110.945 -2.843 . . . . 0.0 110.198 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -101.3 154.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.426 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -127.23 142.31 51.51 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.163 0.985 . . . . 0.0 108.521 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 120.76 7.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.69 -166.12 28.17 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.552 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.85 146.15 50.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 124.671 0.865 . . . . 0.0 113.296 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 50.4 t -97.4 113.23 24.86 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.219 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HB2' HD12 ' D' ' 106' ' ' ILE . 18.1 m-85 -103.77 169.64 8.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.298 1.839 . . . . 0.0 111.743 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -125.44 112.14 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.01 161.59 8.19 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.801 0.441 . . . . 0.0 110.535 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -30.36 -57.11 0.2 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.397 1.879 . . . . 0.0 115.975 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.26 -15.51 63.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.01 1.724 . . . . 0.0 115.022 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.94 27.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.702 1.144 . . . . 0.0 114.77 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -78.93 144.32 34.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.739 1.616 . . . . 0.0 111.79 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -101.42 141.73 33.86 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.728 1.211 . . . . 0.0 111.708 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.8 m -144.02 160.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.777 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -119.45 116.92 27.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -107.28 111.92 24.52 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -133.28 172.0 13.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.125 1.441 . . . . 0.0 111.563 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.438 ' HG3' HG23 ' D' ' 113' ' ' THR . 90.8 mmm -124.78 169.22 12.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.431 -1.258 . . . . 0.0 107.794 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -139.94 162.03 36.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.045 1.402 . . . . 0.0 112.319 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.67 119.17 9.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.25 141.27 38.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 123.649 1.69 . . . . 0.0 110.42 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -125.62 113.91 18.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 110.172 -3.195 . . . . 0.0 109.746 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -77.09 156.94 31.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.982 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.87 82.87 2.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.427 HG11 ' H ' ' A' ' 105' ' ' ASP . 1.6 t -65.8 173.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.684 1.194 . . . . 0.0 111.978 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -117.87 -7.58 10.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.427 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -140.96 148.1 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.869 1.319 . . . . 0.0 110.33 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' D' ' 84' ' ' PHE . 15.7 tt -63.3 -26.28 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.862 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.04 -2.83 33.38 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 117.912 -1.493 . . . . 0.0 115.219 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.55 3.67 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.843 1.321 . . . . 0.0 113.459 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -35.38 61.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.959 -1.088 . . . . 0.0 111.577 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -50.13 -46.34 53.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.163 0.985 . . . . 0.0 113.402 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -14.71 42.65 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.372 -0.83 . . . . 0.0 112.728 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.81 -9.16 58.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.445 HG23 ' HG3' ' D' ' 96' ' ' MET . 61.9 m -95.24 155.97 16.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -154.05 124.15 6.87 Favored 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 126.822 2.049 . . . . 0.0 111.156 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.37 156.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 121.792 2.087 . . . . 0.0 110.203 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.18 -177.56 31.4 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 124.397 1.061 . . . . 0.0 115.023 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -123.67 152.23 42.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.114 0.966 . . . . 0.0 110.984 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -150.4 148.2 28.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.899 0.88 . . . . 0.0 110.67 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.3 mt -132.27 122.94 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.082 -1.011 . . . . 0.0 109.294 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -113.87 153.94 28.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.013 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.0 p -135.73 164.27 28.28 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.307 1.043 . . . . 0.0 110.796 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -57.74 117.7 4.51 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.444 1.098 . . . . 0.0 110.41 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.0 133.68 50.42 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.228 -0.295 . . . . 0.0 110.606 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 76.78 31.3 0.56 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.9 t -58.73 159.72 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -96.42 -172.17 2.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.407 1.883 . . . . 0.0 111.161 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -94.54 118.32 31.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.667 0.787 . . . . 0.0 111.529 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.248 1.02 1 C-N-CA 131.838 4.055 . . . . 0.0 107.178 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.815 -1.088 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 10.1 t -149.38 62.73 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.539 1.638 . . . . 0.0 113.223 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.25 141.72 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.343 1.857 . . . . 0.0 108.128 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -153.21 5.19 0.34 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.925 1.69 . . . . 0.0 112.236 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 30.7 ttp85 -156.75 29.63 0.32 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.982 1.713 . . . . 0.0 111.715 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -152.41 125.81 8.75 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.822 -1.174 . . . . 0.0 112.594 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 131.36 56.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.752 1.263 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.77 127.58 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.908 2.083 . . . . 0.0 106.042 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.22 -28.87 62.42 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 124.414 1.071 . . . . 0.0 112.755 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -53.5 115.84 2.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.93 0.892 . . . . 0.0 110.508 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.72 -132.63 5.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.482 1.515 . . . . 0.0 109.392 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' D' ' 10' ' ' TRP . 16.0 ttmt -144.24 152.51 40.93 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . 0.43 ' H ' ' HG2' ' D' ' 9' ' ' LYS . 55.6 m95 -139.94 162.72 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.544 1.938 . . . . 0.0 111.476 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 14.2 t -139.9 146.95 39.9 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.354 1.062 . . . . 0.0 109.102 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -108.85 148.25 30.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.64 0.776 . . . . 0.0 111.546 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -25.37 59.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.692 1.197 . . . . 0.0 114.108 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 34.9 tp -73.3 -15.85 61.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.596 1.559 . . . . 0.0 113.269 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.04 -12.84 45.14 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.479 1.99 . . . . 0.0 113.89 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -67.96 145.63 54.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.94 1.37 . . . . 0.0 111.166 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -120.95 149.31 42.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.182 -0.949 . . . . 0.0 111.692 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -135.31 142.46 45.84 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.912 -0.493 . . . . 0.0 112.209 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -128.59 132.35 48.19 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.871 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.01 127.6 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.577 1.173 . . . . 0.0 112.307 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.27 134.6 29.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.851 -0.794 . . . . 0.0 110.632 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.02 131.91 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.679 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.71 156.45 38.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.778 1.231 . . . . 0.0 110.275 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 72.8 m -57.29 -23.04 45.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.09 -28.15 68.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.501 -0.75 . . . . 0.0 110.841 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.74 -4.35 34.39 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 125.302 1.429 . . . . 0.0 112.771 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.85 158.98 30.43 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.843 1.322 . . . . 0.0 113.32 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.09 166.36 33.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.71 0.767 . . . . 0.0 112.05 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -128.61 160.07 33.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.552 1.141 . . . . 0.0 108.801 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.93 -175.48 39.52 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 119.974 -1.108 . . . . 0.0 115.465 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 8.7 p -134.75 124.03 24.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.084 1.354 . . . . 0.0 107.927 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -125.3 131.24 53.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.638 -172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.4 HG13 HD11 ' D' ' 46' ' ' LEU . 2.5 mp -123.37 129.67 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.926 0.87 . . . . 0.0 109.015 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.25 137.84 42.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.255 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.53 -6.92 26.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.4 136.87 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.056 0.931 . . . . 0.0 112.175 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.27 161.96 39.9 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.855 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.3 -25.45 54.84 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.715 -0.616 . . . . 0.0 110.555 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -146.85 79.81 9.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 127.277 2.231 . . . . 0.0 109.791 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.91 13.13 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.834 3.689 . . . . 0.0 117.992 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.48 -28.64 1.57 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 118.241 2.056 . . . . 0.0 118.241 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.71 54.77 0.17 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.203 1.502 . . . . 0.0 112.076 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.68 130.54 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.76 -1.213 . . . . 0.0 111.068 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 173.06 10.95 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.274 2.629 . . . . 0.0 108.894 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.4 HD11 HG13 ' D' ' 34' ' ' ILE 0.296 5.4 mp -67.72 131.11 44.96 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 61.1 m -98.31 117.98 64.08 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.762 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.26 137.86 78.06 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.694 1.596 . . . . 0.0 110.264 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -121.9 155.67 34.97 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.446 1.091 . . . . 0.0 110.662 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.62 149.03 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.319 1.848 . . . . 0.0 109.026 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.32 -157.42 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 O-C-N 121.158 -0.964 . . . . 0.0 111.021 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.56 147.06 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.03 0.919 . . . . 0.0 111.568 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -133.12 153.59 51.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.37 1.081 . . . . 0.0 112.969 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.37 157.55 17.56 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.389 1.09 . . . . 0.0 108.539 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 24.33 0.56 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.728 1.611 . . . . 0.0 111.358 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -93.48 -51.57 4.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.602 2.361 . . . . 0.0 111.318 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 172.26 8.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -69.11 -43.47 74.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 0.0 111.075 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.85 71.59 69.68 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.947 1.299 . . . . 0.0 110.851 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -69.86 169.29 19.38 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.076 3.184 . . . . 0.0 118.817 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 36.2 p -86.65 156.23 20.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.018 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' D' ' 83' ' ' CYS . 0.0 OUTLIER -152.62 173.99 14.52 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 123.981 1.848 . . . . 0.0 112.633 174.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.0 148.89 9.17 Favored Glycine 0 N--CA 1.412 -2.941 0 CA-C-N 109.213 -3.63 . . . . 0.0 119.748 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -159.59 153.09 22.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.55 151.3 23.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.601 1.96 . . . . 0.0 110.006 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.47 117.38 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -102.42 111.83 24.29 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.136 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.328 51.1 m95 -70.68 153.11 43.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 124.105 1.907 . . . . 0.0 115.61 -172.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' D' ' 71' ' ' LYS . 9.9 mmpt? -105.76 -43.46 4.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.188 -174.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -92.09 -8.65 45.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -152.58 136.51 16.32 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.204 2.202 . . . . 0.0 107.473 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.83 111.52 7.16 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.691 1.587 . . . . 0.0 110.368 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 93.0 p -165.07 170.73 14.72 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.778 1.631 . . . . 0.0 111.569 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -148.35 142.21 25.74 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.519 1.152 . . . . 0.0 111.586 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.13 123.65 20.9 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 111.25 -2.705 . . . . 0.0 110.357 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 m -100.8 154.04 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -127.21 142.08 51.57 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.01 0.924 . . . . 0.0 108.719 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 119.96 7.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.79 -166.75 27.4 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.132 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -133.56 147.07 51.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 125.051 1.089 . . . . 0.0 112.819 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . 0.405 ' HB2' ' CZ ' ' D' ' 64' ' ' PHE . 44.1 t -97.28 125.35 41.79 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 116.19 -1.862 . . . . 0.0 108.011 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.412 ' HB2' HD12 ' A' ' 106' ' ' ILE . 13.1 m-85 -114.51 172.03 7.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.921 1.689 . . . . 0.0 110.819 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mt -127.87 111.87 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.51 158.73 9.27 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -25.97 -55.16 0.06 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.212 2.205 . . . . 0.0 116.005 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -9.02 58.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.137 2.175 . . . . 0.0 116.001 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.8 51.1 3.51 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 120.082 1.31 . . . . 0.0 109.981 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -124.07 136.35 54.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.795 1.638 . . . . 0.0 109.119 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -101.06 139.82 36.22 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.903 1.335 . . . . 0.0 110.689 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.3 161.05 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.704 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.73 116.78 25.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -106.78 111.13 23.52 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -133.07 172.18 12.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 123.51 1.624 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.445 ' HG3' HG23 ' A' ' 113' ' ' THR . 90.4 mmm -124.92 169.06 12.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -139.26 162.22 35.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.56 1.648 . . . . 0.0 112.55 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 119.81 9.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.699 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.29 141.75 38.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.599 1.812 . . . . 0.0 110.442 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -126.0 113.87 17.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 109.999 -3.273 . . . . 0.0 109.895 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 2.6 t -77.84 158.19 29.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.286 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 56.6 m -105.22 77.62 1.32 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.68 0.752 . . . . 0.0 109.74 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 t -63.55 166.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.106 1.363 . . . . 0.0 112.595 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -112.44 -4.36 14.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.64 147.4 35.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.58 1.181 . . . . 0.0 110.373 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 84' ' ' PHE . 16.0 tt -63.36 -26.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.854 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.49 -3.03 30.66 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 117.659 -1.634 . . . . 0.0 115.432 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.26 3.49 10.34 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.806 1.303 . . . . 0.0 113.636 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.96 60.71 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.819 -1.176 . . . . 0.0 111.816 174.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -49.46 -46.83 48.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 -15.65 41.82 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.29 -0.881 . . . . 0.0 112.789 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 -7.76 53.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 96' ' ' MET . 57.2 m -96.54 154.88 17.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.021 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.19 124.3 7.47 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.627 1.971 . . . . 0.0 111.195 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.52 156.23 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 121.699 2.045 . . . . 0.0 110.047 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -178.6 31.68 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.834 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.51 152.62 40.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.168 0.987 . . . . 0.0 110.83 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -150.61 147.36 27.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.937 0.875 . . . . 0.0 110.837 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.64 120.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.239 -0.913 . . . . 0.0 108.985 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -110.46 154.31 23.8 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.067 0.855 . . . . 0.0 111.539 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -136.68 161.95 34.51 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.378 1.071 . . . . 0.0 110.055 174.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -56.66 128.26 35.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.43 168.38 3.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.408 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -30.12 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.608 2.363 . . . . 0.0 114.944 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 15.6 p -79.08 143.9 35.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 122.417 1.103 . . . . 0.0 111.8 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -74.79 158.0 34.22 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.443 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -70.45 172.38 8.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.397 173.035 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 10.2 t -155.13 -43.7 0.08 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 120.493 1.497 . . . . 0.0 108.194 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 15.9 m -88.94 155.16 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.565 1.146 . . . . 0.0 108.07 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -89.09 -46.25 8.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.484 0.714 . . . . 0.0 112.734 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -172.59 89.31 0.09 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.851 2.06 . . . . 0.0 110.306 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -156.23 132.0 9.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.374 -0.829 . . . . 0.0 112.912 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 132.22 56.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.453 1.101 . . . . 0.0 111.391 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.27 127.64 19.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.847 2.059 . . . . 0.0 106.439 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.66 -30.82 64.6 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.84 117.3 2.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.929 0.892 . . . . 0.0 110.733 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.28 -130.49 4.83 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.755 1.645 . . . . 0.0 109.662 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' B' ' 10' ' ' TRP . 15.1 ttmt -145.25 152.83 40.58 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . 0.424 ' H ' ' HG2' ' B' ' 9' ' ' LYS . 58.0 m95 -138.76 162.73 33.99 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.753 2.021 . . . . 0.0 111.275 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -143.51 145.0 32.21 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.903 0.881 . . . . 0.0 109.195 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -109.7 146.55 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.887 0.875 . . . . 0.0 111.83 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -25.87 53.38 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.21 -16.54 61.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.479 1.512 . . . . 0.0 113.075 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 -12.94 29.98 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.964 2.221 . . . . 0.0 114.033 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -69.0 142.96 54.49 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.836 -1.391 . . . . 0.0 111.993 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.42 143.31 45.72 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.829 -1.169 . . . . 0.0 110.657 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -133.24 139.23 46.84 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.946 -0.471 . . . . 0.0 112.053 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -126.51 132.6 51.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.871 0.868 . . . . 0.0 108.74 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.9 mt -129.05 127.2 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -91.06 0.07 OUTLIER Glycine 0 CA--C 1.528 0.9 0 O-C-N 124.87 1.356 . . . . 0.0 112.096 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.32 135.35 32.12 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.863 -0.787 . . . . 0.0 110.865 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.94 133.61 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.223 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.9 158.26 36.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.358 1.063 . . . . 0.0 110.993 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 64.7 m -57.87 -24.31 57.01 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.753 -1.217 . . . . 0.0 114.021 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -66.15 -29.25 69.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.453 -0.779 . . . . 0.0 110.729 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.19 34.63 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 117.918 -1.49 . . . . 0.0 112.933 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.85 154.15 39.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.798 1.799 . . . . 0.0 111.535 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.35 154.16 31.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -116.78 156.43 27.23 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 109.573 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.62 -176.18 38.1 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.691 1.162 . . . . 0.0 115.02 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -134.87 123.97 24.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 113.259 -1.471 . . . . 0.0 107.298 -174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -124.72 131.29 53.47 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.724 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.418 HG13 HD11 ' B' ' 46' ' ' LEU . 2.4 mp -123.72 129.57 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 122.09 0.948 . . . . 0.0 108.597 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.02 141.23 36.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.251 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.97 21.6 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.96 136.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.201 1.0 . . . . 0.0 111.797 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.94 162.2 39.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.241 -0.912 . . . . 0.0 110.999 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.02 -27.45 60.1 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.445 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.09 80.36 10.33 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.214 2.205 . . . . 0.0 109.758 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.64 12.94 0.23 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.722 3.615 . . . . 0.0 118.073 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.0 -28.97 1.38 Allowed Glycine 0 CA--C 1.54 1.621 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -163.25 53.29 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.152 1.476 . . . . 0.0 112.361 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.74 130.54 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 120.782 -1.199 . . . . 0.0 111.358 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 173.5 10.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.049 2.54 . . . . 0.0 108.945 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.418 HD11 HG13 ' B' ' 34' ' ' ILE 0.292 5.4 mp -67.71 131.51 45.72 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.6 m -99.22 117.69 63.67 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.418 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -54.61 138.85 75.92 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.665 1.577 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.5 148.47 46.22 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.248 0.967 . . . . 0.0 110.641 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.66 148.85 33.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.402 2.281 . . . . 0.0 108.646 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.52 -159.09 32.12 Favored Glycine 0 N--CA 1.443 -0.898 0 O-C-N 120.319 -1.488 . . . . 0.0 109.464 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 mt -145.41 147.58 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.784 0.834 . . . . 0.0 111.473 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -133.15 153.99 51.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 122.409 1.099 . . . . 0.0 113.859 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -91.9 157.09 17.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.549 1.166 . . . . 0.0 108.892 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.38 25.09 0.47 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.018 1.727 . . . . 0.0 111.55 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -93.64 -52.16 4.6 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.601 2.36 . . . . 0.0 112.123 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.97 171.86 8.77 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.7 t -69.65 -42.22 74.51 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.747 0.819 . . . . 0.0 111.161 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 69.32 72.68 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.499 1.12 . . . . 0.0 110.931 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.88 169.14 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.003 3.136 . . . . 0.0 118.454 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -86.44 157.24 19.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.063 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' B' ' 83' ' ' CYS . 0.0 OUTLIER -153.21 174.28 14.47 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 124.18 1.943 . . . . 0.0 112.353 174.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.28 149.11 9.22 Favored Glycine 0 N--CA 1.411 -2.992 0 CA-C-N 109.065 -3.698 . . . . 0.0 120.046 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -159.12 153.48 23.99 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.47 149.94 23.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.984 1.714 . . . . 0.0 109.984 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 117.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 173.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -102.11 110.81 22.87 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.799 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.334 49.9 m95 -70.08 155.54 40.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.958 1.837 . . . . 0.0 115.396 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' B' ' 71' ' ' LYS . 9.8 mmpt? -108.54 -44.26 4.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.355 -1.748 . . . . 0.0 114.143 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -91.18 -8.74 47.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.23 1.012 . . . . 0.0 113.691 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -152.38 137.05 16.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.31 2.244 . . . . 0.0 107.36 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.64 111.77 8.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.497 1.498 . . . . 0.0 110.715 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 93.3 p -165.31 169.92 15.28 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.077 1.751 . . . . 0.0 111.635 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.68 141.87 26.13 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.21 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -137.62 123.82 20.48 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.216 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.95 154.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.536 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.24 141.93 51.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 108.676 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.62 119.86 7.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.55 -167.4 29.12 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.412 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -133.56 146.37 50.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.078 -1.061 . . . . 0.0 112.618 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.418 ' HB2' ' CZ ' ' B' ' 64' ' ' PHE . 41.4 t -97.37 122.0 39.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.087 173.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -111.37 172.49 6.85 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.714 1.606 . . . . 0.0 110.669 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mt -128.41 113.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.97 162.47 6.96 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -30.12 -52.53 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.744 2.017 . . . . 0.0 115.772 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -78.35 -0.7 30.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.393 2.277 . . . . 0.0 116.978 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 50.94 6.87 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.439 -1.413 . . . . 0.0 110.505 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -119.91 141.89 49.2 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.514 2.326 . . . . 0.0 105.432 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -111.38 138.5 47.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.265 1.426 . . . . 0.0 110.99 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.6 m -144.3 161.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.686 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -121.04 118.2 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -108.03 111.55 23.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -133.46 171.91 13.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.066 1.412 . . . . 0.0 111.971 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.444 ' HG3' HG23 ' C' ' 113' ' ' THR . 90.6 mmm -124.63 169.32 12.05 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -139.67 162.02 36.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.489 1.614 . . . . 0.0 112.644 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.58 119.65 9.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.017 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 141.54 38.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 123.677 1.703 . . . . 0.0 110.578 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -126.26 114.0 17.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 110.121 -3.218 . . . . 0.0 110.162 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -78.23 156.65 29.64 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.616 1.198 . . . . 0.0 110.824 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.73 82.45 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.404 ' CG2' ' HB1' ' B' ' 112' ' ' ALA . 1.6 t -66.32 172.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.94 1.296 . . . . 0.0 111.815 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -119.2 -2.77 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.25 146.4 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.346 1.07 . . . . 0.0 111.06 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' C' ' 84' ' ' PHE . 14.8 tt -63.57 -26.88 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.958 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.63 -3.62 34.86 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.979 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.16 3.55 10.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.712 1.256 . . . . 0.0 113.271 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -36.13 62.12 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.041 -1.037 . . . . 0.0 111.575 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -48.68 -46.79 40.9 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 -16.06 38.71 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.267 -0.895 . . . . 0.0 112.673 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . 0.404 ' HB1' ' CG2' ' B' ' 103' ' ' VAL . . . -72.25 -8.34 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.429 HG23 ' HG3' ' C' ' 96' ' ' MET . 57.6 m -96.38 156.65 16.25 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.697 0.399 . . . . 0.0 110.227 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ttm-85 -154.27 124.52 6.89 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 126.933 2.093 . . . . 0.0 111.366 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 p -105.63 156.18 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 121.832 2.105 . . . . 0.0 110.166 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.88 -178.0 31.52 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.232 0.958 . . . . 0.0 114.83 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -123.02 152.72 40.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.285 1.034 . . . . 0.0 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -150.61 146.25 26.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.008 0.908 . . . . 0.0 111.331 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.64 119.14 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.082 -1.011 . . . . 0.0 108.67 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.63 154.45 21.97 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.281 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 20.3 p -138.02 164.16 29.78 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.379 1.072 . . . . 0.0 109.645 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.99 123.72 16.14 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.87 156.6 11.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.039 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.89 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -78.85 -15.81 57.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.027 0.83 . . . . 0.0 111.28 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 57.37 -175.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.146 1.779 . . . . 0.0 111.621 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER -162.4 176.66 10.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.94 1.696 . . . . 0.0 110.145 172.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 C-N-CA 130.131 3.372 . . . . 0.0 111.86 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 7.4 p -91.97 175.46 6.87 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.404 1.881 . . . . 0.0 108.592 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 21.4 t 35.97 79.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 127.316 2.246 . . . . 0.0 114.955 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -172.04 -36.07 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.26 36.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.334 1.454 . . . . 0.0 112.625 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -154.64 125.88 7.31 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.491 -1.38 . . . . 0.0 112.943 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 131.49 56.92 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.924 1.345 . . . . 0.0 110.077 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.61 127.52 22.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' C' ' 64' ' ' PHE . 2.7 mt -73.41 -27.56 61.52 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.414 1.071 . . . . 0.0 112.844 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -53.61 117.28 3.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.861 0.838 . . . . 0.0 110.368 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.98 -130.27 4.79 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.719 1.628 . . . . 0.0 109.525 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' C' ' 10' ' ' TRP . 19.7 ttmt -142.46 151.13 41.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.808 1.29 . . . . 0.0 113.288 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' C' ' 9' ' ' LYS . 50.0 m95 -136.18 162.69 32.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 112.469 -2.15 . . . . 0.0 110.816 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -142.84 142.51 31.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.65 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' C' ' 14' ' ' LEU . 4.2 t30 -108.36 148.06 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.918 0.887 . . . . 0.0 112.529 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -27.9 61.74 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.316 1.446 . . . . 0.0 114.365 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.414 ' H ' ' ND2' ' C' ' 12' ' ' ASN . 33.9 tp -72.34 -15.9 61.87 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.393 1.477 . . . . 0.0 113.176 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -14.34 29.51 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.153 2.311 . . . . 0.0 113.645 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.636 1.218 . . . . 0.0 111.29 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -118.49 144.48 45.98 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.264 -0.897 . . . . 0.0 111.061 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -133.79 141.46 47.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.998 0.428 . . . . 0.0 111.63 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 5.9 m -129.73 132.12 46.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.79 127.37 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.57 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.867 1.354 . . . . 0.0 112.18 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.41 135.12 30.05 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.605 -0.938 . . . . 0.0 110.649 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.71 131.67 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.807 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.46 156.37 39.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.791 1.237 . . . . 0.0 110.229 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -57.29 -23.05 46.0 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -66.05 -28.49 68.88 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.531 -0.731 . . . . 0.0 110.797 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.83 -3.94 34.11 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.167 1.365 . . . . 0.0 112.724 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -77.05 158.76 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.71 1.255 . . . . 0.0 113.316 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.02 166.32 33.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.485 0.659 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.7 160.16 33.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.709 1.203 . . . . 0.0 108.702 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.22 -175.5 39.72 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 119.961 -1.114 . . . . 0.0 115.435 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 9.0 p -134.7 123.96 24.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.811 1.244 . . . . 0.0 107.702 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -125.09 130.56 52.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.612 -171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.413 HG13 HD11 ' C' ' 46' ' ' LEU . 2.3 mp -122.9 129.48 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 CA-C-O 121.932 0.872 . . . . 0.0 108.833 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -104.99 140.31 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.996 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.56 -6.39 22.87 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.64 136.93 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.025 0.93 . . . . 0.0 111.645 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.76 162.21 39.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.985 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.98 -27.49 60.18 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -145.78 80.42 10.57 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.989 2.116 . . . . 0.0 109.766 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.85 13.44 0.22 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.835 3.69 . . . . 0.0 118.044 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.71 -28.62 1.7 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.21 53.39 0.18 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.093 1.447 . . . . 0.0 112.037 -174.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -56.84 130.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.914 -1.116 . . . . 0.0 111.087 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.53 172.27 11.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.109 2.564 . . . . 0.0 109.115 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.413 HD11 HG13 ' C' ' 34' ' ' ILE 0.299 5.4 mp -66.95 130.45 43.2 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 59.4 m -98.08 118.15 64.07 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.977 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -55.0 138.65 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.643 1.562 . . . . 0.0 110.061 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -122.53 155.72 35.65 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.331 1.019 . . . . 0.0 110.852 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.38 149.08 25.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.014 1.726 . . . . 0.0 108.799 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.58 29.78 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 119.353 0.979 . . . . 0.0 111.033 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.42 147.0 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.057 0.932 . . . . 0.0 111.938 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -133.57 154.0 51.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.221 1.008 . . . . 0.0 113.225 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -90.67 159.06 16.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.435 1.112 . . . . 0.0 108.765 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 25.05 0.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.689 1.596 . . . . 0.0 111.57 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -93.36 -51.87 4.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.831 2.453 . . . . 0.0 111.328 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 171.96 10.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -71.08 -41.95 70.01 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.665 0.745 . . . . 0.0 110.955 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.56 67.76 80.32 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.405 1.082 . . . . 0.0 111.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -69.69 170.23 16.99 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.902 3.068 . . . . 0.0 118.268 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 41.7 p -86.63 156.42 20.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.903 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.0 OUTLIER -153.58 173.7 15.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.728 1.728 . . . . 0.0 112.762 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.51 148.49 9.12 Favored Glycine 0 N--CA 1.412 -2.927 0 CA-C-N 109.351 -3.568 . . . . 0.0 119.528 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -159.47 153.18 22.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -87.85 150.94 23.22 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.333 1.853 . . . . 0.0 110.021 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.78 117.13 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -102.39 111.47 23.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.969 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.33 49.9 m95 -70.45 154.7 41.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 124.199 1.952 . . . . 0.0 115.448 -172.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' C' ' 71' ' ' LYS . 9.9 mmpt? -107.54 -43.79 4.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.221 -1.809 . . . . 0.0 114.145 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.79 -8.42 46.77 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.57 136.7 16.48 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.286 2.235 . . . . 0.0 107.448 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -72.53 111.21 7.5 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.556 1.525 . . . . 0.0 110.829 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -165.1 170.07 15.45 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 125.879 1.672 . . . . 0.0 111.441 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -147.8 141.92 26.06 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 122.901 1.334 . . . . 0.0 111.264 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -137.04 124.36 21.91 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 110.88 -2.873 . . . . 0.0 110.387 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 m -101.81 154.31 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.555 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.19 142.32 51.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.102 0.961 . . . . 0.0 108.419 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.09 120.16 7.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.3 -167.31 28.75 Favored Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.11 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.58 146.67 51.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 125.171 1.159 . . . . 0.0 112.656 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 44.7 t -97.23 125.56 41.85 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 115.66 -2.114 . . . . 0.0 108.009 174.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' B' ' 106' ' ' ILE . 13.8 m-85 -114.4 171.27 7.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.928 1.691 . . . . 0.0 110.614 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.03 110.77 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.26 157.67 13.04 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -23.45 -57.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.978 2.111 . . . . 0.0 116.53 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.0 -14.18 62.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.91 20.95 10.66 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.031 0.824 . . . . 0.0 113.68 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -91.09 142.28 27.93 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.849 1.325 . . . . 0.0 110.296 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -101.47 139.46 37.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.281 1.032 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 22.8 m -142.17 161.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.179 1.392 . . . . 0.0 110.057 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 14.8 mt -119.26 116.92 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -107.43 110.76 22.79 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -132.34 171.51 13.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 123.24 1.495 . . . . 0.0 111.862 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.429 ' HG3' HG23 ' B' ' 113' ' ' THR . 91.2 mmm -124.68 169.07 12.32 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -139.36 162.33 35.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 123.378 1.561 . . . . 0.0 112.658 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.76 119.48 9.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.069 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.74 38.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.465 1.602 . . . . 0.0 110.403 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -126.14 113.9 17.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 110.346 -3.116 . . . . 0.0 109.762 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -77.11 156.48 31.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.032 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 52.6 m -103.05 83.14 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.52 172.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.472 1.109 . . . . 0.0 111.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -118.04 -5.21 10.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.93 148.01 37.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.73 1.252 . . . . 0.0 110.202 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.61 -25.73 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.02 -1.446 . . . . 0.0 112.909 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.15 -1.75 36.05 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.579 -1.123 . . . . 0.0 115.393 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.25 3.09 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.287 1.044 . . . . 0.0 113.54 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.91 60.52 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.2 -0.938 . . . . 0.0 111.556 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -50.28 -46.35 55.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.137 0.975 . . . . 0.0 113.565 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -15.12 41.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.158 -0.964 . . . . 0.0 112.577 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.54 -8.12 54.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' THR . . . . . 0.444 HG23 ' HG3' ' B' ' 96' ' ' MET . 62.2 m -96.63 155.12 16.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.675 0.39 . . . . 0.0 110.044 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttm-85 -153.04 124.02 7.43 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 126.931 2.092 . . . . 0.0 111.208 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.09 156.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 121.77 2.077 . . . . 0.0 110.091 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -177.54 31.46 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.206 0.941 . . . . 0.0 114.962 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -123.85 152.41 42.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.276 1.03 . . . . 0.0 110.908 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -150.43 147.0 27.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.936 0.895 . . . . 0.0 111.187 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.97 121.77 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -112.93 153.47 27.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.683 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.7 p -134.13 162.55 31.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.106 0.962 . . . . 0.0 110.317 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -55.5 121.77 9.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.948 0.899 . . . . 0.0 109.691 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -70.54 109.75 5.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.921 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 53.86 90.31 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.46 1.504 . . . . 0.0 111.598 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -94.51 -74.72 0.53 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -76.7 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.683 1.593 . . . . 0.0 109.885 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -156.77 -82.71 0.06 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.669 1.587 . . . . 0.0 112.301 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 114.136 -2.84 . . . . 0.0 114.861 -172.718 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 7.6 p -144.51 88.42 1.93 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.727 1.611 . . . . 0.0 109.36 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.73 142.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.237 0.615 . . . . 0.0 110.434 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -113.38 168.65 9.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.554 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.307 0.8 OUTLIER -154.47 73.56 0.91 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 0.0 111.37 -175.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.91 114.36 3.15 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.062 -1.024 . . . . 0.0 113.191 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -124.09 129.2 50.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.077 0.941 . . . . 0.0 110.963 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -139.61 127.5 22.11 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.248 -1.532 . . . . 0.0 114.279 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.448 HD21 ' CE2' ' A' ' 64' ' ' PHE . 21.1 mt -55.51 -32.84 63.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -54.83 122.02 9.87 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.724 1.249 . . . . 0.0 110.932 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.25 -108.31 0.87 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.512 2.006 . . . . 0.0 111.696 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.12 144.0 20.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -140.76 162.79 34.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.327 1.851 . . . . 0.0 110.632 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -141.71 151.44 42.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.237 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 120' ' ' PHE . 4.6 t30 -116.42 146.31 42.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.376 1.071 . . . . 0.0 112.521 -173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.49 -23.67 64.69 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 tp -71.58 -15.7 62.28 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.703 -1.248 . . . . 0.0 112.115 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.82 -14.35 24.34 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 128.382 2.896 . . . . 0.0 113.686 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p -63.31 144.27 57.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.456 1.128 . . . . 0.0 112.987 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.509 HD22 HD12 ' A' ' 34' ' ' ILE . 6.2 p30 -115.66 140.34 49.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -130.71 139.81 50.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.545 0.688 . . . . 0.0 111.084 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.7 m -129.0 131.52 47.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.21 127.02 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.51 -88.4 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.299 1.0 . . . . 0.0 111.553 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.24 42.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.863 0.839 . . . . 0.0 112.426 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 t -98.14 123.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.017 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.22 156.0 38.51 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 m -55.21 -22.01 16.14 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -72.32 -37.78 68.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.359 0.664 . . . . 0.0 111.237 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.31 -2.66 18.64 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 117.336 -1.813 . . . . 0.0 113.422 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.26 137.44 53.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.928 1.691 . . . . 0.0 107.079 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.25 148.19 25.61 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.16 163.58 15.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.192 0.997 . . . . 0.0 109.374 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.35 -168.0 34.59 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 120.947 -1.095 . . . . 0.0 113.165 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 p -141.54 129.69 22.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.965 1.364 . . . . 0.0 110.831 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.64 141.02 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.019 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.509 HD12 HD22 ' A' ' 17' ' ' ASN . 7.9 mt -131.93 128.75 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.375 1.083 . . . . 0.0 108.53 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.3 m -105.65 133.76 49.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.615 -1.175 . . . . 0.0 113.073 -173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.26 -17.87 23.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.74 142.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.831 1.252 . . . . 0.0 111.83 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.98 153.81 40.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.028 -1.045 . . . . 0.0 111.268 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.54 -24.25 66.35 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -147.88 76.56 10.53 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 128.518 2.727 . . . . 0.0 112.053 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.03 169.56 18.97 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.169 2.579 . . . . 0.0 112.431 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.88 -29.55 1.55 Allowed Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.473 1.035 . . . . 0.0 113.078 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.06 2.89 3.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.559 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -31.83 112.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.151 1.78 . . . . 0.0 114.354 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 157.78 41.59 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.556 1.543 . . . . 0.0 110.879 -176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.72 115.51 1.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.021 2.928 . . . . 0.0 111.623 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 t -103.48 117.06 60.97 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.454 1.102 . . . . 0.0 109.933 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 144.22 82.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.27 2.647 . . . . 0.0 112.552 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.71 155.08 45.64 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.673 0.789 . . . . 0.0 111.863 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -159.75 147.61 17.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.164 1.785 . . . . 0.0 112.296 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.17 -151.55 21.91 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 120.786 1.63 . . . . 0.0 110.954 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.24 137.86 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 113.135 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -120.95 141.03 51.05 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.15 -50.47 71.72 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.503 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.92 14.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 127.395 2.278 . . . . 0.0 116.852 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.76 -47.08 6.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.515 2.726 . . . . 0.0 115.103 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.76 -174.11 2.46 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.319 1.012 . . . . 0.0 111.63 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -83.43 -36.72 24.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -124.41 56.67 12.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.667 1.187 . . . . 0.0 110.497 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.02 164.04 37.16 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.884 3.056 . . . . 0.0 116.309 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.5 p -82.21 167.79 18.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.95 1.3 . . . . 0.0 111.383 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -159.13 162.29 36.43 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.818 -1.176 . . . . 0.0 112.961 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.86 139.24 5.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 118.731 -1.7 . . . . 0.0 117.053 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -163.0 151.73 14.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 m -88.29 148.98 24.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.562 1.945 . . . . 0.0 110.549 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -126.02 117.72 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -97.33 105.4 17.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.147 0.579 . . . . 0.0 112.376 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -74.76 147.99 40.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -110.7 -45.71 3.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.165 -1.38 . . . . 0.0 114.647 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -80.86 -11.3 59.61 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -152.53 133.24 13.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.789 2.436 . . . . 0.0 105.838 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.26 118.52 14.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.695 1.134 . . . . 0.0 111.2 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -178.52 167.15 1.82 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-O 123.625 1.679 . . . . 0.0 110.895 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 t -144.69 144.71 31.36 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.123 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -140.7 131.71 26.19 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 110.15 -3.205 . . . . 0.0 110.312 -172.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.7 143.63 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.06 143.74 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 116.78 9.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.98 -176.13 24.37 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 119.389 -1.386 . . . . 0.0 115.625 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -123.17 147.8 46.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.702 -1.249 . . . . 0.0 111.059 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 39.0 t -96.88 120.81 37.91 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.651 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.24 166.9 11.34 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.731 1.213 . . . . 0.0 114.089 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.01 110.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.01 154.18 16.08 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -33.63 -41.97 0.1 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.619 1.968 . . . . 0.0 115.97 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -13.96 60.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 50.36 2.83 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.44 137.61 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.449 1.9 . . . . 0.0 109.492 174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -101.28 148.24 25.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.004 2.121 . . . . 0.0 112.164 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -152.09 155.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.606 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.04 105.92 10.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HE3' HD13 ' A' ' 119' ' ' ILE . 3.0 mmtt -98.33 119.33 36.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 p -130.35 162.5 28.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.346 1.546 . . . . 0.0 112.632 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.96 162.78 14.49 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -136.84 161.38 36.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.134 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.57 121.57 10.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 113.248 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.76 142.23 38.1 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.923 1.344 . . . . 0.0 112.241 -175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -127.99 113.95 16.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 111.798 -2.455 . . . . 0.0 112.524 -174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.25 0.4 OUTLIER -71.95 165.68 23.71 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 125.269 1.606 . . . . 0.0 110.549 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -113.26 79.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.19 175.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 121.524 -0.735 . . . . 0.0 110.529 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -22.89 15.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.08 150.32 43.32 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 123.156 1.455 . . . . 0.0 112.678 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.3 -27.57 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.141 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.87 9.32 24.85 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.959 0.79 . . . . 0.0 113.934 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -120.59 -0.41 10.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.328 1.051 . . . . 0.0 112.187 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -32.0 70.53 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.646 -1.284 . . . . 0.0 113.408 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.86 -44.91 59.67 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.911 1.684 . . . . 0.0 112.652 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -93.26 -10.63 34.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.332 1.053 . . . . 0.0 113.002 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.42 9.34 1.75 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.372 -0.83 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.9 m -117.45 139.3 51.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.853 0.861 . . . . 0.0 113.195 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.51 116.18 12.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 127.414 2.286 . . . . 0.0 111.281 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.68 152.91 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.725 1.148 . . . . 0.0 110.177 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.32 -174.24 31.97 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.56 154.66 44.91 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.705 -0.879 . . . . 0.0 112.195 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -146.71 152.63 39.15 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.815 1.246 . . . . 0.0 109.736 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.9 mt -136.46 119.01 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 12' ' ' ASN . 21.1 m-85 -109.68 149.38 29.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.331 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -134.74 163.32 30.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -56.82 119.91 7.0 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.845 0.858 . . . . 0.0 110.964 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 123' ' ' LEU . 10.4 tt -77.7 117.21 18.88 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.92 -171.05 0.42 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.661 1.184 . . . . 0.0 113.293 174.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -53.22 0.24 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.476 1.51 . . . . 0.0 111.485 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -100.58 153.46 19.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 111.149 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' NZ ' ' OXT' ' A' ' 128' ' ' GLU . 5.0 tmtm? 70.05 101.52 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.087 2.155 . . . . 0.0 112.421 175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.404 ' OXT' ' NZ ' ' A' ' 127' ' ' LYS . 2.5 mp0 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 129.288 3.035 . . . . 0.0 110.866 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 116.944 -1.503 . . . . 0.0 107.808 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 11.7 m 51.74 85.72 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.52 13.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.423 1.089 . . . . 0.0 113.238 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -66.86 145.71 55.19 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.466 -1.396 . . . . 0.0 112.009 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -139.83 74.55 1.47 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.745 1.618 . . . . 0.0 110.79 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 125.49 10.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.872 -1.142 . . . . 0.0 112.698 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 22.5 p -136.48 130.41 32.53 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.693 0.758 . . . . 0.0 111.501 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -139.77 129.51 24.57 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.4 -1.437 . . . . 0.0 114.56 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.458 HD21 ' CE2' ' D' ' 64' ' ' PHE . 20.7 mt -56.89 -32.16 65.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -55.58 119.71 6.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.968 1.366 . . . . 0.0 111.744 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.94 -116.5 1.99 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.203 1.859 . . . . 0.0 110.819 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.7 146.43 30.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -174.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -141.57 161.92 36.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.232 1.413 . . . . 0.0 111.077 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.2 148.14 37.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -113.03 147.64 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.362 1.065 . . . . 0.0 112.599 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.74 -23.47 64.96 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.8 tp -73.08 -14.47 61.4 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.477 1.511 . . . . 0.0 112.257 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.11 -12.92 34.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.857 2.646 . . . . 0.0 113.913 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.47 148.68 50.09 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.584 1.192 . . . . 0.0 112.824 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . 0.526 HD22 HD12 ' D' ' 34' ' ' ILE . 5.8 p30 -121.66 143.08 49.54 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.58 0.752 . . . . 0.0 110.543 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -132.07 139.88 48.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.605 0.717 . . . . 0.0 111.849 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -127.74 132.78 49.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.74 123.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.42 -79.95 0.24 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.346 1.029 . . . . 0.0 111.78 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.24 42.09 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.848 -0.795 . . . . 0.0 112.084 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -100.53 125.25 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.616 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -69.46 156.7 38.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 20.1 m -55.88 -21.7 21.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -70.75 -35.73 72.78 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.688 0.676 . . . . 0.0 111.283 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.95 -1.39 21.27 Favored Glycine 0 N--CA 1.469 0.9 0 C-N-CA 124.52 1.057 . . . . 0.0 112.95 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.89 149.81 44.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 110.717 173.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.15 163.86 39.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.034 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -125.81 167.69 14.85 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.4 -166.49 33.12 Favored Glycine 0 N--CA 1.467 0.74 0 O-C-N 120.031 -1.668 . . . . 0.0 113.201 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -140.32 132.1 27.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.772 1.273 . . . . 0.0 111.539 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.5 139.1 50.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.463 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.526 HD12 HD22 ' D' ' 17' ' ' ASN . 7.8 mt -129.97 131.48 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.84 0.829 . . . . 0.0 108.789 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 7.7 m -109.32 134.78 51.37 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 -19.22 21.55 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.38 141.54 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.892 1.277 . . . . 0.0 112.161 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.38 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.947 -1.096 . . . . 0.0 111.333 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.99 -24.08 66.7 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -147.91 76.72 10.45 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 128.536 2.734 . . . . 0.0 112.041 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.25 169.35 19.73 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.181 2.587 . . . . 0.0 112.517 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.87 -29.18 1.56 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.574 1.083 . . . . 0.0 113.123 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.29 2.87 3.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.736 -1.126 . . . . 0.0 113.533 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 50.8 mt -32.36 113.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 114.242 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.73 157.96 41.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.55 1.54 . . . . 0.0 110.747 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 tp -47.48 115.36 1.1 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.712 2.805 . . . . 0.0 111.074 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.25 117.15 60.93 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.853 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.02 143.03 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.867 2.378 . . . . 0.0 112.272 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -128.48 163.76 24.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.87 0.868 . . . . 0.0 112.209 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -169.07 149.01 4.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.249 1.42 . . . . 0.0 113.842 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 -150.96 21.56 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 120.883 1.674 . . . . 0.0 111.315 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.32 135.35 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.965 0.906 . . . . 0.0 111.705 -174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -120.16 140.18 51.5 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 110.113 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.21 -50.0 74.86 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.436 -0.79 . . . . 0.0 111.525 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.09 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.67 2.388 . . . . 0.0 116.634 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.94 -46.64 7.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.386 2.675 . . . . 0.0 115.053 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.25 -175.43 3.67 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.26 0.975 . . . . 0.0 112.512 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 40.8 t -81.67 -35.28 30.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.561 0.745 . . . . 0.0 111.576 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.29 58.56 31.44 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 125.041 1.336 . . . . 0.0 111.033 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.91 163.34 38.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.742 2.962 . . . . 0.0 117.317 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -81.63 168.08 18.53 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.197 1.399 . . . . 0.0 111.569 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.458 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -159.12 162.26 36.44 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.736 -1.227 . . . . 0.0 112.967 174.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.0 139.08 5.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 118.873 -1.632 . . . . 0.0 116.871 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.89 153.12 16.26 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -89.11 151.61 22.12 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 127.601 2.36 . . . . 0.0 110.325 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 32.1 t -129.25 119.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -99.2 105.15 17.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.242 0.617 . . . . 0.0 112.004 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -74.34 147.27 42.38 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -110.1 -45.12 3.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.099 -1.409 . . . . 0.0 114.554 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.67 -11.16 59.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.55 132.91 13.68 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.881 2.473 . . . . 0.0 105.671 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.3 118.49 15.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.808 1.185 . . . . 0.0 111.193 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.79 166.55 1.68 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.94 1.696 . . . . 0.0 111.116 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 t -143.96 144.63 31.78 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.217 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 133.25 29.25 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 109.975 -3.284 . . . . 0.0 109.797 -172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.85 143.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.682 0.614 . . . . 0.0 109.548 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -116.3 143.91 44.92 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.7 116.55 8.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.45 -175.72 23.53 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.669 -1.253 . . . . 0.0 115.757 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.42 147.41 47.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.438 -1.381 . . . . 0.0 110.776 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.16 123.61 40.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.872 1.358 . . . . 0.0 110.624 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -116.65 163.02 16.75 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -130.16 110.4 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.96 157.44 9.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -36.22 -40.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.445 1.898 . . . . 0.0 115.578 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -78.2 -10.23 59.55 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.14 51.03 4.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.057 0.836 . . . . 0.0 111.633 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.5 147.08 46.78 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 129.107 2.963 . . . . 0.0 107.401 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -112.73 152.63 28.85 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 120.267 1.394 . . . . 0.0 111.279 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -153.37 158.3 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.516 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 mt -121.17 108.13 13.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . 0.474 ' HE3' HD13 ' D' ' 119' ' ' ILE . 2.8 mmtt -100.76 117.67 35.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -129.28 163.08 26.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.608 1.671 . . . . 0.0 112.88 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.12 162.54 14.8 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 170.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -136.55 161.51 35.68 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.879 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.59 121.94 10.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.298 -1.774 . . . . 0.0 113.05 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 141.76 38.52 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.859 1.314 . . . . 0.0 112.556 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -126.98 114.06 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 111.731 -2.486 . . . . 0.0 112.303 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.63 165.62 23.57 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 125.039 1.462 . . . . 0.0 110.557 173.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 8.3 t -113.53 77.11 1.02 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.82 176.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.23 -22.81 15.45 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.95 150.0 41.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 123.088 1.423 . . . . 0.0 112.914 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.57 -28.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.442 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 9.01 21.35 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.202 0.906 . . . . 0.0 113.961 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.45 -1.81 10.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.556 1.142 . . . . 0.0 111.878 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -31.45 70.27 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.394 -1.441 . . . . 0.0 113.279 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.62 -46.23 58.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.579 1.552 . . . . 0.0 112.52 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -91.73 -10.94 38.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.27 1.028 . . . . 0.0 112.832 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 8.75 2.08 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.605 -0.684 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 19.5 m -116.42 139.22 50.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.986 0.914 . . . . 0.0 113.28 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.54 116.21 12.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.4 2.28 . . . . 0.0 111.151 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.66 152.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.825 1.193 . . . . 0.0 110.394 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.51 -173.83 31.67 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -127.77 154.92 44.83 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.679 -0.895 . . . . 0.0 112.266 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -147.41 151.19 36.07 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.457 1.103 . . . . 0.0 109.746 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . 0.474 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -135.69 119.18 24.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -111.12 151.72 27.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.566 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -137.4 167.64 21.22 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -61.69 125.61 24.41 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.586 -1.321 . . . . 0.0 113.246 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tt -84.65 95.83 9.02 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.87 140.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.712 2.005 . . . . 0.0 113.083 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 20.7 p -152.18 167.58 28.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.218 1.007 . . . . 0.0 111.991 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.8 148.92 44.07 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.858 0.463 . . . . 0.0 110.485 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm 91.92 109.49 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.459 3.103 . . . . 0.0 108.738 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.419 3.088 . . . . 0.0 106.661 -176.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 5.1 m -148.22 146.05 28.51 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 108.781 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.43 105.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.457 1.103 . . . . 0.0 110.899 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.94 -18.73 0.05 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 24.3 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 128.434 2.694 . . . . 0.0 115.644 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.39 128.81 20.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.072 0.949 . . . . 0.0 111.647 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 24.9 p -139.68 127.96 22.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.623 0.769 . . . . 0.0 110.226 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -139.74 127.7 22.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.417 -1.427 . . . . 0.0 114.567 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.459 HD21 ' CE2' ' B' ' 64' ' ' PHE . 20.7 mt -55.62 -32.34 63.06 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -54.47 118.81 4.45 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.323 1.535 . . . . 0.0 111.732 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.14 -106.87 0.66 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.883 1.706 . . . . 0.0 111.302 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.27 146.58 21.51 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -140.71 162.84 34.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.548 1.539 . . . . 0.0 110.578 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -139.36 152.22 46.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -117.5 146.86 43.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 111.864 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -60.89 -22.12 63.99 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.7 tp -73.45 -14.19 61.2 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.959 1.304 . . . . 0.0 112.238 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.69 -13.32 35.39 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 128.069 2.747 . . . . 0.0 113.743 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 3.4 p -64.1 148.62 49.44 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.293 -1.122 . . . . 0.0 112.73 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.512 HD22 HD12 ' B' ' 34' ' ' ILE . 5.7 p30 -122.42 140.42 52.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.471 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -128.71 139.19 52.34 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.976 0.893 . . . . 0.0 111.793 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.93 131.93 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.016 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.39 126.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.4 -86.8 0.13 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.529 1.143 . . . . 0.0 111.531 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.36 154.15 42.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.916 0.865 . . . . 0.0 112.607 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.6 123.57 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.214 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -68.12 155.89 38.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.112 0.415 . . . . 0.0 109.916 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 20.3 m -54.99 -22.29 14.75 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -72.25 -37.42 69.11 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.636 0.653 . . . . 0.0 111.178 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -2.52 19.41 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-O 117.378 -1.79 . . . . 0.0 113.471 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.37 137.52 52.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.078 1.751 . . . . 0.0 107.112 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.31 147.75 25.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.05 162.66 16.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.39 1.076 . . . . 0.0 109.62 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.36 -167.48 33.21 Favored Glycine 0 CA--C 1.523 0.538 0 O-C-N 120.972 -1.08 . . . . 0.0 113.407 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -140.66 131.6 26.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.785 1.279 . . . . 0.0 110.952 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -114.42 138.73 50.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.792 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.512 HD12 HD22 ' B' ' 17' ' ' ASN . 7.6 mt -129.97 132.45 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 16.9 m -110.46 134.75 52.06 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.88 -18.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.59 141.71 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.88 1.272 . . . . 0.0 111.93 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.77 154.19 41.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.994 -1.066 . . . . 0.0 110.959 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.74 -24.55 66.24 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -148.12 76.61 10.29 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.577 2.751 . . . . 0.0 111.979 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.05 169.75 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.152 2.568 . . . . 0.0 112.566 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.82 -29.46 1.56 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.502 1.048 . . . . 0.0 113.158 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.02 2.73 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.512 1.125 . . . . 0.0 113.535 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 52.2 mt -31.9 113.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 126.164 1.786 . . . . 0.0 114.429 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.37 158.54 39.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.455 1.502 . . . . 0.0 110.84 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 tp -48.62 115.41 1.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.672 2.789 . . . . 0.0 111.139 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -103.65 117.79 59.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.944 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.27 144.4 82.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.197 2.598 . . . . 0.0 112.782 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.49 155.51 44.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.831 0.852 . . . . 0.0 111.84 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -160.37 147.65 16.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.183 1.793 . . . . 0.0 112.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.23 -151.53 21.87 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 120.789 1.631 . . . . 0.0 111.051 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.15 137.95 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.855 0.862 . . . . 0.0 113.176 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -121.0 141.1 51.05 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.098 -1.001 . . . . 0.0 110.706 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.81 -50.33 72.74 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.21 -0.931 . . . . 0.0 111.617 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 41.68 16.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 127.504 2.322 . . . . 0.0 116.907 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . 0.255 6.7 ptp180 -93.67 -46.19 7.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.948 2.499 . . . . 0.0 115.095 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 -175.33 4.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.318 1.011 . . . . 0.0 112.802 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -33.1 29.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.384 1.074 . . . . 0.0 111.45 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.03 57.51 30.59 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 124.849 1.26 . . . . 0.0 111.005 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.58 163.34 38.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.366 2.711 . . . . 0.0 117.078 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p -81.79 168.58 17.87 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -159.92 161.97 34.4 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.783 -1.198 . . . . 0.0 113.134 174.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.81 139.28 5.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 118.83 -1.652 . . . . 0.0 117.065 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -163.43 151.86 13.79 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.57 150.89 23.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.513 1.925 . . . . 0.0 110.771 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -127.85 117.75 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -97.63 104.24 16.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.254 0.622 . . . . 0.0 112.264 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.254 32.6 m95 -74.04 147.24 43.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -109.91 -46.05 3.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.461 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.89 -11.28 59.61 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -152.51 133.35 14.03 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.964 2.505 . . . . 0.0 106.055 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.46 118.58 15.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.028 1.285 . . . . 0.0 110.617 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -178.74 166.72 1.71 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.978 1.711 . . . . 0.0 110.952 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -144.38 144.79 31.59 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.273 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -140.53 132.95 28.46 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 110.341 -3.118 . . . . 0.0 110.043 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.05 143.33 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.04 143.85 44.55 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.719 0.637 . . . . 0.0 109.478 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.29 116.85 9.17 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.65 24.92 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.337 -1.411 . . . . 0.0 115.222 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -122.85 148.01 45.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.807 1.534 . . . . 0.0 110.426 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 t -97.04 124.54 41.06 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.255 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -116.09 164.57 14.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.6 mt -131.75 107.91 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -59.29 154.74 15.85 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -35.11 -41.17 0.14 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -11.91 59.88 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.34 52.63 3.34 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 122.199 0.888 . . . . 0.0 111.863 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.16 148.18 45.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 129.135 2.974 . . . . 0.0 105.023 173.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -114.13 150.81 33.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.362 1.465 . . . . 0.0 110.326 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.77 159.93 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.439 1.095 . . . . 0.0 110.398 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 mt -121.9 108.6 13.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.455 ' HE3' HD13 ' B' ' 119' ' ' ILE . 2.6 mmtt -101.46 117.64 35.34 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 172.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -130.0 162.67 28.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.303 1.525 . . . . 0.0 112.463 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.22 163.03 14.35 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -137.04 161.42 36.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.075 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.59 121.6 10.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.303 -1.771 . . . . 0.0 113.203 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.69 142.34 37.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.947 1.356 . . . . 0.0 112.258 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -128.0 113.98 16.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 111.504 -2.589 . . . . 0.0 112.28 -174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.23 165.61 24.07 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 125.147 1.53 . . . . 0.0 110.19 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.9 t -113.69 77.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -66.28 177.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -100.83 -22.45 14.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.88 148.72 43.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 123.047 1.404 . . . . 0.0 112.648 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 18.0 tt -62.24 -27.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.267 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.92 8.49 22.29 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.135 0.874 . . . . 0.0 113.782 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -120.89 -0.46 10.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.39 1.076 . . . . 0.0 112.535 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -31.78 69.86 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 120.785 -1.197 . . . . 0.0 113.466 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -50.25 -46.56 54.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.628 1.571 . . . . 0.0 112.406 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.13 -10.39 39.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.045 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.03 2.03 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.575 -0.703 . . . . 0.0 111.845 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 21.5 m -116.45 139.13 50.78 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.948 0.899 . . . . 0.0 113.158 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.27 116.15 13.17 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.589 2.356 . . . . 0.0 111.163 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.7 152.69 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.699 1.136 . . . . 0.0 110.235 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.19 -174.39 32.02 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.787 -0.831 . . . . 0.0 112.133 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -147.32 150.7 35.26 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.697 1.199 . . . . 0.0 109.571 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.455 HD13 ' HE3' ' B' ' 94' ' ' LYS . 12.4 mt -135.24 119.8 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -110.39 152.11 26.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.171 0.92 . . . . 0.0 109.535 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -136.67 165.79 25.08 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -56.87 136.14 55.77 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.786 -1.196 . . . . 0.0 113.179 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.74 131.28 49.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.34 179.59 0.24 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 129.607 3.163 . . . . 0.0 109.919 -173.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m 98.04 160.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 128.499 2.72 . . . . 0.0 109.952 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 55.23 0.44 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.895 1.678 . . . . 0.0 110.213 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' B' ' 127' ' ' LYS . 4.1 mmpt? -141.75 18.97 2.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.582 2.353 . . . . 0.0 113.403 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.253 1.262 0 O-C-N 125.208 1.567 . . . . 0.0 108.791 173.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 117.203 -1.38 . . . . 0.0 107.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 44.6 m -109.01 118.34 36.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.452 1.023 . . . . 0.0 108.822 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 21.2 t -137.62 110.26 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.92 0.888 . . . . 0.0 108.869 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.02 -32.75 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . 0.342 3.7 ptp180 35.56 54.18 0.84 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.521 2.328 . . . . 0.0 116.045 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.78 132.44 19.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.372 1.069 . . . . 0.0 111.892 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 25.1 p -143.09 125.95 16.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.726 0.81 . . . . 0.0 109.503 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -139.56 129.39 24.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.232 -1.543 . . . . 0.0 114.503 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' C' ' 64' ' ' PHE . 20.2 mt -56.38 -29.75 61.84 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -56.89 121.62 10.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 123.324 1.535 . . . . 0.0 111.643 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.13 -112.02 1.23 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.424 1.964 . . . . 0.0 110.582 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -149.12 147.73 28.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.744 0.818 . . . . 0.0 113.142 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -141.86 162.51 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.293 1.437 . . . . 0.0 110.474 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -140.76 150.76 43.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -115.02 146.42 41.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.103 0.961 . . . . 0.0 112.669 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.89 -21.31 63.2 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.69 -16.21 61.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.297 1.439 . . . . 0.0 112.19 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.45 -13.58 27.92 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.869 2.652 . . . . 0.0 113.984 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.88 149.17 50.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.688 1.244 . . . . 0.0 112.981 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.525 HD22 HD12 ' C' ' 34' ' ' ILE . 5.9 p30 -122.05 142.75 50.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.688 0.795 . . . . 0.0 110.754 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -131.4 139.51 49.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.447 0.641 . . . . 0.0 112.202 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -126.93 132.76 50.79 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.93 123.22 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -77.14 0.43 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.148 0.905 . . . . 0.0 111.908 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.82 157.44 42.93 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.77 0.795 . . . . 0.0 112.176 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 t -101.77 125.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.815 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -69.83 156.58 38.83 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -55.89 -21.69 21.58 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -70.38 -36.11 73.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.251 0.62 . . . . 0.0 111.337 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.04 -0.98 21.16 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 124.614 1.102 . . . . 0.0 112.899 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.67 149.74 43.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.696 0.799 . . . . 0.0 110.73 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -156.21 163.74 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.835 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 168.38 13.87 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.99 -166.86 34.03 Favored Glycine 0 N--CA 1.465 0.633 0 O-C-N 120.073 -1.642 . . . . 0.0 113.212 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -140.64 132.24 27.14 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 123.024 1.393 . . . . 0.0 111.454 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -117.04 138.5 51.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.872 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.525 HD12 HD22 ' C' ' 17' ' ' ASN . 7.5 mt -129.36 131.16 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m -109.53 134.93 51.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.322 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.63 -17.39 22.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.23 141.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.7 1.2 . . . . 0.0 112.099 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.66 154.51 41.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.39 -24.47 65.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -148.0 76.59 10.41 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 128.573 2.749 . . . . 0.0 111.965 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.11 169.39 19.48 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.231 2.62 . . . . 0.0 112.411 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.86 -29.33 1.56 Allowed Glycine 0 N--CA 1.474 1.206 0 C-N-CA 124.57 1.081 . . . . 0.0 113.138 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 2.93 3.32 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 117.656 -1.164 . . . . 0.0 113.529 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 52.4 mt -32.3 113.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.075 1.75 . . . . 0.0 114.311 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.03 158.1 41.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.72 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 tp -47.56 115.42 1.13 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.764 2.826 . . . . 0.0 111.132 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.2 117.23 60.79 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.998 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.13 142.92 85.92 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.877 2.385 . . . . 0.0 112.269 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.66 163.62 24.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.865 0.866 . . . . 0.0 112.311 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 27.4 tp -169.26 148.93 4.02 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 113.936 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.63 -151.07 21.78 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 120.928 1.695 . . . . 0.0 111.414 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.39 135.47 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.806 0.843 . . . . 0.0 111.543 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -119.73 140.68 50.32 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.765 1.226 . . . . 0.0 109.921 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.0 -50.34 72.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.487 -0.758 . . . . 0.0 111.388 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.68 15.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.64 2.376 . . . . 0.0 116.456 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.67 -45.83 7.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.281 2.633 . . . . 0.0 114.895 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -173.97 3.53 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 124.434 1.084 . . . . 0.0 112.765 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 48.4 t -81.02 -37.9 28.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.062 . . . . 0.0 111.027 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.28 58.47 30.77 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 125.111 1.364 . . . . 0.0 111.392 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.68 163.1 40.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.771 2.981 . . . . 0.0 116.953 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -81.5 167.9 18.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.636 1.574 . . . . 0.0 111.657 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.451 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.28 161.81 35.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.662 -1.274 . . . . 0.0 113.064 174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.49 139.21 5.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 118.78 -1.676 . . . . 0.0 116.608 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -162.73 153.72 17.27 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -89.73 151.72 21.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.616 2.366 . . . . 0.0 110.49 174.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 t -129.38 118.42 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -98.53 104.89 16.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 111.976 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -74.33 147.05 42.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.47 -45.98 3.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.337 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -80.51 -11.3 59.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.2 t -152.56 133.22 13.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.915 2.486 . . . . 0.0 105.961 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.04 118.49 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.802 1.183 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.83 166.48 1.66 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.916 1.686 . . . . 0.0 111.085 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -144.02 144.8 31.82 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.102 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -140.4 132.89 28.58 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 109.971 -3.286 . . . . 0.0 109.972 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 144.93 19.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -116.64 144.36 44.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.9 117.16 8.99 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -176.44 24.52 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 119.48 -1.343 . . . . 0.0 115.155 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -123.15 147.51 46.73 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 125.795 1.527 . . . . 0.0 110.527 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 5.4 t -97.09 123.64 40.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.027 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -116.51 164.65 14.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.09 111.55 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -60.89 154.75 21.38 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -34.7 -41.61 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.334 1.854 . . . . 0.0 115.849 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -13.88 60.96 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.55 46.26 4.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.478 1.037 . . . . 0.0 113.097 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.48 151.56 34.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.521 2.728 . . . . 0.0 106.172 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -115.25 150.05 36.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.865 1.666 . . . . 0.0 110.987 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.88 158.95 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.233 1.413 . . . . 0.0 110.762 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mt -121.67 109.91 15.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.682 -2.711 . . . . 0.0 103.682 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . 0.464 ' HE3' HD13 ' C' ' 119' ' ' ILE . 2.9 mmtt -102.35 116.69 33.16 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -129.08 163.13 26.13 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.429 1.585 . . . . 0.0 112.741 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.5 162.88 14.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -136.96 161.6 35.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.952 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.85 121.65 9.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.142 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 142.05 38.08 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.706 1.241 . . . . 0.0 112.319 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -127.54 113.99 16.85 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 111.762 -2.472 . . . . 0.0 112.364 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.255 0.4 OUTLIER -71.79 165.96 23.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.583 173.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -114.22 79.53 1.27 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.53 177.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.59 -0.694 . . . . 0.0 110.52 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.43 -22.79 15.37 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.6 150.01 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.116 1.436 . . . . 0.0 113.134 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.92 -27.25 41.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.145 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.17 9.06 28.21 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.256 0.932 . . . . 0.0 113.738 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -119.49 -1.39 10.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.48 1.112 . . . . 0.0 111.852 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.78 -31.58 70.94 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.385 -1.447 . . . . 0.0 113.142 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -50.44 -45.81 56.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.694 1.597 . . . . 0.0 112.523 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.86 -10.36 36.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.367 1.067 . . . . 0.0 113.026 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.41 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.779 -0.576 . . . . 0.0 111.851 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 22.2 m -116.93 139.56 50.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.887 0.875 . . . . 0.0 113.089 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -136.44 116.18 13.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.624 2.37 . . . . 0.0 111.3 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -99.7 152.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.832 1.196 . . . . 0.0 110.239 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.43 -174.18 32.02 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -127.28 155.33 43.68 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.703 -0.881 . . . . 0.0 112.227 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -147.62 151.23 35.86 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.505 1.122 . . . . 0.0 109.702 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . 0.464 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.5 mt -135.61 118.98 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -109.99 151.08 27.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.527 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.9 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.3 127.71 33.51 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.079 -1.013 . . . . 0.0 111.228 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -73.71 135.62 43.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -41.95 118.14 1.07 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.643 1.977 . . . . 0.0 112.029 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 6.4 t -149.85 -53.0 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.763 -1.21 . . . . 0.0 112.552 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.8 153.18 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.439 2.296 . . . . 0.0 106.712 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 73.67 172.68 0.29 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.426 1.49 . . . . 0.0 108.482 -173.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.344 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.2 m -77.3 169.73 17.81 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.756 1.222 . . . . 0.0 110.522 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.71 147.72 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 110.023 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -117.79 -61.4 1.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.786 0.834 . . . . 0.0 111.745 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 54.11 40.5 31.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.02 1.328 . . . . 0.0 113.889 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -149.19 113.84 5.34 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.939 1.296 . . . . 0.0 112.645 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 130.21 56.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -139.64 130.1 25.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 110.876 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.62 -27.99 61.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -65.02 110.93 2.65 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.22 5.25 0.23 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 118.738 2.255 . . . . 0.0 118.738 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt 68.86 143.92 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.733 2.413 . . . . 0.0 115.642 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -139.14 159.25 42.59 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.278 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -138.45 147.06 42.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.699 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -111.47 145.63 38.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.726 0.81 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.06 -25.02 57.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.453 1.501 . . . . 0.0 113.944 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.08 -16.39 61.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.344 1.858 . . . . 0.0 111.838 174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.27 -9.69 28.84 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.443 2.449 . . . . 0.0 114.28 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -64.46 144.97 56.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.009 1.404 . . . . 0.0 112.121 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -122.97 134.05 54.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -128.12 136.59 51.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.911 0.862 . . . . 0.0 111.671 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -126.97 130.31 49.83 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.846 0.831 . . . . 0.0 109.252 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.59 131.02 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.72 -103.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.807 0 O-C-N 125.692 1.87 . . . . 0.0 110.569 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.48 138.58 52.35 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.596 0.758 . . . . 0.0 111.127 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.88 133.47 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.95 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -69.73 158.06 36.12 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.8 m -54.36 -29.02 46.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -67.68 -33.82 75.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.894 0.77 . . . . 0.0 111.323 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.73 -7.55 22.08 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.624 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.76 151.63 45.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.097 1.448 . . . . 0.0 108.415 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.0 161.59 42.41 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.286 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.53 163.82 20.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.368 -1.742 . . . . 0.0 107.121 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.97 -168.13 35.17 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.508 1.06 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -138.19 146.15 42.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 112.776 -1.712 . . . . 0.0 111.746 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -126.06 141.02 52.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.347 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 145.54 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 139.35 53.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 112.387 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.64 -15.14 17.86 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.48 140.37 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.709 1.203 . . . . 0.0 111.079 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.28 169.39 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.727 -1.233 . . . . 0.0 112.027 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' CG ' HH12 ' A' ' 114' ' ' ARG . 25.7 m-20 -70.65 -43.27 69.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 173.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -128.41 84.34 63.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.529 2.332 . . . . 0.0 107.588 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.76 36.96 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.262 3.308 . . . . 0.0 114.731 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.95 -3.31 90.64 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 119.845 -1.784 . . . . 0.0 115.999 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 -3.33 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.92 1.36 . . . . 0.0 114.342 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.1 mt -20.03 108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 164.87 24.87 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.019 1.727 . . . . 0.0 109.513 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tt -50.74 136.85 21.24 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.643 1.977 . . . . 0.0 114.025 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -119.95 125.94 27.12 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 113.176 -1.829 . . . . 0.0 111.937 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.29 141.99 98.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.596 2.198 . . . . 0.0 111.715 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 142.74 50.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.619 1.199 . . . . 0.0 109.701 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.25 149.24 34.54 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.093 2.557 . . . . 0.0 109.073 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.03 -156.22 27.72 Favored Glycine 0 N--CA 1.452 -0.259 0 O-C-N 120.128 -1.608 . . . . 0.0 109.857 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mt -146.96 146.86 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.244 1.017 . . . . 0.0 111.527 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.48 153.59 43.33 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.343 1.457 . . . . 0.0 112.537 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.5 153.52 40.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.195 -1.566 . . . . 0.0 112.28 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -139.53 20.8 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -93.42 -57.8 2.48 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.271 1.029 . . . . 0.0 112.944 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.79 20.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.185 0.594 . . . . 0.0 112.323 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -81.57 -20.28 40.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 45.28 0.78 Allowed Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.984 1.314 . . . . 0.0 113.253 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.38 -176.76 3.1 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.222 3.281 . . . . 0.0 115.568 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.289 2.8 t -97.02 164.33 12.57 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.884 1.326 . . . . 0.0 112.931 174.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -158.54 168.95 25.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.633 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.04 151.85 21.03 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 120.516 2.967 . . . . 0.0 120.516 -172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -163.52 153.73 15.55 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -92.67 149.88 21.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.601 1.561 . . . . 0.0 108.839 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.87 127.82 68.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -104.32 110.53 22.79 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.434 -0.792 . . . . 0.0 110.935 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -75.91 129.9 37.65 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.587 1.184 . . . . 0.0 112.329 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -90.93 -38.08 13.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.261 -1.336 . . . . 0.0 114.506 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -83.77 -19.7 34.62 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 117.28 5.09 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.28 118.94 6.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.959 1.254 . . . . 0.0 111.711 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -175.64 167.42 3.19 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 126.644 1.978 . . . . 0.0 110.42 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 t -139.79 141.77 36.74 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.427 ' HG1' ' CD1' ' A' ' 99' ' ' LEU . 2.4 m -141.09 122.97 15.39 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.902 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.04 156.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.386 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -132.41 141.87 49.04 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 121.43 9.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.57 173.52 44.95 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 34.4 tt0 -106.71 144.47 33.32 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.429 0.723 . . . . 0.0 111.508 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.0 p -97.65 121.48 39.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.503 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.1 170.59 8.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.491 1.139 . . . . 0.0 111.665 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.9 mt -127.09 116.58 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -58.78 156.03 11.88 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -17.57 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -82.68 -12.9 57.26 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.94 5.67 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.831 1.205 . . . . 0.0 112.796 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.09 152.0 35.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.497 174.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -103.13 146.54 28.25 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.847 1.259 . . . . 0.0 110.207 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.75 164.68 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.052 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.92 118.38 26.15 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -107.09 113.39 26.81 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 p -131.21 172.5 12.06 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.365 1.555 . . . . 0.0 111.346 -174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.447 ' HG3' HG23 ' D' ' 113' ' ' THR . 87.8 mmm -127.8 170.3 12.92 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.706 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -139.76 164.0 31.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.749 1.261 . . . . 0.0 112.208 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.72 121.67 13.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.326 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' CD1' ' HG1' ' A' ' 77' ' ' THR . 0.4 OUTLIER -107.05 138.3 43.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 124.193 1.949 . . . . 0.0 109.934 -177.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.63 114.14 18.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 109.652 -3.431 . . . . 0.0 110.057 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -72.61 167.73 20.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.424 1.702 . . . . 0.0 112.207 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -114.97 87.96 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.05 -170.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.767 1.227 . . . . 0.0 108.428 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -121.61 -28.28 4.59 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.85 -1.156 . . . . 0.0 113.814 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.9 144.96 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.573 1.178 . . . . 0.0 110.986 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.3 tt -61.63 -20.69 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.144 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.86 2.95 47.39 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.387 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.45 7.51 8.34 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.567 1.184 . . . . 0.0 112.9 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.62 -36.07 75.6 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.517 -1.989 . . . . 0.0 111.463 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -48.22 -45.67 34.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.487 1.115 . . . . 0.0 113.401 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.59 -12.47 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.656 1.183 . . . . 0.0 113.576 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.96 1.69 22.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.443 HG23 ' HG3' ' D' ' 96' ' ' MET . 27.0 m -111.66 140.26 46.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.966 0.906 . . . . 0.0 111.499 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.464 HH12 ' CG ' ' A' ' 39' ' ' ASP . 7.6 mtt180 -144.3 130.25 19.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.958 1.303 . . . . 0.0 111.433 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.41 151.45 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 121.038 1.745 . . . . 0.0 110.98 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.97 179.53 27.59 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -120.15 151.56 38.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.121 0.968 . . . . 0.0 110.706 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -149.78 149.52 30.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.233 1.016 . . . . 0.0 110.777 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.9 mt -130.4 133.74 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.08 -1.012 . . . . 0.0 108.289 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -123.92 149.02 46.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.94 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.8 p -132.66 159.76 38.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.71 1.204 . . . . 0.0 110.866 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.24 125.58 24.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 111.122 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.24 113.35 19.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.24 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 58.47 83.43 0.12 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.483 1.113 . . . . 0.0 113.889 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.7 p -46.92 115.94 1.21 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.463 1.105 . . . . 0.0 112.008 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -91.67 -2.58 56.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.779 1.632 . . . . 0.0 112.799 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -119.95 137.59 53.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--O 1.247 0.963 0 C-N-CA 128.299 2.64 . . . . 0.0 107.722 174.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 117.566 -1.207 . . . . 0.0 107.864 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 7.0 m 65.68 148.66 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.944 1.698 . . . . 0.0 115.368 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 19.6 m -141.43 -174.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 119.88 -1.763 . . . . 0.0 111.959 -174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . 53.91 31.84 14.1 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.365 2.357 . . . . 0.0 117.365 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -52.31 128.28 24.77 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.978 2.511 . . . . 0.0 113.602 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -156.1 135.32 12.16 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.285 1.834 . . . . 0.0 112.482 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -149.16 136.5 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.992 1.269 . . . . 0.0 111.632 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 31.3 p -139.45 133.56 31.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.169 2.187 . . . . 0.0 111.549 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.72 -26.42 60.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -65.4 112.1 3.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -4.96 0.36 Allowed Glycine 0 N--CA 1.476 1.316 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 74.68 144.05 0.08 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.418 2.287 . . . . 0.0 114.007 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -139.41 162.16 35.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.134 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -142.49 148.8 38.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.09 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -113.43 146.08 40.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.977 0.911 . . . . 0.0 110.803 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -56.92 -25.39 57.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.967 1.307 . . . . 0.0 113.921 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.19 -15.62 61.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.362 1.865 . . . . 0.0 112.134 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.84 -8.37 31.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 127.304 2.383 . . . . 0.0 114.294 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -64.56 143.97 57.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.14 1.47 . . . . 0.0 112.512 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -121.4 132.07 54.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.901 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -126.74 137.67 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 111.969 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.6 m -128.75 130.39 47.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.244 1.021 . . . . 0.0 109.786 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.26 130.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.4 -97.09 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 125.825 1.953 . . . . 0.0 111.146 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.41 138.16 46.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 110.959 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.07 134.03 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.008 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -69.75 157.84 36.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.499 0.72 . . . . 0.0 111.793 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 64.4 m -54.51 -28.75 47.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -67.81 -32.87 73.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.794 0.724 . . . . 0.0 111.369 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.23 -6.07 23.34 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 124.777 1.179 . . . . 0.0 112.715 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.16 156.99 38.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.456 1.128 . . . . 0.0 110.541 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.59 166.53 33.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 123.186 1.47 . . . . 0.0 110.891 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -129.75 164.72 23.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 112.0 -2.364 . . . . 0.0 105.905 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.13 -167.1 35.05 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 75.1 p -139.23 146.74 40.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.186 -1.507 . . . . 0.0 112.134 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -126.87 141.14 51.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.179 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.406 ' CD1' HD11 ' D' ' 46' ' ' LEU . 4.4 mp -125.89 144.77 34.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -120.85 138.84 53.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.055 0.942 . . . . 0.0 112.522 -173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.76 -15.98 18.28 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.81 140.81 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.577 1.151 . . . . 0.0 111.337 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.66 169.06 23.65 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 120.477 -1.389 . . . . 0.0 111.905 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' D' ' 114' ' ' ARG . 31.2 m-20 -70.29 -43.26 70.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.059 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -128.4 83.93 64.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.522 2.329 . . . . 0.0 107.69 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.9 37.44 0.29 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.323 3.348 . . . . 0.0 114.684 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.5 -2.83 90.66 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 119.893 -1.754 . . . . 0.0 116.063 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.828 1.314 . . . . 0.0 114.401 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mt -19.53 107.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 164.35 25.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.994 1.717 . . . . 0.0 109.494 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.406 HD11 ' CD1' ' D' ' 34' ' ' ILE . 4.4 tt -49.99 136.19 19.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.664 1.986 . . . . 0.0 113.95 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -119.3 125.96 27.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 113.21 -1.813 . . . . 0.0 111.991 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.21 140.67 95.89 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.229 1.953 . . . . 0.0 111.269 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.45 149.78 41.84 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 124.892 1.37 . . . . 0.0 109.359 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 149.34 26.27 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.074 2.15 . . . . 0.0 108.869 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.94 -154.2 25.33 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 120.898 -1.126 . . . . 0.0 111.347 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -146.92 146.02 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.286 1.035 . . . . 0.0 112.033 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.79 153.81 41.9 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.457 1.503 . . . . 0.0 112.325 174.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -73.17 159.17 33.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 119.954 -1.716 . . . . 0.0 112.344 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -145.46 21.75 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -93.46 -58.07 2.4 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.039 0.936 . . . . 0.0 112.453 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.47 169.81 16.69 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.962 0.789 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 26.1 m -90.41 -13.77 34.27 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -136.22 39.75 0.46 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.724 1.209 . . . . 0.0 113.768 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.76 -176.99 3.57 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.792 2.328 . . . . 0.0 114.359 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.305 2.5 t -97.06 164.36 12.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.742 1.258 . . . . 0.0 112.074 174.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.57 168.35 27.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.391 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 151.61 20.51 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 120.742 3.057 . . . . 0.0 120.742 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -163.49 152.78 14.63 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -90.84 150.79 21.41 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.932 1.693 . . . . 0.0 108.776 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.09 128.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.44 110.26 22.53 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -75.74 129.82 37.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.823 1.297 . . . . 0.0 112.608 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -91.51 -37.63 13.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.944 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -83.79 -19.54 34.85 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -152.42 119.01 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.38 119.05 7.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.304 1.411 . . . . 0.0 111.758 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -175.29 166.43 3.38 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 126.531 1.933 . . . . 0.0 110.384 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 141.59 38.07 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.195 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' THR . . . . . 0.426 ' HG1' ' CD1' ' D' ' 99' ' ' LEU . 2.6 m -141.11 123.34 15.68 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 111.364 -2.653 . . . . 0.0 109.947 -172.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.05 156.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.649 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.54 141.92 49.82 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.21 121.26 9.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -174.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.66 173.68 44.49 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 118.665 -1.731 . . . . 0.0 117.19 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 34.6 tt0 -106.63 144.51 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.99 0.9 . . . . 0.0 111.274 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 p -97.66 118.22 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.924 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.27 170.56 8.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.901 0.858 . . . . 0.0 111.911 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 49.9 mt -128.97 114.81 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -58.61 155.85 11.75 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -29.62 2.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -72.07 -17.7 61.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.337 1.455 . . . . 0.0 113.833 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.89 54.38 2.64 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.55 46.8 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 129.51 3.124 . . . . 0.0 108.794 173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -109.54 146.96 33.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.523 1.154 . . . . 0.0 109.971 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 23.3 m -148.44 164.03 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.34 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.29 118.36 25.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -106.76 112.94 26.15 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -130.52 172.12 12.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.553 1.644 . . . . 0.0 111.155 -174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.443 ' HG3' HG23 ' A' ' 113' ' ' THR . 86.5 mmm -127.19 169.99 12.89 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.753 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -139.69 164.01 31.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.657 1.218 . . . . 0.0 111.913 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.09 122.3 13.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.212 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . 0.426 ' CD1' ' HG1' ' D' ' 77' ' ' THR . 0.4 OUTLIER -107.05 139.46 41.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 124.105 1.907 . . . . 0.0 110.11 -177.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.84 114.58 18.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 109.717 -3.402 . . . . 0.0 110.626 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -73.08 167.83 20.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 125.492 1.745 . . . . 0.0 112.429 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -114.7 83.71 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.46 -172.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.904 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -119.05 -30.22 5.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.529 -1.357 . . . . 0.0 112.411 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.06 143.92 43.98 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 111.564 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.61 -22.27 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.666 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.39 1.16 51.98 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 117.635 -1.647 . . . . 0.0 114.445 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.08 7.46 9.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.841 1.321 . . . . 0.0 113.002 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.06 -36.18 74.61 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.696 -1.877 . . . . 0.0 111.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -48.25 -46.03 35.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.377 1.071 . . . . 0.0 113.201 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -90.32 -12.65 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.441 1.096 . . . . 0.0 113.508 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.28 1.0 23.12 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 96' ' ' MET . 24.2 m -111.12 140.85 45.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.231 1.012 . . . . 0.0 111.669 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' D' ' 39' ' ' ASP . 7.3 mtt180 -144.75 130.95 19.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.61 152.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.085 1.766 . . . . 0.0 110.966 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.29 28.79 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -120.13 150.8 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.026 0.93 . . . . 0.0 110.407 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -149.18 148.07 29.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.768 0.794 . . . . 0.0 110.357 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -128.46 133.71 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -123.22 147.45 46.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.559 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 46.9 p -129.81 156.75 43.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.757 1.223 . . . . 0.0 110.009 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -57.75 127.79 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.761 0.825 . . . . 0.0 110.496 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -77.17 85.99 3.63 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -179.21 -92.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.66 1.984 . . . . 0.0 110.184 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 21.4 m 75.9 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.312 2.245 . . . . 0.0 107.703 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . 0.425 ' C ' ' H ' ' D' ' 128' ' ' GLU . 1.9 mt-30 -151.89 -77.36 0.13 Allowed 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 22.1 tptp 77.19 -26.15 0.19 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 127.708 2.403 . . . . 0.0 113.644 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' D' ' 126' ' ' GLN . 2.2 pm0 . . . . . 0 C--O 1.261 1.709 1 C-N-CA 133.133 4.573 . . . . 0.0 109.77 174.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 2.8 m 17.86 73.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 129.173 2.989 . . . . 0.0 117.76 174.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.12 97.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.944 -1.098 . . . . 0.0 112.014 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.38 97.17 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . 0.301 14.3 ptm180 44.67 72.41 0.2 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.192 2.597 . . . . 0.0 117.324 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -147.31 125.81 12.44 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.295 1.038 . . . . 0.0 112.763 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 44.4 t -139.31 133.9 31.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 109.421 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.2 p -139.56 131.72 28.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.748 2.019 . . . . 0.0 110.081 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.45 -25.72 60.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -65.68 111.6 3.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -5.38 0.37 Allowed Glycine 0 N--CA 1.478 1.472 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt 75.34 144.32 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.657 2.383 . . . . 0.0 114.037 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -140.55 162.39 35.46 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.849 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -141.11 149.96 42.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.688 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -112.03 146.26 38.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.618 0.767 . . . . 0.0 110.512 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -57.26 -23.81 50.66 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.499 1.52 . . . . 0.0 113.626 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 24.5 tp -74.52 -16.17 60.84 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.511 1.924 . . . . 0.0 111.932 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.5 -7.68 32.19 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 127.421 2.439 . . . . 0.0 114.272 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -64.41 144.39 57.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.278 1.539 . . . . 0.0 113.14 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -122.85 132.26 54.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.177 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -126.49 136.64 52.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.887 0.851 . . . . 0.0 111.739 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -126.69 130.56 50.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.601 0.715 . . . . 0.0 109.607 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.04 130.14 72.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.61 -98.16 0.09 OUTLIER Glycine 0 CA--C 1.527 0.829 0 O-C-N 125.559 1.787 . . . . 0.0 111.229 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.16 138.21 46.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.709 0.804 . . . . 0.0 110.984 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 p -92.35 133.47 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.018 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -69.27 158.02 35.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.237 0.615 . . . . 0.0 111.344 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 63.9 m -54.4 -29.02 47.46 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -67.76 -33.9 75.76 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.801 . . . . 0.0 111.39 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.83 21.63 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.697 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.52 151.72 45.68 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.116 1.458 . . . . 0.0 108.426 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.27 42.9 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.107 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.3 163.71 20.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.111 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.93 -168.34 35.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-O 122.741 1.19 . . . . 0.0 110.976 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -137.96 146.97 43.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.505 -1.847 . . . . 0.0 111.73 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -126.61 141.13 51.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.228 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.414 ' CD1' HD11 ' B' ' 46' ' ' LEU . 4.5 mp -126.18 144.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -120.89 139.42 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.941 0.896 . . . . 0.0 112.645 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.09 -16.21 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.96 140.65 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.612 1.165 . . . . 0.0 111.116 -176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.72 169.11 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.844 -1.16 . . . . 0.0 112.103 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.449 ' CG ' HH12 ' B' ' 114' ' ' ARG . 27.9 m-20 -70.19 -43.39 70.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.987 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -128.72 83.95 64.63 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.651 2.381 . . . . 0.0 107.66 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.71 37.48 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.263 3.308 . . . . 0.0 114.753 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.69 -2.98 90.72 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 119.839 -1.788 . . . . 0.0 116.041 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.07 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -19.7 107.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.73 24.78 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.98 1.712 . . . . 0.0 109.54 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' B' ' 34' ' ' ILE . 5.0 tt -50.77 137.21 20.73 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 126.556 1.942 . . . . 0.0 113.929 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -120.15 126.24 26.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.094 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.26 141.84 98.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.679 2.253 . . . . 0.0 111.813 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.74 143.13 50.02 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 124.562 1.163 . . . . 0.0 109.614 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.32 149.25 34.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.978 2.511 . . . . 0.0 108.878 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.17 -155.95 27.39 Favored Glycine 0 N--CA 1.453 -0.222 0 O-C-N 120.337 -1.477 . . . . 0.0 109.853 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mt -147.2 147.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.316 1.047 . . . . 0.0 111.618 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.62 154.0 42.94 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.048 1.339 . . . . 0.0 112.431 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -74.06 153.5 39.61 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.223 -1.548 . . . . 0.0 112.063 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -138.6 20.98 2.71 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -93.56 -57.07 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.791 0.836 . . . . 0.0 112.941 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 170.2 16.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.675 0.75 . . . . 0.0 112.972 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.8 m -80.77 -24.53 38.57 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.94 44.97 0.78 Allowed Pre-proline 0 CA--C 1.569 1.685 0 C-N-CA 125.319 1.448 . . . . 0.0 113.156 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.78 -176.23 3.07 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.201 2.6 . . . . 0.0 114.882 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.299 2.9 t -97.26 164.15 12.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.788 1.28 . . . . 0.0 112.508 174.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.56 168.61 26.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.893 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.44 151.53 20.32 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 120.825 3.09 . . . . 0.0 120.825 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -163.09 153.49 16.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -92.15 149.65 21.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.566 1.546 . . . . 0.0 108.849 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.61 128.18 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -104.75 110.61 23.02 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.369 -0.832 . . . . 0.0 110.778 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -76.25 130.67 38.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 122.784 1.278 . . . . 0.0 112.645 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -92.41 -37.81 12.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.737 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -84.1 -19.49 34.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.5 117.32 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.96 118.93 6.84 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.897 1.226 . . . . 0.0 111.76 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -175.56 167.23 3.25 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 126.599 1.96 . . . . 0.0 110.27 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -139.38 142.14 37.55 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.249 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' THR . . . . . 0.41 ' HG1' ' CD1' ' B' ' 99' ' ' LEU . 2.3 m -141.15 123.32 15.63 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 111.462 -2.608 . . . . 0.0 109.588 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 m -99.17 156.53 3.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.512 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.29 141.85 49.14 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.55 121.34 9.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.66 172.52 43.68 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 118.628 -1.748 . . . . 0.0 116.947 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 34.9 tt0 -105.02 144.85 31.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.654 0.74 . . . . 0.0 111.224 -176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 p -97.56 122.89 41.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.106 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -116.98 169.61 9.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.963 0.887 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -126.37 116.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.91 155.55 13.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -21.26 0.8 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 118.104 2.631 . . . . 0.0 118.104 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.43 -12.23 59.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 47.5 4.79 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.259 0.933 . . . . 0.0 112.416 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.69 150.81 42.22 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.257 2.223 . . . . 0.0 110.462 174.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -103.44 145.75 29.53 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.967 1.307 . . . . 0.0 110.228 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.83 164.19 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.865 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.98 118.29 25.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -106.77 113.47 26.98 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.0 p -130.85 172.69 11.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.543 1.64 . . . . 0.0 111.161 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.431 ' HG3' HG23 ' C' ' 113' ' ' THR . 87.7 mmm -127.63 170.12 13.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.554 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -139.82 163.36 32.84 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.573 1.178 . . . . 0.0 111.752 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.13 122.02 14.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.19 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.41 ' CD1' ' HG1' ' B' ' 77' ' ' THR . 0.4 OUTLIER -107.0 138.38 43.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 124.356 2.027 . . . . 0.0 110.108 -177.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.71 114.11 18.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 109.475 -3.511 . . . . 0.0 109.922 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -73.08 167.94 20.09 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 125.508 1.755 . . . . 0.0 112.125 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.4 t -114.87 87.87 2.74 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.04 -171.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.838 1.255 . . . . 0.0 108.243 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.05 -30.52 4.35 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.823 -1.173 . . . . 0.0 112.226 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -112.76 143.2 44.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.255 1.026 . . . . 0.0 111.76 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 14.2 tt -60.37 -22.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.08 -0.963 . . . . 0.0 113.161 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.61 54.48 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 117.701 -1.611 . . . . 0.0 114.55 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.67 7.2 9.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.922 1.289 . . . . 0.0 113.118 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.68 -36.11 73.68 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 119.76 -1.837 . . . . 0.0 111.296 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -48.27 -45.92 35.2 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.429 1.092 . . . . 0.0 113.479 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.36 -12.32 37.98 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.463 1.105 . . . . 0.0 113.345 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.61 1.1 23.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.446 HG23 ' HG3' ' C' ' 96' ' ' MET . 25.4 m -110.86 140.35 45.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.297 1.039 . . . . 0.0 111.938 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.449 HH12 ' CG ' ' B' ' 39' ' ' ASP . 7.5 mtt180 -144.6 130.7 19.47 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.658 1.183 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.39 152.25 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 121.111 1.778 . . . . 0.0 111.209 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.35 179.49 27.95 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -120.48 150.61 40.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.241 1.017 . . . . 0.0 110.344 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.41 148.27 29.26 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.033 0.921 . . . . 0.0 110.41 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 62.7 mt -129.58 133.31 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -122.88 148.01 45.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.985 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.7 p -131.28 159.15 38.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.768 1.227 . . . . 0.0 110.432 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 5.0 mmt-85 -59.14 134.52 57.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.731 0.812 . . . . 0.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 125.15 26.82 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.659 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 77.97 134.28 0.06 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.218 1.807 . . . . 0.0 111.228 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 14.2 m -57.41 109.0 0.61 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.019 0.928 . . . . 0.0 110.285 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -83.08 110.67 18.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.256 -0.903 . . . . 0.0 108.689 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 mttp 87.97 120.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.95 2.5 . . . . 0.0 109.528 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 127.602 2.361 . . . . 0.0 108.842 178.189 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.2 m 61.44 172.62 0.11 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.896 0.879 . . . . 0.0 111.177 -173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 6.4 p -169.56 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.315 1.446 . . . . 0.0 110.63 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -69.19 147.46 51.29 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.46 95.02 2.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.555 0.742 . . . . 0.0 112.09 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -154.76 125.89 7.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.059 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -141.58 135.92 30.54 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.921 1.237 . . . . 0.0 110.777 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 22.4 p -139.48 131.68 28.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.536 1.935 . . . . 0.0 110.844 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -73.54 -24.76 60.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -67.58 112.33 4.67 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.58 -3.22 0.43 Allowed Glycine 0 N--CA 1.481 1.636 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt 74.05 144.5 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.908 2.483 . . . . 0.0 114.446 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -139.54 162.55 34.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.121 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.81 147.38 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.449 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -110.68 145.92 37.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.826 0.85 . . . . 0.0 110.348 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -57.46 -23.39 49.54 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.627 1.571 . . . . 0.0 113.69 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.6 tp -75.04 -16.37 60.59 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.613 1.965 . . . . 0.0 111.895 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.07 -7.86 31.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 127.417 2.436 . . . . 0.0 114.364 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -65.1 145.25 56.54 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.285 1.543 . . . . 0.0 112.656 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -123.84 132.01 53.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.143 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -125.93 137.9 53.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 111.738 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 33.9 m -128.39 129.84 46.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.721 0.772 . . . . 0.0 109.438 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.9 129.73 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.76 -96.59 0.1 OUTLIER Glycine 0 CA--C 1.527 0.786 0 O-C-N 125.638 1.836 . . . . 0.0 111.179 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.92 45.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.758 0.823 . . . . 0.0 110.962 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.97 133.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.011 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -69.49 157.91 36.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.543 0.737 . . . . 0.0 111.831 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 64.3 m -54.58 -28.89 49.42 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -67.78 -32.88 73.77 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.834 0.743 . . . . 0.0 111.303 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.17 -6.06 23.44 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 124.761 1.172 . . . . 0.0 112.763 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.04 157.09 38.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.434 1.112 . . . . 0.0 110.426 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.6 166.55 33.01 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.95 1.357 . . . . 0.0 110.872 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -129.74 165.04 22.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 112.164 -2.289 . . . . 0.0 105.84 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.44 -167.03 35.11 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 122.448 1.027 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.2 p -139.01 147.36 42.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.972 -1.614 . . . . 0.0 112.187 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -127.48 141.26 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' C' ' 46' ' ' LEU . 4.3 mp -125.94 145.65 33.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 2.9 m -122.11 138.95 54.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -13.45 18.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.63 140.16 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.672 1.189 . . . . 0.0 111.429 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.12 169.56 22.11 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.575 -1.328 . . . . 0.0 112.192 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' C' ' 114' ' ' ARG . 30.2 m-20 -70.93 -42.9 69.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.142 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -128.31 84.57 62.84 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.685 2.394 . . . . 0.0 107.506 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.84 36.52 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.168 3.245 . . . . 0.0 114.675 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.88 -3.01 90.58 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 119.909 -1.744 . . . . 0.0 115.99 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.11 -4.11 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.83 1.315 . . . . 0.0 114.47 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mt -19.33 108.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.77 164.09 26.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.073 1.749 . . . . 0.0 109.593 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' C' ' 34' ' ' ILE . 4.4 tt -49.98 136.57 18.44 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.652 1.981 . . . . 0.0 113.943 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -120.07 126.11 27.0 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.18 140.06 93.14 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.636 2.224 . . . . 0.0 111.377 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.09 149.48 42.12 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 124.772 1.295 . . . . 0.0 109.64 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.79 149.44 26.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.98 2.112 . . . . 0.0 108.601 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.95 -154.05 25.21 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 119.163 0.892 . . . . 0.0 111.543 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -147.16 145.95 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.317 1.047 . . . . 0.0 111.923 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.98 153.29 43.01 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.349 1.459 . . . . 0.0 112.321 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -72.77 157.92 36.57 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.94 -1.725 . . . . 0.0 112.298 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -143.88 21.14 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -93.52 -57.26 2.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.931 0.892 . . . . 0.0 112.364 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.18 169.03 17.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.611 0.764 . . . . 0.0 112.179 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -85.38 -19.81 30.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 40.35 0.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 125.085 1.354 . . . . 0.0 113.335 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.95 -177.06 3.63 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.857 2.371 . . . . 0.0 114.531 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.308 2.3 t -96.57 164.09 12.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.711 1.243 . . . . 0.0 112.121 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -158.44 168.25 27.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.653 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.58 151.46 20.14 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 120.61 3.004 . . . . 0.0 120.61 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.19 153.21 15.73 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -91.53 150.44 21.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.996 1.719 . . . . 0.0 108.804 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.49 128.7 68.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -105.46 110.62 23.03 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.817 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.47 130.95 39.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.736 1.255 . . . . 0.0 112.413 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -92.37 -38.35 12.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.964 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -82.94 -19.33 37.43 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.44 119.92 6.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.27 118.89 7.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.369 1.44 . . . . 0.0 111.35 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 6.4 m -175.56 166.38 3.22 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.695 1.998 . . . . 0.0 110.539 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 142.09 38.06 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 122.324 1.059 . . . . 0.0 111.397 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' THR . . . . . 0.407 ' HG1' ' CD1' ' C' ' 99' ' ' LEU . 2.4 m -141.25 124.19 16.25 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 111.284 -2.689 . . . . 0.0 109.831 -172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -100.17 155.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.421 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -131.43 141.76 49.88 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.44 121.46 9.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.55 44.13 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.54 -1.791 . . . . 0.0 116.703 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 35.0 tt0 -105.81 144.89 31.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.379 1.085 . . . . 0.0 111.132 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 30.1 p -97.43 123.23 41.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.356 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.76 170.43 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.733 0.778 . . . . 0.0 112.257 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 49.7 mt -127.28 115.77 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -58.85 154.95 14.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -19.16 0.51 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 176.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -82.31 -9.61 59.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.174 0.99 . . . . 0.0 113.247 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.83 49.75 5.24 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.193 0.901 . . . . 0.0 112.359 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.31 152.88 42.55 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 127.716 2.406 . . . . 0.0 109.506 173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -107.54 145.71 32.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.14 1.376 . . . . 0.0 110.005 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 25.9 m -148.15 165.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.178 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.89 118.63 25.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -106.97 112.62 25.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 3.0 p -129.94 172.87 11.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.533 1.635 . . . . 0.0 111.374 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.446 ' HG3' HG23 ' B' ' 113' ' ' THR . 88.0 mmm -128.31 170.56 12.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -140.43 163.6 32.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.741 1.257 . . . . 0.0 111.804 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.39 122.2 14.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.389 174.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . 0.407 ' CD1' ' HG1' ' C' ' 77' ' ' THR . 0.4 OUTLIER -107.08 139.17 41.93 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 124.122 1.915 . . . . 0.0 110.026 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.27 18.42 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 109.75 -3.386 . . . . 0.0 110.132 -173.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -72.35 168.25 18.77 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.342 1.651 . . . . 0.0 112.41 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -115.43 82.68 1.79 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.97 -172.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.791 1.237 . . . . 0.0 108.916 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -119.73 -28.52 5.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.661 -1.274 . . . . 0.0 112.847 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -116.55 143.28 45.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 122.419 1.104 . . . . 0.0 111.624 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.79 -20.52 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.731 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.4 2.37 57.86 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 118.335 -1.259 . . . . 0.0 114.086 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.04 7.62 8.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.79 1.236 . . . . 0.0 112.994 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.8 -36.07 75.98 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 119.734 -1.853 . . . . 0.0 111.524 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -48.1 -46.02 33.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.602 1.161 . . . . 0.0 113.248 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -90.22 -12.41 38.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.101 . . . . 0.0 113.763 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 1.36 23.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' THR . . . . . 0.431 HG23 ' HG3' ' B' ' 96' ' ' MET . 26.2 m -111.25 140.63 45.65 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.21 1.004 . . . . 0.0 111.385 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.471 HH12 ' CG ' ' C' ' 39' ' ' ASP . 7.4 mtt180 -144.81 130.93 19.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.911 1.284 . . . . 0.0 111.195 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.63 152.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.972 1.715 . . . . 0.0 111.145 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.12 28.3 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -119.9 150.72 40.02 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.146 0.978 . . . . 0.0 110.145 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.52 147.23 27.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.856 0.836 . . . . 0.0 110.406 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.56 132.78 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.87 147.74 45.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.569 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 63.3 p -131.54 158.09 41.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.831 1.252 . . . . 0.0 109.971 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -60.46 136.72 58.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.757 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.55 103.5 11.31 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -0.778 . . . . 0.0 111.387 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 65.27 82.1 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 117.317 2.339 . . . . 0.0 117.317 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 11.1 p -104.78 153.03 21.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.828 1.651 . . . . 0.0 112.396 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -143.45 132.23 22.63 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.165 2.586 . . . . 0.0 104.048 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.406 ' HZ3' ' HB3' ' C' ' 127' ' ' LYS . 0.2 OUTLIER -148.37 21.74 1.06 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.977 1.311 . . . . 0.0 112.865 -174.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.246 0.917 1 C-N-CA 133.662 4.785 . . . . 0.0 105.065 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 116.526 -1.702 . . . . 0.0 106.508 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 12.0 m 38.75 42.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.348 1.859 . . . . 0.0 115.215 -174.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.1 m -95.64 27.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.539 -1.35 . . . . 0.0 112.353 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -62.53 157.4 20.51 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.244 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -126.33 72.63 1.33 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.56 1.544 . . . . 0.0 108.94 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -157.36 155.81 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.111 0.965 . . . . 0.0 111.957 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -131.04 147.03 52.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.1 p -139.84 130.71 26.08 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.278 -1.514 . . . . 0.0 112.646 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.7 -27.45 68.71 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -50.49 118.43 3.04 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 123.575 1.655 . . . . 0.0 112.189 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.11 -119.12 2.58 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.84 2.162 . . . . 0.0 110.017 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -145.01 149.73 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.546 1.138 . . . . 0.0 113.273 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -145.83 159.18 43.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.296 1.438 . . . . 0.0 110.068 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -134.87 150.2 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 HD22 ' ND2' ' A' ' 118' ' ' ASN . 61.0 t-20 -107.96 143.51 36.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.461 1.104 . . . . 0.0 111.265 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.3 -24.03 64.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.39 1.076 . . . . 0.0 112.632 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.485 HD22 HD22 ' A' ' 118' ' ' ASN . 50.0 tp -74.09 -14.34 60.97 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.983 1.313 . . . . 0.0 112.639 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.61 -14.29 32.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 127.049 2.262 . . . . 0.0 113.889 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.61 153.85 22.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.298 1.523 . . . . 0.0 112.741 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.52 146.81 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.149 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -141.29 147.12 37.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -129.89 134.04 47.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.339 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.18 123.72 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.93 -87.06 0.11 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 124.434 1.084 . . . . 0.0 111.567 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.5 42.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.06 0.933 . . . . 0.0 112.145 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.16 125.55 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 113.166 -1.834 . . . . 0.0 108.038 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -71.36 162.81 28.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.995 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -54.91 -23.67 19.93 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -74.75 -32.52 62.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.905 -1.122 . . . . 0.0 113.217 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 -5.4 26.4 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 117.603 -1.665 . . . . 0.0 112.586 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 0.0 OUTLIER -67.06 142.46 57.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.71 156.91 32.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -125.2 168.61 13.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.622 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.52 -167.36 35.64 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.32 0.956 . . . . 0.0 113.838 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.9 p -138.61 133.63 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.758 -1.221 . . . . 0.0 111.308 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -113.65 131.92 55.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.59 129.24 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.251 61.2 m -104.66 142.65 34.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.638 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.24 -10.2 20.57 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -138.99 146.16 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.266 1.026 . . . . 0.0 112.647 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.1 26.4 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.319 -0.863 . . . . 0.0 110.881 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -31.14 63.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -141.1 69.73 28.27 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.454 1.902 . . . . 0.0 113.897 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.53 72.1 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 124.339 3.359 . . . . 0.0 114.183 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.69 2.28 13.64 Favored Glycine 0 N--CA 1.477 1.408 0 O-C-N 120.712 -1.242 . . . . 0.0 114.597 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.14 27.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.805 1.242 . . . . 0.0 112.623 -174.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.56 130.71 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.929 0.871 . . . . 0.0 110.76 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.25 0.5 OUTLIER -140.52 170.2 16.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.616 1.566 . . . . 0.0 110.055 177.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.1 tp -57.53 115.4 2.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.865 2.866 . . . . 0.0 111.0 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.2 m -100.55 120.09 56.97 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.23 142.38 87.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.434 2.089 . . . . 0.0 111.699 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.46 152.98 47.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.802 0.841 . . . . 0.0 111.624 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.59 148.79 16.34 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 110.463 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.48 -152.01 22.66 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 120.883 1.674 . . . . 0.0 110.195 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.2 140.01 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.304 0.642 . . . . 0.0 111.279 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.21 136.41 52.79 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.396 -0.815 . . . . 0.0 111.932 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -68.76 149.79 48.61 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.935 0.874 . . . . 0.0 111.321 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.3 23.98 1.15 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.995 1.318 . . . . 0.0 111.436 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -92.97 -58.2 2.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.361 1.864 . . . . 0.0 111.357 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.05 -178.15 3.21 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.616 1.197 . . . . 0.0 114.169 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -65.73 -57.81 7.15 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.215 1.006 . . . . 0.0 111.845 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -141.52 65.39 20.88 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.917 0.887 . . . . 0.0 110.129 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.34 -174.15 1.53 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.27 2.647 . . . . 0.0 114.546 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.484 ' HG1' ' HB3' ' D' ' 100' ' ' ARG 0.275 4.5 t -96.15 160.72 14.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 123.158 1.456 . . . . 0.0 112.796 174.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.9 167.34 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.469 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.55 147.37 12.91 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.19 156.91 27.38 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -92.9 149.68 21.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.661 1.984 . . . . 0.0 109.535 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.22 117.04 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -92.36 105.5 17.68 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.752 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.266 42.9 m95 -74.3 130.96 40.7 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -89.47 -40.26 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -92.17 -9.46 42.28 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.42 128.37 10.31 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 128.187 2.595 . . . . 0.0 104.865 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.76 118.7 12.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.363 1.078 . . . . 0.0 110.739 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 m -177.07 159.65 1.68 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.001 1.721 . . . . 0.0 110.475 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.63 141.64 35.07 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.033 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.57 126.68 19.65 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.553 -3.022 . . . . 0.0 108.558 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.754 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -124.61 142.56 51.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 116.67 5.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.31 169.21 39.73 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 118.737 -1.697 . . . . 0.0 116.408 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 29.0 tt0 -101.84 148.13 25.68 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.274 1.035 . . . . 0.0 111.723 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 132.82 36.31 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.271 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -121.62 158.09 29.37 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 110.18 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.81 158.58 7.94 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.547 1.139 . . . . 0.0 110.087 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -48.08 -33.77 8.65 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -75.33 -15.26 60.5 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.6 47.15 3.04 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.248 0.928 . . . . 0.0 111.729 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HZ3' ' HB3' ' A' ' 90' ' ' LYS . 4.9 mtpm? -119.8 154.18 34.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.431 1.492 . . . . 0.0 109.639 174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -109.03 151.82 25.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.814 1.645 . . . . 0.0 111.26 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -152.83 156.3 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.189 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 mt -123.42 104.11 8.89 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HE3' HD13 ' A' ' 119' ' ' ILE . 1.2 mmtt -95.04 127.84 41.41 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -139.77 163.07 33.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.792 1.282 . . . . 0.0 112.768 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 19.9 mtp -121.34 160.47 23.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -133.51 162.57 31.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.154 -1.839 . . . . 0.0 113.057 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.81 126.55 23.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.508 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.3 140.79 39.64 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 125.14 1.525 . . . . 0.0 109.972 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HB3' ' HG1' ' D' ' 63' ' ' THR . 0.6 OUTLIER -129.09 118.23 22.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.57 -173.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.8 p -84.99 172.07 11.61 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.7 m -110.71 70.89 0.73 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 107.7 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.46 169.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.048 1.339 . . . . 0.0 109.667 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.34 -11.1 14.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -135.36 152.76 51.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.064 1.412 . . . . 0.0 111.942 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.8 tt -67.43 -20.77 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.376 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.83 4.3 45.83 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.674 -0.641 . . . . 0.0 114.401 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -125.75 1.64 7.45 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.25 -34.58 72.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.987 0.915 . . . . 0.0 113.028 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -48.32 -38.85 20.06 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -97.43 -12.92 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.04 1.336 . . . . 0.0 114.032 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.76 38.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.4 m -108.34 144.94 35.2 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-O 122.352 1.072 . . . . 0.0 109.583 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -141.0 151.84 44.44 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.524 1.529 . . . . 0.0 108.311 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.62 153.19 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.57 1.148 . . . . 0.0 109.411 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.38 32.22 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.141 0.877 . . . . 0.0 111.776 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 17.3 p90 -132.41 159.99 37.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.139 -0.624 . . . . 0.0 112.076 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.485 HD22 HD22 ' A' ' 14' ' ' LEU . 4.6 m120 -150.42 157.35 42.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.542 1.163 . . . . 0.0 109.784 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.483 HD13 ' HE3' ' A' ' 94' ' ' LYS . 8.6 mt -131.93 129.45 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.85 151.97 38.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 124.334 1.022 . . . . 0.0 108.772 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 p -139.84 164.77 29.09 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -57.04 129.62 42.51 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.496 0.718 . . . . 0.0 110.94 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.86 166.82 14.77 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 77.39 -51.96 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.5 m -103.12 84.73 2.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.783 1.233 . . . . 0.0 109.697 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -81.2 -41.69 21.93 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.351 0.596 . . . . 0.0 111.8 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -143.08 179.92 6.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.609 1.964 . . . . 0.0 110.132 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.272 2.27 2 C-N-CA 137.086 6.154 . . . . 0.0 98.551 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 116.507 -1.711 . . . . 0.0 107.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 14.9 t -71.22 -44.38 65.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.853 1.661 . . . . 0.0 112.646 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 11.7 t 60.26 -48.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 128.343 2.657 . . . . 0.0 113.839 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -74.74 139.58 43.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.051 1.341 . . . . 0.0 113.331 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ttm105 -70.18 96.29 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.271 1.829 . . . . 0.0 109.863 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -156.95 155.96 32.23 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 111.516 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 27.5 p -137.67 143.37 41.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.656 1.583 . . . . 0.0 108.888 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 85.2 p -139.98 131.95 27.77 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.346 -1.471 . . . . 0.0 113.552 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.31 -24.04 67.68 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -53.95 118.43 3.99 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.545 1.64 . . . . 0.0 112.092 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.46 -120.73 2.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.261 1.886 . . . . 0.0 109.554 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 113.301 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -147.8 159.89 43.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.18 147.88 46.18 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -105.79 143.57 33.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.652 1.181 . . . . 0.0 111.945 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.79 -24.56 62.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.562 1.145 . . . . 0.0 112.92 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.492 HD22 HD22 ' D' ' 118' ' ' ASN . 45.4 tp -74.84 -13.81 60.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.694 1.197 . . . . 0.0 112.666 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -13.81 36.72 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.973 2.225 . . . . 0.0 113.619 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.2 152.27 25.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.298 1.523 . . . . 0.0 112.439 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.95 146.44 50.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.854 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -141.19 147.29 38.14 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -129.76 134.95 47.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.035 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.08 123.62 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.86 0.12 Allowed Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.128 0.893 . . . . 0.0 111.757 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.09 151.63 38.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.747 -0.855 . . . . 0.0 111.969 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.66 126.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.596 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -70.87 162.8 28.62 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -56.52 -24.92 49.88 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -73.02 -30.95 64.14 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.825 -1.172 . . . . 0.0 112.52 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.11 -1.25 25.49 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.214 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.51 155.61 39.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.152 1.476 . . . . 0.0 112.417 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.47 166.06 34.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.316 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' THR . . . . . 0.515 HG21 ' CD1' ' D' ' 50' ' ' LEU . 3.0 p -125.44 -179.92 4.83 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.81 -167.33 39.49 Favored Glycine 0 N--CA 1.469 0.878 0 O-C-N 119.46 -2.025 . . . . 0.0 113.755 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -137.92 132.31 32.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.101 0.953 . . . . 0.0 112.133 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -112.2 136.13 51.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 mt -125.78 129.53 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 70.4 m -104.74 143.33 33.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.736 -173.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.88 21.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -141.48 145.67 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.359 1.063 . . . . 0.0 112.504 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.05 167.99 26.67 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.111 -0.993 . . . . 0.0 110.896 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -30.98 63.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.9 69.7 29.45 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.448 1.899 . . . . 0.0 113.966 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.53 71.5 2.49 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.324 3.349 . . . . 0.0 114.266 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.17 14.49 Favored Glycine 0 N--CA 1.477 1.389 0 O-C-N 120.734 -1.229 . . . . 0.0 114.595 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.03 28.02 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.721 1.208 . . . . 0.0 112.626 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.69 130.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.946 0.879 . . . . 0.0 110.686 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.09 169.98 16.59 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.683 1.593 . . . . 0.0 109.753 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.17 115.37 2.62 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.249 3.02 . . . . 0.0 111.151 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -100.93 119.48 58.08 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.12 141.17 87.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.365 2.044 . . . . 0.0 111.647 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -125.38 157.15 37.5 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.738 0.815 . . . . 0.0 111.777 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . 0.515 ' CD1' HG21 ' D' ' 30' ' ' THR . 12.5 tp -163.67 149.04 10.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.356 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -148.25 15.26 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 120.298 1.408 . . . . 0.0 110.729 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mt -146.42 139.49 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.179 0.992 . . . . 0.0 110.317 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.91 136.83 54.59 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.224 -0.922 . . . . 0.0 111.549 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -68.58 150.38 48.08 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.659 -1.276 . . . . 0.0 111.782 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -147.26 24.66 1.13 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 111.751 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 15.5 mmt-85 -93.12 -58.19 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.085 1.754 . . . . 0.0 111.448 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 179.89 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -63.68 -55.28 24.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.246 1.018 . . . . 0.0 111.431 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.07 67.83 15.5 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.516 0.726 . . . . 0.0 112.447 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.23 -173.59 1.65 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.166 2.577 . . . . 0.0 115.5 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.511 ' HG1' ' HB3' ' A' ' 100' ' ' ARG 0.273 3.9 t -96.88 161.56 13.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 123.038 1.399 . . . . 0.0 112.997 174.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -151.46 167.99 26.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.352 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.84 147.53 13.1 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.994 2.358 . . . . 0.0 118.994 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.74 156.0 24.66 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.03 149.43 21.23 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.595 1.958 . . . . 0.0 109.594 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.62 117.73 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -93.21 106.38 18.35 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.49 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.268 42.6 m95 -74.26 131.98 41.7 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -172.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -90.48 -39.47 12.59 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.83 -9.51 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.35 129.01 10.79 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.553 2.741 . . . . 0.0 105.374 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.28 118.82 12.65 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.07 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 4.7 m -177.03 159.99 1.73 Allowed 'General case' 0 C--O 1.244 0.779 0 C-N-CA 125.875 1.67 . . . . 0.0 110.34 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.64 141.29 35.1 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.065 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.5 126.26 19.27 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.834 -2.894 . . . . 0.0 108.845 -172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.12 151.5 5.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.808 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 142.28 51.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.84 116.42 5.83 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.2 168.98 39.56 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 118.605 -1.76 . . . . 0.0 116.388 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 28.8 tt0 -101.89 148.31 25.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.782 0.801 . . . . 0.0 111.521 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 49.1 t -95.21 131.72 40.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.716 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -117.59 159.93 22.09 Favored 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 123.685 0.794 . . . . 0.0 112.867 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -124.13 110.37 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.68 158.19 8.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.958 1.303 . . . . 0.0 109.678 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -47.52 -34.27 7.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.96 -18.23 61.4 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 36.4 4.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.705 1.145 . . . . 0.0 112.802 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.41 ' NZ ' ' HB3' ' D' ' 90' ' ' LYS . 8.4 mtpm? -109.14 157.14 19.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.727 1.211 . . . . 0.0 110.189 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -109.21 153.55 23.64 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 119.919 -1.738 . . . . 0.0 111.511 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -153.18 154.57 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.177 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 mt -118.9 106.44 12.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 172.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . 0.485 ' HE3' HD13 ' D' ' 119' ' ' ILE . 1.1 mptt -97.7 125.94 42.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 172.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -138.78 162.91 33.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.75 1.262 . . . . 0.0 112.419 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 18.4 mtp -121.17 160.72 23.2 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -133.92 162.27 32.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.066 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -137.78 126.76 24.17 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.536 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.24 142.06 37.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 125.074 1.484 . . . . 0.0 109.827 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.484 ' HB3' ' HG1' ' A' ' 63' ' ' THR . 0.6 OUTLIER -129.82 117.85 20.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 111.801 -2.454 . . . . 0.0 111.729 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -84.49 171.12 12.82 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 23.4 m -109.09 71.91 0.79 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.79 171.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.838 1.255 . . . . 0.0 109.613 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.64 -4.26 12.81 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.8 150.97 46.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.739 1.257 . . . . 0.0 110.807 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.4 tt -68.33 -21.5 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.183 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.38 3.99 44.38 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.943 0.783 . . . . 0.0 114.294 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.31 1.22 7.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.037 0.935 . . . . 0.0 113.423 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.5 -34.59 71.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 113.034 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -48.21 -39.48 21.23 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -96.78 -12.93 23.02 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.967 1.307 . . . . 0.0 114.189 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.29 -4.62 37.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 6.7 m -108.8 145.42 35.24 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.621 0.724 . . . . 0.0 109.369 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -141.2 151.7 44.0 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.936 1.694 . . . . 0.0 108.854 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.17 153.73 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 109.715 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.78 -176.24 32.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.687 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 18.4 p90 -132.51 160.01 37.76 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.162 -0.61 . . . . 0.0 111.881 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . 0.492 HD22 HD22 ' D' ' 14' ' ' LEU . 4.7 m120 -150.33 157.2 42.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.73 1.252 . . . . 0.0 109.866 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . 0.485 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.0 mt -133.02 130.33 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.66 152.52 41.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.19 0.931 . . . . 0.0 109.417 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 45.2 p -140.66 167.38 22.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -57.4 125.58 23.48 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.326 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.52 128.03 34.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 68.99 102.98 0.06 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.784 2.434 . . . . 0.0 114.266 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.69 -69.77 0.25 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.69 2.396 . . . . 0.0 106.906 174.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 116.64 -77.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 132.106 4.162 . . . . 0.0 113.117 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -145.71 147.75 32.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.595 3.558 . . . . 0.0 103.271 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . 0.347 2.6 pt-20 . . . . . 0 CA--C 1.554 1.128 0 O-C-N 126.02 2.075 . . . . 0.0 113.227 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 37.8 m -73.12 111.96 8.72 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.706 0.684 . . . . 0.0 110.423 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 21.2 t 73.03 86.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.946 2.098 . . . . 0.0 113.45 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.04 61.88 1.52 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.888 1.675 . . . . 0.0 110.268 174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -131.81 16.24 4.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.578 1.551 . . . . 0.0 113.363 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -157.2 155.97 31.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.851 2.061 . . . . 0.0 108.654 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 28.8 p -137.97 140.94 40.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.107 1.763 . . . . 0.0 107.479 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -139.86 131.17 26.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 119.839 -1.788 . . . . 0.0 113.463 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.56 -26.11 68.41 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -52.14 118.09 3.25 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.704 1.716 . . . . 0.0 112.433 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.44 -118.0 2.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.507 2.004 . . . . 0.0 110.306 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -144.75 148.52 34.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.502 1.121 . . . . 0.0 113.621 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -144.87 159.05 43.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.177 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -136.65 148.41 47.41 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -105.81 143.55 33.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.812 1.245 . . . . 0.0 112.215 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.89 -22.33 62.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.731 1.212 . . . . 0.0 112.918 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.491 HD22 HD22 ' B' ' 118' ' ' ASN . 50.2 tp -76.68 -14.5 59.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.838 1.255 . . . . 0.0 112.497 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 -12.83 34.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.707 2.099 . . . . 0.0 113.769 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 153.77 28.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.105 1.431 . . . . 0.0 112.554 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.45 147.56 50.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.628 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -142.03 146.87 36.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m -128.55 135.36 49.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.064 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.7 124.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.19 -86.41 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 O-C-N 124.362 1.039 . . . . 0.0 111.502 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.83 152.59 42.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 122.068 0.937 . . . . 0.0 112.11 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -99.84 125.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 113.124 -1.853 . . . . 0.0 108.288 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -71.38 162.83 28.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 110.94 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -55.09 -23.52 21.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -74.83 -31.82 61.78 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.849 -1.157 . . . . 0.0 113.304 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.78 -5.47 27.61 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.874 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.48 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 0.0 OUTLIER -67.03 142.77 57.08 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.15 156.73 31.41 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -125.01 168.87 12.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.556 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.35 -167.1 35.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 122.461 1.034 . . . . 0.0 113.778 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 12.3 p -138.56 132.33 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.606 -1.297 . . . . 0.0 111.15 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.11 136.36 50.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.222 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mt -126.8 129.37 71.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.252 63.7 m -104.67 143.2 33.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.925 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.44 -8.46 21.09 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 m -140.35 145.74 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.267 1.027 . . . . 0.0 112.601 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.94 167.78 27.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.216 -0.928 . . . . 0.0 111.0 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.94 -31.52 64.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.75 69.83 30.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 126.562 1.945 . . . . 0.0 113.902 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 71.36 2.48 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 124.426 3.417 . . . . 0.0 114.259 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.0 2.17 14.68 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 120.753 -1.217 . . . . 0.0 114.571 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.11 27.9 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.594 1.157 . . . . 0.0 112.561 -174.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 86.4 mt -50.45 130.59 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.816 0.817 . . . . 0.0 110.658 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.59 170.42 15.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.636 1.574 . . . . 0.0 109.833 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.61 115.4 2.75 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.133 2.973 . . . . 0.0 111.068 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m -100.9 119.97 56.79 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.06 142.53 85.68 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.622 2.215 . . . . 0.0 111.853 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.98 153.07 47.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.741 0.816 . . . . 0.0 111.725 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.64 148.77 16.24 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.426 1.49 . . . . 0.0 110.348 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.42 -152.38 23.12 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 120.857 1.662 . . . . 0.0 110.158 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -143.0 139.59 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.78 136.36 53.05 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.508 -0.745 . . . . 0.0 112.081 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -69.25 150.93 46.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.988 0.899 . . . . 0.0 111.358 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.26 18.96 1.22 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.056 1.342 . . . . 0.0 111.865 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 mmt-85 -87.84 -58.19 2.66 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.315 1.846 . . . . 0.0 111.467 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 178.5 4.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.6 t -64.42 -53.37 49.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.602 1.161 . . . . 0.0 111.85 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -143.95 66.51 14.86 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.785 0.834 . . . . 0.0 113.057 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.83 -174.23 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.912 2.408 . . . . 0.0 115.316 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.486 ' HG1' ' HB3' ' C' ' 100' ' ' ARG 0.262 4.2 t -96.35 161.27 14.0 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.689 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -151.49 168.48 24.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.207 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.41 147.16 12.27 Favored Glycine 0 CA--C 1.539 1.58 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -160.05 157.63 29.01 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.45 150.11 20.7 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.516 1.926 . . . . 0.0 109.575 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.51 117.12 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -92.41 105.58 17.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.613 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.267 42.9 m95 -74.12 130.79 40.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -89.32 -40.34 12.85 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -91.9 -9.56 42.77 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.37 128.08 10.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.52 2.728 . . . . 0.0 105.326 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.08 118.88 12.54 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.823 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -177.08 159.95 1.71 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.958 1.703 . . . . 0.0 110.317 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -141.11 141.54 34.18 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.87 126.93 19.47 Favored 'General case' 0 N--CA 1.407 -2.625 0 CA-C-N 110.593 -3.003 . . . . 0.0 108.657 -172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.842 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -124.56 142.72 51.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.41 116.92 5.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.84 168.96 39.94 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 118.816 -1.659 . . . . 0.0 116.546 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 28.8 tt0 -101.81 148.4 25.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.76 0.79 . . . . 0.0 111.356 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 49.8 t -95.2 133.04 39.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.133 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -118.41 158.17 25.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 mt -121.97 108.43 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.14 158.62 8.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.126 0.97 . . . . 0.0 110.466 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -46.95 -32.15 3.65 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.05 -12.22 59.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.65 51.32 3.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.8 156.74 30.05 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 129.658 3.183 . . . . 0.0 108.548 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -118.02 155.31 30.53 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 119.948 -1.72 . . . . 0.0 111.465 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -155.54 155.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -120.12 107.07 12.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.477 ' HE3' HD13 ' B' ' 119' ' ' ILE . 1.0 OUTLIER -98.29 126.14 43.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -139.32 163.08 33.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.688 1.233 . . . . 0.0 112.551 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 19.7 mtp -120.79 160.68 22.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.82 162.63 31.48 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.133 -1.849 . . . . 0.0 113.175 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.73 126.38 23.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.568 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.24 141.0 39.23 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 125.05 1.468 . . . . 0.0 109.84 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.513 ' HB3' ' HG1' ' C' ' 63' ' ' THR . 0.8 OUTLIER -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 111.728 -2.487 . . . . 0.0 111.669 -173.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -84.93 171.81 11.86 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 32.6 m -110.08 71.73 0.77 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.72 170.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.333 1.453 . . . . 0.0 110.012 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.39 -4.52 13.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.05 151.85 47.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.662 1.22 . . . . 0.0 111.067 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 15.7 tt -68.52 -22.29 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.072 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.73 4.53 36.19 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.753 0.692 . . . . 0.0 114.391 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.65 1.38 7.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.65 -34.38 71.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.294 1.038 . . . . 0.0 113.284 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -48.34 -39.51 22.3 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -96.44 -13.35 23.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.902 1.281 . . . . 0.0 114.125 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.06 -5.77 43.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -107.54 145.03 33.71 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 121.822 0.82 . . . . 0.0 109.279 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -140.61 151.31 44.56 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 125.966 1.706 . . . . 0.0 108.751 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.88 154.21 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 119.582 1.083 . . . . 0.0 109.656 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.84 -176.14 32.62 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.093 0.854 . . . . 0.0 111.739 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 17.9 p90 -132.73 160.08 37.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.137 -0.625 . . . . 0.0 112.087 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . 0.491 HD22 HD22 ' B' ' 14' ' ' LEU . 5.3 m120 -150.43 157.07 42.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.665 1.221 . . . . 0.0 110.02 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.477 HD13 ' HE3' ' B' ' 94' ' ' LYS . 8.6 mt -132.65 130.0 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.9 153.36 39.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 124.285 0.991 . . . . 0.0 109.408 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.4 p -141.74 165.67 26.85 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.16 121.79 11.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.803 1.241 . . . . 0.0 111.872 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.29 149.63 47.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 38.0 15.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 9.7 t -59.59 171.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.454 0.702 . . . . 0.0 112.12 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.78 146.26 40.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.924 1.29 . . . . 0.0 107.827 174.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.42 -176.22 0.12 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.492 3.517 . . . . 0.0 109.147 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 O-C-N 125.814 1.946 . . . . 0.0 112.489 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 119.566 -0.254 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.8 p -139.05 -64.95 0.49 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.072 2.149 . . . . 0.0 109.583 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 13.4 m -138.23 21.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 112.063 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 59.48 -81.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.795 2.438 . . . . 0.0 112.827 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.31 64.15 0.33 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.181 2.992 . . . . 0.0 108.5 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -157.17 155.93 31.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.218 1.007 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 p -133.72 143.63 48.61 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -140.04 129.22 23.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 119.581 -1.949 . . . . 0.0 114.248 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.07 -27.32 69.31 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -52.11 114.49 1.34 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 123.035 1.398 . . . . 0.0 111.915 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.96 -109.44 0.74 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.669 1.604 . . . . 0.0 110.979 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -152.0 144.26 23.98 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.87 160.48 39.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.256 1.022 . . . . 0.0 110.699 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.21 148.0 50.81 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -109.3 143.62 38.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.945 0.898 . . . . 0.0 111.859 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -59.6 -25.72 64.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.628 1.171 . . . . 0.0 112.969 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.492 HD22 HD22 ' C' ' 118' ' ' ASN . 48.9 tp -73.58 -14.2 61.15 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.838 -1.164 . . . . 0.0 112.357 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.28 -12.19 36.79 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.82 2.152 . . . . 0.0 113.685 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.86 155.01 28.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 123.393 1.568 . . . . 0.0 112.427 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.39 146.3 51.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.015 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -142.31 144.18 33.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.035 0.922 . . . . 0.0 113.348 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -127.52 134.11 49.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.246 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 95.9 mt -132.64 124.39 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.46 -85.71 0.1 Allowed Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.241 0.963 . . . . 0.0 111.701 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.6 152.33 39.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.846 -0.796 . . . . 0.0 112.283 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.98 126.23 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 113.474 -1.694 . . . . 0.0 108.652 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -71.29 163.23 28.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.541 0.686 . . . . 0.0 111.78 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -56.78 -24.82 53.15 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -73.04 -31.26 64.32 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.736 -1.228 . . . . 0.0 112.524 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.79 -2.26 24.51 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.257 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.44 155.47 40.08 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.016 1.408 . . . . 0.0 112.459 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.89 166.08 34.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.43 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.525 HG21 ' CD1' ' C' ' 50' ' ' LEU . 3.0 p -125.66 -179.34 4.61 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 173.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.0 -166.91 39.22 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 119.208 -2.182 . . . . 0.0 113.222 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 12.4 p -137.13 131.94 33.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.797 0.808 . . . . 0.0 112.199 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -111.39 137.78 48.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.8 129.85 70.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.254 64.9 m -104.8 144.07 32.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.462 -173.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.97 -6.26 21.42 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -141.68 144.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 112.57 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.59 168.03 26.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 110.966 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -31.29 63.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 172.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -140.41 69.94 32.69 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.626 1.97 . . . . 0.0 113.977 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.53 71.56 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.405 3.403 . . . . 0.0 114.195 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.05 1.94 14.64 Favored Glycine 0 N--CA 1.477 1.409 0 O-C-N 120.686 -1.259 . . . . 0.0 114.616 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.91 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.583 1.153 . . . . 0.0 112.554 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.56 130.86 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.898 0.856 . . . . 0.0 110.612 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.15 169.93 16.68 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.773 1.629 . . . . 0.0 109.803 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.8 115.44 2.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 129.264 3.025 . . . . 0.0 111.153 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 57.0 m -100.98 119.47 58.04 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.88 141.75 85.13 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.174 1.916 . . . . 0.0 111.526 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.47 157.02 39.75 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.664 0.786 . . . . 0.0 111.805 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . 0.525 ' CD1' HG21 ' C' ' 30' ' ' THR . 12.6 tp -164.19 148.98 10.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.521 1.528 . . . . 0.0 112.455 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.09 -147.97 14.74 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 120.357 1.435 . . . . 0.0 110.699 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mt -146.84 139.47 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 110.162 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.66 136.66 54.61 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 121.188 -0.945 . . . . 0.0 111.428 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -68.36 150.6 47.99 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.626 -1.296 . . . . 0.0 111.64 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -146.86 25.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.011 1.324 . . . . 0.0 111.717 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 mmt-85 -93.42 -58.2 2.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.173 1.789 . . . . 0.0 111.705 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.25 179.65 4.39 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.594 1.184 . . . . 0.0 113.992 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -63.71 -57.9 8.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.725 0.81 . . . . 0.0 110.795 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.75 66.64 27.63 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.606 0.763 . . . . 0.0 112.065 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -173.31 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.29 2.66 . . . . 0.0 115.245 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.513 ' HG1' ' HB3' ' B' ' 100' ' ' ARG 0.276 4.0 t -96.54 161.51 13.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 123.055 1.407 . . . . 0.0 113.011 174.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -151.75 167.57 27.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.469 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.5 147.79 13.71 Favored Glycine 0 CA--C 1.542 1.771 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.68 156.54 25.64 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -93.57 150.05 20.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.546 1.938 . . . . 0.0 109.618 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.03 117.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -92.74 107.14 18.99 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.347 -0.846 . . . . 0.0 110.42 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.268 43.1 m95 -75.3 131.8 40.56 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -89.95 -40.53 12.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -92.21 -9.23 43.0 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -152.37 127.79 9.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.605 2.762 . . . . 0.0 105.172 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.37 118.84 12.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.2 m -177.2 160.2 1.7 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 126.127 1.771 . . . . 0.0 110.424 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -140.98 141.57 34.38 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.054 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.43 127.32 20.63 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 110.642 -2.981 . . . . 0.0 108.824 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.13 151.19 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.69 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.8 142.42 51.12 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.5 117.16 5.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -173.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 169.0 39.61 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.257 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 28.8 tt0 -101.75 148.66 25.01 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 111.354 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.48 132.67 41.8 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.107 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -117.95 160.28 21.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.01 110.18 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 172.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.79 156.96 10.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 109.912 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -46.76 -34.9 5.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.62 -15.95 61.24 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.62 35.62 5.6 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.365 1.459 . . . . 0.0 113.232 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' C' ' 90' ' ' LYS . 4.6 mtpm? -104.47 163.04 12.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.16 1.384 . . . . 0.0 107.854 173.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -118.49 152.57 35.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.997 1.719 . . . . 0.0 111.182 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -153.34 156.04 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.229 1.411 . . . . 0.0 111.168 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 mt -119.91 108.67 14.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' C' ' 119' ' ' ILE . 1.0 OUTLIER -99.6 126.07 45.53 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 172.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -139.34 162.55 34.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.667 1.223 . . . . 0.0 112.677 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 18.9 mtp -120.3 160.98 21.91 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -133.86 162.76 31.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.995 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 tp -137.81 126.73 24.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.467 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.22 38.84 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 124.881 1.363 . . . . 0.0 109.944 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.486 ' HB3' ' HG1' ' B' ' 63' ' ' THR . 0.5 OUTLIER -129.42 118.92 22.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 111.615 -2.539 . . . . 0.0 111.771 -173.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 96.2 p -85.96 171.68 11.26 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -110.34 71.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.5 171.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.081 1.352 . . . . 0.0 109.529 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -114.07 -5.68 13.1 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.54 151.49 47.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.703 1.24 . . . . 0.0 110.98 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.3 tt -67.79 -22.11 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.932 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.5 3.84 38.84 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.85 -0.972 . . . . 0.0 114.33 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -125.58 1.27 7.57 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.289 1.036 . . . . 0.0 113.747 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.66 -34.39 71.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.148 0.979 . . . . 0.0 112.973 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.54 -39.0 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -96.95 -12.62 23.16 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.028 1.331 . . . . 0.0 114.237 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.57 -4.61 38.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 6.8 m -108.65 144.99 35.67 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.305 1.05 . . . . 0.0 109.672 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -141.31 151.68 43.81 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.547 1.539 . . . . 0.0 108.262 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.23 153.41 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.87 -175.88 32.37 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 123.998 0.808 . . . . 0.0 111.807 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 18.4 p90 -133.09 160.52 36.96 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.086 -0.656 . . . . 0.0 112.26 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . 0.492 HD22 HD22 ' C' ' 14' ' ' LEU . 4.9 m120 -150.65 157.56 43.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.719 1.247 . . . . 0.0 110.276 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' C' ' 94' ' ' LYS . 8.8 mt -133.13 130.87 58.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -124.32 150.93 44.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -139.59 167.59 21.76 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.399 -0.813 . . . . 0.0 109.061 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -57.59 117.33 4.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.222 1.009 . . . . 0.0 111.572 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -77.97 114.34 16.74 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 81.68 81.52 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.647 2.379 . . . . 0.0 113.743 174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t -154.88 142.34 19.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 109.114 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -154.63 132.0 11.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.883 2.073 . . . . 0.0 107.42 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -142.81 14.18 1.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 . . . . . 0 C--O 1.255 1.37 0 C-N-CA 129.384 3.073 . . . . 0.0 110.558 -173.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 117.748 -1.12 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 11.8 t -80.75 39.41 0.48 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.447 1.476 . . . . 0.0 114.932 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.24 30.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 126.071 1.749 . . . . 0.0 109.809 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 61.77 -165.8 0.22 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.744 1.618 . . . . 0.0 113.594 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -145.05 106.9 4.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.263 2.225 . . . . 0.0 108.267 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.66 113.5 3.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.746 1.618 . . . . 0.0 110.076 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 t -116.33 123.44 47.64 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -141.11 134.78 30.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.892 -1.13 . . . . 0.0 112.232 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.65 -18.09 61.07 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -56.15 115.89 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.606 1.162 . . . . 0.0 111.317 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.91 -122.23 3.29 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.926 1.727 . . . . 0.0 111.269 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.45 143.6 26.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -140.35 162.68 34.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.28 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -137.77 146.31 43.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.359 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.403 HD21 ' HB3' ' A' ' 14' ' ' LEU . 6.3 t30 -108.0 145.31 34.09 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.948 0.899 . . . . 0.0 110.581 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.81 -29.45 54.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.963 1.305 . . . . 0.0 114.248 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 12' ' ' ASN . 30.3 tp -70.99 -13.83 62.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.975 1.71 . . . . 0.0 113.402 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.38 22.95 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.31 2.386 . . . . 0.0 113.868 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 156.04 34.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.042 1.421 . . . . 0.0 113.578 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.29 136.14 51.54 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.407 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -130.1 143.26 50.69 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.393 -0.817 . . . . 0.0 112.09 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 m -132.07 133.08 43.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.514 0.726 . . . . 0.0 109.589 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.91 121.75 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -58.19 9.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.311 1.007 . . . . 0.0 112.425 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.32 153.27 3.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.164 1.386 . . . . 0.0 110.557 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.48 130.96 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 124.582 1.176 . . . . 0.0 111.293 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -75.1 168.85 19.18 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 m -55.62 -27.95 52.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -81.77 -35.77 29.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.059 0.845 . . . . 0.0 110.422 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.54 -6.02 9.2 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 117.151 -1.916 . . . . 0.0 114.489 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.9 141.81 56.26 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 119.7 1.75 . . . . 0.0 108.101 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.24 151.0 22.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.85 165.32 11.94 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.42 -165.45 32.09 Favored Glycine 0 C--O 1.237 0.322 0 O-C-N 120.683 -1.261 . . . . 0.0 111.707 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -141.36 143.35 33.94 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 122.227 1.013 . . . . 0.0 112.983 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -118.65 123.9 46.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.246 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.15 126.68 72.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.3 m -105.65 150.51 25.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.3 -11.88 14.82 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.39 146.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.363 1.465 . . . . 0.0 112.091 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.17 42.18 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.292 -1.505 . . . . 0.0 113.265 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -71.57 -21.54 61.87 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.693 0.397 . . . . 0.0 110.598 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -148.47 83.46 7.03 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.828 2.451 . . . . 0.0 109.944 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 28.33 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.545 3.497 . . . . 0.0 115.834 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.12 -5.67 49.17 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 0.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.003 -1.475 . . . . 0.0 114.165 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -20.57 114.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.865 1.666 . . . . 0.0 115.451 -173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 168.18 18.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.351 2.26 . . . . 0.0 107.923 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -53.69 138.25 35.53 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.148 1.379 . . . . 0.0 112.856 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -115.55 121.56 34.32 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.22 144.82 89.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.435 2.757 . . . . 0.0 111.622 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.49 154.86 48.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 111.378 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.81 148.56 20.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.237 1.815 . . . . 0.0 109.916 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.25 -153.4 23.88 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 121.748 2.067 . . . . 0.0 111.775 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -142.17 142.4 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.04 143.98 51.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.35 0.66 . . . . 0.0 111.816 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -79.35 151.43 31.0 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.603 1.192 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -145.94 25.46 1.28 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.43 1.492 . . . . 0.0 111.744 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -93.52 -50.22 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.219 2.208 . . . . 0.0 112.107 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.95 178.19 7.66 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.797 0.808 . . . . 0.0 112.81 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 p -77.82 -41.77 35.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 113.676 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -131.66 56.46 24.26 Favored Pre-proline 0 CA--C 1.554 1.103 0 C-N-CA 125.367 1.467 . . . . 0.0 112.174 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.06 172.06 12.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.975 1.783 . . . . 0.0 115.71 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.51 174.08 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.229 173.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -166.69 165.34 16.54 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.252 -1.794 . . . . 0.0 113.592 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.68 148.32 13.67 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 118.589 2.195 . . . . 0.0 118.589 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -164.13 154.98 15.47 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 152.4 22.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.906 1.683 . . . . 0.0 110.326 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -133.23 116.91 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -99.49 110.13 22.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -76.95 136.81 38.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -38.34 12.54 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.545 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -86.54 -15.67 39.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -152.55 122.23 6.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.195 1.798 . . . . 0.0 107.145 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.65 118.48 5.71 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.175 1.352 . . . . 0.0 110.114 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.9 p -175.18 168.34 3.39 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.04 1.736 . . . . 0.0 110.616 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -147.78 145.33 28.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.254 1.502 . . . . 0.0 111.326 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.02 130.35 31.27 Favored 'General case' 0 N--CA 1.407 -2.621 0 CA-C-N 110.03 -3.259 . . . . 0.0 108.515 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.35 140.79 31.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 O-C-N 123.874 0.734 . . . . 0.0 109.573 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -115.09 147.43 40.21 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.422 0.452 . . . . 0.0 110.561 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 118.25 10.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.39 -172.71 31.21 Favored Glycine 0 CA--C 1.502 -0.768 0 C-N-CA 119.493 -1.336 . . . . 0.0 115.749 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -123.3 149.9 44.24 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 125.101 1.118 . . . . 0.0 113.103 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.49 112.86 24.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.576 -2.556 . . . . 0.0 106.31 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 10.5 m-85 -108.41 155.97 19.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 118.893 0.77 . . . . 0.0 112.625 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -128.9 113.04 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.79 161.65 4.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.812 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -41.63 -48.29 4.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.553 1.541 . . . . 0.0 113.599 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.36 -29.97 70.26 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.23 24.53 5.38 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.124 1.345 . . . . 0.0 114.142 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -92.92 160.5 14.87 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.647 1.223 . . . . 0.0 108.128 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.01 147.67 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.363 1.465 . . . . 0.0 111.405 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -148.27 159.62 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.104 1.362 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.1 mt -122.47 106.43 11.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' HE3' HD13 ' A' ' 119' ' ' ILE . 3.9 mmtt -98.87 123.99 43.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -139.34 168.4 19.91 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.54 1.638 . . . . 0.0 113.652 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -118.71 163.15 17.26 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -136.9 162.23 33.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.632 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -145.52 120.82 10.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.78 -1.554 . . . . 0.0 111.676 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.74 137.57 45.52 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 125.152 1.532 . . . . 0.0 112.897 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -118.95 113.85 21.65 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 111.121 -2.763 . . . . 0.0 110.88 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.282 49.2 m -73.6 168.09 20.01 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.364 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 p -110.4 85.88 2.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.09 -164.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -131.49 -26.07 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.574 -1.329 . . . . 0.0 114.042 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.35 148.89 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.81 1.767 . . . . 0.0 111.916 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.2 -22.49 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.343 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.86 2.69 54.04 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 117.969 -1.462 . . . . 0.0 113.634 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -120.36 1.9 10.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.72 -27.84 66.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.606 -1.934 . . . . 0.0 112.395 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 43.7 p-90 -46.08 -49.49 16.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.302 1.041 . . . . 0.0 113.042 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -89.29 -11.42 43.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.93 0.892 . . . . 0.0 112.703 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.34 -3.03 34.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.237 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -107.72 138.46 43.92 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.746 0.819 . . . . 0.0 112.585 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 114' ' ' ARG . 18.4 mtt85 -141.35 130.37 23.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 110.821 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.45 158.25 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.933 1.242 . . . . 0.0 111.308 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.63 -177.51 36.54 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 14.7 p90 -126.69 155.56 42.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.913 -0.757 . . . . 0.0 111.858 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -148.13 155.73 41.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.539 1.161 . . . . 0.0 110.915 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.479 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.1 mt -139.32 120.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.06 153.92 27.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.466 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -142.14 165.99 25.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 123.5 14.84 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -71.17 112.12 7.06 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.287 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 66.56 87.46 0.12 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.019 1.728 . . . . 0.0 113.612 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t -138.68 40.25 2.19 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.317 1.447 . . . . 0.0 112.064 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 53.58 -161.4 0.12 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.816 1.246 . . . . 0.0 112.785 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.35 -9.92 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 127.628 2.371 . . . . 0.0 114.504 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.246 0.901 1 C-N-CA 134.004 4.921 . . . . 0.0 104.617 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 117.952 -1.023 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 11.1 p -149.39 -83.49 0.1 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.071 1.348 . . . . 0.0 108.903 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.19 166.83 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.743 2.017 . . . . 0.0 108.751 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -121.19 178.63 4.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.936 1.294 . . . . 0.0 110.756 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -122.03 94.95 4.46 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.985 -1.072 . . . . 0.0 111.183 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 115.03 3.56 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.199 1.8 . . . . 0.0 108.422 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.25 123.49 47.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -143.02 136.26 28.23 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.41 -17.87 61.21 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -55.86 118.81 4.93 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.434 1.111 . . . . 0.0 111.704 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.2 -114.83 1.72 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 125.612 1.577 . . . . 0.0 111.239 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.83 141.37 21.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -139.18 162.8 34.08 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.559 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -142.52 147.92 36.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.92 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . 0.415 HD21 ' HB3' ' D' ' 14' ' ' LEU . 5.5 t30 -108.15 145.66 33.84 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.897 0.879 . . . . 0.0 110.487 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.63 -27.02 57.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.819 1.248 . . . . 0.0 113.9 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' D' ' 12' ' ' ASN . 30.5 tp -71.41 -14.62 62.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.753 1.621 . . . . 0.0 113.384 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.14 -13.45 21.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.309 2.385 . . . . 0.0 113.975 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.39 154.55 41.08 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.094 1.447 . . . . 0.0 112.619 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.65 135.13 51.82 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.309 0.644 . . . . 0.0 110.764 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -128.77 144.42 51.16 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.472 -0.768 . . . . 0.0 111.987 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -133.77 131.48 39.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.964 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.81 122.3 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.64 -60.52 6.12 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 124.542 1.151 . . . . 0.0 112.24 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.1 156.08 8.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.538 1.135 . . . . 0.0 110.872 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.23 129.84 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.481 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -75.35 168.21 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.082 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -56.43 -26.8 54.72 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -80.16 -32.76 38.78 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.095 0.861 . . . . 0.0 110.606 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 -6.15 10.3 Favored Glycine 0 C--O 1.221 -0.703 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.486 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.59 149.77 46.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.218 1.407 . . . . 0.0 113.265 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.17 165.56 31.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.769 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 161.96 26.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -172.06 -165.26 28.93 Favored Glycine 0 N--CA 1.464 0.552 0 O-C-N 119.983 -1.698 . . . . 0.0 111.96 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 70.6 p -139.89 141.43 36.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.464 1.126 . . . . 0.0 113.337 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -119.52 122.43 41.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.094 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.75 127.23 71.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 58.2 m -105.6 150.87 25.02 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.79 -12.31 14.62 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.49 146.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.312 1.445 . . . . 0.0 111.935 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.88 161.59 41.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.362 -1.462 . . . . 0.0 113.353 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -72.09 -21.48 61.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.717 0.407 . . . . 0.0 110.747 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.27 83.29 7.23 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 127.857 2.463 . . . . 0.0 109.915 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.76 28.0 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 124.489 3.459 . . . . 0.0 115.951 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.91 -5.65 47.83 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 1.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.136 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -21.53 115.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 168.3 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.401 2.28 . . . . 0.0 107.894 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.01 139.03 35.75 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.325 1.45 . . . . 0.0 112.837 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -116.8 121.59 32.65 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.87 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.21 143.34 93.68 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.452 2.768 . . . . 0.0 111.474 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.63 161.68 33.29 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.998 0.919 . . . . 0.0 111.885 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 tp -166.78 148.4 6.19 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.231 1.412 . . . . 0.0 112.011 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 -152.91 23.54 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 121.171 1.805 . . . . 0.0 111.804 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.56 142.65 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.672 0.789 . . . . 0.0 112.689 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 144.6 51.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.851 1.26 . . . . 0.0 111.183 174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.56 149.49 29.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.942 0.877 . . . . 0.0 109.522 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -143.46 24.53 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.573 1.549 . . . . 0.0 111.648 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.48 -49.68 5.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.748 2.019 . . . . 0.0 111.536 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.23 178.45 8.06 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.087 0.867 . . . . 0.0 112.371 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 13.2 p -77.39 -42.27 36.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.603 1.961 . . . . 0.0 113.907 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -131.28 54.06 13.5 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.237 1.415 . . . . 0.0 112.05 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.25 173.59 9.35 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.571 2.181 . . . . 0.0 115.989 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.67 6.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.72 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -166.7 164.27 16.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.868 -1.515 . . . . 0.0 113.724 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.7 147.84 13.31 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 118.158 2.023 . . . . 0.0 118.158 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -164.05 154.03 14.7 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.7 152.7 21.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.209 1.804 . . . . 0.0 110.06 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -133.59 116.91 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -100.11 110.06 22.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.428 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -76.44 138.62 40.45 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -37.72 11.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.152 -1.386 . . . . 0.0 114.688 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -87.23 -15.7 37.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -152.54 121.68 6.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 126.553 1.941 . . . . 0.0 107.277 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -57.98 118.49 5.44 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.957 1.253 . . . . 0.0 110.179 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 66.1 p -174.75 169.34 3.55 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.992 1.717 . . . . 0.0 110.65 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -148.09 145.71 28.53 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-O 123.501 1.619 . . . . 0.0 111.081 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.77 130.22 31.61 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 109.847 -3.342 . . . . 0.0 108.459 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.69 141.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -115.09 147.73 39.82 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 0.0 110.562 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.29 117.92 9.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.66 -171.9 29.44 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 119.398 -1.382 . . . . 0.0 115.566 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . 0.526 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.4 OUTLIER -127.31 149.95 49.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.528 1.156 . . . . 0.0 113.309 -174.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.63 112.63 24.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.83 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.526 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 11.9 m-85 -111.22 153.09 26.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 119.458 1.026 . . . . 0.0 113.066 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.75 109.94 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 163.16 3.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.475 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -41.63 -42.3 2.46 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -12.67 60.03 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.57 44.71 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.086 1.327 . . . . 0.0 114.898 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -67.76 159.51 30.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.254 1.527 . . . . 0.0 110.705 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -120.11 145.49 46.85 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.858 1.663 . . . . 0.0 111.892 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.31 158.29 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.751 1.22 . . . . 0.0 110.706 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -121.57 106.65 11.57 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . 0.488 ' HE3' HD13 ' D' ' 119' ' ' ILE . 4.2 mmtt -99.34 123.98 44.06 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -139.35 168.22 20.31 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.577 1.656 . . . . 0.0 113.677 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.29 163.39 16.77 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 171.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -137.0 162.45 33.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.254 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -145.82 121.07 10.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.611 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.14 44.49 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 125.062 1.477 . . . . 0.0 112.917 -174.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.45 113.85 21.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 111.177 -2.738 . . . . 0.0 110.943 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.284 49.8 m -73.42 168.3 19.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.279 1.612 . . . . 0.0 111.337 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.9 86.02 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.07 -165.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -130.77 -26.28 2.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 149.23 40.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.859 1.79 . . . . 0.0 111.93 176.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.39 -22.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.213 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.92 4.06 54.72 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.99 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 6.7 m-20 -120.99 2.67 10.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.34 -27.86 67.7 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.587 -1.946 . . . . 0.0 112.046 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . 0.451 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.3 p-90 -45.69 -49.46 14.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.347 1.059 . . . . 0.0 113.107 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -89.61 -11.32 42.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.039 0.936 . . . . 0.0 112.558 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.61 -2.62 33.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.695 0.398 . . . . 0.0 111.437 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -107.9 138.59 43.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.638 0.775 . . . . 0.0 112.78 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' D' ' 114' ' ' ARG . 18.8 mtt85 -141.43 130.18 22.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.856 1.262 . . . . 0.0 111.032 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.32 158.26 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.891 1.223 . . . . 0.0 111.331 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.15 -177.9 36.48 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 14.7 p90 -126.07 155.33 41.74 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.913 -0.757 . . . . 0.0 111.477 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -148.03 154.69 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.072 0.939 . . . . 0.0 110.45 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . 0.488 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -137.31 120.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -111.84 153.26 26.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.348 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -138.38 164.86 28.25 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 121.4 7.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.071 0.948 . . . . 0.0 110.956 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' D' ' 123' ' ' LEU . 3.5 tt -85.96 109.33 18.69 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.58 169.09 0.85 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.232 1.813 . . . . 0.0 108.694 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 9.3 t 43.68 -154.89 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.959 1.704 . . . . 0.0 113.788 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -151.64 140.81 21.28 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.415 1.886 . . . . 0.0 105.971 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . 0.483 0.0 OUTLIER 62.54 -45.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.766 2.826 . . . . 0.0 115.167 -173.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.481 1.08 1 C-N-CA 136.225 5.81 . . . . 0.0 108.751 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 119.12 -0.467 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 13.4 p -111.94 -67.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.973 0.806 . . . . 0.0 110.079 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.84 150.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.825 1.25 . . . . 0.0 109.531 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.77 -168.12 0.24 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.276 1.43 . . . . 0.0 112.799 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -131.81 83.55 2.1 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 110.233 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.23 111.88 2.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.7 1.6 . . . . 0.0 108.978 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.51 123.35 48.3 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -173.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -142.91 135.48 27.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.396 1.078 . . . . 0.0 113.528 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.48 -17.83 61.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -55.94 115.87 2.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.46 1.104 . . . . 0.0 111.407 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.34 -119.72 2.7 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.953 1.739 . . . . 0.0 110.887 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.21 143.79 27.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -142.13 162.78 34.6 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.249 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -142.1 146.84 35.84 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.976 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' B' ' 14' ' ' LEU . 6.6 t30 -107.08 146.25 31.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.15 0.98 . . . . 0.0 110.386 -174.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.8 -27.77 52.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.862 1.265 . . . . 0.0 114.329 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' B' ' 12' ' ' ASN . 30.0 tp -72.14 -14.58 61.86 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.759 1.624 . . . . 0.0 113.225 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.03 -12.28 24.47 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.257 2.36 . . . . 0.0 114.077 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.53 153.58 41.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.154 1.477 . . . . 0.0 113.74 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.8 134.05 52.9 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 174.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -128.06 145.21 51.07 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.544 -0.722 . . . . 0.0 112.408 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -133.33 133.28 42.32 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.43 0.692 . . . . 0.0 109.673 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -132.87 122.18 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.65 -58.85 7.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.226 0.954 . . . . 0.0 112.378 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.64 153.55 4.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.121 1.368 . . . . 0.0 110.626 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.52 131.4 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 124.492 1.12 . . . . 0.0 111.371 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -75.52 168.79 19.34 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -55.61 -27.89 52.13 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -81.83 -35.55 29.3 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.059 0.845 . . . . 0.0 110.44 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 -6.33 9.27 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 117.22 -1.878 . . . . 0.0 114.663 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.07 141.57 57.45 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.48 1.64 . . . . 0.0 108.461 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.22 151.13 22.63 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.95 165.19 12.07 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.15 -164.93 31.14 Favored Glycine 0 C--O 1.237 0.33 0 O-C-N 120.547 -1.346 . . . . 0.0 111.568 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -141.45 142.76 33.64 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.287 1.041 . . . . 0.0 113.011 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -117.58 125.26 50.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.229 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.09 125.93 73.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 30.6 m -106.34 144.98 32.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.88 -13.42 16.96 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.8 146.8 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.182 1.393 . . . . 0.0 112.113 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.66 161.42 42.17 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.301 -1.499 . . . . 0.0 113.264 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.85 -21.52 61.66 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.31 83.05 7.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.858 2.463 . . . . 0.0 110.084 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.8 29.15 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 124.645 3.563 . . . . 0.0 115.895 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.88 -5.49 52.38 Favored Glycine 0 N--CA 1.478 1.434 0 N-CA-C 118.194 2.038 . . . . 0.0 118.194 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.92 2.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.163 1.482 . . . . 0.0 114.148 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -21.27 111.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.15 167.63 16.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.334 2.254 . . . . 0.0 108.181 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.78 138.54 35.46 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.398 1.479 . . . . 0.0 112.846 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -115.55 121.82 33.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.056 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.42 144.75 90.89 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.426 2.751 . . . . 0.0 111.455 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.47 154.36 48.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.148 0.979 . . . . 0.0 111.287 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -156.87 148.79 22.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.066 1.746 . . . . 0.0 109.944 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.19 -153.5 24.05 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 121.933 2.151 . . . . 0.0 111.66 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -142.39 142.43 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 143.45 50.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.192 0.597 . . . . 0.0 111.694 173.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -78.48 152.87 31.82 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.424 1.107 . . . . 0.0 109.549 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -147.29 25.45 1.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.568 1.547 . . . . 0.0 111.68 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -93.46 -49.21 6.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.985 2.114 . . . . 0.0 112.078 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 178.32 8.12 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.3 p -75.47 -43.06 51.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.042 1.737 . . . . 0.0 113.635 174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.2 54.21 13.37 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.25 1.42 . . . . 0.0 112.192 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -67.43 171.82 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.035 1.824 . . . . 0.0 115.79 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 174.58 7.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.129 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.77 164.61 16.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.529 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.4 147.8 12.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.43 154.75 16.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -88.38 150.72 23.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.22 1.808 . . . . 0.0 110.528 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.58 116.92 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -99.32 110.14 22.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.748 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -76.79 136.77 38.99 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.76 -37.93 12.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.667 -174.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -87.28 -15.11 39.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 21.8 t -152.58 122.66 7.07 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.42 1.888 . . . . 0.0 107.309 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.85 118.53 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.932 1.242 . . . . 0.0 110.078 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -174.92 168.98 3.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.19 1.796 . . . . 0.0 110.542 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.79 145.47 28.79 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.243 1.497 . . . . 0.0 111.181 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.31 130.21 30.46 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 110.095 -3.23 . . . . 0.0 108.588 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 m -113.47 140.84 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.892 0.745 . . . . 0.0 109.68 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -115.04 147.29 40.33 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 123.463 0.477 . . . . 0.0 110.452 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 117.99 10.21 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.55 -173.16 30.91 Favored Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 119.728 -1.225 . . . . 0.0 115.645 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.523 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.1 OUTLIER -124.77 149.92 46.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.579 1.18 . . . . 0.0 112.895 -175.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.44 112.66 24.4 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 111.358 -2.656 . . . . 0.0 105.488 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 11.5 m-85 -110.71 155.78 21.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 119.265 0.939 . . . . 0.0 112.666 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.34 117.99 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.95 162.79 10.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.195 0.998 . . . . 0.0 110.578 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -42.7 -44.85 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.595 1.558 . . . . 0.0 114.795 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -24.34 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.787 1.235 . . . . 0.0 113.541 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.46 5.45 26.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.446 1.498 . . . . 0.0 115.094 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -72.57 162.22 29.77 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 119.274 1.537 . . . . 0.0 110.809 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.45 142.51 51.26 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.527 1.531 . . . . 0.0 112.162 -173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.11 159.26 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 125.355 1.462 . . . . 0.0 110.701 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.4 107.18 11.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.474 ' HE3' HD13 ' B' ' 119' ' ' ILE . 3.8 mmtt -99.78 124.5 45.12 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 172.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.5 p -139.71 168.49 19.69 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.637 1.684 . . . . 0.0 113.662 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -118.85 163.18 17.27 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -136.96 162.83 32.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 0.0 111.647 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.19 121.06 9.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.741 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 138.33 44.18 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 125.198 1.561 . . . . 0.0 113.138 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.69 113.89 21.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.357 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.273 49.4 m -73.49 168.08 19.99 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.886 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.3 p -110.24 84.34 1.91 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.28 -167.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -127.2 -26.45 3.09 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.042 -1.036 . . . . 0.0 112.9 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.11 145.93 40.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 123.252 1.501 . . . . 0.0 112.521 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.13 -23.77 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.851 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.78 0.14 62.45 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 117.543 -1.698 . . . . 0.0 114.075 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 1.0 OUTLIER -117.55 1.07 12.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.808 1.304 . . . . 0.0 114.104 -178.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.59 -27.87 66.66 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 119.562 -1.961 . . . . 0.0 112.278 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.409 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 46.4 p-90 -46.38 -49.18 18.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.275 1.03 . . . . 0.0 113.157 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -88.86 -12.69 41.13 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.783 0.833 . . . . 0.0 112.367 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.26 -1.7 24.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.815 0.446 . . . . 0.0 111.577 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -109.13 137.7 46.62 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.614 0.765 . . . . 0.0 113.042 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.467 ' HG3' HH11 ' B' ' 114' ' ' ARG . 19.5 mtt85 -140.69 130.21 24.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.633 1.173 . . . . 0.0 110.676 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.88 158.88 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.044 1.293 . . . . 0.0 111.236 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.73 -177.33 36.47 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 14.4 p90 -126.87 156.03 42.03 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.819 -0.812 . . . . 0.0 111.937 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -148.46 155.34 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.554 1.168 . . . . 0.0 110.856 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.474 HD13 ' HE3' ' B' ' 94' ' ' LYS . 10.5 mt -138.26 119.83 17.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.21 152.52 27.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.467 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 21.5 p -139.13 164.2 30.41 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.57 128.99 31.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.291 1.036 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.16 150.56 47.96 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -11.08 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 129.643 3.177 . . . . 0.0 115.296 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 12.1 t -144.17 4.68 1.25 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' B' ' 127' ' ' LYS . 3.6 tp-100 110.42 -176.44 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 131.197 3.799 . . . . 0.0 108.763 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.404 ' H ' ' HG3' ' B' ' 126' ' ' GLN 0.3 4.3 ptmm? -151.22 41.11 0.72 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -177.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.261 1.68 0 C-N-CA 127.528 2.331 . . . . 0.0 112.962 173.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 117.375 -1.298 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.4 m 50.7 35.25 11.41 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.574 1.15 . . . . 0.0 113.867 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 12.5 m -88.58 166.12 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.23 -51.44 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.543 0.737 . . . . 0.0 111.957 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.09 76.43 0.22 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.149 1.779 . . . . 0.0 111.094 174.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.56 115.46 3.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.619 1.168 . . . . 0.0 110.723 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.39 123.74 48.32 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -143.22 137.9 29.29 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.245 -1.535 . . . . 0.0 113.564 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.43 -18.95 61.08 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -56.29 115.91 2.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.387 1.075 . . . . 0.0 111.615 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.53 -119.63 2.5 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.838 1.685 . . . . 0.0 111.139 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 142.27 24.8 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -140.87 162.8 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.785 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -142.83 145.13 32.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.635 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' C' ' 14' ' ' LEU . 6.2 t30 -105.89 146.97 29.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.186 0.995 . . . . 0.0 110.582 -174.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.18 -26.48 64.83 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.418 ' HB3' HD21 ' C' ' 12' ' ' ASN . 30.3 tp -71.44 -14.63 62.21 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.697 1.599 . . . . 0.0 112.983 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.69 -13.23 22.7 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.071 2.272 . . . . 0.0 113.99 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 154.3 37.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.958 1.379 . . . . 0.0 113.835 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 136.59 53.22 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -130.27 145.37 51.75 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.561 -0.712 . . . . 0.0 112.004 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -134.29 132.46 39.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.259 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.22 120.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.46 -56.9 12.85 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.535 1.147 . . . . 0.0 112.658 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.53 155.63 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.494 1.518 . . . . 0.0 110.648 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.41 129.72 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.611 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -75.18 167.93 20.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -56.38 -27.06 55.1 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -79.53 -33.77 41.7 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.083 0.856 . . . . 0.0 110.647 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.09 9.53 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 124.123 0.868 . . . . 0.0 114.373 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.02 149.96 46.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.218 1.407 . . . . 0.0 113.019 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.22 166.05 30.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.55 0.74 . . . . 0.0 110.84 175.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.8 p -125.57 162.34 25.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.99 -165.55 29.32 Favored Glycine 0 N--CA 1.464 0.542 0 O-C-N 119.955 -1.716 . . . . 0.0 111.986 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.9 p -140.37 140.74 35.59 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.522 1.153 . . . . 0.0 113.116 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -118.63 124.87 48.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.906 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.98 127.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 45.0 m -108.3 145.67 34.06 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.39 -11.6 17.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.91 146.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.102 1.361 . . . . 0.0 111.918 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.38 161.24 42.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.498 -1.376 . . . . 0.0 113.355 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.42 -22.54 61.84 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.603 0.361 . . . . 0.0 110.589 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -147.69 83.57 7.46 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.767 2.427 . . . . 0.0 110.111 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.82 28.27 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 124.548 3.499 . . . . 0.0 115.895 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.75 48.92 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.9 2.3 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.071 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 60.8 mt -22.0 112.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.46 168.21 16.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.449 2.3 . . . . 0.0 108.131 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -53.96 139.1 35.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.463 1.505 . . . . 0.0 112.724 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -116.39 121.16 33.79 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.195 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.15 143.18 93.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.391 2.727 . . . . 0.0 111.56 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.43 161.71 32.99 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.912 0.885 . . . . 0.0 111.694 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 tp -166.56 148.73 6.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.131 1.373 . . . . 0.0 111.87 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.39 -153.04 23.73 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 121.563 1.983 . . . . 0.0 111.986 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.73 142.38 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 112.554 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 144.91 51.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.005 1.322 . . . . 0.0 111.01 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.72 151.13 29.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.771 0.796 . . . . 0.0 109.393 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -143.99 23.95 1.68 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.381 1.472 . . . . 0.0 111.686 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.36 -50.35 5.5 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.894 2.078 . . . . 0.0 111.84 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.36 178.18 7.88 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.822 0.701 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 13.5 p -75.14 -42.48 56.14 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.751 1.62 . . . . 0.0 113.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -132.37 53.54 11.45 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -66.55 172.42 9.26 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 121.804 1.669 . . . . 0.0 115.716 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 174.52 7.12 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.138 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.73 164.24 16.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.558 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.8 147.58 12.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 118.151 2.02 . . . . 0.0 118.151 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -163.52 154.22 16.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.67 152.73 21.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.372 1.869 . . . . 0.0 110.136 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.67 116.84 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -100.26 109.55 21.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.426 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -76.23 138.66 40.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -37.69 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -87.31 -15.49 37.85 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.7 t -152.5 122.41 7.01 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.377 1.871 . . . . 0.0 107.236 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -58.32 118.57 5.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.002 1.274 . . . . 0.0 110.274 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 70.3 p -175.42 168.59 3.25 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.101 1.76 . . . . 0.0 110.553 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.2 t -147.84 146.01 28.94 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-O 123.489 1.614 . . . . 0.0 111.028 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.36 130.15 30.25 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 109.872 -3.331 . . . . 0.0 108.79 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -112.51 142.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -115.5 148.07 39.92 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.885 0.74 . . . . 0.0 110.597 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 117.91 9.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.64 -172.72 30.46 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.547 -1.311 . . . . 0.0 115.687 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.1 OUTLIER -125.86 149.64 48.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.606 1.193 . . . . 0.0 113.028 -174.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.38 112.55 24.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.409 -2.632 . . . . 0.0 105.437 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 12.7 m-85 -110.67 154.43 23.84 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.283 0.947 . . . . 0.0 112.72 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.84 115.34 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.99 162.09 11.96 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.806 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -42.82 -41.86 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.015 1.726 . . . . 0.0 115.577 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.35 -3.24 42.09 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.92 5.2 64.48 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.603 1.573 . . . . 0.0 115.19 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -71.72 162.27 29.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 1.242 . . . . 0.0 110.195 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -123.34 141.46 51.96 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.658 1.583 . . . . 0.0 111.235 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.15 159.44 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 125.368 1.467 . . . . 0.0 110.867 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.23 107.79 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 172.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . 0.479 ' HE3' HD13 ' C' ' 119' ' ' ILE . 3.7 mmtt -100.56 123.97 45.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -138.92 168.1 20.58 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 123.645 1.688 . . . . 0.0 113.866 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -118.29 163.79 16.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -136.97 162.87 32.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.395 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.27 121.19 9.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.683 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.13 44.51 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 125.216 1.572 . . . . 0.0 113.044 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -119.78 113.93 21.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 111.372 -2.649 . . . . 0.0 111.12 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.279 50.2 m -73.49 168.1 19.95 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 125.365 1.666 . . . . 0.0 111.664 174.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.59 86.78 2.38 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.75 -165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -130.0 -25.42 2.52 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.947 -1.095 . . . . 0.0 113.251 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.03 147.16 39.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.366 1.555 . . . . 0.0 112.259 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 18.8 tt -62.93 -23.25 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.892 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.61 60.17 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.767 -1.574 . . . . 0.0 114.075 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . 0.416 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.5 OUTLIER -118.8 0.95 11.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.738 1.269 . . . . 0.0 113.833 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.4 -27.91 66.42 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.629 -1.92 . . . . 0.0 112.368 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . 0.416 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 46.1 p-90 -46.1 -49.13 16.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.229 1.012 . . . . 0.0 113.379 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -89.06 -12.32 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.607 0.763 . . . . 0.0 112.67 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.57 -2.09 27.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.693 0.397 . . . . 0.0 111.409 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 2.0 m -108.55 138.71 44.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.55 0.74 . . . . 0.0 112.742 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' C' ' 114' ' ' ARG . 19.4 mtt85 -141.25 130.55 23.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.943 1.297 . . . . 0.0 110.831 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.17 158.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.272 . . . . 0.0 111.213 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.06 -177.45 36.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 13.4 p90 -126.68 155.82 42.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.851 -0.793 . . . . 0.0 111.861 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -148.47 154.58 40.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.386 1.089 . . . . 0.0 111.089 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . 0.479 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.0 mt -137.17 120.97 22.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.21 152.62 28.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.943 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.5 p -138.44 163.04 32.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.72 135.01 36.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.312 0.645 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.12 156.97 11.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.06 1.41 . . . . 0.0 111.186 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 84.61 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.679 3.192 . . . . 0.0 115.403 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -25.93 3.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -157.03 176.99 12.02 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.987 1.267 . . . . 0.0 110.68 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -136.96 141.23 42.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.567 1.547 . . . . 0.0 112.289 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.249 1.051 1 C-N-CA 137.845 6.458 . . . . 0.0 100.332 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 115.706 -2.092 . . . . 0.0 105.991 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 5.1 m -123.97 95.25 4.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.279 1.854 . . . . 0.0 110.263 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.04 145.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 0.0 109.249 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -64.16 156.25 29.11 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.672 -0.643 . . . . 0.0 111.283 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.34 15.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -131.04 151.45 51.4 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.11 2.164 . . . . 0.0 109.617 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.28 150.09 38.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.367 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 p -139.33 127.44 22.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.205 1.002 . . . . 0.0 112.311 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.403 HD21 ' CE2' ' A' ' 64' ' ' PHE . 73.9 mt -69.24 -34.44 74.83 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -47.57 110.97 0.36 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.021 1.328 . . . . 0.0 111.077 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.38 -130.17 4.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 125.312 1.434 . . . . 0.0 109.584 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -146.14 144.87 30.24 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.073 0.949 . . . . 0.0 112.721 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -136.64 162.9 31.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.188 1.395 . . . . 0.0 111.391 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -140.62 150.95 44.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.11 0.964 . . . . 0.0 109.567 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.66 143.54 47.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.385 1.074 . . . . 0.0 110.348 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -60.52 -22.16 63.28 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.45 1.5 . . . . 0.0 113.338 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.52 -15.61 61.78 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.629 1.172 . . . . 0.0 111.094 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.76 -16.43 18.73 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.639 3.019 . . . . 0.0 113.395 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.42 148.87 40.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.065 1.412 . . . . 0.0 112.955 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.46 136.52 54.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.779 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -127.46 143.26 51.22 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.535 0.684 . . . . 0.0 112.154 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -131.34 130.98 43.39 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.979 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.59 126.03 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.52 -85.55 0.13 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.48 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.03 145.79 30.73 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.86 0.838 . . . . 0.0 111.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.17 129.65 50.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.16 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -75.65 168.96 19.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.995 0.902 . . . . 0.0 112.386 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -58.7 -26.34 63.77 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.89 -40.65 75.53 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.374 -0.829 . . . . 0.0 110.822 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.05 -7.34 12.89 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 117.558 -1.69 . . . . 0.0 112.694 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HB2' HD21 ' D' ' 50' ' ' LEU . 4.7 pt-20 -67.18 146.69 53.96 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.693 1.597 . . . . 0.0 107.469 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.79 166.05 34.67 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.229 175.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 p -124.75 177.76 5.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.8 -167.51 39.76 Favored Glycine 0 CA--C 1.521 0.439 0 O-C-N 120.372 -1.455 . . . . 0.0 112.262 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.4 p -139.8 137.73 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.93 1.347 . . . . 0.0 111.947 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -111.46 138.77 47.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.161 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.5 mt -130.01 128.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.6 m -105.15 144.09 32.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -172.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.6 -13.25 17.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.79 143.15 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.352 1.061 . . . . 0.0 112.715 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.49 43.84 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.407 -0.808 . . . . 0.0 111.74 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.77 -28.52 64.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.765 -0.584 . . . . 0.0 109.499 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -140.64 75.35 26.21 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.966 2.507 . . . . 0.0 110.836 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.14 61.06 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.365 1 C-N-CA 125.627 4.218 . . . . 0.0 115.028 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.44 13.41 39.56 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 120.163 -1.586 . . . . 0.0 116.795 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -172.32 -29.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.037 1.335 . . . . 0.0 113.298 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 47.6 mt 4.48 91.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.449 2.3 . . . . 0.0 116.533 -172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 159.13 18.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 111.563 -2.562 . . . . 0.0 109.337 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tt -46.74 126.82 9.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.848 2.059 . . . . 0.0 113.131 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.8 p -103.8 120.25 51.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 122.966 0.506 . . . . 0.0 111.898 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 144.01 84.62 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.327 2.684 . . . . 0.0 112.872 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.38 154.67 44.71 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.916 0.886 . . . . 0.0 112.418 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -159.75 149.21 18.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.794 2.038 . . . . 0.0 110.112 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.8 -147.69 16.44 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 121.583 1.992 . . . . 0.0 109.961 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.563 ' CG2' HD21 ' D' ' 69' ' ' ASN . 2.8 mt -145.74 141.06 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.688 0.795 . . . . 0.0 112.707 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 139.96 52.68 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.794 -1.191 . . . . 0.0 113.147 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -76.97 158.09 30.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.049 -1.657 . . . . 0.0 113.638 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -158.48 21.63 0.23 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.432 1.493 . . . . 0.0 112.51 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -87.23 -54.62 4.21 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.516 1.126 . . . . 0.0 109.999 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.33 173.11 10.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.748 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.38 -34.74 31.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.786 0.834 . . . . 0.0 112.504 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.22 47.6 2.86 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.993 1.317 . . . . 0.0 112.065 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.9 176.07 10.36 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.16 2.573 . . . . 0.0 115.341 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.329 0.0 OUTLIER -100.13 171.07 8.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 123.21 1.481 . . . . 0.0 112.194 173.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.403 ' CE2' HD21 ' A' ' 6' ' ' LEU . 1.2 p90 -160.64 167.25 27.38 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.401 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.66 144.99 9.52 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 118.482 2.153 . . . . 0.0 118.482 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.25 158.57 30.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -95.35 152.41 18.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.583 1.553 . . . . 0.0 108.823 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.67 118.84 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.523 HD21 ' CG2' ' D' ' 52' ' ' ILE . 5.9 t-20 -92.83 116.21 28.82 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.314 46.2 m95 -80.49 134.64 35.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.413 1.577 . . . . 0.0 114.431 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -89.56 -40.63 12.5 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -88.78 -15.87 33.55 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -151.43 130.29 12.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 129.389 3.076 . . . . 0.0 106.102 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -68.67 118.62 11.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.032 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -173.85 161.76 3.84 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 127.342 2.257 . . . . 0.0 108.802 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 140.15 30.94 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 123.105 1.431 . . . . 0.0 111.151 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -139.08 129.29 25.39 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 110.34 -3.118 . . . . 0.0 110.555 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -106.88 154.84 7.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.039 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.76 142.36 51.33 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.68 121.23 9.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.16 176.15 42.15 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 118.799 -1.667 . . . . 0.0 116.866 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -112.33 149.95 31.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.831 1.301 . . . . 0.0 112.929 -174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 19.6 t -97.18 130.37 44.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.806 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.75 166.03 13.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.94 0.876 . . . . 0.0 111.749 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mt -128.77 109.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -59.57 159.65 8.11 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -28.45 -51.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -11.39 60.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.205 1.802 . . . . 0.0 115.706 -174.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.07 51.77 3.27 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 120.383 1.447 . . . . 0.0 110.235 -173.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.21 136.64 53.07 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.521 2.328 . . . . 0.0 107.755 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -101.34 144.09 30.59 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.628 1.171 . . . . 0.0 109.974 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.9 162.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.652 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.1 116.87 25.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -104.92 120.51 41.62 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 p -137.25 166.91 22.64 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 123.358 1.551 . . . . 0.0 113.723 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.25 165.9 12.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 172.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -141.1 159.6 41.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.238 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.42 126.17 15.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.913 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.18 143.64 40.0 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 125.379 1.674 . . . . 0.0 112.381 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.69 114.34 17.87 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 111.416 -2.629 . . . . 0.0 111.736 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.252 44.6 m -67.12 175.45 2.59 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 125.635 1.834 . . . . 0.0 113.083 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.4 p -117.93 67.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 107.948 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.63 167.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 120.921 -1.112 . . . . 0.0 111.709 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -102.78 -32.35 9.86 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -109.03 148.77 30.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.82 1.295 . . . . 0.0 111.407 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.0 tt -63.32 -30.78 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 113.426 -1.716 . . . . 0.0 109.979 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.88 5.75 3.32 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.801 -1.555 . . . . 0.0 113.726 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.495 ' CG ' ' HZ1' ' A' ' 111' ' ' LYS . 36.7 m-20 -121.41 1.92 10.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.809 1.305 . . . . 0.0 113.69 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -33.48 75.38 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.402 -0.811 . . . . 0.0 111.713 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -46.88 -40.99 15.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HZ1' ' CG ' ' A' ' 108' ' ' ASP . 15.6 pttp -99.34 -6.72 27.38 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.359 1.063 . . . . 0.0 113.463 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.95 0.32 21.51 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.9 m -110.36 138.44 46.74 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.74 0.816 . . . . 0.0 112.072 176.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -140.59 124.79 17.55 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 125.184 1.394 . . . . 0.0 110.723 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.56 158.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.13 1.372 . . . . 0.0 111.317 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.02 -178.46 37.59 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.027 0.822 . . . . 0.0 113.326 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -124.98 156.74 37.6 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.755 -0.85 . . . . 0.0 111.705 175.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -147.7 157.91 43.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.416 1.103 . . . . 0.0 109.664 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.2 mt -133.37 138.36 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -125.72 149.14 48.75 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.285 1.041 . . . . 0.0 111.264 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 p -133.05 161.09 35.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.661 1.184 . . . . 0.0 110.352 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.09 113.16 2.96 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.614 0.765 . . . . 0.0 112.233 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -89.05 94.83 10.08 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 140.35 79.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 129.693 3.197 . . . . 0.0 111.663 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 t -161.74 172.09 16.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.586 1.155 . . . . 0.0 108.956 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -143.91 -59.59 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.37 0.0 OUTLIER 74.56 13.48 3.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.516 1.927 . . . . 0.0 114.965 174.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--O 1.261 1.68 1 C-N-CA 133.876 4.87 . . . . 0.0 105.763 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 116.692 -1.623 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 2.0 m -72.76 55.55 0.38 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.531 1.532 . . . . 0.0 112.405 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 31.0 m -94.91 157.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.732 1.213 . . . . 0.0 110.261 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -95.99 139.33 32.33 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.62 -0.675 . . . . 0.0 111.743 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -64.35 -1.56 1.75 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -133.03 147.29 52.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.953 1.701 . . . . 0.0 109.132 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.3 144.84 43.71 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.255 1.022 . . . . 0.0 109.62 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -139.7 127.85 22.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.8 -33.01 71.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -48.83 113.46 0.79 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.511 1.124 . . . . 0.0 110.531 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.3 -132.5 5.85 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -147.23 143.67 28.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -136.09 162.55 32.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.221 1.408 . . . . 0.0 111.96 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.7 151.79 48.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.229 1.012 . . . . 0.0 109.231 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -119.89 143.79 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.232 1.013 . . . . 0.0 110.681 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -58.41 -25.31 62.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.462 1.505 . . . . 0.0 113.66 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 tp -70.25 -15.47 62.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.588 1.155 . . . . 0.0 111.711 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.23 -12.21 28.73 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 128.238 2.828 . . . . 0.0 113.515 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.65 149.65 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.265 1.507 . . . . 0.0 113.33 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -125.53 137.37 53.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.921 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -128.14 144.36 51.11 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -131.66 131.17 42.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.206 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 80.8 mt -131.13 124.52 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -86.42 0.08 OUTLIER Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.208 0.943 . . . . 0.0 111.733 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.24 145.28 31.22 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.803 -0.822 . . . . 0.0 110.676 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -99.72 130.37 48.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.053 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.99 166.7 23.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 112.382 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -26.02 63.98 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -67.89 -39.25 83.69 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.273 -0.892 . . . . 0.0 111.129 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.53 -6.55 11.53 Favored Glycine 0 C--O 1.221 -0.698 0 C-N-CA 124.728 1.156 . . . . 0.0 113.402 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' D' ' 28' ' ' GLU . 13.0 pt-20 -70.89 152.99 43.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.151 1.781 . . . . 0.0 112.258 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.38 30.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.252 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p -123.53 -177.13 3.63 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.71 -167.13 40.16 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 119.41 -2.056 . . . . 0.0 112.622 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 52.1 p -139.55 137.68 35.63 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.56 0.695 . . . . 0.0 112.346 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -112.83 138.71 49.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.377 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.72 128.42 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 54.6 m -105.74 144.82 31.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.1 -13.62 17.42 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.73 142.76 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.245 1.018 . . . . 0.0 112.607 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.55 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.153 -0.967 . . . . 0.0 111.474 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -70.5 -29.15 65.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.15 75.3 29.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 127.893 2.477 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.12 61.25 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.358 1 C-N-CA 125.629 4.22 . . . . 0.0 115.13 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.61 13.58 38.96 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 120.099 -1.626 . . . . 0.0 116.844 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -172.51 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.158 1.383 . . . . 0.0 113.401 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . 0.321 49.2 mt 4.55 91.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.627 2.371 . . . . 0.0 116.365 -172.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.58 159.31 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.584 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tt -46.82 126.15 8.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.674 1.99 . . . . 0.0 112.88 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.03 120.53 52.02 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.158 0.583 . . . . 0.0 111.634 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.06 143.78 82.18 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.166 2.577 . . . . 0.0 112.438 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.75 160.33 32.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.953 0.901 . . . . 0.0 112.598 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 28' ' ' GLU . 15.3 tp -169.01 149.01 4.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 0.0 112.642 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 -144.1 10.45 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 121.091 1.769 . . . . 0.0 109.774 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . 0.523 ' CG2' HD21 ' A' ' 69' ' ' ASN . 2.9 mt -147.53 139.37 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.769 0.827 . . . . 0.0 111.592 -175.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 138.45 54.05 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.163 1.385 . . . . 0.0 112.612 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -76.7 157.52 31.69 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 119.9 -1.75 . . . . 0.0 113.172 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -156.96 19.39 0.31 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 0.0 112.5 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -84.96 -54.11 4.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.766 1.227 . . . . 0.0 110.085 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 172.67 11.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.911 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -31.77 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.28 1.032 . . . . 0.0 113.378 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -130.17 50.58 6.18 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 125.118 1.367 . . . . 0.0 112.589 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.24 175.96 10.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.989 2.46 . . . . 0.0 116.274 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.335 0.0 OUTLIER -100.82 170.17 8.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.104 1.431 . . . . 0.0 111.808 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -161.01 167.29 26.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.82 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.32 145.43 10.0 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 118.431 2.133 . . . . 0.0 118.431 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.88 158.69 28.68 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -95.02 152.42 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.569 1.948 . . . . 0.0 108.472 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.58 117.78 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . 0.563 HD21 ' CG2' ' A' ' 52' ' ' ILE . 7.2 t-20 -92.85 117.21 29.78 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.407 -0.808 . . . . 0.0 109.927 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.3 46.3 m95 -80.46 137.39 36.47 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.543 1.64 . . . . 0.0 114.246 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -92.67 -39.45 11.28 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.3 -14.94 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -152.27 131.59 12.85 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 129.319 3.048 . . . . 0.0 106.241 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.4 118.64 12.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 10.8 m -173.53 161.82 4.09 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 127.222 2.209 . . . . 0.0 108.978 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.8 t -143.28 140.31 30.56 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.114 1.435 . . . . 0.0 110.842 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.05 128.79 24.74 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 110.509 -3.041 . . . . 0.0 110.451 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.12 154.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.038 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -127.64 141.8 51.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.1 121.69 10.44 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.78 174.46 42.15 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 118.748 -1.691 . . . . 0.0 116.786 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.51 146.65 38.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.021 1.071 . . . . 0.0 111.967 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 48.9 t -97.62 134.23 41.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.138 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.31 164.93 17.05 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.203 1.001 . . . . 0.0 111.366 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.98 105.33 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -63.38 154.22 32.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -22.42 -51.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.072 2.549 . . . . 0.0 117.39 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -76.08 -7.2 54.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.253 1.821 . . . . 0.0 115.784 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.38 51.38 3.52 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.925 0.784 . . . . 0.0 111.231 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 135.96 54.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 108.784 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.29 144.6 29.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.17 0.986 . . . . 0.0 109.572 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.51 159.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.818 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mt -117.72 117.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -105.47 119.06 38.14 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -136.95 167.09 22.16 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.258 1.504 . . . . 0.0 113.639 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.13 166.51 12.15 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -141.58 160.09 40.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.101 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.83 126.6 15.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.771 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.03 144.45 38.59 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 125.51 1.756 . . . . 0.0 112.082 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -127.45 114.36 17.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.677 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 42.5 m -67.01 175.33 2.58 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 125.803 1.939 . . . . 0.0 113.0 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.9 p -117.74 66.64 0.75 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.11 1.364 . . . . 0.0 108.251 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.69 167.47 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.988 -1.07 . . . . 0.0 111.999 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -101.52 -32.26 10.48 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.0 149.89 31.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 122.709 1.242 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.96 -29.01 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.21 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.51 6.13 4.88 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.501 1.048 . . . . 0.0 113.586 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . 0.498 ' CG ' ' HZ1' ' D' ' 111' ' ' LYS . 36.9 m-20 -122.2 2.26 9.77 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.509 1.155 . . . . 0.0 113.712 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.74 -34.02 76.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.312 -0.868 . . . . 0.0 112.14 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -46.19 -41.43 12.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.28 1.032 . . . . 0.0 113.728 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . 0.498 ' HZ1' ' CG ' ' D' ' 108' ' ' ASP . 15.5 pttp -99.48 -6.79 26.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.215 1.006 . . . . 0.0 113.365 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.65 -0.21 22.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -109.33 138.8 45.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.477 0.711 . . . . 0.0 111.792 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -140.76 124.79 17.31 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 125.56 1.544 . . . . 0.0 111.247 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.6 158.89 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.08 1.352 . . . . 0.0 111.166 176.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.17 -179.53 38.43 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.939 0.781 . . . . 0.0 113.441 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.77 156.37 36.19 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.759 -0.848 . . . . 0.0 111.571 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -147.72 157.36 43.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.09 0.948 . . . . 0.0 109.855 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.58 136.65 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -124.45 151.25 44.77 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 18.7 p -134.65 160.81 36.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.746 1.218 . . . . 0.0 110.186 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 129.43 41.36 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.53 -0.731 . . . . 0.0 110.855 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.8 9.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.306 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' D' ' 124' ' ' ARG 0.31 0.0 OUTLIER -58.52 134.96 57.16 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.363 -0.836 . . . . 0.0 112.629 174.303 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -77.32 0.23 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.596 1.158 . . . . 0.0 109.044 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -111.72 131.52 55.25 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.909 1.684 . . . . 0.0 106.563 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.54 59.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.535 1.934 . . . . 0.0 110.35 -172.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 114.996 -2.43 . . . . 0.0 107.842 -172.305 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.6 t -152.78 29.76 0.52 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.81 1.291 . . . . 0.0 112.235 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 10.2 p -153.69 40.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.004 2.121 . . . . 0.0 109.529 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -169.14 153.32 5.42 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.491 -1.381 . . . . 0.0 111.501 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 65.24 -43.96 0.35 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 128.28 2.632 . . . . 0.0 116.669 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -138.13 155.84 48.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.219 2.208 . . . . 0.0 109.038 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.23 142.01 50.89 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 109.478 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -139.66 127.88 22.55 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.23 -31.53 70.16 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -48.96 113.25 0.75 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.332 1.053 . . . . 0.0 111.028 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.32 -131.11 5.24 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.63 1.586 . . . . 0.0 109.452 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -146.38 143.21 28.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.46 1.104 . . . . 0.0 113.293 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -135.56 162.75 31.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.297 1.439 . . . . 0.0 111.737 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -141.27 150.55 42.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.97 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -122.12 143.78 49.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.389 1.076 . . . . 0.0 111.025 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -58.88 -25.34 63.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.608 1.563 . . . . 0.0 113.458 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.9 tp -70.68 -15.63 62.73 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.371 1.081 . . . . 0.0 111.619 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.32 -13.98 23.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 128.415 2.912 . . . . 0.0 113.47 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 148.57 44.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 123.113 1.435 . . . . 0.0 113.252 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -122.7 136.08 54.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.671 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -131.05 131.19 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -130.2 124.39 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.32 -84.34 0.11 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.537 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.79 32.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.76 -0.847 . . . . 0.0 110.85 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.66 130.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.294 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -75.94 168.77 19.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.942 0.877 . . . . 0.0 112.207 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 81.5 p -58.59 -26.08 63.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -70.1 -40.58 74.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.324 -0.86 . . . . 0.0 110.981 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.85 -7.17 13.32 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.523 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.33 146.75 53.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.649 1.58 . . . . 0.0 107.416 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 166.22 34.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.108 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.6 p -125.39 176.85 6.51 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.66 -167.54 39.46 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 120.321 -1.487 . . . . 0.0 112.302 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 48.5 p -139.76 137.52 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.607 1.194 . . . . 0.0 112.016 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -110.88 139.0 46.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.23 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 27.5 mt -130.59 128.02 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 42.7 m -105.21 144.25 32.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.64 -13.72 17.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.24 143.46 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.328 1.051 . . . . 0.0 112.701 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.03 43.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.424 -0.798 . . . . 0.0 111.464 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -71.21 -28.82 64.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.24 75.66 27.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.926 2.49 . . . . 0.0 111.038 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.22 61.86 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.409 1 C-N-CA 125.583 4.188 . . . . 0.0 115.02 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.97 13.56 37.74 Favored Glycine 0 N--CA 1.481 1.659 0 O-C-N 120.269 -1.519 . . . . 0.0 116.862 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -172.36 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.174 1.39 . . . . 0.0 113.297 -174.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . 0.324 50.3 mt 5.35 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.616 2.366 . . . . 0.0 116.323 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.63 159.19 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 111.607 -2.542 . . . . 0.0 109.32 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tt -46.84 127.97 10.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.768 2.027 . . . . 0.0 112.926 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -104.96 120.65 49.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.083 0.553 . . . . 0.0 111.846 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.33 144.38 82.72 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.034 2.489 . . . . 0.0 112.947 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.47 154.37 45.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 112.633 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -159.97 149.14 17.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.531 1.932 . . . . 0.0 109.949 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.72 -147.22 15.32 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 121.389 1.904 . . . . 0.0 109.879 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . 0.548 ' CG2' HD21 ' C' ' 69' ' ' ASN . 2.8 mt -145.67 141.0 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.523 0.729 . . . . 0.0 112.655 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.94 136.84 52.84 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.978 -1.076 . . . . 0.0 113.363 174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -74.01 158.32 34.55 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.96 -1.713 . . . . 0.0 113.557 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -159.58 23.93 0.19 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.483 1.513 . . . . 0.0 111.855 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -90.37 -53.08 4.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.677 1.191 . . . . 0.0 110.331 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.44 174.28 9.13 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.65 1.219 . . . . 0.0 113.36 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.27 -29.69 22.9 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -129.34 49.52 4.78 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.681 1.192 . . . . 0.0 112.627 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.59 175.1 10.65 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.901 2.401 . . . . 0.0 116.169 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.33 0.0 OUTLIER -101.03 169.83 8.68 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 123.048 1.404 . . . . 0.0 111.97 173.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -160.66 167.5 26.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.543 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.71 144.44 9.09 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.96 158.66 31.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.8 m -94.87 152.22 18.57 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.753 1.621 . . . . 0.0 108.802 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.55 118.23 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.56 HD21 ' CG2' ' C' ' 52' ' ' ILE . 7.6 t-20 -92.71 116.53 29.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.733 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.299 46.1 m95 -80.22 136.59 36.5 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 123.465 1.603 . . . . 0.0 114.326 -173.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -91.54 -39.83 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -89.29 -15.42 33.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -151.43 130.23 12.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.202 3.001 . . . . 0.0 105.904 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.66 118.57 11.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.0 m -173.58 161.61 4.02 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 127.253 2.221 . . . . 0.0 109.082 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 140.4 30.48 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.033 1.397 . . . . 0.0 110.694 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.33 129.41 25.15 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 110.549 -3.023 . . . . 0.0 110.558 -171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.44 155.46 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.092 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -128.48 142.22 51.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.41 121.18 9.89 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.18 175.05 41.76 Favored Glycine 0 CA--C 1.504 -0.629 0 C-N-CA 118.708 -1.711 . . . . 0.0 116.627 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -112.85 144.56 42.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.79 1.281 . . . . 0.0 112.083 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 t -97.84 127.22 43.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.873 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -115.31 166.8 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.33 1.052 . . . . 0.0 111.561 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 mt -127.41 108.13 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -62.33 156.76 21.46 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -26.77 -48.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.336 2.254 . . . . 0.0 116.854 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.59 -2.25 41.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 49.26 5.77 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.651 1.114 . . . . 0.0 112.118 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.31 136.94 54.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.873 1.669 . . . . 0.0 108.043 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -101.26 144.23 30.37 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.357 1.063 . . . . 0.0 109.607 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.01 159.93 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.006 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 9.1 mt -118.08 118.42 31.85 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -107.09 118.08 35.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -136.0 166.65 22.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 123.488 1.613 . . . . 0.0 113.712 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -116.83 165.75 12.95 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 p-90 -141.13 160.23 40.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.276 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.92 126.76 15.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.956 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.38 143.16 41.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 125.37 1.669 . . . . 0.0 112.3 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.08 114.23 18.13 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 111.176 -2.738 . . . . 0.0 111.713 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 43.5 m -67.2 175.24 2.73 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 125.778 1.924 . . . . 0.0 112.911 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -117.7 67.66 0.75 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.082 1.353 . . . . 0.0 108.041 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.43 168.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 121.027 -1.046 . . . . 0.0 111.804 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -103.51 -31.35 10.0 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.09 148.63 30.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.838 1.304 . . . . 0.0 111.669 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.405 ' CD1' HG21 ' C' ' 92' ' ' VAL . 14.8 tt -64.42 -29.48 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.653 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.53 5.25 5.78 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.276 0.941 . . . . 0.0 113.254 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.49 ' CG ' ' HZ1' ' B' ' 111' ' ' LYS . 35.1 m-20 -120.92 1.24 10.41 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.387 1.075 . . . . 0.0 113.639 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.12 -32.88 73.51 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.057 0.932 . . . . 0.0 112.435 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -46.93 -41.45 16.08 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.49 ' HZ1' ' CG ' ' B' ' 108' ' ' ASP . 15.5 pttp -98.86 -6.67 28.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.456 1.103 . . . . 0.0 113.419 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.91 0.09 22.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.3 m -109.35 138.41 45.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.596 0.758 . . . . 0.0 112.124 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.98 123.49 15.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.404 1.482 . . . . 0.0 111.433 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.48 158.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.834 1.254 . . . . 0.0 111.062 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.35 -178.21 37.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.86 0.743 . . . . 0.0 113.462 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 0.0 OUTLIER -125.14 156.31 38.55 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.781 -0.835 . . . . 0.0 111.797 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -147.45 155.3 41.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.136 0.97 . . . . 0.0 110.003 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.72 132.07 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -119.9 152.38 37.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.118 0.961 . . . . 0.0 110.821 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 160.38 37.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.447 1.099 . . . . 0.0 109.476 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 122.32 13.78 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.25 160.16 16.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.109 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.79 -56.16 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.108 2.163 . . . . 0.0 113.489 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 19.5 p 55.44 146.11 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.574 2.749 . . . . 0.0 114.658 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -166.68 104.68 0.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.478 2.311 . . . . 0.0 105.037 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.296 0.2 OUTLIER -141.97 21.78 2.11 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.901 1.28 . . . . 0.0 111.04 -174.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 129.546 3.138 . . . . 0.0 106.872 174.45 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 116.823 -1.56 . . . . 0.0 107.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.8 t -94.77 127.65 40.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.567 1.076 . . . . 0.0 110.738 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.39 17.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.692 1.197 . . . . 0.0 110.048 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 57.21 -133.2 1.32 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.994 1.718 . . . . 0.0 111.5 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 10.43 0.45 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.319 1.848 . . . . 0.0 112.059 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -128.89 143.7 50.97 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 124.847 1.259 . . . . 0.0 108.552 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 29.6 p -116.29 141.41 48.19 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.073 0.858 . . . . 0.0 108.865 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -139.64 127.69 22.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.994 -1.066 . . . . 0.0 113.07 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.07 -31.7 71.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -48.27 113.85 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.964 1.306 . . . . 0.0 110.931 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -131.12 5.44 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 125.99 1.757 . . . . 0.0 109.111 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -145.47 146.97 31.69 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -136.59 162.65 32.54 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.993 1.317 . . . . 0.0 111.457 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -136.34 153.25 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.685 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -123.47 143.61 50.05 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.173 0.989 . . . . 0.0 111.093 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.9 -25.9 61.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.907 1.683 . . . . 0.0 113.353 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.25 -15.29 62.43 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.816 1.246 . . . . 0.0 111.788 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.27 -14.49 23.2 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 128.479 2.942 . . . . 0.0 113.513 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 149.4 42.61 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 123.14 1.448 . . . . 0.0 113.088 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -123.34 136.21 54.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.325 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -128.34 139.82 52.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m -127.73 131.63 49.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.688 0.795 . . . . 0.0 109.003 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.9 125.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.71 -85.85 0.09 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.615 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.05 33.84 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.726 -0.867 . . . . 0.0 110.909 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.83 129.05 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.222 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -74.51 166.23 23.87 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.972 0.891 . . . . 0.0 112.356 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -58.78 -25.9 63.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -67.91 -39.12 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.216 -0.927 . . . . 0.0 110.919 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.14 -6.34 12.03 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 124.782 1.182 . . . . 0.0 113.322 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.24 152.76 43.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.071 1.749 . . . . 0.0 112.15 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.38 166.49 30.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.884 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 21.6 p -123.37 -177.47 3.71 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.89 -166.87 39.84 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 119.322 -2.111 . . . . 0.0 112.703 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 59.0 p -139.69 136.89 34.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.257 1.027 . . . . 0.0 112.578 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -111.84 138.4 48.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.38 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.42 127.62 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 55.9 m -105.09 143.65 32.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.61 -13.08 18.72 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.8 143.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.179 0.992 . . . . 0.0 112.907 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.17 161.12 43.31 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.106 -0.996 . . . . 0.0 111.45 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -71.36 -28.81 64.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -140.09 75.38 29.26 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.914 2.486 . . . . 0.0 110.978 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.92 61.41 3.83 Favored 'Trans proline' 0 CA--C 1.551 1.373 1 C-N-CA 125.589 4.192 . . . . 0.0 115.134 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.7 13.56 38.65 Favored Glycine 0 N--CA 1.481 1.645 0 O-C-N 120.141 -1.599 . . . . 0.0 116.817 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -172.58 -29.43 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.21 1.404 . . . . 0.0 113.401 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . 0.325 48.8 mt 5.05 90.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.662 2.385 . . . . 0.0 116.33 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.9 159.24 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.794 -2.457 . . . . 0.0 109.352 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tt -46.76 128.02 10.32 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.624 1.97 . . . . 0.0 112.878 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -104.82 120.46 50.05 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.978 0.511 . . . . 0.0 111.682 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.89 143.0 83.57 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.949 2.432 . . . . 0.0 112.445 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.1 160.29 31.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.021 0.928 . . . . 0.0 112.78 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 tp -169.0 149.19 4.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.479 1.512 . . . . 0.0 112.466 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.26 -144.17 10.54 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 121.122 1.783 . . . . 0.0 109.765 -174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.56 ' CG2' HD21 ' B' ' 69' ' ' ASN . 3.0 mt -147.99 139.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.745 -175.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.77 138.94 53.88 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.613 1.165 . . . . 0.0 112.727 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -76.64 157.82 31.56 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.023 -1.673 . . . . 0.0 113.277 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -157.67 20.3 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.285 1.434 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -86.77 -53.73 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.926 1.29 . . . . 0.0 110.247 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.52 172.46 11.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.814 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.95 -29.31 25.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.857 0.863 . . . . 0.0 113.034 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -130.69 51.86 8.38 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 125.085 1.354 . . . . 0.0 112.726 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 175.72 10.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.935 2.423 . . . . 0.0 116.139 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.333 0.0 OUTLIER -100.77 170.78 8.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.202 1.477 . . . . 0.0 111.742 173.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -161.57 167.07 25.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.684 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.25 144.86 9.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -173.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.36 158.47 29.7 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -94.99 152.64 18.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.336 1.854 . . . . 0.0 108.718 173.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.85 117.8 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . 0.548 HD21 ' CG2' ' B' ' 52' ' ' ILE . 7.3 t-20 -92.78 117.26 29.82 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.235 -0.916 . . . . 0.0 109.866 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.301 46.4 m95 -80.63 137.55 36.36 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 123.456 1.598 . . . . 0.0 114.123 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -92.78 -39.79 11.03 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -89.13 -15.47 33.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -151.22 130.4 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 129.307 3.043 . . . . 0.0 106.299 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -69.03 118.55 12.08 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 10.7 m -174.0 161.37 3.67 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.238 2.215 . . . . 0.0 108.968 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -142.56 140.58 31.8 Favored 'General case' 0 CA--C 1.483 -1.635 0 CA-C-O 123.347 1.546 . . . . 0.0 111.057 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.15 129.97 26.21 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 110.339 -3.119 . . . . 0.0 110.21 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.15 154.84 7.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.974 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.37 142.34 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.49 121.0 9.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.94 41.17 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 118.708 -1.71 . . . . 0.0 116.625 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -112.49 146.5 38.35 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 125.101 1.118 . . . . 0.0 111.805 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.63 135.13 39.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.312 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -123.54 165.9 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.055 0.942 . . . . 0.0 111.118 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.62 108.27 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.01 157.12 25.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -24.85 -48.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.634 2.374 . . . . 0.0 117.339 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -80.39 -3.38 49.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.905 2.082 . . . . 0.0 116.449 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.46 48.11 5.75 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 120.295 1.407 . . . . 0.0 111.963 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 135.62 54.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.198 1.799 . . . . 0.0 109.077 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -101.3 145.97 28.17 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.713 1.244 . . . . 0.0 109.729 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.2 m -150.13 157.07 6.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.934 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.49 115.39 26.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -103.74 119.35 38.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.2 p -136.57 167.31 21.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 123.398 1.57 . . . . 0.0 113.889 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.83 166.11 12.86 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -141.23 160.15 40.71 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.121 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 tt -144.81 125.79 14.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.131 -1.849 . . . . 0.0 112.008 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.52 143.19 39.5 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.065 1.478 . . . . 0.0 112.218 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -126.66 114.19 17.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.516 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -66.75 175.35 2.44 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 126.083 2.114 . . . . 0.0 112.926 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.7 p -118.19 68.98 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.34 1.456 . . . . 0.0 107.675 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.8 171.53 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.889 -1.132 . . . . 0.0 111.539 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -106.7 -32.28 8.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -108.22 148.77 29.47 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.833 1.302 . . . . 0.0 111.588 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -64.07 -29.04 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.888 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 5.56 6.11 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.706 1.146 . . . . 0.0 113.516 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . 0.49 ' CG ' ' HZ1' ' C' ' 111' ' ' LYS . 34.8 m-20 -121.39 1.51 10.17 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.333 1.066 . . . . 0.0 113.694 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -33.07 73.73 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.035 0.922 . . . . 0.0 112.553 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -46.7 -41.43 14.98 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . 0.49 ' HZ1' ' CG ' ' C' ' 108' ' ' ASP . 15.7 pttp -99.34 -6.57 27.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.318 1.047 . . . . 0.0 113.356 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.35 -0.17 21.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 5.9 m -109.9 138.38 46.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.599 0.76 . . . . 0.0 111.636 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.59 124.47 17.26 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 125.65 1.58 . . . . 0.0 111.01 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -99.57 158.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.245 1.418 . . . . 0.0 111.35 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.65 -178.84 38.34 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.809 0.718 . . . . 0.0 113.407 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.41 157.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.733 -0.863 . . . . 0.0 111.911 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -148.39 155.59 41.44 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.967 0.889 . . . . 0.0 109.864 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -132.19 133.28 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -120.76 151.7 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 111.665 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.8 p -135.42 163.15 30.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.024 1.33 . . . . 0.0 109.876 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 115.94 5.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.86 -1.15 . . . . 0.0 111.732 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 tp -71.87 145.64 48.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 61.99 68.49 0.68 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 54.8 p -63.37 156.04 27.07 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.092 -1.005 . . . . 0.0 109.706 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -43.79 -53.64 5.79 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.989 1.316 . . . . 0.0 113.297 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.518 ' CG ' ' H ' ' C' ' 128' ' ' GLU . 17.7 tttm 63.51 168.38 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.793 2.037 . . . . 0.0 112.341 -174.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.518 ' H ' ' CG ' ' C' ' 127' ' ' LYS . 5.3 mm-40 . . . . . 0 CA--C 1.551 0.983 1 C-N-CA 137.557 6.343 . . . . 0.0 102.29 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 116.708 -1.615 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 2.5 m -109.66 39.55 2.08 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 121.091 1.769 . . . . 0.0 113.476 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.67 -6.58 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.739 1.616 . . . . 0.0 113.31 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 54.93 -136.96 1.23 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.49 1.116 . . . . 0.0 111.587 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.316 0.2 OUTLIER -155.82 74.04 0.85 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.506 1.922 . . . . 0.0 111.158 -175.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -156.15 105.14 2.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.585 1.554 . . . . 0.0 111.29 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 p -116.61 137.61 52.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.003 0.921 . . . . 0.0 109.823 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 p -139.77 133.09 29.94 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.196 -1.565 . . . . 0.0 114.348 -174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.13 -32.01 69.47 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -52.35 116.18 2.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.774 1.273 . . . . 0.0 111.83 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.1 -114.47 1.25 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 125.94 1.733 . . . . 0.0 110.209 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -153.16 147.44 25.78 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -140.65 162.75 34.64 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.493 1.517 . . . . 0.0 111.35 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -138.63 147.94 43.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.29 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.28 146.99 38.46 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.709 0.803 . . . . 0.0 110.619 -175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -56.67 -28.6 61.05 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.6 tp -72.29 -15.62 61.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.053 1.741 . . . . 0.0 112.02 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.39 -14.29 25.42 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.048 2.261 . . . . 0.0 113.441 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.7 p -68.51 155.05 40.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.412 1.606 . . . . 0.0 113.134 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -127.02 138.28 53.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.608 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -124.09 136.03 53.96 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.56 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -126.79 130.51 50.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.9 mt -134.43 127.46 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.83 -89.59 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.077 0.861 . . . . 0.0 112.558 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.92 139.65 32.58 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.837 -0.801 . . . . 0.0 111.641 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.8 t -89.61 129.47 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.357 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.56 166.04 15.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.894 0.854 . . . . 0.0 111.589 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.1 p -57.15 -27.81 62.19 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -74.71 -32.83 62.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.698 0.681 . . . . 0.0 111.722 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.67 -7.43 26.05 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.959 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 9.6 pt-20 -66.3 144.27 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.772 1.286 . . . . 0.0 108.487 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -158.18 145.82 18.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.802 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.57 162.01 14.34 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.02 -170.04 36.9 Favored Glycine 0 C--O 1.239 0.416 0 O-C-N 121.187 -0.946 . . . . 0.0 112.664 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -140.15 139.03 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.407 1.098 . . . . 0.0 112.17 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -114.42 138.72 50.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 108.389 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 mt -130.83 126.87 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.5 m -105.05 144.34 31.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.74 -21.96 17.82 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.98 143.26 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.48 1.112 . . . . 0.0 113.27 -174.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.55 159.43 39.7 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.528 -0.732 . . . . 0.0 110.219 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.54 -23.72 58.84 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.95 -0.469 . . . . 0.0 110.909 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -146.43 68.72 12.34 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.221 2.208 . . . . 0.0 111.069 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.71 -79.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 125.08 3.853 . . . . 0.0 116.853 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.87 -48.65 0.01 OUTLIER Glycine 0 CA--C 1.546 1.996 0 C-N-CA 129.561 3.458 . . . . 0.0 120.565 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.84 -5.12 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.25 2.22 . . . . 0.0 113.118 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.347 64.5 mt -8.89 85.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 124.316 2.007 . . . . 0.0 115.009 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.2 151.13 21.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 111.63 -2.532 . . . . 0.0 108.465 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.34 127.19 8.76 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.934 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.32 118.52 57.59 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 123.961 0.788 . . . . 0.0 111.252 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.92 144.07 69.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.727 2.284 . . . . 0.0 112.177 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.5 158.23 35.01 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.765 0.826 . . . . 0.0 111.267 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -159.89 148.97 17.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.319 1.847 . . . . 0.0 110.425 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.9 -157.22 28.95 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 121.062 1.756 . . . . 0.0 110.069 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.7 134.94 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.45 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 136.61 53.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.543 1.137 . . . . 0.0 110.772 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -73.29 151.88 41.18 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.004 0.907 . . . . 0.0 109.746 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.9 26.46 1.37 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.619 -1.301 . . . . 0.0 111.633 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.47 -50.29 5.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 110.717 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 173.29 10.34 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.231 0.957 . . . . 0.0 112.987 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.7 m -83.93 -31.64 25.52 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.762 1.225 . . . . 0.0 113.366 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -128.51 54.94 15.09 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.243 1.417 . . . . 0.0 111.381 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.66 165.18 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.042 2.495 . . . . 0.0 117.553 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.3 p -81.11 164.27 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.115 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.78 163.47 36.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.215 -0.928 . . . . 0.0 113.021 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.89 140.1 6.12 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -159.68 157.55 29.76 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -95.84 151.55 19.3 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.302 1.441 . . . . 0.0 110.651 174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.44 118.13 48.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -93.72 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 109.554 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.301 43.8 m95 -83.07 135.48 34.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.82 -44.02 9.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.953 2.101 . . . . 0.0 116.321 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -91.02 -9.56 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -152.79 126.8 9.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.507 2.323 . . . . 0.0 107.06 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -69.25 118.48 12.19 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.965 1.257 . . . . 0.0 110.503 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -177.23 164.23 2.16 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 126.329 1.851 . . . . 0.0 109.193 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -144.18 143.84 31.27 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.542 1.639 . . . . 0.0 111.549 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.31 125.17 21.12 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 110.33 -3.123 . . . . 0.0 109.691 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.67 152.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -126.33 142.17 51.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 118.14 7.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -174.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.1 -164.94 14.67 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -130.3 150.0 51.74 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.485 0.756 . . . . 0.0 112.216 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.5 t -94.86 124.93 39.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.7 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.46 163.48 15.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.242 1.017 . . . . 0.0 111.966 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.87 110.72 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.16 161.22 9.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.249 0.619 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.37 -51.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -69.24 -33.46 73.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.8 42.44 0.73 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.906 1.241 . . . . 0.0 111.734 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HZ2' ' CD ' ' A' ' 128' ' ' GLU . 3.4 mtpt -110.44 142.64 41.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.302 1.441 . . . . 0.0 109.85 175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -101.58 140.33 36.01 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.856 1.262 . . . . 0.0 111.613 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' D' ' 106' ' ' ILE . 20.1 m -143.62 160.32 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.372 1.069 . . . . 0.0 108.681 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.69 119.25 33.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 119.51 39.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -137.7 172.27 13.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 123.131 1.443 . . . . 0.0 111.992 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 87.9 mmm -126.02 168.9 13.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.588 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -141.49 164.06 31.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.168 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.15 119.67 7.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.056 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 140.11 41.06 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.181 1.467 . . . . 0.0 112.11 -173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -120.16 120.97 37.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 110.804 -2.907 . . . . 0.0 111.237 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -88.7 163.52 15.73 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 125.496 1.748 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -113.81 70.85 0.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.83 -167.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 111.001 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.44 -15.16 3.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.738 -1.851 . . . . 0.0 114.776 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.77 150.23 43.07 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.87 1.319 . . . . 0.0 110.315 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.4 ' CD1' HG21 ' D' ' 92' ' ' VAL . 16.6 tt -62.85 -28.38 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.708 174.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.82 6.89 10.58 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.244 -1.309 . . . . 0.0 113.472 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.491 ' CG ' ' HZ1' ' A' ' 111' ' ' LYS . 38.0 m-20 -121.08 -1.36 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.85 1.325 . . . . 0.0 113.632 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -59.08 -34.75 72.34 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.623 -1.298 . . . . 0.0 112.158 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.73 -39.56 18.07 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.724 1.21 . . . . 0.0 114.16 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' HZ1' ' CG ' ' A' ' 108' ' ' ASP . 12.2 pttp -99.32 -7.65 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.285 1.434 . . . . 0.0 114.011 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 1.8 9.6 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.163 -0.961 . . . . 0.0 113.016 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.416 HG23 ' HG3' ' D' ' 96' ' ' MET . 34.0 m -116.97 145.23 43.77 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.865 0.866 . . . . 0.0 111.537 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.52 129.05 18.06 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 125.759 1.624 . . . . 0.0 110.659 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.71 155.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 120.483 1.492 . . . . 0.0 109.367 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -175.31 28.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.542 1.067 . . . . 0.0 113.08 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 21.4 p90 -125.97 153.01 44.92 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.064 0.945 . . . . 0.0 110.782 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -144.85 152.97 41.1 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.695 1.198 . . . . 0.0 109.865 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.1 mt -135.06 122.17 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -110.6 149.18 30.78 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.521 0.677 . . . . 0.0 110.427 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.5 p -134.16 162.83 31.06 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.081 -1.012 . . . . 0.0 109.662 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -56.87 114.82 2.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.451 0.701 . . . . 0.0 109.928 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -67.79 95.05 0.49 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 175.12 -45.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.679 2.392 . . . . 0.0 114.311 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 m 39.06 58.03 1.87 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.243 1.817 . . . . 0.0 113.166 -174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.62 131.33 25.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.436 1.094 . . . . 0.0 111.091 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt 88.04 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 129.97 3.308 . . . . 0.0 108.488 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.461 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 1.3 tp10 . . . . . 0 C--O 1.248 0.975 0 C-N-CA 127.693 2.397 . . . . 0.0 107.235 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 8.2 tp60 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 117.61 -1.186 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 3.3 m -121.01 -33.38 3.74 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 5.0 t 52.0 80.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.157 1.783 . . . . 0.0 114.694 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.62 -30.42 0.27 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 52.89 64.12 1.98 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.537 1.535 . . . . 0.0 112.989 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -140.8 109.2 5.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.349 -0.844 . . . . 0.0 112.484 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 24.5 p -122.43 135.22 54.64 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.373 1.469 . . . . 0.0 110.236 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -139.91 134.4 31.55 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.389 -1.445 . . . . 0.0 114.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' D' ' 64' ' ' PHE . 43.1 mt -58.6 -32.94 69.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -51.5 117.32 2.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 123.35 1.547 . . . . 0.0 112.098 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.52 -116.72 1.75 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.687 1.613 . . . . 0.0 110.351 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -151.92 147.15 26.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -141.27 162.78 34.65 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.83 1.652 . . . . 0.0 111.927 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -139.73 148.08 41.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.938 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.05 146.98 38.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.781 0.832 . . . . 0.0 110.585 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -57.9 -26.38 62.09 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.16 -16.91 61.98 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.451 1.5 . . . . 0.0 111.74 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.04 -13.74 23.99 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 127.136 2.303 . . . . 0.0 113.627 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -69.77 155.66 40.2 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.308 1.554 . . . . 0.0 112.841 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -127.81 138.35 52.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.044 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -124.11 136.64 54.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.261 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -126.67 131.25 51.45 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.2 127.12 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.03 -89.93 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.91 141.32 32.98 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.608 -0.937 . . . . 0.0 111.219 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -91.4 130.07 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.83 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 165.09 18.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.908 0.861 . . . . 0.0 111.885 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 28.7 p -57.37 -26.96 61.85 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -73.58 -31.97 63.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.849 0.75 . . . . 0.0 111.722 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.99 25.32 Favored Glycine 0 N--CA 1.462 0.389 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.344 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.3 156.81 38.77 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.582 1.191 . . . . 0.0 112.872 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.35 160.25 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.389 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' THR . . . . . 0.493 HG21 ' CD1' ' D' ' 50' ' ' LEU . 0.9 OUTLIER -120.45 156.98 30.33 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 173.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.78 -167.82 28.04 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 120.11 -1.619 . . . . 0.0 112.527 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -140.0 137.74 34.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 122.351 1.072 . . . . 0.0 112.474 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -114.62 139.14 49.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.476 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mt -130.79 127.23 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 86.7 m -105.1 144.17 32.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.64 -21.41 18.24 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 143.75 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 112.974 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.49 39.25 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.722 -0.611 . . . . 0.0 110.238 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.68 -23.46 58.63 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 121.984 -0.447 . . . . 0.0 110.935 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -146.6 68.7 12.12 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.263 2.225 . . . . 0.0 111.087 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -56.79 -78.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 125.05 3.833 . . . . 0.0 116.89 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.66 -48.74 0.01 OUTLIER Glycine 0 CA--C 1.545 1.931 0 C-N-CA 129.651 3.501 . . . . 0.0 120.587 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.68 -5.15 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 127.176 2.19 . . . . 0.0 113.03 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . 0.345 64.9 mt -8.92 86.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 124.337 2.018 . . . . 0.0 115.068 -172.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.29 151.47 21.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.55 174.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 tt -46.51 126.87 8.72 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.295 -2.23 . . . . 0.0 111.772 174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.7 p -102.85 118.68 57.72 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 123.844 0.715 . . . . 0.0 111.381 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.84 144.15 67.88 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.66 2.24 . . . . 0.0 111.962 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.44 162.75 24.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.551 0.74 . . . . 0.0 111.516 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . 0.495 ' CD2' ' HB2' ' A' ' 28' ' ' GLU . 15.9 tp -164.22 149.02 10.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.894 1.678 . . . . 0.0 112.129 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -154.62 25.65 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 120.933 1.697 . . . . 0.0 110.498 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -144.35 133.42 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.359 1.076 . . . . 0.0 110.929 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 136.71 54.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.28 1.432 . . . . 0.0 110.497 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -73.8 151.26 40.63 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.28 -0.887 . . . . 0.0 109.971 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -144.62 26.47 1.42 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.696 -1.252 . . . . 0.0 111.58 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.42 -49.28 6.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 111.289 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 172.8 12.6 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -80.01 -30.66 39.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.781 1.232 . . . . 0.0 113.11 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -133.29 57.68 28.8 Favored Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -71.76 164.25 36.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 N-CA-C 117.494 2.075 . . . . 0.0 117.494 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -81.21 164.1 22.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.944 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -158.35 163.56 37.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.871 0.844 . . . . 0.0 112.758 175.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.43 140.09 6.08 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -159.56 157.91 30.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -96.11 151.38 19.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.91 1.684 . . . . 0.0 110.648 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.47 118.74 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -94.93 113.29 25.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.966 0.906 . . . . 0.0 109.523 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.297 43.8 m95 -82.53 136.01 34.96 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -173.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -92.41 -43.25 9.32 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.899 2.08 . . . . 0.0 116.417 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -91.37 -9.72 43.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.77 127.41 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.422 2.289 . . . . 0.0 107.171 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -69.52 118.48 12.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.009 1.277 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -177.34 163.91 2.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.31 1.844 . . . . 0.0 109.039 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.5 t -144.0 143.78 31.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.893 1.806 . . . . 0.0 111.721 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 110.224 -3.171 . . . . 0.0 109.869 -172.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.1 153.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -127.12 141.97 51.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.36 118.37 7.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -164.95 14.61 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 116.401 1.32 . . . . 0.0 116.401 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -131.09 149.75 52.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.245 0.615 . . . . 0.0 112.024 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 37.9 t -97.25 122.28 40.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.211 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.35 163.46 13.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.138 0.975 . . . . 0.0 112.008 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.79 107.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 160.84 5.36 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.251 0.548 . . . . 0.0 110.103 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.09 -49.97 0.14 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -25.87 61.06 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.83 51.51 1.17 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.881 0.764 . . . . 0.0 111.286 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -120.16 147.73 44.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 128.261 2.624 . . . . 0.0 105.346 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -113.7 137.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.804 1.242 . . . . 0.0 110.135 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 106' ' ' ILE . 26.0 m -139.71 161.86 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 110.05 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.01 120.05 36.64 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 118.41 36.7 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -137.11 171.84 13.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 123.303 1.525 . . . . 0.0 112.151 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.422 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 88.5 mmm -125.95 168.88 13.29 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -141.07 163.72 32.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.312 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -148.11 120.1 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.84 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 140.33 40.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 123.23 1.49 . . . . 0.0 112.044 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.08 119.86 34.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 110.89 -2.868 . . . . 0.0 110.758 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -86.15 162.97 18.11 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 125.257 1.598 . . . . 0.0 112.044 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 3.8 t -112.83 73.17 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.14 -166.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.452 0.701 . . . . 0.0 110.709 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.11 -14.54 3.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 119.907 -1.746 . . . . 0.0 114.569 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -123.46 149.49 45.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 123.086 1.422 . . . . 0.0 110.516 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 92' ' ' VAL . 17.2 tt -62.01 -29.37 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.111 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.0 5.92 11.66 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.45 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . 0.478 ' CG ' ' HZ1' ' D' ' 111' ' ' LYS . 34.7 m-20 -120.41 -1.77 10.13 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.01 1.405 . . . . 0.0 113.575 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.82 -34.99 70.26 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.652 -1.28 . . . . 0.0 112.745 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -47.51 -39.8 17.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.079 1.352 . . . . 0.0 113.912 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . 0.478 ' HZ1' ' CG ' ' D' ' 108' ' ' ASP . 12.5 pttp -99.21 -6.8 27.49 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.322 1.449 . . . . 0.0 114.114 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.75 1.46 10.35 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.88 -1.137 . . . . 0.0 113.126 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 96' ' ' MET . 34.7 m -117.29 145.24 44.1 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.574 0.75 . . . . 0.0 111.604 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.17 129.05 18.42 Favored 'General case' 0 C--O 1.214 -0.81 0 C-N-CA 125.53 1.532 . . . . 0.0 110.681 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.74 155.15 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 120.531 1.514 . . . . 0.0 109.504 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.21 -175.53 29.24 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.628 1.109 . . . . 0.0 113.002 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 21.7 p90 -125.87 153.48 44.09 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.039 0.936 . . . . 0.0 110.68 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.33 153.24 41.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.675 1.19 . . . . 0.0 109.706 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 80.9 mt -135.37 123.93 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.52 149.51 32.57 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 111.064 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -133.56 164.93 26.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.939 0.896 . . . . 0.0 109.82 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -60.93 121.14 11.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.104 -0.997 . . . . 0.0 109.979 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.08 147.5 47.15 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 121.765 -0.584 . . . . 0.0 110.14 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 72.63 -52.47 0.7 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.705 2.802 . . . . 0.0 115.194 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . 0.271 8.6 t 43.59 -162.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.819 1.248 . . . . 0.0 112.41 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -151.22 -49.25 0.12 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.782 2.033 . . . . 0.0 109.128 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -95.09 152.19 18.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 127.377 2.271 . . . . 0.0 110.371 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.134 -2.365 . . . . 0.0 110.892 174.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 2.9 m -138.79 165.99 25.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.319 1.448 . . . . 0.0 107.874 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.74 152.33 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.14 0.976 . . . . 0.0 110.203 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.19 150.98 44.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.534 1.133 . . . . 0.0 108.913 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -145.91 65.64 1.22 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.14 1.376 . . . . 0.0 110.09 -174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -151.99 105.38 3.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.645 0.778 . . . . 0.0 111.232 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.59 134.94 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.322 1.849 . . . . 0.0 109.619 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -139.75 135.71 33.39 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.414 -1.429 . . . . 0.0 114.193 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' B' ' 64' ' ' PHE . 40.7 mt -60.46 -30.57 69.76 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -53.5 116.81 2.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.713 1.244 . . . . 0.0 111.582 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.65 -116.11 1.54 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.474 1.512 . . . . 0.0 110.369 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -152.68 145.3 24.22 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -139.63 162.15 35.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 111.553 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -141.51 145.57 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.607 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.21 148.85 30.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.062 0.945 . . . . 0.0 110.744 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -57.47 -28.91 63.8 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.18 -14.87 61.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.367 1.867 . . . . 0.0 111.91 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.78 -14.02 29.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 127.048 2.261 . . . . 0.0 113.461 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 54.1 p -69.35 155.83 39.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.233 1.516 . . . . 0.0 112.683 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -127.95 139.58 52.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.935 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -125.69 134.83 51.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.563 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -124.97 131.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.0 mt -135.01 127.83 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.6 -89.6 0.11 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.048 0.842 . . . . 0.0 112.52 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.4 140.5 32.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.714 -0.874 . . . . 0.0 111.554 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.3 t -90.96 129.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.402 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.73 165.8 16.55 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.576 0.703 . . . . 0.0 111.533 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 27.5 p -56.98 -27.42 61.37 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -74.89 -32.79 61.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.785 0.721 . . . . 0.0 111.877 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.62 -7.32 26.16 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.164 -1.353 . . . . 0.0 112.856 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.498 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 9.7 pt-20 -66.11 144.58 56.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.857 1.328 . . . . 0.0 108.464 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.44 146.16 18.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.783 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.69 162.25 14.15 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.894 0.877 . . . . 0.0 108.76 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.84 36.86 Favored Glycine 0 C--O 1.238 0.372 0 O-C-N 121.245 -0.909 . . . . 0.0 112.608 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 43.9 p -140.17 139.24 35.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.335 1.064 . . . . 0.0 112.292 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -114.38 139.09 49.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.477 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -131.2 127.1 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 86.5 m -105.0 145.47 30.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.45 -22.37 17.17 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.61 143.44 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.553 1.141 . . . . 0.0 113.093 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.62 159.5 39.68 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.387 -0.82 . . . . 0.0 110.083 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.46 -23.49 58.9 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.017 -0.427 . . . . 0.0 111.083 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.78 68.62 11.84 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 127.256 2.223 . . . . 0.0 110.945 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -56.85 -78.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 125.083 3.856 . . . . 0.0 116.776 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.82 -48.46 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 C-N-CA 129.582 3.468 . . . . 0.0 120.568 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.98 -5.29 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.283 2.233 . . . . 0.0 113.114 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . 0.349 65.7 mt -8.58 85.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 124.354 2.026 . . . . 0.0 115.147 -172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.89 151.11 21.21 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.501 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -46.34 127.3 8.86 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.777 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.46 118.72 56.98 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 123.951 0.782 . . . . 0.0 111.405 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.85 144.12 68.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.58 158.44 34.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.728 0.811 . . . . 0.0 111.22 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.4 tp -160.03 148.94 17.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.409 1.884 . . . . 0.0 110.453 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.86 -157.28 29.01 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 121.018 1.735 . . . . 0.0 110.236 -174.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.62 135.0 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.64 0.733 . . . . 0.0 111.491 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.56 136.71 53.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.723 1.209 . . . . 0.0 110.843 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -73.48 152.49 40.7 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.993 0.902 . . . . 0.0 109.756 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.86 25.82 1.42 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.537 -1.352 . . . . 0.0 111.773 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -93.23 -49.21 6.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.918 1.287 . . . . 0.0 111.238 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.23 172.53 12.69 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.557 1.161 . . . . 0.0 114.042 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.67 -28.6 36.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.492 1.117 . . . . 0.0 113.028 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -135.11 57.09 18.72 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.665 1.186 . . . . 0.0 111.52 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.77 163.95 37.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.598 2.865 . . . . 0.0 117.73 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 69.6 p -80.89 163.74 23.15 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.761 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -158.76 162.84 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.346 -0.846 . . . . 0.0 112.811 175.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.76 140.03 6.08 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -159.59 158.17 31.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.37 151.46 19.52 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.477 1.511 . . . . 0.0 110.632 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -127.38 118.06 48.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -93.74 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.01 0.924 . . . . 0.0 109.501 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.298 43.8 m95 -83.06 135.05 34.98 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.44 -43.86 9.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.179 2.192 . . . . 0.0 116.361 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -91.14 -9.66 44.71 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -152.74 126.32 8.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.479 2.312 . . . . 0.0 106.912 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.12 118.49 12.09 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.046 1.294 . . . . 0.0 110.515 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -177.48 163.57 1.98 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 109.176 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -143.63 144.25 31.82 Favored 'General case' 0 CA--C 1.482 -1.673 0 CA-C-O 123.376 1.56 . . . . 0.0 111.648 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 125.67 21.32 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 110.441 -3.072 . . . . 0.0 109.656 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.03 153.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -126.99 142.03 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 118.06 6.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.09 -165.01 14.76 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -130.83 149.61 52.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.928 1.016 . . . . 0.0 111.75 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.23 125.84 42.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.464 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -113.07 165.44 12.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.267 1.027 . . . . 0.0 112.213 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 22.7 mt -130.56 110.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.91 162.08 4.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.258 0.623 . . . . 0.0 109.567 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -33.33 -48.94 0.26 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -13.44 60.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.64 43.45 4.22 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.225 0.92 . . . . 0.0 112.23 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -113.36 142.67 45.59 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 127.389 2.276 . . . . 0.0 109.324 174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -106.8 141.68 37.64 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.004 1.321 . . . . 0.0 111.271 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 24.8 m -144.55 160.37 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.589 1.156 . . . . 0.0 110.14 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.71 119.43 35.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 118.59 37.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 4.5 p -137.38 172.05 13.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.169 1.461 . . . . 0.0 112.189 -174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 88.4 mmm -125.92 168.87 13.3 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.12 163.99 31.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.583 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.16 119.77 8.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.983 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 139.63 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 124.964 1.415 . . . . 0.0 112.176 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -119.38 120.35 36.63 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 110.684 -2.962 . . . . 0.0 110.676 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -87.79 163.35 16.5 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 125.319 1.637 . . . . 0.0 111.405 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -113.13 72.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.58 -167.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.312 0.645 . . . . 0.0 110.269 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.03 -20.28 3.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.092 -1.63 . . . . 0.0 113.66 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -115.38 148.3 39.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.991 1.377 . . . . 0.0 110.96 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' C' ' 84' ' ' PHE . 16.9 tt -62.85 -28.4 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.516 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.75 5.83 15.31 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 118.003 -1.443 . . . . 0.0 113.831 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' B' ' 111' ' ' LYS . 32.4 m-20 -121.27 -0.93 9.79 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.95 1.375 . . . . 0.0 113.432 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.5 -35.86 70.79 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.737 -1.227 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -47.22 -40.25 15.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.195 1.398 . . . . 0.0 113.802 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' B' ' 108' ' ' ASP . 12.3 pttp -99.04 -7.07 27.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.241 1.416 . . . . 0.0 113.943 177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.58 13.05 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.627 -1.295 . . . . 0.0 113.165 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.427 HG23 ' HG3' ' C' ' 96' ' ' MET . 33.1 m -115.09 145.47 42.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.869 0.868 . . . . 0.0 111.757 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.78 129.86 18.51 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 125.876 1.671 . . . . 0.0 110.42 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.66 155.13 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 120.421 1.464 . . . . 0.0 109.353 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.68 -175.07 28.19 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.673 1.13 . . . . 0.0 113.517 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 21.1 p90 -126.29 152.84 45.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.13 0.972 . . . . 0.0 110.71 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -145.15 151.57 38.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.528 1.131 . . . . 0.0 110.304 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.86 119.74 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -108.69 152.28 25.03 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.933 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -136.91 162.15 34.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.23 1.012 . . . . 0.0 109.566 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -54.55 125.79 21.07 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.51 -0.744 . . . . 0.0 109.668 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.36 83.18 0.56 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 72.52 167.0 0.31 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.823 2.449 . . . . 0.0 108.694 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 3.3 t -171.48 -57.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.196 0.999 . . . . 0.0 111.216 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 55.14 -167.92 0.09 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.871 1.268 . . . . 0.0 110.992 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 150.07 132.53 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.911 3.684 . . . . 0.0 107.859 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.019 0 O-C-N 126.856 2.597 . . . . 0.0 109.663 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 4.4 p -71.71 163.69 27.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.555 1.07 . . . . 0.0 111.868 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.11 -15.57 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 43.39 -132.23 0.63 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 126.092 1.757 . . . . 0.0 114.519 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . 0.354 0.0 OUTLIER 44.88 17.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 129.673 3.189 . . . . 0.0 117.496 -174.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -151.98 105.07 3.05 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.686 -1.259 . . . . 0.0 111.874 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -119.27 133.41 55.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.279 1.832 . . . . 0.0 109.228 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 78.9 p -139.83 133.21 30.01 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.243 -1.536 . . . . 0.0 114.148 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' C' ' 64' ' ' PHE . 40.8 mt -58.23 -32.82 68.68 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -51.76 116.3 2.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.903 1.335 . . . . 0.0 111.729 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.95 -114.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 125.66 1.6 . . . . 0.0 109.829 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -152.9 148.22 26.89 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -141.12 162.67 34.93 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.267 1.427 . . . . 0.0 112.315 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -135.45 147.3 48.89 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.859 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.67 146.81 36.81 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.591 0.756 . . . . 0.0 110.475 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -57.1 -27.46 61.79 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 34.9 tp -72.64 -16.25 61.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.126 1.77 . . . . 0.0 111.986 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.56 -13.81 25.15 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.128 2.299 . . . . 0.0 113.662 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 44.1 p -69.16 156.31 38.92 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.489 1.645 . . . . 0.0 113.128 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -128.86 138.93 52.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.848 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -124.08 136.87 54.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.26 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -126.68 130.72 50.96 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.97 126.87 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.83 -89.59 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.898 0.749 . . . . 0.0 112.63 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.42 32.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.619 -0.93 . . . . 0.0 111.206 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.33 130.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.08 165.33 18.29 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.589 0.709 . . . . 0.0 111.782 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 30.6 p -57.78 -26.76 62.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -73.65 -32.04 63.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.975 0.807 . . . . 0.0 111.733 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.08 -4.55 25.48 Favored Glycine 0 N--CA 1.463 0.462 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.392 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.73 156.49 39.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.432 1.116 . . . . 0.0 112.766 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.81 159.93 33.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.258 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.5 HG21 ' CD1' ' C' ' 50' ' ' LEU . 1.0 OUTLIER -120.34 157.11 29.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 173.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.08 -167.33 27.6 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 120.054 -1.654 . . . . 0.0 112.627 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 54.0 p -139.79 138.14 35.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.514 1.149 . . . . 0.0 112.783 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.9 139.45 49.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.371 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.16 127.06 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.05 145.03 31.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.98 -20.12 18.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.49 142.89 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.548 1.139 . . . . 0.0 113.197 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.42 159.37 39.8 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.326 -0.859 . . . . 0.0 110.215 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.38 -23.42 58.99 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 110.99 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.71 68.88 12.07 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 127.239 2.216 . . . . 0.0 111.029 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.92 -78.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 125.054 3.836 . . . . 0.0 116.86 -173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.51 -48.85 0.01 OUTLIER Glycine 0 CA--C 1.546 1.982 0 C-N-CA 129.65 3.5 . . . . 0.0 120.591 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.49 -5.08 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.307 2.243 . . . . 0.0 113.167 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . 0.345 65.6 mt -9.02 85.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 124.465 2.078 . . . . 0.0 115.301 -172.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.88 151.36 20.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.525 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -46.48 127.08 8.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 112.181 -2.282 . . . . 0.0 111.777 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.25 118.71 57.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 123.85 0.718 . . . . 0.0 111.376 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.74 144.29 66.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.755 2.303 . . . . 0.0 111.869 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.63 162.73 25.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.545 0.738 . . . . 0.0 111.702 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . 0.5 ' CD1' HG21 ' C' ' 30' ' ' THR . 15.6 tp -164.46 148.97 9.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.778 1.631 . . . . 0.0 112.166 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.73 25.79 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 120.866 1.666 . . . . 0.0 110.488 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -143.76 135.18 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.209 1.004 . . . . 0.0 110.984 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.58 136.55 52.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.311 1.444 . . . . 0.0 110.34 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -73.72 151.44 40.7 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.889 0.852 . . . . 0.0 110.172 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -144.56 25.68 1.48 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.573 -1.329 . . . . 0.0 112.017 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -93.51 -49.96 5.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.28 1.432 . . . . 0.0 111.239 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.64 173.11 11.48 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.691 1.245 . . . . 0.0 113.659 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -83.0 -26.47 31.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.107 1.363 . . . . 0.0 113.46 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -134.91 55.74 14.77 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 125.438 1.495 . . . . 0.0 112.2 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.28 163.72 37.66 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.794 2.329 . . . . 0.0 117.878 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 68.2 p -80.86 164.18 22.84 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.033 173.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.4 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.21 163.33 36.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.874 0.845 . . . . 0.0 113.118 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.74 140.81 6.53 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 117.816 1.886 . . . . 0.0 117.816 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -160.3 158.55 30.0 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -96.63 152.02 19.05 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.118 1.767 . . . . 0.0 110.709 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.34 118.12 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -94.22 113.14 25.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.017 0.927 . . . . 0.0 109.447 -174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.295 43.6 m95 -82.46 135.43 35.13 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -172.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -91.56 -44.07 9.29 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.956 2.102 . . . . 0.0 116.226 -173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -90.89 -9.49 46.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.0 t -152.74 126.84 9.09 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 127.448 2.299 . . . . 0.0 107.065 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -69.19 118.48 12.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.0 1.273 . . . . 0.0 110.407 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -177.34 163.59 2.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.393 1.877 . . . . 0.0 109.142 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -143.69 143.89 31.62 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 124.067 1.889 . . . . 0.0 111.613 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.44 125.71 21.65 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 109.99 -3.277 . . . . 0.0 109.86 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.33 153.58 4.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.79 142.15 51.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.72 118.94 7.26 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -174.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.88 -164.29 14.16 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.06 149.46 52.41 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.541 0.789 . . . . 0.0 111.812 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 41.4 t -97.21 123.26 40.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.318 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.403 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.1 m-85 -112.34 164.71 12.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.264 1.025 . . . . 0.0 112.203 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -128.11 111.78 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.85 160.18 6.11 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -33.42 -47.74 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -10.06 59.13 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.07 5.79 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.524 1.056 . . . . 0.0 112.644 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -112.99 143.21 44.68 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 128.208 2.603 . . . . 0.0 108.959 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -109.45 143.93 38.38 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.489 1.495 . . . . 0.0 110.865 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.95 162.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.581 1.152 . . . . 0.0 109.606 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.63 121.02 39.16 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.84 119.07 38.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.7 p -137.31 172.54 12.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.083 1.42 . . . . 0.0 112.371 -174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.427 ' HG3' HG23 ' B' ' 113' ' ' THR . 88.7 mmm -126.97 169.22 13.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -141.15 164.37 30.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.389 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.27 120.01 8.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.949 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.19 140.2 40.43 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 125.022 1.451 . . . . 0.0 112.231 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.25 120.74 36.98 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 111.208 -2.724 . . . . 0.0 111.129 -174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 38.4 t -88.56 163.18 15.99 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 125.176 1.548 . . . . 0.0 111.351 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -113.0 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.96 -165.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.439 0.695 . . . . 0.0 110.453 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.36 -15.65 3.19 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.074 -1.641 . . . . 0.0 114.054 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.58 148.89 43.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.13 1.443 . . . . 0.0 110.798 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.18 -28.34 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.932 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.28 5.84 18.35 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-O 118.121 -1.377 . . . . 0.0 113.866 173.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . 0.483 ' CG ' ' HZ1' ' C' ' 111' ' ' LYS . 35.3 m-20 -121.17 -1.43 9.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.587 1.194 . . . . 0.0 113.481 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.07 -35.71 71.76 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.738 -1.226 . . . . 0.0 112.581 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -47.1 -39.8 13.98 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.018 1.327 . . . . 0.0 113.903 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . 0.483 ' HZ1' ' CG ' ' C' ' 108' ' ' ASP . 12.2 pttp -99.28 -7.21 26.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.16 2.04 9.89 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.537 -1.352 . . . . 0.0 113.09 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' THR . . . . . 0.41 HG23 ' HG3' ' B' ' 96' ' ' MET . 35.8 m -116.96 145.08 43.87 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.977 0.911 . . . . 0.0 111.618 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.23 129.37 18.65 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 125.68 1.592 . . . . 0.0 110.62 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.66 155.08 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 120.558 1.526 . . . . 0.0 109.246 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -175.82 28.83 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.681 1.134 . . . . 0.0 113.441 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 21.1 p90 -125.45 152.95 44.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.541 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.61 152.66 40.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.75 1.22 . . . . 0.0 110.151 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.16 121.5 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -109.02 152.69 24.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -141.02 164.08 31.24 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.136 0.975 . . . . 0.0 110.676 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.39 114.38 2.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.097 0.959 . . . . 0.0 111.24 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.95 140.71 57.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.714 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . 0.325 0.0 OUTLIER 58.46 33.94 23.53 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 4.9 t -61.25 170.03 1.89 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.288 0.635 . . . . 0.0 112.646 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.01 125.92 54.6 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -149.53 110.42 4.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.931 1.292 . . . . 0.0 108.832 -173.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.312 21.8 pm0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.476 1.911 . . . . 0.0 115.081 -173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 115.659 -2.115 . . . . 0.0 105.708 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 7.1 m 34.2 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.18 1.792 . . . . 0.0 113.267 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . 0.338 31.7 m 55.83 -140.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 117.175 -1.393 . . . . 0.0 110.115 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 164.01 -46.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.392 2.677 . . . . 0.0 112.681 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -149.26 96.75 2.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -156.85 120.62 4.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.378 1.445 . . . . 0.0 114.492 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 134.2 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.219 1.408 . . . . 0.0 111.273 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.43 127.54 13.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.022 1.329 . . . . 0.0 109.234 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -73.74 -27.7 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.77 116.1 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.86 1.264 . . . . 0.0 111.204 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.33 -123.52 2.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.411 1.482 . . . . 0.0 110.97 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -147.62 144.65 28.56 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -142.67 159.15 42.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.369 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -141.33 146.95 37.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.409 HD22 ' HB2' ' A' ' 16' ' ' SER . 25.2 p30 -114.21 159.37 20.2 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -55.99 -26.06 46.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.146 2.578 . . . . 0.0 115.164 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.1 tp -76.27 -11.97 60.0 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.608 1.163 . . . . 0.0 111.974 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.89 47.28 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 127.145 2.307 . . . . 0.0 112.931 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.409 ' HB2' HD22 ' A' ' 12' ' ' ASN . 15.8 m -69.21 154.91 41.28 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.596 1.189 . . . . 0.0 111.598 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -128.99 150.56 50.35 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.736 -1.227 . . . . 0.0 110.273 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -134.47 145.4 48.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.339 0.59 . . . . 0.0 112.159 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -129.2 134.75 48.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.767 0.827 . . . . 0.0 109.231 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.31 125.05 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -78.68 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 O-C-N 124.335 1.022 . . . . 0.0 111.199 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.85 30.92 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.83 -0.806 . . . . 0.0 112.407 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.61 132.17 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.337 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -76.52 168.73 19.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.941 0.877 . . . . 0.0 112.521 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 p -56.07 -27.4 53.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -75.64 -34.0 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.539 0.609 . . . . 0.0 112.272 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.65 -10.38 14.26 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.985 -1.453 . . . . 0.0 113.501 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 140.02 58.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.358 2.263 . . . . 0.0 108.991 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.86 147.57 24.34 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 p -107.39 169.31 8.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.566 1.147 . . . . 0.0 109.78 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.04 -168.2 37.18 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.377 -1.452 . . . . 0.0 114.905 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -140.53 129.56 23.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.375 1.084 . . . . 0.0 111.975 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.29 137.79 48.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.12 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.5 mt -127.22 127.43 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.264 73.7 m -105.06 133.0 50.57 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 125.051 1.34 . . . . 0.0 112.986 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.51 27.63 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.46 146.79 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.016 1.327 . . . . 0.0 112.092 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.02 161.69 42.23 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.817 -1.177 . . . . 0.0 111.407 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.98 -29.07 55.36 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 122.037 -0.414 . . . . 0.0 110.353 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -143.02 78.95 14.88 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 127.338 2.255 . . . . 0.0 110.215 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.15 21.28 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.336 1 C-N-CA 125.474 4.116 . . . . 0.0 117.415 -174.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.6 -7.13 5.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 119.289 2.476 . . . . 0.0 119.289 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.93 43.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.686 1.743 . . . . 0.0 111.38 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.5 mt -51.21 125.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.34 -1.475 . . . . 0.0 111.272 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.63 30.4 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.692 1.597 . . . . 0.0 110.389 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -46.71 115.37 1.03 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.971 2.909 . . . . 0.0 110.738 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 t -102.76 119.36 55.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.493 0.717 . . . . 0.0 109.554 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -55.86 142.66 83.79 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.261 2.641 . . . . 0.0 111.431 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.54 154.81 47.42 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 124.017 0.823 . . . . 0.0 111.017 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -156.54 148.75 23.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.736 1.614 . . . . 0.0 110.574 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.21 -157.55 29.43 Favored Glycine 0 C--N 1.333 0.405 0 O-C-N 119.738 -1.851 . . . . 0.0 110.641 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.7 142.01 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.681 0.792 . . . . 0.0 112.836 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.44 136.91 47.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.0 151.12 44.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.671 1.225 . . . . 0.0 112.105 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -151.33 26.95 0.68 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.352 1.861 . . . . 0.0 110.019 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.41 -57.04 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.881 1.672 . . . . 0.0 110.065 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.26 7.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.301 0.64 . . . . 0.0 112.08 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 p -95.19 -17.95 21.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 117.329 -1.32 . . . . 0.0 113.754 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -131.6 45.4 1.71 Allowed Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.895 1.278 . . . . 0.0 112.364 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 171.38 17.28 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.7 2.266 . . . . 0.0 115.452 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.485 ' HG1' ' HB3' ' D' ' 100' ' ' ARG 0.298 0.1 OUTLIER -98.81 163.81 12.47 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.747 1.737 . . . . 0.0 111.199 173.156 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -158.34 166.11 33.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.911 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.6 145.12 10.12 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 118.999 2.359 . . . . 0.0 118.999 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -161.41 153.65 19.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -90.15 149.18 22.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.548 1.939 . . . . 0.0 110.314 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -128.17 118.53 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.67 101.81 12.38 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.449 -0.782 . . . . 0.0 110.429 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -58.69 129.43 42.08 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.49 -32.29 16.42 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -99.8 -11.96 20.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.35 138.01 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.944 2.098 . . . . 0.0 106.728 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -73.45 118.62 16.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.59 1.186 . . . . 0.0 111.254 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.67 159.77 2.37 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.591 1.556 . . . . 0.0 109.604 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -136.58 134.66 37.66 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.4 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.02 138.0 54.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.78 155.2 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -130.96 143.99 51.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.078 0.951 . . . . 0.0 108.844 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.47 118.98 8.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.32 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.73 176.68 44.83 Favored Glycine 0 C--O 1.215 -1.077 0 N-CA-C 118.196 2.038 . . . . 0.0 118.196 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.619 ' NE2' ' H ' ' D' ' 103' ' ' VAL . 0.0 OUTLIER -101.71 150.5 23.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.47 115.14 27.21 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.445 1.716 . . . . 0.0 107.086 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 82' ' ' GLN . 25.5 m-85 -105.64 159.21 16.14 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.761 1.164 . . . . 0.0 113.266 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 mt -120.02 109.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 113.519 -1.673 . . . . 0.0 106.9 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.86 161.41 4.91 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -22.71 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 177.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -10.31 48.88 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.689 0.796 . . . . 0.0 112.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.75 6.44 56.24 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.487 1.042 . . . . 0.0 114.851 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -73.82 165.51 24.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.773 1.286 . . . . 0.0 110.153 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.62 143.42 49.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.738 1.615 . . . . 0.0 111.473 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.51 153.17 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.09 0.956 . . . . 0.0 110.891 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.5 mt -116.46 103.59 10.59 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HE3' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -97.06 114.45 26.09 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -133.26 164.54 26.85 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.216 1.484 . . . . 0.0 112.227 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.43 ' HG3' HG23 ' D' ' 113' ' ' THR . 92.9 mmm -115.29 167.87 10.47 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -139.07 163.87 31.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 0.0 113.423 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 124.66 15.02 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.05 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.15 131.97 53.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.634 1.683 . . . . 0.0 109.036 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.499 ' HB3' ' HG1' ' D' ' 63' ' ' THR . 3.2 tpt85 -114.79 113.67 24.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 111.036 -2.802 . . . . 0.0 109.232 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.271 1.0 OUTLIER -68.26 165.98 17.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.447 . . . . 0.0 111.688 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.1 t -107.3 86.95 2.39 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 121.465 1.939 . . . . 0.0 107.775 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.606 ' H ' ' NE2' ' D' ' 82' ' ' GLN . 8.1 p -86.66 157.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 129.294 3.038 . . . . 0.0 110.96 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -96.84 -34.14 11.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.47 148.84 32.28 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.777 0.799 . . . . 0.0 112.685 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.37 -29.58 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.851 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.63 5.26 38.92 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.4 0.03 8.82 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.333 1.567 . . . . 0.0 113.6 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -28.8 69.32 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.49 -1.381 . . . . 0.0 113.77 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.675 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 62.5 p-90 -49.64 -44.39 47.45 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.946 0.898 . . . . 0.0 113.223 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.675 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -87.63 -12.72 44.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.252 -0.905 . . . . 0.0 113.223 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 -0.69 26.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.513 -0.742 . . . . 0.0 112.247 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.424 HG23 ' HG3' ' D' ' 96' ' ' MET . 35.2 m -110.22 139.84 44.96 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.348 1.059 . . . . 0.0 111.054 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.23 132.96 22.39 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.737 1.215 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -112.31 154.66 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 120.275 1.398 . . . . 0.0 110.961 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -174.45 27.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.938 0.78 . . . . 0.0 114.728 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 9.7 p90 -128.43 156.65 42.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.209 1.004 . . . . 0.0 112.209 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -152.16 150.23 29.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.243 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.478 HD13 ' HE3' ' A' ' 94' ' ' LYS . 9.0 mt -126.66 121.13 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.67 149.49 34.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.6 p -138.8 165.02 28.1 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.62 117.0 2.79 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.649 0.78 . . . . 0.0 110.546 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 123' ' ' LEU . 6.0 tt -68.26 110.33 4.0 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.09 -68.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.263 1.425 . . . . 0.0 110.115 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.7 t 38.63 29.37 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.015 2.526 . . . . 0.0 115.93 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -69.34 12.59 0.16 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm 69.46 5.47 5.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.6 1.96 . . . . 0.0 113.574 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 128.938 2.895 . . . . 0.0 110.354 173.209 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 63.73 8.27 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.666 1.575 . . . . 0.0 114.155 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.95 16.0 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.548 1.139 . . . . 0.0 113.763 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -62.71 -173.25 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.234 1.813 . . . . 0.0 113.769 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 58.78 20.83 8.32 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.61 -1.306 . . . . 0.0 113.707 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -156.75 123.07 4.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.207 -0.933 . . . . 0.0 113.019 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 t -133.04 142.81 48.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.669 0.787 . . . . 0.0 110.964 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.02 135.88 33.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.155 1.782 . . . . 0.0 108.801 174.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.51 -24.78 60.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.045 1.293 . . . . 0.0 113.858 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 115.73 1.7 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.94 1.296 . . . . 0.0 111.08 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.91 -125.72 3.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.982 1.277 . . . . 0.0 110.382 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -147.48 145.81 29.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -143.51 159.85 41.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -140.26 149.21 42.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.88 160.15 19.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -56.24 -26.07 50.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.127 2.571 . . . . 0.0 114.912 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -76.48 -11.04 59.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.793 1.237 . . . . 0.0 112.074 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.17 -15.21 56.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.832 2.158 . . . . 0.0 112.994 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -69.76 154.75 41.54 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.64 1.21 . . . . 0.0 111.643 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.02 151.23 49.94 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.576 -1.327 . . . . 0.0 110.677 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -134.3 146.78 50.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -130.27 134.85 47.53 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.662 0.785 . . . . 0.0 109.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.75 124.18 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.91 -75.86 0.39 Allowed Glycine 0 CA--C 1.527 0.827 0 O-C-N 124.339 1.024 . . . . 0.0 111.394 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.85 156.99 42.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.561 0.695 . . . . 0.0 111.931 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.5 131.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.052 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -77.99 168.57 19.69 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.833 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 61.8 p -57.08 -26.65 60.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -75.04 -30.2 60.99 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.253 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.02 -8.24 18.86 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 124.666 1.127 . . . . 0.0 114.154 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.49 147.72 51.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.51 2.324 . . . . 0.0 113.683 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -156.56 161.61 39.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.023 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -119.2 172.72 7.39 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.4 -167.26 35.43 Favored Glycine 0 N--CA 1.467 0.756 0 O-C-N 119.349 -2.095 . . . . 0.0 114.143 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -139.52 129.24 24.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.482 1.134 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -111.86 138.04 49.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.268 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 80.7 mt -127.16 127.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' THR . . . . . 0.403 ' HG1' ' HZ3' ' D' ' 70' ' ' TRP 0.264 90.5 m -105.1 133.82 49.23 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.816 1.246 . . . . 0.0 112.849 -172.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.65 -16.51 26.9 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 m -135.5 147.05 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.065 1.346 . . . . 0.0 112.167 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.4 161.04 42.71 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.806 -1.184 . . . . 0.0 111.74 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -76.22 -28.76 57.31 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.881 -0.512 . . . . 0.0 110.587 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -143.18 78.95 14.66 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.278 2.231 . . . . 0.0 110.311 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 21.09 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.316 1 C-N-CA 125.44 4.093 . . . . 0.0 117.403 -174.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.46 -7.04 5.17 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.15 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.136 1.774 . . . . 0.0 111.392 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -51.05 126.31 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.303 -1.498 . . . . 0.0 111.288 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.73 164.66 31.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.606 1.562 . . . . 0.0 110.426 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 13.4 tp -46.55 115.36 1.01 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.918 2.887 . . . . 0.0 110.562 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.8 t -103.2 118.63 57.44 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 123.607 0.763 . . . . 0.0 109.221 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.89 141.71 85.26 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.015 2.476 . . . . 0.0 111.094 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -129.76 162.18 29.02 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.199 0.999 . . . . 0.0 111.428 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 18.7 tp -165.5 148.83 8.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.703 1.201 . . . . 0.0 112.104 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.72 25.77 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 121.227 1.83 . . . . 0.0 110.456 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -145.19 141.83 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.878 0.987 . . . . 0.0 111.591 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 133.62 43.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.988 1.315 . . . . 0.0 114.515 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -67.31 147.31 53.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.443 1.116 . . . . 0.0 112.208 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -146.06 27.76 1.15 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.614 1.965 . . . . 0.0 110.127 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.12 -57.28 2.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.629 1.572 . . . . 0.0 110.133 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 175.31 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.527 0.731 . . . . 0.0 112.5 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 p -91.76 -20.59 21.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.673 1.189 . . . . 0.0 113.706 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -133.29 46.14 1.94 Allowed Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 125.227 1.411 . . . . 0.0 112.989 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.76 170.51 19.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.692 2.261 . . . . 0.0 116.006 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.499 ' HG1' ' HB3' ' A' ' 100' ' ' ARG 0.296 0.0 OUTLIER -97.89 161.98 13.47 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 124.023 1.868 . . . . 0.0 111.465 173.092 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.09 166.37 33.48 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.369 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.86 145.52 10.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 118.656 2.223 . . . . 0.0 118.656 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -161.91 152.98 18.04 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -89.44 151.15 22.17 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.62 1.968 . . . . 0.0 110.268 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 70.9 t -130.28 119.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -103.0 102.11 12.14 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 110.426 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . 0.403 ' HZ3' ' HG1' ' D' ' 35' ' ' THR . 84.4 m95 -58.43 129.8 43.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 124.071 1.891 . . . . 0.0 115.216 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.22 -31.58 16.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.57 -11.95 19.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 138.34 18.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.999 2.12 . . . . 0.0 106.484 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.85 118.69 17.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 43.1 t -175.66 160.04 2.41 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.486 1.514 . . . . 0.0 109.558 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.39 134.71 38.08 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.594 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.97 138.58 54.64 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.371 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.69 155.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -131.29 143.65 50.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.081 0.953 . . . . 0.0 108.657 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.61 118.25 8.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.444 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.05 44.4 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 118.185 2.034 . . . . 0.0 118.185 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . 0.606 ' NE2' ' H ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -101.76 150.42 23.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.943 1.025 . . . . 0.0 113.491 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 12.6 p -97.51 118.41 33.95 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.193 -1.821 . . . . 0.0 106.633 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.414 ' CZ ' ' CB ' ' D' ' 82' ' ' GLN . 20.4 m-85 -110.01 155.35 21.94 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.662 1.119 . . . . 0.0 113.849 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 mt -115.55 110.33 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.477 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -58.81 162.02 4.39 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -23.38 1.3 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -4.57 57.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.68 0.792 . . . . 0.0 112.692 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.86 61.85 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.035 1.302 . . . . 0.0 114.977 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -77.32 165.92 23.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.927 1.363 . . . . 0.0 110.505 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -122.06 145.12 48.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.02 1.328 . . . . 0.0 111.212 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.5 154.19 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.381 1.072 . . . . 0.0 110.64 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.98 103.81 10.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . 0.494 ' HE3' HD13 ' D' ' 119' ' ' ILE . 0.6 OUTLIER -96.85 114.27 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -133.05 164.59 26.68 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 123.003 1.383 . . . . 0.0 112.382 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.424 ' HG3' HG23 ' A' ' 113' ' ' THR . 92.3 mmm -115.19 167.86 10.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -139.06 164.0 30.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.412 1.101 . . . . 0.0 113.43 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.1 124.95 15.09 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.922 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.22 132.01 53.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 123.7 1.714 . . . . 0.0 108.964 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.485 ' HB3' ' HG1' ' A' ' 63' ' ' THR . 2.8 tpt85 -114.7 113.6 24.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 111.067 -2.788 . . . . 0.0 108.985 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.266 1.0 OUTLIER -67.37 165.92 15.51 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 116.875 -1.536 . . . . 0.0 111.888 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 29.7 t -107.81 87.3 2.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 121.775 2.079 . . . . 0.0 107.611 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . 0.619 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 8.0 p -88.09 154.86 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 129.215 3.006 . . . . 0.0 110.993 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -93.5 -33.06 13.93 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.83 150.35 35.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.96 -28.83 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.485 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.3 5.75 48.44 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.838 1.208 . . . . 0.0 115.606 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.3 0.42 8.94 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.273 1.536 . . . . 0.0 113.374 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -29.37 69.34 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.387 -1.446 . . . . 0.0 114.226 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . 0.684 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 62.4 p-90 -49.37 -44.75 45.15 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.973 0.909 . . . . 0.0 113.085 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . 0.684 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.0 OUTLIER -87.31 -12.64 45.9 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.04 0.936 . . . . 0.0 113.279 176.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.99 1.12 21.83 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.457 -0.777 . . . . 0.0 112.402 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' THR . . . . . 0.43 HG23 ' HG3' ' A' ' 96' ' ' MET . 33.9 m -111.56 139.7 46.78 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.33 1.052 . . . . 0.0 111.118 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.12 133.35 23.06 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.641 1.176 . . . . 0.0 110.942 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.33 154.74 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 120.4 1.455 . . . . 0.0 110.978 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -173.94 27.33 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.006 0.812 . . . . 0.0 114.744 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 10.0 p90 -128.67 156.39 43.53 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.282 1.033 . . . . 0.0 112.241 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -152.18 149.78 29.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.393 1.077 . . . . 0.0 112.144 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . 0.494 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.4 mt -126.47 123.4 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.675 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 148.39 40.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -139.74 167.29 22.44 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 120.74 7.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.675 1.19 . . . . 0.0 112.495 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.03 114.34 7.22 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.778 -0.63 . . . . 0.0 109.942 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 69.21 114.78 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.726 2.41 . . . . 0.0 113.076 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 20.1 p -144.21 -83.12 0.16 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.973 0.909 . . . . 0.0 109.917 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 61.93 -44.96 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.525 2.33 . . . . 0.0 114.76 -174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -139.08 102.13 4.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.059 1.744 . . . . 0.0 107.619 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.807 1.643 . . . . 0.0 108.937 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . 0.266 10.5 pm0 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.0 m -138.45 153.34 48.84 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.875 1.216 . . . . 0.0 110.408 -174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.61 37.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.166 1.386 . . . . 0.0 113.755 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -69.33 42.27 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.224 1.81 . . . . 0.0 114.907 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -144.46 43.98 1.4 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.495 1.918 . . . . 0.0 111.491 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tmmt? -156.65 120.54 4.33 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.156 -0.965 . . . . 0.0 113.409 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.33 144.0 51.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 111.533 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.06 134.97 32.12 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.827 1.651 . . . . 0.0 109.064 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -73.46 -25.8 60.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.978 1.263 . . . . 0.0 113.683 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.54 115.69 1.45 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 111.069 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.95 -125.6 3.14 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 125.252 1.406 . . . . 0.0 110.334 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -149.58 144.12 26.0 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -142.31 159.44 42.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.577 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 t -138.96 150.36 45.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -114.84 158.89 21.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.825 1.298 . . . . 0.0 114.347 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -54.53 -26.45 31.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.054 2.542 . . . . 0.0 114.879 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.4 tp -75.98 -12.06 60.07 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.897 1.279 . . . . 0.0 112.302 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.16 -15.7 50.67 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.132 2.301 . . . . 0.0 112.991 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -69.81 155.26 40.82 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.718 1.247 . . . . 0.0 111.706 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 150.2 50.72 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.639 -1.288 . . . . 0.0 110.511 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -133.63 147.06 51.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.371 0.605 . . . . 0.0 112.626 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -130.67 134.49 46.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.651 0.78 . . . . 0.0 109.469 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 92.9 mt -132.35 125.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -78.89 0.22 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 124.506 1.129 . . . . 0.0 111.208 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.31 152.7 33.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.629 0.728 . . . . 0.0 112.305 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.64 131.94 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.362 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -76.93 168.4 20.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 0.0 112.472 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 62.8 p -55.79 -27.51 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.58 -33.33 60.59 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.596 0.634 . . . . 0.0 112.327 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.86 -10.05 15.87 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 117.961 -1.466 . . . . 0.0 113.682 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.12 139.89 58.82 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.453 2.301 . . . . 0.0 108.861 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.79 148.54 25.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.0 p -108.94 168.4 9.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.809 1.244 . . . . 0.0 109.633 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 -168.58 37.31 Favored Glycine 0 N--CA 1.466 0.692 0 O-C-N 120.27 -1.519 . . . . 0.0 114.983 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -140.5 130.03 24.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.394 1.092 . . . . 0.0 111.765 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -111.46 138.37 48.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.191 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 78.7 mt -127.66 127.77 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.263 82.4 m -105.16 134.02 48.97 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.792 1.237 . . . . 0.0 112.913 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 -15.44 27.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 146.54 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.936 1.294 . . . . 0.0 111.972 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.31 42.7 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.735 -1.228 . . . . 0.0 111.489 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.48 -29.21 56.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.058 -0.401 . . . . 0.0 110.408 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -142.84 79.18 15.02 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.336 2.254 . . . . 0.0 110.292 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.17 20.55 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.377 1 C-N-CA 125.389 4.06 . . . . 0.0 117.406 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.67 -8.16 5.19 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.99 43.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.702 1.751 . . . . 0.0 111.335 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 70.3 mt -51.12 125.65 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.346 -1.471 . . . . 0.0 111.35 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.17 164.48 31.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.595 1.558 . . . . 0.0 110.449 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -46.49 115.41 1.02 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 129.005 2.922 . . . . 0.0 110.753 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.1 t -103.17 119.83 54.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.544 0.738 . . . . 0.0 109.268 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.03 142.55 85.45 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.363 2.708 . . . . 0.0 111.385 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.38 154.92 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.119 0.887 . . . . 0.0 110.89 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.73 148.72 22.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.621 1.568 . . . . 0.0 110.364 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.0 -158.07 29.97 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 121.25 1.841 . . . . 0.0 110.691 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.64 141.95 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.571 0.748 . . . . 0.0 112.749 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.57 135.01 45.65 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -69.45 149.13 48.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.8 1.286 . . . . 0.0 112.249 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -148.8 27.1 0.89 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.475 1.91 . . . . 0.0 109.841 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.71 -56.55 2.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.522 1.529 . . . . 0.0 109.721 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.89 173.64 10.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.784 0.802 . . . . 0.0 112.88 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -88.85 -23.27 22.84 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 113.505 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -131.88 48.31 3.52 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.255 1.422 . . . . 0.0 113.315 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.82 171.64 17.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.328 2.019 . . . . 0.0 115.58 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.493 ' HG1' ' HB3' ' C' ' 100' ' ' ARG 0.294 0.1 OUTLIER -98.14 163.07 12.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 123.775 1.75 . . . . 0.0 111.368 173.147 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -157.92 165.74 34.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.049 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 145.6 10.63 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 118.988 2.355 . . . . 0.0 118.988 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -161.59 153.94 19.91 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -89.92 149.46 22.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.651 1.98 . . . . 0.0 110.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -128.52 118.73 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -101.81 101.83 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.477 -0.764 . . . . 0.0 110.587 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.9 129.43 42.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 123.853 1.787 . . . . 0.0 115.311 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.62 -32.25 16.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -100.07 -11.92 20.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.5 t -152.46 138.0 17.74 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.807 2.043 . . . . 0.0 106.432 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.8 118.58 16.92 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.618 1.199 . . . . 0.0 111.406 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -175.34 159.99 2.56 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.624 1.57 . . . . 0.0 109.625 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.64 134.47 37.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.293 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.83 137.67 54.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.45 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -109.04 155.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -131.69 144.61 51.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.88 118.49 7.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.705 0.628 . . . . 0.0 109.965 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.8 176.42 44.26 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 118.201 2.041 . . . . 0.0 118.201 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.614 ' NE2' ' H ' ' C' ' 103' ' ' VAL . 0.0 OUTLIER -101.77 150.33 23.26 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 125.021 1.071 . . . . 0.0 113.82 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 10.4 p -97.51 117.43 31.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.621 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.413 ' CZ ' ' CB ' ' B' ' 82' ' ' GLN . 17.6 m-85 -108.81 155.15 21.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 119.804 1.184 . . . . 0.0 113.864 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.19 109.57 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.751 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -58.71 164.94 2.48 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.829 0.706 . . . . 0.0 109.594 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.98 -29.93 3.86 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -8.04 56.38 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.405 1.082 . . . . 0.0 113.27 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.95 10.71 58.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.764 1.173 . . . . 0.0 115.534 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -76.6 168.44 20.07 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.06 1.43 . . . . 0.0 108.895 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -124.58 145.06 49.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.192 1.36 . . . . 0.0 110.687 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.12 153.76 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.197 0.999 . . . . 0.0 111.453 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -117.57 103.32 9.95 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.483 ' HE3' HD13 ' B' ' 119' ' ' ILE . 0.6 OUTLIER -96.8 113.97 25.56 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 173.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -132.8 164.66 26.34 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.099 1.428 . . . . 0.0 112.385 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.433 ' HG3' HG23 ' C' ' 113' ' ' THR . 93.1 mmm -115.73 168.09 10.34 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -139.26 164.14 30.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.637 1.208 . . . . 0.0 113.419 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.73 125.05 15.53 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.088 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.2 131.55 54.05 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 125.412 1.695 . . . . 0.0 109.27 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.492 ' HB3' ' HG1' ' C' ' 63' ' ' THR . 3.5 tpt85 -114.82 113.65 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 110.847 -2.888 . . . . 0.0 108.947 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.261 0.9 OUTLIER -69.02 164.4 22.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.318 1.447 . . . . 0.0 111.994 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.5 t -105.45 87.95 2.73 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 121.462 1.937 . . . . 0.0 107.703 173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.601 ' H ' ' NE2' ' C' ' 82' ' ' GLN . 7.5 p -88.04 156.04 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 129.215 3.006 . . . . 0.0 111.065 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -95.81 -33.31 12.3 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.28 148.46 34.13 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.64 0.733 . . . . 0.0 112.698 -174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 4.8 tt -62.4 -29.79 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.588 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.88 40.66 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.764 1.173 . . . . 0.0 115.888 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.94 -0.36 9.01 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.319 1.559 . . . . 0.0 113.631 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -28.86 69.22 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.48 -1.387 . . . . 0.0 113.792 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.674 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 62.2 p-90 -49.44 -44.28 45.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.092 0.957 . . . . 0.0 113.311 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.674 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.0 OUTLIER -87.99 -12.56 44.12 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.139 -0.975 . . . . 0.0 113.294 176.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -0.54 25.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.424 0.69 . . . . 0.0 112.342 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.412 HG23 ' HG3' ' C' ' 96' ' ' MET . 35.5 m -110.1 139.85 44.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.289 1.036 . . . . 0.0 110.799 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.27 132.6 21.93 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.901 1.28 . . . . 0.0 111.167 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.82 154.59 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 120.213 1.37 . . . . 0.0 110.936 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.04 -174.7 28.08 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.008 0.813 . . . . 0.0 114.733 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 9.8 p90 -128.16 156.59 42.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.222 1.009 . . . . 0.0 112.272 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -152.6 148.88 27.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.299 1.04 . . . . 0.0 112.249 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.483 HD13 ' HE3' ' B' ' 94' ' ' LYS . 9.5 mt -125.31 122.74 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.424 175.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.9 148.68 38.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 28.3 p -140.35 167.78 21.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.32 123.47 16.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.888 -1.132 . . . . 0.0 113.016 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.71 168.05 5.27 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.57 6.38 5.4 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 72.8 p -94.49 104.18 16.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.743 1.617 . . . . 0.0 108.928 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -79.34 -177.07 5.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.695 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 66.51 4.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.626 1.171 . . . . 0.0 108.51 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . 0.403 3.6 pm0 . . . . . 0 C--O 1.248 0.979 0 C-N-CA 130.403 3.481 . . . . 0.0 113.476 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 116.757 -1.592 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.7 38.28 5.61 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 173.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . 0.273 15.4 m 45.02 19.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.32 85.09 0.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.827 1.651 . . . . 0.0 112.428 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -158.59 55.73 0.44 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.908 1.283 . . . . 0.0 111.782 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -156.75 123.44 5.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 45.3 t -132.08 143.63 50.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.828 0.851 . . . . 0.0 111.874 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 135.4 32.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.674 1.99 . . . . 0.0 109.216 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.2 mt -73.41 -24.7 60.31 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.605 1.548 . . . . 0.0 114.283 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -50.79 117.36 2.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.712 1.205 . . . . 0.0 111.237 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.98 -126.38 3.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.239 1.399 . . . . 0.0 110.295 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -147.02 143.42 28.38 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -141.43 158.58 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.682 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -139.07 148.8 43.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -113.46 161.03 17.82 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.909 1.338 . . . . 0.0 114.499 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -57.69 -25.57 60.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.494 2.718 . . . . 0.0 114.899 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.06 -11.02 59.75 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 111.759 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.23 -16.27 53.51 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.945 2.212 . . . . 0.0 112.943 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -69.29 154.58 41.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.598 1.189 . . . . 0.0 111.592 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.1 150.74 50.36 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.613 -1.305 . . . . 0.0 110.558 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.62 145.4 48.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.362 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -129.66 134.06 47.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.52 124.14 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.95 -74.75 0.48 Allowed Glycine 0 CA--C 1.528 0.866 0 O-C-N 124.26 0.975 . . . . 0.0 111.461 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.42 43.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.943 -0.74 . . . . 0.0 111.989 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.52 130.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.192 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -77.13 168.51 19.96 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.877 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 60.2 p -56.64 -26.99 57.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.12 -29.95 60.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.976 0.807 . . . . 0.0 112.395 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.83 -7.87 19.46 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 124.585 1.088 . . . . 0.0 114.339 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.47 148.12 49.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.599 2.36 . . . . 0.0 113.132 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.93 161.51 39.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.982 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -118.83 172.67 7.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.3 -167.58 35.84 Favored Glycine 0 N--CA 1.469 0.848 0 O-C-N 119.334 -2.104 . . . . 0.0 114.409 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 6.3 p -138.57 129.6 26.85 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.756 1.265 . . . . 0.0 112.446 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -112.05 137.64 49.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.302 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -127.31 127.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.261 90.3 m -105.03 134.46 48.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.842 1.257 . . . . 0.0 112.699 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.87 -15.73 26.07 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.88 146.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 161.19 42.71 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.795 -1.19 . . . . 0.0 111.566 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.51 -29.38 56.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.538 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -142.66 79.15 15.37 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.386 2.275 . . . . 0.0 110.377 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.28 21.04 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.386 1 C-N-CA 125.464 4.109 . . . . 0.0 117.356 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.24 -7.56 5.45 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.52 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.139 1.776 . . . . 0.0 111.439 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.12 126.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.418 -1.426 . . . . 0.0 111.379 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.4 164.67 30.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.614 1.565 . . . . 0.0 110.412 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 tp -46.55 115.38 1.02 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 129.06 2.944 . . . . 0.0 110.545 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -102.96 119.06 56.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.547 0.739 . . . . 0.0 109.399 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.97 141.06 86.68 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.157 2.571 . . . . 0.0 111.278 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pp -129.57 162.29 28.56 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.045 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 tp -165.36 148.82 8.19 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.991 1.717 . . . . 0.0 112.243 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.87 25.96 Favored Glycine 0 N--CA 1.448 -0.544 0 O-C-N 119.795 -1.816 . . . . 0.0 110.606 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mt -145.49 142.25 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.838 0.964 . . . . 0.0 111.739 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 135.32 44.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.155 1.382 . . . . 0.0 114.384 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.88 149.58 47.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.482 1.134 . . . . 0.0 112.373 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -148.72 25.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.577 1.951 . . . . 0.0 110.065 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.88 -56.44 2.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.599 1.56 . . . . 0.0 110.347 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 173.92 8.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.773 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 3.9 p -92.25 -19.14 22.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.87 1.268 . . . . 0.0 113.674 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -133.61 46.31 1.98 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.924 1.29 . . . . 0.0 112.682 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.75 170.64 19.56 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.023 2.482 . . . . 0.0 116.19 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.492 ' HG1' ' HB3' ' B' ' 100' ' ' ARG 0.292 0.0 OUTLIER -97.07 162.59 13.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 123.751 1.738 . . . . 0.0 111.282 173.088 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.55 166.11 33.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.267 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.87 145.71 10.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.95 153.49 18.6 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -89.65 150.99 22.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.765 2.026 . . . . 0.0 110.228 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 78.3 t -130.25 119.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -102.83 101.72 11.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -58.43 129.78 43.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.352 1.548 . . . . 0.0 115.137 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.06 -31.8 16.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.38 -11.98 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 32.4 t -152.4 138.09 17.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.827 2.051 . . . . 0.0 106.213 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -74.25 118.61 17.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.591 1.186 . . . . 0.0 111.253 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.03 159.83 2.68 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.557 1.543 . . . . 0.0 109.543 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -135.98 134.66 38.82 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.386 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.24 138.53 54.61 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.408 0.623 . . . . 0.0 111.497 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.59 155.33 11.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -131.14 143.68 50.82 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.942 0.897 . . . . 0.0 108.77 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.35 118.45 8.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.26 176.64 43.86 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . 0.601 ' NE2' ' H ' ' B' ' 103' ' ' VAL . 0.0 OUTLIER -101.67 150.35 23.2 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.928 1.016 . . . . 0.0 113.517 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 11.6 p -97.52 116.97 30.75 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 125.611 1.819 . . . . 0.0 107.34 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.417 ' CZ ' ' CB ' ' C' ' 82' ' ' GLN . 17.5 m-85 -108.66 156.62 19.35 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.552 1.168 . . . . 0.0 113.604 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 9.7 mt -117.37 110.24 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.174 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -58.69 160.5 5.58 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -24.79 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -9.31 52.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.984 0.914 . . . . 0.0 113.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.18 14.97 49.88 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.673 1.13 . . . . 0.0 115.402 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -82.64 166.29 19.3 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.078 1.439 . . . . 0.0 109.075 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -122.39 145.37 48.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.605 1.548 . . . . 0.0 110.767 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.24 153.09 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.712 1.205 . . . . 0.0 111.106 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.25 103.65 10.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' C' ' 119' ' ' ILE . 0.5 OUTLIER -97.13 112.73 24.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 173.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.68 163.82 27.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.093 1.425 . . . . 0.0 112.383 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.412 ' HG3' HG23 ' B' ' 113' ' ' THR . 93.4 mmm -114.95 168.23 10.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -139.45 163.84 31.45 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.428 1.109 . . . . 0.0 113.376 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.87 124.66 15.06 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.123 175.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tp -107.2 131.95 53.59 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 123.769 1.747 . . . . 0.0 108.841 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.493 ' HB3' ' HG1' ' B' ' 63' ' ' THR . 3.2 tpt85 -114.84 113.57 24.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 110.942 -2.844 . . . . 0.0 109.05 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.19 164.83 19.61 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 116.867 -1.54 . . . . 0.0 111.912 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 88.12 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 121.742 2.065 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . 0.614 ' H ' ' NE2' ' B' ' 82' ' ' GLN . 6.6 p -88.45 155.82 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 129.265 3.026 . . . . 0.0 111.138 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -95.08 -32.77 12.95 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -114.02 149.35 35.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.573 0.701 . . . . 0.0 112.671 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 4.8 tt -62.53 -30.22 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.795 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.65 5.28 38.94 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.598 1.094 . . . . 0.0 115.777 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -123.09 0.08 9.01 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.361 1.581 . . . . 0.0 113.735 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.92 69.17 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.365 -1.459 . . . . 0.0 113.806 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . 0.683 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 62.5 p-90 -49.65 -44.24 47.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.87 0.868 . . . . 0.0 113.214 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . 0.683 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.0 OUTLIER -88.16 -12.6 43.49 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.097 -1.002 . . . . 0.0 113.347 176.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 1.48 18.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.708 0.803 . . . . 0.0 112.577 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' THR . . . . . 0.433 HG23 ' HG3' ' B' ' 96' ' ' MET . 33.9 m -112.68 139.61 48.15 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.436 1.094 . . . . 0.0 111.207 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -144.26 133.01 22.41 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.656 1.183 . . . . 0.0 110.94 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.13 154.79 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.364 1.438 . . . . 0.0 110.897 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.39 -174.29 27.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.908 0.766 . . . . 0.0 114.76 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.41 156.72 42.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.219 1.008 . . . . 0.0 112.294 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -152.23 148.67 27.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 112.298 173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' C' ' 94' ' ' LYS . 9.4 mt -124.94 122.2 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.522 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 148.87 37.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.843 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 45.6 p -138.84 167.43 22.04 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.69 122.54 13.05 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.4 -0.813 . . . . 0.0 111.735 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -79.19 77.87 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 159.21 64.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 129.995 3.318 . . . . 0.0 112.784 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 1.8 p -144.2 161.74 38.11 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.196 -1.565 . . . . 0.0 110.746 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 -159.64 0.98 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.961 1.704 . . . . 0.0 109.193 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -170.39 160.09 7.4 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.153 3.381 . . . . 0.0 110.828 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 . . . . . 0 C--O 1.248 1.018 0 O-C-N 125.368 1.667 . . . . 0.0 108.899 171.573 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.4 m -71.15 55.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.576 1.951 . . . . 0.0 113.868 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 63.2 t 64.44 -47.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 128.236 2.614 . . . . 0.0 115.302 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 22.98 62.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.571 2.748 . . . . 0.0 116.208 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.51 52.66 1.18 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -156.8 144.91 19.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.866 1.266 . . . . 0.0 110.413 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.14 154.67 51.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.72 1.208 . . . . 0.0 108.382 173.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.91 129.92 24.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.009 -1.057 . . . . 0.0 111.597 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.1 -25.17 67.98 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -54.56 120.25 6.41 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 123.355 1.55 . . . . 0.0 112.562 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.9 -110.92 1.04 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.979 2.228 . . . . 0.0 110.242 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -152.99 152.1 31.02 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.73 -0.865 . . . . 0.0 113.271 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -140.16 156.33 46.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.801 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.62 146.64 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.394 177.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -116.72 143.33 45.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 111.238 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.04 -24.99 57.81 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.58 1.552 . . . . 0.0 113.825 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.5 tp -67.31 -15.94 63.98 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 120.735 -1.228 . . . . 0.0 111.821 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.09 -9.46 42.98 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 127.645 2.545 . . . . 0.0 113.242 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.4 147.99 52.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.228 -1.16 . . . . 0.0 111.925 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -126.62 151.42 48.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.198 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.41 147.33 33.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -127.97 134.98 49.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.787 0.835 . . . . 0.0 110.291 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.67 121.01 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.13 -65.17 2.7 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.671 1.232 . . . . 0.0 113.291 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.68 137.71 4.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -84.45 137.67 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.76 163.5 27.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.826 0.451 . . . . 0.0 111.348 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -23.69 50.39 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -27.35 63.79 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.137 -0.977 . . . . 0.0 111.165 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.11 48.78 Favored Glycine 0 C--O 1.224 -0.512 0 CA-C-O 117.577 -1.68 . . . . 0.0 112.958 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -70.99 144.6 50.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.779 1.289 . . . . 0.0 108.547 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -156.03 155.77 33.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.682 0.753 . . . . 0.0 112.307 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.75 158.71 36.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.395 1.878 . . . . 0.0 108.267 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.32 -170.67 34.92 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.97 -1.081 . . . . 0.0 114.747 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.6 p -137.53 126.23 23.84 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -126.52 133.14 51.21 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.05 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -121.48 135.61 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 50.1 m -115.77 131.0 57.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.36 3.86 50.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.34 162.28 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 128.116 2.566 . . . . 0.0 108.444 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.46 10.51 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.893 -1.754 . . . . 0.0 111.842 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.64 -24.69 61.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.287 0.235 . . . . 0.0 110.603 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.35 84.01 4.43 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 175.95 8.72 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.815 3.01 . . . . 0.0 112.905 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.51 -33.03 2.83 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.738 1.161 . . . . 0.0 111.981 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -132.77 20.71 4.2 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.4 mt -54.16 127.87 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 122.025 0.916 . . . . 0.0 109.233 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.0 177.12 8.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.655 1.982 . . . . 0.0 107.538 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.0 146.1 3.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.185 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -124.55 113.17 27.43 Favored Pre-proline 0 N--CA 1.426 -1.629 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.674 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.75 134.63 65.69 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.237 1.958 . . . . 0.0 109.668 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.32 151.26 46.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.429 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.3 149.13 37.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.853 2.461 . . . . 0.0 108.012 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.2 -160.79 34.57 Favored Glycine 0 N--CA 1.452 -0.267 0 O-C-N 120.75 -1.219 . . . . 0.0 111.019 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mt -144.58 145.57 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 111.942 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.474 HE22 ' HB2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.662 -1.274 . . . . 0.0 113.108 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -86.81 141.85 28.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.654 1.216 . . . . 0.0 111.191 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HB2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -139.52 29.64 2.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.029 1.332 . . . . 0.0 112.138 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -93.06 -55.05 3.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.644 2.377 . . . . 0.0 111.405 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -179.9 5.9 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -81.77 -39.27 24.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.192 1.397 . . . . 0.0 112.888 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -132.61 46.4 2.13 Favored Pre-proline 0 CA--C 1.568 1.636 0 O-C-N 125.416 1.698 . . . . 0.0 111.473 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.55 177.02 5.84 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.359 2.039 . . . . 0.0 114.676 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.326 0.1 OUTLIER -100.95 169.62 8.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 122.54 1.162 . . . . 0.0 111.603 174.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -162.63 164.18 26.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.393 -173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.39 147.78 13.73 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.836 2.294 . . . . 0.0 118.836 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -161.0 150.5 17.0 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -89.1 147.84 24.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.906 1.682 . . . . 0.0 108.21 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.8 t -129.21 119.72 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -102.87 102.05 12.13 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.372 -173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -69.18 125.36 26.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 121.249 1.84 . . . . 0.0 115.684 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -81.3 -37.35 28.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.435 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.08 -22.29 36.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.603 1.161 . . . . 0.0 113.65 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.43 124.07 7.84 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.59 1.556 . . . . 0.0 108.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -60.78 115.27 3.54 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.595 1.089 . . . . 0.0 111.722 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 p -172.52 158.78 4.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.974 2.109 . . . . 0.0 110.03 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -143.47 142.5 31.2 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-O 123.175 1.464 . . . . 0.0 110.427 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.443 ' HG1' ' CD1' ' A' ' 99' ' ' LEU . 3.1 m -141.8 128.74 20.67 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 109.965 -3.289 . . . . 0.0 109.838 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.54 154.05 6.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.773 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -128.99 141.66 51.18 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.82 118.25 5.66 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.36 -175.44 34.34 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.658 -1.258 . . . . 0.0 115.388 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -126.97 147.2 50.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.235 1.017 . . . . 0.0 112.196 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.41 127.25 43.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.44 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 166.34 13.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.531 0.681 . . . . 0.0 112.461 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.6 mt -127.33 109.03 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.552 -1.658 . . . . 0.0 107.098 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.97 162.34 4.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.392 0.677 . . . . 0.0 110.162 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.42 -32.3 1.32 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.32 -21.09 53.99 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.88 19.98 11.25 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.851 1.215 . . . . 0.0 114.572 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -90.66 153.24 20.44 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.1 1.36 . . . . 0.0 111.559 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.14 134.92 43.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.634 1.574 . . . . 0.0 110.257 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.16 160.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 122.13 0.967 . . . . 0.0 108.819 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.1 mt -124.15 119.06 28.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -106.59 117.77 34.93 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.3 167.27 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.974 1.369 . . . . 0.0 112.554 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -119.36 170.49 9.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -140.55 159.06 43.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.446 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -134.38 121.98 21.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.406 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.443 ' CD1' ' HG1' ' A' ' 77' ' ' THR 0.254 0.5 OUTLIER -107.46 135.89 48.18 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 124.961 1.413 . . . . 0.0 112.055 -176.415 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.98 113.9 23.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 111.857 -2.429 . . . . 0.0 110.167 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -69.82 166.8 18.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.384 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -112.41 85.44 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.44 -161.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.33 -13.64 1.02 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.709 -1.869 . . . . 0.0 114.281 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.06 151.1 49.06 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.298 1.047 . . . . 0.0 111.931 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.9 tt -59.27 -25.49 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.117 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.65 -1.87 19.05 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.193 1.378 . . . . 0.0 114.761 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.0 7.11 6.6 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.138 0.969 . . . . 0.0 112.346 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.57 -32.14 73.66 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 119.443 -2.036 . . . . 0.0 112.866 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -47.67 -40.82 20.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.789 1.235 . . . . 0.0 114.036 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -95.19 -11.61 27.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.403 1.081 . . . . 0.0 113.503 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.17 -0.8 20.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.975 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.61 143.72 42.02 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.432 1.11 . . . . 0.0 111.056 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -142.06 153.78 44.45 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.471 1.509 . . . . 0.0 109.572 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.98 151.19 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.395 1.078 . . . . 0.0 109.903 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.44 -176.69 29.77 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 121.453 0.474 . . . . 0.0 112.104 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 33.6 p90 -124.92 152.03 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.507 0.723 . . . . 0.0 109.98 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -144.53 152.41 40.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.938 0.875 . . . . 0.0 109.301 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt -128.92 135.13 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.93 148.07 45.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -132.01 158.64 40.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.099 0.96 . . . . 0.0 110.655 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.05 118.8 6.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.646 0.779 . . . . 0.0 111.641 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.55 78.19 4.07 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.771 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.67 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.8 m 65.65 116.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.873 2.069 . . . . 0.0 109.239 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -148.51 -94.65 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.88 -163.77 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.69 1.996 . . . . 0.0 109.724 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 . . . . . 0 C--O 1.253 1.277 0 CA-C-O 116.962 -1.494 . . . . 0.0 110.291 174.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.6 m 45.15 47.03 9.93 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.85 122.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.495 -1.378 . . . . 0.0 111.006 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -115.6 7.73 14.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.023 1.329 . . . . 0.0 113.658 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER 38.18 71.61 0.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 128.039 2.536 . . . . 0.0 113.439 -175.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -145.01 141.28 28.79 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.112 0.965 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -143.67 143.54 31.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.633 1.973 . . . . 0.0 107.8 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.83 128.78 23.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.59 -1.319 . . . . 0.0 112.269 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.4 -25.59 68.35 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -53.0 119.27 4.47 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.204 1.478 . . . . 0.0 112.459 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.82 -110.69 1.02 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.841 2.162 . . . . 0.0 110.865 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -152.59 151.86 31.14 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -141.33 158.76 43.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.709 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -133.86 149.04 51.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.57 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -116.19 143.33 45.65 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.904 0.881 . . . . 0.0 110.737 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -58.74 -23.16 59.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.015 1.326 . . . . 0.0 113.475 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.85 -15.94 63.86 Favored 'General case' 0 CA--C 1.555 1.16 0 O-C-N 120.543 -1.348 . . . . 0.0 111.398 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.34 -9.38 42.02 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.65 2.548 . . . . 0.0 113.372 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -66.42 148.25 52.14 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 121.213 -1.169 . . . . 0.0 111.792 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -127.02 151.16 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.196 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 147.35 33.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -127.53 135.96 51.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.761 0.824 . . . . 0.0 109.947 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.68 119.96 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.68 -64.39 3.34 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.58 1.175 . . . . 0.0 113.25 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.56 141.36 4.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.213 1.405 . . . . 0.0 110.214 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.17 136.36 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 122.505 0.322 . . . . 0.0 110.239 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.45 163.59 27.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.275 0.63 . . . . 0.0 111.186 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -21.98 54.05 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -25.45 62.37 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.161 -0.962 . . . . 0.0 111.221 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.89 51.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.248 1.404 . . . . 0.0 113.247 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 150.76 44.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.017 0.927 . . . . 0.0 110.42 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.52 166.34 33.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.347 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.28 160.82 36.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.444 1.898 . . . . 0.0 106.775 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.44 -170.78 35.91 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.418 -1.426 . . . . 0.0 114.599 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 35.2 p -138.22 126.62 23.21 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.408 0.623 . . . . 0.0 109.341 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -126.96 133.42 50.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.935 -172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.46 136.28 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 43.4 m -116.77 130.24 56.6 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 3.24 53.63 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.44 162.22 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 128.085 2.554 . . . . 0.0 108.141 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.38 10.2 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.015 -1.678 . . . . 0.0 111.738 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.52 -24.05 61.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.311 0.244 . . . . 0.0 110.652 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -154.14 83.43 4.21 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 127.277 2.231 . . . . 0.0 109.254 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.69 176.04 8.74 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.553 2.835 . . . . 0.0 112.805 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.02 -33.21 2.86 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.765 1.174 . . . . 0.0 112.33 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -132.59 20.62 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.93 1.292 . . . . 0.0 112.403 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -54.18 127.7 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.236 1.017 . . . . 0.0 109.247 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.01 177.21 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.49 1.916 . . . . 0.0 107.273 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.99 146.65 3.23 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.218 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -125.0 112.98 26.72 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 112.118 -2.31 . . . . 0.0 110.506 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -56.09 132.52 52.45 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.17 1.914 . . . . 0.0 109.263 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.32 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.274 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.42 149.22 31.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.866 2.466 . . . . 0.0 108.066 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.66 -160.24 32.58 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 121.287 -0.883 . . . . 0.0 112.781 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -144.94 145.06 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.384 1.074 . . . . 0.0 112.374 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . 0.511 HE22 ' HB2' ' D' ' 57' ' ' LYS . 0.3 OUTLIER -132.01 150.97 52.01 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.626 -1.296 . . . . 0.0 112.843 175.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.38 141.66 28.47 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.696 0.76 . . . . 0.0 110.399 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . 0.511 ' HB2' HE22 ' D' ' 53' ' ' GLN . 1.0 OUTLIER -138.96 29.84 2.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.983 1.313 . . . . 0.0 112.517 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -92.93 -55.21 3.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.01 2.524 . . . . 0.0 111.399 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -78.95 -39.78 33.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.821 1.648 . . . . 0.0 113.037 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.34 50.14 4.7 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 125.244 1.417 . . . . 0.0 111.429 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 176.78 6.39 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.351 2.7 . . . . 0.0 115.223 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -102.23 168.79 9.13 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.732 1.253 . . . . 0.0 111.435 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -162.22 163.48 28.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.881 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.18 148.05 14.85 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 118.646 2.218 . . . . 0.0 118.646 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -161.63 149.86 15.3 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.93 149.09 23.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.259 1.823 . . . . 0.0 108.238 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.62 121.47 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -104.88 102.31 11.85 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.988 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -68.92 124.47 23.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -80.14 -36.81 34.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.623 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -82.6 -22.01 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 113.591 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 35.2 t -152.55 124.63 8.04 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.544 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -60.86 115.44 3.69 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.897 1.226 . . . . 0.0 111.509 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 9.4 p -172.74 158.94 4.14 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.129 2.172 . . . . 0.0 110.125 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -143.62 142.42 31.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 123.036 1.398 . . . . 0.0 110.296 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' THR . . . . . 0.437 ' HG1' ' CD1' ' D' ' 99' ' ' LEU . 3.0 m -141.8 128.54 20.42 Favored 'General case' 0 N--CA 1.402 -2.825 0 CA-C-N 110.173 -3.194 . . . . 0.0 109.971 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.95 154.41 5.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.773 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -129.65 141.35 50.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.58 118.22 5.74 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.95 -175.25 34.66 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.49 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -127.61 144.91 51.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.704 0.885 . . . . 0.0 112.421 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 36.8 t -97.81 123.63 41.85 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.623 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -115.69 167.26 11.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 118.45 0.568 . . . . 0.0 111.692 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 30.6 mt -126.21 107.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 O-C-N 125.293 1.62 . . . . 0.0 106.741 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -58.99 160.56 5.86 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -44.22 -31.74 1.08 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 118.193 2.664 . . . . 0.0 118.193 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -76.3 -21.94 55.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.26 1.85 29.67 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.111 1.339 . . . . 0.0 115.592 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -74.09 153.66 39.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.257 1.423 . . . . 0.0 112.578 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.38 135.44 42.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.265 1.826 . . . . 0.0 109.964 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 20.6 m -141.97 160.08 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.029 0.931 . . . . 0.0 109.663 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -122.69 118.64 28.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -106.76 117.74 34.84 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 167.95 20.41 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.05 1.405 . . . . 0.0 112.69 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -120.06 170.57 9.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 p-90 -140.57 159.51 42.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.561 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.93 121.86 21.12 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.526 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . 0.437 ' CD1' ' HG1' ' D' ' 77' ' ' THR . 0.5 OUTLIER -107.37 136.01 47.89 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 125.061 1.476 . . . . 0.0 111.767 -176.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -117.12 113.82 22.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.288 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 71.3 m -69.55 167.04 17.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.404 174.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 2.0 p -112.37 86.11 2.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.99 -160.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -140.36 -13.19 1.03 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 119.561 -1.962 . . . . 0.0 114.093 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.57 152.13 48.66 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.565 1.174 . . . . 0.0 112.356 174.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.82 -24.87 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.982 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.93 -1.13 23.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.245 1.402 . . . . 0.0 114.935 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -127.12 6.34 6.49 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.119 0.968 . . . . 0.0 111.916 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.16 -31.79 73.15 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 119.327 -2.108 . . . . 0.0 113.067 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -47.33 -41.61 19.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.343 1.057 . . . . 0.0 113.768 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -94.89 -11.47 28.65 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.403 1.081 . . . . 0.0 113.131 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.02 -1.13 21.35 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.311 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -111.21 143.8 41.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.318 1.056 . . . . 0.0 111.129 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -142.16 153.65 44.23 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.328 1.451 . . . . 0.0 109.486 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.88 151.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.464 1.106 . . . . 0.0 109.724 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.59 -177.23 30.5 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.505 0.503 . . . . 0.0 112.169 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 32.7 p90 -124.28 152.21 43.3 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.901 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -145.16 151.6 38.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.554 0.742 . . . . 0.0 109.46 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 59.7 mt -128.47 136.03 61.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -123.98 148.5 46.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.667 0.387 . . . . 0.0 111.061 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 12.7 p -132.24 161.63 32.96 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.694 1.198 . . . . 0.0 111.176 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -61.51 122.26 14.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.056 0.943 . . . . 0.0 111.784 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 118.54 24.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.282 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.83 59.79 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 76.8 p -70.07 169.63 13.05 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.876 -1.14 . . . . 0.0 112.923 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -152.34 -44.56 0.1 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.198 2.199 . . . . 0.0 109.108 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.22 116.77 22.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.496 1.518 . . . . 0.0 107.868 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.247 0.948 0 C-N-CA 129.08 2.952 . . . . 0.0 108.634 -175.462 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.5 p -110.19 94.16 4.87 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.079 1.352 . . . . 0.0 110.42 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 13.9 p -53.2 -18.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.144 1.778 . . . . 0.0 115.641 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . 60.14 -168.64 0.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.71 1.204 . . . . 0.0 112.523 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . 0.259 22.2 ptt180 167.81 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 128.425 2.69 . . . . 0.0 113.559 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -154.3 141.68 19.64 Favored 'General case' 0 CA--C 1.513 -0.461 0 O-C-N 121.136 -0.977 . . . . 0.0 109.144 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p -143.11 144.21 32.14 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 124.967 1.417 . . . . 0.0 108.529 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.73 127.72 22.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.566 -0.709 . . . . 0.0 112.569 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.85 -25.3 67.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.61 119.49 5.36 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 123.042 1.401 . . . . 0.0 111.984 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.35 -111.2 1.06 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.01 2.243 . . . . 0.0 110.447 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -153.65 152.56 30.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.34 158.18 43.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.884 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.1 146.88 45.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.683 1.193 . . . . 0.0 108.35 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -116.28 143.33 45.66 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 111.188 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -57.8 -24.15 55.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.204 1.401 . . . . 0.0 113.645 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.18 -15.59 63.64 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.644 -1.285 . . . . 0.0 111.735 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.42 43.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.732 2.587 . . . . 0.0 113.418 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.61 147.7 52.92 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.196 -1.179 . . . . 0.0 111.633 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -127.1 152.01 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.12 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.96 147.38 33.86 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -126.89 135.39 50.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.99 120.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.23 -64.85 3.02 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.662 1.226 . . . . 0.0 113.201 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.51 139.8 3.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.241 1.416 . . . . 0.0 110.163 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -86.3 137.36 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.403 0.281 . . . . 0.0 110.576 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.26 163.37 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.678 0.391 . . . . 0.0 111.246 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -23.83 50.11 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -27.11 63.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.3 -0.875 . . . . 0.0 111.285 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.84 -2.12 48.5 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.218 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.18 144.51 51.93 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.524 1.162 . . . . 0.0 108.542 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.79 156.12 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 112.157 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.5 158.33 38.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.341 1.856 . . . . 0.0 108.201 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.33 -170.5 34.73 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 120.973 -1.079 . . . . 0.0 114.758 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 35.9 p -137.19 126.51 24.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.065 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -126.74 133.31 50.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.72 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.41 136.24 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 42.7 m -116.39 130.54 56.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.29 2.7 53.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.302 1.049 . . . . 0.0 113.828 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.09 161.66 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.348 2.259 . . . . 0.0 108.373 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.61 166.67 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 119.971 -1.706 . . . . 0.0 111.909 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.0 -24.65 62.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 122.461 -0.149 . . . . 0.0 110.674 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.3 83.73 4.51 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.152 2.181 . . . . 0.0 109.22 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.54 175.92 8.82 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.842 3.028 . . . . 0.0 112.9 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.41 -33.21 2.81 Favored Glycine 0 N--CA 1.476 1.324 0 C-N-CA 124.715 1.15 . . . . 0.0 112.219 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -132.62 20.75 4.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.005 1.322 . . . . 0.0 112.359 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.25 127.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.08 0.943 . . . . 0.0 109.141 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.19 176.46 8.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.758 2.023 . . . . 0.0 107.57 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.49 146.3 3.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.258 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -125.02 113.26 26.62 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 112.07 -2.332 . . . . 0.0 110.57 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -56.4 134.68 65.79 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.135 1.89 . . . . 0.0 109.65 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.04 151.22 45.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.486 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.32 149.19 37.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.821 2.449 . . . . 0.0 107.839 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 -161.28 35.11 Favored Glycine 0 N--CA 1.451 -0.326 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mt -144.56 144.91 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.961 0.904 . . . . 0.0 111.799 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' B' ' 57' ' ' LYS . 0.1 OUTLIER -133.18 148.26 52.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.301 1.04 . . . . 0.0 113.323 175.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -84.65 141.31 30.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.099 0.952 . . . . 0.0 111.069 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.496 ' HB2' HE22 ' B' ' 53' ' ' GLN . 0.9 OUTLIER -139.05 30.72 2.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.95 1.3 . . . . 0.0 112.222 178.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -93.33 -55.38 3.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.94 2.496 . . . . 0.0 111.72 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.97 179.51 6.17 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.0 m -82.98 -35.53 25.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.842 1.257 . . . . 0.0 113.264 174.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -135.04 49.01 3.29 Favored Pre-proline 0 CA--C 1.562 1.434 0 O-C-N 125.377 1.673 . . . . 0.0 111.4 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.44 177.5 5.98 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.079 2.52 . . . . 0.0 115.272 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.347 0.1 OUTLIER -102.13 168.06 9.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.027 1.394 . . . . 0.0 111.749 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -161.41 163.03 30.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.84 -173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.66 147.26 13.02 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 118.81 2.284 . . . . 0.0 118.81 -173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.9 m -89.28 147.95 23.83 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.066 1.746 . . . . 0.0 108.338 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.34 119.8 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -102.67 102.09 12.26 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.352 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -69.07 125.64 27.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.278 1.854 . . . . 0.0 115.707 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.36 -37.46 28.21 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.514 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.83 -22.14 37.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.516 1.127 . . . . 0.0 113.647 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -152.42 124.79 8.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.722 1.609 . . . . 0.0 108.699 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.97 116.29 4.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.803 1.183 . . . . 0.0 111.173 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 9.2 p -173.01 158.79 3.83 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.059 2.143 . . . . 0.0 109.856 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -143.36 142.6 31.34 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-O 123.117 1.437 . . . . 0.0 110.531 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' THR . . . . . 0.443 ' HG1' ' CD1' ' B' ' 99' ' ' LEU . 3.0 m -142.12 128.46 19.97 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 110.084 -3.234 . . . . 0.0 109.927 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.33 153.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.741 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.11 142.29 50.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.29 118.61 5.59 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.72 -176.75 35.11 Favored Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -127.68 143.22 51.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.36 0.682 . . . . 0.0 112.169 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.52 124.84 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.07 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -116.01 168.27 10.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.239 1.019 . . . . 0.0 111.794 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.2 mt -124.79 109.54 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.286 174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -58.62 157.33 9.36 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -42.31 -30.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.91 -19.38 54.79 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.81 8.57 27.88 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 125.073 1.32 . . . . 0.0 115.583 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -87.48 152.94 21.82 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.931 1.366 . . . . 0.0 112.585 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -100.96 134.83 43.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.565 1.546 . . . . 0.0 110.016 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 m -144.14 145.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 38.0 mt -118.89 92.42 3.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.47 1.129 . . . . 0.0 111.227 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -83.4 113.13 20.53 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.074 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 4.8 p -135.29 168.48 19.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.559 1.647 . . . . 0.0 112.801 -174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -120.12 170.44 9.3 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 124.608 1.163 . . . . 0.0 107.901 172.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -141.11 159.05 43.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.427 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -134.41 122.15 22.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.404 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.443 ' CD1' ' HG1' ' B' ' 77' ' ' THR 0.262 0.4 OUTLIER -107.53 134.64 50.25 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 125.047 1.467 . . . . 0.0 112.216 -176.098 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -115.55 114.06 24.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 112.001 -2.363 . . . . 0.0 110.048 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.259 72.9 m -70.09 167.97 16.56 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.266 1.604 . . . . 0.0 111.465 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -113.29 85.38 2.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 -160.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -140.52 -13.21 1.0 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 119.569 -1.957 . . . . 0.0 114.223 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.17 151.17 49.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.509 1.147 . . . . 0.0 112.003 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 2.2 tt -58.57 -25.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.407 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.64 -2.36 28.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.038 1.304 . . . . 0.0 114.626 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.33 5.87 7.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.214 1.006 . . . . 0.0 112.137 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.5 -32.12 73.63 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 119.55 -1.969 . . . . 0.0 112.668 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -48.0 -41.25 24.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.726 1.21 . . . . 0.0 113.718 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -94.37 -11.43 29.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.349 1.059 . . . . 0.0 113.494 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.1 -0.91 20.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.105 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -111.6 143.65 42.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.168 0.985 . . . . 0.0 111.244 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -142.38 153.48 43.82 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.316 1.446 . . . . 0.0 109.524 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.26 150.64 33.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.689 1.131 . . . . 0.0 109.517 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.99 -177.02 29.71 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.375 0.512 . . . . 0.0 112.184 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 34.9 p90 -124.42 151.77 44.09 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -144.17 151.22 39.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.998 0.904 . . . . 0.0 109.22 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.19 134.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -122.25 149.83 43.15 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.042 0.448 . . . . 0.0 111.038 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 5.3 p -130.86 159.82 36.24 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.94 1.296 . . . . 0.0 110.647 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -58.69 123.81 17.62 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.5 0.72 . . . . 0.0 111.495 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.4 102.86 4.56 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.561 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.83 104.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.128 2.171 . . . . 0.0 113.405 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.93 169.93 15.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.42 -174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -149.87 66.79 0.98 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.263 3.025 . . . . 0.0 105.111 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.76 93.74 2.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 129.412 3.085 . . . . 0.0 110.029 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.261 1.702 0 C-N-CA 129.697 3.199 . . . . 0.0 107.595 174.306 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.7 p -149.85 -64.97 0.21 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.454 1.502 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 m -158.29 154.79 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.51 2.324 . . . . 0.0 109.645 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -71.13 153.18 42.73 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.628 0.728 . . . . 0.0 109.9 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -158.0 29.75 0.26 Allowed 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.742 -1.224 . . . . 0.0 113.766 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -156.55 151.08 25.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.982 1.313 . . . . 0.0 107.591 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 26.6 p -148.37 145.02 27.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.595 1.184 . . . . 0.0 109.788 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.74 127.92 22.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.53 -25.64 68.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.34 118.39 4.07 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.863 1.316 . . . . 0.0 112.08 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.55 -112.17 1.17 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.955 2.217 . . . . 0.0 110.667 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -150.58 151.77 33.09 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -142.0 157.44 44.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.577 -2.101 . . . . 0.0 111.226 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 147.95 50.58 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -115.87 143.41 45.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.929 0.892 . . . . 0.0 110.879 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.1 -24.21 52.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.332 1.453 . . . . 0.0 113.638 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.85 -15.07 63.45 Favored 'General case' 0 CA--C 1.556 1.182 0 O-C-N 120.773 -1.204 . . . . 0.0 111.819 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.39 -9.35 45.37 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.723 2.582 . . . . 0.0 113.324 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -66.62 147.02 53.85 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.202 -1.175 . . . . 0.0 111.618 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -126.52 152.04 47.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.8 147.41 34.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -127.39 135.85 51.05 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.842 0.857 . . . . 0.0 110.22 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -128.31 119.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.51 -63.99 3.75 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.605 1.191 . . . . 0.0 113.308 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.23 143.16 4.22 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.51 1.524 . . . . 0.0 110.265 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.93 135.66 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.735 0.414 . . . . 0.0 110.274 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.7 163.38 28.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.337 0.655 . . . . 0.0 111.287 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -22.02 53.68 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -25.56 62.29 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.23 -0.919 . . . . 0.0 111.253 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.59 51.4 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.273 1.416 . . . . 0.0 113.225 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.1 150.37 43.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 110.333 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.14 166.32 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.795 0.807 . . . . 0.0 111.122 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.49 160.72 37.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.529 1.932 . . . . 0.0 106.844 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.64 -170.9 36.2 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.327 -1.483 . . . . 0.0 114.822 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -137.61 126.63 24.27 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.565 0.698 . . . . 0.0 109.383 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -126.73 133.45 50.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.466 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.49 136.29 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -116.92 130.55 56.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.14 5.08 50.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.2 161.25 17.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.149 2.179 . . . . 0.0 108.261 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.31 166.96 12.34 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.786 -1.821 . . . . 0.0 111.757 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.78 -23.72 61.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.162 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -153.41 84.08 4.39 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 127.211 2.205 . . . . 0.0 109.373 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.69 176.02 8.77 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.557 2.838 . . . . 0.0 112.805 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.04 -33.14 2.87 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.776 1.179 . . . . 0.0 112.284 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -132.64 20.57 4.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.026 1.33 . . . . 0.0 112.328 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 44.8 mt -54.11 127.82 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.249 1.023 . . . . 0.0 109.234 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.13 177.24 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.486 1.914 . . . . 0.0 107.296 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.0 146.82 3.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.118 172.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -125.23 113.08 26.13 Favored Pre-proline 0 N--CA 1.426 -1.651 0 CA-C-N 112.042 -2.345 . . . . 0.0 110.398 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -56.01 132.25 50.84 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.03 1.82 . . . . 0.0 109.223 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.65 154.93 36.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.323 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.6 149.23 31.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.827 2.451 . . . . 0.0 108.142 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.72 -160.04 32.41 Favored Glycine 0 CA--C 1.517 0.186 0 O-C-N 121.383 -0.823 . . . . 0.0 112.71 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.36 144.95 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.319 1.047 . . . . 0.0 112.149 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' C' ' 57' ' ' LYS . 0.4 OUTLIER -131.87 152.04 51.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.857 1.263 . . . . 0.0 112.909 175.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -88.93 140.87 29.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.05 0.929 . . . . 0.0 111.038 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . 0.499 ' HB2' HE22 ' C' ' 53' ' ' GLN . 0.9 OUTLIER -138.17 30.15 2.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.735 1.214 . . . . 0.0 112.237 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -93.37 -55.48 3.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.98 2.512 . . . . 0.0 111.714 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -179.76 5.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -83.94 -35.76 23.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.671 1.188 . . . . 0.0 112.95 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -134.34 48.06 2.87 Favored Pre-proline 0 CA--C 1.564 1.49 0 O-C-N 125.388 1.68 . . . . 0.0 111.823 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.09 176.42 6.28 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.148 2.565 . . . . 0.0 115.518 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.337 0.2 OUTLIER -101.05 169.91 8.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.674 1.226 . . . . 0.0 111.414 174.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.86 163.31 26.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.733 -173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 147.88 14.19 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -161.66 149.81 15.2 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.58 149.21 23.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.245 1.818 . . . . 0.0 108.221 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.63 121.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -104.32 102.19 11.88 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.198 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -68.44 124.35 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.854 1.661 . . . . 0.0 115.427 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -80.07 -37.55 33.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.641 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.78 -22.23 37.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 113.692 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.6 t -152.51 124.61 8.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.75 1.62 . . . . 0.0 108.66 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.68 116.52 4.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.587 1.085 . . . . 0.0 111.132 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 8.6 p -173.29 158.36 3.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.15 2.18 . . . . 0.0 110.02 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -142.69 142.01 31.93 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-O 123.181 1.467 . . . . 0.0 110.488 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' THR . . . . . 0.443 ' HG1' ' CD1' ' C' ' 99' ' ' LEU . 3.1 m -141.86 128.05 19.76 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 110.015 -3.266 . . . . 0.0 110.091 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.66 154.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.785 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.47 141.99 50.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.27 118.69 5.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.07 -176.12 34.78 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -128.9 143.1 50.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 124.484 0.755 . . . . 0.0 112.319 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.56 122.69 40.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.527 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.0 167.81 10.34 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.551 0.691 . . . . 0.0 111.638 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.71 108.34 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.082 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.56 160.93 4.98 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.05 -31.09 0.84 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -79.99 -15.08 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.03 5.6 40.72 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.884 1.23 . . . . 0.0 115.682 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 152.63 28.53 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.017 1.408 . . . . 0.0 112.543 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -100.72 135.96 41.33 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.496 1.518 . . . . 0.0 109.131 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.56 147.36 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.265 1.026 . . . . 0.0 111.36 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 40.7 mt -119.97 92.38 3.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.682 1.23 . . . . 0.0 111.772 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -83.59 112.57 20.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.903 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.5 p -134.36 168.95 17.98 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.607 1.194 . . . . 0.0 112.831 -174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -120.94 170.7 9.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 38.9 p-90 -140.53 159.83 41.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.385 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 tp -135.16 122.1 21.19 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.474 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . 0.443 ' CD1' ' HG1' ' C' ' 77' ' ' THR . 0.4 OUTLIER -107.43 134.98 49.68 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.927 1.392 . . . . 0.0 111.863 -176.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.16 114.09 23.98 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 111.974 -2.375 . . . . 0.0 110.078 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 71.4 m -69.74 168.09 15.74 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 125.299 1.624 . . . . 0.0 111.681 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -112.94 85.64 2.21 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.53 -160.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -141.45 -11.61 0.92 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 119.518 -1.989 . . . . 0.0 114.406 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.46 150.47 50.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.284 1.04 . . . . 0.0 111.723 174.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 2.2 tt -58.13 -25.44 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.4 -2.81 28.97 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.97 1.272 . . . . 0.0 114.611 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.42 6.17 7.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.164 0.986 . . . . 0.0 112.309 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.47 -32.69 74.2 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.757 -1.84 . . . . 0.0 112.741 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -48.28 -41.77 28.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.684 1.194 . . . . 0.0 113.697 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -93.93 -11.67 30.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.242 1.017 . . . . 0.0 113.329 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.61 -1.23 20.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.077 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.35 143.71 41.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.002 0.906 . . . . 0.0 111.373 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -142.56 153.33 43.45 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.463 1.505 . . . . 0.0 109.504 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.04 151.1 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 109.358 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.03 -177.77 30.47 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 121.813 0.674 . . . . 0.0 112.244 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 34.8 p90 -123.84 151.33 43.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.4 0.68 . . . . 0.0 109.419 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -144.18 151.4 39.46 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.995 0.902 . . . . 0.0 108.83 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.67 133.71 67.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -120.81 149.71 42.14 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.134 0.492 . . . . 0.0 111.093 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 33.2 p -134.6 163.48 29.64 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 110.907 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.48 123.76 20.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.062 0.945 . . . . 0.0 113.132 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.84 81.84 8.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 64.46 106.15 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.999 2.12 . . . . 0.0 112.909 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -135.44 -173.26 3.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.709 1.604 . . . . 0.0 111.005 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.87 152.93 11.79 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.417 1.103 . . . . 0.0 109.516 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' C' ' 128' ' ' GLU . 0.9 OUTLIER -111.48 10.26 21.35 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 129.271 3.028 . . . . 0.0 111.408 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.401 ' O ' ' NZ ' ' C' ' 127' ' ' LYS 0.407 4.6 pt-20 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 128.784 2.834 . . . . 0.0 113.648 -173.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . 0.272 6.9 pm0 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 116.756 -1.593 . . . . 0.0 108.889 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 9.2 m -130.8 96.95 4.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.526 1.512 . . . . 0.0 110.663 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.61 50.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 122.648 1.213 . . . . 0.0 113.843 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 3' ' ' LYS . . . -135.09 -73.07 0.47 Allowed 'General case' 0 C--O 1.241 0.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.774 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 59.72 -38.04 0.08 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.633 3.173 . . . . 0.0 114.94 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 1' ' ' ALA . 7.3 mtmp? -105.25 131.59 52.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.908 3.283 . . . . 0.0 106.973 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.3 157.55 24.79 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 p -139.38 127.19 22.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.349 -0.844 . . . . 0.0 113.102 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.39 -27.05 64.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.017 0.527 . . . . 0.0 111.777 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -62.91 120.77 11.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.67 24.86 1.49 Allowed Glycine 0 N--CA 1.476 1.309 0 N-CA-C 118.001 1.96 . . . . 0.0 118.001 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 tttt 69.3 145.96 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.894 2.478 . . . . 0.0 116.911 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -140.99 158.91 43.28 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.334 1.454 . . . . 0.0 112.538 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -132.45 142.85 49.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.853 1.261 . . . . 0.0 108.622 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.75 143.69 44.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.47 1.108 . . . . 0.0 110.128 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -57.06 -30.37 64.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.52 -11.73 61.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.311 1.444 . . . . 0.0 112.586 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.92 -11.19 37.88 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 127.503 2.477 . . . . 0.0 113.519 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -61.06 145.67 50.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 122.781 1.277 . . . . 0.0 112.326 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -122.81 139.99 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -132.71 145.27 50.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.94 0.876 . . . . 0.0 112.416 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 m -128.78 125.54 38.05 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.2 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.77 127.67 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.34 -88.86 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 O-C-N 125.647 1.842 . . . . 0.0 111.08 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.82 143.52 36.86 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.084 -0.657 . . . . 0.0 110.733 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.03 131.92 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.656 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -72.52 159.14 34.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.079 0.943 . . . . 0.0 112.919 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.0 m -54.47 -28.46 44.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.774 1.23 . . . . 0.0 114.212 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -71.11 -34.91 71.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.085 0.554 . . . . 0.0 112.472 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.81 -8.81 12.75 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.531 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 155.27 40.43 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.459 1.63 . . . . 0.0 108.271 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.47 166.12 32.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.975 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.5 148.04 52.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.24 26.34 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 122.554 1.086 . . . . 0.0 113.298 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.9 p -139.49 139.45 36.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.021 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.71 129.52 55.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.929 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -118.28 128.51 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 m -106.11 143.55 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.404 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 -15.63 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.03 142.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 113.154 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.56 168.91 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.39 -38.78 26.0 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.33 74.37 77.46 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.323 1.849 . . . . 0.0 109.227 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.64 6.5 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.165 3.243 . . . . 0.0 117.348 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.66 -21.29 0.8 Allowed Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.04 42.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.709 1.255 . . . . 0.0 111.945 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.59 134.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.835 0.826 . . . . 0.0 111.518 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 0.6 OUTLIER -152.48 171.82 17.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 0.0 111.22 176.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.2 tp -46.69 117.4 1.63 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 129.496 3.119 . . . . 0.0 112.438 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.7 m -111.79 114.05 52.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.899 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.18 145.15 66.88 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.324 2.683 . . . . 0.0 112.82 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.34 51.99 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.526 1.13 . . . . 0.0 111.864 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.75 149.85 39.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.188 2.995 . . . . 0.0 109.282 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.99 -155.33 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -144.82 139.56 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.996 0.903 . . . . 0.0 112.637 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.54 155.74 31.61 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.355 -0.841 . . . . 0.0 111.06 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.24 164.02 21.47 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.767 -1.208 . . . . 0.0 110.723 172.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.94 25.32 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.402 1.081 . . . . 0.0 112.924 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.84 -55.36 3.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.07 2.148 . . . . 0.0 110.454 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 173.19 12.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.711 1.243 . . . . 0.0 113.217 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -43.61 60.58 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.789 2.036 . . . . 0.0 112.176 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -131.41 53.75 12.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.952 1.301 . . . . 0.0 110.309 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.57 176.71 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.161 1.907 . . . . 0.0 116.272 -174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -88.34 161.85 16.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.504 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.37 164.48 29.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.249 -0.907 . . . . 0.0 112.46 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.84 149.47 15.7 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 120.397 2.919 . . . . 0.0 120.397 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -164.29 154.38 14.5 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -90.04 150.57 22.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.047 2.139 . . . . 0.0 109.332 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -129.97 120.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.59 106.01 18.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.653 -174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.12 131.88 46.72 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 121.234 1.834 . . . . 0.0 112.766 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.07 -38.22 12.33 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -90.38 -10.74 42.8 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -152.44 132.5 13.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 127.705 2.402 . . . . 0.0 106.847 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -69.85 118.49 12.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.546 1.066 . . . . 0.0 110.173 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -173.53 170.26 4.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.481 1.912 . . . . 0.0 109.769 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.89 137.95 31.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.979 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.29 165.99 12.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.327 1.06 . . . . 0.0 108.617 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 149.9 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.01 142.11 51.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.46 120.3 9.93 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 179.79 39.46 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 118.935 -1.602 . . . . 0.0 117.079 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.49 147.93 36.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 112.176 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.4 t -97.48 129.0 44.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.866 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -124.1 169.18 11.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.729 1.252 . . . . 0.0 113.72 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.8 mt -131.49 107.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 112.642 -2.072 . . . . 0.0 106.85 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -58.86 157.28 9.96 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.46 -55.13 0.05 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.148 2.179 . . . . 0.0 116.449 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.93 -19.85 62.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.39 1.876 . . . . 0.0 115.976 -173.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.73 53.65 1.19 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -125.59 136.03 52.84 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 126.834 2.053 . . . . 0.0 108.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.34 142.65 32.43 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 111.094 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' D' ' 106' ' ' ILE . 15.1 m -147.23 166.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.188 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.34 122.34 33.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -109.37 116.18 31.35 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.86 160.11 39.85 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.194 1.473 . . . . 0.0 112.15 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -108.25 167.75 9.8 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 172.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -141.32 160.81 39.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.649 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -143.84 127.43 17.02 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.783 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.85 144.65 39.55 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 125.172 1.545 . . . . 0.0 110.818 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.27 116.01 19.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 112.209 -2.268 . . . . 0.0 112.115 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -89.43 158.68 17.64 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 113.396 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -103.68 80.76 1.82 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.7 m -66.8 -173.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.996 0.518 . . . . 0.0 109.658 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.16 -20.83 9.68 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.984 -1.698 . . . . 0.0 114.783 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -124.66 152.42 43.68 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.791 1.282 . . . . 0.0 111.459 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' D' ' 92' ' ' VAL . 10.3 tt -62.44 -27.5 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.181 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.99 23.62 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.291 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -120.08 -0.91 10.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.037 1.419 . . . . 0.0 113.937 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.76 -32.4 69.24 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.968 . . . . 0.0 112.947 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -45.53 -44.6 12.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.609 1.164 . . . . 0.0 113.892 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -93.42 -12.86 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.86 0.864 . . . . 0.0 113.111 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.65 5.57 8.98 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.0 m -113.83 135.5 53.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.909 0.884 . . . . 0.0 111.824 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.67 126.49 22.29 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.61 154.92 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 120.524 1.511 . . . . 0.0 112.235 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.55 30.02 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.606 1.098 . . . . 0.0 113.177 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 24.4 p90 -129.28 153.67 47.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.771 0.828 . . . . 0.0 109.995 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -148.62 149.1 30.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.131 0.972 . . . . 0.0 109.716 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.32 130.63 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.39 -0.819 . . . . 0.0 109.28 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -118.52 153.86 33.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.255 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -137.51 165.1 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.202 1.001 . . . . 0.0 110.447 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -60.83 116.7 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 110.783 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.63 104.44 7.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.543 0.0 OUTLIER 77.18 85.07 0.08 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 123.946 1.831 . . . . 0.0 109.417 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 t -136.45 0.04 2.47 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.389 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.255 3.4 pm0 27.49 -121.22 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.265 2.626 . . . . 0.0 117.428 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -170.25 77.77 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 130.148 3.379 . . . . 0.0 107.472 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.251 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 117.728 -1.13 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 3.3 t -155.63 -43.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.564 1.075 . . . . 0.0 112.868 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 7.4 m -68.61 64.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 127.111 2.164 . . . . 0.0 113.139 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.17 -146.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 70.35 -40.69 0.47 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.996 2.918 . . . . 0.0 113.582 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -106.96 135.08 49.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.961 2.504 . . . . 0.0 107.771 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . 0.414 ' SG ' ' SG ' ' D' ' 83' ' ' CYS . 10.1 p -131.32 142.95 50.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 124.147 0.979 . . . . 0.0 108.388 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 21.1 p -132.63 127.47 35.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -68.21 -26.56 65.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.292 1.037 . . . . 0.0 112.425 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 t -62.57 121.02 12.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.34 40.55 0.62 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 mttt 56.53 150.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 129.087 2.955 . . . . 0.0 118.371 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -142.55 161.97 36.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.567 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -131.76 148.17 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.305 1.442 . . . . 0.0 107.552 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.42 143.41 45.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 109.988 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -56.4 -28.86 60.57 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.23 -12.48 61.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.938 1.695 . . . . 0.0 113.018 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.8 -8.44 36.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.142 2.306 . . . . 0.0 113.775 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -63.59 147.0 52.64 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.827 1.313 . . . . 0.0 112.066 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -124.66 137.83 54.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -130.33 147.18 52.01 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.112 0.958 . . . . 0.0 113.121 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 14.6 m -131.31 125.25 32.28 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.14 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.94 126.55 73.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 -88.05 0.1 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 126.09 2.119 . . . . 0.0 111.073 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.36 142.59 35.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.246 0.618 . . . . 0.0 110.661 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.09 133.02 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.722 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -71.92 160.07 33.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.206 1.003 . . . . 0.0 113.316 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 15.8 m -53.76 -27.33 28.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.249 1.419 . . . . 0.0 114.455 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.99 -34.03 68.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.282 0.633 . . . . 0.0 112.625 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.74 -9.83 12.57 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.981 1.277 . . . . 0.0 113.432 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.3 157.42 37.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.907 1.354 . . . . 0.0 110.634 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.82 166.3 33.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.332 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -131.03 147.68 52.66 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.46 -168.67 24.73 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.859 1.255 . . . . 0.0 112.904 -174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 9.5 p -140.06 139.53 35.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.396 -1.402 . . . . 0.0 112.202 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -118.52 132.92 56.21 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.861 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 60.3 mt -121.47 129.31 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 55.1 m -107.36 143.42 35.68 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.538 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.63 -15.73 18.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.73 142.62 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.012 0.925 . . . . 0.0 112.933 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.35 169.19 22.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.216 -0.928 . . . . 0.0 110.967 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -38.77 25.35 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.15 74.41 77.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.573 1.949 . . . . 0.0 109.375 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.75 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.13 3.22 . . . . 0.0 117.332 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.52 -21.35 0.77 Allowed Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.531 2.172 . . . . 0.0 118.531 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.06 42.38 0.08 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 111.929 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -50.29 133.56 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.397 -0.815 . . . . 0.0 111.748 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . 0.259 0.6 OUTLIER -151.81 171.54 17.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 111.377 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 12.3 tp -46.62 118.38 1.99 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.096 2.958 . . . . 0.0 112.116 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 69.6 m -113.08 112.52 49.86 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.256 1.022 . . . . 0.0 108.581 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -54.47 145.71 56.13 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.143 2.562 . . . . 0.0 112.593 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 143.96 51.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.43 1.092 . . . . 0.0 111.525 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -144.34 151.42 39.31 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 129.021 2.928 . . . . 0.0 109.446 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.55 -155.39 26.43 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -145.07 139.1 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.446 -0.877 . . . . 0.0 112.333 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.42 155.05 32.72 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.176 0.99 . . . . 0.0 110.79 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.15 163.98 22.7 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.43 -1.419 . . . . 0.0 110.81 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.16 26.43 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.231 1.013 . . . . 0.0 112.865 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.4 -56.69 2.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.019 2.128 . . . . 0.0 110.622 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.37 171.86 14.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.376 1.084 . . . . 0.0 113.356 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -43.82 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.2 1.4 . . . . 0.0 111.032 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -132.37 57.67 30.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 111.283 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.61 177.21 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 N-CA-C 116.767 1.795 . . . . 0.0 116.767 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -88.88 162.22 16.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.588 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.63 165.56 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.715 -1.241 . . . . 0.0 112.38 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.91 149.47 15.12 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.7 156.9 18.57 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -92.98 151.07 20.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.23 2.212 . . . . 0.0 108.967 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.41 121.97 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -97.77 106.73 19.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.414 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -67.16 131.7 46.32 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.807 1.639 . . . . 0.0 112.73 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.87 -38.13 12.5 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -90.42 -10.94 41.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.5 132.27 13.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.045 2.538 . . . . 0.0 107.068 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -69.54 118.61 12.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.298 0.954 . . . . 0.0 110.39 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 72.5 p -173.97 170.05 3.93 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 109.886 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -140.9 137.78 33.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.445 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.25 165.53 12.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.205 1.002 . . . . 0.0 108.478 173.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.91 150.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.95 142.03 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.33 120.52 10.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.46 -179.86 39.46 Favored Glycine 0 CA--C 1.497 -1.033 0 N-CA-C 117.274 1.67 . . . . 0.0 117.274 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.98 145.34 41.68 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.692 0.878 . . . . 0.0 112.236 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . 0.414 ' SG ' ' SG ' ' D' ' 4' ' ' CYS . 28.1 t -97.76 125.25 42.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.439 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.19 169.84 9.87 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.456 1.122 . . . . 0.0 113.618 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.8 mt -130.6 107.24 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.056 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.15 155.31 14.25 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.477 0.711 . . . . 0.0 109.097 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -24.15 -56.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 127.091 2.157 . . . . 0.0 116.704 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.23 -17.83 63.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.43 47.89 1.62 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.501 1.046 . . . . 0.0 110.632 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -119.78 139.61 52.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.477 1.511 . . . . 0.0 110.025 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -101.39 143.69 31.12 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 111.108 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 106' ' ' ILE . 15.2 m -148.09 164.28 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.928 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.34 120.52 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -108.75 115.15 29.55 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -136.57 161.58 35.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 123.319 1.533 . . . . 0.0 111.667 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.01 168.53 9.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -142.11 161.28 38.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.306 173.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -144.29 127.06 16.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.808 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.62 144.71 39.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.554 1.159 . . . . 0.0 110.898 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.11 114.59 17.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.011 -2.359 . . . . 0.0 112.13 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 85.7 p -86.97 158.6 19.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 124.813 1.32 . . . . 0.0 113.462 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -103.68 81.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.85 -173.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.039 0.535 . . . . 0.0 109.838 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -115.83 -21.0 9.79 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.119 -1.613 . . . . 0.0 114.789 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -123.85 151.3 43.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.486 1.136 . . . . 0.0 111.702 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . 0.423 ' CD1' HG21 ' A' ' 92' ' ' VAL . 10.8 tt -61.93 -27.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.055 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.77 4.32 22.68 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.356 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -120.13 -0.19 10.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.905 1.353 . . . . 0.0 113.935 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -60.08 -31.38 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.358 -0.839 . . . . 0.0 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -46.54 -44.21 17.66 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.53 1.132 . . . . 0.0 113.97 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -93.63 -12.79 28.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.011 0.924 . . . . 0.0 113.161 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.64 5.11 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 14.5 m -113.08 135.6 53.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.862 0.865 . . . . 0.0 111.726 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.57 126.25 22.14 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.611 -1.185 . . . . 0.0 110.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.91 154.82 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.298 1.408 . . . . 0.0 111.821 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.86 -175.87 30.27 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.687 1.137 . . . . 0.0 113.096 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -126.47 153.43 45.09 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.623 0.769 . . . . 0.0 109.517 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -148.08 148.24 30.43 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.036 0.934 . . . . 0.0 109.271 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 64.9 mt -128.2 131.5 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.031 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -117.74 156.76 27.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.222 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -137.53 160.95 37.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.591 1.156 . . . . 0.0 110.195 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.18 129.54 42.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.891 -0.506 . . . . 0.0 109.735 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.02 -177.55 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.764 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 88.67 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.73 1.212 . . . . 0.0 110.177 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -169.14 1.69 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.93 2.092 . . . . 0.0 109.586 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -55.85 148.53 16.68 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.537 2.335 . . . . 0.0 105.039 173.197 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 117.291 -1.338 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 5.8 m -62.54 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.791 1.637 . . . . 0.0 111.583 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.1 168.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.368 2.267 . . . . 0.0 108.077 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . 134.42 44.95 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 131.029 3.732 . . . . 0.0 109.085 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -150.78 -54.78 0.15 Allowed 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.532 -1.355 . . . . 0.0 113.45 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -109.9 136.83 48.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.291 1.836 . . . . 0.0 107.958 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . 0.407 ' SG ' ' SG ' ' B' ' 83' ' ' CYS . 25.0 p -130.15 147.49 51.89 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.323 1.049 . . . . 0.0 108.275 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -137.64 127.46 25.5 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.549 0.74 . . . . 0.0 112.43 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.09 120.08 10.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.75 43.18 0.5 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt 53.6 148.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.388 3.075 . . . . 0.0 119.175 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -140.83 160.1 40.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.929 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 142.26 47.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.121 1.368 . . . . 0.0 108.514 175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.32 143.5 42.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.966 1.306 . . . . 0.0 110.041 -174.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -56.35 -29.36 61.27 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.9 -12.16 61.38 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.747 1.619 . . . . 0.0 112.836 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.45 -8.13 40.48 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 127.062 2.268 . . . . 0.0 113.635 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.9 t -64.43 145.04 56.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.787 1.294 . . . . 0.0 111.511 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -121.94 141.46 51.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -133.08 147.17 52.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.304 1.049 . . . . 0.0 112.795 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -129.58 125.26 35.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.544 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.56 127.44 75.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.05 -88.45 0.1 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 125.874 1.984 . . . . 0.0 110.987 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.98 145.13 37.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.202 -0.587 . . . . 0.0 110.824 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.02 131.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.729 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -72.79 159.54 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.029 0.919 . . . . 0.0 112.808 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -54.47 -27.87 40.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -71.84 -34.81 69.59 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.148 0.579 . . . . 0.0 112.448 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.82 -9.16 12.63 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.503 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 155.3 40.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.379 1.59 . . . . 0.0 108.225 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.39 166.12 32.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.882 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.14 147.92 52.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.54 26.77 Favored Glycine 0 C--O 1.236 0.24 0 O-C-N 121.623 -0.673 . . . . 0.0 112.81 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 10.7 p -139.89 138.53 35.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.836 -1.182 . . . . 0.0 112.092 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -117.14 132.39 56.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.811 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.13 129.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 45.2 m -107.14 143.56 35.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.742 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.44 -13.59 18.65 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.44 142.06 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.948 0.899 . . . . 0.0 112.806 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.28 168.68 23.33 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.219 -0.926 . . . . 0.0 111.036 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -39.15 25.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -126.85 74.64 75.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.428 1.891 . . . . 0.0 109.321 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.82 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.175 3.25 . . . . 0.0 117.34 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.79 -20.96 0.75 Allowed Glycine 0 CA--C 1.537 1.433 0 N-CA-C 118.523 2.169 . . . . 0.0 118.523 -174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.2 42.34 0.08 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 111.861 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -50.06 134.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.336 -0.852 . . . . 0.0 111.454 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -152.3 171.85 17.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.425 1.49 . . . . 0.0 111.109 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 12.1 tp -46.69 119.34 2.41 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.469 3.108 . . . . 0.0 112.143 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 68.2 m -114.3 113.59 45.92 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.095 0.958 . . . . 0.0 108.579 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -55.28 144.76 69.9 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.622 2.881 . . . . 0.0 112.814 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.04 52.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.613 1.165 . . . . 0.0 111.892 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.41 150.7 40.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.167 2.987 . . . . 0.0 109.266 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.08 -155.43 26.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -144.8 139.48 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.668 -0.766 . . . . 0.0 112.421 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.78 155.15 31.66 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.255 1.022 . . . . 0.0 110.993 172.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.95 163.9 22.97 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.499 -1.375 . . . . 0.0 110.588 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.97 26.38 0.32 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 113.213 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -56.36 2.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.282 2.233 . . . . 0.0 111.022 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.75 171.83 14.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.955 0.883 . . . . 0.0 113.331 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -41.43 66.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.45 1.1 . . . . 0.0 110.91 173.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -132.87 57.9 31.71 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 125.383 1.473 . . . . 0.0 111.07 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.32 176.62 9.71 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.053 1.835 . . . . 0.0 116.654 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -87.71 163.79 16.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.718 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -163.44 164.44 24.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 149.14 15.03 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 119.941 2.736 . . . . 0.0 119.941 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -164.12 154.29 14.8 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -90.06 150.92 21.88 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.927 2.091 . . . . 0.0 109.133 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 74.1 t -130.28 120.72 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -95.76 105.91 17.97 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.612 -1.185 . . . . 0.0 110.793 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -67.1 132.14 47.24 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.165 1.802 . . . . 0.0 112.742 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.46 -38.2 12.1 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.58 -10.4 43.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -152.5 133.28 14.0 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.002 2.521 . . . . 0.0 107.265 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -70.66 118.47 13.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.273 0.942 . . . . 0.0 109.823 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 75.5 p -173.62 170.2 4.12 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.639 1.976 . . . . 0.0 109.928 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.76 137.9 31.92 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.142 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.34 166.12 12.0 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 150.49 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -129.07 141.61 51.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.08 120.3 10.17 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.37 -179.35 38.47 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.915 -1.612 . . . . 0.0 117.106 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -114.31 145.7 41.44 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 125.178 1.163 . . . . 0.0 112.098 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.407 ' SG ' ' SG ' ' B' ' 4' ' ' CYS . 34.6 t -97.76 125.94 42.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.291 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.7 170.89 9.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.76 1.267 . . . . 0.0 113.573 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 mt -131.63 110.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.49 -2.141 . . . . 0.0 106.506 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.5 156.55 19.22 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.59 -53.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -73.63 -8.96 58.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.435 1.894 . . . . 0.0 116.101 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.16 50.87 3.12 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 120.008 1.276 . . . . 0.0 110.684 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -122.87 135.97 54.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.434 1.894 . . . . 0.0 109.746 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -101.83 143.03 32.24 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.308 1.443 . . . . 0.0 112.066 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' C' ' 106' ' ' ILE . 15.3 m -148.56 161.95 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.803 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 mt -122.16 120.21 33.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -108.24 114.47 28.37 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.05 161.06 36.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.306 1.527 . . . . 0.0 112.137 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -109.3 168.06 9.66 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -141.69 160.69 39.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.508 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.46 127.7 17.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.559 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.03 144.59 39.92 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 124.826 1.329 . . . . 0.0 110.987 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -128.23 116.91 20.61 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 112.125 -2.307 . . . . 0.0 112.279 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -90.71 158.66 16.77 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 124.73 1.269 . . . . 0.0 113.627 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.1 m -103.21 80.34 1.83 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -66.76 -174.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -115.66 -22.65 9.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 119.934 -1.729 . . . . 0.0 114.537 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -118.63 148.82 42.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.766 1.269 . . . . 0.0 110.734 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' C' ' 92' ' ' VAL . 10.7 tt -61.05 -28.23 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.77 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.95 4.05 25.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.221 -1.322 . . . . 0.0 115.457 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.83 -1.39 11.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.102 1.451 . . . . 0.0 113.815 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.77 -31.54 68.47 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.341 -0.85 . . . . 0.0 112.824 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -46.43 -44.57 17.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 114.107 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -92.88 -12.78 30.1 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.951 0.9 . . . . 0.0 113.263 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 4.95 10.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 16.2 m -113.12 135.08 54.19 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.915 0.886 . . . . 0.0 111.668 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.48 126.66 22.84 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.541 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.94 154.77 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 120.427 1.467 . . . . 0.0 112.041 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.94 -175.32 30.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.698 1.142 . . . . 0.0 113.056 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 24.2 p90 -128.21 154.63 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.678 0.791 . . . . 0.0 109.965 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -149.71 147.26 27.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.853 0.861 . . . . 0.0 109.831 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 129.54 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.399 -0.813 . . . . 0.0 109.146 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -116.86 155.41 29.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.437 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 32.8 p -137.31 160.42 39.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 110.458 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -59.65 128.58 37.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.79 0.836 . . . . 0.0 111.395 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -91.37 82.15 5.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . 0.303 0.0 OUTLIER 71.24 75.71 0.18 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 171.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 5.6 t -128.54 -22.33 3.34 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 129.136 2.974 . . . . 0.0 114.703 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . 0.457 ' HG2' ' H ' ' B' ' 127' ' ' LYS 0.314 3.5 pm0 50.04 -88.25 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.457 ' H ' ' HG2' ' B' ' 126' ' ' GLN . 26.0 mttm -133.99 127.43 32.31 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.691 2.396 . . . . 0.0 106.253 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 126.861 2.064 . . . . 0.0 107.809 -174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 118.206 -0.902 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 76.0 p -107.15 -11.13 15.69 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 24.5 m -129.74 -171.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.453 1.501 . . . . 0.0 111.009 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.77 -13.58 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -166.16 -33.86 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.716 1.607 . . . . 0.0 112.997 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -87.86 137.28 32.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.783 2.033 . . . . 0.0 109.259 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' C' ' 83' ' ' CYS . 13.1 p -133.54 147.39 51.58 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.838 1.255 . . . . 0.0 108.453 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -137.21 127.51 26.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -68.87 -26.76 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.959 0.904 . . . . 0.0 112.571 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -61.47 120.8 11.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.35 45.2 0.53 Allowed Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.938 1.535 . . . . 0.0 116.938 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt 52.87 149.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -141.83 161.02 38.99 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.427 -1.715 . . . . 0.0 112.139 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.05 144.35 49.97 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.271 1.428 . . . . 0.0 108.519 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.81 143.42 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.105 1.362 . . . . 0.0 109.476 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -55.75 -29.51 59.7 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.76 -12.23 61.43 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.77 1.628 . . . . 0.0 113.007 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.63 -9.09 40.77 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.284 2.373 . . . . 0.0 113.611 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.5 t -63.09 145.91 54.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.82 1.31 . . . . 0.0 111.804 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -122.36 141.09 51.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.17 147.24 52.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.999 0.904 . . . . 0.0 112.823 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.4 m -130.35 125.69 35.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.766 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.47 126.42 74.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.19 -88.71 0.08 OUTLIER Glycine 0 CA--C 1.526 0.77 0 O-C-N 126.036 2.085 . . . . 0.0 111.036 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.37 143.69 35.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.228 0.611 . . . . 0.0 110.862 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.16 132.74 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.739 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -71.77 160.04 33.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.247 1.023 . . . . 0.0 113.304 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 16.0 m -53.84 -27.23 28.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.151 1.381 . . . . 0.0 114.505 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.93 -34.17 68.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.231 0.612 . . . . 0.0 112.588 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.76 -9.88 12.52 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.967 1.27 . . . . 0.0 113.468 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.25 157.59 37.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.967 1.384 . . . . 0.0 110.563 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 166.3 33.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.326 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 148.04 52.66 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.65 -169.12 25.59 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 122.478 1.044 . . . . 0.0 112.746 -174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 10.2 p -139.66 138.96 36.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.686 -1.257 . . . . 0.0 112.032 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -117.19 135.09 54.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.854 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 60.6 mt -123.57 130.17 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 42.1 m -107.92 143.84 36.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.779 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.71 -13.5 18.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.74 141.43 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 112.737 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.84 168.36 23.95 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.204 -0.935 . . . . 0.0 110.992 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.62 -39.27 27.75 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.61 74.62 74.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.469 1.908 . . . . 0.0 109.291 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.8 6.8 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.147 3.232 . . . . 0.0 117.406 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.68 -21.28 0.8 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.14 42.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.732 1.266 . . . . 0.0 111.832 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 54.2 mt -49.95 134.62 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.382 -0.824 . . . . 0.0 111.518 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -152.85 171.6 18.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.222 1.409 . . . . 0.0 111.254 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.3 tp -46.63 118.43 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 129.263 3.025 . . . . 0.0 112.136 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -113.5 112.79 48.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.542 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.5 145.69 56.6 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.173 2.582 . . . . 0.0 112.565 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.2 143.89 51.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.078 0.951 . . . . 0.0 111.329 175.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -143.93 151.53 39.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.339 3.056 . . . . 0.0 109.606 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.85 -155.66 26.72 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -144.87 139.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 114.484 -0.858 . . . . 0.0 112.282 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.19 155.54 31.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.162 0.985 . . . . 0.0 110.739 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.85 163.6 22.2 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.392 -1.442 . . . . 0.0 110.886 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.74 25.09 0.33 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.113 0.965 . . . . 0.0 113.1 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.39 -57.52 2.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.191 2.196 . . . . 0.0 111.08 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.8 172.07 12.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -43.25 64.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.006 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -129.96 57.78 33.33 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 125.223 1.409 . . . . 0.0 111.054 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.37 176.83 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.976 1.784 . . . . 0.0 116.691 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 11.4 p -87.98 162.81 16.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.955 1.702 . . . . 0.0 109.637 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -162.02 165.33 27.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.174 -0.954 . . . . 0.0 112.665 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.64 149.38 15.06 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.14 155.4 15.9 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -91.6 150.78 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.985 2.114 . . . . 0.0 109.151 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.04 121.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -97.78 106.16 18.42 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.59 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -66.58 131.69 46.56 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.779 1.627 . . . . 0.0 112.901 -173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.92 -37.99 12.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.56 -10.71 42.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 26.7 t -152.43 132.55 13.5 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.043 2.537 . . . . 0.0 107.216 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -70.24 118.53 13.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.303 0.956 . . . . 0.0 109.947 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 77.3 p -173.49 170.3 4.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.492 1.917 . . . . 0.0 110.026 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.82 137.88 31.81 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.019 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.22 165.8 12.31 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.329 1.061 . . . . 0.0 108.578 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.42 150.89 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -128.95 142.0 51.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.35 120.3 10.0 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.6 -179.73 38.85 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.79 144.83 42.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.084 0.945 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' C' ' 4' ' ' CYS . 34.2 t -97.85 123.13 41.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.549 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.89 170.42 8.83 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.585 1.183 . . . . 0.0 113.652 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -130.23 111.61 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.928 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.62 157.23 17.96 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -25.85 -53.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.195 2.198 . . . . 0.0 116.856 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.48 -8.61 56.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.78 47.16 4.31 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 120.399 1.454 . . . . 0.0 110.947 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -119.11 141.67 48.59 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.339 2.256 . . . . 0.0 108.209 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -108.41 145.49 34.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.598 1.159 . . . . 0.0 112.168 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' B' ' 106' ' ' ILE . 18.6 m -149.66 165.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.215 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 59.6 mt -124.3 121.59 35.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -109.81 114.19 27.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -136.06 160.76 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.32 1.533 . . . . 0.0 112.033 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.04 168.16 9.57 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -141.6 161.1 38.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.278 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -144.08 127.09 16.45 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.265 -1.788 . . . . 0.0 110.505 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tt -110.5 144.65 39.0 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.577 1.173 . . . . 0.0 110.779 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -128.86 117.21 20.66 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 112.315 -2.22 . . . . 0.0 112.199 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -90.5 158.96 16.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 124.847 1.342 . . . . 0.0 113.848 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -103.07 80.01 1.81 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.84 -175.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.099 0.56 . . . . 0.0 109.924 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -114.47 -23.27 9.42 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.379 -1.451 . . . . 0.0 114.571 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -119.13 149.78 41.13 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.709 1.242 . . . . 0.0 110.455 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . 0.425 ' CD1' HG21 ' B' ' 92' ' ' VAL . 11.5 tt -61.25 -29.06 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.295 174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.91 3.75 19.13 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.324 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.75 -1.19 11.13 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.963 1.381 . . . . 0.0 113.894 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -58.9 -31.74 68.89 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.273 -0.892 . . . . 0.0 112.74 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -46.54 -44.19 17.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.765 1.226 . . . . 0.0 113.95 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -93.14 -12.88 29.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.979 0.912 . . . . 0.0 113.232 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.35 10.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 16.8 m -113.25 135.3 53.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.032 0.933 . . . . 0.0 111.449 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -138.82 125.36 20.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 117.597 -1.192 . . . . 0.0 110.552 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.53 154.85 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.211 1.368 . . . . 0.0 111.851 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.61 -175.47 30.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.714 1.149 . . . . 0.0 113.081 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.48 153.51 46.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.702 0.801 . . . . 0.0 109.81 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -148.63 147.2 28.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.165 0.986 . . . . 0.0 109.707 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -128.32 132.08 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -119.5 156.41 30.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.111 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 38.7 p -139.1 163.68 31.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.697 1.199 . . . . 0.0 110.662 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -60.79 124.66 21.08 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.419 -0.801 . . . . 0.0 111.517 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.89 96.89 8.95 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 79.54 106.14 0.07 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.48 1.912 . . . . 0.0 113.466 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -73.01 43.35 0.12 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.699 -1.251 . . . . 0.0 112.961 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 46.47 -98.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.065 2.546 . . . . 0.0 114.182 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -157.08 172.03 19.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.493 2.717 . . . . 0.0 107.458 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.245 0.816 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 172.282 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 117.29 -1.338 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 13.7 p -61.31 -48.64 80.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.291 1.036 . . . . 0.0 112.404 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 4.6 t -75.91 59.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.202 1.401 . . . . 0.0 111.117 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -85.58 129.85 34.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.628 1.171 . . . . 0.0 108.985 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -162.88 30.71 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.66 152.44 27.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.392 2.277 . . . . 0.0 109.614 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -138.76 153.94 48.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.009 0.818 . . . . 0.0 110.603 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -139.46 126.37 20.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.48 -31.41 72.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -66.3 101.38 0.73 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.75 -8.19 0.11 Allowed Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.1 tttt 75.63 139.09 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.041 2.536 . . . . 0.0 113.721 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -137.73 162.75 33.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.074 1.35 . . . . 0.0 111.617 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -141.05 148.47 40.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.661 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -108.88 151.99 25.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.796 0.838 . . . . 0.0 112.294 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.94 -25.76 66.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.27 -15.98 61.4 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.346 1.858 . . . . 0.0 110.946 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.24 -6.34 34.28 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 127.192 2.329 . . . . 0.0 114.517 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 p -70.56 148.14 48.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.928 1.864 . . . . 0.0 112.219 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -119.11 139.09 52.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.868 -1.145 . . . . 0.0 109.433 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -127.8 136.16 51.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.692 0.758 . . . . 0.0 110.63 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.05 132.21 52.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.65 126.71 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -87.54 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 O-C-N 125.67 1.856 . . . . 0.0 110.611 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.88 29.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.193 -0.592 . . . . 0.0 111.5 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.49 126.55 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.045 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.19 159.3 29.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 112.277 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 t -53.07 -30.15 34.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -63.46 -39.59 94.86 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.006 -1.059 . . . . 0.0 110.97 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.56 -6.75 10.54 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 116.854 -2.081 . . . . 0.0 114.118 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.36 152.8 44.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.812 1.806 . . . . 0.0 109.705 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -152.03 145.27 24.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.304 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.53 155.67 22.91 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.834 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -169.16 30.96 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 122.928 1.293 . . . . 0.0 112.991 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -134.69 129.22 34.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.413 -1.394 . . . . 0.0 111.646 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -123.25 120.64 33.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.991 0.901 . . . . 0.0 111.607 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.99 132.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.9 144.79 42.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.47 -13.99 21.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 143.11 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.572 1.149 . . . . 0.0 112.409 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.23 43.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.467 -1.396 . . . . 0.0 111.505 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 114' ' ' ARG . 8.5 m-20 -70.12 -25.82 63.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.54 83.71 14.71 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.568 1.947 . . . . 0.0 109.747 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.68 177.48 7.49 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.176 2.584 . . . . 0.0 110.47 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.11 -27.35 3.3 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 113.301 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -142.57 23.14 1.97 Allowed 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.72 1.608 . . . . 0.0 110.531 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.21 105.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 123.182 1.468 . . . . 0.0 111.481 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 171.02 7.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.079 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.58 126.63 24.51 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 127.645 2.378 . . . . 0.0 111.62 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -104.09 119.54 53.92 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.646 174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -55.23 149.96 42.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.51 2.14 . . . . 0.0 111.562 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.22 149.46 47.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.324 1.05 . . . . 0.0 110.287 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.86 149.13 29.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.369 2.267 . . . . 0.0 109.159 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.33 -156.87 28.35 Favored Glycine 0 C--O 1.228 -0.236 0 O-C-N 120.355 -1.466 . . . . 0.0 111.058 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -145.99 148.8 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 125.41 1.3 . . . . 0.0 111.704 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 152.81 50.76 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.515 -1.366 . . . . 0.0 112.997 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -101.19 147.12 26.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 14.12 1.77 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.391 1.477 . . . . 0.0 113.533 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -92.56 -42.35 9.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.823 1.649 . . . . 0.0 112.147 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.32 4.62 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.96 0.788 . . . . 0.0 112.64 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 t -70.12 -49.18 53.3 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.582 1.153 . . . . 0.0 112.538 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.34 65.33 72.25 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.07 0.948 . . . . 0.0 111.763 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.15 173.53 5.99 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.537 3.491 . . . . 0.0 116.921 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER -100.36 169.38 9.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 123.443 1.592 . . . . 0.0 110.725 173.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -162.17 162.5 28.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.071 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.87 143.17 8.45 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 118.579 2.192 . . . . 0.0 118.579 -172.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.16 152.33 20.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -89.81 152.23 21.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.032 1.733 . . . . 0.0 109.263 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.71 120.65 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.45 117.97 35.46 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -82.29 136.31 35.06 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.065 -1.647 . . . . 0.0 114.55 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -97.08 -44.38 7.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.836 -1.074 . . . . 0.0 113.836 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -74.83 -19.28 60.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.368 0.667 . . . . 0.0 112.54 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.41 132.81 13.72 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.703 2.801 . . . . 0.0 107.34 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.45 118.88 20.32 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.284 1.402 . . . . 0.0 111.855 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 76.3 p -176.71 164.5 2.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.926 2.09 . . . . 0.0 107.379 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.6 135.67 17.66 Favored 'General case' 0 CA--C 1.47 -2.103 0 CA-C-O 122.202 1.001 . . . . 0.0 108.781 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -135.34 130.28 34.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 111.066 -2.788 . . . . 0.0 111.492 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.92 154.1 5.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 120.742 0.306 . . . . 0.0 110.212 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -127.99 144.2 51.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.84 117.06 4.55 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.16 -177.72 34.51 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.98 138.56 54.65 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.806 0.812 . . . . 0.0 111.178 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.6 t -97.97 112.76 24.57 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.154 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -112.01 168.58 9.48 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.793 1.282 . . . . 0.0 110.148 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.74 113.75 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 112.841 -1.981 . . . . 0.0 107.571 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.09 157.95 14.7 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -44.63 -28.63 0.62 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 118.156 2.651 . . . . 0.0 118.156 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -5.69 55.77 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.17 41.07 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.635 1.112 . . . . 0.0 113.416 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.27 144.53 25.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.522 2.329 . . . . 0.0 109.983 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.26 141.92 33.43 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.587 1.155 . . . . 0.0 109.616 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.6 160.66 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 125.121 1.513 . . . . 0.0 110.36 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 mt -124.43 118.17 26.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -106.39 113.2 26.58 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 p -132.86 165.1 25.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.58 1.657 . . . . 0.0 111.598 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.56 168.52 10.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.037 173.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -141.54 158.08 44.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.272 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.68 127.26 28.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.867 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.5 137.24 45.89 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 124.788 1.305 . . . . 0.0 111.726 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.8 113.84 20.75 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.783 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 m -77.66 164.76 25.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 125.215 1.572 . . . . 0.0 111.755 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.6 m -108.61 85.16 2.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.01 178.2 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -116.25 6.43 13.83 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.35 144.88 33.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.427 174.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.72 -31.11 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.166 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.14 6.67 13.11 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.366 1.46 . . . . 0.0 115.072 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -120.9 3.0 10.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.202 1.001 . . . . 0.0 112.831 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -33.41 75.37 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.966 -1.084 . . . . 0.0 113.196 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -45.7 -41.04 10.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.12 0.968 . . . . 0.0 113.441 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -98.14 -9.02 26.47 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.242 1.017 . . . . 0.0 113.601 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.95 -0.8 19.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -112.58 141.76 45.96 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.568 0.699 . . . . 0.0 111.861 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 39' ' ' ASP . 34.3 mtp180 -138.69 147.96 43.4 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.22 1.408 . . . . 0.0 109.898 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.75 149.51 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.955 1.707 . . . . 0.0 109.836 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.26 -175.26 27.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 123.799 0.714 . . . . 0.0 111.86 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 28.3 p90 -130.69 157.4 42.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.142 0.577 . . . . 0.0 110.282 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -148.81 145.94 27.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.042 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.6 mt -124.81 126.07 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.07 149.65 37.17 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.398 -0.814 . . . . 0.0 109.625 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 p -133.38 157.29 45.9 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.776 -0.578 . . . . 0.0 109.59 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 121.52 9.26 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 tt -75.1 82.81 2.29 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.46 -10.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.122 3.769 . . . . 0.0 112.037 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 t -67.93 4.34 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.87 159.65 33.27 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.487 1.515 . . . . 0.0 110.053 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -62.01 134.97 57.32 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.323 0.649 . . . . 0.0 109.754 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 126.66 1.984 . . . . 0.0 110.436 173.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.488 1.115 . . . . 0.0 111.156 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 53.4 t -145.92 142.51 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.157 1.783 . . . . 0.0 107.916 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.58 165.53 25.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 0.0 111.098 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.8 20.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.551 1.94 . . . . 0.0 113.349 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 155.94 32.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 128.144 2.577 . . . . 0.0 109.414 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p -150.14 145.46 26.32 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.508 1.13 . . . . 0.0 110.538 -174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -139.79 127.15 21.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.21 -27.98 68.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.84 101.2 1.04 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.42 -9.74 0.09 OUTLIER Glycine 0 N--CA 1.484 1.899 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 75.82 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.913 2.485 . . . . 0.0 113.649 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.18 162.73 32.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.846 1.307 . . . . 0.0 111.66 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -139.71 149.7 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.097 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.12 152.73 25.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.675 0.79 . . . . 0.0 111.584 -175.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.59 -26.66 67.21 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.0 tp -72.45 -16.04 61.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.5 1.92 . . . . 0.0 111.237 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.57 -5.59 35.32 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.194 2.33 . . . . 0.0 114.363 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 66.4 p -71.27 149.61 46.02 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.926 1.863 . . . . 0.0 112.252 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -121.99 139.05 54.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.914 -1.116 . . . . 0.0 109.808 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -127.37 136.76 52.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.88 0.848 . . . . 0.0 111.018 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.01 131.72 52.15 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 86.6 mt -127.64 126.74 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.84 -87.49 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 125.023 1.452 . . . . 0.0 110.704 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.61 139.33 31.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.287 -0.537 . . . . 0.0 111.328 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.06 125.46 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.908 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -65.26 159.1 24.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.172 0.589 . . . . 0.0 112.236 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 17.7 t -54.2 -28.58 41.74 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -63.37 -37.21 86.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.982 -1.074 . . . . 0.0 110.983 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.1 -4.87 15.95 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.484 1.516 . . . . 0.0 113.753 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.26 155.42 38.28 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.925 1.363 . . . . 0.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -152.51 154.53 35.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.698 1.237 . . . . 0.0 112.72 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.18 156.05 30.55 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.164 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.06 -168.62 30.45 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.844 1.247 . . . . 0.0 113.394 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -133.9 130.5 37.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.589 -1.306 . . . . 0.0 111.763 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -124.05 121.04 34.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.982 0.896 . . . . 0.0 111.515 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.3 133.45 66.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.99 145.72 41.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.6 -15.97 20.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 143.55 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.441 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.71 158.3 43.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.678 -1.264 . . . . 0.0 111.615 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . 0.485 ' CG ' HH12 ' D' ' 114' ' ' ARG . 9.2 m-20 -69.96 -26.06 63.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.98 83.42 14.05 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.384 1.874 . . . . 0.0 109.441 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.72 177.48 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.091 2.527 . . . . 0.0 110.546 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.9 -27.24 3.35 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 121.346 -0.847 . . . . 0.0 113.324 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 23.32 2.0 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.799 1.64 . . . . 0.0 110.687 -177.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 62.9 mt -57.21 106.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 123.195 1.474 . . . . 0.0 111.296 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.22 170.79 8.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.954 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.78 126.31 21.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 127.409 2.284 . . . . 0.0 111.628 176.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -104.53 119.87 52.35 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.015 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.97 150.4 38.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.354 2.036 . . . . 0.0 111.456 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.85 152.66 50.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 110.059 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.52 149.29 26.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.759 2.024 . . . . 0.0 109.691 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.26 -155.29 26.43 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 119.257 0.935 . . . . 0.0 113.948 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -146.84 148.8 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.717 1.207 . . . . 0.0 111.838 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.04 152.34 49.97 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.482 -1.386 . . . . 0.0 112.794 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -100.2 146.97 26.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 16.17 1.84 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 113.335 -175.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -91.93 -42.12 10.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 174.39 5.34 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -71.8 -47.55 52.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 0.0 112.669 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.5 64.68 73.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 124.644 1.178 . . . . 0.0 112.673 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.43 173.61 8.5 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.654 3.569 . . . . 0.0 116.639 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.303 0.5 OUTLIER -99.15 168.62 9.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.533 1.635 . . . . 0.0 111.086 173.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.54 161.78 27.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.927 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.98 143.6 8.95 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.6 151.64 18.91 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -89.16 154.0 20.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.357 1.863 . . . . 0.0 109.52 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.25 121.04 45.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.84 117.25 33.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -174.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.83 135.16 35.46 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.24 -1.538 . . . . 0.0 114.676 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -95.62 -44.28 7.55 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -74.66 -19.59 60.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.455 0.702 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.39 132.19 13.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.553 2.741 . . . . 0.0 107.491 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -75.98 118.9 19.24 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.444 1.475 . . . . 0.0 112.107 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -176.59 164.12 2.47 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 127.004 2.122 . . . . 0.0 107.196 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.29 135.18 17.65 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-O 122.505 1.145 . . . . 0.0 108.897 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 4.9 m -135.02 130.16 35.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.576 -169.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -103.38 154.58 5.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 120.623 0.249 . . . . 0.0 110.421 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -128.43 144.0 51.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.44 116.91 4.65 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.98 -177.0 33.71 Favored Glycine 0 CA--C 1.503 -0.707 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.73 137.98 54.31 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.66 0.859 . . . . 0.0 110.734 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.92 112.82 24.6 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.266 -1.35 . . . . 0.0 108.771 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.43 169.16 8.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.762 1.225 . . . . 0.0 110.031 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.08 110.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.916 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -60.19 157.3 13.55 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -43.59 -30.17 0.57 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.64 -0.76 48.64 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.76 43.35 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.511 -0.743 . . . . 0.0 113.13 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.85 146.14 23.99 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.748 2.019 . . . . 0.0 109.545 175.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -101.27 142.24 32.98 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.806 1.242 . . . . 0.0 108.795 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 21.9 m -146.26 159.13 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 125.07 1.481 . . . . 0.0 110.7 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 42.4 mt -121.64 117.01 25.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.17 112.28 25.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -132.27 165.62 23.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.613 1.673 . . . . 0.0 111.752 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.19 168.07 10.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 114.729 -1.123 . . . . 0.0 107.977 173.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -141.32 158.34 44.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.243 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.97 127.02 27.88 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.54 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 137.22 46.06 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.767 1.292 . . . . 0.0 111.46 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.72 113.83 20.78 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 113.131 -1.85 . . . . 0.0 110.855 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -77.58 164.9 24.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.829 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -109.25 84.82 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.24 -178.28 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -119.1 6.44 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.94 145.15 34.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.225 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.34 -30.61 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.15 7.08 18.09 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.609 1.576 . . . . 0.0 115.207 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.63 3.21 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.25 1.025 . . . . 0.0 112.888 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.63 -33.04 74.73 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.119 -0.988 . . . . 0.0 112.655 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -45.41 -41.38 9.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 113.636 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -98.3 -8.95 26.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.312 1.045 . . . . 0.0 113.672 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.64 -1.46 21.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 3.7 m -111.85 141.69 45.16 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.748 0.704 . . . . 0.0 111.895 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . 0.485 HH12 ' CG ' ' D' ' 39' ' ' ASP . 35.4 mtp180 -138.35 148.05 44.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.335 1.454 . . . . 0.0 109.961 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.95 149.59 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 120.804 1.638 . . . . 0.0 109.83 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.51 -175.21 27.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.743 0.687 . . . . 0.0 111.877 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 29.1 p90 -130.77 156.78 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.125 0.57 . . . . 0.0 110.051 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -148.28 145.81 28.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.388 0.675 . . . . 0.0 109.922 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.3 mt -124.32 126.45 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -114.84 150.28 35.77 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.069 0.938 . . . . 0.0 110.076 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 61.9 p -133.64 158.81 42.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.683 0.793 . . . . 0.0 110.352 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 126.58 28.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.282 0.633 . . . . 0.0 109.381 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.15 140.55 58.88 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -57.74 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.287 1.835 . . . . 0.0 114.987 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m 54.26 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 127.282 2.233 . . . . 0.0 116.383 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -99.42 130.92 45.72 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 119.02 -2.3 . . . . 0.0 109.748 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.0 86.94 0.1 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.076 2.15 . . . . 0.0 107.981 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . 0.365 9.6 mm-40 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 128.313 2.645 . . . . 0.0 110.379 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 118.142 -0.932 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.0 t -153.86 96.43 1.98 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.347 1.459 . . . . 0.0 107.967 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 23.3 m 17.38 54.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 128.914 2.886 . . . . 0.0 117.262 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.2 -47.02 0.71 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 13.69 72.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 128.047 2.539 . . . . 0.0 114.054 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -141.52 153.53 44.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.148 1.779 . . . . 0.0 110.097 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p -147.01 149.27 32.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 124.58 1.175 . . . . 0.0 111.207 -174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.5 p -139.74 127.02 21.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.71 -28.16 67.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.43 101.97 1.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.36 -14.3 0.13 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 118.592 2.197 . . . . 0.0 118.592 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 tttt 80.7 143.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 128.502 2.721 . . . . 0.0 112.776 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -137.56 162.74 32.94 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 111.536 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.01 154.07 51.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.092 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -114.41 150.79 34.14 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.848 0.859 . . . . 0.0 111.409 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.05 -25.18 66.92 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.77 -16.29 61.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.852 2.061 . . . . 0.0 111.011 173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.07 -6.52 32.53 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.279 2.371 . . . . 0.0 114.603 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 45.4 p -71.49 147.15 48.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.776 1.788 . . . . 0.0 111.907 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.31 139.76 50.85 Favored 'General case' 0 CA--C 1.522 -0.103 0 O-C-N 120.829 -1.169 . . . . 0.0 109.823 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -127.96 135.17 49.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -123.85 130.7 53.03 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -126.12 126.83 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.88 -88.02 0.1 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 125.506 1.754 . . . . 0.0 110.678 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.55 141.22 32.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.069 -0.665 . . . . 0.0 111.966 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.61 126.14 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.256 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.9 158.93 29.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.879 0.472 . . . . 0.0 112.176 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -53.07 -30.05 33.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -63.5 -39.21 93.84 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.924 -1.11 . . . . 0.0 111.005 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.42 -7.22 10.54 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 116.882 -2.066 . . . . 0.0 114.159 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.04 152.74 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.73 1.765 . . . . 0.0 109.757 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -152.18 145.83 24.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.927 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.89 156.31 22.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.941 174.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.63 -169.11 30.75 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-O 122.588 1.104 . . . . 0.0 113.345 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 10.8 p -133.3 129.84 38.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.583 -1.309 . . . . 0.0 112.008 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -122.87 121.26 35.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 122.012 0.91 . . . . 0.0 111.066 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -121.07 132.62 70.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.6 146.93 40.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.69 -16.64 18.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.57 144.42 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 112.387 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.5 158.22 42.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.625 -1.297 . . . . 0.0 111.383 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.484 ' CG ' HH12 ' B' ' 114' ' ' ARG . 8.6 m-20 -69.7 -26.57 64.42 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -140.71 83.44 14.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.689 1.996 . . . . 0.0 109.586 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.58 177.46 7.45 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.19 2.593 . . . . 0.0 110.532 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.98 -27.04 3.36 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.285 -0.885 . . . . 0.0 113.382 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -142.68 23.64 1.92 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.879 1.672 . . . . 0.0 110.666 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.62 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.986 1.374 . . . . 0.0 111.35 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 170.03 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.944 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.21 126.24 18.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.397 2.279 . . . . 0.0 112.184 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.4 m -104.88 120.62 49.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.985 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -55.33 150.23 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.732 2.288 . . . . 0.0 111.818 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.23 149.61 47.28 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.985 0.914 . . . . 0.0 110.302 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.74 149.34 29.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.342 2.257 . . . . 0.0 108.884 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.53 -156.94 28.36 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 120.246 1.385 . . . . 0.0 111.358 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.4 148.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 125.21 1.182 . . . . 0.0 111.612 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 153.92 51.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.748 -1.22 . . . . 0.0 113.061 175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -101.83 147.51 26.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 16.71 1.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.37 1.468 . . . . 0.0 113.394 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -92.85 -40.2 10.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.165 1.786 . . . . 0.0 111.899 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.55 174.31 8.44 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.087 0.867 . . . . 0.0 111.979 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -70.36 -50.15 41.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.126 1.37 . . . . 0.0 112.688 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.43 63.74 70.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.108 0.963 . . . . 0.0 112.107 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -66.73 172.95 8.71 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.446 3.43 . . . . 0.0 116.407 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.306 0.4 OUTLIER -98.9 167.85 10.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.662 1.22 . . . . 0.0 110.823 173.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.83 162.26 29.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.866 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.62 143.8 9.05 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -160.08 153.37 22.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -91.29 151.54 20.85 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.218 1.807 . . . . 0.0 109.485 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.67 120.82 51.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.57 117.42 34.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -82.04 136.4 35.23 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.98 -1.7 . . . . 0.0 114.402 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -97.06 -44.22 7.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.896 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -75.12 -19.29 59.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.833 0.853 . . . . 0.0 112.495 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.44 133.35 14.1 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.832 2.853 . . . . 0.0 107.412 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -77.93 118.91 20.69 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.17 1.35 . . . . 0.0 111.895 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.6 p -176.69 164.32 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.957 2.103 . . . . 0.0 107.18 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.32 135.69 18.01 Favored 'General case' 0 CA--C 1.473 -1.991 0 CA-C-O 122.244 1.021 . . . . 0.0 108.668 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . 0.251 5.2 m -135.88 130.06 33.25 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.337 -169.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.94 154.87 5.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -129.16 143.82 50.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 117.45 4.75 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.35 -177.71 34.68 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 115.951 1.14 . . . . 0.0 115.951 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.22 138.28 54.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.374 0.691 . . . . 0.0 110.456 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.8 112.82 24.57 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.32 168.95 8.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.699 1.238 . . . . 0.0 109.973 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -123.24 109.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.497 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -58.66 158.26 8.14 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -43.56 -35.91 1.88 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.727 2.491 . . . . 0.0 117.727 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -20.51 61.44 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.92 19.73 12.53 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.734 1.159 . . . . 0.0 113.434 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 149.62 26.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.169 1.788 . . . . 0.0 109.097 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -101.36 145.45 28.9 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.401 1.481 . . . . 0.0 110.128 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 23.3 m -147.77 160.21 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.234 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 mt -121.86 117.24 26.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.41 111.37 23.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.0 p -130.93 166.33 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.127 1.917 . . . . 0.0 111.907 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -119.64 168.19 11.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.109 172.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -141.95 157.81 44.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.086 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -135.1 127.29 30.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 136.51 47.28 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 124.882 1.364 . . . . 0.0 111.583 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.15 113.88 21.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.871 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 23.2 m -78.15 164.91 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 124.925 1.391 . . . . 0.0 111.814 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 71.8 m -108.9 87.23 2.44 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 103.009 -2.959 . . . . 0.0 103.009 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.08 -174.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -122.5 7.49 9.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.57 145.68 31.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.293 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.94 -30.72 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.114 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.14 17.03 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.279 1.419 . . . . 0.0 114.902 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.93 3.37 10.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.389 1.095 . . . . 0.0 112.86 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.17 -32.84 74.33 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.228 -0.92 . . . . 0.0 113.261 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -45.29 -41.83 9.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.307 1.043 . . . . 0.0 113.694 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -97.29 -9.65 27.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -0.81 19.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.09 141.91 45.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.358 0.663 . . . . 0.0 111.545 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.484 HH12 ' CG ' ' B' ' 39' ' ' ASP . 35.2 mtp180 -138.4 148.37 44.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.624 1.57 . . . . 0.0 110.114 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.33 149.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 120.594 1.543 . . . . 0.0 109.727 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.69 27.36 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 124.04 0.828 . . . . 0.0 111.694 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 28.6 p90 -129.93 157.11 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.062 0.545 . . . . 0.0 110.096 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -148.68 145.0 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.81 129.1 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -116.88 149.79 39.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.752 0.786 . . . . 0.0 110.944 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 81.6 p -135.18 158.44 44.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.957 0.903 . . . . 0.0 110.014 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 129.53 41.67 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.218 -0.926 . . . . 0.0 110.762 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.1 tp -86.72 132.6 33.82 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.705 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 73.71 168.05 0.3 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.818 1.647 . . . . 0.0 110.416 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t 174.19 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.458 1.903 . . . . 0.0 109.845 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 72.14 -174.17 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.894 1.677 . . . . 0.0 109.928 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -87.36 -51.43 5.95 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.826 0.739 . . . . 0.0 111.655 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.881 1 C-N-CA 134.46 5.104 . . . . 0.0 105.849 -174.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 117.922 -1.037 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.0 168.79 22.83 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.001 1.321 . . . . 0.0 109.431 -174.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . 0.267 17.1 m 43.98 31.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -116.84 -174.42 2.57 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.656 2.382 . . . . 0.0 109.906 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . 0.456 ' HB2' HH11 ' C' ' 2' ' ' ARG . 1.0 OUTLIER 81.88 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.756 2.022 . . . . 0.0 109.825 -174.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -154.21 152.15 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.426 1.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 23.8 p -147.88 147.43 29.74 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.815 0.697 . . . . 0.0 111.386 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.4 p -139.63 126.82 21.19 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -67.69 -29.1 68.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -67.58 102.14 1.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.31 0.11 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 73.2 140.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.637 2.375 . . . . 0.0 113.997 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -137.81 162.73 33.19 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.969 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.9 t -139.45 148.06 42.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.553 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -108.12 152.94 23.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.661 0.784 . . . . 0.0 111.553 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.0 -26.14 65.75 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.6 tp -72.41 -16.15 61.84 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.581 1.953 . . . . 0.0 110.956 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.4 -6.66 34.08 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 127.497 2.475 . . . . 0.0 114.451 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 73.2 p -70.67 148.45 48.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.87 1.835 . . . . 0.0 112.114 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.3 139.62 52.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 120.867 -1.146 . . . . 0.0 109.962 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -128.1 135.81 50.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.44 130.82 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.84 126.29 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.01 -87.64 0.09 OUTLIER Glycine 0 CA--C 1.526 0.74 0 O-C-N 125.41 1.694 . . . . 0.0 110.769 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.53 141.04 32.01 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.233 -0.569 . . . . 0.0 111.387 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.77 125.07 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.155 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -64.93 158.28 25.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.236 0.615 . . . . 0.0 112.252 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 17.6 t -53.74 -28.39 34.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -63.47 -37.15 86.2 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.805 -1.184 . . . . 0.0 111.005 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.31 -4.86 15.47 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.673 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 154.13 38.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.023 1.412 . . . . 0.0 111.287 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -151.71 154.39 36.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.934 0.873 . . . . 0.0 112.278 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -118.34 156.2 29.33 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.538 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -168.79 30.46 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 122.157 0.865 . . . . 0.0 113.52 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -133.45 130.08 38.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.778 -1.211 . . . . 0.0 112.018 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -125.09 120.96 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.627 1.203 . . . . 0.0 111.416 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -119.93 132.66 69.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.2 146.1 42.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.52 -13.89 22.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.34 144.44 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.737 1.215 . . . . 0.0 113.357 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.82 158.55 43.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.282 -1.511 . . . . 0.0 111.645 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . 0.487 ' CG ' HH12 ' C' ' 114' ' ' ARG . 8.3 m-20 -70.46 -26.01 63.44 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -140.84 83.09 14.66 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.552 1.941 . . . . 0.0 109.709 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.6 177.4 7.53 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.089 2.526 . . . . 0.0 110.605 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.27 -27.58 3.26 Favored Glycine 0 N--CA 1.476 1.348 0 O-C-N 121.345 -0.847 . . . . 0.0 113.412 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.99 23.12 2.07 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.893 1.677 . . . . 0.0 110.589 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.95 106.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 122.946 1.355 . . . . 0.0 111.631 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.1 t -113.63 169.56 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.005 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.36 126.89 20.54 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.507 2.323 . . . . 0.0 111.707 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.09 120.09 50.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.336 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.78 149.78 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.461 2.107 . . . . 0.0 111.432 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.66 153.05 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 109.917 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.65 149.31 26.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.859 2.064 . . . . 0.0 109.72 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.6 -155.64 26.96 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 119.207 0.912 . . . . 0.0 113.863 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -146.41 148.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.846 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 153.04 50.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.304 -1.497 . . . . 0.0 112.869 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -101.11 147.46 26.2 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 16.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.019 1.328 . . . . 0.0 113.493 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -92.95 -40.0 10.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.737 1.615 . . . . 0.0 112.06 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.57 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.825 0.85 . . . . 0.0 113.048 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 34.3 t -69.2 -48.47 61.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.429 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.61 64.82 69.61 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.241 1.017 . . . . 0.0 112.614 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -66.22 173.29 7.59 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.497 3.465 . . . . 0.0 116.931 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.305 0.5 OUTLIER -99.18 168.28 10.15 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.504 1.621 . . . . 0.0 111.13 173.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -162.24 162.0 28.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.937 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.63 143.83 9.08 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 118.075 1.99 . . . . 0.0 118.075 -172.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -160.42 152.42 20.18 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -90.01 154.36 19.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.367 1.867 . . . . 0.0 109.242 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -132.64 121.09 44.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.29 115.83 30.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 117.972 0.351 . . . . 0.0 110.12 -174.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.02 135.88 36.47 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -96.38 -44.25 7.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.929 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -74.91 -19.67 60.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.789 0.836 . . . . 0.0 112.563 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -152.35 133.1 14.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.83 2.852 . . . . 0.0 107.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -77.78 118.93 20.6 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.39 1.45 . . . . 0.0 111.974 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 78.7 p -176.51 164.64 2.57 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 126.868 2.067 . . . . 0.0 107.201 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.64 135.45 17.45 Favored 'General case' 0 CA--C 1.475 -1.942 0 CA-C-O 122.593 1.187 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.0 m -135.55 130.07 34.0 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 110.761 -2.927 . . . . 0.0 111.706 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.28 154.81 5.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.676 0.274 . . . . 0.0 110.328 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -128.87 144.0 51.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.81 116.88 4.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.45 -176.98 33.14 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.09 137.82 54.52 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.417 0.716 . . . . 0.0 110.575 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.88 112.85 24.61 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 117.232 -1.366 . . . . 0.0 108.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.17 168.94 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.123 1.369 . . . . 0.0 109.973 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -124.32 109.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.989 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.88 160.17 10.08 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -44.56 -31.92 1.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.02 -25.55 58.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.63 -3.74 19.66 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.909 1.242 . . . . 0.0 114.18 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 145.44 55.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.605 1.962 . . . . 0.0 111.684 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -101.14 140.75 35.0 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.668 1.987 . . . . 0.0 109.902 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 m -144.78 160.1 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.608 1.163 . . . . 0.0 110.954 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 mt -120.7 116.98 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -106.13 110.69 23.02 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -130.94 166.03 21.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 123.625 1.679 . . . . 0.0 112.029 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -119.17 168.72 10.59 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -142.21 158.18 44.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.136 172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.66 127.27 28.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.609 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.58 137.31 45.84 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 124.704 1.253 . . . . 0.0 111.449 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.98 113.87 20.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.798 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -77.89 165.85 23.61 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.891 1.369 . . . . 0.0 111.985 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 69.5 m -109.89 87.24 2.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.33 -172.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.284 -0.885 . . . . 0.0 108.658 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -124.88 7.86 8.08 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.94 145.98 30.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.031 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.29 -31.22 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.559 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.03 6.22 14.64 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.187 1.375 . . . . 0.0 115.471 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -120.61 3.27 10.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.615 1.207 . . . . 0.0 113.089 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.51 -32.63 74.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.296 -0.877 . . . . 0.0 112.948 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -45.64 -41.4 10.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -97.56 -9.83 26.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.159 0.984 . . . . 0.0 113.557 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -0.47 17.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.097 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.64 141.92 45.85 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.433 0.693 . . . . 0.0 111.547 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.487 HH12 ' CG ' ' C' ' 39' ' ' ASP . 35.0 mtp180 -138.65 148.02 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.522 1.529 . . . . 0.0 109.79 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.78 149.32 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 120.655 1.57 . . . . 0.0 109.664 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.69 -176.26 28.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.753 0.692 . . . . 0.0 111.572 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 28.7 p90 -129.7 156.71 43.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.069 0.548 . . . . 0.0 110.336 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -148.12 145.17 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.963 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.55 129.37 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.98 149.85 40.25 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.411 -0.806 . . . . 0.0 110.265 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.9 p -132.11 158.93 40.37 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.377 -0.827 . . . . 0.0 110.215 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 125.85 25.3 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 122.115 -0.366 . . . . 0.0 110.089 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.46 104.44 0.79 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.578 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 84.42 44.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.885 2.074 . . . . 0.0 114.837 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 33.7 p -112.6 151.86 29.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.05 1.295 . . . . 0.0 114.4 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -155.81 -20.44 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -139.86 166.26 25.12 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.566 1.546 . . . . 0.0 110.42 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.398 0 C-N-CA 128.993 2.917 . . . . 0.0 113.808 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 49.5 -153.66 0.12 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 117.683 -1.151 . . . . 0.0 110.944 -173.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.5 t 56.88 -44.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 130.47 3.508 . . . . 0.0 118.372 174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 59.53 -152.27 0.4 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.008 1.723 . . . . 0.0 112.75 -174.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.27 1.8 ptp180 161.89 66.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 130.665 3.586 . . . . 0.0 110.867 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -150.29 140.13 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.875 1.27 . . . . 0.0 112.316 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.22 147.18 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.419 1.104 . . . . 0.0 109.152 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.406 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 69.6 m -139.27 126.71 21.6 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.764 -1.21 . . . . 0.0 111.568 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.08 -25.3 62.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.68 122.15 9.29 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.163 1.458 . . . . 0.0 110.598 174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.63 -118.02 2.38 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.805 2.145 . . . . 0.0 109.154 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -141.53 156.1 45.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.533 1.133 . . . . 0.0 113.37 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.68 160.85 39.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.901 -1.954 . . . . 0.0 111.201 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -139.86 142.24 36.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.84 147.29 31.11 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.713 0.805 . . . . 0.0 112.227 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.0 tp -72.92 -15.59 61.57 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.16 1.384 . . . . 0.0 111.8 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.76 -16.63 21.01 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.547 2.499 . . . . 0.0 113.593 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -61.28 146.57 47.46 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.517 1.151 . . . . 0.0 113.076 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -121.4 139.25 53.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.646 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -131.66 145.63 51.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 111.585 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -129.87 132.73 46.53 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.223 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.58 126.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.39 -95.03 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 O-C-N 124.22 0.95 . . . . 0.0 112.274 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.58 126.89 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.436 -1.038 . . . . 0.0 110.529 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.44 139.3 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.01 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -75.14 166.44 23.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.108 0.963 . . . . 0.0 112.959 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.4 t -56.42 -34.51 66.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.982 1.313 . . . . 0.0 113.358 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -68.91 -35.59 77.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.593 -1.317 . . . . 0.0 111.54 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.68 -6.48 9.71 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.83 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.19 142.62 56.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.439 1.496 . . . . 0.0 111.98 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -155.53 147.47 23.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.731 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 163.73 13.28 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.87 -166.87 29.54 Favored Glycine 0 C--O 1.238 0.378 0 O-C-N 121.335 -0.853 . . . . 0.0 111.895 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -140.01 128.65 23.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.937 -1.132 . . . . 0.0 111.788 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -103.82 137.57 41.65 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.231 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 mt -128.64 126.17 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 37' ' ' VAL . 15.3 m -104.99 140.75 37.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.733 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.28 -2.42 33.76 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.477 ' H ' HG21 ' A' ' 35' ' ' THR . 30.4 m -138.54 163.43 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.616 1.966 . . . . 0.0 111.446 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.37 16.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.834 -1.791 . . . . 0.0 112.857 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -69.46 -47.04 65.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -124.86 79.41 64.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.18 2.992 . . . . 0.0 110.202 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.24 25.42 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 124.825 3.683 . . . . 0.0 116.591 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.36 0.75 63.02 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.107 -1.621 . . . . 0.0 115.799 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.76 30.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -49.03 131.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.034 -1.666 . . . . 0.0 112.399 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.17 165.26 27.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.886 2.074 . . . . 0.0 108.707 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.24 131.04 19.91 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.78 1.632 . . . . 0.0 111.656 174.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 p -108.5 122.66 39.63 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.163 0.506 . . . . 0.0 112.206 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.56 145.36 89.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.151 2.567 . . . . 0.0 111.997 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -133.78 156.6 47.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.553 0.741 . . . . 0.0 112.45 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -158.86 149.06 19.51 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.448 2.299 . . . . 0.0 109.366 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.35 -153.76 23.5 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 120.461 1.482 . . . . 0.0 110.345 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -146.39 138.17 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.493 1.117 . . . . 0.0 112.026 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -122.19 141.27 51.64 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.899 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -57.06 -52.39 65.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.635 0.374 . . . . 0.0 111.152 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HE3' ' OG ' ' A' ' 5' ' ' SER . 16.7 tptm 52.58 -0.76 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.339 2.256 . . . . 0.0 116.363 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -75.08 -56.29 4.89 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.747 2.019 . . . . 0.0 113.408 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.26 173.35 12.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.81 0.814 . . . . 0.0 110.933 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -73.42 -28.93 62.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.471 1.108 . . . . 0.0 113.749 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -141.81 46.47 0.82 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.296 1.439 . . . . 0.0 112.15 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.39 -177.45 3.46 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.127 2.551 . . . . 0.0 114.245 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.3 p -84.91 167.77 15.64 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.143 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.86 159.38 15.89 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.484 1.114 . . . . 0.0 111.277 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.91 148.18 14.71 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.62 162.82 35.3 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -100.59 146.88 26.58 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 127.127 2.171 . . . . 0.0 109.413 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.34 117.0 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -98.65 106.56 18.84 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.893 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.329 52.4 m95 -67.93 158.87 31.75 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 121.56 1.982 . . . . 0.0 115.197 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -39.26 4.02 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -90.44 -11.99 38.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -152.42 143.6 23.19 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.076 2.55 . . . . 0.0 106.393 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.61 118.53 15.65 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.042 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -171.45 164.85 7.0 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.504 1.522 . . . . 0.0 111.644 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -146.99 138.76 24.33 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 123.867 1.794 . . . . 0.0 110.468 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.35 127.26 27.57 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 109.579 -3.464 . . . . 0.0 109.715 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.23 155.87 6.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.011 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.97 139.94 52.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 113.9 5.26 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.38 176.42 29.84 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.04 -1.076 . . . . 0.0 115.509 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 9.7 tt0 -118.05 146.69 43.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.178 -1.511 . . . . 0.0 108.934 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.8 t -97.09 129.61 44.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.368 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -125.72 167.87 14.55 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.867 1.318 . . . . 0.0 112.333 177.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.5 119.02 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 112.668 -2.06 . . . . 0.0 106.7 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -58.44 154.14 14.44 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.47 -23.58 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -7.34 58.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.554 1.142 . . . . 0.0 113.998 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.56 36.93 8.33 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.995 0.809 . . . . 0.0 113.981 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.73 151.91 35.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.868 1.267 . . . . 0.0 110.85 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -101.33 146.33 27.71 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 111.059 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.416 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.9 m -148.17 160.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.329 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.5 mt -121.43 115.64 23.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -105.71 110.65 23.03 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -126.02 166.61 16.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.886 1.327 . . . . 0.0 110.528 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.97 170.9 8.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -144.64 159.24 43.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.215 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -137.72 123.24 19.66 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.451 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 137.79 44.96 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 125.569 1.793 . . . . 0.0 113.185 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -120.16 119.36 33.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.934 2.021 . . . . 0.0 111.762 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -86.25 160.11 19.26 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.309 1.006 . . . . 0.0 110.815 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m -103.43 82.17 2.01 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.16 -12.84 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.41 -29.47 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.3 137.12 51.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.025 1.284 . . . . 0.0 112.383 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.409 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.8 tt -62.5 -25.6 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.31 -3.76 33.42 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.628 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -124.69 3.16 8.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.396 1.078 . . . . 0.0 113.879 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -34.85 60.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.364 -0.835 . . . . 0.0 112.377 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.614 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 55.6 p-90 -49.95 -44.94 50.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.767 1.227 . . . . 0.0 113.542 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.614 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -89.58 -10.78 44.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.387 -0.82 . . . . 0.0 112.429 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.35 -0.05 24.17 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -118.61 146.25 44.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.19 0.596 . . . . 0.0 111.765 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.56 151.66 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.789 1.636 . . . . 0.0 110.498 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.32 148.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.224 1.375 . . . . 0.0 111.556 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.02 -176.8 27.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 122.55 1.083 . . . . 0.0 112.638 175.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -122.15 152.68 39.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.86 0.864 . . . . 0.0 108.812 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -149.63 132.82 16.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.104 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -124.95 121.32 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.585 -0.697 . . . . 0.0 110.725 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -110.38 151.55 27.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.776 -1.557 . . . . 0.0 110.396 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -133.54 160.25 38.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.281 1.032 . . . . 0.0 109.491 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -57.97 110.47 0.93 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.97 117.35 8.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.502 HH11 ' HB3' ' A' ' 124' ' ' ARG . 0.0 OUTLIER 177.54 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.3 t -141.75 164.71 29.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -104.6 150.81 24.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 109.365 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 159.81 43.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.96 1.704 . . . . 0.0 110.077 -173.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 176.087 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 31.6 mm-40 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 116.368 -1.777 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 6.1 m 14.1 88.86 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 128.786 2.834 . . . . 0.0 116.65 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.68 140.28 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.405 1.082 . . . . 0.0 110.899 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -146.35 -58.98 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.725 0.81 . . . . 0.0 110.86 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 47.58 31.76 2.18 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.518 1.127 . . . . 0.0 113.545 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -152.56 144.97 24.04 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.479 1.512 . . . . 0.0 111.821 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 p -116.32 144.43 44.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.054 0.942 . . . . 0.0 108.763 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 59.5 m -139.56 126.91 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.405 -1.434 . . . . 0.0 113.178 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.08 -26.99 64.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.5 121.38 7.59 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.009 1.385 . . . . 0.0 110.47 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.38 -117.9 2.25 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.844 2.164 . . . . 0.0 109.512 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -143.87 152.37 41.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.219 1.008 . . . . 0.0 113.337 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -142.16 158.05 44.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.255 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -136.46 144.95 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.661 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.12 146.58 35.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.553 0.741 . . . . 0.0 112.299 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.13 -23.3 67.38 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.63 -14.69 61.66 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.027 1.331 . . . . 0.0 112.047 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -14.55 31.61 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.564 2.507 . . . . 0.0 113.563 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.34 149.59 41.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.759 1.266 . . . . 0.0 113.059 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -125.12 142.18 51.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.028 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -133.02 143.87 49.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.407 0.622 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -128.38 131.93 48.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.224 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.72 127.14 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -95.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.451 1.094 . . . . 0.0 112.358 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -137.87 127.09 24.49 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.46 -1.024 . . . . 0.0 110.797 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.86 139.96 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.233 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.68 164.1 25.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.974 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.9 t -54.58 -34.22 61.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.178 1.391 . . . . 0.0 114.166 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -66.94 -35.66 80.47 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.288 -1.507 . . . . 0.0 111.545 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.1 -6.21 9.44 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 124.408 1.004 . . . . 0.0 114.313 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.12 147.56 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.17 162.86 40.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.577 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.72 168.15 14.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.14 -164.9 29.9 Favored Glycine 0 C--O 1.238 0.396 0 O-C-N 120.184 -1.573 . . . . 0.0 112.082 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -140.54 128.0 21.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.133 0.968 . . . . 0.0 112.058 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -104.71 138.45 40.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.86 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.49 126.56 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' THR . . . . . 0.475 HG21 ' H ' ' D' ' 37' ' ' VAL . 16.4 m -105.06 141.15 37.14 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.703 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.08 -2.75 33.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.475 ' H ' HG21 ' D' ' 35' ' ' THR . 26.8 m -138.2 163.85 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.41 1.884 . . . . 0.0 111.142 -174.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.32 167.78 15.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.917 -1.74 . . . . 0.0 112.655 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -69.88 -46.56 65.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.284 1.034 . . . . 0.0 108.261 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -125.37 79.16 67.02 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.985 2.914 . . . . 0.0 110.121 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.85 24.47 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.937 3.758 . . . . 0.0 116.59 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.67 60.35 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.182 -1.574 . . . . 0.0 115.915 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.34 29.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mt -48.99 131.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.019 -1.676 . . . . 0.0 112.417 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 164.89 28.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.877 2.071 . . . . 0.0 108.821 174.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.01 130.66 18.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.656 1.582 . . . . 0.0 111.456 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -107.98 122.73 39.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 121.388 0.613 . . . . 0.0 112.408 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.22 144.76 89.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.919 2.412 . . . . 0.0 111.582 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -131.41 164.11 26.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.62 0.768 . . . . 0.0 112.305 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 149.03 8.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.226 1.811 . . . . 0.0 109.483 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.48 -156.28 27.71 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 120.858 1.663 . . . . 0.0 112.952 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mt -146.13 137.11 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.246 1.018 . . . . 0.0 111.486 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -122.13 140.9 52.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.478 1.511 . . . . 0.0 108.578 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' D' ' 58' ' ' ARG . 14.0 m170 -57.14 -50.96 71.19 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.068 -0.395 . . . . 0.0 111.353 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 tptm 51.61 2.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.507 2.323 . . . . 0.0 116.156 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' D' ' 54' ' ' HIS . 27.2 mtt180 -78.81 -56.32 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.129 2.171 . . . . 0.0 113.568 -176.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.65 173.62 12.4 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.467 1.104 . . . . 0.0 111.371 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -74.03 -27.06 60.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.682 -1.151 . . . . 0.0 113.969 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -143.01 48.53 1.01 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 125.2 1.4 . . . . 0.0 112.754 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.8 -177.65 3.49 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.221 2.614 . . . . 0.0 114.939 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -85.51 168.3 14.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.492 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.37 159.84 15.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 111.148 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.13 148.5 15.19 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -159.85 162.66 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -100.6 149.6 23.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.238 2.215 . . . . 0.0 109.01 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -129.1 117.81 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -100.17 107.45 19.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.746 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.336 50.9 m95 -68.68 158.24 34.55 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.102 1.774 . . . . 0.0 115.334 -172.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.35 4.26 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.09 -12.03 36.85 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -152.31 143.9 23.48 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.104 2.562 . . . . 0.0 106.305 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.84 118.53 15.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.101 0.864 . . . . 0.0 110.413 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 90.3 p -171.73 165.19 6.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.352 1.461 . . . . 0.0 111.903 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -146.9 139.2 24.75 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.459 1.6 . . . . 0.0 110.447 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.31 25.94 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 109.631 -3.44 . . . . 0.0 109.856 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.03 155.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.232 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.38 140.24 51.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.76 114.45 5.31 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 178.69 29.28 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.946 -1.121 . . . . 0.0 115.8 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . 0.444 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 12.2 tt0 -120.08 144.91 47.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.456 -1.372 . . . . 0.0 109.17 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 41.4 t -97.31 128.74 44.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.542 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 0.4 OUTLIER -121.61 168.87 11.27 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.792 1.282 . . . . 0.0 111.299 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.28 118.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 112.823 -1.99 . . . . 0.0 106.994 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -58.67 154.87 13.65 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.38 -25.28 0.98 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -6.28 59.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.296 1.039 . . . . 0.0 113.746 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 27.25 20.88 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.544 1.545 . . . . 0.0 114.185 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' D' ' 90' ' ' LYS . 7.1 mtpm? -106.35 153.12 22.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 111.884 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -101.42 145.92 28.3 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 123.328 1.537 . . . . 0.0 110.871 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 106' ' ' ILE . 17.6 m -148.57 159.56 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.643 175.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.2 115.28 23.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -105.9 109.84 21.92 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -125.25 167.33 15.02 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.941 1.353 . . . . 0.0 111.163 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.99 171.14 8.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 159.23 43.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.297 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tp -137.93 123.23 19.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.265 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.7 138.51 43.8 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 125.521 1.763 . . . . 0.0 113.005 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -120.97 117.77 28.14 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 125.898 1.999 . . . . 0.0 111.858 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -83.93 159.99 21.17 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 124.688 1.243 . . . . 0.0 110.977 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -104.22 82.97 2.01 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.0 -12.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 63.93 -28.22 0.09 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.71 136.5 53.32 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.93 1.241 . . . . 0.0 112.301 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . 0.416 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.3 tt -62.09 -25.15 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.04 -4.09 33.34 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.546 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -124.94 3.07 8.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.494 1.117 . . . . 0.0 113.769 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -34.83 57.75 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.333 -0.854 . . . . 0.0 113.053 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . 0.629 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 56.3 p-90 -49.72 -45.69 49.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.7 1.2 . . . . 0.0 113.287 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . 0.629 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.3 OUTLIER -89.06 -11.3 44.49 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.451 -0.781 . . . . 0.0 112.451 177.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.3 23.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 7.6 m -118.24 145.99 44.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.288 0.635 . . . . 0.0 111.884 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.77 151.86 40.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.85 1.66 . . . . 0.0 110.773 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.04 148.68 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 120.13 1.332 . . . . 0.0 111.675 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.21 -177.19 28.23 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 122.465 1.036 . . . . 0.0 112.912 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -120.96 152.88 38.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.778 0.831 . . . . 0.0 109.053 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -149.5 133.41 17.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.225 -174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 48.8 mt -126.09 122.63 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.259 1.028 . . . . 0.0 110.714 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -112.55 148.77 33.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.465 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 16.4 p -133.43 160.3 37.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.424 1.09 . . . . 0.0 109.844 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -55.88 115.62 2.49 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.132 0.573 . . . . 0.0 109.778 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . 0.425 ' C ' ' CD2' ' D' ' 123' ' ' LEU . 3.6 tt -80.01 98.6 7.27 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.6 139.7 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.908 0.483 . . . . 0.0 112.282 173.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' THR . . . . . 0.487 HG21 ' H ' ' D' ' 126' ' ' GLN . 1.7 m 56.0 -160.75 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.427 1.079 . . . . 0.0 110.146 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . 0.487 ' H ' HG21 ' D' ' 125' ' ' THR . 0.0 OUTLIER -136.67 -177.42 4.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.023 1.329 . . . . 0.0 108.254 173.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.96 173.06 12.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.089 1.756 . . . . 0.0 109.591 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.556 0 C-N-CA 125.62 1.568 . . . . 0.0 114.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.6 t -69.97 51.44 0.11 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.771 1.628 . . . . 0.0 114.349 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.04 144.77 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.134 -1.603 . . . . 0.0 111.865 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.23 160.02 33.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -167.98 25.52 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.153 1.781 . . . . 0.0 112.323 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -154.69 142.45 19.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.145 1.378 . . . . 0.0 111.046 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 p -116.46 144.43 44.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.207 1.003 . . . . 0.0 109.736 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 m -139.5 126.81 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.433 -1.417 . . . . 0.0 113.012 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.06 -27.77 62.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -53.17 116.62 2.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.764 1.226 . . . . 0.0 110.385 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.6 -121.14 2.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.974 1.749 . . . . 0.0 109.793 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -143.08 153.4 42.88 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.919 1.288 . . . . 0.0 113.224 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -143.31 160.23 40.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.707 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -138.28 145.14 40.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.677 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -112.11 146.17 38.48 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.478 0.711 . . . . 0.0 112.34 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.13 -24.38 67.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.06 -14.4 62.31 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 112.029 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.96 -13.78 31.7 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.805 2.621 . . . . 0.0 113.738 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -63.64 149.47 46.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.842 1.306 . . . . 0.0 112.865 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -125.38 140.68 52.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.011 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -131.89 145.58 51.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.745 0.784 . . . . 0.0 112.408 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -129.22 133.63 47.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.015 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.03 127.56 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -93.75 0.07 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.922 0.764 . . . . 0.0 112.124 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.46 127.01 21.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.266 -1.138 . . . . 0.0 110.351 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.23 139.12 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.88 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -75.36 167.07 22.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.781 0.832 . . . . 0.0 112.914 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -56.81 -34.37 67.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.01 1.324 . . . . 0.0 113.352 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -68.78 -36.19 77.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.281 -1.512 . . . . 0.0 111.476 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.77 -6.68 9.61 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.786 -1.563 . . . . 0.0 114.858 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -65.99 142.61 57.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.448 1.499 . . . . 0.0 112.45 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.75 147.94 23.56 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.553 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.32 163.09 14.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 174.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.26 -166.86 29.0 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 121.296 -0.877 . . . . 0.0 111.867 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -140.62 128.73 22.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.967 -1.117 . . . . 0.0 111.88 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -103.82 137.92 41.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.101 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -129.25 126.17 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.482 HG21 ' H ' ' B' ' 37' ' ' VAL . 15.4 m -105.11 141.37 36.78 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.853 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.67 -2.27 33.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.482 ' H ' HG21 ' B' ' 35' ' ' THR . 26.9 m -138.5 163.29 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.534 1.933 . . . . 0.0 111.223 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.21 167.7 15.91 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.006 -1.684 . . . . 0.0 112.879 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -70.71 -44.86 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 108.493 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -126.61 79.04 72.02 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 129.035 2.934 . . . . 0.0 109.843 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.08 24.82 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.786 3.658 . . . . 0.0 116.602 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.84 0.63 61.32 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.157 -1.589 . . . . 0.0 115.877 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.45 29.96 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 30.5 mt -49.13 130.94 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 119.899 -1.75 . . . . 0.0 112.445 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.72 165.21 28.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.76 2.024 . . . . 0.0 108.59 174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.48 131.44 20.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.843 1.657 . . . . 0.0 111.806 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 7.3 p -109.54 122.61 38.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.183 0.516 . . . . 0.0 111.53 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.3 145.3 88.07 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.211 2.607 . . . . 0.0 111.92 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.83 156.21 48.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.587 0.755 . . . . 0.0 112.441 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -158.38 149.11 20.41 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.506 2.322 . . . . 0.0 109.483 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.11 -153.79 23.65 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 120.612 1.551 . . . . 0.0 110.254 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mt -146.13 138.48 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.51 1.124 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.73 140.59 52.71 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.082 -1.011 . . . . 0.0 108.681 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -56.47 -52.2 65.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.844 0.458 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tptm 52.87 0.28 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.488 2.315 . . . . 0.0 116.284 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -77.29 -56.3 4.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.137 2.175 . . . . 0.0 113.745 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.73 173.46 12.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 124.288 0.992 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -74.21 -26.26 60.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 117.206 -1.378 . . . . 0.0 113.903 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -143.67 48.74 0.98 Allowed Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 125.465 1.506 . . . . 0.0 112.709 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 -178.62 3.96 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.11 2.54 . . . . 0.0 114.848 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 70.4 p -84.54 167.77 16.02 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.24 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.84 159.83 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.452 1.101 . . . . 0.0 111.285 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.37 148.11 14.35 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -159.66 163.11 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -101.1 147.48 26.18 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.67 1.988 . . . . 0.0 109.303 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.58 117.05 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -98.45 107.03 19.39 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.662 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.331 52.5 m95 -68.31 158.77 32.72 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.594 1.997 . . . . 0.0 114.982 -173.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -38.89 4.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -174.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -90.96 -12.01 37.27 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -152.31 143.24 23.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.038 2.535 . . . . 0.0 106.433 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -72.9 118.39 15.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.081 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -170.92 164.94 7.75 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.742 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.61 138.92 24.94 Favored 'General case' 0 CA--C 1.48 -1.73 0 CA-C-O 123.473 1.606 . . . . 0.0 110.493 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.74 127.36 27.02 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 110.042 -3.254 . . . . 0.0 109.54 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -105.18 155.75 6.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.145 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.21 140.43 51.91 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.01 114.23 5.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.406 0.622 . . . . 0.0 109.327 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.34 178.26 29.64 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 120.072 -1.061 . . . . 0.0 115.587 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 10.8 tt0 -119.83 144.91 47.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.301 -1.449 . . . . 0.0 109.157 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.21 128.73 44.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.724 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 0.4 OUTLIER -121.81 168.82 11.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.913 1.34 . . . . 0.0 110.977 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.3 118.94 57.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.636 -2.075 . . . . 0.0 106.627 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.31 153.56 15.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.48 -26.15 0.53 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.14 -9.44 59.19 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 31.37 10.58 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.521 1.057 . . . . 0.0 114.531 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.26 152.71 24.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.999 1.319 . . . . 0.0 110.85 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -101.43 146.05 28.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.495 1.518 . . . . 0.0 110.99 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.415 HG21 ' CD1' ' C' ' 106' ' ' ILE . 17.8 m -147.62 159.72 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.956 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 67.1 mt -119.44 115.27 23.73 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -105.88 110.65 23.01 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -126.56 167.11 16.1 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.007 1.384 . . . . 0.0 110.81 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 170.85 8.92 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -144.72 158.97 43.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.494 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -137.51 123.21 19.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.416 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.53 137.76 44.99 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 125.66 1.85 . . . . 0.0 113.299 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -120.93 117.1 26.46 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 125.937 2.023 . . . . 0.0 111.94 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 160.43 21.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.541 1.151 . . . . 0.0 111.137 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 3.6 m -104.33 83.35 2.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.46 -12.69 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 t30 64.07 -29.85 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.47 136.16 52.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.152 0.977 . . . . 0.0 112.515 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 2.5 tt -62.42 -26.58 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.12 -3.61 24.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.453 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 5.0 m-20 -124.64 3.34 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.53 1.132 . . . . 0.0 113.874 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -35.76 58.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.226 -0.922 . . . . 0.0 112.306 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.624 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 54.9 p-90 -49.6 -45.24 47.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.378 1.071 . . . . 0.0 113.686 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.624 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -89.39 -11.04 44.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.621 0.768 . . . . 0.0 112.686 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.47 -0.32 25.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.427 -0.797 . . . . 0.0 113.078 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -118.02 146.19 44.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.769 0.713 . . . . 0.0 111.738 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.24 151.75 39.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.785 1.634 . . . . 0.0 110.415 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.19 148.37 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.01 -176.86 27.7 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 122.536 1.076 . . . . 0.0 112.79 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -121.52 153.43 37.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.565 -0.817 . . . . 0.0 108.985 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.1 133.72 16.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.015 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 51.8 mt -126.18 122.64 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.755 0.788 . . . . 0.0 110.637 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -111.7 148.71 32.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.164 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 19.0 p -135.7 162.94 31.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.261 1.024 . . . . 0.0 110.189 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -59.93 115.83 3.69 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.526 -0.734 . . . . 0.0 111.062 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.82 159.13 14.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 25.9 5.58 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 119.795 1.179 . . . . 0.0 114.058 175.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 39.5 p -125.43 168.68 13.25 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.41 1.484 . . . . 0.0 111.763 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -145.05 -161.38 1.29 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.947 1.299 . . . . 0.0 111.381 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.87 78.16 1.68 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.506 1.522 . . . . 0.0 107.551 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 . . . . . 0 C--O 1.248 1.018 0 C-N-CA 126.379 1.872 . . . . 0.0 111.472 175.103 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 6.5 m -71.78 94.84 1.43 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.451 1.1 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 12.9 p -157.65 134.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.965 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.57 164.51 24.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.015 0.436 . . . . 0.0 111.93 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.84 -35.21 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -156.57 143.58 18.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.309 1.444 . . . . 0.0 110.518 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 p -116.41 141.84 47.64 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 122.112 0.958 . . . . 0.0 108.977 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.401 ' OG ' ' HE3' ' C' ' 57' ' ' LYS . 65.0 m -139.39 126.54 21.21 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.368 -1.457 . . . . 0.0 113.026 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.55 -29.63 64.96 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -52.0 118.38 3.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.591 1.186 . . . . 0.0 110.243 174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.53 -122.53 2.94 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.315 1.912 . . . . 0.0 109.336 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -143.03 152.96 42.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.48 1.112 . . . . 0.0 113.113 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -143.59 155.85 44.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.091 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -133.43 145.14 49.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.395 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -109.42 147.43 32.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -65.06 -19.09 65.82 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 -14.91 60.51 Favored 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.963 -1.086 . . . . 0.0 111.273 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.59 -14.07 32.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.222 2.344 . . . . 0.0 113.659 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 149.73 44.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.411 -1.052 . . . . 0.0 112.377 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -125.35 142.82 51.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.956 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -132.41 146.1 51.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 112.507 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -129.64 133.34 47.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.547 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.65 127.23 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.85 -93.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.135 0.897 . . . . 0.0 112.282 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.31 128.29 23.66 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.364 -1.08 . . . . 0.0 110.469 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.21 139.24 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.315 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -77.55 164.03 25.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.98 0.912 . . . . 0.0 112.584 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -54.35 -33.82 59.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.232 1.413 . . . . 0.0 114.217 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.26 -35.45 79.56 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.384 -1.447 . . . . 0.0 111.543 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.41 -6.26 9.24 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 124.369 0.985 . . . . 0.0 114.506 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.9 147.25 47.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -154.8 161.94 41.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.96 0.886 . . . . 0.0 110.728 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 167.72 14.1 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.31 30.28 Favored Glycine 0 C--O 1.238 0.344 0 O-C-N 120.391 -1.443 . . . . 0.0 112.096 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 33.9 p -140.33 129.0 22.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.155 0.978 . . . . 0.0 111.715 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -105.43 138.23 41.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.179 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.22 126.64 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' THR . . . . . 0.477 HG21 ' H ' ' C' ' 37' ' ' VAL . 16.6 m -105.11 141.15 37.18 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.909 -173.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.39 -1.88 34.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.477 ' H ' HG21 ' C' ' 35' ' ' THR . 26.9 m -139.24 163.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.533 1.933 . . . . 0.0 111.31 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.24 167.46 16.07 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 119.894 -1.754 . . . . 0.0 112.871 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -70.16 -45.42 66.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.286 1.034 . . . . 0.0 108.463 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -126.33 78.85 71.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 129.002 2.921 . . . . 0.0 110.114 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.85 24.2 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.909 3.739 . . . . 0.0 116.591 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 0.65 59.7 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.224 -1.548 . . . . 0.0 115.885 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.38 30.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.09 131.4 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.965 -1.709 . . . . 0.0 112.462 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.3 165.44 27.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.775 2.03 . . . . 0.0 108.664 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tt -49.51 131.22 20.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.558 1.543 . . . . 0.0 111.65 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.1 p -109.02 123.04 38.06 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.33 144.61 90.77 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.01 2.473 . . . . 0.0 111.542 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -131.15 164.32 25.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.788 0.835 . . . . 0.0 112.708 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.64 148.93 7.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.064 1.746 . . . . 0.0 109.656 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.34 -156.17 27.55 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 120.898 1.681 . . . . 0.0 112.629 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.2 mt -146.16 137.05 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 123.37 1.557 . . . . 0.0 112.006 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.02 141.65 51.13 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.086 -1.634 . . . . 0.0 108.38 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.15 -50.79 71.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.881 0.31 . . . . 0.0 111.345 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . 0.401 ' HE3' ' OG ' ' C' ' 5' ' ' SER . 16.4 tptm 51.85 2.79 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.351 2.26 . . . . 0.0 115.979 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -79.74 -56.73 4.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.598 1.959 . . . . 0.0 113.546 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.63 174.7 11.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.853 0.721 . . . . 0.0 111.339 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -75.73 -26.68 57.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.583 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.63 48.9 1.13 Allowed Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 125.216 1.407 . . . . 0.0 112.705 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -83.12 -178.3 3.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.805 2.337 . . . . 0.0 115.007 -174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 82.4 p -84.63 168.1 15.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.619 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -166.08 160.29 16.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.457 1.103 . . . . 0.0 111.372 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.3 148.12 14.4 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 119.119 2.408 . . . . 0.0 119.119 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -159.76 162.17 34.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -100.25 150.1 22.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.007 2.123 . . . . 0.0 108.966 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 49.5 t -129.28 117.9 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.96 107.18 19.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.761 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.337 51.3 m95 -67.79 158.11 33.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.247 1.84 . . . . 0.0 115.387 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.16 4.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.2 -12.08 36.38 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 8.3 t -152.32 143.86 23.45 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 128.155 2.582 . . . . 0.0 106.329 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.94 118.55 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.457 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p -171.83 165.13 6.51 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.573 1.549 . . . . 0.0 111.767 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.56 138.97 25.05 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 123.635 1.683 . . . . 0.0 110.606 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.52 26.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-N 109.785 -3.37 . . . . 0.0 109.712 -172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.05 155.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.145 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -128.31 140.06 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.08 115.02 5.34 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.13 177.87 30.52 Favored Glycine 0 CA--C 1.501 -0.792 0 C-N-CA 119.894 -1.146 . . . . 0.0 115.508 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 10.6 tt0 -119.22 145.27 46.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.545 -1.327 . . . . 0.0 108.917 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.27 129.23 44.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.404 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 0.3 OUTLIER -124.8 171.94 9.73 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.009 1.385 . . . . 0.0 111.649 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.81 115.76 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 112.363 -2.199 . . . . 0.0 106.604 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.82 152.42 19.22 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -45.27 -22.89 0.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.57 -10.5 55.82 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.46 43.06 6.3 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.731 1.158 . . . . 0.0 113.495 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -116.05 147.25 41.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.256 1.423 . . . . 0.0 108.382 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -101.26 141.19 34.51 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.969 1.707 . . . . 0.0 109.966 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.93 161.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.29 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.13 116.34 25.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -106.53 110.53 22.77 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 172.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 9.1 p -126.4 165.37 19.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.661 1.22 . . . . 0.0 110.935 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.16 170.66 8.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 172.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -144.37 159.44 42.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.487 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tp -137.79 123.14 19.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.436 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.63 138.41 43.91 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 125.295 1.622 . . . . 0.0 113.065 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -121.43 117.43 26.87 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 125.895 1.997 . . . . 0.0 111.823 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 15.7 m -83.53 159.76 21.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.729 1.268 . . . . 0.0 111.285 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -103.9 83.0 2.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.24 -12.56 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.48 -29.06 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.1 136.54 52.82 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.8 1.286 . . . . 0.0 112.436 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . 0.415 ' CD1' HG21 ' B' ' 92' ' ' VAL . 2.3 tt -62.3 -25.21 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.574 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.61 -3.96 36.57 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.591 -1.116 . . . . 0.0 114.61 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 4.7 m-20 -124.29 2.72 8.49 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.455 1.102 . . . . 0.0 113.92 -177.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -35.67 57.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.381 -0.824 . . . . 0.0 112.361 176.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 57.2 p-90 -49.67 -45.77 49.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.595 1.158 . . . . 0.0 113.311 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . 0.61 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.3 OUTLIER -88.88 -11.03 45.76 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.436 -0.79 . . . . 0.0 112.544 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -0.24 25.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -117.87 146.03 44.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.316 0.647 . . . . 0.0 111.65 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.61 152.06 40.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.745 1.618 . . . . 0.0 110.654 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.21 148.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 120.186 1.357 . . . . 0.0 111.802 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.96 -176.98 27.8 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-O 122.442 1.023 . . . . 0.0 112.809 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -121.55 153.49 37.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.719 0.808 . . . . 0.0 108.834 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.28 132.44 15.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.229 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 mt -124.8 118.04 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.903 0.858 . . . . 0.0 111.068 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.59 150.71 25.15 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.564 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 3.9 p -136.53 159.83 40.61 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.514 1.126 . . . . 0.0 109.859 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -55.36 124.34 16.8 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.742 -0.599 . . . . 0.0 109.813 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.37 162.77 2.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.916 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . 0.315 18.1 ptt180 57.94 19.97 6.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 5.3 m -125.39 73.13 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.214 1.806 . . . . 0.0 107.461 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -55.29 142.09 33.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.6 0.714 . . . . 0.0 109.376 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.333 0.0 OUTLIER -126.71 74.93 1.52 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.299 1.84 . . . . 0.0 106.82 -174.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.313 1.5 pm0 . . . . . 0 C--O 1.258 1.517 0 CA-C-N 110.76 -2.927 . . . . 0.0 114.99 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 3.3 t -117.53 162.76 17.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.4 1.88 . . . . 0.0 108.217 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.35 -23.74 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.272 1.029 . . . . 0.0 112.769 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 52.86 -161.12 0.11 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.486 1.514 . . . . 0.0 113.732 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -161.61 54.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.028 2.531 . . . . 0.0 110.0 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.29 151.73 25.16 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.82 -1.175 . . . . 0.0 109.408 173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.04 133.5 53.64 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -139.54 128.53 23.62 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.811 -1.805 . . . . 0.0 110.695 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.8 mt -68.06 -23.22 64.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -51.58 113.63 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 112.004 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.95 -121.41 2.47 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.788 1.185 . . . . 0.0 110.954 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -151.88 146.28 25.54 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -143.34 163.24 33.58 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.223 1.409 . . . . 0.0 112.065 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -142.76 154.89 44.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.682 -1.151 . . . . 0.0 109.149 174.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 146.35 49.65 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.095 0.861 . . . . 0.0 112.515 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.24 -25.1 13.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.653 2.381 . . . . 0.0 115.012 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.07 -18.78 62.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.371 1.069 . . . . 0.0 112.848 174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.84 -15.76 21.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.828 2.633 . . . . 0.0 113.261 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.4 p -65.99 145.54 55.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 123.297 1.522 . . . . 0.0 113.086 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.98 144.93 46.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.737 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -141.8 147.34 37.11 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 173.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -137.44 135.23 36.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.428 0.691 . . . . 0.0 109.759 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.324 0.65 . . . . 0.0 109.903 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -92.68 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.57 32.25 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.701 -0.882 . . . . 0.0 112.235 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.67 129.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.244 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -70.31 165.84 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.228 0.33 . . . . 0.0 111.62 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -59.78 -24.11 63.82 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.429 -1.42 . . . . 0.0 114.822 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.37 -27.09 46.8 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.895 0.77 . . . . 0.0 112.027 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.27 -6.16 30.31 Favored Glycine 0 N--CA 1.468 0.805 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.539 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 10.0 pt-20 -63.78 138.62 58.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 162.58 38.94 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.395 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 p -129.34 176.9 7.58 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.35 -166.0 37.75 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.566 -1.334 . . . . 0.0 114.095 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -136.76 130.92 32.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.605 1.193 . . . . 0.0 111.781 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -114.52 141.28 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.658 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.4 mt -131.54 133.14 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -107.69 140.56 40.54 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.731 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.33 -11.15 19.65 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.21 141.66 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 111.183 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.26 33.05 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.977 -0.452 . . . . 0.0 110.135 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -77.35 -34.75 55.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.75 83.84 40.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.764 1.626 . . . . 0.0 110.138 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.78 36.05 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.998 3.799 . . . . 0.0 115.075 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.29 -7.21 63.05 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 179.58 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.624 1.97 . . . . 0.0 110.858 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.52 125.56 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 119.988 -1.695 . . . . 0.0 111.05 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.27 165.24 28.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 111.585 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 tp -46.98 115.94 1.22 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 130.781 3.632 . . . . 0.0 113.028 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.6 p -105.9 122.99 40.61 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.456 0.702 . . . . 0.0 111.234 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.62 136.58 74.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.836 2.357 . . . . 0.0 111.318 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.69 155.03 37.27 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.07 0.856 . . . . 0.0 111.694 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -162.37 149.01 13.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.92 1.688 . . . . 0.0 109.349 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.97 -150.01 20.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.296 1.407 . . . . 0.0 109.658 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -144.0 141.48 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.49 0.716 . . . . 0.0 111.271 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 137.53 51.91 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.333 -0.854 . . . . 0.0 110.599 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -68.52 155.07 40.65 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.397 -0.814 . . . . 0.0 111.843 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -146.2 13.98 1.28 Allowed 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.273 -1.517 . . . . 0.0 114.489 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -87.89 -49.11 7.3 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.825 0.739 . . . . 0.0 112.465 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.07 175.06 9.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -78.93 -38.56 36.91 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.798 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -136.31 52.0 5.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.591 1.156 . . . . 0.0 112.567 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.87 173.83 13.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.738 1.625 . . . . 0.0 113.834 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.331 0.6 OUTLIER -95.41 167.38 11.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.571 173.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.56 166.54 31.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.722 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.49 146.61 12.43 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -159.13 152.67 22.79 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.41 151.75 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.286 1.835 . . . . 0.0 109.287 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.16 118.44 40.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.13 116.55 26.4 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.748 -0.595 . . . . 0.0 110.126 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.81 142.35 44.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.385 1.088 . . . . 0.0 110.573 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.69 -39.78 5.27 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.246 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.83 -13.12 54.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.268 1.427 . . . . 0.0 114.439 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.3 t -152.35 132.36 13.42 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.423 2.689 . . . . 0.0 106.06 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.02 117.67 16.09 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.081 1.309 . . . . 0.0 110.416 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -173.65 164.03 4.36 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 126.549 1.94 . . . . 0.0 110.057 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.86 142.6 38.6 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.19 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.38 152.07 51.6 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.79 150.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.748 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.42 143.95 51.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 127.38 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.61 178.47 45.51 Favored Glycine 0 C--O 1.217 -0.915 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -101.21 147.9 25.73 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.856 0.974 . . . . 0.0 112.835 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 21.7 p -97.74 120.53 38.29 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.754 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 82' ' ' GLN 0.299 2.7 m-85 -112.91 162.25 16.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -132.41 109.66 15.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -59.38 162.13 5.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.335 0.654 . . . . 0.0 109.448 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -21.67 2.27 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -8.18 54.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.562 0.745 . . . . 0.0 113.003 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.17 51.96 4.78 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -121.33 146.82 46.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.816 2.446 . . . . 0.0 104.938 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -112.41 150.19 31.47 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.857 1.263 . . . . 0.0 112.182 -172.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.418 ' CG1' ' HD3' ' A' ' 94' ' ' LYS . 1.7 t -148.14 161.33 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.786 1.279 . . . . 0.0 110.681 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.4 mt -125.51 110.49 13.94 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 101.241 -3.614 . . . . 0.0 101.241 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HE3' HD13 ' A' ' 119' ' ' ILE . 7.5 mmmt -102.71 122.35 44.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -138.84 163.76 31.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.477 1.608 . . . . 0.0 114.264 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -112.89 165.24 12.5 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -140.89 159.48 42.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.071 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.21 124.1 14.3 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.833 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.0 tp -107.69 141.7 38.81 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 125.692 1.87 . . . . 0.0 110.689 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -124.41 114.03 18.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 110.298 -3.137 . . . . 0.0 109.455 -174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.251 18.5 m -70.88 164.51 25.19 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.74 1.9 . . . . 0.0 113.094 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -101.44 84.36 2.59 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.38 164.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 127.463 2.305 . . . . 0.0 109.296 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -114.59 -23.19 9.4 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.51 138.29 51.19 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.719 0.771 . . . . 0.0 111.113 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.77 -17.23 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.68 7.75 74.23 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.361 -1.8 . . . . 0.0 115.759 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.87 4.99 15.01 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.853 1.827 . . . . 0.0 112.704 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -62.27 -30.67 71.29 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.054 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.409 ' CD1' HD13 ' C' ' 14' ' ' LEU . 54.7 p-90 -48.97 -40.12 29.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 113.21 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -96.92 -6.25 36.12 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 114.022 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.94 7.0 7.92 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.2 m -122.1 140.46 52.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.757 0.789 . . . . 0.0 113.043 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 119.56 6.48 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.558 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.93 150.19 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.44 1.896 . . . . 0.0 111.51 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.41 -171.48 22.71 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.707 0.67 . . . . 0.0 112.768 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 20.1 p90 -131.38 157.31 43.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.071 -0.664 . . . . 0.0 111.448 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -147.69 160.13 43.03 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.363 1.065 . . . . 0.0 109.15 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.491 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.1 mt -138.71 119.03 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.74 148.44 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.529 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -134.98 165.31 25.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.66 124.4 20.9 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.893 0.877 . . . . 0.0 111.526 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.55 145.36 28.11 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.36 -44.34 0.5 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.89 2.476 . . . . 0.0 117.681 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . 0.277 0.2 OUTLIER 46.3 -156.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.639 1.976 . . . . 0.0 113.442 -176.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -148.49 13.97 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.721 2.808 . . . . 0.0 108.573 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -146.13 -2.73 0.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 114.748 -2.549 . . . . 0.0 116.183 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.256 1.409 0 C-N-CA 130.401 3.48 . . . . 0.0 106.581 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.8 m -68.91 59.14 0.1 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.892 2.077 . . . . 0.0 113.83 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 20.1 m -140.79 42.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.097 2.159 . . . . 0.0 109.968 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -65.01 165.58 10.77 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.419 1.104 . . . . 0.0 113.631 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . 0.308 4.9 ptm180 -134.16 54.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.982 1.313 . . . . 0.0 113.969 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 155.95 31.72 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.562 1.945 . . . . 0.0 109.162 173.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.05 136.26 41.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -139.31 133.49 31.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.662 -1.274 . . . . 0.0 110.696 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.13 -23.2 63.94 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -51.02 114.38 1.16 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.1 1.429 . . . . 0.0 111.592 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.76 -120.54 2.42 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.67 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -152.81 149.74 28.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -147.0 163.21 36.96 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.56 1.544 . . . . 0.0 112.057 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -141.47 154.48 45.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.062 0.945 . . . . 0.0 108.935 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -123.08 145.83 48.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.855 0.862 . . . . 0.0 112.296 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.43 -24.57 13.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.527 2.331 . . . . 0.0 114.816 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' B' ' 110' ' ' TRP . 33.4 tp -70.81 -19.18 62.7 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.976 -1.078 . . . . 0.0 112.858 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.62 -15.69 19.51 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 127.796 2.617 . . . . 0.0 113.392 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -66.42 144.9 56.23 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 123.289 1.518 . . . . 0.0 112.991 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.87 146.07 45.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.698 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -141.99 147.59 37.18 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 18.9 m -136.24 135.25 38.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.517 0.727 . . . . 0.0 110.529 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 92.7 mt -136.94 128.34 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.339 0.656 . . . . 0.0 109.497 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.08 -90.61 0.06 OUTLIER Glycine 0 CA--C 1.533 1.194 0 O-C-N 123.573 0.546 . . . . 0.0 112.557 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.48 141.8 29.82 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.644 -0.915 . . . . 0.0 111.914 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.15 130.01 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.518 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -68.19 164.96 19.3 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.503 0.502 . . . . 0.0 111.795 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -60.47 -23.77 64.74 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.178 -1.576 . . . . 0.0 114.739 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -76.12 -24.77 54.96 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.877 0.762 . . . . 0.0 112.025 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.82 -5.45 32.59 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 124.093 0.854 . . . . 0.0 114.255 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.49 153.27 44.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.966 0.883 . . . . 0.0 112.167 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.45 166.52 33.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.107 176.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -127.09 -177.67 4.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.39 -165.99 39.22 Favored Glycine 0 N--CA 1.469 0.89 0 O-C-N 119.534 -1.979 . . . . 0.0 114.217 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -136.79 130.13 31.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.144 0.973 . . . . 0.0 112.325 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -114.59 141.38 47.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.74 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.9 133.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -108.28 140.66 41.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.749 1.22 . . . . 0.0 111.861 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.46 -11.93 18.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.84 141.08 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 124.093 0.957 . . . . 0.0 111.26 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.9 34.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.057 -0.402 . . . . 0.0 110.185 -174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.91 -34.55 57.69 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -134.92 83.82 39.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.641 1.576 . . . . 0.0 110.244 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 36.09 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 125.009 3.806 . . . . 0.0 115.197 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.12 63.32 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.77 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.538 1.935 . . . . 0.0 110.849 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.21 125.84 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 119.989 -1.695 . . . . 0.0 111.254 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.79 165.91 27.45 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.988 1.315 . . . . 0.0 111.856 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 tp -47.86 115.62 1.22 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.589 3.556 . . . . 0.0 112.782 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -105.69 122.69 41.79 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.469 0.708 . . . . 0.0 110.615 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.92 135.87 71.63 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.492 2.128 . . . . 0.0 110.837 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -121.11 161.02 22.48 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.043 0.84 . . . . 0.0 111.246 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 28' ' ' GLU . 17.7 tp -169.05 149.33 4.25 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.668 1.587 . . . . 0.0 112.182 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.81 -146.96 13.51 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -147.01 139.76 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.965 0.906 . . . . 0.0 110.296 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.79 53.37 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.157 -0.964 . . . . 0.0 110.871 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -70.57 153.52 42.81 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.766 -1.209 . . . . 0.0 111.304 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -143.91 17.23 1.78 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -93.31 -49.0 6.16 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.656 0.782 . . . . 0.0 112.642 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.7 177.25 5.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -81.58 -38.29 26.33 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.596 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.77 51.98 4.69 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.469 1.108 . . . . 0.0 111.875 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.71 175.21 11.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.707 1.605 . . . . 0.0 113.726 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.328 0.7 OUTLIER -96.47 165.91 11.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.018 1.389 . . . . 0.0 112.353 173.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.77 165.96 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.948 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 146.57 12.43 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -159.02 152.42 22.68 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.82 151.75 19.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.872 2.069 . . . . 0.0 109.034 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.87 119.45 45.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.07 118.31 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.322 -0.861 . . . . 0.0 110.601 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -76.52 141.89 41.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.539 1.162 . . . . 0.0 110.498 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.55 -39.65 5.34 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.239 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.67 -13.3 54.48 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 114.268 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 43.2 t -152.34 133.32 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 128.554 2.741 . . . . 0.0 106.211 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -75.3 117.73 17.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.148 1.34 . . . . 0.0 110.347 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -173.72 164.02 4.31 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 109.72 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -138.88 142.59 38.57 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.073 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.96 152.23 51.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.533 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.12 149.53 29.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.768 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.75 126.86 12.05 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.29 178.36 45.28 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.34 147.25 26.53 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 124.63 0.841 . . . . 0.0 112.337 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.83 115.7 28.59 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.445 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' D' ' 82' ' ' GLN 0.275 3.3 m-85 -110.15 162.95 14.09 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -132.74 112.21 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.71 161.95 11.56 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.671 0.788 . . . . 0.0 109.011 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -20.52 0.85 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.09 -2.22 55.71 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.81 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.33 51.57 6.03 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -173.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.23 138.9 54.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.91 2.084 . . . . 0.0 107.185 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -106.69 149.42 27.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.781 1.632 . . . . 0.0 112.261 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . 0.418 ' CG1' ' HD3' ' D' ' 94' ' ' LYS . 1.8 t -150.53 161.64 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 122.729 1.252 . . . . 0.0 110.247 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 mt -125.9 111.27 14.61 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . 0.484 ' HE3' HD13 ' D' ' 119' ' ' ILE . 6.8 mmmt -103.97 120.62 41.42 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -137.35 162.96 32.16 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.792 1.758 . . . . 0.0 114.101 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.45 164.8 12.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -140.54 159.72 41.58 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.887 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.45 124.01 14.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.85 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.51 141.96 38.13 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 125.616 1.822 . . . . 0.0 110.693 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -124.2 114.13 19.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.216 -3.175 . . . . 0.0 109.417 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.263 19.2 m -71.45 163.93 26.78 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.682 1.864 . . . . 0.0 112.762 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -100.25 85.7 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.89 164.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 127.048 2.139 . . . . 0.0 109.065 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.87 -23.84 8.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.44 137.96 51.18 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.601 0.715 . . . . 0.0 111.142 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.1 tt -59.06 -17.74 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 7.31 73.23 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.356 1.932 . . . . 0.0 116.016 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.49 4.66 15.31 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 119.967 1.884 . . . . 0.0 112.969 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -61.35 -31.17 71.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.972 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD13 ' B' ' 14' ' ' LEU . 55.1 p-90 -49.0 -39.58 27.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.117 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -97.72 -5.96 33.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.733 1.213 . . . . 0.0 114.057 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.89 6.74 8.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 18.3 m -121.65 140.18 52.6 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 122.076 0.941 . . . . 0.0 113.251 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.36 121.05 7.51 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.008 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 9.7 p -100.87 150.29 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.732 2.013 . . . . 0.0 111.418 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.42 -171.49 22.73 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.663 0.649 . . . . 0.0 112.502 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -131.67 157.19 44.38 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.02 -0.694 . . . . 0.0 111.517 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -147.9 159.55 43.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.524 1.13 . . . . 0.0 109.095 174.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . 0.484 HD13 ' HE3' ' D' ' 94' ' ' LYS . 7.3 mt -137.83 118.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.61 146.5 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 14.7 p -132.89 163.57 28.84 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.158 0.98 . . . . 0.0 108.64 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.87 124.18 17.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.942 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.34 142.11 47.07 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.301 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 115.45 149.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 1 C-N-CA 131.941 4.097 . . . . 0.0 107.804 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 17.5 p -70.98 -23.53 62.22 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 56.01 -83.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.71 2.004 . . . . 0.0 110.672 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . 0.302 6.6 mtpp 102.2 -9.79 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.278 1 C-N-CA 132.574 4.35 . . . . 0.0 115.093 174.306 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.774 2.83 . . . . 0.0 108.388 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.7 m -140.28 148.05 40.85 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.1 0.96 . . . . 0.0 108.411 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.31 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.22 1.008 . . . . 0.0 109.964 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -96.54 50.43 1.13 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.813 0.845 . . . . 0.0 110.855 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 46.35 62.34 2.34 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.597 1.959 . . . . 0.0 114.727 -174.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.65 155.86 32.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.238 1.815 . . . . 0.0 108.842 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.38 138.78 51.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -139.49 133.32 30.74 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.524 -1.36 . . . . 0.0 111.16 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.45 -23.63 65.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -49.75 112.09 0.6 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.226 1.41 . . . . 0.0 112.308 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.57 -116.0 1.53 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.995 1.284 . . . . 0.0 111.907 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -153.39 147.87 26.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -145.24 163.36 34.67 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.674 1.589 . . . . 0.0 111.987 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -145.47 152.95 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.709 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.53 145.67 48.68 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.73 0.812 . . . . 0.0 112.537 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.63 -26.16 12.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.817 2.447 . . . . 0.0 114.834 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' D' ' 110' ' ' TRP . 32.6 tp -70.21 -19.85 63.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.316 1.046 . . . . 0.0 112.968 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.64 22.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 127.535 2.493 . . . . 0.0 113.574 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -67.83 145.57 54.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.338 1.569 . . . . 0.0 112.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 145.54 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.87 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -142.27 147.75 36.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -137.08 135.81 37.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.67 0.788 . . . . 0.0 109.994 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.1 mt -135.54 127.58 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.391 0.677 . . . . 0.0 110.337 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -75.92 0.57 Allowed Glycine 0 CA--C 1.532 1.1 0 O-C-N 123.922 0.764 . . . . 0.0 113.544 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.06 24.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.808 0.804 . . . . 0.0 112.084 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.89 130.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.91 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.4 166.79 20.95 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.24 0.337 . . . . 0.0 111.804 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 88.1 p -60.52 -24.69 65.55 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.451 -1.406 . . . . 0.0 114.771 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -78.24 -27.12 47.57 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.964 0.802 . . . . 0.0 111.849 173.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.66 30.37 Favored Glycine 0 N--CA 1.468 0.797 0 CA-C-O 117.82 -1.545 . . . . 0.0 113.571 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 10.0 pt-20 -64.17 138.9 58.67 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 173.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.84 162.21 39.71 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.43 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.5 p -129.0 177.27 7.24 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.48 -166.19 37.97 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 120.695 -1.253 . . . . 0.0 114.273 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p -136.63 131.03 33.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.635 1.207 . . . . 0.0 111.696 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -114.36 141.36 47.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.095 -1.412 . . . . 0.0 108.39 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.92 134.51 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -110.03 140.18 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.592 1.157 . . . . 0.0 111.611 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.13 -11.7 19.37 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -137.52 141.17 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.097 0.959 . . . . 0.0 111.325 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.24 32.97 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.999 -0.438 . . . . 0.0 110.21 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -77.14 -34.46 56.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -135.02 83.7 39.18 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.795 1.638 . . . . 0.0 110.244 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.62 36.19 0.26 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.849 3.699 . . . . 0.0 115.129 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.47 -6.98 63.29 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.72 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.591 1.956 . . . . 0.0 110.973 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.58 125.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.137 -1.602 . . . . 0.0 110.922 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.25 165.74 27.5 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.007 1.323 . . . . 0.0 111.688 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tp -46.78 115.99 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.803 3.641 . . . . 0.0 112.995 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -106.19 123.17 39.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.519 0.728 . . . . 0.0 111.199 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 136.73 76.25 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.871 2.381 . . . . 0.0 111.329 174.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.87 155.59 36.34 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 124.023 0.827 . . . . 0.0 111.656 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -162.98 148.84 12.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.834 1.654 . . . . 0.0 109.364 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.19 -149.64 19.69 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.231 1.378 . . . . 0.0 109.672 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -144.64 140.72 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.511 0.725 . . . . 0.0 111.372 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 137.81 52.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.354 -0.841 . . . . 0.0 111.044 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -69.35 154.75 41.53 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.236 0.925 . . . . 0.0 111.152 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -145.22 16.45 1.52 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -92.24 -47.56 7.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.463 0.705 . . . . 0.0 112.685 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.11 175.28 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -76.74 -41.37 45.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.243 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -138.7 54.69 6.95 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.762 1.225 . . . . 0.0 111.843 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.63 174.54 12.68 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.711 1.608 . . . . 0.0 113.699 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.322 0.5 OUTLIER -96.21 166.57 11.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 123.057 1.408 . . . . 0.0 112.039 173.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.02 166.85 32.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.898 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.04 146.33 11.91 Favored Glycine 0 CA--C 1.544 1.901 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -158.92 153.46 24.35 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.23 -1.747 . . . . 0.0 115.66 -174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 151.94 19.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.273 1.829 . . . . 0.0 109.386 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.34 118.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.34 116.62 26.68 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.866 -0.521 . . . . 0.0 110.039 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.67 143.09 44.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.517 1.151 . . . . 0.0 110.565 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -109.46 -39.72 5.1 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.226 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.79 -13.35 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.273 1.429 . . . . 0.0 114.408 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.5 t -152.31 132.52 13.58 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 128.408 2.683 . . . . 0.0 106.059 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -74.8 118.33 17.64 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.189 1.359 . . . . 0.0 110.394 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -174.44 163.81 3.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.661 1.985 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.33 142.33 39.72 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.089 173.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.71 152.32 50.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.648 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.53 150.2 29.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.788 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.67 143.01 51.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 127.34 12.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.83 178.54 44.8 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.12 147.78 25.83 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.663 0.86 . . . . 0.0 112.704 178.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 6.8 p -97.9 115.85 28.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.267 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' B' ' 82' ' ' GLN 0.288 2.9 m-85 -110.24 161.56 15.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.39 112.09 18.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.45 162.76 12.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.642 0.777 . . . . 0.0 109.495 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -23.08 1.03 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.77 -4.66 56.5 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.774 0.83 . . . . 0.0 113.121 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 53.81 5.33 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 122.059 0.81 . . . . 0.0 111.346 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -122.96 140.66 52.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.245 2.618 . . . . 0.0 104.604 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -111.59 148.04 34.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.195 1.798 . . . . 0.0 112.08 -172.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.405 ' CG1' ' HD3' ' B' ' 94' ' ' LYS . 1.9 t -149.12 160.99 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 122.408 1.099 . . . . 0.0 110.546 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 mt -124.91 112.41 16.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 101.697 -3.445 . . . . 0.0 101.697 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.485 ' HE3' HD13 ' B' ' 119' ' ' ILE . 6.3 mmmt -104.96 120.08 40.57 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -137.28 162.8 32.54 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.663 1.697 . . . . 0.0 114.105 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.11 164.88 12.66 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -140.47 159.25 42.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.382 -1.735 . . . . 0.0 111.968 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -142.82 123.99 14.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.997 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.65 141.6 38.9 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 125.779 1.925 . . . . 0.0 110.826 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.9 tpt85 -123.89 114.09 19.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 110.069 -3.241 . . . . 0.0 109.338 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.264 21.6 m -71.48 164.69 25.35 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.639 1.837 . . . . 0.0 112.722 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 59.8 m -101.25 84.55 2.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 127.547 2.339 . . . . 0.0 109.295 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.87 -22.57 9.56 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.057 0.844 . . . . 0.0 113.246 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.48 137.56 51.93 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.757 0.789 . . . . 0.0 111.096 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.76 -17.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.01 6.86 76.58 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.068 -1.962 . . . . 0.0 115.774 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.68 4.38 15.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.802 1.801 . . . . 0.0 112.798 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -30.55 70.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.412 ' CD1' HD13 ' D' ' 14' ' ' LEU . 54.8 p-90 -48.59 -41.15 29.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.269 1.028 . . . . 0.0 113.248 174.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -96.26 -6.22 38.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.577 1.151 . . . . 0.0 113.807 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.02 6.79 8.54 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 16.2 m -121.43 140.23 52.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.06 119.53 6.44 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.549 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -100.51 149.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.472 1.909 . . . . 0.0 111.255 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -171.77 22.8 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.594 0.616 . . . . 0.0 112.801 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -131.5 157.04 44.6 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.084 -0.656 . . . . 0.0 111.544 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -147.71 159.89 43.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.705 1.202 . . . . 0.0 109.277 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.485 HD13 ' HE3' ' B' ' 94' ' ' LYS . 7.3 mt -138.75 119.33 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.44 147.37 34.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 15.0 p -134.85 164.95 26.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.818 0.847 . . . . 0.0 109.131 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -60.22 119.07 7.19 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.54 1.136 . . . . 0.0 111.627 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt -76.81 129.09 35.78 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . 0.492 3.6 tmm_? 65.87 71.18 0.42 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 124.204 1.954 . . . . 0.0 114.02 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 12.5 t -72.75 -169.33 0.55 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.841 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -129.13 152.94 48.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.671 2.388 . . . . 0.0 104.889 173.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.85 164.63 0.18 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.3 1.44 . . . . 0.0 114.09 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.264 1.856 0 C-N-CA 125.684 1.594 . . . . 0.0 111.798 174.491 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 11.2 t -170.66 159.46 6.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.698 1.999 . . . . 0.0 107.981 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 37.9 t -135.8 126.72 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.142 0.883 . . . . 0.0 109.27 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.43 147.17 46.4 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.887 -0.508 . . . . 0.0 111.656 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -62.79 90.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.362 1.465 . . . . 0.0 113.813 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 155.82 31.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.887 2.075 . . . . 0.0 107.835 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.68 138.28 45.78 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 15.4 m -139.35 131.1 27.45 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.568 -1.333 . . . . 0.0 110.95 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.74 -24.05 64.41 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -49.21 114.61 1.05 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.025 1.33 . . . . 0.0 111.747 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.23 -120.46 2.47 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.919 1.247 . . . . 0.0 110.675 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -151.29 147.57 27.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -145.33 163.16 35.38 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.295 1.438 . . . . 0.0 112.234 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -143.65 153.78 42.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.516 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.29 146.26 48.03 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.724 0.809 . . . . 0.0 112.599 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.1 -26.24 15.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.44 2.296 . . . . 0.0 114.74 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 110' ' ' TRP . 32.9 tp -70.19 -20.25 63.13 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.098 -1.001 . . . . 0.0 113.032 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 -13.21 21.94 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.471 2.462 . . . . 0.0 113.607 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 86.8 p -67.57 145.85 54.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.436 1.618 . . . . 0.0 112.852 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.63 144.9 46.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.628 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -141.75 147.44 37.38 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 35.3 m -137.86 136.38 37.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.512 0.725 . . . . 0.0 109.676 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.69 127.91 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.66 0.784 . . . . 0.0 110.721 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.01 -77.93 0.42 Allowed Glycine 0 CA--C 1.532 1.132 0 O-C-N 123.643 0.59 . . . . 0.0 113.909 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.39 145.13 22.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.051 0.925 . . . . 0.0 112.102 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.54 130.06 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.816 0.846 . . . . 0.0 109.776 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.06 164.89 19.17 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.579 0.55 . . . . 0.0 111.783 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 82.1 p -60.58 -25.15 65.99 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.223 -1.548 . . . . 0.0 114.598 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -74.76 -24.95 58.77 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.833 0.742 . . . . 0.0 111.928 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.58 -5.14 32.95 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.09 0.853 . . . . 0.0 114.286 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.0 152.92 44.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.172 0.986 . . . . 0.0 112.133 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.05 166.49 33.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.117 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -127.04 -177.49 4.06 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.01 -165.6 38.92 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 119.486 -2.009 . . . . 0.0 113.947 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 11.3 p -136.67 130.48 32.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.453 1.12 . . . . 0.0 112.369 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.71 141.4 47.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.68 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 mt -130.69 134.19 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 2.9 m -109.97 140.42 43.98 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.447 1.099 . . . . 0.0 111.562 -173.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.35 18.84 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.92 140.92 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 123.772 0.829 . . . . 0.0 111.294 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.86 165.4 35.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.01 -0.431 . . . . 0.0 110.131 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -76.58 -34.75 58.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -134.7 83.78 40.86 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.691 1.596 . . . . 0.0 110.154 173.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.89 36.21 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.917 3.745 . . . . 0.0 115.149 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.13 63.32 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 179.71 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.576 1.95 . . . . 0.0 110.883 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.59 125.68 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.074 -1.641 . . . . 0.0 111.145 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.59 165.05 29.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.958 1.303 . . . . 0.0 111.806 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.28 115.55 1.14 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 130.766 3.626 . . . . 0.0 112.823 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 11.2 p -105.77 122.42 42.61 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.439 0.696 . . . . 0.0 110.74 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.6 135.29 68.63 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.559 2.173 . . . . 0.0 110.755 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.8 161.07 22.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.72 0.808 . . . . 0.0 111.181 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' B' ' 28' ' ' GLU . 17.9 tp -168.98 149.35 4.31 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.544 1.538 . . . . 0.0 112.257 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -147.16 13.92 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 120.185 1.357 . . . . 0.0 109.711 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -146.87 139.85 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.892 0.877 . . . . 0.0 110.24 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.82 53.37 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.86 154.09 42.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.685 -1.259 . . . . 0.0 111.148 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -144.63 14.67 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -89.78 -47.85 7.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.575 0.75 . . . . 0.0 112.389 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.61 172.23 13.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 31.2 t -74.85 -39.86 61.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.18 0.992 . . . . 0.0 112.617 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -138.45 53.47 5.73 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 112.866 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.1 176.04 10.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.461 1.44 . . . . 0.0 113.814 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.7 OUTLIER -97.29 166.0 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.071 1.415 . . . . 0.0 112.492 173.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -156.49 166.4 33.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.146 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.8 146.73 12.48 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -159.16 153.41 23.81 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -93.85 151.82 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.139 2.176 . . . . 0.0 109.002 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -130.9 119.71 45.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.09 118.29 27.56 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.2 -0.938 . . . . 0.0 110.542 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.66 141.55 40.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.121 0.962 . . . . 0.0 110.214 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.94 -40.05 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.225 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.3 -13.12 55.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.326 1.451 . . . . 0.0 114.348 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 43.3 t -152.39 132.98 13.88 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 128.436 2.694 . . . . 0.0 106.175 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.61 117.96 17.02 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.093 1.315 . . . . 0.0 110.244 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 13.9 m -174.18 163.82 3.93 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.545 1.938 . . . . 0.0 109.871 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -139.0 142.48 38.3 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.291 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.01 152.2 51.29 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.679 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.13 149.89 29.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.182 -1.827 . . . . 0.0 107.889 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.06 143.6 51.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 127.07 11.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -174.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.96 178.4 44.98 Favored Glycine 0 CA--C 1.499 -0.943 0 N-CA-C 117.421 1.728 . . . . 0.0 117.421 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . 0.469 ' HB3' ' CE1' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.27 147.17 26.6 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.668 0.864 . . . . 0.0 112.125 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 4.4 p -97.8 115.62 28.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.205 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' C' ' 82' ' ' GLN 0.268 3.5 m-85 -110.67 162.57 14.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.15 112.74 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -62.74 163.48 9.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 0.0 109.416 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.19 -28.16 2.83 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.42 -7.39 58.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.188 0.995 . . . . 0.0 113.104 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.69 53.82 3.89 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -121.72 140.32 52.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.708 2.403 . . . . 0.0 106.012 174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -111.42 147.49 35.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.72 1.608 . . . . 0.0 112.251 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . 0.415 ' CG1' ' HD3' ' C' ' 94' ' ' LYS . 1.8 t -150.11 161.11 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.583 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.48 112.94 17.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . 0.473 ' HE3' HD13 ' C' ' 119' ' ' ILE . 6.6 mmmt -105.46 118.87 37.68 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 174.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.47 161.82 34.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 124.005 1.86 . . . . 0.0 114.043 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.21 165.66 11.74 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -140.91 159.49 42.1 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.037 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -143.27 124.03 14.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.868 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.65 142.07 38.17 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 125.579 1.799 . . . . 0.0 110.68 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 -124.43 114.22 19.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 110.272 -3.149 . . . . 0.0 109.403 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.254 18.5 m -71.4 164.86 24.96 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 125.638 1.836 . . . . 0.0 112.897 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.4 m -102.4 82.58 2.19 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.2 165.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 127.905 2.482 . . . . 0.0 108.971 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -115.65 -23.5 8.7 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.6 139.49 50.05 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.986 0.898 . . . . 0.0 111.34 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.0 tt -60.36 -16.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.73 7.2 74.11 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 117.222 -1.877 . . . . 0.0 115.601 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -115.01 4.87 14.83 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.939 1.87 . . . . 0.0 112.725 174.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.8 -31.12 70.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.204 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD13 ' A' ' 14' ' ' LEU . 54.5 p-90 -49.3 -40.35 34.55 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 113.188 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -96.63 -5.61 38.59 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 113.927 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.51 7.2 8.6 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 18.0 m -122.03 140.67 52.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.767 0.794 . . . . 0.0 113.017 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.07 120.53 6.89 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.308 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -100.95 149.79 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.576 1.95 . . . . 0.0 111.303 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.5 -171.28 22.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.617 0.627 . . . . 0.0 112.653 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -132.06 156.95 45.39 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.106 -0.644 . . . . 0.0 111.569 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -147.79 159.82 43.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.619 1.168 . . . . 0.0 109.256 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . 0.473 HD13 ' HE3' ' C' ' 94' ' ' LYS . 7.2 mt -138.56 119.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.21 147.29 34.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.2 p -135.34 164.62 27.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.716 0.806 . . . . 0.0 109.169 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -59.85 119.92 8.6 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.494 1.518 . . . . 0.0 113.175 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 78.07 9.8 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.57 137.32 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 127.895 2.478 . . . . 0.0 111.751 -173.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 45.0 m -156.52 90.21 1.16 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.24 1.416 . . . . 0.0 107.462 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 57.58 -174.82 0.07 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.289 6.7 tmtt? 60.21 81.21 0.18 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 C--O 1.261 1.676 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.075 172.664 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 3.7 t -178.37 146.8 0.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.567 1.947 . . . . 0.0 107.993 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.65 101.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.794 0.837 . . . . 0.0 110.326 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.77 26.63 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 48.87 99.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.982 2.513 . . . . 0.0 113.871 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.31 127.78 13.16 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.652 -1.28 . . . . 0.0 113.229 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.4 131.7 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.477 1.511 . . . . 0.0 108.284 173.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.08 130.79 22.77 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.62 -26.6 60.86 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -45.39 109.73 0.19 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.866 1.666 . . . . 0.0 111.642 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.28 -125.98 2.93 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.231 0.92 . . . . 0.0 111.003 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -154.6 143.66 21.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -141.04 160.52 39.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.361 1.464 . . . . 0.0 110.983 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 t -136.59 151.65 49.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.58 1.152 . . . . 0.0 108.481 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.92 143.98 45.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 110.919 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -55.51 -23.06 24.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.451 1.901 . . . . 0.0 114.498 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 -18.56 62.57 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.577 -1.327 . . . . 0.0 111.305 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.81 -14.19 19.8 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 128.337 2.875 . . . . 0.0 113.487 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.2 p -71.05 144.7 50.29 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.988 -1.301 . . . . 0.0 112.332 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -120.48 141.77 49.88 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.209 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -130.88 143.52 50.79 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.146 0.974 . . . . 0.0 112.992 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.8 m -131.47 132.02 43.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.562 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.04 126.84 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.62 -89.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.775 0 O-C-N 125.125 1.516 . . . . 0.0 111.118 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.08 152.62 43.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.969 0.89 . . . . 0.0 111.815 176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.78 124.89 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.771 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.83 160.81 28.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.877 0.37 . . . . 0.0 111.961 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -53.97 -22.88 11.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.28 -36.53 77.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.317 0.647 . . . . 0.0 111.225 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -8.04 17.43 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 124.851 1.215 . . . . 0.0 112.534 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 155.33 40.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 108.789 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.82 163.84 34.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.515 177.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -129.16 162.7 27.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.52 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.81 -166.51 27.98 Favored Glycine 0 C--O 1.237 0.29 0 O-C-N 121.219 -0.926 . . . . 0.0 112.369 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 138.54 39.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 122.578 1.18 . . . . 0.0 111.732 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -114.51 140.66 48.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.234 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mt -133.57 126.48 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.3 m -104.99 148.73 26.41 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.86 -18.22 15.83 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.97 138.44 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 111.511 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.1 18.99 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.179 -0.95 . . . . 0.0 112.44 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HZ1' ' C' ' 111' ' ' LYS . 21.5 p-10 -71.25 -26.43 62.9 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.825 -0.547 . . . . 0.0 110.495 173.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -143.77 81.03 12.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.677 2.391 . . . . 0.0 110.346 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.66 33.43 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 124.94 3.76 . . . . 0.0 116.066 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.66 6.38 83.52 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 119.75 -1.844 . . . . 0.0 115.629 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -176.55 11.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.257 59.5 mt -33.5 108.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -173.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -102.38 174.8 5.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.418 -2.173 . . . . 0.0 111.089 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.69 137.14 47.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.379 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 p -114.12 125.9 28.73 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.189 0.596 . . . . 0.0 111.198 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -57.81 144.27 93.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.283 1.989 . . . . 0.0 112.131 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.66 144.24 51.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.153 0.981 . . . . 0.0 110.818 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.88 149.01 30.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.455 2.302 . . . . 0.0 108.621 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.11 -149.04 15.11 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 120.333 -1.479 . . . . 0.0 111.155 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -145.12 138.39 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.872 0.869 . . . . 0.0 112.137 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.49 131.99 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.738 0.815 . . . . 0.0 110.817 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -64.4 156.1 30.38 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.794 -1.191 . . . . 0.0 111.273 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -146.75 13.34 1.16 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.798 1.239 . . . . 0.0 113.279 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -78.69 -58.14 3.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.109 2.564 . . . . 0.0 111.304 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.74 13.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.5 m -78.55 -29.2 46.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.062 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.53 58.98 33.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.933 1.293 . . . . 0.0 112.384 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.96 175.72 9.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.344 2.03 . . . . 0.0 116.001 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -88.92 160.05 17.36 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.572 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -161.09 156.69 24.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.156 -0.965 . . . . 0.0 113.145 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 149.39 17.2 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 119.7 2.64 . . . . 0.0 119.7 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.06 159.69 36.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.8 150.36 20.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.265 1.826 . . . . 0.0 108.398 173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.93 125.98 63.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -104.04 112.4 25.38 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.495 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.355 56.4 m95 -74.47 154.89 38.52 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.86 -50.25 2.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.139 1.776 . . . . 0.0 115.396 -172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -75.58 -15.51 60.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.544 0.737 . . . . 0.0 112.934 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 t -149.26 145.02 26.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.186 2.594 . . . . 0.0 107.295 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.56 116.83 21.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.852 1.31 . . . . 0.0 110.216 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.2 p -168.42 172.06 8.61 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 126.194 1.798 . . . . 0.0 111.045 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.95 142.01 25.98 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.337 1.541 . . . . 0.0 110.711 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.77 132.04 30.04 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.644 -3.435 . . . . 0.0 109.848 -172.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 m -109.54 157.46 9.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.78 137.28 43.26 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 119.96 10.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.48 0.712 . . . . 0.0 110.369 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.38 -173.21 24.62 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -124.0 145.67 49.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 124.968 1.04 . . . . 0.0 111.056 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.6 p -97.8 113.1 24.81 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.443 1.089 . . . . 0.0 112.095 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -102.65 166.94 10.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.883 0.473 . . . . 0.0 111.715 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.3 mt -126.47 110.54 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -58.7 160.73 5.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.218 1.007 . . . . 0.0 108.735 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -49.66 -25.27 2.74 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.79 -13.85 49.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.021 0.929 . . . . 0.0 113.276 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.22 58.24 2.0 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -130.12 148.26 51.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.388 2.675 . . . . 0.0 107.359 172.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -109.58 138.57 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 110.601 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.6 m -141.3 164.17 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 109.518 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 mt -123.31 118.53 27.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -107.57 115.87 30.93 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -133.02 169.43 16.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.886 1.803 . . . . 0.0 112.245 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -121.37 171.17 8.95 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.0 p-90 -146.38 162.75 37.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.13 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -145.59 125.62 13.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.385 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.9 144.65 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 125.115 1.509 . . . . 0.0 114.588 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -128.64 123.5 33.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.035 -2.348 . . . . 0.0 113.755 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.88 156.24 18.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.674 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -103.08 64.15 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.589 -0.695 . . . . 0.0 109.84 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -49.12 153.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.139 1.376 . . . . 0.0 113.003 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.79 -29.76 32.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.13 144.69 43.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.728 1.252 . . . . 0.0 112.641 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.419 ' CD1' HG21 ' D' ' 92' ' ' VAL . 14.0 tt -65.25 -24.24 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.788 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.0 1.18 41.6 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-O 118.106 -1.386 . . . . 0.0 113.54 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.508 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 14.8 m-20 -121.35 6.28 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.804 1.242 . . . . 0.0 114.025 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -33.52 67.9 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 119.755 -1.841 . . . . 0.0 111.705 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.508 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 44.1 p-90 -45.67 -50.34 13.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.826 1.251 . . . . 0.0 113.981 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.584 ' HZ1' ' HA ' ' C' ' 39' ' ' ASP . 4.5 ptmm? -87.83 -11.62 47.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.92 0.888 . . . . 0.0 113.342 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.68 -5.92 54.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.361 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.4 m -103.6 143.7 32.4 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 125.11 1.506 . . . . 0.0 112.174 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -144.05 129.91 19.37 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 124.694 1.198 . . . . 0.0 111.013 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.85 154.8 8.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 120.248 1.385 . . . . 0.0 110.524 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.78 -177.24 32.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.326 0.488 . . . . 0.0 113.259 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 22.8 p90 -125.1 152.58 44.18 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.9 -0.765 . . . . 0.0 111.096 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -148.13 144.04 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.77 128.13 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -115.45 152.75 32.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.975 0.417 . . . . 0.0 110.518 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.8 p -134.69 160.54 37.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.439 1.096 . . . . 0.0 110.054 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -56.81 122.09 11.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.818 0.847 . . . . 0.0 111.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tt -78.43 152.84 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 101.27 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 129.784 3.233 . . . . 0.0 110.231 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -48.93 112.12 0.57 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.648 1.579 . . . . 0.0 110.031 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.99 -37.56 66.96 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.04 -37.8 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.963 2.105 . . . . 0.0 113.501 174.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . 0.282 5.4 tt0 . . . . . 0 C--O 1.246 0.918 0 O-C-N 128.549 3.656 . . . . 0.0 108.77 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 12.4 p -88.52 162.55 16.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.627 0.771 . . . . 0.0 109.757 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 12.0 p -167.21 -39.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.484 1.114 . . . . 0.0 112.639 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -64.18 135.35 56.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.736 0.814 . . . . 0.0 112.124 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -90.68 123.44 34.29 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.795 1.238 . . . . 0.0 110.192 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -156.58 117.36 3.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.81 1.244 . . . . 0.0 112.002 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -116.31 135.31 53.99 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 2.2 t -139.6 136.84 34.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.774 1.23 . . . . 0.0 108.943 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 38.5 mt -73.63 -24.27 60.0 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -48.34 109.8 0.27 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.319 1.448 . . . . 0.0 112.07 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.48 -124.16 2.56 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 124.679 1.133 . . . . 0.0 110.813 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -151.72 144.28 24.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -142.28 157.49 44.77 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.111 1.365 . . . . 0.0 110.968 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -137.16 150.36 47.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 108.492 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -116.02 143.54 45.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.096 0.958 . . . . 0.0 111.042 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.62 -24.73 8.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.79 2.036 . . . . 0.0 114.975 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.61 -18.53 62.88 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.282 -1.511 . . . . 0.0 111.643 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.29 -14.88 18.32 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 128.592 2.996 . . . . 0.0 113.543 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 82.5 p -71.34 144.11 50.02 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.011 -1.288 . . . . 0.0 112.455 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -118.73 142.98 47.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.631 0.773 . . . . 0.0 110.403 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -132.19 143.09 49.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.918 0.866 . . . . 0.0 112.538 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 20.5 m -131.44 132.03 44.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.163 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 70.3 mt -130.01 124.51 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -85.74 0.09 OUTLIER Glycine 0 CA--C 1.527 0.794 0 O-C-N 124.934 1.397 . . . . 0.0 111.224 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.32 155.82 44.55 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 122.045 0.926 . . . . 0.0 111.997 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.98 126.34 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.909 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -79.27 161.61 26.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.75 -23.2 16.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -69.63 -34.3 73.85 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.727 -0.608 . . . . 0.0 111.329 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.4 -6.27 18.93 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 124.918 1.247 . . . . 0.0 112.789 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.68 157.13 38.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 122.122 0.963 . . . . 0.0 111.783 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.06 166.53 32.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.482 1.134 . . . . 0.0 110.126 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -132.33 160.87 35.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.552 -1.658 . . . . 0.0 106.717 173.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.64 -166.65 28.97 Favored Glycine 0 C--O 1.24 0.488 0 CA-C-O 122.479 1.044 . . . . 0.0 112.333 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 40.0 p -137.84 140.33 40.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.502 -1.349 . . . . 0.0 112.001 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -117.15 141.12 48.67 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.994 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -133.31 126.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 90.7 m -104.99 147.92 27.28 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.29 16.26 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.96 138.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.105 0.962 . . . . 0.0 111.37 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.67 170.37 18.3 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.286 -0.884 . . . . 0.0 112.229 -173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . 0.589 ' HA ' ' HZ1' ' B' ' 111' ' ' LYS . 21.9 p-10 -71.59 -26.8 62.75 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.826 -0.546 . . . . 0.0 110.443 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.65 81.24 12.25 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.77 2.428 . . . . 0.0 110.241 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.43 32.56 0.12 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.79 3.66 . . . . 0.0 116.321 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.72 6.14 83.34 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 119.726 -1.859 . . . . 0.0 115.696 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.19 11.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . 0.257 59.6 mt -33.16 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -101.52 173.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.545 -2.116 . . . . 0.0 111.102 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.79 138.06 52.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -114.83 125.61 28.84 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.281 0.633 . . . . 0.0 111.051 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -58.27 143.49 97.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.251 1.967 . . . . 0.0 112.062 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.76 151.02 48.79 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 110.741 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.34 149.16 22.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.774 2.03 . . . . 0.0 108.256 -175.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.73 -148.52 17.72 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 119.462 1.028 . . . . 0.0 112.676 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -144.26 138.71 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.167 0.987 . . . . 0.0 112.395 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 129.44 45.48 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.856 -1.153 . . . . 0.0 110.828 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -62.65 155.32 26.55 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.762 -1.211 . . . . 0.0 111.835 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -146.43 12.52 1.19 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.862 1.265 . . . . 0.0 113.131 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -78.61 -58.17 3.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.35 2.66 . . . . 0.0 111.036 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.36 172.01 12.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.07 0.856 . . . . 0.0 112.603 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -83.39 -25.92 30.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.158 0.983 . . . . 0.0 112.428 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.53 55.33 15.74 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.168 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.69 178.35 7.09 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.984 1.789 . . . . 0.0 115.703 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -89.96 157.07 18.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.5 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.934 -1.104 . . . . 0.0 112.883 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.59 149.19 16.29 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 119.925 2.73 . . . . 0.0 119.925 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.6 158.62 34.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -94.98 151.61 19.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.336 1.854 . . . . 0.0 108.543 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.75 127.85 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -105.73 112.35 25.38 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.332 -0.842 . . . . 0.0 111.288 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.351 56.4 m95 -73.79 155.07 39.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.548 1.642 . . . . 0.0 115.353 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mmpm? -112.97 -49.4 2.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.022 1.729 . . . . 0.0 115.366 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.27 -15.63 59.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 45.7 t -149.52 144.69 26.43 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.228 2.611 . . . . 0.0 106.952 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -81.77 116.82 21.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.753 1.263 . . . . 0.0 110.115 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 92.9 p -168.67 171.35 8.8 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.231 1.813 . . . . 0.0 111.167 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.15 142.25 27.12 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.947 1.356 . . . . 0.0 110.994 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -139.01 131.85 29.24 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-N 109.906 -3.316 . . . . 0.0 110.098 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 m -109.12 156.8 9.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.941 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -133.71 137.29 45.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.58 119.76 10.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.554 0.741 . . . . 0.0 110.357 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.66 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -121.23 144.83 48.39 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.179 1.164 . . . . 0.0 110.551 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -97.65 113.07 24.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.427 1.08 . . . . 0.0 111.148 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -103.91 166.79 10.19 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.58 0.627 . . . . 0.0 111.868 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.71 112.08 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -58.71 164.52 2.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.997 0.919 . . . . 0.0 109.795 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -51.83 -27.0 11.09 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -10.25 58.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.889 0.876 . . . . 0.0 113.099 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.49 39.39 6.32 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.833 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -113.94 147.24 38.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.608 1.563 . . . . 0.0 109.711 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -101.53 139.37 37.28 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.217 1.407 . . . . 0.0 110.647 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 106' ' ' ILE . 22.3 m -141.66 161.04 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.213 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.7 117.34 27.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 174.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -106.58 115.64 30.55 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -132.43 170.1 15.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.936 1.826 . . . . 0.0 111.89 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -121.79 171.23 9.04 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -146.15 162.65 37.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.105 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 tt -145.68 125.71 13.67 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.16 -1.382 . . . . 0.0 113.211 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.08 144.67 38.33 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 125.218 1.574 . . . . 0.0 114.337 -174.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -128.55 123.57 33.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.774 -174.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.95 158.66 16.61 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.98 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -105.37 62.58 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.717 -0.614 . . . . 0.0 110.102 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -48.75 152.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.268 1.427 . . . . 0.0 113.452 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -80.84 -29.69 35.83 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.44 144.7 43.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.772 1.272 . . . . 0.0 113.161 -174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . 0.42 ' CD1' HG21 ' A' ' 92' ' ' VAL . 12.1 tt -64.82 -24.58 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.991 174.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.21 1.07 43.8 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.054 -1.415 . . . . 0.0 113.72 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . 0.503 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 13.6 m-20 -121.06 5.41 10.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.506 1.122 . . . . 0.0 113.931 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -33.93 65.79 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.877 -1.764 . . . . 0.0 111.492 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . 0.503 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.7 p-90 -45.59 -50.36 13.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . 0.571 ' HZ1' ' HA ' ' B' ' 39' ' ' ASP . 4.5 ptmm? -87.86 -11.69 47.07 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.292 -0.88 . . . . 0.0 113.231 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.64 -5.57 53.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.213 -172.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 15.2 m -103.34 143.86 32.12 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.981 1.425 . . . . 0.0 112.38 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -144.51 130.2 19.13 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.815 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.92 154.85 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 120.355 1.434 . . . . 0.0 110.733 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -177.64 33.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.402 0.525 . . . . 0.0 113.453 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.1 p90 -124.88 152.29 44.21 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.842 -0.799 . . . . 0.0 111.088 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.15 143.62 27.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.547 0.739 . . . . 0.0 109.061 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -127.55 131.52 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -120.25 151.5 39.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.446 0.641 . . . . 0.0 111.884 174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 36.8 p -131.07 163.8 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.548 1.139 . . . . 0.0 110.129 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -61.5 115.88 4.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.161 1.385 . . . . 0.0 111.781 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.45 84.19 7.27 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 176.77 -28.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.799 2.04 . . . . 0.0 114.857 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -62.28 140.9 58.49 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 112.242 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.55 6.07 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.5 1.92 . . . . 0.0 114.804 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -140.61 8.71 2.18 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.56 1.544 . . . . 0.0 112.39 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.401 0 C-N-CA 127.682 2.393 . . . . 0.0 110.0 -174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . 0.282 1.8 pm0 . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.711 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 25.0 p -137.81 -167.6 2.17 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 121.524 1.966 . . . . 0.0 113.974 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.42 46.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 127.245 2.218 . . . . 0.0 112.361 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -116.38 -71.04 0.76 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.079 1.352 . . . . 0.0 110.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 25.37 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 128.584 2.754 . . . . 0.0 115.773 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.67 119.95 8.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.378 -0.826 . . . . 0.0 112.088 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 51.2 t -117.96 134.56 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -139.61 136.48 34.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.464 1.106 . . . . 0.0 108.704 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 34.5 mt -73.63 -25.89 60.51 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -46.81 109.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.52 1.528 . . . . 0.0 111.705 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.29 -124.94 2.64 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.524 1.059 . . . . 0.0 111.164 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -153.52 142.26 20.99 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -140.42 158.5 43.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.573 1.549 . . . . 0.0 110.959 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t -137.2 151.19 48.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 108.783 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -117.76 143.67 46.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.148 0.979 . . . . 0.0 110.8 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -55.75 -22.99 26.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.441 1.896 . . . . 0.0 114.442 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.86 -18.06 62.71 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.601 -1.312 . . . . 0.0 111.098 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.21 18.82 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.585 2.993 . . . . 0.0 113.52 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -70.8 145.08 50.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.798 1.299 . . . . 0.0 112.372 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -119.51 140.42 50.53 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.788 0.835 . . . . 0.0 110.321 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -130.54 140.61 50.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.806 0.813 . . . . 0.0 112.728 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.4 m -129.56 131.82 46.66 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.97 125.93 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.31 -88.27 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 125.0 1.437 . . . . 0.0 111.122 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 155.28 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.09 0.947 . . . . 0.0 112.087 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.17 124.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.899 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -77.81 161.3 27.76 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.896 0.379 . . . . 0.0 111.963 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m -54.39 -22.7 13.12 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -69.62 -36.28 76.02 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.241 0.616 . . . . 0.0 111.197 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -8.22 17.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.909 1.243 . . . . 0.0 112.554 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.53 154.5 40.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.579 1.18 . . . . 0.0 109.025 174.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.39 163.56 35.41 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.314 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.56 162.94 26.1 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.436 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.01 -166.22 27.7 Favored Glycine 0 C--O 1.237 0.341 0 O-C-N 121.406 -0.809 . . . . 0.0 112.589 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 37.5 p -136.93 137.12 39.22 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 113.795 -1.202 . . . . 0.0 111.791 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.7 140.62 48.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.238 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.7 mt -133.79 126.77 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -104.95 149.33 25.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -173.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.78 15.38 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.34 138.6 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.77 1.228 . . . . 0.0 111.443 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.2 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.216 -0.928 . . . . 0.0 112.1 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.571 ' HA ' ' HZ1' ' D' ' 111' ' ' LYS . 22.4 p-10 -71.38 -26.84 62.96 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.948 -0.47 . . . . 0.0 110.296 173.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -143.51 81.15 12.47 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.604 2.362 . . . . 0.0 110.293 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -65.94 30.16 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.763 3.642 . . . . 0.0 116.242 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 6.73 76.74 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 119.829 -1.795 . . . . 0.0 116.176 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -176.76 11.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . 0.256 61.5 mt -33.66 109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -102.87 173.97 6.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.838 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tt -70.94 137.86 49.55 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 171.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.2 p -114.85 126.33 28.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.184 0.593 . . . . 0.0 111.188 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -57.85 143.88 94.83 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.416 2.077 . . . . 0.0 112.134 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 144.49 51.13 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.209 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.88 149.07 30.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.565 2.346 . . . . 0.0 108.714 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.26 -149.41 15.88 Favored Glycine 0 CA--C 1.523 0.541 0 O-C-N 120.424 -1.422 . . . . 0.0 111.111 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -144.08 139.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.891 0.877 . . . . 0.0 112.17 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.62 130.72 49.48 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.151 -0.968 . . . . 0.0 110.619 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -63.22 156.06 26.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.683 -1.261 . . . . 0.0 111.577 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -146.16 12.06 1.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.666 1.187 . . . . 0.0 113.106 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -77.56 -57.87 3.58 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.257 2.623 . . . . 0.0 110.861 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.7 171.84 11.31 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.602 1.189 . . . . 0.0 112.911 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 71.3 m -79.19 -29.68 43.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.002 0.921 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.29 56.55 19.03 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 111.631 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.15 178.31 7.31 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 121.908 1.738 . . . . 0.0 115.773 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 p -90.02 156.64 18.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.36 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.68 156.54 31.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.224 -0.923 . . . . 0.0 112.742 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.98 149.77 17.89 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 120.07 2.788 . . . . 0.0 120.07 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -158.25 159.25 35.81 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.09 150.59 20.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.885 1.674 . . . . 0.0 108.478 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -129.02 125.72 63.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -103.72 112.37 25.28 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.507 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.355 57.5 m95 -74.11 154.94 38.93 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.81 -49.42 2.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 115.438 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.42 -15.16 59.99 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -150.44 144.64 25.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.984 2.514 . . . . 0.0 107.278 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.62 116.95 21.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.691 1.234 . . . . 0.0 109.975 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -168.56 171.52 8.82 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.284 1.834 . . . . 0.0 111.208 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.89 142.03 26.07 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 123.202 1.477 . . . . 0.0 110.456 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.51 132.73 31.66 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.629 -3.441 . . . . 0.0 109.577 -173.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.08 157.37 10.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.925 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.22 137.29 44.27 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.05 119.85 10.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.588 0.755 . . . . 0.0 110.018 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 -176.3 27.5 Favored Glycine 0 N--CA 1.463 0.492 0 N-CA-C 116.649 1.42 . . . . 0.0 116.649 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.06 144.56 48.48 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 124.874 0.984 . . . . 0.0 110.41 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 25.7 p -97.63 113.0 24.64 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.452 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.14 166.45 10.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.779 0.718 . . . . 0.0 112.057 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.26 112.42 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -58.59 161.38 4.66 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.264 1.026 . . . . 0.0 108.999 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -48.79 -30.05 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -15.01 57.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.403 1.081 . . . . 0.0 113.221 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.48 54.09 2.47 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -126.99 146.27 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.339 2.256 . . . . 0.0 108.407 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -106.27 138.32 42.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.932 1.693 . . . . 0.0 110.969 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.6 m -141.67 162.24 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.21 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.52 117.68 27.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -106.96 115.48 30.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -132.66 170.0 15.84 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 123.517 1.627 . . . . 0.0 111.952 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -121.8 170.88 9.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -145.84 162.83 36.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.215 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -145.67 125.68 13.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.375 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 144.31 38.61 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 125.037 1.46 . . . . 0.0 114.625 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.26 123.93 35.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 112.023 -2.353 . . . . 0.0 113.777 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 156.55 17.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.137 0.975 . . . . 0.0 111.716 176.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -102.83 63.5 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.146 0.498 . . . . 0.0 109.75 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -49.61 151.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.855 1.262 . . . . 0.0 112.675 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.99 -30.73 39.74 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.05 144.92 42.33 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.49 1.138 . . . . 0.0 113.145 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' C' ' 92' ' ' VAL . 12.7 tt -65.74 -23.41 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.559 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.7 1.43 53.02 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 118.24 -1.311 . . . . 0.0 113.693 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.502 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 13.5 m-20 -121.14 5.63 10.31 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -33.71 66.67 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 119.878 -1.764 . . . . 0.0 111.699 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 44.4 p-90 -45.29 -50.22 12.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.024 1.329 . . . . 0.0 114.264 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.589 ' HZ1' ' HA ' ' D' ' 39' ' ' ASP . 4.1 ptmm? -88.12 -11.41 47.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.82 -6.26 55.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.214 -1.374 . . . . 0.0 114.476 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 15.2 m -102.96 143.75 32.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 125.228 1.58 . . . . 0.0 112.148 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.9 mtt85 -144.34 129.38 18.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.626 1.17 . . . . 0.0 111.061 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.42 154.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.178 1.354 . . . . 0.0 110.867 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.92 -177.64 33.2 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.291 0.472 . . . . 0.0 113.579 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 23.9 p90 -125.13 152.25 44.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.683 -0.892 . . . . 0.0 110.97 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -148.27 143.42 26.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.62 0.768 . . . . 0.0 109.209 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.51 128.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.83 153.51 31.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.108 0.48 . . . . 0.0 111.43 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 42.2 p -136.14 160.74 37.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.285 1.034 . . . . 0.0 111.331 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -58.93 118.24 5.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.042 0.937 . . . . 0.0 111.735 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.0 139.54 35.72 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 67.64 47.27 1.21 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.064 1.346 . . . . 0.0 113.733 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -66.28 -24.68 66.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 55.55 -147.43 0.52 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.309 1.044 . . . . 0.0 111.07 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 tptp -148.05 5.53 0.76 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 117.094 -1.431 . . . . 0.0 113.49 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . 0.307 15.7 mt-10 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 128.875 2.87 . . . . 0.0 107.708 -170.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.3 m 67.56 -45.85 0.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.211 2.204 . . . . 0.0 115.617 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.9 -35.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.072 1.749 . . . . 0.0 114.423 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 24.94 98.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.406 2.682 . . . . 0.0 116.951 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.59 60.51 1.58 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.726 1.21 . . . . 0.0 112.933 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -156.17 118.5 4.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.778 1.231 . . . . 0.0 111.388 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 43.9 t -116.31 136.2 53.21 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -139.75 136.09 33.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.49 -26.15 60.77 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -46.54 109.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.256 1.422 . . . . 0.0 112.139 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.34 -126.9 3.32 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.389 0.995 . . . . 0.0 111.161 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -150.31 144.65 25.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -142.61 158.44 43.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.161 1.384 . . . . 0.0 111.034 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 148.82 45.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.705 1.202 . . . . 0.0 108.391 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -115.93 143.62 45.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.9 0.88 . . . . 0.0 110.769 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -53.45 -24.85 13.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.827 2.051 . . . . 0.0 114.549 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.08 -18.39 63.26 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.192 -1.567 . . . . 0.0 111.565 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.42 -15.0 17.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 128.587 2.994 . . . . 0.0 113.452 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 87.9 p -71.66 144.73 49.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.574 1.187 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.89 142.67 49.47 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.4 -0.813 . . . . 0.0 110.681 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -131.3 144.12 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.28 1.038 . . . . 0.0 112.769 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 17.5 m -132.04 131.55 42.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.232 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 66.8 mt -128.66 124.64 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.53 -84.87 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 125.026 1.454 . . . . 0.0 111.102 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.86 157.42 44.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.068 0.937 . . . . 0.0 112.067 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -109.91 125.81 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.918 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -79.25 161.46 26.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.841 0.456 . . . . 0.0 112.01 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.64 -23.46 17.27 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -69.23 -34.54 74.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.203 0.601 . . . . 0.0 111.413 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.41 -6.35 18.87 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.994 1.283 . . . . 0.0 112.878 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.81 157.78 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.423 1.106 . . . . 0.0 112.07 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 166.35 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.205 174.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -132.08 160.34 36.24 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.06 -166.53 28.26 Favored Glycine 0 C--O 1.239 0.419 0 CA-C-O 122.439 1.021 . . . . 0.0 112.423 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -137.43 140.16 41.11 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.458 -1.371 . . . . 0.0 111.97 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.95 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mt -133.48 126.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -104.99 148.89 26.24 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.36 -18.17 15.53 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.07 138.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.83 1.252 . . . . 0.0 111.475 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 169.98 19.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.365 -0.834 . . . . 0.0 112.369 -173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . 0.584 ' HA ' ' HZ1' ' A' ' 111' ' ' LYS . 21.5 p-10 -71.49 -25.53 62.3 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.836 -0.54 . . . . 0.0 110.534 173.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -145.09 81.2 10.68 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.621 2.369 . . . . 0.0 110.256 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.18 30.99 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 124.686 3.591 . . . . 0.0 116.243 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.35 6.49 79.68 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 119.816 -1.803 . . . . 0.0 116.1 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.46 10.51 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . 0.259 59.8 mt -32.64 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.66 173.59 6.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.042 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -70.28 137.72 50.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.3 p -114.46 126.14 28.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.96 144.31 94.54 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.058 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 150.95 49.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.015 0.926 . . . . 0.0 110.57 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.28 149.23 22.5 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.95 2.1 . . . . 0.0 108.512 -175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.62 -148.44 17.56 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.498 1.045 . . . . 0.0 112.419 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 mp -144.58 138.67 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 124.29 1.036 . . . . 0.0 112.424 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 130.08 47.5 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.816 -1.178 . . . . 0.0 110.561 174.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -62.12 156.26 22.08 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.716 -1.24 . . . . 0.0 111.868 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -147.57 12.87 1.04 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.835 1.254 . . . . 0.0 113.284 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -78.96 -58.16 3.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 128.22 2.608 . . . . 0.0 111.184 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.2 170.28 14.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.853 0.861 . . . . 0.0 112.622 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 73.9 m -81.22 -25.91 36.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.927 173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.93 56.4 16.79 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 125.228 1.411 . . . . 0.0 112.707 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.38 178.95 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.103 1.869 . . . . 0.0 115.84 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -89.54 157.48 18.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.98 1.312 . . . . 0.0 112.728 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -158.75 156.12 29.24 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.232 -0.917 . . . . 0.0 112.862 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.03 149.64 17.59 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.63 158.95 34.81 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -95.27 151.36 19.31 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.272 1.829 . . . . 0.0 108.56 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.7 124.01 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -102.12 112.47 25.15 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.956 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.354 55.4 m95 -73.91 154.87 39.21 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.98 -48.73 2.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.178 1.791 . . . . 0.0 115.529 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.67 -15.12 59.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -150.91 144.82 25.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.07 2.548 . . . . 0.0 107.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.8 117.17 22.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.607 1.094 . . . . 0.0 109.748 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 93.2 p -168.95 171.24 8.47 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.581 1.952 . . . . 0.0 110.942 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -147.59 142.27 26.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-O 123.039 1.399 . . . . 0.0 110.924 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.52 132.03 30.54 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 109.897 -3.319 . . . . 0.0 110.051 -172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -108.95 157.19 9.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.959 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -133.99 137.35 44.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.93 119.53 10.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 0.0 109.82 -174.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.24 -174.68 25.42 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.1 144.52 48.88 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.464 0.743 . . . . 0.0 110.781 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.69 113.0 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 124.139 0.899 . . . . 0.0 110.982 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.75 167.71 9.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.469 0.652 . . . . 0.0 111.557 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.79 113.97 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -58.78 161.2 5.0 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.871 0.868 . . . . 0.0 109.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -51.31 -20.95 1.89 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.72 -11.04 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.535 0.734 . . . . 0.0 112.665 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.94 49.02 3.93 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -122.81 145.82 48.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.639 1.976 . . . . 0.0 109.409 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -102.9 139.17 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.857 1.263 . . . . 0.0 111.024 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.6 m -141.77 163.97 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.97 1.308 . . . . 0.0 109.433 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.52 119.02 28.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -108.14 115.41 30.07 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -132.59 170.06 15.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.978 1.847 . . . . 0.0 112.274 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.11 170.98 9.32 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -146.15 162.69 37.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.233 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -145.64 125.67 13.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.194 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.14 144.69 38.4 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.974 1.421 . . . . 0.0 114.333 -174.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.28 123.1 33.24 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 111.943 -2.389 . . . . 0.0 113.701 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.7 156.22 18.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.699 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -102.97 61.55 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.864 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -48.06 151.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.144 1.377 . . . . 0.0 113.008 174.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -80.17 -31.05 38.89 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.89 145.15 42.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.534 1.159 . . . . 0.0 112.992 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' B' ' 92' ' ' VAL . 13.1 tt -64.84 -24.16 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.707 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 1.73 46.66 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.945 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . 0.502 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 13.2 m-20 -121.32 5.89 10.2 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -33.33 67.92 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 119.896 -1.752 . . . . 0.0 111.7 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 43.9 p-90 -45.59 -49.92 13.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.79 1.236 . . . . 0.0 114.299 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . 0.571 ' HZ1' ' HA ' ' A' ' 39' ' ' ASP . 4.1 ptmm? -88.33 -11.01 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.32 56.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -102.83 143.85 31.92 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 125.134 1.521 . . . . 0.0 112.265 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -144.54 130.03 18.93 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.64 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.25 154.18 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 120.417 1.462 . . . . 0.0 110.644 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -177.84 33.38 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.466 0.555 . . . . 0.0 113.442 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -124.76 152.43 43.84 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.665 -0.903 . . . . 0.0 111.135 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -148.14 143.71 27.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.666 0.787 . . . . 0.0 109.305 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.73 129.16 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.93 152.65 34.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.282 0.563 . . . . 0.0 111.612 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.2 p -135.18 161.86 34.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.447 1.099 . . . . 0.0 110.643 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -57.5 117.29 4.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.621 1.168 . . . . 0.0 112.505 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -86.12 106.54 17.32 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.655 -0.653 . . . . 0.0 109.817 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 80.99 142.07 0.07 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.101 2.56 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 8.9 t -156.43 -40.95 0.08 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.992 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 55.59 -82.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.195 1.798 . . . . 0.0 111.347 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? 62.59 66.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.435 2.294 . . . . 0.0 113.67 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.248 0.984 0 C-N-CA 129.852 3.261 . . . . 0.0 106.6 174.36 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 8.1 p -59.02 -48.33 81.99 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 113.32 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 51.12 -72.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.748 3.219 . . . . 0.0 114.619 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -167.82 73.62 0.12 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.914 2.085 . . . . 0.0 109.295 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 133.0 9.75 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.753 -0.592 . . . . 0.0 111.571 -176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 154.03 31.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.014 0.926 . . . . 0.0 109.408 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.6 p -139.66 127.58 22.15 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.137 -0.977 . . . . 0.0 112.999 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.95 -31.56 72.85 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.594 1.543 . . . . 0.0 113.375 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -66.5 113.68 4.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.26 0.21 0.3 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 119.03 2.372 . . . . 0.0 119.03 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt 73.14 144.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 129.405 3.082 . . . . 0.0 114.362 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -140.27 161.97 36.4 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.321 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -141.44 147.17 37.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.434 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.42 143.42 40.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.729 0.812 . . . . 0.0 110.195 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -56.64 -23.87 44.35 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.478 1.911 . . . . 0.0 113.593 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.61 -18.97 62.18 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.666 1.586 . . . . 0.0 111.499 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.45 -14.79 25.1 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 127.493 2.473 . . . . 0.0 113.582 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 p -67.99 140.3 56.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.361 1.581 . . . . 0.0 112.123 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.47 142.86 46.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -136.48 146.64 46.52 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.297 1.046 . . . . 0.0 112.843 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -134.2 132.17 39.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.313 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.0 mt -133.02 127.14 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.96 -84.52 0.19 Allowed Glycine 0 CA--C 1.526 0.762 0 O-C-N 125.187 1.554 . . . . 0.0 111.475 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 145.49 29.39 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.869 0.842 . . . . 0.0 112.238 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.57 128.9 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.718 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.14 161.88 20.93 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.519 0.676 . . . . 0.0 111.851 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 p -57.97 -20.9 41.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -78.22 -31.56 49.42 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.211 0.914 . . . . 0.0 111.532 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.29 -5.78 23.3 Favored Glycine 0 N--CA 1.466 0.655 0 CA-C-O 117.352 -1.805 . . . . 0.0 114.626 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 145.83 53.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.711 1.755 . . . . 0.0 109.056 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -155.1 140.2 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.05 12.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 -168.94 35.27 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.873 1.263 . . . . 0.0 111.304 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.3 p -133.0 130.26 39.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 123.339 1.543 . . . . 0.0 110.928 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -111.64 136.83 50.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.033 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 mt -132.6 130.27 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.5 145.98 33.91 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.32 -15.19 18.9 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -133.49 140.99 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.626 1.17 . . . . 0.0 112.937 -174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.47 162.53 38.1 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 120.76 -1.212 . . . . 0.0 111.0 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.95 -39.5 79.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.476 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -131.81 84.66 53.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 127.184 2.194 . . . . 0.0 108.082 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.11 175.56 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.423 2.082 . . . . 0.0 111.522 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.58 -31.96 3.29 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.608 1.099 . . . . 0.0 112.543 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.02 28.29 2.12 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.406 1.083 . . . . 0.0 112.164 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -58.25 134.11 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.796 0.807 . . . . 0.0 109.587 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 174.06 11.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.399 1.48 . . . . 0.0 108.984 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.28 132.48 39.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.112 1.765 . . . . 0.0 113.055 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -114.51 125.49 29.11 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.057 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HD3' ' HE3' ' A' ' 71' ' ' LYS . 4.9 Cg_exo -58.51 146.96 88.78 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.235 1.957 . . . . 0.0 110.846 173.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.46 151.66 51.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.26 0.624 . . . . 0.0 110.871 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tp -156.75 149.05 23.21 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.003 1.721 . . . . 0.0 110.872 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.56 -154.26 25.0 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 121.541 1.973 . . . . 0.0 109.833 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 mt -146.7 140.94 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 112.132 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.28 138.24 50.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.792 1.237 . . . . 0.0 110.766 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -70.52 155.56 40.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.837 0.827 . . . . 0.0 110.415 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -138.61 -5.6 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -77.67 -35.09 52.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.85 167.12 12.69 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 m -76.96 -37.99 54.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.298 1.439 . . . . 0.0 114.659 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -139.33 49.92 2.33 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 125.026 1.33 . . . . 0.0 111.877 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.76 -179.04 4.98 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.408 2.739 . . . . 0.0 115.35 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.5 p -87.44 161.31 17.91 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.892 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.51 155.75 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.487 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.82 19.92 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 119.715 2.646 . . . . 0.0 119.715 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -159.72 159.73 33.2 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -97.64 148.72 23.02 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.952 2.501 . . . . 0.0 108.685 173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.52 125.33 63.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -103.68 107.06 17.75 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.555 -174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -72.06 149.19 45.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 123.411 1.577 . . . . 0.0 114.731 -173.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HE3' ' HD3' ' A' ' 48' ' ' PRO . 27.9 mttt -108.54 -45.39 3.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -78.85 -17.23 55.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.287 1.035 . . . . 0.0 112.804 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 128.66 10.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 129.269 3.028 . . . . 0.0 105.397 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.12 119.01 11.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.332 0.969 . . . . 0.0 112.088 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.465 ' HG ' HD21 ' A' ' 99' ' ' LEU . 48.2 t -170.72 167.52 7.71 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.773 1.629 . . . . 0.0 110.919 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -146.13 140.9 27.02 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 124.001 1.857 . . . . 0.0 110.484 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.433 ' HG1' ' CD1' ' A' ' 99' ' ' LEU . 1.5 m -137.24 126.38 24.53 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-N 109.303 -3.589 . . . . 0.0 109.949 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -102.09 161.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.39 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -136.7 137.95 40.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.92 118.14 9.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.14 -179.41 26.84 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.058 -1.068 . . . . 0.0 115.535 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -121.57 148.89 43.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 125.223 1.19 . . . . 0.0 111.264 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.1 t -97.13 127.64 43.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 125.094 1.496 . . . . 0.0 109.911 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -117.7 161.4 19.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.16 0.984 . . . . 0.0 113.517 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.1 mt -127.18 112.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.54 160.56 6.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.104 0.562 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -43.05 -37.26 1.89 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.12 -14.94 60.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.448 1.499 . . . . 0.0 114.773 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 46.82 4.15 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.587 0.613 . . . . 0.0 113.016 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -115.79 160.23 20.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.966 2.106 . . . . 0.0 108.037 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -116.0 144.77 43.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.075 1.762 . . . . 0.0 111.713 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.72 159.36 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.601 1.191 . . . . 0.0 109.592 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.14 102.29 7.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HE3' HD13 ' A' ' 119' ' ' ILE . 2.3 mmtt -96.23 121.42 37.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.4 p -134.01 162.86 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.627 1.204 . . . . 0.0 111.373 -174.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.38 168.16 9.85 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -142.11 163.8 31.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.786 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.97 123.98 12.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.801 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.465 HD21 ' HG ' ' A' ' 75' ' ' SER . 0.3 OUTLIER -110.32 144.87 38.4 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 125.088 1.493 . . . . 0.0 114.025 -174.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -124.52 114.89 20.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.983 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -73.7 162.59 29.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.889 0.876 . . . . 0.0 111.557 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.6 p -99.88 45.69 0.98 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.0 -1.063 . . . . 0.0 111.492 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.4 137.23 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.98 1.712 . . . . 0.0 113.145 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -20.58 61.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -174.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.62 150.93 51.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.16 1.457 . . . . 0.0 113.549 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.0 tt -64.15 -23.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.109 -0.994 . . . . 0.0 113.084 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.47 3.75 58.18 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.071 0.843 . . . . 0.0 113.552 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.7 -0.65 9.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.195 0.998 . . . . 0.0 112.451 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -31.76 69.18 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.208 -0.932 . . . . 0.0 112.85 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -48.18 -41.61 27.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.096 1.358 . . . . 0.0 113.714 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -96.39 -8.59 32.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 -0.9 18.94 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.2 m -113.39 140.97 47.61 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.588 0.755 . . . . 0.0 112.632 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -144.21 131.67 20.97 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.787 1.235 . . . . 0.0 111.738 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.66 156.55 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 110.53 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -175.43 30.89 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.516 0.579 . . . . 0.0 113.225 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -125.14 153.15 43.45 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.795 -0.826 . . . . 0.0 112.112 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 132.13 14.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.746 0.784 . . . . 0.0 110.052 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.481 HD13 ' HE3' ' A' ' 94' ' ' LYS . 15.5 mt -118.93 138.45 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.56 139.97 53.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.821 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.3 p -129.32 154.09 47.2 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -53.01 117.86 3.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.336 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 tt -85.35 123.09 30.41 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HG2' HH11 ' A' ' 124' ' ' ARG . 0.0 OUTLIER -159.8 -167.94 2.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.27 172.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -60.57 164.33 4.63 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.279 0.632 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -121.42 6.81 10.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.67 1.588 . . . . 0.0 111.101 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -131.51 84.0 2.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 128.138 2.575 . . . . 0.0 106.391 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.256 1.421 0 C-N-CA 129.216 3.007 . . . . 0.0 115.473 -178.687 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.56 -45.77 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.556 1.16 . . . . 0.0 110.191 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 21.3 m -65.19 148.4 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 111.812 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -73.71 53.62 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.313 1.445 . . . . 0.0 112.528 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 29.45 61.76 0.15 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 129.065 2.946 . . . . 0.0 114.594 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 146.25 22.7 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 126.218 1.807 . . . . 0.0 109.227 -174.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' D' ' 83' ' ' CYS . 6.2 p -134.58 148.53 50.47 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.27 1.828 . . . . 0.0 107.732 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 65.3 p -139.29 131.12 27.57 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.285 -1.51 . . . . 0.0 114.148 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 50.7 mt -65.04 -31.88 73.33 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.259 1.391 . . . . 0.0 113.924 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -66.33 115.64 6.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.38 8.16 0.29 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 118.296 2.079 . . . . 0.0 118.296 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 66.55 148.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.272 2.629 . . . . 0.0 114.927 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -143.43 161.08 39.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.474 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -140.5 145.7 37.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.545 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -109.54 143.61 38.97 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.178 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.16 -23.34 46.77 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.405 1.882 . . . . 0.0 113.543 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.0 tp -72.4 -19.06 61.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.006 1.722 . . . . 0.0 111.27 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.47 -14.59 22.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.121 2.296 . . . . 0.0 113.622 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -67.52 138.34 56.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.458 1.629 . . . . 0.0 112.202 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.85 141.3 46.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -135.03 147.15 49.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.246 1.022 . . . . 0.0 113.179 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.1 m -134.49 131.96 38.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.068 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -133.13 126.32 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.08 -84.59 0.16 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 125.292 1.62 . . . . 0.0 111.583 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.05 29.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.713 0.757 . . . . 0.0 111.853 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.56 128.8 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.901 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.52 161.54 19.95 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.636 0.731 . . . . 0.0 111.595 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.8 p -58.2 -21.38 47.44 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -75.92 -30.3 58.68 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.176 0.898 . . . . 0.0 111.666 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.77 -4.21 25.98 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.778 1.18 . . . . 0.0 115.061 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.56 150.85 45.67 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.399 1.08 . . . . 0.0 110.926 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -156.46 162.84 39.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.164 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.86 171.97 12.17 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 173.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.21 -167.84 37.3 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 119.947 -1.721 . . . . 0.0 111.628 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 44.0 p -132.95 128.84 37.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.89 1.329 . . . . 0.0 110.823 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -111.65 136.06 51.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.12 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 30.6 mt -132.11 132.39 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.26 145.5 38.65 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 -15.41 19.2 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.55 140.7 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.324 1.05 . . . . 0.0 113.068 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.01 162.4 37.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.132 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.77 -38.85 80.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.628 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -131.89 84.5 53.75 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.987 2.115 . . . . 0.0 108.013 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 175.09 9.58 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.09 1.86 . . . . 0.0 111.417 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.23 -31.45 3.3 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.567 1.079 . . . . 0.0 112.502 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.37 28.13 2.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.341 1.056 . . . . 0.0 112.16 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.9 134.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.929 0.871 . . . . 0.0 109.608 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.18 174.08 11.19 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.314 1.445 . . . . 0.0 108.862 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.53 132.69 40.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 126.248 1.819 . . . . 0.0 113.093 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -114.67 125.67 28.83 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.067 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' PRO . . . . . 0.456 ' HD3' ' HE3' ' D' ' 71' ' ' LYS . 4.8 Cg_exo -58.72 146.92 90.43 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.164 1.909 . . . . 0.0 110.748 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.13 157.41 43.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.441 0.697 . . . . 0.0 111.234 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.89 148.85 15.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.822 1.649 . . . . 0.0 110.381 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -157.7 28.96 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 121.35 1.886 . . . . 0.0 111.999 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.41 138.7 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.094 0.957 . . . . 0.0 111.903 -174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.98 138.17 50.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.537 1.535 . . . . 0.0 110.733 174.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -71.09 154.94 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.408 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -136.8 -6.38 1.91 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -78.61 -35.91 44.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.25 168.57 13.8 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -74.82 -42.55 57.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.244 1.018 . . . . 0.0 113.556 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -137.45 53.07 6.06 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.07 1.348 . . . . 0.0 112.037 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.91 -179.73 5.48 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.264 1.976 . . . . 0.0 115.248 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 34.8 p -87.97 161.91 17.16 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.762 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -159.53 155.97 27.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.57 149.69 19.59 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 119.517 2.567 . . . . 0.0 119.517 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.13 158.07 29.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -96.47 149.22 21.97 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.827 2.451 . . . . 0.0 108.989 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.89 124.87 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -104.23 107.31 18.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.053 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.7 149.6 45.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 123.381 1.562 . . . . 0.0 114.397 -173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . 0.456 ' HE3' ' HD3' ' D' ' 48' ' ' PRO . 27.2 mttt -108.56 -45.06 3.93 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -173.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -79.22 -16.88 55.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.395 1.078 . . . . 0.0 112.917 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -152.26 129.25 11.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.299 3.04 . . . . 0.0 105.453 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.91 118.95 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.355 0.98 . . . . 0.0 111.584 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' SER . . . . . 0.478 ' HG ' HD21 ' D' ' 99' ' ' LEU . 45.5 t -170.5 167.54 8.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 110.776 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -145.9 141.06 27.44 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.832 1.777 . . . . 0.0 110.892 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' THR . . . . . 0.44 ' HG1' ' CD1' ' D' ' 99' ' ' LEU . 1.5 m -137.46 125.25 22.48 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 109.469 -3.514 . . . . 0.0 110.456 -172.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -101.04 161.06 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.355 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.29 138.38 39.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.26 118.16 9.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 109.223 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.23 -178.59 26.18 Favored Glycine 0 CA--C 1.5 -0.85 0 C-N-CA 120.006 -1.092 . . . . 0.0 115.816 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.26 145.58 48.09 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 125.09 1.112 . . . . 0.0 111.263 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' D' ' 4' ' ' CYS . 17.0 t -97.6 118.37 33.95 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.939 1.4 . . . . 0.0 110.653 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.06 163.78 13.02 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -127.94 113.64 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.31 154.99 26.18 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -36.51 -38.98 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -72.37 -29.68 64.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.655 1.582 . . . . 0.0 114.467 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.38 58.72 0.73 Allowed Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.122 1.344 . . . . 0.0 110.949 -173.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -123.72 163.46 21.07 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.414 2.686 . . . . 0.0 107.31 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -124.81 145.74 49.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 121.77 2.077 . . . . 0.0 112.725 -172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.16 159.48 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.679 1.191 . . . . 0.0 110.643 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 19.1 mt -123.22 104.15 8.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' LYS . . . . . 0.46 ' HE3' HD13 ' D' ' 119' ' ' ILE . 1.7 mmtt -98.29 119.05 36.29 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -133.19 161.93 33.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.534 1.159 . . . . 0.0 111.257 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.24 168.45 9.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -142.14 164.25 30.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.477 1.132 . . . . 0.0 111.727 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 124.14 11.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.685 -1.598 . . . . 0.0 113.569 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' LEU . . . . . 0.478 HD21 ' HG ' ' D' ' 75' ' ' SER . 0.3 OUTLIER -110.62 144.81 38.95 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 125.332 1.645 . . . . 0.0 114.078 -174.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -124.63 115.02 20.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.896 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 31.5 m -74.52 161.32 29.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.937 0.895 . . . . 0.0 111.844 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 58.8 p -99.0 45.55 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.85 -1.157 . . . . 0.0 111.356 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.22 137.96 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 112.964 -174.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -19.74 60.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.04 151.75 50.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.862 1.315 . . . . 0.0 113.783 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.89 -24.37 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.367 -0.833 . . . . 0.0 113.171 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.16 3.5 52.09 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.212 0.911 . . . . 0.0 113.6 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.9 -0.78 8.96 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.139 0.976 . . . . 0.0 112.454 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -31.85 68.46 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.408 -0.808 . . . . 0.0 112.747 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -48.3 -41.68 28.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.255 1.422 . . . . 0.0 113.703 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -96.66 -8.6 31.16 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -1.46 20.87 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -112.95 140.83 47.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.531 0.733 . . . . 0.0 112.687 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -144.12 131.34 20.72 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.788 1.235 . . . . 0.0 111.658 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.49 156.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 110.492 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.24 -175.26 31.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.541 0.591 . . . . 0.0 113.434 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -125.06 152.59 44.1 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.734 -0.862 . . . . 0.0 112.004 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.34 12.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.851 0.834 . . . . 0.0 110.166 -175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' ILE . . . . . 0.46 HD13 ' HE3' ' D' ' 94' ' ' LYS . 16.4 mt -116.02 138.29 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.08 141.88 51.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -130.36 154.32 47.8 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -52.83 112.94 0.93 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.246 1.018 . . . . 0.0 110.145 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.47 116.6 13.12 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.36 -59.39 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.307 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 2.1 p 57.12 119.7 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.721 2.008 . . . . 0.0 113.12 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -157.51 118.72 3.61 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.14 -1.6 . . . . 0.0 107.256 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.76 164.86 35.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 128.062 2.545 . . . . 0.0 108.664 -174.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.267 1.979 1 C-N-CA 133.609 4.764 . . . . 0.0 104.514 173.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 117.112 -1.423 . . . . 0.0 108.024 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.6 p -88.38 -62.86 1.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.604 1.162 . . . . 0.0 110.294 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.97 174.27 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.556 1.942 . . . . 0.0 109.11 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.98 158.23 37.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.575 1.15 . . . . 0.0 110.057 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -83.44 56.59 3.64 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.03 -1.044 . . . . 0.0 111.545 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 130.76 8.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.265 -0.897 . . . . 0.0 112.533 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' B' ' 83' ' ' CYS . 25.3 p -116.86 147.77 41.87 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.331 1.852 . . . . 0.0 109.54 -174.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -139.48 129.66 25.25 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.78 -33.22 75.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.13 1.332 . . . . 0.0 114.105 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -65.27 115.55 5.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.82 5.2 0.32 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 68.76 146.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 128.59 2.756 . . . . 0.0 115.483 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -141.97 159.14 42.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.411 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -136.45 143.82 44.09 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.591 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -108.97 143.54 38.11 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.611 0.764 . . . . 0.0 110.571 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -55.62 -25.09 36.9 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.194 1.798 . . . . 0.0 113.332 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.13 -18.92 62.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.633 1.573 . . . . 0.0 111.846 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.94 -16.06 23.27 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.381 2.42 . . . . 0.0 113.414 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 61.5 p -67.29 141.11 57.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.019 1.39 . . . . 0.0 111.89 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.67 141.09 48.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -134.56 147.14 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.569 1.176 . . . . 0.0 112.505 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -134.76 131.17 37.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.57 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 93.9 mt -132.59 126.2 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -84.75 0.17 Allowed Glycine 0 CA--C 1.526 0.769 0 O-C-N 125.348 1.655 . . . . 0.0 111.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.23 146.54 30.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 112.265 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 28.2 t -89.94 128.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.497 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.28 162.18 17.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.527 0.68 . . . . 0.0 111.847 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.2 p -58.0 -20.92 42.24 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -78.35 -31.4 48.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.176 0.898 . . . . 0.0 111.719 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.97 -5.75 23.87 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-O 117.479 -1.734 . . . . 0.0 114.687 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.6 145.34 54.03 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.531 1.665 . . . . 0.0 108.914 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.76 140.1 17.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.18 12.04 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.43 -168.72 34.93 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-O 122.82 1.233 . . . . 0.0 111.132 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -133.59 131.1 39.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.32 -1.44 . . . . 0.0 110.789 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -112.25 137.06 50.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.898 -1.956 . . . . 0.0 108.116 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 27.0 mt -132.96 129.72 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.75 145.73 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.23 -14.75 19.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.93 140.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.559 1.143 . . . . 0.0 112.745 -174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.36 162.85 37.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 110.862 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.48 -38.96 77.9 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.433 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -132.15 84.6 52.28 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.202 2.201 . . . . 0.0 107.995 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.01 175.49 9.06 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.375 2.05 . . . . 0.0 111.486 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.35 -31.41 3.44 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.584 1.088 . . . . 0.0 112.654 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -140.28 28.25 2.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.395 1.078 . . . . 0.0 112.15 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.03 134.41 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.92 0.867 . . . . 0.0 109.562 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.31 173.63 11.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.347 1.459 . . . . 0.0 109.039 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.97 132.93 38.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.15 1.78 . . . . 0.0 113.211 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -115.26 125.86 28.42 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.082 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.455 ' HD3' ' HE3' ' B' ' 71' ' ' LYS . 6.7 Cg_exo -58.42 146.51 89.9 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 0.0 110.811 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.4 151.48 51.5 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.289 0.635 . . . . 0.0 110.7 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 tp -156.78 149.08 23.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.028 1.731 . . . . 0.0 110.845 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.59 25.49 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 121.555 1.979 . . . . 0.0 109.511 -173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mt -146.2 140.23 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.371 1.068 . . . . 0.0 112.403 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.35 137.35 49.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.465 1.106 . . . . 0.0 110.657 174.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -69.91 156.13 39.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 109.992 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -138.81 -5.66 1.51 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -79.15 -36.9 39.72 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.47 166.64 15.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.749 0.656 . . . . 0.0 112.524 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.7 m -79.41 -34.28 41.93 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -139.78 51.88 3.35 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 125.147 1.379 . . . . 0.0 112.351 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.3 -179.5 5.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.734 2.29 . . . . 0.0 115.806 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -87.23 161.55 17.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.941 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.84 155.67 26.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.575 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.68 19.44 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 119.705 2.642 . . . . 0.0 119.705 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -160.07 159.05 31.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -96.52 149.44 21.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.844 2.457 . . . . 0.0 108.783 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.88 125.74 63.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -104.05 106.63 17.2 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 118.223 -0.894 . . . . 0.0 112.373 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -71.8 149.43 45.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.288 1.518 . . . . 0.0 114.591 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.455 ' HE3' ' HD3' ' B' ' 48' ' ' PRO . 28.2 mttt -108.58 -45.24 3.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -79.14 -16.97 55.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 112.857 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 129.17 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.242 3.017 . . . . 0.0 105.455 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.73 119.0 11.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.472 1.033 . . . . 0.0 111.791 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 39.4 t -170.43 167.38 8.25 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.993 1.717 . . . . 0.0 110.738 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -146.12 140.83 26.98 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-O 124.03 1.871 . . . . 0.0 110.453 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' THR . . . . . 0.438 ' HG1' ' CD1' ' B' ' 99' ' ' LEU . 1.5 m -137.52 126.18 23.78 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 109.335 -3.575 . . . . 0.0 110.052 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.8 161.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.328 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.91 138.58 40.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.3 119.43 10.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.668 0.787 . . . . 0.0 109.148 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.81 -178.84 27.85 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.202 -0.999 . . . . 0.0 115.579 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -121.51 145.9 47.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 125.211 1.183 . . . . 0.0 111.058 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' B' ' 4' ' ' CYS . 17.2 t -97.36 121.94 39.83 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.651 1.219 . . . . 0.0 110.012 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -111.98 163.57 14.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.916 1.286 . . . . 0.0 112.648 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 mt -128.08 119.09 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.13 163.63 5.98 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.362 0.601 . . . . 0.0 109.839 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -47.0 -36.84 8.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.85 -25.09 60.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.308 1.443 . . . . 0.0 113.444 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.06 11.37 22.51 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.02 -1.433 . . . . 0.0 115.785 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -81.58 167.21 19.51 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.426 1.613 . . . . 0.0 111.143 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.77 148.19 43.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.065 1.757 . . . . 0.0 112.185 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.99 160.6 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 122.358 1.075 . . . . 0.0 110.61 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -123.49 103.58 8.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.466 ' HE3' HD13 ' B' ' 119' ' ' ILE . 2.0 mmtt -98.14 118.71 35.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -132.41 163.3 29.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.583 1.182 . . . . 0.0 111.534 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -113.15 168.45 9.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -142.57 164.0 31.31 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.184 0.992 . . . . 0.0 111.771 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.38 123.73 11.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.678 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.438 ' CD1' ' HG1' ' B' ' 77' ' ' THR . 0.3 OUTLIER -110.06 144.78 38.14 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 125.197 1.56 . . . . 0.0 114.173 -174.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.4 115.4 20.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 111.822 -2.445 . . . . 0.0 114.298 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 38.4 m -75.81 161.33 29.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.156 0.982 . . . . 0.0 111.134 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.5 p -98.28 45.29 1.02 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.42 137.73 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.91 1.684 . . . . 0.0 112.979 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -20.3 60.86 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -173.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.21 153.13 50.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.84 1.305 . . . . 0.0 113.666 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 16.0 tt -65.03 -22.81 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.76 2.78 58.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.363 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.5 -0.79 9.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.558 1.143 . . . . 0.0 112.436 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -32.07 67.05 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.28 -0.887 . . . . 0.0 112.892 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 57.0 p-90 -48.65 -41.52 31.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.076 1.35 . . . . 0.0 113.764 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -96.65 -8.33 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.91 -1.21 18.7 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.2 m -113.15 140.97 47.46 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.772 0.829 . . . . 0.0 112.807 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -144.13 131.56 20.95 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.708 1.203 . . . . 0.0 111.547 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.54 156.73 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 123.976 0.91 . . . . 0.0 110.73 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.35 -175.91 31.85 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.509 0.576 . . . . 0.0 113.358 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 27.8 p90 -124.56 152.57 43.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.781 -0.834 . . . . 0.0 111.956 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.6 12.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.953 0.883 . . . . 0.0 110.072 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.466 HD13 ' HE3' ' B' ' 94' ' ' LYS . 15.2 mt -116.7 138.74 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -125.19 142.41 51.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.851 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 26.9 p -132.29 158.86 40.76 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -57.55 119.68 6.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.455 1.102 . . . . 0.0 113.255 -173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 tt -93.85 89.06 5.98 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -178.52 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.341 1.456 . . . . 0.0 113.577 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -79.77 144.45 33.57 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.516 1.526 . . . . 0.0 110.498 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -90.16 -46.57 8.36 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -135.2 -54.45 0.8 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 111.129 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 C--O 1.263 1.769 1 C-N-CA 136.386 5.874 . . . . 0.0 105.411 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.44 165.53 23.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.751 1.62 . . . . 0.0 108.276 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.48 141.17 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.391 0.676 . . . . 0.0 109.728 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -137.44 137.28 38.59 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.788 0.835 . . . . 0.0 109.778 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -149.41 94.26 2.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.172 2.189 . . . . 0.0 107.135 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.66 124.22 5.42 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.51 1.124 . . . . 0.0 109.0 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' C' ' 83' ' ' CYS 0.254 16.1 p -116.02 142.94 46.14 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 124.559 1.144 . . . . 0.0 108.343 -173.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 33.1 p -134.83 132.4 38.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.826 1.25 . . . . 0.0 113.858 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.31 -30.03 68.92 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -67.78 111.81 4.5 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.45 -10.32 0.29 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 118.597 2.199 . . . . 0.0 118.597 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt 81.19 146.48 0.08 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 130.513 3.525 . . . . 0.0 113.261 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -140.47 161.45 37.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.227 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -139.09 144.22 38.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.686 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -107.89 143.61 36.27 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.712 0.805 . . . . 0.0 110.275 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.08 -23.91 50.16 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.697 1.599 . . . . 0.0 113.276 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.14 -18.96 62.49 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.729 1.612 . . . . 0.0 111.415 174.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.9 -16.36 23.23 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.363 2.411 . . . . 0.0 113.537 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 51.7 p -66.55 141.04 57.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.215 1.508 . . . . 0.0 112.128 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.75 139.41 51.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.58 147.11 51.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.22 1.009 . . . . 0.0 113.021 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -134.85 131.9 37.96 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.891 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.99 125.6 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.99 -82.0 0.23 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 125.342 1.651 . . . . 0.0 111.379 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.72 151.11 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.681 0.753 . . . . 0.0 112.027 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.63 128.02 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.846 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -65.02 161.09 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.618 0.723 . . . . 0.0 111.675 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 11.7 p -58.03 -20.57 39.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -76.81 -29.91 56.18 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.313 0.96 . . . . 0.0 111.621 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.26 -3.69 26.76 Favored Glycine 0 N--CA 1.468 0.772 0 C-N-CA 124.761 1.172 . . . . 0.0 115.112 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.14 150.31 45.55 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.371 1.069 . . . . 0.0 110.797 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.86 162.73 40.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.041 174.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 172.4 11.62 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.37 -167.08 36.2 Favored Glycine 0 C--O 1.237 0.302 0 O-C-N 120.004 -1.685 . . . . 0.0 111.861 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 34.8 p -133.78 128.57 35.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 123.172 1.463 . . . . 0.0 111.1 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.02 137.21 50.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.14 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.27 133.25 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.92 146.96 40.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.91 -14.06 19.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.16 142.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.746 1.218 . . . . 0.0 112.609 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.42 38.95 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.035 -1.041 . . . . 0.0 110.992 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.95 -39.01 79.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.362 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -132.12 84.69 52.16 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.089 2.156 . . . . 0.0 107.988 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 175.4 9.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.328 2.018 . . . . 0.0 111.506 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.83 -31.37 3.37 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.523 1.059 . . . . 0.0 112.58 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -140.19 28.6 2.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.486 1.114 . . . . 0.0 112.135 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.83 134.54 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.786 0.803 . . . . 0.0 109.462 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.97 174.66 10.65 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.273 1.429 . . . . 0.0 108.888 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.86 133.09 42.75 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.26 1.824 . . . . 0.0 112.963 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 49.0 m -115.37 125.75 28.51 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.153 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . 0.427 ' HD3' ' HE3' ' C' ' 71' ' ' LYS . 5.6 Cg_exo -58.04 146.7 86.43 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.142 1.895 . . . . 0.0 110.92 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.83 157.53 42.63 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.229 0.612 . . . . 0.0 111.187 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 148.89 15.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.835 1.654 . . . . 0.0 110.244 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.83 -157.9 29.15 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 121.57 1.986 . . . . 0.0 111.875 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mt -145.26 138.25 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.17 0.988 . . . . 0.0 111.933 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.17 139.29 51.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.687 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.46 154.64 40.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.486 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -137.28 -6.21 1.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -78.42 -37.2 44.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.31 165.8 16.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.344 0.592 . . . . 0.0 112.538 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 24.8 m -79.05 -34.26 43.95 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -140.2 52.74 3.7 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.897 1.279 . . . . 0.0 112.244 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.79 -179.09 5.11 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.851 2.367 . . . . 0.0 115.95 -174.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -86.5 162.38 18.1 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.792 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -160.22 156.49 26.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.736 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.4 148.98 17.96 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.64 158.77 32.16 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.91 149.78 21.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.825 2.45 . . . . 0.0 108.894 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.58 124.13 58.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.53 107.66 18.59 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.231 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -71.87 149.1 45.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.127 1.441 . . . . 0.0 114.557 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.427 ' HE3' ' HD3' ' C' ' 48' ' ' PRO . 26.5 mttt -108.21 -45.15 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.415 2.005 . . . . 0.0 116.415 -173.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -78.9 -16.93 56.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.204 1.002 . . . . 0.0 112.958 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -152.05 131.57 13.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 129.517 3.127 . . . . 0.0 105.032 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.41 119.04 13.98 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.163 0.892 . . . . 0.0 111.627 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' SER . . . . . 0.474 ' HG ' HD21 ' C' ' 99' ' ' LEU . 48.5 t -170.53 167.59 8.01 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.767 1.627 . . . . 0.0 110.819 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -145.81 141.14 27.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 123.927 1.823 . . . . 0.0 110.763 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' THR . . . . . 0.445 ' HG1' ' CD1' ' C' ' 99' ' ' LEU . 1.5 m -137.59 125.93 23.29 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 109.454 -3.521 . . . . 0.0 110.43 -172.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -102.01 160.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.15 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -136.96 138.36 40.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.4 119.29 9.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.716 0.807 . . . . 0.0 108.875 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.51 -177.88 26.6 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 119.931 -1.128 . . . . 0.0 115.709 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -122.09 145.85 47.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.004 1.061 . . . . 0.0 111.191 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' C' ' 4' ' ' CYS . 14.6 t -97.4 121.73 39.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.803 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.8 162.23 16.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.415 1.086 . . . . 0.0 113.276 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.5 mt -127.86 111.7 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -62.23 162.19 10.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.424 0.69 . . . . 0.0 110.052 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -42.97 -39.53 2.64 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.36 -25.55 63.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.051 1.34 . . . . 0.0 113.784 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.54 10.01 22.33 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.87 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -78.77 164.24 24.7 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.333 1.566 . . . . 0.0 110.862 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.62 148.18 41.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.019 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.91 162.92 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.904 1.281 . . . . 0.0 110.425 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 19.4 mt -126.24 104.21 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' C' ' 119' ' ' ILE . 1.9 mmtt -98.79 118.26 35.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -131.96 163.13 29.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.462 1.125 . . . . 0.0 111.572 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.92 168.82 9.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -143.09 164.29 30.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.199 1.0 . . . . 0.0 111.832 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.4 123.77 11.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.973 -1.467 . . . . 0.0 113.705 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' LEU . . . . . 0.474 HD21 ' HG ' ' C' ' 75' ' ' SER . 0.3 OUTLIER -110.23 144.72 38.49 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.248 1.419 . . . . 0.0 114.068 -174.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.48 114.91 20.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 112.168 -2.287 . . . . 0.0 114.185 -174.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -74.86 161.32 29.66 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.852 0.861 . . . . 0.0 111.938 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 55.4 p -98.27 45.33 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.307 1.043 . . . . 0.0 111.48 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.31 136.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.744 1.618 . . . . 0.0 113.453 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -20.52 61.85 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -174.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.53 151.35 51.09 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.819 1.295 . . . . 0.0 113.597 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 tt -64.28 -21.92 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.56 3.27 64.06 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -122.81 -0.58 9.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.316 1.046 . . . . 0.0 112.621 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -31.55 68.51 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.72 0.808 . . . . 0.0 112.83 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -49.02 -41.16 33.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.009 1.323 . . . . 0.0 113.706 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -96.78 -8.54 30.93 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.01 18.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.3 m -113.41 140.44 48.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.52 0.728 . . . . 0.0 112.66 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -143.69 131.24 21.14 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.639 1.176 . . . . 0.0 111.645 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.37 156.49 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.034 0.933 . . . . 0.0 110.64 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.95 -175.8 31.33 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.352 0.501 . . . . 0.0 113.261 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.21 152.93 42.33 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.786 -0.832 . . . . 0.0 112.053 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.17 128.81 11.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.966 0.889 . . . . 0.0 110.132 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' ILE . . . . . 0.487 HD13 ' HE3' ' C' ' 94' ' ' LYS . 15.3 mt -115.37 140.87 34.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -127.27 141.32 51.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.772 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 18.2 p -131.69 161.17 33.4 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -59.15 119.76 7.93 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.706 0.802 . . . . 0.0 112.546 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tt -84.66 162.95 19.53 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.72 -178.26 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.753 0.821 . . . . 0.0 110.939 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' THR . . . . . . . . . . . . 0.256 5.8 t 53.41 -169.22 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.683 1.593 . . . . 0.0 112.762 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -70.58 172.33 8.74 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.384 -0.822 . . . . 0.0 109.393 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 0.44 5.06 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 115.864 -2.017 . . . . 0.0 115.829 -173.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.26 1.632 0 CA-C-O 117.024 -1.465 . . . . 0.0 109.727 -172.288 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 tttt . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.31 136.97 52.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 122.564 1.173 . . . . 0.0 111.747 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.14 129.03 24.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.909 2.484 . . . . 0.0 107.564 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' A' ' 53' ' ' GLN . 3.8 mt -67.83 -31.25 70.97 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -53.44 116.53 2.5 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.731 0.777 . . . . 0.0 110.947 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.45 -128.85 4.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 10' ' ' TRP . 14.8 ttmt -146.23 152.34 39.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.477 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 55.9 m95 -138.35 162.73 33.66 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 110.879 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 14.7 t -141.3 144.64 34.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.54 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -106.92 147.28 30.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.84 0.856 . . . . 0.0 111.591 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -27.79 58.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.868 1.267 . . . . 0.0 113.94 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.503 HD11 ' CD1' ' C' ' 110' ' ' TRP . 35.1 tp -71.09 -15.99 62.55 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.425 1.49 . . . . 0.0 113.476 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.68 -9.81 44.77 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.871 2.177 . . . . 0.0 114.068 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -71.93 146.73 47.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.685 1.243 . . . . 0.0 110.839 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -122.72 148.36 45.41 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.15 -0.969 . . . . 0.0 111.711 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -135.06 139.81 45.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -126.4 132.68 51.48 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.76 126.71 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.77 -91.0 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.637 1.211 . . . . 0.0 111.97 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 134.61 30.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.519 -0.989 . . . . 0.0 110.387 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.01 133.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.959 0.787 . . . . 0.0 111.241 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.36 158.09 36.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.372 1.069 . . . . 0.0 110.874 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.6 m -57.65 -24.58 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.865 -1.147 . . . . 0.0 113.963 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.409 -0.807 . . . . 0.0 110.766 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.31 -5.01 33.42 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.769 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.23 154.24 39.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.942 1.871 . . . . 0.0 111.608 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.04 154.22 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -116.83 156.28 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.604 1.162 . . . . 0.0 109.557 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.72 -176.57 38.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.651 1.139 . . . . 0.0 115.288 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.441 ' CG2' HD23 ' A' ' 46' ' ' LEU . 7.9 p -134.26 123.29 24.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.279 -1.461 . . . . 0.0 107.724 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' C ' HD12 ' A' ' 34' ' ' ILE . 62.2 t80 -124.38 132.14 53.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.169 -1.832 . . . . 0.0 113.76 -171.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 46' ' ' LEU . 2.4 mp -124.15 131.37 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.735 0.778 . . . . 0.0 108.965 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -106.92 138.27 43.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.087 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.32 24.63 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 30.3 m -137.81 136.96 45.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 124.083 0.953 . . . . 0.0 111.921 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.46 163.13 37.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.172 -0.955 . . . . 0.0 111.012 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.88 -27.13 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.25 80.47 10.13 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 127.281 2.232 . . . . 0.0 109.881 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.92 13.21 0.23 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.736 3.624 . . . . 0.0 117.986 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.31 -28.86 1.53 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.41 53.53 0.17 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.147 1.473 . . . . 0.0 112.28 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.55 130.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.756 -1.215 . . . . 0.0 111.096 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.09 172.32 11.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 128.272 2.629 . . . . 0.0 108.818 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.653 HD12 HG13 ' A' ' 34' ' ' ILE 0.289 5.5 mp -66.69 131.91 46.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.7 m -99.39 117.72 63.46 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.421 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.93 138.72 78.48 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.782 1.655 . . . . 0.0 110.525 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.53 148.49 46.24 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.165 0.916 . . . . 0.0 110.688 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 148.89 33.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.554 2.342 . . . . 0.0 108.64 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.49 -159.03 32.05 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.254 -1.529 . . . . 0.0 109.312 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.9 mt -145.48 146.65 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.717 0.892 . . . . 0.0 111.5 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' A' ' 6' ' ' LEU . 7.0 pt20 -132.29 154.35 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.28 1.038 . . . . 0.0 113.071 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -92.16 157.93 16.45 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.381 1.086 . . . . 0.0 109.098 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 23.53 0.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.726 1.61 . . . . 0.0 111.918 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.46 -52.34 4.55 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.465 2.306 . . . . 0.0 111.93 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.78 174.46 3.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -71.77 -44.84 63.33 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.446 -0.784 . . . . 0.0 111.773 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.59 69.08 81.52 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.688 1.195 . . . . 0.0 110.229 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.22 168.64 17.12 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.903 3.068 . . . . 0.0 118.08 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.5 p -86.06 157.45 20.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.365 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -150.59 174.32 13.11 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 123.989 1.852 . . . . 0.0 112.533 174.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.82 149.62 9.38 Favored Glycine 0 N--CA 1.408 -3.186 0 CA-C-N 108.674 -3.875 . . . . 0.0 120.168 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.31 153.21 23.21 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.4 150.01 23.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.362 1.865 . . . . 0.0 109.985 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.84 117.01 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.538 ' CB ' HG21 ' D' ' 52' ' ' ILE . 39.8 t30 -101.99 110.86 22.94 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.87 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.331 50.5 m95 -70.08 154.79 41.5 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.156 1.931 . . . . 0.0 115.436 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 71' ' ' LYS . 9.9 mmpt? -107.52 -44.18 4.35 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.332 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -91.8 -8.54 46.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 t -152.47 136.61 16.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.359 2.264 . . . . 0.0 107.728 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -72.52 112.35 8.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.658 1.572 . . . . 0.0 110.441 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.1 p -165.98 169.99 14.11 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.011 1.724 . . . . 0.0 111.562 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -148.14 141.62 25.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 122.855 1.312 . . . . 0.0 111.241 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m -137.11 124.06 21.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 110.945 -2.843 . . . . 0.0 110.198 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -101.3 154.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.426 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -127.23 142.31 51.51 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.163 0.985 . . . . 0.0 108.521 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 120.76 7.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -169.69 -166.12 28.17 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.552 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.85 146.15 50.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 124.671 0.865 . . . . 0.0 113.296 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 50.4 t -97.4 113.23 24.86 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.219 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' HD12 ' D' ' 106' ' ' ILE . 18.1 m-85 -103.77 169.64 8.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.298 1.839 . . . . 0.0 111.743 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -125.44 112.14 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.01 161.59 8.19 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.801 0.441 . . . . 0.0 110.535 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -30.36 -57.11 0.2 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.397 1.879 . . . . 0.0 115.975 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.26 -15.51 63.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.01 1.724 . . . . 0.0 115.022 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.94 27.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.702 1.144 . . . . 0.0 114.77 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -78.93 144.32 34.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.739 1.616 . . . . 0.0 111.79 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -101.42 141.73 33.86 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.728 1.211 . . . . 0.0 111.708 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.8 m -144.02 160.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.777 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -119.45 116.92 27.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -107.28 111.92 24.52 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 7.2 p -133.28 172.0 13.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.125 1.441 . . . . 0.0 111.563 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.513 ' HG3' HG21 ' D' ' 113' ' ' THR . 90.8 mmm -124.78 169.22 12.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.431 -1.258 . . . . 0.0 107.794 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -139.94 162.03 36.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.045 1.402 . . . . 0.0 112.319 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -145.67 119.17 9.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.149 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.25 141.27 38.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 123.649 1.69 . . . . 0.0 110.42 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 10.4 tpt180 -125.62 113.91 18.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 110.172 -3.195 . . . . 0.0 109.746 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -77.09 156.94 31.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.982 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.87 82.87 2.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -65.8 173.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.684 1.194 . . . . 0.0 111.978 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.515 ' H ' HG12 ' A' ' 103' ' ' VAL . 4.6 p-10 -117.87 -7.58 10.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.96 148.1 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.869 1.319 . . . . 0.0 110.33 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' D' ' 92' ' ' VAL . 15.7 tt -63.3 -26.28 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.862 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.04 -2.83 33.38 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 117.912 -1.493 . . . . 0.0 115.219 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.55 3.67 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.843 1.321 . . . . 0.0 113.459 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -35.38 61.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.959 -1.088 . . . . 0.0 111.577 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.501 ' CD1' HD11 ' C' ' 14' ' ' LEU . 60.2 p-90 -50.13 -46.34 53.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.163 0.985 . . . . 0.0 113.402 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -14.71 42.65 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.372 -0.83 . . . . 0.0 112.728 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' A' ' 103' ' ' VAL . . . -73.81 -9.16 58.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' D' ' 96' ' ' MET . 61.9 m -95.24 155.97 16.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -154.05 124.15 6.87 Favored 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 126.822 2.049 . . . . 0.0 111.156 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.37 156.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 121.792 2.087 . . . . 0.0 110.203 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.18 -177.56 31.4 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 124.397 1.061 . . . . 0.0 115.023 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 16.2 p90 -123.67 152.23 42.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.114 0.966 . . . . 0.0 110.984 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -150.4 148.2 28.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.899 0.88 . . . . 0.0 110.67 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.3 mt -132.27 122.94 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.082 -1.011 . . . . 0.0 109.294 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -113.87 153.94 28.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.013 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.0 p -135.73 164.27 28.28 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.307 1.043 . . . . 0.0 110.796 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -57.74 117.7 4.51 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.444 1.098 . . . . 0.0 110.41 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 9' ' ' LYS . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.57 0 O-C-N 122.228 -0.295 . . . . 0.0 110.606 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttt . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 131.36 56.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.752 1.263 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.77 127.58 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.908 2.083 . . . . 0.0 106.042 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' D' ' 53' ' ' GLN . 2.4 mt -73.22 -28.87 62.42 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 124.414 1.071 . . . . 0.0 112.755 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -53.5 115.84 2.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.93 0.892 . . . . 0.0 110.508 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.72 -132.63 5.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.482 1.515 . . . . 0.0 109.392 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' LYS . . . . . 0.489 ' HG2' ' H ' ' D' ' 10' ' ' TRP . 16.0 ttmt -144.24 152.51 40.93 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 10' ' ' TRP . . . . . 0.489 ' H ' ' HG2' ' D' ' 9' ' ' LYS . 55.6 m95 -139.94 162.72 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.544 1.938 . . . . 0.0 111.476 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.646 ' HB ' HD12 ' D' ' 123' ' ' LEU . 14.2 t -139.9 146.95 39.9 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.354 1.062 . . . . 0.0 109.102 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -108.85 148.25 30.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.64 0.776 . . . . 0.0 111.546 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -25.37 59.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.692 1.197 . . . . 0.0 114.108 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' B' ' 110' ' ' TRP . 34.9 tp -73.3 -15.85 61.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.596 1.559 . . . . 0.0 113.269 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.04 -12.84 45.14 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.479 1.99 . . . . 0.0 113.89 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -67.96 145.63 54.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.94 1.37 . . . . 0.0 111.166 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -120.95 149.31 42.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.182 -0.949 . . . . 0.0 111.692 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -135.31 142.46 45.84 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.912 -0.493 . . . . 0.0 112.209 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -128.59 132.35 48.19 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.871 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.01 127.6 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.577 1.173 . . . . 0.0 112.307 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.27 134.6 29.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.851 -0.794 . . . . 0.0 110.632 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.02 131.91 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.679 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.71 156.45 38.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.778 1.231 . . . . 0.0 110.275 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 72.8 m -57.29 -23.04 45.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.09 -28.15 68.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.501 -0.75 . . . . 0.0 110.841 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.74 -4.35 34.39 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 125.302 1.429 . . . . 0.0 112.771 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.85 158.98 30.43 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.843 1.322 . . . . 0.0 113.32 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.09 166.36 33.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.71 0.767 . . . . 0.0 112.05 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -128.61 160.07 33.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.552 1.141 . . . . 0.0 108.801 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.93 -175.48 39.52 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 119.974 -1.108 . . . . 0.0 115.465 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.459 ' CG2' HD23 ' D' ' 46' ' ' LEU . 8.7 p -134.75 124.03 24.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.084 1.354 . . . . 0.0 107.927 -174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' TYR . . . . . 0.581 ' C ' HD12 ' D' ' 34' ' ' ILE . 65.0 t80 -125.3 131.24 53.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.638 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.668 HG13 HD12 ' D' ' 46' ' ' LEU . 2.5 mp -123.37 129.67 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.926 0.87 . . . . 0.0 109.015 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.25 137.84 42.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.255 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.53 -6.92 26.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 31.1 m -138.4 136.87 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.056 0.931 . . . . 0.0 112.175 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.27 161.96 39.9 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.855 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.3 -25.45 54.84 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.715 -0.616 . . . . 0.0 110.555 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -146.85 79.81 9.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 127.277 2.231 . . . . 0.0 109.791 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.91 13.13 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.834 3.689 . . . . 0.0 117.992 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.48 -28.64 1.57 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 118.241 2.056 . . . . 0.0 118.241 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.71 54.77 0.17 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.203 1.502 . . . . 0.0 112.076 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.68 130.54 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.76 -1.213 . . . . 0.0 111.068 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 173.06 10.95 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.274 2.629 . . . . 0.0 108.894 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.668 HD12 HG13 ' D' ' 34' ' ' ILE 0.296 5.4 mp -67.72 131.11 44.96 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 61.1 m -98.31 117.98 64.08 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.762 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.26 137.86 78.06 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.694 1.596 . . . . 0.0 110.264 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -121.9 155.67 34.97 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.446 1.091 . . . . 0.0 110.662 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -155.62 149.03 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.319 1.848 . . . . 0.0 109.026 -177.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.32 -157.42 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 O-C-N 121.158 -0.964 . . . . 0.0 111.021 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.538 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -145.56 147.06 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.03 0.919 . . . . 0.0 111.568 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' D' ' 6' ' ' LEU . 5.7 pt20 -133.12 153.59 51.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.37 1.081 . . . . 0.0 112.969 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.37 157.55 17.56 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.389 1.09 . . . . 0.0 108.539 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 24.33 0.56 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.728 1.611 . . . . 0.0 111.358 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -93.48 -51.57 4.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.602 2.361 . . . . 0.0 111.318 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 172.26 8.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -69.11 -43.47 74.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 0.0 111.075 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.85 71.59 69.68 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.947 1.299 . . . . 0.0 110.851 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -69.86 169.29 19.38 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.076 3.184 . . . . 0.0 118.817 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 36.2 p -86.65 156.23 20.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.018 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' D' ' 83' ' ' CYS . 0.0 OUTLIER -152.62 173.99 14.52 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 123.981 1.848 . . . . 0.0 112.633 174.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.0 148.89 9.17 Favored Glycine 0 N--CA 1.412 -2.941 0 CA-C-N 109.213 -3.63 . . . . 0.0 119.748 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -159.59 153.09 22.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.55 151.3 23.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.601 1.96 . . . . 0.0 110.006 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.47 117.38 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.534 ' CB ' HG21 ' A' ' 52' ' ' ILE . 42.4 t30 -102.42 111.83 24.29 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.136 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.328 51.1 m95 -70.68 153.11 43.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 124.105 1.907 . . . . 0.0 115.61 -172.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' D' ' 71' ' ' LYS . 9.9 mmpt? -105.76 -43.46 4.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.188 -174.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -92.09 -8.65 45.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -152.58 136.51 16.32 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.204 2.202 . . . . 0.0 107.473 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.83 111.52 7.16 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.691 1.587 . . . . 0.0 110.368 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 93.0 p -165.07 170.73 14.72 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.778 1.631 . . . . 0.0 111.569 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 64' ' ' PHE . 4.9 t -148.35 142.21 25.74 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.519 1.152 . . . . 0.0 111.586 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.13 123.65 20.9 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 111.25 -2.705 . . . . 0.0 110.357 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 m -100.8 154.04 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -127.21 142.08 51.57 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.01 0.924 . . . . 0.0 108.719 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 119.96 7.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -167.79 -166.75 27.4 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.132 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -133.56 147.07 51.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 125.051 1.089 . . . . 0.0 112.819 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.448 ' HB2' ' CZ ' ' D' ' 64' ' ' PHE . 44.1 t -97.28 125.35 41.79 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 116.19 -1.862 . . . . 0.0 108.011 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.432 ' HB2' HD12 ' A' ' 106' ' ' ILE . 13.1 m-85 -114.51 172.03 7.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.921 1.689 . . . . 0.0 110.819 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mt -127.87 111.87 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.51 158.73 9.27 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -25.97 -55.16 0.06 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.212 2.205 . . . . 0.0 116.005 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -9.02 58.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.137 2.175 . . . . 0.0 116.001 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.8 51.1 3.51 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 120.082 1.31 . . . . 0.0 109.981 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -124.07 136.35 54.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.795 1.638 . . . . 0.0 109.119 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -101.06 139.82 36.22 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.903 1.335 . . . . 0.0 110.689 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 106' ' ' ILE . 19.9 m -144.3 161.05 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.704 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.73 116.78 25.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -106.78 111.13 23.52 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.432 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 6.3 p -133.07 172.18 12.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 123.51 1.624 . . . . 0.0 111.831 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' A' ' 113' ' ' THR . 90.4 mmm -124.92 169.06 12.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -139.26 162.22 35.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.56 1.648 . . . . 0.0 112.55 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -145.68 119.81 9.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.699 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.29 141.75 38.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.599 1.812 . . . . 0.0 110.442 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -126.0 113.87 17.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 109.999 -3.273 . . . . 0.0 109.895 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 2.6 t -77.84 158.19 29.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.286 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 56.6 m -105.22 77.62 1.32 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.68 0.752 . . . . 0.0 109.74 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 103' ' ' VAL . . . . . 0.581 ' CG2' ' HB2' ' D' ' 112' ' ' ALA . 1.5 t -63.55 166.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.106 1.363 . . . . 0.0 112.595 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.405 ' H ' HG12 ' D' ' 103' ' ' VAL . 4.7 p-10 -112.44 -4.36 14.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.64 147.4 35.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.58 1.181 . . . . 0.0 110.373 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.482 ' CD1' HG21 ' A' ' 92' ' ' VAL . 16.0 tt -63.36 -26.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.854 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.49 -3.03 30.66 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 117.659 -1.634 . . . . 0.0 115.432 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.26 3.49 10.34 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.806 1.303 . . . . 0.0 113.636 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.96 60.71 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.819 -1.176 . . . . 0.0 111.816 174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.507 ' CD1' HD11 ' B' ' 14' ' ' LEU . 60.4 p-90 -49.46 -46.83 48.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 -15.65 41.82 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.29 -0.881 . . . . 0.0 112.789 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' D' ' 103' ' ' VAL . . . -73.51 -7.76 53.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.513 HG21 ' HG3' ' A' ' 96' ' ' MET . 57.2 m -96.54 154.88 17.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.021 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.19 124.3 7.47 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.627 1.971 . . . . 0.0 111.195 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.52 156.23 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 121.699 2.045 . . . . 0.0 110.047 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -178.6 31.68 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.834 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 15.6 p90 -122.51 152.62 40.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.168 0.987 . . . . 0.0 110.83 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -150.61 147.36 27.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.937 0.875 . . . . 0.0 110.837 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.64 120.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.239 -0.913 . . . . 0.0 108.985 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -110.46 154.31 23.8 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.067 0.855 . . . . 0.0 111.539 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -136.68 161.95 34.51 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.378 1.071 . . . . 0.0 110.055 174.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -56.66 128.26 35.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 123' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.724 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.408 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 tttt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 132.22 56.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.453 1.101 . . . . 0.0 111.391 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.27 127.64 19.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.847 2.059 . . . . 0.0 106.439 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.66 -30.82 64.6 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.84 117.3 2.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.929 0.892 . . . . 0.0 110.733 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.28 -130.49 4.83 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.755 1.645 . . . . 0.0 109.662 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' B' ' 10' ' ' TRP . 15.1 ttmt -145.25 152.83 40.58 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' TRP . . . . . 0.472 ' H ' ' HG2' ' B' ' 9' ' ' LYS . 58.0 m95 -138.76 162.73 33.99 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.753 2.021 . . . . 0.0 111.275 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -143.51 145.0 32.21 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.903 0.881 . . . . 0.0 109.195 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -109.7 146.55 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.887 0.875 . . . . 0.0 111.83 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -25.87 53.38 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' D' ' 110' ' ' TRP . 35.0 tp -73.21 -16.54 61.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.479 1.512 . . . . 0.0 113.075 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 -12.94 29.98 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.964 2.221 . . . . 0.0 114.033 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -69.0 142.96 54.49 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.836 -1.391 . . . . 0.0 111.993 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -116.42 143.31 45.72 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.829 -1.169 . . . . 0.0 110.657 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -133.24 139.23 46.84 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.946 -0.471 . . . . 0.0 112.053 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -126.51 132.6 51.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.871 0.868 . . . . 0.0 108.74 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.9 mt -129.05 127.2 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -91.06 0.07 OUTLIER Glycine 0 CA--C 1.528 0.9 0 O-C-N 124.87 1.356 . . . . 0.0 112.096 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.32 135.35 32.12 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.863 -0.787 . . . . 0.0 110.865 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.94 133.61 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.223 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.9 158.26 36.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.358 1.063 . . . . 0.0 110.993 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 64.7 m -57.87 -24.31 57.01 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.753 -1.217 . . . . 0.0 114.021 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -66.15 -29.25 69.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.453 -0.779 . . . . 0.0 110.729 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.19 34.63 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 117.918 -1.49 . . . . 0.0 112.933 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.85 154.15 39.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.798 1.799 . . . . 0.0 111.535 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.35 154.16 31.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -116.78 156.43 27.23 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 109.573 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.62 -176.18 38.1 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.691 1.162 . . . . 0.0 115.02 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.449 ' CG2' HD23 ' B' ' 46' ' ' LEU . 7.5 p -134.87 123.97 24.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 113.259 -1.471 . . . . 0.0 107.298 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.574 ' C ' HD12 ' B' ' 34' ' ' ILE . 64.9 t80 -124.72 131.29 53.47 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.724 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.649 HG13 HD12 ' B' ' 46' ' ' LEU . 2.4 mp -123.72 129.57 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 122.09 0.948 . . . . 0.0 108.597 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.02 141.23 36.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.251 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.97 21.6 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.96 136.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.201 1.0 . . . . 0.0 111.797 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.94 162.2 39.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.241 -0.912 . . . . 0.0 110.999 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.02 -27.45 60.1 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.445 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.09 80.36 10.33 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.214 2.205 . . . . 0.0 109.758 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.64 12.94 0.23 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.722 3.615 . . . . 0.0 118.073 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.0 -28.97 1.38 Allowed Glycine 0 CA--C 1.54 1.621 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -163.25 53.29 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.152 1.476 . . . . 0.0 112.361 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.74 130.54 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 120.782 -1.199 . . . . 0.0 111.358 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 173.5 10.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.049 2.54 . . . . 0.0 108.945 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.649 HD12 HG13 ' B' ' 34' ' ' ILE 0.292 5.4 mp -67.71 131.51 45.72 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.6 m -99.22 117.69 63.67 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.418 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -54.61 138.85 75.92 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.665 1.577 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.5 148.47 46.22 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.248 0.967 . . . . 0.0 110.641 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.66 148.85 33.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.402 2.281 . . . . 0.0 108.646 174.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.52 -159.09 32.12 Favored Glycine 0 N--CA 1.443 -0.898 0 O-C-N 120.319 -1.488 . . . . 0.0 109.464 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.9 mt -145.41 147.58 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.784 0.834 . . . . 0.0 111.473 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -133.15 153.99 51.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 122.409 1.099 . . . . 0.0 113.859 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -91.9 157.09 17.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.549 1.166 . . . . 0.0 108.892 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.38 25.09 0.47 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.018 1.727 . . . . 0.0 111.55 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -93.64 -52.16 4.6 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.601 2.36 . . . . 0.0 112.123 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.97 171.86 8.77 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.7 t -69.65 -42.22 74.51 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.747 0.819 . . . . 0.0 111.161 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 69.32 72.68 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.499 1.12 . . . . 0.0 110.931 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.88 169.14 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.003 3.136 . . . . 0.0 118.454 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -86.44 157.24 19.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.063 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' B' ' 83' ' ' CYS . 0.0 OUTLIER -153.21 174.28 14.47 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 124.18 1.943 . . . . 0.0 112.353 174.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.28 149.11 9.22 Favored Glycine 0 N--CA 1.411 -2.992 0 CA-C-N 109.065 -3.698 . . . . 0.0 120.046 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -159.12 153.48 23.99 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.47 149.94 23.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.984 1.714 . . . . 0.0 109.984 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 117.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 173.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.537 ' CB ' HG21 ' C' ' 52' ' ' ILE . 38.6 t30 -102.11 110.81 22.87 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.799 -174.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.334 49.9 m95 -70.08 155.54 40.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.958 1.837 . . . . 0.0 115.396 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' B' ' 71' ' ' LYS . 9.8 mmpt? -108.54 -44.26 4.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.355 -1.748 . . . . 0.0 114.143 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -91.18 -8.74 47.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.23 1.012 . . . . 0.0 113.691 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -152.38 137.05 16.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.31 2.244 . . . . 0.0 107.36 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.64 111.77 8.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.497 1.498 . . . . 0.0 110.715 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 93.3 p -165.31 169.92 15.28 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.077 1.751 . . . . 0.0 111.635 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.68 141.87 26.13 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.21 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.6 m -137.62 123.82 20.48 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.216 -173.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.95 154.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.536 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.24 141.93 51.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 108.676 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.62 119.86 7.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -168.55 -167.4 29.12 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.412 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -133.56 146.37 50.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.078 -1.061 . . . . 0.0 112.618 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' B' ' 64' ' ' PHE . 41.4 t -97.37 122.0 39.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.087 173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.451 ' HB2' HD12 ' C' ' 106' ' ' ILE . 12.2 m-85 -111.37 172.49 6.85 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.714 1.606 . . . . 0.0 110.669 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mt -128.41 113.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.97 162.47 6.96 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -30.12 -52.53 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.744 2.017 . . . . 0.0 115.772 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -78.35 -0.7 30.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.393 2.277 . . . . 0.0 116.978 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 50.94 6.87 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.439 -1.413 . . . . 0.0 110.505 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -119.91 141.89 49.2 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.514 2.326 . . . . 0.0 105.432 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -111.38 138.5 47.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.265 1.426 . . . . 0.0 110.99 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 20.6 m -144.3 161.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.686 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -121.04 118.2 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -108.03 111.55 23.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 6.9 p -133.46 171.91 13.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.066 1.412 . . . . 0.0 111.971 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.519 ' HG3' HG21 ' C' ' 113' ' ' THR . 90.6 mmm -124.63 169.32 12.05 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -139.67 162.02 36.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.489 1.614 . . . . 0.0 112.644 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.47 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.9 OUTLIER -145.58 119.65 9.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.017 179.174 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 141.54 38.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 123.677 1.703 . . . . 0.0 110.578 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -126.26 114.0 17.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 110.121 -3.218 . . . . 0.0 110.162 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -78.23 156.65 29.64 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.616 1.198 . . . . 0.0 110.824 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.73 82.45 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' B' ' 112' ' ' ALA . 1.6 t -66.32 172.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.94 1.296 . . . . 0.0 111.815 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.498 ' H ' HG12 ' B' ' 103' ' ' VAL . 5.1 p-10 -119.2 -2.77 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 174.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.421 ' H ' HG12 ' B' ' 103' ' ' VAL . 0.8 OUTLIER -142.25 146.4 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.346 1.07 . . . . 0.0 111.06 174.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' C' ' 92' ' ' VAL . 14.8 tt -63.57 -26.88 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.958 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.63 -3.62 34.86 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.979 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.16 3.55 10.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.712 1.256 . . . . 0.0 113.271 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -36.13 62.12 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.041 -1.037 . . . . 0.0 111.575 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' D' ' 14' ' ' LEU . 59.0 p-90 -48.68 -46.79 40.9 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 -16.06 38.71 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.267 -0.895 . . . . 0.0 112.673 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' B' ' 103' ' ' VAL . . . -72.25 -8.34 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' C' ' 96' ' ' MET . 57.6 m -96.38 156.65 16.25 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.697 0.399 . . . . 0.0 110.227 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ttm-85 -154.27 124.52 6.89 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 126.933 2.093 . . . . 0.0 111.366 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 p -105.63 156.18 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 121.832 2.105 . . . . 0.0 110.166 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.88 -178.0 31.52 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.232 0.958 . . . . 0.0 114.83 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 15.5 p90 -123.02 152.72 40.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.285 1.034 . . . . 0.0 110.691 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -150.61 146.25 26.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.008 0.908 . . . . 0.0 111.331 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.64 119.14 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.082 -1.011 . . . . 0.0 108.67 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.63 154.45 21.97 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.281 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 20.3 p -138.02 164.16 29.78 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.379 1.072 . . . . 0.0 109.645 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.99 123.72 16.14 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.547 0.837 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.039 174.74 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 tttt . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 131.49 56.92 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.924 1.345 . . . . 0.0 110.077 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.61 127.52 22.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.431 HD12 ' CD ' ' C' ' 53' ' ' GLN . 2.7 mt -73.41 -27.56 61.52 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.414 1.071 . . . . 0.0 112.844 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -53.61 117.28 3.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.861 0.838 . . . . 0.0 110.368 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.98 -130.27 4.79 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.719 1.628 . . . . 0.0 109.525 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' LYS . . . . . 0.433 ' HD2' HD13 ' C' ' 123' ' ' LEU . 19.7 ttmt -142.46 151.13 41.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.808 1.29 . . . . 0.0 113.288 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' TRP . . . . . 0.427 ' H ' ' HG2' ' C' ' 9' ' ' LYS . 50.0 m95 -136.18 162.69 32.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 112.469 -2.15 . . . . 0.0 110.816 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -142.84 142.51 31.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.65 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -108.36 148.06 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.918 0.887 . . . . 0.0 112.529 -174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -27.9 61.74 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.316 1.446 . . . . 0.0 114.365 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' A' ' 110' ' ' TRP . 33.9 tp -72.34 -15.9 61.87 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.393 1.477 . . . . 0.0 113.176 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -14.34 29.51 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.153 2.311 . . . . 0.0 113.645 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.636 1.218 . . . . 0.0 111.29 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -118.49 144.48 45.98 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.264 -0.897 . . . . 0.0 111.061 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -133.79 141.46 47.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.998 0.428 . . . . 0.0 111.63 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 5.9 m -129.73 132.12 46.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.79 127.37 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.57 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.867 1.354 . . . . 0.0 112.18 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.41 135.12 30.05 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.605 -0.938 . . . . 0.0 110.649 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.71 131.67 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.807 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.46 156.37 39.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.791 1.237 . . . . 0.0 110.229 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -57.29 -23.05 46.0 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -66.05 -28.49 68.88 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.531 -0.731 . . . . 0.0 110.797 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.83 -3.94 34.11 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.167 1.365 . . . . 0.0 112.724 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -77.05 158.76 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.71 1.255 . . . . 0.0 113.316 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.02 166.32 33.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.485 0.659 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.7 160.16 33.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.709 1.203 . . . . 0.0 108.702 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.22 -175.5 39.72 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 119.961 -1.114 . . . . 0.0 115.435 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.443 ' CG2' HD23 ' C' ' 46' ' ' LEU . 9.0 p -134.7 123.96 24.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.811 1.244 . . . . 0.0 107.702 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.575 ' C ' HD12 ' C' ' 34' ' ' ILE . 65.4 t80 -125.09 130.56 52.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.612 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.657 HG13 HD12 ' C' ' 46' ' ' LEU . 2.3 mp -122.9 129.48 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 CA-C-O 121.932 0.872 . . . . 0.0 108.833 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -104.99 140.31 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.996 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.56 -6.39 22.87 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.64 136.93 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.025 0.93 . . . . 0.0 111.645 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.76 162.21 39.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.985 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.98 -27.49 60.18 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -145.78 80.42 10.57 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.989 2.116 . . . . 0.0 109.766 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.85 13.44 0.22 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.835 3.69 . . . . 0.0 118.044 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.71 -28.62 1.7 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.21 53.39 0.18 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.093 1.447 . . . . 0.0 112.037 -174.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -56.84 130.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.914 -1.116 . . . . 0.0 111.087 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.53 172.27 11.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.109 2.564 . . . . 0.0 109.115 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.657 HD12 HG13 ' C' ' 34' ' ' ILE 0.299 5.4 mp -66.95 130.45 43.2 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 59.4 m -98.08 118.15 64.07 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.977 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -55.0 138.65 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.643 1.562 . . . . 0.0 110.061 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -122.53 155.72 35.65 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.331 1.019 . . . . 0.0 110.852 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -155.38 149.08 25.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.014 1.726 . . . . 0.0 108.799 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.58 29.78 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 119.353 0.979 . . . . 0.0 111.033 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.42 147.0 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.057 0.932 . . . . 0.0 111.938 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.431 ' CD ' HD12 ' C' ' 6' ' ' LEU . 6.7 pt20 -133.57 154.0 51.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.221 1.008 . . . . 0.0 113.225 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -90.67 159.06 16.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.435 1.112 . . . . 0.0 108.765 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 25.05 0.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.689 1.596 . . . . 0.0 111.57 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -93.36 -51.87 4.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.831 2.453 . . . . 0.0 111.328 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 171.96 10.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -71.08 -41.95 70.01 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.665 0.745 . . . . 0.0 110.955 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.56 67.76 80.32 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.405 1.082 . . . . 0.0 111.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -69.69 170.23 16.99 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.902 3.068 . . . . 0.0 118.268 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 41.7 p -86.63 156.42 20.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.903 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' C' ' 83' ' ' CYS . 0.0 OUTLIER -153.58 173.7 15.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.728 1.728 . . . . 0.0 112.762 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.51 148.49 9.12 Favored Glycine 0 N--CA 1.412 -2.927 0 CA-C-N 109.351 -3.568 . . . . 0.0 119.528 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -159.47 153.18 22.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -87.85 150.94 23.22 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.333 1.853 . . . . 0.0 110.021 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.78 117.13 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' B' ' 52' ' ' ILE . 40.1 t30 -102.39 111.47 23.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.969 -174.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.33 49.9 m95 -70.45 154.7 41.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 124.199 1.952 . . . . 0.0 115.448 -172.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' C' ' 71' ' ' LYS . 9.9 mmpt? -107.54 -43.79 4.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.221 -1.809 . . . . 0.0 114.145 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.79 -8.42 46.77 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.57 136.7 16.48 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.286 2.235 . . . . 0.0 107.448 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -72.53 111.21 7.5 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.556 1.525 . . . . 0.0 110.829 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -165.1 170.07 15.45 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 125.879 1.672 . . . . 0.0 111.441 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -147.8 141.92 26.06 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 122.901 1.334 . . . . 0.0 111.264 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.6 m -137.04 124.36 21.91 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 110.88 -2.873 . . . . 0.0 110.387 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 m -101.81 154.31 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.555 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.19 142.32 51.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.102 0.961 . . . . 0.0 108.419 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.09 120.16 7.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -168.3 -167.31 28.75 Favored Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.11 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.58 146.67 51.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 125.171 1.159 . . . . 0.0 112.656 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 64' ' ' PHE . 44.7 t -97.23 125.56 41.85 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 115.66 -2.114 . . . . 0.0 108.009 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.433 ' HB2' HD12 ' B' ' 106' ' ' ILE . 13.8 m-85 -114.4 171.27 7.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.928 1.691 . . . . 0.0 110.614 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.03 110.77 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.26 157.67 13.04 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -23.45 -57.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.978 2.111 . . . . 0.0 116.53 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.0 -14.18 62.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.91 20.95 10.66 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.031 0.824 . . . . 0.0 113.68 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -91.09 142.28 27.93 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.849 1.325 . . . . 0.0 110.296 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -101.47 139.46 37.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.281 1.032 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.8 m -142.17 161.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.179 1.392 . . . . 0.0 110.057 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 14.8 mt -119.26 116.92 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -107.43 110.76 22.79 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.45 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 6.8 p -132.34 171.51 13.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 123.24 1.495 . . . . 0.0 111.862 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' B' ' 113' ' ' THR . 91.2 mmm -124.68 169.07 12.32 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -139.36 162.33 35.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 123.378 1.561 . . . . 0.0 112.658 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.477 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -145.76 119.48 9.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.069 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.74 38.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.465 1.602 . . . . 0.0 110.403 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -126.14 113.9 17.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 110.346 -3.116 . . . . 0.0 109.762 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -77.11 156.48 31.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.032 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 52.6 m -103.05 83.14 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' C' ' 112' ' ' ALA . 1.6 t -66.52 172.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.472 1.109 . . . . 0.0 111.715 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.499 ' H ' HG12 ' C' ' 103' ' ' VAL . 4.6 p-10 -118.04 -5.21 10.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.93 148.01 37.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.73 1.252 . . . . 0.0 110.202 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' B' ' 92' ' ' VAL . 15.5 tt -63.61 -25.73 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.02 -1.446 . . . . 0.0 112.909 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.15 -1.75 36.05 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.579 -1.123 . . . . 0.0 115.393 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' ASP . . . . . 0.404 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.6 OUTLIER -122.25 3.09 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.287 1.044 . . . . 0.0 113.54 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.91 60.52 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.2 -0.938 . . . . 0.0 111.556 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.503 ' CD1' HD11 ' A' ' 14' ' ' LEU . 60.1 p-90 -50.28 -46.35 55.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.137 0.975 . . . . 0.0 113.565 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -15.12 41.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.158 -0.964 . . . . 0.0 112.577 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 112' ' ' ALA . . . . . 0.578 ' HB2' ' CG2' ' C' ' 103' ' ' VAL . . . -73.54 -8.12 54.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.519 HG21 ' HG3' ' B' ' 96' ' ' MET . 62.2 m -96.63 155.12 16.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.675 0.39 . . . . 0.0 110.044 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttm-85 -153.04 124.02 7.43 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 126.931 2.092 . . . . 0.0 111.208 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.09 156.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 121.77 2.077 . . . . 0.0 110.091 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -177.54 31.46 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.206 0.941 . . . . 0.0 114.962 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 15.9 p90 -123.85 152.41 42.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.276 1.03 . . . . 0.0 110.908 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -150.43 147.0 27.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.936 0.895 . . . . 0.0 111.187 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.97 121.77 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -112.93 153.47 27.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.683 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.7 p -134.13 162.55 31.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.106 0.962 . . . . 0.0 110.317 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -55.5 121.77 9.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.948 0.899 . . . . 0.0 109.691 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.46 ' C ' HD23 ' C' ' 123' ' ' LEU . 5.4 tt . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.921 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -124.09 129.2 50.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.077 0.941 . . . . 0.0 110.963 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -139.61 127.5 22.11 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.248 -1.532 . . . . 0.0 114.279 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 64' ' ' PHE . 21.1 mt -55.51 -32.84 63.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -54.83 122.02 9.87 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.724 1.249 . . . . 0.0 110.932 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.25 -108.31 0.87 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.512 2.006 . . . . 0.0 111.696 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.12 144.0 20.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -140.76 162.79 34.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.327 1.851 . . . . 0.0 110.632 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -141.71 151.44 42.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.237 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 14' ' ' LEU . 4.6 t30 -116.42 146.31 42.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.376 1.071 . . . . 0.0 112.521 -173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.49 -23.67 64.69 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' H ' HD22 ' A' ' 12' ' ' ASN . 28.0 tp -71.58 -15.7 62.28 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.703 -1.248 . . . . 0.0 112.115 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.82 -14.35 24.34 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 128.382 2.896 . . . . 0.0 113.686 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p -63.31 144.27 57.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.456 1.128 . . . . 0.0 112.987 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' OD1' HD12 ' A' ' 34' ' ' ILE . 6.2 p30 -115.66 140.34 49.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -130.71 139.81 50.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.545 0.688 . . . . 0.0 111.084 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.7 m -129.0 131.52 47.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.21 127.02 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.51 -88.4 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.299 1.0 . . . . 0.0 111.553 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.24 42.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.863 0.839 . . . . 0.0 112.426 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 t -98.14 123.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.017 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.22 156.0 38.51 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 m -55.21 -22.01 16.14 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -72.32 -37.78 68.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.359 0.664 . . . . 0.0 111.237 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.31 -2.66 18.64 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 117.336 -1.813 . . . . 0.0 113.422 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HB2' HD21 ' D' ' 50' ' ' LEU . 9.7 pt-20 -69.26 137.44 53.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.928 1.691 . . . . 0.0 107.079 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.25 148.19 25.61 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.16 163.58 15.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.192 0.997 . . . . 0.0 109.374 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.35 -168.0 34.59 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 120.947 -1.095 . . . . 0.0 113.165 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.633 ' HB ' HD11 ' A' ' 46' ' ' LEU . 1.1 p -141.54 129.69 22.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.965 1.364 . . . . 0.0 110.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.64 141.02 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.019 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 46' ' ' LEU . 7.9 mt -131.93 128.75 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.375 1.083 . . . . 0.0 108.53 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.562 ' O ' HG21 ' A' ' 44' ' ' ILE . 35.3 m -105.65 133.76 49.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.615 -1.175 . . . . 0.0 113.073 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.26 -17.87 23.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.74 142.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.831 1.252 . . . . 0.0 111.83 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.98 153.81 40.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.028 -1.045 . . . . 0.0 111.268 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.54 -24.25 66.35 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -147.88 76.56 10.53 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 128.518 2.727 . . . . 0.0 112.053 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.03 169.56 18.97 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.169 2.579 . . . . 0.0 112.431 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.88 -29.55 1.55 Allowed Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.473 1.035 . . . . 0.0 113.078 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.06 2.89 3.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.559 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 35' ' ' THR . 54.9 mt -31.83 112.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.151 1.78 . . . . 0.0 114.354 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 157.78 41.59 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.556 1.543 . . . . 0.0 110.879 -176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.633 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.6 tp -46.72 115.51 1.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.021 2.928 . . . . 0.0 111.623 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 t -103.48 117.06 60.97 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.454 1.102 . . . . 0.0 109.933 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 144.22 82.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.27 2.647 . . . . 0.0 112.552 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.71 155.08 45.64 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.673 0.789 . . . . 0.0 111.863 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -159.75 147.61 17.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.164 1.785 . . . . 0.0 112.296 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.17 -151.55 21.91 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 120.786 1.63 . . . . 0.0 110.954 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.4 mp -141.24 137.86 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 113.135 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -120.95 141.03 51.05 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.15 -50.47 71.72 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.503 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.92 14.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 127.395 2.278 . . . . 0.0 116.852 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.76 -47.08 6.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.515 2.726 . . . . 0.0 115.103 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.76 -174.11 2.46 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.319 1.012 . . . . 0.0 111.63 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -83.43 -36.72 24.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -124.41 56.67 12.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.667 1.187 . . . . 0.0 110.497 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.02 164.04 37.16 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.884 3.056 . . . . 0.0 116.309 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.5 p -82.21 167.79 18.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.95 1.3 . . . . 0.0 111.383 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -159.13 162.29 36.43 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.818 -1.176 . . . . 0.0 112.961 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.86 139.24 5.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 118.731 -1.7 . . . . 0.0 117.053 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -163.0 151.73 14.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 m -88.29 148.98 24.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.562 1.945 . . . . 0.0 110.549 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -126.02 117.72 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' HB2' HG21 ' D' ' 52' ' ' ILE . 44.2 t30 -97.33 105.4 17.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.147 0.579 . . . . 0.0 112.376 -174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 32.4 m95 -74.76 147.99 40.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -110.7 -45.71 3.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.165 -1.38 . . . . 0.0 114.647 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -80.86 -11.3 59.61 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -152.53 133.24 13.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.789 2.436 . . . . 0.0 105.838 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.26 118.52 14.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.695 1.134 . . . . 0.0 111.2 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -178.52 167.15 1.82 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-O 123.625 1.679 . . . . 0.0 110.895 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 t -144.69 144.71 31.36 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.123 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.3 m -140.7 131.71 26.19 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 110.15 -3.205 . . . . 0.0 110.312 -172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.7 143.63 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.06 143.74 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 116.78 9.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HE ' ' D' ' 100' ' ' ARG . . . -151.98 -176.13 24.37 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 119.389 -1.386 . . . . 0.0 115.625 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -123.17 147.8 46.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.702 -1.249 . . . . 0.0 111.059 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 39.0 t -96.88 120.81 37.91 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.651 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' D' ' 106' ' ' ILE . 6.8 m-85 -115.24 166.9 11.34 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.731 1.213 . . . . 0.0 114.089 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.01 110.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.01 154.18 16.08 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -33.63 -41.97 0.1 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.619 1.968 . . . . 0.0 115.97 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -13.96 60.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 50.36 2.83 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.44 137.61 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.449 1.9 . . . . 0.0 109.492 174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -101.28 148.24 25.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.004 2.121 . . . . 0.0 112.164 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.6 t -152.09 155.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.606 -174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HE2' ' A' ' 64' ' ' PHE . 12.9 mt -122.04 105.92 10.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ3' HD11 ' D' ' 106' ' ' ILE . 3.0 mmtt -98.33 119.33 36.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 64' ' ' PHE . 8.9 p -130.35 162.5 28.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.346 1.546 . . . . 0.0 112.632 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.417 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -110.96 162.78 14.49 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -136.84 161.38 36.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.134 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -146.57 121.57 10.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 113.248 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.76 142.23 38.1 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.923 1.344 . . . . 0.0 112.241 -175.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.416 ' HE ' ' HA2' ' D' ' 81' ' ' GLY . 4.3 tpt85 -127.99 113.95 16.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 111.798 -2.455 . . . . 0.0 112.524 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.25 0.4 OUTLIER -71.95 165.68 23.71 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 125.269 1.606 . . . . 0.0 110.549 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -113.26 79.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.19 175.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 121.524 -0.735 . . . . 0.0 110.529 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -22.89 15.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.08 150.32 43.32 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 123.156 1.455 . . . . 0.0 112.678 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' D' ' 84' ' ' PHE . 17.4 tt -61.3 -27.57 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.141 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.87 9.32 24.85 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.959 0.79 . . . . 0.0 113.934 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -120.59 -0.41 10.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.328 1.051 . . . . 0.0 112.187 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -32.0 70.53 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.646 -1.284 . . . . 0.0 113.408 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.86 -44.91 59.67 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.911 1.684 . . . . 0.0 112.652 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -93.26 -10.63 34.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.332 1.053 . . . . 0.0 113.002 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.42 9.34 1.75 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.372 -0.83 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' A' ' 98' ' ' LEU . 20.9 m -117.45 139.3 51.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.853 0.861 . . . . 0.0 113.195 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.51 116.18 12.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 127.414 2.286 . . . . 0.0 111.281 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.68 152.91 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.725 1.148 . . . . 0.0 110.177 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.32 -174.24 31.97 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.56 154.66 44.91 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.705 -0.879 . . . . 0.0 112.195 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -146.71 152.63 39.15 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.815 1.246 . . . . 0.0 109.736 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.416 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.9 mt -136.46 119.01 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 12' ' ' ASN . 21.1 m-85 -109.68 149.38 29.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.331 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -134.74 163.32 30.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -56.82 119.91 7.0 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.845 0.858 . . . . 0.0 110.964 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 123' ' ' LEU . 10.4 tt . . . . . 0 C--O 1.241 0.609 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 4' ' ' CYS . . . . . 0.56 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 22.5 p -136.48 130.41 32.53 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.693 0.758 . . . . 0.0 111.501 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -139.77 129.51 24.57 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.4 -1.437 . . . . 0.0 114.56 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' D' ' 64' ' ' PHE . 20.7 mt -56.89 -32.16 65.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -55.58 119.71 6.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.968 1.366 . . . . 0.0 111.744 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.94 -116.5 1.99 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.203 1.859 . . . . 0.0 110.819 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.7 146.43 30.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -174.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 10' ' ' TRP . . . . . 0.425 ' CH2' HD21 ' D' ' 93' ' ' LEU . 38.2 m95 -141.57 161.92 36.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.232 1.413 . . . . 0.0 111.077 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.2 148.14 37.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' ASN . . . . . 0.512 HD22 ' H ' ' D' ' 14' ' ' LEU . 5.0 t30 -113.03 147.64 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.362 1.065 . . . . 0.0 112.599 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.74 -23.47 64.96 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.512 ' H ' HD22 ' D' ' 12' ' ' ASN . 27.8 tp -73.08 -14.47 61.4 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.477 1.511 . . . . 0.0 112.257 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.11 -12.92 34.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.857 2.646 . . . . 0.0 113.913 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.47 148.68 50.09 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.584 1.192 . . . . 0.0 112.824 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' ASN . . . . . 0.426 ' OD1' HD12 ' D' ' 34' ' ' ILE . 5.8 p30 -121.66 143.08 49.54 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.58 0.752 . . . . 0.0 110.543 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -132.07 139.88 48.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.605 0.717 . . . . 0.0 111.849 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -127.74 132.78 49.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.74 123.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.42 -79.95 0.24 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.346 1.029 . . . . 0.0 111.78 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.24 42.09 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.848 -0.795 . . . . 0.0 112.084 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -100.53 125.25 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.616 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -69.46 156.7 38.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 20.1 m -55.88 -21.7 21.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -70.75 -35.73 72.78 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.688 0.676 . . . . 0.0 111.283 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.95 -1.39 21.27 Favored Glycine 0 N--CA 1.469 0.9 0 C-N-CA 124.52 1.057 . . . . 0.0 112.95 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.89 149.81 44.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 110.717 173.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PHE . . . . . 0.604 ' O ' HD12 ' D' ' 50' ' ' LEU . 27.8 p90 -156.15 163.86 39.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.034 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' THR . . . . . 0.442 HG22 HD13 ' D' ' 50' ' ' LEU . 4.9 p -125.81 167.69 14.85 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.4 -166.49 33.12 Favored Glycine 0 N--CA 1.467 0.74 0 O-C-N 120.031 -1.668 . . . . 0.0 113.201 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.612 ' HB ' HD11 ' D' ' 46' ' ' LEU . 1.2 p -140.32 132.1 27.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.772 1.273 . . . . 0.0 111.539 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.5 139.1 50.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.463 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.556 HG12 HD12 ' D' ' 46' ' ' LEU . 7.8 mt -129.97 131.48 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.84 0.829 . . . . 0.0 108.789 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.583 ' O ' HG21 ' D' ' 44' ' ' ILE . 7.7 m -109.32 134.78 51.37 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 -19.22 21.55 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 28.3 m -131.38 141.54 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.892 1.277 . . . . 0.0 112.161 -174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.38 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.947 -1.096 . . . . 0.0 111.333 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.99 -24.08 66.7 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -147.91 76.72 10.45 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 128.536 2.734 . . . . 0.0 112.041 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.25 169.35 19.73 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.181 2.587 . . . . 0.0 112.517 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.87 -29.18 1.56 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.574 1.083 . . . . 0.0 113.123 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.29 2.87 3.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.736 -1.126 . . . . 0.0 113.533 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.583 HG21 ' O ' ' D' ' 35' ' ' THR . 50.8 mt -32.36 113.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 114.242 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.73 157.96 41.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.55 1.54 . . . . 0.0 110.747 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB ' ' D' ' 32' ' ' THR . 11.9 tp -47.48 115.36 1.1 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.712 2.805 . . . . 0.0 111.074 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.25 117.15 60.93 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.853 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.02 143.03 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.867 2.378 . . . . 0.0 112.272 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' LEU . . . . . 0.412 HD12 ' C ' ' D' ' 49' ' ' LEU . 2.0 pp -128.48 163.76 24.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.87 0.868 . . . . 0.0 112.209 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.604 HD12 ' O ' ' D' ' 29' ' ' PHE . 27.6 tp -169.07 149.01 4.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.249 1.42 . . . . 0.0 113.842 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 -150.96 21.56 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 120.883 1.674 . . . . 0.0 111.315 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.8 mp -142.32 135.35 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.965 0.906 . . . . 0.0 111.705 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -120.16 140.18 51.5 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 110.113 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.21 -50.0 74.86 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.436 -0.79 . . . . 0.0 111.525 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.09 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.67 2.388 . . . . 0.0 116.634 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.94 -46.64 7.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.386 2.675 . . . . 0.0 115.053 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.25 -175.43 3.67 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.26 0.975 . . . . 0.0 112.512 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 40.8 t -81.67 -35.28 30.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.561 0.745 . . . . 0.0 111.576 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.29 58.56 31.44 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 125.041 1.336 . . . . 0.0 111.033 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.91 163.34 38.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.742 2.962 . . . . 0.0 117.317 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -81.63 168.08 18.53 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.197 1.399 . . . . 0.0 111.569 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -159.12 162.26 36.44 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.736 -1.227 . . . . 0.0 112.967 174.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.0 139.08 5.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 118.873 -1.632 . . . . 0.0 116.871 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.89 153.12 16.26 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -89.11 151.61 22.12 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 127.601 2.36 . . . . 0.0 110.325 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 32.1 t -129.25 119.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.546 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.4 t30 -99.2 105.15 17.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.242 0.617 . . . . 0.0 112.004 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -74.34 147.27 42.38 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -110.1 -45.12 3.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.099 -1.409 . . . . 0.0 114.554 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.67 -11.16 59.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.55 132.91 13.68 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.881 2.473 . . . . 0.0 105.671 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.3 118.49 15.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.808 1.185 . . . . 0.0 111.193 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.79 166.55 1.68 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.94 1.696 . . . . 0.0 111.116 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 t -143.96 144.63 31.78 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.217 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.3 m -140.32 133.25 29.25 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 109.975 -3.284 . . . . 0.0 109.797 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.85 143.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.682 0.614 . . . . 0.0 109.548 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -116.3 143.91 44.92 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.7 116.55 8.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -151.45 -175.72 23.53 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.669 -1.253 . . . . 0.0 115.757 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.42 147.41 47.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.438 -1.381 . . . . 0.0 110.776 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.56 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 5.6 t -97.16 123.61 40.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.872 1.358 . . . . 0.0 110.624 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.602 ' HB2' HD12 ' A' ' 106' ' ' ILE . 7.7 m-85 -116.65 163.02 16.75 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -130.16 110.4 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.96 157.44 9.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -36.22 -40.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.445 1.898 . . . . 0.0 115.578 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -78.2 -10.23 59.55 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.14 51.03 4.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.057 0.836 . . . . 0.0 111.633 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.5 147.08 46.78 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 129.107 2.963 . . . . 0.0 107.401 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -112.73 152.63 28.85 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 120.267 1.394 . . . . 0.0 111.279 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.509 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.4 t -153.37 158.3 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.516 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 93' ' ' LEU . . . . . 0.425 HD21 ' CH2' ' D' ' 10' ' ' TRP . 6.9 mt -121.17 108.13 13.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.509 ' CD ' HG11 ' D' ' 92' ' ' VAL . 2.8 mmtt -100.76 117.67 35.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.57 HG22 ' HE1' ' D' ' 64' ' ' PHE . 4.8 p -129.28 163.08 26.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.608 1.671 . . . . 0.0 112.88 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.12 162.54 14.8 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -136.55 161.51 35.68 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.879 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -146.59 121.94 10.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.298 -1.774 . . . . 0.0 113.05 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' LEU . . . . . 0.471 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 141.76 38.52 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.859 1.314 . . . . 0.0 112.556 -176.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HA2' ' A' ' 81' ' ' GLY . 4.2 tpt85 -126.98 114.06 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 111.731 -2.486 . . . . 0.0 112.303 -174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.63 165.62 23.57 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 125.039 1.462 . . . . 0.0 110.557 173.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 8.3 t -113.53 77.11 1.02 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.82 176.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.23 -22.81 15.45 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.95 150.0 41.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 123.088 1.423 . . . . 0.0 112.914 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 84' ' ' PHE . 18.0 tt -62.57 -28.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.442 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 9.01 21.35 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.202 0.906 . . . . 0.0 113.961 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.45 -1.81 10.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.556 1.142 . . . . 0.0 111.878 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -31.45 70.27 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.394 -1.441 . . . . 0.0 113.279 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.62 -46.23 58.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.579 1.552 . . . . 0.0 112.52 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -91.73 -10.94 38.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.27 1.028 . . . . 0.0 112.832 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 8.75 2.08 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.605 -0.684 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' D' ' 98' ' ' LEU . 19.5 m -116.42 139.22 50.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.986 0.914 . . . . 0.0 113.28 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.54 116.21 12.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.4 2.28 . . . . 0.0 111.151 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.66 152.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.825 1.193 . . . . 0.0 110.394 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.51 -173.83 31.67 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -127.77 154.92 44.83 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.679 -0.895 . . . . 0.0 112.266 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -147.41 151.19 36.07 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.457 1.103 . . . . 0.0 109.746 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -135.69 119.18 24.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -111.12 151.72 27.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.566 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -137.4 167.64 21.22 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -61.69 125.61 24.41 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.586 -1.321 . . . . 0.0 113.246 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.164 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.656 ' HB2' ' HG ' ' B' ' 83' ' ' CYS . 24.9 p -139.68 127.96 22.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.623 0.769 . . . . 0.0 110.226 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -139.74 127.7 22.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.417 -1.427 . . . . 0.0 114.567 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.616 HD21 ' CE2' ' B' ' 64' ' ' PHE . 20.7 mt -55.62 -32.34 63.06 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -54.47 118.81 4.45 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.323 1.535 . . . . 0.0 111.732 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.14 -106.87 0.66 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.883 1.706 . . . . 0.0 111.302 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.27 146.58 21.51 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' TRP . . . . . 0.41 ' CH2' HD21 ' B' ' 93' ' ' LEU . 43.4 m95 -140.71 162.84 34.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.548 1.539 . . . . 0.0 110.578 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -139.36 152.22 46.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.479 HD22 ' H ' ' B' ' 14' ' ' LEU . 4.6 t30 -117.5 146.86 43.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 111.864 -174.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -60.89 -22.12 63.99 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.479 ' H ' HD22 ' B' ' 12' ' ' ASN . 26.7 tp -73.45 -14.19 61.2 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.959 1.304 . . . . 0.0 112.238 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.69 -13.32 35.39 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 128.069 2.747 . . . . 0.0 113.743 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 3.4 p -64.1 148.62 49.44 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.293 -1.122 . . . . 0.0 112.73 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.421 ' OD1' HD12 ' B' ' 34' ' ' ILE . 5.7 p30 -122.42 140.42 52.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.471 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -128.71 139.19 52.34 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.976 0.893 . . . . 0.0 111.793 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.93 131.93 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.016 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.39 126.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.4 -86.8 0.13 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.529 1.143 . . . . 0.0 111.531 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.36 154.15 42.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.916 0.865 . . . . 0.0 112.607 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.6 123.57 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.214 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -68.12 155.89 38.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.112 0.415 . . . . 0.0 109.916 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 20.3 m -54.99 -22.29 14.75 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -72.25 -37.42 69.11 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.636 0.653 . . . . 0.0 111.178 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -2.52 19.41 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-O 117.378 -1.79 . . . . 0.0 113.471 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.453 ' HB2' HD21 ' C' ' 50' ' ' LEU . 9.8 pt-20 -69.37 137.52 52.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.078 1.751 . . . . 0.0 107.112 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.4 ' O ' HD12 ' B' ' 50' ' ' LEU . 18.5 p90 -154.31 147.75 25.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.05 162.66 16.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.39 1.076 . . . . 0.0 109.62 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.36 -167.48 33.21 Favored Glycine 0 CA--C 1.523 0.538 0 O-C-N 120.972 -1.08 . . . . 0.0 113.407 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.607 ' HB ' HD11 ' B' ' 46' ' ' LEU . 1.3 p -140.66 131.6 26.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.785 1.279 . . . . 0.0 110.952 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -114.42 138.73 50.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.792 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.553 HG12 HD12 ' B' ' 46' ' ' LEU . 7.6 mt -129.97 132.45 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.582 ' O ' HG21 ' B' ' 44' ' ' ILE . 16.9 m -110.46 134.75 52.06 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.88 -18.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.59 141.71 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.88 1.272 . . . . 0.0 111.93 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.77 154.19 41.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.994 -1.066 . . . . 0.0 110.959 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.74 -24.55 66.24 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -148.12 76.61 10.29 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.577 2.751 . . . . 0.0 111.979 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.05 169.75 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.152 2.568 . . . . 0.0 112.566 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.82 -29.46 1.56 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.502 1.048 . . . . 0.0 113.158 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.02 2.73 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.512 1.125 . . . . 0.0 113.535 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.582 HG21 ' O ' ' B' ' 35' ' ' THR . 52.2 mt -31.9 113.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 126.164 1.786 . . . . 0.0 114.429 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.37 158.54 39.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.455 1.502 . . . . 0.0 110.84 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.607 HD11 ' HB ' ' B' ' 32' ' ' THR . 11.8 tp -48.62 115.41 1.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.672 2.789 . . . . 0.0 111.139 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -103.65 117.79 59.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.944 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.27 144.4 82.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.197 2.598 . . . . 0.0 112.782 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.49 155.51 44.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.831 0.852 . . . . 0.0 111.84 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' B' ' 29' ' ' PHE . 6.0 tp -160.37 147.65 16.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.183 1.793 . . . . 0.0 112.2 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.23 -151.53 21.87 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 120.789 1.631 . . . . 0.0 111.051 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.4 mp -141.15 137.95 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.855 0.862 . . . . 0.0 113.176 -174.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -121.0 141.1 51.05 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.098 -1.001 . . . . 0.0 110.706 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.81 -50.33 72.74 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.21 -0.931 . . . . 0.0 111.617 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 41.68 16.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 127.504 2.322 . . . . 0.0 116.907 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . 0.255 6.7 ptp180 -93.67 -46.19 7.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.948 2.499 . . . . 0.0 115.095 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 -175.33 4.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.318 1.011 . . . . 0.0 112.802 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -33.1 29.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.384 1.074 . . . . 0.0 111.45 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.03 57.51 30.59 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 124.849 1.26 . . . . 0.0 111.005 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.58 163.34 38.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.366 2.711 . . . . 0.0 117.078 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p -81.79 168.58 17.87 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.616 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -159.92 161.97 34.4 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.783 -1.198 . . . . 0.0 113.134 174.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.81 139.28 5.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 118.83 -1.652 . . . . 0.0 117.065 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -163.43 151.86 13.79 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.57 150.89 23.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.513 1.925 . . . . 0.0 110.771 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -127.85 117.75 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.557 ' HB2' HG21 ' C' ' 52' ' ' ILE . 42.4 t30 -97.63 104.24 16.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.254 0.622 . . . . 0.0 112.264 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.254 32.6 m95 -74.04 147.24 43.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -109.91 -46.05 3.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.461 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.89 -11.28 59.61 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -152.51 133.35 14.03 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.964 2.505 . . . . 0.0 106.055 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.46 118.58 15.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.028 1.285 . . . . 0.0 110.617 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -178.74 166.72 1.71 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.978 1.711 . . . . 0.0 110.952 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -144.38 144.79 31.59 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.273 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -140.53 132.95 28.46 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 110.341 -3.118 . . . . 0.0 110.043 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.05 143.33 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.04 143.85 44.55 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.719 0.637 . . . . 0.0 109.478 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.29 116.85 9.17 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HE ' ' C' ' 100' ' ' ARG . . . -152.0 -176.65 24.92 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.337 -1.411 . . . . 0.0 115.222 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -122.85 148.01 45.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.807 1.534 . . . . 0.0 110.426 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.656 ' HG ' ' HB2' ' B' ' 4' ' ' CYS . 5.1 t -97.04 124.54 41.06 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.255 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' C' ' 106' ' ' ILE . 7.9 m-85 -116.09 164.57 14.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.6 mt -131.75 107.91 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -59.29 154.74 15.85 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -35.11 -41.17 0.14 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -11.91 59.88 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.34 52.63 3.34 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 122.199 0.888 . . . . 0.0 111.863 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.16 148.18 45.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 129.135 2.974 . . . . 0.0 105.023 173.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -114.13 150.81 33.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.362 1.465 . . . . 0.0 110.326 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.506 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.5 t -150.77 159.93 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.439 1.095 . . . . 0.0 110.398 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.41 HD21 ' CH2' ' B' ' 10' ' ' TRP . 7.1 mt -121.9 108.6 13.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 172.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.508 ' CE ' HD11 ' C' ' 106' ' ' ILE . 2.6 mmtt -101.46 117.64 35.34 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 172.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.575 HG22 ' HE1' ' B' ' 64' ' ' PHE . 9.2 p -130.0 162.67 28.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.303 1.525 . . . . 0.0 112.463 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.405 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -111.22 163.03 14.35 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 170.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -137.04 161.42 36.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.075 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.59 121.6 10.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.303 -1.771 . . . . 0.0 113.203 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.485 ' N ' HD23 ' B' ' 98' ' ' LEU . 0.3 OUTLIER -107.69 142.34 37.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.947 1.356 . . . . 0.0 112.258 -175.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.437 ' HE ' ' HA2' ' C' ' 81' ' ' GLY . 4.0 tpt85 -128.0 113.98 16.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 111.504 -2.589 . . . . 0.0 112.28 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.23 165.61 24.07 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 125.147 1.53 . . . . 0.0 110.19 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.9 t -113.69 77.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -66.28 177.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -100.83 -22.45 14.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.88 148.72 43.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 123.047 1.404 . . . . 0.0 112.648 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' C' ' 84' ' ' PHE . 18.0 tt -62.24 -27.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.267 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.92 8.49 22.29 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.135 0.874 . . . . 0.0 113.782 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -120.89 -0.46 10.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.39 1.076 . . . . 0.0 112.535 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -31.78 69.86 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 120.785 -1.197 . . . . 0.0 113.466 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 66.0 p-90 -50.25 -46.56 54.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.628 1.571 . . . . 0.0 112.406 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.13 -10.39 39.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.045 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.03 2.03 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.575 -0.703 . . . . 0.0 111.845 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.77 ' CG2' HD21 ' B' ' 98' ' ' LEU . 21.5 m -116.45 139.13 50.78 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.948 0.899 . . . . 0.0 113.158 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.27 116.15 13.17 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.589 2.356 . . . . 0.0 111.163 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.7 152.69 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.699 1.136 . . . . 0.0 110.235 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.19 -174.39 32.02 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.787 -0.831 . . . . 0.0 112.133 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -147.32 150.7 35.26 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.697 1.199 . . . . 0.0 109.571 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.42 HD13 ' HE3' ' B' ' 94' ' ' LYS . 12.4 mt -135.24 119.8 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -110.39 152.11 26.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.171 0.92 . . . . 0.0 109.535 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -136.67 165.79 25.08 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -56.87 136.14 55.77 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.786 -1.196 . . . . 0.0 113.179 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 4' ' ' CYS . . . . . 0.596 ' HB2' ' HG ' ' C' ' 83' ' ' CYS . 25.1 p -143.09 125.95 16.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.726 0.81 . . . . 0.0 109.503 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -139.56 129.39 24.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.232 -1.543 . . . . 0.0 114.503 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' C' ' 64' ' ' PHE . 20.2 mt -56.38 -29.75 61.84 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -56.89 121.62 10.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 123.324 1.535 . . . . 0.0 111.643 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.13 -112.02 1.23 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.424 1.964 . . . . 0.0 110.582 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -149.12 147.73 28.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.744 0.818 . . . . 0.0 113.142 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' TRP . . . . . 0.413 ' CH2' HD21 ' C' ' 93' ' ' LEU . 39.3 m95 -141.86 162.51 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.293 1.437 . . . . 0.0 110.474 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -140.76 150.76 43.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ASN . . . . . 0.419 HD22 ' HB3' ' C' ' 118' ' ' ASN . 9.8 t-20 -115.02 146.42 41.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.103 0.961 . . . . 0.0 112.669 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.89 -21.31 63.2 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.69 -16.21 61.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.297 1.439 . . . . 0.0 112.19 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.45 -13.58 27.92 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.869 2.652 . . . . 0.0 113.984 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.88 149.17 50.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.688 1.244 . . . . 0.0 112.981 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' C' ' 34' ' ' ILE . 5.9 p30 -122.05 142.75 50.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.688 0.795 . . . . 0.0 110.754 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -131.4 139.51 49.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.447 0.641 . . . . 0.0 112.202 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -126.93 132.76 50.79 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.93 123.22 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -77.14 0.43 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.148 0.905 . . . . 0.0 111.908 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.82 157.44 42.93 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.77 0.795 . . . . 0.0 112.176 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 t -101.77 125.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.815 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -69.83 156.58 38.83 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -55.89 -21.69 21.58 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -70.38 -36.11 73.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.251 0.62 . . . . 0.0 111.337 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.04 -0.98 21.16 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 124.614 1.102 . . . . 0.0 112.899 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.67 149.74 43.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.696 0.799 . . . . 0.0 110.73 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PHE . . . . . 0.599 ' O ' HD12 ' C' ' 50' ' ' LEU . 27.9 p90 -156.21 163.74 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.835 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.468 HG22 HD13 ' C' ' 50' ' ' LEU . 4.7 p -125.76 168.38 13.87 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.99 -166.86 34.03 Favored Glycine 0 N--CA 1.465 0.633 0 O-C-N 120.073 -1.642 . . . . 0.0 113.212 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.605 ' HB ' HD11 ' C' ' 46' ' ' LEU . 1.2 p -140.64 132.24 27.14 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 123.024 1.393 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -117.04 138.5 51.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.872 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.538 HG12 HD12 ' C' ' 46' ' ' LEU . 7.5 mt -129.36 131.16 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.561 ' O ' HG21 ' C' ' 44' ' ' ILE . 5.8 m -109.53 134.93 51.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.322 -173.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.63 -17.39 22.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.23 141.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.7 1.2 . . . . 0.0 112.099 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.66 154.51 41.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.39 -24.47 65.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -148.0 76.59 10.41 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 128.573 2.749 . . . . 0.0 111.965 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.11 169.39 19.48 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.231 2.62 . . . . 0.0 112.411 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.86 -29.33 1.56 Allowed Glycine 0 N--CA 1.474 1.206 0 C-N-CA 124.57 1.081 . . . . 0.0 113.138 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 2.93 3.32 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 117.656 -1.164 . . . . 0.0 113.529 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.561 HG21 ' O ' ' C' ' 35' ' ' THR . 52.4 mt -32.3 113.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.075 1.75 . . . . 0.0 114.311 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.03 158.1 41.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.72 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' C' ' 32' ' ' THR . 11.9 tp -47.56 115.42 1.13 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.764 2.826 . . . . 0.0 111.132 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.2 117.23 60.79 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.998 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.13 142.92 85.92 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.877 2.385 . . . . 0.0 112.269 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.418 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -128.66 163.62 24.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.865 0.866 . . . . 0.0 112.311 175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.599 HD12 ' O ' ' C' ' 29' ' ' PHE . 27.4 tp -169.26 148.93 4.02 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 113.936 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.63 -151.07 21.78 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 120.928 1.695 . . . . 0.0 111.414 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.8 mp -142.39 135.47 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.806 0.843 . . . . 0.0 111.543 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -119.73 140.68 50.32 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.765 1.226 . . . . 0.0 109.921 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.0 -50.34 72.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.487 -0.758 . . . . 0.0 111.388 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.68 15.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.64 2.376 . . . . 0.0 116.456 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.67 -45.83 7.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.281 2.633 . . . . 0.0 114.895 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -173.97 3.53 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 124.434 1.084 . . . . 0.0 112.765 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 48.4 t -81.02 -37.9 28.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.062 . . . . 0.0 111.027 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.28 58.47 30.77 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 125.111 1.364 . . . . 0.0 111.392 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.68 163.1 40.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.771 2.981 . . . . 0.0 116.953 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -81.5 167.9 18.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.636 1.574 . . . . 0.0 111.657 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.28 161.81 35.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.662 -1.274 . . . . 0.0 113.064 174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.49 139.21 5.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 118.78 -1.676 . . . . 0.0 116.608 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -162.73 153.72 17.27 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -89.73 151.72 21.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.616 2.366 . . . . 0.0 110.49 174.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 t -129.38 118.42 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' B' ' 52' ' ' ILE . 43.3 t30 -98.53 104.89 16.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 111.976 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' TRP . . . . . 0.411 ' HE1' ' HG1' ' C' ' 77' ' ' THR . 32.9 m95 -74.33 147.05 42.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.47 -45.98 3.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.337 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -80.51 -11.3 59.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.2 t -152.56 133.22 13.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.915 2.486 . . . . 0.0 105.961 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.04 118.49 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.802 1.183 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.83 166.48 1.66 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.916 1.686 . . . . 0.0 111.085 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -144.02 144.8 31.82 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.102 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.411 ' HG1' ' HE1' ' C' ' 70' ' ' TRP . 1.2 m -140.4 132.89 28.58 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 109.971 -3.286 . . . . 0.0 109.972 -172.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 144.93 19.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -116.64 144.36 44.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.9 117.16 8.99 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HE ' ' B' ' 100' ' ' ARG . . . -151.78 -176.44 24.52 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 119.48 -1.343 . . . . 0.0 115.155 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -123.15 147.51 46.73 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 125.795 1.527 . . . . 0.0 110.527 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.596 ' HG ' ' HB2' ' C' ' 4' ' ' CYS . 5.4 t -97.09 123.64 40.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.027 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' B' ' 106' ' ' ILE . 4.6 m-85 -116.51 164.65 14.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.09 111.55 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -60.89 154.75 21.38 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -34.7 -41.61 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.334 1.854 . . . . 0.0 115.849 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -13.88 60.96 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.55 46.26 4.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.478 1.037 . . . . 0.0 113.097 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.48 151.56 34.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.521 2.728 . . . . 0.0 106.172 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -115.25 150.05 36.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.865 1.666 . . . . 0.0 110.987 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.504 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -149.88 158.95 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.233 1.413 . . . . 0.0 110.762 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' LEU . . . . . 0.413 HD21 ' CH2' ' C' ' 10' ' ' TRP . 7.3 mt -121.67 109.91 15.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.682 -2.711 . . . . 0.0 103.682 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.504 ' CD ' HG11 ' C' ' 92' ' ' VAL . 2.9 mmtt -102.35 116.69 33.16 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.598 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.6 p -129.08 163.13 26.13 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.429 1.585 . . . . 0.0 112.741 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.413 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.5 162.88 14.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -136.96 161.6 35.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.952 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -146.85 121.65 9.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.142 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' LEU . . . . . 0.476 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 142.05 38.08 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.706 1.241 . . . . 0.0 112.319 -176.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ARG . . . . . 0.436 ' HE ' ' HA2' ' B' ' 81' ' ' GLY . 4.3 tpt85 -127.54 113.99 16.85 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 111.762 -2.472 . . . . 0.0 112.364 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.255 0.4 OUTLIER -71.79 165.96 23.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.583 173.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -114.22 79.53 1.27 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.53 177.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.59 -0.694 . . . . 0.0 110.52 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.43 -22.79 15.37 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.6 150.01 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.116 1.436 . . . . 0.0 113.134 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' B' ' 84' ' ' PHE . 17.5 tt -61.92 -27.25 41.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.145 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.17 9.06 28.21 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.256 0.932 . . . . 0.0 113.738 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -119.49 -1.39 10.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.48 1.112 . . . . 0.0 111.852 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.78 -31.58 70.94 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.385 -1.447 . . . . 0.0 113.142 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -50.44 -45.81 56.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.694 1.597 . . . . 0.0 112.523 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.86 -10.36 36.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.367 1.067 . . . . 0.0 113.026 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.41 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.779 -0.576 . . . . 0.0 111.851 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' C' ' 98' ' ' LEU . 22.2 m -116.93 139.56 50.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.887 0.875 . . . . 0.0 113.089 175.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -136.44 116.18 13.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.624 2.37 . . . . 0.0 111.3 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -99.7 152.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.832 1.196 . . . . 0.0 110.239 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.43 -174.18 32.02 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -127.28 155.33 43.68 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.703 -0.881 . . . . 0.0 112.227 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 118' ' ' ASN . . . . . 0.419 ' HB3' HD22 ' C' ' 12' ' ' ASN . 13.7 m-20 -147.62 151.23 35.86 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.505 1.122 . . . . 0.0 109.702 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' ILE . . . . . 0.431 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.5 mt -135.61 118.98 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -109.99 151.08 27.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.527 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.9 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.3 127.71 33.51 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.079 -1.013 . . . . 0.0 111.228 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.757 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mttm . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 130.21 56.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -139.64 130.1 25.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 110.876 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.62 -27.99 61.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -65.02 110.93 2.65 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.22 5.25 0.23 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 118.738 2.255 . . . . 0.0 118.738 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt 68.86 143.92 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.733 2.413 . . . . 0.0 115.642 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -139.14 159.25 42.59 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.278 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -138.45 147.06 42.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.699 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 118' ' ' ASN . 39.6 t-20 -111.47 145.63 38.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.726 0.81 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.06 -25.02 57.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.453 1.501 . . . . 0.0 113.944 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.08 -16.39 61.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.344 1.858 . . . . 0.0 111.838 174.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.27 -9.69 28.84 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.443 2.449 . . . . 0.0 114.28 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -64.46 144.97 56.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.009 1.404 . . . . 0.0 112.121 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -122.97 134.05 54.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -128.12 136.59 51.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.911 0.862 . . . . 0.0 111.671 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -126.97 130.31 49.83 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.846 0.831 . . . . 0.0 109.252 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.59 131.02 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.72 -103.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.807 0 O-C-N 125.692 1.87 . . . . 0.0 110.569 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.48 138.58 52.35 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.596 0.758 . . . . 0.0 111.127 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.88 133.47 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.95 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -69.73 158.06 36.12 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.8 m -54.36 -29.02 46.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -67.68 -33.82 75.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.894 0.77 . . . . 0.0 111.323 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.73 -7.55 22.08 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.624 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.76 151.63 45.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.097 1.448 . . . . 0.0 108.415 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -152.0 161.59 42.41 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.286 175.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.53 163.82 20.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.368 -1.742 . . . . 0.0 107.121 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.97 -168.13 35.17 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.508 1.06 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -138.19 146.15 42.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 112.776 -1.712 . . . . 0.0 111.746 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -126.06 141.02 52.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.347 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 46' ' ' LEU . 4.4 mp -126.33 145.54 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 44' ' ' ILE . 3.2 m -121.54 139.35 53.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 112.387 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.64 -15.14 17.86 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 27.2 m -135.48 140.37 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.709 1.203 . . . . 0.0 111.079 -176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.28 169.39 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.727 -1.233 . . . . 0.0 112.027 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' HH12 ' A' ' 114' ' ' ARG . 25.7 m-20 -70.65 -43.27 69.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 173.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -128.41 84.34 63.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.529 2.332 . . . . 0.0 107.588 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.76 36.96 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.262 3.308 . . . . 0.0 114.731 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.95 -3.31 90.64 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 119.845 -1.784 . . . . 0.0 115.999 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 -3.33 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.92 1.36 . . . . 0.0 114.342 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 35' ' ' THR . 28.1 mt -20.03 108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 164.87 24.87 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.019 1.727 . . . . 0.0 109.513 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 34' ' ' ILE . 4.5 tt -50.74 136.85 21.24 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.643 1.977 . . . . 0.0 114.025 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -119.95 125.94 27.12 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 113.176 -1.829 . . . . 0.0 111.937 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.29 141.99 98.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.596 2.198 . . . . 0.0 111.715 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 142.74 50.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.619 1.199 . . . . 0.0 109.701 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.25 149.24 34.54 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.093 2.557 . . . . 0.0 109.073 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.03 -156.22 27.72 Favored Glycine 0 N--CA 1.452 -0.259 0 O-C-N 120.128 -1.608 . . . . 0.0 109.857 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.5 mt -146.96 146.86 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.244 1.017 . . . . 0.0 111.527 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.48 153.59 43.33 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.343 1.457 . . . . 0.0 112.537 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.5 153.52 40.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.195 -1.566 . . . . 0.0 112.28 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -139.53 20.8 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -93.42 -57.8 2.48 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.271 1.029 . . . . 0.0 112.944 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.79 20.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.185 0.594 . . . . 0.0 112.323 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -81.57 -20.28 40.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 45.28 0.78 Allowed Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.984 1.314 . . . . 0.0 113.253 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.38 -176.76 3.1 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.222 3.281 . . . . 0.0 115.568 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.289 2.8 t -97.02 164.33 12.57 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.884 1.326 . . . . 0.0 112.931 174.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -158.54 168.95 25.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.633 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.04 151.85 21.03 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 120.516 2.967 . . . . 0.0 120.516 -172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -163.52 153.73 15.55 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -92.67 149.88 21.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.601 1.561 . . . . 0.0 108.839 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.87 127.82 68.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' D' ' 52' ' ' ILE . 25.7 t-20 -104.32 110.53 22.79 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.434 -0.792 . . . . 0.0 110.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.676 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 91.5 m95 -75.91 129.9 37.65 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.587 1.184 . . . . 0.0 112.329 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -90.93 -38.08 13.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.261 -1.336 . . . . 0.0 114.506 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -83.77 -19.7 34.62 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 117.28 5.09 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.28 118.94 6.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.959 1.254 . . . . 0.0 111.711 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -175.64 167.42 3.19 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 126.644 1.978 . . . . 0.0 110.42 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 t -139.79 141.77 36.74 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.676 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 2.4 m -141.09 122.97 15.39 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.902 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.04 156.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.386 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -132.41 141.87 49.04 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 121.43 9.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -171.57 173.52 44.95 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 34.4 tt0 -106.71 144.47 33.32 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.429 0.723 . . . . 0.0 111.508 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.0 p -97.65 121.48 39.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.503 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.8 m-85 -114.1 170.59 8.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.491 1.139 . . . . 0.0 111.665 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 65.9 mt -127.09 116.58 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -58.78 156.03 11.88 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -17.57 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -82.68 -12.9 57.26 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.94 5.67 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.831 1.205 . . . . 0.0 112.796 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -117.09 152.0 35.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.497 174.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -103.13 146.54 28.25 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.847 1.259 . . . . 0.0 110.207 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.47 HG21 ' CD1' ' D' ' 106' ' ' ILE . 27.7 m -147.75 164.68 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.052 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.92 118.38 26.15 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.7 mmmt -107.09 113.39 26.81 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.455 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 3.0 p -131.21 172.5 12.06 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.365 1.555 . . . . 0.0 111.346 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.8 mmm -127.8 170.3 12.92 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.706 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -139.76 164.0 31.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.749 1.261 . . . . 0.0 112.208 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -141.72 121.67 13.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.326 174.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 138.3 43.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 124.193 1.949 . . . . 0.0 109.934 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.63 114.14 18.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 109.652 -3.431 . . . . 0.0 110.057 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -72.61 167.73 20.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.424 1.702 . . . . 0.0 112.207 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -114.97 87.96 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.05 -170.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.767 1.227 . . . . 0.0 108.428 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -121.61 -28.28 4.59 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.85 -1.156 . . . . 0.0 113.814 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.9 144.96 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.573 1.178 . . . . 0.0 110.986 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' D' ' 94' ' ' LYS . 14.3 tt -61.63 -20.69 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.144 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.86 2.95 47.39 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.387 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.45 7.51 8.34 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.567 1.184 . . . . 0.0 112.9 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.62 -36.07 75.6 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.517 -1.989 . . . . 0.0 111.463 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 58.9 p-90 -48.22 -45.67 34.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.487 1.115 . . . . 0.0 113.401 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.59 -12.47 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.656 1.183 . . . . 0.0 113.576 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.96 1.69 22.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' D' ' 96' ' ' MET . 27.0 m -111.66 140.26 46.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.966 0.906 . . . . 0.0 111.499 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.443 HH12 ' CG ' ' A' ' 39' ' ' ASP . 7.6 mtt180 -144.3 130.25 19.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.958 1.303 . . . . 0.0 111.433 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.41 151.45 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 121.038 1.745 . . . . 0.0 110.98 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.97 179.53 27.59 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -120.15 151.56 38.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.121 0.968 . . . . 0.0 110.706 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.427 ' CG ' HD21 ' A' ' 12' ' ' ASN . 6.3 m-20 -149.78 149.52 30.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.233 1.016 . . . . 0.0 110.777 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.9 mt -130.4 133.74 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.08 -1.012 . . . . 0.0 108.289 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -123.92 149.02 46.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.94 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.8 p -132.66 159.76 38.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.71 1.204 . . . . 0.0 110.866 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.24 125.58 24.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 111.122 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.24 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mttm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -149.16 136.5 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.992 1.269 . . . . 0.0 111.632 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 31.3 p -139.45 133.56 31.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.169 2.187 . . . . 0.0 111.549 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.72 -26.42 60.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -65.4 112.1 3.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -4.96 0.36 Allowed Glycine 0 N--CA 1.476 1.316 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 74.68 144.05 0.08 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.418 2.287 . . . . 0.0 114.007 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -139.41 162.16 35.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.134 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -142.49 148.8 38.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.09 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' ASN . . . . . 0.412 HD21 ' CG ' ' D' ' 118' ' ' ASN . 38.2 t-20 -113.43 146.08 40.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.977 0.911 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -56.92 -25.39 57.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.967 1.307 . . . . 0.0 113.921 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.19 -15.62 61.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.362 1.865 . . . . 0.0 112.134 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.84 -8.37 31.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 127.304 2.383 . . . . 0.0 114.294 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -64.56 143.97 57.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.14 1.47 . . . . 0.0 112.512 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -121.4 132.07 54.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.901 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -126.74 137.67 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 111.969 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.6 m -128.75 130.39 47.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.244 1.021 . . . . 0.0 109.786 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.26 130.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.4 -97.09 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 125.825 1.953 . . . . 0.0 111.146 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.41 138.16 46.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 110.959 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.07 134.03 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.008 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -69.75 157.84 36.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.499 0.72 . . . . 0.0 111.793 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 64.4 m -54.51 -28.75 47.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -67.81 -32.87 73.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.794 0.724 . . . . 0.0 111.369 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.23 -6.07 23.34 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 124.777 1.179 . . . . 0.0 112.715 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.16 156.99 38.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.456 1.128 . . . . 0.0 110.541 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.59 166.53 33.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 123.186 1.47 . . . . 0.0 110.891 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -129.75 164.72 23.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 112.0 -2.364 . . . . 0.0 105.905 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.13 -167.1 35.05 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 75.1 p -139.23 146.74 40.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.186 -1.507 . . . . 0.0 112.134 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -126.87 141.14 51.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.179 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.569 HD11 HD12 ' D' ' 46' ' ' LEU . 4.4 mp -125.89 144.77 34.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.471 ' O ' HG21 ' D' ' 44' ' ' ILE . 3.7 m -120.85 138.84 53.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.055 0.942 . . . . 0.0 112.522 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.76 -15.98 18.28 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.406 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 27.3 m -134.81 140.81 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.577 1.151 . . . . 0.0 111.337 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.66 169.06 23.65 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 120.477 -1.389 . . . . 0.0 111.905 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' D' ' 114' ' ' ARG . 31.2 m-20 -70.29 -43.26 70.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.059 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -128.4 83.93 64.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.522 2.329 . . . . 0.0 107.69 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.9 37.44 0.29 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.323 3.348 . . . . 0.0 114.684 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.5 -2.83 90.66 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 119.893 -1.754 . . . . 0.0 116.063 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.828 1.314 . . . . 0.0 114.401 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.471 HG21 ' O ' ' D' ' 35' ' ' THR . 29.3 mt -19.53 107.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 164.35 25.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.994 1.717 . . . . 0.0 109.494 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.569 HD12 HD11 ' D' ' 34' ' ' ILE . 4.4 tt -49.99 136.19 19.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.664 1.986 . . . . 0.0 113.95 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -119.3 125.96 27.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 113.21 -1.813 . . . . 0.0 111.991 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.21 140.67 95.89 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.229 1.953 . . . . 0.0 111.269 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.45 149.78 41.84 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 124.892 1.37 . . . . 0.0 109.359 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -154.87 149.34 26.27 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.074 2.15 . . . . 0.0 108.869 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.94 -154.2 25.33 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 120.898 -1.126 . . . . 0.0 111.347 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.3 mt -146.92 146.02 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.286 1.035 . . . . 0.0 112.033 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.79 153.81 41.9 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.457 1.503 . . . . 0.0 112.325 174.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -73.17 159.17 33.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 119.954 -1.716 . . . . 0.0 112.344 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -145.46 21.75 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -93.46 -58.07 2.4 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.039 0.936 . . . . 0.0 112.453 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.47 169.81 16.69 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.962 0.789 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 26.1 m -90.41 -13.77 34.27 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -136.22 39.75 0.46 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.724 1.209 . . . . 0.0 113.768 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.76 -176.99 3.57 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.792 2.328 . . . . 0.0 114.359 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.305 2.5 t -97.06 164.36 12.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.742 1.258 . . . . 0.0 112.074 174.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.57 168.35 27.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.391 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 151.61 20.51 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 120.742 3.057 . . . . 0.0 120.742 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -163.49 152.78 14.63 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -90.84 150.79 21.41 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.932 1.693 . . . . 0.0 108.776 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.09 128.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.607 ' HB2' HG21 ' A' ' 52' ' ' ILE . 25.4 t-20 -105.44 110.26 22.53 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -75.74 129.82 37.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.823 1.297 . . . . 0.0 112.608 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -91.51 -37.63 13.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.944 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -83.79 -19.54 34.85 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -152.42 119.01 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.38 119.05 7.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.304 1.411 . . . . 0.0 111.758 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -175.29 166.43 3.38 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 126.531 1.933 . . . . 0.0 110.384 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 141.59 38.07 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.195 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -141.11 123.34 15.68 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 111.364 -2.653 . . . . 0.0 109.947 -172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.05 156.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.649 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.54 141.92 49.82 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.21 121.26 9.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -174.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -170.66 173.68 44.49 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 118.665 -1.731 . . . . 0.0 117.19 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 34.6 tt0 -106.63 144.51 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.99 0.9 . . . . 0.0 111.274 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 p -97.66 118.22 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.924 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.488 ' HB2' HD12 ' A' ' 106' ' ' ILE . 2.8 m-85 -112.27 170.56 8.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.901 0.858 . . . . 0.0 111.911 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 49.9 mt -128.97 114.81 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -58.61 155.85 11.75 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -29.62 2.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -72.07 -17.7 61.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.337 1.455 . . . . 0.0 113.833 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.89 54.38 2.64 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' D' ' 90' ' ' LYS . 0.2 OUTLIER -128.22 153.55 46.8 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 129.51 3.124 . . . . 0.0 108.794 173.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -109.54 146.96 33.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.523 1.154 . . . . 0.0 109.971 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 106' ' ' ILE . 23.3 m -148.44 164.03 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.34 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.29 118.36 25.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.616 ' HE2' HD11 ' A' ' 106' ' ' ILE . 3.8 mmmt -106.76 112.94 26.15 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 2.9 p -130.52 172.12 12.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.553 1.644 . . . . 0.0 111.155 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' A' ' 113' ' ' THR . 86.5 mmm -127.19 169.99 12.89 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.753 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -139.69 164.01 31.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.657 1.218 . . . . 0.0 111.913 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.418 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -142.09 122.3 13.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.212 174.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 139.46 41.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 124.105 1.907 . . . . 0.0 110.11 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.84 114.58 18.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 109.717 -3.402 . . . . 0.0 110.626 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -73.08 167.83 20.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 125.492 1.745 . . . . 0.0 112.429 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -114.7 83.71 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.46 -172.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.904 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -119.05 -30.22 5.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.529 -1.357 . . . . 0.0 112.411 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.06 143.92 43.98 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 111.564 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.583 HD11 ' HE2' ' A' ' 94' ' ' LYS . 14.0 tt -61.61 -22.27 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.666 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.39 1.16 51.98 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 117.635 -1.647 . . . . 0.0 114.445 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.08 7.46 9.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.841 1.321 . . . . 0.0 113.002 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.06 -36.18 74.61 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.696 -1.877 . . . . 0.0 111.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.412 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 58.5 p-90 -48.25 -46.03 35.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.377 1.071 . . . . 0.0 113.201 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -90.32 -12.65 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.441 1.096 . . . . 0.0 113.508 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.28 1.0 23.12 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' A' ' 96' ' ' MET . 24.2 m -111.12 140.85 45.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.231 1.012 . . . . 0.0 111.669 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' D' ' 39' ' ' ASP . 7.3 mtt180 -144.75 130.95 19.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.61 152.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.085 1.766 . . . . 0.0 110.966 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.29 28.79 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -120.13 150.8 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.026 0.93 . . . . 0.0 110.407 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 118' ' ' ASN . . . . . 0.412 ' CG ' HD21 ' D' ' 12' ' ' ASN . 5.6 m-20 -149.18 148.07 29.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.768 0.794 . . . . 0.0 110.357 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -128.46 133.71 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -123.22 147.45 46.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.559 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 46.9 p -129.81 156.75 43.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.757 1.223 . . . . 0.0 110.009 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -57.75 127.79 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.761 0.825 . . . . 0.0 110.496 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 mttm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 44.4 t -139.31 133.9 31.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 109.421 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.2 p -139.56 131.72 28.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.748 2.019 . . . . 0.0 110.081 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.45 -25.72 60.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -65.68 111.6 3.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -5.38 0.37 Allowed Glycine 0 N--CA 1.478 1.472 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt 75.34 144.32 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.657 2.383 . . . . 0.0 114.037 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -140.55 162.39 35.46 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.849 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -141.11 149.96 42.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.688 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -112.03 146.26 38.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.618 0.767 . . . . 0.0 110.512 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -57.26 -23.81 50.66 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.499 1.52 . . . . 0.0 113.626 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 24.5 tp -74.52 -16.17 60.84 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.511 1.924 . . . . 0.0 111.932 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.5 -7.68 32.19 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 127.421 2.439 . . . . 0.0 114.272 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -64.41 144.39 57.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.278 1.539 . . . . 0.0 113.14 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -122.85 132.26 54.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.177 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -126.49 136.64 52.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.887 0.851 . . . . 0.0 111.739 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -126.69 130.56 50.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.601 0.715 . . . . 0.0 109.607 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.04 130.14 72.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.61 -98.16 0.09 OUTLIER Glycine 0 CA--C 1.527 0.829 0 O-C-N 125.559 1.787 . . . . 0.0 111.229 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.16 138.21 46.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.709 0.804 . . . . 0.0 110.984 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 p -92.35 133.47 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.018 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' B' ' 28' ' ' GLU . 20.4 m-20 -69.27 158.02 35.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.237 0.615 . . . . 0.0 111.344 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 63.9 m -54.4 -29.02 47.46 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -67.76 -33.9 75.76 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.801 . . . . 0.0 111.39 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.83 21.63 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.697 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' B' ' 24' ' ' ASN . 15.0 pt-20 -69.52 151.72 45.68 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.116 1.458 . . . . 0.0 108.426 174.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.411 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.0 OUTLIER -151.99 161.27 42.9 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.107 175.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.3 163.71 20.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.111 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.93 -168.34 35.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-O 122.741 1.19 . . . . 0.0 110.976 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -137.96 146.97 43.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.505 -1.847 . . . . 0.0 111.73 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -126.61 141.13 51.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.228 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.59 HD11 HD12 ' B' ' 46' ' ' LEU . 4.5 mp -126.18 144.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.457 ' O ' HG21 ' B' ' 44' ' ' ILE . 3.3 m -120.89 139.42 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.941 0.896 . . . . 0.0 112.645 -173.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.09 -16.21 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.412 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 27.7 m -134.96 140.65 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.612 1.165 . . . . 0.0 111.116 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.72 169.11 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.844 -1.16 . . . . 0.0 112.103 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' CG ' HH12 ' B' ' 114' ' ' ARG . 27.9 m-20 -70.19 -43.39 70.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.987 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -128.72 83.95 64.63 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.651 2.381 . . . . 0.0 107.66 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.71 37.48 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.263 3.308 . . . . 0.0 114.753 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.69 -2.98 90.72 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 119.839 -1.788 . . . . 0.0 116.041 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.07 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.457 HG21 ' O ' ' B' ' 35' ' ' THR . 29.5 mt -19.7 107.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.73 24.78 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.98 1.712 . . . . 0.0 109.54 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.59 HD12 HD11 ' B' ' 34' ' ' ILE . 5.0 tt -50.77 137.21 20.73 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 126.556 1.942 . . . . 0.0 113.929 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -120.15 126.24 26.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.094 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.26 141.84 98.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.679 2.253 . . . . 0.0 111.813 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.74 143.13 50.02 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 124.562 1.163 . . . . 0.0 109.614 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 149.25 34.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.978 2.511 . . . . 0.0 108.878 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.17 -155.95 27.39 Favored Glycine 0 N--CA 1.453 -0.222 0 O-C-N 120.337 -1.477 . . . . 0.0 109.853 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.623 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.5 mt -147.2 147.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.316 1.047 . . . . 0.0 111.618 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.62 154.0 42.94 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.048 1.339 . . . . 0.0 112.431 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -74.06 153.5 39.61 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.223 -1.548 . . . . 0.0 112.063 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -138.6 20.98 2.71 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -93.56 -57.07 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.791 0.836 . . . . 0.0 112.941 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 170.2 16.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.675 0.75 . . . . 0.0 112.972 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.8 m -80.77 -24.53 38.57 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.94 44.97 0.78 Allowed Pre-proline 0 CA--C 1.569 1.685 0 C-N-CA 125.319 1.448 . . . . 0.0 113.156 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.78 -176.23 3.07 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.201 2.6 . . . . 0.0 114.882 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.299 2.9 t -97.26 164.15 12.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.788 1.28 . . . . 0.0 112.508 174.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.56 168.61 26.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.893 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.44 151.53 20.32 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 120.825 3.09 . . . . 0.0 120.825 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -163.09 153.49 16.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -92.15 149.65 21.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.566 1.546 . . . . 0.0 108.849 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.61 128.18 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' C' ' 52' ' ' ILE . 25.8 t-20 -104.75 110.61 23.02 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.369 -0.832 . . . . 0.0 110.778 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -76.25 130.67 38.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 122.784 1.278 . . . . 0.0 112.645 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -92.41 -37.81 12.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.737 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -84.1 -19.49 34.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.5 117.32 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.96 118.93 6.84 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.897 1.226 . . . . 0.0 111.76 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -175.56 167.23 3.25 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 126.599 1.96 . . . . 0.0 110.27 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -139.38 142.14 37.55 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.249 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -141.15 123.32 15.63 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 111.462 -2.608 . . . . 0.0 109.588 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 m -99.17 156.53 3.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.512 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.29 141.85 49.14 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.55 121.34 9.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -169.66 172.52 43.68 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 118.628 -1.748 . . . . 0.0 116.947 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 34.9 tt0 -105.02 144.85 31.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.654 0.74 . . . . 0.0 111.224 -176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 p -97.56 122.89 41.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.106 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.469 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.98 169.61 9.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.963 0.887 . . . . 0.0 111.778 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -126.37 116.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.91 155.55 13.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -21.26 0.8 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 118.104 2.631 . . . . 0.0 118.104 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.43 -12.23 59.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 47.5 4.79 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.259 0.933 . . . . 0.0 112.416 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.69 150.81 42.22 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.257 2.223 . . . . 0.0 110.462 174.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -103.44 145.75 29.53 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.967 1.307 . . . . 0.0 110.228 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 27.1 m -147.83 164.19 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.865 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.98 118.29 25.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.596 ' HE2' HD11 ' C' ' 106' ' ' ILE . 3.8 mmmt -106.77 113.47 26.98 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.445 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 3.0 p -130.85 172.69 11.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.543 1.64 . . . . 0.0 111.161 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.65 ' HG3' HG21 ' C' ' 113' ' ' THR . 87.7 mmm -127.63 170.12 13.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.554 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -139.82 163.36 32.84 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.573 1.178 . . . . 0.0 111.752 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -141.13 122.02 14.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.19 174.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 138.38 43.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 124.356 2.027 . . . . 0.0 110.108 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.71 114.11 18.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 109.475 -3.511 . . . . 0.0 109.922 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -73.08 167.94 20.09 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 125.508 1.755 . . . . 0.0 112.125 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.4 t -114.87 87.87 2.74 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.04 -171.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.838 1.255 . . . . 0.0 108.243 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.05 -30.52 4.35 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.823 -1.173 . . . . 0.0 112.226 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -112.76 143.2 44.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.255 1.026 . . . . 0.0 111.76 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.587 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.2 tt -60.37 -22.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.08 -0.963 . . . . 0.0 113.161 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.61 54.48 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 117.701 -1.611 . . . . 0.0 114.55 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.67 7.2 9.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.922 1.289 . . . . 0.0 113.118 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.68 -36.11 73.68 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 119.76 -1.837 . . . . 0.0 111.296 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.406 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 58.7 p-90 -48.27 -45.92 35.2 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.429 1.092 . . . . 0.0 113.479 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.36 -12.32 37.98 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.463 1.105 . . . . 0.0 113.345 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.61 1.1 23.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.656 HG21 ' HG3' ' C' ' 96' ' ' MET . 25.4 m -110.86 140.35 45.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.297 1.039 . . . . 0.0 111.938 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.438 HH12 ' CG ' ' B' ' 39' ' ' ASP . 7.5 mtt180 -144.6 130.7 19.47 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.658 1.183 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.39 152.25 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 121.111 1.778 . . . . 0.0 111.209 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.35 179.49 27.95 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -120.48 150.61 40.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.241 1.017 . . . . 0.0 110.344 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.41 148.27 29.26 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.033 0.921 . . . . 0.0 110.41 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 62.7 mt -129.58 133.31 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -122.88 148.01 45.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.985 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.7 p -131.28 159.15 38.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.768 1.227 . . . . 0.0 110.432 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 5.0 mmt-85 -59.14 134.52 57.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.731 0.812 . . . . 0.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.659 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 53.5 mttm . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -141.58 135.92 30.54 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.921 1.237 . . . . 0.0 110.777 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 22.4 p -139.48 131.68 28.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.536 1.935 . . . . 0.0 110.844 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -73.54 -24.76 60.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -67.58 112.33 4.67 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.58 -3.22 0.43 Allowed Glycine 0 N--CA 1.481 1.636 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt 74.05 144.5 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.908 2.483 . . . . 0.0 114.446 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -139.54 162.55 34.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.121 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.81 147.38 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.449 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -110.68 145.92 37.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.826 0.85 . . . . 0.0 110.348 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -57.46 -23.39 49.54 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.627 1.571 . . . . 0.0 113.69 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.6 tp -75.04 -16.37 60.59 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.613 1.965 . . . . 0.0 111.895 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.07 -7.86 31.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 127.417 2.436 . . . . 0.0 114.364 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -65.1 145.25 56.54 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.285 1.543 . . . . 0.0 112.656 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -123.84 132.01 53.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.143 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -125.93 137.9 53.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 111.738 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 33.9 m -128.39 129.84 46.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.721 0.772 . . . . 0.0 109.438 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.9 129.73 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.76 -96.59 0.1 OUTLIER Glycine 0 CA--C 1.527 0.786 0 O-C-N 125.638 1.836 . . . . 0.0 111.179 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.92 45.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.758 0.823 . . . . 0.0 110.962 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.97 133.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.011 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -69.49 157.91 36.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.543 0.737 . . . . 0.0 111.831 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 64.3 m -54.58 -28.89 49.42 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -67.78 -32.88 73.77 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.834 0.743 . . . . 0.0 111.303 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.17 -6.06 23.44 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 124.761 1.172 . . . . 0.0 112.763 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.04 157.09 38.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.434 1.112 . . . . 0.0 110.426 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.6 166.55 33.01 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.95 1.357 . . . . 0.0 110.872 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -129.74 165.04 22.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 112.164 -2.289 . . . . 0.0 105.84 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.44 -167.03 35.11 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 122.448 1.027 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.404 ' HB ' HD11 ' C' ' 46' ' ' LEU . 70.2 p -139.01 147.36 42.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.972 -1.614 . . . . 0.0 112.187 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -127.48 141.26 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.587 HD11 HD12 ' C' ' 46' ' ' LEU . 4.3 mp -125.94 145.65 33.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.463 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -122.11 138.95 54.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.144 -173.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -13.45 18.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 27.7 m -136.63 140.16 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.672 1.189 . . . . 0.0 111.429 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.12 169.56 22.11 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.575 -1.328 . . . . 0.0 112.192 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ASP . . . . . 0.447 ' CG ' HH12 ' C' ' 114' ' ' ARG . 30.2 m-20 -70.93 -42.9 69.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.142 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -128.31 84.57 62.84 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.685 2.394 . . . . 0.0 107.506 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.84 36.52 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.168 3.245 . . . . 0.0 114.675 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.88 -3.01 90.58 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 119.909 -1.744 . . . . 0.0 115.99 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.11 -4.11 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.83 1.315 . . . . 0.0 114.47 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.463 HG21 ' O ' ' C' ' 35' ' ' THR . 29.2 mt -19.33 108.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.77 164.09 26.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.073 1.749 . . . . 0.0 109.593 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.587 HD12 HD11 ' C' ' 34' ' ' ILE . 4.4 tt -49.98 136.57 18.44 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.652 1.981 . . . . 0.0 113.943 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -120.07 126.11 27.0 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.18 140.06 93.14 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.636 2.224 . . . . 0.0 111.377 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.09 149.48 42.12 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 124.772 1.295 . . . . 0.0 109.64 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -154.79 149.44 26.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.98 2.112 . . . . 0.0 108.601 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.95 -154.05 25.21 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 119.163 0.892 . . . . 0.0 111.543 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.3 mt -147.16 145.95 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.317 1.047 . . . . 0.0 111.923 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.98 153.29 43.01 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.349 1.459 . . . . 0.0 112.321 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -72.77 157.92 36.57 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.94 -1.725 . . . . 0.0 112.298 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -143.88 21.14 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -93.52 -57.26 2.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.931 0.892 . . . . 0.0 112.364 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.18 169.03 17.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.611 0.764 . . . . 0.0 112.179 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -85.38 -19.81 30.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 40.35 0.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 125.085 1.354 . . . . 0.0 113.335 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.95 -177.06 3.63 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.857 2.371 . . . . 0.0 114.531 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.308 2.3 t -96.57 164.09 12.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.711 1.243 . . . . 0.0 112.121 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -158.44 168.25 27.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.653 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.58 151.46 20.14 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 120.61 3.004 . . . . 0.0 120.61 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.19 153.21 15.73 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -91.53 150.44 21.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.996 1.719 . . . . 0.0 108.804 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.49 128.7 68.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.623 ' HB2' HG21 ' B' ' 52' ' ' ILE . 25.1 t-20 -105.46 110.62 23.03 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.817 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.47 130.95 39.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.736 1.255 . . . . 0.0 112.413 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -92.37 -38.35 12.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.964 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -82.94 -19.33 37.43 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.44 119.92 6.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.27 118.89 7.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.369 1.44 . . . . 0.0 111.35 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 6.4 m -175.56 166.38 3.22 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.695 1.998 . . . . 0.0 110.539 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 142.09 38.06 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 122.324 1.059 . . . . 0.0 111.397 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.4 m -141.25 124.19 16.25 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 111.284 -2.689 . . . . 0.0 109.831 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -100.17 155.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.421 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -131.43 141.76 49.88 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.44 121.46 9.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -170.06 173.55 44.13 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.54 -1.791 . . . . 0.0 116.703 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 35.0 tt0 -105.81 144.89 31.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.379 1.085 . . . . 0.0 111.132 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 30.1 p -97.43 123.23 41.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.356 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.468 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.7 m-85 -117.76 170.43 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.733 0.778 . . . . 0.0 112.257 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 49.7 mt -127.28 115.77 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -58.85 154.95 14.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -19.16 0.51 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 176.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -82.31 -9.61 59.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.174 0.99 . . . . 0.0 113.247 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.83 49.75 5.24 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.193 0.901 . . . . 0.0 112.359 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 0.4 OUTLIER -124.31 152.88 42.55 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 127.716 2.406 . . . . 0.0 109.506 173.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -107.54 145.71 32.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.14 1.376 . . . . 0.0 110.005 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.448 HG21 ' CD1' ' B' ' 106' ' ' ILE . 25.9 m -148.15 165.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.178 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.89 118.63 25.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' B' ' 106' ' ' ILE . 3.7 mmmt -106.97 112.62 25.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 3.0 p -129.94 172.87 11.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.533 1.635 . . . . 0.0 111.374 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.656 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.0 mmm -128.31 170.56 12.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -140.43 163.6 32.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.741 1.257 . . . . 0.0 111.804 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -141.39 122.2 14.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.389 174.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.08 139.17 41.93 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 124.122 1.915 . . . . 0.0 110.026 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.27 18.42 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 109.75 -3.386 . . . . 0.0 110.132 -173.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -72.35 168.25 18.77 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.342 1.651 . . . . 0.0 112.41 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -115.43 82.68 1.79 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.97 -172.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.791 1.237 . . . . 0.0 108.916 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -119.73 -28.52 5.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.661 -1.274 . . . . 0.0 112.847 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -116.55 143.28 45.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 122.419 1.104 . . . . 0.0 111.624 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.0 tt -61.79 -20.52 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.731 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.4 2.37 57.86 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 118.335 -1.259 . . . . 0.0 114.086 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.04 7.62 8.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.79 1.236 . . . . 0.0 112.994 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.8 -36.07 75.98 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 119.734 -1.853 . . . . 0.0 111.524 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 59.1 p-90 -48.1 -46.02 33.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.602 1.161 . . . . 0.0 113.248 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -90.22 -12.41 38.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.101 . . . . 0.0 113.763 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 1.36 23.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.65 HG21 ' HG3' ' B' ' 96' ' ' MET . 26.2 m -111.25 140.63 45.65 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.21 1.004 . . . . 0.0 111.385 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.447 HH12 ' CG ' ' C' ' 39' ' ' ASP . 7.4 mtt180 -144.81 130.93 19.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.911 1.284 . . . . 0.0 111.195 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.63 152.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.972 1.715 . . . . 0.0 111.145 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.12 28.3 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -119.9 150.72 40.02 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.146 0.978 . . . . 0.0 110.145 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.52 147.23 27.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.856 0.836 . . . . 0.0 110.406 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.56 132.78 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.87 147.74 45.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.569 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 63.3 p -131.54 158.09 41.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.831 1.252 . . . . 0.0 109.971 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -60.46 136.72 58.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.757 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 CA--C 1.536 0.419 0 O-C-N 121.456 -0.778 . . . . 0.0 111.387 174.737 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -131.04 147.03 52.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.1 p -139.84 130.71 26.08 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.278 -1.514 . . . . 0.0 112.646 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.7 -27.45 68.71 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -50.49 118.43 3.04 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 123.575 1.655 . . . . 0.0 112.189 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.11 -119.12 2.58 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.84 2.162 . . . . 0.0 110.017 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -145.01 149.73 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.546 1.138 . . . . 0.0 113.273 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -145.83 159.18 43.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.296 1.438 . . . . 0.0 110.068 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -134.87 150.2 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -107.96 143.51 36.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.461 1.104 . . . . 0.0 111.265 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.3 -24.03 64.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.39 1.076 . . . . 0.0 112.632 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 tp -74.09 -14.34 60.97 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.983 1.313 . . . . 0.0 112.639 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.61 -14.29 32.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 127.049 2.262 . . . . 0.0 113.889 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.61 153.85 22.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.298 1.523 . . . . 0.0 112.741 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.52 146.81 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.149 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -141.29 147.12 37.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -129.89 134.04 47.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.339 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.18 123.72 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.93 -87.06 0.11 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 124.434 1.084 . . . . 0.0 111.567 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.5 42.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.06 0.933 . . . . 0.0 112.145 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.16 125.55 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 113.166 -1.834 . . . . 0.0 108.038 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -71.36 162.81 28.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.995 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -54.91 -23.67 19.93 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -74.75 -32.52 62.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.905 -1.122 . . . . 0.0 113.217 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 -5.4 26.4 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 117.603 -1.665 . . . . 0.0 112.586 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 0.0 OUTLIER -67.06 142.46 57.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.71 156.91 32.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 1.5 p -125.2 168.61 13.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.622 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.52 -167.36 35.64 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.32 0.956 . . . . 0.0 113.838 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -138.61 133.63 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.758 -1.221 . . . . 0.0 111.308 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -113.65 131.92 55.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.59 129.24 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.251 61.2 m -104.66 142.65 34.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.638 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.24 -10.2 20.57 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -138.99 146.16 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.266 1.026 . . . . 0.0 112.647 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.1 26.4 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.319 -0.863 . . . . 0.0 110.881 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -31.14 63.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -141.1 69.73 28.27 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.454 1.902 . . . . 0.0 113.897 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.53 72.1 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 124.339 3.359 . . . . 0.0 114.183 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.69 2.28 13.64 Favored Glycine 0 N--CA 1.477 1.408 0 O-C-N 120.712 -1.242 . . . . 0.0 114.597 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.14 27.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.805 1.242 . . . . 0.0 112.623 -174.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.56 130.71 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.929 0.871 . . . . 0.0 110.76 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.25 0.5 OUTLIER -140.52 170.2 16.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.616 1.566 . . . . 0.0 110.055 177.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.1 tp -57.53 115.4 2.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.865 2.866 . . . . 0.0 111.0 174.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.2 m -100.55 120.09 56.97 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.23 142.38 87.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.434 2.089 . . . . 0.0 111.699 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.46 152.98 47.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.802 0.841 . . . . 0.0 111.624 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 30' ' ' THR . 1.1 tp -160.59 148.79 16.34 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 110.463 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.48 -152.01 22.66 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 120.883 1.674 . . . . 0.0 110.195 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -143.2 140.01 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.304 0.642 . . . . 0.0 111.279 -174.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.21 136.41 52.79 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.396 -0.815 . . . . 0.0 111.932 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -68.76 149.79 48.61 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.935 0.874 . . . . 0.0 111.321 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.3 23.98 1.15 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.995 1.318 . . . . 0.0 111.436 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -92.97 -58.2 2.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.361 1.864 . . . . 0.0 111.357 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.05 -178.15 3.21 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.616 1.197 . . . . 0.0 114.169 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -65.73 -57.81 7.15 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.215 1.006 . . . . 0.0 111.845 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -141.52 65.39 20.88 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.917 0.887 . . . . 0.0 110.129 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.34 -174.15 1.53 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.27 2.647 . . . . 0.0 114.546 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.275 4.5 t -96.15 160.72 14.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 123.158 1.456 . . . . 0.0 112.796 174.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.9 167.34 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.469 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.55 147.37 12.91 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.19 156.91 27.38 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -92.9 149.68 21.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.661 1.984 . . . . 0.0 109.535 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.22 117.04 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 42.2 t30 -92.36 105.5 17.68 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.752 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.266 42.9 m95 -74.3 130.96 40.7 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -89.47 -40.26 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -92.17 -9.46 42.28 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.42 128.37 10.31 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 128.187 2.595 . . . . 0.0 104.865 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.76 118.7 12.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.363 1.078 . . . . 0.0 110.739 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 m -177.07 159.65 1.68 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.001 1.721 . . . . 0.0 110.475 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.63 141.64 35.07 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.033 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 99' ' ' LEU . 1.8 m -140.57 126.68 19.65 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.553 -3.022 . . . . 0.0 108.558 -172.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.754 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.544 ' HE2' HD21 ' A' ' 118' ' ' ASN . 41.5 m-85 -124.61 142.56 51.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 116.67 5.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.31 169.21 39.73 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 118.737 -1.697 . . . . 0.0 116.408 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 29.0 tt0 -101.84 148.13 25.68 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.274 1.035 . . . . 0.0 111.723 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 132.82 36.31 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.271 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' D' ' 106' ' ' ILE . 19.7 m-85 -121.62 158.09 29.37 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 110.18 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.81 158.58 7.94 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.547 1.139 . . . . 0.0 110.087 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -48.08 -33.77 8.65 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -75.33 -15.26 60.5 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.6 47.15 3.04 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.248 0.928 . . . . 0.0 111.729 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 4.9 mtpm? -119.8 154.18 34.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.431 1.492 . . . . 0.0 109.639 174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -109.03 151.82 25.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.814 1.645 . . . . 0.0 111.26 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.48 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.3 t -152.83 156.3 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.189 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 mt -123.42 104.11 8.89 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.48 ' CD ' HG11 ' A' ' 92' ' ' VAL . 1.2 mmtt -95.04 127.84 41.41 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -139.77 163.07 33.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.792 1.282 . . . . 0.0 112.768 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 19.9 mtp -121.34 160.47 23.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -133.51 162.57 31.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.154 -1.839 . . . . 0.0 113.057 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.81 126.55 23.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.508 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.409 HD12 HG21 ' A' ' 77' ' ' THR . 0.3 OUTLIER -107.3 140.79 39.64 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 125.14 1.525 . . . . 0.0 109.972 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.09 118.23 22.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.57 -173.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.8 p -84.99 172.07 11.61 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.7 m -110.71 70.89 0.73 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 107.7 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.46 169.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.048 1.339 . . . . 0.0 109.667 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.34 -11.1 14.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -135.36 152.76 51.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.064 1.412 . . . . 0.0 111.942 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -67.43 -20.77 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.376 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.83 4.3 45.83 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.674 -0.641 . . . . 0.0 114.401 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -125.75 1.64 7.45 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.25 -34.58 72.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.987 0.915 . . . . 0.0 113.028 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -48.32 -38.85 20.06 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -97.43 -12.92 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.04 1.336 . . . . 0.0 114.032 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.76 38.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.4 m -108.34 144.94 35.2 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-O 122.352 1.072 . . . . 0.0 109.583 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -141.0 151.84 44.44 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.524 1.529 . . . . 0.0 108.311 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.62 153.19 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.57 1.148 . . . . 0.0 109.411 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.38 32.22 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.141 0.877 . . . . 0.0 111.776 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 17.3 p90 -132.41 159.99 37.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.139 -0.624 . . . . 0.0 112.076 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.544 HD21 ' HE2' ' A' ' 79' ' ' PHE . 53.0 m-20 -150.42 157.35 42.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.542 1.163 . . . . 0.0 109.784 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.4 HD13 ' HE3' ' A' ' 94' ' ' LYS . 8.6 mt -131.93 129.45 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.85 151.97 38.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 124.334 1.022 . . . . 0.0 108.772 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 p -139.84 164.77 29.09 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -57.04 129.62 42.51 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.496 0.718 . . . . 0.0 110.94 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.499 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 4' ' ' CYS . . . . . 0.463 ' HG ' ' HB3' ' D' ' 83' ' ' CYS . 27.5 p -137.67 143.37 41.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.656 1.583 . . . . 0.0 108.888 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 85.2 p -139.98 131.95 27.77 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.346 -1.471 . . . . 0.0 113.552 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.31 -24.04 67.68 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -53.95 118.43 3.99 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.545 1.64 . . . . 0.0 112.092 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.46 -120.73 2.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.261 1.886 . . . . 0.0 109.554 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 113.301 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -147.8 159.89 43.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.18 147.88 46.18 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -105.79 143.57 33.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.652 1.181 . . . . 0.0 111.945 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.79 -24.56 62.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.562 1.145 . . . . 0.0 112.92 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.84 -13.81 60.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.694 1.197 . . . . 0.0 112.666 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -13.81 36.72 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.973 2.225 . . . . 0.0 113.619 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.2 152.27 25.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.298 1.523 . . . . 0.0 112.439 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.95 146.44 50.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.854 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -141.19 147.29 38.14 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -129.76 134.95 47.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.035 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.08 123.62 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.86 0.12 Allowed Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.128 0.893 . . . . 0.0 111.757 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.09 151.63 38.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.747 -0.855 . . . . 0.0 111.969 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.66 126.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.596 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -70.87 162.8 28.62 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -56.52 -24.92 49.88 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -73.02 -30.95 64.14 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.825 -1.172 . . . . 0.0 112.52 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.11 -1.25 25.49 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.214 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.51 155.61 39.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.152 1.476 . . . . 0.0 112.417 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PHE . . . . . 0.439 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -156.47 166.06 34.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.316 174.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 30' ' ' THR . . . . . 0.543 HG22 ' CD1' ' D' ' 50' ' ' LEU . 3.0 p -125.44 -179.92 4.83 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.81 -167.33 39.49 Favored Glycine 0 N--CA 1.469 0.878 0 O-C-N 119.46 -2.025 . . . . 0.0 113.755 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.5 p -137.92 132.31 32.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.101 0.953 . . . . 0.0 112.133 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -112.2 136.13 51.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 mt -125.78 129.53 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 70.4 m -104.74 143.33 33.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.736 -173.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.88 21.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -141.48 145.67 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.359 1.063 . . . . 0.0 112.504 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.05 167.99 26.67 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.111 -0.993 . . . . 0.0 110.896 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -30.98 63.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.9 69.7 29.45 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.448 1.899 . . . . 0.0 113.966 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.53 71.5 2.49 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.324 3.349 . . . . 0.0 114.266 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.17 14.49 Favored Glycine 0 N--CA 1.477 1.389 0 O-C-N 120.734 -1.229 . . . . 0.0 114.595 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.03 28.02 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.721 1.208 . . . . 0.0 112.626 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.69 130.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.946 0.879 . . . . 0.0 110.686 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.09 169.98 16.59 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.683 1.593 . . . . 0.0 109.753 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.3 tp -57.17 115.37 2.62 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.249 3.02 . . . . 0.0 111.151 174.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -100.93 119.48 58.08 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.12 141.17 87.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.365 2.044 . . . . 0.0 111.647 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -125.38 157.15 37.5 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.738 0.815 . . . . 0.0 111.777 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' D' ' 30' ' ' THR . 12.5 tp -163.67 149.04 10.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.356 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -148.25 15.26 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 120.298 1.408 . . . . 0.0 110.729 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mt -146.42 139.49 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.179 0.992 . . . . 0.0 110.317 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.91 136.83 54.59 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.224 -0.922 . . . . 0.0 111.549 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -68.58 150.38 48.08 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.659 -1.276 . . . . 0.0 111.782 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -147.26 24.66 1.13 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 111.751 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 15.5 mmt-85 -93.12 -58.19 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.085 1.754 . . . . 0.0 111.448 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 179.89 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -63.68 -55.28 24.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.246 1.018 . . . . 0.0 111.431 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.07 67.83 15.5 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.516 0.726 . . . . 0.0 112.447 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.23 -173.59 1.65 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.166 2.577 . . . . 0.0 115.5 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.273 3.9 t -96.88 161.56 13.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 123.038 1.399 . . . . 0.0 112.997 174.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -151.46 167.99 26.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.352 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.84 147.53 13.1 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.994 2.358 . . . . 0.0 118.994 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.74 156.0 24.66 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.03 149.43 21.23 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.595 1.958 . . . . 0.0 109.594 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.62 117.73 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.1 t30 -93.21 106.38 18.35 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.49 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.268 42.6 m95 -74.26 131.98 41.7 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -172.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -90.48 -39.47 12.59 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.83 -9.51 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.35 129.01 10.79 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.553 2.741 . . . . 0.0 105.374 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.28 118.82 12.65 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.07 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 4.7 m -177.03 159.99 1.73 Allowed 'General case' 0 C--O 1.244 0.779 0 C-N-CA 125.875 1.67 . . . . 0.0 110.34 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.64 141.29 35.1 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.065 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.413 HG21 HD12 ' D' ' 99' ' ' LEU . 1.8 m -140.5 126.26 19.27 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.834 -2.894 . . . . 0.0 108.845 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.12 151.5 5.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.808 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' PHE . . . . . 0.56 ' HE2' HD21 ' D' ' 118' ' ' ASN . 41.8 m-85 -124.44 142.28 51.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.84 116.42 5.83 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.2 168.98 39.56 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 118.605 -1.76 . . . . 0.0 116.388 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 28.8 tt0 -101.89 148.31 25.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.782 0.801 . . . . 0.0 111.521 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' HG ' ' D' ' 4' ' ' CYS . 49.1 t -95.21 131.72 40.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.716 174.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.589 ' HB2' HD12 ' A' ' 106' ' ' ILE . 24.8 m-85 -117.59 159.93 22.09 Favored 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 123.685 0.794 . . . . 0.0 112.867 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -124.13 110.37 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.68 158.19 8.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.958 1.303 . . . . 0.0 109.678 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -47.52 -34.27 7.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.96 -18.23 61.4 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 36.4 4.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.705 1.145 . . . . 0.0 112.802 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.497 ' NZ ' ' HB3' ' D' ' 90' ' ' LYS . 8.4 mtpm? -109.14 157.14 19.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.727 1.211 . . . . 0.0 110.189 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -109.21 153.55 23.64 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 119.919 -1.738 . . . . 0.0 111.511 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.5 t -153.18 154.57 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.177 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 mt -118.9 106.44 12.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 172.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.1 mptt -97.7 125.94 42.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 172.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -138.78 162.91 33.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.75 1.262 . . . . 0.0 112.419 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 18.4 mtp -121.17 160.72 23.2 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -133.92 162.27 32.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.066 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -137.78 126.76 24.17 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.536 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 99' ' ' LEU . . . . . 0.413 HD12 HG21 ' D' ' 77' ' ' THR . 0.2 OUTLIER -107.24 142.06 37.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 125.074 1.484 . . . . 0.0 109.827 -177.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.82 117.85 20.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 111.801 -2.454 . . . . 0.0 111.729 -173.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -84.49 171.12 12.82 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 23.4 m -109.09 71.91 0.79 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.79 171.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.838 1.255 . . . . 0.0 109.613 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.64 -4.26 12.81 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.8 150.97 46.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.739 1.257 . . . . 0.0 110.807 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.4 tt -68.33 -21.5 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.183 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.38 3.99 44.38 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.943 0.783 . . . . 0.0 114.294 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.31 1.22 7.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.037 0.935 . . . . 0.0 113.423 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.5 -34.59 71.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 113.034 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -48.21 -39.48 21.23 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -96.78 -12.93 23.02 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.967 1.307 . . . . 0.0 114.189 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.29 -4.62 37.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 6.7 m -108.8 145.42 35.24 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.621 0.724 . . . . 0.0 109.369 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -141.2 151.7 44.0 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.936 1.694 . . . . 0.0 108.854 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.17 153.73 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 109.715 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.78 -176.24 32.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.687 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 18.4 p90 -132.51 160.01 37.76 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.162 -0.61 . . . . 0.0 111.881 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 118' ' ' ASN . . . . . 0.56 HD21 ' HE2' ' D' ' 79' ' ' PHE . 59.0 m-20 -150.33 157.2 42.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.73 1.252 . . . . 0.0 109.866 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' ILE . . . . . 0.404 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.0 mt -133.02 130.33 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.66 152.52 41.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.19 0.931 . . . . 0.0 109.417 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 45.2 p -140.66 167.38 22.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -57.4 125.58 23.48 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.326 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.6 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.402 ' HG ' ' CB ' ' B' ' 83' ' ' CYS . 28.8 p -137.97 140.94 40.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.107 1.763 . . . . 0.0 107.479 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -139.86 131.17 26.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 119.839 -1.788 . . . . 0.0 113.463 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.56 -26.11 68.41 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -52.14 118.09 3.25 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.704 1.716 . . . . 0.0 112.433 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.44 -118.0 2.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.507 2.004 . . . . 0.0 110.306 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -144.75 148.52 34.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.502 1.121 . . . . 0.0 113.621 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -144.87 159.05 43.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.177 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -136.65 148.41 47.41 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -105.81 143.55 33.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.812 1.245 . . . . 0.0 112.215 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.89 -22.33 62.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.731 1.212 . . . . 0.0 112.918 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 50.2 tp -76.68 -14.5 59.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.838 1.255 . . . . 0.0 112.497 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 -12.83 34.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.707 2.099 . . . . 0.0 113.769 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 153.77 28.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.105 1.431 . . . . 0.0 112.554 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.45 147.56 50.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.628 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -142.03 146.87 36.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m -128.55 135.36 49.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.064 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.7 124.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.19 -86.41 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 O-C-N 124.362 1.039 . . . . 0.0 111.502 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.83 152.59 42.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 122.068 0.937 . . . . 0.0 112.11 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -99.84 125.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 113.124 -1.853 . . . . 0.0 108.288 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -71.38 162.83 28.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 110.94 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -55.09 -23.52 21.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -74.83 -31.82 61.78 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.849 -1.157 . . . . 0.0 113.304 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.78 -5.47 27.61 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.874 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.495 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 0.0 OUTLIER -67.03 142.77 57.08 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.15 156.73 31.41 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.413 HG22 HD13 ' B' ' 50' ' ' LEU . 1.3 p -125.01 168.87 12.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.556 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.35 -167.1 35.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 122.461 1.034 . . . . 0.0 113.778 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.521 ' HB ' HD11 ' B' ' 46' ' ' LEU . 12.3 p -138.56 132.33 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.606 -1.297 . . . . 0.0 111.15 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.11 136.36 50.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.222 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mt -126.8 129.37 71.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.252 63.7 m -104.67 143.2 33.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.925 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.44 -8.46 21.09 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 m -140.35 145.74 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.267 1.027 . . . . 0.0 112.601 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.94 167.78 27.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.216 -0.928 . . . . 0.0 111.0 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.94 -31.52 64.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.75 69.83 30.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 126.562 1.945 . . . . 0.0 113.902 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 71.36 2.48 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 124.426 3.417 . . . . 0.0 114.259 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.0 2.17 14.68 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 120.753 -1.217 . . . . 0.0 114.571 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.11 27.9 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.594 1.157 . . . . 0.0 112.561 -174.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 86.4 mt -50.45 130.59 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.816 0.817 . . . . 0.0 110.658 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.59 170.42 15.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.636 1.574 . . . . 0.0 109.833 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.8 tp -57.61 115.4 2.75 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.133 2.973 . . . . 0.0 111.068 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m -100.9 119.97 56.79 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.06 142.53 85.68 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.622 2.215 . . . . 0.0 111.853 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.98 153.07 47.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.741 0.816 . . . . 0.0 111.725 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.413 HD13 HG22 ' B' ' 30' ' ' THR . 1.1 tp -160.64 148.77 16.24 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.426 1.49 . . . . 0.0 110.348 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.42 -152.38 23.12 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 120.857 1.662 . . . . 0.0 110.158 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -143.0 139.59 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.78 136.36 53.05 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.508 -0.745 . . . . 0.0 112.081 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -69.25 150.93 46.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.988 0.899 . . . . 0.0 111.358 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.26 18.96 1.22 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.056 1.342 . . . . 0.0 111.865 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 mmt-85 -87.84 -58.19 2.66 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.315 1.846 . . . . 0.0 111.467 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 178.5 4.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.6 t -64.42 -53.37 49.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.602 1.161 . . . . 0.0 111.85 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -143.95 66.51 14.86 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.785 0.834 . . . . 0.0 113.057 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.83 -174.23 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.912 2.408 . . . . 0.0 115.316 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.262 4.2 t -96.35 161.27 14.0 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.689 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -151.49 168.48 24.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.207 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.41 147.16 12.27 Favored Glycine 0 CA--C 1.539 1.58 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -160.05 157.63 29.01 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.45 150.11 20.7 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.516 1.926 . . . . 0.0 109.575 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.51 117.12 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.51 ' HB2' HG21 ' C' ' 52' ' ' ILE . 41.2 t30 -92.41 105.58 17.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.613 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.267 42.9 m95 -74.12 130.79 40.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -89.32 -40.34 12.85 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -91.9 -9.56 42.77 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.37 128.08 10.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.52 2.728 . . . . 0.0 105.326 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.08 118.88 12.54 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.823 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -177.08 159.95 1.71 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.958 1.703 . . . . 0.0 110.317 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -141.11 141.54 34.18 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.87 126.93 19.47 Favored 'General case' 0 N--CA 1.407 -2.625 0 CA-C-N 110.593 -3.003 . . . . 0.0 108.657 -172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.842 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' PHE . . . . . 0.557 ' HE2' HD21 ' B' ' 118' ' ' ASN . 41.4 m-85 -124.56 142.72 51.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.41 116.92 5.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.84 168.96 39.94 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 118.816 -1.659 . . . . 0.0 116.546 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 28.8 tt0 -101.81 148.4 25.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.76 0.79 . . . . 0.0 111.356 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.402 ' CB ' ' HG ' ' B' ' 4' ' ' CYS . 49.8 t -95.2 133.04 39.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.133 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' C' ' 106' ' ' ILE . 18.1 m-85 -118.41 158.17 25.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 mt -121.97 108.43 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.14 158.62 8.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.126 0.97 . . . . 0.0 110.466 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -46.95 -32.15 3.65 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.05 -12.22 59.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.65 51.32 3.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.8 156.74 30.05 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 129.658 3.183 . . . . 0.0 108.548 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -118.02 155.31 30.53 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 119.948 -1.72 . . . . 0.0 111.465 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.493 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.4 t -155.54 155.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -120.12 107.07 12.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' B' ' 92' ' ' VAL . 1.0 OUTLIER -98.29 126.14 43.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -139.32 163.08 33.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.688 1.233 . . . . 0.0 112.551 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 19.7 mtp -120.79 160.68 22.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.82 162.63 31.48 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.133 -1.849 . . . . 0.0 113.175 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.73 126.38 23.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.568 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.24 141.0 39.23 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 125.05 1.468 . . . . 0.0 109.84 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 111.728 -2.487 . . . . 0.0 111.669 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -84.93 171.81 11.86 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 32.6 m -110.08 71.73 0.77 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.72 170.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.333 1.453 . . . . 0.0 110.012 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.39 -4.52 13.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.05 151.85 47.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.662 1.22 . . . . 0.0 111.067 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.7 tt -68.52 -22.29 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.072 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.73 4.53 36.19 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.753 0.692 . . . . 0.0 114.391 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.65 1.38 7.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.65 -34.38 71.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.294 1.038 . . . . 0.0 113.284 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -48.34 -39.51 22.3 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -96.44 -13.35 23.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.902 1.281 . . . . 0.0 114.125 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.06 -5.77 43.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -107.54 145.03 33.71 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 121.822 0.82 . . . . 0.0 109.279 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -140.61 151.31 44.56 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 125.966 1.706 . . . . 0.0 108.751 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.88 154.21 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 119.582 1.083 . . . . 0.0 109.656 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.84 -176.14 32.62 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.093 0.854 . . . . 0.0 111.739 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 17.9 p90 -132.73 160.08 37.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.137 -0.625 . . . . 0.0 112.087 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ASN . . . . . 0.557 HD21 ' HE2' ' B' ' 79' ' ' PHE . 58.0 m-20 -150.43 157.07 42.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.665 1.221 . . . . 0.0 110.02 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.65 130.0 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.9 153.36 39.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 124.285 0.991 . . . . 0.0 109.408 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.4 p -141.74 165.67 26.85 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.16 121.79 11.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.803 1.241 . . . . 0.0 111.872 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.219 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 p -133.72 143.63 48.61 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -140.04 129.22 23.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 119.581 -1.949 . . . . 0.0 114.248 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.07 -27.32 69.31 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -52.11 114.49 1.34 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 123.035 1.398 . . . . 0.0 111.915 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.96 -109.44 0.74 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.669 1.604 . . . . 0.0 110.979 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -152.0 144.26 23.98 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.87 160.48 39.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.256 1.022 . . . . 0.0 110.699 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.21 148.0 50.81 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -109.3 143.62 38.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.945 0.898 . . . . 0.0 111.859 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -59.6 -25.72 64.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.628 1.171 . . . . 0.0 112.969 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.9 tp -73.58 -14.2 61.15 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.838 -1.164 . . . . 0.0 112.357 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.28 -12.19 36.79 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.82 2.152 . . . . 0.0 113.685 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.86 155.01 28.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 123.393 1.568 . . . . 0.0 112.427 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.39 146.3 51.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.015 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -142.31 144.18 33.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.035 0.922 . . . . 0.0 113.348 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -127.52 134.11 49.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.246 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 95.9 mt -132.64 124.39 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.46 -85.71 0.1 Allowed Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.241 0.963 . . . . 0.0 111.701 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.6 152.33 39.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.846 -0.796 . . . . 0.0 112.283 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.98 126.23 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 113.474 -1.694 . . . . 0.0 108.652 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -71.29 163.23 28.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.541 0.686 . . . . 0.0 111.78 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -56.78 -24.82 53.15 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -73.04 -31.26 64.32 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.736 -1.228 . . . . 0.0 112.524 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.79 -2.26 24.51 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.257 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.44 155.47 40.08 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.016 1.408 . . . . 0.0 112.459 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PHE . . . . . 0.448 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -156.89 166.08 34.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.43 174.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.539 HG22 ' CD1' ' C' ' 50' ' ' LEU . 3.0 p -125.66 -179.34 4.61 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 173.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.0 -166.91 39.22 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 119.208 -2.182 . . . . 0.0 113.222 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' C' ' 46' ' ' LEU . 12.4 p -137.13 131.94 33.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.797 0.808 . . . . 0.0 112.199 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -111.39 137.78 48.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.8 129.85 70.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.254 64.9 m -104.8 144.07 32.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.462 -173.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.97 -6.26 21.42 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -141.68 144.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 112.57 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.59 168.03 26.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 110.966 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -31.29 63.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 172.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -140.41 69.94 32.69 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.626 1.97 . . . . 0.0 113.977 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.53 71.56 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.405 3.403 . . . . 0.0 114.195 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.05 1.94 14.64 Favored Glycine 0 N--CA 1.477 1.409 0 O-C-N 120.686 -1.259 . . . . 0.0 114.616 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.91 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.583 1.153 . . . . 0.0 112.554 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.56 130.86 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.898 0.856 . . . . 0.0 110.612 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.15 169.93 16.68 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.773 1.629 . . . . 0.0 109.803 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -56.8 115.44 2.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 129.264 3.025 . . . . 0.0 111.153 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 57.0 m -100.98 119.47 58.04 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.88 141.75 85.13 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.174 1.916 . . . . 0.0 111.526 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.47 157.02 39.75 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.664 0.786 . . . . 0.0 111.805 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' C' ' 30' ' ' THR . 12.6 tp -164.19 148.98 10.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.521 1.528 . . . . 0.0 112.455 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.09 -147.97 14.74 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 120.357 1.435 . . . . 0.0 110.699 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mt -146.84 139.47 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 110.162 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.66 136.66 54.61 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 121.188 -0.945 . . . . 0.0 111.428 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -68.36 150.6 47.99 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.626 -1.296 . . . . 0.0 111.64 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -146.86 25.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.011 1.324 . . . . 0.0 111.717 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 mmt-85 -93.42 -58.2 2.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.173 1.789 . . . . 0.0 111.705 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.25 179.65 4.39 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.594 1.184 . . . . 0.0 113.992 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -63.71 -57.9 8.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.725 0.81 . . . . 0.0 110.795 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.75 66.64 27.63 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.606 0.763 . . . . 0.0 112.065 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -173.31 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.29 2.66 . . . . 0.0 115.245 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.276 4.0 t -96.54 161.51 13.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 123.055 1.407 . . . . 0.0 113.011 174.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -151.75 167.57 27.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.469 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.5 147.79 13.71 Favored Glycine 0 CA--C 1.542 1.771 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.68 156.54 25.64 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -93.57 150.05 20.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.546 1.938 . . . . 0.0 109.618 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.03 117.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.542 ' HB2' HG21 ' B' ' 52' ' ' ILE . 42.7 t30 -92.74 107.14 18.99 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.347 -0.846 . . . . 0.0 110.42 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.268 43.1 m95 -75.3 131.8 40.56 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -89.95 -40.53 12.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -92.21 -9.23 43.0 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -152.37 127.79 9.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.605 2.762 . . . . 0.0 105.172 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.37 118.84 12.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.2 m -177.2 160.2 1.7 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 126.127 1.771 . . . . 0.0 110.424 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -140.98 141.57 34.38 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.054 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.408 HG23 ' HA ' ' C' ' 99' ' ' LEU . 1.8 m -140.43 127.32 20.63 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 110.642 -2.981 . . . . 0.0 108.824 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.13 151.19 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.69 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' PHE . . . . . 0.568 ' HE2' HD21 ' C' ' 118' ' ' ASN . 42.7 m-85 -123.8 142.42 51.12 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.5 117.16 5.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -173.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 169.0 39.61 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.257 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 28.8 tt0 -101.75 148.66 25.01 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 111.354 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.48 132.67 41.8 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.107 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.583 ' HB2' HD12 ' B' ' 106' ' ' ILE . 19.1 m-85 -117.95 160.28 21.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.01 110.18 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 172.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.79 156.96 10.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 109.912 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -46.76 -34.9 5.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.62 -15.95 61.24 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.62 35.62 5.6 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.365 1.459 . . . . 0.0 113.232 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -104.47 163.04 12.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.16 1.384 . . . . 0.0 107.854 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -118.49 152.57 35.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.997 1.719 . . . . 0.0 111.182 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -153.34 156.04 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.229 1.411 . . . . 0.0 111.168 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 mt -119.91 108.67 14.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.0 OUTLIER -99.6 126.07 45.53 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 172.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -139.34 162.55 34.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.667 1.223 . . . . 0.0 112.677 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 18.9 mtp -120.3 160.98 21.91 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -133.86 162.76 31.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.995 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 tp -137.81 126.73 24.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.467 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' LEU . . . . . 0.408 ' HA ' HG23 ' C' ' 77' ' ' THR . 0.3 OUTLIER -107.21 141.22 38.84 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 124.881 1.363 . . . . 0.0 109.944 -177.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.42 118.92 22.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 111.615 -2.539 . . . . 0.0 111.771 -173.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 96.2 p -85.96 171.68 11.26 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -110.34 71.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.5 171.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.081 1.352 . . . . 0.0 109.529 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -114.07 -5.68 13.1 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.54 151.49 47.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.703 1.24 . . . . 0.0 110.98 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.3 tt -67.79 -22.11 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.932 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.5 3.84 38.84 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.85 -0.972 . . . . 0.0 114.33 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -125.58 1.27 7.57 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.289 1.036 . . . . 0.0 113.747 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.66 -34.39 71.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.148 0.979 . . . . 0.0 112.973 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.54 -39.0 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -96.95 -12.62 23.16 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.028 1.331 . . . . 0.0 114.237 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.57 -4.61 38.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 6.8 m -108.65 144.99 35.67 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.305 1.05 . . . . 0.0 109.672 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -141.31 151.68 43.81 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.547 1.539 . . . . 0.0 108.262 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.23 153.41 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.87 -175.88 32.37 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 123.998 0.808 . . . . 0.0 111.807 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 18.4 p90 -133.09 160.52 36.96 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.086 -0.656 . . . . 0.0 112.26 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 118' ' ' ASN . . . . . 0.568 HD21 ' HE2' ' C' ' 79' ' ' PHE . 56.8 m-20 -150.65 157.56 43.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.719 1.247 . . . . 0.0 110.276 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' ILE . . . . . 0.413 HD13 ' HE3' ' C' ' 94' ' ' LYS . 8.8 mt -133.13 130.87 58.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -124.32 150.93 44.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -139.59 167.59 21.76 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.399 -0.813 . . . . 0.0 109.061 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -57.59 117.33 4.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.222 1.009 . . . . 0.0 111.572 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.045 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 t -116.33 123.44 47.64 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -141.11 134.78 30.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.892 -1.13 . . . . 0.0 112.232 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.65 -18.09 61.07 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -56.15 115.89 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.606 1.162 . . . . 0.0 111.317 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.91 -122.23 3.29 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.926 1.727 . . . . 0.0 111.269 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.45 143.6 26.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -140.35 162.68 34.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.28 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -137.77 146.31 43.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.359 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 118' ' ' ASN . 7.0 t-20 -108.0 145.31 34.09 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.948 0.899 . . . . 0.0 110.581 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.81 -29.45 54.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.963 1.305 . . . . 0.0 114.248 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.3 tp -70.99 -13.83 62.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.975 1.71 . . . . 0.0 113.402 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.38 22.95 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.31 2.386 . . . . 0.0 113.868 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 156.04 34.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.042 1.421 . . . . 0.0 113.578 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.29 136.14 51.54 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.407 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -130.1 143.26 50.69 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.393 -0.817 . . . . 0.0 112.09 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 m -132.07 133.08 43.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.514 0.726 . . . . 0.0 109.589 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.91 121.75 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -58.19 9.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.311 1.007 . . . . 0.0 112.425 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.32 153.27 3.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.164 1.386 . . . . 0.0 110.557 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.48 130.96 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 124.582 1.176 . . . . 0.0 111.293 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -75.1 168.85 19.18 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 m -55.62 -27.95 52.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -81.77 -35.77 29.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.059 0.845 . . . . 0.0 110.422 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.54 -6.02 9.2 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 117.151 -1.916 . . . . 0.0 114.489 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB2' HD21 ' D' ' 50' ' ' LEU . 1.4 pt-20 -67.9 141.81 56.26 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 119.7 1.75 . . . . 0.0 108.101 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.24 151.0 22.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.85 165.32 11.94 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.42 -165.45 32.09 Favored Glycine 0 C--O 1.237 0.322 0 O-C-N 120.683 -1.261 . . . . 0.0 111.707 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -141.36 143.35 33.94 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 122.227 1.013 . . . . 0.0 112.983 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -118.65 123.9 46.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.246 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 46' ' ' LEU . 2.8 mp -115.15 126.68 72.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.3 m -105.65 150.51 25.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.3 -11.88 14.82 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.39 146.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.363 1.465 . . . . 0.0 112.091 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.17 42.18 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.292 -1.505 . . . . 0.0 113.265 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -71.57 -21.54 61.87 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.693 0.397 . . . . 0.0 110.598 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -148.47 83.46 7.03 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.828 2.451 . . . . 0.0 109.944 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 28.33 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.545 3.497 . . . . 0.0 115.834 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.12 -5.67 49.17 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 0.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.003 -1.475 . . . . 0.0 114.165 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -20.57 114.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.865 1.666 . . . . 0.0 115.451 -173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 168.18 18.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.351 2.26 . . . . 0.0 107.923 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 34' ' ' ILE . 6.8 tt -53.69 138.25 35.53 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.148 1.379 . . . . 0.0 112.856 174.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -115.55 121.56 34.32 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.22 144.82 89.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.435 2.757 . . . . 0.0 111.622 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.49 154.86 48.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 111.378 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.81 148.56 20.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.237 1.815 . . . . 0.0 109.916 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.25 -153.4 23.88 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 121.748 2.067 . . . . 0.0 111.775 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.9 mt -142.17 142.4 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.04 143.98 51.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.35 0.66 . . . . 0.0 111.816 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -79.35 151.43 31.0 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.603 1.192 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -145.94 25.46 1.28 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.43 1.492 . . . . 0.0 111.744 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -93.52 -50.22 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.219 2.208 . . . . 0.0 112.107 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.95 178.19 7.66 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.797 0.808 . . . . 0.0 112.81 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 p -77.82 -41.77 35.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 113.676 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -131.66 56.46 24.26 Favored Pre-proline 0 CA--C 1.554 1.103 0 C-N-CA 125.367 1.467 . . . . 0.0 112.174 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.06 172.06 12.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.975 1.783 . . . . 0.0 115.71 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -94.51 174.08 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.229 173.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -166.69 165.34 16.54 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.252 -1.794 . . . . 0.0 113.592 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.68 148.32 13.67 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 118.589 2.195 . . . . 0.0 118.589 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -164.13 154.98 15.47 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 152.4 22.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.906 1.683 . . . . 0.0 110.326 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -133.23 116.91 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' D' ' 52' ' ' ILE . 29.3 t30 -99.49 110.13 22.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -76.95 136.81 38.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -38.34 12.54 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.545 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -86.54 -15.67 39.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -152.55 122.23 6.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.195 1.798 . . . . 0.0 107.145 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.65 118.48 5.71 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.175 1.352 . . . . 0.0 110.114 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.9 p -175.18 168.34 3.39 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.04 1.736 . . . . 0.0 110.616 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -147.78 145.33 28.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.254 1.502 . . . . 0.0 111.326 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -137.02 130.35 31.27 Favored 'General case' 0 N--CA 1.407 -2.621 0 CA-C-N 110.03 -3.259 . . . . 0.0 108.515 -173.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.35 140.79 31.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 O-C-N 123.874 0.734 . . . . 0.0 109.573 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -115.09 147.43 40.21 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.422 0.452 . . . . 0.0 110.561 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 118.25 10.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.39 -172.71 31.21 Favored Glycine 0 CA--C 1.502 -0.768 0 C-N-CA 119.493 -1.336 . . . . 0.0 115.749 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -123.3 149.9 44.24 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 125.101 1.118 . . . . 0.0 113.103 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.49 112.86 24.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.576 -2.556 . . . . 0.0 106.31 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' D' ' 106' ' ' ILE . 10.5 m-85 -108.41 155.97 19.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 118.893 0.77 . . . . 0.0 112.625 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -128.9 113.04 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.79 161.65 4.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.812 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -41.63 -48.29 4.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.553 1.541 . . . . 0.0 113.599 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.36 -29.97 70.26 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.23 24.53 5.38 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.124 1.345 . . . . 0.0 114.142 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -92.92 160.5 14.87 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.647 1.223 . . . . 0.0 108.128 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.01 147.67 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.363 1.465 . . . . 0.0 111.405 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' D' ' 106' ' ' ILE . 2.3 t -148.27 159.62 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.104 1.362 . . . . 0.0 110.088 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.1 mt -122.47 106.43 11.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CD ' HG11 ' A' ' 92' ' ' VAL . 3.9 mmtt -98.87 123.99 43.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -139.34 168.4 19.91 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.54 1.638 . . . . 0.0 113.652 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -118.71 163.15 17.26 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -136.9 162.23 33.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.632 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.758 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -145.52 120.82 10.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.78 -1.554 . . . . 0.0 111.676 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.74 137.57 45.52 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 125.152 1.532 . . . . 0.0 112.897 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -118.95 113.85 21.65 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 111.121 -2.763 . . . . 0.0 110.88 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.282 49.2 m -73.6 168.09 20.01 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.364 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 p -110.4 85.88 2.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.09 -164.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -131.49 -26.07 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.574 -1.329 . . . . 0.0 114.042 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.35 148.89 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.81 1.767 . . . . 0.0 111.916 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' D' ' 84' ' ' PHE . 19.5 tt -63.2 -22.49 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.343 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.86 2.69 54.04 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 117.969 -1.462 . . . . 0.0 113.634 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -120.36 1.9 10.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 9.8 t70 -59.72 -27.84 66.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.606 -1.934 . . . . 0.0 112.395 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 43.7 p-90 -46.08 -49.49 16.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.302 1.041 . . . . 0.0 113.042 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -89.29 -11.42 43.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.93 0.892 . . . . 0.0 112.703 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -76.34 -3.03 34.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.237 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.758 ' CG2' HD21 ' A' ' 98' ' ' LEU . 1.9 m -107.72 138.46 43.92 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.746 0.819 . . . . 0.0 112.585 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' HH11 ' A' ' 114' ' ' ARG . 18.4 mtt85 -141.35 130.37 23.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 110.821 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.45 158.25 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.933 1.242 . . . . 0.0 111.308 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.63 -177.51 36.54 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 14.7 p90 -126.69 155.56 42.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.913 -0.757 . . . . 0.0 111.858 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HB3' HD22 ' A' ' 12' ' ' ASN . 14.0 m-20 -148.13 155.73 41.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.539 1.161 . . . . 0.0 110.915 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.1 mt -139.32 120.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.06 153.92 27.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.466 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -142.14 165.99 25.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 123.5 14.84 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.287 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.25 123.49 47.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -143.02 136.26 28.23 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.41 -17.87 61.21 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -55.86 118.81 4.93 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.434 1.111 . . . . 0.0 111.704 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.2 -114.83 1.72 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 125.612 1.577 . . . . 0.0 111.239 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.83 141.37 21.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -139.18 162.8 34.08 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.559 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -142.52 147.92 36.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.92 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' ASN . . . . . 0.442 HD22 ' HB3' ' D' ' 118' ' ' ASN . 6.9 t-20 -108.15 145.66 33.84 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.897 0.879 . . . . 0.0 110.487 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.63 -27.02 57.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.819 1.248 . . . . 0.0 113.9 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' B' ' 110' ' ' TRP . 30.5 tp -71.41 -14.62 62.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.753 1.621 . . . . 0.0 113.384 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.14 -13.45 21.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.309 2.385 . . . . 0.0 113.975 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.39 154.55 41.08 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.094 1.447 . . . . 0.0 112.619 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.65 135.13 51.82 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.309 0.644 . . . . 0.0 110.764 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -128.77 144.42 51.16 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.472 -0.768 . . . . 0.0 111.987 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -133.77 131.48 39.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.964 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.81 122.3 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.64 -60.52 6.12 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 124.542 1.151 . . . . 0.0 112.24 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.1 156.08 8.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.538 1.135 . . . . 0.0 110.872 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.23 129.84 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.481 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -75.35 168.21 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.082 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -56.43 -26.8 54.72 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -80.16 -32.76 38.78 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.095 0.861 . . . . 0.0 110.606 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 -6.15 10.3 Favored Glycine 0 C--O 1.221 -0.703 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.486 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.59 149.77 46.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.218 1.407 . . . . 0.0 113.265 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PHE . . . . . 0.484 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.0 p90 -160.17 165.56 31.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.769 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 161.96 26.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -172.06 -165.26 28.93 Favored Glycine 0 N--CA 1.464 0.552 0 O-C-N 119.983 -1.698 . . . . 0.0 111.96 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 70.6 p -139.89 141.43 36.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.464 1.126 . . . . 0.0 113.337 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -119.52 122.43 41.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.094 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.689 HD11 HD12 ' D' ' 46' ' ' LEU . 2.8 mp -113.75 127.23 71.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 58.2 m -105.6 150.87 25.02 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.79 -12.31 14.62 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.49 146.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.312 1.445 . . . . 0.0 111.935 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.88 161.59 41.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.362 -1.462 . . . . 0.0 113.353 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -72.09 -21.48 61.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.717 0.407 . . . . 0.0 110.747 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.27 83.29 7.23 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 127.857 2.463 . . . . 0.0 109.915 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.76 28.0 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 124.489 3.459 . . . . 0.0 115.951 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.91 -5.65 47.83 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 1.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.136 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -21.53 115.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 168.3 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.401 2.28 . . . . 0.0 107.894 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.689 HD12 HD11 ' D' ' 34' ' ' ILE . 6.8 tt -54.01 139.03 35.75 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.325 1.45 . . . . 0.0 112.837 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -116.8 121.59 32.65 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.87 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.21 143.34 93.68 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.452 2.768 . . . . 0.0 111.474 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' LEU . . . . . 0.452 HD12 ' C ' ' D' ' 49' ' ' LEU . 1.9 pp -132.63 161.68 33.29 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.998 0.919 . . . . 0.0 111.885 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 28' ' ' GLU . 12.0 tp -166.78 148.4 6.19 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.231 1.412 . . . . 0.0 112.011 -175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 -152.91 23.54 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 121.171 1.805 . . . . 0.0 111.804 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -142.56 142.65 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.672 0.789 . . . . 0.0 112.689 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.29 144.6 51.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.851 1.26 . . . . 0.0 111.183 174.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.56 149.49 29.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.942 0.877 . . . . 0.0 109.522 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -143.46 24.53 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.573 1.549 . . . . 0.0 111.648 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.48 -49.68 5.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.748 2.019 . . . . 0.0 111.536 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.23 178.45 8.06 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.087 0.867 . . . . 0.0 112.371 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 13.2 p -77.39 -42.27 36.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.603 1.961 . . . . 0.0 113.907 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -131.28 54.06 13.5 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.237 1.415 . . . . 0.0 112.05 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.25 173.59 9.35 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.571 2.181 . . . . 0.0 115.989 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.67 6.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.72 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -166.7 164.27 16.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.868 -1.515 . . . . 0.0 113.724 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.7 147.84 13.31 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 118.158 2.023 . . . . 0.0 118.158 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -164.05 154.03 14.7 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.7 152.7 21.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.209 1.804 . . . . 0.0 110.06 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -133.59 116.91 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.457 ' HB2' HG21 ' A' ' 52' ' ' ILE . 26.5 t30 -100.11 110.06 22.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.428 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -76.44 138.62 40.45 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -172.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -37.72 11.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.152 -1.386 . . . . 0.0 114.688 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -87.23 -15.7 37.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -152.54 121.68 6.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 126.553 1.941 . . . . 0.0 107.277 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -57.98 118.49 5.44 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.957 1.253 . . . . 0.0 110.179 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 66.1 p -174.75 169.34 3.55 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.992 1.717 . . . . 0.0 110.65 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -148.09 145.71 28.53 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-O 123.501 1.619 . . . . 0.0 111.081 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.0 OUTLIER -136.77 130.22 31.61 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 109.847 -3.342 . . . . 0.0 108.459 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.69 141.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -115.09 147.73 39.82 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 0.0 110.562 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.29 117.92 9.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.66 -171.9 29.44 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 119.398 -1.382 . . . . 0.0 115.566 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.559 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.4 OUTLIER -127.31 149.95 49.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.528 1.156 . . . . 0.0 113.309 -174.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.63 112.63 24.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.83 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' A' ' 106' ' ' ILE . 11.9 m-85 -111.22 153.09 26.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 119.458 1.026 . . . . 0.0 113.066 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.75 109.94 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 163.16 3.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.475 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -41.63 -42.3 2.46 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -12.67 60.03 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.57 44.71 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.086 1.327 . . . . 0.0 114.898 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -67.76 159.51 30.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.254 1.527 . . . . 0.0 110.705 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -120.11 145.49 46.85 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.858 1.663 . . . . 0.0 111.892 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 106' ' ' ILE . 2.2 t -147.31 158.29 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.751 1.22 . . . . 0.0 110.706 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -121.57 106.65 11.57 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.502 ' CD ' HG11 ' D' ' 92' ' ' VAL . 4.2 mmtt -99.34 123.98 44.06 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -139.35 168.22 20.31 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.577 1.656 . . . . 0.0 113.677 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.537 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.39 16.77 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 171.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -137.0 162.45 33.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.254 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -145.82 121.07 10.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.611 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.14 44.49 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 125.062 1.477 . . . . 0.0 112.917 -174.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.45 113.85 21.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 111.177 -2.738 . . . . 0.0 110.943 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.284 49.8 m -73.42 168.3 19.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.279 1.612 . . . . 0.0 111.337 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.9 86.02 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.07 -165.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -130.77 -26.28 2.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 149.23 40.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.859 1.79 . . . . 0.0 111.93 176.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 84' ' ' PHE . 19.1 tt -63.39 -22.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.213 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.92 4.06 54.72 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.99 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' ASP . . . . . 0.482 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 6.7 m-20 -120.99 2.67 10.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' D' ' 112' ' ' ALA . 8.9 t70 -60.34 -27.86 67.7 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.587 -1.946 . . . . 0.0 112.046 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.482 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.3 p-90 -45.69 -49.46 14.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.347 1.059 . . . . 0.0 113.107 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -89.61 -11.32 42.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.039 0.936 . . . . 0.0 112.558 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 112' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' D' ' 109' ' ' ASP . . . -76.61 -2.62 33.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.695 0.398 . . . . 0.0 111.437 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.763 ' CG2' HD21 ' D' ' 98' ' ' LEU . 1.8 m -107.9 138.59 43.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.638 0.775 . . . . 0.0 112.78 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ARG . . . . . 0.502 ' HG3' HH11 ' D' ' 114' ' ' ARG . 18.8 mtt85 -141.43 130.18 22.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.856 1.262 . . . . 0.0 111.032 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.32 158.26 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.891 1.223 . . . . 0.0 111.331 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.15 -177.9 36.48 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 14.7 p90 -126.07 155.33 41.74 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.913 -0.757 . . . . 0.0 111.477 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 118' ' ' ASN . . . . . 0.442 ' HB3' HD22 ' D' ' 12' ' ' ASN . 13.0 m-20 -148.03 154.69 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.072 0.939 . . . . 0.0 110.45 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' ILE . . . . . 0.456 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -137.31 120.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -111.84 153.26 26.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.348 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -138.38 164.86 28.25 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 121.4 7.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.071 0.948 . . . . 0.0 110.956 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 123' ' ' LEU . . . . . 0.502 HD23 ' C ' ' D' ' 123' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.235 0.306 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.51 123.35 48.3 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -173.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -142.91 135.48 27.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.396 1.078 . . . . 0.0 113.528 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.48 -17.83 61.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -55.94 115.87 2.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.46 1.104 . . . . 0.0 111.407 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.34 -119.72 2.7 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.953 1.739 . . . . 0.0 110.887 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.21 143.79 27.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -142.13 162.78 34.6 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.249 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -142.1 146.84 35.84 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.976 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.433 HD22 ' HB3' ' B' ' 118' ' ' ASN . 6.4 t-20 -107.08 146.25 31.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.15 0.98 . . . . 0.0 110.386 -174.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.8 -27.77 52.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.862 1.265 . . . . 0.0 114.329 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.445 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.0 tp -72.14 -14.58 61.86 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.759 1.624 . . . . 0.0 113.225 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.03 -12.28 24.47 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.257 2.36 . . . . 0.0 114.077 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.53 153.58 41.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.154 1.477 . . . . 0.0 113.74 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.8 134.05 52.9 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 174.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -128.06 145.21 51.07 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.544 -0.722 . . . . 0.0 112.408 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -133.33 133.28 42.32 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.43 0.692 . . . . 0.0 109.673 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -132.87 122.18 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.65 -58.85 7.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.226 0.954 . . . . 0.0 112.378 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.64 153.55 4.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.121 1.368 . . . . 0.0 110.626 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.52 131.4 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 124.492 1.12 . . . . 0.0 111.371 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -75.52 168.79 19.34 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -55.61 -27.89 52.13 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -81.83 -35.55 29.3 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.059 0.845 . . . . 0.0 110.44 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 -6.33 9.27 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 117.22 -1.878 . . . . 0.0 114.663 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.514 ' HB2' HD21 ' C' ' 50' ' ' LEU . 1.4 pt-20 -67.07 141.57 57.45 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.48 1.64 . . . . 0.0 108.461 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.22 151.13 22.63 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.95 165.19 12.07 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.15 -164.93 31.14 Favored Glycine 0 C--O 1.237 0.33 0 O-C-N 120.547 -1.346 . . . . 0.0 111.568 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -141.45 142.76 33.64 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.287 1.041 . . . . 0.0 113.011 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -117.58 125.26 50.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.229 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.687 HD11 HD12 ' B' ' 46' ' ' LEU . 2.8 mp -116.09 125.93 73.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 30.6 m -106.34 144.98 32.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.88 -13.42 16.96 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.8 146.8 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.182 1.393 . . . . 0.0 112.113 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.66 161.42 42.17 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.301 -1.499 . . . . 0.0 113.264 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.85 -21.52 61.66 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.31 83.05 7.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.858 2.463 . . . . 0.0 110.084 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.8 29.15 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 124.645 3.563 . . . . 0.0 115.895 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.88 -5.49 52.38 Favored Glycine 0 N--CA 1.478 1.434 0 N-CA-C 118.194 2.038 . . . . 0.0 118.194 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.92 2.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.163 1.482 . . . . 0.0 114.148 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -21.27 111.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.15 167.63 16.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.334 2.254 . . . . 0.0 108.181 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.687 HD12 HD11 ' B' ' 34' ' ' ILE . 6.9 tt -53.78 138.54 35.46 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.398 1.479 . . . . 0.0 112.846 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -115.55 121.82 33.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.056 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.42 144.75 90.89 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.426 2.751 . . . . 0.0 111.455 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.47 154.36 48.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.148 0.979 . . . . 0.0 111.287 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -156.87 148.79 22.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.066 1.746 . . . . 0.0 109.944 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.19 -153.5 24.05 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 121.933 2.151 . . . . 0.0 111.66 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -142.39 142.43 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 143.45 50.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.192 0.597 . . . . 0.0 111.694 173.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -78.48 152.87 31.82 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.424 1.107 . . . . 0.0 109.549 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -147.29 25.45 1.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.568 1.547 . . . . 0.0 111.68 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -93.46 -49.21 6.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.985 2.114 . . . . 0.0 112.078 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 178.32 8.12 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.3 p -75.47 -43.06 51.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.042 1.737 . . . . 0.0 113.635 174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.2 54.21 13.37 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.25 1.42 . . . . 0.0 112.192 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -67.43 171.82 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.035 1.824 . . . . 0.0 115.79 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 174.58 7.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.129 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.77 164.61 16.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.529 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.4 147.8 12.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.43 154.75 16.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -88.38 150.72 23.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.22 1.808 . . . . 0.0 110.528 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.58 116.92 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.465 ' HB2' HG21 ' C' ' 52' ' ' ILE . 29.2 t30 -99.32 110.14 22.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.748 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -76.79 136.77 38.99 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.76 -37.93 12.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.667 -174.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -87.28 -15.11 39.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 21.8 t -152.58 122.66 7.07 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.42 1.888 . . . . 0.0 107.309 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.85 118.53 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.932 1.242 . . . . 0.0 110.078 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -174.92 168.98 3.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.19 1.796 . . . . 0.0 110.542 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.79 145.47 28.79 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.243 1.497 . . . . 0.0 111.181 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.1 m -137.31 130.21 30.46 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 110.095 -3.23 . . . . 0.0 108.588 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 m -113.47 140.84 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.892 0.745 . . . . 0.0 109.68 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -115.04 147.29 40.33 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 123.463 0.477 . . . . 0.0 110.452 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 117.99 10.21 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.55 -173.16 30.91 Favored Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 119.728 -1.225 . . . . 0.0 115.645 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.566 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.1 OUTLIER -124.77 149.92 46.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.579 1.18 . . . . 0.0 112.895 -175.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.44 112.66 24.4 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 111.358 -2.656 . . . . 0.0 105.488 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' C' ' 106' ' ' ILE . 11.5 m-85 -110.71 155.78 21.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 119.265 0.939 . . . . 0.0 112.666 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.34 117.99 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.95 162.79 10.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.195 0.998 . . . . 0.0 110.578 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -42.7 -44.85 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.595 1.558 . . . . 0.0 114.795 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -24.34 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.787 1.235 . . . . 0.0 113.541 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.46 5.45 26.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.446 1.498 . . . . 0.0 115.094 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -72.57 162.22 29.77 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 119.274 1.537 . . . . 0.0 110.809 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.45 142.51 51.26 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.527 1.531 . . . . 0.0 112.162 -173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' C' ' 106' ' ' ILE . 2.2 t -145.11 159.26 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 125.355 1.462 . . . . 0.0 110.701 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.4 107.18 11.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.506 ' CD ' HG11 ' B' ' 92' ' ' VAL . 3.8 mmtt -99.78 124.5 45.12 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 172.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.5 p -139.71 168.49 19.69 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.637 1.684 . . . . 0.0 113.662 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.563 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -118.85 163.18 17.27 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -136.96 162.83 32.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 0.0 111.647 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.19 121.06 9.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 138.33 44.18 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 125.198 1.561 . . . . 0.0 113.138 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.69 113.89 21.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.357 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.273 49.4 m -73.49 168.08 19.99 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.886 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.3 p -110.24 84.34 1.91 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.28 -167.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -127.2 -26.45 3.09 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.042 -1.036 . . . . 0.0 112.9 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.11 145.93 40.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 123.252 1.501 . . . . 0.0 112.521 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' C' ' 84' ' ' PHE . 19.3 tt -62.13 -23.77 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.851 175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.78 0.14 62.45 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 117.543 -1.698 . . . . 0.0 114.075 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 1.0 OUTLIER -117.55 1.07 12.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.808 1.304 . . . . 0.0 114.104 -178.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' B' ' 112' ' ' ALA . 9.7 t70 -59.59 -27.87 66.66 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 119.562 -1.961 . . . . 0.0 112.278 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.45 ' CD1' HD11 ' D' ' 14' ' ' LEU . 46.4 p-90 -46.38 -49.18 18.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.275 1.03 . . . . 0.0 113.157 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -88.86 -12.69 41.13 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.783 0.833 . . . . 0.0 112.367 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' B' ' 109' ' ' ASP . . . -75.26 -1.7 24.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.815 0.446 . . . . 0.0 111.577 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.771 ' CG2' HD21 ' B' ' 98' ' ' LEU . 1.9 m -109.13 137.7 46.62 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.614 0.765 . . . . 0.0 113.042 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.532 ' HG3' HH11 ' B' ' 114' ' ' ARG . 19.5 mtt85 -140.69 130.21 24.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.633 1.173 . . . . 0.0 110.676 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.88 158.88 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.044 1.293 . . . . 0.0 111.236 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.73 -177.33 36.47 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 14.4 p90 -126.87 156.03 42.03 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.819 -0.812 . . . . 0.0 111.937 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ASN . . . . . 0.433 ' HB3' HD22 ' B' ' 12' ' ' ASN . 14.1 m-20 -148.46 155.34 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.554 1.168 . . . . 0.0 110.856 174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.438 HD13 ' HE3' ' B' ' 94' ' ' LYS . 10.5 mt -138.26 119.83 17.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.21 152.52 27.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.467 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 21.5 p -139.13 164.2 30.41 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.57 128.99 31.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.291 1.036 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.093 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 83' ' ' CYS . 0.1 OUTLIER -116.39 123.74 48.32 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -176.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -143.22 137.9 29.29 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.245 -1.535 . . . . 0.0 113.564 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.43 -18.95 61.08 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -56.29 115.91 2.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.387 1.075 . . . . 0.0 111.615 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.53 -119.63 2.5 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.838 1.685 . . . . 0.0 111.139 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 142.27 24.8 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -140.87 162.8 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.785 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -142.83 145.13 32.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.635 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' C' ' 118' ' ' ASN . 6.6 t-20 -105.89 146.97 29.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.186 0.995 . . . . 0.0 110.582 -174.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.18 -26.48 64.83 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 110' ' ' TRP . 30.3 tp -71.44 -14.63 62.21 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.697 1.599 . . . . 0.0 112.983 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.69 -13.23 22.7 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.071 2.272 . . . . 0.0 113.99 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 154.3 37.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.958 1.379 . . . . 0.0 113.835 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 136.59 53.22 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -130.27 145.37 51.75 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.561 -0.712 . . . . 0.0 112.004 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -134.29 132.46 39.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.259 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.22 120.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.46 -56.9 12.85 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.535 1.147 . . . . 0.0 112.658 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.53 155.63 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.494 1.518 . . . . 0.0 110.648 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.41 129.72 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.611 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -75.18 167.93 20.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -56.38 -27.06 55.1 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -79.53 -33.77 41.7 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.083 0.856 . . . . 0.0 110.647 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.09 9.53 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 124.123 0.868 . . . . 0.0 114.373 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.02 149.96 46.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.218 1.407 . . . . 0.0 113.019 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PHE . . . . . 0.477 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.2 p90 -160.22 166.05 30.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.55 0.74 . . . . 0.0 110.84 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.8 p -125.57 162.34 25.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.99 -165.55 29.32 Favored Glycine 0 N--CA 1.464 0.542 0 O-C-N 119.955 -1.716 . . . . 0.0 111.986 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.9 p -140.37 140.74 35.59 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.522 1.153 . . . . 0.0 113.116 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -118.63 124.87 48.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.906 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.694 HD11 HD12 ' C' ' 46' ' ' LEU . 2.9 mp -114.98 127.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 45.0 m -108.3 145.67 34.06 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.39 -11.6 17.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.91 146.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.102 1.361 . . . . 0.0 111.918 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.38 161.24 42.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.498 -1.376 . . . . 0.0 113.355 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.42 -22.54 61.84 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.603 0.361 . . . . 0.0 110.589 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -147.69 83.57 7.46 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.767 2.427 . . . . 0.0 110.111 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.82 28.27 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 124.548 3.499 . . . . 0.0 115.895 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.75 48.92 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.9 2.3 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.071 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 60.8 mt -22.0 112.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.46 168.21 16.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.449 2.3 . . . . 0.0 108.131 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.694 HD12 HD11 ' C' ' 34' ' ' ILE . 6.8 tt -53.96 139.1 35.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.463 1.505 . . . . 0.0 112.724 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -116.39 121.16 33.79 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.195 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.15 143.18 93.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.391 2.727 . . . . 0.0 111.56 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.454 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -132.43 161.71 32.99 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.912 0.885 . . . . 0.0 111.694 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 28' ' ' GLU . 12.0 tp -166.56 148.73 6.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.131 1.373 . . . . 0.0 111.87 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.39 -153.04 23.73 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 121.563 1.983 . . . . 0.0 111.986 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -142.73 142.38 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 112.554 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.05 144.91 51.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.005 1.322 . . . . 0.0 111.01 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.72 151.13 29.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.771 0.796 . . . . 0.0 109.393 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -143.99 23.95 1.68 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.381 1.472 . . . . 0.0 111.686 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.36 -50.35 5.5 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.894 2.078 . . . . 0.0 111.84 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.36 178.18 7.88 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.822 0.701 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 13.5 p -75.14 -42.48 56.14 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.751 1.62 . . . . 0.0 113.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -132.37 53.54 11.45 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -66.55 172.42 9.26 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 121.804 1.669 . . . . 0.0 115.716 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 174.52 7.12 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.138 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.73 164.24 16.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.558 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.8 147.58 12.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 118.151 2.02 . . . . 0.0 118.151 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -163.52 154.22 16.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.67 152.73 21.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.372 1.869 . . . . 0.0 110.136 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.67 116.84 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.437 ' HB2' HG21 ' B' ' 52' ' ' ILE . 26.0 t30 -100.26 109.55 21.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.426 -173.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -76.23 138.66 40.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -37.69 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -87.31 -15.49 37.85 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.7 t -152.5 122.41 7.01 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.377 1.871 . . . . 0.0 107.236 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -58.32 118.57 5.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.002 1.274 . . . . 0.0 110.274 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 70.3 p -175.42 168.59 3.25 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.101 1.76 . . . . 0.0 110.553 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.2 t -147.84 146.01 28.94 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-O 123.489 1.614 . . . . 0.0 111.028 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.36 130.15 30.25 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 109.872 -3.331 . . . . 0.0 108.79 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -112.51 142.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -115.5 148.07 39.92 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.885 0.74 . . . . 0.0 110.597 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 117.91 9.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.64 -172.72 30.46 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.547 -1.311 . . . . 0.0 115.687 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.565 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.1 OUTLIER -125.86 149.64 48.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.606 1.193 . . . . 0.0 113.028 -174.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 4' ' ' CYS . 0.5 OUTLIER -97.38 112.55 24.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.409 -2.632 . . . . 0.0 105.437 -175.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.7 m-85 -110.67 154.43 23.84 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.283 0.947 . . . . 0.0 112.72 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.84 115.34 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.99 162.09 11.96 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.806 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -42.82 -41.86 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.015 1.726 . . . . 0.0 115.577 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.35 -3.24 42.09 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.92 5.2 64.48 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.603 1.573 . . . . 0.0 115.19 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -71.72 162.27 29.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 1.242 . . . . 0.0 110.195 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -123.34 141.46 51.96 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.658 1.583 . . . . 0.0 111.235 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' B' ' 106' ' ' ILE . 2.4 t -143.15 159.44 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 125.368 1.467 . . . . 0.0 110.867 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.23 107.79 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 172.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' C' ' 92' ' ' VAL . 3.7 mmtt -100.56 123.97 45.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -138.92 168.1 20.58 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 123.645 1.688 . . . . 0.0 113.866 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.551 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.79 16.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.135 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -136.97 162.87 32.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.395 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -146.27 121.19 9.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.683 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.13 44.51 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 125.216 1.572 . . . . 0.0 113.044 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -119.78 113.93 21.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 111.372 -2.649 . . . . 0.0 111.12 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.279 50.2 m -73.49 168.1 19.95 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 125.365 1.666 . . . . 0.0 111.664 174.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.59 86.78 2.38 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.75 -165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -130.0 -25.42 2.52 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.947 -1.095 . . . . 0.0 113.251 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.03 147.16 39.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.366 1.555 . . . . 0.0 112.259 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 84' ' ' PHE . 18.8 tt -62.93 -23.25 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.892 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.61 60.17 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.767 -1.574 . . . . 0.0 114.075 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' ASP . . . . . 0.44 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.5 OUTLIER -118.8 0.95 11.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.738 1.269 . . . . 0.0 113.833 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 109' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' C' ' 112' ' ' ALA . 9.0 t70 -59.4 -27.91 66.42 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.629 -1.92 . . . . 0.0 112.368 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.446 ' CD1' HD11 ' A' ' 14' ' ' LEU . 46.1 p-90 -46.1 -49.13 16.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.229 1.012 . . . . 0.0 113.379 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -89.06 -12.32 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.607 0.763 . . . . 0.0 112.67 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' C' ' 109' ' ' ASP . . . -75.57 -2.09 27.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.693 0.397 . . . . 0.0 111.409 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' C' ' 98' ' ' LEU . 2.0 m -108.55 138.71 44.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.55 0.74 . . . . 0.0 112.742 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.504 HH11 ' HG3' ' C' ' 114' ' ' ARG . 19.4 mtt85 -141.25 130.55 23.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.943 1.297 . . . . 0.0 110.831 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.17 158.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.272 . . . . 0.0 111.213 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.06 -177.45 36.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 13.4 p90 -126.68 155.82 42.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.851 -0.793 . . . . 0.0 111.861 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 118' ' ' ASN . . . . . 0.448 ' HB3' HD22 ' C' ' 12' ' ' ASN . 13.9 m-20 -148.47 154.58 40.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.386 1.089 . . . . 0.0 111.089 174.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' ILE . . . . . 0.444 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.0 mt -137.17 120.97 22.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.21 152.62 28.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.943 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.5 p -138.44 163.04 32.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.72 135.01 36.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.312 0.645 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 123.06 1.41 . . . . 0.0 111.186 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.28 150.09 38.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.367 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 p -139.33 127.44 22.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.205 1.002 . . . . 0.0 112.311 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD21 ' CE2' ' A' ' 64' ' ' PHE . 73.9 mt -69.24 -34.44 74.83 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -47.57 110.97 0.36 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.021 1.328 . . . . 0.0 111.077 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.38 -130.17 4.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 125.312 1.434 . . . . 0.0 109.584 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -146.14 144.87 30.24 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.073 0.949 . . . . 0.0 112.721 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -136.64 162.9 31.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.188 1.395 . . . . 0.0 111.391 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -140.62 150.95 44.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.11 0.964 . . . . 0.0 109.567 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.66 143.54 47.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.385 1.074 . . . . 0.0 110.348 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -60.52 -22.16 63.28 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.45 1.5 . . . . 0.0 113.338 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -72.52 -15.61 61.78 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.629 1.172 . . . . 0.0 111.094 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.76 -16.43 18.73 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.639 3.019 . . . . 0.0 113.395 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.42 148.87 40.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.065 1.412 . . . . 0.0 112.955 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -123.46 136.52 54.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.779 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -127.46 143.26 51.22 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.535 0.684 . . . . 0.0 112.154 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -131.34 130.98 43.39 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.979 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.59 126.03 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.52 -85.55 0.13 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.48 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.03 145.79 30.73 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.86 0.838 . . . . 0.0 111.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' A' ' 53' ' ' GLN . 11.2 p -100.17 129.65 50.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.16 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -75.65 168.96 19.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.995 0.902 . . . . 0.0 112.386 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -58.7 -26.34 63.77 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.89 -40.65 75.53 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.374 -0.829 . . . . 0.0 110.822 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.05 -7.34 12.89 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 117.558 -1.69 . . . . 0.0 112.694 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HB2' HD21 ' D' ' 50' ' ' LEU . 4.7 pt-20 -67.18 146.69 53.96 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.693 1.597 . . . . 0.0 107.469 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.79 166.05 34.67 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.229 175.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 p -124.75 177.76 5.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.8 -167.51 39.76 Favored Glycine 0 CA--C 1.521 0.439 0 O-C-N 120.372 -1.455 . . . . 0.0 112.262 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' HD11 ' A' ' 46' ' ' LEU . 49.4 p -139.8 137.73 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.93 1.347 . . . . 0.0 111.947 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -111.46 138.77 47.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.161 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 46' ' ' LEU . 27.5 mt -130.01 128.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 174.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 44' ' ' ILE . 49.6 m -105.15 144.09 32.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -172.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.6 -13.25 17.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.79 143.15 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.352 1.061 . . . . 0.0 112.715 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.49 43.84 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.407 -0.808 . . . . 0.0 111.74 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.77 -28.52 64.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.765 -0.584 . . . . 0.0 109.499 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -140.64 75.35 26.21 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.966 2.507 . . . . 0.0 110.836 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.14 61.06 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.365 1 C-N-CA 125.627 4.218 . . . . 0.0 115.028 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.44 13.41 39.56 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 120.163 -1.586 . . . . 0.0 116.795 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -172.32 -29.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.037 1.335 . . . . 0.0 113.298 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 35' ' ' THR 0.322 47.6 mt 4.48 91.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.449 2.3 . . . . 0.0 116.533 -172.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 159.13 18.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 111.563 -2.562 . . . . 0.0 109.337 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.525 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.2 tt -46.74 126.82 9.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.848 2.059 . . . . 0.0 113.131 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.8 p -103.8 120.25 51.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 122.966 0.506 . . . . 0.0 111.898 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 144.01 84.62 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.327 2.684 . . . . 0.0 112.872 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.38 154.67 44.71 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.916 0.886 . . . . 0.0 112.418 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -159.75 149.21 18.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.794 2.038 . . . . 0.0 110.112 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.8 -147.69 16.44 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 121.583 1.992 . . . . 0.0 109.961 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -145.74 141.06 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.688 0.795 . . . . 0.0 112.707 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.93 139.96 52.68 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.794 -1.191 . . . . 0.0 113.147 174.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -76.97 158.09 30.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.049 -1.657 . . . . 0.0 113.638 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -158.48 21.63 0.23 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.432 1.493 . . . . 0.0 112.51 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -87.23 -54.62 4.21 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.516 1.126 . . . . 0.0 109.999 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.33 173.11 10.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.748 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.38 -34.74 31.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.786 0.834 . . . . 0.0 112.504 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.22 47.6 2.86 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.993 1.317 . . . . 0.0 112.065 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.9 176.07 10.36 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.16 2.573 . . . . 0.0 115.341 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.329 0.0 OUTLIER -100.13 171.07 8.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 123.21 1.481 . . . . 0.0 112.194 173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' A' ' 6' ' ' LEU . 1.2 p90 -160.64 167.25 27.38 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.401 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.66 144.99 9.52 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 118.482 2.153 . . . . 0.0 118.482 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.25 158.57 30.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -95.35 152.41 18.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.583 1.553 . . . . 0.0 108.823 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.67 118.84 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' D' ' 52' ' ' ILE . 0.2 OUTLIER -92.83 116.21 28.82 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -177.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.314 46.2 m95 -80.49 134.64 35.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.413 1.577 . . . . 0.0 114.431 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -89.56 -40.63 12.5 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -88.78 -15.87 33.55 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -151.43 130.29 12.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 129.389 3.076 . . . . 0.0 106.102 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -68.67 118.62 11.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.032 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -173.85 161.76 3.84 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 127.342 2.257 . . . . 0.0 108.802 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 140.15 30.94 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 123.105 1.431 . . . . 0.0 111.151 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.8 m -139.08 129.29 25.39 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 110.34 -3.118 . . . . 0.0 110.555 -171.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -106.88 154.84 7.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.039 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.76 142.36 51.33 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.68 121.23 9.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.16 176.15 42.15 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 118.799 -1.667 . . . . 0.0 116.866 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -112.33 149.95 31.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.831 1.301 . . . . 0.0 112.929 -174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 19.6 t -97.18 130.37 44.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.806 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' D' ' 106' ' ' ILE . 3.8 m-85 -119.75 166.03 13.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.94 0.876 . . . . 0.0 111.749 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mt -128.77 109.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -59.57 159.65 8.11 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -28.45 -51.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -11.39 60.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.205 1.802 . . . . 0.0 115.706 -174.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.07 51.77 3.27 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 120.383 1.447 . . . . 0.0 110.235 -173.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.21 136.64 53.07 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.521 2.328 . . . . 0.0 107.755 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -101.34 144.09 30.59 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.628 1.171 . . . . 0.0 109.974 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.2 m -147.9 162.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.652 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.1 116.87 25.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.5 mmtt -104.92 120.51 41.62 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 p -137.25 166.91 22.64 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 123.358 1.551 . . . . 0.0 113.723 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.425 ' HG3' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -117.25 165.9 12.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 172.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -141.1 159.6 41.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.238 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.9 tt -144.42 126.17 15.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.913 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.18 143.64 40.0 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 125.379 1.674 . . . . 0.0 112.381 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.69 114.34 17.87 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 111.416 -2.629 . . . . 0.0 111.736 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.252 44.6 m -67.12 175.45 2.59 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 125.635 1.834 . . . . 0.0 113.083 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.4 p -117.93 67.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 107.948 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.63 167.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 120.921 -1.112 . . . . 0.0 111.709 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -102.78 -32.35 9.86 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -109.03 148.77 30.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.82 1.295 . . . . 0.0 111.407 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.806 HD11 ' HE2' ' D' ' 94' ' ' LYS . 15.0 tt -63.32 -30.78 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 113.426 -1.716 . . . . 0.0 109.979 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.88 5.75 3.32 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.801 -1.555 . . . . 0.0 113.726 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -121.41 1.92 10.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.809 1.305 . . . . 0.0 113.69 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -33.48 75.38 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.402 -0.811 . . . . 0.0 111.713 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.418 ' CD1' HD11 ' C' ' 14' ' ' LEU . 58.1 p-90 -46.88 -40.99 15.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -99.34 -6.72 27.38 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.359 1.063 . . . . 0.0 113.463 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.95 0.32 21.51 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.798 ' CG2' HD21 ' A' ' 98' ' ' LEU . 5.9 m -110.36 138.44 46.74 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.74 0.816 . . . . 0.0 112.072 176.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -140.59 124.79 17.55 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 125.184 1.394 . . . . 0.0 110.723 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.56 158.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.13 1.372 . . . . 0.0 111.317 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.02 -178.46 37.59 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.027 0.822 . . . . 0.0 113.326 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -124.98 156.74 37.6 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.755 -0.85 . . . . 0.0 111.705 175.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -147.7 157.91 43.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.416 1.103 . . . . 0.0 109.664 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.2 mt -133.37 138.36 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -125.72 149.14 48.75 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.285 1.041 . . . . 0.0 111.264 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 p -133.05 161.09 35.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.661 1.184 . . . . 0.0 110.352 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.09 113.16 2.96 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.614 0.765 . . . . 0.0 112.233 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt . . . . . 0 N--CA 1.462 0.14 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 173.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.3 144.84 43.71 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.255 1.022 . . . . 0.0 109.62 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -139.7 127.85 22.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' D' ' 64' ' ' PHE . 80.5 mt -69.8 -33.01 71.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -48.83 113.46 0.79 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.511 1.124 . . . . 0.0 110.531 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.3 -132.5 5.85 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -147.23 143.67 28.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -136.09 162.55 32.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.221 1.408 . . . . 0.0 111.96 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.43 ' HB ' HD12 ' D' ' 123' ' ' LEU . 8.9 t -137.7 151.79 48.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.229 1.012 . . . . 0.0 109.231 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -119.89 143.79 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.232 1.013 . . . . 0.0 110.681 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -58.41 -25.31 62.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.462 1.505 . . . . 0.0 113.66 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' B' ' 110' ' ' TRP . 28.5 tp -70.25 -15.47 62.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.588 1.155 . . . . 0.0 111.711 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.23 -12.21 28.73 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 128.238 2.828 . . . . 0.0 113.515 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.65 149.65 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.265 1.507 . . . . 0.0 113.33 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -125.53 137.37 53.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.921 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -128.14 144.36 51.11 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -131.66 131.17 42.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.206 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 80.8 mt -131.13 124.52 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -86.42 0.08 OUTLIER Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.208 0.943 . . . . 0.0 111.733 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.24 145.28 31.22 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.803 -0.822 . . . . 0.0 110.676 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' D' ' 53' ' ' GLN . 11.3 p -99.72 130.37 48.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.053 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.99 166.7 23.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 112.382 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -26.02 63.98 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -67.89 -39.25 83.69 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.273 -0.892 . . . . 0.0 111.129 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.53 -6.55 11.53 Favored Glycine 0 C--O 1.221 -0.698 0 C-N-CA 124.728 1.156 . . . . 0.0 113.402 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.89 152.99 43.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.151 1.781 . . . . 0.0 112.258 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.38 30.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.252 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p -123.53 -177.13 3.63 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.71 -167.13 40.16 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 119.41 -2.056 . . . . 0.0 112.622 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' D' ' 46' ' ' LEU . 52.1 p -139.55 137.68 35.63 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.56 0.695 . . . . 0.0 112.346 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -112.83 138.71 49.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.377 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.437 HD11 HD12 ' D' ' 46' ' ' LEU . 31.2 mt -130.72 128.42 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.408 ' O ' HG21 ' D' ' 44' ' ' ILE . 54.6 m -105.74 144.82 31.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.1 -13.62 17.42 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.73 142.76 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.245 1.018 . . . . 0.0 112.607 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.55 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.153 -0.967 . . . . 0.0 111.474 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -70.5 -29.15 65.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.15 75.3 29.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 127.893 2.477 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.12 61.25 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.358 1 C-N-CA 125.629 4.22 . . . . 0.0 115.13 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.61 13.58 38.96 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 120.099 -1.626 . . . . 0.0 116.844 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -172.51 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.158 1.383 . . . . 0.0 113.401 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.408 HG21 ' O ' ' D' ' 35' ' ' THR 0.321 49.2 mt 4.55 91.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.627 2.371 . . . . 0.0 116.365 -172.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.58 159.31 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.584 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.1 tt -46.82 126.15 8.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.674 1.99 . . . . 0.0 112.88 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.03 120.53 52.02 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.158 0.583 . . . . 0.0 111.634 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.06 143.78 82.18 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.166 2.577 . . . . 0.0 112.438 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' LEU . . . . . 0.498 HD12 ' C ' ' D' ' 49' ' ' LEU . 0.6 OUTLIER -127.75 160.33 32.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.953 0.901 . . . . 0.0 112.598 177.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 28' ' ' GLU . 15.3 tp -169.01 149.01 4.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 0.0 112.642 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 -144.1 10.45 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 121.091 1.769 . . . . 0.0 109.774 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.709 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.9 mt -147.53 139.37 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.769 0.827 . . . . 0.0 111.592 -175.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -125.36 138.45 54.05 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.163 1.385 . . . . 0.0 112.612 175.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -76.7 157.52 31.69 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 119.9 -1.75 . . . . 0.0 113.172 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -156.96 19.39 0.31 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 0.0 112.5 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -84.96 -54.11 4.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.766 1.227 . . . . 0.0 110.085 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 172.67 11.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.911 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -31.77 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.28 1.032 . . . . 0.0 113.378 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -130.17 50.58 6.18 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 125.118 1.367 . . . . 0.0 112.589 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.24 175.96 10.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.989 2.46 . . . . 0.0 116.274 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.335 0.0 OUTLIER -100.82 170.17 8.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.104 1.431 . . . . 0.0 111.808 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 64' ' ' PHE . . . . . 0.482 ' CE2' HD21 ' D' ' 6' ' ' LEU . 1.4 p90 -161.01 167.29 26.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.82 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.32 145.43 10.0 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 118.431 2.133 . . . . 0.0 118.431 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.88 158.69 28.68 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -95.02 152.42 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.569 1.948 . . . . 0.0 108.472 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.58 117.78 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.7 ' HB2' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -92.85 117.21 29.78 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.407 -0.808 . . . . 0.0 109.927 -177.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.3 46.3 m95 -80.46 137.39 36.47 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.543 1.64 . . . . 0.0 114.246 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -92.67 -39.45 11.28 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.3 -14.94 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -152.27 131.59 12.85 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 129.319 3.048 . . . . 0.0 106.241 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.4 118.64 12.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 10.8 m -173.53 161.82 4.09 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 127.222 2.209 . . . . 0.0 108.978 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.8 t -143.28 140.31 30.56 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.114 1.435 . . . . 0.0 110.842 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.05 128.79 24.74 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 110.509 -3.041 . . . . 0.0 110.451 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.12 154.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.038 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -127.64 141.8 51.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.1 121.69 10.44 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.78 174.46 42.15 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 118.748 -1.691 . . . . 0.0 116.786 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.51 146.65 38.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.021 1.071 . . . . 0.0 111.967 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 48.9 t -97.62 134.23 41.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.138 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' A' ' 106' ' ' ILE . 5.5 m-85 -122.31 164.93 17.05 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.203 1.001 . . . . 0.0 111.366 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.98 105.33 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -63.38 154.22 32.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -22.42 -51.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.072 2.549 . . . . 0.0 117.39 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -76.08 -7.2 54.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.253 1.821 . . . . 0.0 115.784 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.38 51.38 3.52 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.925 0.784 . . . . 0.0 111.231 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 135.96 54.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 108.784 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.29 144.6 29.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.17 0.986 . . . . 0.0 109.572 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 106' ' ' ILE . 25.1 m -148.51 159.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.818 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mt -117.72 117.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.806 ' HE2' HD11 ' A' ' 106' ' ' ILE . 4.0 mmtt -105.47 119.06 38.14 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -136.95 167.09 22.16 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.258 1.504 . . . . 0.0 113.639 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.421 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -117.13 166.51 12.15 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -141.58 160.09 40.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.101 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.9 tt -144.83 126.6 15.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.771 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.03 144.45 38.59 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 125.51 1.756 . . . . 0.0 112.082 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -127.45 114.36 17.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.677 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 42.5 m -67.01 175.33 2.58 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 125.803 1.939 . . . . 0.0 113.0 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.9 p -117.74 66.64 0.75 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.11 1.364 . . . . 0.0 108.251 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.69 167.47 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.988 -1.07 . . . . 0.0 111.999 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -101.52 -32.26 10.48 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.0 149.89 31.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 122.709 1.242 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.775 HD11 ' HE2' ' A' ' 94' ' ' LYS . 15.2 tt -62.96 -29.01 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.21 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.51 6.13 4.88 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.501 1.048 . . . . 0.0 113.586 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -122.2 2.26 9.77 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.509 1.155 . . . . 0.0 113.712 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.74 -34.02 76.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.312 -0.868 . . . . 0.0 112.14 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.2 p-90 -46.19 -41.43 12.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.28 1.032 . . . . 0.0 113.728 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -99.48 -6.79 26.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.215 1.006 . . . . 0.0 113.365 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.65 -0.21 22.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.776 ' CG2' HD21 ' D' ' 98' ' ' LEU . 5.7 m -109.33 138.8 45.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.477 0.711 . . . . 0.0 111.792 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -140.76 124.79 17.31 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 125.56 1.544 . . . . 0.0 111.247 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.6 158.89 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.08 1.352 . . . . 0.0 111.166 176.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.17 -179.53 38.43 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.939 0.781 . . . . 0.0 113.441 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 0.0 OUTLIER -123.77 156.37 36.19 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.759 -0.848 . . . . 0.0 111.571 176.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -147.72 157.36 43.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.09 0.948 . . . . 0.0 109.855 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.58 136.65 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -124.45 151.25 44.77 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 18.7 p -134.65 160.81 36.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.746 1.218 . . . . 0.0 110.186 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 129.43 41.36 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.53 -0.731 . . . . 0.0 110.855 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 123' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.306 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.23 142.01 50.89 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 109.478 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -139.66 127.88 22.55 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' B' ' 64' ' ' PHE . 84.5 mt -69.23 -31.53 70.16 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -48.96 113.25 0.75 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.332 1.053 . . . . 0.0 111.028 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.32 -131.11 5.24 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.63 1.586 . . . . 0.0 109.452 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -146.38 143.21 28.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.46 1.104 . . . . 0.0 113.293 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' TRP . . . . . 0.421 ' CH2' HD21 ' B' ' 93' ' ' LEU . 45.3 m95 -135.56 162.75 31.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.297 1.439 . . . . 0.0 111.737 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -141.27 150.55 42.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.97 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -122.12 143.78 49.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.389 1.076 . . . . 0.0 111.025 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -58.88 -25.34 63.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.608 1.563 . . . . 0.0 113.458 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' D' ' 110' ' ' TRP . 28.9 tp -70.68 -15.63 62.73 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.371 1.081 . . . . 0.0 111.619 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.32 -13.98 23.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 128.415 2.912 . . . . 0.0 113.47 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 148.57 44.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 123.113 1.435 . . . . 0.0 113.252 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -122.7 136.08 54.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.671 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -131.05 131.19 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -130.2 124.39 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.32 -84.34 0.11 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.537 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.79 32.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.76 -0.847 . . . . 0.0 110.85 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.588 HG21 ' HG3' ' B' ' 53' ' ' GLN . 10.9 p -102.66 130.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.294 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -75.94 168.77 19.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.942 0.877 . . . . 0.0 112.207 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 81.5 p -58.59 -26.08 63.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -70.1 -40.58 74.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.324 -0.86 . . . . 0.0 110.981 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.85 -7.17 13.32 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.523 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' C' ' 50' ' ' LEU . 4.2 pt-20 -67.33 146.75 53.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.649 1.58 . . . . 0.0 107.416 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 166.22 34.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.108 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.6 p -125.39 176.85 6.51 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.66 -167.54 39.46 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 120.321 -1.487 . . . . 0.0 112.302 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.529 ' HB ' HD11 ' B' ' 46' ' ' LEU . 48.5 p -139.76 137.52 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.607 1.194 . . . . 0.0 112.016 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -110.88 139.0 46.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.23 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' B' ' 46' ' ' LEU . 27.5 mt -130.59 128.02 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.406 ' O ' HG21 ' B' ' 44' ' ' ILE . 42.7 m -105.21 144.25 32.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.64 -13.72 17.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.24 143.46 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.328 1.051 . . . . 0.0 112.701 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.03 43.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.424 -0.798 . . . . 0.0 111.464 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -71.21 -28.82 64.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.24 75.66 27.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.926 2.49 . . . . 0.0 111.038 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.22 61.86 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.409 1 C-N-CA 125.583 4.188 . . . . 0.0 115.02 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.97 13.56 37.74 Favored Glycine 0 N--CA 1.481 1.659 0 O-C-N 120.269 -1.519 . . . . 0.0 116.862 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -172.36 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.174 1.39 . . . . 0.0 113.297 -174.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.406 HG21 ' O ' ' B' ' 35' ' ' THR 0.324 50.3 mt 5.35 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.616 2.366 . . . . 0.0 116.323 -172.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.63 159.19 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 111.607 -2.542 . . . . 0.0 109.32 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.5 tt -46.84 127.97 10.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.768 2.027 . . . . 0.0 112.926 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -104.96 120.65 49.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.083 0.553 . . . . 0.0 111.846 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.33 144.38 82.72 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.034 2.489 . . . . 0.0 112.947 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.47 154.37 45.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 112.633 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -159.97 149.14 17.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.531 1.932 . . . . 0.0 109.949 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.72 -147.22 15.32 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 121.389 1.904 . . . . 0.0 109.879 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -145.67 141.0 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.523 0.729 . . . . 0.0 112.655 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.588 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -126.94 136.84 52.84 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.978 -1.076 . . . . 0.0 113.363 174.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -74.01 158.32 34.55 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.96 -1.713 . . . . 0.0 113.557 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -159.58 23.93 0.19 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.483 1.513 . . . . 0.0 111.855 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -90.37 -53.08 4.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.677 1.191 . . . . 0.0 110.331 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.44 174.28 9.13 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.65 1.219 . . . . 0.0 113.36 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.27 -29.69 22.9 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -129.34 49.52 4.78 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.681 1.192 . . . . 0.0 112.627 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.59 175.1 10.65 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.901 2.401 . . . . 0.0 116.169 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.33 0.0 OUTLIER -101.03 169.83 8.68 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 123.048 1.404 . . . . 0.0 111.97 173.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' B' ' 6' ' ' LEU . 1.1 p90 -160.66 167.5 26.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.543 -173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.71 144.44 9.09 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.96 158.66 31.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.8 m -94.87 152.22 18.57 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.753 1.621 . . . . 0.0 108.802 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.55 118.23 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' C' ' 52' ' ' ILE . 0.1 OUTLIER -92.71 116.53 29.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.733 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.299 46.1 m95 -80.22 136.59 36.5 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 123.465 1.603 . . . . 0.0 114.326 -173.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -91.54 -39.83 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -89.29 -15.42 33.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -151.43 130.23 12.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.202 3.001 . . . . 0.0 105.904 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.66 118.57 11.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.0 m -173.58 161.61 4.02 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 127.253 2.221 . . . . 0.0 109.082 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 140.4 30.48 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.033 1.397 . . . . 0.0 110.694 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.9 m -139.33 129.41 25.15 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 110.549 -3.023 . . . . 0.0 110.558 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.44 155.46 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.092 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -128.48 142.22 51.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.41 121.18 9.89 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.18 175.05 41.76 Favored Glycine 0 CA--C 1.504 -0.629 0 C-N-CA 118.708 -1.711 . . . . 0.0 116.627 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -112.85 144.56 42.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.79 1.281 . . . . 0.0 112.083 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 t -97.84 127.22 43.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.873 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' C' ' 106' ' ' ILE . 5.2 m-85 -115.31 166.8 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.33 1.052 . . . . 0.0 111.561 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 mt -127.41 108.13 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -62.33 156.76 21.46 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -26.77 -48.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.336 2.254 . . . . 0.0 116.854 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.59 -2.25 41.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 49.26 5.77 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.651 1.114 . . . . 0.0 112.118 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.31 136.94 54.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.873 1.669 . . . . 0.0 108.043 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -101.26 144.23 30.37 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.357 1.063 . . . . 0.0 109.607 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 21.5 m -148.01 159.93 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.006 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.421 HD21 ' CH2' ' B' ' 10' ' ' TRP . 9.1 mt -118.08 118.42 31.85 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.789 ' HE2' HD11 ' C' ' 106' ' ' ILE . 4.2 mmtt -107.09 118.08 35.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -136.0 166.65 22.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 123.488 1.613 . . . . 0.0 113.712 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.428 ' HG3' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -116.83 165.75 12.95 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 p-90 -141.13 160.23 40.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.276 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.9 tt -144.92 126.76 15.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.956 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.38 143.16 41.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 125.37 1.669 . . . . 0.0 112.3 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.08 114.23 18.13 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 111.176 -2.738 . . . . 0.0 111.713 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 43.5 m -67.2 175.24 2.73 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 125.778 1.924 . . . . 0.0 112.911 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -117.7 67.66 0.75 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.082 1.353 . . . . 0.0 108.041 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.43 168.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 121.027 -1.046 . . . . 0.0 111.804 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -103.51 -31.35 10.0 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.09 148.63 30.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.838 1.304 . . . . 0.0 111.669 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.79 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.8 tt -64.42 -29.48 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.653 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.53 5.25 5.78 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.276 0.941 . . . . 0.0 113.254 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.92 1.24 10.41 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.387 1.075 . . . . 0.0 113.639 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.12 -32.88 73.51 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.057 0.932 . . . . 0.0 112.435 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.3 p-90 -46.93 -41.45 16.08 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -98.86 -6.67 28.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.456 1.103 . . . . 0.0 113.419 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.91 0.09 22.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.799 ' CG2' HD21 ' B' ' 98' ' ' LEU . 5.3 m -109.35 138.41 45.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.596 0.758 . . . . 0.0 112.124 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.98 123.49 15.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.404 1.482 . . . . 0.0 111.433 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.48 158.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.834 1.254 . . . . 0.0 111.062 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.35 -178.21 37.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.86 0.743 . . . . 0.0 113.462 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 0.0 OUTLIER -125.14 156.31 38.55 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.781 -0.835 . . . . 0.0 111.797 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -147.45 155.3 41.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.136 0.97 . . . . 0.0 110.003 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.72 132.07 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -119.9 152.38 37.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.118 0.961 . . . . 0.0 110.821 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 160.38 37.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.447 1.099 . . . . 0.0 109.476 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 122.32 13.78 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.109 174.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 29.6 p -116.29 141.41 48.19 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.073 0.858 . . . . 0.0 108.865 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -139.64 127.69 22.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.994 -1.066 . . . . 0.0 113.07 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' C' ' 64' ' ' PHE . 84.0 mt -68.07 -31.7 71.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -48.27 113.85 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.964 1.306 . . . . 0.0 110.931 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -131.12 5.44 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 125.99 1.757 . . . . 0.0 109.111 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -145.47 146.97 31.69 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -136.59 162.65 32.54 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.993 1.317 . . . . 0.0 111.457 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -136.34 153.25 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.685 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -123.47 143.61 50.05 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.173 0.989 . . . . 0.0 111.093 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.9 -25.9 61.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.907 1.683 . . . . 0.0 113.353 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 110' ' ' TRP . 28.7 tp -71.25 -15.29 62.43 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.816 1.246 . . . . 0.0 111.788 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.27 -14.49 23.2 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 128.479 2.942 . . . . 0.0 113.513 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 149.4 42.61 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 123.14 1.448 . . . . 0.0 113.088 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -123.34 136.21 54.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.325 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -128.34 139.82 52.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m -127.73 131.63 49.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.688 0.795 . . . . 0.0 109.003 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.9 125.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.71 -85.85 0.09 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.615 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.05 33.84 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.726 -0.867 . . . . 0.0 110.909 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.608 HG21 ' HG3' ' C' ' 53' ' ' GLN . 11.0 p -103.83 129.05 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -74.51 166.23 23.87 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.972 0.891 . . . . 0.0 112.356 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -58.78 -25.9 63.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -67.91 -39.12 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.216 -0.927 . . . . 0.0 110.919 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.14 -6.34 12.03 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 124.782 1.182 . . . . 0.0 113.322 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.24 152.76 43.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.071 1.749 . . . . 0.0 112.15 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.38 166.49 30.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.884 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.406 HG22 HD13 ' C' ' 50' ' ' LEU . 21.6 p -123.37 -177.47 3.71 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.89 -166.87 39.84 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 119.322 -2.111 . . . . 0.0 112.703 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.512 ' HB ' HD11 ' C' ' 46' ' ' LEU . 59.0 p -139.69 136.89 34.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.257 1.027 . . . . 0.0 112.578 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -111.84 138.4 48.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.38 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.447 HD11 HD12 ' C' ' 46' ' ' LEU . 27.7 mt -130.42 127.62 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.405 ' O ' HG21 ' C' ' 44' ' ' ILE . 55.9 m -105.09 143.65 32.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.61 -13.08 18.72 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.8 143.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.179 0.992 . . . . 0.0 112.907 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.17 161.12 43.31 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.106 -0.996 . . . . 0.0 111.45 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -71.36 -28.81 64.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -140.09 75.38 29.26 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.914 2.486 . . . . 0.0 110.978 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.92 61.41 3.83 Favored 'Trans proline' 0 CA--C 1.551 1.373 1 C-N-CA 125.589 4.192 . . . . 0.0 115.134 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.7 13.56 38.65 Favored Glycine 0 N--CA 1.481 1.645 0 O-C-N 120.141 -1.599 . . . . 0.0 116.817 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -172.58 -29.43 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.21 1.404 . . . . 0.0 113.401 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.405 HG21 ' O ' ' C' ' 35' ' ' THR 0.325 48.8 mt 5.05 90.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.662 2.385 . . . . 0.0 116.33 -172.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.9 159.24 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.794 -2.457 . . . . 0.0 109.352 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.512 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.2 tt -46.76 128.02 10.32 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.624 1.97 . . . . 0.0 112.878 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -104.82 120.46 50.05 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.978 0.511 . . . . 0.0 111.682 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.89 143.0 83.57 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.949 2.432 . . . . 0.0 112.445 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.495 ' C ' HD12 ' C' ' 49' ' ' LEU . 0.6 OUTLIER -127.1 160.29 31.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.021 0.928 . . . . 0.0 112.78 177.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' B' ' 28' ' ' GLU . 14.9 tp -169.0 149.19 4.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.479 1.512 . . . . 0.0 112.466 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.26 -144.17 10.54 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 121.122 1.783 . . . . 0.0 109.765 -174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.722 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -147.99 139.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.745 -175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.608 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -125.77 138.94 53.88 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.613 1.165 . . . . 0.0 112.727 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -76.64 157.82 31.56 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.023 -1.673 . . . . 0.0 113.277 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -157.67 20.3 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.285 1.434 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -86.77 -53.73 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.926 1.29 . . . . 0.0 110.247 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.52 172.46 11.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.814 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.95 -29.31 25.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.857 0.863 . . . . 0.0 113.034 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -130.69 51.86 8.38 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 125.085 1.354 . . . . 0.0 112.726 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 175.72 10.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.935 2.423 . . . . 0.0 116.139 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.333 0.0 OUTLIER -100.77 170.78 8.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.202 1.477 . . . . 0.0 111.742 173.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' C' ' 6' ' ' LEU . 1.1 p90 -161.57 167.07 25.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.684 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.25 144.86 9.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -173.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.36 158.47 29.7 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -94.99 152.64 18.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.336 1.854 . . . . 0.0 108.718 173.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.85 117.8 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.702 ' HB2' HG21 ' B' ' 52' ' ' ILE . 0.1 OUTLIER -92.78 117.26 29.82 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.235 -0.916 . . . . 0.0 109.866 -177.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.301 46.4 m95 -80.63 137.55 36.36 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 123.456 1.598 . . . . 0.0 114.123 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -92.78 -39.79 11.03 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -89.13 -15.47 33.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -151.22 130.4 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 129.307 3.043 . . . . 0.0 106.299 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -69.03 118.55 12.08 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 10.7 m -174.0 161.37 3.67 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.238 2.215 . . . . 0.0 108.968 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -142.56 140.58 31.8 Favored 'General case' 0 CA--C 1.483 -1.635 0 CA-C-O 123.347 1.546 . . . . 0.0 111.057 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.9 m -139.15 129.97 26.21 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 110.339 -3.119 . . . . 0.0 110.21 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.15 154.84 7.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.974 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.37 142.34 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.49 121.0 9.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.94 41.17 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 118.708 -1.71 . . . . 0.0 116.625 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -112.49 146.5 38.35 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 125.101 1.118 . . . . 0.0 111.805 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.63 135.13 39.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.312 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HB2' HD12 ' B' ' 106' ' ' ILE . 6.3 m-85 -123.54 165.9 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.055 0.942 . . . . 0.0 111.118 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.62 108.27 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.01 157.12 25.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -24.85 -48.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.634 2.374 . . . . 0.0 117.339 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -80.39 -3.38 49.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.905 2.082 . . . . 0.0 116.449 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.46 48.11 5.75 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 120.295 1.407 . . . . 0.0 111.963 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 135.62 54.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.198 1.799 . . . . 0.0 109.077 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -101.3 145.97 28.17 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.713 1.244 . . . . 0.0 109.729 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.2 m -150.13 157.07 6.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.934 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.49 115.39 26.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.79 ' HE2' HD11 ' B' ' 106' ' ' ILE . 4.3 mmtt -103.74 119.35 38.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.2 p -136.57 167.31 21.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 123.398 1.57 . . . . 0.0 113.889 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.423 ' HG3' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -117.83 166.11 12.86 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -141.23 160.15 40.71 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.121 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.792 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.9 tt -144.81 125.79 14.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.131 -1.849 . . . . 0.0 112.008 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.52 143.19 39.5 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.065 1.478 . . . . 0.0 112.218 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -126.66 114.19 17.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.516 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -66.75 175.35 2.44 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 126.083 2.114 . . . . 0.0 112.926 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.7 p -118.19 68.98 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.34 1.456 . . . . 0.0 107.675 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.8 171.53 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.889 -1.132 . . . . 0.0 111.539 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -106.7 -32.28 8.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -108.22 148.77 29.47 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.833 1.302 . . . . 0.0 111.588 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.789 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.9 tt -64.07 -29.04 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.888 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 5.56 6.11 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.706 1.146 . . . . 0.0 113.516 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -121.39 1.51 10.17 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.333 1.066 . . . . 0.0 113.694 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -33.07 73.73 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.035 0.922 . . . . 0.0 112.553 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.1 p-90 -46.7 -41.43 14.98 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -99.34 -6.57 27.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.318 1.047 . . . . 0.0 113.356 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.35 -0.17 21.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.792 ' CG2' HD21 ' C' ' 98' ' ' LEU . 5.9 m -109.9 138.38 46.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.599 0.76 . . . . 0.0 111.636 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.59 124.47 17.26 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 125.65 1.58 . . . . 0.0 111.01 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -99.57 158.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.245 1.418 . . . . 0.0 111.35 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.65 -178.84 38.34 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.809 0.718 . . . . 0.0 113.407 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 0.0 OUTLIER -124.41 157.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.733 -0.863 . . . . 0.0 111.911 176.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -148.39 155.59 41.44 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.967 0.889 . . . . 0.0 109.864 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -132.19 133.28 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -120.76 151.7 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 111.665 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.8 p -135.42 163.15 30.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.024 1.33 . . . . 0.0 109.876 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 115.94 5.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.86 -1.15 . . . . 0.0 111.732 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 tp . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.594 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 p -116.61 137.61 52.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.003 0.921 . . . . 0.0 109.823 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 p -139.77 133.09 29.94 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.196 -1.565 . . . . 0.0 114.348 -174.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 64' ' ' PHE . 42.1 mt -59.13 -32.01 69.47 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -52.35 116.18 2.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.774 1.273 . . . . 0.0 111.83 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.1 -114.47 1.25 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 125.94 1.733 . . . . 0.0 110.209 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -153.16 147.44 25.78 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -140.65 162.75 34.64 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.493 1.517 . . . . 0.0 111.35 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -138.63 147.94 43.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.29 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.468 HD22 ' HB3' ' A' ' 118' ' ' ASN . 3.2 t-20 -113.28 146.99 38.46 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.709 0.803 . . . . 0.0 110.619 -175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -56.67 -28.6 61.05 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.6 tp -72.29 -15.62 61.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.053 1.741 . . . . 0.0 112.02 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.39 -14.29 25.42 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.048 2.261 . . . . 0.0 113.441 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.7 p -68.51 155.05 40.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.412 1.606 . . . . 0.0 113.134 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -127.02 138.28 53.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.608 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -124.09 136.03 53.96 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.56 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -126.79 130.51 50.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.9 mt -134.43 127.46 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.83 -89.59 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.077 0.861 . . . . 0.0 112.558 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.92 139.65 32.58 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.837 -0.801 . . . . 0.0 111.641 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.8 t -89.61 129.47 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.357 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.56 166.04 15.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.894 0.854 . . . . 0.0 111.589 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.1 p -57.15 -27.81 62.19 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -74.71 -32.83 62.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.698 0.681 . . . . 0.0 111.722 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.67 -7.43 26.05 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.959 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 9.6 pt-20 -66.3 144.27 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.772 1.286 . . . . 0.0 108.487 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 50' ' ' LEU . 20.8 p90 -158.18 145.82 18.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.802 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.57 162.01 14.34 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.02 -170.04 36.9 Favored Glycine 0 C--O 1.239 0.416 0 O-C-N 121.187 -0.946 . . . . 0.0 112.664 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' LEU . 46.9 p -140.15 139.03 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.407 1.098 . . . . 0.0 112.17 175.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -114.42 138.72 50.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 108.389 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 46' ' ' LEU . 41.4 mt -130.83 126.87 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG21 ' A' ' 44' ' ' ILE . 86.5 m -105.05 144.34 31.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.74 -21.96 17.82 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.5 m -132.98 143.26 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.48 1.112 . . . . 0.0 113.27 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.55 159.43 39.7 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.528 -0.732 . . . . 0.0 110.219 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.54 -23.72 58.84 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.95 -0.469 . . . . 0.0 110.909 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -146.43 68.72 12.34 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.221 2.208 . . . . 0.0 111.069 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' ILE . 39.0 Cg_endo -56.71 -79.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 125.08 3.853 . . . . 0.0 116.853 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.87 -48.65 0.01 OUTLIER Glycine 0 CA--C 1.546 1.996 0 C-N-CA 129.561 3.458 . . . . 0.0 120.565 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.84 -5.12 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.25 2.22 . . . . 0.0 113.118 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 35' ' ' THR 0.347 64.5 mt -8.89 85.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 124.316 2.007 . . . . 0.0 115.009 -172.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.2 151.13 21.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 111.63 -2.532 . . . . 0.0 108.465 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 32' ' ' THR . 3.3 tt -46.34 127.19 8.76 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.934 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.32 118.52 57.59 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 123.961 0.788 . . . . 0.0 111.252 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.92 144.07 69.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.727 2.284 . . . . 0.0 112.177 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.5 158.23 35.01 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.765 0.826 . . . . 0.0 111.267 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 29' ' ' PHE . 7.6 tp -159.89 148.97 17.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.319 1.847 . . . . 0.0 110.425 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.9 -157.22 28.95 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 121.062 1.756 . . . . 0.0 110.069 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.4 mt -141.7 134.94 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.45 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 136.61 53.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.543 1.137 . . . . 0.0 110.772 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -73.29 151.88 41.18 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.004 0.907 . . . . 0.0 109.746 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.9 26.46 1.37 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.619 -1.301 . . . . 0.0 111.633 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.47 -50.29 5.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 110.717 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 173.29 10.34 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.231 0.957 . . . . 0.0 112.987 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.7 m -83.93 -31.64 25.52 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.762 1.225 . . . . 0.0 113.366 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -128.51 54.94 15.09 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.243 1.417 . . . . 0.0 111.381 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.66 165.18 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.042 2.495 . . . . 0.0 117.553 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.3 p -81.11 164.27 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.115 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -158.78 163.47 36.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.215 -0.928 . . . . 0.0 113.021 175.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.89 140.1 6.12 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -159.68 157.55 29.76 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -95.84 151.55 19.3 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.302 1.441 . . . . 0.0 110.651 174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.44 118.13 48.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 13.7 t30 -93.72 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 109.554 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.301 43.8 m95 -83.07 135.48 34.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.82 -44.02 9.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.953 2.101 . . . . 0.0 116.321 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -91.02 -9.56 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -152.79 126.8 9.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.507 2.323 . . . . 0.0 107.06 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -69.25 118.48 12.19 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.965 1.257 . . . . 0.0 110.503 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -177.23 164.23 2.16 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 126.329 1.851 . . . . 0.0 109.193 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -144.18 143.84 31.27 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.542 1.639 . . . . 0.0 111.549 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.31 125.17 21.12 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 110.33 -3.123 . . . . 0.0 109.691 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.67 152.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -126.33 142.17 51.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 118.14 7.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -174.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.1 -164.94 14.67 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' NE2' ' CE2' ' A' ' 84' ' ' PHE . 38.1 tt0 -130.3 150.0 51.74 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.485 0.756 . . . . 0.0 112.216 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.5 t -94.86 124.93 39.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.7 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE2' ' NE2' ' A' ' 82' ' ' GLN . 5.0 m-85 -114.46 163.48 15.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.242 1.017 . . . . 0.0 111.966 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.87 110.72 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.16 161.22 9.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.249 0.619 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.37 -51.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -69.24 -33.46 73.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.8 42.44 0.73 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.906 1.241 . . . . 0.0 111.734 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -110.44 142.64 41.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.302 1.441 . . . . 0.0 109.85 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -101.58 140.33 36.01 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.856 1.262 . . . . 0.0 111.613 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 20.1 m -143.62 160.32 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.372 1.069 . . . . 0.0 108.681 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.69 119.25 33.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 119.51 39.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.531 HG22 ' HE1' ' A' ' 64' ' ' PHE . 4.4 p -137.7 172.27 13.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 123.131 1.443 . . . . 0.0 111.992 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.585 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.9 mmm -126.02 168.9 13.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.588 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -141.49 164.06 31.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.168 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.669 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -148.15 119.67 7.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.056 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 140.11 41.06 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.181 1.467 . . . . 0.0 112.11 -173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -120.16 120.97 37.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 110.804 -2.907 . . . . 0.0 111.237 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -88.7 163.52 15.73 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 125.496 1.748 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -113.81 70.85 0.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.83 -167.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 111.001 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.44 -15.16 3.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.738 -1.851 . . . . 0.0 114.776 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.77 150.23 43.07 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.87 1.319 . . . . 0.0 110.315 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' D' ' 92' ' ' VAL . 16.6 tt -62.85 -28.38 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.708 174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.82 6.89 10.58 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.244 -1.309 . . . . 0.0 113.472 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -121.08 -1.36 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.85 1.325 . . . . 0.0 113.632 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -59.08 -34.75 72.34 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.623 -1.298 . . . . 0.0 112.158 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.73 -39.56 18.07 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.724 1.21 . . . . 0.0 114.16 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.32 -7.65 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.285 1.434 . . . . 0.0 114.011 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 1.8 9.6 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.163 -0.961 . . . . 0.0 113.016 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.669 ' CG2' HD21 ' A' ' 98' ' ' LEU . 34.0 m -116.97 145.23 43.77 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.865 0.866 . . . . 0.0 111.537 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.52 129.05 18.06 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 125.759 1.624 . . . . 0.0 110.659 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.71 155.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 120.483 1.492 . . . . 0.0 109.367 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -175.31 28.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.542 1.067 . . . . 0.0 113.08 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 21.4 p90 -125.97 153.01 44.92 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.064 0.945 . . . . 0.0 110.782 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' HD22 ' A' ' 12' ' ' ASN . 1.0 OUTLIER -144.85 152.97 41.1 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.695 1.198 . . . . 0.0 109.865 176.227 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.1 mt -135.06 122.17 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -110.6 149.18 30.78 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.521 0.677 . . . . 0.0 110.427 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.5 p -134.16 162.83 31.06 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.081 -1.012 . . . . 0.0 109.662 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -56.87 114.82 2.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.451 0.701 . . . . 0.0 109.928 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.417 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 4' ' ' CYS . . . . . 0.466 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 24.5 p -122.43 135.22 54.64 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.373 1.469 . . . . 0.0 110.236 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -139.91 134.4 31.55 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.389 -1.445 . . . . 0.0 114.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' D' ' 64' ' ' PHE . 43.1 mt -58.6 -32.94 69.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -51.5 117.32 2.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 123.35 1.547 . . . . 0.0 112.098 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.52 -116.72 1.75 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.687 1.613 . . . . 0.0 110.351 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -151.92 147.15 26.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -141.27 162.78 34.65 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.83 1.652 . . . . 0.0 111.927 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -139.73 148.08 41.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.938 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' ASN . . . . . 0.464 HD22 ' HB3' ' D' ' 118' ' ' ASN . 2.9 t-20 -113.05 146.98 38.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.781 0.832 . . . . 0.0 110.585 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -57.9 -26.38 62.09 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.16 -16.91 61.98 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.451 1.5 . . . . 0.0 111.74 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.04 -13.74 23.99 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 127.136 2.303 . . . . 0.0 113.627 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -69.77 155.66 40.2 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.308 1.554 . . . . 0.0 112.841 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -127.81 138.35 52.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.044 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -124.11 136.64 54.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.261 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -126.67 131.25 51.45 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.2 127.12 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.03 -89.93 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.91 141.32 32.98 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.608 -0.937 . . . . 0.0 111.219 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -91.4 130.07 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.83 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 165.09 18.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.908 0.861 . . . . 0.0 111.885 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 28.7 p -57.37 -26.96 61.85 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -73.58 -31.97 63.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.849 0.75 . . . . 0.0 111.722 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.99 25.32 Favored Glycine 0 N--CA 1.462 0.389 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.344 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.3 156.81 38.77 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.582 1.191 . . . . 0.0 112.872 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PHE . . . . . 0.421 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.1 p90 -160.35 160.25 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.389 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' THR . . . . . 0.505 HG22 ' CD1' ' D' ' 50' ' ' LEU . 0.9 OUTLIER -120.45 156.98 30.33 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 173.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.78 -167.82 28.04 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 120.11 -1.619 . . . . 0.0 112.527 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.604 ' HB ' HD11 ' D' ' 46' ' ' LEU . 45.5 p -140.0 137.74 34.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 122.351 1.072 . . . . 0.0 112.474 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -114.62 139.14 49.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.476 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' D' ' 46' ' ' LEU . 44.3 mt -130.79 127.23 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.534 ' O ' HG21 ' D' ' 44' ' ' ILE . 86.7 m -105.1 144.17 32.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.64 -21.41 18.24 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.01 143.75 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 112.974 -174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.49 39.25 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.722 -0.611 . . . . 0.0 110.238 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.68 -23.46 58.63 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 121.984 -0.447 . . . . 0.0 110.935 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -146.6 68.7 12.12 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.263 2.225 . . . . 0.0 111.087 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' D' ' 44' ' ' ILE . 38.7 Cg_endo -56.79 -78.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 125.05 3.833 . . . . 0.0 116.89 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.66 -48.74 0.01 OUTLIER Glycine 0 CA--C 1.545 1.931 0 C-N-CA 129.651 3.501 . . . . 0.0 120.587 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.68 -5.15 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 127.176 2.19 . . . . 0.0 113.03 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.534 HG21 ' O ' ' D' ' 35' ' ' THR 0.345 64.9 mt -8.92 86.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 124.337 2.018 . . . . 0.0 115.068 -172.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.29 151.47 21.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.55 174.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.604 HD11 ' HB ' ' D' ' 32' ' ' THR . 3.5 tt -46.51 126.87 8.72 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.295 -2.23 . . . . 0.0 111.772 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.7 p -102.85 118.68 57.72 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 123.844 0.715 . . . . 0.0 111.381 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.84 144.15 67.88 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.66 2.24 . . . . 0.0 111.962 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.44 162.75 24.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.551 0.74 . . . . 0.0 111.516 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.505 ' CD1' HG22 ' D' ' 30' ' ' THR . 15.9 tp -164.22 149.02 10.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.894 1.678 . . . . 0.0 112.129 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -154.62 25.65 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 120.933 1.697 . . . . 0.0 110.498 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.2 mt -144.35 133.42 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.359 1.076 . . . . 0.0 110.929 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 136.71 54.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.28 1.432 . . . . 0.0 110.497 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -73.8 151.26 40.63 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.28 -0.887 . . . . 0.0 109.971 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -144.62 26.47 1.42 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.696 -1.252 . . . . 0.0 111.58 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.42 -49.28 6.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 111.289 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 172.8 12.6 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -80.01 -30.66 39.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.781 1.232 . . . . 0.0 113.11 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -133.29 57.68 28.8 Favored Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -71.76 164.25 36.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 N-CA-C 117.494 2.075 . . . . 0.0 117.494 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -81.21 164.1 22.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.944 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -158.35 163.56 37.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.871 0.844 . . . . 0.0 112.758 175.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.43 140.09 6.08 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -159.56 157.91 30.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -96.11 151.38 19.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.91 1.684 . . . . 0.0 110.648 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.47 118.74 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 52' ' ' ILE . 14.2 t30 -94.93 113.29 25.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.966 0.906 . . . . 0.0 109.523 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.297 43.8 m95 -82.53 136.01 34.96 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -173.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -92.41 -43.25 9.32 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.899 2.08 . . . . 0.0 116.417 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -91.37 -9.72 43.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.77 127.41 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.422 2.289 . . . . 0.0 107.171 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -69.52 118.48 12.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.009 1.277 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -177.34 163.91 2.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.31 1.844 . . . . 0.0 109.039 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.5 t -144.0 143.78 31.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.893 1.806 . . . . 0.0 111.721 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 110.224 -3.171 . . . . 0.0 109.869 -172.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.1 153.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -127.12 141.97 51.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.36 118.37 7.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -164.95 14.61 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 116.401 1.32 . . . . 0.0 116.401 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.401 ' NE2' ' CE2' ' D' ' 84' ' ' PHE . 37.3 tt0 -131.09 149.75 52.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.245 0.615 . . . . 0.0 112.024 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.466 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 37.9 t -97.25 122.28 40.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.211 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.7 m-85 -109.35 163.46 13.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.138 0.975 . . . . 0.0 112.008 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.79 107.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 160.84 5.36 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.251 0.548 . . . . 0.0 110.103 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.09 -49.97 0.14 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -25.87 61.06 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.83 51.51 1.17 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.881 0.764 . . . . 0.0 111.286 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -120.16 147.73 44.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 128.261 2.624 . . . . 0.0 105.346 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -113.7 137.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.804 1.242 . . . . 0.0 110.135 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 106' ' ' ILE . 26.0 m -139.71 161.86 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 110.05 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.01 120.05 36.64 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 118.41 36.7 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.534 HG22 ' HE1' ' D' ' 64' ' ' PHE . 3.9 p -137.11 171.84 13.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 123.303 1.525 . . . . 0.0 112.151 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.576 ' HG3' HG21 ' A' ' 113' ' ' THR . 88.5 mmm -125.95 168.88 13.29 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -141.07 163.72 32.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.312 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.66 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -148.11 120.1 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.84 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 140.33 40.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 123.23 1.49 . . . . 0.0 112.044 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.08 119.86 34.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 110.89 -2.868 . . . . 0.0 110.758 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -86.15 162.97 18.11 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 125.257 1.598 . . . . 0.0 112.044 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 3.8 t -112.83 73.17 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.14 -166.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.452 0.701 . . . . 0.0 110.709 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.11 -14.54 3.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 119.907 -1.746 . . . . 0.0 114.569 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -123.46 149.49 45.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 123.086 1.422 . . . . 0.0 110.516 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 17.2 tt -62.01 -29.37 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.111 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.0 5.92 11.66 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.45 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -120.41 -1.77 10.13 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.01 1.405 . . . . 0.0 113.575 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.82 -34.99 70.26 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.652 -1.28 . . . . 0.0 112.745 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 62.7 p-90 -47.51 -39.8 17.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.079 1.352 . . . . 0.0 113.912 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -99.21 -6.8 27.49 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.322 1.449 . . . . 0.0 114.114 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.75 1.46 10.35 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.88 -1.137 . . . . 0.0 113.126 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.66 ' CG2' HD21 ' D' ' 98' ' ' LEU . 34.7 m -117.29 145.24 44.1 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.574 0.75 . . . . 0.0 111.604 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.17 129.05 18.42 Favored 'General case' 0 C--O 1.214 -0.81 0 C-N-CA 125.53 1.532 . . . . 0.0 110.681 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.74 155.15 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 120.531 1.514 . . . . 0.0 109.504 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.21 -175.53 29.24 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.628 1.109 . . . . 0.0 113.002 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 21.7 p90 -125.87 153.48 44.09 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.039 0.936 . . . . 0.0 110.68 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 118' ' ' ASN . . . . . 0.464 ' HB3' HD22 ' D' ' 12' ' ' ASN . 1.0 OUTLIER -145.33 153.24 41.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.675 1.19 . . . . 0.0 109.706 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 80.9 mt -135.37 123.93 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.52 149.51 32.57 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 111.064 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -133.56 164.93 26.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.939 0.896 . . . . 0.0 109.82 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -60.93 121.14 11.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.104 -0.997 . . . . 0.0 109.979 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 CA--C 1.55 0.954 0 O-C-N 121.765 -0.584 . . . . 0.0 110.14 174.886 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.41 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 26.0 p -117.59 134.94 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.322 1.849 . . . . 0.0 109.619 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -139.75 135.71 33.39 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.414 -1.429 . . . . 0.0 114.193 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' B' ' 64' ' ' PHE . 40.7 mt -60.46 -30.57 69.76 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -53.5 116.81 2.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.713 1.244 . . . . 0.0 111.582 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.65 -116.11 1.54 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.474 1.512 . . . . 0.0 110.369 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -152.68 145.3 24.22 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -139.63 162.15 35.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 111.553 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -141.51 145.57 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.607 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' B' ' 118' ' ' ASN . 2.6 t-20 -109.21 148.85 30.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.062 0.945 . . . . 0.0 110.744 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -57.47 -28.91 63.8 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.18 -14.87 61.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.367 1.867 . . . . 0.0 111.91 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.78 -14.02 29.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 127.048 2.261 . . . . 0.0 113.461 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 54.1 p -69.35 155.83 39.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.233 1.516 . . . . 0.0 112.683 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -127.95 139.58 52.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.935 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -125.69 134.83 51.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.563 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -124.97 131.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.0 mt -135.01 127.83 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.6 -89.6 0.11 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.048 0.842 . . . . 0.0 112.52 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.4 140.5 32.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.714 -0.874 . . . . 0.0 111.554 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.3 t -90.96 129.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.402 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.73 165.8 16.55 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.576 0.703 . . . . 0.0 111.533 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 27.5 p -56.98 -27.42 61.37 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -74.89 -32.79 61.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.785 0.721 . . . . 0.0 111.877 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.62 -7.32 26.16 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.164 -1.353 . . . . 0.0 112.856 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 9.7 pt-20 -66.11 144.58 56.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.857 1.328 . . . . 0.0 108.464 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.415 ' O ' HD12 ' B' ' 50' ' ' LEU . 21.1 p90 -158.44 146.16 18.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.783 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.69 162.25 14.15 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.894 0.877 . . . . 0.0 108.76 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.84 36.86 Favored Glycine 0 C--O 1.238 0.372 0 O-C-N 121.245 -0.909 . . . . 0.0 112.608 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.6 ' HB ' HD11 ' B' ' 46' ' ' LEU . 43.9 p -140.17 139.24 35.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.335 1.064 . . . . 0.0 112.292 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -114.38 139.09 49.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.477 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.519 HD11 HD12 ' B' ' 46' ' ' LEU . 43.1 mt -131.2 127.1 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.535 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.5 m -105.0 145.47 30.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.45 -22.37 17.17 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -132.61 143.44 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.553 1.141 . . . . 0.0 113.093 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.62 159.5 39.68 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.387 -0.82 . . . . 0.0 110.083 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.46 -23.49 58.9 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.017 -0.427 . . . . 0.0 111.083 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.78 68.62 11.84 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 127.256 2.223 . . . . 0.0 110.945 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.436 ' HB3' HD11 ' B' ' 44' ' ' ILE . 38.4 Cg_endo -56.85 -78.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 125.083 3.856 . . . . 0.0 116.776 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.82 -48.46 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 C-N-CA 129.582 3.468 . . . . 0.0 120.568 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.98 -5.29 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.283 2.233 . . . . 0.0 113.114 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.535 HG21 ' O ' ' B' ' 35' ' ' THR 0.349 65.7 mt -8.58 85.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 124.354 2.026 . . . . 0.0 115.147 -172.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.89 151.11 21.21 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.501 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.6 HD11 ' HB ' ' B' ' 32' ' ' THR . 3.4 tt -46.34 127.3 8.86 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.777 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.46 118.72 56.98 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 123.951 0.782 . . . . 0.0 111.405 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.85 144.12 68.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.58 158.44 34.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.728 0.811 . . . . 0.0 111.22 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.415 HD12 ' O ' ' B' ' 29' ' ' PHE . 7.4 tp -160.03 148.94 17.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.409 1.884 . . . . 0.0 110.453 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.86 -157.28 29.01 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 121.018 1.735 . . . . 0.0 110.236 -174.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.4 mt -141.62 135.0 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.64 0.733 . . . . 0.0 111.491 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.56 136.71 53.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.723 1.209 . . . . 0.0 110.843 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -73.48 152.49 40.7 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.993 0.902 . . . . 0.0 109.756 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.86 25.82 1.42 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.537 -1.352 . . . . 0.0 111.773 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -93.23 -49.21 6.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.918 1.287 . . . . 0.0 111.238 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.23 172.53 12.69 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.557 1.161 . . . . 0.0 114.042 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.67 -28.6 36.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.492 1.117 . . . . 0.0 113.028 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -135.11 57.09 18.72 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.665 1.186 . . . . 0.0 111.52 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.77 163.95 37.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.598 2.865 . . . . 0.0 117.73 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 69.6 p -80.89 163.74 23.15 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.761 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -158.76 162.84 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.346 -0.846 . . . . 0.0 112.811 175.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.76 140.03 6.08 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -159.59 158.17 31.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.37 151.46 19.52 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.477 1.511 . . . . 0.0 110.632 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -127.38 118.06 48.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 52' ' ' ILE . 13.2 t30 -93.74 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.01 0.924 . . . . 0.0 109.501 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.298 43.8 m95 -83.06 135.05 34.98 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.44 -43.86 9.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.179 2.192 . . . . 0.0 116.361 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -91.14 -9.66 44.71 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -152.74 126.32 8.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.479 2.312 . . . . 0.0 106.912 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.12 118.49 12.09 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.046 1.294 . . . . 0.0 110.515 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -177.48 163.57 1.98 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 109.176 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -143.63 144.25 31.82 Favored 'General case' 0 CA--C 1.482 -1.673 0 CA-C-O 123.376 1.56 . . . . 0.0 111.648 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 125.67 21.32 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 110.441 -3.072 . . . . 0.0 109.656 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.03 153.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -126.99 142.03 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 118.06 6.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.09 -165.01 14.76 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' B' ' 84' ' ' PHE . 37.3 tt0 -130.83 149.61 52.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.928 1.016 . . . . 0.0 111.75 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.41 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 45.7 t -97.23 125.84 42.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.464 174.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.442 ' HB2' HD12 ' C' ' 106' ' ' ILE . 4.1 m-85 -113.07 165.44 12.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.267 1.027 . . . . 0.0 112.213 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 22.7 mt -130.56 110.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.91 162.08 4.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.258 0.623 . . . . 0.0 109.567 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -33.33 -48.94 0.26 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -13.44 60.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.64 43.45 4.22 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.225 0.92 . . . . 0.0 112.23 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 6.0 mtpt -113.36 142.67 45.59 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 127.389 2.276 . . . . 0.0 109.324 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -106.8 141.68 37.64 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.004 1.321 . . . . 0.0 111.271 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.8 m -144.55 160.37 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.589 1.156 . . . . 0.0 110.14 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.71 119.43 35.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 118.59 37.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.537 HG22 ' HE1' ' B' ' 64' ' ' PHE . 4.5 p -137.38 172.05 13.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.169 1.461 . . . . 0.0 112.189 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.588 ' HG3' HG21 ' C' ' 113' ' ' THR . 88.4 mmm -125.92 168.87 13.3 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.12 163.99 31.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.583 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -148.16 119.77 8.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.983 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 139.63 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 124.964 1.415 . . . . 0.0 112.176 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -119.38 120.35 36.63 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 110.684 -2.962 . . . . 0.0 110.676 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -87.79 163.35 16.5 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 125.319 1.637 . . . . 0.0 111.405 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -113.13 72.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.58 -167.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.312 0.645 . . . . 0.0 110.269 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.03 -20.28 3.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.092 -1.63 . . . . 0.0 113.66 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -115.38 148.3 39.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.991 1.377 . . . . 0.0 110.96 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.469 ' CD1' HG21 ' C' ' 92' ' ' VAL . 16.9 tt -62.85 -28.4 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.516 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.75 5.83 15.31 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 118.003 -1.443 . . . . 0.0 113.831 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -121.27 -0.93 9.79 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.95 1.375 . . . . 0.0 113.432 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.5 -35.86 70.79 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.737 -1.227 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.41 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 62.9 p-90 -47.22 -40.25 15.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.195 1.398 . . . . 0.0 113.802 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -99.04 -7.07 27.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.241 1.416 . . . . 0.0 113.943 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.58 13.05 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.627 -1.295 . . . . 0.0 113.165 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.672 ' CG2' HD21 ' B' ' 98' ' ' LEU . 33.1 m -115.09 145.47 42.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.869 0.868 . . . . 0.0 111.757 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.78 129.86 18.51 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 125.876 1.671 . . . . 0.0 110.42 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.66 155.13 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 120.421 1.464 . . . . 0.0 109.353 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.68 -175.07 28.19 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.673 1.13 . . . . 0.0 113.517 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 21.1 p90 -126.29 152.84 45.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.13 0.972 . . . . 0.0 110.71 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ASN . . . . . 0.485 ' HB3' HD22 ' B' ' 12' ' ' ASN . 0.9 OUTLIER -145.15 151.57 38.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.528 1.131 . . . . 0.0 110.304 176.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.86 119.74 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -108.69 152.28 25.03 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.933 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -136.91 162.15 34.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.23 1.012 . . . . 0.0 109.566 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -54.55 125.79 21.07 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.51 -0.744 . . . . 0.0 109.668 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.598 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 4' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 24.0 p -119.27 133.41 55.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.279 1.832 . . . . 0.0 109.228 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 78.9 p -139.83 133.21 30.01 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.243 -1.536 . . . . 0.0 114.148 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.629 HD21 ' CE2' ' C' ' 64' ' ' PHE . 40.8 mt -58.23 -32.82 68.68 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -51.76 116.3 2.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.903 1.335 . . . . 0.0 111.729 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.95 -114.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 125.66 1.6 . . . . 0.0 109.829 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -152.9 148.22 26.89 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -141.12 162.67 34.93 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.267 1.427 . . . . 0.0 112.315 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -135.45 147.3 48.89 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.859 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ASN . . . . . 0.5 HD22 ' HB3' ' C' ' 118' ' ' ASN . 2.3 t-20 -111.67 146.81 36.81 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.591 0.756 . . . . 0.0 110.475 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -57.1 -27.46 61.79 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 34.9 tp -72.64 -16.25 61.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.126 1.77 . . . . 0.0 111.986 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.56 -13.81 25.15 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.128 2.299 . . . . 0.0 113.662 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 44.1 p -69.16 156.31 38.92 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.489 1.645 . . . . 0.0 113.128 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -128.86 138.93 52.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.848 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -124.08 136.87 54.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.26 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -126.68 130.72 50.96 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.97 126.87 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.83 -89.59 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.898 0.749 . . . . 0.0 112.63 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.42 32.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.619 -0.93 . . . . 0.0 111.206 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.33 130.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.08 165.33 18.29 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.589 0.709 . . . . 0.0 111.782 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 30.6 p -57.78 -26.76 62.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -73.65 -32.04 63.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.975 0.807 . . . . 0.0 111.733 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.08 -4.55 25.48 Favored Glycine 0 N--CA 1.463 0.462 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.392 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.73 156.49 39.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.432 1.116 . . . . 0.0 112.766 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PHE . . . . . 0.417 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.0 p90 -159.81 159.93 33.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.258 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' CD1' ' C' ' 50' ' ' LEU . 1.0 OUTLIER -120.34 157.11 29.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 173.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.08 -167.33 27.6 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 120.054 -1.654 . . . . 0.0 112.627 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.581 ' HB ' HD11 ' C' ' 46' ' ' LEU . 54.0 p -139.79 138.14 35.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.514 1.149 . . . . 0.0 112.783 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.9 139.45 49.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.371 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.517 HD11 HD12 ' C' ' 46' ' ' LEU . 42.8 mt -131.16 127.06 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 174.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.542 ' O ' HG21 ' C' ' 44' ' ' ILE . 85.1 m -105.05 145.03 31.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.98 -20.12 18.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.49 142.89 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.548 1.139 . . . . 0.0 113.197 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.42 159.37 39.8 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.326 -0.859 . . . . 0.0 110.215 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.38 -23.42 58.99 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 110.99 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.71 68.88 12.07 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 127.239 2.216 . . . . 0.0 111.029 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.448 ' HB3' HD11 ' C' ' 44' ' ' ILE . 38.6 Cg_endo -56.92 -78.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 125.054 3.836 . . . . 0.0 116.86 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.51 -48.85 0.01 OUTLIER Glycine 0 CA--C 1.546 1.982 0 C-N-CA 129.65 3.5 . . . . 0.0 120.591 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.49 -5.08 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.307 2.243 . . . . 0.0 113.167 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.542 HG21 ' O ' ' C' ' 35' ' ' THR 0.345 65.6 mt -9.02 85.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 124.465 2.078 . . . . 0.0 115.301 -172.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.88 151.36 20.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.525 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.581 HD11 ' HB ' ' C' ' 32' ' ' THR . 3.4 tt -46.48 127.08 8.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 112.181 -2.282 . . . . 0.0 111.777 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.25 118.71 57.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 123.85 0.718 . . . . 0.0 111.376 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.74 144.29 66.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.755 2.303 . . . . 0.0 111.869 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.63 162.73 25.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.545 0.738 . . . . 0.0 111.702 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' C' ' 30' ' ' THR . 15.6 tp -164.46 148.97 9.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.778 1.631 . . . . 0.0 112.166 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.73 25.79 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 120.866 1.666 . . . . 0.0 110.488 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -143.76 135.18 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.209 1.004 . . . . 0.0 110.984 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.58 136.55 52.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.311 1.444 . . . . 0.0 110.34 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -73.72 151.44 40.7 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.889 0.852 . . . . 0.0 110.172 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -144.56 25.68 1.48 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.573 -1.329 . . . . 0.0 112.017 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -93.51 -49.96 5.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.28 1.432 . . . . 0.0 111.239 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.64 173.11 11.48 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.691 1.245 . . . . 0.0 113.659 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -83.0 -26.47 31.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.107 1.363 . . . . 0.0 113.46 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -134.91 55.74 14.77 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 125.438 1.495 . . . . 0.0 112.2 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.28 163.72 37.66 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.794 2.329 . . . . 0.0 117.878 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 68.2 p -80.86 164.18 22.84 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.033 173.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' PHE . . . . . 0.629 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.21 163.33 36.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.874 0.845 . . . . 0.0 113.118 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.74 140.81 6.53 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 117.816 1.886 . . . . 0.0 117.816 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -160.3 158.55 30.0 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -96.63 152.02 19.05 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.118 1.767 . . . . 0.0 110.709 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.34 118.12 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' B' ' 52' ' ' ILE . 13.9 t30 -94.22 113.14 25.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.017 0.927 . . . . 0.0 109.447 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.295 43.6 m95 -82.46 135.43 35.13 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -172.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -91.56 -44.07 9.29 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.956 2.102 . . . . 0.0 116.226 -173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -90.89 -9.49 46.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.0 t -152.74 126.84 9.09 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 127.448 2.299 . . . . 0.0 107.065 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -69.19 118.48 12.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.0 1.273 . . . . 0.0 110.407 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -177.34 163.59 2.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.393 1.877 . . . . 0.0 109.142 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -143.69 143.89 31.62 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 124.067 1.889 . . . . 0.0 111.613 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.44 125.71 21.65 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 109.99 -3.277 . . . . 0.0 109.86 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.33 153.58 4.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.79 142.15 51.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.72 118.94 7.26 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -174.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.88 -164.29 14.16 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.415 ' NE2' ' CE2' ' C' ' 84' ' ' PHE . 37.5 tt0 -132.06 149.46 52.41 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.541 0.789 . . . . 0.0 111.812 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.438 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 41.4 t -97.21 123.26 40.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.318 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.1 m-85 -112.34 164.71 12.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.264 1.025 . . . . 0.0 112.203 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -128.11 111.78 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.85 160.18 6.11 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -33.42 -47.74 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -10.06 59.13 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.07 5.79 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.524 1.056 . . . . 0.0 112.644 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -112.99 143.21 44.68 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 128.208 2.603 . . . . 0.0 108.959 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -109.45 143.93 38.38 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.489 1.495 . . . . 0.0 110.865 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.7 m -144.95 162.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.581 1.152 . . . . 0.0 109.606 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.63 121.02 39.16 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.84 119.07 38.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.532 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.7 p -137.31 172.54 12.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.083 1.42 . . . . 0.0 112.371 -174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.586 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.7 mmm -126.97 169.22 13.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -141.15 164.37 30.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.389 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -148.27 120.01 8.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.949 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.19 140.2 40.43 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 125.022 1.451 . . . . 0.0 112.231 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.25 120.74 36.98 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 111.208 -2.724 . . . . 0.0 111.129 -174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 38.4 t -88.56 163.18 15.99 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 125.176 1.548 . . . . 0.0 111.351 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -113.0 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.96 -165.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.439 0.695 . . . . 0.0 110.453 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.36 -15.65 3.19 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.074 -1.641 . . . . 0.0 114.054 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.58 148.89 43.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.13 1.443 . . . . 0.0 110.798 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.473 ' CD1' HG21 ' B' ' 92' ' ' VAL . 16.6 tt -62.18 -28.34 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.932 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.28 5.84 18.35 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-O 118.121 -1.377 . . . . 0.0 113.866 173.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.17 -1.43 9.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.587 1.194 . . . . 0.0 113.481 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.07 -35.71 71.76 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.738 -1.226 . . . . 0.0 112.581 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.42 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 62.7 p-90 -47.1 -39.8 13.98 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.018 1.327 . . . . 0.0 113.903 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.28 -7.21 26.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.16 2.04 9.89 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.537 -1.352 . . . . 0.0 113.09 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.683 ' CG2' HD21 ' C' ' 98' ' ' LEU . 35.8 m -116.96 145.08 43.87 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.977 0.911 . . . . 0.0 111.618 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.23 129.37 18.65 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 125.68 1.592 . . . . 0.0 110.62 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.66 155.08 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 120.558 1.526 . . . . 0.0 109.246 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -175.82 28.83 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.681 1.134 . . . . 0.0 113.441 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 21.1 p90 -125.45 152.95 44.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.541 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' ASN . . . . . 0.5 ' HB3' HD22 ' C' ' 12' ' ' ASN . 0.8 OUTLIER -145.61 152.66 40.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.75 1.22 . . . . 0.0 110.151 176.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.16 121.5 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -109.02 152.69 24.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -141.02 164.08 31.24 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.136 0.975 . . . . 0.0 110.676 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.39 114.38 2.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.097 0.959 . . . . 0.0 111.24 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.714 174.9 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 134.2 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.219 1.408 . . . . 0.0 111.273 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.43 127.54 13.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.022 1.329 . . . . 0.0 109.234 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -73.74 -27.7 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.77 116.1 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.86 1.264 . . . . 0.0 111.204 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.33 -123.52 2.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.411 1.482 . . . . 0.0 110.97 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -147.62 144.65 28.56 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -142.67 159.15 42.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.369 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -141.33 146.95 37.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 16' ' ' SER . 25.2 p30 -114.21 159.37 20.2 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -55.99 -26.06 46.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.146 2.578 . . . . 0.0 115.164 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -76.27 -11.97 60.0 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.608 1.163 . . . . 0.0 111.974 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.89 47.28 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 127.145 2.307 . . . . 0.0 112.931 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 12' ' ' ASN . 15.8 m -69.21 154.91 41.28 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.596 1.189 . . . . 0.0 111.598 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -128.99 150.56 50.35 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.736 -1.227 . . . . 0.0 110.273 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -134.47 145.4 48.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.339 0.59 . . . . 0.0 112.159 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -129.2 134.75 48.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.767 0.827 . . . . 0.0 109.231 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.31 125.05 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -78.68 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 O-C-N 124.335 1.022 . . . . 0.0 111.199 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.85 30.92 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.83 -0.806 . . . . 0.0 112.407 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.61 132.17 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.337 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 7.6 m-20 -76.52 168.73 19.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.941 0.877 . . . . 0.0 112.521 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 p -56.07 -27.4 53.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -75.64 -34.0 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.539 0.609 . . . . 0.0 112.272 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.65 -10.38 14.26 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.985 -1.453 . . . . 0.0 113.501 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 24' ' ' ASN . 10.1 pt-20 -62.56 140.02 58.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.358 2.263 . . . . 0.0 108.991 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.86 147.57 24.34 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 p -107.39 169.31 8.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.566 1.147 . . . . 0.0 109.78 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.04 -168.2 37.18 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.377 -1.452 . . . . 0.0 114.905 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.536 ' HB ' HD11 ' A' ' 46' ' ' LEU . 5.2 p -140.53 129.56 23.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.375 1.084 . . . . 0.0 111.975 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.29 137.79 48.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.12 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.5 mt -127.22 127.43 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 44' ' ' ILE 0.264 73.7 m -105.06 133.0 50.57 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 125.051 1.34 . . . . 0.0 112.986 -172.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.51 27.63 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.46 146.79 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.016 1.327 . . . . 0.0 112.092 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.02 161.69 42.23 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.817 -1.177 . . . . 0.0 111.407 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.98 -29.07 55.36 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 122.037 -0.414 . . . . 0.0 110.353 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -143.02 78.95 14.88 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 127.338 2.255 . . . . 0.0 110.215 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.15 21.28 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.336 1 C-N-CA 125.474 4.116 . . . . 0.0 117.415 -174.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.6 -7.13 5.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 119.289 2.476 . . . . 0.0 119.289 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.93 43.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.686 1.743 . . . . 0.0 111.38 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 35' ' ' THR . 71.5 mt -51.21 125.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.34 -1.475 . . . . 0.0 111.272 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.63 30.4 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.692 1.597 . . . . 0.0 110.389 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.3 tp -46.71 115.37 1.03 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.971 2.909 . . . . 0.0 110.738 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 t -102.76 119.36 55.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.493 0.717 . . . . 0.0 109.554 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -55.86 142.66 83.79 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.261 2.641 . . . . 0.0 111.431 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.54 154.81 47.42 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 124.017 0.823 . . . . 0.0 111.017 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -156.54 148.75 23.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.736 1.614 . . . . 0.0 110.574 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.21 -157.55 29.43 Favored Glycine 0 C--N 1.333 0.405 0 O-C-N 119.738 -1.851 . . . . 0.0 110.641 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.3 mt -142.7 142.01 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.681 0.792 . . . . 0.0 112.836 -174.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.44 136.91 47.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.0 151.12 44.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.671 1.225 . . . . 0.0 112.105 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -151.33 26.95 0.68 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.352 1.861 . . . . 0.0 110.019 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.41 -57.04 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.881 1.672 . . . . 0.0 110.065 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.26 7.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.301 0.64 . . . . 0.0 112.08 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 p -95.19 -17.95 21.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 117.329 -1.32 . . . . 0.0 113.754 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -131.6 45.4 1.71 Allowed Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.895 1.278 . . . . 0.0 112.364 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 171.38 17.28 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.7 2.266 . . . . 0.0 115.452 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.298 0.1 OUTLIER -98.81 163.81 12.47 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.747 1.737 . . . . 0.0 111.199 173.156 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -158.34 166.11 33.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.911 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.6 145.12 10.12 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 118.999 2.359 . . . . 0.0 118.999 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -161.41 153.65 19.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -90.15 149.18 22.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.548 1.939 . . . . 0.0 110.314 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -128.17 118.53 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' D' ' 52' ' ' ILE . 21.3 t30 -101.67 101.81 12.38 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.449 -0.782 . . . . 0.0 110.429 -174.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -58.69 129.43 42.08 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.49 -32.29 16.42 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -99.8 -11.96 20.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.35 138.01 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.944 2.098 . . . . 0.0 106.728 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -73.45 118.62 16.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.59 1.186 . . . . 0.0 111.254 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.67 159.77 2.37 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.591 1.556 . . . . 0.0 109.604 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -136.58 134.66 37.66 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.4 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.887 HG23 HD12 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -123.02 138.0 54.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 174.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.78 155.2 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -130.96 143.99 51.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.078 0.951 . . . . 0.0 108.844 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.47 118.98 8.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.32 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.73 176.68 44.83 Favored Glycine 0 C--O 1.215 -1.077 0 N-CA-C 118.196 2.038 . . . . 0.0 118.196 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -101.71 150.5 23.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.47 115.14 27.21 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.445 1.716 . . . . 0.0 107.086 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB2' HD12 ' D' ' 106' ' ' ILE . 25.5 m-85 -105.64 159.21 16.14 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.761 1.164 . . . . 0.0 113.266 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 16.0 mt -120.02 109.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 113.519 -1.673 . . . . 0.0 106.9 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.86 161.41 4.91 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -22.71 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -10.31 48.88 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.689 0.796 . . . . 0.0 112.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.75 6.44 56.24 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.487 1.042 . . . . 0.0 114.851 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 19.6 mtpp -73.82 165.51 24.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.773 1.286 . . . . 0.0 110.153 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.62 143.42 49.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.738 1.615 . . . . 0.0 111.473 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.543 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.51 153.17 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.09 0.956 . . . . 0.0 110.891 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.5 mt -116.46 103.59 10.59 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' CD ' HG11 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -97.06 114.45 26.09 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -133.26 164.54 26.85 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.216 1.484 . . . . 0.0 112.227 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' D' ' 113' ' ' THR . 92.9 mmm -115.29 167.87 10.47 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -139.07 163.87 31.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 0.0 113.423 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD12 HD12 ' D' ' 98' ' ' LEU . 0.4 OUTLIER -142.91 124.66 15.02 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.05 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.887 HD12 HG23 ' A' ' 77' ' ' THR . 1.7 tp -107.15 131.97 53.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.634 1.683 . . . . 0.0 109.036 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.2 tpt85 -114.79 113.67 24.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 111.036 -2.802 . . . . 0.0 109.232 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.271 1.0 OUTLIER -68.26 165.98 17.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.447 . . . . 0.0 111.688 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.1 t -107.3 86.95 2.39 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 121.465 1.939 . . . . 0.0 107.775 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 108' ' ' ASP . 8.1 p -86.66 157.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 129.294 3.038 . . . . 0.0 110.96 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -96.84 -34.14 11.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.47 148.84 32.28 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.777 0.799 . . . . 0.0 112.685 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' D' ' 84' ' ' PHE . 4.6 tt -62.37 -29.58 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.851 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.63 5.26 38.92 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' A' ' 103' ' ' VAL . 4.7 m-20 -123.4 0.03 8.82 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.333 1.567 . . . . 0.0 113.6 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -28.8 69.32 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.49 -1.381 . . . . 0.0 113.77 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.681 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 62.5 p-90 -49.64 -44.39 47.45 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.946 0.898 . . . . 0.0 113.223 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.681 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -87.63 -12.72 44.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.252 -0.905 . . . . 0.0 113.223 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 -0.69 26.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.513 -0.742 . . . . 0.0 112.247 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.608 HG21 ' HG3' ' D' ' 96' ' ' MET . 35.2 m -110.22 139.84 44.96 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.348 1.059 . . . . 0.0 111.054 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.23 132.96 22.39 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.737 1.215 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -112.31 154.66 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 120.275 1.398 . . . . 0.0 110.961 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -174.45 27.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.938 0.78 . . . . 0.0 114.728 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 9.7 p90 -128.43 156.65 42.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.209 1.004 . . . . 0.0 112.209 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -152.16 150.23 29.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.243 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 94' ' ' LYS . 9.0 mt -126.66 121.13 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.67 149.49 34.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.6 p -138.8 165.02 28.1 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.62 117.0 2.79 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.649 0.78 . . . . 0.0 110.546 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.594 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.23 0.068 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 t -133.04 142.81 48.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.669 0.787 . . . . 0.0 110.964 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.02 135.88 33.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.155 1.782 . . . . 0.0 108.801 174.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.51 -24.78 60.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.045 1.293 . . . . 0.0 113.858 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 115.73 1.7 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.94 1.296 . . . . 0.0 111.08 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.91 -125.72 3.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.982 1.277 . . . . 0.0 110.382 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -147.48 145.81 29.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -143.51 159.85 41.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -140.26 149.21 42.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' D' ' 16' ' ' SER . 24.6 p30 -113.88 160.15 19.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -56.24 -26.07 50.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.127 2.571 . . . . 0.0 114.912 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' B' ' 110' ' ' TRP . 29.1 tp -76.48 -11.04 59.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.793 1.237 . . . . 0.0 112.074 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.17 -15.21 56.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.832 2.158 . . . . 0.0 112.994 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' SER . . . . . 0.432 ' HB2' HD21 ' D' ' 12' ' ' ASN . 15.4 m -69.76 154.75 41.54 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.64 1.21 . . . . 0.0 111.643 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -129.02 151.23 49.94 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.576 -1.327 . . . . 0.0 110.677 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -134.3 146.78 50.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -130.27 134.85 47.53 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.662 0.785 . . . . 0.0 109.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.75 124.18 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.91 -75.86 0.39 Allowed Glycine 0 CA--C 1.527 0.827 0 O-C-N 124.339 1.024 . . . . 0.0 111.394 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.85 156.99 42.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.561 0.695 . . . . 0.0 111.931 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.5 131.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.052 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -77.99 168.57 19.69 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.833 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 61.8 p -57.08 -26.65 60.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -75.04 -30.2 60.99 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.253 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.02 -8.24 18.86 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 124.666 1.127 . . . . 0.0 114.154 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.49 147.72 51.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.51 2.324 . . . . 0.0 113.683 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PHE . . . . . 0.501 ' O ' HD12 ' D' ' 50' ' ' LEU . 52.2 p90 -156.56 161.61 39.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.023 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' THR . . . . . 0.414 HG22 HD13 ' D' ' 50' ' ' LEU . 3.0 p -119.2 172.72 7.39 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 173.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.4 -167.26 35.43 Favored Glycine 0 N--CA 1.467 0.756 0 O-C-N 119.349 -2.095 . . . . 0.0 114.143 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.531 ' HB ' HD11 ' D' ' 46' ' ' LEU . 5.0 p -139.52 129.24 24.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.482 1.134 . . . . 0.0 112.301 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -111.86 138.04 49.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.268 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 80.7 mt -127.16 127.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.424 ' O ' HG21 ' D' ' 44' ' ' ILE 0.264 90.5 m -105.1 133.82 49.23 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.816 1.246 . . . . 0.0 112.849 -172.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.65 -16.51 26.9 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 m -135.5 147.05 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.065 1.346 . . . . 0.0 112.167 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.4 161.04 42.71 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.806 -1.184 . . . . 0.0 111.74 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -76.22 -28.76 57.31 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.881 -0.512 . . . . 0.0 110.587 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -143.18 78.95 14.66 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.278 2.231 . . . . 0.0 110.311 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 21.09 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.316 1 C-N-CA 125.44 4.093 . . . . 0.0 117.403 -174.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.46 -7.04 5.17 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.15 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.136 1.774 . . . . 0.0 111.392 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.424 HG21 ' O ' ' D' ' 35' ' ' THR . 71.2 mt -51.05 126.31 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.303 -1.498 . . . . 0.0 111.288 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.73 164.66 31.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.606 1.562 . . . . 0.0 110.426 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.531 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.4 tp -46.55 115.36 1.01 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.918 2.887 . . . . 0.0 110.562 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.8 t -103.2 118.63 57.44 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 123.607 0.763 . . . . 0.0 109.221 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.89 141.71 85.26 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.015 2.476 . . . . 0.0 111.094 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' LEU . . . . . 0.41 HD12 ' C ' ' D' ' 49' ' ' LEU . 2.2 pp -129.76 162.18 29.02 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.199 0.999 . . . . 0.0 111.428 174.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.501 HD12 ' O ' ' D' ' 29' ' ' PHE . 18.7 tp -165.5 148.83 8.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.703 1.201 . . . . 0.0 112.104 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.72 25.77 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 121.227 1.83 . . . . 0.0 110.456 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.4 mt -145.19 141.83 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.878 0.987 . . . . 0.0 111.591 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 133.62 43.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.988 1.315 . . . . 0.0 114.515 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -67.31 147.31 53.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.443 1.116 . . . . 0.0 112.208 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -146.06 27.76 1.15 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.614 1.965 . . . . 0.0 110.127 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.12 -57.28 2.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.629 1.572 . . . . 0.0 110.133 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 175.31 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.527 0.731 . . . . 0.0 112.5 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 p -91.76 -20.59 21.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.673 1.189 . . . . 0.0 113.706 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -133.29 46.14 1.94 Allowed Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 125.227 1.411 . . . . 0.0 112.989 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.76 170.51 19.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.692 2.261 . . . . 0.0 116.006 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.296 0.0 OUTLIER -97.89 161.98 13.47 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 124.023 1.868 . . . . 0.0 111.465 173.092 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.09 166.37 33.48 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.369 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.86 145.52 10.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 118.656 2.223 . . . . 0.0 118.656 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -161.91 152.98 18.04 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -89.44 151.15 22.17 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.62 1.968 . . . . 0.0 110.268 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 70.9 t -130.28 119.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.451 ' CB ' HG21 ' A' ' 52' ' ' ILE . 21.3 t30 -103.0 102.11 12.14 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 110.426 -174.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -58.43 129.8 43.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 124.071 1.891 . . . . 0.0 115.216 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.22 -31.58 16.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.57 -11.95 19.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 138.34 18.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.999 2.12 . . . . 0.0 106.484 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.85 118.69 17.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 43.1 t -175.66 160.04 2.41 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.486 1.514 . . . . 0.0 109.558 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.39 134.71 38.08 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.594 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.893 HG23 HD12 ' D' ' 99' ' ' LEU . 0.9 OUTLIER -122.97 138.58 54.64 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.371 174.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.69 155.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -131.29 143.65 50.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.081 0.953 . . . . 0.0 108.657 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.61 118.25 8.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.444 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -170.86 176.05 44.4 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 118.185 2.034 . . . . 0.0 118.185 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.447 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.76 150.42 23.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.943 1.025 . . . . 0.0 113.491 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 12.6 p -97.51 118.41 33.95 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.193 -1.821 . . . . 0.0 106.633 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.653 ' HB2' HD12 ' A' ' 106' ' ' ILE . 20.4 m-85 -110.01 155.35 21.94 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.662 1.119 . . . . 0.0 113.849 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 85' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 10.4 mt -115.55 110.33 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.477 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -58.81 162.02 4.39 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -23.38 1.3 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -4.57 57.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.68 0.792 . . . . 0.0 112.692 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.86 61.85 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.035 1.302 . . . . 0.0 114.977 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 22.0 mtpp -77.32 165.92 23.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.927 1.363 . . . . 0.0 110.505 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -122.06 145.12 48.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.02 1.328 . . . . 0.0 111.212 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.534 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -144.5 154.19 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.381 1.072 . . . . 0.0 110.64 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.98 103.81 10.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.534 ' CD ' HG11 ' D' ' 92' ' ' VAL . 0.6 OUTLIER -96.85 114.27 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -133.05 164.59 26.68 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 123.003 1.383 . . . . 0.0 112.382 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.608 ' HG3' HG21 ' A' ' 113' ' ' THR . 92.3 mmm -115.19 167.86 10.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -139.06 164.0 30.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.412 1.101 . . . . 0.0 113.43 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.445 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.4 OUTLIER -143.1 124.95 15.09 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.922 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 99' ' ' LEU . . . . . 0.893 HD12 HG23 ' D' ' 77' ' ' THR . 1.9 tp -107.22 132.01 53.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 123.7 1.714 . . . . 0.0 108.964 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -114.7 113.6 24.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 111.067 -2.788 . . . . 0.0 108.985 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.266 1.0 OUTLIER -67.37 165.92 15.51 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 116.875 -1.536 . . . . 0.0 111.888 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 29.7 t -107.81 87.3 2.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 121.775 2.079 . . . . 0.0 107.611 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 103' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' D' ' 108' ' ' ASP . 8.0 p -88.09 154.86 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 129.215 3.006 . . . . 0.0 110.993 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -93.5 -33.06 13.93 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.83 150.35 35.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 84' ' ' PHE . 4.6 tt -62.96 -28.83 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.485 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.3 5.75 48.44 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.838 1.208 . . . . 0.0 115.606 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' D' ' 103' ' ' VAL . 4.3 m-20 -123.3 0.42 8.94 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.273 1.536 . . . . 0.0 113.374 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -29.37 69.34 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.387 -1.446 . . . . 0.0 114.226 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.675 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 62.4 p-90 -49.37 -44.75 45.15 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.973 0.909 . . . . 0.0 113.085 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 111' ' ' LYS . . . . . 0.675 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.0 OUTLIER -87.31 -12.64 45.9 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.04 0.936 . . . . 0.0 113.279 176.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.99 1.12 21.83 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.457 -0.777 . . . . 0.0 112.402 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 96' ' ' MET . 33.9 m -111.56 139.7 46.78 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.33 1.052 . . . . 0.0 111.118 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 114' ' ' ARG . 2.0 mpt_? -144.12 133.35 23.06 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.641 1.176 . . . . 0.0 110.942 175.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.33 154.74 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 120.4 1.455 . . . . 0.0 110.978 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -173.94 27.33 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.006 0.812 . . . . 0.0 114.744 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 10.0 p90 -128.67 156.39 43.53 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.282 1.033 . . . . 0.0 112.241 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -152.18 149.78 29.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.393 1.077 . . . . 0.0 112.144 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 119' ' ' ILE . . . . . 0.439 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.4 mt -126.47 123.4 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.675 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 148.39 40.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -139.74 167.29 22.44 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 120.74 7.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.675 1.19 . . . . 0.0 112.495 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 118.778 -0.63 . . . . 0.0 109.942 177.599 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tmmt? . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.33 144.0 51.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 111.533 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.06 134.97 32.12 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.827 1.651 . . . . 0.0 109.064 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -73.46 -25.8 60.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.978 1.263 . . . . 0.0 113.683 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.54 115.69 1.45 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 111.069 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.95 -125.6 3.14 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 125.252 1.406 . . . . 0.0 110.334 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -149.58 144.12 26.0 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -142.31 159.44 42.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.577 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 t -138.96 150.36 45.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.424 HD21 ' HB2' ' B' ' 16' ' ' SER . 24.6 p30 -114.84 158.89 21.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.825 1.298 . . . . 0.0 114.347 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -54.53 -26.45 31.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.054 2.542 . . . . 0.0 114.879 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.51 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.4 tp -75.98 -12.06 60.07 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.897 1.279 . . . . 0.0 112.302 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.16 -15.7 50.67 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.132 2.301 . . . . 0.0 112.991 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.424 ' HB2' HD21 ' B' ' 12' ' ' ASN . 15.5 m -69.81 155.26 40.82 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.718 1.247 . . . . 0.0 111.706 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -129.24 150.2 50.72 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.639 -1.288 . . . . 0.0 110.511 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -133.63 147.06 51.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.371 0.605 . . . . 0.0 112.626 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -130.67 134.49 46.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.651 0.78 . . . . 0.0 109.469 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 92.9 mt -132.35 125.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -78.89 0.22 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 124.506 1.129 . . . . 0.0 111.208 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.31 152.7 33.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.629 0.728 . . . . 0.0 112.305 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.64 131.94 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.362 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -76.93 168.4 20.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 0.0 112.472 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 62.8 p -55.79 -27.51 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.58 -33.33 60.59 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.596 0.634 . . . . 0.0 112.327 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.86 -10.05 15.87 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 117.961 -1.466 . . . . 0.0 113.682 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.12 139.89 58.82 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.453 2.301 . . . . 0.0 108.861 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.79 148.54 25.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.0 p -108.94 168.4 9.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.809 1.244 . . . . 0.0 109.633 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 -168.58 37.31 Favored Glycine 0 N--CA 1.466 0.692 0 O-C-N 120.27 -1.519 . . . . 0.0 114.983 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.524 ' HB ' HD11 ' B' ' 46' ' ' LEU . 5.8 p -140.5 130.03 24.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.394 1.092 . . . . 0.0 111.765 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -111.46 138.37 48.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.191 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 78.7 mt -127.66 127.77 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.412 ' O ' HG21 ' B' ' 44' ' ' ILE 0.263 82.4 m -105.16 134.02 48.97 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.792 1.237 . . . . 0.0 112.913 -172.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 -15.44 27.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 146.54 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.936 1.294 . . . . 0.0 111.972 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.31 42.7 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.735 -1.228 . . . . 0.0 111.489 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.48 -29.21 56.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.058 -0.401 . . . . 0.0 110.408 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -142.84 79.18 15.02 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.336 2.254 . . . . 0.0 110.292 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.17 20.55 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.377 1 C-N-CA 125.389 4.06 . . . . 0.0 117.406 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.67 -8.16 5.19 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.99 43.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.702 1.751 . . . . 0.0 111.335 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.412 HG21 ' O ' ' B' ' 35' ' ' THR . 70.3 mt -51.12 125.65 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.346 -1.471 . . . . 0.0 111.35 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.17 164.48 31.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.595 1.558 . . . . 0.0 110.449 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' B' ' 32' ' ' THR . 13.3 tp -46.49 115.41 1.02 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 129.005 2.922 . . . . 0.0 110.753 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.1 t -103.17 119.83 54.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.544 0.738 . . . . 0.0 109.268 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.03 142.55 85.45 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.363 2.708 . . . . 0.0 111.385 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.38 154.92 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.119 0.887 . . . . 0.0 110.89 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.73 148.72 22.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.621 1.568 . . . . 0.0 110.364 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.0 -158.07 29.97 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 121.25 1.841 . . . . 0.0 110.691 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.3 mt -142.64 141.95 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.571 0.748 . . . . 0.0 112.749 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.57 135.01 45.65 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -69.45 149.13 48.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.8 1.286 . . . . 0.0 112.249 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -148.8 27.1 0.89 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.475 1.91 . . . . 0.0 109.841 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.71 -56.55 2.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.522 1.529 . . . . 0.0 109.721 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.89 173.64 10.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.784 0.802 . . . . 0.0 112.88 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -88.85 -23.27 22.84 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 113.505 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -131.88 48.31 3.52 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.255 1.422 . . . . 0.0 113.315 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.82 171.64 17.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.328 2.019 . . . . 0.0 115.58 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.294 0.1 OUTLIER -98.14 163.07 12.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 123.775 1.75 . . . . 0.0 111.368 173.147 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -157.92 165.74 34.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.049 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 145.6 10.63 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 118.988 2.355 . . . . 0.0 118.988 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -161.59 153.94 19.91 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -89.92 149.46 22.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.651 1.98 . . . . 0.0 110.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -128.52 118.73 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' C' ' 52' ' ' ILE . 21.6 t30 -101.81 101.83 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.477 -0.764 . . . . 0.0 110.587 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.9 129.43 42.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 123.853 1.787 . . . . 0.0 115.311 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.62 -32.25 16.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -100.07 -11.92 20.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.5 t -152.46 138.0 17.74 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.807 2.043 . . . . 0.0 106.432 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.8 118.58 16.92 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.618 1.199 . . . . 0.0 111.406 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -175.34 159.99 2.56 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.624 1.57 . . . . 0.0 109.625 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.64 134.47 37.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.293 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.882 HG23 HD12 ' B' ' 99' ' ' LEU . 0.8 OUTLIER -122.83 137.67 54.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.45 174.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -109.04 155.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -131.69 144.61 51.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.88 118.49 7.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.705 0.628 . . . . 0.0 109.965 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' NE ' ' C' ' 100' ' ' ARG . . . -170.8 176.42 44.26 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 118.201 2.041 . . . . 0.0 118.201 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.77 150.33 23.26 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 125.021 1.071 . . . . 0.0 113.82 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 10.4 p -97.51 117.43 31.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.621 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.668 ' HB2' HD12 ' C' ' 106' ' ' ILE . 17.6 m-85 -108.81 155.15 21.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 119.804 1.184 . . . . 0.0 113.864 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.19 109.57 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.751 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -58.71 164.94 2.48 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.829 0.706 . . . . 0.0 109.594 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.98 -29.93 3.86 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -8.04 56.38 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.405 1.082 . . . . 0.0 113.27 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.95 10.71 58.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.764 1.173 . . . . 0.0 115.534 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -76.6 168.44 20.07 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.06 1.43 . . . . 0.0 108.895 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -124.58 145.06 49.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.192 1.36 . . . . 0.0 110.687 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.53 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.1 t -144.12 153.76 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.197 0.999 . . . . 0.0 111.453 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -117.57 103.32 9.95 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.53 ' CD ' HG11 ' B' ' 92' ' ' VAL . 0.6 OUTLIER -96.8 113.97 25.56 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 173.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -132.8 164.66 26.34 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.099 1.428 . . . . 0.0 112.385 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.623 ' HG3' HG21 ' C' ' 113' ' ' THR . 93.1 mmm -115.73 168.09 10.34 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -139.26 164.14 30.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.637 1.208 . . . . 0.0 113.419 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' C' ' 98' ' ' LEU . 0.4 OUTLIER -142.73 125.05 15.53 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.088 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 77' ' ' THR . 1.7 tp -107.2 131.55 54.05 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 125.412 1.695 . . . . 0.0 109.27 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.405 ' NE ' ' HA2' ' C' ' 81' ' ' GLY . 3.5 tpt85 -114.82 113.65 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 110.847 -2.888 . . . . 0.0 108.947 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.261 0.9 OUTLIER -69.02 164.4 22.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.318 1.447 . . . . 0.0 111.994 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.5 t -105.45 87.95 2.73 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 121.462 1.937 . . . . 0.0 107.703 173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' B' ' 108' ' ' ASP . 7.5 p -88.04 156.04 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 129.215 3.006 . . . . 0.0 111.065 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -95.81 -33.31 12.3 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.28 148.46 34.13 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.64 0.733 . . . . 0.0 112.698 -174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' C' ' 84' ' ' PHE . 4.8 tt -62.4 -29.79 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.588 174.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.88 40.66 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.764 1.173 . . . . 0.0 115.888 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' B' ' 103' ' ' VAL . 4.5 m-20 -122.94 -0.36 9.01 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.319 1.559 . . . . 0.0 113.631 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -28.86 69.22 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.48 -1.387 . . . . 0.0 113.792 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.669 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 62.2 p-90 -49.44 -44.28 45.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.092 0.957 . . . . 0.0 113.311 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.669 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.0 OUTLIER -87.99 -12.56 44.12 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.139 -0.975 . . . . 0.0 113.294 176.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -0.54 25.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.424 0.69 . . . . 0.0 112.342 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' C' ' 96' ' ' MET . 35.5 m -110.1 139.85 44.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.289 1.036 . . . . 0.0 110.799 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' D' ' 114' ' ' ARG . 2.0 mpt_? -144.27 132.6 21.93 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.901 1.28 . . . . 0.0 111.167 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.82 154.59 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 120.213 1.37 . . . . 0.0 110.936 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.04 -174.7 28.08 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.008 0.813 . . . . 0.0 114.733 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 9.8 p90 -128.16 156.59 42.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.222 1.009 . . . . 0.0 112.272 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -152.6 148.88 27.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.299 1.04 . . . . 0.0 112.249 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.433 HD13 ' HE3' ' B' ' 94' ' ' LYS . 9.5 mt -125.31 122.74 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.424 175.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.9 148.68 38.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 28.3 p -140.35 167.78 21.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.32 123.47 16.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.888 -1.132 . . . . 0.0 113.016 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.204 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 45.3 t -132.08 143.63 50.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.828 0.851 . . . . 0.0 111.874 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 135.4 32.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.674 1.99 . . . . 0.0 109.216 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.2 mt -73.41 -24.7 60.31 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.605 1.548 . . . . 0.0 114.283 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -50.79 117.36 2.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.712 1.205 . . . . 0.0 111.237 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.98 -126.38 3.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.239 1.399 . . . . 0.0 110.295 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -147.02 143.42 28.38 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -141.43 158.58 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.682 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -139.07 148.8 43.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' C' ' 16' ' ' SER . 25.0 p30 -113.46 161.03 17.82 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.909 1.338 . . . . 0.0 114.499 175.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -57.69 -25.57 60.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.494 2.718 . . . . 0.0 114.899 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 110' ' ' TRP . 29.6 tp -77.06 -11.02 59.75 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 111.759 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.23 -16.27 53.51 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.945 2.212 . . . . 0.0 112.943 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' SER . . . . . 0.434 ' HB2' HD21 ' C' ' 12' ' ' ASN . 15.4 m -69.29 154.58 41.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.598 1.189 . . . . 0.0 111.592 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -129.1 150.74 50.36 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.613 -1.305 . . . . 0.0 110.558 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.62 145.4 48.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.362 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -129.66 134.06 47.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.52 124.14 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.95 -74.75 0.48 Allowed Glycine 0 CA--C 1.528 0.866 0 O-C-N 124.26 0.975 . . . . 0.0 111.461 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.42 43.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.943 -0.74 . . . . 0.0 111.989 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.52 130.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.192 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -77.13 168.51 19.96 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.877 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 60.2 p -56.64 -26.99 57.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.12 -29.95 60.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.976 0.807 . . . . 0.0 112.395 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.83 -7.87 19.46 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 124.585 1.088 . . . . 0.0 114.339 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.47 148.12 49.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.599 2.36 . . . . 0.0 113.132 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PHE . . . . . 0.49 ' O ' HD12 ' C' ' 50' ' ' LEU . 52.3 p90 -156.93 161.51 39.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.982 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.437 HG22 HD13 ' C' ' 50' ' ' LEU . 3.1 p -118.83 172.67 7.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.3 -167.58 35.84 Favored Glycine 0 N--CA 1.469 0.848 0 O-C-N 119.334 -2.104 . . . . 0.0 114.409 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.515 ' HB ' HD11 ' C' ' 46' ' ' LEU . 6.3 p -138.57 129.6 26.85 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.756 1.265 . . . . 0.0 112.446 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -112.05 137.64 49.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.302 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -127.31 127.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.261 90.3 m -105.03 134.46 48.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.842 1.257 . . . . 0.0 112.699 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.87 -15.73 26.07 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.88 146.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 161.19 42.71 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.795 -1.19 . . . . 0.0 111.566 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.51 -29.38 56.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.538 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -142.66 79.15 15.37 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.386 2.275 . . . . 0.0 110.377 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.28 21.04 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.386 1 C-N-CA 125.464 4.109 . . . . 0.0 117.356 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.24 -7.56 5.45 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.52 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.139 1.776 . . . . 0.0 111.439 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.12 126.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.418 -1.426 . . . . 0.0 111.379 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.4 164.67 30.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.614 1.565 . . . . 0.0 110.412 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.515 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -46.55 115.38 1.02 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 129.06 2.944 . . . . 0.0 110.545 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -102.96 119.06 56.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.547 0.739 . . . . 0.0 109.399 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.97 141.06 86.68 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.157 2.571 . . . . 0.0 111.278 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.404 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.4 pp -129.57 162.29 28.56 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.045 174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.49 HD12 ' O ' ' C' ' 29' ' ' PHE . 18.8 tp -165.36 148.82 8.19 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.991 1.717 . . . . 0.0 112.243 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.87 25.96 Favored Glycine 0 N--CA 1.448 -0.544 0 O-C-N 119.795 -1.816 . . . . 0.0 110.606 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.5 mt -145.49 142.25 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.838 0.964 . . . . 0.0 111.739 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 135.32 44.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.155 1.382 . . . . 0.0 114.384 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.88 149.58 47.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.482 1.134 . . . . 0.0 112.373 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -148.72 25.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.577 1.951 . . . . 0.0 110.065 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.88 -56.44 2.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.599 1.56 . . . . 0.0 110.347 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 173.92 8.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.773 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 3.9 p -92.25 -19.14 22.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.87 1.268 . . . . 0.0 113.674 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -133.61 46.31 1.98 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.924 1.29 . . . . 0.0 112.682 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.75 170.64 19.56 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.023 2.482 . . . . 0.0 116.19 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.292 0.0 OUTLIER -97.07 162.59 13.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 123.751 1.738 . . . . 0.0 111.282 173.088 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.55 166.11 33.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.267 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.87 145.71 10.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.95 153.49 18.6 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -89.65 150.99 22.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.765 2.026 . . . . 0.0 110.228 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 78.3 t -130.25 119.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.445 ' CB ' HG21 ' B' ' 52' ' ' ILE . 21.9 t30 -102.83 101.72 11.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -58.43 129.78 43.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.352 1.548 . . . . 0.0 115.137 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.06 -31.8 16.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.38 -11.98 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 32.4 t -152.4 138.09 17.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.827 2.051 . . . . 0.0 106.213 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -74.25 118.61 17.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.591 1.186 . . . . 0.0 111.253 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.03 159.83 2.68 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.557 1.543 . . . . 0.0 109.543 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -135.98 134.66 38.82 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.386 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.859 HG23 HD12 ' C' ' 99' ' ' LEU . 0.9 OUTLIER -123.24 138.53 54.61 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.408 0.623 . . . . 0.0 111.497 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.59 155.33 11.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -131.14 143.68 50.82 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.942 0.897 . . . . 0.0 108.77 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.35 118.45 8.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' B' ' 100' ' ' ARG . . . -170.26 176.64 43.86 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.469 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.67 150.35 23.2 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.928 1.016 . . . . 0.0 113.517 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 11.6 p -97.52 116.97 30.75 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 125.611 1.819 . . . . 0.0 107.34 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.665 ' HB2' HD12 ' B' ' 106' ' ' ILE . 17.5 m-85 -108.66 156.62 19.35 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.552 1.168 . . . . 0.0 113.604 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 9.7 mt -117.37 110.24 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.174 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -58.69 160.5 5.58 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -24.79 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -9.31 52.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.984 0.914 . . . . 0.0 113.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.18 14.97 49.88 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.673 1.13 . . . . 0.0 115.402 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -82.64 166.29 19.3 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.078 1.439 . . . . 0.0 109.075 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -122.39 145.37 48.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.605 1.548 . . . . 0.0 110.767 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.54 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.1 t -144.24 153.09 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.712 1.205 . . . . 0.0 111.106 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.25 103.65 10.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.54 ' CD ' HG11 ' C' ' 92' ' ' VAL . 0.5 OUTLIER -97.13 112.73 24.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 173.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.68 163.82 27.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.093 1.425 . . . . 0.0 112.383 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' B' ' 113' ' ' THR . 93.4 mmm -114.95 168.23 10.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -139.45 163.84 31.45 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.428 1.109 . . . . 0.0 113.376 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' B' ' 98' ' ' LEU . 0.4 OUTLIER -142.87 124.66 15.06 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.123 175.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 99' ' ' LEU . . . . . 0.859 HD12 HG23 ' C' ' 77' ' ' THR . 1.9 tp -107.2 131.95 53.59 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 123.769 1.747 . . . . 0.0 108.841 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ARG . . . . . 0.41 ' NE ' ' HA2' ' B' ' 81' ' ' GLY . 3.2 tpt85 -114.84 113.57 24.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 110.942 -2.844 . . . . 0.0 109.05 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.19 164.83 19.61 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 116.867 -1.54 . . . . 0.0 111.912 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 88.12 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 121.742 2.065 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' C' ' 108' ' ' ASP . 6.6 p -88.45 155.82 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 129.265 3.026 . . . . 0.0 111.138 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -95.08 -32.77 12.95 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -114.02 149.35 35.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.573 0.701 . . . . 0.0 112.671 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' B' ' 84' ' ' PHE . 4.8 tt -62.53 -30.22 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.795 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.65 5.28 38.94 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.598 1.094 . . . . 0.0 115.777 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 108' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' C' ' 103' ' ' VAL . 4.6 m-20 -123.09 0.08 9.01 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.361 1.581 . . . . 0.0 113.735 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.92 69.17 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.365 -1.459 . . . . 0.0 113.806 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.676 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 62.5 p-90 -49.65 -44.24 47.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.87 0.868 . . . . 0.0 113.214 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' LYS . . . . . 0.676 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.0 OUTLIER -88.16 -12.6 43.49 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.097 -1.002 . . . . 0.0 113.347 176.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 1.48 18.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.708 0.803 . . . . 0.0 112.577 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.623 HG21 ' HG3' ' B' ' 96' ' ' MET . 33.9 m -112.68 139.61 48.15 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.436 1.094 . . . . 0.0 111.207 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -144.26 133.01 22.41 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.656 1.183 . . . . 0.0 110.94 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.13 154.79 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.364 1.438 . . . . 0.0 110.897 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.39 -174.29 27.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.908 0.766 . . . . 0.0 114.76 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 10.0 p90 -128.41 156.72 42.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.219 1.008 . . . . 0.0 112.294 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -152.23 148.67 27.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 112.298 173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' C' ' 94' ' ' LYS . 9.4 mt -124.94 122.2 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.522 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 148.87 37.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.843 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 45.6 p -138.84 167.43 22.04 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.69 122.54 13.05 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.4 -0.813 . . . . 0.0 111.735 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.309 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.14 154.67 51.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.72 1.208 . . . . 0.0 108.382 173.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.91 129.92 24.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.009 -1.057 . . . . 0.0 111.597 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.1 -25.17 67.98 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -54.56 120.25 6.41 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 123.355 1.55 . . . . 0.0 112.562 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.9 -110.92 1.04 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.979 2.228 . . . . 0.0 110.242 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HD2' HD13 ' A' ' 123' ' ' LEU . 18.4 ttmt -152.99 152.1 31.02 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.73 -0.865 . . . . 0.0 113.271 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -140.16 156.33 46.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.801 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.62 146.64 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.394 177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -116.72 143.33 45.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 111.238 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.04 -24.99 57.81 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.58 1.552 . . . . 0.0 113.825 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 37' ' ' VAL . 40.5 tp -67.31 -15.94 63.98 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 120.735 -1.228 . . . . 0.0 111.821 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.09 -9.46 42.98 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 127.645 2.545 . . . . 0.0 113.242 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.4 147.99 52.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.228 -1.16 . . . . 0.0 111.925 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -126.62 151.42 48.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.198 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.41 147.33 33.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -127.97 134.98 49.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.787 0.835 . . . . 0.0 110.291 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.67 121.01 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.13 -65.17 2.7 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.671 1.232 . . . . 0.0 113.291 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.68 137.71 4.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -84.45 137.67 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.76 163.5 27.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.826 0.451 . . . . 0.0 111.348 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -23.69 50.39 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -27.35 63.79 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.137 -0.977 . . . . 0.0 111.165 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.11 48.78 Favored Glycine 0 C--O 1.224 -0.512 0 CA-C-O 117.577 -1.68 . . . . 0.0 112.958 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -70.99 144.6 50.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.779 1.289 . . . . 0.0 108.547 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -156.03 155.77 33.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.682 0.753 . . . . 0.0 112.307 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.405 ' HB ' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -127.75 158.71 36.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.395 1.878 . . . . 0.0 108.267 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.32 -170.67 34.92 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.97 -1.081 . . . . 0.0 114.747 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.416 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 35.6 p -137.53 126.23 23.84 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.696 ' C ' HD12 ' A' ' 34' ' ' ILE . 1.4 t80 -126.52 133.14 51.21 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.05 -172.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 46' ' ' LEU . 1.4 mp -121.48 135.61 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 37' ' ' VAL . 50.1 m -115.77 131.0 57.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.36 3.86 50.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 35' ' ' THR . 26.9 m -141.34 162.28 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 128.116 2.566 . . . . 0.0 108.444 -175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.46 10.51 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.893 -1.754 . . . . 0.0 111.842 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.64 -24.69 61.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.287 0.235 . . . . 0.0 110.603 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.35 84.01 4.43 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 175.95 8.72 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.815 3.01 . . . . 0.0 112.905 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.51 -33.03 2.83 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.738 1.161 . . . . 0.0 111.981 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -132.77 20.71 4.2 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 35' ' ' THR . 42.4 mt -54.16 127.87 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 122.025 0.916 . . . . 0.0 109.233 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.0 177.12 8.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.655 1.982 . . . . 0.0 107.538 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.763 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -49.0 146.1 3.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.185 172.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -124.55 113.17 27.43 Favored Pre-proline 0 N--CA 1.426 -1.629 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.674 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.75 134.63 65.69 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.237 1.958 . . . . 0.0 109.668 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.32 151.26 46.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.429 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -143.3 149.13 37.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.853 2.461 . . . . 0.0 108.012 175.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.2 -160.79 34.57 Favored Glycine 0 N--CA 1.452 -0.267 0 O-C-N 120.75 -1.219 . . . . 0.0 111.019 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.8 mt -144.58 145.57 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 111.942 -174.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.662 -1.274 . . . . 0.0 113.108 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -86.81 141.85 28.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.654 1.216 . . . . 0.0 111.191 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 29.64 2.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.029 1.332 . . . . 0.0 112.138 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -93.06 -55.05 3.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.644 2.377 . . . . 0.0 111.405 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -179.9 5.9 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -81.77 -39.27 24.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.192 1.397 . . . . 0.0 112.888 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -132.61 46.4 2.13 Favored Pre-proline 0 CA--C 1.568 1.636 0 O-C-N 125.416 1.698 . . . . 0.0 111.473 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.55 177.02 5.84 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.359 2.039 . . . . 0.0 114.676 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.326 0.1 OUTLIER -100.95 169.62 8.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 122.54 1.162 . . . . 0.0 111.603 174.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -162.63 164.18 26.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.393 -173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.39 147.78 13.73 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.836 2.294 . . . . 0.0 118.836 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -161.0 150.5 17.0 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -89.1 147.84 24.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.906 1.682 . . . . 0.0 108.21 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.8 t -129.21 119.72 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.493 ' CB ' HG21 ' D' ' 52' ' ' ILE . 38.8 t30 -102.87 102.05 12.13 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.372 -173.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -69.18 125.36 26.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 121.249 1.84 . . . . 0.0 115.684 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -81.3 -37.35 28.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.435 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.08 -22.29 36.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.603 1.161 . . . . 0.0 113.65 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.43 124.07 7.84 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.59 1.556 . . . . 0.0 108.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -60.78 115.27 3.54 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.595 1.089 . . . . 0.0 111.722 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 p -172.52 158.78 4.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.974 2.109 . . . . 0.0 110.03 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -143.47 142.5 31.2 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-O 123.175 1.464 . . . . 0.0 110.427 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 128.74 20.67 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 109.965 -3.289 . . . . 0.0 109.838 -171.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.54 154.05 6.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.773 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -128.99 141.66 51.18 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -151.82 118.25 5.66 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.36 -175.44 34.34 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.658 -1.258 . . . . 0.0 115.388 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -126.97 147.2 50.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.235 1.017 . . . . 0.0 112.196 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.41 127.25 43.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.44 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.3 m-85 -120.13 166.34 13.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.531 0.681 . . . . 0.0 112.461 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 39.6 mt -127.33 109.03 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.552 -1.658 . . . . 0.0 107.098 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.97 162.34 4.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.392 0.677 . . . . 0.0 110.162 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.42 -32.3 1.32 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.32 -21.09 53.99 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.88 19.98 11.25 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.851 1.215 . . . . 0.0 114.572 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 mtpt -90.66 153.24 20.44 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.1 1.36 . . . . 0.0 111.559 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.14 134.92 43.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.634 1.574 . . . . 0.0 110.257 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -142.16 160.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 122.13 0.967 . . . . 0.0 108.819 174.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.1 mt -124.15 119.06 28.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -106.59 117.77 34.93 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.3 167.27 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.974 1.369 . . . . 0.0 112.554 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -119.36 170.49 9.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -140.55 159.06 43.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.446 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.435 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.5 tp -134.38 121.98 21.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.406 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER -107.46 135.89 48.18 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 124.961 1.413 . . . . 0.0 112.055 -176.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.98 113.9 23.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 111.857 -2.429 . . . . 0.0 110.167 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -69.82 166.8 18.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.384 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -112.41 85.44 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.44 -161.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.33 -13.64 1.02 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.709 -1.869 . . . . 0.0 114.281 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.06 151.1 49.06 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.298 1.047 . . . . 0.0 111.931 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.454 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.9 tt -59.27 -25.49 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.117 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.65 -1.87 19.05 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.193 1.378 . . . . 0.0 114.761 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.0 7.11 6.6 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.138 0.969 . . . . 0.0 112.346 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.57 -32.14 73.66 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 119.443 -2.036 . . . . 0.0 112.866 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.462 ' CD1' HD11 ' C' ' 14' ' ' LEU . 57.8 p-90 -47.67 -40.82 20.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.789 1.235 . . . . 0.0 114.036 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -95.19 -11.61 27.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.403 1.081 . . . . 0.0 113.503 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.17 -0.8 20.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.975 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.61 143.72 42.02 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.432 1.11 . . . . 0.0 111.056 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -142.06 153.78 44.45 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.471 1.509 . . . . 0.0 109.572 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.98 151.19 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.395 1.078 . . . . 0.0 109.903 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.44 -176.69 29.77 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 121.453 0.474 . . . . 0.0 112.104 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 33.6 p90 -124.92 152.03 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.507 0.723 . . . . 0.0 109.98 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -144.53 152.41 40.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.938 0.875 . . . . 0.0 109.301 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt -128.92 135.13 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.93 148.07 45.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -132.01 158.64 40.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.099 0.96 . . . . 0.0 110.655 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.05 118.8 6.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.646 0.779 . . . . 0.0 111.641 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 123' ' ' LEU . 4.2 tt . . . . . 0 C--O 1.238 0.496 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.771 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? . . . . . 0 C--O 1.225 -0.185 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 4' ' ' CYS . . . . . 0.428 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 22.1 p -143.67 143.54 31.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.633 1.973 . . . . 0.0 107.8 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.83 128.78 23.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.59 -1.319 . . . . 0.0 112.269 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.4 -25.59 68.35 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -53.0 119.27 4.47 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.204 1.478 . . . . 0.0 112.459 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.82 -110.69 1.02 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.841 2.162 . . . . 0.0 110.865 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -152.59 151.86 31.14 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -141.33 158.76 43.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.709 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -133.86 149.04 51.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.57 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -116.19 143.33 45.65 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.904 0.881 . . . . 0.0 110.737 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -58.74 -23.16 59.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.015 1.326 . . . . 0.0 113.475 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.48 HD21 HG21 ' D' ' 37' ' ' VAL . 42.4 tp -67.85 -15.94 63.86 Favored 'General case' 0 CA--C 1.555 1.16 0 O-C-N 120.543 -1.348 . . . . 0.0 111.398 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.34 -9.38 42.02 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.65 2.548 . . . . 0.0 113.372 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -66.42 148.25 52.14 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 121.213 -1.169 . . . . 0.0 111.792 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -127.02 151.16 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.196 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 147.35 33.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -127.53 135.96 51.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.761 0.824 . . . . 0.0 109.947 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.68 119.96 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.68 -64.39 3.34 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.58 1.175 . . . . 0.0 113.25 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.56 141.36 4.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.213 1.405 . . . . 0.0 110.214 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.17 136.36 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 122.505 0.322 . . . . 0.0 110.239 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.45 163.59 27.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.275 0.63 . . . . 0.0 111.186 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -21.98 54.05 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -25.45 62.37 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.161 -0.962 . . . . 0.0 111.221 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.89 51.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.248 1.404 . . . . 0.0 113.247 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 150.76 44.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.017 0.927 . . . . 0.0 110.42 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.52 166.34 33.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.347 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' THR . . . . . 0.479 ' HB ' HD22 ' D' ' 50' ' ' LEU . 0.5 OUTLIER -134.28 160.82 36.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.444 1.898 . . . . 0.0 106.775 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.44 -170.78 35.91 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.418 -1.426 . . . . 0.0 114.599 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.414 ' HB ' ' HG ' ' D' ' 46' ' ' LEU . 35.2 p -138.22 126.62 23.21 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.408 0.623 . . . . 0.0 109.341 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' TYR . . . . . 0.691 ' C ' HD12 ' D' ' 34' ' ' ILE . 1.4 t80 -126.96 133.42 50.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.935 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.76 HD11 ' CD1' ' D' ' 46' ' ' LEU . 1.5 mp -121.46 136.28 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.69 HG22 ' O ' ' D' ' 37' ' ' VAL . 43.4 m -116.77 130.24 56.6 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 3.24 53.63 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.69 ' O ' HG22 ' D' ' 35' ' ' THR . 27.5 m -141.44 162.22 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 128.085 2.554 . . . . 0.0 108.141 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.38 10.2 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.015 -1.678 . . . . 0.0 111.738 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.52 -24.05 61.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.311 0.244 . . . . 0.0 110.652 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -154.14 83.43 4.21 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 127.277 2.231 . . . . 0.0 109.254 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.69 176.04 8.74 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.553 2.835 . . . . 0.0 112.805 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.02 -33.21 2.86 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.765 1.174 . . . . 0.0 112.33 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -132.59 20.62 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.93 1.292 . . . . 0.0 112.403 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.53 HG21 ' O ' ' D' ' 35' ' ' THR . 43.3 mt -54.18 127.7 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.236 1.017 . . . . 0.0 109.247 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.01 177.21 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.49 1.916 . . . . 0.0 107.273 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.76 ' CD1' HD11 ' D' ' 34' ' ' ILE . 0.8 OUTLIER -48.99 146.65 3.23 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.218 172.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -125.0 112.98 26.72 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 112.118 -2.31 . . . . 0.0 110.506 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -56.09 132.52 52.45 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.17 1.914 . . . . 0.0 109.263 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.32 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.274 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' D' ' 30' ' ' THR . 0.3 OUTLIER -148.42 149.22 31.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.866 2.466 . . . . 0.0 108.066 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.66 -160.24 32.58 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 121.287 -0.883 . . . . 0.0 112.781 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.493 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -144.94 145.06 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.384 1.074 . . . . 0.0 112.374 -174.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 150.97 52.01 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.626 -1.296 . . . . 0.0 112.843 175.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.38 141.66 28.47 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.696 0.76 . . . . 0.0 110.399 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.96 29.84 2.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.983 1.313 . . . . 0.0 112.517 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -92.93 -55.21 3.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.01 2.524 . . . . 0.0 111.399 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -78.95 -39.78 33.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.821 1.648 . . . . 0.0 113.037 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.34 50.14 4.7 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 125.244 1.417 . . . . 0.0 111.429 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 176.78 6.39 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.351 2.7 . . . . 0.0 115.223 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -102.23 168.79 9.13 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.732 1.253 . . . . 0.0 111.435 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -162.22 163.48 28.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.881 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.18 148.05 14.85 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 118.646 2.218 . . . . 0.0 118.646 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -161.63 149.86 15.3 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.93 149.09 23.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.259 1.823 . . . . 0.0 108.238 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.62 121.47 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.492 ' CB ' HG21 ' A' ' 52' ' ' ILE . 37.6 t30 -104.88 102.31 11.85 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.988 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -68.92 124.47 23.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -80.14 -36.81 34.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.623 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -82.6 -22.01 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 113.591 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 35.2 t -152.55 124.63 8.04 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.544 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -60.86 115.44 3.69 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.897 1.226 . . . . 0.0 111.509 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 9.4 p -172.74 158.94 4.14 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.129 2.172 . . . . 0.0 110.125 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -143.62 142.42 31.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 123.036 1.398 . . . . 0.0 110.296 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -141.8 128.54 20.42 Favored 'General case' 0 N--CA 1.402 -2.825 0 CA-C-N 110.173 -3.194 . . . . 0.0 109.971 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.95 154.41 5.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.773 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -129.65 141.35 50.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 80' ' ' THR . . . . . 0.435 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -151.58 118.22 5.74 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.95 -175.25 34.66 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.49 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -127.61 144.91 51.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.704 0.885 . . . . 0.0 112.421 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.428 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 36.8 t -97.81 123.63 41.85 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.623 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.4 m-85 -115.69 167.26 11.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 118.45 0.568 . . . . 0.0 111.692 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 30.6 mt -126.21 107.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 O-C-N 125.293 1.62 . . . . 0.0 106.741 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -58.99 160.56 5.86 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -44.22 -31.74 1.08 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 118.193 2.664 . . . . 0.0 118.193 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -76.3 -21.94 55.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.26 1.85 29.67 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.111 1.339 . . . . 0.0 115.592 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -74.09 153.66 39.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.257 1.423 . . . . 0.0 112.578 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.38 135.44 42.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.265 1.826 . . . . 0.0 109.964 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.454 HG21 ' CD1' ' A' ' 106' ' ' ILE . 20.6 m -141.97 160.08 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.029 0.931 . . . . 0.0 109.663 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -122.69 118.64 28.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -106.76 117.74 34.84 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 167.95 20.41 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.05 1.405 . . . . 0.0 112.69 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -120.06 170.57 9.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 p-90 -140.57 159.51 42.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.561 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.437 HD23 ' OG1' ' A' ' 80' ' ' THR . 3.4 tp -134.93 121.86 21.12 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.526 175.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.37 136.01 47.89 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 125.061 1.476 . . . . 0.0 111.767 -176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -117.12 113.82 22.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.288 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 71.3 m -69.55 167.04 17.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.404 174.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 2.0 p -112.37 86.11 2.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.99 -160.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -140.36 -13.19 1.03 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 119.561 -1.962 . . . . 0.0 114.093 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.57 152.13 48.66 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.565 1.174 . . . . 0.0 112.356 174.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.0 tt -59.82 -24.87 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.982 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.93 -1.13 23.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.245 1.402 . . . . 0.0 114.935 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -127.12 6.34 6.49 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.119 0.968 . . . . 0.0 111.916 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.16 -31.79 73.15 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 119.327 -2.108 . . . . 0.0 113.067 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.456 ' CD1' HD11 ' B' ' 14' ' ' LEU . 58.1 p-90 -47.33 -41.61 19.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.343 1.057 . . . . 0.0 113.768 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -94.89 -11.47 28.65 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.403 1.081 . . . . 0.0 113.131 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.02 -1.13 21.35 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.311 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -111.21 143.8 41.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.318 1.056 . . . . 0.0 111.129 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -142.16 153.65 44.23 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.328 1.451 . . . . 0.0 109.486 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.88 151.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.464 1.106 . . . . 0.0 109.724 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.59 -177.23 30.5 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.505 0.503 . . . . 0.0 112.169 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 32.7 p90 -124.28 152.21 43.3 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.901 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -145.16 151.6 38.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.554 0.742 . . . . 0.0 109.46 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 59.7 mt -128.47 136.03 61.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -123.98 148.5 46.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.667 0.387 . . . . 0.0 111.061 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 12.7 p -132.24 161.63 32.96 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.694 1.198 . . . . 0.0 111.176 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -61.51 122.26 14.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.056 0.943 . . . . 0.0 111.784 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.282 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.2 p -143.11 144.21 32.14 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 124.967 1.417 . . . . 0.0 108.529 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.73 127.72 22.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.566 -0.709 . . . . 0.0 112.569 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.85 -25.3 67.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.61 119.49 5.36 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 123.042 1.401 . . . . 0.0 111.984 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.35 -111.2 1.06 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.01 2.243 . . . . 0.0 110.447 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.45 ' HD2' HD13 ' B' ' 123' ' ' LEU . 24.3 ttmt -153.65 152.56 30.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.34 158.18 43.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.884 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.1 146.88 45.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.683 1.193 . . . . 0.0 108.35 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -116.28 143.33 45.66 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 111.188 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -57.8 -24.15 55.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.204 1.401 . . . . 0.0 113.645 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.477 HD21 HG21 ' B' ' 37' ' ' VAL . 39.9 tp -68.18 -15.59 63.64 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.644 -1.285 . . . . 0.0 111.735 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.42 43.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.732 2.587 . . . . 0.0 113.418 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.61 147.7 52.92 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.196 -1.179 . . . . 0.0 111.633 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -127.1 152.01 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.12 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.96 147.38 33.86 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -126.89 135.39 50.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.99 120.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.23 -64.85 3.02 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.662 1.226 . . . . 0.0 113.201 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.51 139.8 3.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.241 1.416 . . . . 0.0 110.163 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -86.3 137.36 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.403 0.281 . . . . 0.0 110.576 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.26 163.37 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.678 0.391 . . . . 0.0 111.246 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -23.83 50.11 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -27.11 63.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.3 -0.875 . . . . 0.0 111.285 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.84 -2.12 48.5 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.218 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.18 144.51 51.93 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.524 1.162 . . . . 0.0 108.542 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.79 156.12 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 112.157 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.5 158.33 38.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.341 1.856 . . . . 0.0 108.201 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.33 -170.5 34.73 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 120.973 -1.079 . . . . 0.0 114.758 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 35.9 p -137.19 126.51 24.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.065 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.694 ' C ' HD12 ' B' ' 34' ' ' ILE . 1.5 t80 -126.74 133.31 50.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.72 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' B' ' 46' ' ' LEU . 1.5 mp -121.41 136.24 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.698 HG22 ' O ' ' B' ' 37' ' ' VAL . 42.7 m -116.39 130.54 56.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.29 2.7 53.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.302 1.049 . . . . 0.0 113.828 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.698 ' O ' HG22 ' B' ' 35' ' ' THR . 28.2 m -141.09 161.66 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.348 2.259 . . . . 0.0 108.373 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.61 166.67 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 119.971 -1.706 . . . . 0.0 111.909 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.0 -24.65 62.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 122.461 -0.149 . . . . 0.0 110.674 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.3 83.73 4.51 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.152 2.181 . . . . 0.0 109.22 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.54 175.92 8.82 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.842 3.028 . . . . 0.0 112.9 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.41 -33.21 2.81 Favored Glycine 0 N--CA 1.476 1.324 0 C-N-CA 124.715 1.15 . . . . 0.0 112.219 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -132.62 20.75 4.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.005 1.322 . . . . 0.0 112.359 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.514 HG21 ' O ' ' B' ' 35' ' ' THR . 43.9 mt -54.25 127.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.08 0.943 . . . . 0.0 109.141 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.19 176.46 8.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.758 2.023 . . . . 0.0 107.57 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.759 ' CD1' HD11 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -48.49 146.3 3.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.258 172.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -125.02 113.26 26.62 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 112.07 -2.332 . . . . 0.0 110.57 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -56.4 134.68 65.79 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.135 1.89 . . . . 0.0 109.65 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.04 151.22 45.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.486 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -143.32 149.19 37.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.821 2.449 . . . . 0.0 107.839 174.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 -161.28 35.11 Favored Glycine 0 N--CA 1.451 -0.326 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.498 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.8 mt -144.56 144.91 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.961 0.904 . . . . 0.0 111.799 -174.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.18 148.26 52.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.301 1.04 . . . . 0.0 113.323 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -84.65 141.31 30.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.099 0.952 . . . . 0.0 111.069 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.05 30.72 2.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.95 1.3 . . . . 0.0 112.222 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -93.33 -55.38 3.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.94 2.496 . . . . 0.0 111.72 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.97 179.51 6.17 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.0 m -82.98 -35.53 25.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.842 1.257 . . . . 0.0 113.264 174.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -135.04 49.01 3.29 Favored Pre-proline 0 CA--C 1.562 1.434 0 O-C-N 125.377 1.673 . . . . 0.0 111.4 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.44 177.5 5.98 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.079 2.52 . . . . 0.0 115.272 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.347 0.1 OUTLIER -102.13 168.06 9.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.027 1.394 . . . . 0.0 111.749 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -161.41 163.03 30.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.84 -173.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.66 147.26 13.02 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 118.81 2.284 . . . . 0.0 118.81 -173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.9 m -89.28 147.95 23.83 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.066 1.746 . . . . 0.0 108.338 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.34 119.8 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.489 ' CB ' HG21 ' C' ' 52' ' ' ILE . 37.8 t30 -102.67 102.09 12.26 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.352 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -69.07 125.64 27.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.278 1.854 . . . . 0.0 115.707 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.36 -37.46 28.21 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.514 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.83 -22.14 37.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.516 1.127 . . . . 0.0 113.647 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -152.42 124.79 8.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.722 1.609 . . . . 0.0 108.699 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.97 116.29 4.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.803 1.183 . . . . 0.0 111.173 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 9.2 p -173.01 158.79 3.83 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.059 2.143 . . . . 0.0 109.856 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -143.36 142.6 31.34 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-O 123.117 1.437 . . . . 0.0 110.531 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -142.12 128.46 19.97 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 110.084 -3.234 . . . . 0.0 109.927 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.33 153.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.741 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.11 142.29 50.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.44 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -152.29 118.61 5.59 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -174.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -162.72 -176.75 35.11 Favored Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -127.68 143.22 51.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.36 0.682 . . . . 0.0 112.169 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 49.9 t -97.52 124.84 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.07 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.402 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.01 168.27 10.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.239 1.019 . . . . 0.0 111.794 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 30.2 mt -124.79 109.54 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.286 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -58.62 157.33 9.36 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -42.31 -30.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.91 -19.38 54.79 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.81 8.57 27.88 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 125.073 1.32 . . . . 0.0 115.583 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 4.6 mtpp -87.48 152.94 21.82 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.931 1.366 . . . . 0.0 112.585 -176.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -100.96 134.83 43.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.565 1.546 . . . . 0.0 110.016 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 m -144.14 145.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 38.0 mt -118.89 92.42 3.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.47 1.129 . . . . 0.0 111.227 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -83.4 113.13 20.53 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.074 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.414 HG22 ' HA3' ' B' ' 81' ' ' GLY . 4.8 p -135.29 168.48 19.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.559 1.647 . . . . 0.0 112.801 -174.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -120.12 170.44 9.3 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 124.608 1.163 . . . . 0.0 107.901 172.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -141.11 159.05 43.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.427 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.5 tp -134.41 122.15 22.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.404 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . 0.262 0.4 OUTLIER -107.53 134.64 50.25 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 125.047 1.467 . . . . 0.0 112.216 -176.098 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 5.4 tpt180 -115.55 114.06 24.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 112.001 -2.363 . . . . 0.0 110.048 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.259 72.9 m -70.09 167.97 16.56 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.266 1.604 . . . . 0.0 111.465 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -113.29 85.38 2.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 -160.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -140.52 -13.21 1.0 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 119.569 -1.957 . . . . 0.0 114.223 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.17 151.17 49.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.509 1.147 . . . . 0.0 112.003 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' C' ' 84' ' ' PHE . 2.2 tt -58.57 -25.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.407 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.64 -2.36 28.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.038 1.304 . . . . 0.0 114.626 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.33 5.87 7.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.214 1.006 . . . . 0.0 112.137 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.5 -32.12 73.63 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 119.55 -1.969 . . . . 0.0 112.668 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.7 p-90 -48.0 -41.25 24.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.726 1.21 . . . . 0.0 113.718 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -94.37 -11.43 29.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.349 1.059 . . . . 0.0 113.494 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.1 -0.91 20.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.105 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -111.6 143.65 42.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.168 0.985 . . . . 0.0 111.244 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -142.38 153.48 43.82 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.316 1.446 . . . . 0.0 109.524 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.26 150.64 33.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.689 1.131 . . . . 0.0 109.517 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.99 -177.02 29.71 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.375 0.512 . . . . 0.0 112.184 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 34.9 p90 -124.42 151.77 44.09 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -144.17 151.22 39.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.998 0.904 . . . . 0.0 109.22 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.19 134.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -122.25 149.83 43.15 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.042 0.448 . . . . 0.0 111.038 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 5.3 p -130.86 159.82 36.24 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.94 1.296 . . . . 0.0 110.647 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -58.69 123.81 17.62 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.5 0.72 . . . . 0.0 111.495 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.45 HD13 ' HD2' ' B' ' 9' ' ' LYS . 2.7 tt . . . . . 0 CA--C 1.527 0.064 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.561 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? . . . . . 0 CA--C 1.515 -0.376 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 26.6 p -148.37 145.02 27.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.595 1.184 . . . . 0.0 109.788 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.74 127.92 22.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.53 -25.64 68.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.34 118.39 4.07 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.863 1.316 . . . . 0.0 112.08 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.55 -112.17 1.17 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.955 2.217 . . . . 0.0 110.667 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -150.58 151.77 33.09 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -142.0 157.44 44.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.577 -2.101 . . . . 0.0 111.226 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 147.95 50.58 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -115.87 143.41 45.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.929 0.892 . . . . 0.0 110.879 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.1 -24.21 52.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.332 1.453 . . . . 0.0 113.638 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.478 HD21 HG21 ' C' ' 37' ' ' VAL . 37.9 tp -67.85 -15.07 63.45 Favored 'General case' 0 CA--C 1.556 1.182 0 O-C-N 120.773 -1.204 . . . . 0.0 111.819 173.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.39 -9.35 45.37 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.723 2.582 . . . . 0.0 113.324 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -66.62 147.02 53.85 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.202 -1.175 . . . . 0.0 111.618 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -126.52 152.04 47.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.8 147.41 34.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -127.39 135.85 51.05 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.842 0.857 . . . . 0.0 110.22 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -128.31 119.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.51 -63.99 3.75 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.605 1.191 . . . . 0.0 113.308 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.23 143.16 4.22 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.51 1.524 . . . . 0.0 110.265 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.93 135.66 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.735 0.414 . . . . 0.0 110.274 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.7 163.38 28.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.337 0.655 . . . . 0.0 111.287 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -22.02 53.68 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -25.56 62.29 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.23 -0.919 . . . . 0.0 111.253 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.59 51.4 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.273 1.416 . . . . 0.0 113.225 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.1 150.37 43.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 110.333 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.14 166.32 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.795 0.807 . . . . 0.0 111.122 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.484 ' HB ' HD22 ' C' ' 50' ' ' LEU . 0.5 OUTLIER -134.49 160.72 37.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.529 1.932 . . . . 0.0 106.844 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.64 -170.9 36.2 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.327 -1.483 . . . . 0.0 114.822 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -137.61 126.63 24.27 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.565 0.698 . . . . 0.0 109.383 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.699 ' C ' HD12 ' C' ' 34' ' ' ILE . 1.6 t80 -126.73 133.45 50.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.466 -172.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.748 HD11 ' CD1' ' C' ' 46' ' ' LEU . 1.6 mp -121.49 136.29 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.687 HG22 ' O ' ' C' ' 37' ' ' VAL . 33.4 m -116.92 130.55 56.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -172.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.14 5.08 50.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.687 ' O ' HG22 ' C' ' 35' ' ' THR . 28.7 m -143.2 161.25 17.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.149 2.179 . . . . 0.0 108.261 -175.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.31 166.96 12.34 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.786 -1.821 . . . . 0.0 111.757 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.78 -23.72 61.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.162 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -153.41 84.08 4.39 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 127.211 2.205 . . . . 0.0 109.373 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.69 176.02 8.77 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.557 2.838 . . . . 0.0 112.805 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.04 -33.14 2.87 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.776 1.179 . . . . 0.0 112.284 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -132.64 20.57 4.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.026 1.33 . . . . 0.0 112.328 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.521 HG21 ' O ' ' C' ' 35' ' ' THR . 44.8 mt -54.11 127.82 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.249 1.023 . . . . 0.0 109.234 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.13 177.24 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.486 1.914 . . . . 0.0 107.296 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.748 ' CD1' HD11 ' C' ' 34' ' ' ILE . 1.0 OUTLIER -49.0 146.82 3.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.118 172.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -125.23 113.08 26.13 Favored Pre-proline 0 N--CA 1.426 -1.651 0 CA-C-N 112.042 -2.345 . . . . 0.0 110.398 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -56.01 132.25 50.84 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.03 1.82 . . . . 0.0 109.223 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.65 154.93 36.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.323 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' C' ' 30' ' ' THR . 0.3 OUTLIER -148.6 149.23 31.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.827 2.451 . . . . 0.0 108.142 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.72 -160.04 32.41 Favored Glycine 0 CA--C 1.517 0.186 0 O-C-N 121.383 -0.823 . . . . 0.0 112.71 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.489 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.36 144.95 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.319 1.047 . . . . 0.0 112.149 -174.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 152.04 51.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.857 1.263 . . . . 0.0 112.909 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -88.93 140.87 29.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.05 0.929 . . . . 0.0 111.038 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 30.15 2.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.735 1.214 . . . . 0.0 112.237 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -93.37 -55.48 3.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.98 2.512 . . . . 0.0 111.714 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -179.76 5.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -83.94 -35.76 23.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.671 1.188 . . . . 0.0 112.95 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -134.34 48.06 2.87 Favored Pre-proline 0 CA--C 1.564 1.49 0 O-C-N 125.388 1.68 . . . . 0.0 111.823 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.09 176.42 6.28 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.148 2.565 . . . . 0.0 115.518 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.337 0.2 OUTLIER -101.05 169.91 8.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.674 1.226 . . . . 0.0 111.414 174.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.86 163.31 26.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.733 -173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 147.88 14.19 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -161.66 149.81 15.2 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.58 149.21 23.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.245 1.818 . . . . 0.0 108.221 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.63 121.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.498 ' CB ' HG21 ' B' ' 52' ' ' ILE . 39.8 t30 -104.32 102.19 11.88 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.198 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -68.44 124.35 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.854 1.661 . . . . 0.0 115.427 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -80.07 -37.55 33.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.641 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.78 -22.23 37.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 113.692 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.6 t -152.51 124.61 8.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.75 1.62 . . . . 0.0 108.66 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.68 116.52 4.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.587 1.085 . . . . 0.0 111.132 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 8.6 p -173.29 158.36 3.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.15 2.18 . . . . 0.0 110.02 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -142.69 142.01 31.93 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-O 123.181 1.467 . . . . 0.0 110.488 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.86 128.05 19.76 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 110.015 -3.266 . . . . 0.0 110.091 -171.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.66 154.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.785 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.47 141.99 50.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.433 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -152.27 118.69 5.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -174.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -163.07 -176.12 34.78 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -128.9 143.1 50.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 124.484 0.755 . . . . 0.0 112.319 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 49.0 t -97.56 122.69 40.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.527 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' B' ' 106' ' ' ILE . 3.5 m-85 -114.0 167.81 10.34 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.551 0.691 . . . . 0.0 111.638 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.71 108.34 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.082 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.56 160.93 4.98 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.05 -31.09 0.84 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -79.99 -15.08 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.03 5.6 40.72 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.884 1.23 . . . . 0.0 115.682 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 152.63 28.53 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.017 1.408 . . . . 0.0 112.543 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -100.72 135.96 41.33 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.496 1.518 . . . . 0.0 109.131 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.56 147.36 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.265 1.026 . . . . 0.0 111.36 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 40.7 mt -119.97 92.38 3.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.682 1.23 . . . . 0.0 111.772 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -83.59 112.57 20.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.903 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.418 HG22 ' HA3' ' C' ' 81' ' ' GLY . 4.5 p -134.36 168.95 17.98 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.607 1.194 . . . . 0.0 112.831 -174.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -120.94 170.7 9.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 38.9 p-90 -140.53 159.83 41.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.385 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.44 HD23 ' OG1' ' B' ' 80' ' ' THR . 3.3 tp -135.16 122.1 21.19 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.474 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.43 134.98 49.68 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.927 1.392 . . . . 0.0 111.863 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.16 114.09 23.98 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 111.974 -2.375 . . . . 0.0 110.078 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 71.4 m -69.74 168.09 15.74 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 125.299 1.624 . . . . 0.0 111.681 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -112.94 85.64 2.21 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.53 -160.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -141.45 -11.61 0.92 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 119.518 -1.989 . . . . 0.0 114.406 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.46 150.47 50.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.284 1.04 . . . . 0.0 111.723 174.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 84' ' ' PHE . 2.2 tt -58.13 -25.44 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.4 -2.81 28.97 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.97 1.272 . . . . 0.0 114.611 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.42 6.17 7.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.164 0.986 . . . . 0.0 112.309 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.47 -32.69 74.2 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.757 -1.84 . . . . 0.0 112.741 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.2 p-90 -48.28 -41.77 28.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.684 1.194 . . . . 0.0 113.697 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -93.93 -11.67 30.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.242 1.017 . . . . 0.0 113.329 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.61 -1.23 20.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.077 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.35 143.71 41.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.002 0.906 . . . . 0.0 111.373 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -142.56 153.33 43.45 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.463 1.505 . . . . 0.0 109.504 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.04 151.1 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 109.358 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.03 -177.77 30.47 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 121.813 0.674 . . . . 0.0 112.244 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 34.8 p90 -123.84 151.33 43.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.4 0.68 . . . . 0.0 109.419 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -144.18 151.4 39.46 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.995 0.902 . . . . 0.0 108.83 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.67 133.71 67.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -120.81 149.71 42.14 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.134 0.492 . . . . 0.0 111.093 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 33.2 p -134.6 163.48 29.64 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 110.907 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.48 123.76 20.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.062 0.945 . . . . 0.0 113.132 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.3 157.55 24.79 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 p -139.38 127.19 22.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.349 -0.844 . . . . 0.0 113.102 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.542 HD12 ' CD ' ' A' ' 53' ' ' GLN . 33.5 mt -69.39 -27.05 64.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.017 0.527 . . . . 0.0 111.777 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -62.91 120.77 11.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.67 24.86 1.49 Allowed Glycine 0 N--CA 1.476 1.309 0 N-CA-C 118.001 1.96 . . . . 0.0 118.001 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 tttt 69.3 145.96 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.894 2.478 . . . . 0.0 116.911 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -140.99 158.91 43.28 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.334 1.454 . . . . 0.0 112.538 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -132.45 142.85 49.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.853 1.261 . . . . 0.0 108.622 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.75 143.69 44.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.47 1.108 . . . . 0.0 110.128 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -57.06 -30.37 64.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.52 -11.73 61.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.311 1.444 . . . . 0.0 112.586 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.92 -11.19 37.88 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 127.503 2.477 . . . . 0.0 113.519 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -61.06 145.67 50.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 122.781 1.277 . . . . 0.0 112.326 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -122.81 139.99 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -132.71 145.27 50.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.94 0.876 . . . . 0.0 112.416 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 m -128.78 125.54 38.05 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.2 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.77 127.67 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.34 -88.86 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 O-C-N 125.647 1.842 . . . . 0.0 111.08 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.82 143.52 36.86 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.084 -0.657 . . . . 0.0 110.733 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.47 HG21 ' CG ' ' A' ' 53' ' ' GLN . 7.4 p -95.03 131.92 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.656 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -72.52 159.14 34.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.079 0.943 . . . . 0.0 112.919 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.0 m -54.47 -28.46 44.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.774 1.23 . . . . 0.0 114.212 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -71.11 -34.91 71.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.085 0.554 . . . . 0.0 112.472 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.81 -8.81 12.75 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.531 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 155.27 40.43 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.459 1.63 . . . . 0.0 108.271 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.47 166.12 32.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.975 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.5 148.04 52.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.24 26.34 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 122.554 1.086 . . . . 0.0 113.298 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.492 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -139.49 139.45 36.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.021 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.71 129.52 55.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.929 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -118.28 128.51 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 m -106.11 143.55 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.404 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 -15.63 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 15.9 m -135.03 142.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 113.154 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.56 168.91 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.39 -38.78 26.0 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.33 74.37 77.46 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.323 1.849 . . . . 0.0 109.227 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.64 6.5 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.165 3.243 . . . . 0.0 117.348 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.66 -21.29 0.8 Allowed Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.04 42.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.709 1.255 . . . . 0.0 111.945 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.59 134.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.835 0.826 . . . . 0.0 111.518 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 0.6 OUTLIER -152.48 171.82 17.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 0.0 111.22 176.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.2 tp -46.69 117.4 1.63 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 129.496 3.119 . . . . 0.0 112.438 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.7 m -111.79 114.05 52.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.899 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.18 145.15 66.88 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.324 2.683 . . . . 0.0 112.82 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.34 51.99 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.526 1.13 . . . . 0.0 111.864 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.75 149.85 39.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.188 2.995 . . . . 0.0 109.282 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.99 -155.33 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.3 mt -144.82 139.56 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.996 0.903 . . . . 0.0 112.637 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.542 ' CD ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -119.54 155.74 31.61 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.355 -0.841 . . . . 0.0 111.06 172.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.24 164.02 21.47 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.767 -1.208 . . . . 0.0 110.723 172.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.94 25.32 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.402 1.081 . . . . 0.0 112.924 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.84 -55.36 3.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.07 2.148 . . . . 0.0 110.454 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 173.19 12.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.711 1.243 . . . . 0.0 113.217 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -43.61 60.58 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.789 2.036 . . . . 0.0 112.176 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -131.41 53.75 12.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.952 1.301 . . . . 0.0 110.309 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.57 176.71 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.161 1.907 . . . . 0.0 116.272 -174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -88.34 161.85 16.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.504 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.37 164.48 29.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.249 -0.907 . . . . 0.0 112.46 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.84 149.47 15.7 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 120.397 2.919 . . . . 0.0 120.397 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -164.29 154.38 14.5 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -90.04 150.57 22.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.047 2.139 . . . . 0.0 109.332 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -129.97 120.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 59.4 t30 -95.59 106.01 18.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.653 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.12 131.88 46.72 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 121.234 1.834 . . . . 0.0 112.766 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.07 -38.22 12.33 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -90.38 -10.74 42.8 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -152.44 132.5 13.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 127.705 2.402 . . . . 0.0 106.847 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -69.85 118.49 12.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.546 1.066 . . . . 0.0 110.173 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -173.53 170.26 4.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.481 1.912 . . . . 0.0 109.769 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.89 137.95 31.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.979 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.446 ' CG2' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -114.29 165.99 12.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.327 1.06 . . . . 0.0 108.617 173.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 149.9 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.01 142.11 51.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.46 120.3 9.93 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 179.79 39.46 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 118.935 -1.602 . . . . 0.0 117.079 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.49 147.93 36.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 112.176 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.4 t -97.48 129.0 44.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.866 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' D' ' 106' ' ' ILE . 0.6 OUTLIER -124.1 169.18 11.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.729 1.252 . . . . 0.0 113.72 177.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.8 mt -131.49 107.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 112.642 -2.072 . . . . 0.0 106.85 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -58.86 157.28 9.96 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.46 -55.13 0.05 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.148 2.179 . . . . 0.0 116.449 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.93 -19.85 62.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.39 1.876 . . . . 0.0 115.976 -173.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.73 53.65 1.19 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -125.59 136.03 52.84 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 126.834 2.053 . . . . 0.0 108.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.34 142.65 32.43 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 111.094 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' D' ' 106' ' ' ILE . 15.1 m -147.23 166.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.188 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.34 122.34 33.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' D' ' 106' ' ' ILE . 1.5 mmmt -109.37 116.18 31.35 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.86 160.11 39.85 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.194 1.473 . . . . 0.0 112.15 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -108.25 167.75 9.8 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 172.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -141.32 160.81 39.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.649 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.3 tt -143.84 127.43 17.02 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.783 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' ' 77' ' ' THR . 1.0 OUTLIER -110.85 144.65 39.55 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 125.172 1.545 . . . . 0.0 110.818 -175.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.426 ' CZ ' ' HA2' ' D' ' 81' ' ' GLY . 2.3 tpt85 -128.27 116.01 19.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 112.209 -2.268 . . . . 0.0 112.115 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -89.43 158.68 17.64 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 113.396 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -103.68 80.76 1.82 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.7 m -66.8 -173.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.996 0.518 . . . . 0.0 109.658 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.16 -20.83 9.68 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.984 -1.698 . . . . 0.0 114.783 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -124.66 152.42 43.68 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.791 1.282 . . . . 0.0 111.459 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.582 HD11 ' HE2' ' D' ' 94' ' ' LYS . 10.3 tt -62.44 -27.5 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.181 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.99 23.62 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.291 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -120.08 -0.91 10.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.037 1.419 . . . . 0.0 113.937 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.76 -32.4 69.24 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.968 . . . . 0.0 112.947 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 60.1 p-90 -45.53 -44.6 12.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.609 1.164 . . . . 0.0 113.892 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -93.42 -12.86 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.86 0.864 . . . . 0.0 113.111 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.65 5.57 8.98 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.0 m -113.83 135.5 53.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.909 0.884 . . . . 0.0 111.824 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.67 126.49 22.29 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.61 154.92 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 120.524 1.511 . . . . 0.0 112.235 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.55 30.02 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.606 1.098 . . . . 0.0 113.177 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 24.4 p90 -129.28 153.67 47.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.771 0.828 . . . . 0.0 109.995 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -148.62 149.1 30.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.131 0.972 . . . . 0.0 109.716 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.32 130.63 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.39 -0.819 . . . . 0.0 109.28 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -118.52 153.86 33.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.255 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -137.51 165.1 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.202 1.001 . . . . 0.0 110.447 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -60.83 116.7 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 110.783 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.53 0.183 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 178.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 10.1 p -131.32 142.95 50.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 124.147 0.979 . . . . 0.0 108.388 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 21.1 p -132.63 127.47 35.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' D' ' 53' ' ' GLN . 28.7 mt -68.21 -26.56 65.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.292 1.037 . . . . 0.0 112.425 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 t -62.57 121.02 12.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.34 40.55 0.62 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 mttt 56.53 150.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 129.087 2.955 . . . . 0.0 118.371 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -142.55 161.97 36.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.567 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -131.76 148.17 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.305 1.442 . . . . 0.0 107.552 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.42 143.41 45.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 109.988 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -56.4 -28.86 60.57 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.23 -12.48 61.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.938 1.695 . . . . 0.0 113.018 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.8 -8.44 36.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.142 2.306 . . . . 0.0 113.775 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -63.59 147.0 52.64 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.827 1.313 . . . . 0.0 112.066 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -124.66 137.83 54.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -130.33 147.18 52.01 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.112 0.958 . . . . 0.0 113.121 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 14.6 m -131.31 125.25 32.28 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.14 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.94 126.55 73.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 -88.05 0.1 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 126.09 2.119 . . . . 0.0 111.073 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.36 142.59 35.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.246 0.618 . . . . 0.0 110.661 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.458 HG21 ' CG ' ' D' ' 53' ' ' GLN . 7.3 p -95.09 133.02 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.722 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -71.92 160.07 33.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.206 1.003 . . . . 0.0 113.316 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 15.8 m -53.76 -27.33 28.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.249 1.419 . . . . 0.0 114.455 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.99 -34.03 68.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.282 0.633 . . . . 0.0 112.625 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.74 -9.83 12.57 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.981 1.277 . . . . 0.0 113.432 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.3 157.42 37.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.907 1.354 . . . . 0.0 110.634 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.82 166.3 33.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.332 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -131.03 147.68 52.66 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.46 -168.67 24.73 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.859 1.255 . . . . 0.0 112.904 -174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' D' ' 46' ' ' LEU . 9.5 p -140.06 139.53 35.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.396 -1.402 . . . . 0.0 112.202 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -118.52 132.92 56.21 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.861 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 60.3 mt -121.47 129.31 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 55.1 m -107.36 143.42 35.68 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.538 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.63 -15.73 18.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.73 142.62 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.012 0.925 . . . . 0.0 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.35 169.19 22.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.216 -0.928 . . . . 0.0 110.967 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -38.77 25.35 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.15 74.41 77.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.573 1.949 . . . . 0.0 109.375 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.75 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.13 3.22 . . . . 0.0 117.332 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.52 -21.35 0.77 Allowed Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.531 2.172 . . . . 0.0 118.531 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.06 42.38 0.08 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 111.929 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -50.29 133.56 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.397 -0.815 . . . . 0.0 111.748 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . 0.259 0.6 OUTLIER -151.81 171.54 17.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 111.377 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' D' ' 32' ' ' THR . 12.3 tp -46.62 118.38 1.99 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.096 2.958 . . . . 0.0 112.116 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 69.6 m -113.08 112.52 49.86 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.256 1.022 . . . . 0.0 108.581 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -54.47 145.71 56.13 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.143 2.562 . . . . 0.0 112.593 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 143.96 51.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.43 1.092 . . . . 0.0 111.525 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -144.34 151.42 39.31 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 129.021 2.928 . . . . 0.0 109.446 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.55 -155.39 26.43 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -145.07 139.1 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.446 -0.877 . . . . 0.0 112.333 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 53' ' ' GLN . . . . . 0.522 ' CD ' HD12 ' D' ' 6' ' ' LEU . 0.0 OUTLIER -119.42 155.05 32.72 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.176 0.99 . . . . 0.0 110.79 173.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.15 163.98 22.7 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.43 -1.419 . . . . 0.0 110.81 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.16 26.43 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.231 1.013 . . . . 0.0 112.865 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.4 -56.69 2.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.019 2.128 . . . . 0.0 110.622 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.37 171.86 14.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.376 1.084 . . . . 0.0 113.356 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -43.82 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.2 1.4 . . . . 0.0 111.032 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -132.37 57.67 30.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 111.283 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.61 177.21 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 N-CA-C 116.767 1.795 . . . . 0.0 116.767 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -88.88 162.22 16.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.588 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.63 165.56 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.715 -1.241 . . . . 0.0 112.38 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.91 149.47 15.12 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.7 156.9 18.57 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -92.98 151.07 20.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.23 2.212 . . . . 0.0 108.967 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.41 121.97 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 53.5 t30 -97.77 106.73 19.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.414 -174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -67.16 131.7 46.32 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.807 1.639 . . . . 0.0 112.73 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.87 -38.13 12.5 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -90.42 -10.94 41.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.5 132.27 13.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.045 2.538 . . . . 0.0 107.068 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -69.54 118.61 12.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.298 0.954 . . . . 0.0 110.39 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 72.5 p -173.97 170.05 3.93 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 109.886 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -140.9 137.78 33.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.445 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.448 ' CG2' HD12 ' D' ' 99' ' ' LEU . 0.6 OUTLIER -114.25 165.53 12.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.205 1.002 . . . . 0.0 108.478 173.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.91 150.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.95 142.03 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.33 120.52 10.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 100' ' ' ARG . . . -165.46 -179.86 39.46 Favored Glycine 0 CA--C 1.497 -1.033 0 N-CA-C 117.274 1.67 . . . . 0.0 117.274 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.98 145.34 41.68 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.692 0.878 . . . . 0.0 112.236 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.485 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 28.1 t -97.76 125.25 42.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.439 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -120.19 169.84 9.87 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.456 1.122 . . . . 0.0 113.618 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.8 mt -130.6 107.24 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.056 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.15 155.31 14.25 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.477 0.711 . . . . 0.0 109.097 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -24.15 -56.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 127.091 2.157 . . . . 0.0 116.704 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.23 -17.83 63.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.43 47.89 1.62 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.501 1.046 . . . . 0.0 110.632 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -119.78 139.61 52.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.477 1.511 . . . . 0.0 110.025 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -101.39 143.69 31.12 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 111.108 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 106' ' ' ILE . 15.2 m -148.09 164.28 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.928 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 93' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' D' ' 83' ' ' CYS . 58.5 mt -124.34 120.52 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.582 ' HE2' HD11 ' A' ' 106' ' ' ILE . 1.7 mmmt -108.75 115.15 29.55 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 172.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -136.57 161.58 35.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 123.319 1.533 . . . . 0.0 111.667 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.418 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -110.01 168.53 9.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -142.11 161.28 38.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.306 173.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -144.29 127.06 16.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.808 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 99' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' D' ' 77' ' ' THR . 1.0 OUTLIER -110.62 144.71 39.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.554 1.159 . . . . 0.0 110.898 -176.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.11 114.59 17.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.011 -2.359 . . . . 0.0 112.13 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 85.7 p -86.97 158.6 19.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 124.813 1.32 . . . . 0.0 113.462 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -103.68 81.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.85 -173.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.039 0.535 . . . . 0.0 109.838 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -115.83 -21.0 9.79 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.119 -1.613 . . . . 0.0 114.789 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -123.85 151.3 43.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.486 1.136 . . . . 0.0 111.702 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.608 HD11 ' HE2' ' A' ' 94' ' ' LYS . 10.8 tt -61.93 -27.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.055 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.77 4.32 22.68 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.356 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -120.13 -0.19 10.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.905 1.353 . . . . 0.0 113.935 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -60.08 -31.38 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.358 -0.839 . . . . 0.0 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 60.4 p-90 -46.54 -44.21 17.66 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.53 1.132 . . . . 0.0 113.97 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -93.63 -12.79 28.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.011 0.924 . . . . 0.0 113.161 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.64 5.11 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' D' ' 98' ' ' LEU . 14.5 m -113.08 135.6 53.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.862 0.865 . . . . 0.0 111.726 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.57 126.25 22.14 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.611 -1.185 . . . . 0.0 110.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.91 154.82 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.298 1.408 . . . . 0.0 111.821 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.86 -175.87 30.27 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.687 1.137 . . . . 0.0 113.096 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.0 p90 -126.47 153.43 45.09 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.623 0.769 . . . . 0.0 109.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.08 148.24 30.43 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.036 0.934 . . . . 0.0 109.271 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 64.9 mt -128.2 131.5 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.031 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -117.74 156.76 27.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.222 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -137.53 160.95 37.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.591 1.156 . . . . 0.0 110.195 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.18 129.54 42.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.891 -0.506 . . . . 0.0 109.735 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.764 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.411 ' HG ' ' HB3' ' B' ' 83' ' ' CYS . 25.0 p -130.15 147.49 51.89 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.323 1.049 . . . . 0.0 108.275 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -137.64 127.46 25.5 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.53 HD12 ' CD ' ' B' ' 53' ' ' GLN . 28.5 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.549 0.74 . . . . 0.0 112.43 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.09 120.08 10.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.75 43.18 0.5 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt 53.6 148.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.388 3.075 . . . . 0.0 119.175 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -140.83 160.1 40.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.929 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 142.26 47.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.121 1.368 . . . . 0.0 108.514 175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.32 143.5 42.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.966 1.306 . . . . 0.0 110.041 -174.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -56.35 -29.36 61.27 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.9 -12.16 61.38 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.747 1.619 . . . . 0.0 112.836 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.45 -8.13 40.48 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 127.062 2.268 . . . . 0.0 113.635 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.9 t -64.43 145.04 56.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.787 1.294 . . . . 0.0 111.511 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -121.94 141.46 51.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -133.08 147.17 52.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.304 1.049 . . . . 0.0 112.795 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -129.58 125.26 35.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.544 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.56 127.44 75.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.05 -88.45 0.1 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 125.874 1.984 . . . . 0.0 110.987 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.98 145.13 37.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.202 -0.587 . . . . 0.0 110.824 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.462 HG21 ' CG ' ' B' ' 53' ' ' GLN . 7.3 p -97.02 131.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.729 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -72.79 159.54 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.029 0.919 . . . . 0.0 112.808 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -54.47 -27.87 40.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -71.84 -34.81 69.59 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.148 0.579 . . . . 0.0 112.448 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.82 -9.16 12.63 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.503 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 155.3 40.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.379 1.59 . . . . 0.0 108.225 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.39 166.12 32.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.882 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.14 147.92 52.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.54 26.77 Favored Glycine 0 C--O 1.236 0.24 0 O-C-N 121.623 -0.673 . . . . 0.0 112.81 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' B' ' 46' ' ' LEU . 10.7 p -139.89 138.53 35.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.836 -1.182 . . . . 0.0 112.092 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -117.14 132.39 56.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.811 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.13 129.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 45.2 m -107.14 143.56 35.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.742 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.44 -13.59 18.65 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -136.44 142.06 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.948 0.899 . . . . 0.0 112.806 -174.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.28 168.68 23.33 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.219 -0.926 . . . . 0.0 111.036 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -39.15 25.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -126.85 74.64 75.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.428 1.891 . . . . 0.0 109.321 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.82 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.175 3.25 . . . . 0.0 117.34 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.79 -20.96 0.75 Allowed Glycine 0 CA--C 1.537 1.433 0 N-CA-C 118.523 2.169 . . . . 0.0 118.523 -174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.2 42.34 0.08 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 111.861 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -50.06 134.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.336 -0.852 . . . . 0.0 111.454 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -152.3 171.85 17.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.425 1.49 . . . . 0.0 111.109 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.1 tp -46.69 119.34 2.41 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.469 3.108 . . . . 0.0 112.143 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 68.2 m -114.3 113.59 45.92 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.095 0.958 . . . . 0.0 108.579 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -55.28 144.76 69.9 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.622 2.881 . . . . 0.0 112.814 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.04 52.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.613 1.165 . . . . 0.0 111.892 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.41 150.7 40.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.167 2.987 . . . . 0.0 109.266 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.08 -155.43 26.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.2 mt -144.8 139.48 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.668 -0.766 . . . . 0.0 112.421 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.53 ' CD ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -118.78 155.15 31.66 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.255 1.022 . . . . 0.0 110.993 172.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.95 163.9 22.97 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.499 -1.375 . . . . 0.0 110.588 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.97 26.38 0.32 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 113.213 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -56.36 2.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.282 2.233 . . . . 0.0 111.022 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.75 171.83 14.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.955 0.883 . . . . 0.0 113.331 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -41.43 66.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.45 1.1 . . . . 0.0 110.91 173.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -132.87 57.9 31.71 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 125.383 1.473 . . . . 0.0 111.07 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.32 176.62 9.71 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.053 1.835 . . . . 0.0 116.654 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -87.71 163.79 16.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.718 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -163.44 164.44 24.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 149.14 15.03 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 119.941 2.736 . . . . 0.0 119.941 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -164.12 154.29 14.8 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -90.06 150.92 21.88 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.927 2.091 . . . . 0.0 109.133 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 74.1 t -130.28 120.72 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.5 ' HB2' HG21 ' C' ' 52' ' ' ILE . 56.2 t30 -95.76 105.91 17.97 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.612 -1.185 . . . . 0.0 110.793 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -67.1 132.14 47.24 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.165 1.802 . . . . 0.0 112.742 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.46 -38.2 12.1 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.58 -10.4 43.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -152.5 133.28 14.0 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.002 2.521 . . . . 0.0 107.265 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -70.66 118.47 13.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.273 0.942 . . . . 0.0 109.823 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 75.5 p -173.62 170.2 4.12 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.639 1.976 . . . . 0.0 109.928 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.76 137.9 31.92 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.142 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.447 ' CG2' HD12 ' B' ' 99' ' ' LEU . 0.6 OUTLIER -114.34 166.12 12.0 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 150.49 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -129.07 141.61 51.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.08 120.3 10.17 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.37 -179.35 38.47 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.915 -1.612 . . . . 0.0 117.106 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -114.31 145.7 41.44 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 125.178 1.163 . . . . 0.0 112.098 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.411 ' HB3' ' HG ' ' B' ' 4' ' ' CYS . 34.6 t -97.76 125.94 42.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.291 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.6 OUTLIER -120.7 170.89 9.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.76 1.267 . . . . 0.0 113.573 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 mt -131.63 110.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.49 -2.141 . . . . 0.0 106.506 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.5 156.55 19.22 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.59 -53.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -73.63 -8.96 58.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.435 1.894 . . . . 0.0 116.101 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.16 50.87 3.12 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 120.008 1.276 . . . . 0.0 110.684 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -122.87 135.97 54.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.434 1.894 . . . . 0.0 109.746 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -101.83 143.03 32.24 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.308 1.443 . . . . 0.0 112.066 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.525 HG21 ' CD1' ' C' ' 106' ' ' ILE . 15.3 m -148.56 161.95 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.803 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 mt -122.16 120.21 33.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.572 ' HE2' HD11 ' C' ' 106' ' ' ILE . 1.5 mmmt -108.24 114.47 28.37 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.05 161.06 36.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.306 1.527 . . . . 0.0 112.137 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -109.3 168.06 9.66 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -141.69 160.69 39.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.508 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -143.46 127.7 17.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.559 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' B' ' 77' ' ' THR . 1.0 OUTLIER -111.03 144.59 39.92 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 124.826 1.329 . . . . 0.0 110.987 -176.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.413 ' CZ ' ' HA2' ' C' ' 81' ' ' GLY . 2.5 tpt85 -128.23 116.91 20.61 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 112.125 -2.307 . . . . 0.0 112.279 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -90.71 158.66 16.77 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 124.73 1.269 . . . . 0.0 113.627 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.1 m -103.21 80.34 1.83 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -66.76 -174.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -115.66 -22.65 9.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 119.934 -1.729 . . . . 0.0 114.537 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -118.63 148.82 42.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.766 1.269 . . . . 0.0 110.734 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.534 HD11 ' HE2' ' C' ' 94' ' ' LYS . 10.7 tt -61.05 -28.23 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.77 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.95 4.05 25.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.221 -1.322 . . . . 0.0 115.457 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.83 -1.39 11.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.102 1.451 . . . . 0.0 113.815 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.77 -31.54 68.47 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.341 -0.85 . . . . 0.0 112.824 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 60.8 p-90 -46.43 -44.57 17.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 114.107 177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -92.88 -12.78 30.1 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.951 0.9 . . . . 0.0 113.263 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 4.95 10.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' B' ' 98' ' ' LEU . 16.2 m -113.12 135.08 54.19 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.915 0.886 . . . . 0.0 111.668 174.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.48 126.66 22.84 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.541 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.94 154.77 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 120.427 1.467 . . . . 0.0 112.041 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.94 -175.32 30.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.698 1.142 . . . . 0.0 113.056 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 24.2 p90 -128.21 154.63 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.678 0.791 . . . . 0.0 109.965 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -149.71 147.26 27.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.853 0.861 . . . . 0.0 109.831 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 129.54 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.399 -0.813 . . . . 0.0 109.146 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -116.86 155.41 29.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.437 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 32.8 p -137.31 160.42 39.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 110.458 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -59.65 128.58 37.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.79 0.836 . . . . 0.0 111.395 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.334 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.1 p -133.54 147.39 51.58 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.838 1.255 . . . . 0.0 108.453 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -137.21 127.51 26.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.519 HD12 ' CD ' ' C' ' 53' ' ' GLN . 30.3 mt -68.87 -26.76 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.959 0.904 . . . . 0.0 112.571 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -61.47 120.8 11.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.35 45.2 0.53 Allowed Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.938 1.535 . . . . 0.0 116.938 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt 52.87 149.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -141.83 161.02 38.99 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.427 -1.715 . . . . 0.0 112.139 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.05 144.35 49.97 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.271 1.428 . . . . 0.0 108.519 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.81 143.42 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.105 1.362 . . . . 0.0 109.476 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -55.75 -29.51 59.7 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.76 -12.23 61.43 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.77 1.628 . . . . 0.0 113.007 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.63 -9.09 40.77 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.284 2.373 . . . . 0.0 113.611 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.5 t -63.09 145.91 54.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.82 1.31 . . . . 0.0 111.804 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -122.36 141.09 51.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.17 147.24 52.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.999 0.904 . . . . 0.0 112.823 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.4 m -130.35 125.69 35.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.766 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.47 126.42 74.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.19 -88.71 0.08 OUTLIER Glycine 0 CA--C 1.526 0.77 0 O-C-N 126.036 2.085 . . . . 0.0 111.036 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.37 143.69 35.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.228 0.611 . . . . 0.0 110.862 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.454 HG21 ' CG ' ' C' ' 53' ' ' GLN . 7.3 p -96.16 132.74 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.739 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -71.77 160.04 33.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.247 1.023 . . . . 0.0 113.304 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 16.0 m -53.84 -27.23 28.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.151 1.381 . . . . 0.0 114.505 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.93 -34.17 68.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.231 0.612 . . . . 0.0 112.588 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.76 -9.88 12.52 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.967 1.27 . . . . 0.0 113.468 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.25 157.59 37.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.967 1.384 . . . . 0.0 110.563 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 166.3 33.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.326 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 148.04 52.66 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.65 -169.12 25.59 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 122.478 1.044 . . . . 0.0 112.746 -174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' C' ' 46' ' ' LEU . 10.2 p -139.66 138.96 36.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.686 -1.257 . . . . 0.0 112.032 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -117.19 135.09 54.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.854 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 60.6 mt -123.57 130.17 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 42.1 m -107.92 143.84 36.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.779 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.71 -13.5 18.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 16.6 m -136.74 141.43 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 112.737 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.84 168.36 23.95 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.204 -0.935 . . . . 0.0 110.992 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.62 -39.27 27.75 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.61 74.62 74.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.469 1.908 . . . . 0.0 109.291 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.8 6.8 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.147 3.232 . . . . 0.0 117.406 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.68 -21.28 0.8 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.14 42.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.732 1.266 . . . . 0.0 111.832 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 54.2 mt -49.95 134.62 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.382 -0.824 . . . . 0.0 111.518 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -152.85 171.6 18.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.222 1.409 . . . . 0.0 111.254 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' C' ' 32' ' ' THR . 12.3 tp -46.63 118.43 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 129.263 3.025 . . . . 0.0 112.136 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -113.5 112.79 48.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.542 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.5 145.69 56.6 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.173 2.582 . . . . 0.0 112.565 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.2 143.89 51.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.078 0.951 . . . . 0.0 111.329 175.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -143.93 151.53 39.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.339 3.056 . . . . 0.0 109.606 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.85 -155.66 26.72 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -144.87 139.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 114.484 -0.858 . . . . 0.0 112.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.519 ' CD ' HD12 ' C' ' 6' ' ' LEU . 0.0 OUTLIER -119.19 155.54 31.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.162 0.985 . . . . 0.0 110.739 173.053 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.85 163.6 22.2 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.392 -1.442 . . . . 0.0 110.886 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.74 25.09 0.33 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.113 0.965 . . . . 0.0 113.1 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.39 -57.52 2.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.191 2.196 . . . . 0.0 111.08 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.8 172.07 12.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -43.25 64.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.006 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -129.96 57.78 33.33 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 125.223 1.409 . . . . 0.0 111.054 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.37 176.83 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.976 1.784 . . . . 0.0 116.691 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 11.4 p -87.98 162.81 16.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.955 1.702 . . . . 0.0 109.637 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -162.02 165.33 27.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.174 -0.954 . . . . 0.0 112.665 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.64 149.38 15.06 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.14 155.4 15.9 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -91.6 150.78 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.985 2.114 . . . . 0.0 109.151 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.04 121.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.4 t30 -97.78 106.16 18.42 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.59 -174.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -66.58 131.69 46.56 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.779 1.627 . . . . 0.0 112.901 -173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.92 -37.99 12.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.56 -10.71 42.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 26.7 t -152.43 132.55 13.5 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.043 2.537 . . . . 0.0 107.216 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -70.24 118.53 13.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.303 0.956 . . . . 0.0 109.947 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 77.3 p -173.49 170.3 4.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.492 1.917 . . . . 0.0 110.026 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.82 137.88 31.81 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.019 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.441 ' CG2' HD12 ' C' ' 99' ' ' LEU . 0.6 OUTLIER -114.22 165.8 12.31 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.329 1.061 . . . . 0.0 108.578 173.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.42 150.89 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -128.95 142.0 51.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.35 120.3 10.0 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' CZ ' ' B' ' 100' ' ' ARG . . . -164.6 -179.73 38.85 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.79 144.83 42.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.084 0.945 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 34.2 t -97.85 123.13 41.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.549 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -117.89 170.42 8.83 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.585 1.183 . . . . 0.0 113.652 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -130.23 111.61 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.928 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.62 157.23 17.96 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -25.85 -53.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.195 2.198 . . . . 0.0 116.856 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.48 -8.61 56.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.78 47.16 4.31 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 120.399 1.454 . . . . 0.0 110.947 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -119.11 141.67 48.59 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.339 2.256 . . . . 0.0 108.209 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -108.41 145.49 34.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.598 1.159 . . . . 0.0 112.168 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' B' ' 106' ' ' ILE . 18.6 m -149.66 165.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.215 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 59.6 mt -124.3 121.59 35.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.534 ' HE2' HD11 ' B' ' 106' ' ' ILE . 1.4 mmmt -109.81 114.19 27.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -136.06 160.76 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.32 1.533 . . . . 0.0 112.033 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.42 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -109.04 168.16 9.57 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -141.6 161.1 38.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.278 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -144.08 127.09 16.45 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.265 -1.788 . . . . 0.0 110.505 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 99' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' C' ' 77' ' ' THR . 1.1 tt -110.5 144.65 39.0 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.577 1.173 . . . . 0.0 110.779 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -128.86 117.21 20.66 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 112.315 -2.22 . . . . 0.0 112.199 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -90.5 158.96 16.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 124.847 1.342 . . . . 0.0 113.848 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -103.07 80.01 1.81 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.84 -175.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.099 0.56 . . . . 0.0 109.924 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -114.47 -23.27 9.42 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.379 -1.451 . . . . 0.0 114.571 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -119.13 149.78 41.13 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.709 1.242 . . . . 0.0 110.455 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' B' ' 94' ' ' LYS . 11.5 tt -61.25 -29.06 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.295 174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.91 3.75 19.13 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.324 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.75 -1.19 11.13 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.963 1.381 . . . . 0.0 113.894 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -58.9 -31.74 68.89 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.273 -0.892 . . . . 0.0 112.74 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 61.0 p-90 -46.54 -44.19 17.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.765 1.226 . . . . 0.0 113.95 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -93.14 -12.88 29.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.979 0.912 . . . . 0.0 113.232 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.35 10.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' C' ' 98' ' ' LEU . 16.8 m -113.25 135.3 53.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.032 0.933 . . . . 0.0 111.449 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -138.82 125.36 20.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 117.597 -1.192 . . . . 0.0 110.552 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.53 154.85 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.211 1.368 . . . . 0.0 111.851 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.61 -175.47 30.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.714 1.149 . . . . 0.0 113.081 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.9 p90 -127.48 153.51 46.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.702 0.801 . . . . 0.0 109.81 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -148.63 147.2 28.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.165 0.986 . . . . 0.0 109.707 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -128.32 132.08 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -119.5 156.41 30.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.111 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 38.7 p -139.1 163.68 31.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.697 1.199 . . . . 0.0 110.662 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -60.79 124.66 21.08 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.419 -0.801 . . . . 0.0 111.517 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.667 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -138.76 153.94 48.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.009 0.818 . . . . 0.0 110.603 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -139.46 126.37 20.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.48 -31.41 72.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -66.3 101.38 0.73 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.75 -8.19 0.11 Allowed Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.1 tttt 75.63 139.09 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.041 2.536 . . . . 0.0 113.721 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -137.73 162.75 33.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.074 1.35 . . . . 0.0 111.617 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -141.05 148.47 40.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.661 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -108.88 151.99 25.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.796 0.838 . . . . 0.0 112.294 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.94 -25.76 66.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' C' ' 110' ' ' TRP . 27.4 tp -73.27 -15.98 61.4 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.346 1.858 . . . . 0.0 110.946 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.24 -6.34 34.28 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 127.192 2.329 . . . . 0.0 114.517 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 p -70.56 148.14 48.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.928 1.864 . . . . 0.0 112.219 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -119.11 139.09 52.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.868 -1.145 . . . . 0.0 109.433 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -127.8 136.16 51.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.692 0.758 . . . . 0.0 110.63 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.05 132.21 52.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.65 126.71 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -87.54 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 O-C-N 125.67 1.856 . . . . 0.0 110.611 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.88 29.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.193 -0.592 . . . . 0.0 111.5 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.49 126.55 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.045 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.19 159.3 29.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 112.277 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 t -53.07 -30.15 34.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -63.46 -39.59 94.86 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.006 -1.059 . . . . 0.0 110.97 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.56 -6.75 10.54 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 116.854 -2.081 . . . . 0.0 114.118 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.36 152.8 44.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.812 1.806 . . . . 0.0 109.705 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -152.03 145.27 24.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.304 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.53 155.67 22.91 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.834 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -169.16 30.96 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 122.928 1.293 . . . . 0.0 112.991 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.508 ' HB ' HD21 ' A' ' 46' ' ' LEU . 4.3 p -134.69 129.22 34.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.413 -1.394 . . . . 0.0 111.646 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -123.25 120.64 33.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.991 0.901 . . . . 0.0 111.607 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.99 132.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.488 ' O ' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -114.9 144.79 42.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.47 -13.99 21.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 143.11 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.572 1.149 . . . . 0.0 112.409 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.23 43.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.467 -1.396 . . . . 0.0 111.505 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.12 -25.82 63.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.54 83.71 14.71 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.568 1.947 . . . . 0.0 109.747 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.68 177.48 7.49 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.176 2.584 . . . . 0.0 110.47 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.11 -27.35 3.3 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 113.301 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -142.57 23.14 1.97 Allowed 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.72 1.608 . . . . 0.0 110.531 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 35' ' ' THR . 63.3 mt -57.21 105.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 123.182 1.468 . . . . 0.0 111.481 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 171.02 7.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.079 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -54.58 126.63 24.51 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 127.645 2.378 . . . . 0.0 111.62 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -104.09 119.54 53.92 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.646 174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -55.23 149.96 42.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.51 2.14 . . . . 0.0 111.562 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.22 149.46 47.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.324 1.05 . . . . 0.0 110.287 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -150.86 149.13 29.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.369 2.267 . . . . 0.0 109.159 177.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.33 -156.87 28.35 Favored Glycine 0 C--O 1.228 -0.236 0 O-C-N 120.355 -1.466 . . . . 0.0 111.058 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.555 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.4 mt -145.99 148.8 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 125.41 1.3 . . . . 0.0 111.704 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 152.81 50.76 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.515 -1.366 . . . . 0.0 112.997 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -101.19 147.12 26.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 14.12 1.77 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.391 1.477 . . . . 0.0 113.533 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -92.56 -42.35 9.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.823 1.649 . . . . 0.0 112.147 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.32 4.62 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.96 0.788 . . . . 0.0 112.64 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 t -70.12 -49.18 53.3 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.582 1.153 . . . . 0.0 112.538 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.34 65.33 72.25 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.07 0.948 . . . . 0.0 111.763 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.15 173.53 5.99 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.537 3.491 . . . . 0.0 116.921 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER -100.36 169.38 9.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 123.443 1.592 . . . . 0.0 110.725 173.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -162.17 162.5 28.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.071 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.87 143.17 8.45 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 118.579 2.192 . . . . 0.0 118.579 -172.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.16 152.33 20.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.514 ' HB ' HD12 ' D' ' 52' ' ' ILE . 1.8 m -89.81 152.23 21.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.032 1.733 . . . . 0.0 109.263 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.71 120.65 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.581 ' CB ' HG21 ' D' ' 52' ' ' ILE . 0.2 OUTLIER -104.45 117.97 35.46 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -82.29 136.31 35.06 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.065 -1.647 . . . . 0.0 114.55 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -97.08 -44.38 7.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.836 -1.074 . . . . 0.0 113.836 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -74.83 -19.28 60.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.368 0.667 . . . . 0.0 112.54 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.41 132.81 13.72 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.703 2.801 . . . . 0.0 107.34 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.45 118.88 20.32 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.284 1.402 . . . . 0.0 111.855 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 76.3 p -176.71 164.5 2.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.926 2.09 . . . . 0.0 107.379 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.6 135.67 17.66 Favored 'General case' 0 CA--C 1.47 -2.103 0 CA-C-O 122.202 1.001 . . . . 0.0 108.781 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -135.34 130.28 34.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 111.066 -2.788 . . . . 0.0 111.492 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.92 154.1 5.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 120.742 0.306 . . . . 0.0 110.212 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -127.99 144.2 51.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.419 HG23 HG13 ' D' ' 78' ' ' VAL . 0.0 OUTLIER -153.84 117.06 4.55 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -161.16 -177.72 34.51 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.451 HE22 HG22 ' D' ' 103' ' ' VAL . 9.7 tt0 -122.98 138.56 54.65 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.806 0.812 . . . . 0.0 111.178 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.6 t -97.97 112.76 24.57 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.154 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -112.01 168.58 9.48 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.793 1.282 . . . . 0.0 110.148 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.74 113.75 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 112.841 -1.981 . . . . 0.0 107.571 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.09 157.95 14.7 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -44.63 -28.63 0.62 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 118.156 2.651 . . . . 0.0 118.156 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -5.69 55.77 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.17 41.07 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.635 1.112 . . . . 0.0 113.416 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.27 144.53 25.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.522 2.329 . . . . 0.0 109.983 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.26 141.92 33.43 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.587 1.155 . . . . 0.0 109.616 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -146.6 160.66 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 125.121 1.513 . . . . 0.0 110.36 175.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 mt -124.43 118.17 26.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -106.39 113.2 26.58 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.6 p -132.86 165.1 25.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.58 1.657 . . . . 0.0 111.598 -173.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.56 168.52 10.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.037 173.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -141.54 158.08 44.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.272 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.68 127.26 28.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.867 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.5 137.24 45.89 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 124.788 1.305 . . . . 0.0 111.726 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.8 113.84 20.75 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.783 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 m -77.66 164.76 25.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 125.215 1.572 . . . . 0.0 111.755 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.6 m -108.61 85.16 2.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.01 178.2 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -116.25 6.43 13.83 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.35 144.88 33.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.427 174.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.2 tt -60.72 -31.11 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.166 174.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.14 6.67 13.11 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.366 1.46 . . . . 0.0 115.072 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -120.9 3.0 10.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.202 1.001 . . . . 0.0 112.831 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -33.41 75.37 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.966 -1.084 . . . . 0.0 113.196 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.41 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.6 p-90 -45.7 -41.04 10.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.12 0.968 . . . . 0.0 113.441 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -98.14 -9.02 26.47 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.242 1.017 . . . . 0.0 113.601 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.95 -0.8 19.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -112.58 141.76 45.96 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.568 0.699 . . . . 0.0 111.861 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -138.69 147.96 43.4 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.22 1.408 . . . . 0.0 109.898 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.75 149.51 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.955 1.707 . . . . 0.0 109.836 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.26 -175.26 27.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 123.799 0.714 . . . . 0.0 111.86 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 28.3 p90 -130.69 157.4 42.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.142 0.577 . . . . 0.0 110.282 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -148.81 145.94 27.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.042 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.6 mt -124.81 126.07 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.07 149.65 37.17 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.398 -0.814 . . . . 0.0 109.625 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 p -133.38 157.29 45.9 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.776 -0.578 . . . . 0.0 109.59 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 121.52 9.26 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.7 tt . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 4' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' D' ' 83' ' ' CYS . 25.3 p -150.14 145.46 26.32 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.508 1.13 . . . . 0.0 110.538 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -139.79 127.15 21.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.21 -27.98 68.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.84 101.2 1.04 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.42 -9.74 0.09 OUTLIER Glycine 0 N--CA 1.484 1.899 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -174.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 75.82 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.913 2.485 . . . . 0.0 113.649 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.18 162.73 32.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.846 1.307 . . . . 0.0 111.66 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -139.71 149.7 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.097 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.12 152.73 25.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.675 0.79 . . . . 0.0 111.584 -175.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.59 -26.66 67.21 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' B' ' 110' ' ' TRP . 27.0 tp -72.45 -16.04 61.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.5 1.92 . . . . 0.0 111.237 173.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.57 -5.59 35.32 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.194 2.33 . . . . 0.0 114.363 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 66.4 p -71.27 149.61 46.02 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.926 1.863 . . . . 0.0 112.252 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -121.99 139.05 54.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.914 -1.116 . . . . 0.0 109.808 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -127.37 136.76 52.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.88 0.848 . . . . 0.0 111.018 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.01 131.72 52.15 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 86.6 mt -127.64 126.74 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.84 -87.49 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 125.023 1.452 . . . . 0.0 110.704 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.61 139.33 31.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.287 -0.537 . . . . 0.0 111.328 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.06 125.46 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.908 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -65.26 159.1 24.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.172 0.589 . . . . 0.0 112.236 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 17.7 t -54.2 -28.58 41.74 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -63.37 -37.21 86.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.982 -1.074 . . . . 0.0 110.983 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.1 -4.87 15.95 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.484 1.516 . . . . 0.0 113.753 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.26 155.42 38.28 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.925 1.363 . . . . 0.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -152.51 154.53 35.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.698 1.237 . . . . 0.0 112.72 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.18 156.05 30.55 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.164 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.06 -168.62 30.45 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.844 1.247 . . . . 0.0 113.394 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.524 ' HB ' HD21 ' D' ' 46' ' ' LEU . 7.2 p -133.9 130.5 37.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.589 -1.306 . . . . 0.0 111.763 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -124.05 121.04 34.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.982 0.896 . . . . 0.0 111.515 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.3 133.45 66.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.456 ' O ' HG21 ' D' ' 44' ' ' ILE . 1.0 OUTLIER -114.99 145.72 41.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -173.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.6 -15.97 20.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 143.55 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.441 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.71 158.3 43.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.678 -1.264 . . . . 0.0 111.615 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.96 -26.06 63.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.98 83.42 14.05 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.384 1.874 . . . . 0.0 109.441 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.72 177.48 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.091 2.527 . . . . 0.0 110.546 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.9 -27.24 3.35 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 121.346 -0.847 . . . . 0.0 113.324 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 23.32 2.0 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.799 1.64 . . . . 0.0 110.687 -177.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.456 HG21 ' O ' ' D' ' 35' ' ' THR . 62.9 mt -57.21 106.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 123.195 1.474 . . . . 0.0 111.296 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.22 170.79 8.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.954 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' D' ' 32' ' ' THR . 0.4 OUTLIER -53.78 126.31 21.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 127.409 2.284 . . . . 0.0 111.628 176.194 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -104.53 119.87 52.35 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.015 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.97 150.4 38.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.354 2.036 . . . . 0.0 111.456 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.85 152.66 50.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 110.059 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -154.52 149.29 26.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.759 2.024 . . . . 0.0 109.691 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.26 -155.29 26.43 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 119.257 0.935 . . . . 0.0 113.948 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.1 mt -146.84 148.8 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.717 1.207 . . . . 0.0 111.838 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.04 152.34 49.97 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.482 -1.386 . . . . 0.0 112.794 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -100.2 146.97 26.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 16.17 1.84 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 113.335 -175.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -91.93 -42.12 10.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 174.39 5.34 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -71.8 -47.55 52.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 0.0 112.669 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.5 64.68 73.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 124.644 1.178 . . . . 0.0 112.673 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.43 173.61 8.5 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.654 3.569 . . . . 0.0 116.639 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.303 0.5 OUTLIER -99.15 168.62 9.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.533 1.635 . . . . 0.0 111.086 173.308 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.54 161.78 27.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.927 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.98 143.6 8.95 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.6 151.64 18.91 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 52' ' ' ILE . 1.7 m -89.16 154.0 20.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.357 1.863 . . . . 0.0 109.52 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.25 121.04 45.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.555 ' CB ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -104.84 117.25 33.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -174.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.83 135.16 35.46 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.24 -1.538 . . . . 0.0 114.676 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -95.62 -44.28 7.55 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -74.66 -19.59 60.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.455 0.702 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.39 132.19 13.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.553 2.741 . . . . 0.0 107.491 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -75.98 118.9 19.24 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.444 1.475 . . . . 0.0 112.107 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -176.59 164.12 2.47 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 127.004 2.122 . . . . 0.0 107.196 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.29 135.18 17.65 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-O 122.505 1.145 . . . . 0.0 108.897 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 4.9 m -135.02 130.16 35.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.576 -169.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.419 HG13 HG23 ' A' ' 80' ' ' THR . 4.2 m -103.38 154.58 5.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 120.623 0.249 . . . . 0.0 110.421 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -128.43 144.0 51.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.44 116.91 4.65 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -160.98 -177.0 33.71 Favored Glycine 0 CA--C 1.503 -0.707 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.73 137.98 54.31 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.66 0.859 . . . . 0.0 110.734 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' D' ' 4' ' ' CYS . 42.7 t -97.92 112.82 24.6 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.266 -1.35 . . . . 0.0 108.771 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.43 169.16 8.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.762 1.225 . . . . 0.0 110.031 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.08 110.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.916 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -60.19 157.3 13.55 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -43.59 -30.17 0.57 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.64 -0.76 48.64 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.76 43.35 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.511 -0.743 . . . . 0.0 113.13 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.85 146.14 23.99 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.748 2.019 . . . . 0.0 109.545 175.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -101.27 142.24 32.98 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.806 1.242 . . . . 0.0 108.795 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' A' ' 106' ' ' ILE . 21.9 m -146.26 159.13 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 125.07 1.481 . . . . 0.0 110.7 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 42.4 mt -121.64 117.01 25.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.17 112.28 25.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' D' ' 81' ' ' GLY . 2.2 p -132.27 165.62 23.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.613 1.673 . . . . 0.0 111.752 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.19 168.07 10.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 114.729 -1.123 . . . . 0.0 107.977 173.087 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -141.32 158.34 44.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.243 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.97 127.02 27.88 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.54 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 137.22 46.06 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.767 1.292 . . . . 0.0 111.46 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' D' ' 100' ' ' ARG . 6.2 tpt180 -120.72 113.83 20.78 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 113.131 -1.85 . . . . 0.0 110.855 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -77.58 164.9 24.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.829 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -109.25 84.82 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 103' ' ' VAL . . . . . 0.451 HG22 HE22 ' A' ' 82' ' ' GLN . 33.4 m -74.24 -178.28 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -119.1 6.44 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.94 145.15 34.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.225 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 1.2 tt -60.34 -30.61 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.15 7.08 18.09 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.609 1.576 . . . . 0.0 115.207 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.63 3.21 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.25 1.025 . . . . 0.0 112.888 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.63 -33.04 74.73 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.119 -0.988 . . . . 0.0 112.655 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.42 ' CD1' HD11 ' B' ' 14' ' ' LEU . 56.5 p-90 -45.41 -41.38 9.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 113.636 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -98.3 -8.95 26.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.312 1.045 . . . . 0.0 113.672 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.64 -1.46 21.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 3.7 m -111.85 141.69 45.16 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.748 0.704 . . . . 0.0 111.895 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -138.35 148.05 44.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.335 1.454 . . . . 0.0 109.961 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.95 149.59 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 120.804 1.638 . . . . 0.0 109.83 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.51 -175.21 27.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.743 0.687 . . . . 0.0 111.877 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 29.1 p90 -130.77 156.78 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.125 0.57 . . . . 0.0 110.051 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -148.28 145.81 28.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.388 0.675 . . . . 0.0 109.922 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.3 mt -124.32 126.45 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -114.84 150.28 35.77 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.069 0.938 . . . . 0.0 110.076 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 61.9 p -133.64 158.81 42.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.683 0.793 . . . . 0.0 110.352 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 126.58 28.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.282 0.633 . . . . 0.0 109.381 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p -147.01 149.27 32.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 124.58 1.175 . . . . 0.0 111.207 -174.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.5 p -139.74 127.02 21.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.71 -28.16 67.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.43 101.97 1.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.36 -14.3 0.13 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 118.592 2.197 . . . . 0.0 118.592 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.4 ' HD3' ' CD2' ' B' ' 123' ' ' LEU . 4.9 tttt 80.7 143.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 128.502 2.721 . . . . 0.0 112.776 -176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -137.56 162.74 32.94 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 111.536 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.756 ' HB ' HD13 ' B' ' 123' ' ' LEU . 6.1 t -134.01 154.07 51.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.092 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -114.41 150.79 34.14 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.848 0.859 . . . . 0.0 111.409 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.05 -25.18 66.92 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' D' ' 110' ' ' TRP . 27.2 tp -73.77 -16.29 61.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.852 2.061 . . . . 0.0 111.011 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.07 -6.52 32.53 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.279 2.371 . . . . 0.0 114.603 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 45.4 p -71.49 147.15 48.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.776 1.788 . . . . 0.0 111.907 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -118.31 139.76 50.85 Favored 'General case' 0 CA--C 1.522 -0.103 0 O-C-N 120.829 -1.169 . . . . 0.0 109.823 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -127.96 135.17 49.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -123.85 130.7 53.03 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -126.12 126.83 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.88 -88.02 0.1 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 125.506 1.754 . . . . 0.0 110.678 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.55 141.22 32.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.069 -0.665 . . . . 0.0 111.966 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.61 126.14 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.256 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.9 158.93 29.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.879 0.472 . . . . 0.0 112.176 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -53.07 -30.05 33.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -63.5 -39.21 93.84 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.924 -1.11 . . . . 0.0 111.005 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.42 -7.22 10.54 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 116.882 -2.066 . . . . 0.0 114.159 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.04 152.74 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.73 1.765 . . . . 0.0 109.757 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -152.18 145.83 24.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.927 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.89 156.31 22.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.941 174.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.63 -169.11 30.75 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-O 122.588 1.104 . . . . 0.0 113.345 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.532 ' HB ' HD21 ' B' ' 46' ' ' LEU . 10.8 p -133.3 129.84 38.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.583 -1.309 . . . . 0.0 112.008 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -122.87 121.26 35.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 122.012 0.91 . . . . 0.0 111.066 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -121.07 132.62 70.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.436 ' O ' HG21 ' B' ' 44' ' ' ILE . 1.0 OUTLIER -114.6 146.93 40.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.69 -16.64 18.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.57 144.42 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 112.387 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.5 158.22 42.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.625 -1.297 . . . . 0.0 111.383 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.7 -26.57 64.42 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -140.71 83.44 14.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.689 1.996 . . . . 0.0 109.586 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.58 177.46 7.45 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.19 2.593 . . . . 0.0 110.532 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.98 -27.04 3.36 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.285 -0.885 . . . . 0.0 113.382 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -142.68 23.64 1.92 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.879 1.672 . . . . 0.0 110.666 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.436 HG21 ' O ' ' B' ' 35' ' ' THR . 64.4 mt -57.62 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.986 1.374 . . . . 0.0 111.35 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 170.03 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.944 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' B' ' 32' ' ' THR . 0.5 OUTLIER -52.21 126.24 18.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.397 2.279 . . . . 0.0 112.184 174.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.4 m -104.88 120.62 49.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.985 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -55.33 150.23 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.732 2.288 . . . . 0.0 111.818 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.23 149.61 47.28 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.985 0.914 . . . . 0.0 110.302 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' C' ' 50' ' ' LEU . 0.2 OUTLIER -150.74 149.34 29.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.342 2.257 . . . . 0.0 108.884 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.53 -156.94 28.36 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 120.246 1.385 . . . . 0.0 111.358 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.557 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.4 mt -146.4 148.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 125.21 1.182 . . . . 0.0 111.612 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 153.92 51.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.748 -1.22 . . . . 0.0 113.061 175.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -101.83 147.51 26.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 16.71 1.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.37 1.468 . . . . 0.0 113.394 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -92.85 -40.2 10.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.165 1.786 . . . . 0.0 111.899 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.55 174.31 8.44 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.087 0.867 . . . . 0.0 111.979 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -70.36 -50.15 41.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.126 1.37 . . . . 0.0 112.688 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.43 63.74 70.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.108 0.963 . . . . 0.0 112.107 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -66.73 172.95 8.71 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.446 3.43 . . . . 0.0 116.407 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.306 0.4 OUTLIER -98.9 167.85 10.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.662 1.22 . . . . 0.0 110.823 173.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.83 162.26 29.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.866 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.62 143.8 9.05 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -160.08 153.37 22.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.524 ' HB ' HD12 ' C' ' 52' ' ' ILE . 1.6 m -91.29 151.54 20.85 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.218 1.807 . . . . 0.0 109.485 173.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.67 120.82 51.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.569 ' CB ' HG21 ' C' ' 52' ' ' ILE . 0.1 OUTLIER -104.57 117.42 34.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -82.04 136.4 35.23 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.98 -1.7 . . . . 0.0 114.402 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -97.06 -44.22 7.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.896 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -75.12 -19.29 59.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.833 0.853 . . . . 0.0 112.495 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.44 133.35 14.1 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.832 2.853 . . . . 0.0 107.412 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -77.93 118.91 20.69 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.17 1.35 . . . . 0.0 111.895 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.6 p -176.69 164.32 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.957 2.103 . . . . 0.0 107.18 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.32 135.69 18.01 Favored 'General case' 0 CA--C 1.473 -1.991 0 CA-C-O 122.244 1.021 . . . . 0.0 108.668 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . 0.251 5.2 m -135.88 130.06 33.25 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.337 -169.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.94 154.87 5.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -129.16 143.82 50.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.402 HG23 HG13 ' C' ' 78' ' ' VAL . 0.0 OUTLIER -153.58 117.45 4.75 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -161.35 -177.71 34.68 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 115.951 1.14 . . . . 0.0 115.951 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.462 HE22 HG22 ' C' ' 103' ' ' VAL . 9.7 tt0 -123.22 138.28 54.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.374 0.691 . . . . 0.0 110.456 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.8 112.82 24.57 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.32 168.95 8.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.699 1.238 . . . . 0.0 109.973 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -123.24 109.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.497 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -58.66 158.26 8.14 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -43.56 -35.91 1.88 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.727 2.491 . . . . 0.0 117.727 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -20.51 61.44 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.92 19.73 12.53 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.734 1.159 . . . . 0.0 113.434 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 149.62 26.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.169 1.788 . . . . 0.0 109.097 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -101.36 145.45 28.9 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.401 1.481 . . . . 0.0 110.128 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' C' ' 106' ' ' ILE . 23.3 m -147.77 160.21 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.234 174.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 mt -121.86 117.24 26.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.41 111.37 23.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' B' ' 81' ' ' GLY . 2.0 p -130.93 166.33 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.127 1.917 . . . . 0.0 111.907 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -119.64 168.19 11.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.109 172.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -141.95 157.81 44.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.086 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -135.1 127.29 30.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 136.51 47.28 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 124.882 1.364 . . . . 0.0 111.583 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 6.3 tpt180 -120.15 113.88 21.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.871 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 23.2 m -78.15 164.91 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 124.925 1.391 . . . . 0.0 111.814 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 71.8 m -108.9 87.23 2.44 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 103.009 -2.959 . . . . 0.0 103.009 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.08 -174.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -122.5 7.49 9.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.57 145.68 31.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.293 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' C' ' 92' ' ' VAL . 1.2 tt -60.94 -30.72 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.114 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.14 17.03 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.279 1.419 . . . . 0.0 114.902 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.93 3.37 10.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.389 1.095 . . . . 0.0 112.86 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.17 -32.84 74.33 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.228 -0.92 . . . . 0.0 113.261 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' D' ' 14' ' ' LEU . 56.5 p-90 -45.29 -41.83 9.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.307 1.043 . . . . 0.0 113.694 175.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -97.29 -9.65 27.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -0.81 19.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.09 141.91 45.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.358 0.663 . . . . 0.0 111.545 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -138.4 148.37 44.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.624 1.57 . . . . 0.0 110.114 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.33 149.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 120.594 1.543 . . . . 0.0 109.727 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.69 27.36 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 124.04 0.828 . . . . 0.0 111.694 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 28.6 p90 -129.93 157.11 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.062 0.545 . . . . 0.0 110.096 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -148.68 145.0 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.81 129.1 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -116.88 149.79 39.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.752 0.786 . . . . 0.0 110.944 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 81.6 p -135.18 158.44 44.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.957 0.903 . . . . 0.0 110.014 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 129.53 41.67 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.218 -0.926 . . . . 0.0 110.762 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.756 HD13 ' HB ' ' B' ' 11' ' ' THR . 18.1 tp . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.705 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 23.8 p -147.88 147.43 29.74 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.815 0.697 . . . . 0.0 111.386 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.4 p -139.63 126.82 21.19 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -67.69 -29.1 68.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -67.58 102.14 1.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.31 0.11 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 73.2 140.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.637 2.375 . . . . 0.0 113.997 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -137.81 162.73 33.19 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.969 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.9 t -139.45 148.06 42.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.553 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -108.12 152.94 23.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.661 0.784 . . . . 0.0 111.553 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.0 -26.14 65.75 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.41 HD11 ' CD1' ' A' ' 110' ' ' TRP . 27.6 tp -72.41 -16.15 61.84 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.581 1.953 . . . . 0.0 110.956 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.4 -6.66 34.08 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 127.497 2.475 . . . . 0.0 114.451 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 73.2 p -70.67 148.45 48.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.87 1.835 . . . . 0.0 112.114 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.3 139.62 52.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 120.867 -1.146 . . . . 0.0 109.962 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -128.1 135.81 50.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.44 130.82 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.84 126.29 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.01 -87.64 0.09 OUTLIER Glycine 0 CA--C 1.526 0.74 0 O-C-N 125.41 1.694 . . . . 0.0 110.769 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.53 141.04 32.01 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.233 -0.569 . . . . 0.0 111.387 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.77 125.07 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.155 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -64.93 158.28 25.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.236 0.615 . . . . 0.0 112.252 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 17.6 t -53.74 -28.39 34.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -63.47 -37.15 86.2 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.805 -1.184 . . . . 0.0 111.005 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.31 -4.86 15.47 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.673 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 154.13 38.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.023 1.412 . . . . 0.0 111.287 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -151.71 154.39 36.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.934 0.873 . . . . 0.0 112.278 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -118.34 156.2 29.33 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.538 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -168.79 30.46 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 122.157 0.865 . . . . 0.0 113.52 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.5 ' HB ' HD21 ' C' ' 46' ' ' LEU . 7.2 p -133.45 130.08 38.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.778 -1.211 . . . . 0.0 112.018 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -125.09 120.96 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.627 1.203 . . . . 0.0 111.416 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -119.93 132.66 69.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.48 ' O ' HG21 ' C' ' 44' ' ' ILE . 0.8 OUTLIER -116.2 146.1 42.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -173.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.52 -13.89 22.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.468 ' H ' HG23 ' C' ' 35' ' ' THR . 27.8 m -134.34 144.44 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.737 1.215 . . . . 0.0 113.357 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.82 158.55 43.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.282 -1.511 . . . . 0.0 111.645 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.46 -26.01 63.44 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -140.84 83.09 14.66 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.552 1.941 . . . . 0.0 109.709 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.6 177.4 7.53 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.089 2.526 . . . . 0.0 110.605 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.27 -27.58 3.26 Favored Glycine 0 N--CA 1.476 1.348 0 O-C-N 121.345 -0.847 . . . . 0.0 113.412 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.99 23.12 2.07 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.893 1.677 . . . . 0.0 110.589 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.48 HG21 ' O ' ' C' ' 35' ' ' THR . 70.7 mt -56.95 106.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 122.946 1.355 . . . . 0.0 111.631 -174.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.1 t -113.63 169.56 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.005 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' C' ' 32' ' ' THR . 0.5 OUTLIER -52.36 126.89 20.54 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.507 2.323 . . . . 0.0 111.707 174.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.09 120.09 50.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.336 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.78 149.78 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.461 2.107 . . . . 0.0 111.432 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.66 153.05 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 109.917 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' B' ' 50' ' ' LEU . 0.3 OUTLIER -154.65 149.31 26.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.859 2.064 . . . . 0.0 109.72 -178.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.6 -155.64 26.96 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 119.207 0.912 . . . . 0.0 113.863 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.569 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.1 mt -146.41 148.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.846 -174.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 153.04 50.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.304 -1.497 . . . . 0.0 112.869 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -101.11 147.46 26.2 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 16.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.019 1.328 . . . . 0.0 113.493 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -92.95 -40.0 10.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.737 1.615 . . . . 0.0 112.06 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.57 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.825 0.85 . . . . 0.0 113.048 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 34.3 t -69.2 -48.47 61.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.429 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.61 64.82 69.61 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.241 1.017 . . . . 0.0 112.614 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -66.22 173.29 7.59 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.497 3.465 . . . . 0.0 116.931 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.305 0.5 OUTLIER -99.18 168.28 10.15 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.504 1.621 . . . . 0.0 111.13 173.126 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -162.24 162.0 28.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.937 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.63 143.83 9.08 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 118.075 1.99 . . . . 0.0 118.075 -172.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -160.42 152.42 20.18 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.5 ' HB ' HD12 ' B' ' 52' ' ' ILE . 1.7 m -90.01 154.36 19.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.367 1.867 . . . . 0.0 109.242 173.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -132.64 121.09 44.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.557 ' CB ' HG21 ' B' ' 52' ' ' ILE . 0.2 OUTLIER -105.29 115.83 30.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 117.972 0.351 . . . . 0.0 110.12 -174.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.02 135.88 36.47 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -96.38 -44.25 7.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.929 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -74.91 -19.67 60.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.789 0.836 . . . . 0.0 112.563 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -152.35 133.1 14.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.83 2.852 . . . . 0.0 107.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -77.78 118.93 20.6 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.39 1.45 . . . . 0.0 111.974 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 78.7 p -176.51 164.64 2.57 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 126.868 2.067 . . . . 0.0 107.201 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.64 135.45 17.45 Favored 'General case' 0 CA--C 1.475 -1.942 0 CA-C-O 122.593 1.187 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.0 m -135.55 130.07 34.0 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 110.761 -2.927 . . . . 0.0 111.706 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.402 HG13 HG23 ' B' ' 80' ' ' THR . 4.0 m -103.28 154.81 5.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.676 0.274 . . . . 0.0 110.328 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -128.87 144.0 51.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.81 116.88 4.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -160.45 -176.98 33.14 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.09 137.82 54.52 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.417 0.716 . . . . 0.0 110.575 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.88 112.85 24.61 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 117.232 -1.366 . . . . 0.0 108.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.17 168.94 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.123 1.369 . . . . 0.0 109.973 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -124.32 109.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.989 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.88 160.17 10.08 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -44.56 -31.92 1.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.02 -25.55 58.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.63 -3.74 19.66 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.909 1.242 . . . . 0.0 114.18 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 145.44 55.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.605 1.962 . . . . 0.0 111.684 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -101.14 140.75 35.0 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.668 1.987 . . . . 0.0 109.902 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.431 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.5 m -144.78 160.1 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.608 1.163 . . . . 0.0 110.954 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 mt -120.7 116.98 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -106.13 110.69 23.02 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.434 HG22 ' HA3' ' C' ' 81' ' ' GLY . 2.2 p -130.94 166.03 21.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 123.625 1.679 . . . . 0.0 112.029 -174.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -119.17 168.72 10.59 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -142.21 158.18 44.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.136 172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.66 127.27 28.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.609 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.58 137.31 45.84 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 124.704 1.253 . . . . 0.0 111.449 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.98 113.87 20.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.798 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -77.89 165.85 23.61 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.891 1.369 . . . . 0.0 111.985 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 69.5 m -109.89 87.24 2.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' VAL . . . . . 0.462 HG22 HE22 ' B' ' 82' ' ' GLN . 35.1 m -75.33 -172.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.284 -0.885 . . . . 0.0 108.658 174.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -124.88 7.86 8.08 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.94 145.98 30.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.031 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' B' ' 92' ' ' VAL . 1.2 tt -59.29 -31.22 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.559 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.03 6.22 14.64 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.187 1.375 . . . . 0.0 115.471 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -120.61 3.27 10.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.615 1.207 . . . . 0.0 113.089 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.51 -32.63 74.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.296 -0.877 . . . . 0.0 112.948 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.414 ' CD1' HD11 ' A' ' 14' ' ' LEU . 56.2 p-90 -45.64 -41.4 10.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -97.56 -9.83 26.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.159 0.984 . . . . 0.0 113.557 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -0.47 17.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.097 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.64 141.92 45.85 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.433 0.693 . . . . 0.0 111.547 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -138.65 148.02 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.522 1.529 . . . . 0.0 109.79 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.78 149.32 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 120.655 1.57 . . . . 0.0 109.664 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.69 -176.26 28.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.753 0.692 . . . . 0.0 111.572 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 28.7 p90 -129.7 156.71 43.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.069 0.548 . . . . 0.0 110.336 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -148.12 145.17 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.963 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.55 129.37 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.98 149.85 40.25 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.411 -0.806 . . . . 0.0 110.265 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.9 p -132.11 158.93 40.37 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.377 -0.827 . . . . 0.0 110.215 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 125.85 25.3 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 122.115 -0.366 . . . . 0.0 110.089 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.578 -177.101 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 pttt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.22 147.18 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.419 1.104 . . . . 0.0 109.152 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.425 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 69.6 m -139.27 126.71 21.6 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.764 -1.21 . . . . 0.0 111.568 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.08 -25.3 62.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.68 122.15 9.29 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.163 1.458 . . . . 0.0 110.598 174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.63 -118.02 2.38 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.805 2.145 . . . . 0.0 109.154 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -141.53 156.1 45.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.533 1.133 . . . . 0.0 113.37 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.68 160.85 39.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.901 -1.954 . . . . 0.0 111.201 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -139.86 142.24 36.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.84 147.29 31.11 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.713 0.805 . . . . 0.0 112.227 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' C' ' 110' ' ' TRP . 33.0 tp -72.92 -15.59 61.57 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.16 1.384 . . . . 0.0 111.8 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.76 -16.63 21.01 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.547 2.499 . . . . 0.0 113.593 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -61.28 146.57 47.46 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.517 1.151 . . . . 0.0 113.076 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -121.4 139.25 53.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.646 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -131.66 145.63 51.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 111.585 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -129.87 132.73 46.53 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.223 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.58 126.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.39 -95.03 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 O-C-N 124.22 0.95 . . . . 0.0 112.274 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.58 126.89 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.436 -1.038 . . . . 0.0 110.529 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.44 139.3 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.01 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.42 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 10.8 t-20 -75.14 166.44 23.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.108 0.963 . . . . 0.0 112.959 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.4 t -56.42 -34.51 66.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.982 1.313 . . . . 0.0 113.358 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -68.91 -35.59 77.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.593 -1.317 . . . . 0.0 111.54 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.68 -6.48 9.71 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.83 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 24' ' ' ASN . 8.3 pt-20 -67.19 142.62 56.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.439 1.496 . . . . 0.0 111.98 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -155.53 147.47 23.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.731 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 163.73 13.28 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.87 -166.87 29.54 Favored Glycine 0 C--O 1.238 0.378 0 O-C-N 121.335 -0.853 . . . . 0.0 111.895 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.571 ' HB ' HD11 ' A' ' 46' ' ' LEU . 33.7 p -140.01 128.65 23.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.937 -1.132 . . . . 0.0 111.788 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -103.82 137.57 41.65 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.231 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 46' ' ' LEU . 22.7 mt -128.64 126.17 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 37' ' ' VAL . 15.3 m -104.99 140.75 37.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.733 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.28 -2.42 33.76 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG21 HD21 ' A' ' 14' ' ' LEU . 30.4 m -138.54 163.43 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.616 1.966 . . . . 0.0 111.446 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.37 16.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.834 -1.791 . . . . 0.0 112.857 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -69.46 -47.04 65.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -124.86 79.41 64.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.18 2.992 . . . . 0.0 110.202 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.24 25.42 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 124.825 3.683 . . . . 0.0 116.591 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.36 0.75 63.02 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.107 -1.621 . . . . 0.0 115.799 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.76 30.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -49.03 131.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.034 -1.666 . . . . 0.0 112.399 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.17 165.26 27.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.886 2.074 . . . . 0.0 108.707 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 32' ' ' THR . 5.1 tt -49.24 131.04 19.91 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.78 1.632 . . . . 0.0 111.656 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 p -108.5 122.66 39.63 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.163 0.506 . . . . 0.0 112.206 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.56 145.36 89.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.151 2.567 . . . . 0.0 111.997 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -133.78 156.6 47.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.553 0.741 . . . . 0.0 112.45 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -158.86 149.06 19.51 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.448 2.299 . . . . 0.0 109.366 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.35 -153.76 23.5 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 120.461 1.482 . . . . 0.0 110.345 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.547 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.3 mt -146.39 138.17 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.493 1.117 . . . . 0.0 112.026 -174.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -122.19 141.27 51.64 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.899 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -57.06 -52.39 65.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.635 0.374 . . . . 0.0 111.152 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HE3' ' OG ' ' A' ' 5' ' ' SER . 16.7 tptm 52.58 -0.76 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.339 2.256 . . . . 0.0 116.363 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -75.08 -56.29 4.89 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.747 2.019 . . . . 0.0 113.408 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . . . -79.26 173.35 12.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.81 0.814 . . . . 0.0 110.933 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -73.42 -28.93 62.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.471 1.108 . . . . 0.0 113.749 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -141.81 46.47 0.82 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.296 1.439 . . . . 0.0 112.15 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 48.4 Cg_endo -82.39 -177.45 3.46 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.127 2.551 . . . . 0.0 114.245 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.3 p -84.91 167.77 15.64 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.143 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.86 159.38 15.89 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.484 1.114 . . . . 0.0 111.277 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.91 148.18 14.71 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.62 162.82 35.3 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.484 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.8 m -100.59 146.88 26.58 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 127.127 2.171 . . . . 0.0 109.413 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.34 117.0 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.541 ' HB2' HG21 ' D' ' 52' ' ' ILE . 53.3 t30 -98.65 106.56 18.84 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.893 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.329 52.4 m95 -67.93 158.87 31.75 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 121.56 1.982 . . . . 0.0 115.197 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -39.26 4.02 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -90.44 -11.99 38.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -152.42 143.6 23.19 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.076 2.55 . . . . 0.0 106.393 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.61 118.53 15.65 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.042 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -171.45 164.85 7.0 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.504 1.522 . . . . 0.0 111.644 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -146.99 138.76 24.33 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 123.867 1.794 . . . . 0.0 110.468 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.35 127.26 27.57 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 109.579 -3.464 . . . . 0.0 109.715 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.23 155.87 6.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.011 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.97 139.94 52.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.405 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -149.48 113.9 5.26 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -174.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.38 176.42 29.84 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.04 -1.076 . . . . 0.0 115.509 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 9.7 tt0 -118.05 146.69 43.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.178 -1.511 . . . . 0.0 108.934 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.8 t -97.09 129.61 44.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.368 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -125.72 167.87 14.55 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.867 1.318 . . . . 0.0 112.333 177.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.5 119.02 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 112.668 -2.06 . . . . 0.0 106.7 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -58.44 154.14 14.44 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.47 -23.58 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -7.34 58.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.554 1.142 . . . . 0.0 113.998 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.56 36.93 8.33 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.995 0.809 . . . . 0.0 113.981 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.73 151.91 35.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.868 1.267 . . . . 0.0 110.85 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -101.33 146.33 27.71 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 111.059 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.9 m -148.17 160.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.329 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.5 mt -121.43 115.64 23.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -105.71 110.65 23.03 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.427 HG22 ' HA3' ' A' ' 81' ' ' GLY . 6.2 p -126.02 166.61 16.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.886 1.327 . . . . 0.0 110.528 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.97 170.9 8.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -144.64 159.24 43.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.215 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.0 tp -137.72 123.24 19.66 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.451 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 137.79 44.96 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 125.569 1.793 . . . . 0.0 113.185 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -120.16 119.36 33.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.934 2.021 . . . . 0.0 111.762 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -86.25 160.11 19.26 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.309 1.006 . . . . 0.0 110.815 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m -103.43 82.17 2.01 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.16 -12.84 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.41 -29.47 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.3 137.12 51.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.025 1.284 . . . . 0.0 112.383 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.488 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.8 tt -62.5 -25.6 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.31 -3.76 33.42 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.628 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -124.69 3.16 8.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.396 1.078 . . . . 0.0 113.879 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -34.85 60.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.364 -0.835 . . . . 0.0 112.377 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.608 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 55.6 p-90 -49.95 -44.94 50.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.767 1.227 . . . . 0.0 113.542 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.608 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -89.58 -10.78 44.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.387 -0.82 . . . . 0.0 112.429 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.35 -0.05 24.17 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -118.61 146.25 44.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.19 0.596 . . . . 0.0 111.765 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.56 151.66 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.789 1.636 . . . . 0.0 110.498 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.32 148.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.224 1.375 . . . . 0.0 111.556 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.02 -176.8 27.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 122.55 1.083 . . . . 0.0 112.638 175.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -122.15 152.68 39.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.86 0.864 . . . . 0.0 108.812 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -149.63 132.82 16.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.104 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -124.95 121.32 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.585 -0.697 . . . . 0.0 110.725 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -110.38 151.55 27.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.776 -1.557 . . . . 0.0 110.396 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -133.54 160.25 38.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.281 1.032 . . . . 0.0 109.491 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -57.97 110.47 0.93 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 123' ' ' LEU . 7.0 tt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 N--CA 1.466 0.344 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 p -116.32 144.43 44.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.054 0.942 . . . . 0.0 108.763 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 5' ' ' SER . . . . . 0.404 ' OG ' ' HE3' ' D' ' 57' ' ' LYS . 59.5 m -139.56 126.91 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.405 -1.434 . . . . 0.0 113.178 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.08 -26.99 64.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.5 121.38 7.59 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.009 1.385 . . . . 0.0 110.47 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.38 -117.9 2.25 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.844 2.164 . . . . 0.0 109.512 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -143.87 152.37 41.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.219 1.008 . . . . 0.0 113.337 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -142.16 158.05 44.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.255 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -136.46 144.95 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.661 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.12 146.58 35.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.553 0.741 . . . . 0.0 112.299 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.13 -23.3 67.38 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.56 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.8 tp -72.63 -14.69 61.66 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.027 1.331 . . . . 0.0 112.047 174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -14.55 31.61 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.564 2.507 . . . . 0.0 113.563 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.34 149.59 41.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.759 1.266 . . . . 0.0 113.059 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -125.12 142.18 51.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.028 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -133.02 143.87 49.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.407 0.622 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -128.38 131.93 48.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.224 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.72 127.14 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -95.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.451 1.094 . . . . 0.0 112.358 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -137.87 127.09 24.49 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.46 -1.024 . . . . 0.0 110.797 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.86 139.96 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.233 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.68 164.1 25.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.974 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.9 t -54.58 -34.22 61.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.178 1.391 . . . . 0.0 114.166 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -66.94 -35.66 80.47 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.288 -1.507 . . . . 0.0 111.545 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.1 -6.21 9.44 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 124.408 1.004 . . . . 0.0 114.313 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.12 147.56 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.17 162.86 40.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.577 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.72 168.15 14.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.14 -164.9 29.9 Favored Glycine 0 C--O 1.238 0.396 0 O-C-N 120.184 -1.573 . . . . 0.0 112.082 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.583 ' HB ' HD11 ' D' ' 46' ' ' LEU . 35.5 p -140.54 128.0 21.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.133 0.968 . . . . 0.0 112.058 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -104.71 138.45 40.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.86 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' D' ' 46' ' ' LEU . 21.7 mt -129.49 126.56 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.431 HG22 ' H ' ' D' ' 37' ' ' VAL . 16.4 m -105.06 141.15 37.14 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.703 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.08 -2.75 33.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.479 HG21 HD21 ' D' ' 14' ' ' LEU . 26.8 m -138.2 163.85 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.41 1.884 . . . . 0.0 111.142 -174.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.32 167.78 15.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.917 -1.74 . . . . 0.0 112.655 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -69.88 -46.56 65.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.284 1.034 . . . . 0.0 108.261 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -125.37 79.16 67.02 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.985 2.914 . . . . 0.0 110.121 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.85 24.47 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.937 3.758 . . . . 0.0 116.59 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.67 60.35 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.182 -1.574 . . . . 0.0 115.915 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.34 29.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' D' ' 72' ' ' PHE . 30.8 mt -48.99 131.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.019 -1.676 . . . . 0.0 112.417 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 164.89 28.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.877 2.071 . . . . 0.0 108.821 174.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' D' ' 32' ' ' THR . 5.1 tt -49.01 130.66 18.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.656 1.582 . . . . 0.0 111.456 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -107.98 122.73 39.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 121.388 0.613 . . . . 0.0 112.408 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.22 144.76 89.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.919 2.412 . . . . 0.0 111.582 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' LEU . . . . . 0.422 HD12 ' C ' ' D' ' 49' ' ' LEU . 2.0 pp -131.41 164.11 26.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.62 0.768 . . . . 0.0 112.305 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -165.52 149.03 8.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.226 1.811 . . . . 0.0 109.483 -174.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.48 -156.28 27.71 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 120.858 1.663 . . . . 0.0 112.952 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -146.13 137.11 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.246 1.018 . . . . 0.0 111.486 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.13 140.9 52.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.478 1.511 . . . . 0.0 108.578 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.14 -50.96 71.19 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.068 -0.395 . . . . 0.0 111.353 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' LYS . . . . . 0.404 ' HE3' ' OG ' ' D' ' 5' ' ' SER . 15.1 tptm 51.61 2.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.507 2.323 . . . . 0.0 116.156 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -78.81 -56.32 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.129 2.171 . . . . 0.0 113.568 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' D' ' 62' ' ' PRO . . . -79.65 173.62 12.4 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.467 1.104 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -74.03 -27.06 60.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.682 -1.151 . . . . 0.0 113.969 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -143.01 48.53 1.01 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 125.2 1.4 . . . . 0.0 112.754 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' D' ' 59' ' ' ALA . 45.4 Cg_endo -82.8 -177.65 3.49 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.221 2.614 . . . . 0.0 114.939 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -85.51 168.3 14.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.492 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.37 159.84 15.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 111.148 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.13 148.5 15.19 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -159.85 162.66 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' THR . . . . . 0.506 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.8 m -100.6 149.6 23.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.238 2.215 . . . . 0.0 109.01 173.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -129.1 117.81 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 52' ' ' ILE . 51.2 t30 -100.17 107.45 19.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.746 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.336 50.9 m95 -68.68 158.24 34.55 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.102 1.774 . . . . 0.0 115.334 -172.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.35 4.26 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 72' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' D' ' 44' ' ' ILE . 47.0 p90 -91.09 -12.03 36.85 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -152.31 143.9 23.48 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.104 2.562 . . . . 0.0 106.305 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.84 118.53 15.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.101 0.864 . . . . 0.0 110.413 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 90.3 p -171.73 165.19 6.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.352 1.461 . . . . 0.0 111.903 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -146.9 139.2 24.75 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.459 1.6 . . . . 0.0 110.447 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.31 25.94 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 109.631 -3.44 . . . . 0.0 109.856 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.03 155.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.232 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.38 140.24 51.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 80' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -149.76 114.45 5.31 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -152.2 178.69 29.28 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.946 -1.121 . . . . 0.0 115.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 12.2 tt0 -120.08 144.91 47.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.456 -1.372 . . . . 0.0 109.17 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' D' ' 93' ' ' LEU . 41.4 t -97.31 128.74 44.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.542 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 0.4 OUTLIER -121.61 168.87 11.27 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.792 1.282 . . . . 0.0 111.299 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.28 118.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 112.823 -1.99 . . . . 0.0 106.994 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -58.67 154.87 13.65 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.38 -25.28 0.98 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -6.28 59.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.296 1.039 . . . . 0.0 113.746 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 27.25 20.88 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.544 1.545 . . . . 0.0 114.185 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -106.35 153.12 22.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 111.884 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -101.42 145.92 28.3 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 123.328 1.537 . . . . 0.0 110.871 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 106' ' ' ILE . 17.6 m -148.57 159.56 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.643 175.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 93' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' D' ' 83' ' ' CYS . 67.4 mt -119.2 115.28 23.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -105.9 109.84 21.92 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.412 HG22 ' HA3' ' D' ' 81' ' ' GLY . 6.6 p -125.25 167.33 15.02 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.941 1.353 . . . . 0.0 111.163 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.99 171.14 8.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 159.23 43.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.297 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.405 HD23 ' OG1' ' A' ' 80' ' ' THR . 2.9 tp -137.93 123.23 19.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.265 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.7 138.51 43.8 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 125.521 1.763 . . . . 0.0 113.005 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -120.97 117.77 28.14 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 125.898 1.999 . . . . 0.0 111.858 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -83.93 159.99 21.17 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 124.688 1.243 . . . . 0.0 110.977 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -104.22 82.97 2.01 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.0 -12.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 63.93 -28.22 0.09 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.71 136.5 53.32 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.93 1.241 . . . . 0.0 112.301 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.3 tt -62.09 -25.15 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.04 -4.09 33.34 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.546 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 4.7 m-20 -124.94 3.07 8.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.494 1.117 . . . . 0.0 113.769 -176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -52.97 -34.83 57.75 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.333 -0.854 . . . . 0.0 113.053 175.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.618 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 56.3 p-90 -49.72 -45.69 49.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.7 1.2 . . . . 0.0 113.287 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 111' ' ' LYS . . . . . 0.618 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.3 OUTLIER -89.06 -11.3 44.49 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.451 -0.781 . . . . 0.0 112.451 177.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.3 23.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 7.6 m -118.24 145.99 44.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.288 0.635 . . . . 0.0 111.884 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.77 151.86 40.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.85 1.66 . . . . 0.0 110.773 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.04 148.68 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 120.13 1.332 . . . . 0.0 111.675 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.21 -177.19 28.23 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 122.465 1.036 . . . . 0.0 112.912 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -120.96 152.88 38.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.778 0.831 . . . . 0.0 109.053 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -149.5 133.41 17.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.225 -174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 48.8 mt -126.09 122.63 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.259 1.028 . . . . 0.0 110.714 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -112.55 148.77 33.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.465 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 16.4 p -133.43 160.3 37.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.424 1.09 . . . . 0.0 109.844 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -55.88 115.62 2.49 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.132 0.573 . . . . 0.0 109.778 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 123' ' ' LEU . . . . . 0.505 HD23 ' C ' ' D' ' 123' ' ' LEU . 3.6 tt . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 120.142 0.02 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 p -116.46 144.43 44.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.207 1.003 . . . . 0.0 109.736 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.405 ' OG ' ' HE3' ' B' ' 57' ' ' LYS . 53.6 m -139.5 126.81 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.433 -1.417 . . . . 0.0 113.012 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.06 -27.77 62.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -53.17 116.62 2.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.764 1.226 . . . . 0.0 110.385 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.6 -121.14 2.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.974 1.749 . . . . 0.0 109.793 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -143.08 153.4 42.88 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.919 1.288 . . . . 0.0 113.224 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -143.31 160.23 40.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.707 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.444 ' HB ' HD12 ' B' ' 123' ' ' LEU . 14.3 t -138.28 145.14 40.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.677 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -112.11 146.17 38.48 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.478 0.711 . . . . 0.0 112.34 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.13 -24.38 67.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.593 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.6 tp -71.06 -14.4 62.31 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 112.029 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.96 -13.78 31.7 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.805 2.621 . . . . 0.0 113.738 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -63.64 149.47 46.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.842 1.306 . . . . 0.0 112.865 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -125.38 140.68 52.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.011 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -131.89 145.58 51.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.745 0.784 . . . . 0.0 112.408 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -129.22 133.63 47.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.015 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.03 127.56 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -93.75 0.07 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.922 0.764 . . . . 0.0 112.124 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.46 127.01 21.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.266 -1.138 . . . . 0.0 110.351 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.23 139.12 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.88 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' B' ' 28' ' ' GLU . 10.2 t-20 -75.36 167.07 22.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.781 0.832 . . . . 0.0 112.914 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -56.81 -34.37 67.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.01 1.324 . . . . 0.0 113.352 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -68.78 -36.19 77.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.281 -1.512 . . . . 0.0 111.476 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.77 -6.68 9.61 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.786 -1.563 . . . . 0.0 114.858 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' B' ' 24' ' ' ASN . 8.4 pt-20 -65.99 142.61 57.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.448 1.499 . . . . 0.0 112.45 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.75 147.94 23.56 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.553 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.32 163.09 14.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 174.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.26 -166.86 29.0 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 121.296 -0.877 . . . . 0.0 111.867 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.57 ' HB ' HD11 ' B' ' 46' ' ' LEU . 33.1 p -140.62 128.73 22.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.967 -1.117 . . . . 0.0 111.88 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -103.82 137.92 41.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.101 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.478 HD11 HD12 ' B' ' 46' ' ' LEU . 21.9 mt -129.25 126.17 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 37' ' ' VAL . 15.4 m -105.11 141.37 36.78 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.853 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.67 -2.27 33.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.485 HG21 HD21 ' B' ' 14' ' ' LEU . 26.9 m -138.5 163.29 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.534 1.933 . . . . 0.0 111.223 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.21 167.7 15.91 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.006 -1.684 . . . . 0.0 112.879 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -70.71 -44.86 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 108.493 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -126.61 79.04 72.02 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 129.035 2.934 . . . . 0.0 109.843 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.08 24.82 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.786 3.658 . . . . 0.0 116.602 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.84 0.63 61.32 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.157 -1.589 . . . . 0.0 115.877 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.45 29.96 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' B' ' 72' ' ' PHE . 30.5 mt -49.13 130.94 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 119.899 -1.75 . . . . 0.0 112.445 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.72 165.21 28.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.76 2.024 . . . . 0.0 108.59 174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' B' ' 32' ' ' THR . 5.1 tt -49.48 131.44 20.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.843 1.657 . . . . 0.0 111.806 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 7.3 p -109.54 122.61 38.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.183 0.516 . . . . 0.0 111.53 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.3 145.3 88.07 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.211 2.607 . . . . 0.0 111.92 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.83 156.21 48.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.587 0.755 . . . . 0.0 112.441 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -158.38 149.11 20.41 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.506 2.322 . . . . 0.0 109.483 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.11 -153.79 23.65 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 120.612 1.551 . . . . 0.0 110.254 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.3 mt -146.13 138.48 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.51 1.124 . . . . 0.0 112.086 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -122.73 140.59 52.71 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.082 -1.011 . . . . 0.0 108.681 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -56.47 -52.2 65.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.844 0.458 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' OG ' ' B' ' 5' ' ' SER . 16.0 tptm 52.87 0.28 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.488 2.315 . . . . 0.0 116.284 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -77.29 -56.3 4.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.137 2.175 . . . . 0.0 113.745 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' B' ' 62' ' ' PRO . . . -78.73 173.46 12.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 124.288 0.992 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -74.21 -26.26 60.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 117.206 -1.378 . . . . 0.0 113.903 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -143.67 48.74 0.98 Allowed Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 125.465 1.506 . . . . 0.0 112.709 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 59' ' ' ALA . 49.8 Cg_endo -82.93 -178.62 3.96 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.11 2.54 . . . . 0.0 114.848 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 70.4 p -84.54 167.77 16.02 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.24 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.84 159.83 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.452 1.101 . . . . 0.0 111.285 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.37 148.11 14.35 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -159.66 163.11 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.483 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.9 m -101.1 147.48 26.18 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.67 1.988 . . . . 0.0 109.303 173.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.58 117.05 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.545 ' HB2' HG21 ' C' ' 52' ' ' ILE . 42.9 t30 -98.45 107.03 19.39 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.662 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.331 52.5 m95 -68.31 158.77 32.72 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.594 1.997 . . . . 0.0 114.982 -173.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -38.89 4.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -174.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' B' ' 44' ' ' ILE . 47.5 p90 -90.96 -12.01 37.27 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -152.31 143.24 23.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.038 2.535 . . . . 0.0 106.433 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -72.9 118.39 15.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.081 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -170.92 164.94 7.75 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.742 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.61 138.92 24.94 Favored 'General case' 0 CA--C 1.48 -1.73 0 CA-C-O 123.473 1.606 . . . . 0.0 110.493 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.74 127.36 27.02 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 110.042 -3.254 . . . . 0.0 109.54 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -105.18 155.75 6.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.145 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.21 140.43 51.91 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.401 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -150.01 114.23 5.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.406 0.622 . . . . 0.0 109.327 -174.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -152.34 178.26 29.64 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 120.072 -1.061 . . . . 0.0 115.587 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.479 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 10.8 tt0 -119.83 144.91 47.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.301 -1.449 . . . . 0.0 109.157 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.419 ' SG ' HD23 ' B' ' 93' ' ' LEU . 49.7 t -97.21 128.73 44.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.724 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 0.4 OUTLIER -121.81 168.82 11.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.913 1.34 . . . . 0.0 110.977 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.3 118.94 57.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.636 -2.075 . . . . 0.0 106.627 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.31 153.56 15.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.48 -26.15 0.53 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.14 -9.44 59.19 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 31.37 10.58 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.521 1.057 . . . . 0.0 114.531 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.26 152.71 24.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.999 1.319 . . . . 0.0 110.85 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -101.43 146.05 28.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.495 1.518 . . . . 0.0 110.99 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' C' ' 106' ' ' ILE . 17.8 m -147.62 159.72 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.956 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 67.1 mt -119.44 115.27 23.73 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -105.88 110.65 23.01 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.402 HG22 ' HA3' ' B' ' 81' ' ' GLY . 7.2 p -126.56 167.11 16.1 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.007 1.384 . . . . 0.0 110.81 -174.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 170.85 8.92 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -144.72 158.97 43.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.494 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.408 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.1 tp -137.51 123.21 19.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.416 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.53 137.76 44.99 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 125.66 1.85 . . . . 0.0 113.299 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -120.93 117.1 26.46 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 125.937 2.023 . . . . 0.0 111.94 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 160.43 21.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.541 1.151 . . . . 0.0 111.137 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 3.6 m -104.33 83.35 2.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.46 -12.69 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 t30 64.07 -29.85 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.47 136.16 52.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.152 0.977 . . . . 0.0 112.515 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' C' ' 92' ' ' VAL . 2.5 tt -62.42 -26.58 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.12 -3.61 24.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.453 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 5.0 m-20 -124.64 3.34 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.53 1.132 . . . . 0.0 113.874 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -52.88 -35.76 58.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.226 -0.922 . . . . 0.0 112.306 175.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 54.9 p-90 -49.6 -45.24 47.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.378 1.071 . . . . 0.0 113.686 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.61 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -89.39 -11.04 44.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.621 0.768 . . . . 0.0 112.686 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.47 -0.32 25.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.427 -0.797 . . . . 0.0 113.078 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -118.02 146.19 44.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.769 0.713 . . . . 0.0 111.738 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.24 151.75 39.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.785 1.634 . . . . 0.0 110.415 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.19 148.37 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.01 -176.86 27.7 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 122.536 1.076 . . . . 0.0 112.79 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -121.52 153.43 37.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.565 -0.817 . . . . 0.0 108.985 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.1 133.72 16.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.015 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 51.8 mt -126.18 122.64 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.755 0.788 . . . . 0.0 110.637 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 12.4 m-85 -111.7 148.71 32.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.164 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 19.0 p -135.7 162.94 31.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.261 1.024 . . . . 0.0 110.189 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -59.93 115.83 3.69 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.526 -0.734 . . . . 0.0 111.062 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' B' ' 11' ' ' THR . 3.8 tt . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 p -116.41 141.84 47.64 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 122.112 0.958 . . . . 0.0 108.977 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 5' ' ' SER . . . . . 0.419 ' OG ' ' HE3' ' C' ' 57' ' ' LYS . 65.0 m -139.39 126.54 21.21 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.368 -1.457 . . . . 0.0 113.026 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.55 -29.63 64.96 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -52.0 118.38 3.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.591 1.186 . . . . 0.0 110.243 174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.53 -122.53 2.94 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.315 1.912 . . . . 0.0 109.336 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -143.03 152.96 42.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.48 1.112 . . . . 0.0 113.113 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -143.59 155.85 44.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.091 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.409 ' HB ' HD12 ' C' ' 123' ' ' LEU . 9.9 t -133.43 145.14 49.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.395 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -109.42 147.43 32.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -65.06 -19.09 65.82 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.561 HD11 ' CD1' ' A' ' 110' ' ' TRP . 35.0 tp -75.36 -14.91 60.51 Favored 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.963 -1.086 . . . . 0.0 111.273 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.59 -14.07 32.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.222 2.344 . . . . 0.0 113.659 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 149.73 44.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.411 -1.052 . . . . 0.0 112.377 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -125.35 142.82 51.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.956 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -132.41 146.1 51.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 112.507 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -129.64 133.34 47.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.547 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.65 127.23 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.85 -93.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.135 0.897 . . . . 0.0 112.282 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.31 128.29 23.66 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.364 -1.08 . . . . 0.0 110.469 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.21 139.24 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.315 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -77.55 164.03 25.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.98 0.912 . . . . 0.0 112.584 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -54.35 -33.82 59.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.232 1.413 . . . . 0.0 114.217 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.26 -35.45 79.56 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.384 -1.447 . . . . 0.0 111.543 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.41 -6.26 9.24 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 124.369 0.985 . . . . 0.0 114.506 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.9 147.25 47.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -154.8 161.94 41.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.96 0.886 . . . . 0.0 110.728 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 167.72 14.1 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.31 30.28 Favored Glycine 0 C--O 1.238 0.344 0 O-C-N 120.391 -1.443 . . . . 0.0 112.096 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.573 ' HB ' HD11 ' C' ' 46' ' ' LEU . 33.9 p -140.33 129.0 22.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.155 0.978 . . . . 0.0 111.715 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -105.43 138.23 41.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.179 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.453 HD11 HD12 ' C' ' 46' ' ' LEU . 22.8 mt -129.22 126.64 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.438 HG22 ' H ' ' C' ' 37' ' ' VAL . 16.6 m -105.11 141.15 37.18 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.909 -173.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.39 -1.88 34.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.48 HG21 HD21 ' C' ' 14' ' ' LEU . 26.9 m -139.24 163.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.533 1.933 . . . . 0.0 111.31 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.24 167.46 16.07 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 119.894 -1.754 . . . . 0.0 112.871 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -70.16 -45.42 66.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.286 1.034 . . . . 0.0 108.463 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -126.33 78.85 71.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 129.002 2.921 . . . . 0.0 110.114 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.85 24.2 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.909 3.739 . . . . 0.0 116.591 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 0.65 59.7 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.224 -1.548 . . . . 0.0 115.885 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.38 30.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.09 131.4 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.965 -1.709 . . . . 0.0 112.462 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.3 165.44 27.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.775 2.03 . . . . 0.0 108.664 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' C' ' 32' ' ' THR . 5.3 tt -49.51 131.22 20.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.558 1.543 . . . . 0.0 111.65 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.1 p -109.02 123.04 38.06 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.33 144.61 90.77 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.01 2.473 . . . . 0.0 111.542 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.416 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.0 pp -131.15 164.32 25.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.788 0.835 . . . . 0.0 112.708 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -165.64 148.93 7.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.064 1.746 . . . . 0.0 109.656 -174.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.34 -156.17 27.55 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 120.898 1.681 . . . . 0.0 112.629 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.545 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -146.16 137.05 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 123.37 1.557 . . . . 0.0 112.006 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.02 141.65 51.13 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.086 -1.634 . . . . 0.0 108.38 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.15 -50.79 71.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.881 0.31 . . . . 0.0 111.345 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' LYS . . . . . 0.419 ' HE3' ' OG ' ' C' ' 5' ' ' SER . 16.4 tptm 51.85 2.79 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.351 2.26 . . . . 0.0 115.979 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -79.74 -56.73 4.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.598 1.959 . . . . 0.0 113.546 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' C' ' 62' ' ' PRO . . . -78.63 174.7 11.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.853 0.721 . . . . 0.0 111.339 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -75.73 -26.68 57.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.583 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.63 48.9 1.13 Allowed Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 125.216 1.407 . . . . 0.0 112.705 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' C' ' 59' ' ' ALA . 46.5 Cg_endo -83.12 -178.3 3.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.805 2.337 . . . . 0.0 115.007 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 82.4 p -84.63 168.1 15.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.619 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -166.08 160.29 16.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.457 1.103 . . . . 0.0 111.372 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.3 148.12 14.4 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 119.119 2.408 . . . . 0.0 119.119 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -159.76 162.17 34.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.502 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.8 m -100.25 150.1 22.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.007 2.123 . . . . 0.0 108.966 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 49.5 t -129.28 117.9 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.6 t30 -99.96 107.18 19.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.761 -174.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.337 51.3 m95 -67.79 158.11 33.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.247 1.84 . . . . 0.0 115.387 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.16 4.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.2 -12.08 36.38 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 8.3 t -152.32 143.86 23.45 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 128.155 2.582 . . . . 0.0 106.329 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.94 118.55 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.457 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p -171.83 165.13 6.51 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.573 1.549 . . . . 0.0 111.767 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.56 138.97 25.05 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 123.635 1.683 . . . . 0.0 110.606 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.52 26.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-N 109.785 -3.37 . . . . 0.0 109.712 -172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.05 155.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.145 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -128.31 140.06 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.408 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -150.08 115.02 5.34 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.541 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -153.13 177.87 30.52 Favored Glycine 0 CA--C 1.501 -0.792 0 C-N-CA 119.894 -1.146 . . . . 0.0 115.508 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 10.6 tt0 -119.22 145.27 46.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.545 -1.327 . . . . 0.0 108.917 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.443 ' SG ' HD23 ' C' ' 93' ' ' LEU . 49.9 t -97.27 129.23 44.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.404 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 0.3 OUTLIER -124.8 171.94 9.73 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.009 1.385 . . . . 0.0 111.649 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.81 115.76 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 112.363 -2.199 . . . . 0.0 106.604 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.82 152.42 19.22 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -45.27 -22.89 0.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.57 -10.5 55.82 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.46 43.06 6.3 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.731 1.158 . . . . 0.0 113.495 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -116.05 147.25 41.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.256 1.423 . . . . 0.0 108.382 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -101.26 141.19 34.51 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.969 1.707 . . . . 0.0 109.966 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.6 m -143.93 161.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.29 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' LEU . . . . . 0.443 HD23 ' SG ' ' C' ' 83' ' ' CYS . 62.7 mt -120.13 116.34 25.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -106.53 110.53 22.77 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 172.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' C' ' 81' ' ' GLY . 9.1 p -126.4 165.37 19.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.661 1.22 . . . . 0.0 110.935 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.16 170.66 8.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 172.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -144.37 159.44 42.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.487 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' B' ' 80' ' ' THR . 2.9 tp -137.79 123.14 19.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.436 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.63 138.41 43.91 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 125.295 1.622 . . . . 0.0 113.065 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -121.43 117.43 26.87 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 125.895 1.997 . . . . 0.0 111.823 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 15.7 m -83.53 159.76 21.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.729 1.268 . . . . 0.0 111.285 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -103.9 83.0 2.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.24 -12.56 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.48 -29.06 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.1 136.54 52.82 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.8 1.286 . . . . 0.0 112.436 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' B' ' 92' ' ' VAL . 2.3 tt -62.3 -25.21 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.574 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.61 -3.96 36.57 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.591 -1.116 . . . . 0.0 114.61 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 4.7 m-20 -124.29 2.72 8.49 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.455 1.102 . . . . 0.0 113.92 -177.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 109' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -52.86 -35.67 57.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.381 -0.824 . . . . 0.0 112.361 176.109 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.603 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 57.2 p-90 -49.67 -45.77 49.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.595 1.158 . . . . 0.0 113.311 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 111' ' ' LYS . . . . . 0.603 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.3 OUTLIER -88.88 -11.03 45.76 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.436 -0.79 . . . . 0.0 112.544 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -0.24 25.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -117.87 146.03 44.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.316 0.647 . . . . 0.0 111.65 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.61 152.06 40.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.745 1.618 . . . . 0.0 110.654 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.21 148.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 120.186 1.357 . . . . 0.0 111.802 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.96 -176.98 27.8 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-O 122.442 1.023 . . . . 0.0 112.809 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -121.55 153.49 37.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.719 0.808 . . . . 0.0 108.834 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.28 132.44 15.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.229 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 mt -124.8 118.04 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.903 0.858 . . . . 0.0 111.068 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 13.1 m-85 -105.59 150.71 25.15 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.564 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 3.9 p -136.53 159.83 40.61 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.514 1.126 . . . . 0.0 109.859 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -55.36 124.34 16.8 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.742 -0.599 . . . . 0.0 109.813 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.409 HD12 ' HB ' ' C' ' 11' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.916 174.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.04 133.5 53.64 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -139.54 128.53 23.62 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.811 -1.805 . . . . 0.0 110.695 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.8 mt -68.06 -23.22 64.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -51.58 113.63 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 112.004 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.95 -121.41 2.47 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.788 1.185 . . . . 0.0 110.954 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -151.88 146.28 25.54 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -143.34 163.24 33.58 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.223 1.409 . . . . 0.0 112.065 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.451 ' HB ' HD12 ' A' ' 123' ' ' LEU . 6.3 t -142.76 154.89 44.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.682 -1.151 . . . . 0.0 109.149 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 146.35 49.65 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.095 0.861 . . . . 0.0 112.515 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.24 -25.1 13.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.653 2.381 . . . . 0.0 115.012 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.07 -18.78 62.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.371 1.069 . . . . 0.0 112.848 174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.84 -15.76 21.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.828 2.633 . . . . 0.0 113.261 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.4 p -65.99 145.54 55.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 123.297 1.522 . . . . 0.0 113.086 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.98 144.93 46.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.737 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -141.8 147.34 37.11 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 173.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -137.44 135.23 36.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.428 0.691 . . . . 0.0 109.759 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.324 0.65 . . . . 0.0 109.903 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -92.68 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.57 32.25 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.701 -0.882 . . . . 0.0 112.235 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.67 129.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.244 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -70.31 165.84 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.228 0.33 . . . . 0.0 111.62 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -59.78 -24.11 63.82 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.429 -1.42 . . . . 0.0 114.822 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.37 -27.09 46.8 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.895 0.77 . . . . 0.0 112.027 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.27 -6.16 30.31 Favored Glycine 0 N--CA 1.468 0.805 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.539 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' D' ' 50' ' ' LEU . 10.0 pt-20 -63.78 138.62 58.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 162.58 38.94 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.395 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 50' ' ' LEU . 2.8 p -129.34 176.9 7.58 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.35 -166.0 37.75 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.566 -1.334 . . . . 0.0 114.095 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 46' ' ' LEU . 12.7 p -136.76 130.92 32.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.605 1.193 . . . . 0.0 111.781 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -114.52 141.28 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.658 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.4 mt -131.54 133.14 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 44' ' ' ILE . 2.7 m -107.69 140.56 40.54 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.731 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.33 -11.15 19.65 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.6 m -138.21 141.66 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 111.183 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.26 33.05 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.977 -0.452 . . . . 0.0 110.135 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -77.35 -34.75 55.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.75 83.84 40.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.764 1.626 . . . . 0.0 110.138 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.78 36.05 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.998 3.799 . . . . 0.0 115.075 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.29 -7.21 63.05 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 179.58 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.624 1.97 . . . . 0.0 110.858 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 35' ' ' THR . 63.4 mt -56.52 125.56 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 119.988 -1.695 . . . . 0.0 111.05 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.27 165.24 28.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 111.585 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.469 HD11 ' HB ' ' A' ' 32' ' ' THR . 10.3 tp -46.98 115.94 1.22 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 130.781 3.632 . . . . 0.0 113.028 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.6 p -105.9 122.99 40.61 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.456 0.702 . . . . 0.0 111.234 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.62 136.58 74.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.836 2.357 . . . . 0.0 111.318 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.69 155.03 37.27 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.07 0.856 . . . . 0.0 111.694 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 30' ' ' THR . 1.5 tp -162.37 149.01 13.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.92 1.688 . . . . 0.0 109.349 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.97 -150.01 20.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.296 1.407 . . . . 0.0 109.658 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -144.0 141.48 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.49 0.716 . . . . 0.0 111.271 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 137.53 51.91 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.333 -0.854 . . . . 0.0 110.599 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -68.52 155.07 40.65 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.397 -0.814 . . . . 0.0 111.843 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -146.2 13.98 1.28 Allowed 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.273 -1.517 . . . . 0.0 114.489 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -87.89 -49.11 7.3 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.825 0.739 . . . . 0.0 112.465 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.07 175.06 9.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -78.93 -38.56 36.91 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.798 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -136.31 52.0 5.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.591 1.156 . . . . 0.0 112.567 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.87 173.83 13.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.738 1.625 . . . . 0.0 113.834 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.331 0.6 OUTLIER -95.41 167.38 11.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.571 173.664 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.56 166.54 31.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.722 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.49 146.61 12.43 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -159.13 152.67 22.79 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.41 151.75 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.286 1.835 . . . . 0.0 109.287 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.16 118.44 40.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.645 ' HB2' HG21 ' D' ' 52' ' ' ILE . 1.9 t-20 -88.13 116.55 26.4 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.748 -0.595 . . . . 0.0 110.126 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.81 142.35 44.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.385 1.088 . . . . 0.0 110.573 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.69 -39.78 5.27 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.246 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.83 -13.12 54.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.268 1.427 . . . . 0.0 114.439 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.3 t -152.35 132.36 13.42 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.423 2.689 . . . . 0.0 106.06 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.02 117.67 16.09 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.081 1.309 . . . . 0.0 110.416 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -173.65 164.03 4.36 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 126.549 1.94 . . . . 0.0 110.057 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.86 142.6 38.6 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.19 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -132.38 152.07 51.6 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.462 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.79 150.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.748 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.42 143.95 51.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 127.38 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.61 178.47 45.51 Favored Glycine 0 C--O 1.217 -0.915 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -101.21 147.9 25.73 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.856 0.974 . . . . 0.0 112.835 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 21.7 p -97.74 120.53 38.29 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.754 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 82' ' ' GLN 0.299 2.7 m-85 -112.91 162.25 16.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -132.41 109.66 15.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -59.38 162.13 5.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.335 0.654 . . . . 0.0 109.448 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -21.67 2.27 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -8.18 54.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.562 0.745 . . . . 0.0 113.003 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.17 51.96 4.78 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -121.33 146.82 46.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.816 2.446 . . . . 0.0 104.938 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -112.41 150.19 31.47 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.857 1.263 . . . . 0.0 112.182 -172.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.689 HG11 ' HD3' ' A' ' 94' ' ' LYS . 1.7 t -148.14 161.33 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.786 1.279 . . . . 0.0 110.681 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.4 mt -125.51 110.49 13.94 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 101.241 -3.614 . . . . 0.0 101.241 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HD3' HG11 ' A' ' 92' ' ' VAL . 7.5 mmmt -102.71 122.35 44.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -138.84 163.76 31.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.477 1.608 . . . . 0.0 114.264 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.5 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.89 165.24 12.5 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.381 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -140.89 159.48 42.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.071 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.804 HD21 HG23 ' A' ' 113' ' ' THR . 1.2 tt -143.21 124.1 14.3 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.833 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 77' ' ' THR . 3.0 tp -107.69 141.7 38.81 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 125.692 1.87 . . . . 0.0 110.689 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.402 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.3 tpt85 -124.41 114.03 18.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 110.298 -3.137 . . . . 0.0 109.455 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.251 18.5 m -70.88 164.51 25.19 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.74 1.9 . . . . 0.0 113.094 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.408 ' HA ' ' OE1' ' D' ' 82' ' ' GLN . 58.4 m -101.44 84.36 2.59 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 112' ' ' ALA . 2.3 t -79.38 164.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 127.463 2.305 . . . . 0.0 109.296 174.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -114.59 -23.19 9.4 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.51 138.29 51.19 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.719 0.771 . . . . 0.0 111.113 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -59.77 -17.23 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.68 7.75 74.23 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.361 -1.8 . . . . 0.0 115.759 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.87 4.99 15.01 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.853 1.827 . . . . 0.0 112.704 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -62.27 -30.67 71.29 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.054 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CD1' HD11 ' C' ' 14' ' ' LEU . 54.7 p-90 -48.97 -40.12 29.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 113.21 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -96.92 -6.25 36.12 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 114.022 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 103' ' ' VAL . . . -78.94 7.0 7.92 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.804 HG23 HD21 ' A' ' 98' ' ' LEU . 19.2 m -122.1 140.46 52.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.757 0.789 . . . . 0.0 113.043 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 119.56 6.48 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.558 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.93 150.19 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.44 1.896 . . . . 0.0 111.51 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.41 -171.48 22.71 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.707 0.67 . . . . 0.0 112.768 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -131.38 157.31 43.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.071 -0.664 . . . . 0.0 111.448 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -147.69 160.13 43.03 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.363 1.065 . . . . 0.0 109.15 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.1 mt -138.71 119.03 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.74 148.44 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.529 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -134.98 165.31 25.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.66 124.4 20.9 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.893 0.877 . . . . 0.0 111.526 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 11' ' ' THR . 6.0 tt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.05 136.26 41.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -139.31 133.49 31.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.662 -1.274 . . . . 0.0 110.696 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.13 -23.2 63.94 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -51.02 114.38 1.16 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.1 1.429 . . . . 0.0 111.592 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.76 -120.54 2.42 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.67 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -152.81 149.74 28.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -147.0 163.21 36.96 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.56 1.544 . . . . 0.0 112.057 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.499 ' HB ' HD12 ' D' ' 123' ' ' LEU . 12.9 t -141.47 154.48 45.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.062 0.945 . . . . 0.0 108.935 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -123.08 145.83 48.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.855 0.862 . . . . 0.0 112.296 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.43 -24.57 13.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.527 2.331 . . . . 0.0 114.816 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' B' ' 110' ' ' TRP . 33.4 tp -70.81 -19.18 62.7 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.976 -1.078 . . . . 0.0 112.858 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.62 -15.69 19.51 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 127.796 2.617 . . . . 0.0 113.392 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -66.42 144.9 56.23 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 123.289 1.518 . . . . 0.0 112.991 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.87 146.07 45.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.698 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -141.99 147.59 37.18 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 18.9 m -136.24 135.25 38.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.517 0.727 . . . . 0.0 110.529 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 92.7 mt -136.94 128.34 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.339 0.656 . . . . 0.0 109.497 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.08 -90.61 0.06 OUTLIER Glycine 0 CA--C 1.533 1.194 0 O-C-N 123.573 0.546 . . . . 0.0 112.557 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.48 141.8 29.82 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.644 -0.915 . . . . 0.0 111.914 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.15 130.01 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.518 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -68.19 164.96 19.3 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.503 0.502 . . . . 0.0 111.795 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -60.47 -23.77 64.74 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.178 -1.576 . . . . 0.0 114.739 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -76.12 -24.77 54.96 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.877 0.762 . . . . 0.0 112.025 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.82 -5.45 32.59 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 124.093 0.854 . . . . 0.0 114.255 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.49 153.27 44.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.966 0.883 . . . . 0.0 112.167 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PHE . . . . . 0.559 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -155.45 166.52 33.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.107 176.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 30' ' ' THR . . . . . 0.433 HG22 HD13 ' D' ' 50' ' ' LEU . 15.9 p -127.09 -177.67 4.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.39 -165.99 39.22 Favored Glycine 0 N--CA 1.469 0.89 0 O-C-N 119.534 -1.979 . . . . 0.0 114.217 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.476 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.1 p -136.79 130.13 31.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.144 0.973 . . . . 0.0 112.325 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -114.59 141.38 47.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.74 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.9 133.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.45 ' O ' HG21 ' D' ' 44' ' ' ILE . 2.8 m -108.28 140.66 41.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.749 1.22 . . . . 0.0 111.861 -173.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.46 -11.93 18.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 18.3 m -137.84 141.08 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 124.093 0.957 . . . . 0.0 111.26 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.9 34.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.057 -0.402 . . . . 0.0 110.185 -174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.91 -34.55 57.69 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -134.92 83.82 39.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.641 1.576 . . . . 0.0 110.244 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 36.09 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 125.009 3.806 . . . . 0.0 115.197 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.12 63.32 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.77 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.538 1.935 . . . . 0.0 110.849 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.45 HG21 ' O ' ' D' ' 35' ' ' THR . 63.7 mt -56.21 125.84 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 119.989 -1.695 . . . . 0.0 111.254 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.79 165.91 27.45 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.988 1.315 . . . . 0.0 111.856 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' D' ' 32' ' ' THR . 10.9 tp -47.86 115.62 1.22 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.589 3.556 . . . . 0.0 112.782 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -105.69 122.69 41.79 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.469 0.708 . . . . 0.0 110.615 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.92 135.87 71.63 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.492 2.128 . . . . 0.0 110.837 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' LEU . . . . . 0.465 HD12 ' C ' ' D' ' 49' ' ' LEU . 1.2 pp -121.11 161.02 22.48 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.043 0.84 . . . . 0.0 111.246 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.559 HD12 ' O ' ' D' ' 29' ' ' PHE . 17.7 tp -169.05 149.33 4.25 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.668 1.587 . . . . 0.0 112.182 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.81 -146.96 13.51 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.0 mt -147.01 139.76 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.965 0.906 . . . . 0.0 110.296 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.79 53.37 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.157 -0.964 . . . . 0.0 110.871 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -70.57 153.52 42.81 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.766 -1.209 . . . . 0.0 111.304 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -143.91 17.23 1.78 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -93.31 -49.0 6.16 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.656 0.782 . . . . 0.0 112.642 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.7 177.25 5.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -81.58 -38.29 26.33 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.596 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.77 51.98 4.69 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.469 1.108 . . . . 0.0 111.875 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.71 175.21 11.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.707 1.605 . . . . 0.0 113.726 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.328 0.7 OUTLIER -96.47 165.91 11.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.018 1.389 . . . . 0.0 112.353 173.553 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.77 165.96 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.948 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 146.57 12.43 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -159.02 152.42 22.68 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.82 151.75 19.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.872 2.069 . . . . 0.0 109.034 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.87 119.45 45.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.672 ' HB2' HG21 ' A' ' 52' ' ' ILE . 1.7 t-20 -88.07 118.31 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.322 -0.861 . . . . 0.0 110.601 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -76.52 141.89 41.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.539 1.162 . . . . 0.0 110.498 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.55 -39.65 5.34 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.239 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.67 -13.3 54.48 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 114.268 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 43.2 t -152.34 133.32 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 128.554 2.741 . . . . 0.0 106.211 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -75.3 117.73 17.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.148 1.34 . . . . 0.0 110.347 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -173.72 164.02 4.31 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 109.72 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -138.88 142.59 38.57 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.073 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.753 HG23 HD12 ' D' ' 99' ' ' LEU . 0.0 OUTLIER -131.96 152.23 51.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.533 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.12 149.53 29.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.768 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.75 126.86 12.05 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -173.29 178.36 45.28 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.34 147.25 26.53 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 124.63 0.841 . . . . 0.0 112.337 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.83 115.7 28.59 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.445 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' D' ' 82' ' ' GLN 0.275 3.3 m-85 -110.15 162.95 14.09 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -132.74 112.21 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.71 161.95 11.56 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.671 0.788 . . . . 0.0 109.011 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -20.52 0.85 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.09 -2.22 55.71 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.81 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.33 51.57 6.03 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -173.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.23 138.9 54.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.91 2.084 . . . . 0.0 107.185 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -106.69 149.42 27.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.781 1.632 . . . . 0.0 112.261 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.675 HG11 ' HD3' ' D' ' 94' ' ' LYS . 1.8 t -150.53 161.64 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 122.729 1.252 . . . . 0.0 110.247 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 mt -125.9 111.27 14.61 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.675 ' HD3' HG11 ' D' ' 92' ' ' VAL . 6.8 mmmt -103.97 120.62 41.42 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -137.35 162.96 32.16 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.792 1.758 . . . . 0.0 114.101 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -112.45 164.8 12.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -140.54 159.72 41.58 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.887 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.807 HD21 HG23 ' D' ' 113' ' ' THR . 1.2 tt -143.45 124.01 14.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.85 175.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 99' ' ' LEU . . . . . 0.753 HD12 HG23 ' D' ' 77' ' ' THR . 3.1 tp -107.51 141.96 38.13 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 125.616 1.822 . . . . 0.0 110.693 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -124.2 114.13 19.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.216 -3.175 . . . . 0.0 109.417 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.263 19.2 m -71.45 163.93 26.78 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.682 1.864 . . . . 0.0 112.762 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 102' ' ' SER . . . . . 0.407 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 55.2 m -100.25 85.7 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 103' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' D' ' 112' ' ' ALA . 2.3 t -80.89 164.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 127.048 2.139 . . . . 0.0 109.065 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.87 -23.84 8.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.44 137.96 51.18 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.601 0.715 . . . . 0.0 111.142 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.527 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.1 tt -59.06 -17.74 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 7.31 73.23 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.356 1.932 . . . . 0.0 116.016 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.49 4.66 15.31 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 119.967 1.884 . . . . 0.0 112.969 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -61.35 -31.17 71.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.972 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.487 ' CD1' HD11 ' B' ' 14' ' ' LEU . 55.1 p-90 -49.0 -39.58 27.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.117 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -97.72 -5.96 33.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.733 1.213 . . . . 0.0 114.057 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 112' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' D' ' 103' ' ' VAL . . . -78.89 6.74 8.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.807 HG23 HD21 ' D' ' 98' ' ' LEU . 18.3 m -121.65 140.18 52.6 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 122.076 0.941 . . . . 0.0 113.251 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.36 121.05 7.51 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.008 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 9.7 p -100.87 150.29 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.732 2.013 . . . . 0.0 111.418 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.42 -171.49 22.73 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.663 0.649 . . . . 0.0 112.502 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -131.67 157.19 44.38 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.02 -0.694 . . . . 0.0 111.517 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -147.9 159.55 43.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.524 1.13 . . . . 0.0 109.095 174.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 119' ' ' ILE . . . . . 0.436 HD13 ' HE3' ' D' ' 94' ' ' LYS . 7.3 mt -137.83 118.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.61 146.5 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 14.7 p -132.89 163.57 28.84 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.158 0.98 . . . . 0.0 108.64 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.87 124.18 17.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.942 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 123' ' ' LEU . . . . . 0.499 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.301 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.38 138.78 51.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -139.49 133.32 30.74 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.524 -1.36 . . . . 0.0 111.16 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.45 -23.63 65.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -49.75 112.09 0.6 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.226 1.41 . . . . 0.0 112.308 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.57 -116.0 1.53 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.995 1.284 . . . . 0.0 111.907 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -153.39 147.87 26.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -145.24 163.36 34.67 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.674 1.589 . . . . 0.0 111.987 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -145.47 152.95 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.709 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.53 145.67 48.68 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.73 0.812 . . . . 0.0 112.537 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.63 -26.16 12.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.817 2.447 . . . . 0.0 114.834 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.6 tp -70.21 -19.85 63.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.316 1.046 . . . . 0.0 112.968 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.64 22.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 127.535 2.493 . . . . 0.0 113.574 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -67.83 145.57 54.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.338 1.569 . . . . 0.0 112.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 145.54 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.87 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -142.27 147.75 36.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -137.08 135.81 37.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.67 0.788 . . . . 0.0 109.994 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.1 mt -135.54 127.58 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.391 0.677 . . . . 0.0 110.337 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -75.92 0.57 Allowed Glycine 0 CA--C 1.532 1.1 0 O-C-N 123.922 0.764 . . . . 0.0 113.544 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.06 24.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.808 0.804 . . . . 0.0 112.084 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.89 130.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.91 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.4 166.79 20.95 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.24 0.337 . . . . 0.0 111.804 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 88.1 p -60.52 -24.69 65.55 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.451 -1.406 . . . . 0.0 114.771 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -78.24 -27.12 47.57 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.964 0.802 . . . . 0.0 111.849 173.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.66 30.37 Favored Glycine 0 N--CA 1.468 0.797 0 CA-C-O 117.82 -1.545 . . . . 0.0 113.571 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' C' ' 50' ' ' LEU . 10.0 pt-20 -64.17 138.9 58.67 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 173.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.84 162.21 39.71 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.43 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.416 HG22 HD13 ' B' ' 50' ' ' LEU . 2.5 p -129.0 177.27 7.24 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.48 -166.19 37.97 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 120.695 -1.253 . . . . 0.0 114.273 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.46 ' HB ' HD11 ' B' ' 46' ' ' LEU . 16.3 p -136.63 131.03 33.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.635 1.207 . . . . 0.0 111.696 175.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -114.36 141.36 47.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.095 -1.412 . . . . 0.0 108.39 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.92 134.51 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.462 ' O ' HG21 ' B' ' 44' ' ' ILE . 2.6 m -110.03 140.18 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.592 1.157 . . . . 0.0 111.611 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.13 -11.7 19.37 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 19.0 m -137.52 141.17 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.097 0.959 . . . . 0.0 111.325 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.24 32.97 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.999 -0.438 . . . . 0.0 110.21 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -77.14 -34.46 56.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -135.02 83.7 39.18 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.795 1.638 . . . . 0.0 110.244 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.62 36.19 0.26 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.849 3.699 . . . . 0.0 115.129 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.47 -6.98 63.29 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.72 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.591 1.956 . . . . 0.0 110.973 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.462 HG21 ' O ' ' B' ' 35' ' ' THR . 62.9 mt -56.58 125.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.137 -1.602 . . . . 0.0 110.922 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.25 165.74 27.5 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.007 1.323 . . . . 0.0 111.688 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' B' ' 32' ' ' THR . 10.1 tp -46.78 115.99 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.803 3.641 . . . . 0.0 112.995 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -106.19 123.17 39.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.519 0.728 . . . . 0.0 111.199 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 136.73 76.25 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.871 2.381 . . . . 0.0 111.329 174.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.87 155.59 36.34 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 124.023 0.827 . . . . 0.0 111.656 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.416 HD13 HG22 ' B' ' 30' ' ' THR . 1.5 tp -162.98 148.84 12.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.834 1.654 . . . . 0.0 109.364 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.19 -149.64 19.69 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.231 1.378 . . . . 0.0 109.672 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -144.64 140.72 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.511 0.725 . . . . 0.0 111.372 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 137.81 52.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.354 -0.841 . . . . 0.0 111.044 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -69.35 154.75 41.53 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.236 0.925 . . . . 0.0 111.152 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -145.22 16.45 1.52 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -92.24 -47.56 7.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.463 0.705 . . . . 0.0 112.685 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.11 175.28 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -76.74 -41.37 45.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.243 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -138.7 54.69 6.95 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.762 1.225 . . . . 0.0 111.843 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.63 174.54 12.68 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.711 1.608 . . . . 0.0 113.699 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.322 0.5 OUTLIER -96.21 166.57 11.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 123.057 1.408 . . . . 0.0 112.039 173.423 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.02 166.85 32.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.898 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.04 146.33 11.91 Favored Glycine 0 CA--C 1.544 1.901 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -158.92 153.46 24.35 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.23 -1.747 . . . . 0.0 115.66 -174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 151.94 19.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.273 1.829 . . . . 0.0 109.386 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.34 118.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' C' ' 52' ' ' ILE . 1.9 t-20 -88.34 116.62 26.68 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.866 -0.521 . . . . 0.0 110.039 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.67 143.09 44.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.517 1.151 . . . . 0.0 110.565 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -109.46 -39.72 5.1 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.226 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.79 -13.35 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.273 1.429 . . . . 0.0 114.408 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.5 t -152.31 132.52 13.58 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 128.408 2.683 . . . . 0.0 106.059 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -74.8 118.33 17.64 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.189 1.359 . . . . 0.0 110.394 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -174.44 163.81 3.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.661 1.985 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.33 142.33 39.72 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.089 173.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.766 HG23 HD12 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -131.71 152.32 50.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.648 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.53 150.2 29.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.788 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.67 143.01 51.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 127.34 12.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.83 178.54 44.8 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLN . . . . . 0.572 ' HB3' ' CE1' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.12 147.78 25.83 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.663 0.86 . . . . 0.0 112.704 178.133 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 6.8 p -97.9 115.85 28.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.267 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' B' ' 82' ' ' GLN 0.288 2.9 m-85 -110.24 161.56 15.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.39 112.09 18.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.45 162.76 12.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.642 0.777 . . . . 0.0 109.495 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -23.08 1.03 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.77 -4.66 56.5 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.774 0.83 . . . . 0.0 113.121 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 53.81 5.33 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 122.059 0.81 . . . . 0.0 111.346 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -122.96 140.66 52.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.245 2.618 . . . . 0.0 104.604 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -111.59 148.04 34.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.195 1.798 . . . . 0.0 112.08 -172.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.665 HG11 ' HD3' ' B' ' 94' ' ' LYS . 1.9 t -149.12 160.99 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 122.408 1.099 . . . . 0.0 110.546 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 mt -124.91 112.41 16.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 101.697 -3.445 . . . . 0.0 101.697 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.665 ' HD3' HG11 ' B' ' 92' ' ' VAL . 6.3 mmmt -104.96 120.08 40.57 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -137.28 162.8 32.54 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.663 1.697 . . . . 0.0 114.105 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.503 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -112.11 164.88 12.66 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.254 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -140.47 159.25 42.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.382 -1.735 . . . . 0.0 111.968 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.806 HD21 HG23 ' B' ' 113' ' ' THR . 1.2 tt -142.82 123.99 14.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.997 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.766 HD12 HG23 ' B' ' 77' ' ' THR . 3.1 tp -107.65 141.6 38.9 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 125.779 1.925 . . . . 0.0 110.826 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.9 tpt85 -123.89 114.09 19.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 110.069 -3.241 . . . . 0.0 109.338 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.264 21.6 m -71.48 164.69 25.35 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.639 1.837 . . . . 0.0 112.722 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.41 ' HA ' ' OE1' ' C' ' 82' ' ' GLN . 59.8 m -101.25 84.55 2.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' B' ' 112' ' ' ALA . 2.3 t -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 127.547 2.339 . . . . 0.0 109.295 175.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.87 -22.57 9.56 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.057 0.844 . . . . 0.0 113.246 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.48 137.56 51.93 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.757 0.789 . . . . 0.0 111.096 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.0 tt -59.76 -17.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.01 6.86 76.58 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.068 -1.962 . . . . 0.0 115.774 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.68 4.38 15.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.802 1.801 . . . . 0.0 112.798 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -30.55 70.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.485 ' CD1' HD11 ' D' ' 14' ' ' LEU . 54.8 p-90 -48.59 -41.15 29.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.269 1.028 . . . . 0.0 113.248 174.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -96.26 -6.22 38.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.577 1.151 . . . . 0.0 113.807 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' B' ' 103' ' ' VAL . . . -79.02 6.79 8.54 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.806 HG23 HD21 ' B' ' 98' ' ' LEU . 16.2 m -121.43 140.23 52.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.06 119.53 6.44 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.549 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -100.51 149.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.472 1.909 . . . . 0.0 111.255 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -171.77 22.8 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.594 0.616 . . . . 0.0 112.801 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -131.5 157.04 44.6 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.084 -0.656 . . . . 0.0 111.544 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -147.71 159.89 43.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.705 1.202 . . . . 0.0 109.277 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.434 HD13 ' HE3' ' B' ' 94' ' ' LYS . 7.3 mt -138.75 119.33 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.44 147.37 34.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 15.0 p -134.85 164.95 26.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.818 0.847 . . . . 0.0 109.131 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -60.22 119.07 7.19 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.54 1.136 . . . . 0.0 111.627 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.441 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.68 138.28 45.78 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 15.4 m -139.35 131.1 27.45 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.568 -1.333 . . . . 0.0 110.95 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.74 -24.05 64.41 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -49.21 114.61 1.05 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.025 1.33 . . . . 0.0 111.747 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.23 -120.46 2.47 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.919 1.247 . . . . 0.0 110.675 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -151.29 147.57 27.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -145.33 163.16 35.38 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.295 1.438 . . . . 0.0 112.234 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -143.65 153.78 42.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.516 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.29 146.26 48.03 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.724 0.809 . . . . 0.0 112.599 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.1 -26.24 15.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.44 2.296 . . . . 0.0 114.74 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 110' ' ' TRP . 32.9 tp -70.19 -20.25 63.13 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.098 -1.001 . . . . 0.0 113.032 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 -13.21 21.94 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.471 2.462 . . . . 0.0 113.607 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 86.8 p -67.57 145.85 54.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.436 1.618 . . . . 0.0 112.852 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.63 144.9 46.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.628 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -141.75 147.44 37.38 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 35.3 m -137.86 136.38 37.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.512 0.725 . . . . 0.0 109.676 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.69 127.91 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.66 0.784 . . . . 0.0 110.721 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.01 -77.93 0.42 Allowed Glycine 0 CA--C 1.532 1.132 0 O-C-N 123.643 0.59 . . . . 0.0 113.909 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.39 145.13 22.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.051 0.925 . . . . 0.0 112.102 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.54 130.06 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.816 0.846 . . . . 0.0 109.776 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.06 164.89 19.17 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.579 0.55 . . . . 0.0 111.783 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 82.1 p -60.58 -25.15 65.99 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.223 -1.548 . . . . 0.0 114.598 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -74.76 -24.95 58.77 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.833 0.742 . . . . 0.0 111.928 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.58 -5.14 32.95 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.09 0.853 . . . . 0.0 114.286 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.0 152.92 44.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.172 0.986 . . . . 0.0 112.133 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PHE . . . . . 0.558 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -155.05 166.49 33.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.117 176.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.454 HG22 HD13 ' C' ' 50' ' ' LEU . 15.2 p -127.04 -177.49 4.06 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.01 -165.6 38.92 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 119.486 -2.009 . . . . 0.0 113.947 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.471 ' HB ' HD11 ' C' ' 46' ' ' LEU . 11.3 p -136.67 130.48 32.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.453 1.12 . . . . 0.0 112.369 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.71 141.4 47.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.68 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 mt -130.69 134.19 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.449 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -109.97 140.42 43.98 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.447 1.099 . . . . 0.0 111.562 -173.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.35 18.84 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 18.9 m -136.92 140.92 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 123.772 0.829 . . . . 0.0 111.294 -175.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.86 165.4 35.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.01 -0.431 . . . . 0.0 110.131 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -76.58 -34.75 58.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -134.7 83.78 40.86 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.691 1.596 . . . . 0.0 110.154 173.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.89 36.21 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.917 3.745 . . . . 0.0 115.149 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.13 63.32 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 179.71 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.576 1.95 . . . . 0.0 110.883 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.449 HG21 ' O ' ' C' ' 35' ' ' THR . 63.9 mt -56.59 125.68 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.074 -1.641 . . . . 0.0 111.145 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.59 165.05 29.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.958 1.303 . . . . 0.0 111.806 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' C' ' 32' ' ' THR . 10.4 tp -47.28 115.55 1.14 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 130.766 3.626 . . . . 0.0 112.823 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 11.2 p -105.77 122.42 42.61 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.439 0.696 . . . . 0.0 110.74 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.6 135.29 68.63 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.559 2.173 . . . . 0.0 110.755 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.461 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.2 pp -120.8 161.07 22.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.72 0.808 . . . . 0.0 111.181 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.558 HD12 ' O ' ' C' ' 29' ' ' PHE . 17.9 tp -168.98 149.35 4.31 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.544 1.538 . . . . 0.0 112.257 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -147.16 13.92 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 120.185 1.357 . . . . 0.0 109.711 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -146.87 139.85 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.892 0.877 . . . . 0.0 110.24 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.82 53.37 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.86 154.09 42.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.685 -1.259 . . . . 0.0 111.148 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -144.63 14.67 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -89.78 -47.85 7.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.575 0.75 . . . . 0.0 112.389 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.61 172.23 13.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 31.2 t -74.85 -39.86 61.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.18 0.992 . . . . 0.0 112.617 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -138.45 53.47 5.73 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 112.866 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.1 176.04 10.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.461 1.44 . . . . 0.0 113.814 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.324 0.7 OUTLIER -97.29 166.0 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.071 1.415 . . . . 0.0 112.492 173.718 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -156.49 166.4 33.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.146 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.8 146.73 12.48 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -159.16 153.41 23.81 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -93.85 151.82 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.139 2.176 . . . . 0.0 109.002 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -130.9 119.71 45.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.684 ' HB2' HG21 ' B' ' 52' ' ' ILE . 1.6 t-20 -88.09 118.29 27.56 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.2 -0.938 . . . . 0.0 110.542 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.66 141.55 40.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.121 0.962 . . . . 0.0 110.214 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.94 -40.05 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.225 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.3 -13.12 55.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.326 1.451 . . . . 0.0 114.348 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 43.3 t -152.39 132.98 13.88 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 128.436 2.694 . . . . 0.0 106.175 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.61 117.96 17.02 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.093 1.315 . . . . 0.0 110.244 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 13.9 m -174.18 163.82 3.93 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.545 1.938 . . . . 0.0 109.871 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -139.0 142.48 38.3 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.291 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 77' ' ' THR . . . . . 0.764 HG23 HD12 ' C' ' 99' ' ' LEU . 0.0 OUTLIER -132.01 152.2 51.29 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.679 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.13 149.89 29.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.182 -1.827 . . . . 0.0 107.889 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.06 143.6 51.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 127.07 11.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -174.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.96 178.4 44.98 Favored Glycine 0 CA--C 1.499 -0.943 0 N-CA-C 117.421 1.728 . . . . 0.0 117.421 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLN . . . . . 0.586 ' HB3' ' CE1' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.27 147.17 26.6 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.668 0.864 . . . . 0.0 112.125 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 4.4 p -97.8 115.62 28.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.205 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' C' ' 82' ' ' GLN 0.268 3.5 m-85 -110.67 162.57 14.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.15 112.74 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -62.74 163.48 9.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 0.0 109.416 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.19 -28.16 2.83 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.42 -7.39 58.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.188 0.995 . . . . 0.0 113.104 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.69 53.82 3.89 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -121.72 140.32 52.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.708 2.403 . . . . 0.0 106.012 174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -111.42 147.49 35.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.72 1.608 . . . . 0.0 112.251 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.679 HG11 ' HD3' ' C' ' 94' ' ' LYS . 1.8 t -150.11 161.11 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.583 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.48 112.94 17.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.679 ' HD3' HG11 ' C' ' 92' ' ' VAL . 6.6 mmmt -105.46 118.87 37.68 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 174.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.47 161.82 34.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 124.005 1.86 . . . . 0.0 114.043 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.496 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.21 165.66 11.74 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 172.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -140.91 159.49 42.1 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.037 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.828 HD21 HG23 ' C' ' 113' ' ' THR . 1.2 tt -143.27 124.03 14.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.868 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 99' ' ' LEU . . . . . 0.764 HD12 HG23 ' C' ' 77' ' ' THR . 3.1 tp -107.65 142.07 38.17 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 125.579 1.799 . . . . 0.0 110.68 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 -124.43 114.22 19.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 110.272 -3.149 . . . . 0.0 109.403 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.254 18.5 m -71.4 164.86 24.96 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 125.638 1.836 . . . . 0.0 112.897 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.4 m -102.4 82.58 2.19 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 103' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' C' ' 112' ' ' ALA . 2.3 t -77.2 165.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 127.905 2.482 . . . . 0.0 108.971 174.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -115.65 -23.5 8.7 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.6 139.49 50.05 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.986 0.898 . . . . 0.0 111.34 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.0 tt -60.36 -16.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.73 7.2 74.11 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 117.222 -1.877 . . . . 0.0 115.601 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -115.01 4.87 14.83 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.939 1.87 . . . . 0.0 112.725 174.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.8 -31.12 70.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.204 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.492 ' CD1' HD11 ' A' ' 14' ' ' LEU . 54.5 p-90 -49.3 -40.35 34.55 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 113.188 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -96.63 -5.61 38.59 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 113.927 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' C' ' 103' ' ' VAL . . . -79.51 7.2 8.6 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.828 HG23 HD21 ' C' ' 98' ' ' LEU . 18.0 m -122.03 140.67 52.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.767 0.794 . . . . 0.0 113.017 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.07 120.53 6.89 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.308 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -100.95 149.79 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.576 1.95 . . . . 0.0 111.303 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.5 -171.28 22.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.617 0.627 . . . . 0.0 112.653 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -132.06 156.95 45.39 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.106 -0.644 . . . . 0.0 111.569 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -147.79 159.82 43.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.619 1.168 . . . . 0.0 109.256 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' ILE . . . . . 0.425 HD13 ' HE3' ' C' ' 94' ' ' LYS . 7.2 mt -138.56 119.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.21 147.29 34.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.2 p -135.34 164.62 27.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.716 0.806 . . . . 0.0 109.169 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -59.85 119.92 8.6 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.494 1.518 . . . . 0.0 113.175 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 mttt . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.4 131.7 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.477 1.511 . . . . 0.0 108.284 173.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.08 130.79 22.77 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.62 -26.6 60.86 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -45.39 109.73 0.19 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.866 1.666 . . . . 0.0 111.642 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.28 -125.98 2.93 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.231 0.92 . . . . 0.0 111.003 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -154.6 143.66 21.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -141.04 160.52 39.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.361 1.464 . . . . 0.0 110.983 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 2.9 t -136.59 151.65 49.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.58 1.152 . . . . 0.0 108.481 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.92 143.98 45.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 110.919 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -55.51 -23.06 24.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.451 1.901 . . . . 0.0 114.498 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.03 -18.56 62.57 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.577 -1.327 . . . . 0.0 111.305 174.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.81 -14.19 19.8 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 128.337 2.875 . . . . 0.0 113.487 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.2 p -71.05 144.7 50.29 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.988 -1.301 . . . . 0.0 112.332 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -120.48 141.77 49.88 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.209 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -130.88 143.52 50.79 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.146 0.974 . . . . 0.0 112.992 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.8 m -131.47 132.02 43.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.562 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.04 126.84 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.62 -89.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.775 0 O-C-N 125.125 1.516 . . . . 0.0 111.118 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.08 152.62 43.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.969 0.89 . . . . 0.0 111.815 176.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 53' ' ' GLN . 14.0 p -103.78 124.89 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.771 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.83 160.81 28.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.877 0.37 . . . . 0.0 111.961 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -53.97 -22.88 11.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.28 -36.53 77.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.317 0.647 . . . . 0.0 111.225 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -8.04 17.43 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 124.851 1.215 . . . . 0.0 112.534 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 155.33 40.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 108.789 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -159.82 163.84 34.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.515 177.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -129.16 162.7 27.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.52 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.81 -166.51 27.98 Favored Glycine 0 C--O 1.237 0.29 0 O-C-N 121.219 -0.926 . . . . 0.0 112.369 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.674 ' HB ' HD11 ' A' ' 46' ' ' LEU . 39.6 p -137.39 138.54 39.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 122.578 1.18 . . . . 0.0 111.732 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -114.51 140.66 48.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.234 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 46' ' ' LEU . 41.3 mt -133.57 126.48 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 44' ' ' ILE . 85.3 m -104.99 148.73 26.41 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.86 -18.22 15.83 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.6 m -132.97 138.44 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 111.511 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.1 18.99 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.179 -0.95 . . . . 0.0 112.44 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.25 -26.43 62.9 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.825 -0.547 . . . . 0.0 110.495 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -143.77 81.03 12.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.677 2.391 . . . . 0.0 110.346 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.66 33.43 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 124.94 3.76 . . . . 0.0 116.066 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.66 6.38 83.52 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 119.75 -1.844 . . . . 0.0 115.629 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -176.55 11.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 35' ' ' THR 0.257 59.5 mt -33.5 108.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -173.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -102.38 174.8 5.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.418 -2.173 . . . . 0.0 111.089 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.0 tt -71.69 137.14 47.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.379 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 p -114.12 125.9 28.73 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.189 0.596 . . . . 0.0 111.198 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -57.81 144.27 93.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.283 1.989 . . . . 0.0 112.131 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.66 144.24 51.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.153 0.981 . . . . 0.0 110.818 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.01 30.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.455 2.302 . . . . 0.0 108.621 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.11 -149.04 15.11 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 120.333 -1.479 . . . . 0.0 111.155 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.655 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.5 mp -145.12 138.39 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.872 0.869 . . . . 0.0 112.137 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.596 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.49 131.99 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.738 0.815 . . . . 0.0 110.817 173.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 62' ' ' PRO . 9.5 m-70 -64.4 156.1 30.38 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.794 -1.191 . . . . 0.0 111.273 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -146.75 13.34 1.16 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.798 1.239 . . . . 0.0 113.279 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -78.69 -58.14 3.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.109 2.564 . . . . 0.0 111.304 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.74 13.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.5 m -78.55 -29.2 46.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.062 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.53 58.98 33.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.933 1.293 . . . . 0.0 112.384 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 54' ' ' HIS . 55.2 Cg_endo -80.96 175.72 9.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.344 2.03 . . . . 0.0 116.001 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -88.92 160.05 17.36 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.572 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -161.09 156.69 24.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.156 -0.965 . . . . 0.0 113.145 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 149.39 17.2 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 119.7 2.64 . . . . 0.0 119.7 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.06 159.69 36.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.408 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.9 m -96.8 150.36 20.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.265 1.826 . . . . 0.0 108.398 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.93 125.98 63.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HB2' HG21 ' D' ' 52' ' ' ILE . 21.7 t-20 -104.04 112.4 25.38 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.495 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE1' ' HG1' ' A' ' 77' ' ' THR 0.355 56.4 m95 -74.47 154.89 38.52 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -173.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.86 -50.25 2.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.139 1.776 . . . . 0.0 115.396 -172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -75.58 -15.51 60.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.544 0.737 . . . . 0.0 112.934 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 t -149.26 145.02 26.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.186 2.594 . . . . 0.0 107.295 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.56 116.83 21.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.852 1.31 . . . . 0.0 110.216 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.2 p -168.42 172.06 8.61 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 126.194 1.798 . . . . 0.0 111.045 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.95 142.01 25.98 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.337 1.541 . . . . 0.0 110.711 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.422 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 1.7 m -138.77 132.04 30.04 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.644 -3.435 . . . . 0.0 109.848 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 m -109.54 157.46 9.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.78 137.28 43.26 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 119.96 10.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.48 0.712 . . . . 0.0 110.369 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.38 -173.21 24.62 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -124.0 145.67 49.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 124.968 1.04 . . . . 0.0 111.056 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.6 p -97.8 113.1 24.81 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.443 1.089 . . . . 0.0 112.095 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -102.65 166.94 10.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.883 0.473 . . . . 0.0 111.715 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.3 mt -126.47 110.54 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -58.7 160.73 5.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.218 1.007 . . . . 0.0 108.735 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -49.66 -25.27 2.74 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.79 -13.85 49.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.021 0.929 . . . . 0.0 113.276 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.22 58.24 2.0 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -130.12 148.26 51.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.388 2.675 . . . . 0.0 107.359 172.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -109.58 138.57 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 110.601 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.6 m -141.3 164.17 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 109.518 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 mt -123.31 118.53 27.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -107.57 115.87 30.93 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -133.02 169.43 16.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.886 1.803 . . . . 0.0 112.245 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.469 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -121.37 171.17 8.95 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.0 p-90 -146.38 162.75 37.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.13 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.794 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.7 tt -145.59 125.62 13.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.385 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.9 144.65 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 125.115 1.509 . . . . 0.0 114.588 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -128.64 123.5 33.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.035 -2.348 . . . . 0.0 113.755 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.88 156.24 18.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.674 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -103.08 64.15 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.589 -0.695 . . . . 0.0 109.84 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.12 153.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.139 1.376 . . . . 0.0 113.003 174.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.79 -29.76 32.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.13 144.69 43.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.728 1.252 . . . . 0.0 112.641 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.505 ' CD1' HG21 ' D' ' 92' ' ' VAL . 14.0 tt -65.25 -24.24 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.788 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.0 1.18 41.6 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-O 118.106 -1.386 . . . . 0.0 113.54 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.798 ' HB3' HG11 ' A' ' 103' ' ' VAL . 14.8 m-20 -121.35 6.28 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.804 1.242 . . . . 0.0 114.025 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -33.52 67.9 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 119.755 -1.841 . . . . 0.0 111.705 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 44.1 p-90 -45.67 -50.34 13.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.826 1.251 . . . . 0.0 113.981 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.83 -11.62 47.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.92 0.888 . . . . 0.0 113.342 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.68 -5.92 54.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.361 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.794 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.4 m -103.6 143.7 32.4 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 125.11 1.506 . . . . 0.0 112.174 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -144.05 129.91 19.37 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 124.694 1.198 . . . . 0.0 111.013 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.85 154.8 8.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 120.248 1.385 . . . . 0.0 110.524 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.78 -177.24 32.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.326 0.488 . . . . 0.0 113.259 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 22.8 p90 -125.1 152.58 44.18 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.9 -0.765 . . . . 0.0 111.096 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -148.13 144.04 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.77 128.13 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -115.45 152.75 32.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.975 0.417 . . . . 0.0 110.518 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.8 p -134.69 160.54 37.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.439 1.096 . . . . 0.0 110.054 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -56.81 122.09 11.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.818 0.847 . . . . 0.0 111.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 11' ' ' THR . 4.1 tt . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 83.2 mttt . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -116.31 135.31 53.99 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 2.2 t -139.6 136.84 34.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.774 1.23 . . . . 0.0 108.943 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 38.5 mt -73.63 -24.27 60.0 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -48.34 109.8 0.27 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.319 1.448 . . . . 0.0 112.07 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.48 -124.16 2.56 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 124.679 1.133 . . . . 0.0 110.813 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -151.72 144.28 24.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -142.28 157.49 44.77 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.111 1.365 . . . . 0.0 110.968 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -137.16 150.36 47.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 108.492 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -116.02 143.54 45.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.096 0.958 . . . . 0.0 111.042 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.62 -24.73 8.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.79 2.036 . . . . 0.0 114.975 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.4 tp -70.61 -18.53 62.88 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.282 -1.511 . . . . 0.0 111.643 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.29 -14.88 18.32 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 128.592 2.996 . . . . 0.0 113.543 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 82.5 p -71.34 144.11 50.02 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.011 -1.288 . . . . 0.0 112.455 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -118.73 142.98 47.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.631 0.773 . . . . 0.0 110.403 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -132.19 143.09 49.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.918 0.866 . . . . 0.0 112.538 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 20.5 m -131.44 132.03 44.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.163 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 70.3 mt -130.01 124.51 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -85.74 0.09 OUTLIER Glycine 0 CA--C 1.527 0.794 0 O-C-N 124.934 1.397 . . . . 0.0 111.224 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.32 155.82 44.55 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 122.045 0.926 . . . . 0.0 111.997 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' D' ' 53' ' ' GLN . 14.6 p -107.98 126.34 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.909 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -79.27 161.61 26.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.75 -23.2 16.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -69.63 -34.3 73.85 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.727 -0.608 . . . . 0.0 111.329 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.4 -6.27 18.93 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 124.918 1.247 . . . . 0.0 112.789 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.68 157.13 38.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 122.122 0.963 . . . . 0.0 111.783 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.06 166.53 32.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.482 1.134 . . . . 0.0 110.126 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -132.33 160.87 35.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.552 -1.658 . . . . 0.0 106.717 173.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.64 -166.65 28.97 Favored Glycine 0 C--O 1.24 0.488 0 CA-C-O 122.479 1.044 . . . . 0.0 112.333 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.662 ' HB ' HD11 ' D' ' 46' ' ' LEU . 40.0 p -137.84 140.33 40.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.502 -1.349 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -117.15 141.12 48.67 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.994 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.509 HD11 HD12 ' D' ' 46' ' ' LEU . 43.1 mt -133.31 126.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.465 ' O ' HG21 ' D' ' 44' ' ' ILE . 90.7 m -104.99 147.92 27.28 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.29 16.26 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.7 m -132.96 138.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.105 0.962 . . . . 0.0 111.37 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.67 170.37 18.3 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.286 -0.884 . . . . 0.0 112.229 -173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -71.59 -26.8 62.75 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.826 -0.546 . . . . 0.0 110.443 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.65 81.24 12.25 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.77 2.428 . . . . 0.0 110.241 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.43 32.56 0.12 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.79 3.66 . . . . 0.0 116.321 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.72 6.14 83.34 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 119.726 -1.859 . . . . 0.0 115.696 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.19 11.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.465 HG21 ' O ' ' D' ' 35' ' ' THR 0.257 59.6 mt -33.16 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -173.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -101.52 173.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.545 -2.116 . . . . 0.0 111.102 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.0 tt -69.79 138.06 52.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -114.83 125.61 28.84 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.281 0.633 . . . . 0.0 111.051 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -58.27 143.49 97.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.251 1.967 . . . . 0.0 112.062 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.76 151.02 48.79 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 110.741 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -157.34 149.16 22.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.774 2.03 . . . . 0.0 108.256 -175.539 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.73 -148.52 17.72 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 119.462 1.028 . . . . 0.0 112.676 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.669 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mp -144.26 138.71 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.167 0.987 . . . . 0.0 112.395 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -128.92 129.44 45.48 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.856 -1.153 . . . . 0.0 110.828 174.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' D' ' 62' ' ' PRO . 10.0 m-70 -62.65 155.32 26.55 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.762 -1.211 . . . . 0.0 111.835 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -146.43 12.52 1.19 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.862 1.265 . . . . 0.0 113.131 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -78.61 -58.17 3.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.35 2.66 . . . . 0.0 111.036 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.36 172.01 12.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.07 0.856 . . . . 0.0 112.603 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -83.39 -25.92 30.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.158 0.983 . . . . 0.0 112.428 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.53 55.33 15.74 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.168 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' D' ' 54' ' ' HIS . 57.7 Cg_endo -80.69 178.35 7.09 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.984 1.789 . . . . 0.0 115.703 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -89.96 157.07 18.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.5 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.934 -1.104 . . . . 0.0 112.883 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.59 149.19 16.29 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 119.925 2.73 . . . . 0.0 119.925 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.6 158.62 34.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' THR . . . . . 0.438 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.2 m -94.98 151.61 19.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.336 1.854 . . . . 0.0 108.543 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.75 127.85 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.655 ' HB2' HG21 ' A' ' 52' ' ' ILE . 21.9 t-20 -105.73 112.35 25.38 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.332 -0.842 . . . . 0.0 111.288 -174.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.351 56.4 m95 -73.79 155.07 39.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.548 1.642 . . . . 0.0 115.353 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mmpm? -112.97 -49.4 2.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.022 1.729 . . . . 0.0 115.366 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.27 -15.63 59.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 45.7 t -149.52 144.69 26.43 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.228 2.611 . . . . 0.0 106.952 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -81.77 116.82 21.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.753 1.263 . . . . 0.0 110.115 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 92.9 p -168.67 171.35 8.8 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.231 1.813 . . . . 0.0 111.167 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.15 142.25 27.12 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.947 1.356 . . . . 0.0 110.994 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -139.01 131.85 29.24 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-N 109.906 -3.316 . . . . 0.0 110.098 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 m -109.12 156.8 9.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.941 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -133.71 137.29 45.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.58 119.76 10.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.554 0.741 . . . . 0.0 110.357 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.66 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -121.23 144.83 48.39 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.179 1.164 . . . . 0.0 110.551 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -97.65 113.07 24.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.427 1.08 . . . . 0.0 111.148 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -103.91 166.79 10.19 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.58 0.627 . . . . 0.0 111.868 -177.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.71 112.08 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -58.71 164.52 2.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.997 0.919 . . . . 0.0 109.795 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -51.83 -27.0 11.09 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -10.25 58.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.889 0.876 . . . . 0.0 113.099 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.49 39.39 6.32 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.833 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -113.94 147.24 38.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.608 1.563 . . . . 0.0 109.711 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -101.53 139.37 37.28 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.217 1.407 . . . . 0.0 110.647 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 106' ' ' ILE . 22.3 m -141.66 161.04 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.213 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.7 117.34 27.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 174.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -106.58 115.64 30.55 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -132.43 170.1 15.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.936 1.826 . . . . 0.0 111.89 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -121.79 171.23 9.04 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -146.15 162.65 37.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.105 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.8 tt -145.68 125.71 13.67 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.16 -1.382 . . . . 0.0 113.211 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' LEU . . . . . 0.402 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -110.08 144.67 38.33 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 125.218 1.574 . . . . 0.0 114.337 -174.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -128.55 123.57 33.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.774 -174.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.95 158.66 16.61 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.98 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -105.37 62.58 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.717 -0.614 . . . . 0.0 110.102 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 103' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' D' ' 108' ' ' ASP . 0.1 OUTLIER -48.75 152.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.268 1.427 . . . . 0.0 113.452 174.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -80.84 -29.69 35.83 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.44 144.7 43.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.772 1.272 . . . . 0.0 113.161 -174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 92' ' ' VAL . 12.1 tt -64.82 -24.58 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.991 174.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.21 1.07 43.8 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.054 -1.415 . . . . 0.0 113.72 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' ASP . . . . . 0.787 ' HB3' HG11 ' D' ' 103' ' ' VAL . 13.6 m-20 -121.06 5.41 10.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.506 1.122 . . . . 0.0 113.931 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -33.93 65.79 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.877 -1.764 . . . . 0.0 111.492 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.7 p-90 -45.59 -50.36 13.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.86 -11.69 47.07 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.292 -0.88 . . . . 0.0 113.231 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.64 -5.57 53.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.213 -172.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.781 ' CG2' HD21 ' D' ' 98' ' ' LEU . 15.2 m -103.34 143.86 32.12 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.981 1.425 . . . . 0.0 112.38 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -144.51 130.2 19.13 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.815 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.92 154.85 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 120.355 1.434 . . . . 0.0 110.733 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -177.64 33.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.402 0.525 . . . . 0.0 113.453 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.1 p90 -124.88 152.29 44.21 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.842 -0.799 . . . . 0.0 111.088 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.15 143.62 27.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.547 0.739 . . . . 0.0 109.061 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -127.55 131.52 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -120.25 151.5 39.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.446 0.641 . . . . 0.0 111.884 174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 36.8 p -131.07 163.8 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.548 1.139 . . . . 0.0 110.129 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -61.5 115.88 4.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.161 1.385 . . . . 0.0 111.781 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.464 0.258 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 174.688 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 51.2 t -117.96 134.56 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -139.61 136.48 34.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.464 1.106 . . . . 0.0 108.704 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 34.5 mt -73.63 -25.89 60.51 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -46.81 109.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.52 1.528 . . . . 0.0 111.705 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.29 -124.94 2.64 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.524 1.059 . . . . 0.0 111.164 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -153.52 142.26 20.99 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -140.42 158.5 43.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.573 1.549 . . . . 0.0 110.959 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t -137.2 151.19 48.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 108.783 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -117.76 143.67 46.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.148 0.979 . . . . 0.0 110.8 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -55.75 -22.99 26.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.441 1.896 . . . . 0.0 114.442 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.7 tp -70.86 -18.06 62.71 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.601 -1.312 . . . . 0.0 111.098 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.21 18.82 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.585 2.993 . . . . 0.0 113.52 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -70.8 145.08 50.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.798 1.299 . . . . 0.0 112.372 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -119.51 140.42 50.53 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.788 0.835 . . . . 0.0 110.321 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -130.54 140.61 50.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.806 0.813 . . . . 0.0 112.728 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.4 m -129.56 131.82 46.66 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.97 125.93 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.31 -88.27 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 125.0 1.437 . . . . 0.0 111.122 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 155.28 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.09 0.947 . . . . 0.0 112.087 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' B' ' 53' ' ' GLN . 15.0 p -107.17 124.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.899 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -77.81 161.3 27.76 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.896 0.379 . . . . 0.0 111.963 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m -54.39 -22.7 13.12 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -69.62 -36.28 76.02 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.241 0.616 . . . . 0.0 111.197 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -8.22 17.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.909 1.243 . . . . 0.0 112.554 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.53 154.5 40.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.579 1.18 . . . . 0.0 109.025 174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -159.39 163.56 35.41 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.314 177.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.56 162.94 26.1 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.436 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.01 -166.22 27.7 Favored Glycine 0 C--O 1.237 0.341 0 O-C-N 121.406 -0.809 . . . . 0.0 112.589 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.688 ' HB ' HD11 ' B' ' 46' ' ' LEU . 37.5 p -136.93 137.12 39.22 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 113.795 -1.202 . . . . 0.0 111.791 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.7 140.62 48.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.238 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.513 HD11 HD12 ' B' ' 46' ' ' LEU . 39.7 mt -133.79 126.77 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 174.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.439 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.0 m -104.95 149.33 25.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -173.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.78 15.38 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.8 m -133.34 138.6 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.77 1.228 . . . . 0.0 111.443 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.2 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.216 -0.928 . . . . 0.0 112.1 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -71.38 -26.84 62.96 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.948 -0.47 . . . . 0.0 110.296 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -143.51 81.15 12.47 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.604 2.362 . . . . 0.0 110.293 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -65.94 30.16 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.763 3.642 . . . . 0.0 116.242 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 6.73 76.74 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 119.829 -1.795 . . . . 0.0 116.176 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -176.76 11.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.439 HG21 ' O ' ' B' ' 35' ' ' THR 0.256 61.5 mt -33.66 109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.189 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -102.87 173.97 6.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.838 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.688 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.2 tt -70.94 137.86 49.55 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 171.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.2 p -114.85 126.33 28.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.184 0.593 . . . . 0.0 111.188 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -57.85 143.88 94.83 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.416 2.077 . . . . 0.0 112.134 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 144.49 51.13 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.209 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.07 30.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.565 2.346 . . . . 0.0 108.714 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.26 -149.41 15.88 Favored Glycine 0 CA--C 1.523 0.541 0 O-C-N 120.424 -1.422 . . . . 0.0 111.111 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.657 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.5 mp -144.08 139.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.891 0.877 . . . . 0.0 112.17 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -127.62 130.72 49.48 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.151 -0.968 . . . . 0.0 110.619 173.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 54' ' ' HIS . . . . . 0.429 ' HB2' ' HB2' ' B' ' 62' ' ' PRO . 10.0 m-70 -63.22 156.06 26.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.683 -1.261 . . . . 0.0 111.577 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -146.16 12.06 1.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.666 1.187 . . . . 0.0 113.106 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -77.56 -57.87 3.58 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.257 2.623 . . . . 0.0 110.861 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.7 171.84 11.31 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.602 1.189 . . . . 0.0 112.911 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 71.3 m -79.19 -29.68 43.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.002 0.921 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.29 56.55 19.03 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 111.631 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' B' ' 54' ' ' HIS . 58.7 Cg_endo -80.15 178.31 7.31 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 121.908 1.738 . . . . 0.0 115.773 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 p -90.02 156.64 18.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.36 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.68 156.54 31.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.224 -0.923 . . . . 0.0 112.742 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.98 149.77 17.89 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 120.07 2.788 . . . . 0.0 120.07 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -158.25 159.25 35.81 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.42 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.8 m -96.09 150.59 20.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.885 1.674 . . . . 0.0 108.478 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -129.02 125.72 63.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.652 ' HB2' HG21 ' C' ' 52' ' ' ILE . 22.0 t-20 -103.72 112.37 25.28 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.507 -174.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' TRP . . . . . 0.443 ' HE1' ' HG1' ' B' ' 77' ' ' THR 0.355 57.5 m95 -74.11 154.94 38.93 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -173.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.81 -49.42 2.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 115.438 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.42 -15.16 59.99 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -150.44 144.64 25.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.984 2.514 . . . . 0.0 107.278 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.62 116.95 21.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.691 1.234 . . . . 0.0 109.975 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -168.56 171.52 8.82 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.284 1.834 . . . . 0.0 111.208 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.89 142.03 26.07 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 123.202 1.477 . . . . 0.0 110.456 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' THR . . . . . 0.443 ' HG1' ' HE1' ' B' ' 70' ' ' TRP . 1.7 m -138.51 132.73 31.66 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.629 -3.441 . . . . 0.0 109.577 -173.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.08 157.37 10.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.925 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.22 137.29 44.27 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.05 119.85 10.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.588 0.755 . . . . 0.0 110.018 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 -176.3 27.5 Favored Glycine 0 N--CA 1.463 0.492 0 N-CA-C 116.649 1.42 . . . . 0.0 116.649 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.06 144.56 48.48 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 124.874 0.984 . . . . 0.0 110.41 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 25.7 p -97.63 113.0 24.64 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.452 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.7 OUTLIER -104.14 166.45 10.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.779 0.718 . . . . 0.0 112.057 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.26 112.42 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -58.59 161.38 4.66 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.264 1.026 . . . . 0.0 108.999 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -48.79 -30.05 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -15.01 57.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.403 1.081 . . . . 0.0 113.221 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.48 54.09 2.47 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 31.8 mtpt -126.99 146.27 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.339 2.256 . . . . 0.0 108.407 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -106.27 138.32 42.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.932 1.693 . . . . 0.0 110.969 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.494 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.6 m -141.67 162.24 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.21 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.52 117.68 27.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -106.96 115.48 30.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -132.66 170.0 15.84 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 123.517 1.627 . . . . 0.0 111.952 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.463 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -121.8 170.88 9.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -145.84 162.83 36.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.215 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.7 tt -145.67 125.68 13.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.375 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 144.31 38.61 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 125.037 1.46 . . . . 0.0 114.625 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.26 123.93 35.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 112.023 -2.353 . . . . 0.0 113.777 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 156.55 17.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.137 0.975 . . . . 0.0 111.716 176.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -102.83 63.5 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.146 0.498 . . . . 0.0 109.75 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.817 HG11 ' HB3' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -49.61 151.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.855 1.262 . . . . 0.0 112.675 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.99 -30.73 39.74 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.05 144.92 42.33 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.49 1.138 . . . . 0.0 113.145 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.487 ' CD1' HG21 ' C' ' 92' ' ' VAL . 12.7 tt -65.74 -23.41 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.559 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.7 1.43 53.02 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 118.24 -1.311 . . . . 0.0 113.693 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.817 ' HB3' HG11 ' B' ' 103' ' ' VAL . 13.5 m-20 -121.14 5.63 10.31 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -33.71 66.67 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 119.878 -1.764 . . . . 0.0 111.699 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 44.4 p-90 -45.29 -50.22 12.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.024 1.329 . . . . 0.0 114.264 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.12 -11.41 47.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.82 -6.26 55.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.214 -1.374 . . . . 0.0 114.476 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.796 ' CG2' HD21 ' B' ' 98' ' ' LEU . 15.2 m -102.96 143.75 32.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 125.228 1.58 . . . . 0.0 112.148 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.9 mtt85 -144.34 129.38 18.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.626 1.17 . . . . 0.0 111.061 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.42 154.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.178 1.354 . . . . 0.0 110.867 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.92 -177.64 33.2 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.291 0.472 . . . . 0.0 113.579 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 23.9 p90 -125.13 152.25 44.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.683 -0.892 . . . . 0.0 110.97 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -148.27 143.42 26.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.62 0.768 . . . . 0.0 109.209 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.51 128.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.83 153.51 31.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.108 0.48 . . . . 0.0 111.43 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 42.2 p -136.14 160.74 37.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.285 1.034 . . . . 0.0 111.331 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -58.93 118.24 5.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.042 0.937 . . . . 0.0 111.735 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.632 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 118.528 -0.748 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 43.9 t -116.31 136.2 53.21 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -139.75 136.09 33.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.49 -26.15 60.77 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -46.54 109.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.256 1.422 . . . . 0.0 112.139 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.34 -126.9 3.32 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.389 0.995 . . . . 0.0 111.161 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -150.31 144.65 25.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -142.61 158.44 43.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.161 1.384 . . . . 0.0 111.034 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 148.82 45.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.705 1.202 . . . . 0.0 108.391 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -115.93 143.62 45.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.9 0.88 . . . . 0.0 110.769 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -53.45 -24.85 13.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.827 2.051 . . . . 0.0 114.549 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.442 HD11 ' CD1' ' A' ' 110' ' ' TRP . 31.3 tp -70.08 -18.39 63.26 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.192 -1.567 . . . . 0.0 111.565 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.42 -15.0 17.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 128.587 2.994 . . . . 0.0 113.452 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 87.9 p -71.66 144.73 49.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.574 1.187 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.89 142.67 49.47 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.4 -0.813 . . . . 0.0 110.681 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -131.3 144.12 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.28 1.038 . . . . 0.0 112.769 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 17.5 m -132.04 131.55 42.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.232 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 66.8 mt -128.66 124.64 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.53 -84.87 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 125.026 1.454 . . . . 0.0 111.102 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.86 157.42 44.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.068 0.937 . . . . 0.0 112.067 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' C' ' 53' ' ' GLN . 13.6 p -109.91 125.81 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.918 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -79.25 161.46 26.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.841 0.456 . . . . 0.0 112.01 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.64 -23.46 17.27 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -69.23 -34.54 74.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.203 0.601 . . . . 0.0 111.413 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.41 -6.35 18.87 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.994 1.283 . . . . 0.0 112.878 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.81 157.78 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.423 1.106 . . . . 0.0 112.07 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 166.35 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.205 174.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -132.08 160.34 36.24 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.06 -166.53 28.26 Favored Glycine 0 C--O 1.239 0.419 0 CA-C-O 122.439 1.021 . . . . 0.0 112.423 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.668 ' HB ' HD11 ' C' ' 46' ' ' LEU . 39.9 p -137.43 140.16 41.11 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.458 -1.371 . . . . 0.0 111.97 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.95 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' C' ' 46' ' ' LEU . 41.2 mt -133.48 126.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.454 ' O ' HG21 ' C' ' 44' ' ' ILE . 89.9 m -104.99 148.89 26.24 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.36 -18.17 15.53 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 17.1 m -133.07 138.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.83 1.252 . . . . 0.0 111.475 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 169.98 19.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.365 -0.834 . . . . 0.0 112.369 -173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.49 -25.53 62.3 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.836 -0.54 . . . . 0.0 110.534 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -145.09 81.2 10.68 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.621 2.369 . . . . 0.0 110.256 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.18 30.99 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 124.686 3.591 . . . . 0.0 116.243 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.35 6.49 79.68 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 119.816 -1.803 . . . . 0.0 116.1 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.46 10.51 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.454 HG21 ' O ' ' C' ' 35' ' ' THR 0.259 59.8 mt -32.64 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -173.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.66 173.59 6.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.042 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.668 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.0 tt -70.28 137.72 50.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.3 p -114.46 126.14 28.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.96 144.31 94.54 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.058 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 150.95 49.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.015 0.926 . . . . 0.0 110.57 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -157.28 149.23 22.5 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.95 2.1 . . . . 0.0 108.512 -175.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.62 -148.44 17.56 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.498 1.045 . . . . 0.0 112.419 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.652 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mp -144.58 138.67 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 124.29 1.036 . . . . 0.0 112.424 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.591 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -128.17 130.08 47.5 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.816 -1.178 . . . . 0.0 110.561 174.12 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 54' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' C' ' 62' ' ' PRO . 10.7 m-70 -62.12 156.26 22.08 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.716 -1.24 . . . . 0.0 111.868 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -147.57 12.87 1.04 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.835 1.254 . . . . 0.0 113.284 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -78.96 -58.16 3.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 128.22 2.608 . . . . 0.0 111.184 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.2 170.28 14.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.853 0.861 . . . . 0.0 112.622 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 73.9 m -81.22 -25.91 36.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.927 173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.93 56.4 16.79 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 125.228 1.411 . . . . 0.0 112.707 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' C' ' 54' ' ' HIS . 59.8 Cg_endo -81.38 178.95 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.103 1.869 . . . . 0.0 115.84 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -89.54 157.48 18.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.98 1.312 . . . . 0.0 112.728 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -158.75 156.12 29.24 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.232 -0.917 . . . . 0.0 112.862 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.03 149.64 17.59 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.63 158.95 34.81 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.446 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.4 m -95.27 151.36 19.31 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.272 1.829 . . . . 0.0 108.56 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.7 124.01 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.657 ' HB2' HG21 ' B' ' 52' ' ' ILE . 22.5 t-20 -102.12 112.47 25.15 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.956 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.354 55.4 m95 -73.91 154.87 39.21 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.98 -48.73 2.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.178 1.791 . . . . 0.0 115.529 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.67 -15.12 59.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -150.91 144.82 25.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.07 2.548 . . . . 0.0 107.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.8 117.17 22.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.607 1.094 . . . . 0.0 109.748 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 93.2 p -168.95 171.24 8.47 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.581 1.952 . . . . 0.0 110.942 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -147.59 142.27 26.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-O 123.039 1.399 . . . . 0.0 110.924 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.52 132.03 30.54 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 109.897 -3.319 . . . . 0.0 110.051 -172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -108.95 157.19 9.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.959 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -133.99 137.35 44.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.93 119.53 10.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 0.0 109.82 -174.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.24 -174.68 25.42 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.1 144.52 48.88 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.464 0.743 . . . . 0.0 110.781 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.69 113.0 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 124.139 0.899 . . . . 0.0 110.982 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -104.75 167.71 9.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.469 0.652 . . . . 0.0 111.557 -177.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.79 113.97 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -58.78 161.2 5.0 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.871 0.868 . . . . 0.0 109.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -51.31 -20.95 1.89 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.72 -11.04 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.535 0.734 . . . . 0.0 112.665 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.94 49.02 3.93 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -122.81 145.82 48.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.639 1.976 . . . . 0.0 109.409 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -102.9 139.17 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.857 1.263 . . . . 0.0 111.024 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.6 m -141.77 163.97 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.97 1.308 . . . . 0.0 109.433 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.52 119.02 28.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -108.14 115.41 30.07 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -132.59 170.06 15.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.978 1.847 . . . . 0.0 112.274 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.436 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -122.11 170.98 9.32 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 172.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -146.15 162.69 37.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.233 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.786 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.7 tt -145.64 125.67 13.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.194 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 99' ' ' LEU . . . . . 0.403 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -110.14 144.69 38.4 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.974 1.421 . . . . 0.0 114.333 -174.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.28 123.1 33.24 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 111.943 -2.389 . . . . 0.0 113.701 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.7 156.22 18.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.699 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -102.97 61.55 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.864 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 103' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' C' ' 108' ' ' ASP . 0.1 OUTLIER -48.06 151.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.144 1.377 . . . . 0.0 113.008 174.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -80.17 -31.05 38.89 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.89 145.15 42.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.534 1.159 . . . . 0.0 112.992 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.494 ' CD1' HG21 ' B' ' 92' ' ' VAL . 13.1 tt -64.84 -24.16 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.707 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 1.73 46.66 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.945 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' ASP . . . . . 0.794 ' HB3' HG11 ' C' ' 103' ' ' VAL . 13.2 m-20 -121.32 5.89 10.2 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -33.33 67.92 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 119.896 -1.752 . . . . 0.0 111.7 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.538 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 43.9 p-90 -45.59 -49.92 13.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.79 1.236 . . . . 0.0 114.299 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.33 -11.01 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.32 56.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.786 ' CG2' HD21 ' C' ' 98' ' ' LEU . 15.5 m -102.83 143.85 31.92 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 125.134 1.521 . . . . 0.0 112.265 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -144.54 130.03 18.93 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.64 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.25 154.18 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 120.417 1.462 . . . . 0.0 110.644 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -177.84 33.38 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.466 0.555 . . . . 0.0 113.442 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.8 p90 -124.76 152.43 43.84 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.665 -0.903 . . . . 0.0 111.135 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -148.14 143.71 27.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.666 0.787 . . . . 0.0 109.305 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.73 129.16 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.93 152.65 34.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.282 0.563 . . . . 0.0 111.612 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.2 p -135.18 161.86 34.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.447 1.099 . . . . 0.0 110.643 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -57.5 117.29 4.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.621 1.168 . . . . 0.0 112.505 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.466 0.374 0 O-C-N 121.655 -0.653 . . . . 0.0 109.817 176.391 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 154.03 31.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.014 0.926 . . . . 0.0 109.408 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.6 p -139.66 127.58 22.15 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.137 -0.977 . . . . 0.0 112.999 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.95 -31.56 72.85 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.594 1.543 . . . . 0.0 113.375 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -66.5 113.68 4.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.26 0.21 0.3 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 119.03 2.372 . . . . 0.0 119.03 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt 73.14 144.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 129.405 3.082 . . . . 0.0 114.362 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -140.27 161.97 36.4 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.321 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -141.44 147.17 37.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.434 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.42 143.42 40.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.729 0.812 . . . . 0.0 110.195 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -56.64 -23.87 44.35 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.478 1.911 . . . . 0.0 113.593 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' C' ' 110' ' ' TRP . 31.7 tp -71.61 -18.97 62.18 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.666 1.586 . . . . 0.0 111.499 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.45 -14.79 25.1 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 127.493 2.473 . . . . 0.0 113.582 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 p -67.99 140.3 56.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.361 1.581 . . . . 0.0 112.123 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.47 142.86 46.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -136.48 146.64 46.52 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.297 1.046 . . . . 0.0 112.843 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -134.2 132.17 39.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.313 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.0 mt -133.02 127.14 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.96 -84.52 0.19 Allowed Glycine 0 CA--C 1.526 0.762 0 O-C-N 125.187 1.554 . . . . 0.0 111.475 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 145.49 29.39 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.869 0.842 . . . . 0.0 112.238 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.57 128.9 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.718 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.14 161.88 20.93 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.519 0.676 . . . . 0.0 111.851 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 p -57.97 -20.9 41.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -78.22 -31.56 49.42 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.211 0.914 . . . . 0.0 111.532 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.29 -5.78 23.3 Favored Glycine 0 N--CA 1.466 0.655 0 CA-C-O 117.352 -1.805 . . . . 0.0 114.626 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 145.83 53.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.711 1.755 . . . . 0.0 109.056 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -155.1 140.2 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.05 12.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 -168.94 35.27 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.873 1.263 . . . . 0.0 111.304 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.664 ' HB ' HD11 ' A' ' 46' ' ' LEU . 43.3 p -133.0 130.26 39.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 123.339 1.543 . . . . 0.0 110.928 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -111.64 136.83 50.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.033 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD12 ' A' ' 46' ' ' LEU . 33.0 mt -132.6 130.27 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -108.5 145.98 33.91 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.32 -15.19 18.9 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.0 m -133.49 140.99 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.626 1.17 . . . . 0.0 112.937 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.47 162.53 38.1 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 120.76 -1.212 . . . . 0.0 111.0 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.95 -39.5 79.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.476 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -131.81 84.66 53.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 127.184 2.194 . . . . 0.0 108.082 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.11 175.56 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.423 2.082 . . . . 0.0 111.522 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.58 -31.96 3.29 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.608 1.099 . . . . 0.0 112.543 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.02 28.29 2.12 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.406 1.083 . . . . 0.0 112.164 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -58.25 134.11 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.796 0.807 . . . . 0.0 109.587 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 174.06 11.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.399 1.48 . . . . 0.0 108.984 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' HB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -53.28 132.48 39.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.112 1.765 . . . . 0.0 113.055 175.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -114.51 125.49 29.11 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.057 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' HE3' ' A' ' 71' ' ' LYS . 4.9 Cg_exo -58.51 146.96 88.78 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.235 1.957 . . . . 0.0 110.846 173.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.46 151.66 51.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.26 0.624 . . . . 0.0 110.871 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tp -156.75 149.05 23.21 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.003 1.721 . . . . 0.0 110.872 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.56 -154.26 25.0 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 121.541 1.973 . . . . 0.0 109.833 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.9 mt -146.7 140.94 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 112.132 -174.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.28 138.24 50.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.792 1.237 . . . . 0.0 110.766 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -70.52 155.56 40.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.837 0.827 . . . . 0.0 110.415 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -138.61 -5.6 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -77.67 -35.09 52.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.85 167.12 12.69 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 m -76.96 -37.99 54.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.298 1.439 . . . . 0.0 114.659 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -139.33 49.92 2.33 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 125.026 1.33 . . . . 0.0 111.877 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.76 -179.04 4.98 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.408 2.739 . . . . 0.0 115.35 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.5 p -87.44 161.31 17.91 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.892 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.51 155.75 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.487 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.82 19.92 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 119.715 2.646 . . . . 0.0 119.715 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -159.72 159.73 33.2 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -97.64 148.72 23.02 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.952 2.501 . . . . 0.0 108.685 173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.52 125.33 63.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 48.8 t30 -103.68 107.06 17.75 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.555 -174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -72.06 149.19 45.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 123.411 1.577 . . . . 0.0 114.731 -173.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HE3' ' HD3' ' A' ' 48' ' ' PRO . 27.9 mttt -108.54 -45.39 3.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -78.85 -17.23 55.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.287 1.035 . . . . 0.0 112.804 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 128.66 10.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 129.269 3.028 . . . . 0.0 105.397 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.12 119.01 11.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.332 0.969 . . . . 0.0 112.088 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 t -170.72 167.52 7.71 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.773 1.629 . . . . 0.0 110.919 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -146.13 140.9 27.02 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 124.001 1.857 . . . . 0.0 110.484 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.5 m -137.24 126.38 24.53 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-N 109.303 -3.589 . . . . 0.0 109.949 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -102.09 161.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.39 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -136.7 137.95 40.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.92 118.14 9.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.14 -179.41 26.84 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.058 -1.068 . . . . 0.0 115.535 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -121.57 148.89 43.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 125.223 1.19 . . . . 0.0 111.264 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.1 t -97.13 127.64 43.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 125.094 1.496 . . . . 0.0 109.911 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' D' ' 106' ' ' ILE . 7.7 m-85 -117.7 161.4 19.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.16 0.984 . . . . 0.0 113.517 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 28.1 mt -127.18 112.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.54 160.56 6.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.104 0.562 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -43.05 -37.26 1.89 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.12 -14.94 60.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.448 1.499 . . . . 0.0 114.773 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 46.82 4.15 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.587 0.613 . . . . 0.0 113.016 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 12.3 mtpt -115.79 160.23 20.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.966 2.106 . . . . 0.0 108.037 173.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -116.0 144.77 43.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.075 1.762 . . . . 0.0 111.713 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.72 159.36 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.601 1.191 . . . . 0.0 109.592 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 120' ' ' PHE . 24.8 mt -125.14 102.29 7.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' A' ' 92' ' ' VAL . 2.3 mmtt -96.23 121.42 37.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.4 p -134.01 162.86 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.627 1.204 . . . . 0.0 111.373 -174.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.421 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.38 168.16 9.85 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 171.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -142.11 163.8 31.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.786 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.7 OUTLIER -145.97 123.98 12.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.801 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.32 144.87 38.4 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 125.088 1.493 . . . . 0.0 114.025 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -124.52 114.89 20.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.983 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -73.7 162.59 29.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.889 0.876 . . . . 0.0 111.557 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.6 p -99.88 45.69 0.98 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.0 -1.063 . . . . 0.0 111.492 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -52.4 137.23 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.98 1.712 . . . . 0.0 113.145 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -20.58 61.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -174.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.62 150.93 51.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.16 1.457 . . . . 0.0 113.549 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' D' ' 84' ' ' PHE . 16.0 tt -64.15 -23.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.109 -0.994 . . . . 0.0 113.084 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.47 3.75 58.18 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.071 0.843 . . . . 0.0 113.552 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 103' ' ' VAL . 1.1 m-20 -122.7 -0.65 9.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.195 0.998 . . . . 0.0 112.451 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -31.76 69.18 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.208 -0.932 . . . . 0.0 112.85 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.7 p-90 -48.18 -41.61 27.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.096 1.358 . . . . 0.0 113.714 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 15.2 pttm -96.39 -8.59 32.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 -0.9 18.94 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.742 ' CG2' HD21 ' A' ' 98' ' ' LEU . 8.2 m -113.39 140.97 47.61 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.588 0.755 . . . . 0.0 112.632 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -144.21 131.67 20.97 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.787 1.235 . . . . 0.0 111.738 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.66 156.55 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 110.53 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -175.43 30.89 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.516 0.579 . . . . 0.0 113.225 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -125.14 153.15 43.45 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.795 -0.826 . . . . 0.0 112.112 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 132.13 14.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.746 0.784 . . . . 0.0 110.052 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.419 HD13 ' HE3' ' A' ' 94' ' ' LYS . 15.5 mt -118.93 138.45 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 21.0 m-85 -124.56 139.97 53.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.821 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.3 p -129.32 154.09 47.2 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -53.01 117.86 3.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.336 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.472 HD23 ' C ' ' A' ' 123' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 p -134.58 148.53 50.47 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.27 1.828 . . . . 0.0 107.732 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 65.3 p -139.29 131.12 27.57 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.285 -1.51 . . . . 0.0 114.148 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 50.7 mt -65.04 -31.88 73.33 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.259 1.391 . . . . 0.0 113.924 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -66.33 115.64 6.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.38 8.16 0.29 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 118.296 2.079 . . . . 0.0 118.296 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 66.55 148.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.272 2.629 . . . . 0.0 114.927 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -143.43 161.08 39.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.474 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -140.5 145.7 37.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.545 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -109.54 143.61 38.97 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.178 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.16 -23.34 46.77 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.405 1.882 . . . . 0.0 113.543 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.52 HD11 ' CD1' ' B' ' 110' ' ' TRP . 32.0 tp -72.4 -19.06 61.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.006 1.722 . . . . 0.0 111.27 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.47 -14.59 22.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.121 2.296 . . . . 0.0 113.622 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -67.52 138.34 56.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.458 1.629 . . . . 0.0 112.202 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.85 141.3 46.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -135.03 147.15 49.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.246 1.022 . . . . 0.0 113.179 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.1 m -134.49 131.96 38.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.068 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -133.13 126.32 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.08 -84.59 0.16 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 125.292 1.62 . . . . 0.0 111.583 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.05 29.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.713 0.757 . . . . 0.0 111.853 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.56 128.8 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.901 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.52 161.54 19.95 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.636 0.731 . . . . 0.0 111.595 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.8 p -58.2 -21.38 47.44 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -75.92 -30.3 58.68 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.176 0.898 . . . . 0.0 111.666 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.77 -4.21 25.98 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.778 1.18 . . . . 0.0 115.061 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.56 150.85 45.67 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.399 1.08 . . . . 0.0 110.926 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -156.46 162.84 39.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.164 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.86 171.97 12.17 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 173.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.21 -167.84 37.3 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 119.947 -1.721 . . . . 0.0 111.628 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' THR . . . . . 0.646 ' HB ' HD11 ' D' ' 46' ' ' LEU . 44.0 p -132.95 128.84 37.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.89 1.329 . . . . 0.0 110.823 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -111.65 136.06 51.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.12 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.412 HD11 HD12 ' D' ' 46' ' ' LEU . 30.6 mt -132.11 132.39 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' THR . . . . . 0.438 HG23 ' H ' ' D' ' 37' ' ' VAL . 1.0 OUTLIER -111.26 145.5 38.65 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 -15.41 19.2 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.438 ' H ' HG23 ' D' ' 35' ' ' THR . 18.6 m -133.55 140.7 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.324 1.05 . . . . 0.0 113.068 -174.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.01 162.4 37.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.132 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.77 -38.85 80.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.628 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -131.89 84.5 53.75 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.987 2.115 . . . . 0.0 108.013 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 175.09 9.58 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.09 1.86 . . . . 0.0 111.417 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.23 -31.45 3.3 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.567 1.079 . . . . 0.0 112.502 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.37 28.13 2.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.341 1.056 . . . . 0.0 112.16 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.9 134.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.929 0.871 . . . . 0.0 109.608 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.18 174.08 11.19 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.314 1.445 . . . . 0.0 108.862 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.646 HD11 ' HB ' ' D' ' 32' ' ' THR . 0.9 OUTLIER -53.53 132.69 40.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 126.248 1.819 . . . . 0.0 113.093 175.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -114.67 125.67 28.83 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.067 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' D' ' 71' ' ' LYS . 4.8 Cg_exo -58.72 146.92 90.43 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.164 1.909 . . . . 0.0 110.748 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.13 157.41 43.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.441 0.697 . . . . 0.0 111.234 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.89 148.85 15.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.822 1.649 . . . . 0.0 110.381 -174.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -157.7 28.96 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 121.35 1.886 . . . . 0.0 111.999 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.6 mt -145.41 138.7 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.094 0.957 . . . . 0.0 111.903 -174.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.98 138.17 50.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.537 1.535 . . . . 0.0 110.733 174.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -71.09 154.94 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.408 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -136.8 -6.38 1.91 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -78.61 -35.91 44.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.25 168.57 13.8 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -74.82 -42.55 57.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.244 1.018 . . . . 0.0 113.556 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -137.45 53.07 6.06 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.07 1.348 . . . . 0.0 112.037 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.91 -179.73 5.48 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.264 1.976 . . . . 0.0 115.248 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 34.8 p -87.97 161.91 17.16 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.762 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -159.53 155.97 27.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.57 149.69 19.59 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 119.517 2.567 . . . . 0.0 119.517 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.13 158.07 29.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -96.47 149.22 21.97 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.827 2.451 . . . . 0.0 108.989 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.89 124.87 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 69' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 52' ' ' ILE . 44.5 t30 -104.23 107.31 18.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.053 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.7 149.6 45.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 123.381 1.562 . . . . 0.0 114.397 -173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 71' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' D' ' 48' ' ' PRO . 27.2 mttt -108.56 -45.06 3.93 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -173.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -79.22 -16.88 55.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.395 1.078 . . . . 0.0 112.917 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -152.26 129.25 11.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.299 3.04 . . . . 0.0 105.453 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.91 118.95 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.355 0.98 . . . . 0.0 111.584 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 45.5 t -170.5 167.54 8.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 110.776 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -145.9 141.06 27.44 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.832 1.777 . . . . 0.0 110.892 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.46 125.25 22.48 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 109.469 -3.514 . . . . 0.0 110.456 -172.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -101.04 161.06 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.355 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.29 138.38 39.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.26 118.16 9.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 109.223 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -151.23 -178.59 26.18 Favored Glycine 0 CA--C 1.5 -0.85 0 C-N-CA 120.006 -1.092 . . . . 0.0 115.816 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.26 145.58 48.09 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 125.09 1.112 . . . . 0.0 111.263 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' D' ' 93' ' ' LEU . 17.0 t -97.6 118.37 33.95 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.939 1.4 . . . . 0.0 110.653 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' A' ' 106' ' ' ILE . 8.9 m-85 -109.06 163.78 13.02 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 85' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 7.8 mt -127.94 113.64 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 174.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.31 154.99 26.18 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -36.51 -38.98 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -72.37 -29.68 64.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.655 1.582 . . . . 0.0 114.467 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.38 58.72 0.73 Allowed Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.122 1.344 . . . . 0.0 110.949 -173.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 19.2 mtpt -123.72 163.46 21.07 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.414 2.686 . . . . 0.0 107.31 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -124.81 145.74 49.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 121.77 2.077 . . . . 0.0 112.725 -172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' VAL . . . . . 0.554 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -145.16 159.48 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.679 1.191 . . . . 0.0 110.643 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' D' ' 120' ' ' PHE . 19.1 mt -123.22 104.15 8.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 94' ' ' LYS . . . . . 0.554 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.7 mmtt -98.29 119.05 36.29 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 95' ' ' THR . . . . . 0.401 HG22 ' HA3' ' D' ' 81' ' ' GLY . 1.9 p -133.19 161.93 33.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.534 1.159 . . . . 0.0 111.257 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 96' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.24 168.45 9.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -142.14 164.25 30.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.477 1.132 . . . . 0.0 111.727 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.7 OUTLIER -146.9 124.14 11.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.685 -1.598 . . . . 0.0 113.569 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.62 144.81 38.95 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 125.332 1.645 . . . . 0.0 114.078 -174.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -124.63 115.02 20.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.896 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 31.5 m -74.52 161.32 29.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.937 0.895 . . . . 0.0 111.844 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 58.8 p -99.0 45.55 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.85 -1.157 . . . . 0.0 111.356 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 103' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' D' ' 108' ' ' ASP . 0.3 OUTLIER -52.22 137.96 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 112.964 -174.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -19.74 60.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.04 151.75 50.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.862 1.315 . . . . 0.0 113.783 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.7 tt -63.89 -24.37 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.367 -0.833 . . . . 0.0 113.171 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.16 3.5 52.09 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.212 0.911 . . . . 0.0 113.6 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' ASP . . . . . 0.402 ' HB3' HG21 ' D' ' 103' ' ' VAL . 1.2 m-20 -122.9 -0.78 8.96 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.139 0.976 . . . . 0.0 112.454 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -31.85 68.46 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.408 -0.808 . . . . 0.0 112.747 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.1 p-90 -48.3 -41.68 28.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.255 1.422 . . . . 0.0 113.703 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 111' ' ' LYS . . . . . 0.405 ' HB3' ' CZ3' ' D' ' 110' ' ' TRP . 15.1 pttm -96.66 -8.6 31.16 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -1.46 20.87 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' THR . . . . . 0.746 ' CG2' HD21 ' D' ' 98' ' ' LEU . 8.5 m -112.95 140.83 47.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.531 0.733 . . . . 0.0 112.687 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -144.12 131.34 20.72 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.788 1.235 . . . . 0.0 111.658 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.49 156.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 110.492 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.24 -175.26 31.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.541 0.591 . . . . 0.0 113.434 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -125.06 152.59 44.1 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.734 -0.862 . . . . 0.0 112.004 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.34 12.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.851 0.834 . . . . 0.0 110.166 -175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' ILE . . . . . 0.412 HD13 ' HE3' ' D' ' 94' ' ' LYS . 16.4 mt -116.02 138.29 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' D' ' 93' ' ' LEU . 21.0 m-85 -125.08 141.88 51.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -130.36 154.32 47.8 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -52.83 112.94 0.93 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.246 1.018 . . . . 0.0 110.145 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 123' ' ' LEU . . . . . 0.57 HD23 ' C ' ' D' ' 123' ' ' LEU . 7.7 tt . . . . . 0 CA--C 1.51 -0.571 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.416 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.3 p -116.86 147.77 41.87 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.331 1.852 . . . . 0.0 109.54 -174.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -139.48 129.66 25.25 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.78 -33.22 75.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.13 1.332 . . . . 0.0 114.105 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -65.27 115.55 5.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.82 5.2 0.32 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 68.76 146.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 128.59 2.756 . . . . 0.0 115.483 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -141.97 159.14 42.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.411 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.407 ' HB ' HD12 ' B' ' 123' ' ' LEU . 13.7 t -136.45 143.82 44.09 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.591 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -108.97 143.54 38.11 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.611 0.764 . . . . 0.0 110.571 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -55.62 -25.09 36.9 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.194 1.798 . . . . 0.0 113.332 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' D' ' 110' ' ' TRP . 29.6 tp -71.13 -18.92 62.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.633 1.573 . . . . 0.0 111.846 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.94 -16.06 23.27 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.381 2.42 . . . . 0.0 113.414 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 61.5 p -67.29 141.11 57.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.019 1.39 . . . . 0.0 111.89 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.67 141.09 48.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -134.56 147.14 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.569 1.176 . . . . 0.0 112.505 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -134.76 131.17 37.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.57 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 93.9 mt -132.59 126.2 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -84.75 0.17 Allowed Glycine 0 CA--C 1.526 0.769 0 O-C-N 125.348 1.655 . . . . 0.0 111.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.23 146.54 30.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 112.265 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 28.2 t -89.94 128.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.497 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.28 162.18 17.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.527 0.68 . . . . 0.0 111.847 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.2 p -58.0 -20.92 42.24 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -78.35 -31.4 48.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.176 0.898 . . . . 0.0 111.719 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.97 -5.75 23.87 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-O 117.479 -1.734 . . . . 0.0 114.687 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.6 145.34 54.03 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.531 1.665 . . . . 0.0 108.914 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.76 140.1 17.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.18 12.04 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.43 -168.72 34.93 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-O 122.82 1.233 . . . . 0.0 111.132 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.654 ' HB ' HD11 ' B' ' 46' ' ' LEU . 41.7 p -133.59 131.1 39.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.32 -1.44 . . . . 0.0 110.789 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -112.25 137.06 50.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.898 -1.956 . . . . 0.0 108.116 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.42 HD11 HD12 ' B' ' 46' ' ' LEU . 27.0 mt -132.96 129.72 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.445 HG23 ' H ' ' B' ' 37' ' ' VAL . 1.0 OUTLIER -108.75 145.73 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -175.48 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.23 -14.75 19.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 35' ' ' THR . 18.4 m -133.93 140.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.559 1.143 . . . . 0.0 112.745 -174.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.36 162.85 37.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 110.862 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.48 -38.96 77.9 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.433 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -132.15 84.6 52.28 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.202 2.201 . . . . 0.0 107.995 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.01 175.49 9.06 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.375 2.05 . . . . 0.0 111.486 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.35 -31.41 3.44 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.584 1.088 . . . . 0.0 112.654 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -140.28 28.25 2.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.395 1.078 . . . . 0.0 112.15 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.03 134.41 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.92 0.867 . . . . 0.0 109.562 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.31 173.63 11.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.347 1.459 . . . . 0.0 109.039 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.654 HD11 ' HB ' ' B' ' 32' ' ' THR . 0.9 OUTLIER -52.97 132.93 38.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.15 1.78 . . . . 0.0 113.211 175.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -115.26 125.86 28.42 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.082 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' HE3' ' B' ' 71' ' ' LYS . 6.7 Cg_exo -58.42 146.51 89.9 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 0.0 110.811 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.4 151.48 51.5 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.289 0.635 . . . . 0.0 110.7 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 tp -156.78 149.08 23.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.028 1.731 . . . . 0.0 110.845 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.59 25.49 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 121.555 1.979 . . . . 0.0 109.511 -173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' C' ' 69' ' ' ASN . 4.0 mt -146.2 140.23 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.371 1.068 . . . . 0.0 112.403 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.35 137.35 49.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.465 1.106 . . . . 0.0 110.657 174.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -69.91 156.13 39.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 109.992 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -138.81 -5.66 1.51 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -79.15 -36.9 39.72 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.47 166.64 15.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.749 0.656 . . . . 0.0 112.524 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.7 m -79.41 -34.28 41.93 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -139.78 51.88 3.35 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 125.147 1.379 . . . . 0.0 112.351 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.3 -179.5 5.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.734 2.29 . . . . 0.0 115.806 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -87.23 161.55 17.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.941 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.84 155.67 26.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.575 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.68 19.44 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 119.705 2.642 . . . . 0.0 119.705 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -160.07 159.05 31.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -96.52 149.44 21.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.844 2.457 . . . . 0.0 108.783 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.88 125.74 63.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.606 ' HB2' HG21 ' C' ' 52' ' ' ILE . 48.5 t30 -104.05 106.63 17.2 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 118.223 -0.894 . . . . 0.0 112.373 -174.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -71.8 149.43 45.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.288 1.518 . . . . 0.0 114.591 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.503 ' HE3' ' HD3' ' B' ' 48' ' ' PRO . 28.2 mttt -108.58 -45.24 3.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -79.14 -16.97 55.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 112.857 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 129.17 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.242 3.017 . . . . 0.0 105.455 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.73 119.0 11.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.472 1.033 . . . . 0.0 111.791 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 39.4 t -170.43 167.38 8.25 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.993 1.717 . . . . 0.0 110.738 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -146.12 140.83 26.98 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-O 124.03 1.871 . . . . 0.0 110.453 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.52 126.18 23.78 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 109.335 -3.575 . . . . 0.0 110.052 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.8 161.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.328 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.91 138.58 40.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.3 119.43 10.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.668 0.787 . . . . 0.0 109.148 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.81 -178.84 27.85 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.202 -0.999 . . . . 0.0 115.579 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -121.51 145.9 47.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 125.211 1.183 . . . . 0.0 111.058 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' CYS . . . . . 0.456 ' SG ' HD23 ' B' ' 93' ' ' LEU . 17.2 t -97.36 121.94 39.83 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.651 1.219 . . . . 0.0 110.012 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.564 ' HB2' HD12 ' C' ' 106' ' ' ILE . 10.7 m-85 -111.98 163.57 14.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.916 1.286 . . . . 0.0 112.648 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 19.2 mt -128.08 119.09 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.13 163.63 5.98 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.362 0.601 . . . . 0.0 109.839 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -47.0 -36.84 8.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.85 -25.09 60.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.308 1.443 . . . . 0.0 113.444 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.06 11.37 22.51 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.02 -1.433 . . . . 0.0 115.785 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 9.5 mtpt -81.58 167.21 19.51 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.426 1.613 . . . . 0.0 111.143 174.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.77 148.19 43.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.065 1.757 . . . . 0.0 112.185 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.537 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.2 t -146.99 160.6 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 122.358 1.075 . . . . 0.0 110.61 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 18.6 mt -123.49 103.58 8.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' LYS . . . . . 0.537 ' CD ' HG11 ' B' ' 92' ' ' VAL . 2.0 mmtt -98.14 118.71 35.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -132.41 163.3 29.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.583 1.182 . . . . 0.0 111.534 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -113.15 168.45 9.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -142.57 164.0 31.31 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.184 0.992 . . . . 0.0 111.771 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -146.38 123.73 11.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.678 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.06 144.78 38.14 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 125.197 1.56 . . . . 0.0 114.173 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.4 115.4 20.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 111.822 -2.445 . . . . 0.0 114.298 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 38.4 m -75.81 161.33 29.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.156 0.982 . . . . 0.0 111.134 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.5 p -98.28 45.29 1.02 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 108' ' ' ASP . 0.3 OUTLIER -51.42 137.73 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.91 1.684 . . . . 0.0 112.979 -174.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -20.3 60.86 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -173.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.21 153.13 50.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.84 1.305 . . . . 0.0 113.666 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' C' ' 84' ' ' PHE . 16.0 tt -65.03 -22.81 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.76 2.78 58.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.363 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.406 ' HB3' HG21 ' B' ' 103' ' ' VAL . 1.5 m-20 -122.5 -0.79 9.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.558 1.143 . . . . 0.0 112.436 -174.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -32.07 67.05 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.28 -0.887 . . . . 0.0 112.892 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.52 ' CD1' HD11 ' D' ' 14' ' ' LEU . 57.0 p-90 -48.65 -41.52 31.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.076 1.35 . . . . 0.0 113.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 110' ' ' TRP . 14.8 pttm -96.65 -8.33 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.91 -1.21 18.7 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.745 ' CG2' HD21 ' B' ' 98' ' ' LEU . 8.2 m -113.15 140.97 47.46 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.772 0.829 . . . . 0.0 112.807 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -144.13 131.56 20.95 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.708 1.203 . . . . 0.0 111.547 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.54 156.73 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 123.976 0.91 . . . . 0.0 110.73 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.35 -175.91 31.85 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.509 0.576 . . . . 0.0 113.358 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 27.8 p90 -124.56 152.57 43.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.781 -0.834 . . . . 0.0 111.956 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.6 12.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.953 0.883 . . . . 0.0 110.072 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.411 HD13 ' HE3' ' B' ' 94' ' ' LYS . 15.2 mt -116.7 138.74 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 24.5 m-85 -125.19 142.41 51.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.851 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 26.9 p -132.29 158.86 40.76 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -57.55 119.68 6.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.455 1.102 . . . . 0.0 113.255 -173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.413 ' O ' HD23 ' B' ' 123' ' ' LEU . 8.7 tt . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . 0.254 16.1 p -116.02 142.94 46.14 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 124.559 1.144 . . . . 0.0 108.343 -173.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 33.1 p -134.83 132.4 38.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.826 1.25 . . . . 0.0 113.858 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.31 -30.03 68.92 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -67.78 111.81 4.5 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.45 -10.32 0.29 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 118.597 2.199 . . . . 0.0 118.597 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt 81.19 146.48 0.08 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 130.513 3.525 . . . . 0.0 113.261 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -140.47 161.45 37.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.227 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -139.09 144.22 38.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.686 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -107.89 143.61 36.27 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.712 0.805 . . . . 0.0 110.275 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.08 -23.91 50.16 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.697 1.599 . . . . 0.0 113.276 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 110' ' ' TRP . 30.6 tp -71.14 -18.96 62.49 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.729 1.612 . . . . 0.0 111.415 174.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.9 -16.36 23.23 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.363 2.411 . . . . 0.0 113.537 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 51.7 p -66.55 141.04 57.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.215 1.508 . . . . 0.0 112.128 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.75 139.41 51.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.58 147.11 51.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.22 1.009 . . . . 0.0 113.021 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -134.85 131.9 37.96 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.891 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.99 125.6 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.99 -82.0 0.23 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 125.342 1.651 . . . . 0.0 111.379 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.72 151.11 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.681 0.753 . . . . 0.0 112.027 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.63 128.02 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.846 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -65.02 161.09 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.618 0.723 . . . . 0.0 111.675 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 11.7 p -58.03 -20.57 39.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -76.81 -29.91 56.18 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.313 0.96 . . . . 0.0 111.621 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.26 -3.69 26.76 Favored Glycine 0 N--CA 1.468 0.772 0 C-N-CA 124.761 1.172 . . . . 0.0 115.112 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.14 150.31 45.55 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.371 1.069 . . . . 0.0 110.797 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.86 162.73 40.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.041 174.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 172.4 11.62 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.37 -167.08 36.2 Favored Glycine 0 C--O 1.237 0.302 0 O-C-N 120.004 -1.685 . . . . 0.0 111.861 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' THR . . . . . 0.629 ' HB ' HD11 ' C' ' 46' ' ' LEU . 34.8 p -133.78 128.57 35.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 123.172 1.463 . . . . 0.0 111.1 174.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.02 137.21 50.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.14 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.411 HD11 HD12 ' C' ' 46' ' ' LEU . 25.7 mt -132.27 133.25 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 35' ' ' THR . . . . . 0.508 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.8 OUTLIER -114.92 146.96 40.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.14 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.91 -14.06 19.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.508 ' H ' HG23 ' C' ' 35' ' ' THR . 17.1 m -134.16 142.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.746 1.218 . . . . 0.0 112.609 -174.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.42 38.95 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.035 -1.041 . . . . 0.0 110.992 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.95 -39.01 79.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.362 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -132.12 84.69 52.16 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.089 2.156 . . . . 0.0 107.988 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 175.4 9.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.328 2.018 . . . . 0.0 111.506 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.83 -31.37 3.37 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.523 1.059 . . . . 0.0 112.58 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -140.19 28.6 2.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.486 1.114 . . . . 0.0 112.135 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.83 134.54 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.786 0.803 . . . . 0.0 109.462 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.97 174.66 10.65 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.273 1.429 . . . . 0.0 108.888 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' C' ' 32' ' ' THR . 1.0 OUTLIER -53.86 133.09 42.75 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.26 1.824 . . . . 0.0 112.963 174.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 49.0 m -115.37 125.75 28.51 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.153 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HE3' ' C' ' 71' ' ' LYS . 5.6 Cg_exo -58.04 146.7 86.43 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.142 1.895 . . . . 0.0 110.92 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.83 157.53 42.63 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.229 0.612 . . . . 0.0 111.187 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.513 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -161.3 148.89 15.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.835 1.654 . . . . 0.0 110.244 -174.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.83 -157.9 29.15 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 121.57 1.986 . . . . 0.0 111.875 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.6 mt -145.26 138.25 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.17 0.988 . . . . 0.0 111.933 -174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.17 139.29 51.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.687 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.46 154.64 40.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.486 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -137.28 -6.21 1.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -78.42 -37.2 44.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.31 165.8 16.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.344 0.592 . . . . 0.0 112.538 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 24.8 m -79.05 -34.26 43.95 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -140.2 52.74 3.7 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.897 1.279 . . . . 0.0 112.244 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.79 -179.09 5.11 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.851 2.367 . . . . 0.0 115.95 -174.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -86.5 162.38 18.1 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.792 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -160.22 156.49 26.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.736 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.4 148.98 17.96 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.64 158.77 32.16 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.91 149.78 21.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.825 2.45 . . . . 0.0 108.894 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.58 124.13 58.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' ASN . . . . . 0.587 ' HB2' HG21 ' B' ' 52' ' ' ILE . 44.0 t30 -103.53 107.66 18.59 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.231 -174.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -71.87 149.1 45.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.127 1.441 . . . . 0.0 114.557 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.452 ' HE3' ' HD3' ' C' ' 48' ' ' PRO . 26.5 mttt -108.21 -45.15 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.415 2.005 . . . . 0.0 116.415 -173.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -78.9 -16.93 56.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.204 1.002 . . . . 0.0 112.958 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -152.05 131.57 13.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 129.517 3.127 . . . . 0.0 105.032 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.41 119.04 13.98 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.163 0.892 . . . . 0.0 111.627 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 48.5 t -170.53 167.59 8.01 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.767 1.627 . . . . 0.0 110.819 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -145.81 141.14 27.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 123.927 1.823 . . . . 0.0 110.763 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.59 125.93 23.29 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 109.454 -3.521 . . . . 0.0 110.43 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -102.01 160.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.15 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -136.96 138.36 40.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.4 119.29 9.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.716 0.807 . . . . 0.0 108.875 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.51 -177.88 26.6 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 119.931 -1.128 . . . . 0.0 115.709 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -122.09 145.85 47.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.004 1.061 . . . . 0.0 111.191 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' C' ' 93' ' ' LEU . 14.6 t -97.4 121.73 39.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.803 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.575 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.8 m-85 -112.8 162.23 16.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.415 1.086 . . . . 0.0 113.276 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 27.5 mt -127.86 111.7 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -62.23 162.19 10.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.424 0.69 . . . . 0.0 110.052 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -42.97 -39.53 2.64 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.36 -25.55 63.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.051 1.34 . . . . 0.0 113.784 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.54 10.01 22.33 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.87 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 15.0 mtpp -78.77 164.24 24.7 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.333 1.566 . . . . 0.0 110.862 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.62 148.18 41.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.019 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.2 t -146.91 162.92 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.904 1.281 . . . . 0.0 110.425 176.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' C' ' 120' ' ' PHE . 19.4 mt -126.24 104.21 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.9 mmtt -98.79 118.26 35.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -131.96 163.13 29.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.462 1.125 . . . . 0.0 111.572 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' MET . . . . . 0.415 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -112.92 168.82 9.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -143.09 164.29 30.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.199 1.0 . . . . 0.0 111.832 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.747 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.7 OUTLIER -146.4 123.77 11.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.973 -1.467 . . . . 0.0 113.705 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.23 144.72 38.49 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.248 1.419 . . . . 0.0 114.068 -174.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.48 114.91 20.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 112.168 -2.287 . . . . 0.0 114.185 -174.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -74.86 161.32 29.66 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.852 0.861 . . . . 0.0 111.938 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 55.4 p -98.27 45.33 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.307 1.043 . . . . 0.0 111.48 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.31 136.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.744 1.618 . . . . 0.0 113.453 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -20.52 61.85 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -174.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.53 151.35 51.09 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.819 1.295 . . . . 0.0 113.597 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.9 tt -64.28 -21.92 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.56 3.27 64.06 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -122.81 -0.58 9.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.316 1.046 . . . . 0.0 112.621 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -31.55 68.51 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.72 0.808 . . . . 0.0 112.83 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 110' ' ' TRP . . . . . 0.524 ' CD1' HD11 ' A' ' 14' ' ' LEU . 57.4 p-90 -49.02 -41.16 33.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.009 1.323 . . . . 0.0 113.706 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 111' ' ' LYS . . . . . 0.406 ' HB3' ' CZ3' ' C' ' 110' ' ' TRP . 14.9 pttm -96.78 -8.54 30.93 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.01 18.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' THR . . . . . 0.747 ' CG2' HD21 ' C' ' 98' ' ' LEU . 8.3 m -113.41 140.44 48.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.52 0.728 . . . . 0.0 112.66 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -143.69 131.24 21.14 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.639 1.176 . . . . 0.0 111.645 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.37 156.49 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.034 0.933 . . . . 0.0 110.64 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.95 -175.8 31.33 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.352 0.501 . . . . 0.0 113.261 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 27.5 p90 -124.21 152.93 42.33 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.786 -0.832 . . . . 0.0 112.053 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.17 128.81 11.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.966 0.889 . . . . 0.0 110.132 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' ILE . . . . . 0.427 HD13 ' HE3' ' C' ' 94' ' ' LYS . 15.3 mt -115.37 140.87 34.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 25.2 m-85 -127.27 141.32 51.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.772 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 18.2 p -131.69 161.17 33.4 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -59.15 119.76 7.93 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.706 0.802 . . . . 0.0 112.546 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 172.332 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' -3' ' ' GLN . 10.7 mm-40 . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 118.797 -0.621 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 18.5 p -86.87 -42.92 12.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.547 1.139 . . . . 0.0 111.972 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.63 137.11 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 142.9 101.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 129.702 3.201 . . . . 0.0 111.615 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 51.86 25.83 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -146.66 124.46 11.91 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.396 1.078 . . . . 0.0 113.228 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.31 136.97 52.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 122.564 1.173 . . . . 0.0 111.747 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.14 129.03 24.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.909 2.484 . . . . 0.0 107.564 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' A' ' 53' ' ' GLN . 3.8 mt -67.83 -31.25 70.97 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -53.44 116.53 2.5 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.731 0.777 . . . . 0.0 110.947 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.45 -128.85 4.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 10' ' ' TRP . 14.8 ttmt -146.23 152.34 39.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 55.9 m95 -138.35 162.73 33.66 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 110.879 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 14.7 t -141.3 144.64 34.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.54 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -106.92 147.28 30.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.84 0.856 . . . . 0.0 111.591 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -27.79 58.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.868 1.267 . . . . 0.0 113.94 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.503 HD11 ' CD1' ' C' ' 110' ' ' TRP . 35.1 tp -71.09 -15.99 62.55 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.425 1.49 . . . . 0.0 113.476 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.68 -9.81 44.77 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.871 2.177 . . . . 0.0 114.068 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -71.93 146.73 47.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.685 1.243 . . . . 0.0 110.839 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -122.72 148.36 45.41 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.15 -0.969 . . . . 0.0 111.711 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -135.06 139.81 45.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -126.4 132.68 51.48 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.76 126.71 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.77 -91.0 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.637 1.211 . . . . 0.0 111.97 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 134.61 30.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.519 -0.989 . . . . 0.0 110.387 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.01 133.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.959 0.787 . . . . 0.0 111.241 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.36 158.09 36.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.372 1.069 . . . . 0.0 110.874 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.6 m -57.65 -24.58 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.865 -1.147 . . . . 0.0 113.963 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.409 -0.807 . . . . 0.0 110.766 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.31 -5.01 33.42 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.769 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.23 154.24 39.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.942 1.871 . . . . 0.0 111.608 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.04 154.22 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -116.83 156.28 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.604 1.162 . . . . 0.0 109.557 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.72 -176.57 38.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.651 1.139 . . . . 0.0 115.288 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.441 ' CG2' HD23 ' A' ' 46' ' ' LEU . 7.9 p -134.26 123.29 24.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.279 -1.461 . . . . 0.0 107.724 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' C ' HD12 ' A' ' 34' ' ' ILE . 62.2 t80 -124.38 132.14 53.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.169 -1.832 . . . . 0.0 113.76 -171.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 46' ' ' LEU . 2.4 mp -124.15 131.37 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.735 0.778 . . . . 0.0 108.965 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -106.92 138.27 43.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.087 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.32 24.63 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 30.3 m -137.81 136.96 45.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 124.083 0.953 . . . . 0.0 111.921 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.46 163.13 37.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.172 -0.955 . . . . 0.0 111.012 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.88 -27.13 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.25 80.47 10.13 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 127.281 2.232 . . . . 0.0 109.881 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.92 13.21 0.23 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.736 3.624 . . . . 0.0 117.986 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.31 -28.86 1.53 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.41 53.53 0.17 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.147 1.473 . . . . 0.0 112.28 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.55 130.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.756 -1.215 . . . . 0.0 111.096 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.09 172.32 11.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 128.272 2.629 . . . . 0.0 108.818 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.653 HD12 HG13 ' A' ' 34' ' ' ILE 0.289 5.5 mp -66.69 131.91 46.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.7 m -99.39 117.72 63.46 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.421 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.93 138.72 78.48 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.782 1.655 . . . . 0.0 110.525 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.53 148.49 46.24 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.165 0.916 . . . . 0.0 110.688 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 148.89 33.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.554 2.342 . . . . 0.0 108.64 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.49 -159.03 32.05 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.254 -1.529 . . . . 0.0 109.312 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.9 mt -145.48 146.65 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.717 0.892 . . . . 0.0 111.5 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' A' ' 6' ' ' LEU . 7.0 pt20 -132.29 154.35 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.28 1.038 . . . . 0.0 113.071 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -92.16 157.93 16.45 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.381 1.086 . . . . 0.0 109.098 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 23.53 0.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.726 1.61 . . . . 0.0 111.918 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.46 -52.34 4.55 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.465 2.306 . . . . 0.0 111.93 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.78 174.46 3.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -71.77 -44.84 63.33 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.446 -0.784 . . . . 0.0 111.773 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.59 69.08 81.52 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.688 1.195 . . . . 0.0 110.229 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.22 168.64 17.12 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.903 3.068 . . . . 0.0 118.08 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.5 p -86.06 157.45 20.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.365 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -150.59 174.32 13.11 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 123.989 1.852 . . . . 0.0 112.533 174.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.82 149.62 9.38 Favored Glycine 0 N--CA 1.408 -3.186 0 CA-C-N 108.674 -3.875 . . . . 0.0 120.168 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.31 153.21 23.21 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.4 150.01 23.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.362 1.865 . . . . 0.0 109.985 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.84 117.01 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.538 ' CB ' HG21 ' D' ' 52' ' ' ILE . 39.8 t30 -101.99 110.86 22.94 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.87 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.331 50.5 m95 -70.08 154.79 41.5 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.156 1.931 . . . . 0.0 115.436 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 71' ' ' LYS . 9.9 mmpt? -107.52 -44.18 4.35 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.332 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -91.8 -8.54 46.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 t -152.47 136.61 16.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.359 2.264 . . . . 0.0 107.728 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -72.52 112.35 8.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.658 1.572 . . . . 0.0 110.441 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.1 p -165.98 169.99 14.11 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.011 1.724 . . . . 0.0 111.562 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -148.14 141.62 25.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 122.855 1.312 . . . . 0.0 111.241 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m -137.11 124.06 21.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 110.945 -2.843 . . . . 0.0 110.198 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -101.3 154.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.426 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -127.23 142.31 51.51 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.163 0.985 . . . . 0.0 108.521 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 120.76 7.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -169.69 -166.12 28.17 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.552 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.85 146.15 50.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 124.671 0.865 . . . . 0.0 113.296 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 50.4 t -97.4 113.23 24.86 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.219 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' HD12 ' D' ' 106' ' ' ILE . 18.1 m-85 -103.77 169.64 8.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.298 1.839 . . . . 0.0 111.743 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -125.44 112.14 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.01 161.59 8.19 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.801 0.441 . . . . 0.0 110.535 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -30.36 -57.11 0.2 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.397 1.879 . . . . 0.0 115.975 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.26 -15.51 63.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.01 1.724 . . . . 0.0 115.022 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.94 27.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.702 1.144 . . . . 0.0 114.77 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -78.93 144.32 34.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.739 1.616 . . . . 0.0 111.79 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -101.42 141.73 33.86 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.728 1.211 . . . . 0.0 111.708 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.8 m -144.02 160.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.777 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -119.45 116.92 27.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -107.28 111.92 24.52 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 7.2 p -133.28 172.0 13.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.125 1.441 . . . . 0.0 111.563 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.513 ' HG3' HG21 ' D' ' 113' ' ' THR . 90.8 mmm -124.78 169.22 12.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.431 -1.258 . . . . 0.0 107.794 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -139.94 162.03 36.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.045 1.402 . . . . 0.0 112.319 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -145.67 119.17 9.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.149 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.25 141.27 38.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 123.649 1.69 . . . . 0.0 110.42 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 10.4 tpt180 -125.62 113.91 18.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 110.172 -3.195 . . . . 0.0 109.746 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -77.09 156.94 31.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.982 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.87 82.87 2.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -65.8 173.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.684 1.194 . . . . 0.0 111.978 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.515 ' H ' HG12 ' A' ' 103' ' ' VAL . 4.6 p-10 -117.87 -7.58 10.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.96 148.1 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.869 1.319 . . . . 0.0 110.33 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' D' ' 92' ' ' VAL . 15.7 tt -63.3 -26.28 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.862 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.04 -2.83 33.38 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 117.912 -1.493 . . . . 0.0 115.219 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.55 3.67 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.843 1.321 . . . . 0.0 113.459 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -35.38 61.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.959 -1.088 . . . . 0.0 111.577 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.501 ' CD1' HD11 ' C' ' 14' ' ' LEU . 60.2 p-90 -50.13 -46.34 53.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.163 0.985 . . . . 0.0 113.402 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -14.71 42.65 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.372 -0.83 . . . . 0.0 112.728 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' A' ' 103' ' ' VAL . . . -73.81 -9.16 58.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' D' ' 96' ' ' MET . 61.9 m -95.24 155.97 16.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -154.05 124.15 6.87 Favored 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 126.822 2.049 . . . . 0.0 111.156 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.37 156.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 121.792 2.087 . . . . 0.0 110.203 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.18 -177.56 31.4 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 124.397 1.061 . . . . 0.0 115.023 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 16.2 p90 -123.67 152.23 42.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.114 0.966 . . . . 0.0 110.984 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -150.4 148.2 28.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.899 0.88 . . . . 0.0 110.67 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.3 mt -132.27 122.94 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.082 -1.011 . . . . 0.0 109.294 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -113.87 153.94 28.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.013 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.0 p -135.73 164.27 28.28 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.307 1.043 . . . . 0.0 110.796 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -57.74 117.7 4.51 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.444 1.098 . . . . 0.0 110.41 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -67.0 133.68 50.42 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.228 -0.295 . . . . 0.0 110.606 177.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 76.78 31.3 0.56 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.9 t -58.73 159.72 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -96.42 -172.17 2.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.407 1.883 . . . . 0.0 111.161 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -94.54 118.32 31.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.667 0.787 . . . . 0.0 111.529 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.248 1.02 1 C-N-CA 131.838 4.055 . . . . 0.0 107.178 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.815 -1.088 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 10.1 t -149.38 62.73 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.539 1.638 . . . . 0.0 113.223 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.25 141.72 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.343 1.857 . . . . 0.0 108.128 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -153.21 5.19 0.34 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.925 1.69 . . . . 0.0 112.236 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 30.7 ttp85 -156.75 29.63 0.32 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.982 1.713 . . . . 0.0 111.715 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -152.41 125.81 8.75 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.822 -1.174 . . . . 0.0 112.594 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 131.36 56.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.752 1.263 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.77 127.58 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.908 2.083 . . . . 0.0 106.042 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' D' ' 53' ' ' GLN . 2.4 mt -73.22 -28.87 62.42 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 124.414 1.071 . . . . 0.0 112.755 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -53.5 115.84 2.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.93 0.892 . . . . 0.0 110.508 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.72 -132.63 5.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.482 1.515 . . . . 0.0 109.392 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' LYS . . . . . 0.489 ' HG2' ' H ' ' D' ' 10' ' ' TRP . 16.0 ttmt -144.24 152.51 40.93 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' TRP . . . . . 0.489 ' H ' ' HG2' ' D' ' 9' ' ' LYS . 55.6 m95 -139.94 162.72 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.544 1.938 . . . . 0.0 111.476 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.646 ' HB ' HD12 ' D' ' 123' ' ' LEU . 14.2 t -139.9 146.95 39.9 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.354 1.062 . . . . 0.0 109.102 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -108.85 148.25 30.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.64 0.776 . . . . 0.0 111.546 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -25.37 59.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.692 1.197 . . . . 0.0 114.108 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' B' ' 110' ' ' TRP . 34.9 tp -73.3 -15.85 61.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.596 1.559 . . . . 0.0 113.269 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.04 -12.84 45.14 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.479 1.99 . . . . 0.0 113.89 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -67.96 145.63 54.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.94 1.37 . . . . 0.0 111.166 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -120.95 149.31 42.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.182 -0.949 . . . . 0.0 111.692 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -135.31 142.46 45.84 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.912 -0.493 . . . . 0.0 112.209 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -128.59 132.35 48.19 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.871 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.01 127.6 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.577 1.173 . . . . 0.0 112.307 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.27 134.6 29.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.851 -0.794 . . . . 0.0 110.632 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.02 131.91 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.679 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.71 156.45 38.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.778 1.231 . . . . 0.0 110.275 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 72.8 m -57.29 -23.04 45.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.09 -28.15 68.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.501 -0.75 . . . . 0.0 110.841 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.74 -4.35 34.39 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 125.302 1.429 . . . . 0.0 112.771 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.85 158.98 30.43 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.843 1.322 . . . . 0.0 113.32 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.09 166.36 33.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.71 0.767 . . . . 0.0 112.05 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -128.61 160.07 33.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.552 1.141 . . . . 0.0 108.801 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.93 -175.48 39.52 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 119.974 -1.108 . . . . 0.0 115.465 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.459 ' CG2' HD23 ' D' ' 46' ' ' LEU . 8.7 p -134.75 124.03 24.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.084 1.354 . . . . 0.0 107.927 -174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' TYR . . . . . 0.581 ' C ' HD12 ' D' ' 34' ' ' ILE . 65.0 t80 -125.3 131.24 53.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.638 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.668 HG13 HD12 ' D' ' 46' ' ' LEU . 2.5 mp -123.37 129.67 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.926 0.87 . . . . 0.0 109.015 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.25 137.84 42.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.255 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.53 -6.92 26.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 31.1 m -138.4 136.87 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.056 0.931 . . . . 0.0 112.175 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.27 161.96 39.9 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.855 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.3 -25.45 54.84 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.715 -0.616 . . . . 0.0 110.555 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -146.85 79.81 9.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 127.277 2.231 . . . . 0.0 109.791 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.91 13.13 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.834 3.689 . . . . 0.0 117.992 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.48 -28.64 1.57 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 118.241 2.056 . . . . 0.0 118.241 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.71 54.77 0.17 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.203 1.502 . . . . 0.0 112.076 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.68 130.54 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.76 -1.213 . . . . 0.0 111.068 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 173.06 10.95 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.274 2.629 . . . . 0.0 108.894 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.668 HD12 HG13 ' D' ' 34' ' ' ILE 0.296 5.4 mp -67.72 131.11 44.96 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 61.1 m -98.31 117.98 64.08 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.762 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.26 137.86 78.06 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.694 1.596 . . . . 0.0 110.264 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -121.9 155.67 34.97 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.446 1.091 . . . . 0.0 110.662 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -155.62 149.03 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.319 1.848 . . . . 0.0 109.026 -177.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.32 -157.42 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 O-C-N 121.158 -0.964 . . . . 0.0 111.021 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.538 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -145.56 147.06 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.03 0.919 . . . . 0.0 111.568 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' D' ' 6' ' ' LEU . 5.7 pt20 -133.12 153.59 51.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.37 1.081 . . . . 0.0 112.969 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.37 157.55 17.56 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.389 1.09 . . . . 0.0 108.539 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 24.33 0.56 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.728 1.611 . . . . 0.0 111.358 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -93.48 -51.57 4.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.602 2.361 . . . . 0.0 111.318 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 172.26 8.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -69.11 -43.47 74.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 0.0 111.075 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.85 71.59 69.68 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.947 1.299 . . . . 0.0 110.851 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -69.86 169.29 19.38 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.076 3.184 . . . . 0.0 118.817 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 36.2 p -86.65 156.23 20.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.018 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' D' ' 83' ' ' CYS . 0.0 OUTLIER -152.62 173.99 14.52 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 123.981 1.848 . . . . 0.0 112.633 174.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.0 148.89 9.17 Favored Glycine 0 N--CA 1.412 -2.941 0 CA-C-N 109.213 -3.63 . . . . 0.0 119.748 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -159.59 153.09 22.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.55 151.3 23.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.601 1.96 . . . . 0.0 110.006 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.47 117.38 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.534 ' CB ' HG21 ' A' ' 52' ' ' ILE . 42.4 t30 -102.42 111.83 24.29 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.136 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.328 51.1 m95 -70.68 153.11 43.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 124.105 1.907 . . . . 0.0 115.61 -172.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' D' ' 71' ' ' LYS . 9.9 mmpt? -105.76 -43.46 4.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.188 -174.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -92.09 -8.65 45.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -152.58 136.51 16.32 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.204 2.202 . . . . 0.0 107.473 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.83 111.52 7.16 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.691 1.587 . . . . 0.0 110.368 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 93.0 p -165.07 170.73 14.72 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.778 1.631 . . . . 0.0 111.569 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 64' ' ' PHE . 4.9 t -148.35 142.21 25.74 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.519 1.152 . . . . 0.0 111.586 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.13 123.65 20.9 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 111.25 -2.705 . . . . 0.0 110.357 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 m -100.8 154.04 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -127.21 142.08 51.57 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.01 0.924 . . . . 0.0 108.719 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 119.96 7.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -167.79 -166.75 27.4 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.132 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -133.56 147.07 51.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 125.051 1.089 . . . . 0.0 112.819 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.448 ' HB2' ' CZ ' ' D' ' 64' ' ' PHE . 44.1 t -97.28 125.35 41.79 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 116.19 -1.862 . . . . 0.0 108.011 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.432 ' HB2' HD12 ' A' ' 106' ' ' ILE . 13.1 m-85 -114.51 172.03 7.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.921 1.689 . . . . 0.0 110.819 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mt -127.87 111.87 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.51 158.73 9.27 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -25.97 -55.16 0.06 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.212 2.205 . . . . 0.0 116.005 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -9.02 58.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.137 2.175 . . . . 0.0 116.001 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.8 51.1 3.51 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 120.082 1.31 . . . . 0.0 109.981 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -124.07 136.35 54.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.795 1.638 . . . . 0.0 109.119 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -101.06 139.82 36.22 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.903 1.335 . . . . 0.0 110.689 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 106' ' ' ILE . 19.9 m -144.3 161.05 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.704 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.73 116.78 25.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -106.78 111.13 23.52 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.432 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 6.3 p -133.07 172.18 12.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 123.51 1.624 . . . . 0.0 111.831 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' A' ' 113' ' ' THR . 90.4 mmm -124.92 169.06 12.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -139.26 162.22 35.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.56 1.648 . . . . 0.0 112.55 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -145.68 119.81 9.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.699 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.29 141.75 38.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.599 1.812 . . . . 0.0 110.442 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -126.0 113.87 17.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 109.999 -3.273 . . . . 0.0 109.895 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 2.6 t -77.84 158.19 29.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.286 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 56.6 m -105.22 77.62 1.32 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.68 0.752 . . . . 0.0 109.74 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' VAL . . . . . 0.581 ' CG2' ' HB2' ' D' ' 112' ' ' ALA . 1.5 t -63.55 166.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.106 1.363 . . . . 0.0 112.595 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.405 ' H ' HG12 ' D' ' 103' ' ' VAL . 4.7 p-10 -112.44 -4.36 14.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.64 147.4 35.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.58 1.181 . . . . 0.0 110.373 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.482 ' CD1' HG21 ' A' ' 92' ' ' VAL . 16.0 tt -63.36 -26.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.854 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.49 -3.03 30.66 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 117.659 -1.634 . . . . 0.0 115.432 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.26 3.49 10.34 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.806 1.303 . . . . 0.0 113.636 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.96 60.71 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.819 -1.176 . . . . 0.0 111.816 174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.507 ' CD1' HD11 ' B' ' 14' ' ' LEU . 60.4 p-90 -49.46 -46.83 48.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 -15.65 41.82 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.29 -0.881 . . . . 0.0 112.789 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' D' ' 103' ' ' VAL . . . -73.51 -7.76 53.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.513 HG21 ' HG3' ' A' ' 96' ' ' MET . 57.2 m -96.54 154.88 17.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.021 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.19 124.3 7.47 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.627 1.971 . . . . 0.0 111.195 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.52 156.23 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 121.699 2.045 . . . . 0.0 110.047 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -178.6 31.68 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.834 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 15.6 p90 -122.51 152.62 40.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.168 0.987 . . . . 0.0 110.83 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -150.61 147.36 27.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.937 0.875 . . . . 0.0 110.837 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.64 120.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.239 -0.913 . . . . 0.0 108.985 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -110.46 154.31 23.8 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.067 0.855 . . . . 0.0 111.539 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -136.68 161.95 34.51 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.378 1.071 . . . . 0.0 110.055 174.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -56.66 128.26 35.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER -62.43 168.38 3.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.408 174.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -30.12 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.608 2.363 . . . . 0.0 114.944 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 15.6 p -79.08 143.9 35.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 122.417 1.103 . . . . 0.0 111.8 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -74.79 158.0 34.22 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.443 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -70.45 172.38 8.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.397 173.035 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 10.2 t -155.13 -43.7 0.08 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 120.493 1.497 . . . . 0.0 108.194 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 15.9 m -88.94 155.16 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.565 1.146 . . . . 0.0 108.07 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -89.09 -46.25 8.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.484 0.714 . . . . 0.0 112.734 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -172.59 89.31 0.09 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.851 2.06 . . . . 0.0 110.306 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -156.23 132.0 9.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.374 -0.829 . . . . 0.0 112.912 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 132.22 56.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.453 1.101 . . . . 0.0 111.391 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.27 127.64 19.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.847 2.059 . . . . 0.0 106.439 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.66 -30.82 64.6 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.84 117.3 2.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.929 0.892 . . . . 0.0 110.733 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.28 -130.49 4.83 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.755 1.645 . . . . 0.0 109.662 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' B' ' 10' ' ' TRP . 15.1 ttmt -145.25 152.83 40.58 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' TRP . . . . . 0.472 ' H ' ' HG2' ' B' ' 9' ' ' LYS . 58.0 m95 -138.76 162.73 33.99 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.753 2.021 . . . . 0.0 111.275 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -143.51 145.0 32.21 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.903 0.881 . . . . 0.0 109.195 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -109.7 146.55 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.887 0.875 . . . . 0.0 111.83 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -25.87 53.38 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' D' ' 110' ' ' TRP . 35.0 tp -73.21 -16.54 61.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.479 1.512 . . . . 0.0 113.075 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 -12.94 29.98 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.964 2.221 . . . . 0.0 114.033 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -69.0 142.96 54.49 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.836 -1.391 . . . . 0.0 111.993 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -116.42 143.31 45.72 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.829 -1.169 . . . . 0.0 110.657 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -133.24 139.23 46.84 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.946 -0.471 . . . . 0.0 112.053 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -126.51 132.6 51.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.871 0.868 . . . . 0.0 108.74 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.9 mt -129.05 127.2 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -91.06 0.07 OUTLIER Glycine 0 CA--C 1.528 0.9 0 O-C-N 124.87 1.356 . . . . 0.0 112.096 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.32 135.35 32.12 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.863 -0.787 . . . . 0.0 110.865 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.94 133.61 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.223 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.9 158.26 36.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.358 1.063 . . . . 0.0 110.993 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 64.7 m -57.87 -24.31 57.01 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.753 -1.217 . . . . 0.0 114.021 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -66.15 -29.25 69.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.453 -0.779 . . . . 0.0 110.729 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.19 34.63 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 117.918 -1.49 . . . . 0.0 112.933 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.85 154.15 39.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.798 1.799 . . . . 0.0 111.535 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.35 154.16 31.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -116.78 156.43 27.23 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 109.573 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.62 -176.18 38.1 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.691 1.162 . . . . 0.0 115.02 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.449 ' CG2' HD23 ' B' ' 46' ' ' LEU . 7.5 p -134.87 123.97 24.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 113.259 -1.471 . . . . 0.0 107.298 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.574 ' C ' HD12 ' B' ' 34' ' ' ILE . 64.9 t80 -124.72 131.29 53.47 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.724 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.649 HG13 HD12 ' B' ' 46' ' ' LEU . 2.4 mp -123.72 129.57 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 122.09 0.948 . . . . 0.0 108.597 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.02 141.23 36.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.251 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.97 21.6 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.96 136.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.201 1.0 . . . . 0.0 111.797 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.94 162.2 39.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.241 -0.912 . . . . 0.0 110.999 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.02 -27.45 60.1 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.445 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.09 80.36 10.33 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.214 2.205 . . . . 0.0 109.758 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.64 12.94 0.23 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.722 3.615 . . . . 0.0 118.073 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.0 -28.97 1.38 Allowed Glycine 0 CA--C 1.54 1.621 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -163.25 53.29 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.152 1.476 . . . . 0.0 112.361 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.74 130.54 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 120.782 -1.199 . . . . 0.0 111.358 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 173.5 10.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.049 2.54 . . . . 0.0 108.945 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.649 HD12 HG13 ' B' ' 34' ' ' ILE 0.292 5.4 mp -67.71 131.51 45.72 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.6 m -99.22 117.69 63.67 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.418 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -54.61 138.85 75.92 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.665 1.577 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.5 148.47 46.22 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.248 0.967 . . . . 0.0 110.641 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.66 148.85 33.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.402 2.281 . . . . 0.0 108.646 174.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.52 -159.09 32.12 Favored Glycine 0 N--CA 1.443 -0.898 0 O-C-N 120.319 -1.488 . . . . 0.0 109.464 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.9 mt -145.41 147.58 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.784 0.834 . . . . 0.0 111.473 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -133.15 153.99 51.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 122.409 1.099 . . . . 0.0 113.859 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -91.9 157.09 17.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.549 1.166 . . . . 0.0 108.892 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.38 25.09 0.47 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.018 1.727 . . . . 0.0 111.55 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -93.64 -52.16 4.6 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.601 2.36 . . . . 0.0 112.123 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.97 171.86 8.77 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.7 t -69.65 -42.22 74.51 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.747 0.819 . . . . 0.0 111.161 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 69.32 72.68 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.499 1.12 . . . . 0.0 110.931 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.88 169.14 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.003 3.136 . . . . 0.0 118.454 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -86.44 157.24 19.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.063 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' B' ' 83' ' ' CYS . 0.0 OUTLIER -153.21 174.28 14.47 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 124.18 1.943 . . . . 0.0 112.353 174.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.28 149.11 9.22 Favored Glycine 0 N--CA 1.411 -2.992 0 CA-C-N 109.065 -3.698 . . . . 0.0 120.046 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -159.12 153.48 23.99 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.47 149.94 23.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.984 1.714 . . . . 0.0 109.984 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 117.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 173.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.537 ' CB ' HG21 ' C' ' 52' ' ' ILE . 38.6 t30 -102.11 110.81 22.87 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.799 -174.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.334 49.9 m95 -70.08 155.54 40.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.958 1.837 . . . . 0.0 115.396 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' B' ' 71' ' ' LYS . 9.8 mmpt? -108.54 -44.26 4.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.355 -1.748 . . . . 0.0 114.143 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -91.18 -8.74 47.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.23 1.012 . . . . 0.0 113.691 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -152.38 137.05 16.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.31 2.244 . . . . 0.0 107.36 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.64 111.77 8.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.497 1.498 . . . . 0.0 110.715 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 93.3 p -165.31 169.92 15.28 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.077 1.751 . . . . 0.0 111.635 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.68 141.87 26.13 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.21 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.6 m -137.62 123.82 20.48 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.216 -173.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.95 154.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.536 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.24 141.93 51.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 108.676 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.62 119.86 7.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -168.55 -167.4 29.12 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.412 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -133.56 146.37 50.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.078 -1.061 . . . . 0.0 112.618 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' B' ' 64' ' ' PHE . 41.4 t -97.37 122.0 39.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.087 173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.451 ' HB2' HD12 ' C' ' 106' ' ' ILE . 12.2 m-85 -111.37 172.49 6.85 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.714 1.606 . . . . 0.0 110.669 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mt -128.41 113.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.97 162.47 6.96 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -30.12 -52.53 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.744 2.017 . . . . 0.0 115.772 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -78.35 -0.7 30.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.393 2.277 . . . . 0.0 116.978 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 50.94 6.87 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.439 -1.413 . . . . 0.0 110.505 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -119.91 141.89 49.2 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.514 2.326 . . . . 0.0 105.432 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -111.38 138.5 47.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.265 1.426 . . . . 0.0 110.99 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 20.6 m -144.3 161.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.686 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -121.04 118.2 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -108.03 111.55 23.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 6.9 p -133.46 171.91 13.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.066 1.412 . . . . 0.0 111.971 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.519 ' HG3' HG21 ' C' ' 113' ' ' THR . 90.6 mmm -124.63 169.32 12.05 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -139.67 162.02 36.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.489 1.614 . . . . 0.0 112.644 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.47 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.9 OUTLIER -145.58 119.65 9.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.017 179.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 141.54 38.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 123.677 1.703 . . . . 0.0 110.578 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -126.26 114.0 17.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 110.121 -3.218 . . . . 0.0 110.162 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -78.23 156.65 29.64 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.616 1.198 . . . . 0.0 110.824 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.73 82.45 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' B' ' 112' ' ' ALA . 1.6 t -66.32 172.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.94 1.296 . . . . 0.0 111.815 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.498 ' H ' HG12 ' B' ' 103' ' ' VAL . 5.1 p-10 -119.2 -2.77 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 174.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.421 ' H ' HG12 ' B' ' 103' ' ' VAL . 0.8 OUTLIER -142.25 146.4 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.346 1.07 . . . . 0.0 111.06 174.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' C' ' 92' ' ' VAL . 14.8 tt -63.57 -26.88 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.958 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.63 -3.62 34.86 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.979 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.16 3.55 10.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.712 1.256 . . . . 0.0 113.271 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -36.13 62.12 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.041 -1.037 . . . . 0.0 111.575 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' D' ' 14' ' ' LEU . 59.0 p-90 -48.68 -46.79 40.9 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 -16.06 38.71 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.267 -0.895 . . . . 0.0 112.673 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' B' ' 103' ' ' VAL . . . -72.25 -8.34 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' C' ' 96' ' ' MET . 57.6 m -96.38 156.65 16.25 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.697 0.399 . . . . 0.0 110.227 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ttm-85 -154.27 124.52 6.89 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 126.933 2.093 . . . . 0.0 111.366 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 p -105.63 156.18 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 121.832 2.105 . . . . 0.0 110.166 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.88 -178.0 31.52 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.232 0.958 . . . . 0.0 114.83 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 15.5 p90 -123.02 152.72 40.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.285 1.034 . . . . 0.0 110.691 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -150.61 146.25 26.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.008 0.908 . . . . 0.0 111.331 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.64 119.14 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.082 -1.011 . . . . 0.0 108.67 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.63 154.45 21.97 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.281 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 20.3 p -138.02 164.16 29.78 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.379 1.072 . . . . 0.0 109.645 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.99 123.72 16.14 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.87 156.6 11.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.039 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.89 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -78.85 -15.81 57.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.027 0.83 . . . . 0.0 111.28 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 57.37 -175.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.146 1.779 . . . . 0.0 111.621 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER -162.4 176.66 10.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.94 1.696 . . . . 0.0 110.145 172.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 C-N-CA 130.131 3.372 . . . . 0.0 111.86 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 7.4 p -91.97 175.46 6.87 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.404 1.881 . . . . 0.0 108.592 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 21.4 t 35.97 79.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 127.316 2.246 . . . . 0.0 114.955 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -172.04 -36.07 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.26 36.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.334 1.454 . . . . 0.0 112.625 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -154.64 125.88 7.31 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.491 -1.38 . . . . 0.0 112.943 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 131.49 56.92 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.924 1.345 . . . . 0.0 110.077 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.61 127.52 22.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.431 HD12 ' CD ' ' C' ' 53' ' ' GLN . 2.7 mt -73.41 -27.56 61.52 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.414 1.071 . . . . 0.0 112.844 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -53.61 117.28 3.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.861 0.838 . . . . 0.0 110.368 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.98 -130.27 4.79 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.719 1.628 . . . . 0.0 109.525 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' LYS . . . . . 0.433 ' HD2' HD13 ' C' ' 123' ' ' LEU . 19.7 ttmt -142.46 151.13 41.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.808 1.29 . . . . 0.0 113.288 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' TRP . . . . . 0.427 ' H ' ' HG2' ' C' ' 9' ' ' LYS . 50.0 m95 -136.18 162.69 32.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 112.469 -2.15 . . . . 0.0 110.816 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -142.84 142.51 31.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.65 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -108.36 148.06 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.918 0.887 . . . . 0.0 112.529 -174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -27.9 61.74 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.316 1.446 . . . . 0.0 114.365 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' A' ' 110' ' ' TRP . 33.9 tp -72.34 -15.9 61.87 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.393 1.477 . . . . 0.0 113.176 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -14.34 29.51 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.153 2.311 . . . . 0.0 113.645 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.636 1.218 . . . . 0.0 111.29 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -118.49 144.48 45.98 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.264 -0.897 . . . . 0.0 111.061 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -133.79 141.46 47.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.998 0.428 . . . . 0.0 111.63 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 5.9 m -129.73 132.12 46.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.79 127.37 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.57 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.867 1.354 . . . . 0.0 112.18 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.41 135.12 30.05 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.605 -0.938 . . . . 0.0 110.649 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.71 131.67 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.807 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.46 156.37 39.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.791 1.237 . . . . 0.0 110.229 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -57.29 -23.05 46.0 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -66.05 -28.49 68.88 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.531 -0.731 . . . . 0.0 110.797 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.83 -3.94 34.11 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.167 1.365 . . . . 0.0 112.724 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -77.05 158.76 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.71 1.255 . . . . 0.0 113.316 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.02 166.32 33.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.485 0.659 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.7 160.16 33.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.709 1.203 . . . . 0.0 108.702 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.22 -175.5 39.72 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 119.961 -1.114 . . . . 0.0 115.435 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.443 ' CG2' HD23 ' C' ' 46' ' ' LEU . 9.0 p -134.7 123.96 24.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.811 1.244 . . . . 0.0 107.702 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.575 ' C ' HD12 ' C' ' 34' ' ' ILE . 65.4 t80 -125.09 130.56 52.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.612 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.657 HG13 HD12 ' C' ' 46' ' ' LEU . 2.3 mp -122.9 129.48 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 CA-C-O 121.932 0.872 . . . . 0.0 108.833 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -104.99 140.31 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.996 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.56 -6.39 22.87 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.64 136.93 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.025 0.93 . . . . 0.0 111.645 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.76 162.21 39.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.985 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.98 -27.49 60.18 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -145.78 80.42 10.57 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.989 2.116 . . . . 0.0 109.766 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.85 13.44 0.22 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.835 3.69 . . . . 0.0 118.044 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.71 -28.62 1.7 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.21 53.39 0.18 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.093 1.447 . . . . 0.0 112.037 -174.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -56.84 130.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.914 -1.116 . . . . 0.0 111.087 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.53 172.27 11.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.109 2.564 . . . . 0.0 109.115 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.657 HD12 HG13 ' C' ' 34' ' ' ILE 0.299 5.4 mp -66.95 130.45 43.2 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 59.4 m -98.08 118.15 64.07 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.977 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -55.0 138.65 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.643 1.562 . . . . 0.0 110.061 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -122.53 155.72 35.65 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.331 1.019 . . . . 0.0 110.852 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -155.38 149.08 25.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.014 1.726 . . . . 0.0 108.799 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.58 29.78 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 119.353 0.979 . . . . 0.0 111.033 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.42 147.0 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.057 0.932 . . . . 0.0 111.938 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.431 ' CD ' HD12 ' C' ' 6' ' ' LEU . 6.7 pt20 -133.57 154.0 51.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.221 1.008 . . . . 0.0 113.225 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -90.67 159.06 16.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.435 1.112 . . . . 0.0 108.765 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 25.05 0.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.689 1.596 . . . . 0.0 111.57 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -93.36 -51.87 4.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.831 2.453 . . . . 0.0 111.328 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 171.96 10.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -71.08 -41.95 70.01 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.665 0.745 . . . . 0.0 110.955 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.56 67.76 80.32 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.405 1.082 . . . . 0.0 111.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -69.69 170.23 16.99 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.902 3.068 . . . . 0.0 118.268 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 41.7 p -86.63 156.42 20.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.903 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' C' ' 83' ' ' CYS . 0.0 OUTLIER -153.58 173.7 15.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.728 1.728 . . . . 0.0 112.762 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.51 148.49 9.12 Favored Glycine 0 N--CA 1.412 -2.927 0 CA-C-N 109.351 -3.568 . . . . 0.0 119.528 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -159.47 153.18 22.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -87.85 150.94 23.22 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.333 1.853 . . . . 0.0 110.021 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.78 117.13 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' B' ' 52' ' ' ILE . 40.1 t30 -102.39 111.47 23.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.969 -174.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.33 49.9 m95 -70.45 154.7 41.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 124.199 1.952 . . . . 0.0 115.448 -172.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' C' ' 71' ' ' LYS . 9.9 mmpt? -107.54 -43.79 4.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.221 -1.809 . . . . 0.0 114.145 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.79 -8.42 46.77 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.57 136.7 16.48 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.286 2.235 . . . . 0.0 107.448 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -72.53 111.21 7.5 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.556 1.525 . . . . 0.0 110.829 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -165.1 170.07 15.45 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 125.879 1.672 . . . . 0.0 111.441 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -147.8 141.92 26.06 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 122.901 1.334 . . . . 0.0 111.264 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.6 m -137.04 124.36 21.91 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 110.88 -2.873 . . . . 0.0 110.387 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 m -101.81 154.31 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.555 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.19 142.32 51.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.102 0.961 . . . . 0.0 108.419 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.09 120.16 7.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -168.3 -167.31 28.75 Favored Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.11 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.58 146.67 51.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 125.171 1.159 . . . . 0.0 112.656 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 64' ' ' PHE . 44.7 t -97.23 125.56 41.85 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 115.66 -2.114 . . . . 0.0 108.009 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.433 ' HB2' HD12 ' B' ' 106' ' ' ILE . 13.8 m-85 -114.4 171.27 7.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.928 1.691 . . . . 0.0 110.614 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.03 110.77 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.26 157.67 13.04 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -23.45 -57.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.978 2.111 . . . . 0.0 116.53 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.0 -14.18 62.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.91 20.95 10.66 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.031 0.824 . . . . 0.0 113.68 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -91.09 142.28 27.93 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.849 1.325 . . . . 0.0 110.296 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -101.47 139.46 37.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.281 1.032 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.8 m -142.17 161.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.179 1.392 . . . . 0.0 110.057 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 14.8 mt -119.26 116.92 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -107.43 110.76 22.79 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.45 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 6.8 p -132.34 171.51 13.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 123.24 1.495 . . . . 0.0 111.862 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' B' ' 113' ' ' THR . 91.2 mmm -124.68 169.07 12.32 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -139.36 162.33 35.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 123.378 1.561 . . . . 0.0 112.658 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.477 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -145.76 119.48 9.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.069 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.74 38.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.465 1.602 . . . . 0.0 110.403 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -126.14 113.9 17.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 110.346 -3.116 . . . . 0.0 109.762 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -77.11 156.48 31.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.032 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 52.6 m -103.05 83.14 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' C' ' 112' ' ' ALA . 1.6 t -66.52 172.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.472 1.109 . . . . 0.0 111.715 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.499 ' H ' HG12 ' C' ' 103' ' ' VAL . 4.6 p-10 -118.04 -5.21 10.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.93 148.01 37.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.73 1.252 . . . . 0.0 110.202 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' B' ' 92' ' ' VAL . 15.5 tt -63.61 -25.73 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.02 -1.446 . . . . 0.0 112.909 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.15 -1.75 36.05 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.579 -1.123 . . . . 0.0 115.393 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' ASP . . . . . 0.404 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.6 OUTLIER -122.25 3.09 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.287 1.044 . . . . 0.0 113.54 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.91 60.52 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.2 -0.938 . . . . 0.0 111.556 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.503 ' CD1' HD11 ' A' ' 14' ' ' LEU . 60.1 p-90 -50.28 -46.35 55.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.137 0.975 . . . . 0.0 113.565 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -15.12 41.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.158 -0.964 . . . . 0.0 112.577 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 112' ' ' ALA . . . . . 0.578 ' HB2' ' CG2' ' C' ' 103' ' ' VAL . . . -73.54 -8.12 54.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.519 HG21 ' HG3' ' B' ' 96' ' ' MET . 62.2 m -96.63 155.12 16.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.675 0.39 . . . . 0.0 110.044 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttm-85 -153.04 124.02 7.43 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 126.931 2.092 . . . . 0.0 111.208 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.09 156.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 121.77 2.077 . . . . 0.0 110.091 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -177.54 31.46 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.206 0.941 . . . . 0.0 114.962 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 15.9 p90 -123.85 152.41 42.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.276 1.03 . . . . 0.0 110.908 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -150.43 147.0 27.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.936 0.895 . . . . 0.0 111.187 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.97 121.77 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -112.93 153.47 27.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.683 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.7 p -134.13 162.55 31.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.106 0.962 . . . . 0.0 110.317 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -55.5 121.77 9.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.948 0.899 . . . . 0.0 109.691 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.46 ' C ' HD23 ' C' ' 123' ' ' LEU . 5.4 tt -70.54 109.75 5.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.921 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.452 ' HB2' HD23 ' C' ' 123' ' ' LEU . 1.8 tmm_? 53.86 90.31 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.46 1.504 . . . . 0.0 111.598 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -94.51 -74.72 0.53 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -76.7 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.683 1.593 . . . . 0.0 109.885 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -156.77 -82.71 0.06 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.669 1.587 . . . . 0.0 112.301 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 114.136 -2.84 . . . . 0.0 114.861 -172.718 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 7.6 p -144.51 88.42 1.93 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.727 1.611 . . . . 0.0 109.36 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.73 142.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.237 0.615 . . . . 0.0 110.434 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -113.38 168.65 9.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.554 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.307 0.8 OUTLIER -154.47 73.56 0.91 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 0.0 111.37 -175.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.91 114.36 3.15 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.062 -1.024 . . . . 0.0 113.191 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -124.09 129.2 50.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.077 0.941 . . . . 0.0 110.963 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -139.61 127.5 22.11 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.248 -1.532 . . . . 0.0 114.279 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 64' ' ' PHE . 21.1 mt -55.51 -32.84 63.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -54.83 122.02 9.87 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.724 1.249 . . . . 0.0 110.932 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.25 -108.31 0.87 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.512 2.006 . . . . 0.0 111.696 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.12 144.0 20.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -140.76 162.79 34.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.327 1.851 . . . . 0.0 110.632 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -141.71 151.44 42.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.237 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 14' ' ' LEU . 4.6 t30 -116.42 146.31 42.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.376 1.071 . . . . 0.0 112.521 -173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.49 -23.67 64.69 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' H ' HD22 ' A' ' 12' ' ' ASN . 28.0 tp -71.58 -15.7 62.28 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.703 -1.248 . . . . 0.0 112.115 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.82 -14.35 24.34 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 128.382 2.896 . . . . 0.0 113.686 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p -63.31 144.27 57.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.456 1.128 . . . . 0.0 112.987 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' OD1' HD12 ' A' ' 34' ' ' ILE . 6.2 p30 -115.66 140.34 49.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -130.71 139.81 50.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.545 0.688 . . . . 0.0 111.084 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.7 m -129.0 131.52 47.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.21 127.02 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.51 -88.4 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.299 1.0 . . . . 0.0 111.553 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.24 42.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.863 0.839 . . . . 0.0 112.426 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 t -98.14 123.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.017 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.22 156.0 38.51 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 m -55.21 -22.01 16.14 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -72.32 -37.78 68.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.359 0.664 . . . . 0.0 111.237 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.31 -2.66 18.64 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 117.336 -1.813 . . . . 0.0 113.422 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HB2' HD21 ' D' ' 50' ' ' LEU . 9.7 pt-20 -69.26 137.44 53.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.928 1.691 . . . . 0.0 107.079 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.25 148.19 25.61 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.16 163.58 15.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.192 0.997 . . . . 0.0 109.374 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.35 -168.0 34.59 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 120.947 -1.095 . . . . 0.0 113.165 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.633 ' HB ' HD11 ' A' ' 46' ' ' LEU . 1.1 p -141.54 129.69 22.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.965 1.364 . . . . 0.0 110.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.64 141.02 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.019 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 46' ' ' LEU . 7.9 mt -131.93 128.75 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.375 1.083 . . . . 0.0 108.53 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.562 ' O ' HG21 ' A' ' 44' ' ' ILE . 35.3 m -105.65 133.76 49.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.615 -1.175 . . . . 0.0 113.073 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.26 -17.87 23.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.74 142.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.831 1.252 . . . . 0.0 111.83 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.98 153.81 40.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.028 -1.045 . . . . 0.0 111.268 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.54 -24.25 66.35 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -147.88 76.56 10.53 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 128.518 2.727 . . . . 0.0 112.053 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.03 169.56 18.97 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.169 2.579 . . . . 0.0 112.431 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.88 -29.55 1.55 Allowed Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.473 1.035 . . . . 0.0 113.078 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.06 2.89 3.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.559 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 35' ' ' THR . 54.9 mt -31.83 112.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.151 1.78 . . . . 0.0 114.354 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 157.78 41.59 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.556 1.543 . . . . 0.0 110.879 -176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.633 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.6 tp -46.72 115.51 1.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.021 2.928 . . . . 0.0 111.623 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 t -103.48 117.06 60.97 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.454 1.102 . . . . 0.0 109.933 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 144.22 82.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.27 2.647 . . . . 0.0 112.552 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.71 155.08 45.64 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.673 0.789 . . . . 0.0 111.863 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -159.75 147.61 17.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.164 1.785 . . . . 0.0 112.296 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.17 -151.55 21.91 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 120.786 1.63 . . . . 0.0 110.954 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.4 mp -141.24 137.86 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 113.135 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -120.95 141.03 51.05 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.15 -50.47 71.72 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.503 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.92 14.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 127.395 2.278 . . . . 0.0 116.852 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.76 -47.08 6.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.515 2.726 . . . . 0.0 115.103 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.76 -174.11 2.46 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.319 1.012 . . . . 0.0 111.63 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -83.43 -36.72 24.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -124.41 56.67 12.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.667 1.187 . . . . 0.0 110.497 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.02 164.04 37.16 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.884 3.056 . . . . 0.0 116.309 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.5 p -82.21 167.79 18.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.95 1.3 . . . . 0.0 111.383 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -159.13 162.29 36.43 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.818 -1.176 . . . . 0.0 112.961 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.86 139.24 5.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 118.731 -1.7 . . . . 0.0 117.053 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -163.0 151.73 14.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 m -88.29 148.98 24.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.562 1.945 . . . . 0.0 110.549 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -126.02 117.72 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' HB2' HG21 ' D' ' 52' ' ' ILE . 44.2 t30 -97.33 105.4 17.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.147 0.579 . . . . 0.0 112.376 -174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 32.4 m95 -74.76 147.99 40.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -110.7 -45.71 3.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.165 -1.38 . . . . 0.0 114.647 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -80.86 -11.3 59.61 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -152.53 133.24 13.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.789 2.436 . . . . 0.0 105.838 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.26 118.52 14.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.695 1.134 . . . . 0.0 111.2 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -178.52 167.15 1.82 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-O 123.625 1.679 . . . . 0.0 110.895 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 t -144.69 144.71 31.36 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.123 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.3 m -140.7 131.71 26.19 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 110.15 -3.205 . . . . 0.0 110.312 -172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.7 143.63 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.06 143.74 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 116.78 9.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HE ' ' D' ' 100' ' ' ARG . . . -151.98 -176.13 24.37 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 119.389 -1.386 . . . . 0.0 115.625 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -123.17 147.8 46.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.702 -1.249 . . . . 0.0 111.059 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 39.0 t -96.88 120.81 37.91 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.651 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' D' ' 106' ' ' ILE . 6.8 m-85 -115.24 166.9 11.34 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.731 1.213 . . . . 0.0 114.089 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.01 110.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.01 154.18 16.08 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -33.63 -41.97 0.1 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.619 1.968 . . . . 0.0 115.97 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -13.96 60.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 50.36 2.83 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.44 137.61 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.449 1.9 . . . . 0.0 109.492 174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -101.28 148.24 25.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.004 2.121 . . . . 0.0 112.164 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.6 t -152.09 155.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.606 -174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HE2' ' A' ' 64' ' ' PHE . 12.9 mt -122.04 105.92 10.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ3' HD11 ' D' ' 106' ' ' ILE . 3.0 mmtt -98.33 119.33 36.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 64' ' ' PHE . 8.9 p -130.35 162.5 28.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.346 1.546 . . . . 0.0 112.632 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.417 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -110.96 162.78 14.49 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -136.84 161.38 36.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.134 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -146.57 121.57 10.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 113.248 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.76 142.23 38.1 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.923 1.344 . . . . 0.0 112.241 -175.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.416 ' HE ' ' HA2' ' D' ' 81' ' ' GLY . 4.3 tpt85 -127.99 113.95 16.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 111.798 -2.455 . . . . 0.0 112.524 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.25 0.4 OUTLIER -71.95 165.68 23.71 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 125.269 1.606 . . . . 0.0 110.549 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -113.26 79.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.19 175.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 121.524 -0.735 . . . . 0.0 110.529 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -22.89 15.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.08 150.32 43.32 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 123.156 1.455 . . . . 0.0 112.678 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' D' ' 84' ' ' PHE . 17.4 tt -61.3 -27.57 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.141 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.87 9.32 24.85 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.959 0.79 . . . . 0.0 113.934 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -120.59 -0.41 10.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.328 1.051 . . . . 0.0 112.187 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -32.0 70.53 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.646 -1.284 . . . . 0.0 113.408 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.86 -44.91 59.67 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.911 1.684 . . . . 0.0 112.652 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -93.26 -10.63 34.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.332 1.053 . . . . 0.0 113.002 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.42 9.34 1.75 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.372 -0.83 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' A' ' 98' ' ' LEU . 20.9 m -117.45 139.3 51.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.853 0.861 . . . . 0.0 113.195 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.51 116.18 12.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 127.414 2.286 . . . . 0.0 111.281 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.68 152.91 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.725 1.148 . . . . 0.0 110.177 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.32 -174.24 31.97 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.56 154.66 44.91 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.705 -0.879 . . . . 0.0 112.195 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -146.71 152.63 39.15 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.815 1.246 . . . . 0.0 109.736 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.416 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.9 mt -136.46 119.01 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 12' ' ' ASN . 21.1 m-85 -109.68 149.38 29.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.331 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -134.74 163.32 30.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -56.82 119.91 7.0 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.845 0.858 . . . . 0.0 110.964 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 123' ' ' LEU . 10.4 tt -77.7 117.21 18.88 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.92 -171.05 0.42 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.661 1.184 . . . . 0.0 113.293 174.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -53.22 0.24 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.476 1.51 . . . . 0.0 111.485 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -100.58 153.46 19.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 111.149 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? 70.05 101.52 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.087 2.155 . . . . 0.0 112.421 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 129.288 3.035 . . . . 0.0 110.866 174.253 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 116.944 -1.503 . . . . 0.0 107.808 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 11.7 m 51.74 85.72 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.52 13.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.423 1.089 . . . . 0.0 113.238 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -66.86 145.71 55.19 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.466 -1.396 . . . . 0.0 112.009 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -139.83 74.55 1.47 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.745 1.618 . . . . 0.0 110.79 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 125.49 10.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.872 -1.142 . . . . 0.0 112.698 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' CYS . . . . . 0.56 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 22.5 p -136.48 130.41 32.53 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.693 0.758 . . . . 0.0 111.501 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -139.77 129.51 24.57 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.4 -1.437 . . . . 0.0 114.56 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' D' ' 64' ' ' PHE . 20.7 mt -56.89 -32.16 65.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -55.58 119.71 6.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.968 1.366 . . . . 0.0 111.744 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.94 -116.5 1.99 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.203 1.859 . . . . 0.0 110.819 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.7 146.43 30.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -174.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' TRP . . . . . 0.425 ' CH2' HD21 ' D' ' 93' ' ' LEU . 38.2 m95 -141.57 161.92 36.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.232 1.413 . . . . 0.0 111.077 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.2 148.14 37.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' ASN . . . . . 0.512 HD22 ' H ' ' D' ' 14' ' ' LEU . 5.0 t30 -113.03 147.64 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.362 1.065 . . . . 0.0 112.599 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.74 -23.47 64.96 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.512 ' H ' HD22 ' D' ' 12' ' ' ASN . 27.8 tp -73.08 -14.47 61.4 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.477 1.511 . . . . 0.0 112.257 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.11 -12.92 34.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.857 2.646 . . . . 0.0 113.913 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.47 148.68 50.09 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.584 1.192 . . . . 0.0 112.824 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' ASN . . . . . 0.426 ' OD1' HD12 ' D' ' 34' ' ' ILE . 5.8 p30 -121.66 143.08 49.54 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.58 0.752 . . . . 0.0 110.543 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -132.07 139.88 48.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.605 0.717 . . . . 0.0 111.849 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -127.74 132.78 49.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.74 123.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.42 -79.95 0.24 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.346 1.029 . . . . 0.0 111.78 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.24 42.09 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.848 -0.795 . . . . 0.0 112.084 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -100.53 125.25 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.616 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -69.46 156.7 38.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 20.1 m -55.88 -21.7 21.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -70.75 -35.73 72.78 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.688 0.676 . . . . 0.0 111.283 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.95 -1.39 21.27 Favored Glycine 0 N--CA 1.469 0.9 0 C-N-CA 124.52 1.057 . . . . 0.0 112.95 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.89 149.81 44.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 110.717 173.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PHE . . . . . 0.604 ' O ' HD12 ' D' ' 50' ' ' LEU . 27.8 p90 -156.15 163.86 39.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.034 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.442 HG22 HD13 ' D' ' 50' ' ' LEU . 4.9 p -125.81 167.69 14.85 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.4 -166.49 33.12 Favored Glycine 0 N--CA 1.467 0.74 0 O-C-N 120.031 -1.668 . . . . 0.0 113.201 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.612 ' HB ' HD11 ' D' ' 46' ' ' LEU . 1.2 p -140.32 132.1 27.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.772 1.273 . . . . 0.0 111.539 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.5 139.1 50.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.463 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.556 HG12 HD12 ' D' ' 46' ' ' LEU . 7.8 mt -129.97 131.48 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.84 0.829 . . . . 0.0 108.789 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.583 ' O ' HG21 ' D' ' 44' ' ' ILE . 7.7 m -109.32 134.78 51.37 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 -19.22 21.55 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 28.3 m -131.38 141.54 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.892 1.277 . . . . 0.0 112.161 -174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.38 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.947 -1.096 . . . . 0.0 111.333 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.99 -24.08 66.7 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -147.91 76.72 10.45 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 128.536 2.734 . . . . 0.0 112.041 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.25 169.35 19.73 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.181 2.587 . . . . 0.0 112.517 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.87 -29.18 1.56 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.574 1.083 . . . . 0.0 113.123 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.29 2.87 3.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.736 -1.126 . . . . 0.0 113.533 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.583 HG21 ' O ' ' D' ' 35' ' ' THR . 50.8 mt -32.36 113.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 114.242 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.73 157.96 41.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.55 1.54 . . . . 0.0 110.747 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB ' ' D' ' 32' ' ' THR . 11.9 tp -47.48 115.36 1.1 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.712 2.805 . . . . 0.0 111.074 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.25 117.15 60.93 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.853 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.02 143.03 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.867 2.378 . . . . 0.0 112.272 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.412 HD12 ' C ' ' D' ' 49' ' ' LEU . 2.0 pp -128.48 163.76 24.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.87 0.868 . . . . 0.0 112.209 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.604 HD12 ' O ' ' D' ' 29' ' ' PHE . 27.6 tp -169.07 149.01 4.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.249 1.42 . . . . 0.0 113.842 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 -150.96 21.56 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 120.883 1.674 . . . . 0.0 111.315 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.8 mp -142.32 135.35 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.965 0.906 . . . . 0.0 111.705 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -120.16 140.18 51.5 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 110.113 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.21 -50.0 74.86 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.436 -0.79 . . . . 0.0 111.525 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.09 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.67 2.388 . . . . 0.0 116.634 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.94 -46.64 7.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.386 2.675 . . . . 0.0 115.053 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.25 -175.43 3.67 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.26 0.975 . . . . 0.0 112.512 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 40.8 t -81.67 -35.28 30.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.561 0.745 . . . . 0.0 111.576 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.29 58.56 31.44 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 125.041 1.336 . . . . 0.0 111.033 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.91 163.34 38.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.742 2.962 . . . . 0.0 117.317 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -81.63 168.08 18.53 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.197 1.399 . . . . 0.0 111.569 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -159.12 162.26 36.44 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.736 -1.227 . . . . 0.0 112.967 174.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.0 139.08 5.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 118.873 -1.632 . . . . 0.0 116.871 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.89 153.12 16.26 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -89.11 151.61 22.12 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 127.601 2.36 . . . . 0.0 110.325 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 32.1 t -129.25 119.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.546 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.4 t30 -99.2 105.15 17.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.242 0.617 . . . . 0.0 112.004 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -74.34 147.27 42.38 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -110.1 -45.12 3.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.099 -1.409 . . . . 0.0 114.554 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.67 -11.16 59.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.55 132.91 13.68 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.881 2.473 . . . . 0.0 105.671 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.3 118.49 15.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.808 1.185 . . . . 0.0 111.193 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.79 166.55 1.68 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.94 1.696 . . . . 0.0 111.116 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 t -143.96 144.63 31.78 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.217 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.3 m -140.32 133.25 29.25 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 109.975 -3.284 . . . . 0.0 109.797 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.85 143.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.682 0.614 . . . . 0.0 109.548 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -116.3 143.91 44.92 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.7 116.55 8.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -151.45 -175.72 23.53 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.669 -1.253 . . . . 0.0 115.757 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.42 147.41 47.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.438 -1.381 . . . . 0.0 110.776 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.56 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 5.6 t -97.16 123.61 40.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.872 1.358 . . . . 0.0 110.624 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.602 ' HB2' HD12 ' A' ' 106' ' ' ILE . 7.7 m-85 -116.65 163.02 16.75 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -130.16 110.4 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.96 157.44 9.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -36.22 -40.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.445 1.898 . . . . 0.0 115.578 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -78.2 -10.23 59.55 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.14 51.03 4.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.057 0.836 . . . . 0.0 111.633 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.5 147.08 46.78 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 129.107 2.963 . . . . 0.0 107.401 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -112.73 152.63 28.85 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 120.267 1.394 . . . . 0.0 111.279 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.509 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.4 t -153.37 158.3 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.516 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 93' ' ' LEU . . . . . 0.425 HD21 ' CH2' ' D' ' 10' ' ' TRP . 6.9 mt -121.17 108.13 13.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.509 ' CD ' HG11 ' D' ' 92' ' ' VAL . 2.8 mmtt -100.76 117.67 35.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.57 HG22 ' HE1' ' D' ' 64' ' ' PHE . 4.8 p -129.28 163.08 26.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.608 1.671 . . . . 0.0 112.88 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.12 162.54 14.8 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -136.55 161.51 35.68 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.879 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -146.59 121.94 10.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.298 -1.774 . . . . 0.0 113.05 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' LEU . . . . . 0.471 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 141.76 38.52 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.859 1.314 . . . . 0.0 112.556 -176.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HA2' ' A' ' 81' ' ' GLY . 4.2 tpt85 -126.98 114.06 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 111.731 -2.486 . . . . 0.0 112.303 -174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.63 165.62 23.57 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 125.039 1.462 . . . . 0.0 110.557 173.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 8.3 t -113.53 77.11 1.02 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.82 176.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.23 -22.81 15.45 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.95 150.0 41.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 123.088 1.423 . . . . 0.0 112.914 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 84' ' ' PHE . 18.0 tt -62.57 -28.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.442 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 9.01 21.35 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.202 0.906 . . . . 0.0 113.961 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.45 -1.81 10.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.556 1.142 . . . . 0.0 111.878 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -31.45 70.27 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.394 -1.441 . . . . 0.0 113.279 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.62 -46.23 58.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.579 1.552 . . . . 0.0 112.52 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -91.73 -10.94 38.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.27 1.028 . . . . 0.0 112.832 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 8.75 2.08 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.605 -0.684 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' D' ' 98' ' ' LEU . 19.5 m -116.42 139.22 50.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.986 0.914 . . . . 0.0 113.28 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.54 116.21 12.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.4 2.28 . . . . 0.0 111.151 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.66 152.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.825 1.193 . . . . 0.0 110.394 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.51 -173.83 31.67 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -127.77 154.92 44.83 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.679 -0.895 . . . . 0.0 112.266 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -147.41 151.19 36.07 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.457 1.103 . . . . 0.0 109.746 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -135.69 119.18 24.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -111.12 151.72 27.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.566 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -137.4 167.64 21.22 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -61.69 125.61 24.41 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.586 -1.321 . . . . 0.0 113.246 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tt -84.65 95.83 9.02 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.87 140.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.712 2.005 . . . . 0.0 113.083 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 20.7 p -152.18 167.58 28.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.218 1.007 . . . . 0.0 111.991 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.8 148.92 44.07 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.858 0.463 . . . . 0.0 110.485 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm 91.92 109.49 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.459 3.103 . . . . 0.0 108.738 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.419 3.088 . . . . 0.0 106.661 -176.843 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' B' ' -3' ' ' GLN . 9.4 mm-40 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 5.1 m -148.22 146.05 28.51 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 108.781 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.43 105.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.457 1.103 . . . . 0.0 110.899 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.94 -18.73 0.05 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 24.3 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 128.434 2.694 . . . . 0.0 115.644 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.39 128.81 20.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.072 0.949 . . . . 0.0 111.647 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.656 ' HB2' ' HG ' ' B' ' 83' ' ' CYS . 24.9 p -139.68 127.96 22.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.623 0.769 . . . . 0.0 110.226 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -139.74 127.7 22.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.417 -1.427 . . . . 0.0 114.567 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.616 HD21 ' CE2' ' B' ' 64' ' ' PHE . 20.7 mt -55.62 -32.34 63.06 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -54.47 118.81 4.45 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.323 1.535 . . . . 0.0 111.732 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.14 -106.87 0.66 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.883 1.706 . . . . 0.0 111.302 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.27 146.58 21.51 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' TRP . . . . . 0.41 ' CH2' HD21 ' B' ' 93' ' ' LEU . 43.4 m95 -140.71 162.84 34.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.548 1.539 . . . . 0.0 110.578 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -139.36 152.22 46.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.479 HD22 ' H ' ' B' ' 14' ' ' LEU . 4.6 t30 -117.5 146.86 43.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 111.864 -174.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -60.89 -22.12 63.99 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.479 ' H ' HD22 ' B' ' 12' ' ' ASN . 26.7 tp -73.45 -14.19 61.2 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.959 1.304 . . . . 0.0 112.238 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.69 -13.32 35.39 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 128.069 2.747 . . . . 0.0 113.743 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 3.4 p -64.1 148.62 49.44 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.293 -1.122 . . . . 0.0 112.73 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.421 ' OD1' HD12 ' B' ' 34' ' ' ILE . 5.7 p30 -122.42 140.42 52.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.471 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -128.71 139.19 52.34 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.976 0.893 . . . . 0.0 111.793 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.93 131.93 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.016 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.39 126.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.4 -86.8 0.13 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.529 1.143 . . . . 0.0 111.531 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.36 154.15 42.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.916 0.865 . . . . 0.0 112.607 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.6 123.57 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.214 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -68.12 155.89 38.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.112 0.415 . . . . 0.0 109.916 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 20.3 m -54.99 -22.29 14.75 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -72.25 -37.42 69.11 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.636 0.653 . . . . 0.0 111.178 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -2.52 19.41 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-O 117.378 -1.79 . . . . 0.0 113.471 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.453 ' HB2' HD21 ' C' ' 50' ' ' LEU . 9.8 pt-20 -69.37 137.52 52.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.078 1.751 . . . . 0.0 107.112 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.4 ' O ' HD12 ' B' ' 50' ' ' LEU . 18.5 p90 -154.31 147.75 25.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.05 162.66 16.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.39 1.076 . . . . 0.0 109.62 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.36 -167.48 33.21 Favored Glycine 0 CA--C 1.523 0.538 0 O-C-N 120.972 -1.08 . . . . 0.0 113.407 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.607 ' HB ' HD11 ' B' ' 46' ' ' LEU . 1.3 p -140.66 131.6 26.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.785 1.279 . . . . 0.0 110.952 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -114.42 138.73 50.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.792 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.553 HG12 HD12 ' B' ' 46' ' ' LEU . 7.6 mt -129.97 132.45 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.582 ' O ' HG21 ' B' ' 44' ' ' ILE . 16.9 m -110.46 134.75 52.06 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.88 -18.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.59 141.71 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.88 1.272 . . . . 0.0 111.93 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.77 154.19 41.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.994 -1.066 . . . . 0.0 110.959 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.74 -24.55 66.24 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -148.12 76.61 10.29 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.577 2.751 . . . . 0.0 111.979 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.05 169.75 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.152 2.568 . . . . 0.0 112.566 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.82 -29.46 1.56 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.502 1.048 . . . . 0.0 113.158 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.02 2.73 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.512 1.125 . . . . 0.0 113.535 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.582 HG21 ' O ' ' B' ' 35' ' ' THR . 52.2 mt -31.9 113.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 126.164 1.786 . . . . 0.0 114.429 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.37 158.54 39.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.455 1.502 . . . . 0.0 110.84 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.607 HD11 ' HB ' ' B' ' 32' ' ' THR . 11.8 tp -48.62 115.41 1.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.672 2.789 . . . . 0.0 111.139 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -103.65 117.79 59.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.944 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.27 144.4 82.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.197 2.598 . . . . 0.0 112.782 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.49 155.51 44.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.831 0.852 . . . . 0.0 111.84 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' B' ' 29' ' ' PHE . 6.0 tp -160.37 147.65 16.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.183 1.793 . . . . 0.0 112.2 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.23 -151.53 21.87 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 120.789 1.631 . . . . 0.0 111.051 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.4 mp -141.15 137.95 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.855 0.862 . . . . 0.0 113.176 -174.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -121.0 141.1 51.05 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.098 -1.001 . . . . 0.0 110.706 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.81 -50.33 72.74 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.21 -0.931 . . . . 0.0 111.617 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 41.68 16.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 127.504 2.322 . . . . 0.0 116.907 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . 0.255 6.7 ptp180 -93.67 -46.19 7.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.948 2.499 . . . . 0.0 115.095 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 -175.33 4.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.318 1.011 . . . . 0.0 112.802 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -33.1 29.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.384 1.074 . . . . 0.0 111.45 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.03 57.51 30.59 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 124.849 1.26 . . . . 0.0 111.005 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.58 163.34 38.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.366 2.711 . . . . 0.0 117.078 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p -81.79 168.58 17.87 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.616 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -159.92 161.97 34.4 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.783 -1.198 . . . . 0.0 113.134 174.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.81 139.28 5.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 118.83 -1.652 . . . . 0.0 117.065 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -163.43 151.86 13.79 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.57 150.89 23.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.513 1.925 . . . . 0.0 110.771 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -127.85 117.75 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.557 ' HB2' HG21 ' C' ' 52' ' ' ILE . 42.4 t30 -97.63 104.24 16.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.254 0.622 . . . . 0.0 112.264 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.254 32.6 m95 -74.04 147.24 43.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -109.91 -46.05 3.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.461 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.89 -11.28 59.61 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -152.51 133.35 14.03 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.964 2.505 . . . . 0.0 106.055 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.46 118.58 15.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.028 1.285 . . . . 0.0 110.617 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -178.74 166.72 1.71 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.978 1.711 . . . . 0.0 110.952 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -144.38 144.79 31.59 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.273 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -140.53 132.95 28.46 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 110.341 -3.118 . . . . 0.0 110.043 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.05 143.33 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.04 143.85 44.55 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.719 0.637 . . . . 0.0 109.478 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.29 116.85 9.17 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HE ' ' C' ' 100' ' ' ARG . . . -152.0 -176.65 24.92 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.337 -1.411 . . . . 0.0 115.222 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -122.85 148.01 45.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.807 1.534 . . . . 0.0 110.426 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.656 ' HG ' ' HB2' ' B' ' 4' ' ' CYS . 5.1 t -97.04 124.54 41.06 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.255 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' C' ' 106' ' ' ILE . 7.9 m-85 -116.09 164.57 14.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.6 mt -131.75 107.91 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -59.29 154.74 15.85 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -35.11 -41.17 0.14 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -11.91 59.88 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.34 52.63 3.34 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 122.199 0.888 . . . . 0.0 111.863 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.16 148.18 45.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 129.135 2.974 . . . . 0.0 105.023 173.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -114.13 150.81 33.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.362 1.465 . . . . 0.0 110.326 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.506 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.5 t -150.77 159.93 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.439 1.095 . . . . 0.0 110.398 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.41 HD21 ' CH2' ' B' ' 10' ' ' TRP . 7.1 mt -121.9 108.6 13.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 172.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.508 ' CE ' HD11 ' C' ' 106' ' ' ILE . 2.6 mmtt -101.46 117.64 35.34 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 172.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.575 HG22 ' HE1' ' B' ' 64' ' ' PHE . 9.2 p -130.0 162.67 28.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.303 1.525 . . . . 0.0 112.463 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.405 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -111.22 163.03 14.35 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 170.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -137.04 161.42 36.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.075 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.59 121.6 10.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.303 -1.771 . . . . 0.0 113.203 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.485 ' N ' HD23 ' B' ' 98' ' ' LEU . 0.3 OUTLIER -107.69 142.34 37.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.947 1.356 . . . . 0.0 112.258 -175.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.437 ' HE ' ' HA2' ' C' ' 81' ' ' GLY . 4.0 tpt85 -128.0 113.98 16.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 111.504 -2.589 . . . . 0.0 112.28 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.23 165.61 24.07 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 125.147 1.53 . . . . 0.0 110.19 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.9 t -113.69 77.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -66.28 177.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -100.83 -22.45 14.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.88 148.72 43.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 123.047 1.404 . . . . 0.0 112.648 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' C' ' 84' ' ' PHE . 18.0 tt -62.24 -27.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.267 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.92 8.49 22.29 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.135 0.874 . . . . 0.0 113.782 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -120.89 -0.46 10.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.39 1.076 . . . . 0.0 112.535 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -31.78 69.86 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 120.785 -1.197 . . . . 0.0 113.466 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 66.0 p-90 -50.25 -46.56 54.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.628 1.571 . . . . 0.0 112.406 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.13 -10.39 39.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.045 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.03 2.03 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.575 -0.703 . . . . 0.0 111.845 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.77 ' CG2' HD21 ' B' ' 98' ' ' LEU . 21.5 m -116.45 139.13 50.78 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.948 0.899 . . . . 0.0 113.158 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.27 116.15 13.17 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.589 2.356 . . . . 0.0 111.163 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.7 152.69 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.699 1.136 . . . . 0.0 110.235 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.19 -174.39 32.02 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.787 -0.831 . . . . 0.0 112.133 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -147.32 150.7 35.26 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.697 1.199 . . . . 0.0 109.571 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.42 HD13 ' HE3' ' B' ' 94' ' ' LYS . 12.4 mt -135.24 119.8 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -110.39 152.11 26.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.171 0.92 . . . . 0.0 109.535 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -136.67 165.79 25.08 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -56.87 136.14 55.77 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.786 -1.196 . . . . 0.0 113.179 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.53 HD23 ' H ' ' B' ' 124' ' ' ARG . 0.4 OUTLIER -102.74 131.28 49.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.53 ' H ' HD23 ' B' ' 123' ' ' LEU . 0.1 OUTLIER 71.34 179.59 0.24 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 129.607 3.163 . . . . 0.0 109.919 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m 98.04 160.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 128.499 2.72 . . . . 0.0 109.952 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 55.23 0.44 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.895 1.678 . . . . 0.0 110.213 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' B' ' 127' ' ' LYS . 4.1 mmpt? -141.75 18.97 2.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.582 2.353 . . . . 0.0 113.403 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.253 1.262 0 O-C-N 125.208 1.567 . . . . 0.0 108.791 173.354 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 117.203 -1.38 . . . . 0.0 107.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 44.6 m -109.01 118.34 36.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.452 1.023 . . . . 0.0 108.822 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 21.2 t -137.62 110.26 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.92 0.888 . . . . 0.0 108.869 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.02 -32.75 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . 0.342 3.7 ptp180 35.56 54.18 0.84 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.521 2.328 . . . . 0.0 116.045 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.78 132.44 19.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.372 1.069 . . . . 0.0 111.892 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' CYS . . . . . 0.596 ' HB2' ' HG ' ' C' ' 83' ' ' CYS . 25.1 p -143.09 125.95 16.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.726 0.81 . . . . 0.0 109.503 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -139.56 129.39 24.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.232 -1.543 . . . . 0.0 114.503 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' C' ' 64' ' ' PHE . 20.2 mt -56.38 -29.75 61.84 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -56.89 121.62 10.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 123.324 1.535 . . . . 0.0 111.643 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.13 -112.02 1.23 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.424 1.964 . . . . 0.0 110.582 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -149.12 147.73 28.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.744 0.818 . . . . 0.0 113.142 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' TRP . . . . . 0.413 ' CH2' HD21 ' C' ' 93' ' ' LEU . 39.3 m95 -141.86 162.51 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.293 1.437 . . . . 0.0 110.474 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -140.76 150.76 43.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ASN . . . . . 0.419 HD22 ' HB3' ' C' ' 118' ' ' ASN . 9.8 t-20 -115.02 146.42 41.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.103 0.961 . . . . 0.0 112.669 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.89 -21.31 63.2 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.69 -16.21 61.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.297 1.439 . . . . 0.0 112.19 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.45 -13.58 27.92 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.869 2.652 . . . . 0.0 113.984 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.88 149.17 50.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.688 1.244 . . . . 0.0 112.981 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' C' ' 34' ' ' ILE . 5.9 p30 -122.05 142.75 50.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.688 0.795 . . . . 0.0 110.754 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -131.4 139.51 49.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.447 0.641 . . . . 0.0 112.202 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -126.93 132.76 50.79 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.93 123.22 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -77.14 0.43 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.148 0.905 . . . . 0.0 111.908 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.82 157.44 42.93 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.77 0.795 . . . . 0.0 112.176 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 t -101.77 125.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.815 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -69.83 156.58 38.83 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -55.89 -21.69 21.58 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -70.38 -36.11 73.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.251 0.62 . . . . 0.0 111.337 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.04 -0.98 21.16 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 124.614 1.102 . . . . 0.0 112.899 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.67 149.74 43.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.696 0.799 . . . . 0.0 110.73 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PHE . . . . . 0.599 ' O ' HD12 ' C' ' 50' ' ' LEU . 27.9 p90 -156.21 163.74 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.835 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.468 HG22 HD13 ' C' ' 50' ' ' LEU . 4.7 p -125.76 168.38 13.87 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.99 -166.86 34.03 Favored Glycine 0 N--CA 1.465 0.633 0 O-C-N 120.073 -1.642 . . . . 0.0 113.212 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.605 ' HB ' HD11 ' C' ' 46' ' ' LEU . 1.2 p -140.64 132.24 27.14 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 123.024 1.393 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -117.04 138.5 51.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.872 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.538 HG12 HD12 ' C' ' 46' ' ' LEU . 7.5 mt -129.36 131.16 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.561 ' O ' HG21 ' C' ' 44' ' ' ILE . 5.8 m -109.53 134.93 51.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.322 -173.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.63 -17.39 22.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.23 141.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.7 1.2 . . . . 0.0 112.099 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.66 154.51 41.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.39 -24.47 65.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -148.0 76.59 10.41 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 128.573 2.749 . . . . 0.0 111.965 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.11 169.39 19.48 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.231 2.62 . . . . 0.0 112.411 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.86 -29.33 1.56 Allowed Glycine 0 N--CA 1.474 1.206 0 C-N-CA 124.57 1.081 . . . . 0.0 113.138 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 2.93 3.32 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 117.656 -1.164 . . . . 0.0 113.529 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.561 HG21 ' O ' ' C' ' 35' ' ' THR . 52.4 mt -32.3 113.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.075 1.75 . . . . 0.0 114.311 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.03 158.1 41.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.72 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' C' ' 32' ' ' THR . 11.9 tp -47.56 115.42 1.13 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.764 2.826 . . . . 0.0 111.132 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.2 117.23 60.79 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.998 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.13 142.92 85.92 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.877 2.385 . . . . 0.0 112.269 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.418 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -128.66 163.62 24.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.865 0.866 . . . . 0.0 112.311 175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.599 HD12 ' O ' ' C' ' 29' ' ' PHE . 27.4 tp -169.26 148.93 4.02 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 113.936 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.63 -151.07 21.78 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 120.928 1.695 . . . . 0.0 111.414 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.8 mp -142.39 135.47 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.806 0.843 . . . . 0.0 111.543 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -119.73 140.68 50.32 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.765 1.226 . . . . 0.0 109.921 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.0 -50.34 72.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.487 -0.758 . . . . 0.0 111.388 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.68 15.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.64 2.376 . . . . 0.0 116.456 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.67 -45.83 7.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.281 2.633 . . . . 0.0 114.895 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -173.97 3.53 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 124.434 1.084 . . . . 0.0 112.765 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 48.4 t -81.02 -37.9 28.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.062 . . . . 0.0 111.027 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.28 58.47 30.77 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 125.111 1.364 . . . . 0.0 111.392 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.68 163.1 40.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.771 2.981 . . . . 0.0 116.953 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -81.5 167.9 18.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.636 1.574 . . . . 0.0 111.657 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.28 161.81 35.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.662 -1.274 . . . . 0.0 113.064 174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.49 139.21 5.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 118.78 -1.676 . . . . 0.0 116.608 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -162.73 153.72 17.27 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -89.73 151.72 21.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.616 2.366 . . . . 0.0 110.49 174.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 t -129.38 118.42 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' B' ' 52' ' ' ILE . 43.3 t30 -98.53 104.89 16.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 111.976 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' TRP . . . . . 0.411 ' HE1' ' HG1' ' C' ' 77' ' ' THR . 32.9 m95 -74.33 147.05 42.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.47 -45.98 3.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.337 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -80.51 -11.3 59.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.2 t -152.56 133.22 13.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.915 2.486 . . . . 0.0 105.961 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.04 118.49 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.802 1.183 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.83 166.48 1.66 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.916 1.686 . . . . 0.0 111.085 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -144.02 144.8 31.82 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.102 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.411 ' HG1' ' HE1' ' C' ' 70' ' ' TRP . 1.2 m -140.4 132.89 28.58 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 109.971 -3.286 . . . . 0.0 109.972 -172.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 144.93 19.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -116.64 144.36 44.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.9 117.16 8.99 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HE ' ' B' ' 100' ' ' ARG . . . -151.78 -176.44 24.52 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 119.48 -1.343 . . . . 0.0 115.155 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -123.15 147.51 46.73 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 125.795 1.527 . . . . 0.0 110.527 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.596 ' HG ' ' HB2' ' C' ' 4' ' ' CYS . 5.4 t -97.09 123.64 40.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.027 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' B' ' 106' ' ' ILE . 4.6 m-85 -116.51 164.65 14.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.09 111.55 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -60.89 154.75 21.38 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -34.7 -41.61 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.334 1.854 . . . . 0.0 115.849 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -13.88 60.96 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.55 46.26 4.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.478 1.037 . . . . 0.0 113.097 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.48 151.56 34.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.521 2.728 . . . . 0.0 106.172 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -115.25 150.05 36.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.865 1.666 . . . . 0.0 110.987 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.504 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -149.88 158.95 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.233 1.413 . . . . 0.0 110.762 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' LEU . . . . . 0.413 HD21 ' CH2' ' C' ' 10' ' ' TRP . 7.3 mt -121.67 109.91 15.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.682 -2.711 . . . . 0.0 103.682 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.504 ' CD ' HG11 ' C' ' 92' ' ' VAL . 2.9 mmtt -102.35 116.69 33.16 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.598 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.6 p -129.08 163.13 26.13 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.429 1.585 . . . . 0.0 112.741 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.413 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.5 162.88 14.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -136.96 161.6 35.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.952 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -146.85 121.65 9.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.142 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' LEU . . . . . 0.476 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 142.05 38.08 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.706 1.241 . . . . 0.0 112.319 -176.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.436 ' HE ' ' HA2' ' B' ' 81' ' ' GLY . 4.3 tpt85 -127.54 113.99 16.85 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 111.762 -2.472 . . . . 0.0 112.364 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.255 0.4 OUTLIER -71.79 165.96 23.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.583 173.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -114.22 79.53 1.27 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.53 177.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.59 -0.694 . . . . 0.0 110.52 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.43 -22.79 15.37 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.6 150.01 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.116 1.436 . . . . 0.0 113.134 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' B' ' 84' ' ' PHE . 17.5 tt -61.92 -27.25 41.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.145 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.17 9.06 28.21 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.256 0.932 . . . . 0.0 113.738 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -119.49 -1.39 10.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.48 1.112 . . . . 0.0 111.852 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.78 -31.58 70.94 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.385 -1.447 . . . . 0.0 113.142 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -50.44 -45.81 56.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.694 1.597 . . . . 0.0 112.523 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.86 -10.36 36.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.367 1.067 . . . . 0.0 113.026 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.41 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.779 -0.576 . . . . 0.0 111.851 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' C' ' 98' ' ' LEU . 22.2 m -116.93 139.56 50.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.887 0.875 . . . . 0.0 113.089 175.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -136.44 116.18 13.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.624 2.37 . . . . 0.0 111.3 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -99.7 152.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.832 1.196 . . . . 0.0 110.239 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.43 -174.18 32.02 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -127.28 155.33 43.68 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.703 -0.881 . . . . 0.0 112.227 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' ASN . . . . . 0.419 ' HB3' HD22 ' C' ' 12' ' ' ASN . 13.7 m-20 -147.62 151.23 35.86 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.505 1.122 . . . . 0.0 109.702 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' ILE . . . . . 0.431 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.5 mt -135.61 118.98 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -109.99 151.08 27.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.527 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.9 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.3 127.71 33.51 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.079 -1.013 . . . . 0.0 111.228 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -73.71 135.62 43.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -41.95 118.14 1.07 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.643 1.977 . . . . 0.0 112.029 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 6.4 t -149.85 -53.0 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.763 -1.21 . . . . 0.0 112.552 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.8 153.18 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.439 2.296 . . . . 0.0 106.712 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 73.67 172.68 0.29 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.426 1.49 . . . . 0.0 108.482 -173.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.344 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.2 m -77.3 169.73 17.81 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.756 1.222 . . . . 0.0 110.522 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.71 147.72 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 110.023 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -117.79 -61.4 1.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.786 0.834 . . . . 0.0 111.745 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 54.11 40.5 31.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.02 1.328 . . . . 0.0 113.889 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -149.19 113.84 5.34 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.939 1.296 . . . . 0.0 112.645 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 130.21 56.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -139.64 130.1 25.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 110.876 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.62 -27.99 61.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -65.02 110.93 2.65 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.22 5.25 0.23 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 118.738 2.255 . . . . 0.0 118.738 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt 68.86 143.92 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.733 2.413 . . . . 0.0 115.642 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -139.14 159.25 42.59 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.278 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -138.45 147.06 42.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.699 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 118' ' ' ASN . 39.6 t-20 -111.47 145.63 38.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.726 0.81 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.06 -25.02 57.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.453 1.501 . . . . 0.0 113.944 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.08 -16.39 61.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.344 1.858 . . . . 0.0 111.838 174.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.27 -9.69 28.84 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.443 2.449 . . . . 0.0 114.28 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -64.46 144.97 56.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.009 1.404 . . . . 0.0 112.121 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -122.97 134.05 54.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -128.12 136.59 51.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.911 0.862 . . . . 0.0 111.671 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -126.97 130.31 49.83 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.846 0.831 . . . . 0.0 109.252 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.59 131.02 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.72 -103.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.807 0 O-C-N 125.692 1.87 . . . . 0.0 110.569 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.48 138.58 52.35 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.596 0.758 . . . . 0.0 111.127 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.88 133.47 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.95 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -69.73 158.06 36.12 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.8 m -54.36 -29.02 46.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -67.68 -33.82 75.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.894 0.77 . . . . 0.0 111.323 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.73 -7.55 22.08 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.624 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.76 151.63 45.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.097 1.448 . . . . 0.0 108.415 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -152.0 161.59 42.41 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.286 175.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.53 163.82 20.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.368 -1.742 . . . . 0.0 107.121 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.97 -168.13 35.17 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.508 1.06 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -138.19 146.15 42.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 112.776 -1.712 . . . . 0.0 111.746 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -126.06 141.02 52.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.347 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 46' ' ' LEU . 4.4 mp -126.33 145.54 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 44' ' ' ILE . 3.2 m -121.54 139.35 53.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 112.387 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.64 -15.14 17.86 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 27.2 m -135.48 140.37 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.709 1.203 . . . . 0.0 111.079 -176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.28 169.39 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.727 -1.233 . . . . 0.0 112.027 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' HH12 ' A' ' 114' ' ' ARG . 25.7 m-20 -70.65 -43.27 69.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 173.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -128.41 84.34 63.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.529 2.332 . . . . 0.0 107.588 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.76 36.96 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.262 3.308 . . . . 0.0 114.731 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.95 -3.31 90.64 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 119.845 -1.784 . . . . 0.0 115.999 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 -3.33 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.92 1.36 . . . . 0.0 114.342 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 35' ' ' THR . 28.1 mt -20.03 108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 164.87 24.87 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.019 1.727 . . . . 0.0 109.513 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 34' ' ' ILE . 4.5 tt -50.74 136.85 21.24 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.643 1.977 . . . . 0.0 114.025 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -119.95 125.94 27.12 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 113.176 -1.829 . . . . 0.0 111.937 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.29 141.99 98.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.596 2.198 . . . . 0.0 111.715 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 142.74 50.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.619 1.199 . . . . 0.0 109.701 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.25 149.24 34.54 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.093 2.557 . . . . 0.0 109.073 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.03 -156.22 27.72 Favored Glycine 0 N--CA 1.452 -0.259 0 O-C-N 120.128 -1.608 . . . . 0.0 109.857 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.5 mt -146.96 146.86 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.244 1.017 . . . . 0.0 111.527 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.48 153.59 43.33 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.343 1.457 . . . . 0.0 112.537 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.5 153.52 40.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.195 -1.566 . . . . 0.0 112.28 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -139.53 20.8 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -93.42 -57.8 2.48 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.271 1.029 . . . . 0.0 112.944 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.79 20.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.185 0.594 . . . . 0.0 112.323 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -81.57 -20.28 40.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 45.28 0.78 Allowed Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.984 1.314 . . . . 0.0 113.253 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.38 -176.76 3.1 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.222 3.281 . . . . 0.0 115.568 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.289 2.8 t -97.02 164.33 12.57 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.884 1.326 . . . . 0.0 112.931 174.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -158.54 168.95 25.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.633 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.04 151.85 21.03 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 120.516 2.967 . . . . 0.0 120.516 -172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -163.52 153.73 15.55 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -92.67 149.88 21.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.601 1.561 . . . . 0.0 108.839 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.87 127.82 68.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' D' ' 52' ' ' ILE . 25.7 t-20 -104.32 110.53 22.79 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.434 -0.792 . . . . 0.0 110.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.676 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 91.5 m95 -75.91 129.9 37.65 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.587 1.184 . . . . 0.0 112.329 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -90.93 -38.08 13.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.261 -1.336 . . . . 0.0 114.506 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -83.77 -19.7 34.62 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 117.28 5.09 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.28 118.94 6.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.959 1.254 . . . . 0.0 111.711 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -175.64 167.42 3.19 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 126.644 1.978 . . . . 0.0 110.42 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 t -139.79 141.77 36.74 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.676 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 2.4 m -141.09 122.97 15.39 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.902 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.04 156.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.386 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -132.41 141.87 49.04 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 121.43 9.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -171.57 173.52 44.95 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 34.4 tt0 -106.71 144.47 33.32 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.429 0.723 . . . . 0.0 111.508 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.0 p -97.65 121.48 39.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.503 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.8 m-85 -114.1 170.59 8.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.491 1.139 . . . . 0.0 111.665 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 65.9 mt -127.09 116.58 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -58.78 156.03 11.88 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -17.57 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -82.68 -12.9 57.26 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.94 5.67 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.831 1.205 . . . . 0.0 112.796 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -117.09 152.0 35.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.497 174.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -103.13 146.54 28.25 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.847 1.259 . . . . 0.0 110.207 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.47 HG21 ' CD1' ' D' ' 106' ' ' ILE . 27.7 m -147.75 164.68 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.052 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.92 118.38 26.15 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.7 mmmt -107.09 113.39 26.81 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.455 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 3.0 p -131.21 172.5 12.06 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.365 1.555 . . . . 0.0 111.346 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.8 mmm -127.8 170.3 12.92 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.706 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -139.76 164.0 31.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.749 1.261 . . . . 0.0 112.208 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -141.72 121.67 13.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.326 174.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 138.3 43.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 124.193 1.949 . . . . 0.0 109.934 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.63 114.14 18.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 109.652 -3.431 . . . . 0.0 110.057 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -72.61 167.73 20.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.424 1.702 . . . . 0.0 112.207 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -114.97 87.96 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.05 -170.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.767 1.227 . . . . 0.0 108.428 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -121.61 -28.28 4.59 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.85 -1.156 . . . . 0.0 113.814 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.9 144.96 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.573 1.178 . . . . 0.0 110.986 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' D' ' 94' ' ' LYS . 14.3 tt -61.63 -20.69 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.144 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.86 2.95 47.39 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.387 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.45 7.51 8.34 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.567 1.184 . . . . 0.0 112.9 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.62 -36.07 75.6 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.517 -1.989 . . . . 0.0 111.463 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 58.9 p-90 -48.22 -45.67 34.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.487 1.115 . . . . 0.0 113.401 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.59 -12.47 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.656 1.183 . . . . 0.0 113.576 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.96 1.69 22.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' D' ' 96' ' ' MET . 27.0 m -111.66 140.26 46.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.966 0.906 . . . . 0.0 111.499 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.443 HH12 ' CG ' ' A' ' 39' ' ' ASP . 7.6 mtt180 -144.3 130.25 19.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.958 1.303 . . . . 0.0 111.433 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.41 151.45 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 121.038 1.745 . . . . 0.0 110.98 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.97 179.53 27.59 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -120.15 151.56 38.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.121 0.968 . . . . 0.0 110.706 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.427 ' CG ' HD21 ' A' ' 12' ' ' ASN . 6.3 m-20 -149.78 149.52 30.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.233 1.016 . . . . 0.0 110.777 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.9 mt -130.4 133.74 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.08 -1.012 . . . . 0.0 108.289 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -123.92 149.02 46.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.94 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.8 p -132.66 159.76 38.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.71 1.204 . . . . 0.0 110.866 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.24 125.58 24.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 111.122 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.24 113.35 19.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.24 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 58.47 83.43 0.12 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.483 1.113 . . . . 0.0 113.889 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.7 p -46.92 115.94 1.21 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.463 1.105 . . . . 0.0 112.008 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -91.67 -2.58 56.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.779 1.632 . . . . 0.0 112.799 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -119.95 137.59 53.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--O 1.247 0.963 0 C-N-CA 128.299 2.64 . . . . 0.0 107.722 174.711 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 117.566 -1.207 . . . . 0.0 107.864 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 7.0 m 65.68 148.66 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.944 1.698 . . . . 0.0 115.368 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 19.6 m -141.43 -174.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 119.88 -1.763 . . . . 0.0 111.959 -174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . 53.91 31.84 14.1 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.365 2.357 . . . . 0.0 117.365 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -52.31 128.28 24.77 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.978 2.511 . . . . 0.0 113.602 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -156.1 135.32 12.16 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.285 1.834 . . . . 0.0 112.482 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -149.16 136.5 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.992 1.269 . . . . 0.0 111.632 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 31.3 p -139.45 133.56 31.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.169 2.187 . . . . 0.0 111.549 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.72 -26.42 60.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -65.4 112.1 3.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -4.96 0.36 Allowed Glycine 0 N--CA 1.476 1.316 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 74.68 144.05 0.08 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.418 2.287 . . . . 0.0 114.007 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -139.41 162.16 35.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.134 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -142.49 148.8 38.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.09 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' ASN . . . . . 0.412 HD21 ' CG ' ' D' ' 118' ' ' ASN . 38.2 t-20 -113.43 146.08 40.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.977 0.911 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -56.92 -25.39 57.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.967 1.307 . . . . 0.0 113.921 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.19 -15.62 61.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.362 1.865 . . . . 0.0 112.134 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.84 -8.37 31.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 127.304 2.383 . . . . 0.0 114.294 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -64.56 143.97 57.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.14 1.47 . . . . 0.0 112.512 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -121.4 132.07 54.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.901 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -126.74 137.67 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 111.969 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.6 m -128.75 130.39 47.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.244 1.021 . . . . 0.0 109.786 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.26 130.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.4 -97.09 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 125.825 1.953 . . . . 0.0 111.146 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.41 138.16 46.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 110.959 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.07 134.03 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.008 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -69.75 157.84 36.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.499 0.72 . . . . 0.0 111.793 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 64.4 m -54.51 -28.75 47.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -67.81 -32.87 73.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.794 0.724 . . . . 0.0 111.369 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.23 -6.07 23.34 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 124.777 1.179 . . . . 0.0 112.715 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.16 156.99 38.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.456 1.128 . . . . 0.0 110.541 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.59 166.53 33.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 123.186 1.47 . . . . 0.0 110.891 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -129.75 164.72 23.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 112.0 -2.364 . . . . 0.0 105.905 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.13 -167.1 35.05 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 75.1 p -139.23 146.74 40.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.186 -1.507 . . . . 0.0 112.134 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -126.87 141.14 51.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.179 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.569 HD11 HD12 ' D' ' 46' ' ' LEU . 4.4 mp -125.89 144.77 34.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.471 ' O ' HG21 ' D' ' 44' ' ' ILE . 3.7 m -120.85 138.84 53.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.055 0.942 . . . . 0.0 112.522 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.76 -15.98 18.28 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.406 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 27.3 m -134.81 140.81 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.577 1.151 . . . . 0.0 111.337 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.66 169.06 23.65 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 120.477 -1.389 . . . . 0.0 111.905 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' D' ' 114' ' ' ARG . 31.2 m-20 -70.29 -43.26 70.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.059 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -128.4 83.93 64.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.522 2.329 . . . . 0.0 107.69 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.9 37.44 0.29 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.323 3.348 . . . . 0.0 114.684 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.5 -2.83 90.66 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 119.893 -1.754 . . . . 0.0 116.063 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.828 1.314 . . . . 0.0 114.401 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.471 HG21 ' O ' ' D' ' 35' ' ' THR . 29.3 mt -19.53 107.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 164.35 25.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.994 1.717 . . . . 0.0 109.494 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.569 HD12 HD11 ' D' ' 34' ' ' ILE . 4.4 tt -49.99 136.19 19.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.664 1.986 . . . . 0.0 113.95 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -119.3 125.96 27.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 113.21 -1.813 . . . . 0.0 111.991 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.21 140.67 95.89 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.229 1.953 . . . . 0.0 111.269 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.45 149.78 41.84 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 124.892 1.37 . . . . 0.0 109.359 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -154.87 149.34 26.27 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.074 2.15 . . . . 0.0 108.869 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.94 -154.2 25.33 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 120.898 -1.126 . . . . 0.0 111.347 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.3 mt -146.92 146.02 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.286 1.035 . . . . 0.0 112.033 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.79 153.81 41.9 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.457 1.503 . . . . 0.0 112.325 174.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -73.17 159.17 33.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 119.954 -1.716 . . . . 0.0 112.344 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -145.46 21.75 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -93.46 -58.07 2.4 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.039 0.936 . . . . 0.0 112.453 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.47 169.81 16.69 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.962 0.789 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 26.1 m -90.41 -13.77 34.27 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -136.22 39.75 0.46 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.724 1.209 . . . . 0.0 113.768 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.76 -176.99 3.57 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.792 2.328 . . . . 0.0 114.359 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.305 2.5 t -97.06 164.36 12.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.742 1.258 . . . . 0.0 112.074 174.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.57 168.35 27.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.391 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 151.61 20.51 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 120.742 3.057 . . . . 0.0 120.742 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -163.49 152.78 14.63 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -90.84 150.79 21.41 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.932 1.693 . . . . 0.0 108.776 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.09 128.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.607 ' HB2' HG21 ' A' ' 52' ' ' ILE . 25.4 t-20 -105.44 110.26 22.53 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -75.74 129.82 37.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.823 1.297 . . . . 0.0 112.608 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -91.51 -37.63 13.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.944 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -83.79 -19.54 34.85 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -152.42 119.01 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.38 119.05 7.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.304 1.411 . . . . 0.0 111.758 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -175.29 166.43 3.38 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 126.531 1.933 . . . . 0.0 110.384 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 141.59 38.07 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.195 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -141.11 123.34 15.68 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 111.364 -2.653 . . . . 0.0 109.947 -172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.05 156.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.649 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.54 141.92 49.82 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.21 121.26 9.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -174.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -170.66 173.68 44.49 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 118.665 -1.731 . . . . 0.0 117.19 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 34.6 tt0 -106.63 144.51 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.99 0.9 . . . . 0.0 111.274 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 p -97.66 118.22 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.924 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.488 ' HB2' HD12 ' A' ' 106' ' ' ILE . 2.8 m-85 -112.27 170.56 8.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.901 0.858 . . . . 0.0 111.911 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 49.9 mt -128.97 114.81 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -58.61 155.85 11.75 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -29.62 2.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -72.07 -17.7 61.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.337 1.455 . . . . 0.0 113.833 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.89 54.38 2.64 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' D' ' 90' ' ' LYS . 0.2 OUTLIER -128.22 153.55 46.8 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 129.51 3.124 . . . . 0.0 108.794 173.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -109.54 146.96 33.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.523 1.154 . . . . 0.0 109.971 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 106' ' ' ILE . 23.3 m -148.44 164.03 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.34 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.29 118.36 25.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.616 ' HE2' HD11 ' A' ' 106' ' ' ILE . 3.8 mmmt -106.76 112.94 26.15 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 2.9 p -130.52 172.12 12.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.553 1.644 . . . . 0.0 111.155 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' A' ' 113' ' ' THR . 86.5 mmm -127.19 169.99 12.89 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.753 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -139.69 164.01 31.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.657 1.218 . . . . 0.0 111.913 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.418 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -142.09 122.3 13.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.212 174.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 139.46 41.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 124.105 1.907 . . . . 0.0 110.11 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.84 114.58 18.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 109.717 -3.402 . . . . 0.0 110.626 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -73.08 167.83 20.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 125.492 1.745 . . . . 0.0 112.429 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -114.7 83.71 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.46 -172.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.904 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -119.05 -30.22 5.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.529 -1.357 . . . . 0.0 112.411 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.06 143.92 43.98 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 111.564 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.583 HD11 ' HE2' ' A' ' 94' ' ' LYS . 14.0 tt -61.61 -22.27 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.666 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.39 1.16 51.98 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 117.635 -1.647 . . . . 0.0 114.445 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.08 7.46 9.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.841 1.321 . . . . 0.0 113.002 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.06 -36.18 74.61 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.696 -1.877 . . . . 0.0 111.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.412 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 58.5 p-90 -48.25 -46.03 35.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.377 1.071 . . . . 0.0 113.201 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -90.32 -12.65 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.441 1.096 . . . . 0.0 113.508 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.28 1.0 23.12 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' A' ' 96' ' ' MET . 24.2 m -111.12 140.85 45.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.231 1.012 . . . . 0.0 111.669 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' D' ' 39' ' ' ASP . 7.3 mtt180 -144.75 130.95 19.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.61 152.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.085 1.766 . . . . 0.0 110.966 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.29 28.79 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -120.13 150.8 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.026 0.93 . . . . 0.0 110.407 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 118' ' ' ASN . . . . . 0.412 ' CG ' HD21 ' D' ' 12' ' ' ASN . 5.6 m-20 -149.18 148.07 29.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.768 0.794 . . . . 0.0 110.357 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -128.46 133.71 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -123.22 147.45 46.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.559 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 46.9 p -129.81 156.75 43.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.757 1.223 . . . . 0.0 110.009 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -57.75 127.79 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.761 0.825 . . . . 0.0 110.496 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -77.17 85.99 3.63 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -179.21 -92.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.66 1.984 . . . . 0.0 110.184 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 21.4 m 75.9 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.312 2.245 . . . . 0.0 107.703 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' D' ' 128' ' ' GLU . 1.9 mt-30 -151.89 -77.36 0.13 Allowed 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 22.1 tptp 77.19 -26.15 0.19 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 127.708 2.403 . . . . 0.0 113.644 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' D' ' 126' ' ' GLN . 2.2 pm0 . . . . . 0 C--O 1.261 1.709 1 C-N-CA 133.133 4.573 . . . . 0.0 109.77 174.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 2.8 m 17.86 73.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 129.173 2.989 . . . . 0.0 117.76 174.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.12 97.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.944 -1.098 . . . . 0.0 112.014 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.38 97.17 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . 0.301 14.3 ptm180 44.67 72.41 0.2 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.192 2.597 . . . . 0.0 117.324 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -147.31 125.81 12.44 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.295 1.038 . . . . 0.0 112.763 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 44.4 t -139.31 133.9 31.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 109.421 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.2 p -139.56 131.72 28.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.748 2.019 . . . . 0.0 110.081 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.45 -25.72 60.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -65.68 111.6 3.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -5.38 0.37 Allowed Glycine 0 N--CA 1.478 1.472 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt 75.34 144.32 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.657 2.383 . . . . 0.0 114.037 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -140.55 162.39 35.46 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.849 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -141.11 149.96 42.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.688 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -112.03 146.26 38.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.618 0.767 . . . . 0.0 110.512 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -57.26 -23.81 50.66 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.499 1.52 . . . . 0.0 113.626 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 24.5 tp -74.52 -16.17 60.84 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.511 1.924 . . . . 0.0 111.932 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.5 -7.68 32.19 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 127.421 2.439 . . . . 0.0 114.272 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -64.41 144.39 57.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.278 1.539 . . . . 0.0 113.14 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -122.85 132.26 54.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.177 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -126.49 136.64 52.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.887 0.851 . . . . 0.0 111.739 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -126.69 130.56 50.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.601 0.715 . . . . 0.0 109.607 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.04 130.14 72.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.61 -98.16 0.09 OUTLIER Glycine 0 CA--C 1.527 0.829 0 O-C-N 125.559 1.787 . . . . 0.0 111.229 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.16 138.21 46.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.709 0.804 . . . . 0.0 110.984 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 p -92.35 133.47 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.018 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' B' ' 28' ' ' GLU . 20.4 m-20 -69.27 158.02 35.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.237 0.615 . . . . 0.0 111.344 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 63.9 m -54.4 -29.02 47.46 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -67.76 -33.9 75.76 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.801 . . . . 0.0 111.39 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.83 21.63 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.697 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' B' ' 24' ' ' ASN . 15.0 pt-20 -69.52 151.72 45.68 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.116 1.458 . . . . 0.0 108.426 174.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.411 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.0 OUTLIER -151.99 161.27 42.9 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.107 175.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.3 163.71 20.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.111 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.93 -168.34 35.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-O 122.741 1.19 . . . . 0.0 110.976 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -137.96 146.97 43.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.505 -1.847 . . . . 0.0 111.73 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -126.61 141.13 51.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.228 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.59 HD11 HD12 ' B' ' 46' ' ' LEU . 4.5 mp -126.18 144.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.457 ' O ' HG21 ' B' ' 44' ' ' ILE . 3.3 m -120.89 139.42 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.941 0.896 . . . . 0.0 112.645 -173.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.09 -16.21 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.412 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 27.7 m -134.96 140.65 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.612 1.165 . . . . 0.0 111.116 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.72 169.11 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.844 -1.16 . . . . 0.0 112.103 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' CG ' HH12 ' B' ' 114' ' ' ARG . 27.9 m-20 -70.19 -43.39 70.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.987 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -128.72 83.95 64.63 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.651 2.381 . . . . 0.0 107.66 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.71 37.48 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.263 3.308 . . . . 0.0 114.753 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.69 -2.98 90.72 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 119.839 -1.788 . . . . 0.0 116.041 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.07 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.457 HG21 ' O ' ' B' ' 35' ' ' THR . 29.5 mt -19.7 107.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.73 24.78 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.98 1.712 . . . . 0.0 109.54 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.59 HD12 HD11 ' B' ' 34' ' ' ILE . 5.0 tt -50.77 137.21 20.73 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 126.556 1.942 . . . . 0.0 113.929 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -120.15 126.24 26.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.094 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.26 141.84 98.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.679 2.253 . . . . 0.0 111.813 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.74 143.13 50.02 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 124.562 1.163 . . . . 0.0 109.614 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 149.25 34.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.978 2.511 . . . . 0.0 108.878 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.17 -155.95 27.39 Favored Glycine 0 N--CA 1.453 -0.222 0 O-C-N 120.337 -1.477 . . . . 0.0 109.853 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.623 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.5 mt -147.2 147.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.316 1.047 . . . . 0.0 111.618 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.62 154.0 42.94 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.048 1.339 . . . . 0.0 112.431 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -74.06 153.5 39.61 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.223 -1.548 . . . . 0.0 112.063 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -138.6 20.98 2.71 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -93.56 -57.07 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.791 0.836 . . . . 0.0 112.941 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 170.2 16.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.675 0.75 . . . . 0.0 112.972 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.8 m -80.77 -24.53 38.57 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.94 44.97 0.78 Allowed Pre-proline 0 CA--C 1.569 1.685 0 C-N-CA 125.319 1.448 . . . . 0.0 113.156 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.78 -176.23 3.07 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.201 2.6 . . . . 0.0 114.882 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.299 2.9 t -97.26 164.15 12.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.788 1.28 . . . . 0.0 112.508 174.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.56 168.61 26.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.893 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.44 151.53 20.32 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 120.825 3.09 . . . . 0.0 120.825 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -163.09 153.49 16.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -92.15 149.65 21.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.566 1.546 . . . . 0.0 108.849 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.61 128.18 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' C' ' 52' ' ' ILE . 25.8 t-20 -104.75 110.61 23.02 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.369 -0.832 . . . . 0.0 110.778 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -76.25 130.67 38.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 122.784 1.278 . . . . 0.0 112.645 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -92.41 -37.81 12.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.737 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -84.1 -19.49 34.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.5 117.32 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.96 118.93 6.84 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.897 1.226 . . . . 0.0 111.76 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -175.56 167.23 3.25 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 126.599 1.96 . . . . 0.0 110.27 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -139.38 142.14 37.55 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.249 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -141.15 123.32 15.63 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 111.462 -2.608 . . . . 0.0 109.588 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 m -99.17 156.53 3.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.512 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.29 141.85 49.14 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.55 121.34 9.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -169.66 172.52 43.68 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 118.628 -1.748 . . . . 0.0 116.947 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 34.9 tt0 -105.02 144.85 31.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.654 0.74 . . . . 0.0 111.224 -176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 p -97.56 122.89 41.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.106 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.469 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.98 169.61 9.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.963 0.887 . . . . 0.0 111.778 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -126.37 116.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.91 155.55 13.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -21.26 0.8 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 118.104 2.631 . . . . 0.0 118.104 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.43 -12.23 59.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 47.5 4.79 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.259 0.933 . . . . 0.0 112.416 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.69 150.81 42.22 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.257 2.223 . . . . 0.0 110.462 174.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -103.44 145.75 29.53 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.967 1.307 . . . . 0.0 110.228 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 27.1 m -147.83 164.19 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.865 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.98 118.29 25.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.596 ' HE2' HD11 ' C' ' 106' ' ' ILE . 3.8 mmmt -106.77 113.47 26.98 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.445 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 3.0 p -130.85 172.69 11.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.543 1.64 . . . . 0.0 111.161 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.65 ' HG3' HG21 ' C' ' 113' ' ' THR . 87.7 mmm -127.63 170.12 13.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.554 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -139.82 163.36 32.84 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.573 1.178 . . . . 0.0 111.752 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -141.13 122.02 14.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.19 174.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 138.38 43.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 124.356 2.027 . . . . 0.0 110.108 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.71 114.11 18.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 109.475 -3.511 . . . . 0.0 109.922 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -73.08 167.94 20.09 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 125.508 1.755 . . . . 0.0 112.125 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.4 t -114.87 87.87 2.74 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.04 -171.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.838 1.255 . . . . 0.0 108.243 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.05 -30.52 4.35 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.823 -1.173 . . . . 0.0 112.226 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -112.76 143.2 44.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.255 1.026 . . . . 0.0 111.76 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.587 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.2 tt -60.37 -22.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.08 -0.963 . . . . 0.0 113.161 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.61 54.48 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 117.701 -1.611 . . . . 0.0 114.55 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.67 7.2 9.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.922 1.289 . . . . 0.0 113.118 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.68 -36.11 73.68 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 119.76 -1.837 . . . . 0.0 111.296 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.406 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 58.7 p-90 -48.27 -45.92 35.2 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.429 1.092 . . . . 0.0 113.479 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.36 -12.32 37.98 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.463 1.105 . . . . 0.0 113.345 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.61 1.1 23.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.656 HG21 ' HG3' ' C' ' 96' ' ' MET . 25.4 m -110.86 140.35 45.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.297 1.039 . . . . 0.0 111.938 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.438 HH12 ' CG ' ' B' ' 39' ' ' ASP . 7.5 mtt180 -144.6 130.7 19.47 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.658 1.183 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.39 152.25 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 121.111 1.778 . . . . 0.0 111.209 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.35 179.49 27.95 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -120.48 150.61 40.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.241 1.017 . . . . 0.0 110.344 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.41 148.27 29.26 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.033 0.921 . . . . 0.0 110.41 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 62.7 mt -129.58 133.31 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -122.88 148.01 45.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.985 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.7 p -131.28 159.15 38.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.768 1.227 . . . . 0.0 110.432 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 5.0 mmt-85 -59.14 134.52 57.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.731 0.812 . . . . 0.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 125.15 26.82 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.659 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 77.97 134.28 0.06 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.218 1.807 . . . . 0.0 111.228 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 14.2 m -57.41 109.0 0.61 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.019 0.928 . . . . 0.0 110.285 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -83.08 110.67 18.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.256 -0.903 . . . . 0.0 108.689 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 mttp 87.97 120.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.95 2.5 . . . . 0.0 109.528 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 127.602 2.361 . . . . 0.0 108.842 178.189 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.2 m 61.44 172.62 0.11 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.896 0.879 . . . . 0.0 111.177 -173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 6.4 p -169.56 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.315 1.446 . . . . 0.0 110.63 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -69.19 147.46 51.29 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.46 95.02 2.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.555 0.742 . . . . 0.0 112.09 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -154.76 125.89 7.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.059 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -141.58 135.92 30.54 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.921 1.237 . . . . 0.0 110.777 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 22.4 p -139.48 131.68 28.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.536 1.935 . . . . 0.0 110.844 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -73.54 -24.76 60.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -67.58 112.33 4.67 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.58 -3.22 0.43 Allowed Glycine 0 N--CA 1.481 1.636 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt 74.05 144.5 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.908 2.483 . . . . 0.0 114.446 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -139.54 162.55 34.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.121 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.81 147.38 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.449 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -110.68 145.92 37.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.826 0.85 . . . . 0.0 110.348 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -57.46 -23.39 49.54 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.627 1.571 . . . . 0.0 113.69 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.6 tp -75.04 -16.37 60.59 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.613 1.965 . . . . 0.0 111.895 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.07 -7.86 31.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 127.417 2.436 . . . . 0.0 114.364 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -65.1 145.25 56.54 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.285 1.543 . . . . 0.0 112.656 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -123.84 132.01 53.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.143 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -125.93 137.9 53.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 111.738 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 33.9 m -128.39 129.84 46.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.721 0.772 . . . . 0.0 109.438 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.9 129.73 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.76 -96.59 0.1 OUTLIER Glycine 0 CA--C 1.527 0.786 0 O-C-N 125.638 1.836 . . . . 0.0 111.179 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.92 45.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.758 0.823 . . . . 0.0 110.962 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.97 133.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.011 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -69.49 157.91 36.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.543 0.737 . . . . 0.0 111.831 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 64.3 m -54.58 -28.89 49.42 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -67.78 -32.88 73.77 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.834 0.743 . . . . 0.0 111.303 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.17 -6.06 23.44 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 124.761 1.172 . . . . 0.0 112.763 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.04 157.09 38.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.434 1.112 . . . . 0.0 110.426 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.6 166.55 33.01 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.95 1.357 . . . . 0.0 110.872 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -129.74 165.04 22.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 112.164 -2.289 . . . . 0.0 105.84 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.44 -167.03 35.11 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 122.448 1.027 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.404 ' HB ' HD11 ' C' ' 46' ' ' LEU . 70.2 p -139.01 147.36 42.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.972 -1.614 . . . . 0.0 112.187 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -127.48 141.26 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.587 HD11 HD12 ' C' ' 46' ' ' LEU . 4.3 mp -125.94 145.65 33.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.463 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -122.11 138.95 54.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.144 -173.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -13.45 18.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 27.7 m -136.63 140.16 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.672 1.189 . . . . 0.0 111.429 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.12 169.56 22.11 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.575 -1.328 . . . . 0.0 112.192 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ASP . . . . . 0.447 ' CG ' HH12 ' C' ' 114' ' ' ARG . 30.2 m-20 -70.93 -42.9 69.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.142 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -128.31 84.57 62.84 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.685 2.394 . . . . 0.0 107.506 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.84 36.52 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.168 3.245 . . . . 0.0 114.675 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.88 -3.01 90.58 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 119.909 -1.744 . . . . 0.0 115.99 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.11 -4.11 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.83 1.315 . . . . 0.0 114.47 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.463 HG21 ' O ' ' C' ' 35' ' ' THR . 29.2 mt -19.33 108.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.77 164.09 26.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.073 1.749 . . . . 0.0 109.593 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.587 HD12 HD11 ' C' ' 34' ' ' ILE . 4.4 tt -49.98 136.57 18.44 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.652 1.981 . . . . 0.0 113.943 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -120.07 126.11 27.0 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.18 140.06 93.14 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.636 2.224 . . . . 0.0 111.377 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.09 149.48 42.12 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 124.772 1.295 . . . . 0.0 109.64 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -154.79 149.44 26.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.98 2.112 . . . . 0.0 108.601 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.95 -154.05 25.21 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 119.163 0.892 . . . . 0.0 111.543 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.3 mt -147.16 145.95 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.317 1.047 . . . . 0.0 111.923 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.98 153.29 43.01 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.349 1.459 . . . . 0.0 112.321 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -72.77 157.92 36.57 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.94 -1.725 . . . . 0.0 112.298 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -143.88 21.14 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -93.52 -57.26 2.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.931 0.892 . . . . 0.0 112.364 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.18 169.03 17.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.611 0.764 . . . . 0.0 112.179 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -85.38 -19.81 30.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 40.35 0.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 125.085 1.354 . . . . 0.0 113.335 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.95 -177.06 3.63 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.857 2.371 . . . . 0.0 114.531 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.308 2.3 t -96.57 164.09 12.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.711 1.243 . . . . 0.0 112.121 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -158.44 168.25 27.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.653 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.58 151.46 20.14 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 120.61 3.004 . . . . 0.0 120.61 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.19 153.21 15.73 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -91.53 150.44 21.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.996 1.719 . . . . 0.0 108.804 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.49 128.7 68.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.623 ' HB2' HG21 ' B' ' 52' ' ' ILE . 25.1 t-20 -105.46 110.62 23.03 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.817 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.47 130.95 39.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.736 1.255 . . . . 0.0 112.413 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -92.37 -38.35 12.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.964 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -82.94 -19.33 37.43 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.44 119.92 6.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.27 118.89 7.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.369 1.44 . . . . 0.0 111.35 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 6.4 m -175.56 166.38 3.22 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.695 1.998 . . . . 0.0 110.539 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 142.09 38.06 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 122.324 1.059 . . . . 0.0 111.397 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.4 m -141.25 124.19 16.25 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 111.284 -2.689 . . . . 0.0 109.831 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -100.17 155.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.421 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -131.43 141.76 49.88 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.44 121.46 9.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -170.06 173.55 44.13 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.54 -1.791 . . . . 0.0 116.703 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 35.0 tt0 -105.81 144.89 31.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.379 1.085 . . . . 0.0 111.132 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 30.1 p -97.43 123.23 41.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.356 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.468 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.7 m-85 -117.76 170.43 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.733 0.778 . . . . 0.0 112.257 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 49.7 mt -127.28 115.77 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -58.85 154.95 14.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -19.16 0.51 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 176.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -82.31 -9.61 59.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.174 0.99 . . . . 0.0 113.247 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.83 49.75 5.24 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.193 0.901 . . . . 0.0 112.359 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 0.4 OUTLIER -124.31 152.88 42.55 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 127.716 2.406 . . . . 0.0 109.506 173.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -107.54 145.71 32.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.14 1.376 . . . . 0.0 110.005 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.448 HG21 ' CD1' ' B' ' 106' ' ' ILE . 25.9 m -148.15 165.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.178 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.89 118.63 25.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' B' ' 106' ' ' ILE . 3.7 mmmt -106.97 112.62 25.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 3.0 p -129.94 172.87 11.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.533 1.635 . . . . 0.0 111.374 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.656 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.0 mmm -128.31 170.56 12.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -140.43 163.6 32.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.741 1.257 . . . . 0.0 111.804 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -141.39 122.2 14.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.389 174.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.08 139.17 41.93 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 124.122 1.915 . . . . 0.0 110.026 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.27 18.42 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 109.75 -3.386 . . . . 0.0 110.132 -173.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -72.35 168.25 18.77 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.342 1.651 . . . . 0.0 112.41 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -115.43 82.68 1.79 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.97 -172.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.791 1.237 . . . . 0.0 108.916 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -119.73 -28.52 5.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.661 -1.274 . . . . 0.0 112.847 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -116.55 143.28 45.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 122.419 1.104 . . . . 0.0 111.624 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.0 tt -61.79 -20.52 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.731 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.4 2.37 57.86 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 118.335 -1.259 . . . . 0.0 114.086 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.04 7.62 8.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.79 1.236 . . . . 0.0 112.994 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.8 -36.07 75.98 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 119.734 -1.853 . . . . 0.0 111.524 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 59.1 p-90 -48.1 -46.02 33.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.602 1.161 . . . . 0.0 113.248 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -90.22 -12.41 38.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.101 . . . . 0.0 113.763 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 1.36 23.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.65 HG21 ' HG3' ' B' ' 96' ' ' MET . 26.2 m -111.25 140.63 45.65 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.21 1.004 . . . . 0.0 111.385 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.447 HH12 ' CG ' ' C' ' 39' ' ' ASP . 7.4 mtt180 -144.81 130.93 19.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.911 1.284 . . . . 0.0 111.195 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.63 152.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.972 1.715 . . . . 0.0 111.145 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.12 28.3 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -119.9 150.72 40.02 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.146 0.978 . . . . 0.0 110.145 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.52 147.23 27.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.856 0.836 . . . . 0.0 110.406 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.56 132.78 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.87 147.74 45.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.569 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 63.3 p -131.54 158.09 41.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.831 1.252 . . . . 0.0 109.971 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -60.46 136.72 58.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.757 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.55 103.5 11.31 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -0.778 . . . . 0.0 111.387 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 65.27 82.1 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 117.317 2.339 . . . . 0.0 117.317 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 11.1 p -104.78 153.03 21.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.828 1.651 . . . . 0.0 112.396 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -143.45 132.23 22.63 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.165 2.586 . . . . 0.0 104.048 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.37 21.74 1.06 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.977 1.311 . . . . 0.0 112.865 -174.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.246 0.917 1 C-N-CA 133.662 4.785 . . . . 0.0 105.065 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 116.526 -1.702 . . . . 0.0 106.508 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 12.0 m 38.75 42.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.348 1.859 . . . . 0.0 115.215 -174.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.1 m -95.64 27.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.539 -1.35 . . . . 0.0 112.353 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -62.53 157.4 20.51 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.244 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -126.33 72.63 1.33 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.56 1.544 . . . . 0.0 108.94 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -157.36 155.81 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.111 0.965 . . . . 0.0 111.957 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -131.04 147.03 52.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.1 p -139.84 130.71 26.08 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.278 -1.514 . . . . 0.0 112.646 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.7 -27.45 68.71 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -50.49 118.43 3.04 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 123.575 1.655 . . . . 0.0 112.189 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.11 -119.12 2.58 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.84 2.162 . . . . 0.0 110.017 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -145.01 149.73 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.546 1.138 . . . . 0.0 113.273 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -145.83 159.18 43.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.296 1.438 . . . . 0.0 110.068 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -134.87 150.2 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -107.96 143.51 36.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.461 1.104 . . . . 0.0 111.265 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.3 -24.03 64.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.39 1.076 . . . . 0.0 112.632 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 tp -74.09 -14.34 60.97 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.983 1.313 . . . . 0.0 112.639 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.61 -14.29 32.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 127.049 2.262 . . . . 0.0 113.889 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.61 153.85 22.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.298 1.523 . . . . 0.0 112.741 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.52 146.81 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.149 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -141.29 147.12 37.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -129.89 134.04 47.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.339 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.18 123.72 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.93 -87.06 0.11 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 124.434 1.084 . . . . 0.0 111.567 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.5 42.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.06 0.933 . . . . 0.0 112.145 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.16 125.55 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 113.166 -1.834 . . . . 0.0 108.038 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -71.36 162.81 28.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.995 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -54.91 -23.67 19.93 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -74.75 -32.52 62.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.905 -1.122 . . . . 0.0 113.217 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 -5.4 26.4 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 117.603 -1.665 . . . . 0.0 112.586 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 0.0 OUTLIER -67.06 142.46 57.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.71 156.91 32.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 1.5 p -125.2 168.61 13.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.622 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.52 -167.36 35.64 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.32 0.956 . . . . 0.0 113.838 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -138.61 133.63 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.758 -1.221 . . . . 0.0 111.308 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -113.65 131.92 55.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.59 129.24 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.251 61.2 m -104.66 142.65 34.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.638 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.24 -10.2 20.57 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -138.99 146.16 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.266 1.026 . . . . 0.0 112.647 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.1 26.4 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.319 -0.863 . . . . 0.0 110.881 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -31.14 63.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -141.1 69.73 28.27 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.454 1.902 . . . . 0.0 113.897 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.53 72.1 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 124.339 3.359 . . . . 0.0 114.183 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.69 2.28 13.64 Favored Glycine 0 N--CA 1.477 1.408 0 O-C-N 120.712 -1.242 . . . . 0.0 114.597 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.14 27.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.805 1.242 . . . . 0.0 112.623 -174.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.56 130.71 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.929 0.871 . . . . 0.0 110.76 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.25 0.5 OUTLIER -140.52 170.2 16.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.616 1.566 . . . . 0.0 110.055 177.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.1 tp -57.53 115.4 2.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.865 2.866 . . . . 0.0 111.0 174.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.2 m -100.55 120.09 56.97 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.23 142.38 87.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.434 2.089 . . . . 0.0 111.699 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.46 152.98 47.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.802 0.841 . . . . 0.0 111.624 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 30' ' ' THR . 1.1 tp -160.59 148.79 16.34 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 110.463 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.48 -152.01 22.66 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 120.883 1.674 . . . . 0.0 110.195 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -143.2 140.01 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.304 0.642 . . . . 0.0 111.279 -174.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.21 136.41 52.79 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.396 -0.815 . . . . 0.0 111.932 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -68.76 149.79 48.61 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.935 0.874 . . . . 0.0 111.321 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.3 23.98 1.15 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.995 1.318 . . . . 0.0 111.436 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -92.97 -58.2 2.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.361 1.864 . . . . 0.0 111.357 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.05 -178.15 3.21 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.616 1.197 . . . . 0.0 114.169 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -65.73 -57.81 7.15 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.215 1.006 . . . . 0.0 111.845 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -141.52 65.39 20.88 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.917 0.887 . . . . 0.0 110.129 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.34 -174.15 1.53 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.27 2.647 . . . . 0.0 114.546 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.275 4.5 t -96.15 160.72 14.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 123.158 1.456 . . . . 0.0 112.796 174.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.9 167.34 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.469 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.55 147.37 12.91 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.19 156.91 27.38 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -92.9 149.68 21.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.661 1.984 . . . . 0.0 109.535 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.22 117.04 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 42.2 t30 -92.36 105.5 17.68 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.752 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.266 42.9 m95 -74.3 130.96 40.7 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -89.47 -40.26 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -92.17 -9.46 42.28 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.42 128.37 10.31 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 128.187 2.595 . . . . 0.0 104.865 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.76 118.7 12.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.363 1.078 . . . . 0.0 110.739 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 m -177.07 159.65 1.68 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.001 1.721 . . . . 0.0 110.475 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.63 141.64 35.07 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.033 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 99' ' ' LEU . 1.8 m -140.57 126.68 19.65 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.553 -3.022 . . . . 0.0 108.558 -172.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.754 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.544 ' HE2' HD21 ' A' ' 118' ' ' ASN . 41.5 m-85 -124.61 142.56 51.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 116.67 5.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.31 169.21 39.73 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 118.737 -1.697 . . . . 0.0 116.408 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 29.0 tt0 -101.84 148.13 25.68 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.274 1.035 . . . . 0.0 111.723 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 132.82 36.31 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.271 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' D' ' 106' ' ' ILE . 19.7 m-85 -121.62 158.09 29.37 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 110.18 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.81 158.58 7.94 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.547 1.139 . . . . 0.0 110.087 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -48.08 -33.77 8.65 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -75.33 -15.26 60.5 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.6 47.15 3.04 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.248 0.928 . . . . 0.0 111.729 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 4.9 mtpm? -119.8 154.18 34.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.431 1.492 . . . . 0.0 109.639 174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -109.03 151.82 25.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.814 1.645 . . . . 0.0 111.26 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.48 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.3 t -152.83 156.3 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.189 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 mt -123.42 104.11 8.89 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.48 ' CD ' HG11 ' A' ' 92' ' ' VAL . 1.2 mmtt -95.04 127.84 41.41 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -139.77 163.07 33.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.792 1.282 . . . . 0.0 112.768 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 19.9 mtp -121.34 160.47 23.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -133.51 162.57 31.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.154 -1.839 . . . . 0.0 113.057 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.81 126.55 23.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.508 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.409 HD12 HG21 ' A' ' 77' ' ' THR . 0.3 OUTLIER -107.3 140.79 39.64 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 125.14 1.525 . . . . 0.0 109.972 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.09 118.23 22.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.57 -173.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.8 p -84.99 172.07 11.61 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.7 m -110.71 70.89 0.73 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 107.7 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.46 169.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.048 1.339 . . . . 0.0 109.667 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.34 -11.1 14.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -135.36 152.76 51.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.064 1.412 . . . . 0.0 111.942 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -67.43 -20.77 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.376 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.83 4.3 45.83 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.674 -0.641 . . . . 0.0 114.401 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -125.75 1.64 7.45 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.25 -34.58 72.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.987 0.915 . . . . 0.0 113.028 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -48.32 -38.85 20.06 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -97.43 -12.92 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.04 1.336 . . . . 0.0 114.032 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.76 38.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.4 m -108.34 144.94 35.2 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-O 122.352 1.072 . . . . 0.0 109.583 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -141.0 151.84 44.44 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.524 1.529 . . . . 0.0 108.311 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.62 153.19 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.57 1.148 . . . . 0.0 109.411 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.38 32.22 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.141 0.877 . . . . 0.0 111.776 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 17.3 p90 -132.41 159.99 37.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.139 -0.624 . . . . 0.0 112.076 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.544 HD21 ' HE2' ' A' ' 79' ' ' PHE . 53.0 m-20 -150.42 157.35 42.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.542 1.163 . . . . 0.0 109.784 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.4 HD13 ' HE3' ' A' ' 94' ' ' LYS . 8.6 mt -131.93 129.45 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.85 151.97 38.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 124.334 1.022 . . . . 0.0 108.772 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 p -139.84 164.77 29.09 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -57.04 129.62 42.51 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.496 0.718 . . . . 0.0 110.94 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.86 166.82 14.77 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 77.39 -51.96 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.5 m -103.12 84.73 2.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.783 1.233 . . . . 0.0 109.697 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -81.2 -41.69 21.93 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.351 0.596 . . . . 0.0 111.8 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -143.08 179.92 6.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.609 1.964 . . . . 0.0 110.132 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.272 2.27 2 C-N-CA 137.086 6.154 . . . . 0.0 98.551 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 116.507 -1.711 . . . . 0.0 107.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 14.9 t -71.22 -44.38 65.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.853 1.661 . . . . 0.0 112.646 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 11.7 t 60.26 -48.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 128.343 2.657 . . . . 0.0 113.839 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -74.74 139.58 43.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.051 1.341 . . . . 0.0 113.331 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ttm105 -70.18 96.29 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.271 1.829 . . . . 0.0 109.863 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -156.95 155.96 32.23 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 111.516 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' CYS . . . . . 0.463 ' HG ' ' HB3' ' D' ' 83' ' ' CYS . 27.5 p -137.67 143.37 41.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.656 1.583 . . . . 0.0 108.888 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 85.2 p -139.98 131.95 27.77 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.346 -1.471 . . . . 0.0 113.552 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.31 -24.04 67.68 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -53.95 118.43 3.99 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.545 1.64 . . . . 0.0 112.092 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.46 -120.73 2.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.261 1.886 . . . . 0.0 109.554 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 113.301 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -147.8 159.89 43.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.18 147.88 46.18 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -105.79 143.57 33.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.652 1.181 . . . . 0.0 111.945 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.79 -24.56 62.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.562 1.145 . . . . 0.0 112.92 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.84 -13.81 60.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.694 1.197 . . . . 0.0 112.666 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -13.81 36.72 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.973 2.225 . . . . 0.0 113.619 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.2 152.27 25.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.298 1.523 . . . . 0.0 112.439 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.95 146.44 50.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.854 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -141.19 147.29 38.14 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -129.76 134.95 47.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.035 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.08 123.62 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.86 0.12 Allowed Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.128 0.893 . . . . 0.0 111.757 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.09 151.63 38.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.747 -0.855 . . . . 0.0 111.969 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.66 126.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.596 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -70.87 162.8 28.62 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -56.52 -24.92 49.88 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -73.02 -30.95 64.14 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.825 -1.172 . . . . 0.0 112.52 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.11 -1.25 25.49 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.214 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.51 155.61 39.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.152 1.476 . . . . 0.0 112.417 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PHE . . . . . 0.439 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -156.47 166.06 34.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.316 174.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.543 HG22 ' CD1' ' D' ' 50' ' ' LEU . 3.0 p -125.44 -179.92 4.83 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.81 -167.33 39.49 Favored Glycine 0 N--CA 1.469 0.878 0 O-C-N 119.46 -2.025 . . . . 0.0 113.755 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.5 p -137.92 132.31 32.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.101 0.953 . . . . 0.0 112.133 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -112.2 136.13 51.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 mt -125.78 129.53 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 70.4 m -104.74 143.33 33.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.736 -173.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.88 21.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -141.48 145.67 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.359 1.063 . . . . 0.0 112.504 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.05 167.99 26.67 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.111 -0.993 . . . . 0.0 110.896 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -30.98 63.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.9 69.7 29.45 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.448 1.899 . . . . 0.0 113.966 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.53 71.5 2.49 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.324 3.349 . . . . 0.0 114.266 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.17 14.49 Favored Glycine 0 N--CA 1.477 1.389 0 O-C-N 120.734 -1.229 . . . . 0.0 114.595 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.03 28.02 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.721 1.208 . . . . 0.0 112.626 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.69 130.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.946 0.879 . . . . 0.0 110.686 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.09 169.98 16.59 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.683 1.593 . . . . 0.0 109.753 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.3 tp -57.17 115.37 2.62 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.249 3.02 . . . . 0.0 111.151 174.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -100.93 119.48 58.08 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.12 141.17 87.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.365 2.044 . . . . 0.0 111.647 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -125.38 157.15 37.5 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.738 0.815 . . . . 0.0 111.777 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' D' ' 30' ' ' THR . 12.5 tp -163.67 149.04 10.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.356 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -148.25 15.26 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 120.298 1.408 . . . . 0.0 110.729 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mt -146.42 139.49 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.179 0.992 . . . . 0.0 110.317 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.91 136.83 54.59 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.224 -0.922 . . . . 0.0 111.549 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -68.58 150.38 48.08 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.659 -1.276 . . . . 0.0 111.782 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -147.26 24.66 1.13 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 111.751 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 15.5 mmt-85 -93.12 -58.19 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.085 1.754 . . . . 0.0 111.448 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 179.89 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -63.68 -55.28 24.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.246 1.018 . . . . 0.0 111.431 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.07 67.83 15.5 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.516 0.726 . . . . 0.0 112.447 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.23 -173.59 1.65 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.166 2.577 . . . . 0.0 115.5 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.273 3.9 t -96.88 161.56 13.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 123.038 1.399 . . . . 0.0 112.997 174.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -151.46 167.99 26.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.352 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.84 147.53 13.1 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.994 2.358 . . . . 0.0 118.994 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.74 156.0 24.66 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.03 149.43 21.23 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.595 1.958 . . . . 0.0 109.594 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.62 117.73 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.1 t30 -93.21 106.38 18.35 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.49 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.268 42.6 m95 -74.26 131.98 41.7 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -172.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -90.48 -39.47 12.59 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.83 -9.51 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.35 129.01 10.79 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.553 2.741 . . . . 0.0 105.374 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.28 118.82 12.65 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.07 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 4.7 m -177.03 159.99 1.73 Allowed 'General case' 0 C--O 1.244 0.779 0 C-N-CA 125.875 1.67 . . . . 0.0 110.34 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.64 141.29 35.1 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.065 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.413 HG21 HD12 ' D' ' 99' ' ' LEU . 1.8 m -140.5 126.26 19.27 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.834 -2.894 . . . . 0.0 108.845 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.12 151.5 5.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.808 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' PHE . . . . . 0.56 ' HE2' HD21 ' D' ' 118' ' ' ASN . 41.8 m-85 -124.44 142.28 51.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.84 116.42 5.83 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.2 168.98 39.56 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 118.605 -1.76 . . . . 0.0 116.388 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 28.8 tt0 -101.89 148.31 25.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.782 0.801 . . . . 0.0 111.521 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' HG ' ' D' ' 4' ' ' CYS . 49.1 t -95.21 131.72 40.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.716 174.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.589 ' HB2' HD12 ' A' ' 106' ' ' ILE . 24.8 m-85 -117.59 159.93 22.09 Favored 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 123.685 0.794 . . . . 0.0 112.867 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -124.13 110.37 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.68 158.19 8.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.958 1.303 . . . . 0.0 109.678 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -47.52 -34.27 7.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.96 -18.23 61.4 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 36.4 4.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.705 1.145 . . . . 0.0 112.802 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.497 ' NZ ' ' HB3' ' D' ' 90' ' ' LYS . 8.4 mtpm? -109.14 157.14 19.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.727 1.211 . . . . 0.0 110.189 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -109.21 153.55 23.64 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 119.919 -1.738 . . . . 0.0 111.511 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.5 t -153.18 154.57 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.177 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 mt -118.9 106.44 12.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 172.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.1 mptt -97.7 125.94 42.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 172.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -138.78 162.91 33.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.75 1.262 . . . . 0.0 112.419 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 18.4 mtp -121.17 160.72 23.2 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -133.92 162.27 32.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.066 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -137.78 126.76 24.17 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.536 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 99' ' ' LEU . . . . . 0.413 HD12 HG21 ' D' ' 77' ' ' THR . 0.2 OUTLIER -107.24 142.06 37.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 125.074 1.484 . . . . 0.0 109.827 -177.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.82 117.85 20.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 111.801 -2.454 . . . . 0.0 111.729 -173.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -84.49 171.12 12.82 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 23.4 m -109.09 71.91 0.79 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.79 171.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.838 1.255 . . . . 0.0 109.613 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.64 -4.26 12.81 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.8 150.97 46.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.739 1.257 . . . . 0.0 110.807 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.4 tt -68.33 -21.5 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.183 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.38 3.99 44.38 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.943 0.783 . . . . 0.0 114.294 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.31 1.22 7.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.037 0.935 . . . . 0.0 113.423 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.5 -34.59 71.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 113.034 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -48.21 -39.48 21.23 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -96.78 -12.93 23.02 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.967 1.307 . . . . 0.0 114.189 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.29 -4.62 37.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 6.7 m -108.8 145.42 35.24 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.621 0.724 . . . . 0.0 109.369 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -141.2 151.7 44.0 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.936 1.694 . . . . 0.0 108.854 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.17 153.73 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 109.715 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.78 -176.24 32.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.687 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 18.4 p90 -132.51 160.01 37.76 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.162 -0.61 . . . . 0.0 111.881 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 118' ' ' ASN . . . . . 0.56 HD21 ' HE2' ' D' ' 79' ' ' PHE . 59.0 m-20 -150.33 157.2 42.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.73 1.252 . . . . 0.0 109.866 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' ILE . . . . . 0.404 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.0 mt -133.02 130.33 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.66 152.52 41.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.19 0.931 . . . . 0.0 109.417 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 45.2 p -140.66 167.38 22.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -57.4 125.58 23.48 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.326 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.52 128.03 34.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 68.99 102.98 0.06 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.784 2.434 . . . . 0.0 114.266 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.69 -69.77 0.25 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.69 2.396 . . . . 0.0 106.906 174.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 116.64 -77.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 132.106 4.162 . . . . 0.0 113.117 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -145.71 147.75 32.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.595 3.558 . . . . 0.0 103.271 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . 0.347 2.6 pt-20 . . . . . 0 CA--C 1.554 1.128 0 O-C-N 126.02 2.075 . . . . 0.0 113.227 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -3' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' B' ' -3' ' ' GLN . 2.6 tp-100 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 37.8 m -73.12 111.96 8.72 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.706 0.684 . . . . 0.0 110.423 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 21.2 t 73.03 86.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.946 2.098 . . . . 0.0 113.45 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.04 61.88 1.52 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.888 1.675 . . . . 0.0 110.268 174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -131.81 16.24 4.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.578 1.551 . . . . 0.0 113.363 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -157.2 155.97 31.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.851 2.061 . . . . 0.0 108.654 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.402 ' HG ' ' CB ' ' B' ' 83' ' ' CYS . 28.8 p -137.97 140.94 40.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.107 1.763 . . . . 0.0 107.479 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -139.86 131.17 26.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 119.839 -1.788 . . . . 0.0 113.463 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.56 -26.11 68.41 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -52.14 118.09 3.25 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.704 1.716 . . . . 0.0 112.433 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.44 -118.0 2.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.507 2.004 . . . . 0.0 110.306 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -144.75 148.52 34.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.502 1.121 . . . . 0.0 113.621 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -144.87 159.05 43.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.177 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -136.65 148.41 47.41 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -105.81 143.55 33.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.812 1.245 . . . . 0.0 112.215 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.89 -22.33 62.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.731 1.212 . . . . 0.0 112.918 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 50.2 tp -76.68 -14.5 59.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.838 1.255 . . . . 0.0 112.497 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 -12.83 34.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.707 2.099 . . . . 0.0 113.769 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 153.77 28.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.105 1.431 . . . . 0.0 112.554 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.45 147.56 50.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.628 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -142.03 146.87 36.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m -128.55 135.36 49.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.064 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.7 124.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.19 -86.41 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 O-C-N 124.362 1.039 . . . . 0.0 111.502 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.83 152.59 42.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 122.068 0.937 . . . . 0.0 112.11 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -99.84 125.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 113.124 -1.853 . . . . 0.0 108.288 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -71.38 162.83 28.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 110.94 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -55.09 -23.52 21.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -74.83 -31.82 61.78 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.849 -1.157 . . . . 0.0 113.304 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.78 -5.47 27.61 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.874 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.495 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 0.0 OUTLIER -67.03 142.77 57.08 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.15 156.73 31.41 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.413 HG22 HD13 ' B' ' 50' ' ' LEU . 1.3 p -125.01 168.87 12.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.556 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.35 -167.1 35.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 122.461 1.034 . . . . 0.0 113.778 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.521 ' HB ' HD11 ' B' ' 46' ' ' LEU . 12.3 p -138.56 132.33 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.606 -1.297 . . . . 0.0 111.15 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.11 136.36 50.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.222 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mt -126.8 129.37 71.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.252 63.7 m -104.67 143.2 33.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.925 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.44 -8.46 21.09 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 m -140.35 145.74 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.267 1.027 . . . . 0.0 112.601 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.94 167.78 27.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.216 -0.928 . . . . 0.0 111.0 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.94 -31.52 64.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.75 69.83 30.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 126.562 1.945 . . . . 0.0 113.902 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 71.36 2.48 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 124.426 3.417 . . . . 0.0 114.259 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.0 2.17 14.68 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 120.753 -1.217 . . . . 0.0 114.571 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.11 27.9 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.594 1.157 . . . . 0.0 112.561 -174.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 86.4 mt -50.45 130.59 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.816 0.817 . . . . 0.0 110.658 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.59 170.42 15.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.636 1.574 . . . . 0.0 109.833 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.8 tp -57.61 115.4 2.75 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.133 2.973 . . . . 0.0 111.068 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m -100.9 119.97 56.79 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.06 142.53 85.68 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.622 2.215 . . . . 0.0 111.853 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.98 153.07 47.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.741 0.816 . . . . 0.0 111.725 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.413 HD13 HG22 ' B' ' 30' ' ' THR . 1.1 tp -160.64 148.77 16.24 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.426 1.49 . . . . 0.0 110.348 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.42 -152.38 23.12 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 120.857 1.662 . . . . 0.0 110.158 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -143.0 139.59 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.78 136.36 53.05 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.508 -0.745 . . . . 0.0 112.081 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -69.25 150.93 46.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.988 0.899 . . . . 0.0 111.358 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.26 18.96 1.22 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.056 1.342 . . . . 0.0 111.865 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 mmt-85 -87.84 -58.19 2.66 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.315 1.846 . . . . 0.0 111.467 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 178.5 4.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.6 t -64.42 -53.37 49.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.602 1.161 . . . . 0.0 111.85 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -143.95 66.51 14.86 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.785 0.834 . . . . 0.0 113.057 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.83 -174.23 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.912 2.408 . . . . 0.0 115.316 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.262 4.2 t -96.35 161.27 14.0 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.689 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -151.49 168.48 24.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.207 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.41 147.16 12.27 Favored Glycine 0 CA--C 1.539 1.58 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -160.05 157.63 29.01 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.45 150.11 20.7 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.516 1.926 . . . . 0.0 109.575 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.51 117.12 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.51 ' HB2' HG21 ' C' ' 52' ' ' ILE . 41.2 t30 -92.41 105.58 17.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.613 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.267 42.9 m95 -74.12 130.79 40.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -89.32 -40.34 12.85 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -91.9 -9.56 42.77 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.37 128.08 10.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.52 2.728 . . . . 0.0 105.326 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.08 118.88 12.54 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.823 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -177.08 159.95 1.71 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.958 1.703 . . . . 0.0 110.317 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -141.11 141.54 34.18 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.87 126.93 19.47 Favored 'General case' 0 N--CA 1.407 -2.625 0 CA-C-N 110.593 -3.003 . . . . 0.0 108.657 -172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.842 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' PHE . . . . . 0.557 ' HE2' HD21 ' B' ' 118' ' ' ASN . 41.4 m-85 -124.56 142.72 51.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.41 116.92 5.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.84 168.96 39.94 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 118.816 -1.659 . . . . 0.0 116.546 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 28.8 tt0 -101.81 148.4 25.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.76 0.79 . . . . 0.0 111.356 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.402 ' CB ' ' HG ' ' B' ' 4' ' ' CYS . 49.8 t -95.2 133.04 39.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.133 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' C' ' 106' ' ' ILE . 18.1 m-85 -118.41 158.17 25.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 mt -121.97 108.43 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.14 158.62 8.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.126 0.97 . . . . 0.0 110.466 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -46.95 -32.15 3.65 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.05 -12.22 59.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.65 51.32 3.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.8 156.74 30.05 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 129.658 3.183 . . . . 0.0 108.548 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -118.02 155.31 30.53 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 119.948 -1.72 . . . . 0.0 111.465 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.493 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.4 t -155.54 155.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -120.12 107.07 12.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' B' ' 92' ' ' VAL . 1.0 OUTLIER -98.29 126.14 43.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -139.32 163.08 33.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.688 1.233 . . . . 0.0 112.551 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 19.7 mtp -120.79 160.68 22.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.82 162.63 31.48 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.133 -1.849 . . . . 0.0 113.175 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.73 126.38 23.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.568 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.24 141.0 39.23 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 125.05 1.468 . . . . 0.0 109.84 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 111.728 -2.487 . . . . 0.0 111.669 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -84.93 171.81 11.86 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 32.6 m -110.08 71.73 0.77 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.72 170.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.333 1.453 . . . . 0.0 110.012 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.39 -4.52 13.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.05 151.85 47.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.662 1.22 . . . . 0.0 111.067 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.7 tt -68.52 -22.29 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.072 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.73 4.53 36.19 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.753 0.692 . . . . 0.0 114.391 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.65 1.38 7.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.65 -34.38 71.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.294 1.038 . . . . 0.0 113.284 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -48.34 -39.51 22.3 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -96.44 -13.35 23.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.902 1.281 . . . . 0.0 114.125 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.06 -5.77 43.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -107.54 145.03 33.71 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 121.822 0.82 . . . . 0.0 109.279 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -140.61 151.31 44.56 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 125.966 1.706 . . . . 0.0 108.751 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.88 154.21 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 119.582 1.083 . . . . 0.0 109.656 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.84 -176.14 32.62 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.093 0.854 . . . . 0.0 111.739 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 17.9 p90 -132.73 160.08 37.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.137 -0.625 . . . . 0.0 112.087 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ASN . . . . . 0.557 HD21 ' HE2' ' B' ' 79' ' ' PHE . 58.0 m-20 -150.43 157.07 42.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.665 1.221 . . . . 0.0 110.02 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.65 130.0 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.9 153.36 39.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 124.285 0.991 . . . . 0.0 109.408 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.4 p -141.74 165.67 26.85 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.16 121.79 11.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.803 1.241 . . . . 0.0 111.872 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.29 149.63 47.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 38.0 15.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 9.7 t -59.59 171.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.454 0.702 . . . . 0.0 112.12 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -113.78 146.26 40.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.924 1.29 . . . . 0.0 107.827 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.42 -176.22 0.12 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.492 3.517 . . . . 0.0 109.147 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 O-C-N 125.814 1.946 . . . . 0.0 112.489 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 119.566 -0.254 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.8 p -139.05 -64.95 0.49 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.072 2.149 . . . . 0.0 109.583 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 13.4 m -138.23 21.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 112.063 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 59.48 -81.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.795 2.438 . . . . 0.0 112.827 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.31 64.15 0.33 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.181 2.992 . . . . 0.0 108.5 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -157.17 155.93 31.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.218 1.007 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 p -133.72 143.63 48.61 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -140.04 129.22 23.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 119.581 -1.949 . . . . 0.0 114.248 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.07 -27.32 69.31 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -52.11 114.49 1.34 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 123.035 1.398 . . . . 0.0 111.915 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.96 -109.44 0.74 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.669 1.604 . . . . 0.0 110.979 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -152.0 144.26 23.98 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.87 160.48 39.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.256 1.022 . . . . 0.0 110.699 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.21 148.0 50.81 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -109.3 143.62 38.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.945 0.898 . . . . 0.0 111.859 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -59.6 -25.72 64.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.628 1.171 . . . . 0.0 112.969 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.9 tp -73.58 -14.2 61.15 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.838 -1.164 . . . . 0.0 112.357 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.28 -12.19 36.79 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.82 2.152 . . . . 0.0 113.685 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.86 155.01 28.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 123.393 1.568 . . . . 0.0 112.427 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.39 146.3 51.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.015 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -142.31 144.18 33.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.035 0.922 . . . . 0.0 113.348 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -127.52 134.11 49.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.246 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 95.9 mt -132.64 124.39 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.46 -85.71 0.1 Allowed Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.241 0.963 . . . . 0.0 111.701 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.6 152.33 39.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.846 -0.796 . . . . 0.0 112.283 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.98 126.23 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 113.474 -1.694 . . . . 0.0 108.652 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -71.29 163.23 28.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.541 0.686 . . . . 0.0 111.78 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -56.78 -24.82 53.15 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -73.04 -31.26 64.32 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.736 -1.228 . . . . 0.0 112.524 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.79 -2.26 24.51 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.257 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.44 155.47 40.08 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.016 1.408 . . . . 0.0 112.459 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PHE . . . . . 0.448 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -156.89 166.08 34.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.43 174.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.539 HG22 ' CD1' ' C' ' 50' ' ' LEU . 3.0 p -125.66 -179.34 4.61 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 173.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.0 -166.91 39.22 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 119.208 -2.182 . . . . 0.0 113.222 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' C' ' 46' ' ' LEU . 12.4 p -137.13 131.94 33.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.797 0.808 . . . . 0.0 112.199 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -111.39 137.78 48.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.8 129.85 70.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.254 64.9 m -104.8 144.07 32.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.462 -173.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.97 -6.26 21.42 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -141.68 144.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 112.57 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.59 168.03 26.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 110.966 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -31.29 63.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 172.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -140.41 69.94 32.69 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.626 1.97 . . . . 0.0 113.977 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.53 71.56 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.405 3.403 . . . . 0.0 114.195 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.05 1.94 14.64 Favored Glycine 0 N--CA 1.477 1.409 0 O-C-N 120.686 -1.259 . . . . 0.0 114.616 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.91 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.583 1.153 . . . . 0.0 112.554 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.56 130.86 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.898 0.856 . . . . 0.0 110.612 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.15 169.93 16.68 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.773 1.629 . . . . 0.0 109.803 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -56.8 115.44 2.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 129.264 3.025 . . . . 0.0 111.153 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 57.0 m -100.98 119.47 58.04 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.88 141.75 85.13 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.174 1.916 . . . . 0.0 111.526 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.47 157.02 39.75 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.664 0.786 . . . . 0.0 111.805 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' C' ' 30' ' ' THR . 12.6 tp -164.19 148.98 10.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.521 1.528 . . . . 0.0 112.455 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.09 -147.97 14.74 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 120.357 1.435 . . . . 0.0 110.699 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mt -146.84 139.47 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 110.162 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.66 136.66 54.61 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 121.188 -0.945 . . . . 0.0 111.428 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -68.36 150.6 47.99 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.626 -1.296 . . . . 0.0 111.64 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -146.86 25.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.011 1.324 . . . . 0.0 111.717 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 mmt-85 -93.42 -58.2 2.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.173 1.789 . . . . 0.0 111.705 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.25 179.65 4.39 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.594 1.184 . . . . 0.0 113.992 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -63.71 -57.9 8.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.725 0.81 . . . . 0.0 110.795 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.75 66.64 27.63 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.606 0.763 . . . . 0.0 112.065 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -173.31 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.29 2.66 . . . . 0.0 115.245 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.276 4.0 t -96.54 161.51 13.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 123.055 1.407 . . . . 0.0 113.011 174.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -151.75 167.57 27.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.469 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.5 147.79 13.71 Favored Glycine 0 CA--C 1.542 1.771 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.68 156.54 25.64 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -93.57 150.05 20.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.546 1.938 . . . . 0.0 109.618 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.03 117.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.542 ' HB2' HG21 ' B' ' 52' ' ' ILE . 42.7 t30 -92.74 107.14 18.99 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.347 -0.846 . . . . 0.0 110.42 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.268 43.1 m95 -75.3 131.8 40.56 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -89.95 -40.53 12.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -92.21 -9.23 43.0 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -152.37 127.79 9.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.605 2.762 . . . . 0.0 105.172 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.37 118.84 12.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.2 m -177.2 160.2 1.7 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 126.127 1.771 . . . . 0.0 110.424 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -140.98 141.57 34.38 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.054 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.408 HG23 ' HA ' ' C' ' 99' ' ' LEU . 1.8 m -140.43 127.32 20.63 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 110.642 -2.981 . . . . 0.0 108.824 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.13 151.19 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.69 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' PHE . . . . . 0.568 ' HE2' HD21 ' C' ' 118' ' ' ASN . 42.7 m-85 -123.8 142.42 51.12 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.5 117.16 5.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -173.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 169.0 39.61 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.257 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 28.8 tt0 -101.75 148.66 25.01 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 111.354 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.48 132.67 41.8 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.107 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.583 ' HB2' HD12 ' B' ' 106' ' ' ILE . 19.1 m-85 -117.95 160.28 21.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.01 110.18 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 172.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.79 156.96 10.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 109.912 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -46.76 -34.9 5.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.62 -15.95 61.24 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.62 35.62 5.6 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.365 1.459 . . . . 0.0 113.232 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -104.47 163.04 12.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.16 1.384 . . . . 0.0 107.854 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -118.49 152.57 35.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.997 1.719 . . . . 0.0 111.182 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -153.34 156.04 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.229 1.411 . . . . 0.0 111.168 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 mt -119.91 108.67 14.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.0 OUTLIER -99.6 126.07 45.53 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 172.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -139.34 162.55 34.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.667 1.223 . . . . 0.0 112.677 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 18.9 mtp -120.3 160.98 21.91 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -133.86 162.76 31.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.995 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 tp -137.81 126.73 24.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.467 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' LEU . . . . . 0.408 ' HA ' HG23 ' C' ' 77' ' ' THR . 0.3 OUTLIER -107.21 141.22 38.84 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 124.881 1.363 . . . . 0.0 109.944 -177.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.42 118.92 22.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 111.615 -2.539 . . . . 0.0 111.771 -173.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 96.2 p -85.96 171.68 11.26 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -110.34 71.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.5 171.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.081 1.352 . . . . 0.0 109.529 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -114.07 -5.68 13.1 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.54 151.49 47.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.703 1.24 . . . . 0.0 110.98 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.3 tt -67.79 -22.11 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.932 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.5 3.84 38.84 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.85 -0.972 . . . . 0.0 114.33 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -125.58 1.27 7.57 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.289 1.036 . . . . 0.0 113.747 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.66 -34.39 71.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.148 0.979 . . . . 0.0 112.973 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.54 -39.0 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -96.95 -12.62 23.16 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.028 1.331 . . . . 0.0 114.237 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.57 -4.61 38.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 6.8 m -108.65 144.99 35.67 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.305 1.05 . . . . 0.0 109.672 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -141.31 151.68 43.81 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.547 1.539 . . . . 0.0 108.262 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.23 153.41 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.87 -175.88 32.37 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 123.998 0.808 . . . . 0.0 111.807 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 18.4 p90 -133.09 160.52 36.96 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.086 -0.656 . . . . 0.0 112.26 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 118' ' ' ASN . . . . . 0.568 HD21 ' HE2' ' C' ' 79' ' ' PHE . 56.8 m-20 -150.65 157.56 43.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.719 1.247 . . . . 0.0 110.276 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' ILE . . . . . 0.413 HD13 ' HE3' ' C' ' 94' ' ' LYS . 8.8 mt -133.13 130.87 58.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -124.32 150.93 44.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -139.59 167.59 21.76 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.399 -0.813 . . . . 0.0 109.061 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -57.59 117.33 4.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.222 1.009 . . . . 0.0 111.572 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -77.97 114.34 16.74 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 81.68 81.52 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.647 2.379 . . . . 0.0 113.743 174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t -154.88 142.34 19.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 109.114 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -154.63 132.0 11.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.883 2.073 . . . . 0.0 107.42 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -142.81 14.18 1.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 . . . . . 0 C--O 1.255 1.37 0 C-N-CA 129.384 3.073 . . . . 0.0 110.558 -173.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 117.748 -1.12 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 11.8 t -80.75 39.41 0.48 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.447 1.476 . . . . 0.0 114.932 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.24 30.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 126.071 1.749 . . . . 0.0 109.809 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 61.77 -165.8 0.22 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.744 1.618 . . . . 0.0 113.594 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -145.05 106.9 4.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.263 2.225 . . . . 0.0 108.267 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.66 113.5 3.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.746 1.618 . . . . 0.0 110.076 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 t -116.33 123.44 47.64 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -141.11 134.78 30.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.892 -1.13 . . . . 0.0 112.232 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.65 -18.09 61.07 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -56.15 115.89 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.606 1.162 . . . . 0.0 111.317 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.91 -122.23 3.29 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.926 1.727 . . . . 0.0 111.269 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.45 143.6 26.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -140.35 162.68 34.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.28 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -137.77 146.31 43.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.359 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 118' ' ' ASN . 7.0 t-20 -108.0 145.31 34.09 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.948 0.899 . . . . 0.0 110.581 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.81 -29.45 54.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.963 1.305 . . . . 0.0 114.248 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.3 tp -70.99 -13.83 62.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.975 1.71 . . . . 0.0 113.402 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.38 22.95 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.31 2.386 . . . . 0.0 113.868 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 156.04 34.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.042 1.421 . . . . 0.0 113.578 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.29 136.14 51.54 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.407 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -130.1 143.26 50.69 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.393 -0.817 . . . . 0.0 112.09 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 m -132.07 133.08 43.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.514 0.726 . . . . 0.0 109.589 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.91 121.75 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -58.19 9.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.311 1.007 . . . . 0.0 112.425 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.32 153.27 3.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.164 1.386 . . . . 0.0 110.557 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.48 130.96 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 124.582 1.176 . . . . 0.0 111.293 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -75.1 168.85 19.18 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 m -55.62 -27.95 52.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -81.77 -35.77 29.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.059 0.845 . . . . 0.0 110.422 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.54 -6.02 9.2 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 117.151 -1.916 . . . . 0.0 114.489 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB2' HD21 ' D' ' 50' ' ' LEU . 1.4 pt-20 -67.9 141.81 56.26 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 119.7 1.75 . . . . 0.0 108.101 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.24 151.0 22.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.85 165.32 11.94 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.42 -165.45 32.09 Favored Glycine 0 C--O 1.237 0.322 0 O-C-N 120.683 -1.261 . . . . 0.0 111.707 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -141.36 143.35 33.94 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 122.227 1.013 . . . . 0.0 112.983 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -118.65 123.9 46.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.246 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 46' ' ' LEU . 2.8 mp -115.15 126.68 72.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.3 m -105.65 150.51 25.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.3 -11.88 14.82 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.39 146.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.363 1.465 . . . . 0.0 112.091 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.17 42.18 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.292 -1.505 . . . . 0.0 113.265 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -71.57 -21.54 61.87 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.693 0.397 . . . . 0.0 110.598 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -148.47 83.46 7.03 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.828 2.451 . . . . 0.0 109.944 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 28.33 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.545 3.497 . . . . 0.0 115.834 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.12 -5.67 49.17 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 0.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.003 -1.475 . . . . 0.0 114.165 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -20.57 114.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.865 1.666 . . . . 0.0 115.451 -173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 168.18 18.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.351 2.26 . . . . 0.0 107.923 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 34' ' ' ILE . 6.8 tt -53.69 138.25 35.53 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.148 1.379 . . . . 0.0 112.856 174.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -115.55 121.56 34.32 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.22 144.82 89.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.435 2.757 . . . . 0.0 111.622 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.49 154.86 48.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 111.378 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.81 148.56 20.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.237 1.815 . . . . 0.0 109.916 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.25 -153.4 23.88 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 121.748 2.067 . . . . 0.0 111.775 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.9 mt -142.17 142.4 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.04 143.98 51.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.35 0.66 . . . . 0.0 111.816 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -79.35 151.43 31.0 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.603 1.192 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -145.94 25.46 1.28 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.43 1.492 . . . . 0.0 111.744 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -93.52 -50.22 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.219 2.208 . . . . 0.0 112.107 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.95 178.19 7.66 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.797 0.808 . . . . 0.0 112.81 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 p -77.82 -41.77 35.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 113.676 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -131.66 56.46 24.26 Favored Pre-proline 0 CA--C 1.554 1.103 0 C-N-CA 125.367 1.467 . . . . 0.0 112.174 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.06 172.06 12.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.975 1.783 . . . . 0.0 115.71 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -94.51 174.08 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.229 173.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -166.69 165.34 16.54 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.252 -1.794 . . . . 0.0 113.592 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.68 148.32 13.67 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 118.589 2.195 . . . . 0.0 118.589 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -164.13 154.98 15.47 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 152.4 22.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.906 1.683 . . . . 0.0 110.326 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -133.23 116.91 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' D' ' 52' ' ' ILE . 29.3 t30 -99.49 110.13 22.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -76.95 136.81 38.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -38.34 12.54 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.545 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -86.54 -15.67 39.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -152.55 122.23 6.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.195 1.798 . . . . 0.0 107.145 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.65 118.48 5.71 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.175 1.352 . . . . 0.0 110.114 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.9 p -175.18 168.34 3.39 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.04 1.736 . . . . 0.0 110.616 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -147.78 145.33 28.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.254 1.502 . . . . 0.0 111.326 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -137.02 130.35 31.27 Favored 'General case' 0 N--CA 1.407 -2.621 0 CA-C-N 110.03 -3.259 . . . . 0.0 108.515 -173.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.35 140.79 31.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 O-C-N 123.874 0.734 . . . . 0.0 109.573 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -115.09 147.43 40.21 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.422 0.452 . . . . 0.0 110.561 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 118.25 10.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.39 -172.71 31.21 Favored Glycine 0 CA--C 1.502 -0.768 0 C-N-CA 119.493 -1.336 . . . . 0.0 115.749 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -123.3 149.9 44.24 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 125.101 1.118 . . . . 0.0 113.103 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.49 112.86 24.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.576 -2.556 . . . . 0.0 106.31 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' D' ' 106' ' ' ILE . 10.5 m-85 -108.41 155.97 19.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 118.893 0.77 . . . . 0.0 112.625 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -128.9 113.04 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.79 161.65 4.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.812 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -41.63 -48.29 4.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.553 1.541 . . . . 0.0 113.599 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.36 -29.97 70.26 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.23 24.53 5.38 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.124 1.345 . . . . 0.0 114.142 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -92.92 160.5 14.87 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.647 1.223 . . . . 0.0 108.128 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.01 147.67 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.363 1.465 . . . . 0.0 111.405 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' D' ' 106' ' ' ILE . 2.3 t -148.27 159.62 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.104 1.362 . . . . 0.0 110.088 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.1 mt -122.47 106.43 11.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CD ' HG11 ' A' ' 92' ' ' VAL . 3.9 mmtt -98.87 123.99 43.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -139.34 168.4 19.91 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.54 1.638 . . . . 0.0 113.652 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -118.71 163.15 17.26 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -136.9 162.23 33.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.632 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.758 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -145.52 120.82 10.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.78 -1.554 . . . . 0.0 111.676 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.74 137.57 45.52 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 125.152 1.532 . . . . 0.0 112.897 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -118.95 113.85 21.65 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 111.121 -2.763 . . . . 0.0 110.88 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.282 49.2 m -73.6 168.09 20.01 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.364 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 p -110.4 85.88 2.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.09 -164.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -131.49 -26.07 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.574 -1.329 . . . . 0.0 114.042 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.35 148.89 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.81 1.767 . . . . 0.0 111.916 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' D' ' 84' ' ' PHE . 19.5 tt -63.2 -22.49 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.343 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.86 2.69 54.04 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 117.969 -1.462 . . . . 0.0 113.634 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -120.36 1.9 10.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 9.8 t70 -59.72 -27.84 66.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.606 -1.934 . . . . 0.0 112.395 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 43.7 p-90 -46.08 -49.49 16.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.302 1.041 . . . . 0.0 113.042 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -89.29 -11.42 43.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.93 0.892 . . . . 0.0 112.703 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -76.34 -3.03 34.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.237 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.758 ' CG2' HD21 ' A' ' 98' ' ' LEU . 1.9 m -107.72 138.46 43.92 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.746 0.819 . . . . 0.0 112.585 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' HH11 ' A' ' 114' ' ' ARG . 18.4 mtt85 -141.35 130.37 23.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 110.821 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.45 158.25 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.933 1.242 . . . . 0.0 111.308 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.63 -177.51 36.54 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 14.7 p90 -126.69 155.56 42.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.913 -0.757 . . . . 0.0 111.858 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HB3' HD22 ' A' ' 12' ' ' ASN . 14.0 m-20 -148.13 155.73 41.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.539 1.161 . . . . 0.0 110.915 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.1 mt -139.32 120.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.06 153.92 27.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.466 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -142.14 165.99 25.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 123.5 14.84 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -71.17 112.12 7.06 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.287 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 66.56 87.46 0.12 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.019 1.728 . . . . 0.0 113.612 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t -138.68 40.25 2.19 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.317 1.447 . . . . 0.0 112.064 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 53.58 -161.4 0.12 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.816 1.246 . . . . 0.0 112.785 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -157.35 -9.92 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 127.628 2.371 . . . . 0.0 114.504 -174.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 127' ' ' LYS . 3.0 tt0 . . . . . 0 C--O 1.246 0.901 1 C-N-CA 134.004 4.921 . . . . 0.0 104.617 -173.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 117.952 -1.023 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 11.1 p -149.39 -83.49 0.1 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.071 1.348 . . . . 0.0 108.903 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.19 166.83 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.743 2.017 . . . . 0.0 108.751 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -121.19 178.63 4.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.936 1.294 . . . . 0.0 110.756 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -122.03 94.95 4.46 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.985 -1.072 . . . . 0.0 111.183 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 115.03 3.56 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.199 1.8 . . . . 0.0 108.422 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.25 123.49 47.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -143.02 136.26 28.23 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.41 -17.87 61.21 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -55.86 118.81 4.93 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.434 1.111 . . . . 0.0 111.704 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.2 -114.83 1.72 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 125.612 1.577 . . . . 0.0 111.239 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.83 141.37 21.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -139.18 162.8 34.08 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.559 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -142.52 147.92 36.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.92 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' ASN . . . . . 0.442 HD22 ' HB3' ' D' ' 118' ' ' ASN . 6.9 t-20 -108.15 145.66 33.84 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.897 0.879 . . . . 0.0 110.487 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.63 -27.02 57.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.819 1.248 . . . . 0.0 113.9 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' B' ' 110' ' ' TRP . 30.5 tp -71.41 -14.62 62.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.753 1.621 . . . . 0.0 113.384 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.14 -13.45 21.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.309 2.385 . . . . 0.0 113.975 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.39 154.55 41.08 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.094 1.447 . . . . 0.0 112.619 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.65 135.13 51.82 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.309 0.644 . . . . 0.0 110.764 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -128.77 144.42 51.16 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.472 -0.768 . . . . 0.0 111.987 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -133.77 131.48 39.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.964 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.81 122.3 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.64 -60.52 6.12 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 124.542 1.151 . . . . 0.0 112.24 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.1 156.08 8.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.538 1.135 . . . . 0.0 110.872 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.23 129.84 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.481 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -75.35 168.21 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.082 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -56.43 -26.8 54.72 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -80.16 -32.76 38.78 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.095 0.861 . . . . 0.0 110.606 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 -6.15 10.3 Favored Glycine 0 C--O 1.221 -0.703 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.486 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.59 149.77 46.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.218 1.407 . . . . 0.0 113.265 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PHE . . . . . 0.484 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.0 p90 -160.17 165.56 31.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.769 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 161.96 26.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -172.06 -165.26 28.93 Favored Glycine 0 N--CA 1.464 0.552 0 O-C-N 119.983 -1.698 . . . . 0.0 111.96 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 70.6 p -139.89 141.43 36.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.464 1.126 . . . . 0.0 113.337 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -119.52 122.43 41.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.094 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.689 HD11 HD12 ' D' ' 46' ' ' LEU . 2.8 mp -113.75 127.23 71.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 58.2 m -105.6 150.87 25.02 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.79 -12.31 14.62 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.49 146.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.312 1.445 . . . . 0.0 111.935 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.88 161.59 41.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.362 -1.462 . . . . 0.0 113.353 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -72.09 -21.48 61.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.717 0.407 . . . . 0.0 110.747 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.27 83.29 7.23 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 127.857 2.463 . . . . 0.0 109.915 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.76 28.0 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 124.489 3.459 . . . . 0.0 115.951 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.91 -5.65 47.83 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 1.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.136 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -21.53 115.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 168.3 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.401 2.28 . . . . 0.0 107.894 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.689 HD12 HD11 ' D' ' 34' ' ' ILE . 6.8 tt -54.01 139.03 35.75 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.325 1.45 . . . . 0.0 112.837 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -116.8 121.59 32.65 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.87 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.21 143.34 93.68 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.452 2.768 . . . . 0.0 111.474 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.452 HD12 ' C ' ' D' ' 49' ' ' LEU . 1.9 pp -132.63 161.68 33.29 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.998 0.919 . . . . 0.0 111.885 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 28' ' ' GLU . 12.0 tp -166.78 148.4 6.19 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.231 1.412 . . . . 0.0 112.011 -175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 -152.91 23.54 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 121.171 1.805 . . . . 0.0 111.804 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -142.56 142.65 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.672 0.789 . . . . 0.0 112.689 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.29 144.6 51.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.851 1.26 . . . . 0.0 111.183 174.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.56 149.49 29.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.942 0.877 . . . . 0.0 109.522 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -143.46 24.53 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.573 1.549 . . . . 0.0 111.648 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.48 -49.68 5.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.748 2.019 . . . . 0.0 111.536 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.23 178.45 8.06 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.087 0.867 . . . . 0.0 112.371 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 13.2 p -77.39 -42.27 36.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.603 1.961 . . . . 0.0 113.907 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -131.28 54.06 13.5 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.237 1.415 . . . . 0.0 112.05 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.25 173.59 9.35 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.571 2.181 . . . . 0.0 115.989 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.67 6.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.72 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -166.7 164.27 16.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.868 -1.515 . . . . 0.0 113.724 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.7 147.84 13.31 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 118.158 2.023 . . . . 0.0 118.158 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -164.05 154.03 14.7 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.7 152.7 21.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.209 1.804 . . . . 0.0 110.06 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -133.59 116.91 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.457 ' HB2' HG21 ' A' ' 52' ' ' ILE . 26.5 t30 -100.11 110.06 22.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.428 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -76.44 138.62 40.45 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -172.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -37.72 11.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.152 -1.386 . . . . 0.0 114.688 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -87.23 -15.7 37.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -152.54 121.68 6.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 126.553 1.941 . . . . 0.0 107.277 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -57.98 118.49 5.44 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.957 1.253 . . . . 0.0 110.179 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 66.1 p -174.75 169.34 3.55 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.992 1.717 . . . . 0.0 110.65 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -148.09 145.71 28.53 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-O 123.501 1.619 . . . . 0.0 111.081 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.0 OUTLIER -136.77 130.22 31.61 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 109.847 -3.342 . . . . 0.0 108.459 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.69 141.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -115.09 147.73 39.82 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 0.0 110.562 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.29 117.92 9.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.66 -171.9 29.44 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 119.398 -1.382 . . . . 0.0 115.566 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.559 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.4 OUTLIER -127.31 149.95 49.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.528 1.156 . . . . 0.0 113.309 -174.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.63 112.63 24.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.83 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' A' ' 106' ' ' ILE . 11.9 m-85 -111.22 153.09 26.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 119.458 1.026 . . . . 0.0 113.066 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.75 109.94 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 163.16 3.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.475 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -41.63 -42.3 2.46 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -12.67 60.03 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.57 44.71 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.086 1.327 . . . . 0.0 114.898 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -67.76 159.51 30.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.254 1.527 . . . . 0.0 110.705 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -120.11 145.49 46.85 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.858 1.663 . . . . 0.0 111.892 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 106' ' ' ILE . 2.2 t -147.31 158.29 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.751 1.22 . . . . 0.0 110.706 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -121.57 106.65 11.57 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.502 ' CD ' HG11 ' D' ' 92' ' ' VAL . 4.2 mmtt -99.34 123.98 44.06 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -139.35 168.22 20.31 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.577 1.656 . . . . 0.0 113.677 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.537 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.39 16.77 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 171.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -137.0 162.45 33.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.254 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -145.82 121.07 10.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.611 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.14 44.49 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 125.062 1.477 . . . . 0.0 112.917 -174.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.45 113.85 21.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 111.177 -2.738 . . . . 0.0 110.943 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.284 49.8 m -73.42 168.3 19.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.279 1.612 . . . . 0.0 111.337 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.9 86.02 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.07 -165.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -130.77 -26.28 2.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 149.23 40.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.859 1.79 . . . . 0.0 111.93 176.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 84' ' ' PHE . 19.1 tt -63.39 -22.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.213 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.92 4.06 54.72 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.99 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' ASP . . . . . 0.482 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 6.7 m-20 -120.99 2.67 10.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' D' ' 112' ' ' ALA . 8.9 t70 -60.34 -27.86 67.7 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.587 -1.946 . . . . 0.0 112.046 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.482 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.3 p-90 -45.69 -49.46 14.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.347 1.059 . . . . 0.0 113.107 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -89.61 -11.32 42.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.039 0.936 . . . . 0.0 112.558 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' D' ' 109' ' ' ASP . . . -76.61 -2.62 33.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.695 0.398 . . . . 0.0 111.437 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.763 ' CG2' HD21 ' D' ' 98' ' ' LEU . 1.8 m -107.9 138.59 43.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.638 0.775 . . . . 0.0 112.78 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ARG . . . . . 0.502 ' HG3' HH11 ' D' ' 114' ' ' ARG . 18.8 mtt85 -141.43 130.18 22.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.856 1.262 . . . . 0.0 111.032 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.32 158.26 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.891 1.223 . . . . 0.0 111.331 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.15 -177.9 36.48 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 14.7 p90 -126.07 155.33 41.74 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.913 -0.757 . . . . 0.0 111.477 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 118' ' ' ASN . . . . . 0.442 ' HB3' HD22 ' D' ' 12' ' ' ASN . 13.0 m-20 -148.03 154.69 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.072 0.939 . . . . 0.0 110.45 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' ILE . . . . . 0.456 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -137.31 120.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -111.84 153.26 26.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.348 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -138.38 164.86 28.25 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 121.4 7.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.071 0.948 . . . . 0.0 110.956 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 123' ' ' LEU . . . . . 0.611 HD23 ' N ' ' D' ' 124' ' ' ARG . 3.5 tt -85.96 109.33 18.69 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 124' ' ' ARG . . . . . 0.611 ' N ' HD23 ' D' ' 123' ' ' LEU . 0.1 OUTLIER 178.58 169.09 0.85 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.232 1.813 . . . . 0.0 108.694 173.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 9.3 t 43.68 -154.89 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.959 1.704 . . . . 0.0 113.788 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -151.64 140.81 21.28 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.415 1.886 . . . . 0.0 105.971 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . 0.483 0.0 OUTLIER 62.54 -45.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.766 2.826 . . . . 0.0 115.167 -173.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.481 1.08 1 C-N-CA 136.225 5.81 . . . . 0.0 108.751 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 119.12 -0.467 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 13.4 p -111.94 -67.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.973 0.806 . . . . 0.0 110.079 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.84 150.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.825 1.25 . . . . 0.0 109.531 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.77 -168.12 0.24 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.276 1.43 . . . . 0.0 112.799 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -131.81 83.55 2.1 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 110.233 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.23 111.88 2.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.7 1.6 . . . . 0.0 108.978 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.51 123.35 48.3 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -173.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -142.91 135.48 27.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.396 1.078 . . . . 0.0 113.528 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.48 -17.83 61.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -55.94 115.87 2.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.46 1.104 . . . . 0.0 111.407 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.34 -119.72 2.7 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.953 1.739 . . . . 0.0 110.887 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.21 143.79 27.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -142.13 162.78 34.6 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.249 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -142.1 146.84 35.84 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.976 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.433 HD22 ' HB3' ' B' ' 118' ' ' ASN . 6.4 t-20 -107.08 146.25 31.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.15 0.98 . . . . 0.0 110.386 -174.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.8 -27.77 52.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.862 1.265 . . . . 0.0 114.329 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.445 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.0 tp -72.14 -14.58 61.86 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.759 1.624 . . . . 0.0 113.225 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.03 -12.28 24.47 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.257 2.36 . . . . 0.0 114.077 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.53 153.58 41.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.154 1.477 . . . . 0.0 113.74 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.8 134.05 52.9 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 174.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -128.06 145.21 51.07 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.544 -0.722 . . . . 0.0 112.408 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -133.33 133.28 42.32 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.43 0.692 . . . . 0.0 109.673 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -132.87 122.18 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.65 -58.85 7.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.226 0.954 . . . . 0.0 112.378 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.64 153.55 4.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.121 1.368 . . . . 0.0 110.626 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.52 131.4 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 124.492 1.12 . . . . 0.0 111.371 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -75.52 168.79 19.34 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -55.61 -27.89 52.13 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -81.83 -35.55 29.3 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.059 0.845 . . . . 0.0 110.44 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 -6.33 9.27 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 117.22 -1.878 . . . . 0.0 114.663 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.514 ' HB2' HD21 ' C' ' 50' ' ' LEU . 1.4 pt-20 -67.07 141.57 57.45 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.48 1.64 . . . . 0.0 108.461 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.22 151.13 22.63 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.95 165.19 12.07 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.15 -164.93 31.14 Favored Glycine 0 C--O 1.237 0.33 0 O-C-N 120.547 -1.346 . . . . 0.0 111.568 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -141.45 142.76 33.64 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.287 1.041 . . . . 0.0 113.011 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -117.58 125.26 50.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.229 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.687 HD11 HD12 ' B' ' 46' ' ' LEU . 2.8 mp -116.09 125.93 73.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 30.6 m -106.34 144.98 32.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.88 -13.42 16.96 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.8 146.8 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.182 1.393 . . . . 0.0 112.113 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.66 161.42 42.17 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.301 -1.499 . . . . 0.0 113.264 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.85 -21.52 61.66 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.31 83.05 7.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.858 2.463 . . . . 0.0 110.084 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.8 29.15 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 124.645 3.563 . . . . 0.0 115.895 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.88 -5.49 52.38 Favored Glycine 0 N--CA 1.478 1.434 0 N-CA-C 118.194 2.038 . . . . 0.0 118.194 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.92 2.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.163 1.482 . . . . 0.0 114.148 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -21.27 111.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.15 167.63 16.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.334 2.254 . . . . 0.0 108.181 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.687 HD12 HD11 ' B' ' 34' ' ' ILE . 6.9 tt -53.78 138.54 35.46 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.398 1.479 . . . . 0.0 112.846 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -115.55 121.82 33.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.056 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.42 144.75 90.89 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.426 2.751 . . . . 0.0 111.455 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.47 154.36 48.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.148 0.979 . . . . 0.0 111.287 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -156.87 148.79 22.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.066 1.746 . . . . 0.0 109.944 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.19 -153.5 24.05 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 121.933 2.151 . . . . 0.0 111.66 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -142.39 142.43 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 143.45 50.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.192 0.597 . . . . 0.0 111.694 173.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -78.48 152.87 31.82 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.424 1.107 . . . . 0.0 109.549 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -147.29 25.45 1.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.568 1.547 . . . . 0.0 111.68 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -93.46 -49.21 6.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.985 2.114 . . . . 0.0 112.078 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 178.32 8.12 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.3 p -75.47 -43.06 51.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.042 1.737 . . . . 0.0 113.635 174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.2 54.21 13.37 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.25 1.42 . . . . 0.0 112.192 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -67.43 171.82 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.035 1.824 . . . . 0.0 115.79 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 174.58 7.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.129 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.77 164.61 16.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.529 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.4 147.8 12.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.43 154.75 16.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -88.38 150.72 23.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.22 1.808 . . . . 0.0 110.528 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.58 116.92 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.465 ' HB2' HG21 ' C' ' 52' ' ' ILE . 29.2 t30 -99.32 110.14 22.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.748 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -76.79 136.77 38.99 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.76 -37.93 12.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.667 -174.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -87.28 -15.11 39.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 21.8 t -152.58 122.66 7.07 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.42 1.888 . . . . 0.0 107.309 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.85 118.53 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.932 1.242 . . . . 0.0 110.078 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -174.92 168.98 3.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.19 1.796 . . . . 0.0 110.542 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.79 145.47 28.79 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.243 1.497 . . . . 0.0 111.181 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.1 m -137.31 130.21 30.46 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 110.095 -3.23 . . . . 0.0 108.588 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 m -113.47 140.84 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.892 0.745 . . . . 0.0 109.68 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -115.04 147.29 40.33 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 123.463 0.477 . . . . 0.0 110.452 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 117.99 10.21 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.55 -173.16 30.91 Favored Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 119.728 -1.225 . . . . 0.0 115.645 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.566 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.1 OUTLIER -124.77 149.92 46.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.579 1.18 . . . . 0.0 112.895 -175.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.44 112.66 24.4 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 111.358 -2.656 . . . . 0.0 105.488 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' C' ' 106' ' ' ILE . 11.5 m-85 -110.71 155.78 21.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 119.265 0.939 . . . . 0.0 112.666 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.34 117.99 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.95 162.79 10.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.195 0.998 . . . . 0.0 110.578 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -42.7 -44.85 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.595 1.558 . . . . 0.0 114.795 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -24.34 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.787 1.235 . . . . 0.0 113.541 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.46 5.45 26.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.446 1.498 . . . . 0.0 115.094 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -72.57 162.22 29.77 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 119.274 1.537 . . . . 0.0 110.809 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.45 142.51 51.26 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.527 1.531 . . . . 0.0 112.162 -173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' C' ' 106' ' ' ILE . 2.2 t -145.11 159.26 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 125.355 1.462 . . . . 0.0 110.701 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.4 107.18 11.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.506 ' CD ' HG11 ' B' ' 92' ' ' VAL . 3.8 mmtt -99.78 124.5 45.12 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 172.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.5 p -139.71 168.49 19.69 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.637 1.684 . . . . 0.0 113.662 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.563 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -118.85 163.18 17.27 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -136.96 162.83 32.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 0.0 111.647 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.19 121.06 9.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 138.33 44.18 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 125.198 1.561 . . . . 0.0 113.138 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.69 113.89 21.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.357 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.273 49.4 m -73.49 168.08 19.99 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.886 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.3 p -110.24 84.34 1.91 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.28 -167.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -127.2 -26.45 3.09 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.042 -1.036 . . . . 0.0 112.9 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.11 145.93 40.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 123.252 1.501 . . . . 0.0 112.521 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' C' ' 84' ' ' PHE . 19.3 tt -62.13 -23.77 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.851 175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.78 0.14 62.45 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 117.543 -1.698 . . . . 0.0 114.075 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 1.0 OUTLIER -117.55 1.07 12.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.808 1.304 . . . . 0.0 114.104 -178.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' B' ' 112' ' ' ALA . 9.7 t70 -59.59 -27.87 66.66 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 119.562 -1.961 . . . . 0.0 112.278 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.45 ' CD1' HD11 ' D' ' 14' ' ' LEU . 46.4 p-90 -46.38 -49.18 18.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.275 1.03 . . . . 0.0 113.157 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -88.86 -12.69 41.13 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.783 0.833 . . . . 0.0 112.367 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' B' ' 109' ' ' ASP . . . -75.26 -1.7 24.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.815 0.446 . . . . 0.0 111.577 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.771 ' CG2' HD21 ' B' ' 98' ' ' LEU . 1.9 m -109.13 137.7 46.62 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.614 0.765 . . . . 0.0 113.042 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.532 ' HG3' HH11 ' B' ' 114' ' ' ARG . 19.5 mtt85 -140.69 130.21 24.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.633 1.173 . . . . 0.0 110.676 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.88 158.88 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.044 1.293 . . . . 0.0 111.236 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.73 -177.33 36.47 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 14.4 p90 -126.87 156.03 42.03 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.819 -0.812 . . . . 0.0 111.937 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ASN . . . . . 0.433 ' HB3' HD22 ' B' ' 12' ' ' ASN . 14.1 m-20 -148.46 155.34 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.554 1.168 . . . . 0.0 110.856 174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.438 HD13 ' HE3' ' B' ' 94' ' ' LYS . 10.5 mt -138.26 119.83 17.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.21 152.52 27.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.467 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 21.5 p -139.13 164.2 30.41 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.57 128.99 31.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.291 1.036 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.16 150.56 47.96 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -11.08 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 129.643 3.177 . . . . 0.0 115.296 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 12.1 t -144.17 4.68 1.25 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 110.42 -176.44 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 131.197 3.799 . . . . 0.0 108.763 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.3 4.3 ptmm? -151.22 41.11 0.72 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' B' ' 128' ' ' GLU . 1.1 pm0 . . . . . 0 C--O 1.261 1.68 0 C-N-CA 127.528 2.331 . . . . 0.0 112.962 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 117.375 -1.298 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.4 m 50.7 35.25 11.41 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.574 1.15 . . . . 0.0 113.867 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 12.5 m -88.58 166.12 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.23 -51.44 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.543 0.737 . . . . 0.0 111.957 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.09 76.43 0.22 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.149 1.779 . . . . 0.0 111.094 174.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.56 115.46 3.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.619 1.168 . . . . 0.0 110.723 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 83' ' ' CYS . 0.1 OUTLIER -116.39 123.74 48.32 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -176.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -143.22 137.9 29.29 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.245 -1.535 . . . . 0.0 113.564 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.43 -18.95 61.08 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -56.29 115.91 2.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.387 1.075 . . . . 0.0 111.615 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.53 -119.63 2.5 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.838 1.685 . . . . 0.0 111.139 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 142.27 24.8 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -140.87 162.8 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.785 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -142.83 145.13 32.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.635 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' C' ' 118' ' ' ASN . 6.6 t-20 -105.89 146.97 29.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.186 0.995 . . . . 0.0 110.582 -174.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.18 -26.48 64.83 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 110' ' ' TRP . 30.3 tp -71.44 -14.63 62.21 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.697 1.599 . . . . 0.0 112.983 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.69 -13.23 22.7 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.071 2.272 . . . . 0.0 113.99 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 154.3 37.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.958 1.379 . . . . 0.0 113.835 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 136.59 53.22 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -130.27 145.37 51.75 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.561 -0.712 . . . . 0.0 112.004 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -134.29 132.46 39.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.259 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.22 120.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.46 -56.9 12.85 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.535 1.147 . . . . 0.0 112.658 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.53 155.63 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.494 1.518 . . . . 0.0 110.648 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.41 129.72 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.611 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -75.18 167.93 20.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -56.38 -27.06 55.1 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -79.53 -33.77 41.7 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.083 0.856 . . . . 0.0 110.647 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.09 9.53 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 124.123 0.868 . . . . 0.0 114.373 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.02 149.96 46.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.218 1.407 . . . . 0.0 113.019 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PHE . . . . . 0.477 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.2 p90 -160.22 166.05 30.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.55 0.74 . . . . 0.0 110.84 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.8 p -125.57 162.34 25.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.99 -165.55 29.32 Favored Glycine 0 N--CA 1.464 0.542 0 O-C-N 119.955 -1.716 . . . . 0.0 111.986 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.9 p -140.37 140.74 35.59 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.522 1.153 . . . . 0.0 113.116 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -118.63 124.87 48.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.906 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.694 HD11 HD12 ' C' ' 46' ' ' LEU . 2.9 mp -114.98 127.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 45.0 m -108.3 145.67 34.06 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.39 -11.6 17.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.91 146.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.102 1.361 . . . . 0.0 111.918 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.38 161.24 42.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.498 -1.376 . . . . 0.0 113.355 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.42 -22.54 61.84 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.603 0.361 . . . . 0.0 110.589 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -147.69 83.57 7.46 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.767 2.427 . . . . 0.0 110.111 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.82 28.27 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 124.548 3.499 . . . . 0.0 115.895 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.75 48.92 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.9 2.3 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.071 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 60.8 mt -22.0 112.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.46 168.21 16.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.449 2.3 . . . . 0.0 108.131 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.694 HD12 HD11 ' C' ' 34' ' ' ILE . 6.8 tt -53.96 139.1 35.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.463 1.505 . . . . 0.0 112.724 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -116.39 121.16 33.79 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.195 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.15 143.18 93.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.391 2.727 . . . . 0.0 111.56 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.454 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -132.43 161.71 32.99 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.912 0.885 . . . . 0.0 111.694 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 28' ' ' GLU . 12.0 tp -166.56 148.73 6.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.131 1.373 . . . . 0.0 111.87 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.39 -153.04 23.73 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 121.563 1.983 . . . . 0.0 111.986 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -142.73 142.38 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 112.554 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.05 144.91 51.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.005 1.322 . . . . 0.0 111.01 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.72 151.13 29.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.771 0.796 . . . . 0.0 109.393 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -143.99 23.95 1.68 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.381 1.472 . . . . 0.0 111.686 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.36 -50.35 5.5 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.894 2.078 . . . . 0.0 111.84 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.36 178.18 7.88 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.822 0.701 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 13.5 p -75.14 -42.48 56.14 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.751 1.62 . . . . 0.0 113.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -132.37 53.54 11.45 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -66.55 172.42 9.26 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 121.804 1.669 . . . . 0.0 115.716 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 174.52 7.12 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.138 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.73 164.24 16.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.558 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.8 147.58 12.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 118.151 2.02 . . . . 0.0 118.151 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -163.52 154.22 16.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.67 152.73 21.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.372 1.869 . . . . 0.0 110.136 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.67 116.84 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.437 ' HB2' HG21 ' B' ' 52' ' ' ILE . 26.0 t30 -100.26 109.55 21.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.426 -173.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -76.23 138.66 40.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -37.69 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -87.31 -15.49 37.85 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.7 t -152.5 122.41 7.01 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.377 1.871 . . . . 0.0 107.236 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -58.32 118.57 5.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.002 1.274 . . . . 0.0 110.274 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 70.3 p -175.42 168.59 3.25 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.101 1.76 . . . . 0.0 110.553 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.2 t -147.84 146.01 28.94 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-O 123.489 1.614 . . . . 0.0 111.028 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.36 130.15 30.25 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 109.872 -3.331 . . . . 0.0 108.79 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -112.51 142.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -115.5 148.07 39.92 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.885 0.74 . . . . 0.0 110.597 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 117.91 9.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.64 -172.72 30.46 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.547 -1.311 . . . . 0.0 115.687 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.565 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.1 OUTLIER -125.86 149.64 48.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.606 1.193 . . . . 0.0 113.028 -174.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 4' ' ' CYS . 0.5 OUTLIER -97.38 112.55 24.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.409 -2.632 . . . . 0.0 105.437 -175.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.7 m-85 -110.67 154.43 23.84 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.283 0.947 . . . . 0.0 112.72 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.84 115.34 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.99 162.09 11.96 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.806 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -42.82 -41.86 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.015 1.726 . . . . 0.0 115.577 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.35 -3.24 42.09 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.92 5.2 64.48 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.603 1.573 . . . . 0.0 115.19 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -71.72 162.27 29.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 1.242 . . . . 0.0 110.195 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -123.34 141.46 51.96 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.658 1.583 . . . . 0.0 111.235 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' B' ' 106' ' ' ILE . 2.4 t -143.15 159.44 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 125.368 1.467 . . . . 0.0 110.867 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.23 107.79 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 172.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' C' ' 92' ' ' VAL . 3.7 mmtt -100.56 123.97 45.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -138.92 168.1 20.58 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 123.645 1.688 . . . . 0.0 113.866 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.551 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.79 16.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.135 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -136.97 162.87 32.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.395 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -146.27 121.19 9.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.683 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.13 44.51 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 125.216 1.572 . . . . 0.0 113.044 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -119.78 113.93 21.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 111.372 -2.649 . . . . 0.0 111.12 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.279 50.2 m -73.49 168.1 19.95 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 125.365 1.666 . . . . 0.0 111.664 174.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.59 86.78 2.38 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.75 -165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -130.0 -25.42 2.52 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.947 -1.095 . . . . 0.0 113.251 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.03 147.16 39.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.366 1.555 . . . . 0.0 112.259 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 84' ' ' PHE . 18.8 tt -62.93 -23.25 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.892 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.61 60.17 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.767 -1.574 . . . . 0.0 114.075 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' ASP . . . . . 0.44 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.5 OUTLIER -118.8 0.95 11.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.738 1.269 . . . . 0.0 113.833 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 109' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' C' ' 112' ' ' ALA . 9.0 t70 -59.4 -27.91 66.42 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.629 -1.92 . . . . 0.0 112.368 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.446 ' CD1' HD11 ' A' ' 14' ' ' LEU . 46.1 p-90 -46.1 -49.13 16.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.229 1.012 . . . . 0.0 113.379 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -89.06 -12.32 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.607 0.763 . . . . 0.0 112.67 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' C' ' 109' ' ' ASP . . . -75.57 -2.09 27.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.693 0.397 . . . . 0.0 111.409 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' C' ' 98' ' ' LEU . 2.0 m -108.55 138.71 44.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.55 0.74 . . . . 0.0 112.742 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.504 HH11 ' HG3' ' C' ' 114' ' ' ARG . 19.4 mtt85 -141.25 130.55 23.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.943 1.297 . . . . 0.0 110.831 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.17 158.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.272 . . . . 0.0 111.213 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.06 -177.45 36.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 13.4 p90 -126.68 155.82 42.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.851 -0.793 . . . . 0.0 111.861 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 118' ' ' ASN . . . . . 0.448 ' HB3' HD22 ' C' ' 12' ' ' ASN . 13.9 m-20 -148.47 154.58 40.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.386 1.089 . . . . 0.0 111.089 174.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' ILE . . . . . 0.444 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.0 mt -137.17 120.97 22.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.21 152.62 28.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.943 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.5 p -138.44 163.04 32.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.72 135.01 36.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.312 0.645 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.12 156.97 11.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.06 1.41 . . . . 0.0 111.186 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 84.61 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.679 3.192 . . . . 0.0 115.403 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -25.93 3.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -157.03 176.99 12.02 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.987 1.267 . . . . 0.0 110.68 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -136.96 141.23 42.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.567 1.547 . . . . 0.0 112.289 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.249 1.051 1 C-N-CA 137.845 6.458 . . . . 0.0 100.332 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 115.706 -2.092 . . . . 0.0 105.991 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 5.1 m -123.97 95.25 4.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.279 1.854 . . . . 0.0 110.263 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.04 145.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 0.0 109.249 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -64.16 156.25 29.11 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.672 -0.643 . . . . 0.0 111.283 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.34 15.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -131.04 151.45 51.4 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.11 2.164 . . . . 0.0 109.617 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.28 150.09 38.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.367 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 p -139.33 127.44 22.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.205 1.002 . . . . 0.0 112.311 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD21 ' CE2' ' A' ' 64' ' ' PHE . 73.9 mt -69.24 -34.44 74.83 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -47.57 110.97 0.36 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.021 1.328 . . . . 0.0 111.077 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.38 -130.17 4.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 125.312 1.434 . . . . 0.0 109.584 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -146.14 144.87 30.24 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.073 0.949 . . . . 0.0 112.721 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -136.64 162.9 31.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.188 1.395 . . . . 0.0 111.391 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -140.62 150.95 44.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.11 0.964 . . . . 0.0 109.567 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.66 143.54 47.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.385 1.074 . . . . 0.0 110.348 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -60.52 -22.16 63.28 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.45 1.5 . . . . 0.0 113.338 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -72.52 -15.61 61.78 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.629 1.172 . . . . 0.0 111.094 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.76 -16.43 18.73 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.639 3.019 . . . . 0.0 113.395 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.42 148.87 40.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.065 1.412 . . . . 0.0 112.955 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -123.46 136.52 54.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.779 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -127.46 143.26 51.22 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.535 0.684 . . . . 0.0 112.154 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -131.34 130.98 43.39 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.979 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.59 126.03 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.52 -85.55 0.13 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.48 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.03 145.79 30.73 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.86 0.838 . . . . 0.0 111.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' A' ' 53' ' ' GLN . 11.2 p -100.17 129.65 50.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.16 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -75.65 168.96 19.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.995 0.902 . . . . 0.0 112.386 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -58.7 -26.34 63.77 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.89 -40.65 75.53 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.374 -0.829 . . . . 0.0 110.822 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.05 -7.34 12.89 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 117.558 -1.69 . . . . 0.0 112.694 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HB2' HD21 ' D' ' 50' ' ' LEU . 4.7 pt-20 -67.18 146.69 53.96 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.693 1.597 . . . . 0.0 107.469 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.79 166.05 34.67 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.229 175.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 p -124.75 177.76 5.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.8 -167.51 39.76 Favored Glycine 0 CA--C 1.521 0.439 0 O-C-N 120.372 -1.455 . . . . 0.0 112.262 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' HD11 ' A' ' 46' ' ' LEU . 49.4 p -139.8 137.73 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.93 1.347 . . . . 0.0 111.947 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -111.46 138.77 47.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.161 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 46' ' ' LEU . 27.5 mt -130.01 128.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 174.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 44' ' ' ILE . 49.6 m -105.15 144.09 32.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -172.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.6 -13.25 17.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.79 143.15 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.352 1.061 . . . . 0.0 112.715 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.49 43.84 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.407 -0.808 . . . . 0.0 111.74 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.77 -28.52 64.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.765 -0.584 . . . . 0.0 109.499 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -140.64 75.35 26.21 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.966 2.507 . . . . 0.0 110.836 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.14 61.06 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.365 1 C-N-CA 125.627 4.218 . . . . 0.0 115.028 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.44 13.41 39.56 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 120.163 -1.586 . . . . 0.0 116.795 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -172.32 -29.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.037 1.335 . . . . 0.0 113.298 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 35' ' ' THR 0.322 47.6 mt 4.48 91.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.449 2.3 . . . . 0.0 116.533 -172.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 159.13 18.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 111.563 -2.562 . . . . 0.0 109.337 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.525 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.2 tt -46.74 126.82 9.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.848 2.059 . . . . 0.0 113.131 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.8 p -103.8 120.25 51.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 122.966 0.506 . . . . 0.0 111.898 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 144.01 84.62 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.327 2.684 . . . . 0.0 112.872 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.38 154.67 44.71 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.916 0.886 . . . . 0.0 112.418 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -159.75 149.21 18.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.794 2.038 . . . . 0.0 110.112 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.8 -147.69 16.44 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 121.583 1.992 . . . . 0.0 109.961 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -145.74 141.06 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.688 0.795 . . . . 0.0 112.707 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.93 139.96 52.68 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.794 -1.191 . . . . 0.0 113.147 174.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -76.97 158.09 30.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.049 -1.657 . . . . 0.0 113.638 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -158.48 21.63 0.23 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.432 1.493 . . . . 0.0 112.51 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -87.23 -54.62 4.21 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.516 1.126 . . . . 0.0 109.999 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.33 173.11 10.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.748 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.38 -34.74 31.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.786 0.834 . . . . 0.0 112.504 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.22 47.6 2.86 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.993 1.317 . . . . 0.0 112.065 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.9 176.07 10.36 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.16 2.573 . . . . 0.0 115.341 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.329 0.0 OUTLIER -100.13 171.07 8.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 123.21 1.481 . . . . 0.0 112.194 173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' A' ' 6' ' ' LEU . 1.2 p90 -160.64 167.25 27.38 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.401 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.66 144.99 9.52 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 118.482 2.153 . . . . 0.0 118.482 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.25 158.57 30.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -95.35 152.41 18.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.583 1.553 . . . . 0.0 108.823 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.67 118.84 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' D' ' 52' ' ' ILE . 0.2 OUTLIER -92.83 116.21 28.82 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -177.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.314 46.2 m95 -80.49 134.64 35.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.413 1.577 . . . . 0.0 114.431 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -89.56 -40.63 12.5 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -88.78 -15.87 33.55 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -151.43 130.29 12.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 129.389 3.076 . . . . 0.0 106.102 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -68.67 118.62 11.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.032 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -173.85 161.76 3.84 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 127.342 2.257 . . . . 0.0 108.802 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 140.15 30.94 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 123.105 1.431 . . . . 0.0 111.151 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.8 m -139.08 129.29 25.39 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 110.34 -3.118 . . . . 0.0 110.555 -171.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -106.88 154.84 7.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.039 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.76 142.36 51.33 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.68 121.23 9.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.16 176.15 42.15 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 118.799 -1.667 . . . . 0.0 116.866 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -112.33 149.95 31.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.831 1.301 . . . . 0.0 112.929 -174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 19.6 t -97.18 130.37 44.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.806 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' D' ' 106' ' ' ILE . 3.8 m-85 -119.75 166.03 13.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.94 0.876 . . . . 0.0 111.749 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mt -128.77 109.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -59.57 159.65 8.11 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -28.45 -51.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -11.39 60.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.205 1.802 . . . . 0.0 115.706 -174.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.07 51.77 3.27 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 120.383 1.447 . . . . 0.0 110.235 -173.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.21 136.64 53.07 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.521 2.328 . . . . 0.0 107.755 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -101.34 144.09 30.59 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.628 1.171 . . . . 0.0 109.974 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.2 m -147.9 162.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.652 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.1 116.87 25.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.5 mmtt -104.92 120.51 41.62 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 p -137.25 166.91 22.64 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 123.358 1.551 . . . . 0.0 113.723 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.425 ' HG3' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -117.25 165.9 12.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 172.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -141.1 159.6 41.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.238 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.9 tt -144.42 126.17 15.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.913 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.18 143.64 40.0 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 125.379 1.674 . . . . 0.0 112.381 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.69 114.34 17.87 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 111.416 -2.629 . . . . 0.0 111.736 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.252 44.6 m -67.12 175.45 2.59 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 125.635 1.834 . . . . 0.0 113.083 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.4 p -117.93 67.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 107.948 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.63 167.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 120.921 -1.112 . . . . 0.0 111.709 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -102.78 -32.35 9.86 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -109.03 148.77 30.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.82 1.295 . . . . 0.0 111.407 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.806 HD11 ' HE2' ' D' ' 94' ' ' LYS . 15.0 tt -63.32 -30.78 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 113.426 -1.716 . . . . 0.0 109.979 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.88 5.75 3.32 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.801 -1.555 . . . . 0.0 113.726 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -121.41 1.92 10.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.809 1.305 . . . . 0.0 113.69 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -33.48 75.38 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.402 -0.811 . . . . 0.0 111.713 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.418 ' CD1' HD11 ' C' ' 14' ' ' LEU . 58.1 p-90 -46.88 -40.99 15.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -99.34 -6.72 27.38 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.359 1.063 . . . . 0.0 113.463 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.95 0.32 21.51 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.798 ' CG2' HD21 ' A' ' 98' ' ' LEU . 5.9 m -110.36 138.44 46.74 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.74 0.816 . . . . 0.0 112.072 176.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -140.59 124.79 17.55 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 125.184 1.394 . . . . 0.0 110.723 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.56 158.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.13 1.372 . . . . 0.0 111.317 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.02 -178.46 37.59 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.027 0.822 . . . . 0.0 113.326 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -124.98 156.74 37.6 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.755 -0.85 . . . . 0.0 111.705 175.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -147.7 157.91 43.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.416 1.103 . . . . 0.0 109.664 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.2 mt -133.37 138.36 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -125.72 149.14 48.75 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.285 1.041 . . . . 0.0 111.264 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 p -133.05 161.09 35.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.661 1.184 . . . . 0.0 110.352 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.09 113.16 2.96 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.614 0.765 . . . . 0.0 112.233 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -89.05 94.83 10.08 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 140.35 79.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 129.693 3.197 . . . . 0.0 111.663 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 t -161.74 172.09 16.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.586 1.155 . . . . 0.0 108.956 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -143.91 -59.59 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.37 0.0 OUTLIER 74.56 13.48 3.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.516 1.927 . . . . 0.0 114.965 174.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--O 1.261 1.68 1 C-N-CA 133.876 4.87 . . . . 0.0 105.763 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 116.692 -1.623 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 2.0 m -72.76 55.55 0.38 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.531 1.532 . . . . 0.0 112.405 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 31.0 m -94.91 157.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.732 1.213 . . . . 0.0 110.261 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -95.99 139.33 32.33 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.62 -0.675 . . . . 0.0 111.743 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -64.35 -1.56 1.75 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -133.03 147.29 52.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.953 1.701 . . . . 0.0 109.132 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.3 144.84 43.71 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.255 1.022 . . . . 0.0 109.62 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -139.7 127.85 22.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' D' ' 64' ' ' PHE . 80.5 mt -69.8 -33.01 71.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -48.83 113.46 0.79 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.511 1.124 . . . . 0.0 110.531 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.3 -132.5 5.85 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -147.23 143.67 28.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -136.09 162.55 32.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.221 1.408 . . . . 0.0 111.96 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.43 ' HB ' HD12 ' D' ' 123' ' ' LEU . 8.9 t -137.7 151.79 48.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.229 1.012 . . . . 0.0 109.231 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -119.89 143.79 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.232 1.013 . . . . 0.0 110.681 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -58.41 -25.31 62.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.462 1.505 . . . . 0.0 113.66 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' B' ' 110' ' ' TRP . 28.5 tp -70.25 -15.47 62.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.588 1.155 . . . . 0.0 111.711 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.23 -12.21 28.73 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 128.238 2.828 . . . . 0.0 113.515 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.65 149.65 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.265 1.507 . . . . 0.0 113.33 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -125.53 137.37 53.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.921 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -128.14 144.36 51.11 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -131.66 131.17 42.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.206 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 80.8 mt -131.13 124.52 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -86.42 0.08 OUTLIER Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.208 0.943 . . . . 0.0 111.733 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.24 145.28 31.22 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.803 -0.822 . . . . 0.0 110.676 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' D' ' 53' ' ' GLN . 11.3 p -99.72 130.37 48.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.053 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.99 166.7 23.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 112.382 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -26.02 63.98 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -67.89 -39.25 83.69 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.273 -0.892 . . . . 0.0 111.129 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.53 -6.55 11.53 Favored Glycine 0 C--O 1.221 -0.698 0 C-N-CA 124.728 1.156 . . . . 0.0 113.402 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.89 152.99 43.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.151 1.781 . . . . 0.0 112.258 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.38 30.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.252 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p -123.53 -177.13 3.63 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.71 -167.13 40.16 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 119.41 -2.056 . . . . 0.0 112.622 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' D' ' 46' ' ' LEU . 52.1 p -139.55 137.68 35.63 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.56 0.695 . . . . 0.0 112.346 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -112.83 138.71 49.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.377 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.437 HD11 HD12 ' D' ' 46' ' ' LEU . 31.2 mt -130.72 128.42 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.408 ' O ' HG21 ' D' ' 44' ' ' ILE . 54.6 m -105.74 144.82 31.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.1 -13.62 17.42 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.73 142.76 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.245 1.018 . . . . 0.0 112.607 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.55 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.153 -0.967 . . . . 0.0 111.474 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -70.5 -29.15 65.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.15 75.3 29.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 127.893 2.477 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.12 61.25 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.358 1 C-N-CA 125.629 4.22 . . . . 0.0 115.13 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.61 13.58 38.96 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 120.099 -1.626 . . . . 0.0 116.844 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -172.51 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.158 1.383 . . . . 0.0 113.401 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.408 HG21 ' O ' ' D' ' 35' ' ' THR 0.321 49.2 mt 4.55 91.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.627 2.371 . . . . 0.0 116.365 -172.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.58 159.31 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.584 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.1 tt -46.82 126.15 8.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.674 1.99 . . . . 0.0 112.88 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.03 120.53 52.02 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.158 0.583 . . . . 0.0 111.634 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.06 143.78 82.18 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.166 2.577 . . . . 0.0 112.438 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.498 HD12 ' C ' ' D' ' 49' ' ' LEU . 0.6 OUTLIER -127.75 160.33 32.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.953 0.901 . . . . 0.0 112.598 177.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 28' ' ' GLU . 15.3 tp -169.01 149.01 4.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 0.0 112.642 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 -144.1 10.45 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 121.091 1.769 . . . . 0.0 109.774 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.709 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.9 mt -147.53 139.37 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.769 0.827 . . . . 0.0 111.592 -175.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -125.36 138.45 54.05 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.163 1.385 . . . . 0.0 112.612 175.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -76.7 157.52 31.69 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 119.9 -1.75 . . . . 0.0 113.172 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -156.96 19.39 0.31 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 0.0 112.5 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -84.96 -54.11 4.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.766 1.227 . . . . 0.0 110.085 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 172.67 11.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.911 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -31.77 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.28 1.032 . . . . 0.0 113.378 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -130.17 50.58 6.18 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 125.118 1.367 . . . . 0.0 112.589 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.24 175.96 10.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.989 2.46 . . . . 0.0 116.274 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.335 0.0 OUTLIER -100.82 170.17 8.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.104 1.431 . . . . 0.0 111.808 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.482 ' CE2' HD21 ' D' ' 6' ' ' LEU . 1.4 p90 -161.01 167.29 26.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.82 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.32 145.43 10.0 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 118.431 2.133 . . . . 0.0 118.431 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.88 158.69 28.68 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -95.02 152.42 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.569 1.948 . . . . 0.0 108.472 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.58 117.78 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.7 ' HB2' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -92.85 117.21 29.78 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.407 -0.808 . . . . 0.0 109.927 -177.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.3 46.3 m95 -80.46 137.39 36.47 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.543 1.64 . . . . 0.0 114.246 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -92.67 -39.45 11.28 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.3 -14.94 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -152.27 131.59 12.85 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 129.319 3.048 . . . . 0.0 106.241 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.4 118.64 12.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 10.8 m -173.53 161.82 4.09 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 127.222 2.209 . . . . 0.0 108.978 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.8 t -143.28 140.31 30.56 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.114 1.435 . . . . 0.0 110.842 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.05 128.79 24.74 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 110.509 -3.041 . . . . 0.0 110.451 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.12 154.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.038 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -127.64 141.8 51.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.1 121.69 10.44 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.78 174.46 42.15 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 118.748 -1.691 . . . . 0.0 116.786 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.51 146.65 38.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.021 1.071 . . . . 0.0 111.967 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 48.9 t -97.62 134.23 41.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.138 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' A' ' 106' ' ' ILE . 5.5 m-85 -122.31 164.93 17.05 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.203 1.001 . . . . 0.0 111.366 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.98 105.33 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -63.38 154.22 32.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -22.42 -51.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.072 2.549 . . . . 0.0 117.39 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -76.08 -7.2 54.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.253 1.821 . . . . 0.0 115.784 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.38 51.38 3.52 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.925 0.784 . . . . 0.0 111.231 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 135.96 54.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 108.784 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.29 144.6 29.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.17 0.986 . . . . 0.0 109.572 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 106' ' ' ILE . 25.1 m -148.51 159.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.818 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mt -117.72 117.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.806 ' HE2' HD11 ' A' ' 106' ' ' ILE . 4.0 mmtt -105.47 119.06 38.14 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -136.95 167.09 22.16 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.258 1.504 . . . . 0.0 113.639 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.421 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -117.13 166.51 12.15 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -141.58 160.09 40.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.101 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.9 tt -144.83 126.6 15.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.771 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.03 144.45 38.59 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 125.51 1.756 . . . . 0.0 112.082 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -127.45 114.36 17.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.677 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 42.5 m -67.01 175.33 2.58 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 125.803 1.939 . . . . 0.0 113.0 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.9 p -117.74 66.64 0.75 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.11 1.364 . . . . 0.0 108.251 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.69 167.47 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.988 -1.07 . . . . 0.0 111.999 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -101.52 -32.26 10.48 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.0 149.89 31.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 122.709 1.242 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.775 HD11 ' HE2' ' A' ' 94' ' ' LYS . 15.2 tt -62.96 -29.01 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.21 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.51 6.13 4.88 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.501 1.048 . . . . 0.0 113.586 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -122.2 2.26 9.77 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.509 1.155 . . . . 0.0 113.712 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.74 -34.02 76.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.312 -0.868 . . . . 0.0 112.14 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.2 p-90 -46.19 -41.43 12.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.28 1.032 . . . . 0.0 113.728 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -99.48 -6.79 26.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.215 1.006 . . . . 0.0 113.365 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.65 -0.21 22.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.776 ' CG2' HD21 ' D' ' 98' ' ' LEU . 5.7 m -109.33 138.8 45.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.477 0.711 . . . . 0.0 111.792 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -140.76 124.79 17.31 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 125.56 1.544 . . . . 0.0 111.247 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.6 158.89 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.08 1.352 . . . . 0.0 111.166 176.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.17 -179.53 38.43 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.939 0.781 . . . . 0.0 113.441 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 0.0 OUTLIER -123.77 156.37 36.19 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.759 -0.848 . . . . 0.0 111.571 176.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -147.72 157.36 43.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.09 0.948 . . . . 0.0 109.855 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.58 136.65 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -124.45 151.25 44.77 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 18.7 p -134.65 160.81 36.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.746 1.218 . . . . 0.0 110.186 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 129.43 41.36 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.53 -0.731 . . . . 0.0 110.855 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 123' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER -66.87 168.8 9.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.306 175.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 124' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' D' ' 124' ' ' ARG 0.31 0.0 OUTLIER -58.52 134.96 57.16 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.363 -0.836 . . . . 0.0 112.629 174.303 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -77.32 0.23 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.596 1.158 . . . . 0.0 109.044 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -111.72 131.52 55.25 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.909 1.684 . . . . 0.0 106.563 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.54 59.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.535 1.934 . . . . 0.0 110.35 -172.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 114.996 -2.43 . . . . 0.0 107.842 -172.305 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.6 t -152.78 29.76 0.52 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.81 1.291 . . . . 0.0 112.235 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 10.2 p -153.69 40.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.004 2.121 . . . . 0.0 109.529 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -169.14 153.32 5.42 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.491 -1.381 . . . . 0.0 111.501 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 65.24 -43.96 0.35 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 128.28 2.632 . . . . 0.0 116.669 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -138.13 155.84 48.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.219 2.208 . . . . 0.0 109.038 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.23 142.01 50.89 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 109.478 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -139.66 127.88 22.55 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' B' ' 64' ' ' PHE . 84.5 mt -69.23 -31.53 70.16 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -48.96 113.25 0.75 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.332 1.053 . . . . 0.0 111.028 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.32 -131.11 5.24 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.63 1.586 . . . . 0.0 109.452 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -146.38 143.21 28.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.46 1.104 . . . . 0.0 113.293 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' TRP . . . . . 0.421 ' CH2' HD21 ' B' ' 93' ' ' LEU . 45.3 m95 -135.56 162.75 31.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.297 1.439 . . . . 0.0 111.737 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -141.27 150.55 42.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.97 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -122.12 143.78 49.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.389 1.076 . . . . 0.0 111.025 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -58.88 -25.34 63.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.608 1.563 . . . . 0.0 113.458 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' D' ' 110' ' ' TRP . 28.9 tp -70.68 -15.63 62.73 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.371 1.081 . . . . 0.0 111.619 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.32 -13.98 23.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 128.415 2.912 . . . . 0.0 113.47 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 148.57 44.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 123.113 1.435 . . . . 0.0 113.252 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -122.7 136.08 54.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.671 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -131.05 131.19 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -130.2 124.39 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.32 -84.34 0.11 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.537 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.79 32.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.76 -0.847 . . . . 0.0 110.85 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.588 HG21 ' HG3' ' B' ' 53' ' ' GLN . 10.9 p -102.66 130.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.294 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -75.94 168.77 19.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.942 0.877 . . . . 0.0 112.207 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 81.5 p -58.59 -26.08 63.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -70.1 -40.58 74.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.324 -0.86 . . . . 0.0 110.981 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.85 -7.17 13.32 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.523 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' C' ' 50' ' ' LEU . 4.2 pt-20 -67.33 146.75 53.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.649 1.58 . . . . 0.0 107.416 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 166.22 34.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.108 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.6 p -125.39 176.85 6.51 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.66 -167.54 39.46 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 120.321 -1.487 . . . . 0.0 112.302 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.529 ' HB ' HD11 ' B' ' 46' ' ' LEU . 48.5 p -139.76 137.52 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.607 1.194 . . . . 0.0 112.016 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -110.88 139.0 46.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.23 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' B' ' 46' ' ' LEU . 27.5 mt -130.59 128.02 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.406 ' O ' HG21 ' B' ' 44' ' ' ILE . 42.7 m -105.21 144.25 32.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.64 -13.72 17.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.24 143.46 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.328 1.051 . . . . 0.0 112.701 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.03 43.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.424 -0.798 . . . . 0.0 111.464 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -71.21 -28.82 64.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.24 75.66 27.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.926 2.49 . . . . 0.0 111.038 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.22 61.86 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.409 1 C-N-CA 125.583 4.188 . . . . 0.0 115.02 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.97 13.56 37.74 Favored Glycine 0 N--CA 1.481 1.659 0 O-C-N 120.269 -1.519 . . . . 0.0 116.862 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -172.36 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.174 1.39 . . . . 0.0 113.297 -174.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.406 HG21 ' O ' ' B' ' 35' ' ' THR 0.324 50.3 mt 5.35 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.616 2.366 . . . . 0.0 116.323 -172.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.63 159.19 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 111.607 -2.542 . . . . 0.0 109.32 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.5 tt -46.84 127.97 10.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.768 2.027 . . . . 0.0 112.926 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -104.96 120.65 49.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.083 0.553 . . . . 0.0 111.846 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.33 144.38 82.72 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.034 2.489 . . . . 0.0 112.947 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.47 154.37 45.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 112.633 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -159.97 149.14 17.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.531 1.932 . . . . 0.0 109.949 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.72 -147.22 15.32 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 121.389 1.904 . . . . 0.0 109.879 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -145.67 141.0 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.523 0.729 . . . . 0.0 112.655 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.588 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -126.94 136.84 52.84 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.978 -1.076 . . . . 0.0 113.363 174.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -74.01 158.32 34.55 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.96 -1.713 . . . . 0.0 113.557 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -159.58 23.93 0.19 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.483 1.513 . . . . 0.0 111.855 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -90.37 -53.08 4.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.677 1.191 . . . . 0.0 110.331 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.44 174.28 9.13 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.65 1.219 . . . . 0.0 113.36 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.27 -29.69 22.9 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -129.34 49.52 4.78 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.681 1.192 . . . . 0.0 112.627 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.59 175.1 10.65 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.901 2.401 . . . . 0.0 116.169 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.33 0.0 OUTLIER -101.03 169.83 8.68 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 123.048 1.404 . . . . 0.0 111.97 173.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' B' ' 6' ' ' LEU . 1.1 p90 -160.66 167.5 26.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.543 -173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.71 144.44 9.09 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.96 158.66 31.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.8 m -94.87 152.22 18.57 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.753 1.621 . . . . 0.0 108.802 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.55 118.23 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' C' ' 52' ' ' ILE . 0.1 OUTLIER -92.71 116.53 29.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.733 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.299 46.1 m95 -80.22 136.59 36.5 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 123.465 1.603 . . . . 0.0 114.326 -173.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -91.54 -39.83 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -89.29 -15.42 33.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -151.43 130.23 12.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.202 3.001 . . . . 0.0 105.904 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.66 118.57 11.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.0 m -173.58 161.61 4.02 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 127.253 2.221 . . . . 0.0 109.082 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 140.4 30.48 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.033 1.397 . . . . 0.0 110.694 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.9 m -139.33 129.41 25.15 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 110.549 -3.023 . . . . 0.0 110.558 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.44 155.46 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.092 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -128.48 142.22 51.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.41 121.18 9.89 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.18 175.05 41.76 Favored Glycine 0 CA--C 1.504 -0.629 0 C-N-CA 118.708 -1.711 . . . . 0.0 116.627 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -112.85 144.56 42.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.79 1.281 . . . . 0.0 112.083 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 t -97.84 127.22 43.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.873 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' C' ' 106' ' ' ILE . 5.2 m-85 -115.31 166.8 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.33 1.052 . . . . 0.0 111.561 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 mt -127.41 108.13 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -62.33 156.76 21.46 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -26.77 -48.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.336 2.254 . . . . 0.0 116.854 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.59 -2.25 41.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 49.26 5.77 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.651 1.114 . . . . 0.0 112.118 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.31 136.94 54.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.873 1.669 . . . . 0.0 108.043 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -101.26 144.23 30.37 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.357 1.063 . . . . 0.0 109.607 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 21.5 m -148.01 159.93 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.006 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.421 HD21 ' CH2' ' B' ' 10' ' ' TRP . 9.1 mt -118.08 118.42 31.85 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.789 ' HE2' HD11 ' C' ' 106' ' ' ILE . 4.2 mmtt -107.09 118.08 35.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -136.0 166.65 22.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 123.488 1.613 . . . . 0.0 113.712 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.428 ' HG3' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -116.83 165.75 12.95 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 p-90 -141.13 160.23 40.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.276 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.9 tt -144.92 126.76 15.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.956 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.38 143.16 41.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 125.37 1.669 . . . . 0.0 112.3 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.08 114.23 18.13 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 111.176 -2.738 . . . . 0.0 111.713 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 43.5 m -67.2 175.24 2.73 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 125.778 1.924 . . . . 0.0 112.911 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -117.7 67.66 0.75 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.082 1.353 . . . . 0.0 108.041 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.43 168.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 121.027 -1.046 . . . . 0.0 111.804 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -103.51 -31.35 10.0 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.09 148.63 30.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.838 1.304 . . . . 0.0 111.669 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.79 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.8 tt -64.42 -29.48 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.653 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.53 5.25 5.78 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.276 0.941 . . . . 0.0 113.254 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.92 1.24 10.41 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.387 1.075 . . . . 0.0 113.639 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.12 -32.88 73.51 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.057 0.932 . . . . 0.0 112.435 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.3 p-90 -46.93 -41.45 16.08 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -98.86 -6.67 28.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.456 1.103 . . . . 0.0 113.419 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.91 0.09 22.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.799 ' CG2' HD21 ' B' ' 98' ' ' LEU . 5.3 m -109.35 138.41 45.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.596 0.758 . . . . 0.0 112.124 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.98 123.49 15.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.404 1.482 . . . . 0.0 111.433 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.48 158.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.834 1.254 . . . . 0.0 111.062 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.35 -178.21 37.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.86 0.743 . . . . 0.0 113.462 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 0.0 OUTLIER -125.14 156.31 38.55 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.781 -0.835 . . . . 0.0 111.797 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -147.45 155.3 41.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.136 0.97 . . . . 0.0 110.003 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.72 132.07 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -119.9 152.38 37.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.118 0.961 . . . . 0.0 110.821 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 160.38 37.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.447 1.099 . . . . 0.0 109.476 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 122.32 13.78 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' B' ' 124' ' ' ARG . 6.4 tt -63.25 160.16 16.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.109 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.478 ' HB2' HD23 ' B' ' 123' ' ' LEU . 0.0 OUTLIER 77.79 -56.16 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.108 2.163 . . . . 0.0 113.489 172.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 19.5 p 55.44 146.11 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.574 2.749 . . . . 0.0 114.658 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -166.68 104.68 0.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.478 2.311 . . . . 0.0 105.037 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.296 0.2 OUTLIER -141.97 21.78 2.11 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.901 1.28 . . . . 0.0 111.04 -174.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 129.546 3.138 . . . . 0.0 106.872 174.45 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 116.823 -1.56 . . . . 0.0 107.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.8 t -94.77 127.65 40.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.567 1.076 . . . . 0.0 110.738 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.39 17.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.692 1.197 . . . . 0.0 110.048 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 57.21 -133.2 1.32 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.994 1.718 . . . . 0.0 111.5 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 10.43 0.45 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.319 1.848 . . . . 0.0 112.059 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -128.89 143.7 50.97 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 124.847 1.259 . . . . 0.0 108.552 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 29.6 p -116.29 141.41 48.19 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.073 0.858 . . . . 0.0 108.865 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -139.64 127.69 22.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.994 -1.066 . . . . 0.0 113.07 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' C' ' 64' ' ' PHE . 84.0 mt -68.07 -31.7 71.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -48.27 113.85 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.964 1.306 . . . . 0.0 110.931 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -131.12 5.44 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 125.99 1.757 . . . . 0.0 109.111 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -145.47 146.97 31.69 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -136.59 162.65 32.54 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.993 1.317 . . . . 0.0 111.457 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -136.34 153.25 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.685 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -123.47 143.61 50.05 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.173 0.989 . . . . 0.0 111.093 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.9 -25.9 61.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.907 1.683 . . . . 0.0 113.353 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 110' ' ' TRP . 28.7 tp -71.25 -15.29 62.43 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.816 1.246 . . . . 0.0 111.788 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.27 -14.49 23.2 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 128.479 2.942 . . . . 0.0 113.513 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 149.4 42.61 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 123.14 1.448 . . . . 0.0 113.088 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -123.34 136.21 54.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.325 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -128.34 139.82 52.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m -127.73 131.63 49.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.688 0.795 . . . . 0.0 109.003 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.9 125.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.71 -85.85 0.09 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.615 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.05 33.84 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.726 -0.867 . . . . 0.0 110.909 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.608 HG21 ' HG3' ' C' ' 53' ' ' GLN . 11.0 p -103.83 129.05 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -74.51 166.23 23.87 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.972 0.891 . . . . 0.0 112.356 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -58.78 -25.9 63.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -67.91 -39.12 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.216 -0.927 . . . . 0.0 110.919 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.14 -6.34 12.03 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 124.782 1.182 . . . . 0.0 113.322 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.24 152.76 43.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.071 1.749 . . . . 0.0 112.15 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.38 166.49 30.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.884 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.406 HG22 HD13 ' C' ' 50' ' ' LEU . 21.6 p -123.37 -177.47 3.71 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.89 -166.87 39.84 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 119.322 -2.111 . . . . 0.0 112.703 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.512 ' HB ' HD11 ' C' ' 46' ' ' LEU . 59.0 p -139.69 136.89 34.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.257 1.027 . . . . 0.0 112.578 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -111.84 138.4 48.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.38 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.447 HD11 HD12 ' C' ' 46' ' ' LEU . 27.7 mt -130.42 127.62 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.405 ' O ' HG21 ' C' ' 44' ' ' ILE . 55.9 m -105.09 143.65 32.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.61 -13.08 18.72 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.8 143.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.179 0.992 . . . . 0.0 112.907 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.17 161.12 43.31 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.106 -0.996 . . . . 0.0 111.45 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -71.36 -28.81 64.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -140.09 75.38 29.26 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.914 2.486 . . . . 0.0 110.978 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.92 61.41 3.83 Favored 'Trans proline' 0 CA--C 1.551 1.373 1 C-N-CA 125.589 4.192 . . . . 0.0 115.134 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.7 13.56 38.65 Favored Glycine 0 N--CA 1.481 1.645 0 O-C-N 120.141 -1.599 . . . . 0.0 116.817 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -172.58 -29.43 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.21 1.404 . . . . 0.0 113.401 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.405 HG21 ' O ' ' C' ' 35' ' ' THR 0.325 48.8 mt 5.05 90.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.662 2.385 . . . . 0.0 116.33 -172.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.9 159.24 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.794 -2.457 . . . . 0.0 109.352 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.512 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.2 tt -46.76 128.02 10.32 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.624 1.97 . . . . 0.0 112.878 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -104.82 120.46 50.05 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.978 0.511 . . . . 0.0 111.682 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.89 143.0 83.57 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.949 2.432 . . . . 0.0 112.445 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.495 ' C ' HD12 ' C' ' 49' ' ' LEU . 0.6 OUTLIER -127.1 160.29 31.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.021 0.928 . . . . 0.0 112.78 177.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' B' ' 28' ' ' GLU . 14.9 tp -169.0 149.19 4.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.479 1.512 . . . . 0.0 112.466 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.26 -144.17 10.54 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 121.122 1.783 . . . . 0.0 109.765 -174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.722 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -147.99 139.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.745 -175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.608 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -125.77 138.94 53.88 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.613 1.165 . . . . 0.0 112.727 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -76.64 157.82 31.56 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.023 -1.673 . . . . 0.0 113.277 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -157.67 20.3 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.285 1.434 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -86.77 -53.73 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.926 1.29 . . . . 0.0 110.247 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.52 172.46 11.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.814 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.95 -29.31 25.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.857 0.863 . . . . 0.0 113.034 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -130.69 51.86 8.38 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 125.085 1.354 . . . . 0.0 112.726 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 175.72 10.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.935 2.423 . . . . 0.0 116.139 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.333 0.0 OUTLIER -100.77 170.78 8.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.202 1.477 . . . . 0.0 111.742 173.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' C' ' 6' ' ' LEU . 1.1 p90 -161.57 167.07 25.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.684 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.25 144.86 9.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -173.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.36 158.47 29.7 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -94.99 152.64 18.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.336 1.854 . . . . 0.0 108.718 173.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.85 117.8 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.702 ' HB2' HG21 ' B' ' 52' ' ' ILE . 0.1 OUTLIER -92.78 117.26 29.82 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.235 -0.916 . . . . 0.0 109.866 -177.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.301 46.4 m95 -80.63 137.55 36.36 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 123.456 1.598 . . . . 0.0 114.123 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -92.78 -39.79 11.03 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -89.13 -15.47 33.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -151.22 130.4 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 129.307 3.043 . . . . 0.0 106.299 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -69.03 118.55 12.08 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 10.7 m -174.0 161.37 3.67 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.238 2.215 . . . . 0.0 108.968 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -142.56 140.58 31.8 Favored 'General case' 0 CA--C 1.483 -1.635 0 CA-C-O 123.347 1.546 . . . . 0.0 111.057 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.9 m -139.15 129.97 26.21 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 110.339 -3.119 . . . . 0.0 110.21 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.15 154.84 7.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.974 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.37 142.34 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.49 121.0 9.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.94 41.17 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 118.708 -1.71 . . . . 0.0 116.625 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -112.49 146.5 38.35 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 125.101 1.118 . . . . 0.0 111.805 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.63 135.13 39.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.312 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HB2' HD12 ' B' ' 106' ' ' ILE . 6.3 m-85 -123.54 165.9 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.055 0.942 . . . . 0.0 111.118 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.62 108.27 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.01 157.12 25.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -24.85 -48.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.634 2.374 . . . . 0.0 117.339 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -80.39 -3.38 49.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.905 2.082 . . . . 0.0 116.449 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.46 48.11 5.75 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 120.295 1.407 . . . . 0.0 111.963 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 135.62 54.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.198 1.799 . . . . 0.0 109.077 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -101.3 145.97 28.17 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.713 1.244 . . . . 0.0 109.729 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.2 m -150.13 157.07 6.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.934 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.49 115.39 26.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.79 ' HE2' HD11 ' B' ' 106' ' ' ILE . 4.3 mmtt -103.74 119.35 38.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.2 p -136.57 167.31 21.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 123.398 1.57 . . . . 0.0 113.889 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.423 ' HG3' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -117.83 166.11 12.86 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -141.23 160.15 40.71 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.121 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.792 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.9 tt -144.81 125.79 14.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.131 -1.849 . . . . 0.0 112.008 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.52 143.19 39.5 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.065 1.478 . . . . 0.0 112.218 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -126.66 114.19 17.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.516 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -66.75 175.35 2.44 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 126.083 2.114 . . . . 0.0 112.926 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.7 p -118.19 68.98 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.34 1.456 . . . . 0.0 107.675 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.8 171.53 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.889 -1.132 . . . . 0.0 111.539 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -106.7 -32.28 8.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -108.22 148.77 29.47 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.833 1.302 . . . . 0.0 111.588 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.789 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.9 tt -64.07 -29.04 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.888 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 5.56 6.11 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.706 1.146 . . . . 0.0 113.516 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -121.39 1.51 10.17 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.333 1.066 . . . . 0.0 113.694 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -33.07 73.73 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.035 0.922 . . . . 0.0 112.553 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.1 p-90 -46.7 -41.43 14.98 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -99.34 -6.57 27.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.318 1.047 . . . . 0.0 113.356 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.35 -0.17 21.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.792 ' CG2' HD21 ' C' ' 98' ' ' LEU . 5.9 m -109.9 138.38 46.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.599 0.76 . . . . 0.0 111.636 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.59 124.47 17.26 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 125.65 1.58 . . . . 0.0 111.01 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -99.57 158.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.245 1.418 . . . . 0.0 111.35 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.65 -178.84 38.34 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.809 0.718 . . . . 0.0 113.407 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 0.0 OUTLIER -124.41 157.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.733 -0.863 . . . . 0.0 111.911 176.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -148.39 155.59 41.44 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.967 0.889 . . . . 0.0 109.864 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -132.19 133.28 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -120.76 151.7 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 111.665 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.8 p -135.42 163.15 30.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.024 1.33 . . . . 0.0 109.876 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 115.94 5.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.86 -1.15 . . . . 0.0 111.732 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 tp -71.87 145.64 48.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 61.99 68.49 0.68 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 54.8 p -63.37 156.04 27.07 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.092 -1.005 . . . . 0.0 109.706 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -43.79 -53.64 5.79 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.989 1.316 . . . . 0.0 113.297 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' C' ' 128' ' ' GLU . 17.7 tttm 63.51 168.38 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.793 2.037 . . . . 0.0 112.341 -174.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.496 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 5.3 mm-40 . . . . . 0 CA--C 1.551 0.983 1 C-N-CA 137.557 6.343 . . . . 0.0 102.29 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 116.708 -1.615 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 2.5 m -109.66 39.55 2.08 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 121.091 1.769 . . . . 0.0 113.476 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.67 -6.58 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.739 1.616 . . . . 0.0 113.31 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 54.93 -136.96 1.23 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.49 1.116 . . . . 0.0 111.587 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.316 0.2 OUTLIER -155.82 74.04 0.85 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.506 1.922 . . . . 0.0 111.158 -175.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -156.15 105.14 2.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.585 1.554 . . . . 0.0 111.29 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 p -116.61 137.61 52.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.003 0.921 . . . . 0.0 109.823 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 p -139.77 133.09 29.94 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.196 -1.565 . . . . 0.0 114.348 -174.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 64' ' ' PHE . 42.1 mt -59.13 -32.01 69.47 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -52.35 116.18 2.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.774 1.273 . . . . 0.0 111.83 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.1 -114.47 1.25 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 125.94 1.733 . . . . 0.0 110.209 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -153.16 147.44 25.78 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -140.65 162.75 34.64 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.493 1.517 . . . . 0.0 111.35 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -138.63 147.94 43.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.29 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.468 HD22 ' HB3' ' A' ' 118' ' ' ASN . 3.2 t-20 -113.28 146.99 38.46 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.709 0.803 . . . . 0.0 110.619 -175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -56.67 -28.6 61.05 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.6 tp -72.29 -15.62 61.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.053 1.741 . . . . 0.0 112.02 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.39 -14.29 25.42 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.048 2.261 . . . . 0.0 113.441 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.7 p -68.51 155.05 40.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.412 1.606 . . . . 0.0 113.134 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -127.02 138.28 53.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.608 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -124.09 136.03 53.96 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.56 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -126.79 130.51 50.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.9 mt -134.43 127.46 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.83 -89.59 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.077 0.861 . . . . 0.0 112.558 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.92 139.65 32.58 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.837 -0.801 . . . . 0.0 111.641 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.8 t -89.61 129.47 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.357 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.56 166.04 15.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.894 0.854 . . . . 0.0 111.589 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.1 p -57.15 -27.81 62.19 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -74.71 -32.83 62.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.698 0.681 . . . . 0.0 111.722 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.67 -7.43 26.05 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.959 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 9.6 pt-20 -66.3 144.27 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.772 1.286 . . . . 0.0 108.487 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 50' ' ' LEU . 20.8 p90 -158.18 145.82 18.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.802 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.57 162.01 14.34 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.02 -170.04 36.9 Favored Glycine 0 C--O 1.239 0.416 0 O-C-N 121.187 -0.946 . . . . 0.0 112.664 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' LEU . 46.9 p -140.15 139.03 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.407 1.098 . . . . 0.0 112.17 175.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -114.42 138.72 50.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 108.389 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 46' ' ' LEU . 41.4 mt -130.83 126.87 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG21 ' A' ' 44' ' ' ILE . 86.5 m -105.05 144.34 31.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.74 -21.96 17.82 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.5 m -132.98 143.26 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.48 1.112 . . . . 0.0 113.27 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.55 159.43 39.7 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.528 -0.732 . . . . 0.0 110.219 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.54 -23.72 58.84 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.95 -0.469 . . . . 0.0 110.909 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -146.43 68.72 12.34 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.221 2.208 . . . . 0.0 111.069 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' ILE . 39.0 Cg_endo -56.71 -79.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 125.08 3.853 . . . . 0.0 116.853 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.87 -48.65 0.01 OUTLIER Glycine 0 CA--C 1.546 1.996 0 C-N-CA 129.561 3.458 . . . . 0.0 120.565 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.84 -5.12 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.25 2.22 . . . . 0.0 113.118 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 35' ' ' THR 0.347 64.5 mt -8.89 85.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 124.316 2.007 . . . . 0.0 115.009 -172.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.2 151.13 21.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 111.63 -2.532 . . . . 0.0 108.465 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 32' ' ' THR . 3.3 tt -46.34 127.19 8.76 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.934 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.32 118.52 57.59 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 123.961 0.788 . . . . 0.0 111.252 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.92 144.07 69.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.727 2.284 . . . . 0.0 112.177 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.5 158.23 35.01 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.765 0.826 . . . . 0.0 111.267 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 29' ' ' PHE . 7.6 tp -159.89 148.97 17.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.319 1.847 . . . . 0.0 110.425 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.9 -157.22 28.95 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 121.062 1.756 . . . . 0.0 110.069 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.4 mt -141.7 134.94 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.45 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 136.61 53.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.543 1.137 . . . . 0.0 110.772 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -73.29 151.88 41.18 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.004 0.907 . . . . 0.0 109.746 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.9 26.46 1.37 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.619 -1.301 . . . . 0.0 111.633 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.47 -50.29 5.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 110.717 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 173.29 10.34 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.231 0.957 . . . . 0.0 112.987 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.7 m -83.93 -31.64 25.52 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.762 1.225 . . . . 0.0 113.366 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -128.51 54.94 15.09 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.243 1.417 . . . . 0.0 111.381 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.66 165.18 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.042 2.495 . . . . 0.0 117.553 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.3 p -81.11 164.27 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.115 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -158.78 163.47 36.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.215 -0.928 . . . . 0.0 113.021 175.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.89 140.1 6.12 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -159.68 157.55 29.76 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -95.84 151.55 19.3 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.302 1.441 . . . . 0.0 110.651 174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.44 118.13 48.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 13.7 t30 -93.72 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 109.554 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.301 43.8 m95 -83.07 135.48 34.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.82 -44.02 9.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.953 2.101 . . . . 0.0 116.321 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -91.02 -9.56 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -152.79 126.8 9.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.507 2.323 . . . . 0.0 107.06 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -69.25 118.48 12.19 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.965 1.257 . . . . 0.0 110.503 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -177.23 164.23 2.16 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 126.329 1.851 . . . . 0.0 109.193 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -144.18 143.84 31.27 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.542 1.639 . . . . 0.0 111.549 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.31 125.17 21.12 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 110.33 -3.123 . . . . 0.0 109.691 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.67 152.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -126.33 142.17 51.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 118.14 7.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -174.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.1 -164.94 14.67 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' NE2' ' CE2' ' A' ' 84' ' ' PHE . 38.1 tt0 -130.3 150.0 51.74 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.485 0.756 . . . . 0.0 112.216 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.5 t -94.86 124.93 39.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.7 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE2' ' NE2' ' A' ' 82' ' ' GLN . 5.0 m-85 -114.46 163.48 15.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.242 1.017 . . . . 0.0 111.966 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.87 110.72 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.16 161.22 9.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.249 0.619 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.37 -51.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -69.24 -33.46 73.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.8 42.44 0.73 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.906 1.241 . . . . 0.0 111.734 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 128' ' ' GLU . 3.4 mtpt -110.44 142.64 41.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.302 1.441 . . . . 0.0 109.85 175.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -101.58 140.33 36.01 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.856 1.262 . . . . 0.0 111.613 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 20.1 m -143.62 160.32 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.372 1.069 . . . . 0.0 108.681 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.69 119.25 33.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 119.51 39.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.531 HG22 ' HE1' ' A' ' 64' ' ' PHE . 4.4 p -137.7 172.27 13.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 123.131 1.443 . . . . 0.0 111.992 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.585 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.9 mmm -126.02 168.9 13.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.588 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -141.49 164.06 31.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.168 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.669 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -148.15 119.67 7.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.056 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 140.11 41.06 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.181 1.467 . . . . 0.0 112.11 -173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -120.16 120.97 37.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 110.804 -2.907 . . . . 0.0 111.237 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -88.7 163.52 15.73 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 125.496 1.748 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -113.81 70.85 0.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -61.83 -167.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 111.001 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.44 -15.16 3.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.738 -1.851 . . . . 0.0 114.776 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.77 150.23 43.07 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.87 1.319 . . . . 0.0 110.315 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' D' ' 92' ' ' VAL . 16.6 tt -62.85 -28.38 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.708 174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.82 6.89 10.58 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.244 -1.309 . . . . 0.0 113.472 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -121.08 -1.36 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.85 1.325 . . . . 0.0 113.632 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -59.08 -34.75 72.34 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.623 -1.298 . . . . 0.0 112.158 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.73 -39.56 18.07 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.724 1.21 . . . . 0.0 114.16 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.32 -7.65 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.285 1.434 . . . . 0.0 114.011 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 1.8 9.6 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.163 -0.961 . . . . 0.0 113.016 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.669 ' CG2' HD21 ' A' ' 98' ' ' LEU . 34.0 m -116.97 145.23 43.77 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.865 0.866 . . . . 0.0 111.537 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.52 129.05 18.06 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 125.759 1.624 . . . . 0.0 110.659 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.71 155.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 120.483 1.492 . . . . 0.0 109.367 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -175.31 28.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.542 1.067 . . . . 0.0 113.08 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 21.4 p90 -125.97 153.01 44.92 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.064 0.945 . . . . 0.0 110.782 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' HD22 ' A' ' 12' ' ' ASN . 1.0 OUTLIER -144.85 152.97 41.1 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.695 1.198 . . . . 0.0 109.865 176.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.1 mt -135.06 122.17 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -110.6 149.18 30.78 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.521 0.677 . . . . 0.0 110.427 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.5 p -134.16 162.83 31.06 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.081 -1.012 . . . . 0.0 109.662 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -56.87 114.82 2.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.451 0.701 . . . . 0.0 109.928 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -67.79 95.05 0.49 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 175.12 -45.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.679 2.392 . . . . 0.0 114.311 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 m 39.06 58.03 1.87 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.243 1.817 . . . . 0.0 113.166 -174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.62 131.33 25.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.436 1.094 . . . . 0.0 111.091 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt 88.04 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 129.97 3.308 . . . . 0.0 108.488 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 1.3 tp10 . . . . . 0 C--O 1.248 0.975 0 C-N-CA 127.693 2.397 . . . . 0.0 107.235 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' -3' ' ' GLN . . . . . 0.514 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 8.2 tp60 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 117.61 -1.186 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 3.3 m -121.01 -33.38 3.74 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 5.0 t 52.0 80.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.157 1.783 . . . . 0.0 114.694 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.62 -30.42 0.27 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 52.89 64.12 1.98 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.537 1.535 . . . . 0.0 112.989 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -140.8 109.2 5.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.349 -0.844 . . . . 0.0 112.484 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' CYS . . . . . 0.466 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 24.5 p -122.43 135.22 54.64 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.373 1.469 . . . . 0.0 110.236 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -139.91 134.4 31.55 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.389 -1.445 . . . . 0.0 114.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' D' ' 64' ' ' PHE . 43.1 mt -58.6 -32.94 69.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -51.5 117.32 2.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 123.35 1.547 . . . . 0.0 112.098 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.52 -116.72 1.75 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.687 1.613 . . . . 0.0 110.351 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -151.92 147.15 26.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -141.27 162.78 34.65 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.83 1.652 . . . . 0.0 111.927 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -139.73 148.08 41.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.938 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' ASN . . . . . 0.464 HD22 ' HB3' ' D' ' 118' ' ' ASN . 2.9 t-20 -113.05 146.98 38.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.781 0.832 . . . . 0.0 110.585 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -57.9 -26.38 62.09 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.16 -16.91 61.98 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.451 1.5 . . . . 0.0 111.74 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.04 -13.74 23.99 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 127.136 2.303 . . . . 0.0 113.627 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -69.77 155.66 40.2 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.308 1.554 . . . . 0.0 112.841 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -127.81 138.35 52.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.044 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -124.11 136.64 54.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.261 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -126.67 131.25 51.45 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.2 127.12 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.03 -89.93 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.91 141.32 32.98 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.608 -0.937 . . . . 0.0 111.219 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -91.4 130.07 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.83 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 165.09 18.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.908 0.861 . . . . 0.0 111.885 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 28.7 p -57.37 -26.96 61.85 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -73.58 -31.97 63.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.849 0.75 . . . . 0.0 111.722 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.99 25.32 Favored Glycine 0 N--CA 1.462 0.389 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.344 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.3 156.81 38.77 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.582 1.191 . . . . 0.0 112.872 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PHE . . . . . 0.421 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.1 p90 -160.35 160.25 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.389 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.505 HG22 ' CD1' ' D' ' 50' ' ' LEU . 0.9 OUTLIER -120.45 156.98 30.33 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 173.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.78 -167.82 28.04 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 120.11 -1.619 . . . . 0.0 112.527 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.604 ' HB ' HD11 ' D' ' 46' ' ' LEU . 45.5 p -140.0 137.74 34.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 122.351 1.072 . . . . 0.0 112.474 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -114.62 139.14 49.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.476 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' D' ' 46' ' ' LEU . 44.3 mt -130.79 127.23 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.534 ' O ' HG21 ' D' ' 44' ' ' ILE . 86.7 m -105.1 144.17 32.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.64 -21.41 18.24 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.01 143.75 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 112.974 -174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.49 39.25 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.722 -0.611 . . . . 0.0 110.238 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.68 -23.46 58.63 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 121.984 -0.447 . . . . 0.0 110.935 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -146.6 68.7 12.12 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.263 2.225 . . . . 0.0 111.087 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' D' ' 44' ' ' ILE . 38.7 Cg_endo -56.79 -78.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 125.05 3.833 . . . . 0.0 116.89 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.66 -48.74 0.01 OUTLIER Glycine 0 CA--C 1.545 1.931 0 C-N-CA 129.651 3.501 . . . . 0.0 120.587 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.68 -5.15 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 127.176 2.19 . . . . 0.0 113.03 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.534 HG21 ' O ' ' D' ' 35' ' ' THR 0.345 64.9 mt -8.92 86.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 124.337 2.018 . . . . 0.0 115.068 -172.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.29 151.47 21.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.55 174.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.604 HD11 ' HB ' ' D' ' 32' ' ' THR . 3.5 tt -46.51 126.87 8.72 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.295 -2.23 . . . . 0.0 111.772 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.7 p -102.85 118.68 57.72 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 123.844 0.715 . . . . 0.0 111.381 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.84 144.15 67.88 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.66 2.24 . . . . 0.0 111.962 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.44 162.75 24.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.551 0.74 . . . . 0.0 111.516 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.505 ' CD1' HG22 ' D' ' 30' ' ' THR . 15.9 tp -164.22 149.02 10.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.894 1.678 . . . . 0.0 112.129 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -154.62 25.65 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 120.933 1.697 . . . . 0.0 110.498 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.2 mt -144.35 133.42 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.359 1.076 . . . . 0.0 110.929 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 136.71 54.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.28 1.432 . . . . 0.0 110.497 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -73.8 151.26 40.63 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.28 -0.887 . . . . 0.0 109.971 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -144.62 26.47 1.42 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.696 -1.252 . . . . 0.0 111.58 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.42 -49.28 6.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 111.289 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 172.8 12.6 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -80.01 -30.66 39.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.781 1.232 . . . . 0.0 113.11 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -133.29 57.68 28.8 Favored Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -71.76 164.25 36.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 N-CA-C 117.494 2.075 . . . . 0.0 117.494 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -81.21 164.1 22.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.944 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -158.35 163.56 37.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.871 0.844 . . . . 0.0 112.758 175.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.43 140.09 6.08 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -159.56 157.91 30.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -96.11 151.38 19.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.91 1.684 . . . . 0.0 110.648 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.47 118.74 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 52' ' ' ILE . 14.2 t30 -94.93 113.29 25.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.966 0.906 . . . . 0.0 109.523 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.297 43.8 m95 -82.53 136.01 34.96 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -173.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -92.41 -43.25 9.32 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.899 2.08 . . . . 0.0 116.417 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -91.37 -9.72 43.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.77 127.41 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.422 2.289 . . . . 0.0 107.171 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -69.52 118.48 12.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.009 1.277 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -177.34 163.91 2.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.31 1.844 . . . . 0.0 109.039 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.5 t -144.0 143.78 31.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.893 1.806 . . . . 0.0 111.721 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 110.224 -3.171 . . . . 0.0 109.869 -172.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.1 153.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -127.12 141.97 51.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.36 118.37 7.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -164.95 14.61 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 116.401 1.32 . . . . 0.0 116.401 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.401 ' NE2' ' CE2' ' D' ' 84' ' ' PHE . 37.3 tt0 -131.09 149.75 52.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.245 0.615 . . . . 0.0 112.024 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.466 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 37.9 t -97.25 122.28 40.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.211 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.7 m-85 -109.35 163.46 13.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.138 0.975 . . . . 0.0 112.008 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.79 107.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 160.84 5.36 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.251 0.548 . . . . 0.0 110.103 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.09 -49.97 0.14 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -25.87 61.06 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.83 51.51 1.17 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.881 0.764 . . . . 0.0 111.286 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -120.16 147.73 44.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 128.261 2.624 . . . . 0.0 105.346 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -113.7 137.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.804 1.242 . . . . 0.0 110.135 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 106' ' ' ILE . 26.0 m -139.71 161.86 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 110.05 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.01 120.05 36.64 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 118.41 36.7 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.534 HG22 ' HE1' ' D' ' 64' ' ' PHE . 3.9 p -137.11 171.84 13.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 123.303 1.525 . . . . 0.0 112.151 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.576 ' HG3' HG21 ' A' ' 113' ' ' THR . 88.5 mmm -125.95 168.88 13.29 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -141.07 163.72 32.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.312 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.66 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -148.11 120.1 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.84 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 140.33 40.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 123.23 1.49 . . . . 0.0 112.044 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.08 119.86 34.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 110.89 -2.868 . . . . 0.0 110.758 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -86.15 162.97 18.11 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 125.257 1.598 . . . . 0.0 112.044 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 3.8 t -112.83 73.17 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.14 -166.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.452 0.701 . . . . 0.0 110.709 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.11 -14.54 3.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 119.907 -1.746 . . . . 0.0 114.569 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -123.46 149.49 45.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 123.086 1.422 . . . . 0.0 110.516 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 17.2 tt -62.01 -29.37 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.111 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.0 5.92 11.66 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.45 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -120.41 -1.77 10.13 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.01 1.405 . . . . 0.0 113.575 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.82 -34.99 70.26 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.652 -1.28 . . . . 0.0 112.745 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 62.7 p-90 -47.51 -39.8 17.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.079 1.352 . . . . 0.0 113.912 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -99.21 -6.8 27.49 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.322 1.449 . . . . 0.0 114.114 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.75 1.46 10.35 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.88 -1.137 . . . . 0.0 113.126 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.66 ' CG2' HD21 ' D' ' 98' ' ' LEU . 34.7 m -117.29 145.24 44.1 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.574 0.75 . . . . 0.0 111.604 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.17 129.05 18.42 Favored 'General case' 0 C--O 1.214 -0.81 0 C-N-CA 125.53 1.532 . . . . 0.0 110.681 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.74 155.15 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 120.531 1.514 . . . . 0.0 109.504 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.21 -175.53 29.24 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.628 1.109 . . . . 0.0 113.002 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 21.7 p90 -125.87 153.48 44.09 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.039 0.936 . . . . 0.0 110.68 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 118' ' ' ASN . . . . . 0.464 ' HB3' HD22 ' D' ' 12' ' ' ASN . 1.0 OUTLIER -145.33 153.24 41.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.675 1.19 . . . . 0.0 109.706 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 80.9 mt -135.37 123.93 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.52 149.51 32.57 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 111.064 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -133.56 164.93 26.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.939 0.896 . . . . 0.0 109.82 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -60.93 121.14 11.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.104 -0.997 . . . . 0.0 109.979 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.08 147.5 47.15 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 121.765 -0.584 . . . . 0.0 110.14 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 72.63 -52.47 0.7 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.705 2.802 . . . . 0.0 115.194 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . 0.271 8.6 t 43.59 -162.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.819 1.248 . . . . 0.0 112.41 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -151.22 -49.25 0.12 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.782 2.033 . . . . 0.0 109.128 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -95.09 152.19 18.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 127.377 2.271 . . . . 0.0 110.371 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.134 -2.365 . . . . 0.0 110.892 174.315 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 2.9 m -138.79 165.99 25.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.319 1.448 . . . . 0.0 107.874 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.74 152.33 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.14 0.976 . . . . 0.0 110.203 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.19 150.98 44.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.534 1.133 . . . . 0.0 108.913 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -145.91 65.64 1.22 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.14 1.376 . . . . 0.0 110.09 -174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -151.99 105.38 3.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.645 0.778 . . . . 0.0 111.232 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.41 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 26.0 p -117.59 134.94 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.322 1.849 . . . . 0.0 109.619 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -139.75 135.71 33.39 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.414 -1.429 . . . . 0.0 114.193 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' B' ' 64' ' ' PHE . 40.7 mt -60.46 -30.57 69.76 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -53.5 116.81 2.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.713 1.244 . . . . 0.0 111.582 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.65 -116.11 1.54 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.474 1.512 . . . . 0.0 110.369 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -152.68 145.3 24.22 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -139.63 162.15 35.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 111.553 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -141.51 145.57 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.607 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' B' ' 118' ' ' ASN . 2.6 t-20 -109.21 148.85 30.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.062 0.945 . . . . 0.0 110.744 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -57.47 -28.91 63.8 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.18 -14.87 61.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.367 1.867 . . . . 0.0 111.91 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.78 -14.02 29.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 127.048 2.261 . . . . 0.0 113.461 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 54.1 p -69.35 155.83 39.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.233 1.516 . . . . 0.0 112.683 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -127.95 139.58 52.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.935 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -125.69 134.83 51.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.563 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -124.97 131.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.0 mt -135.01 127.83 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.6 -89.6 0.11 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.048 0.842 . . . . 0.0 112.52 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.4 140.5 32.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.714 -0.874 . . . . 0.0 111.554 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.3 t -90.96 129.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.402 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.73 165.8 16.55 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.576 0.703 . . . . 0.0 111.533 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 27.5 p -56.98 -27.42 61.37 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -74.89 -32.79 61.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.785 0.721 . . . . 0.0 111.877 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.62 -7.32 26.16 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.164 -1.353 . . . . 0.0 112.856 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 9.7 pt-20 -66.11 144.58 56.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.857 1.328 . . . . 0.0 108.464 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.415 ' O ' HD12 ' B' ' 50' ' ' LEU . 21.1 p90 -158.44 146.16 18.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.783 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.69 162.25 14.15 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.894 0.877 . . . . 0.0 108.76 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.84 36.86 Favored Glycine 0 C--O 1.238 0.372 0 O-C-N 121.245 -0.909 . . . . 0.0 112.608 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.6 ' HB ' HD11 ' B' ' 46' ' ' LEU . 43.9 p -140.17 139.24 35.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.335 1.064 . . . . 0.0 112.292 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -114.38 139.09 49.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.477 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.519 HD11 HD12 ' B' ' 46' ' ' LEU . 43.1 mt -131.2 127.1 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.535 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.5 m -105.0 145.47 30.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.45 -22.37 17.17 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -132.61 143.44 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.553 1.141 . . . . 0.0 113.093 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.62 159.5 39.68 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.387 -0.82 . . . . 0.0 110.083 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.46 -23.49 58.9 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.017 -0.427 . . . . 0.0 111.083 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.78 68.62 11.84 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 127.256 2.223 . . . . 0.0 110.945 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.436 ' HB3' HD11 ' B' ' 44' ' ' ILE . 38.4 Cg_endo -56.85 -78.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 125.083 3.856 . . . . 0.0 116.776 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.82 -48.46 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 C-N-CA 129.582 3.468 . . . . 0.0 120.568 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.98 -5.29 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.283 2.233 . . . . 0.0 113.114 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.535 HG21 ' O ' ' B' ' 35' ' ' THR 0.349 65.7 mt -8.58 85.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 124.354 2.026 . . . . 0.0 115.147 -172.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.89 151.11 21.21 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.501 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.6 HD11 ' HB ' ' B' ' 32' ' ' THR . 3.4 tt -46.34 127.3 8.86 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.777 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.46 118.72 56.98 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 123.951 0.782 . . . . 0.0 111.405 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.85 144.12 68.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.58 158.44 34.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.728 0.811 . . . . 0.0 111.22 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.415 HD12 ' O ' ' B' ' 29' ' ' PHE . 7.4 tp -160.03 148.94 17.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.409 1.884 . . . . 0.0 110.453 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.86 -157.28 29.01 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 121.018 1.735 . . . . 0.0 110.236 -174.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.4 mt -141.62 135.0 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.64 0.733 . . . . 0.0 111.491 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.56 136.71 53.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.723 1.209 . . . . 0.0 110.843 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -73.48 152.49 40.7 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.993 0.902 . . . . 0.0 109.756 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.86 25.82 1.42 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.537 -1.352 . . . . 0.0 111.773 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -93.23 -49.21 6.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.918 1.287 . . . . 0.0 111.238 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.23 172.53 12.69 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.557 1.161 . . . . 0.0 114.042 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.67 -28.6 36.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.492 1.117 . . . . 0.0 113.028 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -135.11 57.09 18.72 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.665 1.186 . . . . 0.0 111.52 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.77 163.95 37.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.598 2.865 . . . . 0.0 117.73 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 69.6 p -80.89 163.74 23.15 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.761 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -158.76 162.84 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.346 -0.846 . . . . 0.0 112.811 175.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.76 140.03 6.08 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -159.59 158.17 31.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.37 151.46 19.52 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.477 1.511 . . . . 0.0 110.632 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -127.38 118.06 48.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 52' ' ' ILE . 13.2 t30 -93.74 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.01 0.924 . . . . 0.0 109.501 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.298 43.8 m95 -83.06 135.05 34.98 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.44 -43.86 9.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.179 2.192 . . . . 0.0 116.361 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -91.14 -9.66 44.71 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -152.74 126.32 8.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.479 2.312 . . . . 0.0 106.912 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.12 118.49 12.09 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.046 1.294 . . . . 0.0 110.515 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -177.48 163.57 1.98 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 109.176 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -143.63 144.25 31.82 Favored 'General case' 0 CA--C 1.482 -1.673 0 CA-C-O 123.376 1.56 . . . . 0.0 111.648 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 125.67 21.32 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 110.441 -3.072 . . . . 0.0 109.656 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.03 153.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -126.99 142.03 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 118.06 6.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.09 -165.01 14.76 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' B' ' 84' ' ' PHE . 37.3 tt0 -130.83 149.61 52.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.928 1.016 . . . . 0.0 111.75 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.41 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 45.7 t -97.23 125.84 42.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.464 174.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.442 ' HB2' HD12 ' C' ' 106' ' ' ILE . 4.1 m-85 -113.07 165.44 12.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.267 1.027 . . . . 0.0 112.213 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 22.7 mt -130.56 110.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.91 162.08 4.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.258 0.623 . . . . 0.0 109.567 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -33.33 -48.94 0.26 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -13.44 60.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.64 43.45 4.22 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.225 0.92 . . . . 0.0 112.23 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 6.0 mtpt -113.36 142.67 45.59 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 127.389 2.276 . . . . 0.0 109.324 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -106.8 141.68 37.64 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.004 1.321 . . . . 0.0 111.271 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.8 m -144.55 160.37 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.589 1.156 . . . . 0.0 110.14 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.71 119.43 35.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 118.59 37.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.537 HG22 ' HE1' ' B' ' 64' ' ' PHE . 4.5 p -137.38 172.05 13.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.169 1.461 . . . . 0.0 112.189 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.588 ' HG3' HG21 ' C' ' 113' ' ' THR . 88.4 mmm -125.92 168.87 13.3 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.12 163.99 31.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.583 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -148.16 119.77 8.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.983 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 139.63 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 124.964 1.415 . . . . 0.0 112.176 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -119.38 120.35 36.63 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 110.684 -2.962 . . . . 0.0 110.676 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -87.79 163.35 16.5 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 125.319 1.637 . . . . 0.0 111.405 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -113.13 72.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.58 -167.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.312 0.645 . . . . 0.0 110.269 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.03 -20.28 3.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.092 -1.63 . . . . 0.0 113.66 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -115.38 148.3 39.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.991 1.377 . . . . 0.0 110.96 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.469 ' CD1' HG21 ' C' ' 92' ' ' VAL . 16.9 tt -62.85 -28.4 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.516 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.75 5.83 15.31 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 118.003 -1.443 . . . . 0.0 113.831 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -121.27 -0.93 9.79 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.95 1.375 . . . . 0.0 113.432 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.5 -35.86 70.79 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.737 -1.227 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.41 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 62.9 p-90 -47.22 -40.25 15.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.195 1.398 . . . . 0.0 113.802 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -99.04 -7.07 27.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.241 1.416 . . . . 0.0 113.943 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.58 13.05 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.627 -1.295 . . . . 0.0 113.165 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.672 ' CG2' HD21 ' B' ' 98' ' ' LEU . 33.1 m -115.09 145.47 42.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.869 0.868 . . . . 0.0 111.757 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.78 129.86 18.51 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 125.876 1.671 . . . . 0.0 110.42 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.66 155.13 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 120.421 1.464 . . . . 0.0 109.353 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.68 -175.07 28.19 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.673 1.13 . . . . 0.0 113.517 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 21.1 p90 -126.29 152.84 45.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.13 0.972 . . . . 0.0 110.71 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ASN . . . . . 0.485 ' HB3' HD22 ' B' ' 12' ' ' ASN . 0.9 OUTLIER -145.15 151.57 38.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.528 1.131 . . . . 0.0 110.304 176.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.86 119.74 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -108.69 152.28 25.03 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.933 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -136.91 162.15 34.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.23 1.012 . . . . 0.0 109.566 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -54.55 125.79 21.07 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.51 -0.744 . . . . 0.0 109.668 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.36 83.18 0.56 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 72.52 167.0 0.31 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.823 2.449 . . . . 0.0 108.694 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 3.3 t -171.48 -57.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.196 0.999 . . . . 0.0 111.216 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 55.14 -167.92 0.09 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.871 1.268 . . . . 0.0 110.992 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 150.07 132.53 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.911 3.684 . . . . 0.0 107.859 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.019 0 O-C-N 126.856 2.597 . . . . 0.0 109.663 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 4.4 p -71.71 163.69 27.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.555 1.07 . . . . 0.0 111.868 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.11 -15.57 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 43.39 -132.23 0.63 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 126.092 1.757 . . . . 0.0 114.519 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . 0.354 0.0 OUTLIER 44.88 17.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 129.673 3.189 . . . . 0.0 117.496 -174.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -151.98 105.07 3.05 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.686 -1.259 . . . . 0.0 111.874 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 24.0 p -119.27 133.41 55.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.279 1.832 . . . . 0.0 109.228 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 78.9 p -139.83 133.21 30.01 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.243 -1.536 . . . . 0.0 114.148 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.629 HD21 ' CE2' ' C' ' 64' ' ' PHE . 40.8 mt -58.23 -32.82 68.68 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -51.76 116.3 2.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.903 1.335 . . . . 0.0 111.729 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.95 -114.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 125.66 1.6 . . . . 0.0 109.829 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -152.9 148.22 26.89 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -141.12 162.67 34.93 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.267 1.427 . . . . 0.0 112.315 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -135.45 147.3 48.89 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.859 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ASN . . . . . 0.5 HD22 ' HB3' ' C' ' 118' ' ' ASN . 2.3 t-20 -111.67 146.81 36.81 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.591 0.756 . . . . 0.0 110.475 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -57.1 -27.46 61.79 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 34.9 tp -72.64 -16.25 61.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.126 1.77 . . . . 0.0 111.986 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.56 -13.81 25.15 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.128 2.299 . . . . 0.0 113.662 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 44.1 p -69.16 156.31 38.92 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.489 1.645 . . . . 0.0 113.128 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -128.86 138.93 52.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.848 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -124.08 136.87 54.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.26 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -126.68 130.72 50.96 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.97 126.87 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.83 -89.59 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.898 0.749 . . . . 0.0 112.63 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.42 32.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.619 -0.93 . . . . 0.0 111.206 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.33 130.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.08 165.33 18.29 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.589 0.709 . . . . 0.0 111.782 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 30.6 p -57.78 -26.76 62.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -73.65 -32.04 63.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.975 0.807 . . . . 0.0 111.733 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.08 -4.55 25.48 Favored Glycine 0 N--CA 1.463 0.462 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.392 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.73 156.49 39.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.432 1.116 . . . . 0.0 112.766 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PHE . . . . . 0.417 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.0 p90 -159.81 159.93 33.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.258 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' CD1' ' C' ' 50' ' ' LEU . 1.0 OUTLIER -120.34 157.11 29.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 173.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.08 -167.33 27.6 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 120.054 -1.654 . . . . 0.0 112.627 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.581 ' HB ' HD11 ' C' ' 46' ' ' LEU . 54.0 p -139.79 138.14 35.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.514 1.149 . . . . 0.0 112.783 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.9 139.45 49.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.371 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.517 HD11 HD12 ' C' ' 46' ' ' LEU . 42.8 mt -131.16 127.06 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 174.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.542 ' O ' HG21 ' C' ' 44' ' ' ILE . 85.1 m -105.05 145.03 31.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.98 -20.12 18.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.49 142.89 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.548 1.139 . . . . 0.0 113.197 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.42 159.37 39.8 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.326 -0.859 . . . . 0.0 110.215 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.38 -23.42 58.99 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 110.99 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.71 68.88 12.07 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 127.239 2.216 . . . . 0.0 111.029 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.448 ' HB3' HD11 ' C' ' 44' ' ' ILE . 38.6 Cg_endo -56.92 -78.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 125.054 3.836 . . . . 0.0 116.86 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.51 -48.85 0.01 OUTLIER Glycine 0 CA--C 1.546 1.982 0 C-N-CA 129.65 3.5 . . . . 0.0 120.591 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.49 -5.08 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.307 2.243 . . . . 0.0 113.167 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.542 HG21 ' O ' ' C' ' 35' ' ' THR 0.345 65.6 mt -9.02 85.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 124.465 2.078 . . . . 0.0 115.301 -172.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.88 151.36 20.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.525 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.581 HD11 ' HB ' ' C' ' 32' ' ' THR . 3.4 tt -46.48 127.08 8.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 112.181 -2.282 . . . . 0.0 111.777 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.25 118.71 57.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 123.85 0.718 . . . . 0.0 111.376 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.74 144.29 66.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.755 2.303 . . . . 0.0 111.869 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.63 162.73 25.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.545 0.738 . . . . 0.0 111.702 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' C' ' 30' ' ' THR . 15.6 tp -164.46 148.97 9.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.778 1.631 . . . . 0.0 112.166 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.73 25.79 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 120.866 1.666 . . . . 0.0 110.488 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -143.76 135.18 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.209 1.004 . . . . 0.0 110.984 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.58 136.55 52.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.311 1.444 . . . . 0.0 110.34 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -73.72 151.44 40.7 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.889 0.852 . . . . 0.0 110.172 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -144.56 25.68 1.48 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.573 -1.329 . . . . 0.0 112.017 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -93.51 -49.96 5.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.28 1.432 . . . . 0.0 111.239 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.64 173.11 11.48 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.691 1.245 . . . . 0.0 113.659 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -83.0 -26.47 31.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.107 1.363 . . . . 0.0 113.46 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -134.91 55.74 14.77 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 125.438 1.495 . . . . 0.0 112.2 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.28 163.72 37.66 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.794 2.329 . . . . 0.0 117.878 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 68.2 p -80.86 164.18 22.84 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.033 173.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.629 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.21 163.33 36.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.874 0.845 . . . . 0.0 113.118 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.74 140.81 6.53 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 117.816 1.886 . . . . 0.0 117.816 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -160.3 158.55 30.0 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -96.63 152.02 19.05 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.118 1.767 . . . . 0.0 110.709 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.34 118.12 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' B' ' 52' ' ' ILE . 13.9 t30 -94.22 113.14 25.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.017 0.927 . . . . 0.0 109.447 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.295 43.6 m95 -82.46 135.43 35.13 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -172.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -91.56 -44.07 9.29 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.956 2.102 . . . . 0.0 116.226 -173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -90.89 -9.49 46.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.0 t -152.74 126.84 9.09 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 127.448 2.299 . . . . 0.0 107.065 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -69.19 118.48 12.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.0 1.273 . . . . 0.0 110.407 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -177.34 163.59 2.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.393 1.877 . . . . 0.0 109.142 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -143.69 143.89 31.62 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 124.067 1.889 . . . . 0.0 111.613 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.44 125.71 21.65 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 109.99 -3.277 . . . . 0.0 109.86 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.33 153.58 4.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.79 142.15 51.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.72 118.94 7.26 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -174.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.88 -164.29 14.16 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.415 ' NE2' ' CE2' ' C' ' 84' ' ' PHE . 37.5 tt0 -132.06 149.46 52.41 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.541 0.789 . . . . 0.0 111.812 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.438 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 41.4 t -97.21 123.26 40.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.318 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.1 m-85 -112.34 164.71 12.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.264 1.025 . . . . 0.0 112.203 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -128.11 111.78 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.85 160.18 6.11 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -33.42 -47.74 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -10.06 59.13 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.07 5.79 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.524 1.056 . . . . 0.0 112.644 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -112.99 143.21 44.68 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 128.208 2.603 . . . . 0.0 108.959 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -109.45 143.93 38.38 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.489 1.495 . . . . 0.0 110.865 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.7 m -144.95 162.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.581 1.152 . . . . 0.0 109.606 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.63 121.02 39.16 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.84 119.07 38.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.532 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.7 p -137.31 172.54 12.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.083 1.42 . . . . 0.0 112.371 -174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.586 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.7 mmm -126.97 169.22 13.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -141.15 164.37 30.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.389 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -148.27 120.01 8.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.949 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.19 140.2 40.43 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 125.022 1.451 . . . . 0.0 112.231 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.25 120.74 36.98 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 111.208 -2.724 . . . . 0.0 111.129 -174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 38.4 t -88.56 163.18 15.99 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 125.176 1.548 . . . . 0.0 111.351 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -113.0 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.96 -165.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.439 0.695 . . . . 0.0 110.453 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.36 -15.65 3.19 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.074 -1.641 . . . . 0.0 114.054 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.58 148.89 43.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.13 1.443 . . . . 0.0 110.798 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.473 ' CD1' HG21 ' B' ' 92' ' ' VAL . 16.6 tt -62.18 -28.34 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.932 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.28 5.84 18.35 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-O 118.121 -1.377 . . . . 0.0 113.866 173.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.17 -1.43 9.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.587 1.194 . . . . 0.0 113.481 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.07 -35.71 71.76 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.738 -1.226 . . . . 0.0 112.581 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.42 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 62.7 p-90 -47.1 -39.8 13.98 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.018 1.327 . . . . 0.0 113.903 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.28 -7.21 26.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.16 2.04 9.89 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.537 -1.352 . . . . 0.0 113.09 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.683 ' CG2' HD21 ' C' ' 98' ' ' LEU . 35.8 m -116.96 145.08 43.87 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.977 0.911 . . . . 0.0 111.618 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.23 129.37 18.65 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 125.68 1.592 . . . . 0.0 110.62 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.66 155.08 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 120.558 1.526 . . . . 0.0 109.246 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -175.82 28.83 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.681 1.134 . . . . 0.0 113.441 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 21.1 p90 -125.45 152.95 44.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.541 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' ASN . . . . . 0.5 ' HB3' HD22 ' C' ' 12' ' ' ASN . 0.8 OUTLIER -145.61 152.66 40.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.75 1.22 . . . . 0.0 110.151 176.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.16 121.5 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -109.02 152.69 24.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -141.02 164.08 31.24 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.136 0.975 . . . . 0.0 110.676 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.39 114.38 2.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.097 0.959 . . . . 0.0 111.24 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.95 140.71 57.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.714 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . 0.325 0.0 OUTLIER 58.46 33.94 23.53 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 4.9 t -61.25 170.03 1.89 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.288 0.635 . . . . 0.0 112.646 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.01 125.92 54.6 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -149.53 110.42 4.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.931 1.292 . . . . 0.0 108.832 -173.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.312 21.8 pm0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.476 1.911 . . . . 0.0 115.081 -173.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 115.659 -2.115 . . . . 0.0 105.708 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 7.1 m 34.2 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.18 1.792 . . . . 0.0 113.267 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . 0.338 31.7 m 55.83 -140.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 117.175 -1.393 . . . . 0.0 110.115 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 164.01 -46.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.392 2.677 . . . . 0.0 112.681 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -149.26 96.75 2.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -156.85 120.62 4.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.378 1.445 . . . . 0.0 114.492 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 134.2 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.219 1.408 . . . . 0.0 111.273 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.43 127.54 13.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.022 1.329 . . . . 0.0 109.234 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -73.74 -27.7 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.77 116.1 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.86 1.264 . . . . 0.0 111.204 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.33 -123.52 2.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.411 1.482 . . . . 0.0 110.97 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -147.62 144.65 28.56 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -142.67 159.15 42.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.369 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -141.33 146.95 37.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 16' ' ' SER . 25.2 p30 -114.21 159.37 20.2 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -55.99 -26.06 46.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.146 2.578 . . . . 0.0 115.164 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -76.27 -11.97 60.0 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.608 1.163 . . . . 0.0 111.974 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.89 47.28 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 127.145 2.307 . . . . 0.0 112.931 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 12' ' ' ASN . 15.8 m -69.21 154.91 41.28 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.596 1.189 . . . . 0.0 111.598 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -128.99 150.56 50.35 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.736 -1.227 . . . . 0.0 110.273 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -134.47 145.4 48.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.339 0.59 . . . . 0.0 112.159 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -129.2 134.75 48.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.767 0.827 . . . . 0.0 109.231 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.31 125.05 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -78.68 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 O-C-N 124.335 1.022 . . . . 0.0 111.199 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.85 30.92 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.83 -0.806 . . . . 0.0 112.407 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.61 132.17 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.337 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 7.6 m-20 -76.52 168.73 19.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.941 0.877 . . . . 0.0 112.521 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 p -56.07 -27.4 53.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -75.64 -34.0 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.539 0.609 . . . . 0.0 112.272 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.65 -10.38 14.26 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.985 -1.453 . . . . 0.0 113.501 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 24' ' ' ASN . 10.1 pt-20 -62.56 140.02 58.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.358 2.263 . . . . 0.0 108.991 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.86 147.57 24.34 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 p -107.39 169.31 8.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.566 1.147 . . . . 0.0 109.78 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.04 -168.2 37.18 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.377 -1.452 . . . . 0.0 114.905 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.536 ' HB ' HD11 ' A' ' 46' ' ' LEU . 5.2 p -140.53 129.56 23.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.375 1.084 . . . . 0.0 111.975 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.29 137.79 48.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.12 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.5 mt -127.22 127.43 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 44' ' ' ILE 0.264 73.7 m -105.06 133.0 50.57 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 125.051 1.34 . . . . 0.0 112.986 -172.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.51 27.63 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.46 146.79 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.016 1.327 . . . . 0.0 112.092 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.02 161.69 42.23 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.817 -1.177 . . . . 0.0 111.407 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.98 -29.07 55.36 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 122.037 -0.414 . . . . 0.0 110.353 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -143.02 78.95 14.88 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 127.338 2.255 . . . . 0.0 110.215 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.15 21.28 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.336 1 C-N-CA 125.474 4.116 . . . . 0.0 117.415 -174.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.6 -7.13 5.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 119.289 2.476 . . . . 0.0 119.289 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.93 43.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.686 1.743 . . . . 0.0 111.38 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 35' ' ' THR . 71.5 mt -51.21 125.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.34 -1.475 . . . . 0.0 111.272 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.63 30.4 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.692 1.597 . . . . 0.0 110.389 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.3 tp -46.71 115.37 1.03 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.971 2.909 . . . . 0.0 110.738 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 t -102.76 119.36 55.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.493 0.717 . . . . 0.0 109.554 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -55.86 142.66 83.79 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.261 2.641 . . . . 0.0 111.431 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.54 154.81 47.42 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 124.017 0.823 . . . . 0.0 111.017 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -156.54 148.75 23.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.736 1.614 . . . . 0.0 110.574 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.21 -157.55 29.43 Favored Glycine 0 C--N 1.333 0.405 0 O-C-N 119.738 -1.851 . . . . 0.0 110.641 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.3 mt -142.7 142.01 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.681 0.792 . . . . 0.0 112.836 -174.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.44 136.91 47.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.0 151.12 44.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.671 1.225 . . . . 0.0 112.105 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -151.33 26.95 0.68 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.352 1.861 . . . . 0.0 110.019 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.41 -57.04 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.881 1.672 . . . . 0.0 110.065 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.26 7.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.301 0.64 . . . . 0.0 112.08 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 p -95.19 -17.95 21.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 117.329 -1.32 . . . . 0.0 113.754 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -131.6 45.4 1.71 Allowed Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.895 1.278 . . . . 0.0 112.364 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 171.38 17.28 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.7 2.266 . . . . 0.0 115.452 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.298 0.1 OUTLIER -98.81 163.81 12.47 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.747 1.737 . . . . 0.0 111.199 173.156 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -158.34 166.11 33.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.911 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.6 145.12 10.12 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 118.999 2.359 . . . . 0.0 118.999 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -161.41 153.65 19.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -90.15 149.18 22.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.548 1.939 . . . . 0.0 110.314 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -128.17 118.53 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' D' ' 52' ' ' ILE . 21.3 t30 -101.67 101.81 12.38 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.449 -0.782 . . . . 0.0 110.429 -174.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -58.69 129.43 42.08 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.49 -32.29 16.42 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -99.8 -11.96 20.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.35 138.01 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.944 2.098 . . . . 0.0 106.728 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -73.45 118.62 16.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.59 1.186 . . . . 0.0 111.254 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.67 159.77 2.37 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.591 1.556 . . . . 0.0 109.604 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -136.58 134.66 37.66 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.4 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.887 HG23 HD12 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -123.02 138.0 54.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 174.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.78 155.2 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -130.96 143.99 51.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.078 0.951 . . . . 0.0 108.844 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.47 118.98 8.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.32 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.73 176.68 44.83 Favored Glycine 0 C--O 1.215 -1.077 0 N-CA-C 118.196 2.038 . . . . 0.0 118.196 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -101.71 150.5 23.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.47 115.14 27.21 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.445 1.716 . . . . 0.0 107.086 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB2' HD12 ' D' ' 106' ' ' ILE . 25.5 m-85 -105.64 159.21 16.14 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.761 1.164 . . . . 0.0 113.266 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 16.0 mt -120.02 109.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 113.519 -1.673 . . . . 0.0 106.9 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.86 161.41 4.91 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -22.71 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -10.31 48.88 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.689 0.796 . . . . 0.0 112.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.75 6.44 56.24 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.487 1.042 . . . . 0.0 114.851 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 19.6 mtpp -73.82 165.51 24.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.773 1.286 . . . . 0.0 110.153 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.62 143.42 49.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.738 1.615 . . . . 0.0 111.473 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.543 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.51 153.17 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.09 0.956 . . . . 0.0 110.891 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.5 mt -116.46 103.59 10.59 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' CD ' HG11 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -97.06 114.45 26.09 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -133.26 164.54 26.85 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.216 1.484 . . . . 0.0 112.227 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' D' ' 113' ' ' THR . 92.9 mmm -115.29 167.87 10.47 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -139.07 163.87 31.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 0.0 113.423 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD12 HD12 ' D' ' 98' ' ' LEU . 0.4 OUTLIER -142.91 124.66 15.02 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.05 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.887 HD12 HG23 ' A' ' 77' ' ' THR . 1.7 tp -107.15 131.97 53.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.634 1.683 . . . . 0.0 109.036 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.2 tpt85 -114.79 113.67 24.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 111.036 -2.802 . . . . 0.0 109.232 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.271 1.0 OUTLIER -68.26 165.98 17.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.447 . . . . 0.0 111.688 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.1 t -107.3 86.95 2.39 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 121.465 1.939 . . . . 0.0 107.775 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 108' ' ' ASP . 8.1 p -86.66 157.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 129.294 3.038 . . . . 0.0 110.96 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -96.84 -34.14 11.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.47 148.84 32.28 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.777 0.799 . . . . 0.0 112.685 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' D' ' 84' ' ' PHE . 4.6 tt -62.37 -29.58 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.851 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.63 5.26 38.92 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' A' ' 103' ' ' VAL . 4.7 m-20 -123.4 0.03 8.82 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.333 1.567 . . . . 0.0 113.6 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -28.8 69.32 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.49 -1.381 . . . . 0.0 113.77 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.681 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 62.5 p-90 -49.64 -44.39 47.45 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.946 0.898 . . . . 0.0 113.223 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.681 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -87.63 -12.72 44.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.252 -0.905 . . . . 0.0 113.223 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 -0.69 26.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.513 -0.742 . . . . 0.0 112.247 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.608 HG21 ' HG3' ' D' ' 96' ' ' MET . 35.2 m -110.22 139.84 44.96 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.348 1.059 . . . . 0.0 111.054 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.23 132.96 22.39 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.737 1.215 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -112.31 154.66 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 120.275 1.398 . . . . 0.0 110.961 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -174.45 27.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.938 0.78 . . . . 0.0 114.728 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 9.7 p90 -128.43 156.65 42.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.209 1.004 . . . . 0.0 112.209 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -152.16 150.23 29.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.243 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 94' ' ' LYS . 9.0 mt -126.66 121.13 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.67 149.49 34.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.6 p -138.8 165.02 28.1 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.62 117.0 2.79 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.649 0.78 . . . . 0.0 110.546 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.594 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -68.26 110.33 4.0 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.5 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.2 OUTLIER 177.09 -68.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.263 1.425 . . . . 0.0 110.115 174.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.7 t 38.63 29.37 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.015 2.526 . . . . 0.0 115.93 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -69.34 12.59 0.16 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm 69.46 5.47 5.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.6 1.96 . . . . 0.0 113.574 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 128.938 2.895 . . . . 0.0 110.354 173.209 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 63.73 8.27 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.666 1.575 . . . . 0.0 114.155 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.95 16.0 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.548 1.139 . . . . 0.0 113.763 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -62.71 -173.25 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.234 1.813 . . . . 0.0 113.769 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 58.78 20.83 8.32 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.61 -1.306 . . . . 0.0 113.707 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -156.75 123.07 4.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.207 -0.933 . . . . 0.0 113.019 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 t -133.04 142.81 48.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.669 0.787 . . . . 0.0 110.964 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.02 135.88 33.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.155 1.782 . . . . 0.0 108.801 174.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.51 -24.78 60.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.045 1.293 . . . . 0.0 113.858 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 115.73 1.7 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.94 1.296 . . . . 0.0 111.08 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.91 -125.72 3.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.982 1.277 . . . . 0.0 110.382 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -147.48 145.81 29.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -143.51 159.85 41.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -140.26 149.21 42.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' D' ' 16' ' ' SER . 24.6 p30 -113.88 160.15 19.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -56.24 -26.07 50.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.127 2.571 . . . . 0.0 114.912 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' B' ' 110' ' ' TRP . 29.1 tp -76.48 -11.04 59.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.793 1.237 . . . . 0.0 112.074 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.17 -15.21 56.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.832 2.158 . . . . 0.0 112.994 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' SER . . . . . 0.432 ' HB2' HD21 ' D' ' 12' ' ' ASN . 15.4 m -69.76 154.75 41.54 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.64 1.21 . . . . 0.0 111.643 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -129.02 151.23 49.94 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.576 -1.327 . . . . 0.0 110.677 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -134.3 146.78 50.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -130.27 134.85 47.53 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.662 0.785 . . . . 0.0 109.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.75 124.18 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.91 -75.86 0.39 Allowed Glycine 0 CA--C 1.527 0.827 0 O-C-N 124.339 1.024 . . . . 0.0 111.394 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.85 156.99 42.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.561 0.695 . . . . 0.0 111.931 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.5 131.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.052 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -77.99 168.57 19.69 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.833 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 61.8 p -57.08 -26.65 60.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -75.04 -30.2 60.99 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.253 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.02 -8.24 18.86 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 124.666 1.127 . . . . 0.0 114.154 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.49 147.72 51.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.51 2.324 . . . . 0.0 113.683 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PHE . . . . . 0.501 ' O ' HD12 ' D' ' 50' ' ' LEU . 52.2 p90 -156.56 161.61 39.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.023 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.414 HG22 HD13 ' D' ' 50' ' ' LEU . 3.0 p -119.2 172.72 7.39 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 173.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.4 -167.26 35.43 Favored Glycine 0 N--CA 1.467 0.756 0 O-C-N 119.349 -2.095 . . . . 0.0 114.143 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.531 ' HB ' HD11 ' D' ' 46' ' ' LEU . 5.0 p -139.52 129.24 24.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.482 1.134 . . . . 0.0 112.301 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -111.86 138.04 49.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.268 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 80.7 mt -127.16 127.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.424 ' O ' HG21 ' D' ' 44' ' ' ILE 0.264 90.5 m -105.1 133.82 49.23 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.816 1.246 . . . . 0.0 112.849 -172.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.65 -16.51 26.9 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 m -135.5 147.05 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.065 1.346 . . . . 0.0 112.167 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.4 161.04 42.71 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.806 -1.184 . . . . 0.0 111.74 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -76.22 -28.76 57.31 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.881 -0.512 . . . . 0.0 110.587 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -143.18 78.95 14.66 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.278 2.231 . . . . 0.0 110.311 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 21.09 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.316 1 C-N-CA 125.44 4.093 . . . . 0.0 117.403 -174.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.46 -7.04 5.17 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.15 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.136 1.774 . . . . 0.0 111.392 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.424 HG21 ' O ' ' D' ' 35' ' ' THR . 71.2 mt -51.05 126.31 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.303 -1.498 . . . . 0.0 111.288 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.73 164.66 31.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.606 1.562 . . . . 0.0 110.426 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.531 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.4 tp -46.55 115.36 1.01 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.918 2.887 . . . . 0.0 110.562 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.8 t -103.2 118.63 57.44 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 123.607 0.763 . . . . 0.0 109.221 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.89 141.71 85.26 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.015 2.476 . . . . 0.0 111.094 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.41 HD12 ' C ' ' D' ' 49' ' ' LEU . 2.2 pp -129.76 162.18 29.02 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.199 0.999 . . . . 0.0 111.428 174.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.501 HD12 ' O ' ' D' ' 29' ' ' PHE . 18.7 tp -165.5 148.83 8.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.703 1.201 . . . . 0.0 112.104 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.72 25.77 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 121.227 1.83 . . . . 0.0 110.456 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.4 mt -145.19 141.83 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.878 0.987 . . . . 0.0 111.591 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 133.62 43.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.988 1.315 . . . . 0.0 114.515 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -67.31 147.31 53.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.443 1.116 . . . . 0.0 112.208 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -146.06 27.76 1.15 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.614 1.965 . . . . 0.0 110.127 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.12 -57.28 2.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.629 1.572 . . . . 0.0 110.133 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 175.31 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.527 0.731 . . . . 0.0 112.5 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 p -91.76 -20.59 21.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.673 1.189 . . . . 0.0 113.706 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -133.29 46.14 1.94 Allowed Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 125.227 1.411 . . . . 0.0 112.989 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.76 170.51 19.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.692 2.261 . . . . 0.0 116.006 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.296 0.0 OUTLIER -97.89 161.98 13.47 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 124.023 1.868 . . . . 0.0 111.465 173.092 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.09 166.37 33.48 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.369 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.86 145.52 10.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 118.656 2.223 . . . . 0.0 118.656 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -161.91 152.98 18.04 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -89.44 151.15 22.17 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.62 1.968 . . . . 0.0 110.268 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 70.9 t -130.28 119.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.451 ' CB ' HG21 ' A' ' 52' ' ' ILE . 21.3 t30 -103.0 102.11 12.14 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 110.426 -174.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -58.43 129.8 43.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 124.071 1.891 . . . . 0.0 115.216 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.22 -31.58 16.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.57 -11.95 19.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 138.34 18.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.999 2.12 . . . . 0.0 106.484 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.85 118.69 17.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 43.1 t -175.66 160.04 2.41 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.486 1.514 . . . . 0.0 109.558 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.39 134.71 38.08 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.594 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.893 HG23 HD12 ' D' ' 99' ' ' LEU . 0.9 OUTLIER -122.97 138.58 54.64 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.371 174.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.69 155.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -131.29 143.65 50.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.081 0.953 . . . . 0.0 108.657 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.61 118.25 8.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.444 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -170.86 176.05 44.4 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 118.185 2.034 . . . . 0.0 118.185 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.447 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.76 150.42 23.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.943 1.025 . . . . 0.0 113.491 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 12.6 p -97.51 118.41 33.95 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.193 -1.821 . . . . 0.0 106.633 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.653 ' HB2' HD12 ' A' ' 106' ' ' ILE . 20.4 m-85 -110.01 155.35 21.94 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.662 1.119 . . . . 0.0 113.849 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 85' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 10.4 mt -115.55 110.33 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.477 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -58.81 162.02 4.39 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -23.38 1.3 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -4.57 57.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.68 0.792 . . . . 0.0 112.692 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.86 61.85 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.035 1.302 . . . . 0.0 114.977 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 22.0 mtpp -77.32 165.92 23.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.927 1.363 . . . . 0.0 110.505 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -122.06 145.12 48.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.02 1.328 . . . . 0.0 111.212 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.534 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -144.5 154.19 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.381 1.072 . . . . 0.0 110.64 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.98 103.81 10.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.534 ' CD ' HG11 ' D' ' 92' ' ' VAL . 0.6 OUTLIER -96.85 114.27 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -133.05 164.59 26.68 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 123.003 1.383 . . . . 0.0 112.382 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.608 ' HG3' HG21 ' A' ' 113' ' ' THR . 92.3 mmm -115.19 167.86 10.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -139.06 164.0 30.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.412 1.101 . . . . 0.0 113.43 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.445 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.4 OUTLIER -143.1 124.95 15.09 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.922 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 99' ' ' LEU . . . . . 0.893 HD12 HG23 ' D' ' 77' ' ' THR . 1.9 tp -107.22 132.01 53.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 123.7 1.714 . . . . 0.0 108.964 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -114.7 113.6 24.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 111.067 -2.788 . . . . 0.0 108.985 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.266 1.0 OUTLIER -67.37 165.92 15.51 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 116.875 -1.536 . . . . 0.0 111.888 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 29.7 t -107.81 87.3 2.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 121.775 2.079 . . . . 0.0 107.611 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' D' ' 108' ' ' ASP . 8.0 p -88.09 154.86 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 129.215 3.006 . . . . 0.0 110.993 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -93.5 -33.06 13.93 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.83 150.35 35.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 84' ' ' PHE . 4.6 tt -62.96 -28.83 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.485 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.3 5.75 48.44 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.838 1.208 . . . . 0.0 115.606 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' D' ' 103' ' ' VAL . 4.3 m-20 -123.3 0.42 8.94 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.273 1.536 . . . . 0.0 113.374 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -29.37 69.34 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.387 -1.446 . . . . 0.0 114.226 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.675 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 62.4 p-90 -49.37 -44.75 45.15 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.973 0.909 . . . . 0.0 113.085 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 111' ' ' LYS . . . . . 0.675 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.0 OUTLIER -87.31 -12.64 45.9 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.04 0.936 . . . . 0.0 113.279 176.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.99 1.12 21.83 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.457 -0.777 . . . . 0.0 112.402 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 96' ' ' MET . 33.9 m -111.56 139.7 46.78 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.33 1.052 . . . . 0.0 111.118 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 114' ' ' ARG . 2.0 mpt_? -144.12 133.35 23.06 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.641 1.176 . . . . 0.0 110.942 175.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.33 154.74 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 120.4 1.455 . . . . 0.0 110.978 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -173.94 27.33 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.006 0.812 . . . . 0.0 114.744 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 10.0 p90 -128.67 156.39 43.53 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.282 1.033 . . . . 0.0 112.241 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -152.18 149.78 29.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.393 1.077 . . . . 0.0 112.144 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 119' ' ' ILE . . . . . 0.439 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.4 mt -126.47 123.4 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.675 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 148.39 40.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -139.74 167.29 22.44 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 120.74 7.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.675 1.19 . . . . 0.0 112.495 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.03 114.34 7.22 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.778 -0.63 . . . . 0.0 109.942 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 69.21 114.78 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.726 2.41 . . . . 0.0 113.076 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 20.1 p -144.21 -83.12 0.16 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.973 0.909 . . . . 0.0 109.917 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 61.93 -44.96 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.525 2.33 . . . . 0.0 114.76 -174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -139.08 102.13 4.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.059 1.744 . . . . 0.0 107.619 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.807 1.643 . . . . 0.0 108.937 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . 0.266 10.5 pm0 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.0 m -138.45 153.34 48.84 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.875 1.216 . . . . 0.0 110.408 -174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.61 37.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.166 1.386 . . . . 0.0 113.755 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -69.33 42.27 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.224 1.81 . . . . 0.0 114.907 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -144.46 43.98 1.4 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.495 1.918 . . . . 0.0 111.491 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tmmt? -156.65 120.54 4.33 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.156 -0.965 . . . . 0.0 113.409 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.33 144.0 51.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 111.533 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.06 134.97 32.12 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.827 1.651 . . . . 0.0 109.064 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -73.46 -25.8 60.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.978 1.263 . . . . 0.0 113.683 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.54 115.69 1.45 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 111.069 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.95 -125.6 3.14 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 125.252 1.406 . . . . 0.0 110.334 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -149.58 144.12 26.0 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -142.31 159.44 42.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.577 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 t -138.96 150.36 45.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.424 HD21 ' HB2' ' B' ' 16' ' ' SER . 24.6 p30 -114.84 158.89 21.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.825 1.298 . . . . 0.0 114.347 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -54.53 -26.45 31.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.054 2.542 . . . . 0.0 114.879 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.51 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.4 tp -75.98 -12.06 60.07 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.897 1.279 . . . . 0.0 112.302 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.16 -15.7 50.67 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.132 2.301 . . . . 0.0 112.991 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.424 ' HB2' HD21 ' B' ' 12' ' ' ASN . 15.5 m -69.81 155.26 40.82 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.718 1.247 . . . . 0.0 111.706 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -129.24 150.2 50.72 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.639 -1.288 . . . . 0.0 110.511 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -133.63 147.06 51.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.371 0.605 . . . . 0.0 112.626 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -130.67 134.49 46.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.651 0.78 . . . . 0.0 109.469 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 92.9 mt -132.35 125.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -78.89 0.22 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 124.506 1.129 . . . . 0.0 111.208 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.31 152.7 33.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.629 0.728 . . . . 0.0 112.305 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.64 131.94 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.362 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -76.93 168.4 20.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 0.0 112.472 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 62.8 p -55.79 -27.51 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.58 -33.33 60.59 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.596 0.634 . . . . 0.0 112.327 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.86 -10.05 15.87 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 117.961 -1.466 . . . . 0.0 113.682 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.12 139.89 58.82 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.453 2.301 . . . . 0.0 108.861 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.79 148.54 25.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.0 p -108.94 168.4 9.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.809 1.244 . . . . 0.0 109.633 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 -168.58 37.31 Favored Glycine 0 N--CA 1.466 0.692 0 O-C-N 120.27 -1.519 . . . . 0.0 114.983 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.524 ' HB ' HD11 ' B' ' 46' ' ' LEU . 5.8 p -140.5 130.03 24.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.394 1.092 . . . . 0.0 111.765 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -111.46 138.37 48.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.191 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 78.7 mt -127.66 127.77 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.412 ' O ' HG21 ' B' ' 44' ' ' ILE 0.263 82.4 m -105.16 134.02 48.97 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.792 1.237 . . . . 0.0 112.913 -172.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 -15.44 27.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 146.54 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.936 1.294 . . . . 0.0 111.972 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.31 42.7 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.735 -1.228 . . . . 0.0 111.489 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.48 -29.21 56.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.058 -0.401 . . . . 0.0 110.408 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -142.84 79.18 15.02 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.336 2.254 . . . . 0.0 110.292 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.17 20.55 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.377 1 C-N-CA 125.389 4.06 . . . . 0.0 117.406 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.67 -8.16 5.19 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.99 43.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.702 1.751 . . . . 0.0 111.335 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.412 HG21 ' O ' ' B' ' 35' ' ' THR . 70.3 mt -51.12 125.65 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.346 -1.471 . . . . 0.0 111.35 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.17 164.48 31.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.595 1.558 . . . . 0.0 110.449 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' B' ' 32' ' ' THR . 13.3 tp -46.49 115.41 1.02 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 129.005 2.922 . . . . 0.0 110.753 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.1 t -103.17 119.83 54.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.544 0.738 . . . . 0.0 109.268 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.03 142.55 85.45 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.363 2.708 . . . . 0.0 111.385 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.38 154.92 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.119 0.887 . . . . 0.0 110.89 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.73 148.72 22.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.621 1.568 . . . . 0.0 110.364 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.0 -158.07 29.97 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 121.25 1.841 . . . . 0.0 110.691 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.3 mt -142.64 141.95 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.571 0.748 . . . . 0.0 112.749 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.57 135.01 45.65 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -69.45 149.13 48.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.8 1.286 . . . . 0.0 112.249 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -148.8 27.1 0.89 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.475 1.91 . . . . 0.0 109.841 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.71 -56.55 2.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.522 1.529 . . . . 0.0 109.721 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.89 173.64 10.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.784 0.802 . . . . 0.0 112.88 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -88.85 -23.27 22.84 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 113.505 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -131.88 48.31 3.52 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.255 1.422 . . . . 0.0 113.315 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.82 171.64 17.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.328 2.019 . . . . 0.0 115.58 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.294 0.1 OUTLIER -98.14 163.07 12.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 123.775 1.75 . . . . 0.0 111.368 173.147 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -157.92 165.74 34.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.049 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 145.6 10.63 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 118.988 2.355 . . . . 0.0 118.988 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -161.59 153.94 19.91 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -89.92 149.46 22.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.651 1.98 . . . . 0.0 110.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -128.52 118.73 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' C' ' 52' ' ' ILE . 21.6 t30 -101.81 101.83 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.477 -0.764 . . . . 0.0 110.587 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.9 129.43 42.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 123.853 1.787 . . . . 0.0 115.311 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.62 -32.25 16.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -100.07 -11.92 20.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.5 t -152.46 138.0 17.74 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.807 2.043 . . . . 0.0 106.432 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.8 118.58 16.92 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.618 1.199 . . . . 0.0 111.406 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -175.34 159.99 2.56 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.624 1.57 . . . . 0.0 109.625 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.64 134.47 37.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.293 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.882 HG23 HD12 ' B' ' 99' ' ' LEU . 0.8 OUTLIER -122.83 137.67 54.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.45 174.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -109.04 155.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -131.69 144.61 51.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.88 118.49 7.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.705 0.628 . . . . 0.0 109.965 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' NE ' ' C' ' 100' ' ' ARG . . . -170.8 176.42 44.26 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 118.201 2.041 . . . . 0.0 118.201 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.77 150.33 23.26 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 125.021 1.071 . . . . 0.0 113.82 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 10.4 p -97.51 117.43 31.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.621 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.668 ' HB2' HD12 ' C' ' 106' ' ' ILE . 17.6 m-85 -108.81 155.15 21.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 119.804 1.184 . . . . 0.0 113.864 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.19 109.57 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.751 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -58.71 164.94 2.48 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.829 0.706 . . . . 0.0 109.594 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.98 -29.93 3.86 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -8.04 56.38 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.405 1.082 . . . . 0.0 113.27 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.95 10.71 58.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.764 1.173 . . . . 0.0 115.534 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -76.6 168.44 20.07 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.06 1.43 . . . . 0.0 108.895 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -124.58 145.06 49.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.192 1.36 . . . . 0.0 110.687 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.53 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.1 t -144.12 153.76 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.197 0.999 . . . . 0.0 111.453 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -117.57 103.32 9.95 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.53 ' CD ' HG11 ' B' ' 92' ' ' VAL . 0.6 OUTLIER -96.8 113.97 25.56 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 173.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -132.8 164.66 26.34 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.099 1.428 . . . . 0.0 112.385 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.623 ' HG3' HG21 ' C' ' 113' ' ' THR . 93.1 mmm -115.73 168.09 10.34 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -139.26 164.14 30.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.637 1.208 . . . . 0.0 113.419 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' C' ' 98' ' ' LEU . 0.4 OUTLIER -142.73 125.05 15.53 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.088 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 77' ' ' THR . 1.7 tp -107.2 131.55 54.05 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 125.412 1.695 . . . . 0.0 109.27 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.405 ' NE ' ' HA2' ' C' ' 81' ' ' GLY . 3.5 tpt85 -114.82 113.65 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 110.847 -2.888 . . . . 0.0 108.947 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.261 0.9 OUTLIER -69.02 164.4 22.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.318 1.447 . . . . 0.0 111.994 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.5 t -105.45 87.95 2.73 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 121.462 1.937 . . . . 0.0 107.703 173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' B' ' 108' ' ' ASP . 7.5 p -88.04 156.04 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 129.215 3.006 . . . . 0.0 111.065 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -95.81 -33.31 12.3 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.28 148.46 34.13 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.64 0.733 . . . . 0.0 112.698 -174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' C' ' 84' ' ' PHE . 4.8 tt -62.4 -29.79 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.588 174.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.88 40.66 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.764 1.173 . . . . 0.0 115.888 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' B' ' 103' ' ' VAL . 4.5 m-20 -122.94 -0.36 9.01 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.319 1.559 . . . . 0.0 113.631 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -28.86 69.22 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.48 -1.387 . . . . 0.0 113.792 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.669 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 62.2 p-90 -49.44 -44.28 45.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.092 0.957 . . . . 0.0 113.311 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.669 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.0 OUTLIER -87.99 -12.56 44.12 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.139 -0.975 . . . . 0.0 113.294 176.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -0.54 25.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.424 0.69 . . . . 0.0 112.342 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' C' ' 96' ' ' MET . 35.5 m -110.1 139.85 44.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.289 1.036 . . . . 0.0 110.799 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' D' ' 114' ' ' ARG . 2.0 mpt_? -144.27 132.6 21.93 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.901 1.28 . . . . 0.0 111.167 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.82 154.59 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 120.213 1.37 . . . . 0.0 110.936 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.04 -174.7 28.08 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.008 0.813 . . . . 0.0 114.733 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 9.8 p90 -128.16 156.59 42.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.222 1.009 . . . . 0.0 112.272 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -152.6 148.88 27.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.299 1.04 . . . . 0.0 112.249 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.433 HD13 ' HE3' ' B' ' 94' ' ' LYS . 9.5 mt -125.31 122.74 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.424 175.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.9 148.68 38.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 28.3 p -140.35 167.78 21.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.32 123.47 16.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.888 -1.132 . . . . 0.0 113.016 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.71 168.05 5.27 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.57 6.38 5.4 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 72.8 p -94.49 104.18 16.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.743 1.617 . . . . 0.0 108.928 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -79.34 -177.07 5.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.695 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 66.51 4.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.626 1.171 . . . . 0.0 108.51 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . 0.403 3.6 pm0 . . . . . 0 C--O 1.248 0.979 0 C-N-CA 130.403 3.481 . . . . 0.0 113.476 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 116.757 -1.592 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.7 38.28 5.61 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 173.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . 0.273 15.4 m 45.02 19.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.32 85.09 0.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.827 1.651 . . . . 0.0 112.428 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -158.59 55.73 0.44 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.908 1.283 . . . . 0.0 111.782 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -156.75 123.44 5.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 45.3 t -132.08 143.63 50.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.828 0.851 . . . . 0.0 111.874 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 135.4 32.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.674 1.99 . . . . 0.0 109.216 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.2 mt -73.41 -24.7 60.31 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.605 1.548 . . . . 0.0 114.283 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -50.79 117.36 2.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.712 1.205 . . . . 0.0 111.237 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.98 -126.38 3.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.239 1.399 . . . . 0.0 110.295 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -147.02 143.42 28.38 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -141.43 158.58 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.682 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -139.07 148.8 43.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' C' ' 16' ' ' SER . 25.0 p30 -113.46 161.03 17.82 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.909 1.338 . . . . 0.0 114.499 175.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -57.69 -25.57 60.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.494 2.718 . . . . 0.0 114.899 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 110' ' ' TRP . 29.6 tp -77.06 -11.02 59.75 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 111.759 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.23 -16.27 53.51 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.945 2.212 . . . . 0.0 112.943 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' SER . . . . . 0.434 ' HB2' HD21 ' C' ' 12' ' ' ASN . 15.4 m -69.29 154.58 41.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.598 1.189 . . . . 0.0 111.592 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -129.1 150.74 50.36 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.613 -1.305 . . . . 0.0 110.558 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.62 145.4 48.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.362 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -129.66 134.06 47.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.52 124.14 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.95 -74.75 0.48 Allowed Glycine 0 CA--C 1.528 0.866 0 O-C-N 124.26 0.975 . . . . 0.0 111.461 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.42 43.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.943 -0.74 . . . . 0.0 111.989 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.52 130.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.192 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -77.13 168.51 19.96 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.877 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 60.2 p -56.64 -26.99 57.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.12 -29.95 60.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.976 0.807 . . . . 0.0 112.395 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.83 -7.87 19.46 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 124.585 1.088 . . . . 0.0 114.339 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.47 148.12 49.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.599 2.36 . . . . 0.0 113.132 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PHE . . . . . 0.49 ' O ' HD12 ' C' ' 50' ' ' LEU . 52.3 p90 -156.93 161.51 39.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.982 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.437 HG22 HD13 ' C' ' 50' ' ' LEU . 3.1 p -118.83 172.67 7.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.3 -167.58 35.84 Favored Glycine 0 N--CA 1.469 0.848 0 O-C-N 119.334 -2.104 . . . . 0.0 114.409 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.515 ' HB ' HD11 ' C' ' 46' ' ' LEU . 6.3 p -138.57 129.6 26.85 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.756 1.265 . . . . 0.0 112.446 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -112.05 137.64 49.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.302 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -127.31 127.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.261 90.3 m -105.03 134.46 48.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.842 1.257 . . . . 0.0 112.699 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.87 -15.73 26.07 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.88 146.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 161.19 42.71 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.795 -1.19 . . . . 0.0 111.566 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.51 -29.38 56.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.538 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -142.66 79.15 15.37 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.386 2.275 . . . . 0.0 110.377 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.28 21.04 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.386 1 C-N-CA 125.464 4.109 . . . . 0.0 117.356 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.24 -7.56 5.45 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.52 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.139 1.776 . . . . 0.0 111.439 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.12 126.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.418 -1.426 . . . . 0.0 111.379 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.4 164.67 30.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.614 1.565 . . . . 0.0 110.412 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.515 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -46.55 115.38 1.02 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 129.06 2.944 . . . . 0.0 110.545 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -102.96 119.06 56.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.547 0.739 . . . . 0.0 109.399 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.97 141.06 86.68 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.157 2.571 . . . . 0.0 111.278 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.404 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.4 pp -129.57 162.29 28.56 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.045 174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.49 HD12 ' O ' ' C' ' 29' ' ' PHE . 18.8 tp -165.36 148.82 8.19 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.991 1.717 . . . . 0.0 112.243 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.87 25.96 Favored Glycine 0 N--CA 1.448 -0.544 0 O-C-N 119.795 -1.816 . . . . 0.0 110.606 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.5 mt -145.49 142.25 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.838 0.964 . . . . 0.0 111.739 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 135.32 44.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.155 1.382 . . . . 0.0 114.384 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.88 149.58 47.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.482 1.134 . . . . 0.0 112.373 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -148.72 25.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.577 1.951 . . . . 0.0 110.065 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.88 -56.44 2.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.599 1.56 . . . . 0.0 110.347 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 173.92 8.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.773 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 3.9 p -92.25 -19.14 22.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.87 1.268 . . . . 0.0 113.674 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -133.61 46.31 1.98 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.924 1.29 . . . . 0.0 112.682 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.75 170.64 19.56 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.023 2.482 . . . . 0.0 116.19 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.292 0.0 OUTLIER -97.07 162.59 13.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 123.751 1.738 . . . . 0.0 111.282 173.088 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.55 166.11 33.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.267 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.87 145.71 10.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.95 153.49 18.6 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -89.65 150.99 22.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.765 2.026 . . . . 0.0 110.228 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 78.3 t -130.25 119.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.445 ' CB ' HG21 ' B' ' 52' ' ' ILE . 21.9 t30 -102.83 101.72 11.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -58.43 129.78 43.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.352 1.548 . . . . 0.0 115.137 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.06 -31.8 16.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.38 -11.98 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 32.4 t -152.4 138.09 17.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.827 2.051 . . . . 0.0 106.213 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -74.25 118.61 17.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.591 1.186 . . . . 0.0 111.253 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.03 159.83 2.68 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.557 1.543 . . . . 0.0 109.543 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -135.98 134.66 38.82 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.386 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.859 HG23 HD12 ' C' ' 99' ' ' LEU . 0.9 OUTLIER -123.24 138.53 54.61 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.408 0.623 . . . . 0.0 111.497 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.59 155.33 11.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -131.14 143.68 50.82 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.942 0.897 . . . . 0.0 108.77 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.35 118.45 8.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' B' ' 100' ' ' ARG . . . -170.26 176.64 43.86 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.469 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.67 150.35 23.2 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.928 1.016 . . . . 0.0 113.517 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 11.6 p -97.52 116.97 30.75 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 125.611 1.819 . . . . 0.0 107.34 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.665 ' HB2' HD12 ' B' ' 106' ' ' ILE . 17.5 m-85 -108.66 156.62 19.35 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.552 1.168 . . . . 0.0 113.604 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 9.7 mt -117.37 110.24 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.174 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -58.69 160.5 5.58 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -24.79 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -9.31 52.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.984 0.914 . . . . 0.0 113.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.18 14.97 49.88 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.673 1.13 . . . . 0.0 115.402 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -82.64 166.29 19.3 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.078 1.439 . . . . 0.0 109.075 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -122.39 145.37 48.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.605 1.548 . . . . 0.0 110.767 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.54 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.1 t -144.24 153.09 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.712 1.205 . . . . 0.0 111.106 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.25 103.65 10.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.54 ' CD ' HG11 ' C' ' 92' ' ' VAL . 0.5 OUTLIER -97.13 112.73 24.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 173.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.68 163.82 27.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.093 1.425 . . . . 0.0 112.383 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' B' ' 113' ' ' THR . 93.4 mmm -114.95 168.23 10.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -139.45 163.84 31.45 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.428 1.109 . . . . 0.0 113.376 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' B' ' 98' ' ' LEU . 0.4 OUTLIER -142.87 124.66 15.06 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.123 175.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 99' ' ' LEU . . . . . 0.859 HD12 HG23 ' C' ' 77' ' ' THR . 1.9 tp -107.2 131.95 53.59 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 123.769 1.747 . . . . 0.0 108.841 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.41 ' NE ' ' HA2' ' B' ' 81' ' ' GLY . 3.2 tpt85 -114.84 113.57 24.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 110.942 -2.844 . . . . 0.0 109.05 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.19 164.83 19.61 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 116.867 -1.54 . . . . 0.0 111.912 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 88.12 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 121.742 2.065 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' C' ' 108' ' ' ASP . 6.6 p -88.45 155.82 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 129.265 3.026 . . . . 0.0 111.138 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -95.08 -32.77 12.95 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -114.02 149.35 35.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.573 0.701 . . . . 0.0 112.671 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' B' ' 84' ' ' PHE . 4.8 tt -62.53 -30.22 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.795 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.65 5.28 38.94 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.598 1.094 . . . . 0.0 115.777 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' C' ' 103' ' ' VAL . 4.6 m-20 -123.09 0.08 9.01 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.361 1.581 . . . . 0.0 113.735 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.92 69.17 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.365 -1.459 . . . . 0.0 113.806 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.676 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 62.5 p-90 -49.65 -44.24 47.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.87 0.868 . . . . 0.0 113.214 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' LYS . . . . . 0.676 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.0 OUTLIER -88.16 -12.6 43.49 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.097 -1.002 . . . . 0.0 113.347 176.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 1.48 18.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.708 0.803 . . . . 0.0 112.577 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.623 HG21 ' HG3' ' B' ' 96' ' ' MET . 33.9 m -112.68 139.61 48.15 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.436 1.094 . . . . 0.0 111.207 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -144.26 133.01 22.41 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.656 1.183 . . . . 0.0 110.94 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.13 154.79 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.364 1.438 . . . . 0.0 110.897 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.39 -174.29 27.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.908 0.766 . . . . 0.0 114.76 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 10.0 p90 -128.41 156.72 42.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.219 1.008 . . . . 0.0 112.294 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -152.23 148.67 27.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 112.298 173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' C' ' 94' ' ' LYS . 9.4 mt -124.94 122.2 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.522 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 148.87 37.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.843 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 45.6 p -138.84 167.43 22.04 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.69 122.54 13.05 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.4 -0.813 . . . . 0.0 111.735 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -79.19 77.87 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 159.21 64.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 129.995 3.318 . . . . 0.0 112.784 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 1.8 p -144.2 161.74 38.11 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.196 -1.565 . . . . 0.0 110.746 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 -159.64 0.98 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.961 1.704 . . . . 0.0 109.193 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -170.39 160.09 7.4 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.153 3.381 . . . . 0.0 110.828 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 . . . . . 0 C--O 1.248 1.018 0 O-C-N 125.368 1.667 . . . . 0.0 108.899 171.573 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.4 m -71.15 55.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.576 1.951 . . . . 0.0 113.868 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 63.2 t 64.44 -47.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 128.236 2.614 . . . . 0.0 115.302 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 22.98 62.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.571 2.748 . . . . 0.0 116.208 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.51 52.66 1.18 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -156.8 144.91 19.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.866 1.266 . . . . 0.0 110.413 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.14 154.67 51.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.72 1.208 . . . . 0.0 108.382 173.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.91 129.92 24.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.009 -1.057 . . . . 0.0 111.597 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.1 -25.17 67.98 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -54.56 120.25 6.41 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 123.355 1.55 . . . . 0.0 112.562 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.9 -110.92 1.04 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.979 2.228 . . . . 0.0 110.242 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HD2' HD13 ' A' ' 123' ' ' LEU . 18.4 ttmt -152.99 152.1 31.02 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.73 -0.865 . . . . 0.0 113.271 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -140.16 156.33 46.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.801 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.62 146.64 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.394 177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -116.72 143.33 45.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 111.238 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.04 -24.99 57.81 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.58 1.552 . . . . 0.0 113.825 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 37' ' ' VAL . 40.5 tp -67.31 -15.94 63.98 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 120.735 -1.228 . . . . 0.0 111.821 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.09 -9.46 42.98 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 127.645 2.545 . . . . 0.0 113.242 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.4 147.99 52.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.228 -1.16 . . . . 0.0 111.925 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -126.62 151.42 48.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.198 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.41 147.33 33.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -127.97 134.98 49.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.787 0.835 . . . . 0.0 110.291 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.67 121.01 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.13 -65.17 2.7 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.671 1.232 . . . . 0.0 113.291 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.68 137.71 4.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -84.45 137.67 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.76 163.5 27.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.826 0.451 . . . . 0.0 111.348 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -23.69 50.39 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -27.35 63.79 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.137 -0.977 . . . . 0.0 111.165 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.11 48.78 Favored Glycine 0 C--O 1.224 -0.512 0 CA-C-O 117.577 -1.68 . . . . 0.0 112.958 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -70.99 144.6 50.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.779 1.289 . . . . 0.0 108.547 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -156.03 155.77 33.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.682 0.753 . . . . 0.0 112.307 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 ' HB ' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -127.75 158.71 36.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.395 1.878 . . . . 0.0 108.267 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.32 -170.67 34.92 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.97 -1.081 . . . . 0.0 114.747 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.416 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 35.6 p -137.53 126.23 23.84 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.696 ' C ' HD12 ' A' ' 34' ' ' ILE . 1.4 t80 -126.52 133.14 51.21 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.05 -172.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 46' ' ' LEU . 1.4 mp -121.48 135.61 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 37' ' ' VAL . 50.1 m -115.77 131.0 57.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.36 3.86 50.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 35' ' ' THR . 26.9 m -141.34 162.28 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 128.116 2.566 . . . . 0.0 108.444 -175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.46 10.51 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.893 -1.754 . . . . 0.0 111.842 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.64 -24.69 61.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.287 0.235 . . . . 0.0 110.603 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.35 84.01 4.43 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 175.95 8.72 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.815 3.01 . . . . 0.0 112.905 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.51 -33.03 2.83 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.738 1.161 . . . . 0.0 111.981 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -132.77 20.71 4.2 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 35' ' ' THR . 42.4 mt -54.16 127.87 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 122.025 0.916 . . . . 0.0 109.233 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.0 177.12 8.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.655 1.982 . . . . 0.0 107.538 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.763 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -49.0 146.1 3.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.185 172.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -124.55 113.17 27.43 Favored Pre-proline 0 N--CA 1.426 -1.629 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.674 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.75 134.63 65.69 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.237 1.958 . . . . 0.0 109.668 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.32 151.26 46.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.429 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -143.3 149.13 37.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.853 2.461 . . . . 0.0 108.012 175.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.2 -160.79 34.57 Favored Glycine 0 N--CA 1.452 -0.267 0 O-C-N 120.75 -1.219 . . . . 0.0 111.019 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.8 mt -144.58 145.57 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 111.942 -174.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.662 -1.274 . . . . 0.0 113.108 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -86.81 141.85 28.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.654 1.216 . . . . 0.0 111.191 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 29.64 2.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.029 1.332 . . . . 0.0 112.138 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -93.06 -55.05 3.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.644 2.377 . . . . 0.0 111.405 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -179.9 5.9 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -81.77 -39.27 24.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.192 1.397 . . . . 0.0 112.888 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -132.61 46.4 2.13 Favored Pre-proline 0 CA--C 1.568 1.636 0 O-C-N 125.416 1.698 . . . . 0.0 111.473 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.55 177.02 5.84 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.359 2.039 . . . . 0.0 114.676 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.326 0.1 OUTLIER -100.95 169.62 8.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 122.54 1.162 . . . . 0.0 111.603 174.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -162.63 164.18 26.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.393 -173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.39 147.78 13.73 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.836 2.294 . . . . 0.0 118.836 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -161.0 150.5 17.0 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -89.1 147.84 24.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.906 1.682 . . . . 0.0 108.21 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.8 t -129.21 119.72 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.493 ' CB ' HG21 ' D' ' 52' ' ' ILE . 38.8 t30 -102.87 102.05 12.13 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.372 -173.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -69.18 125.36 26.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 121.249 1.84 . . . . 0.0 115.684 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -81.3 -37.35 28.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.435 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.08 -22.29 36.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.603 1.161 . . . . 0.0 113.65 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.43 124.07 7.84 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.59 1.556 . . . . 0.0 108.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -60.78 115.27 3.54 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.595 1.089 . . . . 0.0 111.722 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 p -172.52 158.78 4.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.974 2.109 . . . . 0.0 110.03 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -143.47 142.5 31.2 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-O 123.175 1.464 . . . . 0.0 110.427 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 128.74 20.67 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 109.965 -3.289 . . . . 0.0 109.838 -171.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.54 154.05 6.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.773 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -128.99 141.66 51.18 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -151.82 118.25 5.66 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.36 -175.44 34.34 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.658 -1.258 . . . . 0.0 115.388 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -126.97 147.2 50.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.235 1.017 . . . . 0.0 112.196 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.41 127.25 43.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.44 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.3 m-85 -120.13 166.34 13.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.531 0.681 . . . . 0.0 112.461 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 39.6 mt -127.33 109.03 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.552 -1.658 . . . . 0.0 107.098 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.97 162.34 4.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.392 0.677 . . . . 0.0 110.162 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.42 -32.3 1.32 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.32 -21.09 53.99 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.88 19.98 11.25 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.851 1.215 . . . . 0.0 114.572 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 mtpt -90.66 153.24 20.44 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.1 1.36 . . . . 0.0 111.559 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.14 134.92 43.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.634 1.574 . . . . 0.0 110.257 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -142.16 160.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 122.13 0.967 . . . . 0.0 108.819 174.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.1 mt -124.15 119.06 28.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -106.59 117.77 34.93 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.3 167.27 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.974 1.369 . . . . 0.0 112.554 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -119.36 170.49 9.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -140.55 159.06 43.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.446 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.5 tp -134.38 121.98 21.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.406 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER -107.46 135.89 48.18 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 124.961 1.413 . . . . 0.0 112.055 -176.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.98 113.9 23.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 111.857 -2.429 . . . . 0.0 110.167 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -69.82 166.8 18.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.384 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -112.41 85.44 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.44 -161.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.33 -13.64 1.02 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.709 -1.869 . . . . 0.0 114.281 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.06 151.1 49.06 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.298 1.047 . . . . 0.0 111.931 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.454 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.9 tt -59.27 -25.49 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.117 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.65 -1.87 19.05 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.193 1.378 . . . . 0.0 114.761 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.0 7.11 6.6 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.138 0.969 . . . . 0.0 112.346 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.57 -32.14 73.66 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 119.443 -2.036 . . . . 0.0 112.866 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.462 ' CD1' HD11 ' C' ' 14' ' ' LEU . 57.8 p-90 -47.67 -40.82 20.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.789 1.235 . . . . 0.0 114.036 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -95.19 -11.61 27.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.403 1.081 . . . . 0.0 113.503 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.17 -0.8 20.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.975 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.61 143.72 42.02 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.432 1.11 . . . . 0.0 111.056 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -142.06 153.78 44.45 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.471 1.509 . . . . 0.0 109.572 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.98 151.19 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.395 1.078 . . . . 0.0 109.903 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.44 -176.69 29.77 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 121.453 0.474 . . . . 0.0 112.104 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 33.6 p90 -124.92 152.03 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.507 0.723 . . . . 0.0 109.98 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -144.53 152.41 40.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.938 0.875 . . . . 0.0 109.301 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt -128.92 135.13 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.93 148.07 45.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -132.01 158.64 40.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.099 0.96 . . . . 0.0 110.655 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.05 118.8 6.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.646 0.779 . . . . 0.0 111.641 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 123' ' ' LEU . 4.2 tt -77.55 78.19 4.07 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.771 174.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.67 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.8 m 65.65 116.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.873 2.069 . . . . 0.0 109.239 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -148.51 -94.65 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.88 -163.77 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.69 1.996 . . . . 0.0 109.724 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 . . . . . 0 C--O 1.253 1.277 0 CA-C-O 116.962 -1.494 . . . . 0.0 110.291 174.874 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.6 m 45.15 47.03 9.93 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.85 122.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.495 -1.378 . . . . 0.0 111.006 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -115.6 7.73 14.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.023 1.329 . . . . 0.0 113.658 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER 38.18 71.61 0.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 128.039 2.536 . . . . 0.0 113.439 -175.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -145.01 141.28 28.79 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.112 0.965 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' CYS . . . . . 0.428 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 22.1 p -143.67 143.54 31.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.633 1.973 . . . . 0.0 107.8 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.83 128.78 23.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.59 -1.319 . . . . 0.0 112.269 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.4 -25.59 68.35 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -53.0 119.27 4.47 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.204 1.478 . . . . 0.0 112.459 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.82 -110.69 1.02 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.841 2.162 . . . . 0.0 110.865 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -152.59 151.86 31.14 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -141.33 158.76 43.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.709 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -133.86 149.04 51.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.57 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -116.19 143.33 45.65 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.904 0.881 . . . . 0.0 110.737 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -58.74 -23.16 59.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.015 1.326 . . . . 0.0 113.475 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.48 HD21 HG21 ' D' ' 37' ' ' VAL . 42.4 tp -67.85 -15.94 63.86 Favored 'General case' 0 CA--C 1.555 1.16 0 O-C-N 120.543 -1.348 . . . . 0.0 111.398 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.34 -9.38 42.02 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.65 2.548 . . . . 0.0 113.372 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -66.42 148.25 52.14 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 121.213 -1.169 . . . . 0.0 111.792 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -127.02 151.16 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.196 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 147.35 33.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -127.53 135.96 51.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.761 0.824 . . . . 0.0 109.947 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.68 119.96 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.68 -64.39 3.34 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.58 1.175 . . . . 0.0 113.25 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.56 141.36 4.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.213 1.405 . . . . 0.0 110.214 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.17 136.36 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 122.505 0.322 . . . . 0.0 110.239 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.45 163.59 27.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.275 0.63 . . . . 0.0 111.186 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -21.98 54.05 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -25.45 62.37 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.161 -0.962 . . . . 0.0 111.221 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.89 51.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.248 1.404 . . . . 0.0 113.247 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 150.76 44.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.017 0.927 . . . . 0.0 110.42 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.52 166.34 33.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.347 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.479 ' HB ' HD22 ' D' ' 50' ' ' LEU . 0.5 OUTLIER -134.28 160.82 36.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.444 1.898 . . . . 0.0 106.775 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.44 -170.78 35.91 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.418 -1.426 . . . . 0.0 114.599 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.414 ' HB ' ' HG ' ' D' ' 46' ' ' LEU . 35.2 p -138.22 126.62 23.21 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.408 0.623 . . . . 0.0 109.341 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' TYR . . . . . 0.691 ' C ' HD12 ' D' ' 34' ' ' ILE . 1.4 t80 -126.96 133.42 50.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.935 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.76 HD11 ' CD1' ' D' ' 46' ' ' LEU . 1.5 mp -121.46 136.28 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.69 HG22 ' O ' ' D' ' 37' ' ' VAL . 43.4 m -116.77 130.24 56.6 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 3.24 53.63 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.69 ' O ' HG22 ' D' ' 35' ' ' THR . 27.5 m -141.44 162.22 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 128.085 2.554 . . . . 0.0 108.141 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.38 10.2 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.015 -1.678 . . . . 0.0 111.738 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.52 -24.05 61.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.311 0.244 . . . . 0.0 110.652 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -154.14 83.43 4.21 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 127.277 2.231 . . . . 0.0 109.254 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.69 176.04 8.74 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.553 2.835 . . . . 0.0 112.805 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.02 -33.21 2.86 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.765 1.174 . . . . 0.0 112.33 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -132.59 20.62 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.93 1.292 . . . . 0.0 112.403 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.53 HG21 ' O ' ' D' ' 35' ' ' THR . 43.3 mt -54.18 127.7 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.236 1.017 . . . . 0.0 109.247 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.01 177.21 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.49 1.916 . . . . 0.0 107.273 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.76 ' CD1' HD11 ' D' ' 34' ' ' ILE . 0.8 OUTLIER -48.99 146.65 3.23 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.218 172.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -125.0 112.98 26.72 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 112.118 -2.31 . . . . 0.0 110.506 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -56.09 132.52 52.45 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.17 1.914 . . . . 0.0 109.263 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.32 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.274 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' D' ' 30' ' ' THR . 0.3 OUTLIER -148.42 149.22 31.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.866 2.466 . . . . 0.0 108.066 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.66 -160.24 32.58 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 121.287 -0.883 . . . . 0.0 112.781 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.493 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -144.94 145.06 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.384 1.074 . . . . 0.0 112.374 -174.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 150.97 52.01 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.626 -1.296 . . . . 0.0 112.843 175.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.38 141.66 28.47 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.696 0.76 . . . . 0.0 110.399 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.96 29.84 2.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.983 1.313 . . . . 0.0 112.517 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -92.93 -55.21 3.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.01 2.524 . . . . 0.0 111.399 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -78.95 -39.78 33.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.821 1.648 . . . . 0.0 113.037 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.34 50.14 4.7 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 125.244 1.417 . . . . 0.0 111.429 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 176.78 6.39 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.351 2.7 . . . . 0.0 115.223 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -102.23 168.79 9.13 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.732 1.253 . . . . 0.0 111.435 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -162.22 163.48 28.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.881 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.18 148.05 14.85 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 118.646 2.218 . . . . 0.0 118.646 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -161.63 149.86 15.3 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.93 149.09 23.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.259 1.823 . . . . 0.0 108.238 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.62 121.47 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.492 ' CB ' HG21 ' A' ' 52' ' ' ILE . 37.6 t30 -104.88 102.31 11.85 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.988 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -68.92 124.47 23.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -80.14 -36.81 34.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.623 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -82.6 -22.01 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 113.591 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 35.2 t -152.55 124.63 8.04 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.544 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -60.86 115.44 3.69 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.897 1.226 . . . . 0.0 111.509 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 9.4 p -172.74 158.94 4.14 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.129 2.172 . . . . 0.0 110.125 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -143.62 142.42 31.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 123.036 1.398 . . . . 0.0 110.296 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -141.8 128.54 20.42 Favored 'General case' 0 N--CA 1.402 -2.825 0 CA-C-N 110.173 -3.194 . . . . 0.0 109.971 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.95 154.41 5.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.773 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -129.65 141.35 50.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 80' ' ' THR . . . . . 0.435 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -151.58 118.22 5.74 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.95 -175.25 34.66 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.49 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -127.61 144.91 51.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.704 0.885 . . . . 0.0 112.421 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.428 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 36.8 t -97.81 123.63 41.85 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.623 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.4 m-85 -115.69 167.26 11.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 118.45 0.568 . . . . 0.0 111.692 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 30.6 mt -126.21 107.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 O-C-N 125.293 1.62 . . . . 0.0 106.741 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -58.99 160.56 5.86 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -44.22 -31.74 1.08 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 118.193 2.664 . . . . 0.0 118.193 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -76.3 -21.94 55.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.26 1.85 29.67 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.111 1.339 . . . . 0.0 115.592 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -74.09 153.66 39.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.257 1.423 . . . . 0.0 112.578 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.38 135.44 42.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.265 1.826 . . . . 0.0 109.964 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.454 HG21 ' CD1' ' A' ' 106' ' ' ILE . 20.6 m -141.97 160.08 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.029 0.931 . . . . 0.0 109.663 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -122.69 118.64 28.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -106.76 117.74 34.84 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 167.95 20.41 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.05 1.405 . . . . 0.0 112.69 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -120.06 170.57 9.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 p-90 -140.57 159.51 42.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.561 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.437 HD23 ' OG1' ' A' ' 80' ' ' THR . 3.4 tp -134.93 121.86 21.12 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.526 175.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.37 136.01 47.89 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 125.061 1.476 . . . . 0.0 111.767 -176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -117.12 113.82 22.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.288 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 71.3 m -69.55 167.04 17.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.404 174.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 2.0 p -112.37 86.11 2.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.99 -160.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -140.36 -13.19 1.03 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 119.561 -1.962 . . . . 0.0 114.093 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.57 152.13 48.66 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.565 1.174 . . . . 0.0 112.356 174.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.0 tt -59.82 -24.87 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.982 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.93 -1.13 23.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.245 1.402 . . . . 0.0 114.935 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -127.12 6.34 6.49 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.119 0.968 . . . . 0.0 111.916 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.16 -31.79 73.15 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 119.327 -2.108 . . . . 0.0 113.067 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.456 ' CD1' HD11 ' B' ' 14' ' ' LEU . 58.1 p-90 -47.33 -41.61 19.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.343 1.057 . . . . 0.0 113.768 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -94.89 -11.47 28.65 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.403 1.081 . . . . 0.0 113.131 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.02 -1.13 21.35 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.311 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -111.21 143.8 41.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.318 1.056 . . . . 0.0 111.129 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -142.16 153.65 44.23 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.328 1.451 . . . . 0.0 109.486 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.88 151.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.464 1.106 . . . . 0.0 109.724 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.59 -177.23 30.5 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.505 0.503 . . . . 0.0 112.169 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 32.7 p90 -124.28 152.21 43.3 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.901 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -145.16 151.6 38.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.554 0.742 . . . . 0.0 109.46 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 59.7 mt -128.47 136.03 61.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -123.98 148.5 46.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.667 0.387 . . . . 0.0 111.061 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 12.7 p -132.24 161.63 32.96 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.694 1.198 . . . . 0.0 111.176 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -61.51 122.26 14.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.056 0.943 . . . . 0.0 111.784 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 118.54 24.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.282 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.83 59.79 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 76.8 p -70.07 169.63 13.05 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.876 -1.14 . . . . 0.0 112.923 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -152.34 -44.56 0.1 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.198 2.199 . . . . 0.0 109.108 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.22 116.77 22.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.496 1.518 . . . . 0.0 107.868 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.247 0.948 0 C-N-CA 129.08 2.952 . . . . 0.0 108.634 -175.462 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.5 p -110.19 94.16 4.87 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.079 1.352 . . . . 0.0 110.42 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 13.9 p -53.2 -18.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.144 1.778 . . . . 0.0 115.641 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . 60.14 -168.64 0.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.71 1.204 . . . . 0.0 112.523 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . 0.259 22.2 ptt180 167.81 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 128.425 2.69 . . . . 0.0 113.559 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -154.3 141.68 19.64 Favored 'General case' 0 CA--C 1.513 -0.461 0 O-C-N 121.136 -0.977 . . . . 0.0 109.144 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.2 p -143.11 144.21 32.14 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 124.967 1.417 . . . . 0.0 108.529 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.73 127.72 22.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.566 -0.709 . . . . 0.0 112.569 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.85 -25.3 67.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.61 119.49 5.36 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 123.042 1.401 . . . . 0.0 111.984 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.35 -111.2 1.06 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.01 2.243 . . . . 0.0 110.447 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.45 ' HD2' HD13 ' B' ' 123' ' ' LEU . 24.3 ttmt -153.65 152.56 30.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.34 158.18 43.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.884 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.1 146.88 45.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.683 1.193 . . . . 0.0 108.35 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -116.28 143.33 45.66 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 111.188 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -57.8 -24.15 55.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.204 1.401 . . . . 0.0 113.645 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.477 HD21 HG21 ' B' ' 37' ' ' VAL . 39.9 tp -68.18 -15.59 63.64 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.644 -1.285 . . . . 0.0 111.735 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.42 43.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.732 2.587 . . . . 0.0 113.418 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.61 147.7 52.92 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.196 -1.179 . . . . 0.0 111.633 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -127.1 152.01 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.12 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.96 147.38 33.86 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -126.89 135.39 50.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.99 120.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.23 -64.85 3.02 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.662 1.226 . . . . 0.0 113.201 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.51 139.8 3.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.241 1.416 . . . . 0.0 110.163 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -86.3 137.36 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.403 0.281 . . . . 0.0 110.576 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.26 163.37 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.678 0.391 . . . . 0.0 111.246 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -23.83 50.11 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -27.11 63.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.3 -0.875 . . . . 0.0 111.285 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.84 -2.12 48.5 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.218 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.18 144.51 51.93 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.524 1.162 . . . . 0.0 108.542 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.79 156.12 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 112.157 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.5 158.33 38.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.341 1.856 . . . . 0.0 108.201 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.33 -170.5 34.73 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 120.973 -1.079 . . . . 0.0 114.758 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 35.9 p -137.19 126.51 24.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.065 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.694 ' C ' HD12 ' B' ' 34' ' ' ILE . 1.5 t80 -126.74 133.31 50.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.72 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' B' ' 46' ' ' LEU . 1.5 mp -121.41 136.24 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.698 HG22 ' O ' ' B' ' 37' ' ' VAL . 42.7 m -116.39 130.54 56.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.29 2.7 53.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.302 1.049 . . . . 0.0 113.828 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.698 ' O ' HG22 ' B' ' 35' ' ' THR . 28.2 m -141.09 161.66 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.348 2.259 . . . . 0.0 108.373 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.61 166.67 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 119.971 -1.706 . . . . 0.0 111.909 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.0 -24.65 62.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 122.461 -0.149 . . . . 0.0 110.674 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.3 83.73 4.51 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.152 2.181 . . . . 0.0 109.22 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.54 175.92 8.82 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.842 3.028 . . . . 0.0 112.9 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.41 -33.21 2.81 Favored Glycine 0 N--CA 1.476 1.324 0 C-N-CA 124.715 1.15 . . . . 0.0 112.219 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -132.62 20.75 4.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.005 1.322 . . . . 0.0 112.359 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.514 HG21 ' O ' ' B' ' 35' ' ' THR . 43.9 mt -54.25 127.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.08 0.943 . . . . 0.0 109.141 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.19 176.46 8.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.758 2.023 . . . . 0.0 107.57 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.759 ' CD1' HD11 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -48.49 146.3 3.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.258 172.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -125.02 113.26 26.62 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 112.07 -2.332 . . . . 0.0 110.57 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -56.4 134.68 65.79 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.135 1.89 . . . . 0.0 109.65 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.04 151.22 45.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.486 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -143.32 149.19 37.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.821 2.449 . . . . 0.0 107.839 174.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 -161.28 35.11 Favored Glycine 0 N--CA 1.451 -0.326 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.498 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.8 mt -144.56 144.91 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.961 0.904 . . . . 0.0 111.799 -174.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.18 148.26 52.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.301 1.04 . . . . 0.0 113.323 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -84.65 141.31 30.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.099 0.952 . . . . 0.0 111.069 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.05 30.72 2.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.95 1.3 . . . . 0.0 112.222 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -93.33 -55.38 3.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.94 2.496 . . . . 0.0 111.72 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.97 179.51 6.17 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.0 m -82.98 -35.53 25.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.842 1.257 . . . . 0.0 113.264 174.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -135.04 49.01 3.29 Favored Pre-proline 0 CA--C 1.562 1.434 0 O-C-N 125.377 1.673 . . . . 0.0 111.4 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.44 177.5 5.98 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.079 2.52 . . . . 0.0 115.272 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.347 0.1 OUTLIER -102.13 168.06 9.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.027 1.394 . . . . 0.0 111.749 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -161.41 163.03 30.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.84 -173.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.66 147.26 13.02 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 118.81 2.284 . . . . 0.0 118.81 -173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.9 m -89.28 147.95 23.83 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.066 1.746 . . . . 0.0 108.338 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.34 119.8 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.489 ' CB ' HG21 ' C' ' 52' ' ' ILE . 37.8 t30 -102.67 102.09 12.26 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.352 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -69.07 125.64 27.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.278 1.854 . . . . 0.0 115.707 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.36 -37.46 28.21 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.514 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.83 -22.14 37.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.516 1.127 . . . . 0.0 113.647 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -152.42 124.79 8.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.722 1.609 . . . . 0.0 108.699 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.97 116.29 4.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.803 1.183 . . . . 0.0 111.173 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 9.2 p -173.01 158.79 3.83 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.059 2.143 . . . . 0.0 109.856 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -143.36 142.6 31.34 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-O 123.117 1.437 . . . . 0.0 110.531 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -142.12 128.46 19.97 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 110.084 -3.234 . . . . 0.0 109.927 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.33 153.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.741 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.11 142.29 50.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.44 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -152.29 118.61 5.59 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -174.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -162.72 -176.75 35.11 Favored Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -127.68 143.22 51.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.36 0.682 . . . . 0.0 112.169 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 49.9 t -97.52 124.84 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.07 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.402 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.01 168.27 10.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.239 1.019 . . . . 0.0 111.794 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 30.2 mt -124.79 109.54 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.286 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -58.62 157.33 9.36 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -42.31 -30.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.91 -19.38 54.79 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.81 8.57 27.88 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 125.073 1.32 . . . . 0.0 115.583 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 4.6 mtpp -87.48 152.94 21.82 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.931 1.366 . . . . 0.0 112.585 -176.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -100.96 134.83 43.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.565 1.546 . . . . 0.0 110.016 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 m -144.14 145.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 38.0 mt -118.89 92.42 3.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.47 1.129 . . . . 0.0 111.227 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -83.4 113.13 20.53 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.074 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.414 HG22 ' HA3' ' B' ' 81' ' ' GLY . 4.8 p -135.29 168.48 19.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.559 1.647 . . . . 0.0 112.801 -174.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -120.12 170.44 9.3 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 124.608 1.163 . . . . 0.0 107.901 172.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -141.11 159.05 43.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.427 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.5 tp -134.41 122.15 22.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.404 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . 0.262 0.4 OUTLIER -107.53 134.64 50.25 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 125.047 1.467 . . . . 0.0 112.216 -176.098 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 5.4 tpt180 -115.55 114.06 24.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 112.001 -2.363 . . . . 0.0 110.048 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.259 72.9 m -70.09 167.97 16.56 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.266 1.604 . . . . 0.0 111.465 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -113.29 85.38 2.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 -160.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -140.52 -13.21 1.0 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 119.569 -1.957 . . . . 0.0 114.223 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.17 151.17 49.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.509 1.147 . . . . 0.0 112.003 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' C' ' 84' ' ' PHE . 2.2 tt -58.57 -25.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.407 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.64 -2.36 28.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.038 1.304 . . . . 0.0 114.626 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.33 5.87 7.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.214 1.006 . . . . 0.0 112.137 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.5 -32.12 73.63 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 119.55 -1.969 . . . . 0.0 112.668 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.7 p-90 -48.0 -41.25 24.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.726 1.21 . . . . 0.0 113.718 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -94.37 -11.43 29.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.349 1.059 . . . . 0.0 113.494 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.1 -0.91 20.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.105 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -111.6 143.65 42.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.168 0.985 . . . . 0.0 111.244 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -142.38 153.48 43.82 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.316 1.446 . . . . 0.0 109.524 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.26 150.64 33.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.689 1.131 . . . . 0.0 109.517 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.99 -177.02 29.71 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.375 0.512 . . . . 0.0 112.184 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 34.9 p90 -124.42 151.77 44.09 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -144.17 151.22 39.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.998 0.904 . . . . 0.0 109.22 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.19 134.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -122.25 149.83 43.15 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.042 0.448 . . . . 0.0 111.038 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 5.3 p -130.86 159.82 36.24 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.94 1.296 . . . . 0.0 110.647 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -58.69 123.81 17.62 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.5 0.72 . . . . 0.0 111.495 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' B' ' 124' ' ' ARG . 2.7 tt -74.4 102.86 4.56 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.561 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.607 ' HB2' HD23 ' B' ' 123' ' ' LEU . 0.0 OUTLIER 60.83 104.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.128 2.171 . . . . 0.0 113.405 173.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.93 169.93 15.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.42 -174.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -149.87 66.79 0.98 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.263 3.025 . . . . 0.0 105.111 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.76 93.74 2.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 129.412 3.085 . . . . 0.0 110.029 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.261 1.702 0 C-N-CA 129.697 3.199 . . . . 0.0 107.595 174.306 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.7 p -149.85 -64.97 0.21 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.454 1.502 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 m -158.29 154.79 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.51 2.324 . . . . 0.0 109.645 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -71.13 153.18 42.73 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.628 0.728 . . . . 0.0 109.9 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -158.0 29.75 0.26 Allowed 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.742 -1.224 . . . . 0.0 113.766 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -156.55 151.08 25.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.982 1.313 . . . . 0.0 107.591 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 26.6 p -148.37 145.02 27.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.595 1.184 . . . . 0.0 109.788 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.74 127.92 22.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.53 -25.64 68.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.34 118.39 4.07 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.863 1.316 . . . . 0.0 112.08 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.55 -112.17 1.17 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.955 2.217 . . . . 0.0 110.667 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -150.58 151.77 33.09 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -142.0 157.44 44.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.577 -2.101 . . . . 0.0 111.226 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 147.95 50.58 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -115.87 143.41 45.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.929 0.892 . . . . 0.0 110.879 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.1 -24.21 52.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.332 1.453 . . . . 0.0 113.638 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.478 HD21 HG21 ' C' ' 37' ' ' VAL . 37.9 tp -67.85 -15.07 63.45 Favored 'General case' 0 CA--C 1.556 1.182 0 O-C-N 120.773 -1.204 . . . . 0.0 111.819 173.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.39 -9.35 45.37 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.723 2.582 . . . . 0.0 113.324 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -66.62 147.02 53.85 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.202 -1.175 . . . . 0.0 111.618 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -126.52 152.04 47.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.8 147.41 34.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -127.39 135.85 51.05 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.842 0.857 . . . . 0.0 110.22 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -128.31 119.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.51 -63.99 3.75 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.605 1.191 . . . . 0.0 113.308 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.23 143.16 4.22 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.51 1.524 . . . . 0.0 110.265 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.93 135.66 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.735 0.414 . . . . 0.0 110.274 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.7 163.38 28.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.337 0.655 . . . . 0.0 111.287 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -22.02 53.68 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -25.56 62.29 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.23 -0.919 . . . . 0.0 111.253 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.59 51.4 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.273 1.416 . . . . 0.0 113.225 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.1 150.37 43.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 110.333 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.14 166.32 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.795 0.807 . . . . 0.0 111.122 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.484 ' HB ' HD22 ' C' ' 50' ' ' LEU . 0.5 OUTLIER -134.49 160.72 37.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.529 1.932 . . . . 0.0 106.844 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.64 -170.9 36.2 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.327 -1.483 . . . . 0.0 114.822 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -137.61 126.63 24.27 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.565 0.698 . . . . 0.0 109.383 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.699 ' C ' HD12 ' C' ' 34' ' ' ILE . 1.6 t80 -126.73 133.45 50.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.466 -172.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.748 HD11 ' CD1' ' C' ' 46' ' ' LEU . 1.6 mp -121.49 136.29 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.687 HG22 ' O ' ' C' ' 37' ' ' VAL . 33.4 m -116.92 130.55 56.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -172.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.14 5.08 50.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.687 ' O ' HG22 ' C' ' 35' ' ' THR . 28.7 m -143.2 161.25 17.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.149 2.179 . . . . 0.0 108.261 -175.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.31 166.96 12.34 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.786 -1.821 . . . . 0.0 111.757 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.78 -23.72 61.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.162 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -153.41 84.08 4.39 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 127.211 2.205 . . . . 0.0 109.373 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.69 176.02 8.77 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.557 2.838 . . . . 0.0 112.805 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.04 -33.14 2.87 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.776 1.179 . . . . 0.0 112.284 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -132.64 20.57 4.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.026 1.33 . . . . 0.0 112.328 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.521 HG21 ' O ' ' C' ' 35' ' ' THR . 44.8 mt -54.11 127.82 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.249 1.023 . . . . 0.0 109.234 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.13 177.24 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.486 1.914 . . . . 0.0 107.296 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.748 ' CD1' HD11 ' C' ' 34' ' ' ILE . 1.0 OUTLIER -49.0 146.82 3.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.118 172.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -125.23 113.08 26.13 Favored Pre-proline 0 N--CA 1.426 -1.651 0 CA-C-N 112.042 -2.345 . . . . 0.0 110.398 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -56.01 132.25 50.84 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.03 1.82 . . . . 0.0 109.223 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.65 154.93 36.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.323 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' C' ' 30' ' ' THR . 0.3 OUTLIER -148.6 149.23 31.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.827 2.451 . . . . 0.0 108.142 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.72 -160.04 32.41 Favored Glycine 0 CA--C 1.517 0.186 0 O-C-N 121.383 -0.823 . . . . 0.0 112.71 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.489 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.36 144.95 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.319 1.047 . . . . 0.0 112.149 -174.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 152.04 51.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.857 1.263 . . . . 0.0 112.909 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -88.93 140.87 29.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.05 0.929 . . . . 0.0 111.038 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 30.15 2.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.735 1.214 . . . . 0.0 112.237 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -93.37 -55.48 3.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.98 2.512 . . . . 0.0 111.714 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -179.76 5.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -83.94 -35.76 23.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.671 1.188 . . . . 0.0 112.95 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -134.34 48.06 2.87 Favored Pre-proline 0 CA--C 1.564 1.49 0 O-C-N 125.388 1.68 . . . . 0.0 111.823 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.09 176.42 6.28 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.148 2.565 . . . . 0.0 115.518 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.337 0.2 OUTLIER -101.05 169.91 8.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.674 1.226 . . . . 0.0 111.414 174.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.86 163.31 26.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.733 -173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 147.88 14.19 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -161.66 149.81 15.2 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.58 149.21 23.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.245 1.818 . . . . 0.0 108.221 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.63 121.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.498 ' CB ' HG21 ' B' ' 52' ' ' ILE . 39.8 t30 -104.32 102.19 11.88 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.198 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -68.44 124.35 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.854 1.661 . . . . 0.0 115.427 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -80.07 -37.55 33.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.641 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.78 -22.23 37.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 113.692 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.6 t -152.51 124.61 8.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.75 1.62 . . . . 0.0 108.66 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.68 116.52 4.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.587 1.085 . . . . 0.0 111.132 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 8.6 p -173.29 158.36 3.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.15 2.18 . . . . 0.0 110.02 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -142.69 142.01 31.93 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-O 123.181 1.467 . . . . 0.0 110.488 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.86 128.05 19.76 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 110.015 -3.266 . . . . 0.0 110.091 -171.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.66 154.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.785 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.47 141.99 50.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.433 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -152.27 118.69 5.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -174.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -163.07 -176.12 34.78 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -128.9 143.1 50.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 124.484 0.755 . . . . 0.0 112.319 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 49.0 t -97.56 122.69 40.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.527 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' B' ' 106' ' ' ILE . 3.5 m-85 -114.0 167.81 10.34 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.551 0.691 . . . . 0.0 111.638 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.71 108.34 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.082 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.56 160.93 4.98 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.05 -31.09 0.84 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -79.99 -15.08 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.03 5.6 40.72 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.884 1.23 . . . . 0.0 115.682 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 152.63 28.53 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.017 1.408 . . . . 0.0 112.543 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -100.72 135.96 41.33 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.496 1.518 . . . . 0.0 109.131 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.56 147.36 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.265 1.026 . . . . 0.0 111.36 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 40.7 mt -119.97 92.38 3.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.682 1.23 . . . . 0.0 111.772 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -83.59 112.57 20.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.903 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.418 HG22 ' HA3' ' C' ' 81' ' ' GLY . 4.5 p -134.36 168.95 17.98 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.607 1.194 . . . . 0.0 112.831 -174.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -120.94 170.7 9.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 38.9 p-90 -140.53 159.83 41.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.385 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.44 HD23 ' OG1' ' B' ' 80' ' ' THR . 3.3 tp -135.16 122.1 21.19 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.474 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.43 134.98 49.68 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.927 1.392 . . . . 0.0 111.863 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.16 114.09 23.98 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 111.974 -2.375 . . . . 0.0 110.078 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 71.4 m -69.74 168.09 15.74 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 125.299 1.624 . . . . 0.0 111.681 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -112.94 85.64 2.21 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.53 -160.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -141.45 -11.61 0.92 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 119.518 -1.989 . . . . 0.0 114.406 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.46 150.47 50.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.284 1.04 . . . . 0.0 111.723 174.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 84' ' ' PHE . 2.2 tt -58.13 -25.44 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.4 -2.81 28.97 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.97 1.272 . . . . 0.0 114.611 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.42 6.17 7.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.164 0.986 . . . . 0.0 112.309 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.47 -32.69 74.2 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.757 -1.84 . . . . 0.0 112.741 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.2 p-90 -48.28 -41.77 28.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.684 1.194 . . . . 0.0 113.697 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -93.93 -11.67 30.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.242 1.017 . . . . 0.0 113.329 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.61 -1.23 20.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.077 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.35 143.71 41.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.002 0.906 . . . . 0.0 111.373 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -142.56 153.33 43.45 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.463 1.505 . . . . 0.0 109.504 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.04 151.1 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 109.358 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.03 -177.77 30.47 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 121.813 0.674 . . . . 0.0 112.244 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 34.8 p90 -123.84 151.33 43.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.4 0.68 . . . . 0.0 109.419 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -144.18 151.4 39.46 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.995 0.902 . . . . 0.0 108.83 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.67 133.71 67.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -120.81 149.71 42.14 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.134 0.492 . . . . 0.0 111.093 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 33.2 p -134.6 163.48 29.64 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 110.907 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.48 123.76 20.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.062 0.945 . . . . 0.0 113.132 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.84 81.84 8.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 64.46 106.15 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.999 2.12 . . . . 0.0 112.909 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -135.44 -173.26 3.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.709 1.604 . . . . 0.0 111.005 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.87 152.93 11.79 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.417 1.103 . . . . 0.0 109.516 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.48 10.26 21.35 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 129.271 3.028 . . . . 0.0 111.408 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.407 4.6 pt-20 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 128.784 2.834 . . . . 0.0 113.648 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . 0.272 6.9 pm0 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 116.756 -1.593 . . . . 0.0 108.889 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 9.2 m -130.8 96.95 4.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.526 1.512 . . . . 0.0 110.663 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.61 50.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 122.648 1.213 . . . . 0.0 113.843 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.09 -73.07 0.47 Allowed 'General case' 0 C--O 1.241 0.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.774 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 59.72 -38.04 0.08 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.633 3.173 . . . . 0.0 114.94 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -105.25 131.59 52.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.908 3.283 . . . . 0.0 106.973 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.3 157.55 24.79 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 p -139.38 127.19 22.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.349 -0.844 . . . . 0.0 113.102 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.542 HD12 ' CD ' ' A' ' 53' ' ' GLN . 33.5 mt -69.39 -27.05 64.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.017 0.527 . . . . 0.0 111.777 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -62.91 120.77 11.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.67 24.86 1.49 Allowed Glycine 0 N--CA 1.476 1.309 0 N-CA-C 118.001 1.96 . . . . 0.0 118.001 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 tttt 69.3 145.96 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.894 2.478 . . . . 0.0 116.911 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -140.99 158.91 43.28 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.334 1.454 . . . . 0.0 112.538 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -132.45 142.85 49.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.853 1.261 . . . . 0.0 108.622 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.75 143.69 44.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.47 1.108 . . . . 0.0 110.128 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -57.06 -30.37 64.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.52 -11.73 61.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.311 1.444 . . . . 0.0 112.586 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.92 -11.19 37.88 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 127.503 2.477 . . . . 0.0 113.519 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -61.06 145.67 50.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 122.781 1.277 . . . . 0.0 112.326 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -122.81 139.99 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -132.71 145.27 50.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.94 0.876 . . . . 0.0 112.416 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 m -128.78 125.54 38.05 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.2 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.77 127.67 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.34 -88.86 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 O-C-N 125.647 1.842 . . . . 0.0 111.08 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.82 143.52 36.86 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.084 -0.657 . . . . 0.0 110.733 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.47 HG21 ' CG ' ' A' ' 53' ' ' GLN . 7.4 p -95.03 131.92 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.656 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -72.52 159.14 34.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.079 0.943 . . . . 0.0 112.919 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.0 m -54.47 -28.46 44.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.774 1.23 . . . . 0.0 114.212 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -71.11 -34.91 71.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.085 0.554 . . . . 0.0 112.472 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.81 -8.81 12.75 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.531 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 155.27 40.43 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.459 1.63 . . . . 0.0 108.271 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.47 166.12 32.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.975 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.5 148.04 52.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.24 26.34 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 122.554 1.086 . . . . 0.0 113.298 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.492 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -139.49 139.45 36.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.021 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.71 129.52 55.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.929 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -118.28 128.51 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 m -106.11 143.55 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.404 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 -15.63 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 15.9 m -135.03 142.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 113.154 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.56 168.91 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.39 -38.78 26.0 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.33 74.37 77.46 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.323 1.849 . . . . 0.0 109.227 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.64 6.5 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.165 3.243 . . . . 0.0 117.348 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.66 -21.29 0.8 Allowed Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.04 42.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.709 1.255 . . . . 0.0 111.945 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.59 134.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.835 0.826 . . . . 0.0 111.518 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 0.6 OUTLIER -152.48 171.82 17.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 0.0 111.22 176.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.2 tp -46.69 117.4 1.63 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 129.496 3.119 . . . . 0.0 112.438 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.7 m -111.79 114.05 52.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.899 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.18 145.15 66.88 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.324 2.683 . . . . 0.0 112.82 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.34 51.99 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.526 1.13 . . . . 0.0 111.864 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.75 149.85 39.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.188 2.995 . . . . 0.0 109.282 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.99 -155.33 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.3 mt -144.82 139.56 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.996 0.903 . . . . 0.0 112.637 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.542 ' CD ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -119.54 155.74 31.61 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.355 -0.841 . . . . 0.0 111.06 172.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.24 164.02 21.47 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.767 -1.208 . . . . 0.0 110.723 172.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.94 25.32 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.402 1.081 . . . . 0.0 112.924 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.84 -55.36 3.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.07 2.148 . . . . 0.0 110.454 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 173.19 12.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.711 1.243 . . . . 0.0 113.217 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -43.61 60.58 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.789 2.036 . . . . 0.0 112.176 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -131.41 53.75 12.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.952 1.301 . . . . 0.0 110.309 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.57 176.71 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.161 1.907 . . . . 0.0 116.272 -174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -88.34 161.85 16.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.504 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.37 164.48 29.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.249 -0.907 . . . . 0.0 112.46 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.84 149.47 15.7 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 120.397 2.919 . . . . 0.0 120.397 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -164.29 154.38 14.5 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -90.04 150.57 22.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.047 2.139 . . . . 0.0 109.332 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -129.97 120.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 59.4 t30 -95.59 106.01 18.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.653 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.12 131.88 46.72 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 121.234 1.834 . . . . 0.0 112.766 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.07 -38.22 12.33 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -90.38 -10.74 42.8 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -152.44 132.5 13.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 127.705 2.402 . . . . 0.0 106.847 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -69.85 118.49 12.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.546 1.066 . . . . 0.0 110.173 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -173.53 170.26 4.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.481 1.912 . . . . 0.0 109.769 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.89 137.95 31.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.979 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.446 ' CG2' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -114.29 165.99 12.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.327 1.06 . . . . 0.0 108.617 173.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 149.9 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.01 142.11 51.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.46 120.3 9.93 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 179.79 39.46 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 118.935 -1.602 . . . . 0.0 117.079 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.49 147.93 36.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 112.176 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.4 t -97.48 129.0 44.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.866 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' D' ' 106' ' ' ILE . 0.6 OUTLIER -124.1 169.18 11.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.729 1.252 . . . . 0.0 113.72 177.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.8 mt -131.49 107.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 112.642 -2.072 . . . . 0.0 106.85 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -58.86 157.28 9.96 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.46 -55.13 0.05 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.148 2.179 . . . . 0.0 116.449 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.93 -19.85 62.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.39 1.876 . . . . 0.0 115.976 -173.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.73 53.65 1.19 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -125.59 136.03 52.84 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 126.834 2.053 . . . . 0.0 108.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.34 142.65 32.43 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 111.094 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' D' ' 106' ' ' ILE . 15.1 m -147.23 166.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.188 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.34 122.34 33.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' D' ' 106' ' ' ILE . 1.5 mmmt -109.37 116.18 31.35 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.86 160.11 39.85 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.194 1.473 . . . . 0.0 112.15 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -108.25 167.75 9.8 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 172.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -141.32 160.81 39.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.649 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.3 tt -143.84 127.43 17.02 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.783 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' ' 77' ' ' THR . 1.0 OUTLIER -110.85 144.65 39.55 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 125.172 1.545 . . . . 0.0 110.818 -175.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.426 ' CZ ' ' HA2' ' D' ' 81' ' ' GLY . 2.3 tpt85 -128.27 116.01 19.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 112.209 -2.268 . . . . 0.0 112.115 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -89.43 158.68 17.64 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 113.396 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -103.68 80.76 1.82 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.7 m -66.8 -173.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.996 0.518 . . . . 0.0 109.658 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.16 -20.83 9.68 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.984 -1.698 . . . . 0.0 114.783 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -124.66 152.42 43.68 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.791 1.282 . . . . 0.0 111.459 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.582 HD11 ' HE2' ' D' ' 94' ' ' LYS . 10.3 tt -62.44 -27.5 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.181 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.99 23.62 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.291 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -120.08 -0.91 10.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.037 1.419 . . . . 0.0 113.937 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.76 -32.4 69.24 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.968 . . . . 0.0 112.947 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 60.1 p-90 -45.53 -44.6 12.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.609 1.164 . . . . 0.0 113.892 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -93.42 -12.86 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.86 0.864 . . . . 0.0 113.111 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.65 5.57 8.98 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.0 m -113.83 135.5 53.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.909 0.884 . . . . 0.0 111.824 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.67 126.49 22.29 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.61 154.92 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 120.524 1.511 . . . . 0.0 112.235 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.55 30.02 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.606 1.098 . . . . 0.0 113.177 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 24.4 p90 -129.28 153.67 47.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.771 0.828 . . . . 0.0 109.995 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -148.62 149.1 30.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.131 0.972 . . . . 0.0 109.716 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.32 130.63 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.39 -0.819 . . . . 0.0 109.28 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -118.52 153.86 33.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.255 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -137.51 165.1 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.202 1.001 . . . . 0.0 110.447 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -60.83 116.7 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 110.783 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.63 104.44 7.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.543 0.0 OUTLIER 77.18 85.07 0.08 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 123.946 1.831 . . . . 0.0 109.417 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 t -136.45 0.04 2.47 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.389 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.255 3.4 pm0 27.49 -121.22 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.265 2.626 . . . . 0.0 117.428 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -170.25 77.77 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 130.148 3.379 . . . . 0.0 107.472 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.251 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 117.728 -1.13 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 3.3 t -155.63 -43.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.564 1.075 . . . . 0.0 112.868 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 7.4 m -68.61 64.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 127.111 2.164 . . . . 0.0 113.139 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.17 -146.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 70.35 -40.69 0.47 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.996 2.918 . . . . 0.0 113.582 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -106.96 135.08 49.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.961 2.504 . . . . 0.0 107.771 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 10.1 p -131.32 142.95 50.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 124.147 0.979 . . . . 0.0 108.388 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 21.1 p -132.63 127.47 35.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' D' ' 53' ' ' GLN . 28.7 mt -68.21 -26.56 65.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.292 1.037 . . . . 0.0 112.425 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 t -62.57 121.02 12.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.34 40.55 0.62 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 mttt 56.53 150.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 129.087 2.955 . . . . 0.0 118.371 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -142.55 161.97 36.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.567 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -131.76 148.17 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.305 1.442 . . . . 0.0 107.552 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.42 143.41 45.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 109.988 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -56.4 -28.86 60.57 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.23 -12.48 61.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.938 1.695 . . . . 0.0 113.018 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.8 -8.44 36.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.142 2.306 . . . . 0.0 113.775 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -63.59 147.0 52.64 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.827 1.313 . . . . 0.0 112.066 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -124.66 137.83 54.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -130.33 147.18 52.01 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.112 0.958 . . . . 0.0 113.121 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 14.6 m -131.31 125.25 32.28 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.14 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.94 126.55 73.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 -88.05 0.1 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 126.09 2.119 . . . . 0.0 111.073 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.36 142.59 35.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.246 0.618 . . . . 0.0 110.661 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.458 HG21 ' CG ' ' D' ' 53' ' ' GLN . 7.3 p -95.09 133.02 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.722 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -71.92 160.07 33.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.206 1.003 . . . . 0.0 113.316 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 15.8 m -53.76 -27.33 28.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.249 1.419 . . . . 0.0 114.455 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.99 -34.03 68.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.282 0.633 . . . . 0.0 112.625 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.74 -9.83 12.57 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.981 1.277 . . . . 0.0 113.432 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.3 157.42 37.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.907 1.354 . . . . 0.0 110.634 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.82 166.3 33.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.332 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -131.03 147.68 52.66 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.46 -168.67 24.73 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.859 1.255 . . . . 0.0 112.904 -174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' D' ' 46' ' ' LEU . 9.5 p -140.06 139.53 35.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.396 -1.402 . . . . 0.0 112.202 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -118.52 132.92 56.21 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.861 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 60.3 mt -121.47 129.31 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 55.1 m -107.36 143.42 35.68 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.538 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.63 -15.73 18.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.73 142.62 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.012 0.925 . . . . 0.0 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.35 169.19 22.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.216 -0.928 . . . . 0.0 110.967 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -38.77 25.35 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.15 74.41 77.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.573 1.949 . . . . 0.0 109.375 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.75 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.13 3.22 . . . . 0.0 117.332 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.52 -21.35 0.77 Allowed Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.531 2.172 . . . . 0.0 118.531 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.06 42.38 0.08 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 111.929 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -50.29 133.56 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.397 -0.815 . . . . 0.0 111.748 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . 0.259 0.6 OUTLIER -151.81 171.54 17.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 111.377 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' D' ' 32' ' ' THR . 12.3 tp -46.62 118.38 1.99 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.096 2.958 . . . . 0.0 112.116 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 69.6 m -113.08 112.52 49.86 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.256 1.022 . . . . 0.0 108.581 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -54.47 145.71 56.13 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.143 2.562 . . . . 0.0 112.593 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 143.96 51.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.43 1.092 . . . . 0.0 111.525 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -144.34 151.42 39.31 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 129.021 2.928 . . . . 0.0 109.446 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.55 -155.39 26.43 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -145.07 139.1 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.446 -0.877 . . . . 0.0 112.333 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 53' ' ' GLN . . . . . 0.522 ' CD ' HD12 ' D' ' 6' ' ' LEU . 0.0 OUTLIER -119.42 155.05 32.72 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.176 0.99 . . . . 0.0 110.79 173.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.15 163.98 22.7 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.43 -1.419 . . . . 0.0 110.81 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.16 26.43 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.231 1.013 . . . . 0.0 112.865 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.4 -56.69 2.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.019 2.128 . . . . 0.0 110.622 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.37 171.86 14.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.376 1.084 . . . . 0.0 113.356 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -43.82 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.2 1.4 . . . . 0.0 111.032 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -132.37 57.67 30.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 111.283 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.61 177.21 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 N-CA-C 116.767 1.795 . . . . 0.0 116.767 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -88.88 162.22 16.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.588 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.63 165.56 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.715 -1.241 . . . . 0.0 112.38 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.91 149.47 15.12 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.7 156.9 18.57 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -92.98 151.07 20.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.23 2.212 . . . . 0.0 108.967 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.41 121.97 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 53.5 t30 -97.77 106.73 19.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.414 -174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -67.16 131.7 46.32 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.807 1.639 . . . . 0.0 112.73 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.87 -38.13 12.5 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -90.42 -10.94 41.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.5 132.27 13.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.045 2.538 . . . . 0.0 107.068 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -69.54 118.61 12.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.298 0.954 . . . . 0.0 110.39 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 72.5 p -173.97 170.05 3.93 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 109.886 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -140.9 137.78 33.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.445 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.448 ' CG2' HD12 ' D' ' 99' ' ' LEU . 0.6 OUTLIER -114.25 165.53 12.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.205 1.002 . . . . 0.0 108.478 173.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.91 150.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.95 142.03 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.33 120.52 10.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 100' ' ' ARG . . . -165.46 -179.86 39.46 Favored Glycine 0 CA--C 1.497 -1.033 0 N-CA-C 117.274 1.67 . . . . 0.0 117.274 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.98 145.34 41.68 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.692 0.878 . . . . 0.0 112.236 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.485 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 28.1 t -97.76 125.25 42.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.439 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -120.19 169.84 9.87 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.456 1.122 . . . . 0.0 113.618 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.8 mt -130.6 107.24 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.056 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.15 155.31 14.25 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.477 0.711 . . . . 0.0 109.097 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -24.15 -56.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 127.091 2.157 . . . . 0.0 116.704 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.23 -17.83 63.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.43 47.89 1.62 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.501 1.046 . . . . 0.0 110.632 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -119.78 139.61 52.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.477 1.511 . . . . 0.0 110.025 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -101.39 143.69 31.12 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 111.108 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 106' ' ' ILE . 15.2 m -148.09 164.28 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.928 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 93' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' D' ' 83' ' ' CYS . 58.5 mt -124.34 120.52 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.582 ' HE2' HD11 ' A' ' 106' ' ' ILE . 1.7 mmmt -108.75 115.15 29.55 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 172.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -136.57 161.58 35.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 123.319 1.533 . . . . 0.0 111.667 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.418 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -110.01 168.53 9.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -142.11 161.28 38.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.306 173.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -144.29 127.06 16.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.808 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' D' ' 77' ' ' THR . 1.0 OUTLIER -110.62 144.71 39.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.554 1.159 . . . . 0.0 110.898 -176.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.11 114.59 17.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.011 -2.359 . . . . 0.0 112.13 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 85.7 p -86.97 158.6 19.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 124.813 1.32 . . . . 0.0 113.462 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -103.68 81.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.85 -173.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.039 0.535 . . . . 0.0 109.838 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -115.83 -21.0 9.79 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.119 -1.613 . . . . 0.0 114.789 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -123.85 151.3 43.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.486 1.136 . . . . 0.0 111.702 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.608 HD11 ' HE2' ' A' ' 94' ' ' LYS . 10.8 tt -61.93 -27.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.055 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.77 4.32 22.68 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.356 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -120.13 -0.19 10.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.905 1.353 . . . . 0.0 113.935 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -60.08 -31.38 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.358 -0.839 . . . . 0.0 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 60.4 p-90 -46.54 -44.21 17.66 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.53 1.132 . . . . 0.0 113.97 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -93.63 -12.79 28.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.011 0.924 . . . . 0.0 113.161 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.64 5.11 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' D' ' 98' ' ' LEU . 14.5 m -113.08 135.6 53.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.862 0.865 . . . . 0.0 111.726 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.57 126.25 22.14 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.611 -1.185 . . . . 0.0 110.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.91 154.82 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.298 1.408 . . . . 0.0 111.821 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.86 -175.87 30.27 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.687 1.137 . . . . 0.0 113.096 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.0 p90 -126.47 153.43 45.09 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.623 0.769 . . . . 0.0 109.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.08 148.24 30.43 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.036 0.934 . . . . 0.0 109.271 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 64.9 mt -128.2 131.5 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.031 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -117.74 156.76 27.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.222 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -137.53 160.95 37.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.591 1.156 . . . . 0.0 110.195 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.18 129.54 42.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.891 -0.506 . . . . 0.0 109.735 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.02 -177.55 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.764 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 88.67 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.73 1.212 . . . . 0.0 110.177 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -169.14 1.69 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.93 2.092 . . . . 0.0 109.586 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -55.85 148.53 16.68 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.537 2.335 . . . . 0.0 105.039 173.197 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 117.291 -1.338 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -2' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' B' ' -1' ' ' VAL . 5.8 m -62.54 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.791 1.637 . . . . 0.0 111.583 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' -1' ' ' VAL . . . . . 0.405 ' H ' ' HB ' ' B' ' -2' ' ' THR . 8.0 p -148.1 168.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.368 2.267 . . . . 0.0 108.077 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . 134.42 44.95 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 131.029 3.732 . . . . 0.0 109.085 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -150.78 -54.78 0.15 Allowed 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.532 -1.355 . . . . 0.0 113.45 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -109.9 136.83 48.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.291 1.836 . . . . 0.0 107.958 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.411 ' HG ' ' HB3' ' B' ' 83' ' ' CYS . 25.0 p -130.15 147.49 51.89 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.323 1.049 . . . . 0.0 108.275 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -137.64 127.46 25.5 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.53 HD12 ' CD ' ' B' ' 53' ' ' GLN . 28.5 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.549 0.74 . . . . 0.0 112.43 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.09 120.08 10.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.75 43.18 0.5 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt 53.6 148.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.388 3.075 . . . . 0.0 119.175 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -140.83 160.1 40.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.929 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 142.26 47.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.121 1.368 . . . . 0.0 108.514 175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.32 143.5 42.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.966 1.306 . . . . 0.0 110.041 -174.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -56.35 -29.36 61.27 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.9 -12.16 61.38 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.747 1.619 . . . . 0.0 112.836 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.45 -8.13 40.48 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 127.062 2.268 . . . . 0.0 113.635 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.9 t -64.43 145.04 56.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.787 1.294 . . . . 0.0 111.511 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -121.94 141.46 51.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -133.08 147.17 52.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.304 1.049 . . . . 0.0 112.795 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -129.58 125.26 35.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.544 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.56 127.44 75.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.05 -88.45 0.1 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 125.874 1.984 . . . . 0.0 110.987 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.98 145.13 37.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.202 -0.587 . . . . 0.0 110.824 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.462 HG21 ' CG ' ' B' ' 53' ' ' GLN . 7.3 p -97.02 131.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.729 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -72.79 159.54 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.029 0.919 . . . . 0.0 112.808 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -54.47 -27.87 40.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -71.84 -34.81 69.59 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.148 0.579 . . . . 0.0 112.448 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.82 -9.16 12.63 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.503 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 155.3 40.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.379 1.59 . . . . 0.0 108.225 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.39 166.12 32.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.882 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.14 147.92 52.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.54 26.77 Favored Glycine 0 C--O 1.236 0.24 0 O-C-N 121.623 -0.673 . . . . 0.0 112.81 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' B' ' 46' ' ' LEU . 10.7 p -139.89 138.53 35.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.836 -1.182 . . . . 0.0 112.092 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -117.14 132.39 56.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.811 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.13 129.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 45.2 m -107.14 143.56 35.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.742 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.44 -13.59 18.65 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -136.44 142.06 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.948 0.899 . . . . 0.0 112.806 -174.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.28 168.68 23.33 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.219 -0.926 . . . . 0.0 111.036 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -39.15 25.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -126.85 74.64 75.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.428 1.891 . . . . 0.0 109.321 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.82 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.175 3.25 . . . . 0.0 117.34 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.79 -20.96 0.75 Allowed Glycine 0 CA--C 1.537 1.433 0 N-CA-C 118.523 2.169 . . . . 0.0 118.523 -174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.2 42.34 0.08 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 111.861 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -50.06 134.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.336 -0.852 . . . . 0.0 111.454 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -152.3 171.85 17.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.425 1.49 . . . . 0.0 111.109 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.1 tp -46.69 119.34 2.41 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.469 3.108 . . . . 0.0 112.143 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 68.2 m -114.3 113.59 45.92 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.095 0.958 . . . . 0.0 108.579 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -55.28 144.76 69.9 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.622 2.881 . . . . 0.0 112.814 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.04 52.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.613 1.165 . . . . 0.0 111.892 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.41 150.7 40.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.167 2.987 . . . . 0.0 109.266 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.08 -155.43 26.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.2 mt -144.8 139.48 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.668 -0.766 . . . . 0.0 112.421 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.53 ' CD ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -118.78 155.15 31.66 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.255 1.022 . . . . 0.0 110.993 172.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.95 163.9 22.97 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.499 -1.375 . . . . 0.0 110.588 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.97 26.38 0.32 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 113.213 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -56.36 2.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.282 2.233 . . . . 0.0 111.022 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.75 171.83 14.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.955 0.883 . . . . 0.0 113.331 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -41.43 66.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.45 1.1 . . . . 0.0 110.91 173.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -132.87 57.9 31.71 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 125.383 1.473 . . . . 0.0 111.07 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.32 176.62 9.71 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.053 1.835 . . . . 0.0 116.654 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -87.71 163.79 16.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.718 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -163.44 164.44 24.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 149.14 15.03 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 119.941 2.736 . . . . 0.0 119.941 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -164.12 154.29 14.8 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -90.06 150.92 21.88 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.927 2.091 . . . . 0.0 109.133 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 74.1 t -130.28 120.72 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.5 ' HB2' HG21 ' C' ' 52' ' ' ILE . 56.2 t30 -95.76 105.91 17.97 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.612 -1.185 . . . . 0.0 110.793 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -67.1 132.14 47.24 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.165 1.802 . . . . 0.0 112.742 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.46 -38.2 12.1 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.58 -10.4 43.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -152.5 133.28 14.0 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.002 2.521 . . . . 0.0 107.265 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -70.66 118.47 13.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.273 0.942 . . . . 0.0 109.823 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 75.5 p -173.62 170.2 4.12 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.639 1.976 . . . . 0.0 109.928 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.76 137.9 31.92 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.142 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.447 ' CG2' HD12 ' B' ' 99' ' ' LEU . 0.6 OUTLIER -114.34 166.12 12.0 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 150.49 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -129.07 141.61 51.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.08 120.3 10.17 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.37 -179.35 38.47 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.915 -1.612 . . . . 0.0 117.106 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -114.31 145.7 41.44 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 125.178 1.163 . . . . 0.0 112.098 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.411 ' HB3' ' HG ' ' B' ' 4' ' ' CYS . 34.6 t -97.76 125.94 42.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.291 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.6 OUTLIER -120.7 170.89 9.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.76 1.267 . . . . 0.0 113.573 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 mt -131.63 110.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.49 -2.141 . . . . 0.0 106.506 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.5 156.55 19.22 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.59 -53.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -73.63 -8.96 58.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.435 1.894 . . . . 0.0 116.101 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.16 50.87 3.12 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 120.008 1.276 . . . . 0.0 110.684 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -122.87 135.97 54.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.434 1.894 . . . . 0.0 109.746 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -101.83 143.03 32.24 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.308 1.443 . . . . 0.0 112.066 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.525 HG21 ' CD1' ' C' ' 106' ' ' ILE . 15.3 m -148.56 161.95 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.803 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 mt -122.16 120.21 33.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.572 ' HE2' HD11 ' C' ' 106' ' ' ILE . 1.5 mmmt -108.24 114.47 28.37 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.05 161.06 36.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.306 1.527 . . . . 0.0 112.137 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -109.3 168.06 9.66 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -141.69 160.69 39.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.508 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -143.46 127.7 17.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.559 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' B' ' 77' ' ' THR . 1.0 OUTLIER -111.03 144.59 39.92 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 124.826 1.329 . . . . 0.0 110.987 -176.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.413 ' CZ ' ' HA2' ' C' ' 81' ' ' GLY . 2.5 tpt85 -128.23 116.91 20.61 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 112.125 -2.307 . . . . 0.0 112.279 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -90.71 158.66 16.77 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 124.73 1.269 . . . . 0.0 113.627 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.1 m -103.21 80.34 1.83 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -66.76 -174.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -115.66 -22.65 9.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 119.934 -1.729 . . . . 0.0 114.537 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -118.63 148.82 42.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.766 1.269 . . . . 0.0 110.734 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.534 HD11 ' HE2' ' C' ' 94' ' ' LYS . 10.7 tt -61.05 -28.23 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.77 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.95 4.05 25.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.221 -1.322 . . . . 0.0 115.457 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.83 -1.39 11.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.102 1.451 . . . . 0.0 113.815 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.77 -31.54 68.47 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.341 -0.85 . . . . 0.0 112.824 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 60.8 p-90 -46.43 -44.57 17.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 114.107 177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -92.88 -12.78 30.1 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.951 0.9 . . . . 0.0 113.263 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 4.95 10.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' B' ' 98' ' ' LEU . 16.2 m -113.12 135.08 54.19 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.915 0.886 . . . . 0.0 111.668 174.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.48 126.66 22.84 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.541 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.94 154.77 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 120.427 1.467 . . . . 0.0 112.041 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.94 -175.32 30.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.698 1.142 . . . . 0.0 113.056 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 24.2 p90 -128.21 154.63 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.678 0.791 . . . . 0.0 109.965 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -149.71 147.26 27.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.853 0.861 . . . . 0.0 109.831 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 129.54 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.399 -0.813 . . . . 0.0 109.146 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -116.86 155.41 29.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.437 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 32.8 p -137.31 160.42 39.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 110.458 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -59.65 128.58 37.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.79 0.836 . . . . 0.0 111.395 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -91.37 82.15 5.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . 0.303 0.0 OUTLIER 71.24 75.71 0.18 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 171.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 5.6 t -128.54 -22.33 3.34 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 129.136 2.974 . . . . 0.0 114.703 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLN . . . . . 0.488 ' HG2' ' H ' ' B' ' 127' ' ' LYS 0.314 3.5 pm0 50.04 -88.25 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.488 ' H ' ' HG2' ' B' ' 126' ' ' GLN . 26.0 mttm -133.99 127.43 32.31 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.691 2.396 . . . . 0.0 106.253 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 126.861 2.064 . . . . 0.0 107.809 -174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 118.206 -0.902 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 76.0 p -107.15 -11.13 15.69 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 24.5 m -129.74 -171.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.453 1.501 . . . . 0.0 111.009 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.77 -13.58 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -166.16 -33.86 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.716 1.607 . . . . 0.0 112.997 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -87.86 137.28 32.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.783 2.033 . . . . 0.0 109.259 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.1 p -133.54 147.39 51.58 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.838 1.255 . . . . 0.0 108.453 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -137.21 127.51 26.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.519 HD12 ' CD ' ' C' ' 53' ' ' GLN . 30.3 mt -68.87 -26.76 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.959 0.904 . . . . 0.0 112.571 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -61.47 120.8 11.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.35 45.2 0.53 Allowed Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.938 1.535 . . . . 0.0 116.938 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt 52.87 149.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -141.83 161.02 38.99 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.427 -1.715 . . . . 0.0 112.139 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.05 144.35 49.97 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.271 1.428 . . . . 0.0 108.519 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.81 143.42 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.105 1.362 . . . . 0.0 109.476 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -55.75 -29.51 59.7 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.76 -12.23 61.43 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.77 1.628 . . . . 0.0 113.007 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.63 -9.09 40.77 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.284 2.373 . . . . 0.0 113.611 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.5 t -63.09 145.91 54.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.82 1.31 . . . . 0.0 111.804 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -122.36 141.09 51.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.17 147.24 52.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.999 0.904 . . . . 0.0 112.823 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.4 m -130.35 125.69 35.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.766 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.47 126.42 74.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.19 -88.71 0.08 OUTLIER Glycine 0 CA--C 1.526 0.77 0 O-C-N 126.036 2.085 . . . . 0.0 111.036 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.37 143.69 35.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.228 0.611 . . . . 0.0 110.862 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.454 HG21 ' CG ' ' C' ' 53' ' ' GLN . 7.3 p -96.16 132.74 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.739 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -71.77 160.04 33.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.247 1.023 . . . . 0.0 113.304 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 16.0 m -53.84 -27.23 28.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.151 1.381 . . . . 0.0 114.505 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.93 -34.17 68.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.231 0.612 . . . . 0.0 112.588 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.76 -9.88 12.52 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.967 1.27 . . . . 0.0 113.468 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.25 157.59 37.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.967 1.384 . . . . 0.0 110.563 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 166.3 33.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.326 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 148.04 52.66 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.65 -169.12 25.59 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 122.478 1.044 . . . . 0.0 112.746 -174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' C' ' 46' ' ' LEU . 10.2 p -139.66 138.96 36.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.686 -1.257 . . . . 0.0 112.032 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -117.19 135.09 54.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.854 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 60.6 mt -123.57 130.17 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 42.1 m -107.92 143.84 36.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.779 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.71 -13.5 18.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 16.6 m -136.74 141.43 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 112.737 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.84 168.36 23.95 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.204 -0.935 . . . . 0.0 110.992 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.62 -39.27 27.75 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.61 74.62 74.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.469 1.908 . . . . 0.0 109.291 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.8 6.8 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.147 3.232 . . . . 0.0 117.406 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.68 -21.28 0.8 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.14 42.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.732 1.266 . . . . 0.0 111.832 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 54.2 mt -49.95 134.62 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.382 -0.824 . . . . 0.0 111.518 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -152.85 171.6 18.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.222 1.409 . . . . 0.0 111.254 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' C' ' 32' ' ' THR . 12.3 tp -46.63 118.43 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 129.263 3.025 . . . . 0.0 112.136 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -113.5 112.79 48.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.542 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.5 145.69 56.6 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.173 2.582 . . . . 0.0 112.565 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.2 143.89 51.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.078 0.951 . . . . 0.0 111.329 175.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -143.93 151.53 39.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.339 3.056 . . . . 0.0 109.606 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.85 -155.66 26.72 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -144.87 139.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 114.484 -0.858 . . . . 0.0 112.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.519 ' CD ' HD12 ' C' ' 6' ' ' LEU . 0.0 OUTLIER -119.19 155.54 31.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.162 0.985 . . . . 0.0 110.739 173.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.85 163.6 22.2 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.392 -1.442 . . . . 0.0 110.886 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.74 25.09 0.33 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.113 0.965 . . . . 0.0 113.1 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.39 -57.52 2.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.191 2.196 . . . . 0.0 111.08 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.8 172.07 12.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -43.25 64.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.006 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -129.96 57.78 33.33 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 125.223 1.409 . . . . 0.0 111.054 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.37 176.83 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.976 1.784 . . . . 0.0 116.691 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 11.4 p -87.98 162.81 16.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.955 1.702 . . . . 0.0 109.637 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -162.02 165.33 27.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.174 -0.954 . . . . 0.0 112.665 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.64 149.38 15.06 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.14 155.4 15.9 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -91.6 150.78 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.985 2.114 . . . . 0.0 109.151 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.04 121.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.4 t30 -97.78 106.16 18.42 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.59 -174.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -66.58 131.69 46.56 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.779 1.627 . . . . 0.0 112.901 -173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.92 -37.99 12.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.56 -10.71 42.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 26.7 t -152.43 132.55 13.5 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.043 2.537 . . . . 0.0 107.216 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -70.24 118.53 13.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.303 0.956 . . . . 0.0 109.947 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 77.3 p -173.49 170.3 4.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.492 1.917 . . . . 0.0 110.026 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.82 137.88 31.81 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.019 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.441 ' CG2' HD12 ' C' ' 99' ' ' LEU . 0.6 OUTLIER -114.22 165.8 12.31 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.329 1.061 . . . . 0.0 108.578 173.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.42 150.89 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -128.95 142.0 51.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.35 120.3 10.0 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' CZ ' ' B' ' 100' ' ' ARG . . . -164.6 -179.73 38.85 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.79 144.83 42.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.084 0.945 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 34.2 t -97.85 123.13 41.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.549 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -117.89 170.42 8.83 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.585 1.183 . . . . 0.0 113.652 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -130.23 111.61 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.928 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.62 157.23 17.96 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -25.85 -53.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.195 2.198 . . . . 0.0 116.856 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.48 -8.61 56.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.78 47.16 4.31 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 120.399 1.454 . . . . 0.0 110.947 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -119.11 141.67 48.59 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.339 2.256 . . . . 0.0 108.209 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -108.41 145.49 34.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.598 1.159 . . . . 0.0 112.168 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' B' ' 106' ' ' ILE . 18.6 m -149.66 165.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.215 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 59.6 mt -124.3 121.59 35.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.534 ' HE2' HD11 ' B' ' 106' ' ' ILE . 1.4 mmmt -109.81 114.19 27.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -136.06 160.76 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.32 1.533 . . . . 0.0 112.033 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.42 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -109.04 168.16 9.57 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -141.6 161.1 38.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.278 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -144.08 127.09 16.45 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.265 -1.788 . . . . 0.0 110.505 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' C' ' 77' ' ' THR . 1.1 tt -110.5 144.65 39.0 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.577 1.173 . . . . 0.0 110.779 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -128.86 117.21 20.66 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 112.315 -2.22 . . . . 0.0 112.199 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -90.5 158.96 16.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 124.847 1.342 . . . . 0.0 113.848 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -103.07 80.01 1.81 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.84 -175.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.099 0.56 . . . . 0.0 109.924 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -114.47 -23.27 9.42 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.379 -1.451 . . . . 0.0 114.571 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -119.13 149.78 41.13 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.709 1.242 . . . . 0.0 110.455 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' B' ' 94' ' ' LYS . 11.5 tt -61.25 -29.06 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.295 174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.91 3.75 19.13 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.324 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.75 -1.19 11.13 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.963 1.381 . . . . 0.0 113.894 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -58.9 -31.74 68.89 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.273 -0.892 . . . . 0.0 112.74 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 61.0 p-90 -46.54 -44.19 17.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.765 1.226 . . . . 0.0 113.95 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -93.14 -12.88 29.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.979 0.912 . . . . 0.0 113.232 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.35 10.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' C' ' 98' ' ' LEU . 16.8 m -113.25 135.3 53.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.032 0.933 . . . . 0.0 111.449 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -138.82 125.36 20.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 117.597 -1.192 . . . . 0.0 110.552 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.53 154.85 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.211 1.368 . . . . 0.0 111.851 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.61 -175.47 30.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.714 1.149 . . . . 0.0 113.081 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.9 p90 -127.48 153.51 46.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.702 0.801 . . . . 0.0 109.81 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -148.63 147.2 28.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.165 0.986 . . . . 0.0 109.707 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -128.32 132.08 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -119.5 156.41 30.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.111 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 38.7 p -139.1 163.68 31.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.697 1.199 . . . . 0.0 110.662 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -60.79 124.66 21.08 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.419 -0.801 . . . . 0.0 111.517 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.89 96.89 8.95 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 79.54 106.14 0.07 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.48 1.912 . . . . 0.0 113.466 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -73.01 43.35 0.12 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.699 -1.251 . . . . 0.0 112.961 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 46.47 -98.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.065 2.546 . . . . 0.0 114.182 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -157.08 172.03 19.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.493 2.717 . . . . 0.0 107.458 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.245 0.816 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 172.282 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 117.29 -1.338 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 13.7 p -61.31 -48.64 80.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.291 1.036 . . . . 0.0 112.404 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 4.6 t -75.91 59.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.202 1.401 . . . . 0.0 111.117 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -85.58 129.85 34.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.628 1.171 . . . . 0.0 108.985 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -162.88 30.71 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.66 152.44 27.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.392 2.277 . . . . 0.0 109.614 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -138.76 153.94 48.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.009 0.818 . . . . 0.0 110.603 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -139.46 126.37 20.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.48 -31.41 72.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -66.3 101.38 0.73 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.75 -8.19 0.11 Allowed Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.1 tttt 75.63 139.09 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.041 2.536 . . . . 0.0 113.721 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -137.73 162.75 33.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.074 1.35 . . . . 0.0 111.617 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -141.05 148.47 40.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.661 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -108.88 151.99 25.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.796 0.838 . . . . 0.0 112.294 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.94 -25.76 66.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' C' ' 110' ' ' TRP . 27.4 tp -73.27 -15.98 61.4 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.346 1.858 . . . . 0.0 110.946 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.24 -6.34 34.28 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 127.192 2.329 . . . . 0.0 114.517 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 p -70.56 148.14 48.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.928 1.864 . . . . 0.0 112.219 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -119.11 139.09 52.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.868 -1.145 . . . . 0.0 109.433 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -127.8 136.16 51.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.692 0.758 . . . . 0.0 110.63 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.05 132.21 52.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.65 126.71 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -87.54 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 O-C-N 125.67 1.856 . . . . 0.0 110.611 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.88 29.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.193 -0.592 . . . . 0.0 111.5 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.49 126.55 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.045 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.19 159.3 29.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 112.277 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 t -53.07 -30.15 34.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -63.46 -39.59 94.86 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.006 -1.059 . . . . 0.0 110.97 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.56 -6.75 10.54 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 116.854 -2.081 . . . . 0.0 114.118 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.36 152.8 44.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.812 1.806 . . . . 0.0 109.705 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -152.03 145.27 24.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.304 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.53 155.67 22.91 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.834 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -169.16 30.96 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 122.928 1.293 . . . . 0.0 112.991 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.508 ' HB ' HD21 ' A' ' 46' ' ' LEU . 4.3 p -134.69 129.22 34.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.413 -1.394 . . . . 0.0 111.646 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -123.25 120.64 33.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.991 0.901 . . . . 0.0 111.607 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.99 132.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.488 ' O ' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -114.9 144.79 42.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.47 -13.99 21.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 143.11 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.572 1.149 . . . . 0.0 112.409 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.23 43.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.467 -1.396 . . . . 0.0 111.505 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.12 -25.82 63.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.54 83.71 14.71 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.568 1.947 . . . . 0.0 109.747 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.68 177.48 7.49 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.176 2.584 . . . . 0.0 110.47 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.11 -27.35 3.3 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 113.301 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -142.57 23.14 1.97 Allowed 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.72 1.608 . . . . 0.0 110.531 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 35' ' ' THR . 63.3 mt -57.21 105.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 123.182 1.468 . . . . 0.0 111.481 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 171.02 7.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.079 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -54.58 126.63 24.51 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 127.645 2.378 . . . . 0.0 111.62 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -104.09 119.54 53.92 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.646 174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -55.23 149.96 42.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.51 2.14 . . . . 0.0 111.562 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.22 149.46 47.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.324 1.05 . . . . 0.0 110.287 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -150.86 149.13 29.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.369 2.267 . . . . 0.0 109.159 177.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.33 -156.87 28.35 Favored Glycine 0 C--O 1.228 -0.236 0 O-C-N 120.355 -1.466 . . . . 0.0 111.058 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.555 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.4 mt -145.99 148.8 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 125.41 1.3 . . . . 0.0 111.704 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 152.81 50.76 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.515 -1.366 . . . . 0.0 112.997 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -101.19 147.12 26.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 14.12 1.77 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.391 1.477 . . . . 0.0 113.533 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -92.56 -42.35 9.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.823 1.649 . . . . 0.0 112.147 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.32 4.62 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.96 0.788 . . . . 0.0 112.64 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 t -70.12 -49.18 53.3 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.582 1.153 . . . . 0.0 112.538 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.34 65.33 72.25 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.07 0.948 . . . . 0.0 111.763 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.15 173.53 5.99 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.537 3.491 . . . . 0.0 116.921 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER -100.36 169.38 9.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 123.443 1.592 . . . . 0.0 110.725 173.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -162.17 162.5 28.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.071 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.87 143.17 8.45 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 118.579 2.192 . . . . 0.0 118.579 -172.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.16 152.33 20.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.514 ' HB ' HD12 ' D' ' 52' ' ' ILE . 1.8 m -89.81 152.23 21.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.032 1.733 . . . . 0.0 109.263 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.71 120.65 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.581 ' CB ' HG21 ' D' ' 52' ' ' ILE . 0.2 OUTLIER -104.45 117.97 35.46 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -82.29 136.31 35.06 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.065 -1.647 . . . . 0.0 114.55 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -97.08 -44.38 7.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.836 -1.074 . . . . 0.0 113.836 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -74.83 -19.28 60.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.368 0.667 . . . . 0.0 112.54 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.41 132.81 13.72 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.703 2.801 . . . . 0.0 107.34 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.45 118.88 20.32 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.284 1.402 . . . . 0.0 111.855 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 76.3 p -176.71 164.5 2.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.926 2.09 . . . . 0.0 107.379 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.6 135.67 17.66 Favored 'General case' 0 CA--C 1.47 -2.103 0 CA-C-O 122.202 1.001 . . . . 0.0 108.781 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -135.34 130.28 34.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 111.066 -2.788 . . . . 0.0 111.492 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.92 154.1 5.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 120.742 0.306 . . . . 0.0 110.212 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -127.99 144.2 51.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.419 HG23 HG13 ' D' ' 78' ' ' VAL . 0.0 OUTLIER -153.84 117.06 4.55 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -161.16 -177.72 34.51 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.451 HE22 HG22 ' D' ' 103' ' ' VAL . 9.7 tt0 -122.98 138.56 54.65 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.806 0.812 . . . . 0.0 111.178 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.6 t -97.97 112.76 24.57 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.154 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -112.01 168.58 9.48 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.793 1.282 . . . . 0.0 110.148 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.74 113.75 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 112.841 -1.981 . . . . 0.0 107.571 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.09 157.95 14.7 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -44.63 -28.63 0.62 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 118.156 2.651 . . . . 0.0 118.156 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -5.69 55.77 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.17 41.07 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.635 1.112 . . . . 0.0 113.416 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.27 144.53 25.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.522 2.329 . . . . 0.0 109.983 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.26 141.92 33.43 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.587 1.155 . . . . 0.0 109.616 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -146.6 160.66 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 125.121 1.513 . . . . 0.0 110.36 175.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 mt -124.43 118.17 26.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -106.39 113.2 26.58 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.6 p -132.86 165.1 25.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.58 1.657 . . . . 0.0 111.598 -173.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.56 168.52 10.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.037 173.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -141.54 158.08 44.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.272 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.68 127.26 28.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.867 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.5 137.24 45.89 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 124.788 1.305 . . . . 0.0 111.726 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.8 113.84 20.75 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.783 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 m -77.66 164.76 25.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 125.215 1.572 . . . . 0.0 111.755 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.6 m -108.61 85.16 2.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.01 178.2 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -116.25 6.43 13.83 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.35 144.88 33.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.427 174.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.2 tt -60.72 -31.11 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.166 174.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.14 6.67 13.11 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.366 1.46 . . . . 0.0 115.072 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -120.9 3.0 10.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.202 1.001 . . . . 0.0 112.831 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -33.41 75.37 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.966 -1.084 . . . . 0.0 113.196 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.41 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.6 p-90 -45.7 -41.04 10.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.12 0.968 . . . . 0.0 113.441 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -98.14 -9.02 26.47 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.242 1.017 . . . . 0.0 113.601 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.95 -0.8 19.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -112.58 141.76 45.96 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.568 0.699 . . . . 0.0 111.861 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -138.69 147.96 43.4 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.22 1.408 . . . . 0.0 109.898 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.75 149.51 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.955 1.707 . . . . 0.0 109.836 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.26 -175.26 27.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 123.799 0.714 . . . . 0.0 111.86 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 28.3 p90 -130.69 157.4 42.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.142 0.577 . . . . 0.0 110.282 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -148.81 145.94 27.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.042 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.6 mt -124.81 126.07 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.07 149.65 37.17 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.398 -0.814 . . . . 0.0 109.625 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 p -133.38 157.29 45.9 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.776 -0.578 . . . . 0.0 109.59 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 121.52 9.26 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.7 tt -75.1 82.81 2.29 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.46 -10.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.122 3.769 . . . . 0.0 112.037 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 t -67.93 4.34 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.87 159.65 33.27 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.487 1.515 . . . . 0.0 110.053 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -62.01 134.97 57.32 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.323 0.649 . . . . 0.0 109.754 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 126.66 1.984 . . . . 0.0 110.436 173.399 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.488 1.115 . . . . 0.0 111.156 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 53.4 t -145.92 142.51 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.157 1.783 . . . . 0.0 107.916 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.58 165.53 25.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 0.0 111.098 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.8 20.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.551 1.94 . . . . 0.0 113.349 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 155.94 32.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 128.144 2.577 . . . . 0.0 109.414 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 4' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' D' ' 83' ' ' CYS . 25.3 p -150.14 145.46 26.32 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.508 1.13 . . . . 0.0 110.538 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -139.79 127.15 21.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.21 -27.98 68.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.84 101.2 1.04 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.42 -9.74 0.09 OUTLIER Glycine 0 N--CA 1.484 1.899 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -174.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 75.82 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.913 2.485 . . . . 0.0 113.649 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.18 162.73 32.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.846 1.307 . . . . 0.0 111.66 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -139.71 149.7 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.097 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.12 152.73 25.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.675 0.79 . . . . 0.0 111.584 -175.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.59 -26.66 67.21 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' B' ' 110' ' ' TRP . 27.0 tp -72.45 -16.04 61.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.5 1.92 . . . . 0.0 111.237 173.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.57 -5.59 35.32 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.194 2.33 . . . . 0.0 114.363 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 66.4 p -71.27 149.61 46.02 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.926 1.863 . . . . 0.0 112.252 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -121.99 139.05 54.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.914 -1.116 . . . . 0.0 109.808 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -127.37 136.76 52.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.88 0.848 . . . . 0.0 111.018 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.01 131.72 52.15 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 86.6 mt -127.64 126.74 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.84 -87.49 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 125.023 1.452 . . . . 0.0 110.704 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.61 139.33 31.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.287 -0.537 . . . . 0.0 111.328 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.06 125.46 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.908 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -65.26 159.1 24.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.172 0.589 . . . . 0.0 112.236 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 17.7 t -54.2 -28.58 41.74 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -63.37 -37.21 86.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.982 -1.074 . . . . 0.0 110.983 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.1 -4.87 15.95 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.484 1.516 . . . . 0.0 113.753 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.26 155.42 38.28 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.925 1.363 . . . . 0.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -152.51 154.53 35.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.698 1.237 . . . . 0.0 112.72 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.18 156.05 30.55 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.164 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.06 -168.62 30.45 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.844 1.247 . . . . 0.0 113.394 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.524 ' HB ' HD21 ' D' ' 46' ' ' LEU . 7.2 p -133.9 130.5 37.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.589 -1.306 . . . . 0.0 111.763 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -124.05 121.04 34.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.982 0.896 . . . . 0.0 111.515 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.3 133.45 66.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.456 ' O ' HG21 ' D' ' 44' ' ' ILE . 1.0 OUTLIER -114.99 145.72 41.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -173.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.6 -15.97 20.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 143.55 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.441 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.71 158.3 43.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.678 -1.264 . . . . 0.0 111.615 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.96 -26.06 63.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.98 83.42 14.05 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.384 1.874 . . . . 0.0 109.441 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.72 177.48 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.091 2.527 . . . . 0.0 110.546 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.9 -27.24 3.35 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 121.346 -0.847 . . . . 0.0 113.324 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 23.32 2.0 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.799 1.64 . . . . 0.0 110.687 -177.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.456 HG21 ' O ' ' D' ' 35' ' ' THR . 62.9 mt -57.21 106.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 123.195 1.474 . . . . 0.0 111.296 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.22 170.79 8.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.954 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' D' ' 32' ' ' THR . 0.4 OUTLIER -53.78 126.31 21.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 127.409 2.284 . . . . 0.0 111.628 176.194 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -104.53 119.87 52.35 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.015 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.97 150.4 38.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.354 2.036 . . . . 0.0 111.456 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.85 152.66 50.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 110.059 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -154.52 149.29 26.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.759 2.024 . . . . 0.0 109.691 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.26 -155.29 26.43 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 119.257 0.935 . . . . 0.0 113.948 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.1 mt -146.84 148.8 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.717 1.207 . . . . 0.0 111.838 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.04 152.34 49.97 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.482 -1.386 . . . . 0.0 112.794 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -100.2 146.97 26.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 16.17 1.84 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 113.335 -175.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -91.93 -42.12 10.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 174.39 5.34 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -71.8 -47.55 52.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 0.0 112.669 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.5 64.68 73.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 124.644 1.178 . . . . 0.0 112.673 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.43 173.61 8.5 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.654 3.569 . . . . 0.0 116.639 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.303 0.5 OUTLIER -99.15 168.62 9.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.533 1.635 . . . . 0.0 111.086 173.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.54 161.78 27.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.927 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.98 143.6 8.95 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.6 151.64 18.91 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 52' ' ' ILE . 1.7 m -89.16 154.0 20.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.357 1.863 . . . . 0.0 109.52 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.25 121.04 45.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.555 ' CB ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -104.84 117.25 33.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -174.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.83 135.16 35.46 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.24 -1.538 . . . . 0.0 114.676 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -95.62 -44.28 7.55 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -74.66 -19.59 60.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.455 0.702 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.39 132.19 13.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.553 2.741 . . . . 0.0 107.491 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -75.98 118.9 19.24 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.444 1.475 . . . . 0.0 112.107 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -176.59 164.12 2.47 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 127.004 2.122 . . . . 0.0 107.196 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.29 135.18 17.65 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-O 122.505 1.145 . . . . 0.0 108.897 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 4.9 m -135.02 130.16 35.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.576 -169.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.419 HG13 HG23 ' A' ' 80' ' ' THR . 4.2 m -103.38 154.58 5.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 120.623 0.249 . . . . 0.0 110.421 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -128.43 144.0 51.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.44 116.91 4.65 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -160.98 -177.0 33.71 Favored Glycine 0 CA--C 1.503 -0.707 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.73 137.98 54.31 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.66 0.859 . . . . 0.0 110.734 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' D' ' 4' ' ' CYS . 42.7 t -97.92 112.82 24.6 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.266 -1.35 . . . . 0.0 108.771 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.43 169.16 8.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.762 1.225 . . . . 0.0 110.031 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.08 110.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.916 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -60.19 157.3 13.55 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -43.59 -30.17 0.57 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.64 -0.76 48.64 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.76 43.35 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.511 -0.743 . . . . 0.0 113.13 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.85 146.14 23.99 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.748 2.019 . . . . 0.0 109.545 175.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -101.27 142.24 32.98 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.806 1.242 . . . . 0.0 108.795 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' A' ' 106' ' ' ILE . 21.9 m -146.26 159.13 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 125.07 1.481 . . . . 0.0 110.7 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 42.4 mt -121.64 117.01 25.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.17 112.28 25.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' D' ' 81' ' ' GLY . 2.2 p -132.27 165.62 23.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.613 1.673 . . . . 0.0 111.752 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.19 168.07 10.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 114.729 -1.123 . . . . 0.0 107.977 173.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -141.32 158.34 44.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.243 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.97 127.02 27.88 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.54 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 137.22 46.06 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.767 1.292 . . . . 0.0 111.46 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' D' ' 100' ' ' ARG . 6.2 tpt180 -120.72 113.83 20.78 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 113.131 -1.85 . . . . 0.0 110.855 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -77.58 164.9 24.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.829 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -109.25 84.82 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 103' ' ' VAL . . . . . 0.451 HG22 HE22 ' A' ' 82' ' ' GLN . 33.4 m -74.24 -178.28 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -119.1 6.44 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.94 145.15 34.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.225 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 1.2 tt -60.34 -30.61 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.15 7.08 18.09 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.609 1.576 . . . . 0.0 115.207 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.63 3.21 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.25 1.025 . . . . 0.0 112.888 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.63 -33.04 74.73 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.119 -0.988 . . . . 0.0 112.655 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.42 ' CD1' HD11 ' B' ' 14' ' ' LEU . 56.5 p-90 -45.41 -41.38 9.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 113.636 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -98.3 -8.95 26.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.312 1.045 . . . . 0.0 113.672 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.64 -1.46 21.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 3.7 m -111.85 141.69 45.16 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.748 0.704 . . . . 0.0 111.895 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -138.35 148.05 44.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.335 1.454 . . . . 0.0 109.961 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.95 149.59 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 120.804 1.638 . . . . 0.0 109.83 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.51 -175.21 27.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.743 0.687 . . . . 0.0 111.877 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 29.1 p90 -130.77 156.78 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.125 0.57 . . . . 0.0 110.051 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -148.28 145.81 28.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.388 0.675 . . . . 0.0 109.922 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.3 mt -124.32 126.45 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -114.84 150.28 35.77 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.069 0.938 . . . . 0.0 110.076 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 61.9 p -133.64 158.81 42.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.683 0.793 . . . . 0.0 110.352 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 126.58 28.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.282 0.633 . . . . 0.0 109.381 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.15 140.55 58.88 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -57.74 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.287 1.835 . . . . 0.0 114.987 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m 54.26 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 127.282 2.233 . . . . 0.0 116.383 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -99.42 130.92 45.72 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 119.02 -2.3 . . . . 0.0 109.748 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.0 86.94 0.1 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.076 2.15 . . . . 0.0 107.981 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . 0.365 9.6 mm-40 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 128.313 2.645 . . . . 0.0 110.379 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 118.142 -0.932 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.0 t -153.86 96.43 1.98 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.347 1.459 . . . . 0.0 107.967 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 23.3 m 17.38 54.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 128.914 2.886 . . . . 0.0 117.262 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.2 -47.02 0.71 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 13.69 72.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 128.047 2.539 . . . . 0.0 114.054 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -141.52 153.53 44.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.148 1.779 . . . . 0.0 110.097 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p -147.01 149.27 32.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 124.58 1.175 . . . . 0.0 111.207 -174.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.5 p -139.74 127.02 21.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.71 -28.16 67.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.43 101.97 1.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.36 -14.3 0.13 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 118.592 2.197 . . . . 0.0 118.592 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.4 ' HD3' ' CD2' ' B' ' 123' ' ' LEU . 4.9 tttt 80.7 143.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 128.502 2.721 . . . . 0.0 112.776 -176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -137.56 162.74 32.94 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 111.536 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.756 ' HB ' HD13 ' B' ' 123' ' ' LEU . 6.1 t -134.01 154.07 51.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.092 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -114.41 150.79 34.14 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.848 0.859 . . . . 0.0 111.409 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.05 -25.18 66.92 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' D' ' 110' ' ' TRP . 27.2 tp -73.77 -16.29 61.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.852 2.061 . . . . 0.0 111.011 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.07 -6.52 32.53 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.279 2.371 . . . . 0.0 114.603 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 45.4 p -71.49 147.15 48.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.776 1.788 . . . . 0.0 111.907 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -118.31 139.76 50.85 Favored 'General case' 0 CA--C 1.522 -0.103 0 O-C-N 120.829 -1.169 . . . . 0.0 109.823 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -127.96 135.17 49.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -123.85 130.7 53.03 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -126.12 126.83 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.88 -88.02 0.1 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 125.506 1.754 . . . . 0.0 110.678 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.55 141.22 32.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.069 -0.665 . . . . 0.0 111.966 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.61 126.14 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.256 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.9 158.93 29.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.879 0.472 . . . . 0.0 112.176 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -53.07 -30.05 33.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -63.5 -39.21 93.84 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.924 -1.11 . . . . 0.0 111.005 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.42 -7.22 10.54 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 116.882 -2.066 . . . . 0.0 114.159 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.04 152.74 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.73 1.765 . . . . 0.0 109.757 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -152.18 145.83 24.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.927 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.89 156.31 22.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.941 174.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.63 -169.11 30.75 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-O 122.588 1.104 . . . . 0.0 113.345 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.532 ' HB ' HD21 ' B' ' 46' ' ' LEU . 10.8 p -133.3 129.84 38.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.583 -1.309 . . . . 0.0 112.008 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -122.87 121.26 35.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 122.012 0.91 . . . . 0.0 111.066 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -121.07 132.62 70.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.436 ' O ' HG21 ' B' ' 44' ' ' ILE . 1.0 OUTLIER -114.6 146.93 40.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.69 -16.64 18.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.57 144.42 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 112.387 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.5 158.22 42.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.625 -1.297 . . . . 0.0 111.383 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.7 -26.57 64.42 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -140.71 83.44 14.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.689 1.996 . . . . 0.0 109.586 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.58 177.46 7.45 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.19 2.593 . . . . 0.0 110.532 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.98 -27.04 3.36 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.285 -0.885 . . . . 0.0 113.382 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -142.68 23.64 1.92 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.879 1.672 . . . . 0.0 110.666 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.436 HG21 ' O ' ' B' ' 35' ' ' THR . 64.4 mt -57.62 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.986 1.374 . . . . 0.0 111.35 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 170.03 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.944 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' B' ' 32' ' ' THR . 0.5 OUTLIER -52.21 126.24 18.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.397 2.279 . . . . 0.0 112.184 174.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.4 m -104.88 120.62 49.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.985 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -55.33 150.23 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.732 2.288 . . . . 0.0 111.818 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.23 149.61 47.28 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.985 0.914 . . . . 0.0 110.302 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' C' ' 50' ' ' LEU . 0.2 OUTLIER -150.74 149.34 29.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.342 2.257 . . . . 0.0 108.884 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.53 -156.94 28.36 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 120.246 1.385 . . . . 0.0 111.358 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.557 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.4 mt -146.4 148.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 125.21 1.182 . . . . 0.0 111.612 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 153.92 51.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.748 -1.22 . . . . 0.0 113.061 175.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -101.83 147.51 26.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 16.71 1.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.37 1.468 . . . . 0.0 113.394 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -92.85 -40.2 10.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.165 1.786 . . . . 0.0 111.899 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.55 174.31 8.44 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.087 0.867 . . . . 0.0 111.979 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -70.36 -50.15 41.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.126 1.37 . . . . 0.0 112.688 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.43 63.74 70.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.108 0.963 . . . . 0.0 112.107 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -66.73 172.95 8.71 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.446 3.43 . . . . 0.0 116.407 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.306 0.4 OUTLIER -98.9 167.85 10.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.662 1.22 . . . . 0.0 110.823 173.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.83 162.26 29.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.866 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.62 143.8 9.05 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -160.08 153.37 22.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.524 ' HB ' HD12 ' C' ' 52' ' ' ILE . 1.6 m -91.29 151.54 20.85 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.218 1.807 . . . . 0.0 109.485 173.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.67 120.82 51.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.569 ' CB ' HG21 ' C' ' 52' ' ' ILE . 0.1 OUTLIER -104.57 117.42 34.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -82.04 136.4 35.23 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.98 -1.7 . . . . 0.0 114.402 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -97.06 -44.22 7.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.896 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -75.12 -19.29 59.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.833 0.853 . . . . 0.0 112.495 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.44 133.35 14.1 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.832 2.853 . . . . 0.0 107.412 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -77.93 118.91 20.69 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.17 1.35 . . . . 0.0 111.895 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.6 p -176.69 164.32 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.957 2.103 . . . . 0.0 107.18 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.32 135.69 18.01 Favored 'General case' 0 CA--C 1.473 -1.991 0 CA-C-O 122.244 1.021 . . . . 0.0 108.668 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . 0.251 5.2 m -135.88 130.06 33.25 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.337 -169.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.94 154.87 5.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -129.16 143.82 50.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.402 HG23 HG13 ' C' ' 78' ' ' VAL . 0.0 OUTLIER -153.58 117.45 4.75 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -161.35 -177.71 34.68 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 115.951 1.14 . . . . 0.0 115.951 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.462 HE22 HG22 ' C' ' 103' ' ' VAL . 9.7 tt0 -123.22 138.28 54.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.374 0.691 . . . . 0.0 110.456 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.8 112.82 24.57 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.32 168.95 8.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.699 1.238 . . . . 0.0 109.973 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -123.24 109.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.497 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -58.66 158.26 8.14 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -43.56 -35.91 1.88 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.727 2.491 . . . . 0.0 117.727 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -20.51 61.44 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.92 19.73 12.53 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.734 1.159 . . . . 0.0 113.434 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 149.62 26.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.169 1.788 . . . . 0.0 109.097 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -101.36 145.45 28.9 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.401 1.481 . . . . 0.0 110.128 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' C' ' 106' ' ' ILE . 23.3 m -147.77 160.21 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.234 174.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 mt -121.86 117.24 26.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.41 111.37 23.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' B' ' 81' ' ' GLY . 2.0 p -130.93 166.33 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.127 1.917 . . . . 0.0 111.907 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -119.64 168.19 11.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.109 172.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -141.95 157.81 44.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.086 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -135.1 127.29 30.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 136.51 47.28 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 124.882 1.364 . . . . 0.0 111.583 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 6.3 tpt180 -120.15 113.88 21.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.871 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 23.2 m -78.15 164.91 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 124.925 1.391 . . . . 0.0 111.814 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 71.8 m -108.9 87.23 2.44 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 103.009 -2.959 . . . . 0.0 103.009 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.08 -174.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -122.5 7.49 9.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.57 145.68 31.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.293 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' C' ' 92' ' ' VAL . 1.2 tt -60.94 -30.72 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.114 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.14 17.03 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.279 1.419 . . . . 0.0 114.902 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.93 3.37 10.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.389 1.095 . . . . 0.0 112.86 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.17 -32.84 74.33 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.228 -0.92 . . . . 0.0 113.261 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' D' ' 14' ' ' LEU . 56.5 p-90 -45.29 -41.83 9.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.307 1.043 . . . . 0.0 113.694 175.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -97.29 -9.65 27.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -0.81 19.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.09 141.91 45.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.358 0.663 . . . . 0.0 111.545 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -138.4 148.37 44.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.624 1.57 . . . . 0.0 110.114 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.33 149.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 120.594 1.543 . . . . 0.0 109.727 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.69 27.36 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 124.04 0.828 . . . . 0.0 111.694 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 28.6 p90 -129.93 157.11 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.062 0.545 . . . . 0.0 110.096 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -148.68 145.0 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.81 129.1 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -116.88 149.79 39.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.752 0.786 . . . . 0.0 110.944 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 81.6 p -135.18 158.44 44.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.957 0.903 . . . . 0.0 110.014 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 129.53 41.67 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.218 -0.926 . . . . 0.0 110.762 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.756 HD13 ' HB ' ' B' ' 11' ' ' THR . 18.1 tp -86.72 132.6 33.82 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.705 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 73.71 168.05 0.3 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.818 1.647 . . . . 0.0 110.416 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t 174.19 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.458 1.903 . . . . 0.0 109.845 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 72.14 -174.17 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.894 1.677 . . . . 0.0 109.928 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -87.36 -51.43 5.95 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.826 0.739 . . . . 0.0 111.655 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.881 1 C-N-CA 134.46 5.104 . . . . 0.0 105.849 -174.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 117.922 -1.037 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.0 168.79 22.83 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.001 1.321 . . . . 0.0 109.431 -174.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . 0.267 17.1 m 43.98 31.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -116.84 -174.42 2.57 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.656 2.382 . . . . 0.0 109.906 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ARG . . . . . 0.44 ' HB2' HH11 ' C' ' 2' ' ' ARG . 1.0 OUTLIER 81.88 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.756 2.022 . . . . 0.0 109.825 -174.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -154.21 152.15 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.426 1.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 23.8 p -147.88 147.43 29.74 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.815 0.697 . . . . 0.0 111.386 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.4 p -139.63 126.82 21.19 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -67.69 -29.1 68.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -67.58 102.14 1.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.31 0.11 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 73.2 140.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.637 2.375 . . . . 0.0 113.997 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -137.81 162.73 33.19 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.969 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.9 t -139.45 148.06 42.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.553 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -108.12 152.94 23.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.661 0.784 . . . . 0.0 111.553 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.0 -26.14 65.75 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.41 HD11 ' CD1' ' A' ' 110' ' ' TRP . 27.6 tp -72.41 -16.15 61.84 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.581 1.953 . . . . 0.0 110.956 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.4 -6.66 34.08 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 127.497 2.475 . . . . 0.0 114.451 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 73.2 p -70.67 148.45 48.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.87 1.835 . . . . 0.0 112.114 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.3 139.62 52.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 120.867 -1.146 . . . . 0.0 109.962 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -128.1 135.81 50.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.44 130.82 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.84 126.29 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.01 -87.64 0.09 OUTLIER Glycine 0 CA--C 1.526 0.74 0 O-C-N 125.41 1.694 . . . . 0.0 110.769 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.53 141.04 32.01 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.233 -0.569 . . . . 0.0 111.387 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.77 125.07 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.155 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -64.93 158.28 25.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.236 0.615 . . . . 0.0 112.252 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 17.6 t -53.74 -28.39 34.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -63.47 -37.15 86.2 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.805 -1.184 . . . . 0.0 111.005 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.31 -4.86 15.47 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.673 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 154.13 38.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.023 1.412 . . . . 0.0 111.287 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -151.71 154.39 36.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.934 0.873 . . . . 0.0 112.278 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -118.34 156.2 29.33 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.538 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -168.79 30.46 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 122.157 0.865 . . . . 0.0 113.52 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.5 ' HB ' HD21 ' C' ' 46' ' ' LEU . 7.2 p -133.45 130.08 38.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.778 -1.211 . . . . 0.0 112.018 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -125.09 120.96 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.627 1.203 . . . . 0.0 111.416 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -119.93 132.66 69.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.48 ' O ' HG21 ' C' ' 44' ' ' ILE . 0.8 OUTLIER -116.2 146.1 42.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -173.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.52 -13.89 22.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.468 ' H ' HG23 ' C' ' 35' ' ' THR . 27.8 m -134.34 144.44 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.737 1.215 . . . . 0.0 113.357 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.82 158.55 43.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.282 -1.511 . . . . 0.0 111.645 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.46 -26.01 63.44 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -140.84 83.09 14.66 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.552 1.941 . . . . 0.0 109.709 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.6 177.4 7.53 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.089 2.526 . . . . 0.0 110.605 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.27 -27.58 3.26 Favored Glycine 0 N--CA 1.476 1.348 0 O-C-N 121.345 -0.847 . . . . 0.0 113.412 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.99 23.12 2.07 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.893 1.677 . . . . 0.0 110.589 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.48 HG21 ' O ' ' C' ' 35' ' ' THR . 70.7 mt -56.95 106.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 122.946 1.355 . . . . 0.0 111.631 -174.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.1 t -113.63 169.56 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.005 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' C' ' 32' ' ' THR . 0.5 OUTLIER -52.36 126.89 20.54 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.507 2.323 . . . . 0.0 111.707 174.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.09 120.09 50.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.336 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.78 149.78 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.461 2.107 . . . . 0.0 111.432 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.66 153.05 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 109.917 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' B' ' 50' ' ' LEU . 0.3 OUTLIER -154.65 149.31 26.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.859 2.064 . . . . 0.0 109.72 -178.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.6 -155.64 26.96 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 119.207 0.912 . . . . 0.0 113.863 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.569 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.1 mt -146.41 148.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.846 -174.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 153.04 50.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.304 -1.497 . . . . 0.0 112.869 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -101.11 147.46 26.2 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 16.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.019 1.328 . . . . 0.0 113.493 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -92.95 -40.0 10.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.737 1.615 . . . . 0.0 112.06 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.57 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.825 0.85 . . . . 0.0 113.048 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 34.3 t -69.2 -48.47 61.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.429 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.61 64.82 69.61 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.241 1.017 . . . . 0.0 112.614 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -66.22 173.29 7.59 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.497 3.465 . . . . 0.0 116.931 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.305 0.5 OUTLIER -99.18 168.28 10.15 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.504 1.621 . . . . 0.0 111.13 173.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -162.24 162.0 28.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.937 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.63 143.83 9.08 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 118.075 1.99 . . . . 0.0 118.075 -172.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -160.42 152.42 20.18 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.5 ' HB ' HD12 ' B' ' 52' ' ' ILE . 1.7 m -90.01 154.36 19.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.367 1.867 . . . . 0.0 109.242 173.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -132.64 121.09 44.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.557 ' CB ' HG21 ' B' ' 52' ' ' ILE . 0.2 OUTLIER -105.29 115.83 30.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 117.972 0.351 . . . . 0.0 110.12 -174.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.02 135.88 36.47 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -96.38 -44.25 7.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.929 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -74.91 -19.67 60.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.789 0.836 . . . . 0.0 112.563 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -152.35 133.1 14.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.83 2.852 . . . . 0.0 107.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -77.78 118.93 20.6 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.39 1.45 . . . . 0.0 111.974 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 78.7 p -176.51 164.64 2.57 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 126.868 2.067 . . . . 0.0 107.201 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.64 135.45 17.45 Favored 'General case' 0 CA--C 1.475 -1.942 0 CA-C-O 122.593 1.187 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.0 m -135.55 130.07 34.0 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 110.761 -2.927 . . . . 0.0 111.706 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.402 HG13 HG23 ' B' ' 80' ' ' THR . 4.0 m -103.28 154.81 5.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.676 0.274 . . . . 0.0 110.328 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -128.87 144.0 51.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.81 116.88 4.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -160.45 -176.98 33.14 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.09 137.82 54.52 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.417 0.716 . . . . 0.0 110.575 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.88 112.85 24.61 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 117.232 -1.366 . . . . 0.0 108.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.17 168.94 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.123 1.369 . . . . 0.0 109.973 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -124.32 109.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.989 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.88 160.17 10.08 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -44.56 -31.92 1.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.02 -25.55 58.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.63 -3.74 19.66 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.909 1.242 . . . . 0.0 114.18 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 145.44 55.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.605 1.962 . . . . 0.0 111.684 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -101.14 140.75 35.0 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.668 1.987 . . . . 0.0 109.902 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.431 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.5 m -144.78 160.1 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.608 1.163 . . . . 0.0 110.954 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 mt -120.7 116.98 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -106.13 110.69 23.02 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.434 HG22 ' HA3' ' C' ' 81' ' ' GLY . 2.2 p -130.94 166.03 21.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 123.625 1.679 . . . . 0.0 112.029 -174.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -119.17 168.72 10.59 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -142.21 158.18 44.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.136 172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.66 127.27 28.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.609 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.58 137.31 45.84 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 124.704 1.253 . . . . 0.0 111.449 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.98 113.87 20.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.798 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -77.89 165.85 23.61 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.891 1.369 . . . . 0.0 111.985 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 69.5 m -109.89 87.24 2.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' VAL . . . . . 0.462 HG22 HE22 ' B' ' 82' ' ' GLN . 35.1 m -75.33 -172.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.284 -0.885 . . . . 0.0 108.658 174.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -124.88 7.86 8.08 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.94 145.98 30.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.031 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' B' ' 92' ' ' VAL . 1.2 tt -59.29 -31.22 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.559 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.03 6.22 14.64 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.187 1.375 . . . . 0.0 115.471 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -120.61 3.27 10.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.615 1.207 . . . . 0.0 113.089 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.51 -32.63 74.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.296 -0.877 . . . . 0.0 112.948 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.414 ' CD1' HD11 ' A' ' 14' ' ' LEU . 56.2 p-90 -45.64 -41.4 10.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -97.56 -9.83 26.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.159 0.984 . . . . 0.0 113.557 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -0.47 17.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.097 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.64 141.92 45.85 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.433 0.693 . . . . 0.0 111.547 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -138.65 148.02 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.522 1.529 . . . . 0.0 109.79 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.78 149.32 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 120.655 1.57 . . . . 0.0 109.664 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.69 -176.26 28.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.753 0.692 . . . . 0.0 111.572 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 28.7 p90 -129.7 156.71 43.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.069 0.548 . . . . 0.0 110.336 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -148.12 145.17 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.963 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.55 129.37 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.98 149.85 40.25 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.411 -0.806 . . . . 0.0 110.265 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.9 p -132.11 158.93 40.37 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.377 -0.827 . . . . 0.0 110.215 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 125.85 25.3 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 122.115 -0.366 . . . . 0.0 110.089 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.46 104.44 0.79 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.578 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 84.42 44.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.885 2.074 . . . . 0.0 114.837 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 33.7 p -112.6 151.86 29.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.05 1.295 . . . . 0.0 114.4 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -155.81 -20.44 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -139.86 166.26 25.12 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.566 1.546 . . . . 0.0 110.42 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.398 0 C-N-CA 128.993 2.917 . . . . 0.0 113.808 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' -1' ' ' VAL . 1.0 OUTLIER 49.5 -153.66 0.12 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 117.683 -1.151 . . . . 0.0 110.944 -173.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' -1' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' -2' ' ' THR . 11.5 t 56.88 -44.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 130.47 3.508 . . . . 0.0 118.372 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 59.53 -152.27 0.4 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.008 1.723 . . . . 0.0 112.75 -174.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.27 1.8 ptp180 161.89 66.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 130.665 3.586 . . . . 0.0 110.867 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -150.29 140.13 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.875 1.27 . . . . 0.0 112.316 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.22 147.18 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.419 1.104 . . . . 0.0 109.152 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.425 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 69.6 m -139.27 126.71 21.6 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.764 -1.21 . . . . 0.0 111.568 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.08 -25.3 62.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.68 122.15 9.29 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.163 1.458 . . . . 0.0 110.598 174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.63 -118.02 2.38 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.805 2.145 . . . . 0.0 109.154 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -141.53 156.1 45.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.533 1.133 . . . . 0.0 113.37 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.68 160.85 39.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.901 -1.954 . . . . 0.0 111.201 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -139.86 142.24 36.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.84 147.29 31.11 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.713 0.805 . . . . 0.0 112.227 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' C' ' 110' ' ' TRP . 33.0 tp -72.92 -15.59 61.57 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.16 1.384 . . . . 0.0 111.8 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.76 -16.63 21.01 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.547 2.499 . . . . 0.0 113.593 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -61.28 146.57 47.46 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.517 1.151 . . . . 0.0 113.076 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -121.4 139.25 53.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.646 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -131.66 145.63 51.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 111.585 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -129.87 132.73 46.53 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.223 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.58 126.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.39 -95.03 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 O-C-N 124.22 0.95 . . . . 0.0 112.274 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.58 126.89 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.436 -1.038 . . . . 0.0 110.529 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.44 139.3 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.01 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.42 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 10.8 t-20 -75.14 166.44 23.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.108 0.963 . . . . 0.0 112.959 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.4 t -56.42 -34.51 66.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.982 1.313 . . . . 0.0 113.358 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -68.91 -35.59 77.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.593 -1.317 . . . . 0.0 111.54 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.68 -6.48 9.71 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.83 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 24' ' ' ASN . 8.3 pt-20 -67.19 142.62 56.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.439 1.496 . . . . 0.0 111.98 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -155.53 147.47 23.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.731 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 163.73 13.28 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.87 -166.87 29.54 Favored Glycine 0 C--O 1.238 0.378 0 O-C-N 121.335 -0.853 . . . . 0.0 111.895 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.571 ' HB ' HD11 ' A' ' 46' ' ' LEU . 33.7 p -140.01 128.65 23.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.937 -1.132 . . . . 0.0 111.788 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -103.82 137.57 41.65 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.231 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 46' ' ' LEU . 22.7 mt -128.64 126.17 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 37' ' ' VAL . 15.3 m -104.99 140.75 37.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.733 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.28 -2.42 33.76 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG21 HD21 ' A' ' 14' ' ' LEU . 30.4 m -138.54 163.43 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.616 1.966 . . . . 0.0 111.446 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.37 16.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.834 -1.791 . . . . 0.0 112.857 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -69.46 -47.04 65.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -124.86 79.41 64.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.18 2.992 . . . . 0.0 110.202 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.24 25.42 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 124.825 3.683 . . . . 0.0 116.591 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.36 0.75 63.02 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.107 -1.621 . . . . 0.0 115.799 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.76 30.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -49.03 131.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.034 -1.666 . . . . 0.0 112.399 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.17 165.26 27.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.886 2.074 . . . . 0.0 108.707 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 32' ' ' THR . 5.1 tt -49.24 131.04 19.91 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.78 1.632 . . . . 0.0 111.656 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 p -108.5 122.66 39.63 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.163 0.506 . . . . 0.0 112.206 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.56 145.36 89.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.151 2.567 . . . . 0.0 111.997 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -133.78 156.6 47.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.553 0.741 . . . . 0.0 112.45 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -158.86 149.06 19.51 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.448 2.299 . . . . 0.0 109.366 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.35 -153.76 23.5 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 120.461 1.482 . . . . 0.0 110.345 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.547 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.3 mt -146.39 138.17 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.493 1.117 . . . . 0.0 112.026 -174.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -122.19 141.27 51.64 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.899 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -57.06 -52.39 65.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.635 0.374 . . . . 0.0 111.152 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HE3' ' OG ' ' A' ' 5' ' ' SER . 16.7 tptm 52.58 -0.76 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.339 2.256 . . . . 0.0 116.363 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -75.08 -56.29 4.89 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.747 2.019 . . . . 0.0 113.408 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . . . -79.26 173.35 12.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.81 0.814 . . . . 0.0 110.933 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -73.42 -28.93 62.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.471 1.108 . . . . 0.0 113.749 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -141.81 46.47 0.82 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.296 1.439 . . . . 0.0 112.15 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 48.4 Cg_endo -82.39 -177.45 3.46 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.127 2.551 . . . . 0.0 114.245 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.3 p -84.91 167.77 15.64 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.143 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.86 159.38 15.89 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.484 1.114 . . . . 0.0 111.277 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.91 148.18 14.71 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.62 162.82 35.3 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.484 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.8 m -100.59 146.88 26.58 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 127.127 2.171 . . . . 0.0 109.413 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.34 117.0 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.541 ' HB2' HG21 ' D' ' 52' ' ' ILE . 53.3 t30 -98.65 106.56 18.84 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.893 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.329 52.4 m95 -67.93 158.87 31.75 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 121.56 1.982 . . . . 0.0 115.197 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -39.26 4.02 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -90.44 -11.99 38.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -152.42 143.6 23.19 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.076 2.55 . . . . 0.0 106.393 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.61 118.53 15.65 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.042 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -171.45 164.85 7.0 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.504 1.522 . . . . 0.0 111.644 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -146.99 138.76 24.33 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 123.867 1.794 . . . . 0.0 110.468 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.35 127.26 27.57 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 109.579 -3.464 . . . . 0.0 109.715 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.23 155.87 6.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.011 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.97 139.94 52.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.405 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -149.48 113.9 5.26 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -174.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.38 176.42 29.84 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.04 -1.076 . . . . 0.0 115.509 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 9.7 tt0 -118.05 146.69 43.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.178 -1.511 . . . . 0.0 108.934 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.8 t -97.09 129.61 44.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.368 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -125.72 167.87 14.55 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.867 1.318 . . . . 0.0 112.333 177.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.5 119.02 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 112.668 -2.06 . . . . 0.0 106.7 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -58.44 154.14 14.44 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.47 -23.58 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -7.34 58.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.554 1.142 . . . . 0.0 113.998 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.56 36.93 8.33 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.995 0.809 . . . . 0.0 113.981 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.73 151.91 35.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.868 1.267 . . . . 0.0 110.85 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -101.33 146.33 27.71 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 111.059 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.9 m -148.17 160.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.329 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.5 mt -121.43 115.64 23.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -105.71 110.65 23.03 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.427 HG22 ' HA3' ' A' ' 81' ' ' GLY . 6.2 p -126.02 166.61 16.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.886 1.327 . . . . 0.0 110.528 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.97 170.9 8.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -144.64 159.24 43.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.215 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.0 tp -137.72 123.24 19.66 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.451 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 137.79 44.96 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 125.569 1.793 . . . . 0.0 113.185 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -120.16 119.36 33.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.934 2.021 . . . . 0.0 111.762 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -86.25 160.11 19.26 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.309 1.006 . . . . 0.0 110.815 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m -103.43 82.17 2.01 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.16 -12.84 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.41 -29.47 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.3 137.12 51.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.025 1.284 . . . . 0.0 112.383 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.488 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.8 tt -62.5 -25.6 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.31 -3.76 33.42 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.628 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -124.69 3.16 8.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.396 1.078 . . . . 0.0 113.879 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -34.85 60.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.364 -0.835 . . . . 0.0 112.377 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.608 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 55.6 p-90 -49.95 -44.94 50.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.767 1.227 . . . . 0.0 113.542 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.608 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -89.58 -10.78 44.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.387 -0.82 . . . . 0.0 112.429 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.35 -0.05 24.17 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -118.61 146.25 44.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.19 0.596 . . . . 0.0 111.765 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.56 151.66 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.789 1.636 . . . . 0.0 110.498 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.32 148.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.224 1.375 . . . . 0.0 111.556 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.02 -176.8 27.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 122.55 1.083 . . . . 0.0 112.638 175.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -122.15 152.68 39.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.86 0.864 . . . . 0.0 108.812 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -149.63 132.82 16.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.104 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -124.95 121.32 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.585 -0.697 . . . . 0.0 110.725 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -110.38 151.55 27.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.776 -1.557 . . . . 0.0 110.396 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -133.54 160.25 38.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.281 1.032 . . . . 0.0 109.491 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -57.97 110.47 0.93 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 123' ' ' LEU . 7.0 tt -65.97 117.35 8.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.537 HH11 ' HB3' ' A' ' 124' ' ' ARG . 0.0 OUTLIER 177.54 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.3 t -141.75 164.71 29.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -104.6 150.81 24.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 109.365 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 159.81 43.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.96 1.704 . . . . 0.0 110.077 -173.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 176.087 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' -3' ' ' GLN . . . . . 0.464 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 31.6 mm-40 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 116.368 -1.777 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 6.1 m 14.1 88.86 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 128.786 2.834 . . . . 0.0 116.65 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.68 140.28 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.405 1.082 . . . . 0.0 110.899 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -146.35 -58.98 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.725 0.81 . . . . 0.0 110.86 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 47.58 31.76 2.18 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.518 1.127 . . . . 0.0 113.545 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -152.56 144.97 24.04 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.479 1.512 . . . . 0.0 111.821 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 p -116.32 144.43 44.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.054 0.942 . . . . 0.0 108.763 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' SER . . . . . 0.404 ' OG ' ' HE3' ' D' ' 57' ' ' LYS . 59.5 m -139.56 126.91 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.405 -1.434 . . . . 0.0 113.178 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.08 -26.99 64.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.5 121.38 7.59 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.009 1.385 . . . . 0.0 110.47 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.38 -117.9 2.25 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.844 2.164 . . . . 0.0 109.512 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -143.87 152.37 41.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.219 1.008 . . . . 0.0 113.337 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -142.16 158.05 44.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.255 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -136.46 144.95 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.661 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.12 146.58 35.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.553 0.741 . . . . 0.0 112.299 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.13 -23.3 67.38 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.56 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.8 tp -72.63 -14.69 61.66 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.027 1.331 . . . . 0.0 112.047 174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -14.55 31.61 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.564 2.507 . . . . 0.0 113.563 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.34 149.59 41.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.759 1.266 . . . . 0.0 113.059 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -125.12 142.18 51.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.028 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -133.02 143.87 49.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.407 0.622 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -128.38 131.93 48.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.224 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.72 127.14 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -95.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.451 1.094 . . . . 0.0 112.358 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -137.87 127.09 24.49 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.46 -1.024 . . . . 0.0 110.797 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.86 139.96 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.233 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.68 164.1 25.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.974 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.9 t -54.58 -34.22 61.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.178 1.391 . . . . 0.0 114.166 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -66.94 -35.66 80.47 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.288 -1.507 . . . . 0.0 111.545 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.1 -6.21 9.44 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 124.408 1.004 . . . . 0.0 114.313 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.12 147.56 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.17 162.86 40.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.577 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.72 168.15 14.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.14 -164.9 29.9 Favored Glycine 0 C--O 1.238 0.396 0 O-C-N 120.184 -1.573 . . . . 0.0 112.082 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.583 ' HB ' HD11 ' D' ' 46' ' ' LEU . 35.5 p -140.54 128.0 21.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.133 0.968 . . . . 0.0 112.058 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -104.71 138.45 40.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.86 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' D' ' 46' ' ' LEU . 21.7 mt -129.49 126.56 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.431 HG22 ' H ' ' D' ' 37' ' ' VAL . 16.4 m -105.06 141.15 37.14 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.703 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.08 -2.75 33.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.479 HG21 HD21 ' D' ' 14' ' ' LEU . 26.8 m -138.2 163.85 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.41 1.884 . . . . 0.0 111.142 -174.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.32 167.78 15.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.917 -1.74 . . . . 0.0 112.655 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -69.88 -46.56 65.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.284 1.034 . . . . 0.0 108.261 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -125.37 79.16 67.02 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.985 2.914 . . . . 0.0 110.121 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.85 24.47 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.937 3.758 . . . . 0.0 116.59 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.67 60.35 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.182 -1.574 . . . . 0.0 115.915 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.34 29.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' D' ' 72' ' ' PHE . 30.8 mt -48.99 131.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.019 -1.676 . . . . 0.0 112.417 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 164.89 28.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.877 2.071 . . . . 0.0 108.821 174.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' D' ' 32' ' ' THR . 5.1 tt -49.01 130.66 18.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.656 1.582 . . . . 0.0 111.456 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -107.98 122.73 39.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 121.388 0.613 . . . . 0.0 112.408 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.22 144.76 89.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.919 2.412 . . . . 0.0 111.582 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.422 HD12 ' C ' ' D' ' 49' ' ' LEU . 2.0 pp -131.41 164.11 26.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.62 0.768 . . . . 0.0 112.305 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -165.52 149.03 8.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.226 1.811 . . . . 0.0 109.483 -174.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.48 -156.28 27.71 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 120.858 1.663 . . . . 0.0 112.952 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -146.13 137.11 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.246 1.018 . . . . 0.0 111.486 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.13 140.9 52.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.478 1.511 . . . . 0.0 108.578 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.14 -50.96 71.19 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.068 -0.395 . . . . 0.0 111.353 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' LYS . . . . . 0.404 ' HE3' ' OG ' ' D' ' 5' ' ' SER . 15.1 tptm 51.61 2.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.507 2.323 . . . . 0.0 116.156 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -78.81 -56.32 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.129 2.171 . . . . 0.0 113.568 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' D' ' 62' ' ' PRO . . . -79.65 173.62 12.4 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.467 1.104 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -74.03 -27.06 60.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.682 -1.151 . . . . 0.0 113.969 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -143.01 48.53 1.01 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 125.2 1.4 . . . . 0.0 112.754 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' D' ' 59' ' ' ALA . 45.4 Cg_endo -82.8 -177.65 3.49 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.221 2.614 . . . . 0.0 114.939 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -85.51 168.3 14.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.492 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.37 159.84 15.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 111.148 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.13 148.5 15.19 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -159.85 162.66 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' THR . . . . . 0.506 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.8 m -100.6 149.6 23.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.238 2.215 . . . . 0.0 109.01 173.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -129.1 117.81 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 52' ' ' ILE . 51.2 t30 -100.17 107.45 19.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.746 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.336 50.9 m95 -68.68 158.24 34.55 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.102 1.774 . . . . 0.0 115.334 -172.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.35 4.26 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 72' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' D' ' 44' ' ' ILE . 47.0 p90 -91.09 -12.03 36.85 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -152.31 143.9 23.48 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.104 2.562 . . . . 0.0 106.305 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.84 118.53 15.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.101 0.864 . . . . 0.0 110.413 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 90.3 p -171.73 165.19 6.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.352 1.461 . . . . 0.0 111.903 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -146.9 139.2 24.75 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.459 1.6 . . . . 0.0 110.447 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.31 25.94 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 109.631 -3.44 . . . . 0.0 109.856 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.03 155.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.232 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.38 140.24 51.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 80' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -149.76 114.45 5.31 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -152.2 178.69 29.28 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.946 -1.121 . . . . 0.0 115.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 12.2 tt0 -120.08 144.91 47.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.456 -1.372 . . . . 0.0 109.17 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' D' ' 93' ' ' LEU . 41.4 t -97.31 128.74 44.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.542 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 0.4 OUTLIER -121.61 168.87 11.27 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.792 1.282 . . . . 0.0 111.299 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.28 118.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 112.823 -1.99 . . . . 0.0 106.994 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -58.67 154.87 13.65 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.38 -25.28 0.98 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -6.28 59.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.296 1.039 . . . . 0.0 113.746 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 27.25 20.88 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.544 1.545 . . . . 0.0 114.185 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -106.35 153.12 22.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 111.884 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -101.42 145.92 28.3 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 123.328 1.537 . . . . 0.0 110.871 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 106' ' ' ILE . 17.6 m -148.57 159.56 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.643 175.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 93' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' D' ' 83' ' ' CYS . 67.4 mt -119.2 115.28 23.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -105.9 109.84 21.92 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.412 HG22 ' HA3' ' D' ' 81' ' ' GLY . 6.6 p -125.25 167.33 15.02 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.941 1.353 . . . . 0.0 111.163 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.99 171.14 8.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 159.23 43.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.297 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.405 HD23 ' OG1' ' A' ' 80' ' ' THR . 2.9 tp -137.93 123.23 19.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.265 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.7 138.51 43.8 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 125.521 1.763 . . . . 0.0 113.005 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -120.97 117.77 28.14 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 125.898 1.999 . . . . 0.0 111.858 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -83.93 159.99 21.17 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 124.688 1.243 . . . . 0.0 110.977 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -104.22 82.97 2.01 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.0 -12.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 63.93 -28.22 0.09 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.71 136.5 53.32 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.93 1.241 . . . . 0.0 112.301 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.3 tt -62.09 -25.15 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.04 -4.09 33.34 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.546 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 4.7 m-20 -124.94 3.07 8.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.494 1.117 . . . . 0.0 113.769 -176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -52.97 -34.83 57.75 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.333 -0.854 . . . . 0.0 113.053 175.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.618 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 56.3 p-90 -49.72 -45.69 49.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.7 1.2 . . . . 0.0 113.287 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 111' ' ' LYS . . . . . 0.618 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.3 OUTLIER -89.06 -11.3 44.49 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.451 -0.781 . . . . 0.0 112.451 177.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.3 23.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 7.6 m -118.24 145.99 44.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.288 0.635 . . . . 0.0 111.884 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.77 151.86 40.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.85 1.66 . . . . 0.0 110.773 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.04 148.68 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 120.13 1.332 . . . . 0.0 111.675 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.21 -177.19 28.23 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 122.465 1.036 . . . . 0.0 112.912 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -120.96 152.88 38.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.778 0.831 . . . . 0.0 109.053 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -149.5 133.41 17.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.225 -174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 48.8 mt -126.09 122.63 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.259 1.028 . . . . 0.0 110.714 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -112.55 148.77 33.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.465 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 16.4 p -133.43 160.3 37.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.424 1.09 . . . . 0.0 109.844 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -55.88 115.62 2.49 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.132 0.573 . . . . 0.0 109.778 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 123' ' ' LEU . . . . . 0.505 HD23 ' C ' ' D' ' 123' ' ' LEU . 3.6 tt -80.01 98.6 7.27 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.6 139.7 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.908 0.483 . . . . 0.0 112.282 173.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 125' ' ' THR . . . . . 0.532 HG22 ' H ' ' D' ' 126' ' ' GLN . 1.7 m 56.0 -160.75 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.427 1.079 . . . . 0.0 110.146 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 126' ' ' GLN . . . . . 0.532 ' H ' HG22 ' D' ' 125' ' ' THR . 0.0 OUTLIER -136.67 -177.42 4.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.023 1.329 . . . . 0.0 108.254 173.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.96 173.06 12.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.089 1.756 . . . . 0.0 109.591 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.556 0 C-N-CA 125.62 1.568 . . . . 0.0 114.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.6 t -69.97 51.44 0.11 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.771 1.628 . . . . 0.0 114.349 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.04 144.77 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.134 -1.603 . . . . 0.0 111.865 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.23 160.02 33.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -167.98 25.52 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.153 1.781 . . . . 0.0 112.323 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -154.69 142.45 19.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.145 1.378 . . . . 0.0 111.046 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 p -116.46 144.43 44.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.207 1.003 . . . . 0.0 109.736 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.405 ' OG ' ' HE3' ' B' ' 57' ' ' LYS . 53.6 m -139.5 126.81 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.433 -1.417 . . . . 0.0 113.012 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.06 -27.77 62.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -53.17 116.62 2.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.764 1.226 . . . . 0.0 110.385 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.6 -121.14 2.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.974 1.749 . . . . 0.0 109.793 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -143.08 153.4 42.88 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.919 1.288 . . . . 0.0 113.224 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -143.31 160.23 40.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.707 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.444 ' HB ' HD12 ' B' ' 123' ' ' LEU . 14.3 t -138.28 145.14 40.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.677 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -112.11 146.17 38.48 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.478 0.711 . . . . 0.0 112.34 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.13 -24.38 67.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.593 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.6 tp -71.06 -14.4 62.31 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 112.029 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.96 -13.78 31.7 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.805 2.621 . . . . 0.0 113.738 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -63.64 149.47 46.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.842 1.306 . . . . 0.0 112.865 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -125.38 140.68 52.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.011 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -131.89 145.58 51.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.745 0.784 . . . . 0.0 112.408 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -129.22 133.63 47.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.015 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.03 127.56 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -93.75 0.07 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.922 0.764 . . . . 0.0 112.124 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.46 127.01 21.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.266 -1.138 . . . . 0.0 110.351 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.23 139.12 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.88 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' B' ' 28' ' ' GLU . 10.2 t-20 -75.36 167.07 22.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.781 0.832 . . . . 0.0 112.914 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -56.81 -34.37 67.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.01 1.324 . . . . 0.0 113.352 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -68.78 -36.19 77.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.281 -1.512 . . . . 0.0 111.476 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.77 -6.68 9.61 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.786 -1.563 . . . . 0.0 114.858 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' B' ' 24' ' ' ASN . 8.4 pt-20 -65.99 142.61 57.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.448 1.499 . . . . 0.0 112.45 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.75 147.94 23.56 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.553 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.32 163.09 14.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 174.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.26 -166.86 29.0 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 121.296 -0.877 . . . . 0.0 111.867 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.57 ' HB ' HD11 ' B' ' 46' ' ' LEU . 33.1 p -140.62 128.73 22.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.967 -1.117 . . . . 0.0 111.88 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -103.82 137.92 41.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.101 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.478 HD11 HD12 ' B' ' 46' ' ' LEU . 21.9 mt -129.25 126.17 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 37' ' ' VAL . 15.4 m -105.11 141.37 36.78 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.853 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.67 -2.27 33.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.485 HG21 HD21 ' B' ' 14' ' ' LEU . 26.9 m -138.5 163.29 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.534 1.933 . . . . 0.0 111.223 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.21 167.7 15.91 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.006 -1.684 . . . . 0.0 112.879 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -70.71 -44.86 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 108.493 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -126.61 79.04 72.02 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 129.035 2.934 . . . . 0.0 109.843 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.08 24.82 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.786 3.658 . . . . 0.0 116.602 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.84 0.63 61.32 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.157 -1.589 . . . . 0.0 115.877 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.45 29.96 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' B' ' 72' ' ' PHE . 30.5 mt -49.13 130.94 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 119.899 -1.75 . . . . 0.0 112.445 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.72 165.21 28.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.76 2.024 . . . . 0.0 108.59 174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' B' ' 32' ' ' THR . 5.1 tt -49.48 131.44 20.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.843 1.657 . . . . 0.0 111.806 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 7.3 p -109.54 122.61 38.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.183 0.516 . . . . 0.0 111.53 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.3 145.3 88.07 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.211 2.607 . . . . 0.0 111.92 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.83 156.21 48.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.587 0.755 . . . . 0.0 112.441 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -158.38 149.11 20.41 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.506 2.322 . . . . 0.0 109.483 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.11 -153.79 23.65 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 120.612 1.551 . . . . 0.0 110.254 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.3 mt -146.13 138.48 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.51 1.124 . . . . 0.0 112.086 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -122.73 140.59 52.71 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.082 -1.011 . . . . 0.0 108.681 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -56.47 -52.2 65.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.844 0.458 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' OG ' ' B' ' 5' ' ' SER . 16.0 tptm 52.87 0.28 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.488 2.315 . . . . 0.0 116.284 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -77.29 -56.3 4.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.137 2.175 . . . . 0.0 113.745 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' B' ' 62' ' ' PRO . . . -78.73 173.46 12.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 124.288 0.992 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -74.21 -26.26 60.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 117.206 -1.378 . . . . 0.0 113.903 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -143.67 48.74 0.98 Allowed Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 125.465 1.506 . . . . 0.0 112.709 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 59' ' ' ALA . 49.8 Cg_endo -82.93 -178.62 3.96 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.11 2.54 . . . . 0.0 114.848 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 70.4 p -84.54 167.77 16.02 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.24 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.84 159.83 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.452 1.101 . . . . 0.0 111.285 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.37 148.11 14.35 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -159.66 163.11 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.483 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.9 m -101.1 147.48 26.18 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.67 1.988 . . . . 0.0 109.303 173.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.58 117.05 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.545 ' HB2' HG21 ' C' ' 52' ' ' ILE . 42.9 t30 -98.45 107.03 19.39 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.662 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.331 52.5 m95 -68.31 158.77 32.72 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.594 1.997 . . . . 0.0 114.982 -173.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -38.89 4.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -174.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' B' ' 44' ' ' ILE . 47.5 p90 -90.96 -12.01 37.27 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -152.31 143.24 23.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.038 2.535 . . . . 0.0 106.433 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -72.9 118.39 15.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.081 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -170.92 164.94 7.75 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.742 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.61 138.92 24.94 Favored 'General case' 0 CA--C 1.48 -1.73 0 CA-C-O 123.473 1.606 . . . . 0.0 110.493 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.74 127.36 27.02 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 110.042 -3.254 . . . . 0.0 109.54 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -105.18 155.75 6.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.145 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.21 140.43 51.91 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.401 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -150.01 114.23 5.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.406 0.622 . . . . 0.0 109.327 -174.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -152.34 178.26 29.64 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 120.072 -1.061 . . . . 0.0 115.587 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.479 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 10.8 tt0 -119.83 144.91 47.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.301 -1.449 . . . . 0.0 109.157 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.419 ' SG ' HD23 ' B' ' 93' ' ' LEU . 49.7 t -97.21 128.73 44.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.724 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 0.4 OUTLIER -121.81 168.82 11.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.913 1.34 . . . . 0.0 110.977 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.3 118.94 57.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.636 -2.075 . . . . 0.0 106.627 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.31 153.56 15.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.48 -26.15 0.53 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.14 -9.44 59.19 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 31.37 10.58 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.521 1.057 . . . . 0.0 114.531 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.26 152.71 24.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.999 1.319 . . . . 0.0 110.85 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -101.43 146.05 28.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.495 1.518 . . . . 0.0 110.99 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' C' ' 106' ' ' ILE . 17.8 m -147.62 159.72 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.956 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 67.1 mt -119.44 115.27 23.73 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -105.88 110.65 23.01 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.402 HG22 ' HA3' ' B' ' 81' ' ' GLY . 7.2 p -126.56 167.11 16.1 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.007 1.384 . . . . 0.0 110.81 -174.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 170.85 8.92 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -144.72 158.97 43.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.494 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.408 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.1 tp -137.51 123.21 19.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.416 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.53 137.76 44.99 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 125.66 1.85 . . . . 0.0 113.299 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -120.93 117.1 26.46 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 125.937 2.023 . . . . 0.0 111.94 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 160.43 21.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.541 1.151 . . . . 0.0 111.137 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 3.6 m -104.33 83.35 2.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.46 -12.69 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 t30 64.07 -29.85 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.47 136.16 52.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.152 0.977 . . . . 0.0 112.515 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' C' ' 92' ' ' VAL . 2.5 tt -62.42 -26.58 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.12 -3.61 24.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.453 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 5.0 m-20 -124.64 3.34 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.53 1.132 . . . . 0.0 113.874 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -52.88 -35.76 58.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.226 -0.922 . . . . 0.0 112.306 175.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 54.9 p-90 -49.6 -45.24 47.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.378 1.071 . . . . 0.0 113.686 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.61 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -89.39 -11.04 44.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.621 0.768 . . . . 0.0 112.686 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.47 -0.32 25.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.427 -0.797 . . . . 0.0 113.078 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -118.02 146.19 44.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.769 0.713 . . . . 0.0 111.738 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.24 151.75 39.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.785 1.634 . . . . 0.0 110.415 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.19 148.37 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.01 -176.86 27.7 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 122.536 1.076 . . . . 0.0 112.79 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -121.52 153.43 37.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.565 -0.817 . . . . 0.0 108.985 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.1 133.72 16.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.015 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 51.8 mt -126.18 122.64 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.755 0.788 . . . . 0.0 110.637 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 12.4 m-85 -111.7 148.71 32.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.164 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 19.0 p -135.7 162.94 31.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.261 1.024 . . . . 0.0 110.189 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -59.93 115.83 3.69 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.526 -0.734 . . . . 0.0 111.062 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' B' ' 11' ' ' THR . 3.8 tt -61.82 159.13 14.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 25.9 5.58 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 119.795 1.179 . . . . 0.0 114.058 175.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 39.5 p -125.43 168.68 13.25 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.41 1.484 . . . . 0.0 111.763 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -145.05 -161.38 1.29 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.947 1.299 . . . . 0.0 111.381 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.87 78.16 1.68 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.506 1.522 . . . . 0.0 107.551 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 . . . . . 0 C--O 1.248 1.018 0 C-N-CA 126.379 1.872 . . . . 0.0 111.472 175.103 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 6.5 m -71.78 94.84 1.43 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.451 1.1 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 12.9 p -157.65 134.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.965 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.57 164.51 24.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.015 0.436 . . . . 0.0 111.93 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.84 -35.21 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -156.57 143.58 18.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.309 1.444 . . . . 0.0 110.518 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 p -116.41 141.84 47.64 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 122.112 0.958 . . . . 0.0 108.977 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.419 ' OG ' ' HE3' ' C' ' 57' ' ' LYS . 65.0 m -139.39 126.54 21.21 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.368 -1.457 . . . . 0.0 113.026 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.55 -29.63 64.96 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -52.0 118.38 3.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.591 1.186 . . . . 0.0 110.243 174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.53 -122.53 2.94 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.315 1.912 . . . . 0.0 109.336 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -143.03 152.96 42.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.48 1.112 . . . . 0.0 113.113 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -143.59 155.85 44.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.091 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.409 ' HB ' HD12 ' C' ' 123' ' ' LEU . 9.9 t -133.43 145.14 49.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.395 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -109.42 147.43 32.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -65.06 -19.09 65.82 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.561 HD11 ' CD1' ' A' ' 110' ' ' TRP . 35.0 tp -75.36 -14.91 60.51 Favored 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.963 -1.086 . . . . 0.0 111.273 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.59 -14.07 32.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.222 2.344 . . . . 0.0 113.659 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 149.73 44.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.411 -1.052 . . . . 0.0 112.377 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -125.35 142.82 51.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.956 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -132.41 146.1 51.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 112.507 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -129.64 133.34 47.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.547 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.65 127.23 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.85 -93.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.135 0.897 . . . . 0.0 112.282 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.31 128.29 23.66 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.364 -1.08 . . . . 0.0 110.469 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.21 139.24 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.315 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -77.55 164.03 25.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.98 0.912 . . . . 0.0 112.584 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -54.35 -33.82 59.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.232 1.413 . . . . 0.0 114.217 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.26 -35.45 79.56 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.384 -1.447 . . . . 0.0 111.543 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.41 -6.26 9.24 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 124.369 0.985 . . . . 0.0 114.506 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.9 147.25 47.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -154.8 161.94 41.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.96 0.886 . . . . 0.0 110.728 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 167.72 14.1 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.31 30.28 Favored Glycine 0 C--O 1.238 0.344 0 O-C-N 120.391 -1.443 . . . . 0.0 112.096 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.573 ' HB ' HD11 ' C' ' 46' ' ' LEU . 33.9 p -140.33 129.0 22.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.155 0.978 . . . . 0.0 111.715 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -105.43 138.23 41.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.179 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.453 HD11 HD12 ' C' ' 46' ' ' LEU . 22.8 mt -129.22 126.64 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.438 HG22 ' H ' ' C' ' 37' ' ' VAL . 16.6 m -105.11 141.15 37.18 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.909 -173.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.39 -1.88 34.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.48 HG21 HD21 ' C' ' 14' ' ' LEU . 26.9 m -139.24 163.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.533 1.933 . . . . 0.0 111.31 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.24 167.46 16.07 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 119.894 -1.754 . . . . 0.0 112.871 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -70.16 -45.42 66.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.286 1.034 . . . . 0.0 108.463 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -126.33 78.85 71.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 129.002 2.921 . . . . 0.0 110.114 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.85 24.2 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.909 3.739 . . . . 0.0 116.591 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 0.65 59.7 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.224 -1.548 . . . . 0.0 115.885 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.38 30.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.09 131.4 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.965 -1.709 . . . . 0.0 112.462 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.3 165.44 27.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.775 2.03 . . . . 0.0 108.664 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' C' ' 32' ' ' THR . 5.3 tt -49.51 131.22 20.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.558 1.543 . . . . 0.0 111.65 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.1 p -109.02 123.04 38.06 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.33 144.61 90.77 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.01 2.473 . . . . 0.0 111.542 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.416 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.0 pp -131.15 164.32 25.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.788 0.835 . . . . 0.0 112.708 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -165.64 148.93 7.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.064 1.746 . . . . 0.0 109.656 -174.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.34 -156.17 27.55 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 120.898 1.681 . . . . 0.0 112.629 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.545 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -146.16 137.05 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 123.37 1.557 . . . . 0.0 112.006 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.02 141.65 51.13 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.086 -1.634 . . . . 0.0 108.38 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.15 -50.79 71.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.881 0.31 . . . . 0.0 111.345 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' LYS . . . . . 0.419 ' HE3' ' OG ' ' C' ' 5' ' ' SER . 16.4 tptm 51.85 2.79 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.351 2.26 . . . . 0.0 115.979 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -79.74 -56.73 4.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.598 1.959 . . . . 0.0 113.546 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' C' ' 62' ' ' PRO . . . -78.63 174.7 11.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.853 0.721 . . . . 0.0 111.339 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -75.73 -26.68 57.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.583 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.63 48.9 1.13 Allowed Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 125.216 1.407 . . . . 0.0 112.705 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' C' ' 59' ' ' ALA . 46.5 Cg_endo -83.12 -178.3 3.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.805 2.337 . . . . 0.0 115.007 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 82.4 p -84.63 168.1 15.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.619 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -166.08 160.29 16.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.457 1.103 . . . . 0.0 111.372 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.3 148.12 14.4 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 119.119 2.408 . . . . 0.0 119.119 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -159.76 162.17 34.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.502 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.8 m -100.25 150.1 22.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.007 2.123 . . . . 0.0 108.966 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 49.5 t -129.28 117.9 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.6 t30 -99.96 107.18 19.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.761 -174.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.337 51.3 m95 -67.79 158.11 33.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.247 1.84 . . . . 0.0 115.387 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.16 4.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.2 -12.08 36.38 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 8.3 t -152.32 143.86 23.45 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 128.155 2.582 . . . . 0.0 106.329 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.94 118.55 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.457 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p -171.83 165.13 6.51 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.573 1.549 . . . . 0.0 111.767 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.56 138.97 25.05 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 123.635 1.683 . . . . 0.0 110.606 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.52 26.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-N 109.785 -3.37 . . . . 0.0 109.712 -172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.05 155.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.145 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -128.31 140.06 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.408 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -150.08 115.02 5.34 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -153.13 177.87 30.52 Favored Glycine 0 CA--C 1.501 -0.792 0 C-N-CA 119.894 -1.146 . . . . 0.0 115.508 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 10.6 tt0 -119.22 145.27 46.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.545 -1.327 . . . . 0.0 108.917 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.443 ' SG ' HD23 ' C' ' 93' ' ' LEU . 49.9 t -97.27 129.23 44.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.404 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 0.3 OUTLIER -124.8 171.94 9.73 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.009 1.385 . . . . 0.0 111.649 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.81 115.76 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 112.363 -2.199 . . . . 0.0 106.604 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.82 152.42 19.22 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -45.27 -22.89 0.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.57 -10.5 55.82 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.46 43.06 6.3 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.731 1.158 . . . . 0.0 113.495 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -116.05 147.25 41.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.256 1.423 . . . . 0.0 108.382 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -101.26 141.19 34.51 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.969 1.707 . . . . 0.0 109.966 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.6 m -143.93 161.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.29 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' LEU . . . . . 0.443 HD23 ' SG ' ' C' ' 83' ' ' CYS . 62.7 mt -120.13 116.34 25.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -106.53 110.53 22.77 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 172.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' C' ' 81' ' ' GLY . 9.1 p -126.4 165.37 19.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.661 1.22 . . . . 0.0 110.935 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.16 170.66 8.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 172.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -144.37 159.44 42.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.487 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' B' ' 80' ' ' THR . 2.9 tp -137.79 123.14 19.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.436 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.63 138.41 43.91 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 125.295 1.622 . . . . 0.0 113.065 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -121.43 117.43 26.87 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 125.895 1.997 . . . . 0.0 111.823 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 15.7 m -83.53 159.76 21.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.729 1.268 . . . . 0.0 111.285 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -103.9 83.0 2.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.24 -12.56 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.48 -29.06 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.1 136.54 52.82 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.8 1.286 . . . . 0.0 112.436 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' B' ' 92' ' ' VAL . 2.3 tt -62.3 -25.21 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.574 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.61 -3.96 36.57 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.591 -1.116 . . . . 0.0 114.61 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 4.7 m-20 -124.29 2.72 8.49 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.455 1.102 . . . . 0.0 113.92 -177.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 109' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -52.86 -35.67 57.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.381 -0.824 . . . . 0.0 112.361 176.109 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.603 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 57.2 p-90 -49.67 -45.77 49.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.595 1.158 . . . . 0.0 113.311 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 111' ' ' LYS . . . . . 0.603 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.3 OUTLIER -88.88 -11.03 45.76 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.436 -0.79 . . . . 0.0 112.544 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -0.24 25.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -117.87 146.03 44.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.316 0.647 . . . . 0.0 111.65 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.61 152.06 40.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.745 1.618 . . . . 0.0 110.654 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.21 148.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 120.186 1.357 . . . . 0.0 111.802 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.96 -176.98 27.8 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-O 122.442 1.023 . . . . 0.0 112.809 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -121.55 153.49 37.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.719 0.808 . . . . 0.0 108.834 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.28 132.44 15.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.229 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 mt -124.8 118.04 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.903 0.858 . . . . 0.0 111.068 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 13.1 m-85 -105.59 150.71 25.15 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.564 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 3.9 p -136.53 159.83 40.61 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.514 1.126 . . . . 0.0 109.859 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -55.36 124.34 16.8 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.742 -0.599 . . . . 0.0 109.813 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.409 HD12 ' HB ' ' C' ' 11' ' ' THR . 0.3 OUTLIER -57.37 162.77 2.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.916 174.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . 0.315 18.1 ptt180 57.94 19.97 6.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 5.3 m -125.39 73.13 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.214 1.806 . . . . 0.0 107.461 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -55.29 142.09 33.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.6 0.714 . . . . 0.0 109.376 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.333 0.0 OUTLIER -126.71 74.93 1.52 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.299 1.84 . . . . 0.0 106.82 -174.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.313 1.5 pm0 . . . . . 0 C--O 1.258 1.517 0 CA-C-N 110.76 -2.927 . . . . 0.0 114.99 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 3.3 t -117.53 162.76 17.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.4 1.88 . . . . 0.0 108.217 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.35 -23.74 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.272 1.029 . . . . 0.0 112.769 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 52.86 -161.12 0.11 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.486 1.514 . . . . 0.0 113.732 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -161.61 54.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.028 2.531 . . . . 0.0 110.0 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.29 151.73 25.16 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.82 -1.175 . . . . 0.0 109.408 173.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.04 133.5 53.64 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -139.54 128.53 23.62 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.811 -1.805 . . . . 0.0 110.695 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.8 mt -68.06 -23.22 64.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -51.58 113.63 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 112.004 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.95 -121.41 2.47 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.788 1.185 . . . . 0.0 110.954 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -151.88 146.28 25.54 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -143.34 163.24 33.58 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.223 1.409 . . . . 0.0 112.065 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.451 ' HB ' HD12 ' A' ' 123' ' ' LEU . 6.3 t -142.76 154.89 44.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.682 -1.151 . . . . 0.0 109.149 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 146.35 49.65 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.095 0.861 . . . . 0.0 112.515 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.24 -25.1 13.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.653 2.381 . . . . 0.0 115.012 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.07 -18.78 62.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.371 1.069 . . . . 0.0 112.848 174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.84 -15.76 21.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.828 2.633 . . . . 0.0 113.261 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.4 p -65.99 145.54 55.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 123.297 1.522 . . . . 0.0 113.086 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.98 144.93 46.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.737 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -141.8 147.34 37.11 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 173.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -137.44 135.23 36.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.428 0.691 . . . . 0.0 109.759 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.324 0.65 . . . . 0.0 109.903 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -92.68 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.57 32.25 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.701 -0.882 . . . . 0.0 112.235 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.67 129.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.244 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -70.31 165.84 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.228 0.33 . . . . 0.0 111.62 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -59.78 -24.11 63.82 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.429 -1.42 . . . . 0.0 114.822 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.37 -27.09 46.8 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.895 0.77 . . . . 0.0 112.027 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.27 -6.16 30.31 Favored Glycine 0 N--CA 1.468 0.805 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.539 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' D' ' 50' ' ' LEU . 10.0 pt-20 -63.78 138.62 58.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 162.58 38.94 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.395 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 50' ' ' LEU . 2.8 p -129.34 176.9 7.58 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.35 -166.0 37.75 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.566 -1.334 . . . . 0.0 114.095 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 46' ' ' LEU . 12.7 p -136.76 130.92 32.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.605 1.193 . . . . 0.0 111.781 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -114.52 141.28 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.658 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.4 mt -131.54 133.14 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 44' ' ' ILE . 2.7 m -107.69 140.56 40.54 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.731 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.33 -11.15 19.65 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.6 m -138.21 141.66 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 111.183 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.26 33.05 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.977 -0.452 . . . . 0.0 110.135 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -77.35 -34.75 55.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.75 83.84 40.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.764 1.626 . . . . 0.0 110.138 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.78 36.05 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.998 3.799 . . . . 0.0 115.075 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.29 -7.21 63.05 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 179.58 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.624 1.97 . . . . 0.0 110.858 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 35' ' ' THR . 63.4 mt -56.52 125.56 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 119.988 -1.695 . . . . 0.0 111.05 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.27 165.24 28.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 111.585 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.469 HD11 ' HB ' ' A' ' 32' ' ' THR . 10.3 tp -46.98 115.94 1.22 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 130.781 3.632 . . . . 0.0 113.028 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.6 p -105.9 122.99 40.61 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.456 0.702 . . . . 0.0 111.234 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.62 136.58 74.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.836 2.357 . . . . 0.0 111.318 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.69 155.03 37.27 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.07 0.856 . . . . 0.0 111.694 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 30' ' ' THR . 1.5 tp -162.37 149.01 13.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.92 1.688 . . . . 0.0 109.349 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.97 -150.01 20.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.296 1.407 . . . . 0.0 109.658 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -144.0 141.48 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.49 0.716 . . . . 0.0 111.271 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 137.53 51.91 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.333 -0.854 . . . . 0.0 110.599 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -68.52 155.07 40.65 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.397 -0.814 . . . . 0.0 111.843 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -146.2 13.98 1.28 Allowed 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.273 -1.517 . . . . 0.0 114.489 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -87.89 -49.11 7.3 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.825 0.739 . . . . 0.0 112.465 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.07 175.06 9.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -78.93 -38.56 36.91 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.798 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -136.31 52.0 5.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.591 1.156 . . . . 0.0 112.567 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.87 173.83 13.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.738 1.625 . . . . 0.0 113.834 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.331 0.6 OUTLIER -95.41 167.38 11.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.571 173.664 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.56 166.54 31.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.722 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.49 146.61 12.43 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -159.13 152.67 22.79 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.41 151.75 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.286 1.835 . . . . 0.0 109.287 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.16 118.44 40.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.645 ' HB2' HG21 ' D' ' 52' ' ' ILE . 1.9 t-20 -88.13 116.55 26.4 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.748 -0.595 . . . . 0.0 110.126 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.81 142.35 44.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.385 1.088 . . . . 0.0 110.573 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.69 -39.78 5.27 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.246 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.83 -13.12 54.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.268 1.427 . . . . 0.0 114.439 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.3 t -152.35 132.36 13.42 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.423 2.689 . . . . 0.0 106.06 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.02 117.67 16.09 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.081 1.309 . . . . 0.0 110.416 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -173.65 164.03 4.36 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 126.549 1.94 . . . . 0.0 110.057 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.86 142.6 38.6 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.19 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -132.38 152.07 51.6 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.462 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.79 150.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.748 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.42 143.95 51.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 127.38 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.61 178.47 45.51 Favored Glycine 0 C--O 1.217 -0.915 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -101.21 147.9 25.73 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.856 0.974 . . . . 0.0 112.835 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 21.7 p -97.74 120.53 38.29 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.754 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 82' ' ' GLN 0.299 2.7 m-85 -112.91 162.25 16.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -132.41 109.66 15.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -59.38 162.13 5.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.335 0.654 . . . . 0.0 109.448 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -21.67 2.27 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -8.18 54.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.562 0.745 . . . . 0.0 113.003 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.17 51.96 4.78 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -121.33 146.82 46.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.816 2.446 . . . . 0.0 104.938 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -112.41 150.19 31.47 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.857 1.263 . . . . 0.0 112.182 -172.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.689 HG11 ' HD3' ' A' ' 94' ' ' LYS . 1.7 t -148.14 161.33 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.786 1.279 . . . . 0.0 110.681 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.4 mt -125.51 110.49 13.94 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 101.241 -3.614 . . . . 0.0 101.241 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HD3' HG11 ' A' ' 92' ' ' VAL . 7.5 mmmt -102.71 122.35 44.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -138.84 163.76 31.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.477 1.608 . . . . 0.0 114.264 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.5 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.89 165.24 12.5 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -140.89 159.48 42.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.071 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.804 HD21 HG23 ' A' ' 113' ' ' THR . 1.2 tt -143.21 124.1 14.3 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.833 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 77' ' ' THR . 3.0 tp -107.69 141.7 38.81 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 125.692 1.87 . . . . 0.0 110.689 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.402 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.3 tpt85 -124.41 114.03 18.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 110.298 -3.137 . . . . 0.0 109.455 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.251 18.5 m -70.88 164.51 25.19 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.74 1.9 . . . . 0.0 113.094 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.408 ' HA ' ' OE1' ' D' ' 82' ' ' GLN . 58.4 m -101.44 84.36 2.59 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 112' ' ' ALA . 2.3 t -79.38 164.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 127.463 2.305 . . . . 0.0 109.296 174.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -114.59 -23.19 9.4 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.51 138.29 51.19 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.719 0.771 . . . . 0.0 111.113 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -59.77 -17.23 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.68 7.75 74.23 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.361 -1.8 . . . . 0.0 115.759 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.87 4.99 15.01 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.853 1.827 . . . . 0.0 112.704 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -62.27 -30.67 71.29 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.054 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CD1' HD11 ' C' ' 14' ' ' LEU . 54.7 p-90 -48.97 -40.12 29.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 113.21 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -96.92 -6.25 36.12 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 114.022 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 103' ' ' VAL . . . -78.94 7.0 7.92 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.804 HG23 HD21 ' A' ' 98' ' ' LEU . 19.2 m -122.1 140.46 52.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.757 0.789 . . . . 0.0 113.043 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 119.56 6.48 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.558 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.93 150.19 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.44 1.896 . . . . 0.0 111.51 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.41 -171.48 22.71 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.707 0.67 . . . . 0.0 112.768 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -131.38 157.31 43.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.071 -0.664 . . . . 0.0 111.448 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -147.69 160.13 43.03 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.363 1.065 . . . . 0.0 109.15 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.1 mt -138.71 119.03 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.74 148.44 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.529 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -134.98 165.31 25.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.66 124.4 20.9 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.893 0.877 . . . . 0.0 111.526 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 11' ' ' THR . 6.0 tt -84.55 145.36 28.11 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.36 -44.34 0.5 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.89 2.476 . . . . 0.0 117.681 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . 0.277 0.2 OUTLIER 46.3 -156.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.639 1.976 . . . . 0.0 113.442 -176.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -148.49 13.97 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.721 2.808 . . . . 0.0 108.573 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -146.13 -2.73 0.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 114.748 -2.549 . . . . 0.0 116.183 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.256 1.409 0 C-N-CA 130.401 3.48 . . . . 0.0 106.581 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.8 m -68.91 59.14 0.1 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.892 2.077 . . . . 0.0 113.83 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 20.1 m -140.79 42.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.097 2.159 . . . . 0.0 109.968 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -65.01 165.58 10.77 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.419 1.104 . . . . 0.0 113.631 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . 0.308 4.9 ptm180 -134.16 54.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.982 1.313 . . . . 0.0 113.969 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 155.95 31.72 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.562 1.945 . . . . 0.0 109.162 173.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.05 136.26 41.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -139.31 133.49 31.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.662 -1.274 . . . . 0.0 110.696 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.13 -23.2 63.94 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -51.02 114.38 1.16 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.1 1.429 . . . . 0.0 111.592 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.76 -120.54 2.42 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.67 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -152.81 149.74 28.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -147.0 163.21 36.96 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.56 1.544 . . . . 0.0 112.057 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.499 ' HB ' HD12 ' D' ' 123' ' ' LEU . 12.9 t -141.47 154.48 45.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.062 0.945 . . . . 0.0 108.935 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -123.08 145.83 48.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.855 0.862 . . . . 0.0 112.296 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.43 -24.57 13.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.527 2.331 . . . . 0.0 114.816 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' B' ' 110' ' ' TRP . 33.4 tp -70.81 -19.18 62.7 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.976 -1.078 . . . . 0.0 112.858 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.62 -15.69 19.51 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 127.796 2.617 . . . . 0.0 113.392 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -66.42 144.9 56.23 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 123.289 1.518 . . . . 0.0 112.991 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.87 146.07 45.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.698 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -141.99 147.59 37.18 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 18.9 m -136.24 135.25 38.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.517 0.727 . . . . 0.0 110.529 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 92.7 mt -136.94 128.34 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.339 0.656 . . . . 0.0 109.497 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.08 -90.61 0.06 OUTLIER Glycine 0 CA--C 1.533 1.194 0 O-C-N 123.573 0.546 . . . . 0.0 112.557 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.48 141.8 29.82 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.644 -0.915 . . . . 0.0 111.914 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.15 130.01 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.518 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -68.19 164.96 19.3 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.503 0.502 . . . . 0.0 111.795 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -60.47 -23.77 64.74 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.178 -1.576 . . . . 0.0 114.739 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -76.12 -24.77 54.96 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.877 0.762 . . . . 0.0 112.025 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.82 -5.45 32.59 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 124.093 0.854 . . . . 0.0 114.255 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.49 153.27 44.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.966 0.883 . . . . 0.0 112.167 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PHE . . . . . 0.559 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -155.45 166.52 33.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.107 176.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.433 HG22 HD13 ' D' ' 50' ' ' LEU . 15.9 p -127.09 -177.67 4.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.39 -165.99 39.22 Favored Glycine 0 N--CA 1.469 0.89 0 O-C-N 119.534 -1.979 . . . . 0.0 114.217 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.476 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.1 p -136.79 130.13 31.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.144 0.973 . . . . 0.0 112.325 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -114.59 141.38 47.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.74 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.9 133.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.45 ' O ' HG21 ' D' ' 44' ' ' ILE . 2.8 m -108.28 140.66 41.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.749 1.22 . . . . 0.0 111.861 -173.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.46 -11.93 18.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 18.3 m -137.84 141.08 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 124.093 0.957 . . . . 0.0 111.26 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.9 34.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.057 -0.402 . . . . 0.0 110.185 -174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.91 -34.55 57.69 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -134.92 83.82 39.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.641 1.576 . . . . 0.0 110.244 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 36.09 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 125.009 3.806 . . . . 0.0 115.197 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.12 63.32 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.77 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.538 1.935 . . . . 0.0 110.849 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.45 HG21 ' O ' ' D' ' 35' ' ' THR . 63.7 mt -56.21 125.84 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 119.989 -1.695 . . . . 0.0 111.254 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.79 165.91 27.45 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.988 1.315 . . . . 0.0 111.856 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' D' ' 32' ' ' THR . 10.9 tp -47.86 115.62 1.22 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.589 3.556 . . . . 0.0 112.782 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -105.69 122.69 41.79 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.469 0.708 . . . . 0.0 110.615 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.92 135.87 71.63 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.492 2.128 . . . . 0.0 110.837 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.465 HD12 ' C ' ' D' ' 49' ' ' LEU . 1.2 pp -121.11 161.02 22.48 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.043 0.84 . . . . 0.0 111.246 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.559 HD12 ' O ' ' D' ' 29' ' ' PHE . 17.7 tp -169.05 149.33 4.25 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.668 1.587 . . . . 0.0 112.182 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.81 -146.96 13.51 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.0 mt -147.01 139.76 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.965 0.906 . . . . 0.0 110.296 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.79 53.37 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.157 -0.964 . . . . 0.0 110.871 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -70.57 153.52 42.81 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.766 -1.209 . . . . 0.0 111.304 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -143.91 17.23 1.78 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -93.31 -49.0 6.16 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.656 0.782 . . . . 0.0 112.642 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.7 177.25 5.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -81.58 -38.29 26.33 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.596 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.77 51.98 4.69 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.469 1.108 . . . . 0.0 111.875 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.71 175.21 11.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.707 1.605 . . . . 0.0 113.726 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.328 0.7 OUTLIER -96.47 165.91 11.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.018 1.389 . . . . 0.0 112.353 173.553 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.77 165.96 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.948 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 146.57 12.43 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -159.02 152.42 22.68 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.82 151.75 19.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.872 2.069 . . . . 0.0 109.034 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.87 119.45 45.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.672 ' HB2' HG21 ' A' ' 52' ' ' ILE . 1.7 t-20 -88.07 118.31 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.322 -0.861 . . . . 0.0 110.601 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -76.52 141.89 41.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.539 1.162 . . . . 0.0 110.498 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.55 -39.65 5.34 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.239 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.67 -13.3 54.48 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 114.268 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 43.2 t -152.34 133.32 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 128.554 2.741 . . . . 0.0 106.211 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -75.3 117.73 17.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.148 1.34 . . . . 0.0 110.347 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -173.72 164.02 4.31 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 109.72 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -138.88 142.59 38.57 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.073 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.753 HG23 HD12 ' D' ' 99' ' ' LEU . 0.0 OUTLIER -131.96 152.23 51.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.533 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.12 149.53 29.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.768 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.75 126.86 12.05 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -173.29 178.36 45.28 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.34 147.25 26.53 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 124.63 0.841 . . . . 0.0 112.337 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.83 115.7 28.59 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.445 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' D' ' 82' ' ' GLN 0.275 3.3 m-85 -110.15 162.95 14.09 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -132.74 112.21 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.71 161.95 11.56 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.671 0.788 . . . . 0.0 109.011 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -20.52 0.85 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.09 -2.22 55.71 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.81 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.33 51.57 6.03 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -173.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.23 138.9 54.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.91 2.084 . . . . 0.0 107.185 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -106.69 149.42 27.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.781 1.632 . . . . 0.0 112.261 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.675 HG11 ' HD3' ' D' ' 94' ' ' LYS . 1.8 t -150.53 161.64 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 122.729 1.252 . . . . 0.0 110.247 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 mt -125.9 111.27 14.61 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.675 ' HD3' HG11 ' D' ' 92' ' ' VAL . 6.8 mmmt -103.97 120.62 41.42 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -137.35 162.96 32.16 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.792 1.758 . . . . 0.0 114.101 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -112.45 164.8 12.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -140.54 159.72 41.58 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.887 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.807 HD21 HG23 ' D' ' 113' ' ' THR . 1.2 tt -143.45 124.01 14.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.85 175.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' LEU . . . . . 0.753 HD12 HG23 ' D' ' 77' ' ' THR . 3.1 tp -107.51 141.96 38.13 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 125.616 1.822 . . . . 0.0 110.693 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -124.2 114.13 19.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.216 -3.175 . . . . 0.0 109.417 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.263 19.2 m -71.45 163.93 26.78 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.682 1.864 . . . . 0.0 112.762 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 102' ' ' SER . . . . . 0.407 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 55.2 m -100.25 85.7 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 103' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' D' ' 112' ' ' ALA . 2.3 t -80.89 164.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 127.048 2.139 . . . . 0.0 109.065 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.87 -23.84 8.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.44 137.96 51.18 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.601 0.715 . . . . 0.0 111.142 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.527 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.1 tt -59.06 -17.74 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 7.31 73.23 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.356 1.932 . . . . 0.0 116.016 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.49 4.66 15.31 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 119.967 1.884 . . . . 0.0 112.969 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -61.35 -31.17 71.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.972 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.487 ' CD1' HD11 ' B' ' 14' ' ' LEU . 55.1 p-90 -49.0 -39.58 27.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.117 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -97.72 -5.96 33.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.733 1.213 . . . . 0.0 114.057 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 112' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' D' ' 103' ' ' VAL . . . -78.89 6.74 8.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.807 HG23 HD21 ' D' ' 98' ' ' LEU . 18.3 m -121.65 140.18 52.6 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 122.076 0.941 . . . . 0.0 113.251 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.36 121.05 7.51 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.008 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 9.7 p -100.87 150.29 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.732 2.013 . . . . 0.0 111.418 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.42 -171.49 22.73 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.663 0.649 . . . . 0.0 112.502 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -131.67 157.19 44.38 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.02 -0.694 . . . . 0.0 111.517 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -147.9 159.55 43.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.524 1.13 . . . . 0.0 109.095 174.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 119' ' ' ILE . . . . . 0.436 HD13 ' HE3' ' D' ' 94' ' ' LYS . 7.3 mt -137.83 118.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.61 146.5 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 14.7 p -132.89 163.57 28.84 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.158 0.98 . . . . 0.0 108.64 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.87 124.18 17.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.942 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 123' ' ' LEU . . . . . 0.499 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.6 OUTLIER -73.34 142.11 47.07 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.301 174.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 115.45 149.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 1 C-N-CA 131.941 4.097 . . . . 0.0 107.804 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 17.5 p -70.98 -23.53 62.22 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 56.01 -83.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.71 2.004 . . . . 0.0 110.672 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . 0.302 6.6 mtpp 102.2 -9.79 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.278 1 C-N-CA 132.574 4.35 . . . . 0.0 115.093 174.306 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.774 2.83 . . . . 0.0 108.388 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.7 m -140.28 148.05 40.85 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.1 0.96 . . . . 0.0 108.411 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.31 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.22 1.008 . . . . 0.0 109.964 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -96.54 50.43 1.13 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.813 0.845 . . . . 0.0 110.855 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 46.35 62.34 2.34 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.597 1.959 . . . . 0.0 114.727 -174.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.65 155.86 32.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.238 1.815 . . . . 0.0 108.842 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.38 138.78 51.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -139.49 133.32 30.74 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.524 -1.36 . . . . 0.0 111.16 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.45 -23.63 65.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -49.75 112.09 0.6 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.226 1.41 . . . . 0.0 112.308 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.57 -116.0 1.53 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.995 1.284 . . . . 0.0 111.907 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -153.39 147.87 26.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -145.24 163.36 34.67 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.674 1.589 . . . . 0.0 111.987 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -145.47 152.95 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.709 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.53 145.67 48.68 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.73 0.812 . . . . 0.0 112.537 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.63 -26.16 12.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.817 2.447 . . . . 0.0 114.834 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.6 tp -70.21 -19.85 63.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.316 1.046 . . . . 0.0 112.968 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.64 22.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 127.535 2.493 . . . . 0.0 113.574 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -67.83 145.57 54.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.338 1.569 . . . . 0.0 112.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 145.54 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.87 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -142.27 147.75 36.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -137.08 135.81 37.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.67 0.788 . . . . 0.0 109.994 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.1 mt -135.54 127.58 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.391 0.677 . . . . 0.0 110.337 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -75.92 0.57 Allowed Glycine 0 CA--C 1.532 1.1 0 O-C-N 123.922 0.764 . . . . 0.0 113.544 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.06 24.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.808 0.804 . . . . 0.0 112.084 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.89 130.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.91 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.4 166.79 20.95 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.24 0.337 . . . . 0.0 111.804 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 88.1 p -60.52 -24.69 65.55 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.451 -1.406 . . . . 0.0 114.771 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -78.24 -27.12 47.57 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.964 0.802 . . . . 0.0 111.849 173.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.66 30.37 Favored Glycine 0 N--CA 1.468 0.797 0 CA-C-O 117.82 -1.545 . . . . 0.0 113.571 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' C' ' 50' ' ' LEU . 10.0 pt-20 -64.17 138.9 58.67 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 173.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.84 162.21 39.71 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.43 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.416 HG22 HD13 ' B' ' 50' ' ' LEU . 2.5 p -129.0 177.27 7.24 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.48 -166.19 37.97 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 120.695 -1.253 . . . . 0.0 114.273 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.46 ' HB ' HD11 ' B' ' 46' ' ' LEU . 16.3 p -136.63 131.03 33.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.635 1.207 . . . . 0.0 111.696 175.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -114.36 141.36 47.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.095 -1.412 . . . . 0.0 108.39 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.92 134.51 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.462 ' O ' HG21 ' B' ' 44' ' ' ILE . 2.6 m -110.03 140.18 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.592 1.157 . . . . 0.0 111.611 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.13 -11.7 19.37 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 19.0 m -137.52 141.17 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.097 0.959 . . . . 0.0 111.325 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.24 32.97 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.999 -0.438 . . . . 0.0 110.21 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -77.14 -34.46 56.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -135.02 83.7 39.18 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.795 1.638 . . . . 0.0 110.244 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.62 36.19 0.26 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.849 3.699 . . . . 0.0 115.129 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.47 -6.98 63.29 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.72 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.591 1.956 . . . . 0.0 110.973 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.462 HG21 ' O ' ' B' ' 35' ' ' THR . 62.9 mt -56.58 125.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.137 -1.602 . . . . 0.0 110.922 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.25 165.74 27.5 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.007 1.323 . . . . 0.0 111.688 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' B' ' 32' ' ' THR . 10.1 tp -46.78 115.99 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.803 3.641 . . . . 0.0 112.995 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -106.19 123.17 39.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.519 0.728 . . . . 0.0 111.199 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 136.73 76.25 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.871 2.381 . . . . 0.0 111.329 174.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.87 155.59 36.34 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 124.023 0.827 . . . . 0.0 111.656 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.416 HD13 HG22 ' B' ' 30' ' ' THR . 1.5 tp -162.98 148.84 12.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.834 1.654 . . . . 0.0 109.364 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.19 -149.64 19.69 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.231 1.378 . . . . 0.0 109.672 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -144.64 140.72 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.511 0.725 . . . . 0.0 111.372 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 137.81 52.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.354 -0.841 . . . . 0.0 111.044 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -69.35 154.75 41.53 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.236 0.925 . . . . 0.0 111.152 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -145.22 16.45 1.52 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -92.24 -47.56 7.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.463 0.705 . . . . 0.0 112.685 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.11 175.28 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -76.74 -41.37 45.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.243 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -138.7 54.69 6.95 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.762 1.225 . . . . 0.0 111.843 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.63 174.54 12.68 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.711 1.608 . . . . 0.0 113.699 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.322 0.5 OUTLIER -96.21 166.57 11.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 123.057 1.408 . . . . 0.0 112.039 173.423 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.02 166.85 32.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.898 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.04 146.33 11.91 Favored Glycine 0 CA--C 1.544 1.901 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -158.92 153.46 24.35 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.23 -1.747 . . . . 0.0 115.66 -174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 151.94 19.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.273 1.829 . . . . 0.0 109.386 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.34 118.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' C' ' 52' ' ' ILE . 1.9 t-20 -88.34 116.62 26.68 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.866 -0.521 . . . . 0.0 110.039 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.67 143.09 44.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.517 1.151 . . . . 0.0 110.565 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -109.46 -39.72 5.1 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.226 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.79 -13.35 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.273 1.429 . . . . 0.0 114.408 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.5 t -152.31 132.52 13.58 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 128.408 2.683 . . . . 0.0 106.059 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -74.8 118.33 17.64 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.189 1.359 . . . . 0.0 110.394 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -174.44 163.81 3.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.661 1.985 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.33 142.33 39.72 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.089 173.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.766 HG23 HD12 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -131.71 152.32 50.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.648 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.53 150.2 29.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.788 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.67 143.01 51.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 127.34 12.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.83 178.54 44.8 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.572 ' HB3' ' CE1' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.12 147.78 25.83 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.663 0.86 . . . . 0.0 112.704 178.133 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 6.8 p -97.9 115.85 28.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.267 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' B' ' 82' ' ' GLN 0.288 2.9 m-85 -110.24 161.56 15.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.39 112.09 18.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.45 162.76 12.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.642 0.777 . . . . 0.0 109.495 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -23.08 1.03 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.77 -4.66 56.5 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.774 0.83 . . . . 0.0 113.121 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 53.81 5.33 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 122.059 0.81 . . . . 0.0 111.346 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -122.96 140.66 52.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.245 2.618 . . . . 0.0 104.604 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -111.59 148.04 34.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.195 1.798 . . . . 0.0 112.08 -172.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.665 HG11 ' HD3' ' B' ' 94' ' ' LYS . 1.9 t -149.12 160.99 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 122.408 1.099 . . . . 0.0 110.546 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 mt -124.91 112.41 16.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 101.697 -3.445 . . . . 0.0 101.697 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.665 ' HD3' HG11 ' B' ' 92' ' ' VAL . 6.3 mmmt -104.96 120.08 40.57 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -137.28 162.8 32.54 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.663 1.697 . . . . 0.0 114.105 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.503 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -112.11 164.88 12.66 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.254 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -140.47 159.25 42.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.382 -1.735 . . . . 0.0 111.968 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.806 HD21 HG23 ' B' ' 113' ' ' THR . 1.2 tt -142.82 123.99 14.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.997 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.766 HD12 HG23 ' B' ' 77' ' ' THR . 3.1 tp -107.65 141.6 38.9 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 125.779 1.925 . . . . 0.0 110.826 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.9 tpt85 -123.89 114.09 19.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 110.069 -3.241 . . . . 0.0 109.338 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.264 21.6 m -71.48 164.69 25.35 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.639 1.837 . . . . 0.0 112.722 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.41 ' HA ' ' OE1' ' C' ' 82' ' ' GLN . 59.8 m -101.25 84.55 2.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' B' ' 112' ' ' ALA . 2.3 t -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 127.547 2.339 . . . . 0.0 109.295 175.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.87 -22.57 9.56 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.057 0.844 . . . . 0.0 113.246 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.48 137.56 51.93 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.757 0.789 . . . . 0.0 111.096 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.0 tt -59.76 -17.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.01 6.86 76.58 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.068 -1.962 . . . . 0.0 115.774 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.68 4.38 15.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.802 1.801 . . . . 0.0 112.798 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -30.55 70.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.485 ' CD1' HD11 ' D' ' 14' ' ' LEU . 54.8 p-90 -48.59 -41.15 29.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.269 1.028 . . . . 0.0 113.248 174.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -96.26 -6.22 38.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.577 1.151 . . . . 0.0 113.807 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' B' ' 103' ' ' VAL . . . -79.02 6.79 8.54 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.806 HG23 HD21 ' B' ' 98' ' ' LEU . 16.2 m -121.43 140.23 52.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.06 119.53 6.44 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.549 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -100.51 149.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.472 1.909 . . . . 0.0 111.255 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -171.77 22.8 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.594 0.616 . . . . 0.0 112.801 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -131.5 157.04 44.6 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.084 -0.656 . . . . 0.0 111.544 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -147.71 159.89 43.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.705 1.202 . . . . 0.0 109.277 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.434 HD13 ' HE3' ' B' ' 94' ' ' LYS . 7.3 mt -138.75 119.33 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.44 147.37 34.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 15.0 p -134.85 164.95 26.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.818 0.847 . . . . 0.0 109.131 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -60.22 119.07 7.19 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.54 1.136 . . . . 0.0 111.627 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt -76.81 129.09 35.78 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . 0.492 3.6 tmm_? 65.87 71.18 0.42 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 124.204 1.954 . . . . 0.0 114.02 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 12.5 t -72.75 -169.33 0.55 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.841 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -129.13 152.94 48.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.671 2.388 . . . . 0.0 104.889 173.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.85 164.63 0.18 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.3 1.44 . . . . 0.0 114.09 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.264 1.856 0 C-N-CA 125.684 1.594 . . . . 0.0 111.798 174.491 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 11.2 t -170.66 159.46 6.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.698 1.999 . . . . 0.0 107.981 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 37.9 t -135.8 126.72 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.142 0.883 . . . . 0.0 109.27 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.43 147.17 46.4 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.887 -0.508 . . . . 0.0 111.656 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -62.79 90.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.362 1.465 . . . . 0.0 113.813 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 155.82 31.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.887 2.075 . . . . 0.0 107.835 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.68 138.28 45.78 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 15.4 m -139.35 131.1 27.45 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.568 -1.333 . . . . 0.0 110.95 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.74 -24.05 64.41 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -49.21 114.61 1.05 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.025 1.33 . . . . 0.0 111.747 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.23 -120.46 2.47 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.919 1.247 . . . . 0.0 110.675 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -151.29 147.57 27.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -145.33 163.16 35.38 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.295 1.438 . . . . 0.0 112.234 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -143.65 153.78 42.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.516 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.29 146.26 48.03 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.724 0.809 . . . . 0.0 112.599 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.1 -26.24 15.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.44 2.296 . . . . 0.0 114.74 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 110' ' ' TRP . 32.9 tp -70.19 -20.25 63.13 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.098 -1.001 . . . . 0.0 113.032 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 -13.21 21.94 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.471 2.462 . . . . 0.0 113.607 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 86.8 p -67.57 145.85 54.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.436 1.618 . . . . 0.0 112.852 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.63 144.9 46.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.628 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -141.75 147.44 37.38 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 35.3 m -137.86 136.38 37.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.512 0.725 . . . . 0.0 109.676 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.69 127.91 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.66 0.784 . . . . 0.0 110.721 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.01 -77.93 0.42 Allowed Glycine 0 CA--C 1.532 1.132 0 O-C-N 123.643 0.59 . . . . 0.0 113.909 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.39 145.13 22.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.051 0.925 . . . . 0.0 112.102 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.54 130.06 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.816 0.846 . . . . 0.0 109.776 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.06 164.89 19.17 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.579 0.55 . . . . 0.0 111.783 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 82.1 p -60.58 -25.15 65.99 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.223 -1.548 . . . . 0.0 114.598 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -74.76 -24.95 58.77 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.833 0.742 . . . . 0.0 111.928 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.58 -5.14 32.95 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.09 0.853 . . . . 0.0 114.286 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.0 152.92 44.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.172 0.986 . . . . 0.0 112.133 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PHE . . . . . 0.558 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -155.05 166.49 33.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.117 176.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.454 HG22 HD13 ' C' ' 50' ' ' LEU . 15.2 p -127.04 -177.49 4.06 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.01 -165.6 38.92 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 119.486 -2.009 . . . . 0.0 113.947 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.471 ' HB ' HD11 ' C' ' 46' ' ' LEU . 11.3 p -136.67 130.48 32.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.453 1.12 . . . . 0.0 112.369 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.71 141.4 47.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.68 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 mt -130.69 134.19 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.449 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -109.97 140.42 43.98 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.447 1.099 . . . . 0.0 111.562 -173.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.35 18.84 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 18.9 m -136.92 140.92 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 123.772 0.829 . . . . 0.0 111.294 -175.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.86 165.4 35.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.01 -0.431 . . . . 0.0 110.131 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -76.58 -34.75 58.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -134.7 83.78 40.86 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.691 1.596 . . . . 0.0 110.154 173.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.89 36.21 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.917 3.745 . . . . 0.0 115.149 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.13 63.32 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 179.71 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.576 1.95 . . . . 0.0 110.883 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.449 HG21 ' O ' ' C' ' 35' ' ' THR . 63.9 mt -56.59 125.68 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.074 -1.641 . . . . 0.0 111.145 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.59 165.05 29.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.958 1.303 . . . . 0.0 111.806 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' C' ' 32' ' ' THR . 10.4 tp -47.28 115.55 1.14 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 130.766 3.626 . . . . 0.0 112.823 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 11.2 p -105.77 122.42 42.61 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.439 0.696 . . . . 0.0 110.74 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.6 135.29 68.63 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.559 2.173 . . . . 0.0 110.755 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.461 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.2 pp -120.8 161.07 22.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.72 0.808 . . . . 0.0 111.181 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.558 HD12 ' O ' ' C' ' 29' ' ' PHE . 17.9 tp -168.98 149.35 4.31 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.544 1.538 . . . . 0.0 112.257 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -147.16 13.92 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 120.185 1.357 . . . . 0.0 109.711 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -146.87 139.85 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.892 0.877 . . . . 0.0 110.24 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.82 53.37 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.86 154.09 42.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.685 -1.259 . . . . 0.0 111.148 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -144.63 14.67 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -89.78 -47.85 7.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.575 0.75 . . . . 0.0 112.389 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.61 172.23 13.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 31.2 t -74.85 -39.86 61.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.18 0.992 . . . . 0.0 112.617 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -138.45 53.47 5.73 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 112.866 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.1 176.04 10.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.461 1.44 . . . . 0.0 113.814 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.324 0.7 OUTLIER -97.29 166.0 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.071 1.415 . . . . 0.0 112.492 173.718 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -156.49 166.4 33.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.146 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.8 146.73 12.48 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -159.16 153.41 23.81 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -93.85 151.82 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.139 2.176 . . . . 0.0 109.002 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -130.9 119.71 45.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.684 ' HB2' HG21 ' B' ' 52' ' ' ILE . 1.6 t-20 -88.09 118.29 27.56 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.2 -0.938 . . . . 0.0 110.542 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.66 141.55 40.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.121 0.962 . . . . 0.0 110.214 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.94 -40.05 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.225 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.3 -13.12 55.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.326 1.451 . . . . 0.0 114.348 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 43.3 t -152.39 132.98 13.88 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 128.436 2.694 . . . . 0.0 106.175 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.61 117.96 17.02 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.093 1.315 . . . . 0.0 110.244 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 13.9 m -174.18 163.82 3.93 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.545 1.938 . . . . 0.0 109.871 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -139.0 142.48 38.3 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.291 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' THR . . . . . 0.764 HG23 HD12 ' C' ' 99' ' ' LEU . 0.0 OUTLIER -132.01 152.2 51.29 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.679 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.13 149.89 29.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.182 -1.827 . . . . 0.0 107.889 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.06 143.6 51.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 127.07 11.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -174.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.96 178.4 44.98 Favored Glycine 0 CA--C 1.499 -0.943 0 N-CA-C 117.421 1.728 . . . . 0.0 117.421 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLN . . . . . 0.586 ' HB3' ' CE1' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.27 147.17 26.6 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.668 0.864 . . . . 0.0 112.125 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 4.4 p -97.8 115.62 28.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.205 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' C' ' 82' ' ' GLN 0.268 3.5 m-85 -110.67 162.57 14.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.15 112.74 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -62.74 163.48 9.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 0.0 109.416 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.19 -28.16 2.83 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.42 -7.39 58.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.188 0.995 . . . . 0.0 113.104 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.69 53.82 3.89 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -121.72 140.32 52.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.708 2.403 . . . . 0.0 106.012 174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -111.42 147.49 35.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.72 1.608 . . . . 0.0 112.251 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.679 HG11 ' HD3' ' C' ' 94' ' ' LYS . 1.8 t -150.11 161.11 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.583 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.48 112.94 17.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.679 ' HD3' HG11 ' C' ' 92' ' ' VAL . 6.6 mmmt -105.46 118.87 37.68 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 174.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.47 161.82 34.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 124.005 1.86 . . . . 0.0 114.043 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.496 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.21 165.66 11.74 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 172.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -140.91 159.49 42.1 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.037 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.828 HD21 HG23 ' C' ' 113' ' ' THR . 1.2 tt -143.27 124.03 14.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.868 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 99' ' ' LEU . . . . . 0.764 HD12 HG23 ' C' ' 77' ' ' THR . 3.1 tp -107.65 142.07 38.17 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 125.579 1.799 . . . . 0.0 110.68 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 -124.43 114.22 19.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 110.272 -3.149 . . . . 0.0 109.403 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.254 18.5 m -71.4 164.86 24.96 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 125.638 1.836 . . . . 0.0 112.897 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.4 m -102.4 82.58 2.19 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' C' ' 112' ' ' ALA . 2.3 t -77.2 165.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 127.905 2.482 . . . . 0.0 108.971 174.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -115.65 -23.5 8.7 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.6 139.49 50.05 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.986 0.898 . . . . 0.0 111.34 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.0 tt -60.36 -16.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.73 7.2 74.11 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 117.222 -1.877 . . . . 0.0 115.601 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -115.01 4.87 14.83 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.939 1.87 . . . . 0.0 112.725 174.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.8 -31.12 70.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.204 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.492 ' CD1' HD11 ' A' ' 14' ' ' LEU . 54.5 p-90 -49.3 -40.35 34.55 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 113.188 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -96.63 -5.61 38.59 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 113.927 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' C' ' 103' ' ' VAL . . . -79.51 7.2 8.6 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.828 HG23 HD21 ' C' ' 98' ' ' LEU . 18.0 m -122.03 140.67 52.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.767 0.794 . . . . 0.0 113.017 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.07 120.53 6.89 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.308 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -100.95 149.79 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.576 1.95 . . . . 0.0 111.303 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.5 -171.28 22.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.617 0.627 . . . . 0.0 112.653 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -132.06 156.95 45.39 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.106 -0.644 . . . . 0.0 111.569 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -147.79 159.82 43.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.619 1.168 . . . . 0.0 109.256 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' ILE . . . . . 0.425 HD13 ' HE3' ' C' ' 94' ' ' LYS . 7.2 mt -138.56 119.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.21 147.29 34.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.2 p -135.34 164.62 27.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.716 0.806 . . . . 0.0 109.169 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -59.85 119.92 8.6 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.494 1.518 . . . . 0.0 113.175 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 78.07 9.8 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.57 137.32 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 127.895 2.478 . . . . 0.0 111.751 -173.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 45.0 m -156.52 90.21 1.16 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.24 1.416 . . . . 0.0 107.462 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 57.58 -174.82 0.07 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.289 6.7 tmtt? 60.21 81.21 0.18 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 C--O 1.261 1.676 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.075 172.664 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 3.7 t -178.37 146.8 0.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.567 1.947 . . . . 0.0 107.993 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.65 101.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.794 0.837 . . . . 0.0 110.326 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.77 26.63 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 48.87 99.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.982 2.513 . . . . 0.0 113.871 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.31 127.78 13.16 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.652 -1.28 . . . . 0.0 113.229 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.4 131.7 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.477 1.511 . . . . 0.0 108.284 173.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.08 130.79 22.77 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.62 -26.6 60.86 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -45.39 109.73 0.19 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.866 1.666 . . . . 0.0 111.642 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.28 -125.98 2.93 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.231 0.92 . . . . 0.0 111.003 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -154.6 143.66 21.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -141.04 160.52 39.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.361 1.464 . . . . 0.0 110.983 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 2.9 t -136.59 151.65 49.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.58 1.152 . . . . 0.0 108.481 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.92 143.98 45.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 110.919 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -55.51 -23.06 24.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.451 1.901 . . . . 0.0 114.498 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.03 -18.56 62.57 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.577 -1.327 . . . . 0.0 111.305 174.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.81 -14.19 19.8 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 128.337 2.875 . . . . 0.0 113.487 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.2 p -71.05 144.7 50.29 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.988 -1.301 . . . . 0.0 112.332 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -120.48 141.77 49.88 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.209 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -130.88 143.52 50.79 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.146 0.974 . . . . 0.0 112.992 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.8 m -131.47 132.02 43.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.562 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.04 126.84 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.62 -89.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.775 0 O-C-N 125.125 1.516 . . . . 0.0 111.118 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.08 152.62 43.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.969 0.89 . . . . 0.0 111.815 176.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 53' ' ' GLN . 14.0 p -103.78 124.89 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.771 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.83 160.81 28.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.877 0.37 . . . . 0.0 111.961 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -53.97 -22.88 11.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.28 -36.53 77.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.317 0.647 . . . . 0.0 111.225 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -8.04 17.43 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 124.851 1.215 . . . . 0.0 112.534 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 155.33 40.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 108.789 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -159.82 163.84 34.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.515 177.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -129.16 162.7 27.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.52 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.81 -166.51 27.98 Favored Glycine 0 C--O 1.237 0.29 0 O-C-N 121.219 -0.926 . . . . 0.0 112.369 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.674 ' HB ' HD11 ' A' ' 46' ' ' LEU . 39.6 p -137.39 138.54 39.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 122.578 1.18 . . . . 0.0 111.732 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -114.51 140.66 48.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.234 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 46' ' ' LEU . 41.3 mt -133.57 126.48 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 44' ' ' ILE . 85.3 m -104.99 148.73 26.41 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.86 -18.22 15.83 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.6 m -132.97 138.44 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 111.511 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.1 18.99 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.179 -0.95 . . . . 0.0 112.44 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.25 -26.43 62.9 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.825 -0.547 . . . . 0.0 110.495 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -143.77 81.03 12.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.677 2.391 . . . . 0.0 110.346 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.66 33.43 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 124.94 3.76 . . . . 0.0 116.066 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.66 6.38 83.52 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 119.75 -1.844 . . . . 0.0 115.629 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -176.55 11.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 35' ' ' THR 0.257 59.5 mt -33.5 108.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -173.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -102.38 174.8 5.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.418 -2.173 . . . . 0.0 111.089 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.0 tt -71.69 137.14 47.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.379 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 p -114.12 125.9 28.73 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.189 0.596 . . . . 0.0 111.198 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -57.81 144.27 93.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.283 1.989 . . . . 0.0 112.131 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.66 144.24 51.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.153 0.981 . . . . 0.0 110.818 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.01 30.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.455 2.302 . . . . 0.0 108.621 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.11 -149.04 15.11 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 120.333 -1.479 . . . . 0.0 111.155 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.655 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.5 mp -145.12 138.39 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.872 0.869 . . . . 0.0 112.137 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.596 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.49 131.99 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.738 0.815 . . . . 0.0 110.817 173.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 62' ' ' PRO . 9.5 m-70 -64.4 156.1 30.38 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.794 -1.191 . . . . 0.0 111.273 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -146.75 13.34 1.16 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.798 1.239 . . . . 0.0 113.279 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -78.69 -58.14 3.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.109 2.564 . . . . 0.0 111.304 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.74 13.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.5 m -78.55 -29.2 46.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.062 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.53 58.98 33.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.933 1.293 . . . . 0.0 112.384 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 54' ' ' HIS . 55.2 Cg_endo -80.96 175.72 9.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.344 2.03 . . . . 0.0 116.001 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -88.92 160.05 17.36 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.572 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -161.09 156.69 24.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.156 -0.965 . . . . 0.0 113.145 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 149.39 17.2 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 119.7 2.64 . . . . 0.0 119.7 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.06 159.69 36.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.408 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.9 m -96.8 150.36 20.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.265 1.826 . . . . 0.0 108.398 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.93 125.98 63.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HB2' HG21 ' D' ' 52' ' ' ILE . 21.7 t-20 -104.04 112.4 25.38 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.495 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE1' ' HG1' ' A' ' 77' ' ' THR 0.355 56.4 m95 -74.47 154.89 38.52 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -173.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.86 -50.25 2.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.139 1.776 . . . . 0.0 115.396 -172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -75.58 -15.51 60.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.544 0.737 . . . . 0.0 112.934 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 t -149.26 145.02 26.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.186 2.594 . . . . 0.0 107.295 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.56 116.83 21.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.852 1.31 . . . . 0.0 110.216 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.2 p -168.42 172.06 8.61 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 126.194 1.798 . . . . 0.0 111.045 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.95 142.01 25.98 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.337 1.541 . . . . 0.0 110.711 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.422 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 1.7 m -138.77 132.04 30.04 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.644 -3.435 . . . . 0.0 109.848 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 m -109.54 157.46 9.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.78 137.28 43.26 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 119.96 10.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.48 0.712 . . . . 0.0 110.369 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.38 -173.21 24.62 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -124.0 145.67 49.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 124.968 1.04 . . . . 0.0 111.056 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.6 p -97.8 113.1 24.81 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.443 1.089 . . . . 0.0 112.095 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -102.65 166.94 10.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.883 0.473 . . . . 0.0 111.715 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.3 mt -126.47 110.54 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -58.7 160.73 5.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.218 1.007 . . . . 0.0 108.735 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -49.66 -25.27 2.74 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.79 -13.85 49.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.021 0.929 . . . . 0.0 113.276 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.22 58.24 2.0 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -130.12 148.26 51.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.388 2.675 . . . . 0.0 107.359 172.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -109.58 138.57 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 110.601 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.6 m -141.3 164.17 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 109.518 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 mt -123.31 118.53 27.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -107.57 115.87 30.93 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -133.02 169.43 16.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.886 1.803 . . . . 0.0 112.245 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.469 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -121.37 171.17 8.95 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.0 p-90 -146.38 162.75 37.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.13 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.794 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.7 tt -145.59 125.62 13.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.385 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.9 144.65 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 125.115 1.509 . . . . 0.0 114.588 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -128.64 123.5 33.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.035 -2.348 . . . . 0.0 113.755 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.88 156.24 18.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.674 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -103.08 64.15 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.589 -0.695 . . . . 0.0 109.84 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.12 153.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.139 1.376 . . . . 0.0 113.003 174.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.79 -29.76 32.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.13 144.69 43.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.728 1.252 . . . . 0.0 112.641 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.505 ' CD1' HG21 ' D' ' 92' ' ' VAL . 14.0 tt -65.25 -24.24 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.788 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.0 1.18 41.6 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-O 118.106 -1.386 . . . . 0.0 113.54 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.798 ' HB3' HG11 ' A' ' 103' ' ' VAL . 14.8 m-20 -121.35 6.28 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.804 1.242 . . . . 0.0 114.025 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -33.52 67.9 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 119.755 -1.841 . . . . 0.0 111.705 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 44.1 p-90 -45.67 -50.34 13.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.826 1.251 . . . . 0.0 113.981 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.83 -11.62 47.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.92 0.888 . . . . 0.0 113.342 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.68 -5.92 54.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.361 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.794 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.4 m -103.6 143.7 32.4 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 125.11 1.506 . . . . 0.0 112.174 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -144.05 129.91 19.37 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 124.694 1.198 . . . . 0.0 111.013 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.85 154.8 8.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 120.248 1.385 . . . . 0.0 110.524 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.78 -177.24 32.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.326 0.488 . . . . 0.0 113.259 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 22.8 p90 -125.1 152.58 44.18 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.9 -0.765 . . . . 0.0 111.096 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -148.13 144.04 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.77 128.13 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -115.45 152.75 32.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.975 0.417 . . . . 0.0 110.518 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.8 p -134.69 160.54 37.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.439 1.096 . . . . 0.0 110.054 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -56.81 122.09 11.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.818 0.847 . . . . 0.0 111.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 11' ' ' THR . 4.1 tt -78.43 152.84 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 101.27 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 129.784 3.233 . . . . 0.0 110.231 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -48.93 112.12 0.57 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.648 1.579 . . . . 0.0 110.031 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.99 -37.56 66.96 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.04 -37.8 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.963 2.105 . . . . 0.0 113.501 174.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . 0.282 5.4 tt0 . . . . . 0 C--O 1.246 0.918 0 O-C-N 128.549 3.656 . . . . 0.0 108.77 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 12.4 p -88.52 162.55 16.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.627 0.771 . . . . 0.0 109.757 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 12.0 p -167.21 -39.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.484 1.114 . . . . 0.0 112.639 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -64.18 135.35 56.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.736 0.814 . . . . 0.0 112.124 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -90.68 123.44 34.29 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.795 1.238 . . . . 0.0 110.192 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -156.58 117.36 3.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.81 1.244 . . . . 0.0 112.002 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -116.31 135.31 53.99 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 2.2 t -139.6 136.84 34.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.774 1.23 . . . . 0.0 108.943 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 38.5 mt -73.63 -24.27 60.0 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -48.34 109.8 0.27 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.319 1.448 . . . . 0.0 112.07 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.48 -124.16 2.56 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 124.679 1.133 . . . . 0.0 110.813 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -151.72 144.28 24.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -142.28 157.49 44.77 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.111 1.365 . . . . 0.0 110.968 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -137.16 150.36 47.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 108.492 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -116.02 143.54 45.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.096 0.958 . . . . 0.0 111.042 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.62 -24.73 8.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.79 2.036 . . . . 0.0 114.975 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.4 tp -70.61 -18.53 62.88 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.282 -1.511 . . . . 0.0 111.643 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.29 -14.88 18.32 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 128.592 2.996 . . . . 0.0 113.543 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 82.5 p -71.34 144.11 50.02 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.011 -1.288 . . . . 0.0 112.455 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -118.73 142.98 47.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.631 0.773 . . . . 0.0 110.403 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -132.19 143.09 49.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.918 0.866 . . . . 0.0 112.538 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 20.5 m -131.44 132.03 44.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.163 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 70.3 mt -130.01 124.51 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -85.74 0.09 OUTLIER Glycine 0 CA--C 1.527 0.794 0 O-C-N 124.934 1.397 . . . . 0.0 111.224 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.32 155.82 44.55 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 122.045 0.926 . . . . 0.0 111.997 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' D' ' 53' ' ' GLN . 14.6 p -107.98 126.34 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.909 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -79.27 161.61 26.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.75 -23.2 16.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -69.63 -34.3 73.85 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.727 -0.608 . . . . 0.0 111.329 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.4 -6.27 18.93 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 124.918 1.247 . . . . 0.0 112.789 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.68 157.13 38.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 122.122 0.963 . . . . 0.0 111.783 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.06 166.53 32.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.482 1.134 . . . . 0.0 110.126 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -132.33 160.87 35.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.552 -1.658 . . . . 0.0 106.717 173.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.64 -166.65 28.97 Favored Glycine 0 C--O 1.24 0.488 0 CA-C-O 122.479 1.044 . . . . 0.0 112.333 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.662 ' HB ' HD11 ' D' ' 46' ' ' LEU . 40.0 p -137.84 140.33 40.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.502 -1.349 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -117.15 141.12 48.67 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.994 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.509 HD11 HD12 ' D' ' 46' ' ' LEU . 43.1 mt -133.31 126.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.465 ' O ' HG21 ' D' ' 44' ' ' ILE . 90.7 m -104.99 147.92 27.28 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.29 16.26 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.7 m -132.96 138.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.105 0.962 . . . . 0.0 111.37 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.67 170.37 18.3 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.286 -0.884 . . . . 0.0 112.229 -173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -71.59 -26.8 62.75 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.826 -0.546 . . . . 0.0 110.443 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.65 81.24 12.25 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.77 2.428 . . . . 0.0 110.241 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.43 32.56 0.12 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.79 3.66 . . . . 0.0 116.321 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.72 6.14 83.34 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 119.726 -1.859 . . . . 0.0 115.696 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.19 11.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.465 HG21 ' O ' ' D' ' 35' ' ' THR 0.257 59.6 mt -33.16 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -173.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -101.52 173.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.545 -2.116 . . . . 0.0 111.102 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.0 tt -69.79 138.06 52.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -114.83 125.61 28.84 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.281 0.633 . . . . 0.0 111.051 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -58.27 143.49 97.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.251 1.967 . . . . 0.0 112.062 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.76 151.02 48.79 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 110.741 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -157.34 149.16 22.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.774 2.03 . . . . 0.0 108.256 -175.539 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.73 -148.52 17.72 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 119.462 1.028 . . . . 0.0 112.676 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.669 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mp -144.26 138.71 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.167 0.987 . . . . 0.0 112.395 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -128.92 129.44 45.48 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.856 -1.153 . . . . 0.0 110.828 174.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' D' ' 62' ' ' PRO . 10.0 m-70 -62.65 155.32 26.55 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.762 -1.211 . . . . 0.0 111.835 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -146.43 12.52 1.19 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.862 1.265 . . . . 0.0 113.131 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -78.61 -58.17 3.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.35 2.66 . . . . 0.0 111.036 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.36 172.01 12.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.07 0.856 . . . . 0.0 112.603 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -83.39 -25.92 30.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.158 0.983 . . . . 0.0 112.428 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.53 55.33 15.74 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.168 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' D' ' 54' ' ' HIS . 57.7 Cg_endo -80.69 178.35 7.09 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.984 1.789 . . . . 0.0 115.703 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -89.96 157.07 18.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.5 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.934 -1.104 . . . . 0.0 112.883 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.59 149.19 16.29 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 119.925 2.73 . . . . 0.0 119.925 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.6 158.62 34.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' THR . . . . . 0.438 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.2 m -94.98 151.61 19.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.336 1.854 . . . . 0.0 108.543 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.75 127.85 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.655 ' HB2' HG21 ' A' ' 52' ' ' ILE . 21.9 t-20 -105.73 112.35 25.38 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.332 -0.842 . . . . 0.0 111.288 -174.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.351 56.4 m95 -73.79 155.07 39.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.548 1.642 . . . . 0.0 115.353 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mmpm? -112.97 -49.4 2.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.022 1.729 . . . . 0.0 115.366 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.27 -15.63 59.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 45.7 t -149.52 144.69 26.43 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.228 2.611 . . . . 0.0 106.952 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -81.77 116.82 21.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.753 1.263 . . . . 0.0 110.115 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 92.9 p -168.67 171.35 8.8 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.231 1.813 . . . . 0.0 111.167 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.15 142.25 27.12 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.947 1.356 . . . . 0.0 110.994 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -139.01 131.85 29.24 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-N 109.906 -3.316 . . . . 0.0 110.098 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 m -109.12 156.8 9.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.941 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -133.71 137.29 45.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.58 119.76 10.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.554 0.741 . . . . 0.0 110.357 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.66 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -121.23 144.83 48.39 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.179 1.164 . . . . 0.0 110.551 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -97.65 113.07 24.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.427 1.08 . . . . 0.0 111.148 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -103.91 166.79 10.19 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.58 0.627 . . . . 0.0 111.868 -177.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.71 112.08 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -58.71 164.52 2.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.997 0.919 . . . . 0.0 109.795 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -51.83 -27.0 11.09 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -10.25 58.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.889 0.876 . . . . 0.0 113.099 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.49 39.39 6.32 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.833 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -113.94 147.24 38.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.608 1.563 . . . . 0.0 109.711 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -101.53 139.37 37.28 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.217 1.407 . . . . 0.0 110.647 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 106' ' ' ILE . 22.3 m -141.66 161.04 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.213 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.7 117.34 27.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 174.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -106.58 115.64 30.55 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -132.43 170.1 15.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.936 1.826 . . . . 0.0 111.89 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -121.79 171.23 9.04 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -146.15 162.65 37.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.105 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.8 tt -145.68 125.71 13.67 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.16 -1.382 . . . . 0.0 113.211 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' LEU . . . . . 0.402 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -110.08 144.67 38.33 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 125.218 1.574 . . . . 0.0 114.337 -174.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -128.55 123.57 33.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.774 -174.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.95 158.66 16.61 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.98 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -105.37 62.58 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.717 -0.614 . . . . 0.0 110.102 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' D' ' 108' ' ' ASP . 0.1 OUTLIER -48.75 152.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.268 1.427 . . . . 0.0 113.452 174.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -80.84 -29.69 35.83 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.44 144.7 43.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.772 1.272 . . . . 0.0 113.161 -174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 92' ' ' VAL . 12.1 tt -64.82 -24.58 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.991 174.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.21 1.07 43.8 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.054 -1.415 . . . . 0.0 113.72 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' ASP . . . . . 0.787 ' HB3' HG11 ' D' ' 103' ' ' VAL . 13.6 m-20 -121.06 5.41 10.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.506 1.122 . . . . 0.0 113.931 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -33.93 65.79 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.877 -1.764 . . . . 0.0 111.492 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.7 p-90 -45.59 -50.36 13.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.86 -11.69 47.07 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.292 -0.88 . . . . 0.0 113.231 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.64 -5.57 53.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.213 -172.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.781 ' CG2' HD21 ' D' ' 98' ' ' LEU . 15.2 m -103.34 143.86 32.12 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.981 1.425 . . . . 0.0 112.38 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -144.51 130.2 19.13 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.815 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.92 154.85 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 120.355 1.434 . . . . 0.0 110.733 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -177.64 33.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.402 0.525 . . . . 0.0 113.453 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.1 p90 -124.88 152.29 44.21 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.842 -0.799 . . . . 0.0 111.088 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.15 143.62 27.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.547 0.739 . . . . 0.0 109.061 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -127.55 131.52 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -120.25 151.5 39.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.446 0.641 . . . . 0.0 111.884 174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 36.8 p -131.07 163.8 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.548 1.139 . . . . 0.0 110.129 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -61.5 115.88 4.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.161 1.385 . . . . 0.0 111.781 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.45 84.19 7.27 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 176.77 -28.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.799 2.04 . . . . 0.0 114.857 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -62.28 140.9 58.49 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 112.242 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.55 6.07 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.5 1.92 . . . . 0.0 114.804 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -140.61 8.71 2.18 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.56 1.544 . . . . 0.0 112.39 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.401 0 C-N-CA 127.682 2.393 . . . . 0.0 110.0 -174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . 0.282 1.8 pm0 . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.711 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 25.0 p -137.81 -167.6 2.17 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 121.524 1.966 . . . . 0.0 113.974 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.42 46.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 127.245 2.218 . . . . 0.0 112.361 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -116.38 -71.04 0.76 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.079 1.352 . . . . 0.0 110.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 25.37 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 128.584 2.754 . . . . 0.0 115.773 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.67 119.95 8.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.378 -0.826 . . . . 0.0 112.088 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 51.2 t -117.96 134.56 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -139.61 136.48 34.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.464 1.106 . . . . 0.0 108.704 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 34.5 mt -73.63 -25.89 60.51 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -46.81 109.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.52 1.528 . . . . 0.0 111.705 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.29 -124.94 2.64 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.524 1.059 . . . . 0.0 111.164 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -153.52 142.26 20.99 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -140.42 158.5 43.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.573 1.549 . . . . 0.0 110.959 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t -137.2 151.19 48.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 108.783 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -117.76 143.67 46.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.148 0.979 . . . . 0.0 110.8 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -55.75 -22.99 26.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.441 1.896 . . . . 0.0 114.442 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.7 tp -70.86 -18.06 62.71 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.601 -1.312 . . . . 0.0 111.098 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.21 18.82 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.585 2.993 . . . . 0.0 113.52 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -70.8 145.08 50.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.798 1.299 . . . . 0.0 112.372 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -119.51 140.42 50.53 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.788 0.835 . . . . 0.0 110.321 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -130.54 140.61 50.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.806 0.813 . . . . 0.0 112.728 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.4 m -129.56 131.82 46.66 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.97 125.93 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.31 -88.27 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 125.0 1.437 . . . . 0.0 111.122 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 155.28 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.09 0.947 . . . . 0.0 112.087 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' B' ' 53' ' ' GLN . 15.0 p -107.17 124.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.899 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -77.81 161.3 27.76 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.896 0.379 . . . . 0.0 111.963 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m -54.39 -22.7 13.12 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -69.62 -36.28 76.02 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.241 0.616 . . . . 0.0 111.197 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -8.22 17.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.909 1.243 . . . . 0.0 112.554 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.53 154.5 40.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.579 1.18 . . . . 0.0 109.025 174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -159.39 163.56 35.41 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.314 177.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.56 162.94 26.1 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.436 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.01 -166.22 27.7 Favored Glycine 0 C--O 1.237 0.341 0 O-C-N 121.406 -0.809 . . . . 0.0 112.589 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.688 ' HB ' HD11 ' B' ' 46' ' ' LEU . 37.5 p -136.93 137.12 39.22 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 113.795 -1.202 . . . . 0.0 111.791 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.7 140.62 48.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.238 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.513 HD11 HD12 ' B' ' 46' ' ' LEU . 39.7 mt -133.79 126.77 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 174.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.439 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.0 m -104.95 149.33 25.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -173.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.78 15.38 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.8 m -133.34 138.6 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.77 1.228 . . . . 0.0 111.443 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.2 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.216 -0.928 . . . . 0.0 112.1 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -71.38 -26.84 62.96 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.948 -0.47 . . . . 0.0 110.296 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -143.51 81.15 12.47 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.604 2.362 . . . . 0.0 110.293 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -65.94 30.16 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.763 3.642 . . . . 0.0 116.242 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 6.73 76.74 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 119.829 -1.795 . . . . 0.0 116.176 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -176.76 11.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.439 HG21 ' O ' ' B' ' 35' ' ' THR 0.256 61.5 mt -33.66 109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.189 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -102.87 173.97 6.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.838 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.688 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.2 tt -70.94 137.86 49.55 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 171.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.2 p -114.85 126.33 28.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.184 0.593 . . . . 0.0 111.188 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -57.85 143.88 94.83 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.416 2.077 . . . . 0.0 112.134 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 144.49 51.13 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.209 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.07 30.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.565 2.346 . . . . 0.0 108.714 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.26 -149.41 15.88 Favored Glycine 0 CA--C 1.523 0.541 0 O-C-N 120.424 -1.422 . . . . 0.0 111.111 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.657 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.5 mp -144.08 139.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.891 0.877 . . . . 0.0 112.17 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -127.62 130.72 49.48 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.151 -0.968 . . . . 0.0 110.619 173.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 54' ' ' HIS . . . . . 0.429 ' HB2' ' HB2' ' B' ' 62' ' ' PRO . 10.0 m-70 -63.22 156.06 26.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.683 -1.261 . . . . 0.0 111.577 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -146.16 12.06 1.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.666 1.187 . . . . 0.0 113.106 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -77.56 -57.87 3.58 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.257 2.623 . . . . 0.0 110.861 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.7 171.84 11.31 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.602 1.189 . . . . 0.0 112.911 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 71.3 m -79.19 -29.68 43.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.002 0.921 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.29 56.55 19.03 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 111.631 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' B' ' 54' ' ' HIS . 58.7 Cg_endo -80.15 178.31 7.31 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 121.908 1.738 . . . . 0.0 115.773 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 p -90.02 156.64 18.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.36 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.68 156.54 31.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.224 -0.923 . . . . 0.0 112.742 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.98 149.77 17.89 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 120.07 2.788 . . . . 0.0 120.07 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -158.25 159.25 35.81 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.42 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.8 m -96.09 150.59 20.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.885 1.674 . . . . 0.0 108.478 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -129.02 125.72 63.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.652 ' HB2' HG21 ' C' ' 52' ' ' ILE . 22.0 t-20 -103.72 112.37 25.28 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.507 -174.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' TRP . . . . . 0.443 ' HE1' ' HG1' ' B' ' 77' ' ' THR 0.355 57.5 m95 -74.11 154.94 38.93 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -173.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.81 -49.42 2.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 115.438 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.42 -15.16 59.99 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -150.44 144.64 25.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.984 2.514 . . . . 0.0 107.278 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.62 116.95 21.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.691 1.234 . . . . 0.0 109.975 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -168.56 171.52 8.82 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.284 1.834 . . . . 0.0 111.208 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.89 142.03 26.07 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 123.202 1.477 . . . . 0.0 110.456 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' THR . . . . . 0.443 ' HG1' ' HE1' ' B' ' 70' ' ' TRP . 1.7 m -138.51 132.73 31.66 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.629 -3.441 . . . . 0.0 109.577 -173.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.08 157.37 10.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.925 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.22 137.29 44.27 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.05 119.85 10.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.588 0.755 . . . . 0.0 110.018 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 -176.3 27.5 Favored Glycine 0 N--CA 1.463 0.492 0 N-CA-C 116.649 1.42 . . . . 0.0 116.649 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.06 144.56 48.48 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 124.874 0.984 . . . . 0.0 110.41 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 25.7 p -97.63 113.0 24.64 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.452 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.7 OUTLIER -104.14 166.45 10.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.779 0.718 . . . . 0.0 112.057 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.26 112.42 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -58.59 161.38 4.66 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.264 1.026 . . . . 0.0 108.999 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -48.79 -30.05 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -15.01 57.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.403 1.081 . . . . 0.0 113.221 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.48 54.09 2.47 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 31.8 mtpt -126.99 146.27 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.339 2.256 . . . . 0.0 108.407 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -106.27 138.32 42.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.932 1.693 . . . . 0.0 110.969 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.494 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.6 m -141.67 162.24 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.21 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.52 117.68 27.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -106.96 115.48 30.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -132.66 170.0 15.84 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 123.517 1.627 . . . . 0.0 111.952 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.463 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -121.8 170.88 9.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -145.84 162.83 36.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.215 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.7 tt -145.67 125.68 13.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.375 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 144.31 38.61 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 125.037 1.46 . . . . 0.0 114.625 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.26 123.93 35.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 112.023 -2.353 . . . . 0.0 113.777 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 156.55 17.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.137 0.975 . . . . 0.0 111.716 176.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -102.83 63.5 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.146 0.498 . . . . 0.0 109.75 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.817 HG11 ' HB3' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -49.61 151.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.855 1.262 . . . . 0.0 112.675 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.99 -30.73 39.74 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.05 144.92 42.33 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.49 1.138 . . . . 0.0 113.145 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.487 ' CD1' HG21 ' C' ' 92' ' ' VAL . 12.7 tt -65.74 -23.41 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.559 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.7 1.43 53.02 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 118.24 -1.311 . . . . 0.0 113.693 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.817 ' HB3' HG11 ' B' ' 103' ' ' VAL . 13.5 m-20 -121.14 5.63 10.31 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -33.71 66.67 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 119.878 -1.764 . . . . 0.0 111.699 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 44.4 p-90 -45.29 -50.22 12.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.024 1.329 . . . . 0.0 114.264 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.12 -11.41 47.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.82 -6.26 55.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.214 -1.374 . . . . 0.0 114.476 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.796 ' CG2' HD21 ' B' ' 98' ' ' LEU . 15.2 m -102.96 143.75 32.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 125.228 1.58 . . . . 0.0 112.148 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.9 mtt85 -144.34 129.38 18.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.626 1.17 . . . . 0.0 111.061 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.42 154.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.178 1.354 . . . . 0.0 110.867 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.92 -177.64 33.2 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.291 0.472 . . . . 0.0 113.579 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 23.9 p90 -125.13 152.25 44.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.683 -0.892 . . . . 0.0 110.97 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -148.27 143.42 26.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.62 0.768 . . . . 0.0 109.209 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.51 128.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.83 153.51 31.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.108 0.48 . . . . 0.0 111.43 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 42.2 p -136.14 160.74 37.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.285 1.034 . . . . 0.0 111.331 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -58.93 118.24 5.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.042 0.937 . . . . 0.0 111.735 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.0 139.54 35.72 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 67.64 47.27 1.21 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.064 1.346 . . . . 0.0 113.733 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -66.28 -24.68 66.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 55.55 -147.43 0.52 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.309 1.044 . . . . 0.0 111.07 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 tptp -148.05 5.53 0.76 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 117.094 -1.431 . . . . 0.0 113.49 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . 0.307 15.7 mt-10 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 128.875 2.87 . . . . 0.0 107.708 -170.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.3 m 67.56 -45.85 0.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.211 2.204 . . . . 0.0 115.617 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.9 -35.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.072 1.749 . . . . 0.0 114.423 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 24.94 98.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.406 2.682 . . . . 0.0 116.951 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.59 60.51 1.58 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.726 1.21 . . . . 0.0 112.933 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -156.17 118.5 4.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.778 1.231 . . . . 0.0 111.388 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 43.9 t -116.31 136.2 53.21 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -139.75 136.09 33.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.49 -26.15 60.77 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -46.54 109.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.256 1.422 . . . . 0.0 112.139 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.34 -126.9 3.32 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.389 0.995 . . . . 0.0 111.161 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -150.31 144.65 25.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -142.61 158.44 43.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.161 1.384 . . . . 0.0 111.034 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 148.82 45.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.705 1.202 . . . . 0.0 108.391 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -115.93 143.62 45.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.9 0.88 . . . . 0.0 110.769 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -53.45 -24.85 13.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.827 2.051 . . . . 0.0 114.549 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.442 HD11 ' CD1' ' A' ' 110' ' ' TRP . 31.3 tp -70.08 -18.39 63.26 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.192 -1.567 . . . . 0.0 111.565 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.42 -15.0 17.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 128.587 2.994 . . . . 0.0 113.452 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 87.9 p -71.66 144.73 49.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.574 1.187 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.89 142.67 49.47 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.4 -0.813 . . . . 0.0 110.681 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -131.3 144.12 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.28 1.038 . . . . 0.0 112.769 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 17.5 m -132.04 131.55 42.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.232 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 66.8 mt -128.66 124.64 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.53 -84.87 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 125.026 1.454 . . . . 0.0 111.102 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.86 157.42 44.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.068 0.937 . . . . 0.0 112.067 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' C' ' 53' ' ' GLN . 13.6 p -109.91 125.81 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.918 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -79.25 161.46 26.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.841 0.456 . . . . 0.0 112.01 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.64 -23.46 17.27 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -69.23 -34.54 74.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.203 0.601 . . . . 0.0 111.413 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.41 -6.35 18.87 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.994 1.283 . . . . 0.0 112.878 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.81 157.78 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.423 1.106 . . . . 0.0 112.07 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 166.35 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.205 174.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -132.08 160.34 36.24 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.06 -166.53 28.26 Favored Glycine 0 C--O 1.239 0.419 0 CA-C-O 122.439 1.021 . . . . 0.0 112.423 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.668 ' HB ' HD11 ' C' ' 46' ' ' LEU . 39.9 p -137.43 140.16 41.11 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.458 -1.371 . . . . 0.0 111.97 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.95 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' C' ' 46' ' ' LEU . 41.2 mt -133.48 126.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.454 ' O ' HG21 ' C' ' 44' ' ' ILE . 89.9 m -104.99 148.89 26.24 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.36 -18.17 15.53 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 17.1 m -133.07 138.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.83 1.252 . . . . 0.0 111.475 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 169.98 19.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.365 -0.834 . . . . 0.0 112.369 -173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.49 -25.53 62.3 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.836 -0.54 . . . . 0.0 110.534 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -145.09 81.2 10.68 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.621 2.369 . . . . 0.0 110.256 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.18 30.99 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 124.686 3.591 . . . . 0.0 116.243 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.35 6.49 79.68 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 119.816 -1.803 . . . . 0.0 116.1 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.46 10.51 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.454 HG21 ' O ' ' C' ' 35' ' ' THR 0.259 59.8 mt -32.64 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -173.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.66 173.59 6.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.042 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.668 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.0 tt -70.28 137.72 50.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.3 p -114.46 126.14 28.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.96 144.31 94.54 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.058 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 150.95 49.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.015 0.926 . . . . 0.0 110.57 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -157.28 149.23 22.5 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.95 2.1 . . . . 0.0 108.512 -175.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.62 -148.44 17.56 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.498 1.045 . . . . 0.0 112.419 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.652 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mp -144.58 138.67 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 124.29 1.036 . . . . 0.0 112.424 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.591 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -128.17 130.08 47.5 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.816 -1.178 . . . . 0.0 110.561 174.12 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 54' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' C' ' 62' ' ' PRO . 10.7 m-70 -62.12 156.26 22.08 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.716 -1.24 . . . . 0.0 111.868 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -147.57 12.87 1.04 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.835 1.254 . . . . 0.0 113.284 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -78.96 -58.16 3.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 128.22 2.608 . . . . 0.0 111.184 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.2 170.28 14.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.853 0.861 . . . . 0.0 112.622 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 73.9 m -81.22 -25.91 36.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.927 173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.93 56.4 16.79 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 125.228 1.411 . . . . 0.0 112.707 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' C' ' 54' ' ' HIS . 59.8 Cg_endo -81.38 178.95 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.103 1.869 . . . . 0.0 115.84 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -89.54 157.48 18.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.98 1.312 . . . . 0.0 112.728 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -158.75 156.12 29.24 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.232 -0.917 . . . . 0.0 112.862 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.03 149.64 17.59 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.63 158.95 34.81 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.446 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.4 m -95.27 151.36 19.31 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.272 1.829 . . . . 0.0 108.56 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.7 124.01 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.657 ' HB2' HG21 ' B' ' 52' ' ' ILE . 22.5 t-20 -102.12 112.47 25.15 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.956 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.354 55.4 m95 -73.91 154.87 39.21 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.98 -48.73 2.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.178 1.791 . . . . 0.0 115.529 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.67 -15.12 59.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -150.91 144.82 25.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.07 2.548 . . . . 0.0 107.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.8 117.17 22.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.607 1.094 . . . . 0.0 109.748 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 93.2 p -168.95 171.24 8.47 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.581 1.952 . . . . 0.0 110.942 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -147.59 142.27 26.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-O 123.039 1.399 . . . . 0.0 110.924 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.52 132.03 30.54 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 109.897 -3.319 . . . . 0.0 110.051 -172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -108.95 157.19 9.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.959 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -133.99 137.35 44.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.93 119.53 10.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 0.0 109.82 -174.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.24 -174.68 25.42 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.1 144.52 48.88 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.464 0.743 . . . . 0.0 110.781 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.69 113.0 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 124.139 0.899 . . . . 0.0 110.982 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -104.75 167.71 9.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.469 0.652 . . . . 0.0 111.557 -177.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.79 113.97 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -58.78 161.2 5.0 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.871 0.868 . . . . 0.0 109.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -51.31 -20.95 1.89 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.72 -11.04 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.535 0.734 . . . . 0.0 112.665 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.94 49.02 3.93 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -122.81 145.82 48.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.639 1.976 . . . . 0.0 109.409 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -102.9 139.17 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.857 1.263 . . . . 0.0 111.024 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.6 m -141.77 163.97 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.97 1.308 . . . . 0.0 109.433 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.52 119.02 28.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -108.14 115.41 30.07 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -132.59 170.06 15.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.978 1.847 . . . . 0.0 112.274 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.436 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -122.11 170.98 9.32 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 172.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -146.15 162.69 37.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.233 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.786 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.7 tt -145.64 125.67 13.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.194 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 99' ' ' LEU . . . . . 0.403 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -110.14 144.69 38.4 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.974 1.421 . . . . 0.0 114.333 -174.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.28 123.1 33.24 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 111.943 -2.389 . . . . 0.0 113.701 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.7 156.22 18.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.699 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -102.97 61.55 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.864 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' C' ' 108' ' ' ASP . 0.1 OUTLIER -48.06 151.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.144 1.377 . . . . 0.0 113.008 174.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -80.17 -31.05 38.89 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.89 145.15 42.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.534 1.159 . . . . 0.0 112.992 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.494 ' CD1' HG21 ' B' ' 92' ' ' VAL . 13.1 tt -64.84 -24.16 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.707 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 1.73 46.66 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.945 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' ASP . . . . . 0.794 ' HB3' HG11 ' C' ' 103' ' ' VAL . 13.2 m-20 -121.32 5.89 10.2 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -33.33 67.92 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 119.896 -1.752 . . . . 0.0 111.7 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.538 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 43.9 p-90 -45.59 -49.92 13.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.79 1.236 . . . . 0.0 114.299 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.33 -11.01 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.32 56.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.786 ' CG2' HD21 ' C' ' 98' ' ' LEU . 15.5 m -102.83 143.85 31.92 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 125.134 1.521 . . . . 0.0 112.265 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -144.54 130.03 18.93 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.64 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.25 154.18 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 120.417 1.462 . . . . 0.0 110.644 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -177.84 33.38 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.466 0.555 . . . . 0.0 113.442 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.8 p90 -124.76 152.43 43.84 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.665 -0.903 . . . . 0.0 111.135 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -148.14 143.71 27.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.666 0.787 . . . . 0.0 109.305 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.73 129.16 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.93 152.65 34.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.282 0.563 . . . . 0.0 111.612 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.2 p -135.18 161.86 34.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.447 1.099 . . . . 0.0 110.643 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -57.5 117.29 4.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.621 1.168 . . . . 0.0 112.505 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -86.12 106.54 17.32 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.655 -0.653 . . . . 0.0 109.817 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 80.99 142.07 0.07 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.101 2.56 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 8.9 t -156.43 -40.95 0.08 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.992 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 55.59 -82.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.195 1.798 . . . . 0.0 111.347 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? 62.59 66.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.435 2.294 . . . . 0.0 113.67 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.248 0.984 0 C-N-CA 129.852 3.261 . . . . 0.0 106.6 174.36 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 8.1 p -59.02 -48.33 81.99 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 113.32 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 51.12 -72.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.748 3.219 . . . . 0.0 114.619 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -167.82 73.62 0.12 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.914 2.085 . . . . 0.0 109.295 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 133.0 9.75 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.753 -0.592 . . . . 0.0 111.571 -176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 154.03 31.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.014 0.926 . . . . 0.0 109.408 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.6 p -139.66 127.58 22.15 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.137 -0.977 . . . . 0.0 112.999 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.95 -31.56 72.85 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.594 1.543 . . . . 0.0 113.375 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -66.5 113.68 4.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.26 0.21 0.3 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 119.03 2.372 . . . . 0.0 119.03 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt 73.14 144.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 129.405 3.082 . . . . 0.0 114.362 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -140.27 161.97 36.4 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.321 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -141.44 147.17 37.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.434 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.42 143.42 40.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.729 0.812 . . . . 0.0 110.195 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -56.64 -23.87 44.35 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.478 1.911 . . . . 0.0 113.593 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' C' ' 110' ' ' TRP . 31.7 tp -71.61 -18.97 62.18 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.666 1.586 . . . . 0.0 111.499 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.45 -14.79 25.1 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 127.493 2.473 . . . . 0.0 113.582 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 p -67.99 140.3 56.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.361 1.581 . . . . 0.0 112.123 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.47 142.86 46.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -136.48 146.64 46.52 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.297 1.046 . . . . 0.0 112.843 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -134.2 132.17 39.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.313 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.0 mt -133.02 127.14 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.96 -84.52 0.19 Allowed Glycine 0 CA--C 1.526 0.762 0 O-C-N 125.187 1.554 . . . . 0.0 111.475 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 145.49 29.39 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.869 0.842 . . . . 0.0 112.238 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.57 128.9 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.718 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.14 161.88 20.93 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.519 0.676 . . . . 0.0 111.851 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 p -57.97 -20.9 41.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -78.22 -31.56 49.42 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.211 0.914 . . . . 0.0 111.532 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.29 -5.78 23.3 Favored Glycine 0 N--CA 1.466 0.655 0 CA-C-O 117.352 -1.805 . . . . 0.0 114.626 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 145.83 53.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.711 1.755 . . . . 0.0 109.056 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -155.1 140.2 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.05 12.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 -168.94 35.27 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.873 1.263 . . . . 0.0 111.304 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.664 ' HB ' HD11 ' A' ' 46' ' ' LEU . 43.3 p -133.0 130.26 39.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 123.339 1.543 . . . . 0.0 110.928 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -111.64 136.83 50.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.033 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD12 ' A' ' 46' ' ' LEU . 33.0 mt -132.6 130.27 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -108.5 145.98 33.91 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.32 -15.19 18.9 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.0 m -133.49 140.99 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.626 1.17 . . . . 0.0 112.937 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.47 162.53 38.1 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 120.76 -1.212 . . . . 0.0 111.0 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.95 -39.5 79.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.476 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -131.81 84.66 53.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 127.184 2.194 . . . . 0.0 108.082 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.11 175.56 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.423 2.082 . . . . 0.0 111.522 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.58 -31.96 3.29 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.608 1.099 . . . . 0.0 112.543 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.02 28.29 2.12 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.406 1.083 . . . . 0.0 112.164 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -58.25 134.11 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.796 0.807 . . . . 0.0 109.587 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 174.06 11.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.399 1.48 . . . . 0.0 108.984 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' HB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -53.28 132.48 39.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.112 1.765 . . . . 0.0 113.055 175.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -114.51 125.49 29.11 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.057 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' HE3' ' A' ' 71' ' ' LYS . 4.9 Cg_exo -58.51 146.96 88.78 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.235 1.957 . . . . 0.0 110.846 173.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.46 151.66 51.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.26 0.624 . . . . 0.0 110.871 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tp -156.75 149.05 23.21 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.003 1.721 . . . . 0.0 110.872 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.56 -154.26 25.0 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 121.541 1.973 . . . . 0.0 109.833 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.9 mt -146.7 140.94 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 112.132 -174.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.28 138.24 50.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.792 1.237 . . . . 0.0 110.766 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -70.52 155.56 40.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.837 0.827 . . . . 0.0 110.415 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -138.61 -5.6 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -77.67 -35.09 52.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.85 167.12 12.69 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 m -76.96 -37.99 54.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.298 1.439 . . . . 0.0 114.659 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -139.33 49.92 2.33 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 125.026 1.33 . . . . 0.0 111.877 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.76 -179.04 4.98 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.408 2.739 . . . . 0.0 115.35 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.5 p -87.44 161.31 17.91 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.892 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.51 155.75 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.487 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.82 19.92 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 119.715 2.646 . . . . 0.0 119.715 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -159.72 159.73 33.2 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -97.64 148.72 23.02 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.952 2.501 . . . . 0.0 108.685 173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.52 125.33 63.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 48.8 t30 -103.68 107.06 17.75 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.555 -174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -72.06 149.19 45.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 123.411 1.577 . . . . 0.0 114.731 -173.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HE3' ' HD3' ' A' ' 48' ' ' PRO . 27.9 mttt -108.54 -45.39 3.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -78.85 -17.23 55.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.287 1.035 . . . . 0.0 112.804 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 128.66 10.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 129.269 3.028 . . . . 0.0 105.397 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.12 119.01 11.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.332 0.969 . . . . 0.0 112.088 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 t -170.72 167.52 7.71 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.773 1.629 . . . . 0.0 110.919 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -146.13 140.9 27.02 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 124.001 1.857 . . . . 0.0 110.484 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.5 m -137.24 126.38 24.53 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-N 109.303 -3.589 . . . . 0.0 109.949 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -102.09 161.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.39 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -136.7 137.95 40.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.92 118.14 9.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.14 -179.41 26.84 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.058 -1.068 . . . . 0.0 115.535 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -121.57 148.89 43.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 125.223 1.19 . . . . 0.0 111.264 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.1 t -97.13 127.64 43.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 125.094 1.496 . . . . 0.0 109.911 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' D' ' 106' ' ' ILE . 7.7 m-85 -117.7 161.4 19.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.16 0.984 . . . . 0.0 113.517 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 28.1 mt -127.18 112.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.54 160.56 6.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.104 0.562 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -43.05 -37.26 1.89 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.12 -14.94 60.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.448 1.499 . . . . 0.0 114.773 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 46.82 4.15 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.587 0.613 . . . . 0.0 113.016 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 12.3 mtpt -115.79 160.23 20.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.966 2.106 . . . . 0.0 108.037 173.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -116.0 144.77 43.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.075 1.762 . . . . 0.0 111.713 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.72 159.36 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.601 1.191 . . . . 0.0 109.592 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 120' ' ' PHE . 24.8 mt -125.14 102.29 7.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' A' ' 92' ' ' VAL . 2.3 mmtt -96.23 121.42 37.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.4 p -134.01 162.86 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.627 1.204 . . . . 0.0 111.373 -174.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.421 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.38 168.16 9.85 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 171.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -142.11 163.8 31.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.786 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.7 OUTLIER -145.97 123.98 12.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.801 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.32 144.87 38.4 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 125.088 1.493 . . . . 0.0 114.025 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -124.52 114.89 20.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.983 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -73.7 162.59 29.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.889 0.876 . . . . 0.0 111.557 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.6 p -99.88 45.69 0.98 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.0 -1.063 . . . . 0.0 111.492 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -52.4 137.23 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.98 1.712 . . . . 0.0 113.145 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -20.58 61.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -174.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.62 150.93 51.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.16 1.457 . . . . 0.0 113.549 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' D' ' 84' ' ' PHE . 16.0 tt -64.15 -23.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.109 -0.994 . . . . 0.0 113.084 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.47 3.75 58.18 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.071 0.843 . . . . 0.0 113.552 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 103' ' ' VAL . 1.1 m-20 -122.7 -0.65 9.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.195 0.998 . . . . 0.0 112.451 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -31.76 69.18 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.208 -0.932 . . . . 0.0 112.85 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.7 p-90 -48.18 -41.61 27.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.096 1.358 . . . . 0.0 113.714 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 15.2 pttm -96.39 -8.59 32.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 -0.9 18.94 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.742 ' CG2' HD21 ' A' ' 98' ' ' LEU . 8.2 m -113.39 140.97 47.61 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.588 0.755 . . . . 0.0 112.632 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -144.21 131.67 20.97 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.787 1.235 . . . . 0.0 111.738 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.66 156.55 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 110.53 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -175.43 30.89 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.516 0.579 . . . . 0.0 113.225 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -125.14 153.15 43.45 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.795 -0.826 . . . . 0.0 112.112 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 132.13 14.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.746 0.784 . . . . 0.0 110.052 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.419 HD13 ' HE3' ' A' ' 94' ' ' LYS . 15.5 mt -118.93 138.45 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 21.0 m-85 -124.56 139.97 53.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.821 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.3 p -129.32 154.09 47.2 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -53.01 117.86 3.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.336 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 124' ' ' ARG . 4.4 tt -85.35 123.09 30.41 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.734 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -159.8 -167.94 2.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.27 172.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -60.57 164.33 4.63 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.279 0.632 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -121.42 6.81 10.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.67 1.588 . . . . 0.0 111.101 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -131.51 84.0 2.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 128.138 2.575 . . . . 0.0 106.391 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.256 1.421 0 C-N-CA 129.216 3.007 . . . . 0.0 115.473 -178.687 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' -3' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 7.2 mm-40 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.56 -45.77 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.556 1.16 . . . . 0.0 110.191 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 21.3 m -65.19 148.4 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 111.812 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -73.71 53.62 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.313 1.445 . . . . 0.0 112.528 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 29.45 61.76 0.15 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 129.065 2.946 . . . . 0.0 114.594 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 146.25 22.7 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 126.218 1.807 . . . . 0.0 109.227 -174.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 p -134.58 148.53 50.47 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.27 1.828 . . . . 0.0 107.732 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 65.3 p -139.29 131.12 27.57 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.285 -1.51 . . . . 0.0 114.148 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 50.7 mt -65.04 -31.88 73.33 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.259 1.391 . . . . 0.0 113.924 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -66.33 115.64 6.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.38 8.16 0.29 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 118.296 2.079 . . . . 0.0 118.296 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 66.55 148.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.272 2.629 . . . . 0.0 114.927 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -143.43 161.08 39.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.474 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -140.5 145.7 37.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.545 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -109.54 143.61 38.97 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.178 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.16 -23.34 46.77 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.405 1.882 . . . . 0.0 113.543 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.52 HD11 ' CD1' ' B' ' 110' ' ' TRP . 32.0 tp -72.4 -19.06 61.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.006 1.722 . . . . 0.0 111.27 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.47 -14.59 22.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.121 2.296 . . . . 0.0 113.622 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -67.52 138.34 56.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.458 1.629 . . . . 0.0 112.202 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.85 141.3 46.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -135.03 147.15 49.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.246 1.022 . . . . 0.0 113.179 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.1 m -134.49 131.96 38.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.068 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -133.13 126.32 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.08 -84.59 0.16 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 125.292 1.62 . . . . 0.0 111.583 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.05 29.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.713 0.757 . . . . 0.0 111.853 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.56 128.8 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.901 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.52 161.54 19.95 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.636 0.731 . . . . 0.0 111.595 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.8 p -58.2 -21.38 47.44 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -75.92 -30.3 58.68 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.176 0.898 . . . . 0.0 111.666 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.77 -4.21 25.98 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.778 1.18 . . . . 0.0 115.061 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.56 150.85 45.67 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.399 1.08 . . . . 0.0 110.926 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -156.46 162.84 39.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.164 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.86 171.97 12.17 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 173.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.21 -167.84 37.3 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 119.947 -1.721 . . . . 0.0 111.628 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' THR . . . . . 0.646 ' HB ' HD11 ' D' ' 46' ' ' LEU . 44.0 p -132.95 128.84 37.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.89 1.329 . . . . 0.0 110.823 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -111.65 136.06 51.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.12 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.412 HD11 HD12 ' D' ' 46' ' ' LEU . 30.6 mt -132.11 132.39 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' THR . . . . . 0.438 HG23 ' H ' ' D' ' 37' ' ' VAL . 1.0 OUTLIER -111.26 145.5 38.65 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 -15.41 19.2 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.438 ' H ' HG23 ' D' ' 35' ' ' THR . 18.6 m -133.55 140.7 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.324 1.05 . . . . 0.0 113.068 -174.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.01 162.4 37.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.132 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.77 -38.85 80.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.628 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -131.89 84.5 53.75 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.987 2.115 . . . . 0.0 108.013 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 175.09 9.58 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.09 1.86 . . . . 0.0 111.417 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.23 -31.45 3.3 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.567 1.079 . . . . 0.0 112.502 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.37 28.13 2.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.341 1.056 . . . . 0.0 112.16 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.9 134.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.929 0.871 . . . . 0.0 109.608 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.18 174.08 11.19 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.314 1.445 . . . . 0.0 108.862 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.646 HD11 ' HB ' ' D' ' 32' ' ' THR . 0.9 OUTLIER -53.53 132.69 40.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 126.248 1.819 . . . . 0.0 113.093 175.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -114.67 125.67 28.83 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.067 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' D' ' 71' ' ' LYS . 4.8 Cg_exo -58.72 146.92 90.43 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.164 1.909 . . . . 0.0 110.748 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.13 157.41 43.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.441 0.697 . . . . 0.0 111.234 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.89 148.85 15.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.822 1.649 . . . . 0.0 110.381 -174.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -157.7 28.96 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 121.35 1.886 . . . . 0.0 111.999 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.6 mt -145.41 138.7 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.094 0.957 . . . . 0.0 111.903 -174.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.98 138.17 50.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.537 1.535 . . . . 0.0 110.733 174.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -71.09 154.94 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.408 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -136.8 -6.38 1.91 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -78.61 -35.91 44.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.25 168.57 13.8 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -74.82 -42.55 57.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.244 1.018 . . . . 0.0 113.556 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -137.45 53.07 6.06 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.07 1.348 . . . . 0.0 112.037 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.91 -179.73 5.48 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.264 1.976 . . . . 0.0 115.248 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 34.8 p -87.97 161.91 17.16 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.762 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -159.53 155.97 27.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.57 149.69 19.59 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 119.517 2.567 . . . . 0.0 119.517 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.13 158.07 29.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -96.47 149.22 21.97 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.827 2.451 . . . . 0.0 108.989 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.89 124.87 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 69' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 52' ' ' ILE . 44.5 t30 -104.23 107.31 18.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.053 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.7 149.6 45.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 123.381 1.562 . . . . 0.0 114.397 -173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' D' ' 48' ' ' PRO . 27.2 mttt -108.56 -45.06 3.93 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -173.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -79.22 -16.88 55.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.395 1.078 . . . . 0.0 112.917 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -152.26 129.25 11.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.299 3.04 . . . . 0.0 105.453 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.91 118.95 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.355 0.98 . . . . 0.0 111.584 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 45.5 t -170.5 167.54 8.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 110.776 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -145.9 141.06 27.44 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.832 1.777 . . . . 0.0 110.892 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.46 125.25 22.48 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 109.469 -3.514 . . . . 0.0 110.456 -172.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -101.04 161.06 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.355 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.29 138.38 39.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.26 118.16 9.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 109.223 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -151.23 -178.59 26.18 Favored Glycine 0 CA--C 1.5 -0.85 0 C-N-CA 120.006 -1.092 . . . . 0.0 115.816 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.26 145.58 48.09 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 125.09 1.112 . . . . 0.0 111.263 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' D' ' 93' ' ' LEU . 17.0 t -97.6 118.37 33.95 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.939 1.4 . . . . 0.0 110.653 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' A' ' 106' ' ' ILE . 8.9 m-85 -109.06 163.78 13.02 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 85' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 7.8 mt -127.94 113.64 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 174.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.31 154.99 26.18 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -36.51 -38.98 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -72.37 -29.68 64.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.655 1.582 . . . . 0.0 114.467 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.38 58.72 0.73 Allowed Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.122 1.344 . . . . 0.0 110.949 -173.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 19.2 mtpt -123.72 163.46 21.07 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.414 2.686 . . . . 0.0 107.31 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -124.81 145.74 49.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 121.77 2.077 . . . . 0.0 112.725 -172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' VAL . . . . . 0.554 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -145.16 159.48 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.679 1.191 . . . . 0.0 110.643 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' D' ' 120' ' ' PHE . 19.1 mt -123.22 104.15 8.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 94' ' ' LYS . . . . . 0.554 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.7 mmtt -98.29 119.05 36.29 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' THR . . . . . 0.401 HG22 ' HA3' ' D' ' 81' ' ' GLY . 1.9 p -133.19 161.93 33.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.534 1.159 . . . . 0.0 111.257 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.24 168.45 9.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -142.14 164.25 30.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.477 1.132 . . . . 0.0 111.727 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.7 OUTLIER -146.9 124.14 11.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.685 -1.598 . . . . 0.0 113.569 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.62 144.81 38.95 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 125.332 1.645 . . . . 0.0 114.078 -174.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -124.63 115.02 20.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.896 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 31.5 m -74.52 161.32 29.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.937 0.895 . . . . 0.0 111.844 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 58.8 p -99.0 45.55 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.85 -1.157 . . . . 0.0 111.356 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' D' ' 108' ' ' ASP . 0.3 OUTLIER -52.22 137.96 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 112.964 -174.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -19.74 60.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.04 151.75 50.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.862 1.315 . . . . 0.0 113.783 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.7 tt -63.89 -24.37 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.367 -0.833 . . . . 0.0 113.171 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.16 3.5 52.09 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.212 0.911 . . . . 0.0 113.6 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' ASP . . . . . 0.402 ' HB3' HG21 ' D' ' 103' ' ' VAL . 1.2 m-20 -122.9 -0.78 8.96 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.139 0.976 . . . . 0.0 112.454 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -31.85 68.46 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.408 -0.808 . . . . 0.0 112.747 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.1 p-90 -48.3 -41.68 28.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.255 1.422 . . . . 0.0 113.703 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 111' ' ' LYS . . . . . 0.405 ' HB3' ' CZ3' ' D' ' 110' ' ' TRP . 15.1 pttm -96.66 -8.6 31.16 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -1.46 20.87 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' THR . . . . . 0.746 ' CG2' HD21 ' D' ' 98' ' ' LEU . 8.5 m -112.95 140.83 47.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.531 0.733 . . . . 0.0 112.687 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -144.12 131.34 20.72 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.788 1.235 . . . . 0.0 111.658 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.49 156.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 110.492 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.24 -175.26 31.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.541 0.591 . . . . 0.0 113.434 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -125.06 152.59 44.1 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.734 -0.862 . . . . 0.0 112.004 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.34 12.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.851 0.834 . . . . 0.0 110.166 -175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' ILE . . . . . 0.412 HD13 ' HE3' ' D' ' 94' ' ' LYS . 16.4 mt -116.02 138.29 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' D' ' 93' ' ' LEU . 21.0 m-85 -125.08 141.88 51.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -130.36 154.32 47.8 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -52.83 112.94 0.93 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.246 1.018 . . . . 0.0 110.145 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 123' ' ' LEU . . . . . 0.57 HD23 ' C ' ' D' ' 123' ' ' LEU . 7.7 tt -72.47 116.6 13.12 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.36 -59.39 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.307 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 2.1 p 57.12 119.7 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.721 2.008 . . . . 0.0 113.12 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -157.51 118.72 3.61 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.14 -1.6 . . . . 0.0 107.256 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.76 164.86 35.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 128.062 2.545 . . . . 0.0 108.664 -174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.267 1.979 1 C-N-CA 133.609 4.764 . . . . 0.0 104.514 173.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 117.112 -1.423 . . . . 0.0 108.024 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.6 p -88.38 -62.86 1.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.604 1.162 . . . . 0.0 110.294 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.97 174.27 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.556 1.942 . . . . 0.0 109.11 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.98 158.23 37.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.575 1.15 . . . . 0.0 110.057 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -83.44 56.59 3.64 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.03 -1.044 . . . . 0.0 111.545 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 130.76 8.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.265 -0.897 . . . . 0.0 112.533 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.416 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.3 p -116.86 147.77 41.87 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.331 1.852 . . . . 0.0 109.54 -174.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -139.48 129.66 25.25 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.78 -33.22 75.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.13 1.332 . . . . 0.0 114.105 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -65.27 115.55 5.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.82 5.2 0.32 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 68.76 146.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 128.59 2.756 . . . . 0.0 115.483 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -141.97 159.14 42.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.411 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.407 ' HB ' HD12 ' B' ' 123' ' ' LEU . 13.7 t -136.45 143.82 44.09 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.591 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -108.97 143.54 38.11 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.611 0.764 . . . . 0.0 110.571 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -55.62 -25.09 36.9 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.194 1.798 . . . . 0.0 113.332 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' D' ' 110' ' ' TRP . 29.6 tp -71.13 -18.92 62.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.633 1.573 . . . . 0.0 111.846 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.94 -16.06 23.27 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.381 2.42 . . . . 0.0 113.414 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 61.5 p -67.29 141.11 57.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.019 1.39 . . . . 0.0 111.89 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.67 141.09 48.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -134.56 147.14 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.569 1.176 . . . . 0.0 112.505 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -134.76 131.17 37.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.57 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 93.9 mt -132.59 126.2 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -84.75 0.17 Allowed Glycine 0 CA--C 1.526 0.769 0 O-C-N 125.348 1.655 . . . . 0.0 111.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.23 146.54 30.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 112.265 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 28.2 t -89.94 128.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.497 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.28 162.18 17.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.527 0.68 . . . . 0.0 111.847 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.2 p -58.0 -20.92 42.24 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -78.35 -31.4 48.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.176 0.898 . . . . 0.0 111.719 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.97 -5.75 23.87 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-O 117.479 -1.734 . . . . 0.0 114.687 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.6 145.34 54.03 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.531 1.665 . . . . 0.0 108.914 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.76 140.1 17.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.18 12.04 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.43 -168.72 34.93 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-O 122.82 1.233 . . . . 0.0 111.132 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.654 ' HB ' HD11 ' B' ' 46' ' ' LEU . 41.7 p -133.59 131.1 39.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.32 -1.44 . . . . 0.0 110.789 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -112.25 137.06 50.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.898 -1.956 . . . . 0.0 108.116 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.42 HD11 HD12 ' B' ' 46' ' ' LEU . 27.0 mt -132.96 129.72 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.445 HG23 ' H ' ' B' ' 37' ' ' VAL . 1.0 OUTLIER -108.75 145.73 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -175.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.23 -14.75 19.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 35' ' ' THR . 18.4 m -133.93 140.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.559 1.143 . . . . 0.0 112.745 -174.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.36 162.85 37.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 110.862 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.48 -38.96 77.9 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.433 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -132.15 84.6 52.28 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.202 2.201 . . . . 0.0 107.995 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.01 175.49 9.06 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.375 2.05 . . . . 0.0 111.486 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.35 -31.41 3.44 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.584 1.088 . . . . 0.0 112.654 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -140.28 28.25 2.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.395 1.078 . . . . 0.0 112.15 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.03 134.41 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.92 0.867 . . . . 0.0 109.562 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.31 173.63 11.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.347 1.459 . . . . 0.0 109.039 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.654 HD11 ' HB ' ' B' ' 32' ' ' THR . 0.9 OUTLIER -52.97 132.93 38.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.15 1.78 . . . . 0.0 113.211 175.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -115.26 125.86 28.42 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.082 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' HE3' ' B' ' 71' ' ' LYS . 6.7 Cg_exo -58.42 146.51 89.9 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 0.0 110.811 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.4 151.48 51.5 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.289 0.635 . . . . 0.0 110.7 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 tp -156.78 149.08 23.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.028 1.731 . . . . 0.0 110.845 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.59 25.49 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 121.555 1.979 . . . . 0.0 109.511 -173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' C' ' 69' ' ' ASN . 4.0 mt -146.2 140.23 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.371 1.068 . . . . 0.0 112.403 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.35 137.35 49.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.465 1.106 . . . . 0.0 110.657 174.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -69.91 156.13 39.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 109.992 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -138.81 -5.66 1.51 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -79.15 -36.9 39.72 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.47 166.64 15.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.749 0.656 . . . . 0.0 112.524 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.7 m -79.41 -34.28 41.93 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -139.78 51.88 3.35 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 125.147 1.379 . . . . 0.0 112.351 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.3 -179.5 5.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.734 2.29 . . . . 0.0 115.806 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -87.23 161.55 17.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.941 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.84 155.67 26.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.575 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.68 19.44 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 119.705 2.642 . . . . 0.0 119.705 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -160.07 159.05 31.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -96.52 149.44 21.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.844 2.457 . . . . 0.0 108.783 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.88 125.74 63.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.606 ' HB2' HG21 ' C' ' 52' ' ' ILE . 48.5 t30 -104.05 106.63 17.2 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 118.223 -0.894 . . . . 0.0 112.373 -174.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -71.8 149.43 45.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.288 1.518 . . . . 0.0 114.591 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.503 ' HE3' ' HD3' ' B' ' 48' ' ' PRO . 28.2 mttt -108.58 -45.24 3.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -79.14 -16.97 55.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 112.857 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 129.17 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.242 3.017 . . . . 0.0 105.455 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.73 119.0 11.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.472 1.033 . . . . 0.0 111.791 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 39.4 t -170.43 167.38 8.25 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.993 1.717 . . . . 0.0 110.738 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -146.12 140.83 26.98 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-O 124.03 1.871 . . . . 0.0 110.453 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.52 126.18 23.78 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 109.335 -3.575 . . . . 0.0 110.052 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.8 161.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.328 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.91 138.58 40.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.3 119.43 10.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.668 0.787 . . . . 0.0 109.148 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.81 -178.84 27.85 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.202 -0.999 . . . . 0.0 115.579 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -121.51 145.9 47.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 125.211 1.183 . . . . 0.0 111.058 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.456 ' SG ' HD23 ' B' ' 93' ' ' LEU . 17.2 t -97.36 121.94 39.83 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.651 1.219 . . . . 0.0 110.012 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.564 ' HB2' HD12 ' C' ' 106' ' ' ILE . 10.7 m-85 -111.98 163.57 14.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.916 1.286 . . . . 0.0 112.648 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 19.2 mt -128.08 119.09 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.13 163.63 5.98 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.362 0.601 . . . . 0.0 109.839 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -47.0 -36.84 8.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.85 -25.09 60.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.308 1.443 . . . . 0.0 113.444 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.06 11.37 22.51 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.02 -1.433 . . . . 0.0 115.785 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 9.5 mtpt -81.58 167.21 19.51 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.426 1.613 . . . . 0.0 111.143 174.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.77 148.19 43.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.065 1.757 . . . . 0.0 112.185 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.537 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.2 t -146.99 160.6 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 122.358 1.075 . . . . 0.0 110.61 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 18.6 mt -123.49 103.58 8.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.537 ' CD ' HG11 ' B' ' 92' ' ' VAL . 2.0 mmtt -98.14 118.71 35.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -132.41 163.3 29.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.583 1.182 . . . . 0.0 111.534 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -113.15 168.45 9.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -142.57 164.0 31.31 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.184 0.992 . . . . 0.0 111.771 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -146.38 123.73 11.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.678 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.06 144.78 38.14 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 125.197 1.56 . . . . 0.0 114.173 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.4 115.4 20.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 111.822 -2.445 . . . . 0.0 114.298 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 38.4 m -75.81 161.33 29.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.156 0.982 . . . . 0.0 111.134 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.5 p -98.28 45.29 1.02 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 108' ' ' ASP . 0.3 OUTLIER -51.42 137.73 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.91 1.684 . . . . 0.0 112.979 -174.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -20.3 60.86 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -173.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.21 153.13 50.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.84 1.305 . . . . 0.0 113.666 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' C' ' 84' ' ' PHE . 16.0 tt -65.03 -22.81 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.76 2.78 58.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.363 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.406 ' HB3' HG21 ' B' ' 103' ' ' VAL . 1.5 m-20 -122.5 -0.79 9.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.558 1.143 . . . . 0.0 112.436 -174.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -32.07 67.05 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.28 -0.887 . . . . 0.0 112.892 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.52 ' CD1' HD11 ' D' ' 14' ' ' LEU . 57.0 p-90 -48.65 -41.52 31.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.076 1.35 . . . . 0.0 113.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 110' ' ' TRP . 14.8 pttm -96.65 -8.33 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.91 -1.21 18.7 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.745 ' CG2' HD21 ' B' ' 98' ' ' LEU . 8.2 m -113.15 140.97 47.46 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.772 0.829 . . . . 0.0 112.807 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -144.13 131.56 20.95 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.708 1.203 . . . . 0.0 111.547 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.54 156.73 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 123.976 0.91 . . . . 0.0 110.73 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.35 -175.91 31.85 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.509 0.576 . . . . 0.0 113.358 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 27.8 p90 -124.56 152.57 43.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.781 -0.834 . . . . 0.0 111.956 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.6 12.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.953 0.883 . . . . 0.0 110.072 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.411 HD13 ' HE3' ' B' ' 94' ' ' LYS . 15.2 mt -116.7 138.74 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 24.5 m-85 -125.19 142.41 51.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.851 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 26.9 p -132.29 158.86 40.76 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -57.55 119.68 6.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.455 1.102 . . . . 0.0 113.255 -173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.413 ' O ' HD23 ' B' ' 123' ' ' LEU . 8.7 tt -93.85 89.06 5.98 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -178.52 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.341 1.456 . . . . 0.0 113.577 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -79.77 144.45 33.57 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.516 1.526 . . . . 0.0 110.498 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -90.16 -46.57 8.36 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -135.2 -54.45 0.8 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 111.129 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 C--O 1.263 1.769 1 C-N-CA 136.386 5.874 . . . . 0.0 105.411 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.44 165.53 23.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.751 1.62 . . . . 0.0 108.276 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.48 141.17 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.391 0.676 . . . . 0.0 109.728 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -137.44 137.28 38.59 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.788 0.835 . . . . 0.0 109.778 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -149.41 94.26 2.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.172 2.189 . . . . 0.0 107.135 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.66 124.22 5.42 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.51 1.124 . . . . 0.0 109.0 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . 0.254 16.1 p -116.02 142.94 46.14 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 124.559 1.144 . . . . 0.0 108.343 -173.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 33.1 p -134.83 132.4 38.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.826 1.25 . . . . 0.0 113.858 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.31 -30.03 68.92 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -67.78 111.81 4.5 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.45 -10.32 0.29 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 118.597 2.199 . . . . 0.0 118.597 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt 81.19 146.48 0.08 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 130.513 3.525 . . . . 0.0 113.261 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -140.47 161.45 37.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.227 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -139.09 144.22 38.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.686 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -107.89 143.61 36.27 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.712 0.805 . . . . 0.0 110.275 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.08 -23.91 50.16 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.697 1.599 . . . . 0.0 113.276 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 110' ' ' TRP . 30.6 tp -71.14 -18.96 62.49 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.729 1.612 . . . . 0.0 111.415 174.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.9 -16.36 23.23 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.363 2.411 . . . . 0.0 113.537 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 51.7 p -66.55 141.04 57.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.215 1.508 . . . . 0.0 112.128 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.75 139.41 51.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.58 147.11 51.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.22 1.009 . . . . 0.0 113.021 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -134.85 131.9 37.96 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.891 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.99 125.6 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.99 -82.0 0.23 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 125.342 1.651 . . . . 0.0 111.379 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.72 151.11 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.681 0.753 . . . . 0.0 112.027 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.63 128.02 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.846 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -65.02 161.09 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.618 0.723 . . . . 0.0 111.675 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 11.7 p -58.03 -20.57 39.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -76.81 -29.91 56.18 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.313 0.96 . . . . 0.0 111.621 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.26 -3.69 26.76 Favored Glycine 0 N--CA 1.468 0.772 0 C-N-CA 124.761 1.172 . . . . 0.0 115.112 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.14 150.31 45.55 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.371 1.069 . . . . 0.0 110.797 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.86 162.73 40.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.041 174.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 172.4 11.62 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.37 -167.08 36.2 Favored Glycine 0 C--O 1.237 0.302 0 O-C-N 120.004 -1.685 . . . . 0.0 111.861 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' THR . . . . . 0.629 ' HB ' HD11 ' C' ' 46' ' ' LEU . 34.8 p -133.78 128.57 35.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 123.172 1.463 . . . . 0.0 111.1 174.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.02 137.21 50.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.14 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.411 HD11 HD12 ' C' ' 46' ' ' LEU . 25.7 mt -132.27 133.25 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 35' ' ' THR . . . . . 0.508 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.8 OUTLIER -114.92 146.96 40.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.91 -14.06 19.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.508 ' H ' HG23 ' C' ' 35' ' ' THR . 17.1 m -134.16 142.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.746 1.218 . . . . 0.0 112.609 -174.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.42 38.95 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.035 -1.041 . . . . 0.0 110.992 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.95 -39.01 79.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.362 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -132.12 84.69 52.16 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.089 2.156 . . . . 0.0 107.988 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 175.4 9.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.328 2.018 . . . . 0.0 111.506 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.83 -31.37 3.37 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.523 1.059 . . . . 0.0 112.58 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -140.19 28.6 2.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.486 1.114 . . . . 0.0 112.135 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.83 134.54 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.786 0.803 . . . . 0.0 109.462 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.97 174.66 10.65 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.273 1.429 . . . . 0.0 108.888 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' C' ' 32' ' ' THR . 1.0 OUTLIER -53.86 133.09 42.75 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.26 1.824 . . . . 0.0 112.963 174.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 49.0 m -115.37 125.75 28.51 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.153 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HE3' ' C' ' 71' ' ' LYS . 5.6 Cg_exo -58.04 146.7 86.43 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.142 1.895 . . . . 0.0 110.92 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.83 157.53 42.63 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.229 0.612 . . . . 0.0 111.187 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.513 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -161.3 148.89 15.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.835 1.654 . . . . 0.0 110.244 -174.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.83 -157.9 29.15 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 121.57 1.986 . . . . 0.0 111.875 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.6 mt -145.26 138.25 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.17 0.988 . . . . 0.0 111.933 -174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.17 139.29 51.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.687 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.46 154.64 40.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.486 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -137.28 -6.21 1.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -78.42 -37.2 44.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.31 165.8 16.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.344 0.592 . . . . 0.0 112.538 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 24.8 m -79.05 -34.26 43.95 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -140.2 52.74 3.7 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.897 1.279 . . . . 0.0 112.244 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.79 -179.09 5.11 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.851 2.367 . . . . 0.0 115.95 -174.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -86.5 162.38 18.1 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.792 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -160.22 156.49 26.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.736 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.4 148.98 17.96 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.64 158.77 32.16 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.91 149.78 21.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.825 2.45 . . . . 0.0 108.894 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.58 124.13 58.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' ASN . . . . . 0.587 ' HB2' HG21 ' B' ' 52' ' ' ILE . 44.0 t30 -103.53 107.66 18.59 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.231 -174.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -71.87 149.1 45.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.127 1.441 . . . . 0.0 114.557 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.452 ' HE3' ' HD3' ' C' ' 48' ' ' PRO . 26.5 mttt -108.21 -45.15 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.415 2.005 . . . . 0.0 116.415 -173.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -78.9 -16.93 56.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.204 1.002 . . . . 0.0 112.958 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -152.05 131.57 13.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 129.517 3.127 . . . . 0.0 105.032 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.41 119.04 13.98 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.163 0.892 . . . . 0.0 111.627 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 48.5 t -170.53 167.59 8.01 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.767 1.627 . . . . 0.0 110.819 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -145.81 141.14 27.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 123.927 1.823 . . . . 0.0 110.763 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.59 125.93 23.29 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 109.454 -3.521 . . . . 0.0 110.43 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -102.01 160.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.15 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -136.96 138.36 40.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.4 119.29 9.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.716 0.807 . . . . 0.0 108.875 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.51 -177.88 26.6 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 119.931 -1.128 . . . . 0.0 115.709 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -122.09 145.85 47.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.004 1.061 . . . . 0.0 111.191 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' C' ' 93' ' ' LEU . 14.6 t -97.4 121.73 39.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.803 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.575 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.8 m-85 -112.8 162.23 16.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.415 1.086 . . . . 0.0 113.276 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 27.5 mt -127.86 111.7 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -62.23 162.19 10.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.424 0.69 . . . . 0.0 110.052 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -42.97 -39.53 2.64 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.36 -25.55 63.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.051 1.34 . . . . 0.0 113.784 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.54 10.01 22.33 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.87 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 15.0 mtpp -78.77 164.24 24.7 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.333 1.566 . . . . 0.0 110.862 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.62 148.18 41.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.019 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.2 t -146.91 162.92 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.904 1.281 . . . . 0.0 110.425 176.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' C' ' 120' ' ' PHE . 19.4 mt -126.24 104.21 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.9 mmtt -98.79 118.26 35.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -131.96 163.13 29.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.462 1.125 . . . . 0.0 111.572 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.415 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -112.92 168.82 9.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -143.09 164.29 30.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.199 1.0 . . . . 0.0 111.832 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.747 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.7 OUTLIER -146.4 123.77 11.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.973 -1.467 . . . . 0.0 113.705 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.23 144.72 38.49 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.248 1.419 . . . . 0.0 114.068 -174.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.48 114.91 20.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 112.168 -2.287 . . . . 0.0 114.185 -174.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -74.86 161.32 29.66 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.852 0.861 . . . . 0.0 111.938 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 55.4 p -98.27 45.33 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.307 1.043 . . . . 0.0 111.48 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.31 136.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.744 1.618 . . . . 0.0 113.453 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -20.52 61.85 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -174.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.53 151.35 51.09 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.819 1.295 . . . . 0.0 113.597 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.9 tt -64.28 -21.92 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.56 3.27 64.06 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -122.81 -0.58 9.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.316 1.046 . . . . 0.0 112.621 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -31.55 68.51 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.72 0.808 . . . . 0.0 112.83 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 110' ' ' TRP . . . . . 0.524 ' CD1' HD11 ' A' ' 14' ' ' LEU . 57.4 p-90 -49.02 -41.16 33.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.009 1.323 . . . . 0.0 113.706 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' LYS . . . . . 0.406 ' HB3' ' CZ3' ' C' ' 110' ' ' TRP . 14.9 pttm -96.78 -8.54 30.93 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.01 18.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' THR . . . . . 0.747 ' CG2' HD21 ' C' ' 98' ' ' LEU . 8.3 m -113.41 140.44 48.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.52 0.728 . . . . 0.0 112.66 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -143.69 131.24 21.14 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.639 1.176 . . . . 0.0 111.645 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.37 156.49 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.034 0.933 . . . . 0.0 110.64 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.95 -175.8 31.33 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.352 0.501 . . . . 0.0 113.261 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 27.5 p90 -124.21 152.93 42.33 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.786 -0.832 . . . . 0.0 112.053 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.17 128.81 11.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.966 0.889 . . . . 0.0 110.132 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' ILE . . . . . 0.427 HD13 ' HE3' ' C' ' 94' ' ' LYS . 15.3 mt -115.37 140.87 34.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 25.2 m-85 -127.27 141.32 51.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.772 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 18.2 p -131.69 161.17 33.4 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -59.15 119.76 7.93 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.706 0.802 . . . . 0.0 112.546 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' C' ' 124' ' ' ARG . 7.3 tt -84.66 162.95 19.53 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 172.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.414 ' HB2' HD23 ' C' ' 123' ' ' LEU . 0.0 OUTLIER 72.72 -178.26 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.753 0.821 . . . . 0.0 110.939 174.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 125' ' ' THR . . . . . . . . . . . . 0.256 5.8 t 53.41 -169.22 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.683 1.593 . . . . 0.0 112.762 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -70.58 172.33 8.74 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.384 -0.822 . . . . 0.0 109.393 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 0.44 5.06 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 115.864 -2.017 . . . . 0.0 115.829 -173.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.26 1.632 0 CA-C-O 117.024 -1.465 . . . . 0.0 109.727 -172.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 tttt . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.31 136.97 52.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 122.564 1.173 . . . . 0.0 111.747 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.14 129.03 24.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.909 2.484 . . . . 0.0 107.564 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' A' ' 53' ' ' GLN . 3.8 mt -67.83 -31.25 70.97 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -53.44 116.53 2.5 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.731 0.777 . . . . 0.0 110.947 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.45 -128.85 4.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 10' ' ' TRP . 14.8 ttmt -146.23 152.34 39.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.477 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 55.9 m95 -138.35 162.73 33.66 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 110.879 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 14.7 t -141.3 144.64 34.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.54 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.632 HD22 ' H ' ' A' ' 14' ' ' LEU . 4.2 t30 -106.92 147.28 30.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.84 0.856 . . . . 0.0 111.591 -174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -27.79 58.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.868 1.267 . . . . 0.0 113.94 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 12' ' ' ASN . 35.1 tp -71.09 -15.99 62.55 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.425 1.49 . . . . 0.0 113.476 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.68 -9.81 44.77 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.871 2.177 . . . . 0.0 114.068 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -71.93 146.73 47.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.685 1.243 . . . . 0.0 110.839 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -122.72 148.36 45.41 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.15 -0.969 . . . . 0.0 111.711 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -135.06 139.81 45.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -126.4 132.68 51.48 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.76 126.71 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.77 -91.0 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.637 1.211 . . . . 0.0 111.97 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 134.61 30.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.519 -0.989 . . . . 0.0 110.387 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.01 133.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.959 0.787 . . . . 0.0 111.241 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.36 158.09 36.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.372 1.069 . . . . 0.0 110.874 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.6 m -57.65 -24.58 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.865 -1.147 . . . . 0.0 113.963 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.409 -0.807 . . . . 0.0 110.766 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.31 -5.01 33.42 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.769 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.23 154.24 39.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.942 1.871 . . . . 0.0 111.608 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.04 154.22 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -116.83 156.28 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.604 1.162 . . . . 0.0 109.557 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.72 -176.57 38.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.651 1.139 . . . . 0.0 115.288 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.441 ' CG2' HD23 ' A' ' 46' ' ' LEU . 7.9 p -134.26 123.29 24.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.279 -1.461 . . . . 0.0 107.724 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' C ' HD12 ' A' ' 34' ' ' ILE . 62.2 t80 -124.38 132.14 53.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.169 -1.832 . . . . 0.0 113.76 -171.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 46' ' ' LEU . 2.4 mp -124.15 131.37 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.735 0.778 . . . . 0.0 108.965 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -106.92 138.27 43.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.087 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.32 24.63 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 30.3 m -137.81 136.96 45.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 124.083 0.953 . . . . 0.0 111.921 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.46 163.13 37.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.172 -0.955 . . . . 0.0 111.012 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.88 -27.13 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.25 80.47 10.13 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 127.281 2.232 . . . . 0.0 109.881 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.92 13.21 0.23 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.736 3.624 . . . . 0.0 117.986 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.31 -28.86 1.53 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.41 53.53 0.17 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.147 1.473 . . . . 0.0 112.28 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.55 130.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.756 -1.215 . . . . 0.0 111.096 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.09 172.32 11.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 128.272 2.629 . . . . 0.0 108.818 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.653 HD12 HG13 ' A' ' 34' ' ' ILE 0.289 5.5 mp -66.69 131.91 46.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.7 m -99.39 117.72 63.46 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.421 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.93 138.72 78.48 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.782 1.655 . . . . 0.0 110.525 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.53 148.49 46.24 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.165 0.916 . . . . 0.0 110.688 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 148.89 33.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.554 2.342 . . . . 0.0 108.64 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.49 -159.03 32.05 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.254 -1.529 . . . . 0.0 109.312 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.9 mt -145.48 146.65 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.717 0.892 . . . . 0.0 111.5 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' A' ' 6' ' ' LEU . 7.0 pt20 -132.29 154.35 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.28 1.038 . . . . 0.0 113.071 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -92.16 157.93 16.45 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.381 1.086 . . . . 0.0 109.098 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 23.53 0.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.726 1.61 . . . . 0.0 111.918 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.46 -52.34 4.55 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.465 2.306 . . . . 0.0 111.93 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.78 174.46 3.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -71.77 -44.84 63.33 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.446 -0.784 . . . . 0.0 111.773 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.59 69.08 81.52 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.688 1.195 . . . . 0.0 110.229 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.22 168.64 17.12 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.903 3.068 . . . . 0.0 118.08 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.5 p -86.06 157.45 20.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.365 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -150.59 174.32 13.11 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 123.989 1.852 . . . . 0.0 112.533 174.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.82 149.62 9.38 Favored Glycine 0 N--CA 1.408 -3.186 0 CA-C-N 108.674 -3.875 . . . . 0.0 120.168 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.31 153.21 23.21 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.4 150.01 23.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.362 1.865 . . . . 0.0 109.985 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.84 117.01 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.538 ' CB ' HG21 ' D' ' 52' ' ' ILE . 39.8 t30 -101.99 110.86 22.94 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.87 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.331 50.5 m95 -70.08 154.79 41.5 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.156 1.931 . . . . 0.0 115.436 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 9.9 mmpt? -107.52 -44.18 4.35 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.332 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -91.8 -8.54 46.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 t -152.47 136.61 16.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.359 2.264 . . . . 0.0 107.728 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -72.52 112.35 8.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.658 1.572 . . . . 0.0 110.441 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.1 p -165.98 169.99 14.11 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.011 1.724 . . . . 0.0 111.562 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -148.14 141.62 25.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 122.855 1.312 . . . . 0.0 111.241 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m -137.11 124.06 21.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 110.945 -2.843 . . . . 0.0 110.198 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -101.3 154.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.426 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -127.23 142.31 51.51 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.163 0.985 . . . . 0.0 108.521 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 120.76 7.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -169.69 -166.12 28.17 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.552 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.85 146.15 50.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 124.671 0.865 . . . . 0.0 113.296 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 50.4 t -97.4 113.23 24.86 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.219 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' HD12 ' D' ' 106' ' ' ILE . 18.1 m-85 -103.77 169.64 8.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.298 1.839 . . . . 0.0 111.743 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -125.44 112.14 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.01 161.59 8.19 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.801 0.441 . . . . 0.0 110.535 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -30.36 -57.11 0.2 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.397 1.879 . . . . 0.0 115.975 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.26 -15.51 63.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.01 1.724 . . . . 0.0 115.022 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.94 27.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.702 1.144 . . . . 0.0 114.77 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -78.93 144.32 34.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.739 1.616 . . . . 0.0 111.79 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -101.42 141.73 33.86 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.728 1.211 . . . . 0.0 111.708 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.8 m -144.02 160.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.777 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -119.45 116.92 27.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -107.28 111.92 24.52 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 7.2 p -133.28 172.0 13.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.125 1.441 . . . . 0.0 111.563 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.513 ' HG3' HG21 ' D' ' 113' ' ' THR . 90.8 mmm -124.78 169.22 12.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.431 -1.258 . . . . 0.0 107.794 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -139.94 162.03 36.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.045 1.402 . . . . 0.0 112.319 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -145.67 119.17 9.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.149 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.25 141.27 38.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 123.649 1.69 . . . . 0.0 110.42 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 10.4 tpt180 -125.62 113.91 18.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 110.172 -3.195 . . . . 0.0 109.746 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -77.09 156.94 31.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.982 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.87 82.87 2.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -65.8 173.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.684 1.194 . . . . 0.0 111.978 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.515 ' H ' HG12 ' A' ' 103' ' ' VAL . 4.6 p-10 -117.87 -7.58 10.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.96 148.1 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.869 1.319 . . . . 0.0 110.33 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' D' ' 92' ' ' VAL . 15.7 tt -63.3 -26.28 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.862 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.04 -2.83 33.38 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 117.912 -1.493 . . . . 0.0 115.219 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.55 3.67 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.843 1.321 . . . . 0.0 113.459 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -35.38 61.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.959 -1.088 . . . . 0.0 111.577 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.501 ' CD1' HD11 ' C' ' 14' ' ' LEU . 60.2 p-90 -50.13 -46.34 53.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.163 0.985 . . . . 0.0 113.402 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -14.71 42.65 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.372 -0.83 . . . . 0.0 112.728 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' A' ' 103' ' ' VAL . . . -73.81 -9.16 58.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' D' ' 96' ' ' MET . 61.9 m -95.24 155.97 16.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -154.05 124.15 6.87 Favored 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 126.822 2.049 . . . . 0.0 111.156 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.37 156.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 121.792 2.087 . . . . 0.0 110.203 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.18 -177.56 31.4 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 124.397 1.061 . . . . 0.0 115.023 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 16.2 p90 -123.67 152.23 42.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.114 0.966 . . . . 0.0 110.984 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -150.4 148.2 28.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.899 0.88 . . . . 0.0 110.67 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.3 mt -132.27 122.94 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.082 -1.011 . . . . 0.0 109.294 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -113.87 153.94 28.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.013 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.0 p -135.73 164.27 28.28 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.307 1.043 . . . . 0.0 110.796 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -57.74 117.7 4.51 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.444 1.098 . . . . 0.0 110.41 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 9' ' ' LYS . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.57 0 O-C-N 122.228 -0.295 . . . . 0.0 110.606 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttt . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 131.36 56.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.752 1.263 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.77 127.58 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.908 2.083 . . . . 0.0 106.042 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' D' ' 53' ' ' GLN . 2.4 mt -73.22 -28.87 62.42 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 124.414 1.071 . . . . 0.0 112.755 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -53.5 115.84 2.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.93 0.892 . . . . 0.0 110.508 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.72 -132.63 5.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.482 1.515 . . . . 0.0 109.392 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . 0.489 ' HG2' ' H ' ' D' ' 10' ' ' TRP . 16.0 ttmt -144.24 152.51 40.93 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . 0.489 ' H ' ' HG2' ' D' ' 9' ' ' LYS . 55.6 m95 -139.94 162.72 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.544 1.938 . . . . 0.0 111.476 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.646 ' HB ' HD12 ' D' ' 123' ' ' LEU . 14.2 t -139.9 146.95 39.9 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.354 1.062 . . . . 0.0 109.102 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.666 HD22 ' H ' ' D' ' 14' ' ' LEU . 3.8 t30 -108.85 148.25 30.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.64 0.776 . . . . 0.0 111.546 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -25.37 59.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.692 1.197 . . . . 0.0 114.108 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.666 ' H ' HD22 ' D' ' 12' ' ' ASN . 34.9 tp -73.3 -15.85 61.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.596 1.559 . . . . 0.0 113.269 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.04 -12.84 45.14 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.479 1.99 . . . . 0.0 113.89 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -67.96 145.63 54.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.94 1.37 . . . . 0.0 111.166 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -120.95 149.31 42.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.182 -0.949 . . . . 0.0 111.692 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -135.31 142.46 45.84 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.912 -0.493 . . . . 0.0 112.209 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -128.59 132.35 48.19 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.871 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.01 127.6 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.577 1.173 . . . . 0.0 112.307 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.27 134.6 29.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.851 -0.794 . . . . 0.0 110.632 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.02 131.91 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.679 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.71 156.45 38.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.778 1.231 . . . . 0.0 110.275 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 72.8 m -57.29 -23.04 45.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.09 -28.15 68.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.501 -0.75 . . . . 0.0 110.841 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.74 -4.35 34.39 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 125.302 1.429 . . . . 0.0 112.771 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.85 158.98 30.43 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.843 1.322 . . . . 0.0 113.32 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.09 166.36 33.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.71 0.767 . . . . 0.0 112.05 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -128.61 160.07 33.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.552 1.141 . . . . 0.0 108.801 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.93 -175.48 39.52 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 119.974 -1.108 . . . . 0.0 115.465 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.459 ' CG2' HD23 ' D' ' 46' ' ' LEU . 8.7 p -134.75 124.03 24.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.084 1.354 . . . . 0.0 107.927 -174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . 0.581 ' C ' HD12 ' D' ' 34' ' ' ILE . 65.0 t80 -125.3 131.24 53.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.638 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.668 HG13 HD12 ' D' ' 46' ' ' LEU . 2.5 mp -123.37 129.67 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.926 0.87 . . . . 0.0 109.015 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.25 137.84 42.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.255 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.53 -6.92 26.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 31.1 m -138.4 136.87 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.056 0.931 . . . . 0.0 112.175 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.27 161.96 39.9 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.855 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.3 -25.45 54.84 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.715 -0.616 . . . . 0.0 110.555 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -146.85 79.81 9.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 127.277 2.231 . . . . 0.0 109.791 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.91 13.13 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.834 3.689 . . . . 0.0 117.992 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.48 -28.64 1.57 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 118.241 2.056 . . . . 0.0 118.241 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.71 54.77 0.17 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.203 1.502 . . . . 0.0 112.076 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.68 130.54 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.76 -1.213 . . . . 0.0 111.068 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 173.06 10.95 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.274 2.629 . . . . 0.0 108.894 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.668 HD12 HG13 ' D' ' 34' ' ' ILE 0.296 5.4 mp -67.72 131.11 44.96 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 61.1 m -98.31 117.98 64.08 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.762 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.26 137.86 78.06 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.694 1.596 . . . . 0.0 110.264 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -121.9 155.67 34.97 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.446 1.091 . . . . 0.0 110.662 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -155.62 149.03 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.319 1.848 . . . . 0.0 109.026 -177.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.32 -157.42 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 O-C-N 121.158 -0.964 . . . . 0.0 111.021 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.538 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -145.56 147.06 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.03 0.919 . . . . 0.0 111.568 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' D' ' 6' ' ' LEU . 5.7 pt20 -133.12 153.59 51.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.37 1.081 . . . . 0.0 112.969 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.37 157.55 17.56 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.389 1.09 . . . . 0.0 108.539 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 24.33 0.56 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.728 1.611 . . . . 0.0 111.358 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -93.48 -51.57 4.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.602 2.361 . . . . 0.0 111.318 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 172.26 8.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -69.11 -43.47 74.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 0.0 111.075 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.85 71.59 69.68 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.947 1.299 . . . . 0.0 110.851 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -69.86 169.29 19.38 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.076 3.184 . . . . 0.0 118.817 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 36.2 p -86.65 156.23 20.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.018 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' D' ' 83' ' ' CYS . 0.0 OUTLIER -152.62 173.99 14.52 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 123.981 1.848 . . . . 0.0 112.633 174.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.0 148.89 9.17 Favored Glycine 0 N--CA 1.412 -2.941 0 CA-C-N 109.213 -3.63 . . . . 0.0 119.748 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -159.59 153.09 22.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.55 151.3 23.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.601 1.96 . . . . 0.0 110.006 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.47 117.38 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.534 ' CB ' HG21 ' A' ' 52' ' ' ILE . 42.4 t30 -102.42 111.83 24.29 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.136 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.328 51.1 m95 -70.68 153.11 43.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 124.105 1.907 . . . . 0.0 115.61 -172.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' D' ' 71' ' ' LYS . 9.9 mmpt? -105.76 -43.46 4.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.188 -174.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -92.09 -8.65 45.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -152.58 136.51 16.32 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.204 2.202 . . . . 0.0 107.473 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.83 111.52 7.16 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.691 1.587 . . . . 0.0 110.368 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 93.0 p -165.07 170.73 14.72 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.778 1.631 . . . . 0.0 111.569 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 64' ' ' PHE . 4.9 t -148.35 142.21 25.74 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.519 1.152 . . . . 0.0 111.586 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.13 123.65 20.9 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 111.25 -2.705 . . . . 0.0 110.357 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 m -100.8 154.04 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -127.21 142.08 51.57 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.01 0.924 . . . . 0.0 108.719 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 119.96 7.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -167.79 -166.75 27.4 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.132 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -133.56 147.07 51.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 125.051 1.089 . . . . 0.0 112.819 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.448 ' HB2' ' CZ ' ' D' ' 64' ' ' PHE . 44.1 t -97.28 125.35 41.79 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 116.19 -1.862 . . . . 0.0 108.011 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.432 ' HB2' HD12 ' A' ' 106' ' ' ILE . 13.1 m-85 -114.51 172.03 7.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.921 1.689 . . . . 0.0 110.819 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mt -127.87 111.87 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.51 158.73 9.27 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -25.97 -55.16 0.06 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.212 2.205 . . . . 0.0 116.005 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -9.02 58.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.137 2.175 . . . . 0.0 116.001 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.8 51.1 3.51 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 120.082 1.31 . . . . 0.0 109.981 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -124.07 136.35 54.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.795 1.638 . . . . 0.0 109.119 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -101.06 139.82 36.22 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.903 1.335 . . . . 0.0 110.689 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 106' ' ' ILE . 19.9 m -144.3 161.05 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.704 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.73 116.78 25.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -106.78 111.13 23.52 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.432 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 6.3 p -133.07 172.18 12.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 123.51 1.624 . . . . 0.0 111.831 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' A' ' 113' ' ' THR . 90.4 mmm -124.92 169.06 12.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -139.26 162.22 35.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.56 1.648 . . . . 0.0 112.55 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -145.68 119.81 9.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.699 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.29 141.75 38.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.599 1.812 . . . . 0.0 110.442 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -126.0 113.87 17.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 109.999 -3.273 . . . . 0.0 109.895 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 2.6 t -77.84 158.19 29.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.286 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 56.6 m -105.22 77.62 1.32 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.68 0.752 . . . . 0.0 109.74 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.581 ' CG2' ' HB2' ' D' ' 112' ' ' ALA . 1.5 t -63.55 166.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.106 1.363 . . . . 0.0 112.595 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.405 ' H ' HG12 ' D' ' 103' ' ' VAL . 4.7 p-10 -112.44 -4.36 14.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.64 147.4 35.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.58 1.181 . . . . 0.0 110.373 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.482 ' CD1' HG21 ' A' ' 92' ' ' VAL . 16.0 tt -63.36 -26.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.854 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.49 -3.03 30.66 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 117.659 -1.634 . . . . 0.0 115.432 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.26 3.49 10.34 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.806 1.303 . . . . 0.0 113.636 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.96 60.71 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.819 -1.176 . . . . 0.0 111.816 174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.507 ' CD1' HD11 ' B' ' 14' ' ' LEU . 60.4 p-90 -49.46 -46.83 48.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 -15.65 41.82 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.29 -0.881 . . . . 0.0 112.789 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' D' ' 103' ' ' VAL . . . -73.51 -7.76 53.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.513 HG21 ' HG3' ' A' ' 96' ' ' MET . 57.2 m -96.54 154.88 17.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.021 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.19 124.3 7.47 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.627 1.971 . . . . 0.0 111.195 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.52 156.23 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 121.699 2.045 . . . . 0.0 110.047 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -178.6 31.68 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.834 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 15.6 p90 -122.51 152.62 40.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.168 0.987 . . . . 0.0 110.83 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -150.61 147.36 27.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.937 0.875 . . . . 0.0 110.837 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.64 120.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.239 -0.913 . . . . 0.0 108.985 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -110.46 154.31 23.8 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.067 0.855 . . . . 0.0 111.539 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -136.68 161.95 34.51 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.378 1.071 . . . . 0.0 110.055 174.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -56.66 128.26 35.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.724 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.408 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 tttt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 132.22 56.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.453 1.101 . . . . 0.0 111.391 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.27 127.64 19.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.847 2.059 . . . . 0.0 106.439 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.66 -30.82 64.6 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.84 117.3 2.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.929 0.892 . . . . 0.0 110.733 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.28 -130.49 4.83 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.755 1.645 . . . . 0.0 109.662 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' B' ' 10' ' ' TRP . 15.1 ttmt -145.25 152.83 40.58 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . 0.472 ' H ' ' HG2' ' B' ' 9' ' ' LYS . 58.0 m95 -138.76 162.73 33.99 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.753 2.021 . . . . 0.0 111.275 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -143.51 145.0 32.21 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.903 0.881 . . . . 0.0 109.195 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.62 HD22 ' H ' ' B' ' 14' ' ' LEU . 4.1 t30 -109.7 146.55 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.887 0.875 . . . . 0.0 111.83 -174.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -25.87 53.38 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.62 ' H ' HD22 ' B' ' 12' ' ' ASN . 35.0 tp -73.21 -16.54 61.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.479 1.512 . . . . 0.0 113.075 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 -12.94 29.98 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.964 2.221 . . . . 0.0 114.033 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -69.0 142.96 54.49 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.836 -1.391 . . . . 0.0 111.993 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.42 143.31 45.72 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.829 -1.169 . . . . 0.0 110.657 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -133.24 139.23 46.84 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.946 -0.471 . . . . 0.0 112.053 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -126.51 132.6 51.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.871 0.868 . . . . 0.0 108.74 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.9 mt -129.05 127.2 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -91.06 0.07 OUTLIER Glycine 0 CA--C 1.528 0.9 0 O-C-N 124.87 1.356 . . . . 0.0 112.096 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.32 135.35 32.12 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.863 -0.787 . . . . 0.0 110.865 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.94 133.61 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.223 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.9 158.26 36.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.358 1.063 . . . . 0.0 110.993 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 64.7 m -57.87 -24.31 57.01 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.753 -1.217 . . . . 0.0 114.021 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -66.15 -29.25 69.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.453 -0.779 . . . . 0.0 110.729 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.19 34.63 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 117.918 -1.49 . . . . 0.0 112.933 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.85 154.15 39.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.798 1.799 . . . . 0.0 111.535 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.35 154.16 31.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -116.78 156.43 27.23 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 109.573 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.62 -176.18 38.1 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.691 1.162 . . . . 0.0 115.02 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.449 ' CG2' HD23 ' B' ' 46' ' ' LEU . 7.5 p -134.87 123.97 24.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 113.259 -1.471 . . . . 0.0 107.298 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.574 ' C ' HD12 ' B' ' 34' ' ' ILE . 64.9 t80 -124.72 131.29 53.47 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.724 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.649 HG13 HD12 ' B' ' 46' ' ' LEU . 2.4 mp -123.72 129.57 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 122.09 0.948 . . . . 0.0 108.597 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.02 141.23 36.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.251 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.97 21.6 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.96 136.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.201 1.0 . . . . 0.0 111.797 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.94 162.2 39.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.241 -0.912 . . . . 0.0 110.999 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.02 -27.45 60.1 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.445 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.09 80.36 10.33 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.214 2.205 . . . . 0.0 109.758 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.64 12.94 0.23 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.722 3.615 . . . . 0.0 118.073 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.0 -28.97 1.38 Allowed Glycine 0 CA--C 1.54 1.621 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -163.25 53.29 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.152 1.476 . . . . 0.0 112.361 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.74 130.54 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 120.782 -1.199 . . . . 0.0 111.358 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 173.5 10.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.049 2.54 . . . . 0.0 108.945 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.649 HD12 HG13 ' B' ' 34' ' ' ILE 0.292 5.4 mp -67.71 131.51 45.72 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.6 m -99.22 117.69 63.67 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.418 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -54.61 138.85 75.92 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.665 1.577 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.5 148.47 46.22 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.248 0.967 . . . . 0.0 110.641 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.66 148.85 33.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.402 2.281 . . . . 0.0 108.646 174.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.52 -159.09 32.12 Favored Glycine 0 N--CA 1.443 -0.898 0 O-C-N 120.319 -1.488 . . . . 0.0 109.464 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.9 mt -145.41 147.58 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.784 0.834 . . . . 0.0 111.473 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -133.15 153.99 51.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 122.409 1.099 . . . . 0.0 113.859 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -91.9 157.09 17.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.549 1.166 . . . . 0.0 108.892 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.38 25.09 0.47 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.018 1.727 . . . . 0.0 111.55 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -93.64 -52.16 4.6 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.601 2.36 . . . . 0.0 112.123 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.97 171.86 8.77 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.7 t -69.65 -42.22 74.51 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.747 0.819 . . . . 0.0 111.161 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 69.32 72.68 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.499 1.12 . . . . 0.0 110.931 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.88 169.14 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.003 3.136 . . . . 0.0 118.454 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -86.44 157.24 19.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.063 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' B' ' 83' ' ' CYS . 0.0 OUTLIER -153.21 174.28 14.47 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 124.18 1.943 . . . . 0.0 112.353 174.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.28 149.11 9.22 Favored Glycine 0 N--CA 1.411 -2.992 0 CA-C-N 109.065 -3.698 . . . . 0.0 120.046 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -159.12 153.48 23.99 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.47 149.94 23.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.984 1.714 . . . . 0.0 109.984 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 117.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 173.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.537 ' CB ' HG21 ' C' ' 52' ' ' ILE . 38.6 t30 -102.11 110.81 22.87 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.799 -174.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.334 49.9 m95 -70.08 155.54 40.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.958 1.837 . . . . 0.0 115.396 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' B' ' 71' ' ' LYS . 9.8 mmpt? -108.54 -44.26 4.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.355 -1.748 . . . . 0.0 114.143 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -91.18 -8.74 47.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.23 1.012 . . . . 0.0 113.691 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -152.38 137.05 16.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.31 2.244 . . . . 0.0 107.36 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.64 111.77 8.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.497 1.498 . . . . 0.0 110.715 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 93.3 p -165.31 169.92 15.28 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.077 1.751 . . . . 0.0 111.635 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.68 141.87 26.13 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.21 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.6 m -137.62 123.82 20.48 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.216 -173.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.95 154.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.536 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.24 141.93 51.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 108.676 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.62 119.86 7.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -168.55 -167.4 29.12 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.412 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -133.56 146.37 50.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.078 -1.061 . . . . 0.0 112.618 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' B' ' 64' ' ' PHE . 41.4 t -97.37 122.0 39.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.087 173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.451 ' HB2' HD12 ' C' ' 106' ' ' ILE . 12.2 m-85 -111.37 172.49 6.85 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.714 1.606 . . . . 0.0 110.669 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mt -128.41 113.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.97 162.47 6.96 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -30.12 -52.53 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.744 2.017 . . . . 0.0 115.772 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -78.35 -0.7 30.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.393 2.277 . . . . 0.0 116.978 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 50.94 6.87 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.439 -1.413 . . . . 0.0 110.505 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -119.91 141.89 49.2 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.514 2.326 . . . . 0.0 105.432 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -111.38 138.5 47.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.265 1.426 . . . . 0.0 110.99 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 20.6 m -144.3 161.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.686 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -121.04 118.2 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -108.03 111.55 23.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 6.9 p -133.46 171.91 13.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.066 1.412 . . . . 0.0 111.971 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.519 ' HG3' HG21 ' C' ' 113' ' ' THR . 90.6 mmm -124.63 169.32 12.05 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -139.67 162.02 36.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.489 1.614 . . . . 0.0 112.644 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.47 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.9 OUTLIER -145.58 119.65 9.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.017 179.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 141.54 38.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 123.677 1.703 . . . . 0.0 110.578 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -126.26 114.0 17.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 110.121 -3.218 . . . . 0.0 110.162 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -78.23 156.65 29.64 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.616 1.198 . . . . 0.0 110.824 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.73 82.45 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' B' ' 112' ' ' ALA . 1.6 t -66.32 172.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.94 1.296 . . . . 0.0 111.815 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.498 ' H ' HG12 ' B' ' 103' ' ' VAL . 5.1 p-10 -119.2 -2.77 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 174.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.421 ' H ' HG12 ' B' ' 103' ' ' VAL . 0.8 OUTLIER -142.25 146.4 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.346 1.07 . . . . 0.0 111.06 174.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' C' ' 92' ' ' VAL . 14.8 tt -63.57 -26.88 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.958 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.63 -3.62 34.86 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.979 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.16 3.55 10.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.712 1.256 . . . . 0.0 113.271 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -36.13 62.12 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.041 -1.037 . . . . 0.0 111.575 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' D' ' 14' ' ' LEU . 59.0 p-90 -48.68 -46.79 40.9 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 -16.06 38.71 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.267 -0.895 . . . . 0.0 112.673 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' B' ' 103' ' ' VAL . . . -72.25 -8.34 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' C' ' 96' ' ' MET . 57.6 m -96.38 156.65 16.25 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.697 0.399 . . . . 0.0 110.227 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ttm-85 -154.27 124.52 6.89 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 126.933 2.093 . . . . 0.0 111.366 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 p -105.63 156.18 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 121.832 2.105 . . . . 0.0 110.166 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.88 -178.0 31.52 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.232 0.958 . . . . 0.0 114.83 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 15.5 p90 -123.02 152.72 40.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.285 1.034 . . . . 0.0 110.691 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -150.61 146.25 26.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.008 0.908 . . . . 0.0 111.331 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.64 119.14 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.082 -1.011 . . . . 0.0 108.67 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.63 154.45 21.97 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.281 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 20.3 p -138.02 164.16 29.78 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.379 1.072 . . . . 0.0 109.645 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.99 123.72 16.14 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.547 0.837 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.039 174.74 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 tttt . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 131.49 56.92 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.924 1.345 . . . . 0.0 110.077 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.61 127.52 22.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.431 HD12 ' CD ' ' C' ' 53' ' ' GLN . 2.7 mt -73.41 -27.56 61.52 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.414 1.071 . . . . 0.0 112.844 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -53.61 117.28 3.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.861 0.838 . . . . 0.0 110.368 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.98 -130.27 4.79 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.719 1.628 . . . . 0.0 109.525 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . 0.433 ' HD2' HD13 ' C' ' 123' ' ' LEU . 19.7 ttmt -142.46 151.13 41.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.808 1.29 . . . . 0.0 113.288 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . 0.427 ' H ' ' HG2' ' C' ' 9' ' ' LYS . 50.0 m95 -136.18 162.69 32.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 112.469 -2.15 . . . . 0.0 110.816 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -142.84 142.51 31.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.65 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . 0.616 HD22 ' H ' ' C' ' 14' ' ' LEU . 4.2 t30 -108.36 148.06 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.918 0.887 . . . . 0.0 112.529 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -27.9 61.74 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.316 1.446 . . . . 0.0 114.365 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.616 ' H ' HD22 ' C' ' 12' ' ' ASN . 33.9 tp -72.34 -15.9 61.87 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.393 1.477 . . . . 0.0 113.176 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -14.34 29.51 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.153 2.311 . . . . 0.0 113.645 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.636 1.218 . . . . 0.0 111.29 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -118.49 144.48 45.98 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.264 -0.897 . . . . 0.0 111.061 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -133.79 141.46 47.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.998 0.428 . . . . 0.0 111.63 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 5.9 m -129.73 132.12 46.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.79 127.37 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.57 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.867 1.354 . . . . 0.0 112.18 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.41 135.12 30.05 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.605 -0.938 . . . . 0.0 110.649 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.71 131.67 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.807 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.46 156.37 39.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.791 1.237 . . . . 0.0 110.229 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -57.29 -23.05 46.0 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -66.05 -28.49 68.88 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.531 -0.731 . . . . 0.0 110.797 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.83 -3.94 34.11 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.167 1.365 . . . . 0.0 112.724 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -77.05 158.76 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.71 1.255 . . . . 0.0 113.316 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.02 166.32 33.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.485 0.659 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.7 160.16 33.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.709 1.203 . . . . 0.0 108.702 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.22 -175.5 39.72 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 119.961 -1.114 . . . . 0.0 115.435 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.443 ' CG2' HD23 ' C' ' 46' ' ' LEU . 9.0 p -134.7 123.96 24.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.811 1.244 . . . . 0.0 107.702 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.575 ' C ' HD12 ' C' ' 34' ' ' ILE . 65.4 t80 -125.09 130.56 52.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.612 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.657 HG13 HD12 ' C' ' 46' ' ' LEU . 2.3 mp -122.9 129.48 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 CA-C-O 121.932 0.872 . . . . 0.0 108.833 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -104.99 140.31 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.996 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.56 -6.39 22.87 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.64 136.93 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.025 0.93 . . . . 0.0 111.645 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.76 162.21 39.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.985 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.98 -27.49 60.18 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -145.78 80.42 10.57 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.989 2.116 . . . . 0.0 109.766 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.85 13.44 0.22 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.835 3.69 . . . . 0.0 118.044 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.71 -28.62 1.7 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.21 53.39 0.18 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.093 1.447 . . . . 0.0 112.037 -174.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -56.84 130.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.914 -1.116 . . . . 0.0 111.087 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.53 172.27 11.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.109 2.564 . . . . 0.0 109.115 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.657 HD12 HG13 ' C' ' 34' ' ' ILE 0.299 5.4 mp -66.95 130.45 43.2 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 59.4 m -98.08 118.15 64.07 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.977 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -55.0 138.65 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.643 1.562 . . . . 0.0 110.061 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -122.53 155.72 35.65 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.331 1.019 . . . . 0.0 110.852 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -155.38 149.08 25.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.014 1.726 . . . . 0.0 108.799 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.58 29.78 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 119.353 0.979 . . . . 0.0 111.033 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.42 147.0 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.057 0.932 . . . . 0.0 111.938 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.431 ' CD ' HD12 ' C' ' 6' ' ' LEU . 6.7 pt20 -133.57 154.0 51.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.221 1.008 . . . . 0.0 113.225 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -90.67 159.06 16.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.435 1.112 . . . . 0.0 108.765 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 25.05 0.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.689 1.596 . . . . 0.0 111.57 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -93.36 -51.87 4.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.831 2.453 . . . . 0.0 111.328 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 171.96 10.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -71.08 -41.95 70.01 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.665 0.745 . . . . 0.0 110.955 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.56 67.76 80.32 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.405 1.082 . . . . 0.0 111.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -69.69 170.23 16.99 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.902 3.068 . . . . 0.0 118.268 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 41.7 p -86.63 156.42 20.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.903 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' C' ' 83' ' ' CYS . 0.0 OUTLIER -153.58 173.7 15.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.728 1.728 . . . . 0.0 112.762 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.51 148.49 9.12 Favored Glycine 0 N--CA 1.412 -2.927 0 CA-C-N 109.351 -3.568 . . . . 0.0 119.528 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -159.47 153.18 22.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -87.85 150.94 23.22 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.333 1.853 . . . . 0.0 110.021 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.78 117.13 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' B' ' 52' ' ' ILE . 40.1 t30 -102.39 111.47 23.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.969 -174.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.33 49.9 m95 -70.45 154.7 41.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 124.199 1.952 . . . . 0.0 115.448 -172.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' C' ' 71' ' ' LYS . 9.9 mmpt? -107.54 -43.79 4.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.221 -1.809 . . . . 0.0 114.145 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.79 -8.42 46.77 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.57 136.7 16.48 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.286 2.235 . . . . 0.0 107.448 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -72.53 111.21 7.5 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.556 1.525 . . . . 0.0 110.829 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -165.1 170.07 15.45 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 125.879 1.672 . . . . 0.0 111.441 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -147.8 141.92 26.06 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 122.901 1.334 . . . . 0.0 111.264 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.6 m -137.04 124.36 21.91 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 110.88 -2.873 . . . . 0.0 110.387 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 m -101.81 154.31 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.555 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.19 142.32 51.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.102 0.961 . . . . 0.0 108.419 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.09 120.16 7.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -168.3 -167.31 28.75 Favored Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.11 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.58 146.67 51.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 125.171 1.159 . . . . 0.0 112.656 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 64' ' ' PHE . 44.7 t -97.23 125.56 41.85 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 115.66 -2.114 . . . . 0.0 108.009 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.433 ' HB2' HD12 ' B' ' 106' ' ' ILE . 13.8 m-85 -114.4 171.27 7.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.928 1.691 . . . . 0.0 110.614 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.03 110.77 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.26 157.67 13.04 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -23.45 -57.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.978 2.111 . . . . 0.0 116.53 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.0 -14.18 62.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.91 20.95 10.66 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.031 0.824 . . . . 0.0 113.68 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -91.09 142.28 27.93 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.849 1.325 . . . . 0.0 110.296 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -101.47 139.46 37.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.281 1.032 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.8 m -142.17 161.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.179 1.392 . . . . 0.0 110.057 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 14.8 mt -119.26 116.92 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -107.43 110.76 22.79 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.45 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 6.8 p -132.34 171.51 13.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 123.24 1.495 . . . . 0.0 111.862 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' B' ' 113' ' ' THR . 91.2 mmm -124.68 169.07 12.32 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -139.36 162.33 35.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 123.378 1.561 . . . . 0.0 112.658 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.477 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -145.76 119.48 9.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.069 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.74 38.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.465 1.602 . . . . 0.0 110.403 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -126.14 113.9 17.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 110.346 -3.116 . . . . 0.0 109.762 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -77.11 156.48 31.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.032 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 52.6 m -103.05 83.14 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' C' ' 112' ' ' ALA . 1.6 t -66.52 172.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.472 1.109 . . . . 0.0 111.715 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.499 ' H ' HG12 ' C' ' 103' ' ' VAL . 4.6 p-10 -118.04 -5.21 10.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.93 148.01 37.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.73 1.252 . . . . 0.0 110.202 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' B' ' 92' ' ' VAL . 15.5 tt -63.61 -25.73 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.02 -1.446 . . . . 0.0 112.909 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.15 -1.75 36.05 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.579 -1.123 . . . . 0.0 115.393 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . 0.404 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.6 OUTLIER -122.25 3.09 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.287 1.044 . . . . 0.0 113.54 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.91 60.52 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.2 -0.938 . . . . 0.0 111.556 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.503 ' CD1' HD11 ' A' ' 14' ' ' LEU . 60.1 p-90 -50.28 -46.35 55.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.137 0.975 . . . . 0.0 113.565 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -15.12 41.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.158 -0.964 . . . . 0.0 112.577 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . 0.578 ' HB2' ' CG2' ' C' ' 103' ' ' VAL . . . -73.54 -8.12 54.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.519 HG21 ' HG3' ' B' ' 96' ' ' MET . 62.2 m -96.63 155.12 16.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.675 0.39 . . . . 0.0 110.044 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttm-85 -153.04 124.02 7.43 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 126.931 2.092 . . . . 0.0 111.208 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.09 156.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 121.77 2.077 . . . . 0.0 110.091 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -177.54 31.46 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.206 0.941 . . . . 0.0 114.962 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 15.9 p90 -123.85 152.41 42.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.276 1.03 . . . . 0.0 110.908 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -150.43 147.0 27.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.936 0.895 . . . . 0.0 111.187 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.97 121.77 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -112.93 153.47 27.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.683 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.7 p -134.13 162.55 31.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.106 0.962 . . . . 0.0 110.317 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -55.5 121.77 9.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.948 0.899 . . . . 0.0 109.691 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.46 HD23 ' C ' ' C' ' 123' ' ' LEU . 5.4 tt . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.921 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -124.09 129.2 50.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.077 0.941 . . . . 0.0 110.963 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -139.61 127.5 22.11 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.248 -1.532 . . . . 0.0 114.279 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 64' ' ' PHE . 21.1 mt -55.51 -32.84 63.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -54.83 122.02 9.87 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.724 1.249 . . . . 0.0 110.932 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.25 -108.31 0.87 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.512 2.006 . . . . 0.0 111.696 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.12 144.0 20.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -140.76 162.79 34.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.327 1.851 . . . . 0.0 110.632 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -141.71 151.44 42.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.237 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 14' ' ' LEU . 4.6 t30 -116.42 146.31 42.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.376 1.071 . . . . 0.0 112.521 -173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.49 -23.67 64.69 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' H ' HD22 ' A' ' 12' ' ' ASN . 28.0 tp -71.58 -15.7 62.28 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.703 -1.248 . . . . 0.0 112.115 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.82 -14.35 24.34 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 128.382 2.896 . . . . 0.0 113.686 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p -63.31 144.27 57.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.456 1.128 . . . . 0.0 112.987 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' OD1' HD12 ' A' ' 34' ' ' ILE . 6.2 p30 -115.66 140.34 49.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -130.71 139.81 50.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.545 0.688 . . . . 0.0 111.084 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.7 m -129.0 131.52 47.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.21 127.02 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.51 -88.4 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.299 1.0 . . . . 0.0 111.553 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.24 42.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.863 0.839 . . . . 0.0 112.426 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 t -98.14 123.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.017 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.22 156.0 38.51 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 m -55.21 -22.01 16.14 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -72.32 -37.78 68.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.359 0.664 . . . . 0.0 111.237 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.31 -2.66 18.64 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 117.336 -1.813 . . . . 0.0 113.422 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HB2' HD21 ' D' ' 50' ' ' LEU . 9.7 pt-20 -69.26 137.44 53.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.928 1.691 . . . . 0.0 107.079 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.25 148.19 25.61 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.16 163.58 15.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.192 0.997 . . . . 0.0 109.374 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.35 -168.0 34.59 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 120.947 -1.095 . . . . 0.0 113.165 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.633 ' HB ' HD11 ' A' ' 46' ' ' LEU . 1.1 p -141.54 129.69 22.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.965 1.364 . . . . 0.0 110.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.64 141.02 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.019 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 46' ' ' LEU . 7.9 mt -131.93 128.75 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.375 1.083 . . . . 0.0 108.53 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 ' O ' HG21 ' A' ' 44' ' ' ILE . 35.3 m -105.65 133.76 49.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.615 -1.175 . . . . 0.0 113.073 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.26 -17.87 23.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.74 142.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.831 1.252 . . . . 0.0 111.83 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.98 153.81 40.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.028 -1.045 . . . . 0.0 111.268 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.54 -24.25 66.35 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -147.88 76.56 10.53 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 128.518 2.727 . . . . 0.0 112.053 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.03 169.56 18.97 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.169 2.579 . . . . 0.0 112.431 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.88 -29.55 1.55 Allowed Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.473 1.035 . . . . 0.0 113.078 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.06 2.89 3.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.559 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 35' ' ' THR . 54.9 mt -31.83 112.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.151 1.78 . . . . 0.0 114.354 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 157.78 41.59 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.556 1.543 . . . . 0.0 110.879 -176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.633 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.6 tp -46.72 115.51 1.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.021 2.928 . . . . 0.0 111.623 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 t -103.48 117.06 60.97 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.454 1.102 . . . . 0.0 109.933 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 144.22 82.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.27 2.647 . . . . 0.0 112.552 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.71 155.08 45.64 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.673 0.789 . . . . 0.0 111.863 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -159.75 147.61 17.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.164 1.785 . . . . 0.0 112.296 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.17 -151.55 21.91 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 120.786 1.63 . . . . 0.0 110.954 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.4 mp -141.24 137.86 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 113.135 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -120.95 141.03 51.05 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.15 -50.47 71.72 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.503 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.92 14.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 127.395 2.278 . . . . 0.0 116.852 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.76 -47.08 6.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.515 2.726 . . . . 0.0 115.103 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.76 -174.11 2.46 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.319 1.012 . . . . 0.0 111.63 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -83.43 -36.72 24.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -124.41 56.67 12.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.667 1.187 . . . . 0.0 110.497 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.02 164.04 37.16 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.884 3.056 . . . . 0.0 116.309 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.5 p -82.21 167.79 18.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.95 1.3 . . . . 0.0 111.383 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -159.13 162.29 36.43 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.818 -1.176 . . . . 0.0 112.961 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.86 139.24 5.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 118.731 -1.7 . . . . 0.0 117.053 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -163.0 151.73 14.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 m -88.29 148.98 24.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.562 1.945 . . . . 0.0 110.549 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -126.02 117.72 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' HB2' HG21 ' D' ' 52' ' ' ILE . 9.7 t-20 -97.33 105.4 17.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.147 0.579 . . . . 0.0 112.376 -174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 32.4 m95 -74.76 147.99 40.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -110.7 -45.71 3.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.165 -1.38 . . . . 0.0 114.647 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -80.86 -11.3 59.61 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -152.53 133.24 13.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.789 2.436 . . . . 0.0 105.838 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.26 118.52 14.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.695 1.134 . . . . 0.0 111.2 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -178.52 167.15 1.82 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-O 123.625 1.679 . . . . 0.0 110.895 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 t -144.69 144.71 31.36 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.123 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.3 m -140.7 131.71 26.19 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 110.15 -3.205 . . . . 0.0 110.312 -172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.7 143.63 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.06 143.74 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 116.78 9.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HE ' ' D' ' 100' ' ' ARG . . . -151.98 -176.13 24.37 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 119.389 -1.386 . . . . 0.0 115.625 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -123.17 147.8 46.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.702 -1.249 . . . . 0.0 111.059 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 39.0 t -96.88 120.81 37.91 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.651 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' D' ' 106' ' ' ILE . 6.8 m-85 -115.24 166.9 11.34 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.731 1.213 . . . . 0.0 114.089 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.01 110.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.01 154.18 16.08 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -33.63 -41.97 0.1 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.619 1.968 . . . . 0.0 115.97 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -13.96 60.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 50.36 2.83 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.44 137.61 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.449 1.9 . . . . 0.0 109.492 174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -101.28 148.24 25.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.004 2.121 . . . . 0.0 112.164 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.6 t -152.09 155.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.606 -174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HE2' ' A' ' 64' ' ' PHE . 12.9 mt -122.04 105.92 10.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ3' HD11 ' D' ' 106' ' ' ILE . 3.0 mmtt -98.33 119.33 36.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 64' ' ' PHE . 8.9 p -130.35 162.5 28.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.346 1.546 . . . . 0.0 112.632 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.417 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -110.96 162.78 14.49 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -136.84 161.38 36.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.134 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -146.57 121.57 10.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 113.248 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.76 142.23 38.1 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.923 1.344 . . . . 0.0 112.241 -175.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.416 ' HE ' ' HA2' ' D' ' 81' ' ' GLY . 4.3 tpt85 -127.99 113.95 16.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 111.798 -2.455 . . . . 0.0 112.524 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.25 0.4 OUTLIER -71.95 165.68 23.71 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 125.269 1.606 . . . . 0.0 110.549 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -113.26 79.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.19 175.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 121.524 -0.735 . . . . 0.0 110.529 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -22.89 15.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.08 150.32 43.32 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 123.156 1.455 . . . . 0.0 112.678 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' D' ' 84' ' ' PHE . 17.4 tt -61.3 -27.57 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.141 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.87 9.32 24.85 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.959 0.79 . . . . 0.0 113.934 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -120.59 -0.41 10.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.328 1.051 . . . . 0.0 112.187 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -32.0 70.53 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.646 -1.284 . . . . 0.0 113.408 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.86 -44.91 59.67 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.911 1.684 . . . . 0.0 112.652 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -93.26 -10.63 34.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.332 1.053 . . . . 0.0 113.002 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.42 9.34 1.75 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.372 -0.83 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' A' ' 98' ' ' LEU . 20.9 m -117.45 139.3 51.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.853 0.861 . . . . 0.0 113.195 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.51 116.18 12.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 127.414 2.286 . . . . 0.0 111.281 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.68 152.91 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.725 1.148 . . . . 0.0 110.177 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.32 -174.24 31.97 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.56 154.66 44.91 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.705 -0.879 . . . . 0.0 112.195 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -146.71 152.63 39.15 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.815 1.246 . . . . 0.0 109.736 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.416 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.9 mt -136.46 119.01 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 12' ' ' ASN . 21.1 m-85 -109.68 149.38 29.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.331 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -134.74 163.32 30.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -56.82 119.91 7.0 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.845 0.858 . . . . 0.0 110.964 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 123' ' ' LEU . 10.4 tt . . . . . 0 C--O 1.241 0.609 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . 0.56 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 22.5 p -136.48 130.41 32.53 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.693 0.758 . . . . 0.0 111.501 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -139.77 129.51 24.57 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.4 -1.437 . . . . 0.0 114.56 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' D' ' 64' ' ' PHE . 20.7 mt -56.89 -32.16 65.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -55.58 119.71 6.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.968 1.366 . . . . 0.0 111.744 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.94 -116.5 1.99 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.203 1.859 . . . . 0.0 110.819 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.7 146.43 30.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -174.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . 0.425 ' CH2' HD21 ' D' ' 93' ' ' LEU . 38.2 m95 -141.57 161.92 36.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.232 1.413 . . . . 0.0 111.077 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.2 148.14 37.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.512 HD22 ' H ' ' D' ' 14' ' ' LEU . 5.0 t30 -113.03 147.64 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.362 1.065 . . . . 0.0 112.599 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.74 -23.47 64.96 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.512 ' H ' HD22 ' D' ' 12' ' ' ASN . 27.8 tp -73.08 -14.47 61.4 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.477 1.511 . . . . 0.0 112.257 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.11 -12.92 34.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.857 2.646 . . . . 0.0 113.913 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.47 148.68 50.09 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.584 1.192 . . . . 0.0 112.824 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . 0.426 ' OD1' HD12 ' D' ' 34' ' ' ILE . 5.8 p30 -121.66 143.08 49.54 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.58 0.752 . . . . 0.0 110.543 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -132.07 139.88 48.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.605 0.717 . . . . 0.0 111.849 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -127.74 132.78 49.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.74 123.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.42 -79.95 0.24 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.346 1.029 . . . . 0.0 111.78 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.24 42.09 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.848 -0.795 . . . . 0.0 112.084 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -100.53 125.25 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.616 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -69.46 156.7 38.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 20.1 m -55.88 -21.7 21.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -70.75 -35.73 72.78 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.688 0.676 . . . . 0.0 111.283 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.95 -1.39 21.27 Favored Glycine 0 N--CA 1.469 0.9 0 C-N-CA 124.52 1.057 . . . . 0.0 112.95 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.89 149.81 44.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 110.717 173.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . 0.604 ' O ' HD12 ' D' ' 50' ' ' LEU . 27.8 p90 -156.15 163.86 39.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.034 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . 0.442 HG22 HD13 ' D' ' 50' ' ' LEU . 4.9 p -125.81 167.69 14.85 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.4 -166.49 33.12 Favored Glycine 0 N--CA 1.467 0.74 0 O-C-N 120.031 -1.668 . . . . 0.0 113.201 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.612 ' HB ' HD11 ' D' ' 46' ' ' LEU . 1.2 p -140.32 132.1 27.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.772 1.273 . . . . 0.0 111.539 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.5 139.1 50.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.463 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.556 HG12 HD12 ' D' ' 46' ' ' LEU . 7.8 mt -129.97 131.48 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.84 0.829 . . . . 0.0 108.789 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.583 ' O ' HG21 ' D' ' 44' ' ' ILE . 7.7 m -109.32 134.78 51.37 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 -19.22 21.55 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 28.3 m -131.38 141.54 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.892 1.277 . . . . 0.0 112.161 -174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.38 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.947 -1.096 . . . . 0.0 111.333 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.99 -24.08 66.7 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -147.91 76.72 10.45 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 128.536 2.734 . . . . 0.0 112.041 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.25 169.35 19.73 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.181 2.587 . . . . 0.0 112.517 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.87 -29.18 1.56 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.574 1.083 . . . . 0.0 113.123 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.29 2.87 3.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.736 -1.126 . . . . 0.0 113.533 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.583 HG21 ' O ' ' D' ' 35' ' ' THR . 50.8 mt -32.36 113.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 114.242 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.73 157.96 41.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.55 1.54 . . . . 0.0 110.747 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB ' ' D' ' 32' ' ' THR . 11.9 tp -47.48 115.36 1.1 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.712 2.805 . . . . 0.0 111.074 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.25 117.15 60.93 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.853 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.02 143.03 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.867 2.378 . . . . 0.0 112.272 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . 0.412 ' C ' HD12 ' D' ' 49' ' ' LEU . 2.0 pp -128.48 163.76 24.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.87 0.868 . . . . 0.0 112.209 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.604 HD12 ' O ' ' D' ' 29' ' ' PHE . 27.6 tp -169.07 149.01 4.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.249 1.42 . . . . 0.0 113.842 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 -150.96 21.56 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 120.883 1.674 . . . . 0.0 111.315 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.8 mp -142.32 135.35 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.965 0.906 . . . . 0.0 111.705 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -120.16 140.18 51.5 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 110.113 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.21 -50.0 74.86 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.436 -0.79 . . . . 0.0 111.525 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.09 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.67 2.388 . . . . 0.0 116.634 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.94 -46.64 7.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.386 2.675 . . . . 0.0 115.053 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.25 -175.43 3.67 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.26 0.975 . . . . 0.0 112.512 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 40.8 t -81.67 -35.28 30.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.561 0.745 . . . . 0.0 111.576 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.29 58.56 31.44 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 125.041 1.336 . . . . 0.0 111.033 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.91 163.34 38.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.742 2.962 . . . . 0.0 117.317 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -81.63 168.08 18.53 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.197 1.399 . . . . 0.0 111.569 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -159.12 162.26 36.44 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.736 -1.227 . . . . 0.0 112.967 174.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.0 139.08 5.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 118.873 -1.632 . . . . 0.0 116.871 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.89 153.12 16.26 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -89.11 151.61 22.12 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 127.601 2.36 . . . . 0.0 110.325 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 32.1 t -129.25 119.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.546 ' HB2' HG21 ' A' ' 52' ' ' ILE . 10.0 t-20 -99.2 105.15 17.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.242 0.617 . . . . 0.0 112.004 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -74.34 147.27 42.38 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -110.1 -45.12 3.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.099 -1.409 . . . . 0.0 114.554 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.67 -11.16 59.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.55 132.91 13.68 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.881 2.473 . . . . 0.0 105.671 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.3 118.49 15.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.808 1.185 . . . . 0.0 111.193 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.79 166.55 1.68 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.94 1.696 . . . . 0.0 111.116 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 t -143.96 144.63 31.78 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.217 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.3 m -140.32 133.25 29.25 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 109.975 -3.284 . . . . 0.0 109.797 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.85 143.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.682 0.614 . . . . 0.0 109.548 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -116.3 143.91 44.92 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.7 116.55 8.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -151.45 -175.72 23.53 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.669 -1.253 . . . . 0.0 115.757 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.42 147.41 47.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.438 -1.381 . . . . 0.0 110.776 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.56 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 5.6 t -97.16 123.61 40.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.872 1.358 . . . . 0.0 110.624 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.602 ' HB2' HD12 ' A' ' 106' ' ' ILE . 7.7 m-85 -116.65 163.02 16.75 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -130.16 110.4 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.96 157.44 9.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -36.22 -40.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.445 1.898 . . . . 0.0 115.578 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -78.2 -10.23 59.55 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.14 51.03 4.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.057 0.836 . . . . 0.0 111.633 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.5 147.08 46.78 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 129.107 2.963 . . . . 0.0 107.401 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -112.73 152.63 28.85 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 120.267 1.394 . . . . 0.0 111.279 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.509 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.4 t -153.37 158.3 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.516 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . 0.425 HD21 ' CH2' ' D' ' 10' ' ' TRP . 6.9 mt -121.17 108.13 13.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.509 ' CD ' HG11 ' D' ' 92' ' ' VAL . 2.8 mmtt -100.76 117.67 35.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.57 HG22 ' HE1' ' D' ' 64' ' ' PHE . 4.8 p -129.28 163.08 26.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.608 1.671 . . . . 0.0 112.88 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.12 162.54 14.8 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -136.55 161.51 35.68 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.879 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -146.59 121.94 10.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.298 -1.774 . . . . 0.0 113.05 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . 0.471 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 141.76 38.52 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.859 1.314 . . . . 0.0 112.556 -176.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HA2' ' A' ' 81' ' ' GLY . 4.2 tpt85 -126.98 114.06 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 111.731 -2.486 . . . . 0.0 112.303 -174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.63 165.62 23.57 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 125.039 1.462 . . . . 0.0 110.557 173.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 8.3 t -113.53 77.11 1.02 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.82 176.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.23 -22.81 15.45 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.95 150.0 41.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 123.088 1.423 . . . . 0.0 112.914 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 84' ' ' PHE . 18.0 tt -62.57 -28.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.442 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 9.01 21.35 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.202 0.906 . . . . 0.0 113.961 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.45 -1.81 10.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.556 1.142 . . . . 0.0 111.878 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -31.45 70.27 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.394 -1.441 . . . . 0.0 113.279 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.62 -46.23 58.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.579 1.552 . . . . 0.0 112.52 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -91.73 -10.94 38.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.27 1.028 . . . . 0.0 112.832 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 8.75 2.08 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.605 -0.684 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' D' ' 98' ' ' LEU . 19.5 m -116.42 139.22 50.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.986 0.914 . . . . 0.0 113.28 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.54 116.21 12.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.4 2.28 . . . . 0.0 111.151 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.66 152.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.825 1.193 . . . . 0.0 110.394 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.51 -173.83 31.67 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -127.77 154.92 44.83 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.679 -0.895 . . . . 0.0 112.266 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -147.41 151.19 36.07 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.457 1.103 . . . . 0.0 109.746 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -135.69 119.18 24.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -111.12 151.72 27.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.566 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -137.4 167.64 21.22 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -61.69 125.61 24.41 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.586 -1.321 . . . . 0.0 113.246 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.164 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.656 ' HB2' ' HG ' ' B' ' 83' ' ' CYS . 24.9 p -139.68 127.96 22.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.623 0.769 . . . . 0.0 110.226 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -139.74 127.7 22.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.417 -1.427 . . . . 0.0 114.567 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.616 HD21 ' CE2' ' B' ' 64' ' ' PHE . 20.7 mt -55.62 -32.34 63.06 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -54.47 118.81 4.45 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.323 1.535 . . . . 0.0 111.732 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.14 -106.87 0.66 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.883 1.706 . . . . 0.0 111.302 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.27 146.58 21.51 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . 0.41 ' CH2' HD21 ' B' ' 93' ' ' LEU . 43.4 m95 -140.71 162.84 34.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.548 1.539 . . . . 0.0 110.578 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -139.36 152.22 46.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.479 HD22 ' H ' ' B' ' 14' ' ' LEU . 4.6 t30 -117.5 146.86 43.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 111.864 -174.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -60.89 -22.12 63.99 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.479 ' H ' HD22 ' B' ' 12' ' ' ASN . 26.7 tp -73.45 -14.19 61.2 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.959 1.304 . . . . 0.0 112.238 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.69 -13.32 35.39 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 128.069 2.747 . . . . 0.0 113.743 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 3.4 p -64.1 148.62 49.44 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.293 -1.122 . . . . 0.0 112.73 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.421 ' OD1' HD12 ' B' ' 34' ' ' ILE . 5.7 p30 -122.42 140.42 52.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.471 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -128.71 139.19 52.34 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.976 0.893 . . . . 0.0 111.793 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.93 131.93 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.016 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.39 126.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.4 -86.8 0.13 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.529 1.143 . . . . 0.0 111.531 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.36 154.15 42.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.916 0.865 . . . . 0.0 112.607 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.6 123.57 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.214 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -68.12 155.89 38.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.112 0.415 . . . . 0.0 109.916 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 20.3 m -54.99 -22.29 14.75 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -72.25 -37.42 69.11 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.636 0.653 . . . . 0.0 111.178 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -2.52 19.41 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-O 117.378 -1.79 . . . . 0.0 113.471 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.453 ' HB2' HD21 ' C' ' 50' ' ' LEU . 9.8 pt-20 -69.37 137.52 52.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.078 1.751 . . . . 0.0 107.112 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.4 ' O ' HD12 ' B' ' 50' ' ' LEU . 18.5 p90 -154.31 147.75 25.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.05 162.66 16.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.39 1.076 . . . . 0.0 109.62 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.36 -167.48 33.21 Favored Glycine 0 CA--C 1.523 0.538 0 O-C-N 120.972 -1.08 . . . . 0.0 113.407 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.607 ' HB ' HD11 ' B' ' 46' ' ' LEU . 1.3 p -140.66 131.6 26.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.785 1.279 . . . . 0.0 110.952 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -114.42 138.73 50.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.792 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.553 HG12 HD12 ' B' ' 46' ' ' LEU . 7.6 mt -129.97 132.45 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.582 ' O ' HG21 ' B' ' 44' ' ' ILE . 16.9 m -110.46 134.75 52.06 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.88 -18.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.59 141.71 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.88 1.272 . . . . 0.0 111.93 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.77 154.19 41.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.994 -1.066 . . . . 0.0 110.959 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.74 -24.55 66.24 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -148.12 76.61 10.29 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.577 2.751 . . . . 0.0 111.979 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.05 169.75 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.152 2.568 . . . . 0.0 112.566 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.82 -29.46 1.56 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.502 1.048 . . . . 0.0 113.158 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.02 2.73 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.512 1.125 . . . . 0.0 113.535 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.582 HG21 ' O ' ' B' ' 35' ' ' THR . 52.2 mt -31.9 113.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 126.164 1.786 . . . . 0.0 114.429 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.37 158.54 39.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.455 1.502 . . . . 0.0 110.84 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.607 HD11 ' HB ' ' B' ' 32' ' ' THR . 11.8 tp -48.62 115.41 1.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.672 2.789 . . . . 0.0 111.139 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -103.65 117.79 59.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.944 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.27 144.4 82.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.197 2.598 . . . . 0.0 112.782 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.49 155.51 44.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.831 0.852 . . . . 0.0 111.84 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' B' ' 29' ' ' PHE . 6.0 tp -160.37 147.65 16.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.183 1.793 . . . . 0.0 112.2 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.23 -151.53 21.87 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 120.789 1.631 . . . . 0.0 111.051 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.4 mp -141.15 137.95 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.855 0.862 . . . . 0.0 113.176 -174.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -121.0 141.1 51.05 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.098 -1.001 . . . . 0.0 110.706 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.81 -50.33 72.74 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.21 -0.931 . . . . 0.0 111.617 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 41.68 16.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 127.504 2.322 . . . . 0.0 116.907 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . 0.255 6.7 ptp180 -93.67 -46.19 7.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.948 2.499 . . . . 0.0 115.095 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 -175.33 4.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.318 1.011 . . . . 0.0 112.802 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -33.1 29.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.384 1.074 . . . . 0.0 111.45 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.03 57.51 30.59 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 124.849 1.26 . . . . 0.0 111.005 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.58 163.34 38.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.366 2.711 . . . . 0.0 117.078 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p -81.79 168.58 17.87 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.616 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -159.92 161.97 34.4 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.783 -1.198 . . . . 0.0 113.134 174.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.81 139.28 5.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 118.83 -1.652 . . . . 0.0 117.065 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -163.43 151.86 13.79 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.57 150.89 23.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.513 1.925 . . . . 0.0 110.771 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -127.85 117.75 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.557 ' HB2' HG21 ' C' ' 52' ' ' ILE . 8.6 t-20 -97.63 104.24 16.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.254 0.622 . . . . 0.0 112.264 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.254 32.6 m95 -74.04 147.24 43.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -109.91 -46.05 3.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.461 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.89 -11.28 59.61 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -152.51 133.35 14.03 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.964 2.505 . . . . 0.0 106.055 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.46 118.58 15.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.028 1.285 . . . . 0.0 110.617 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -178.74 166.72 1.71 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.978 1.711 . . . . 0.0 110.952 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -144.38 144.79 31.59 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.273 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -140.53 132.95 28.46 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 110.341 -3.118 . . . . 0.0 110.043 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.05 143.33 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.04 143.85 44.55 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.719 0.637 . . . . 0.0 109.478 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.29 116.85 9.17 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HE ' ' C' ' 100' ' ' ARG . . . -152.0 -176.65 24.92 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.337 -1.411 . . . . 0.0 115.222 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -122.85 148.01 45.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.807 1.534 . . . . 0.0 110.426 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.656 ' HG ' ' HB2' ' B' ' 4' ' ' CYS . 5.1 t -97.04 124.54 41.06 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.255 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' C' ' 106' ' ' ILE . 7.9 m-85 -116.09 164.57 14.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.6 mt -131.75 107.91 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -59.29 154.74 15.85 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -35.11 -41.17 0.14 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -11.91 59.88 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.34 52.63 3.34 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 122.199 0.888 . . . . 0.0 111.863 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.16 148.18 45.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 129.135 2.974 . . . . 0.0 105.023 173.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -114.13 150.81 33.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.362 1.465 . . . . 0.0 110.326 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.506 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.5 t -150.77 159.93 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.439 1.095 . . . . 0.0 110.398 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.41 HD21 ' CH2' ' B' ' 10' ' ' TRP . 7.1 mt -121.9 108.6 13.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 172.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.508 ' CE ' HD11 ' C' ' 106' ' ' ILE . 2.6 mmtt -101.46 117.64 35.34 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 172.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.575 HG22 ' HE1' ' B' ' 64' ' ' PHE . 9.2 p -130.0 162.67 28.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.303 1.525 . . . . 0.0 112.463 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.405 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -111.22 163.03 14.35 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 170.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -137.04 161.42 36.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.075 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.59 121.6 10.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.303 -1.771 . . . . 0.0 113.203 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.485 ' N ' HD23 ' B' ' 98' ' ' LEU . 0.3 OUTLIER -107.69 142.34 37.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.947 1.356 . . . . 0.0 112.258 -175.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.437 ' HE ' ' HA2' ' C' ' 81' ' ' GLY . 4.0 tpt85 -128.0 113.98 16.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 111.504 -2.589 . . . . 0.0 112.28 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.23 165.61 24.07 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 125.147 1.53 . . . . 0.0 110.19 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.9 t -113.69 77.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -66.28 177.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -100.83 -22.45 14.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.88 148.72 43.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 123.047 1.404 . . . . 0.0 112.648 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' C' ' 84' ' ' PHE . 18.0 tt -62.24 -27.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.267 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.92 8.49 22.29 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.135 0.874 . . . . 0.0 113.782 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -120.89 -0.46 10.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.39 1.076 . . . . 0.0 112.535 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -31.78 69.86 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 120.785 -1.197 . . . . 0.0 113.466 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 66.0 p-90 -50.25 -46.56 54.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.628 1.571 . . . . 0.0 112.406 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.13 -10.39 39.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.045 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.03 2.03 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.575 -0.703 . . . . 0.0 111.845 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.77 ' CG2' HD21 ' B' ' 98' ' ' LEU . 21.5 m -116.45 139.13 50.78 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.948 0.899 . . . . 0.0 113.158 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.27 116.15 13.17 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.589 2.356 . . . . 0.0 111.163 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.7 152.69 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.699 1.136 . . . . 0.0 110.235 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.19 -174.39 32.02 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.787 -0.831 . . . . 0.0 112.133 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -147.32 150.7 35.26 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.697 1.199 . . . . 0.0 109.571 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.42 HD13 ' HE3' ' B' ' 94' ' ' LYS . 12.4 mt -135.24 119.8 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -110.39 152.11 26.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.171 0.92 . . . . 0.0 109.535 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -136.67 165.79 25.08 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -56.87 136.14 55.77 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.786 -1.196 . . . . 0.0 113.179 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . 0.596 ' HB2' ' HG ' ' C' ' 83' ' ' CYS . 25.1 p -143.09 125.95 16.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.726 0.81 . . . . 0.0 109.503 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -139.56 129.39 24.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.232 -1.543 . . . . 0.0 114.503 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' C' ' 64' ' ' PHE . 20.2 mt -56.38 -29.75 61.84 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -56.89 121.62 10.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 123.324 1.535 . . . . 0.0 111.643 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.13 -112.02 1.23 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.424 1.964 . . . . 0.0 110.582 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -149.12 147.73 28.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.744 0.818 . . . . 0.0 113.142 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . 0.413 ' CH2' HD21 ' C' ' 93' ' ' LEU . 39.3 m95 -141.86 162.51 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.293 1.437 . . . . 0.0 110.474 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -140.76 150.76 43.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . 0.504 HD22 ' H ' ' C' ' 14' ' ' LEU . 4.6 t30 -115.02 146.42 41.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.103 0.961 . . . . 0.0 112.669 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.89 -21.31 63.2 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.504 ' H ' HD22 ' C' ' 12' ' ' ASN . 29.8 tp -73.69 -16.21 61.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.297 1.439 . . . . 0.0 112.19 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.45 -13.58 27.92 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.869 2.652 . . . . 0.0 113.984 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.88 149.17 50.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.688 1.244 . . . . 0.0 112.981 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' C' ' 34' ' ' ILE . 5.9 p30 -122.05 142.75 50.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.688 0.795 . . . . 0.0 110.754 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -131.4 139.51 49.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.447 0.641 . . . . 0.0 112.202 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -126.93 132.76 50.79 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.93 123.22 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -77.14 0.43 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.148 0.905 . . . . 0.0 111.908 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.82 157.44 42.93 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.77 0.795 . . . . 0.0 112.176 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 t -101.77 125.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.815 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -69.83 156.58 38.83 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -55.89 -21.69 21.58 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -70.38 -36.11 73.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.251 0.62 . . . . 0.0 111.337 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.04 -0.98 21.16 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 124.614 1.102 . . . . 0.0 112.899 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.67 149.74 43.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.696 0.799 . . . . 0.0 110.73 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . 0.599 ' O ' HD12 ' C' ' 50' ' ' LEU . 27.9 p90 -156.21 163.74 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.835 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.468 HG22 HD13 ' C' ' 50' ' ' LEU . 4.7 p -125.76 168.38 13.87 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.99 -166.86 34.03 Favored Glycine 0 N--CA 1.465 0.633 0 O-C-N 120.073 -1.642 . . . . 0.0 113.212 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.605 ' HB ' HD11 ' C' ' 46' ' ' LEU . 1.2 p -140.64 132.24 27.14 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 123.024 1.393 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -117.04 138.5 51.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.872 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.538 HG12 HD12 ' C' ' 46' ' ' LEU . 7.5 mt -129.36 131.16 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.561 ' O ' HG21 ' C' ' 44' ' ' ILE . 5.8 m -109.53 134.93 51.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.322 -173.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.63 -17.39 22.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.23 141.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.7 1.2 . . . . 0.0 112.099 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.66 154.51 41.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.39 -24.47 65.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -148.0 76.59 10.41 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 128.573 2.749 . . . . 0.0 111.965 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.11 169.39 19.48 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.231 2.62 . . . . 0.0 112.411 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.86 -29.33 1.56 Allowed Glycine 0 N--CA 1.474 1.206 0 C-N-CA 124.57 1.081 . . . . 0.0 113.138 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 2.93 3.32 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 117.656 -1.164 . . . . 0.0 113.529 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.561 HG21 ' O ' ' C' ' 35' ' ' THR . 52.4 mt -32.3 113.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.075 1.75 . . . . 0.0 114.311 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.03 158.1 41.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.72 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' C' ' 32' ' ' THR . 11.9 tp -47.56 115.42 1.13 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.764 2.826 . . . . 0.0 111.132 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.2 117.23 60.79 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.998 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.13 142.92 85.92 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.877 2.385 . . . . 0.0 112.269 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.418 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -128.66 163.62 24.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.865 0.866 . . . . 0.0 112.311 175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.599 HD12 ' O ' ' C' ' 29' ' ' PHE . 27.4 tp -169.26 148.93 4.02 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 113.936 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.63 -151.07 21.78 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 120.928 1.695 . . . . 0.0 111.414 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.8 mp -142.39 135.47 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.806 0.843 . . . . 0.0 111.543 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -119.73 140.68 50.32 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.765 1.226 . . . . 0.0 109.921 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.0 -50.34 72.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.487 -0.758 . . . . 0.0 111.388 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.68 15.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.64 2.376 . . . . 0.0 116.456 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.67 -45.83 7.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.281 2.633 . . . . 0.0 114.895 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -173.97 3.53 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 124.434 1.084 . . . . 0.0 112.765 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 48.4 t -81.02 -37.9 28.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.062 . . . . 0.0 111.027 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.28 58.47 30.77 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 125.111 1.364 . . . . 0.0 111.392 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.68 163.1 40.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.771 2.981 . . . . 0.0 116.953 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -81.5 167.9 18.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.636 1.574 . . . . 0.0 111.657 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.28 161.81 35.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.662 -1.274 . . . . 0.0 113.064 174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.49 139.21 5.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 118.78 -1.676 . . . . 0.0 116.608 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -162.73 153.72 17.27 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -89.73 151.72 21.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.616 2.366 . . . . 0.0 110.49 174.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 t -129.38 118.42 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' B' ' 52' ' ' ILE . 10.0 t-20 -98.53 104.89 16.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 111.976 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . 0.411 ' HE1' ' HG1' ' C' ' 77' ' ' THR . 32.9 m95 -74.33 147.05 42.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.47 -45.98 3.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.337 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -80.51 -11.3 59.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.2 t -152.56 133.22 13.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.915 2.486 . . . . 0.0 105.961 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.04 118.49 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.802 1.183 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.83 166.48 1.66 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.916 1.686 . . . . 0.0 111.085 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -144.02 144.8 31.82 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.102 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.411 ' HG1' ' HE1' ' C' ' 70' ' ' TRP . 1.2 m -140.4 132.89 28.58 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 109.971 -3.286 . . . . 0.0 109.972 -172.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 144.93 19.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -116.64 144.36 44.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.9 117.16 8.99 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HE ' ' B' ' 100' ' ' ARG . . . -151.78 -176.44 24.52 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 119.48 -1.343 . . . . 0.0 115.155 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -123.15 147.51 46.73 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 125.795 1.527 . . . . 0.0 110.527 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.596 ' HG ' ' HB2' ' C' ' 4' ' ' CYS . 5.4 t -97.09 123.64 40.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.027 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' B' ' 106' ' ' ILE . 4.6 m-85 -116.51 164.65 14.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.09 111.55 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -60.89 154.75 21.38 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -34.7 -41.61 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.334 1.854 . . . . 0.0 115.849 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -13.88 60.96 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.55 46.26 4.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.478 1.037 . . . . 0.0 113.097 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.48 151.56 34.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.521 2.728 . . . . 0.0 106.172 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -115.25 150.05 36.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.865 1.666 . . . . 0.0 110.987 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.504 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -149.88 158.95 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.233 1.413 . . . . 0.0 110.762 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . 0.413 HD21 ' CH2' ' C' ' 10' ' ' TRP . 7.3 mt -121.67 109.91 15.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.682 -2.711 . . . . 0.0 103.682 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.504 ' CD ' HG11 ' C' ' 92' ' ' VAL . 2.9 mmtt -102.35 116.69 33.16 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.598 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.6 p -129.08 163.13 26.13 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.429 1.585 . . . . 0.0 112.741 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.413 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.5 162.88 14.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -136.96 161.6 35.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.952 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -146.85 121.65 9.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.142 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . 0.476 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 142.05 38.08 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.706 1.241 . . . . 0.0 112.319 -176.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . 0.436 ' HE ' ' HA2' ' B' ' 81' ' ' GLY . 4.3 tpt85 -127.54 113.99 16.85 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 111.762 -2.472 . . . . 0.0 112.364 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.255 0.4 OUTLIER -71.79 165.96 23.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.583 173.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -114.22 79.53 1.27 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.53 177.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.59 -0.694 . . . . 0.0 110.52 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.43 -22.79 15.37 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.6 150.01 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.116 1.436 . . . . 0.0 113.134 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' B' ' 84' ' ' PHE . 17.5 tt -61.92 -27.25 41.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.145 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.17 9.06 28.21 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.256 0.932 . . . . 0.0 113.738 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -119.49 -1.39 10.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.48 1.112 . . . . 0.0 111.852 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.78 -31.58 70.94 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.385 -1.447 . . . . 0.0 113.142 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -50.44 -45.81 56.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.694 1.597 . . . . 0.0 112.523 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.86 -10.36 36.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.367 1.067 . . . . 0.0 113.026 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.41 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.779 -0.576 . . . . 0.0 111.851 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' C' ' 98' ' ' LEU . 22.2 m -116.93 139.56 50.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.887 0.875 . . . . 0.0 113.089 175.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -136.44 116.18 13.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.624 2.37 . . . . 0.0 111.3 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -99.7 152.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.832 1.196 . . . . 0.0 110.239 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.43 -174.18 32.02 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -127.28 155.33 43.68 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.703 -0.881 . . . . 0.0 112.227 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -147.62 151.23 35.86 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.505 1.122 . . . . 0.0 109.702 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . 0.431 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.5 mt -135.61 118.98 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -109.99 151.08 27.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.527 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.9 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.3 127.71 33.51 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.079 -1.013 . . . . 0.0 111.228 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.757 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mttm . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 130.21 56.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -139.64 130.1 25.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 110.876 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.62 -27.99 61.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -65.02 110.93 2.65 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.22 5.25 0.23 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 118.738 2.255 . . . . 0.0 118.738 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt 68.86 143.92 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.733 2.413 . . . . 0.0 115.642 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -139.14 159.25 42.59 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.278 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -138.45 147.06 42.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.699 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 118' ' ' ASN . 39.6 t-20 -111.47 145.63 38.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.726 0.81 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.06 -25.02 57.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.453 1.501 . . . . 0.0 113.944 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.08 -16.39 61.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.344 1.858 . . . . 0.0 111.838 174.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.27 -9.69 28.84 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.443 2.449 . . . . 0.0 114.28 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -64.46 144.97 56.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.009 1.404 . . . . 0.0 112.121 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -122.97 134.05 54.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -128.12 136.59 51.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.911 0.862 . . . . 0.0 111.671 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -126.97 130.31 49.83 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.846 0.831 . . . . 0.0 109.252 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.59 131.02 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.72 -103.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.807 0 O-C-N 125.692 1.87 . . . . 0.0 110.569 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.48 138.58 52.35 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.596 0.758 . . . . 0.0 111.127 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.88 133.47 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.95 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -69.73 158.06 36.12 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.8 m -54.36 -29.02 46.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -67.68 -33.82 75.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.894 0.77 . . . . 0.0 111.323 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.73 -7.55 22.08 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.624 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.76 151.63 45.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.097 1.448 . . . . 0.0 108.415 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -152.0 161.59 42.41 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.286 175.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.53 163.82 20.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.368 -1.742 . . . . 0.0 107.121 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.97 -168.13 35.17 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.508 1.06 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -138.19 146.15 42.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 112.776 -1.712 . . . . 0.0 111.746 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -126.06 141.02 52.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.347 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 46' ' ' LEU . 4.4 mp -126.33 145.54 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 44' ' ' ILE . 3.2 m -121.54 139.35 53.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 112.387 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.64 -15.14 17.86 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 27.2 m -135.48 140.37 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.709 1.203 . . . . 0.0 111.079 -176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.28 169.39 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.727 -1.233 . . . . 0.0 112.027 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' HH12 ' A' ' 114' ' ' ARG . 25.7 m-20 -70.65 -43.27 69.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 173.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -128.41 84.34 63.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.529 2.332 . . . . 0.0 107.588 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.76 36.96 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.262 3.308 . . . . 0.0 114.731 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.95 -3.31 90.64 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 119.845 -1.784 . . . . 0.0 115.999 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 -3.33 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.92 1.36 . . . . 0.0 114.342 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 35' ' ' THR . 28.1 mt -20.03 108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 164.87 24.87 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.019 1.727 . . . . 0.0 109.513 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 34' ' ' ILE . 4.5 tt -50.74 136.85 21.24 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.643 1.977 . . . . 0.0 114.025 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -119.95 125.94 27.12 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 113.176 -1.829 . . . . 0.0 111.937 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.29 141.99 98.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.596 2.198 . . . . 0.0 111.715 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 142.74 50.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.619 1.199 . . . . 0.0 109.701 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.25 149.24 34.54 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.093 2.557 . . . . 0.0 109.073 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.03 -156.22 27.72 Favored Glycine 0 N--CA 1.452 -0.259 0 O-C-N 120.128 -1.608 . . . . 0.0 109.857 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.5 mt -146.96 146.86 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.244 1.017 . . . . 0.0 111.527 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.48 153.59 43.33 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.343 1.457 . . . . 0.0 112.537 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.5 153.52 40.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.195 -1.566 . . . . 0.0 112.28 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -139.53 20.8 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -93.42 -57.8 2.48 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.271 1.029 . . . . 0.0 112.944 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.79 20.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.185 0.594 . . . . 0.0 112.323 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -81.57 -20.28 40.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 45.28 0.78 Allowed Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.984 1.314 . . . . 0.0 113.253 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.38 -176.76 3.1 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.222 3.281 . . . . 0.0 115.568 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.289 2.8 t -97.02 164.33 12.57 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.884 1.326 . . . . 0.0 112.931 174.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -158.54 168.95 25.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.633 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.04 151.85 21.03 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 120.516 2.967 . . . . 0.0 120.516 -172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -163.52 153.73 15.55 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -92.67 149.88 21.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.601 1.561 . . . . 0.0 108.839 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.87 127.82 68.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' D' ' 52' ' ' ILE . 25.7 t-20 -104.32 110.53 22.79 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.434 -0.792 . . . . 0.0 110.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.676 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 91.5 m95 -75.91 129.9 37.65 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.587 1.184 . . . . 0.0 112.329 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -90.93 -38.08 13.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.261 -1.336 . . . . 0.0 114.506 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -83.77 -19.7 34.62 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 117.28 5.09 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.28 118.94 6.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.959 1.254 . . . . 0.0 111.711 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -175.64 167.42 3.19 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 126.644 1.978 . . . . 0.0 110.42 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 t -139.79 141.77 36.74 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.676 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 2.4 m -141.09 122.97 15.39 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.902 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.04 156.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.386 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -132.41 141.87 49.04 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 121.43 9.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -171.57 173.52 44.95 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 34.4 tt0 -106.71 144.47 33.32 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.429 0.723 . . . . 0.0 111.508 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.0 p -97.65 121.48 39.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.503 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.8 m-85 -114.1 170.59 8.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.491 1.139 . . . . 0.0 111.665 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 65.9 mt -127.09 116.58 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -58.78 156.03 11.88 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -17.57 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -82.68 -12.9 57.26 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.94 5.67 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.831 1.205 . . . . 0.0 112.796 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -117.09 152.0 35.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.497 174.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -103.13 146.54 28.25 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.847 1.259 . . . . 0.0 110.207 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.47 HG21 ' CD1' ' D' ' 106' ' ' ILE . 27.7 m -147.75 164.68 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.052 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.92 118.38 26.15 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.7 mmmt -107.09 113.39 26.81 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.455 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 3.0 p -131.21 172.5 12.06 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.365 1.555 . . . . 0.0 111.346 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.8 mmm -127.8 170.3 12.92 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.706 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -139.76 164.0 31.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.749 1.261 . . . . 0.0 112.208 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -141.72 121.67 13.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.326 174.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 138.3 43.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 124.193 1.949 . . . . 0.0 109.934 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.63 114.14 18.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 109.652 -3.431 . . . . 0.0 110.057 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -72.61 167.73 20.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.424 1.702 . . . . 0.0 112.207 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -114.97 87.96 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.05 -170.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.767 1.227 . . . . 0.0 108.428 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -121.61 -28.28 4.59 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.85 -1.156 . . . . 0.0 113.814 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.9 144.96 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.573 1.178 . . . . 0.0 110.986 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' D' ' 94' ' ' LYS . 14.3 tt -61.63 -20.69 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.144 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.86 2.95 47.39 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.387 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.45 7.51 8.34 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.567 1.184 . . . . 0.0 112.9 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.62 -36.07 75.6 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.517 -1.989 . . . . 0.0 111.463 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 58.9 p-90 -48.22 -45.67 34.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.487 1.115 . . . . 0.0 113.401 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.59 -12.47 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.656 1.183 . . . . 0.0 113.576 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.96 1.69 22.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' D' ' 96' ' ' MET . 27.0 m -111.66 140.26 46.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.966 0.906 . . . . 0.0 111.499 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.443 HH12 ' CG ' ' A' ' 39' ' ' ASP . 7.6 mtt180 -144.3 130.25 19.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.958 1.303 . . . . 0.0 111.433 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.41 151.45 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 121.038 1.745 . . . . 0.0 110.98 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.97 179.53 27.59 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -120.15 151.56 38.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.121 0.968 . . . . 0.0 110.706 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.427 ' CG ' HD21 ' A' ' 12' ' ' ASN . 6.3 m-20 -149.78 149.52 30.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.233 1.016 . . . . 0.0 110.777 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.9 mt -130.4 133.74 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.08 -1.012 . . . . 0.0 108.289 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -123.92 149.02 46.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.94 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.8 p -132.66 159.76 38.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.71 1.204 . . . . 0.0 110.866 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.24 125.58 24.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 111.122 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.24 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mttm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -149.16 136.5 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.992 1.269 . . . . 0.0 111.632 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 31.3 p -139.45 133.56 31.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.169 2.187 . . . . 0.0 111.549 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.72 -26.42 60.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -65.4 112.1 3.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -4.96 0.36 Allowed Glycine 0 N--CA 1.476 1.316 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 74.68 144.05 0.08 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.418 2.287 . . . . 0.0 114.007 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -139.41 162.16 35.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.134 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -142.49 148.8 38.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.09 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.412 HD21 ' CG ' ' D' ' 118' ' ' ASN . 38.2 t-20 -113.43 146.08 40.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.977 0.911 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -56.92 -25.39 57.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.967 1.307 . . . . 0.0 113.921 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.19 -15.62 61.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.362 1.865 . . . . 0.0 112.134 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.84 -8.37 31.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 127.304 2.383 . . . . 0.0 114.294 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -64.56 143.97 57.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.14 1.47 . . . . 0.0 112.512 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -121.4 132.07 54.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.901 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -126.74 137.67 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 111.969 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.6 m -128.75 130.39 47.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.244 1.021 . . . . 0.0 109.786 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.26 130.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.4 -97.09 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 125.825 1.953 . . . . 0.0 111.146 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.41 138.16 46.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 110.959 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.07 134.03 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.008 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -69.75 157.84 36.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.499 0.72 . . . . 0.0 111.793 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 64.4 m -54.51 -28.75 47.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -67.81 -32.87 73.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.794 0.724 . . . . 0.0 111.369 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.23 -6.07 23.34 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 124.777 1.179 . . . . 0.0 112.715 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.16 156.99 38.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.456 1.128 . . . . 0.0 110.541 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.59 166.53 33.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 123.186 1.47 . . . . 0.0 110.891 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -129.75 164.72 23.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 112.0 -2.364 . . . . 0.0 105.905 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.13 -167.1 35.05 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 75.1 p -139.23 146.74 40.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.186 -1.507 . . . . 0.0 112.134 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -126.87 141.14 51.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.179 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.569 HD11 HD12 ' D' ' 46' ' ' LEU . 4.4 mp -125.89 144.77 34.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.471 ' O ' HG21 ' D' ' 44' ' ' ILE . 3.7 m -120.85 138.84 53.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.055 0.942 . . . . 0.0 112.522 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.76 -15.98 18.28 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.406 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 27.3 m -134.81 140.81 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.577 1.151 . . . . 0.0 111.337 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.66 169.06 23.65 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 120.477 -1.389 . . . . 0.0 111.905 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' D' ' 114' ' ' ARG . 31.2 m-20 -70.29 -43.26 70.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.059 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -128.4 83.93 64.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.522 2.329 . . . . 0.0 107.69 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.9 37.44 0.29 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.323 3.348 . . . . 0.0 114.684 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.5 -2.83 90.66 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 119.893 -1.754 . . . . 0.0 116.063 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.828 1.314 . . . . 0.0 114.401 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.471 HG21 ' O ' ' D' ' 35' ' ' THR . 29.3 mt -19.53 107.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 164.35 25.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.994 1.717 . . . . 0.0 109.494 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.569 HD12 HD11 ' D' ' 34' ' ' ILE . 4.4 tt -49.99 136.19 19.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.664 1.986 . . . . 0.0 113.95 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -119.3 125.96 27.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 113.21 -1.813 . . . . 0.0 111.991 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.21 140.67 95.89 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.229 1.953 . . . . 0.0 111.269 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.45 149.78 41.84 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 124.892 1.37 . . . . 0.0 109.359 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -154.87 149.34 26.27 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.074 2.15 . . . . 0.0 108.869 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.94 -154.2 25.33 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 120.898 -1.126 . . . . 0.0 111.347 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.3 mt -146.92 146.02 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.286 1.035 . . . . 0.0 112.033 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.79 153.81 41.9 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.457 1.503 . . . . 0.0 112.325 174.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -73.17 159.17 33.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 119.954 -1.716 . . . . 0.0 112.344 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -145.46 21.75 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -93.46 -58.07 2.4 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.039 0.936 . . . . 0.0 112.453 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.47 169.81 16.69 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.962 0.789 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 26.1 m -90.41 -13.77 34.27 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -136.22 39.75 0.46 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.724 1.209 . . . . 0.0 113.768 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.76 -176.99 3.57 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.792 2.328 . . . . 0.0 114.359 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.305 2.5 t -97.06 164.36 12.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.742 1.258 . . . . 0.0 112.074 174.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.57 168.35 27.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.391 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 151.61 20.51 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 120.742 3.057 . . . . 0.0 120.742 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -163.49 152.78 14.63 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -90.84 150.79 21.41 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.932 1.693 . . . . 0.0 108.776 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.09 128.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.607 ' HB2' HG21 ' A' ' 52' ' ' ILE . 25.4 t-20 -105.44 110.26 22.53 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -75.74 129.82 37.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.823 1.297 . . . . 0.0 112.608 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -91.51 -37.63 13.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.944 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -83.79 -19.54 34.85 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -152.42 119.01 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.38 119.05 7.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.304 1.411 . . . . 0.0 111.758 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -175.29 166.43 3.38 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 126.531 1.933 . . . . 0.0 110.384 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 141.59 38.07 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.195 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -141.11 123.34 15.68 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 111.364 -2.653 . . . . 0.0 109.947 -172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.05 156.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.649 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.54 141.92 49.82 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.21 121.26 9.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -174.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -170.66 173.68 44.49 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 118.665 -1.731 . . . . 0.0 117.19 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 34.6 tt0 -106.63 144.51 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.99 0.9 . . . . 0.0 111.274 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 p -97.66 118.22 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.924 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.488 ' HB2' HD12 ' A' ' 106' ' ' ILE . 2.8 m-85 -112.27 170.56 8.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.901 0.858 . . . . 0.0 111.911 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 49.9 mt -128.97 114.81 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -58.61 155.85 11.75 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -29.62 2.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -72.07 -17.7 61.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.337 1.455 . . . . 0.0 113.833 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.89 54.38 2.64 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' D' ' 90' ' ' LYS . 0.2 OUTLIER -128.22 153.55 46.8 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 129.51 3.124 . . . . 0.0 108.794 173.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -109.54 146.96 33.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.523 1.154 . . . . 0.0 109.971 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 106' ' ' ILE . 23.3 m -148.44 164.03 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.34 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.29 118.36 25.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.616 ' HE2' HD11 ' A' ' 106' ' ' ILE . 3.8 mmmt -106.76 112.94 26.15 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 2.9 p -130.52 172.12 12.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.553 1.644 . . . . 0.0 111.155 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' A' ' 113' ' ' THR . 86.5 mmm -127.19 169.99 12.89 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.753 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -139.69 164.01 31.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.657 1.218 . . . . 0.0 111.913 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.418 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -142.09 122.3 13.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.212 174.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 139.46 41.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 124.105 1.907 . . . . 0.0 110.11 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.84 114.58 18.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 109.717 -3.402 . . . . 0.0 110.626 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -73.08 167.83 20.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 125.492 1.745 . . . . 0.0 112.429 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -114.7 83.71 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.46 -172.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.904 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -119.05 -30.22 5.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.529 -1.357 . . . . 0.0 112.411 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.06 143.92 43.98 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 111.564 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.583 HD11 ' HE2' ' A' ' 94' ' ' LYS . 14.0 tt -61.61 -22.27 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.666 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.39 1.16 51.98 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 117.635 -1.647 . . . . 0.0 114.445 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.08 7.46 9.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.841 1.321 . . . . 0.0 113.002 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.06 -36.18 74.61 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.696 -1.877 . . . . 0.0 111.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.412 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 58.5 p-90 -48.25 -46.03 35.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.377 1.071 . . . . 0.0 113.201 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -90.32 -12.65 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.441 1.096 . . . . 0.0 113.508 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.28 1.0 23.12 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' A' ' 96' ' ' MET . 24.2 m -111.12 140.85 45.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.231 1.012 . . . . 0.0 111.669 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' D' ' 39' ' ' ASP . 7.3 mtt180 -144.75 130.95 19.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.61 152.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.085 1.766 . . . . 0.0 110.966 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.29 28.79 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -120.13 150.8 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.026 0.93 . . . . 0.0 110.407 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . 0.412 ' CG ' HD21 ' D' ' 12' ' ' ASN . 5.6 m-20 -149.18 148.07 29.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.768 0.794 . . . . 0.0 110.357 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -128.46 133.71 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -123.22 147.45 46.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.559 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 46.9 p -129.81 156.75 43.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.757 1.223 . . . . 0.0 110.009 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -57.75 127.79 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.761 0.825 . . . . 0.0 110.496 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 mttm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 44.4 t -139.31 133.9 31.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 109.421 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.2 p -139.56 131.72 28.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.748 2.019 . . . . 0.0 110.081 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.45 -25.72 60.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -65.68 111.6 3.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -5.38 0.37 Allowed Glycine 0 N--CA 1.478 1.472 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt 75.34 144.32 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.657 2.383 . . . . 0.0 114.037 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -140.55 162.39 35.46 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.849 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -141.11 149.96 42.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.688 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -112.03 146.26 38.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.618 0.767 . . . . 0.0 110.512 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -57.26 -23.81 50.66 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.499 1.52 . . . . 0.0 113.626 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 24.5 tp -74.52 -16.17 60.84 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.511 1.924 . . . . 0.0 111.932 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.5 -7.68 32.19 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 127.421 2.439 . . . . 0.0 114.272 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -64.41 144.39 57.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.278 1.539 . . . . 0.0 113.14 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -122.85 132.26 54.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.177 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -126.49 136.64 52.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.887 0.851 . . . . 0.0 111.739 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -126.69 130.56 50.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.601 0.715 . . . . 0.0 109.607 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.04 130.14 72.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.61 -98.16 0.09 OUTLIER Glycine 0 CA--C 1.527 0.829 0 O-C-N 125.559 1.787 . . . . 0.0 111.229 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.16 138.21 46.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.709 0.804 . . . . 0.0 110.984 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 p -92.35 133.47 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.018 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' B' ' 28' ' ' GLU . 20.4 m-20 -69.27 158.02 35.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.237 0.615 . . . . 0.0 111.344 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 63.9 m -54.4 -29.02 47.46 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -67.76 -33.9 75.76 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.801 . . . . 0.0 111.39 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.83 21.63 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.697 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' B' ' 24' ' ' ASN . 15.0 pt-20 -69.52 151.72 45.68 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.116 1.458 . . . . 0.0 108.426 174.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.411 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.0 OUTLIER -151.99 161.27 42.9 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.107 175.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.3 163.71 20.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.111 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.93 -168.34 35.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-O 122.741 1.19 . . . . 0.0 110.976 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -137.96 146.97 43.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.505 -1.847 . . . . 0.0 111.73 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -126.61 141.13 51.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.228 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.59 HD11 HD12 ' B' ' 46' ' ' LEU . 4.5 mp -126.18 144.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.457 ' O ' HG21 ' B' ' 44' ' ' ILE . 3.3 m -120.89 139.42 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.941 0.896 . . . . 0.0 112.645 -173.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.09 -16.21 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.412 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 27.7 m -134.96 140.65 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.612 1.165 . . . . 0.0 111.116 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.72 169.11 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.844 -1.16 . . . . 0.0 112.103 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' CG ' HH12 ' B' ' 114' ' ' ARG . 27.9 m-20 -70.19 -43.39 70.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.987 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -128.72 83.95 64.63 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.651 2.381 . . . . 0.0 107.66 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.71 37.48 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.263 3.308 . . . . 0.0 114.753 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.69 -2.98 90.72 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 119.839 -1.788 . . . . 0.0 116.041 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.07 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.457 HG21 ' O ' ' B' ' 35' ' ' THR . 29.5 mt -19.7 107.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.73 24.78 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.98 1.712 . . . . 0.0 109.54 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.59 HD12 HD11 ' B' ' 34' ' ' ILE . 5.0 tt -50.77 137.21 20.73 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 126.556 1.942 . . . . 0.0 113.929 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -120.15 126.24 26.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.094 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.26 141.84 98.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.679 2.253 . . . . 0.0 111.813 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.74 143.13 50.02 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 124.562 1.163 . . . . 0.0 109.614 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 149.25 34.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.978 2.511 . . . . 0.0 108.878 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.17 -155.95 27.39 Favored Glycine 0 N--CA 1.453 -0.222 0 O-C-N 120.337 -1.477 . . . . 0.0 109.853 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.623 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.5 mt -147.2 147.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.316 1.047 . . . . 0.0 111.618 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.62 154.0 42.94 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.048 1.339 . . . . 0.0 112.431 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -74.06 153.5 39.61 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.223 -1.548 . . . . 0.0 112.063 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -138.6 20.98 2.71 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -93.56 -57.07 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.791 0.836 . . . . 0.0 112.941 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 170.2 16.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.675 0.75 . . . . 0.0 112.972 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.8 m -80.77 -24.53 38.57 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.94 44.97 0.78 Allowed Pre-proline 0 CA--C 1.569 1.685 0 C-N-CA 125.319 1.448 . . . . 0.0 113.156 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.78 -176.23 3.07 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.201 2.6 . . . . 0.0 114.882 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.299 2.9 t -97.26 164.15 12.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.788 1.28 . . . . 0.0 112.508 174.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.56 168.61 26.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.893 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.44 151.53 20.32 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 120.825 3.09 . . . . 0.0 120.825 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -163.09 153.49 16.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -92.15 149.65 21.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.566 1.546 . . . . 0.0 108.849 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.61 128.18 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' C' ' 52' ' ' ILE . 25.8 t-20 -104.75 110.61 23.02 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.369 -0.832 . . . . 0.0 110.778 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -76.25 130.67 38.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 122.784 1.278 . . . . 0.0 112.645 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -92.41 -37.81 12.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.737 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -84.1 -19.49 34.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.5 117.32 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.96 118.93 6.84 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.897 1.226 . . . . 0.0 111.76 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -175.56 167.23 3.25 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 126.599 1.96 . . . . 0.0 110.27 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -139.38 142.14 37.55 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.249 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -141.15 123.32 15.63 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 111.462 -2.608 . . . . 0.0 109.588 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 m -99.17 156.53 3.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.512 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.29 141.85 49.14 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.55 121.34 9.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -169.66 172.52 43.68 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 118.628 -1.748 . . . . 0.0 116.947 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 34.9 tt0 -105.02 144.85 31.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.654 0.74 . . . . 0.0 111.224 -176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 p -97.56 122.89 41.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.106 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.469 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.98 169.61 9.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.963 0.887 . . . . 0.0 111.778 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -126.37 116.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.91 155.55 13.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -21.26 0.8 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 118.104 2.631 . . . . 0.0 118.104 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.43 -12.23 59.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 47.5 4.79 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.259 0.933 . . . . 0.0 112.416 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.69 150.81 42.22 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.257 2.223 . . . . 0.0 110.462 174.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -103.44 145.75 29.53 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.967 1.307 . . . . 0.0 110.228 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 27.1 m -147.83 164.19 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.865 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.98 118.29 25.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.596 ' HE2' HD11 ' C' ' 106' ' ' ILE . 3.8 mmmt -106.77 113.47 26.98 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.445 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 3.0 p -130.85 172.69 11.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.543 1.64 . . . . 0.0 111.161 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.65 ' HG3' HG21 ' C' ' 113' ' ' THR . 87.7 mmm -127.63 170.12 13.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.554 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -139.82 163.36 32.84 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.573 1.178 . . . . 0.0 111.752 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -141.13 122.02 14.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.19 174.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 138.38 43.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 124.356 2.027 . . . . 0.0 110.108 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.71 114.11 18.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 109.475 -3.511 . . . . 0.0 109.922 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -73.08 167.94 20.09 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 125.508 1.755 . . . . 0.0 112.125 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.4 t -114.87 87.87 2.74 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.04 -171.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.838 1.255 . . . . 0.0 108.243 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.05 -30.52 4.35 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.823 -1.173 . . . . 0.0 112.226 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -112.76 143.2 44.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.255 1.026 . . . . 0.0 111.76 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.587 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.2 tt -60.37 -22.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.08 -0.963 . . . . 0.0 113.161 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.61 54.48 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 117.701 -1.611 . . . . 0.0 114.55 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.67 7.2 9.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.922 1.289 . . . . 0.0 113.118 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.68 -36.11 73.68 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 119.76 -1.837 . . . . 0.0 111.296 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.406 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 58.7 p-90 -48.27 -45.92 35.2 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.429 1.092 . . . . 0.0 113.479 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.36 -12.32 37.98 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.463 1.105 . . . . 0.0 113.345 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.61 1.1 23.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.656 HG21 ' HG3' ' C' ' 96' ' ' MET . 25.4 m -110.86 140.35 45.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.297 1.039 . . . . 0.0 111.938 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.438 HH12 ' CG ' ' B' ' 39' ' ' ASP . 7.5 mtt180 -144.6 130.7 19.47 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.658 1.183 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.39 152.25 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 121.111 1.778 . . . . 0.0 111.209 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.35 179.49 27.95 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -120.48 150.61 40.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.241 1.017 . . . . 0.0 110.344 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.41 148.27 29.26 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.033 0.921 . . . . 0.0 110.41 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 62.7 mt -129.58 133.31 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -122.88 148.01 45.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.985 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.7 p -131.28 159.15 38.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.768 1.227 . . . . 0.0 110.432 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 5.0 mmt-85 -59.14 134.52 57.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.731 0.812 . . . . 0.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.659 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 53.5 mttm . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -141.58 135.92 30.54 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.921 1.237 . . . . 0.0 110.777 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 22.4 p -139.48 131.68 28.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.536 1.935 . . . . 0.0 110.844 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -73.54 -24.76 60.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -67.58 112.33 4.67 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.58 -3.22 0.43 Allowed Glycine 0 N--CA 1.481 1.636 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt 74.05 144.5 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.908 2.483 . . . . 0.0 114.446 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -139.54 162.55 34.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.121 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.81 147.38 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.449 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -110.68 145.92 37.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.826 0.85 . . . . 0.0 110.348 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -57.46 -23.39 49.54 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.627 1.571 . . . . 0.0 113.69 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.6 tp -75.04 -16.37 60.59 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.613 1.965 . . . . 0.0 111.895 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.07 -7.86 31.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 127.417 2.436 . . . . 0.0 114.364 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -65.1 145.25 56.54 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.285 1.543 . . . . 0.0 112.656 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -123.84 132.01 53.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.143 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -125.93 137.9 53.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 111.738 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 33.9 m -128.39 129.84 46.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.721 0.772 . . . . 0.0 109.438 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.9 129.73 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.76 -96.59 0.1 OUTLIER Glycine 0 CA--C 1.527 0.786 0 O-C-N 125.638 1.836 . . . . 0.0 111.179 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.92 45.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.758 0.823 . . . . 0.0 110.962 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.97 133.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.011 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -69.49 157.91 36.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.543 0.737 . . . . 0.0 111.831 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 64.3 m -54.58 -28.89 49.42 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -67.78 -32.88 73.77 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.834 0.743 . . . . 0.0 111.303 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.17 -6.06 23.44 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 124.761 1.172 . . . . 0.0 112.763 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.04 157.09 38.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.434 1.112 . . . . 0.0 110.426 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.6 166.55 33.01 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.95 1.357 . . . . 0.0 110.872 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -129.74 165.04 22.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 112.164 -2.289 . . . . 0.0 105.84 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.44 -167.03 35.11 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 122.448 1.027 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.404 ' HB ' HD11 ' C' ' 46' ' ' LEU . 70.2 p -139.01 147.36 42.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.972 -1.614 . . . . 0.0 112.187 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -127.48 141.26 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.587 HD11 HD12 ' C' ' 46' ' ' LEU . 4.3 mp -125.94 145.65 33.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.463 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -122.11 138.95 54.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.144 -173.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -13.45 18.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 27.7 m -136.63 140.16 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.672 1.189 . . . . 0.0 111.429 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.12 169.56 22.11 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.575 -1.328 . . . . 0.0 112.192 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . 0.447 ' CG ' HH12 ' C' ' 114' ' ' ARG . 30.2 m-20 -70.93 -42.9 69.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.142 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -128.31 84.57 62.84 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.685 2.394 . . . . 0.0 107.506 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.84 36.52 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.168 3.245 . . . . 0.0 114.675 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.88 -3.01 90.58 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 119.909 -1.744 . . . . 0.0 115.99 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.11 -4.11 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.83 1.315 . . . . 0.0 114.47 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.463 HG21 ' O ' ' C' ' 35' ' ' THR . 29.2 mt -19.33 108.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.77 164.09 26.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.073 1.749 . . . . 0.0 109.593 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.587 HD12 HD11 ' C' ' 34' ' ' ILE . 4.4 tt -49.98 136.57 18.44 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.652 1.981 . . . . 0.0 113.943 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -120.07 126.11 27.0 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.18 140.06 93.14 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.636 2.224 . . . . 0.0 111.377 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.09 149.48 42.12 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 124.772 1.295 . . . . 0.0 109.64 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -154.79 149.44 26.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.98 2.112 . . . . 0.0 108.601 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.95 -154.05 25.21 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 119.163 0.892 . . . . 0.0 111.543 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.3 mt -147.16 145.95 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.317 1.047 . . . . 0.0 111.923 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.98 153.29 43.01 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.349 1.459 . . . . 0.0 112.321 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -72.77 157.92 36.57 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.94 -1.725 . . . . 0.0 112.298 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -143.88 21.14 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -93.52 -57.26 2.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.931 0.892 . . . . 0.0 112.364 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.18 169.03 17.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.611 0.764 . . . . 0.0 112.179 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -85.38 -19.81 30.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 40.35 0.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 125.085 1.354 . . . . 0.0 113.335 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.95 -177.06 3.63 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.857 2.371 . . . . 0.0 114.531 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.308 2.3 t -96.57 164.09 12.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.711 1.243 . . . . 0.0 112.121 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -158.44 168.25 27.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.653 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.58 151.46 20.14 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 120.61 3.004 . . . . 0.0 120.61 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.19 153.21 15.73 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -91.53 150.44 21.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.996 1.719 . . . . 0.0 108.804 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.49 128.7 68.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.623 ' HB2' HG21 ' B' ' 52' ' ' ILE . 25.1 t-20 -105.46 110.62 23.03 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.817 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.47 130.95 39.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.736 1.255 . . . . 0.0 112.413 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -92.37 -38.35 12.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.964 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -82.94 -19.33 37.43 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.44 119.92 6.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.27 118.89 7.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.369 1.44 . . . . 0.0 111.35 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 6.4 m -175.56 166.38 3.22 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.695 1.998 . . . . 0.0 110.539 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 142.09 38.06 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 122.324 1.059 . . . . 0.0 111.397 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.4 m -141.25 124.19 16.25 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 111.284 -2.689 . . . . 0.0 109.831 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -100.17 155.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.421 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -131.43 141.76 49.88 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.44 121.46 9.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -170.06 173.55 44.13 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.54 -1.791 . . . . 0.0 116.703 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 35.0 tt0 -105.81 144.89 31.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.379 1.085 . . . . 0.0 111.132 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 30.1 p -97.43 123.23 41.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.356 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.468 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.7 m-85 -117.76 170.43 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.733 0.778 . . . . 0.0 112.257 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 49.7 mt -127.28 115.77 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -58.85 154.95 14.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -19.16 0.51 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 176.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -82.31 -9.61 59.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.174 0.99 . . . . 0.0 113.247 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.83 49.75 5.24 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.193 0.901 . . . . 0.0 112.359 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 0.4 OUTLIER -124.31 152.88 42.55 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 127.716 2.406 . . . . 0.0 109.506 173.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -107.54 145.71 32.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.14 1.376 . . . . 0.0 110.005 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.448 HG21 ' CD1' ' B' ' 106' ' ' ILE . 25.9 m -148.15 165.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.178 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.89 118.63 25.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' B' ' 106' ' ' ILE . 3.7 mmmt -106.97 112.62 25.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 3.0 p -129.94 172.87 11.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.533 1.635 . . . . 0.0 111.374 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.656 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.0 mmm -128.31 170.56 12.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -140.43 163.6 32.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.741 1.257 . . . . 0.0 111.804 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -141.39 122.2 14.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.389 174.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.08 139.17 41.93 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 124.122 1.915 . . . . 0.0 110.026 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.27 18.42 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 109.75 -3.386 . . . . 0.0 110.132 -173.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -72.35 168.25 18.77 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.342 1.651 . . . . 0.0 112.41 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -115.43 82.68 1.79 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.97 -172.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.791 1.237 . . . . 0.0 108.916 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -119.73 -28.52 5.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.661 -1.274 . . . . 0.0 112.847 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -116.55 143.28 45.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 122.419 1.104 . . . . 0.0 111.624 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.0 tt -61.79 -20.52 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.731 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.4 2.37 57.86 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 118.335 -1.259 . . . . 0.0 114.086 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.04 7.62 8.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.79 1.236 . . . . 0.0 112.994 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.8 -36.07 75.98 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 119.734 -1.853 . . . . 0.0 111.524 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 59.1 p-90 -48.1 -46.02 33.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.602 1.161 . . . . 0.0 113.248 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -90.22 -12.41 38.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.101 . . . . 0.0 113.763 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 1.36 23.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.65 HG21 ' HG3' ' B' ' 96' ' ' MET . 26.2 m -111.25 140.63 45.65 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.21 1.004 . . . . 0.0 111.385 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.447 HH12 ' CG ' ' C' ' 39' ' ' ASP . 7.4 mtt180 -144.81 130.93 19.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.911 1.284 . . . . 0.0 111.195 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.63 152.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.972 1.715 . . . . 0.0 111.145 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.12 28.3 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -119.9 150.72 40.02 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.146 0.978 . . . . 0.0 110.145 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.52 147.23 27.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.856 0.836 . . . . 0.0 110.406 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.56 132.78 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.87 147.74 45.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.569 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 63.3 p -131.54 158.09 41.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.831 1.252 . . . . 0.0 109.971 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -60.46 136.72 58.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.757 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 CA--C 1.536 0.419 0 O-C-N 121.456 -0.778 . . . . 0.0 111.387 174.737 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -131.04 147.03 52.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.1 p -139.84 130.71 26.08 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.278 -1.514 . . . . 0.0 112.646 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.7 -27.45 68.71 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -50.49 118.43 3.04 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 123.575 1.655 . . . . 0.0 112.189 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.11 -119.12 2.58 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.84 2.162 . . . . 0.0 110.017 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -145.01 149.73 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.546 1.138 . . . . 0.0 113.273 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -145.83 159.18 43.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.296 1.438 . . . . 0.0 110.068 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -134.87 150.2 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -107.96 143.51 36.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.461 1.104 . . . . 0.0 111.265 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.3 -24.03 64.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.39 1.076 . . . . 0.0 112.632 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 HD21 ' A' ' 118' ' ' ASN . 50.0 tp -74.09 -14.34 60.97 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.983 1.313 . . . . 0.0 112.639 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.61 -14.29 32.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 127.049 2.262 . . . . 0.0 113.889 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.61 153.85 22.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.298 1.523 . . . . 0.0 112.741 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.52 146.81 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.149 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -141.29 147.12 37.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -129.89 134.04 47.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.339 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.18 123.72 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.93 -87.06 0.11 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 124.434 1.084 . . . . 0.0 111.567 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.5 42.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.06 0.933 . . . . 0.0 112.145 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.16 125.55 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 113.166 -1.834 . . . . 0.0 108.038 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -71.36 162.81 28.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.995 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -54.91 -23.67 19.93 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -74.75 -32.52 62.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.905 -1.122 . . . . 0.0 113.217 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 -5.4 26.4 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 117.603 -1.665 . . . . 0.0 112.586 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 0.0 OUTLIER -67.06 142.46 57.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.71 156.91 32.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 1.5 p -125.2 168.61 13.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.622 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.52 -167.36 35.64 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.32 0.956 . . . . 0.0 113.838 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -138.61 133.63 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.758 -1.221 . . . . 0.0 111.308 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -113.65 131.92 55.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.59 129.24 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.251 61.2 m -104.66 142.65 34.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.638 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.24 -10.2 20.57 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -138.99 146.16 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.266 1.026 . . . . 0.0 112.647 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.1 26.4 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.319 -0.863 . . . . 0.0 110.881 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -31.14 63.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -141.1 69.73 28.27 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.454 1.902 . . . . 0.0 113.897 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.53 72.1 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 124.339 3.359 . . . . 0.0 114.183 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.69 2.28 13.64 Favored Glycine 0 N--CA 1.477 1.408 0 O-C-N 120.712 -1.242 . . . . 0.0 114.597 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.14 27.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.805 1.242 . . . . 0.0 112.623 -174.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.56 130.71 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.929 0.871 . . . . 0.0 110.76 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.25 0.5 OUTLIER -140.52 170.2 16.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.616 1.566 . . . . 0.0 110.055 177.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.1 tp -57.53 115.4 2.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.865 2.866 . . . . 0.0 111.0 174.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.2 m -100.55 120.09 56.97 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.23 142.38 87.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.434 2.089 . . . . 0.0 111.699 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.46 152.98 47.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.802 0.841 . . . . 0.0 111.624 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 30' ' ' THR . 1.1 tp -160.59 148.79 16.34 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 110.463 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.48 -152.01 22.66 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 120.883 1.674 . . . . 0.0 110.195 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -143.2 140.01 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.304 0.642 . . . . 0.0 111.279 -174.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.21 136.41 52.79 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.396 -0.815 . . . . 0.0 111.932 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -68.76 149.79 48.61 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.935 0.874 . . . . 0.0 111.321 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.3 23.98 1.15 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.995 1.318 . . . . 0.0 111.436 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -92.97 -58.2 2.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.361 1.864 . . . . 0.0 111.357 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.05 -178.15 3.21 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.616 1.197 . . . . 0.0 114.169 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -65.73 -57.81 7.15 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.215 1.006 . . . . 0.0 111.845 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -141.52 65.39 20.88 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.917 0.887 . . . . 0.0 110.129 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.34 -174.15 1.53 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.27 2.647 . . . . 0.0 114.546 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.275 4.5 t -96.15 160.72 14.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 123.158 1.456 . . . . 0.0 112.796 174.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.9 167.34 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.469 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.55 147.37 12.91 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.19 156.91 27.38 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -92.9 149.68 21.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.661 1.984 . . . . 0.0 109.535 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.22 117.04 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 19.6 t-20 -92.36 105.5 17.68 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.752 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.266 42.9 m95 -74.3 130.96 40.7 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -89.47 -40.26 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -92.17 -9.46 42.28 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.42 128.37 10.31 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 128.187 2.595 . . . . 0.0 104.865 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.76 118.7 12.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.363 1.078 . . . . 0.0 110.739 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 m -177.07 159.65 1.68 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.001 1.721 . . . . 0.0 110.475 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.63 141.64 35.07 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.033 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 99' ' ' LEU . 1.8 m -140.57 126.68 19.65 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.553 -3.022 . . . . 0.0 108.558 -172.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.754 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -124.61 142.56 51.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 116.67 5.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.31 169.21 39.73 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 118.737 -1.697 . . . . 0.0 116.408 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 29.0 tt0 -101.84 148.13 25.68 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.274 1.035 . . . . 0.0 111.723 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 132.82 36.31 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.271 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' D' ' 106' ' ' ILE . 19.7 m-85 -121.62 158.09 29.37 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 110.18 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.81 158.58 7.94 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.547 1.139 . . . . 0.0 110.087 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -48.08 -33.77 8.65 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -75.33 -15.26 60.5 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.6 47.15 3.04 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.248 0.928 . . . . 0.0 111.729 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 4.9 mtpm? -119.8 154.18 34.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.431 1.492 . . . . 0.0 109.639 174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -109.03 151.82 25.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.814 1.645 . . . . 0.0 111.26 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.48 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.3 t -152.83 156.3 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.189 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 mt -123.42 104.11 8.89 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.48 ' CD ' HG11 ' A' ' 92' ' ' VAL . 1.2 mmtt -95.04 127.84 41.41 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -139.77 163.07 33.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.792 1.282 . . . . 0.0 112.768 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 19.9 mtp -121.34 160.47 23.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -133.51 162.57 31.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.154 -1.839 . . . . 0.0 113.057 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.81 126.55 23.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.508 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.409 HD12 HG21 ' A' ' 77' ' ' THR . 0.3 OUTLIER -107.3 140.79 39.64 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 125.14 1.525 . . . . 0.0 109.972 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.09 118.23 22.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.57 -173.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.8 p -84.99 172.07 11.61 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.7 m -110.71 70.89 0.73 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 107.7 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.46 169.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.048 1.339 . . . . 0.0 109.667 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.34 -11.1 14.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -135.36 152.76 51.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.064 1.412 . . . . 0.0 111.942 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -67.43 -20.77 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.376 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.83 4.3 45.83 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.674 -0.641 . . . . 0.0 114.401 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -125.75 1.64 7.45 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.25 -34.58 72.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.987 0.915 . . . . 0.0 113.028 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -48.32 -38.85 20.06 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -97.43 -12.92 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.04 1.336 . . . . 0.0 114.032 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.76 38.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.4 m -108.34 144.94 35.2 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-O 122.352 1.072 . . . . 0.0 109.583 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -141.0 151.84 44.44 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.524 1.529 . . . . 0.0 108.311 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.62 153.19 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.57 1.148 . . . . 0.0 109.411 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.38 32.22 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.141 0.877 . . . . 0.0 111.776 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 17.3 p90 -132.41 159.99 37.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.139 -0.624 . . . . 0.0 112.076 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.586 HD21 HD22 ' A' ' 14' ' ' LEU . 4.6 m120 -150.42 157.35 42.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.542 1.163 . . . . 0.0 109.784 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.4 HD13 ' HE3' ' A' ' 94' ' ' LYS . 8.6 mt -131.93 129.45 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.85 151.97 38.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 124.334 1.022 . . . . 0.0 108.772 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 p -139.84 164.77 29.09 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -57.04 129.62 42.51 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.496 0.718 . . . . 0.0 110.94 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.499 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . 0.463 ' HG ' ' HB3' ' D' ' 83' ' ' CYS . 27.5 p -137.67 143.37 41.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.656 1.583 . . . . 0.0 108.888 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 85.2 p -139.98 131.95 27.77 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.346 -1.471 . . . . 0.0 113.552 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.31 -24.04 67.68 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -53.95 118.43 3.99 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.545 1.64 . . . . 0.0 112.092 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.46 -120.73 2.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.261 1.886 . . . . 0.0 109.554 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 113.301 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -147.8 159.89 43.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.18 147.88 46.18 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -105.79 143.57 33.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.652 1.181 . . . . 0.0 111.945 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.79 -24.56 62.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.562 1.145 . . . . 0.0 112.92 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.634 HD22 HD21 ' D' ' 118' ' ' ASN . 45.4 tp -74.84 -13.81 60.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.694 1.197 . . . . 0.0 112.666 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -13.81 36.72 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.973 2.225 . . . . 0.0 113.619 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.2 152.27 25.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.298 1.523 . . . . 0.0 112.439 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.95 146.44 50.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.854 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -141.19 147.29 38.14 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -129.76 134.95 47.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.035 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.08 123.62 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.86 0.12 Allowed Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.128 0.893 . . . . 0.0 111.757 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.09 151.63 38.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.747 -0.855 . . . . 0.0 111.969 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.66 126.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.596 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -70.87 162.8 28.62 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -56.52 -24.92 49.88 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -73.02 -30.95 64.14 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.825 -1.172 . . . . 0.0 112.52 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.11 -1.25 25.49 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.214 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.51 155.61 39.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.152 1.476 . . . . 0.0 112.417 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . 0.439 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -156.47 166.06 34.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.316 174.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . 0.543 HG22 ' CD1' ' D' ' 50' ' ' LEU . 3.0 p -125.44 -179.92 4.83 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.81 -167.33 39.49 Favored Glycine 0 N--CA 1.469 0.878 0 O-C-N 119.46 -2.025 . . . . 0.0 113.755 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.5 p -137.92 132.31 32.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.101 0.953 . . . . 0.0 112.133 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -112.2 136.13 51.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 mt -125.78 129.53 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 70.4 m -104.74 143.33 33.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.736 -173.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.88 21.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -141.48 145.67 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.359 1.063 . . . . 0.0 112.504 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.05 167.99 26.67 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.111 -0.993 . . . . 0.0 110.896 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -30.98 63.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.9 69.7 29.45 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.448 1.899 . . . . 0.0 113.966 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.53 71.5 2.49 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.324 3.349 . . . . 0.0 114.266 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.17 14.49 Favored Glycine 0 N--CA 1.477 1.389 0 O-C-N 120.734 -1.229 . . . . 0.0 114.595 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.03 28.02 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.721 1.208 . . . . 0.0 112.626 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.69 130.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.946 0.879 . . . . 0.0 110.686 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.09 169.98 16.59 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.683 1.593 . . . . 0.0 109.753 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.3 tp -57.17 115.37 2.62 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.249 3.02 . . . . 0.0 111.151 174.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -100.93 119.48 58.08 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.12 141.17 87.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.365 2.044 . . . . 0.0 111.647 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -125.38 157.15 37.5 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.738 0.815 . . . . 0.0 111.777 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' D' ' 30' ' ' THR . 12.5 tp -163.67 149.04 10.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.356 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -148.25 15.26 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 120.298 1.408 . . . . 0.0 110.729 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mt -146.42 139.49 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.179 0.992 . . . . 0.0 110.317 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.91 136.83 54.59 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.224 -0.922 . . . . 0.0 111.549 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -68.58 150.38 48.08 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.659 -1.276 . . . . 0.0 111.782 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -147.26 24.66 1.13 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 111.751 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 15.5 mmt-85 -93.12 -58.19 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.085 1.754 . . . . 0.0 111.448 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 179.89 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -63.68 -55.28 24.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.246 1.018 . . . . 0.0 111.431 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.07 67.83 15.5 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.516 0.726 . . . . 0.0 112.447 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.23 -173.59 1.65 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.166 2.577 . . . . 0.0 115.5 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.273 3.9 t -96.88 161.56 13.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 123.038 1.399 . . . . 0.0 112.997 174.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -151.46 167.99 26.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.352 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.84 147.53 13.1 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.994 2.358 . . . . 0.0 118.994 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.74 156.0 24.66 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.03 149.43 21.23 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.595 1.958 . . . . 0.0 109.594 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.62 117.73 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' A' ' 52' ' ' ILE . 19.6 t-20 -93.21 106.38 18.35 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.49 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.268 42.6 m95 -74.26 131.98 41.7 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -172.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -90.48 -39.47 12.59 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.83 -9.51 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.35 129.01 10.79 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.553 2.741 . . . . 0.0 105.374 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.28 118.82 12.65 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.07 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 4.7 m -177.03 159.99 1.73 Allowed 'General case' 0 C--O 1.244 0.779 0 C-N-CA 125.875 1.67 . . . . 0.0 110.34 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.64 141.29 35.1 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.065 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.413 HG21 HD12 ' D' ' 99' ' ' LEU . 1.8 m -140.5 126.26 19.27 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.834 -2.894 . . . . 0.0 108.845 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.12 151.5 5.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.808 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 142.28 51.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.84 116.42 5.83 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.2 168.98 39.56 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 118.605 -1.76 . . . . 0.0 116.388 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 28.8 tt0 -101.89 148.31 25.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.782 0.801 . . . . 0.0 111.521 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' HG ' ' D' ' 4' ' ' CYS . 49.1 t -95.21 131.72 40.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.716 174.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.589 ' HB2' HD12 ' A' ' 106' ' ' ILE . 24.8 m-85 -117.59 159.93 22.09 Favored 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 123.685 0.794 . . . . 0.0 112.867 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -124.13 110.37 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.68 158.19 8.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.958 1.303 . . . . 0.0 109.678 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -47.52 -34.27 7.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.96 -18.23 61.4 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 36.4 4.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.705 1.145 . . . . 0.0 112.802 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.497 ' HB3' ' NZ ' ' D' ' 90' ' ' LYS . 8.4 mtpm? -109.14 157.14 19.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.727 1.211 . . . . 0.0 110.189 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -109.21 153.55 23.64 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 119.919 -1.738 . . . . 0.0 111.511 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.5 t -153.18 154.57 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.177 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 mt -118.9 106.44 12.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 172.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.1 mptt -97.7 125.94 42.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 172.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -138.78 162.91 33.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.75 1.262 . . . . 0.0 112.419 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 18.4 mtp -121.17 160.72 23.2 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -133.92 162.27 32.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.066 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -137.78 126.76 24.17 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.536 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . 0.413 HD12 HG21 ' D' ' 77' ' ' THR . 0.2 OUTLIER -107.24 142.06 37.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 125.074 1.484 . . . . 0.0 109.827 -177.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.82 117.85 20.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 111.801 -2.454 . . . . 0.0 111.729 -173.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -84.49 171.12 12.82 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 23.4 m -109.09 71.91 0.79 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.79 171.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.838 1.255 . . . . 0.0 109.613 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.64 -4.26 12.81 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.8 150.97 46.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.739 1.257 . . . . 0.0 110.807 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.4 tt -68.33 -21.5 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.183 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.38 3.99 44.38 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.943 0.783 . . . . 0.0 114.294 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.31 1.22 7.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.037 0.935 . . . . 0.0 113.423 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.5 -34.59 71.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 113.034 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -48.21 -39.48 21.23 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -96.78 -12.93 23.02 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.967 1.307 . . . . 0.0 114.189 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.29 -4.62 37.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 6.7 m -108.8 145.42 35.24 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.621 0.724 . . . . 0.0 109.369 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -141.2 151.7 44.0 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.936 1.694 . . . . 0.0 108.854 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.17 153.73 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 109.715 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.78 -176.24 32.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.687 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 18.4 p90 -132.51 160.01 37.76 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.162 -0.61 . . . . 0.0 111.881 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . 0.634 HD21 HD22 ' D' ' 14' ' ' LEU . 4.7 m120 -150.33 157.2 42.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.73 1.252 . . . . 0.0 109.866 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . 0.404 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.0 mt -133.02 130.33 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.66 152.52 41.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.19 0.931 . . . . 0.0 109.417 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 45.2 p -140.66 167.38 22.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -57.4 125.58 23.48 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.326 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.402 ' HG ' ' CB ' ' B' ' 83' ' ' CYS . 28.8 p -137.97 140.94 40.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.107 1.763 . . . . 0.0 107.479 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -139.86 131.17 26.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 119.839 -1.788 . . . . 0.0 113.463 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.56 -26.11 68.41 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -52.14 118.09 3.25 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.704 1.716 . . . . 0.0 112.433 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.44 -118.0 2.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.507 2.004 . . . . 0.0 110.306 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -144.75 148.52 34.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.502 1.121 . . . . 0.0 113.621 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -144.87 159.05 43.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.177 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -136.65 148.41 47.41 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -105.81 143.55 33.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.812 1.245 . . . . 0.0 112.215 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.89 -22.33 62.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.731 1.212 . . . . 0.0 112.918 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.62 HD22 HD21 ' B' ' 118' ' ' ASN . 50.2 tp -76.68 -14.5 59.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.838 1.255 . . . . 0.0 112.497 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 -12.83 34.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.707 2.099 . . . . 0.0 113.769 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 153.77 28.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.105 1.431 . . . . 0.0 112.554 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.45 147.56 50.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.628 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -142.03 146.87 36.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m -128.55 135.36 49.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.064 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.7 124.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.19 -86.41 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 O-C-N 124.362 1.039 . . . . 0.0 111.502 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.83 152.59 42.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 122.068 0.937 . . . . 0.0 112.11 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -99.84 125.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 113.124 -1.853 . . . . 0.0 108.288 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -71.38 162.83 28.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 110.94 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -55.09 -23.52 21.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -74.83 -31.82 61.78 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.849 -1.157 . . . . 0.0 113.304 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.78 -5.47 27.61 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.874 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.495 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 0.0 OUTLIER -67.03 142.77 57.08 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.15 156.73 31.41 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.413 HG22 HD13 ' B' ' 50' ' ' LEU . 1.3 p -125.01 168.87 12.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.556 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.35 -167.1 35.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 122.461 1.034 . . . . 0.0 113.778 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.521 ' HB ' HD11 ' B' ' 46' ' ' LEU . 12.3 p -138.56 132.33 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.606 -1.297 . . . . 0.0 111.15 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.11 136.36 50.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.222 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mt -126.8 129.37 71.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.252 63.7 m -104.67 143.2 33.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.925 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.44 -8.46 21.09 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 m -140.35 145.74 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.267 1.027 . . . . 0.0 112.601 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.94 167.78 27.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.216 -0.928 . . . . 0.0 111.0 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.94 -31.52 64.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.75 69.83 30.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 126.562 1.945 . . . . 0.0 113.902 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 71.36 2.48 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 124.426 3.417 . . . . 0.0 114.259 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.0 2.17 14.68 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 120.753 -1.217 . . . . 0.0 114.571 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.11 27.9 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.594 1.157 . . . . 0.0 112.561 -174.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 86.4 mt -50.45 130.59 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.816 0.817 . . . . 0.0 110.658 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.59 170.42 15.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.636 1.574 . . . . 0.0 109.833 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.8 tp -57.61 115.4 2.75 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.133 2.973 . . . . 0.0 111.068 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m -100.9 119.97 56.79 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.06 142.53 85.68 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.622 2.215 . . . . 0.0 111.853 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.98 153.07 47.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.741 0.816 . . . . 0.0 111.725 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.413 HD13 HG22 ' B' ' 30' ' ' THR . 1.1 tp -160.64 148.77 16.24 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.426 1.49 . . . . 0.0 110.348 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.42 -152.38 23.12 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 120.857 1.662 . . . . 0.0 110.158 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -143.0 139.59 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.78 136.36 53.05 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.508 -0.745 . . . . 0.0 112.081 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -69.25 150.93 46.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.988 0.899 . . . . 0.0 111.358 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.26 18.96 1.22 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.056 1.342 . . . . 0.0 111.865 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 mmt-85 -87.84 -58.19 2.66 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.315 1.846 . . . . 0.0 111.467 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 178.5 4.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.6 t -64.42 -53.37 49.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.602 1.161 . . . . 0.0 111.85 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -143.95 66.51 14.86 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.785 0.834 . . . . 0.0 113.057 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.83 -174.23 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.912 2.408 . . . . 0.0 115.316 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.262 4.2 t -96.35 161.27 14.0 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.689 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -151.49 168.48 24.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.207 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.41 147.16 12.27 Favored Glycine 0 CA--C 1.539 1.58 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -160.05 157.63 29.01 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.45 150.11 20.7 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.516 1.926 . . . . 0.0 109.575 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.51 117.12 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.51 ' HB2' HG21 ' C' ' 52' ' ' ILE . 20.1 t-20 -92.41 105.58 17.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.613 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.267 42.9 m95 -74.12 130.79 40.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -89.32 -40.34 12.85 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -91.9 -9.56 42.77 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.37 128.08 10.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.52 2.728 . . . . 0.0 105.326 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.08 118.88 12.54 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.823 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -177.08 159.95 1.71 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.958 1.703 . . . . 0.0 110.317 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -141.11 141.54 34.18 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.87 126.93 19.47 Favored 'General case' 0 N--CA 1.407 -2.625 0 CA-C-N 110.593 -3.003 . . . . 0.0 108.657 -172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.842 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -124.56 142.72 51.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.41 116.92 5.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.84 168.96 39.94 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 118.816 -1.659 . . . . 0.0 116.546 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 28.8 tt0 -101.81 148.4 25.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.76 0.79 . . . . 0.0 111.356 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.402 ' CB ' ' HG ' ' B' ' 4' ' ' CYS . 49.8 t -95.2 133.04 39.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.133 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' C' ' 106' ' ' ILE . 18.1 m-85 -118.41 158.17 25.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 mt -121.97 108.43 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.14 158.62 8.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.126 0.97 . . . . 0.0 110.466 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -46.95 -32.15 3.65 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.05 -12.22 59.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.65 51.32 3.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.8 156.74 30.05 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 129.658 3.183 . . . . 0.0 108.548 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -118.02 155.31 30.53 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 119.948 -1.72 . . . . 0.0 111.465 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.493 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.4 t -155.54 155.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -120.12 107.07 12.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' B' ' 92' ' ' VAL . 1.0 OUTLIER -98.29 126.14 43.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -139.32 163.08 33.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.688 1.233 . . . . 0.0 112.551 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 19.7 mtp -120.79 160.68 22.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.82 162.63 31.48 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.133 -1.849 . . . . 0.0 113.175 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.73 126.38 23.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.568 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.24 141.0 39.23 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 125.05 1.468 . . . . 0.0 109.84 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 111.728 -2.487 . . . . 0.0 111.669 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -84.93 171.81 11.86 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 32.6 m -110.08 71.73 0.77 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.72 170.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.333 1.453 . . . . 0.0 110.012 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.39 -4.52 13.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.05 151.85 47.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.662 1.22 . . . . 0.0 111.067 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.7 tt -68.52 -22.29 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.072 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.73 4.53 36.19 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.753 0.692 . . . . 0.0 114.391 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.65 1.38 7.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.65 -34.38 71.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.294 1.038 . . . . 0.0 113.284 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -48.34 -39.51 22.3 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -96.44 -13.35 23.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.902 1.281 . . . . 0.0 114.125 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.06 -5.77 43.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -107.54 145.03 33.71 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 121.822 0.82 . . . . 0.0 109.279 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -140.61 151.31 44.56 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 125.966 1.706 . . . . 0.0 108.751 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.88 154.21 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 119.582 1.083 . . . . 0.0 109.656 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.84 -176.14 32.62 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.093 0.854 . . . . 0.0 111.739 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 17.9 p90 -132.73 160.08 37.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.137 -0.625 . . . . 0.0 112.087 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . 0.62 HD21 HD22 ' B' ' 14' ' ' LEU . 5.3 m120 -150.43 157.07 42.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.665 1.221 . . . . 0.0 110.02 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.65 130.0 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.9 153.36 39.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 124.285 0.991 . . . . 0.0 109.408 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.4 p -141.74 165.67 26.85 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.16 121.79 11.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.803 1.241 . . . . 0.0 111.872 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.219 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 p -133.72 143.63 48.61 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -140.04 129.22 23.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 119.581 -1.949 . . . . 0.0 114.248 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.07 -27.32 69.31 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -52.11 114.49 1.34 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 123.035 1.398 . . . . 0.0 111.915 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.96 -109.44 0.74 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.669 1.604 . . . . 0.0 110.979 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -152.0 144.26 23.98 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.87 160.48 39.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.256 1.022 . . . . 0.0 110.699 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.21 148.0 50.81 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -109.3 143.62 38.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.945 0.898 . . . . 0.0 111.859 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -59.6 -25.72 64.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.628 1.171 . . . . 0.0 112.969 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.64 HD22 HD21 ' C' ' 118' ' ' ASN . 48.9 tp -73.58 -14.2 61.15 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.838 -1.164 . . . . 0.0 112.357 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.28 -12.19 36.79 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.82 2.152 . . . . 0.0 113.685 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.86 155.01 28.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 123.393 1.568 . . . . 0.0 112.427 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.39 146.3 51.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.015 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -142.31 144.18 33.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.035 0.922 . . . . 0.0 113.348 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -127.52 134.11 49.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.246 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 95.9 mt -132.64 124.39 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.46 -85.71 0.1 Allowed Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.241 0.963 . . . . 0.0 111.701 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.6 152.33 39.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.846 -0.796 . . . . 0.0 112.283 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.98 126.23 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 113.474 -1.694 . . . . 0.0 108.652 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -71.29 163.23 28.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.541 0.686 . . . . 0.0 111.78 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -56.78 -24.82 53.15 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -73.04 -31.26 64.32 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.736 -1.228 . . . . 0.0 112.524 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.79 -2.26 24.51 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.257 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.44 155.47 40.08 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.016 1.408 . . . . 0.0 112.459 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . 0.448 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -156.89 166.08 34.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.43 174.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.539 HG22 ' CD1' ' C' ' 50' ' ' LEU . 3.0 p -125.66 -179.34 4.61 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 173.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.0 -166.91 39.22 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 119.208 -2.182 . . . . 0.0 113.222 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' C' ' 46' ' ' LEU . 12.4 p -137.13 131.94 33.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.797 0.808 . . . . 0.0 112.199 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -111.39 137.78 48.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.8 129.85 70.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.254 64.9 m -104.8 144.07 32.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.462 -173.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.97 -6.26 21.42 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -141.68 144.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 112.57 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.59 168.03 26.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 110.966 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -31.29 63.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 172.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -140.41 69.94 32.69 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.626 1.97 . . . . 0.0 113.977 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.53 71.56 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.405 3.403 . . . . 0.0 114.195 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.05 1.94 14.64 Favored Glycine 0 N--CA 1.477 1.409 0 O-C-N 120.686 -1.259 . . . . 0.0 114.616 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.91 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.583 1.153 . . . . 0.0 112.554 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.56 130.86 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.898 0.856 . . . . 0.0 110.612 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.15 169.93 16.68 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.773 1.629 . . . . 0.0 109.803 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -56.8 115.44 2.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 129.264 3.025 . . . . 0.0 111.153 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 57.0 m -100.98 119.47 58.04 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.88 141.75 85.13 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.174 1.916 . . . . 0.0 111.526 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.47 157.02 39.75 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.664 0.786 . . . . 0.0 111.805 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' C' ' 30' ' ' THR . 12.6 tp -164.19 148.98 10.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.521 1.528 . . . . 0.0 112.455 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.09 -147.97 14.74 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 120.357 1.435 . . . . 0.0 110.699 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mt -146.84 139.47 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 110.162 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.66 136.66 54.61 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 121.188 -0.945 . . . . 0.0 111.428 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -68.36 150.6 47.99 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.626 -1.296 . . . . 0.0 111.64 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -146.86 25.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.011 1.324 . . . . 0.0 111.717 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 mmt-85 -93.42 -58.2 2.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.173 1.789 . . . . 0.0 111.705 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.25 179.65 4.39 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.594 1.184 . . . . 0.0 113.992 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -63.71 -57.9 8.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.725 0.81 . . . . 0.0 110.795 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.75 66.64 27.63 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.606 0.763 . . . . 0.0 112.065 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -173.31 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.29 2.66 . . . . 0.0 115.245 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.276 4.0 t -96.54 161.51 13.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 123.055 1.407 . . . . 0.0 113.011 174.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -151.75 167.57 27.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.469 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.5 147.79 13.71 Favored Glycine 0 CA--C 1.542 1.771 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.68 156.54 25.64 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -93.57 150.05 20.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.546 1.938 . . . . 0.0 109.618 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.03 117.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.542 ' HB2' HG21 ' B' ' 52' ' ' ILE . 19.6 t-20 -92.74 107.14 18.99 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.347 -0.846 . . . . 0.0 110.42 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.268 43.1 m95 -75.3 131.8 40.56 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -89.95 -40.53 12.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -92.21 -9.23 43.0 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -152.37 127.79 9.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.605 2.762 . . . . 0.0 105.172 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.37 118.84 12.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.2 m -177.2 160.2 1.7 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 126.127 1.771 . . . . 0.0 110.424 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -140.98 141.57 34.38 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.054 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.408 HG23 ' HA ' ' C' ' 99' ' ' LEU . 1.8 m -140.43 127.32 20.63 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 110.642 -2.981 . . . . 0.0 108.824 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.13 151.19 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.69 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.8 142.42 51.12 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.5 117.16 5.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -173.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 169.0 39.61 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.257 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 28.8 tt0 -101.75 148.66 25.01 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 111.354 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.48 132.67 41.8 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.107 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.583 ' HB2' HD12 ' B' ' 106' ' ' ILE . 19.1 m-85 -117.95 160.28 21.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.01 110.18 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 172.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.79 156.96 10.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 109.912 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -46.76 -34.9 5.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.62 -15.95 61.24 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.62 35.62 5.6 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.365 1.459 . . . . 0.0 113.232 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -104.47 163.04 12.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.16 1.384 . . . . 0.0 107.854 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -118.49 152.57 35.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.997 1.719 . . . . 0.0 111.182 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -153.34 156.04 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.229 1.411 . . . . 0.0 111.168 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 mt -119.91 108.67 14.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.0 OUTLIER -99.6 126.07 45.53 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 172.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -139.34 162.55 34.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.667 1.223 . . . . 0.0 112.677 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 18.9 mtp -120.3 160.98 21.91 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -133.86 162.76 31.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.995 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 tp -137.81 126.73 24.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.467 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . 0.408 ' HA ' HG23 ' C' ' 77' ' ' THR . 0.3 OUTLIER -107.21 141.22 38.84 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 124.881 1.363 . . . . 0.0 109.944 -177.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.42 118.92 22.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 111.615 -2.539 . . . . 0.0 111.771 -173.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 96.2 p -85.96 171.68 11.26 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -110.34 71.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.5 171.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.081 1.352 . . . . 0.0 109.529 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -114.07 -5.68 13.1 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.54 151.49 47.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.703 1.24 . . . . 0.0 110.98 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.3 tt -67.79 -22.11 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.932 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.5 3.84 38.84 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.85 -0.972 . . . . 0.0 114.33 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -125.58 1.27 7.57 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.289 1.036 . . . . 0.0 113.747 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.66 -34.39 71.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.148 0.979 . . . . 0.0 112.973 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.54 -39.0 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -96.95 -12.62 23.16 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.028 1.331 . . . . 0.0 114.237 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.57 -4.61 38.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 6.8 m -108.65 144.99 35.67 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.305 1.05 . . . . 0.0 109.672 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -141.31 151.68 43.81 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.547 1.539 . . . . 0.0 108.262 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.23 153.41 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.87 -175.88 32.37 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 123.998 0.808 . . . . 0.0 111.807 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 18.4 p90 -133.09 160.52 36.96 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.086 -0.656 . . . . 0.0 112.26 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . 0.64 HD21 HD22 ' C' ' 14' ' ' LEU . 4.9 m120 -150.65 157.56 43.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.719 1.247 . . . . 0.0 110.276 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . 0.413 HD13 ' HE3' ' C' ' 94' ' ' LYS . 8.8 mt -133.13 130.87 58.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -124.32 150.93 44.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -139.59 167.59 21.76 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.399 -0.813 . . . . 0.0 109.061 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -57.59 117.33 4.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.222 1.009 . . . . 0.0 111.572 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.045 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 t -116.33 123.44 47.64 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -141.11 134.78 30.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.892 -1.13 . . . . 0.0 112.232 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.65 -18.09 61.07 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -56.15 115.89 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.606 1.162 . . . . 0.0 111.317 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.91 -122.23 3.29 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.926 1.727 . . . . 0.0 111.269 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.45 143.6 26.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -140.35 162.68 34.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.28 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -137.77 146.31 43.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.359 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 14' ' ' LEU . 6.3 t30 -108.0 145.31 34.09 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.948 0.899 . . . . 0.0 110.581 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.81 -29.45 54.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.963 1.305 . . . . 0.0 114.248 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' H ' HD22 ' A' ' 12' ' ' ASN . 30.3 tp -70.99 -13.83 62.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.975 1.71 . . . . 0.0 113.402 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.38 22.95 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.31 2.386 . . . . 0.0 113.868 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 156.04 34.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.042 1.421 . . . . 0.0 113.578 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.29 136.14 51.54 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.407 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -130.1 143.26 50.69 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.393 -0.817 . . . . 0.0 112.09 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 m -132.07 133.08 43.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.514 0.726 . . . . 0.0 109.589 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.91 121.75 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -58.19 9.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.311 1.007 . . . . 0.0 112.425 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.32 153.27 3.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.164 1.386 . . . . 0.0 110.557 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.48 130.96 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 124.582 1.176 . . . . 0.0 111.293 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -75.1 168.85 19.18 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 m -55.62 -27.95 52.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -81.77 -35.77 29.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.059 0.845 . . . . 0.0 110.422 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.54 -6.02 9.2 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 117.151 -1.916 . . . . 0.0 114.489 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB2' HD21 ' D' ' 50' ' ' LEU . 1.4 pt-20 -67.9 141.81 56.26 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 119.7 1.75 . . . . 0.0 108.101 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.24 151.0 22.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.85 165.32 11.94 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.42 -165.45 32.09 Favored Glycine 0 C--O 1.237 0.322 0 O-C-N 120.683 -1.261 . . . . 0.0 111.707 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -141.36 143.35 33.94 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 122.227 1.013 . . . . 0.0 112.983 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -118.65 123.9 46.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.246 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 46' ' ' LEU . 2.8 mp -115.15 126.68 72.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.3 m -105.65 150.51 25.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.3 -11.88 14.82 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.39 146.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.363 1.465 . . . . 0.0 112.091 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.17 42.18 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.292 -1.505 . . . . 0.0 113.265 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -71.57 -21.54 61.87 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.693 0.397 . . . . 0.0 110.598 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -148.47 83.46 7.03 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.828 2.451 . . . . 0.0 109.944 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 28.33 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.545 3.497 . . . . 0.0 115.834 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.12 -5.67 49.17 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 0.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.003 -1.475 . . . . 0.0 114.165 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -20.57 114.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.865 1.666 . . . . 0.0 115.451 -173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 168.18 18.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.351 2.26 . . . . 0.0 107.923 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 34' ' ' ILE . 6.8 tt -53.69 138.25 35.53 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.148 1.379 . . . . 0.0 112.856 174.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -115.55 121.56 34.32 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.22 144.82 89.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.435 2.757 . . . . 0.0 111.622 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.49 154.86 48.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 111.378 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.81 148.56 20.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.237 1.815 . . . . 0.0 109.916 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.25 -153.4 23.88 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 121.748 2.067 . . . . 0.0 111.775 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.9 mt -142.17 142.4 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.04 143.98 51.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.35 0.66 . . . . 0.0 111.816 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -79.35 151.43 31.0 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.603 1.192 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -145.94 25.46 1.28 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.43 1.492 . . . . 0.0 111.744 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -93.52 -50.22 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.219 2.208 . . . . 0.0 112.107 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.95 178.19 7.66 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.797 0.808 . . . . 0.0 112.81 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 p -77.82 -41.77 35.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 113.676 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -131.66 56.46 24.26 Favored Pre-proline 0 CA--C 1.554 1.103 0 C-N-CA 125.367 1.467 . . . . 0.0 112.174 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.06 172.06 12.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.975 1.783 . . . . 0.0 115.71 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -94.51 174.08 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.229 173.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -166.69 165.34 16.54 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.252 -1.794 . . . . 0.0 113.592 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.68 148.32 13.67 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 118.589 2.195 . . . . 0.0 118.589 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -164.13 154.98 15.47 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 152.4 22.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.906 1.683 . . . . 0.0 110.326 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -133.23 116.91 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' D' ' 52' ' ' ILE . 29.3 t30 -99.49 110.13 22.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -76.95 136.81 38.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -38.34 12.54 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.545 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -86.54 -15.67 39.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -152.55 122.23 6.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.195 1.798 . . . . 0.0 107.145 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.65 118.48 5.71 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.175 1.352 . . . . 0.0 110.114 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.9 p -175.18 168.34 3.39 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.04 1.736 . . . . 0.0 110.616 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -147.78 145.33 28.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.254 1.502 . . . . 0.0 111.326 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -137.02 130.35 31.27 Favored 'General case' 0 N--CA 1.407 -2.621 0 CA-C-N 110.03 -3.259 . . . . 0.0 108.515 -173.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.35 140.79 31.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 O-C-N 123.874 0.734 . . . . 0.0 109.573 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -115.09 147.43 40.21 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.422 0.452 . . . . 0.0 110.561 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 118.25 10.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.39 -172.71 31.21 Favored Glycine 0 CA--C 1.502 -0.768 0 C-N-CA 119.493 -1.336 . . . . 0.0 115.749 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -123.3 149.9 44.24 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 125.101 1.118 . . . . 0.0 113.103 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.49 112.86 24.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.576 -2.556 . . . . 0.0 106.31 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' D' ' 106' ' ' ILE . 10.5 m-85 -108.41 155.97 19.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 118.893 0.77 . . . . 0.0 112.625 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -128.9 113.04 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.79 161.65 4.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.812 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -41.63 -48.29 4.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.553 1.541 . . . . 0.0 113.599 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.36 -29.97 70.26 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.23 24.53 5.38 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.124 1.345 . . . . 0.0 114.142 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -92.92 160.5 14.87 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.647 1.223 . . . . 0.0 108.128 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.01 147.67 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.363 1.465 . . . . 0.0 111.405 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' D' ' 106' ' ' ILE . 2.3 t -148.27 159.62 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.104 1.362 . . . . 0.0 110.088 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.1 mt -122.47 106.43 11.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CD ' HG11 ' A' ' 92' ' ' VAL . 3.9 mmtt -98.87 123.99 43.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -139.34 168.4 19.91 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.54 1.638 . . . . 0.0 113.652 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -118.71 163.15 17.26 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -136.9 162.23 33.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.632 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.758 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -145.52 120.82 10.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.78 -1.554 . . . . 0.0 111.676 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.74 137.57 45.52 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 125.152 1.532 . . . . 0.0 112.897 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -118.95 113.85 21.65 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 111.121 -2.763 . . . . 0.0 110.88 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.282 49.2 m -73.6 168.09 20.01 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.364 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 p -110.4 85.88 2.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.09 -164.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -131.49 -26.07 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.574 -1.329 . . . . 0.0 114.042 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.35 148.89 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.81 1.767 . . . . 0.0 111.916 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' D' ' 84' ' ' PHE . 19.5 tt -63.2 -22.49 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.343 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.86 2.69 54.04 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 117.969 -1.462 . . . . 0.0 113.634 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -120.36 1.9 10.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 9.8 t70 -59.72 -27.84 66.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.606 -1.934 . . . . 0.0 112.395 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 43.7 p-90 -46.08 -49.49 16.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.302 1.041 . . . . 0.0 113.042 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -89.29 -11.42 43.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.93 0.892 . . . . 0.0 112.703 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -76.34 -3.03 34.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.237 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.758 ' CG2' HD21 ' A' ' 98' ' ' LEU . 1.9 m -107.72 138.46 43.92 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.746 0.819 . . . . 0.0 112.585 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' HH11 ' A' ' 114' ' ' ARG . 18.4 mtt85 -141.35 130.37 23.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 110.821 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.45 158.25 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.933 1.242 . . . . 0.0 111.308 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.63 -177.51 36.54 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 14.7 p90 -126.69 155.56 42.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.913 -0.757 . . . . 0.0 111.858 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -148.13 155.73 41.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.539 1.161 . . . . 0.0 110.915 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.1 mt -139.32 120.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.06 153.92 27.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.466 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -142.14 165.99 25.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 123.5 14.84 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.287 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.25 123.49 47.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -143.02 136.26 28.23 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.41 -17.87 61.21 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -55.86 118.81 4.93 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.434 1.111 . . . . 0.0 111.704 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.2 -114.83 1.72 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 125.612 1.577 . . . . 0.0 111.239 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.83 141.37 21.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -139.18 162.8 34.08 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.559 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -142.52 147.92 36.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.92 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.52 HD22 ' H ' ' D' ' 14' ' ' LEU . 5.5 t30 -108.15 145.66 33.84 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.897 0.879 . . . . 0.0 110.487 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.63 -27.02 57.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.819 1.248 . . . . 0.0 113.9 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.52 ' H ' HD22 ' D' ' 12' ' ' ASN . 30.5 tp -71.41 -14.62 62.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.753 1.621 . . . . 0.0 113.384 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.14 -13.45 21.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.309 2.385 . . . . 0.0 113.975 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.39 154.55 41.08 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.094 1.447 . . . . 0.0 112.619 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.65 135.13 51.82 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.309 0.644 . . . . 0.0 110.764 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -128.77 144.42 51.16 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.472 -0.768 . . . . 0.0 111.987 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -133.77 131.48 39.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.964 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.81 122.3 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.64 -60.52 6.12 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 124.542 1.151 . . . . 0.0 112.24 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.1 156.08 8.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.538 1.135 . . . . 0.0 110.872 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.23 129.84 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.481 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -75.35 168.21 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.082 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -56.43 -26.8 54.72 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -80.16 -32.76 38.78 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.095 0.861 . . . . 0.0 110.606 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 -6.15 10.3 Favored Glycine 0 C--O 1.221 -0.703 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.486 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.59 149.77 46.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.218 1.407 . . . . 0.0 113.265 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . 0.484 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.0 p90 -160.17 165.56 31.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.769 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 161.96 26.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -172.06 -165.26 28.93 Favored Glycine 0 N--CA 1.464 0.552 0 O-C-N 119.983 -1.698 . . . . 0.0 111.96 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 70.6 p -139.89 141.43 36.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.464 1.126 . . . . 0.0 113.337 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -119.52 122.43 41.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.094 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.689 HD11 HD12 ' D' ' 46' ' ' LEU . 2.8 mp -113.75 127.23 71.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 58.2 m -105.6 150.87 25.02 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.79 -12.31 14.62 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.49 146.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.312 1.445 . . . . 0.0 111.935 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.88 161.59 41.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.362 -1.462 . . . . 0.0 113.353 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -72.09 -21.48 61.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.717 0.407 . . . . 0.0 110.747 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.27 83.29 7.23 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 127.857 2.463 . . . . 0.0 109.915 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.76 28.0 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 124.489 3.459 . . . . 0.0 115.951 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.91 -5.65 47.83 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 1.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.136 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -21.53 115.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 168.3 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.401 2.28 . . . . 0.0 107.894 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.689 HD12 HD11 ' D' ' 34' ' ' ILE . 6.8 tt -54.01 139.03 35.75 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.325 1.45 . . . . 0.0 112.837 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -116.8 121.59 32.65 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.87 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.21 143.34 93.68 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.452 2.768 . . . . 0.0 111.474 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . 0.452 ' C ' HD12 ' D' ' 49' ' ' LEU . 1.9 pp -132.63 161.68 33.29 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.998 0.919 . . . . 0.0 111.885 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 28' ' ' GLU . 12.0 tp -166.78 148.4 6.19 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.231 1.412 . . . . 0.0 112.011 -175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 -152.91 23.54 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 121.171 1.805 . . . . 0.0 111.804 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -142.56 142.65 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.672 0.789 . . . . 0.0 112.689 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 144.6 51.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.851 1.26 . . . . 0.0 111.183 174.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.56 149.49 29.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.942 0.877 . . . . 0.0 109.522 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -143.46 24.53 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.573 1.549 . . . . 0.0 111.648 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.48 -49.68 5.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.748 2.019 . . . . 0.0 111.536 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.23 178.45 8.06 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.087 0.867 . . . . 0.0 112.371 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 13.2 p -77.39 -42.27 36.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.603 1.961 . . . . 0.0 113.907 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -131.28 54.06 13.5 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.237 1.415 . . . . 0.0 112.05 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.25 173.59 9.35 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.571 2.181 . . . . 0.0 115.989 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.67 6.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.72 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -166.7 164.27 16.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.868 -1.515 . . . . 0.0 113.724 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.7 147.84 13.31 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 118.158 2.023 . . . . 0.0 118.158 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -164.05 154.03 14.7 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.7 152.7 21.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.209 1.804 . . . . 0.0 110.06 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -133.59 116.91 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.457 ' HB2' HG21 ' A' ' 52' ' ' ILE . 26.5 t30 -100.11 110.06 22.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.428 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -76.44 138.62 40.45 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -172.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -37.72 11.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.152 -1.386 . . . . 0.0 114.688 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -87.23 -15.7 37.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -152.54 121.68 6.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 126.553 1.941 . . . . 0.0 107.277 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -57.98 118.49 5.44 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.957 1.253 . . . . 0.0 110.179 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 66.1 p -174.75 169.34 3.55 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.992 1.717 . . . . 0.0 110.65 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -148.09 145.71 28.53 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-O 123.501 1.619 . . . . 0.0 111.081 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.0 OUTLIER -136.77 130.22 31.61 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 109.847 -3.342 . . . . 0.0 108.459 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.69 141.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -115.09 147.73 39.82 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 0.0 110.562 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.29 117.92 9.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.66 -171.9 29.44 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 119.398 -1.382 . . . . 0.0 115.566 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.559 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.4 OUTLIER -127.31 149.95 49.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.528 1.156 . . . . 0.0 113.309 -174.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.63 112.63 24.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.83 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' A' ' 106' ' ' ILE . 11.9 m-85 -111.22 153.09 26.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 119.458 1.026 . . . . 0.0 113.066 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.75 109.94 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 163.16 3.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.475 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -41.63 -42.3 2.46 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -12.67 60.03 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.57 44.71 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.086 1.327 . . . . 0.0 114.898 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -67.76 159.51 30.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.254 1.527 . . . . 0.0 110.705 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -120.11 145.49 46.85 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.858 1.663 . . . . 0.0 111.892 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 106' ' ' ILE . 2.2 t -147.31 158.29 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.751 1.22 . . . . 0.0 110.706 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -121.57 106.65 11.57 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.502 ' CD ' HG11 ' D' ' 92' ' ' VAL . 4.2 mmtt -99.34 123.98 44.06 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -139.35 168.22 20.31 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.577 1.656 . . . . 0.0 113.677 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.537 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.39 16.77 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 171.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -137.0 162.45 33.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.254 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -145.82 121.07 10.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.611 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.14 44.49 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 125.062 1.477 . . . . 0.0 112.917 -174.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.45 113.85 21.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 111.177 -2.738 . . . . 0.0 110.943 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.284 49.8 m -73.42 168.3 19.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.279 1.612 . . . . 0.0 111.337 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.9 86.02 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.07 -165.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -130.77 -26.28 2.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 149.23 40.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.859 1.79 . . . . 0.0 111.93 176.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 84' ' ' PHE . 19.1 tt -63.39 -22.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.213 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.92 4.06 54.72 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.99 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . 0.482 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 6.7 m-20 -120.99 2.67 10.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' D' ' 112' ' ' ALA . 8.9 t70 -60.34 -27.86 67.7 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.587 -1.946 . . . . 0.0 112.046 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.482 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.3 p-90 -45.69 -49.46 14.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.347 1.059 . . . . 0.0 113.107 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -89.61 -11.32 42.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.039 0.936 . . . . 0.0 112.558 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' D' ' 109' ' ' ASP . . . -76.61 -2.62 33.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.695 0.398 . . . . 0.0 111.437 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.763 ' CG2' HD21 ' D' ' 98' ' ' LEU . 1.8 m -107.9 138.59 43.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.638 0.775 . . . . 0.0 112.78 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . 0.502 HH11 ' HG3' ' D' ' 114' ' ' ARG . 18.8 mtt85 -141.43 130.18 22.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.856 1.262 . . . . 0.0 111.032 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.32 158.26 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.891 1.223 . . . . 0.0 111.331 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.15 -177.9 36.48 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 14.7 p90 -126.07 155.33 41.74 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.913 -0.757 . . . . 0.0 111.477 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -148.03 154.69 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.072 0.939 . . . . 0.0 110.45 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . 0.456 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -137.31 120.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -111.84 153.26 26.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.348 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -138.38 164.86 28.25 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 121.4 7.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.071 0.948 . . . . 0.0 110.956 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . 0.502 HD23 ' C ' ' D' ' 123' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.235 0.306 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.51 123.35 48.3 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -173.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -142.91 135.48 27.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.396 1.078 . . . . 0.0 113.528 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.48 -17.83 61.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -55.94 115.87 2.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.46 1.104 . . . . 0.0 111.407 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.34 -119.72 2.7 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.953 1.739 . . . . 0.0 110.887 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.21 143.79 27.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -142.13 162.78 34.6 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.249 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -142.1 146.84 35.84 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.976 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.52 HD22 ' H ' ' B' ' 14' ' ' LEU . 6.6 t30 -107.08 146.25 31.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.15 0.98 . . . . 0.0 110.386 -174.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.8 -27.77 52.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.862 1.265 . . . . 0.0 114.329 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.52 ' H ' HD22 ' B' ' 12' ' ' ASN . 30.0 tp -72.14 -14.58 61.86 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.759 1.624 . . . . 0.0 113.225 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.03 -12.28 24.47 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.257 2.36 . . . . 0.0 114.077 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.53 153.58 41.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.154 1.477 . . . . 0.0 113.74 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.8 134.05 52.9 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 174.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -128.06 145.21 51.07 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.544 -0.722 . . . . 0.0 112.408 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -133.33 133.28 42.32 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.43 0.692 . . . . 0.0 109.673 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -132.87 122.18 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.65 -58.85 7.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.226 0.954 . . . . 0.0 112.378 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.64 153.55 4.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.121 1.368 . . . . 0.0 110.626 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.52 131.4 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 124.492 1.12 . . . . 0.0 111.371 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -75.52 168.79 19.34 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -55.61 -27.89 52.13 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -81.83 -35.55 29.3 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.059 0.845 . . . . 0.0 110.44 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 -6.33 9.27 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 117.22 -1.878 . . . . 0.0 114.663 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.514 ' HB2' HD21 ' C' ' 50' ' ' LEU . 1.4 pt-20 -67.07 141.57 57.45 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.48 1.64 . . . . 0.0 108.461 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.22 151.13 22.63 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.95 165.19 12.07 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.15 -164.93 31.14 Favored Glycine 0 C--O 1.237 0.33 0 O-C-N 120.547 -1.346 . . . . 0.0 111.568 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -141.45 142.76 33.64 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.287 1.041 . . . . 0.0 113.011 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -117.58 125.26 50.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.229 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.687 HD11 HD12 ' B' ' 46' ' ' LEU . 2.8 mp -116.09 125.93 73.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 30.6 m -106.34 144.98 32.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.88 -13.42 16.96 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.8 146.8 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.182 1.393 . . . . 0.0 112.113 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.66 161.42 42.17 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.301 -1.499 . . . . 0.0 113.264 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.85 -21.52 61.66 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.31 83.05 7.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.858 2.463 . . . . 0.0 110.084 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.8 29.15 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 124.645 3.563 . . . . 0.0 115.895 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.88 -5.49 52.38 Favored Glycine 0 N--CA 1.478 1.434 0 N-CA-C 118.194 2.038 . . . . 0.0 118.194 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.92 2.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.163 1.482 . . . . 0.0 114.148 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -21.27 111.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.15 167.63 16.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.334 2.254 . . . . 0.0 108.181 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.687 HD12 HD11 ' B' ' 34' ' ' ILE . 6.9 tt -53.78 138.54 35.46 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.398 1.479 . . . . 0.0 112.846 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -115.55 121.82 33.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.056 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.42 144.75 90.89 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.426 2.751 . . . . 0.0 111.455 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.47 154.36 48.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.148 0.979 . . . . 0.0 111.287 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -156.87 148.79 22.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.066 1.746 . . . . 0.0 109.944 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.19 -153.5 24.05 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 121.933 2.151 . . . . 0.0 111.66 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -142.39 142.43 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 143.45 50.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.192 0.597 . . . . 0.0 111.694 173.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -78.48 152.87 31.82 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.424 1.107 . . . . 0.0 109.549 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -147.29 25.45 1.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.568 1.547 . . . . 0.0 111.68 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -93.46 -49.21 6.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.985 2.114 . . . . 0.0 112.078 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 178.32 8.12 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.3 p -75.47 -43.06 51.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.042 1.737 . . . . 0.0 113.635 174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.2 54.21 13.37 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.25 1.42 . . . . 0.0 112.192 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -67.43 171.82 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.035 1.824 . . . . 0.0 115.79 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 174.58 7.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.129 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.77 164.61 16.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.529 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.4 147.8 12.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.43 154.75 16.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -88.38 150.72 23.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.22 1.808 . . . . 0.0 110.528 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.58 116.92 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.465 ' HB2' HG21 ' C' ' 52' ' ' ILE . 29.2 t30 -99.32 110.14 22.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.748 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -76.79 136.77 38.99 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.76 -37.93 12.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.667 -174.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -87.28 -15.11 39.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 21.8 t -152.58 122.66 7.07 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.42 1.888 . . . . 0.0 107.309 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.85 118.53 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.932 1.242 . . . . 0.0 110.078 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -174.92 168.98 3.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.19 1.796 . . . . 0.0 110.542 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.79 145.47 28.79 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.243 1.497 . . . . 0.0 111.181 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.1 m -137.31 130.21 30.46 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 110.095 -3.23 . . . . 0.0 108.588 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 m -113.47 140.84 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.892 0.745 . . . . 0.0 109.68 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -115.04 147.29 40.33 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 123.463 0.477 . . . . 0.0 110.452 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 117.99 10.21 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.55 -173.16 30.91 Favored Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 119.728 -1.225 . . . . 0.0 115.645 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.566 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.1 OUTLIER -124.77 149.92 46.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.579 1.18 . . . . 0.0 112.895 -175.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.44 112.66 24.4 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 111.358 -2.656 . . . . 0.0 105.488 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' C' ' 106' ' ' ILE . 11.5 m-85 -110.71 155.78 21.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 119.265 0.939 . . . . 0.0 112.666 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.34 117.99 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.95 162.79 10.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.195 0.998 . . . . 0.0 110.578 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -42.7 -44.85 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.595 1.558 . . . . 0.0 114.795 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -24.34 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.787 1.235 . . . . 0.0 113.541 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.46 5.45 26.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.446 1.498 . . . . 0.0 115.094 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -72.57 162.22 29.77 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 119.274 1.537 . . . . 0.0 110.809 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.45 142.51 51.26 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.527 1.531 . . . . 0.0 112.162 -173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' C' ' 106' ' ' ILE . 2.2 t -145.11 159.26 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 125.355 1.462 . . . . 0.0 110.701 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.4 107.18 11.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.506 ' CD ' HG11 ' B' ' 92' ' ' VAL . 3.8 mmtt -99.78 124.5 45.12 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 172.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.5 p -139.71 168.49 19.69 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.637 1.684 . . . . 0.0 113.662 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.563 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -118.85 163.18 17.27 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -136.96 162.83 32.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 0.0 111.647 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.19 121.06 9.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 138.33 44.18 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 125.198 1.561 . . . . 0.0 113.138 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.69 113.89 21.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.357 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.273 49.4 m -73.49 168.08 19.99 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.886 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.3 p -110.24 84.34 1.91 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.28 -167.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -127.2 -26.45 3.09 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.042 -1.036 . . . . 0.0 112.9 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.11 145.93 40.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 123.252 1.501 . . . . 0.0 112.521 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' C' ' 84' ' ' PHE . 19.3 tt -62.13 -23.77 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.851 175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.78 0.14 62.45 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 117.543 -1.698 . . . . 0.0 114.075 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 1.0 OUTLIER -117.55 1.07 12.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.808 1.304 . . . . 0.0 114.104 -178.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' B' ' 112' ' ' ALA . 9.7 t70 -59.59 -27.87 66.66 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 119.562 -1.961 . . . . 0.0 112.278 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.45 ' CD1' HD11 ' D' ' 14' ' ' LEU . 46.4 p-90 -46.38 -49.18 18.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.275 1.03 . . . . 0.0 113.157 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -88.86 -12.69 41.13 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.783 0.833 . . . . 0.0 112.367 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' B' ' 109' ' ' ASP . . . -75.26 -1.7 24.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.815 0.446 . . . . 0.0 111.577 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.771 ' CG2' HD21 ' B' ' 98' ' ' LEU . 1.9 m -109.13 137.7 46.62 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.614 0.765 . . . . 0.0 113.042 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.532 HH11 ' HG3' ' B' ' 114' ' ' ARG . 19.5 mtt85 -140.69 130.21 24.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.633 1.173 . . . . 0.0 110.676 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.88 158.88 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.044 1.293 . . . . 0.0 111.236 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.73 -177.33 36.47 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 14.4 p90 -126.87 156.03 42.03 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.819 -0.812 . . . . 0.0 111.937 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -148.46 155.34 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.554 1.168 . . . . 0.0 110.856 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.438 HD13 ' HE3' ' B' ' 94' ' ' LYS . 10.5 mt -138.26 119.83 17.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.21 152.52 27.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.467 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 21.5 p -139.13 164.2 30.41 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.57 128.99 31.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.291 1.036 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.093 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 83' ' ' CYS . 0.1 OUTLIER -116.39 123.74 48.32 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -176.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -143.22 137.9 29.29 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.245 -1.535 . . . . 0.0 113.564 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.43 -18.95 61.08 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -56.29 115.91 2.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.387 1.075 . . . . 0.0 111.615 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.53 -119.63 2.5 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.838 1.685 . . . . 0.0 111.139 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 142.27 24.8 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -140.87 162.8 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.785 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -142.83 145.13 32.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.635 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . 0.502 HD22 ' H ' ' C' ' 14' ' ' LEU . 6.2 t30 -105.89 146.97 29.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.186 0.995 . . . . 0.0 110.582 -174.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.18 -26.48 64.83 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.502 ' H ' HD22 ' C' ' 12' ' ' ASN . 30.3 tp -71.44 -14.63 62.21 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.697 1.599 . . . . 0.0 112.983 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.69 -13.23 22.7 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.071 2.272 . . . . 0.0 113.99 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 154.3 37.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.958 1.379 . . . . 0.0 113.835 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 136.59 53.22 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -130.27 145.37 51.75 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.561 -0.712 . . . . 0.0 112.004 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -134.29 132.46 39.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.259 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.22 120.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.46 -56.9 12.85 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.535 1.147 . . . . 0.0 112.658 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.53 155.63 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.494 1.518 . . . . 0.0 110.648 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.41 129.72 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.611 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -75.18 167.93 20.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -56.38 -27.06 55.1 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -79.53 -33.77 41.7 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.083 0.856 . . . . 0.0 110.647 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.09 9.53 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 124.123 0.868 . . . . 0.0 114.373 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.02 149.96 46.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.218 1.407 . . . . 0.0 113.019 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . 0.477 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.2 p90 -160.22 166.05 30.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.55 0.74 . . . . 0.0 110.84 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.8 p -125.57 162.34 25.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.99 -165.55 29.32 Favored Glycine 0 N--CA 1.464 0.542 0 O-C-N 119.955 -1.716 . . . . 0.0 111.986 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.9 p -140.37 140.74 35.59 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.522 1.153 . . . . 0.0 113.116 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -118.63 124.87 48.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.906 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.694 HD11 HD12 ' C' ' 46' ' ' LEU . 2.9 mp -114.98 127.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 45.0 m -108.3 145.67 34.06 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.39 -11.6 17.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.91 146.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.102 1.361 . . . . 0.0 111.918 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.38 161.24 42.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.498 -1.376 . . . . 0.0 113.355 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.42 -22.54 61.84 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.603 0.361 . . . . 0.0 110.589 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -147.69 83.57 7.46 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.767 2.427 . . . . 0.0 110.111 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.82 28.27 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 124.548 3.499 . . . . 0.0 115.895 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.75 48.92 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.9 2.3 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.071 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 60.8 mt -22.0 112.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.46 168.21 16.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.449 2.3 . . . . 0.0 108.131 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.694 HD12 HD11 ' C' ' 34' ' ' ILE . 6.8 tt -53.96 139.1 35.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.463 1.505 . . . . 0.0 112.724 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -116.39 121.16 33.79 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.195 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.15 143.18 93.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.391 2.727 . . . . 0.0 111.56 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.454 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -132.43 161.71 32.99 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.912 0.885 . . . . 0.0 111.694 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 28' ' ' GLU . 12.0 tp -166.56 148.73 6.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.131 1.373 . . . . 0.0 111.87 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.39 -153.04 23.73 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 121.563 1.983 . . . . 0.0 111.986 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -142.73 142.38 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 112.554 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 144.91 51.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.005 1.322 . . . . 0.0 111.01 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.72 151.13 29.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.771 0.796 . . . . 0.0 109.393 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -143.99 23.95 1.68 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.381 1.472 . . . . 0.0 111.686 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.36 -50.35 5.5 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.894 2.078 . . . . 0.0 111.84 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.36 178.18 7.88 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.822 0.701 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 13.5 p -75.14 -42.48 56.14 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.751 1.62 . . . . 0.0 113.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -132.37 53.54 11.45 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -66.55 172.42 9.26 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 121.804 1.669 . . . . 0.0 115.716 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 174.52 7.12 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.138 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.73 164.24 16.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.558 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.8 147.58 12.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 118.151 2.02 . . . . 0.0 118.151 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -163.52 154.22 16.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.67 152.73 21.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.372 1.869 . . . . 0.0 110.136 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.67 116.84 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.437 ' HB2' HG21 ' B' ' 52' ' ' ILE . 26.0 t30 -100.26 109.55 21.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.426 -173.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -76.23 138.66 40.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -37.69 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -87.31 -15.49 37.85 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.7 t -152.5 122.41 7.01 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.377 1.871 . . . . 0.0 107.236 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -58.32 118.57 5.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.002 1.274 . . . . 0.0 110.274 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 70.3 p -175.42 168.59 3.25 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.101 1.76 . . . . 0.0 110.553 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.2 t -147.84 146.01 28.94 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-O 123.489 1.614 . . . . 0.0 111.028 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.36 130.15 30.25 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 109.872 -3.331 . . . . 0.0 108.79 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -112.51 142.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -115.5 148.07 39.92 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.885 0.74 . . . . 0.0 110.597 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 117.91 9.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.64 -172.72 30.46 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.547 -1.311 . . . . 0.0 115.687 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.565 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.1 OUTLIER -125.86 149.64 48.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.606 1.193 . . . . 0.0 113.028 -174.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 4' ' ' CYS . 0.5 OUTLIER -97.38 112.55 24.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.409 -2.632 . . . . 0.0 105.437 -175.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.7 m-85 -110.67 154.43 23.84 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.283 0.947 . . . . 0.0 112.72 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.84 115.34 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.99 162.09 11.96 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.806 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -42.82 -41.86 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.015 1.726 . . . . 0.0 115.577 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.35 -3.24 42.09 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.92 5.2 64.48 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.603 1.573 . . . . 0.0 115.19 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -71.72 162.27 29.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 1.242 . . . . 0.0 110.195 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -123.34 141.46 51.96 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.658 1.583 . . . . 0.0 111.235 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' B' ' 106' ' ' ILE . 2.4 t -143.15 159.44 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 125.368 1.467 . . . . 0.0 110.867 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.23 107.79 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 172.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' C' ' 92' ' ' VAL . 3.7 mmtt -100.56 123.97 45.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -138.92 168.1 20.58 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 123.645 1.688 . . . . 0.0 113.866 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.551 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.79 16.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -136.97 162.87 32.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.395 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -146.27 121.19 9.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.683 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.13 44.51 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 125.216 1.572 . . . . 0.0 113.044 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -119.78 113.93 21.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 111.372 -2.649 . . . . 0.0 111.12 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.279 50.2 m -73.49 168.1 19.95 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 125.365 1.666 . . . . 0.0 111.664 174.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.59 86.78 2.38 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.75 -165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -130.0 -25.42 2.52 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.947 -1.095 . . . . 0.0 113.251 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.03 147.16 39.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.366 1.555 . . . . 0.0 112.259 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 84' ' ' PHE . 18.8 tt -62.93 -23.25 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.892 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.61 60.17 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.767 -1.574 . . . . 0.0 114.075 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . 0.44 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.5 OUTLIER -118.8 0.95 11.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.738 1.269 . . . . 0.0 113.833 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' C' ' 112' ' ' ALA . 9.0 t70 -59.4 -27.91 66.42 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.629 -1.92 . . . . 0.0 112.368 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.446 ' CD1' HD11 ' A' ' 14' ' ' LEU . 46.1 p-90 -46.1 -49.13 16.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.229 1.012 . . . . 0.0 113.379 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -89.06 -12.32 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.607 0.763 . . . . 0.0 112.67 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' C' ' 109' ' ' ASP . . . -75.57 -2.09 27.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.693 0.397 . . . . 0.0 111.409 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' C' ' 98' ' ' LEU . 2.0 m -108.55 138.71 44.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.55 0.74 . . . . 0.0 112.742 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.504 HH11 ' HG3' ' C' ' 114' ' ' ARG . 19.4 mtt85 -141.25 130.55 23.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.943 1.297 . . . . 0.0 110.831 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.17 158.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.272 . . . . 0.0 111.213 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.06 -177.45 36.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 13.4 p90 -126.68 155.82 42.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.851 -0.793 . . . . 0.0 111.861 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -148.47 154.58 40.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.386 1.089 . . . . 0.0 111.089 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . 0.444 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.0 mt -137.17 120.97 22.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.21 152.62 28.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.943 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.5 p -138.44 163.04 32.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.72 135.01 36.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.312 0.645 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 123.06 1.41 . . . . 0.0 111.186 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.28 150.09 38.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.367 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 p -139.33 127.44 22.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.205 1.002 . . . . 0.0 112.311 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD21 ' CE2' ' A' ' 64' ' ' PHE . 73.9 mt -69.24 -34.44 74.83 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -47.57 110.97 0.36 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.021 1.328 . . . . 0.0 111.077 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.38 -130.17 4.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 125.312 1.434 . . . . 0.0 109.584 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -146.14 144.87 30.24 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.073 0.949 . . . . 0.0 112.721 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -136.64 162.9 31.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.188 1.395 . . . . 0.0 111.391 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -140.62 150.95 44.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.11 0.964 . . . . 0.0 109.567 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.66 143.54 47.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.385 1.074 . . . . 0.0 110.348 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -60.52 -22.16 63.28 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.45 1.5 . . . . 0.0 113.338 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -72.52 -15.61 61.78 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.629 1.172 . . . . 0.0 111.094 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.76 -16.43 18.73 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.639 3.019 . . . . 0.0 113.395 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.42 148.87 40.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.065 1.412 . . . . 0.0 112.955 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.46 136.52 54.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.779 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -127.46 143.26 51.22 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.535 0.684 . . . . 0.0 112.154 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -131.34 130.98 43.39 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.979 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.59 126.03 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.52 -85.55 0.13 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.48 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.03 145.79 30.73 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.86 0.838 . . . . 0.0 111.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' A' ' 53' ' ' GLN . 11.2 p -100.17 129.65 50.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.16 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -75.65 168.96 19.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.995 0.902 . . . . 0.0 112.386 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -58.7 -26.34 63.77 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.89 -40.65 75.53 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.374 -0.829 . . . . 0.0 110.822 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.05 -7.34 12.89 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 117.558 -1.69 . . . . 0.0 112.694 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HB2' HD21 ' D' ' 50' ' ' LEU . 4.7 pt-20 -67.18 146.69 53.96 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.693 1.597 . . . . 0.0 107.469 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.79 166.05 34.67 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.229 175.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 p -124.75 177.76 5.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.8 -167.51 39.76 Favored Glycine 0 CA--C 1.521 0.439 0 O-C-N 120.372 -1.455 . . . . 0.0 112.262 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' HD11 ' A' ' 46' ' ' LEU . 49.4 p -139.8 137.73 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.93 1.347 . . . . 0.0 111.947 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -111.46 138.77 47.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.161 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 46' ' ' LEU . 27.5 mt -130.01 128.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 174.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 44' ' ' ILE . 49.6 m -105.15 144.09 32.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -172.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.6 -13.25 17.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.79 143.15 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.352 1.061 . . . . 0.0 112.715 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.49 43.84 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.407 -0.808 . . . . 0.0 111.74 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.77 -28.52 64.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.765 -0.584 . . . . 0.0 109.499 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -140.64 75.35 26.21 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.966 2.507 . . . . 0.0 110.836 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.14 61.06 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.365 1 C-N-CA 125.627 4.218 . . . . 0.0 115.028 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.44 13.41 39.56 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 120.163 -1.586 . . . . 0.0 116.795 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -172.32 -29.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.037 1.335 . . . . 0.0 113.298 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 35' ' ' THR 0.322 47.6 mt 4.48 91.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.449 2.3 . . . . 0.0 116.533 -172.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 159.13 18.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 111.563 -2.562 . . . . 0.0 109.337 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.525 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.2 tt -46.74 126.82 9.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.848 2.059 . . . . 0.0 113.131 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.8 p -103.8 120.25 51.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 122.966 0.506 . . . . 0.0 111.898 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 144.01 84.62 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.327 2.684 . . . . 0.0 112.872 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.38 154.67 44.71 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.916 0.886 . . . . 0.0 112.418 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -159.75 149.21 18.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.794 2.038 . . . . 0.0 110.112 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.8 -147.69 16.44 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 121.583 1.992 . . . . 0.0 109.961 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -145.74 141.06 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.688 0.795 . . . . 0.0 112.707 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.93 139.96 52.68 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.794 -1.191 . . . . 0.0 113.147 174.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -76.97 158.09 30.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.049 -1.657 . . . . 0.0 113.638 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -158.48 21.63 0.23 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.432 1.493 . . . . 0.0 112.51 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -87.23 -54.62 4.21 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.516 1.126 . . . . 0.0 109.999 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.33 173.11 10.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.748 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.38 -34.74 31.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.786 0.834 . . . . 0.0 112.504 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.22 47.6 2.86 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.993 1.317 . . . . 0.0 112.065 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.9 176.07 10.36 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.16 2.573 . . . . 0.0 115.341 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.329 0.0 OUTLIER -100.13 171.07 8.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 123.21 1.481 . . . . 0.0 112.194 173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' A' ' 6' ' ' LEU . 1.2 p90 -160.64 167.25 27.38 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.401 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.66 144.99 9.52 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 118.482 2.153 . . . . 0.0 118.482 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.25 158.57 30.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -95.35 152.41 18.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.583 1.553 . . . . 0.0 108.823 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.67 118.84 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' D' ' 52' ' ' ILE . 5.9 t-20 -92.83 116.21 28.82 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.314 46.2 m95 -80.49 134.64 35.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.413 1.577 . . . . 0.0 114.431 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -89.56 -40.63 12.5 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -88.78 -15.87 33.55 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -151.43 130.29 12.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 129.389 3.076 . . . . 0.0 106.102 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -68.67 118.62 11.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.032 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -173.85 161.76 3.84 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 127.342 2.257 . . . . 0.0 108.802 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 140.15 30.94 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 123.105 1.431 . . . . 0.0 111.151 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.8 m -139.08 129.29 25.39 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 110.34 -3.118 . . . . 0.0 110.555 -171.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -106.88 154.84 7.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.039 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.76 142.36 51.33 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.68 121.23 9.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.16 176.15 42.15 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 118.799 -1.667 . . . . 0.0 116.866 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -112.33 149.95 31.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.831 1.301 . . . . 0.0 112.929 -174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 19.6 t -97.18 130.37 44.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.806 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' D' ' 106' ' ' ILE . 3.8 m-85 -119.75 166.03 13.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.94 0.876 . . . . 0.0 111.749 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mt -128.77 109.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -59.57 159.65 8.11 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -28.45 -51.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -11.39 60.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.205 1.802 . . . . 0.0 115.706 -174.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.07 51.77 3.27 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 120.383 1.447 . . . . 0.0 110.235 -173.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.21 136.64 53.07 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.521 2.328 . . . . 0.0 107.755 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -101.34 144.09 30.59 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.628 1.171 . . . . 0.0 109.974 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.2 m -147.9 162.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.652 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.1 116.87 25.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.5 mmtt -104.92 120.51 41.62 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 p -137.25 166.91 22.64 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 123.358 1.551 . . . . 0.0 113.723 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.425 ' HG3' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -117.25 165.9 12.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 172.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -141.1 159.6 41.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.238 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.9 tt -144.42 126.17 15.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.913 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.18 143.64 40.0 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 125.379 1.674 . . . . 0.0 112.381 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.69 114.34 17.87 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 111.416 -2.629 . . . . 0.0 111.736 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.252 44.6 m -67.12 175.45 2.59 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 125.635 1.834 . . . . 0.0 113.083 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.4 p -117.93 67.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 107.948 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.63 167.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 120.921 -1.112 . . . . 0.0 111.709 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -102.78 -32.35 9.86 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -109.03 148.77 30.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.82 1.295 . . . . 0.0 111.407 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.806 HD11 ' HE2' ' D' ' 94' ' ' LYS . 15.0 tt -63.32 -30.78 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 113.426 -1.716 . . . . 0.0 109.979 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.88 5.75 3.32 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.801 -1.555 . . . . 0.0 113.726 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -121.41 1.92 10.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.809 1.305 . . . . 0.0 113.69 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -33.48 75.38 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.402 -0.811 . . . . 0.0 111.713 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.418 ' CD1' HD11 ' C' ' 14' ' ' LEU . 58.1 p-90 -46.88 -40.99 15.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -99.34 -6.72 27.38 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.359 1.063 . . . . 0.0 113.463 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.95 0.32 21.51 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.798 ' CG2' HD21 ' A' ' 98' ' ' LEU . 5.9 m -110.36 138.44 46.74 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.74 0.816 . . . . 0.0 112.072 176.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -140.59 124.79 17.55 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 125.184 1.394 . . . . 0.0 110.723 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.56 158.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.13 1.372 . . . . 0.0 111.317 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.02 -178.46 37.59 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.027 0.822 . . . . 0.0 113.326 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -124.98 156.74 37.6 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.755 -0.85 . . . . 0.0 111.705 175.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -147.7 157.91 43.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.416 1.103 . . . . 0.0 109.664 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.2 mt -133.37 138.36 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -125.72 149.14 48.75 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.285 1.041 . . . . 0.0 111.264 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 p -133.05 161.09 35.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.661 1.184 . . . . 0.0 110.352 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.09 113.16 2.96 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.614 0.765 . . . . 0.0 112.233 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt . . . . . 0 N--CA 1.462 0.14 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 173.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.3 144.84 43.71 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.255 1.022 . . . . 0.0 109.62 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -139.7 127.85 22.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' D' ' 64' ' ' PHE . 80.5 mt -69.8 -33.01 71.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -48.83 113.46 0.79 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.511 1.124 . . . . 0.0 110.531 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.3 -132.5 5.85 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -147.23 143.67 28.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -136.09 162.55 32.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.221 1.408 . . . . 0.0 111.96 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.43 ' HB ' HD12 ' D' ' 123' ' ' LEU . 8.9 t -137.7 151.79 48.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.229 1.012 . . . . 0.0 109.231 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -119.89 143.79 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.232 1.013 . . . . 0.0 110.681 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -58.41 -25.31 62.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.462 1.505 . . . . 0.0 113.66 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' B' ' 110' ' ' TRP . 28.5 tp -70.25 -15.47 62.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.588 1.155 . . . . 0.0 111.711 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.23 -12.21 28.73 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 128.238 2.828 . . . . 0.0 113.515 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.65 149.65 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.265 1.507 . . . . 0.0 113.33 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -125.53 137.37 53.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.921 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -128.14 144.36 51.11 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -131.66 131.17 42.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.206 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 80.8 mt -131.13 124.52 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -86.42 0.08 OUTLIER Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.208 0.943 . . . . 0.0 111.733 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.24 145.28 31.22 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.803 -0.822 . . . . 0.0 110.676 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' D' ' 53' ' ' GLN . 11.3 p -99.72 130.37 48.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.053 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.99 166.7 23.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 112.382 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -26.02 63.98 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -67.89 -39.25 83.69 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.273 -0.892 . . . . 0.0 111.129 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.53 -6.55 11.53 Favored Glycine 0 C--O 1.221 -0.698 0 C-N-CA 124.728 1.156 . . . . 0.0 113.402 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.89 152.99 43.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.151 1.781 . . . . 0.0 112.258 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.38 30.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.252 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p -123.53 -177.13 3.63 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.71 -167.13 40.16 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 119.41 -2.056 . . . . 0.0 112.622 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' D' ' 46' ' ' LEU . 52.1 p -139.55 137.68 35.63 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.56 0.695 . . . . 0.0 112.346 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -112.83 138.71 49.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.377 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.437 HD11 HD12 ' D' ' 46' ' ' LEU . 31.2 mt -130.72 128.42 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.408 ' O ' HG21 ' D' ' 44' ' ' ILE . 54.6 m -105.74 144.82 31.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.1 -13.62 17.42 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.73 142.76 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.245 1.018 . . . . 0.0 112.607 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.55 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.153 -0.967 . . . . 0.0 111.474 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -70.5 -29.15 65.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.15 75.3 29.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 127.893 2.477 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.12 61.25 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.358 1 C-N-CA 125.629 4.22 . . . . 0.0 115.13 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.61 13.58 38.96 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 120.099 -1.626 . . . . 0.0 116.844 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -172.51 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.158 1.383 . . . . 0.0 113.401 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.408 HG21 ' O ' ' D' ' 35' ' ' THR 0.321 49.2 mt 4.55 91.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.627 2.371 . . . . 0.0 116.365 -172.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.58 159.31 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.584 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.1 tt -46.82 126.15 8.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.674 1.99 . . . . 0.0 112.88 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.03 120.53 52.02 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.158 0.583 . . . . 0.0 111.634 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.06 143.78 82.18 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.166 2.577 . . . . 0.0 112.438 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . 0.498 ' C ' HD12 ' D' ' 49' ' ' LEU . 0.6 OUTLIER -127.75 160.33 32.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.953 0.901 . . . . 0.0 112.598 177.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 28' ' ' GLU . 15.3 tp -169.01 149.01 4.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 0.0 112.642 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 -144.1 10.45 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 121.091 1.769 . . . . 0.0 109.774 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.709 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.9 mt -147.53 139.37 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.769 0.827 . . . . 0.0 111.592 -175.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -125.36 138.45 54.05 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.163 1.385 . . . . 0.0 112.612 175.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -76.7 157.52 31.69 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 119.9 -1.75 . . . . 0.0 113.172 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -156.96 19.39 0.31 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 0.0 112.5 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -84.96 -54.11 4.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.766 1.227 . . . . 0.0 110.085 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 172.67 11.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.911 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -31.77 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.28 1.032 . . . . 0.0 113.378 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -130.17 50.58 6.18 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 125.118 1.367 . . . . 0.0 112.589 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.24 175.96 10.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.989 2.46 . . . . 0.0 116.274 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.335 0.0 OUTLIER -100.82 170.17 8.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.104 1.431 . . . . 0.0 111.808 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . 0.482 ' CE2' HD21 ' D' ' 6' ' ' LEU . 1.4 p90 -161.01 167.29 26.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.82 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.32 145.43 10.0 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 118.431 2.133 . . . . 0.0 118.431 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.88 158.69 28.68 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -95.02 152.42 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.569 1.948 . . . . 0.0 108.472 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.58 117.78 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.7 ' HB2' HG21 ' A' ' 52' ' ' ILE . 7.2 t-20 -92.85 117.21 29.78 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.407 -0.808 . . . . 0.0 109.927 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.3 46.3 m95 -80.46 137.39 36.47 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.543 1.64 . . . . 0.0 114.246 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -92.67 -39.45 11.28 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.3 -14.94 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -152.27 131.59 12.85 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 129.319 3.048 . . . . 0.0 106.241 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.4 118.64 12.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 10.8 m -173.53 161.82 4.09 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 127.222 2.209 . . . . 0.0 108.978 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.8 t -143.28 140.31 30.56 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.114 1.435 . . . . 0.0 110.842 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.05 128.79 24.74 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 110.509 -3.041 . . . . 0.0 110.451 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.12 154.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.038 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -127.64 141.8 51.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.1 121.69 10.44 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.78 174.46 42.15 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 118.748 -1.691 . . . . 0.0 116.786 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.51 146.65 38.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.021 1.071 . . . . 0.0 111.967 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 48.9 t -97.62 134.23 41.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.138 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' A' ' 106' ' ' ILE . 5.5 m-85 -122.31 164.93 17.05 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.203 1.001 . . . . 0.0 111.366 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.98 105.33 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -63.38 154.22 32.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -22.42 -51.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.072 2.549 . . . . 0.0 117.39 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -76.08 -7.2 54.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.253 1.821 . . . . 0.0 115.784 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.38 51.38 3.52 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.925 0.784 . . . . 0.0 111.231 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 135.96 54.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 108.784 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.29 144.6 29.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.17 0.986 . . . . 0.0 109.572 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 106' ' ' ILE . 25.1 m -148.51 159.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.818 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mt -117.72 117.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.806 ' HE2' HD11 ' A' ' 106' ' ' ILE . 4.0 mmtt -105.47 119.06 38.14 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -136.95 167.09 22.16 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.258 1.504 . . . . 0.0 113.639 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.421 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -117.13 166.51 12.15 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -141.58 160.09 40.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.101 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.9 tt -144.83 126.6 15.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.771 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.03 144.45 38.59 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 125.51 1.756 . . . . 0.0 112.082 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -127.45 114.36 17.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.677 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 42.5 m -67.01 175.33 2.58 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 125.803 1.939 . . . . 0.0 113.0 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.9 p -117.74 66.64 0.75 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.11 1.364 . . . . 0.0 108.251 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.69 167.47 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.988 -1.07 . . . . 0.0 111.999 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -101.52 -32.26 10.48 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.0 149.89 31.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 122.709 1.242 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.775 HD11 ' HE2' ' A' ' 94' ' ' LYS . 15.2 tt -62.96 -29.01 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.21 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.51 6.13 4.88 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.501 1.048 . . . . 0.0 113.586 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -122.2 2.26 9.77 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.509 1.155 . . . . 0.0 113.712 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.74 -34.02 76.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.312 -0.868 . . . . 0.0 112.14 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.2 p-90 -46.19 -41.43 12.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.28 1.032 . . . . 0.0 113.728 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -99.48 -6.79 26.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.215 1.006 . . . . 0.0 113.365 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.65 -0.21 22.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.776 ' CG2' HD21 ' D' ' 98' ' ' LEU . 5.7 m -109.33 138.8 45.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.477 0.711 . . . . 0.0 111.792 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -140.76 124.79 17.31 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 125.56 1.544 . . . . 0.0 111.247 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.6 158.89 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.08 1.352 . . . . 0.0 111.166 176.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.17 -179.53 38.43 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.939 0.781 . . . . 0.0 113.441 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 0.0 OUTLIER -123.77 156.37 36.19 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.759 -0.848 . . . . 0.0 111.571 176.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -147.72 157.36 43.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.09 0.948 . . . . 0.0 109.855 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.58 136.65 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -124.45 151.25 44.77 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 18.7 p -134.65 160.81 36.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.746 1.218 . . . . 0.0 110.186 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 129.43 41.36 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.53 -0.731 . . . . 0.0 110.855 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.306 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.23 142.01 50.89 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 109.478 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -139.66 127.88 22.55 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' B' ' 64' ' ' PHE . 84.5 mt -69.23 -31.53 70.16 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -48.96 113.25 0.75 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.332 1.053 . . . . 0.0 111.028 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.32 -131.11 5.24 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.63 1.586 . . . . 0.0 109.452 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -146.38 143.21 28.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.46 1.104 . . . . 0.0 113.293 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . 0.421 ' CH2' HD21 ' B' ' 93' ' ' LEU . 45.3 m95 -135.56 162.75 31.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.297 1.439 . . . . 0.0 111.737 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -141.27 150.55 42.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.97 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -122.12 143.78 49.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.389 1.076 . . . . 0.0 111.025 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -58.88 -25.34 63.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.608 1.563 . . . . 0.0 113.458 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' D' ' 110' ' ' TRP . 28.9 tp -70.68 -15.63 62.73 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.371 1.081 . . . . 0.0 111.619 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.32 -13.98 23.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 128.415 2.912 . . . . 0.0 113.47 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 148.57 44.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 123.113 1.435 . . . . 0.0 113.252 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -122.7 136.08 54.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.671 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -131.05 131.19 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -130.2 124.39 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.32 -84.34 0.11 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.537 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.79 32.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.76 -0.847 . . . . 0.0 110.85 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.588 HG21 ' HG3' ' B' ' 53' ' ' GLN . 10.9 p -102.66 130.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.294 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -75.94 168.77 19.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.942 0.877 . . . . 0.0 112.207 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 81.5 p -58.59 -26.08 63.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -70.1 -40.58 74.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.324 -0.86 . . . . 0.0 110.981 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.85 -7.17 13.32 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.523 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' C' ' 50' ' ' LEU . 4.2 pt-20 -67.33 146.75 53.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.649 1.58 . . . . 0.0 107.416 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 166.22 34.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.108 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.6 p -125.39 176.85 6.51 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.66 -167.54 39.46 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 120.321 -1.487 . . . . 0.0 112.302 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.529 ' HB ' HD11 ' B' ' 46' ' ' LEU . 48.5 p -139.76 137.52 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.607 1.194 . . . . 0.0 112.016 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -110.88 139.0 46.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.23 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' B' ' 46' ' ' LEU . 27.5 mt -130.59 128.02 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.406 ' O ' HG21 ' B' ' 44' ' ' ILE . 42.7 m -105.21 144.25 32.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.64 -13.72 17.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.24 143.46 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.328 1.051 . . . . 0.0 112.701 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.03 43.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.424 -0.798 . . . . 0.0 111.464 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -71.21 -28.82 64.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.24 75.66 27.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.926 2.49 . . . . 0.0 111.038 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.22 61.86 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.409 1 C-N-CA 125.583 4.188 . . . . 0.0 115.02 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.97 13.56 37.74 Favored Glycine 0 N--CA 1.481 1.659 0 O-C-N 120.269 -1.519 . . . . 0.0 116.862 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -172.36 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.174 1.39 . . . . 0.0 113.297 -174.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.406 HG21 ' O ' ' B' ' 35' ' ' THR 0.324 50.3 mt 5.35 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.616 2.366 . . . . 0.0 116.323 -172.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.63 159.19 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 111.607 -2.542 . . . . 0.0 109.32 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.5 tt -46.84 127.97 10.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.768 2.027 . . . . 0.0 112.926 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -104.96 120.65 49.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.083 0.553 . . . . 0.0 111.846 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.33 144.38 82.72 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.034 2.489 . . . . 0.0 112.947 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.47 154.37 45.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 112.633 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -159.97 149.14 17.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.531 1.932 . . . . 0.0 109.949 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.72 -147.22 15.32 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 121.389 1.904 . . . . 0.0 109.879 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -145.67 141.0 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.523 0.729 . . . . 0.0 112.655 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.588 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -126.94 136.84 52.84 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.978 -1.076 . . . . 0.0 113.363 174.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -74.01 158.32 34.55 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.96 -1.713 . . . . 0.0 113.557 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -159.58 23.93 0.19 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.483 1.513 . . . . 0.0 111.855 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -90.37 -53.08 4.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.677 1.191 . . . . 0.0 110.331 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.44 174.28 9.13 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.65 1.219 . . . . 0.0 113.36 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.27 -29.69 22.9 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -129.34 49.52 4.78 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.681 1.192 . . . . 0.0 112.627 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.59 175.1 10.65 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.901 2.401 . . . . 0.0 116.169 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.33 0.0 OUTLIER -101.03 169.83 8.68 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 123.048 1.404 . . . . 0.0 111.97 173.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' B' ' 6' ' ' LEU . 1.1 p90 -160.66 167.5 26.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.543 -173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.71 144.44 9.09 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.96 158.66 31.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.8 m -94.87 152.22 18.57 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.753 1.621 . . . . 0.0 108.802 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.55 118.23 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' C' ' 52' ' ' ILE . 7.6 t-20 -92.71 116.53 29.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.733 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.299 46.1 m95 -80.22 136.59 36.5 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 123.465 1.603 . . . . 0.0 114.326 -173.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -91.54 -39.83 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -89.29 -15.42 33.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -151.43 130.23 12.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.202 3.001 . . . . 0.0 105.904 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.66 118.57 11.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.0 m -173.58 161.61 4.02 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 127.253 2.221 . . . . 0.0 109.082 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 140.4 30.48 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.033 1.397 . . . . 0.0 110.694 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.9 m -139.33 129.41 25.15 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 110.549 -3.023 . . . . 0.0 110.558 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.44 155.46 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.092 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -128.48 142.22 51.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.41 121.18 9.89 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.18 175.05 41.76 Favored Glycine 0 CA--C 1.504 -0.629 0 C-N-CA 118.708 -1.711 . . . . 0.0 116.627 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -112.85 144.56 42.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.79 1.281 . . . . 0.0 112.083 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 t -97.84 127.22 43.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.873 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' C' ' 106' ' ' ILE . 5.2 m-85 -115.31 166.8 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.33 1.052 . . . . 0.0 111.561 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 mt -127.41 108.13 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -62.33 156.76 21.46 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -26.77 -48.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.336 2.254 . . . . 0.0 116.854 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.59 -2.25 41.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 49.26 5.77 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.651 1.114 . . . . 0.0 112.118 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.31 136.94 54.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.873 1.669 . . . . 0.0 108.043 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -101.26 144.23 30.37 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.357 1.063 . . . . 0.0 109.607 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 21.5 m -148.01 159.93 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.006 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.421 HD21 ' CH2' ' B' ' 10' ' ' TRP . 9.1 mt -118.08 118.42 31.85 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.789 ' HE2' HD11 ' C' ' 106' ' ' ILE . 4.2 mmtt -107.09 118.08 35.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -136.0 166.65 22.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 123.488 1.613 . . . . 0.0 113.712 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.428 ' HG3' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -116.83 165.75 12.95 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 p-90 -141.13 160.23 40.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.276 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.9 tt -144.92 126.76 15.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.956 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.38 143.16 41.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 125.37 1.669 . . . . 0.0 112.3 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.08 114.23 18.13 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 111.176 -2.738 . . . . 0.0 111.713 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 43.5 m -67.2 175.24 2.73 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 125.778 1.924 . . . . 0.0 112.911 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -117.7 67.66 0.75 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.082 1.353 . . . . 0.0 108.041 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.43 168.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 121.027 -1.046 . . . . 0.0 111.804 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -103.51 -31.35 10.0 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.09 148.63 30.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.838 1.304 . . . . 0.0 111.669 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.79 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.8 tt -64.42 -29.48 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.653 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.53 5.25 5.78 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.276 0.941 . . . . 0.0 113.254 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.92 1.24 10.41 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.387 1.075 . . . . 0.0 113.639 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.12 -32.88 73.51 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.057 0.932 . . . . 0.0 112.435 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.3 p-90 -46.93 -41.45 16.08 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -98.86 -6.67 28.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.456 1.103 . . . . 0.0 113.419 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.91 0.09 22.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.799 ' CG2' HD21 ' B' ' 98' ' ' LEU . 5.3 m -109.35 138.41 45.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.596 0.758 . . . . 0.0 112.124 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.98 123.49 15.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.404 1.482 . . . . 0.0 111.433 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.48 158.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.834 1.254 . . . . 0.0 111.062 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.35 -178.21 37.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.86 0.743 . . . . 0.0 113.462 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 0.0 OUTLIER -125.14 156.31 38.55 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.781 -0.835 . . . . 0.0 111.797 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -147.45 155.3 41.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.136 0.97 . . . . 0.0 110.003 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.72 132.07 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -119.9 152.38 37.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.118 0.961 . . . . 0.0 110.821 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 160.38 37.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.447 1.099 . . . . 0.0 109.476 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 122.32 13.78 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.109 174.881 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 29.6 p -116.29 141.41 48.19 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.073 0.858 . . . . 0.0 108.865 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -139.64 127.69 22.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.994 -1.066 . . . . 0.0 113.07 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' C' ' 64' ' ' PHE . 84.0 mt -68.07 -31.7 71.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -48.27 113.85 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.964 1.306 . . . . 0.0 110.931 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -131.12 5.44 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 125.99 1.757 . . . . 0.0 109.111 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -145.47 146.97 31.69 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -136.59 162.65 32.54 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.993 1.317 . . . . 0.0 111.457 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -136.34 153.25 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.685 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -123.47 143.61 50.05 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.173 0.989 . . . . 0.0 111.093 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.9 -25.9 61.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.907 1.683 . . . . 0.0 113.353 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 110' ' ' TRP . 28.7 tp -71.25 -15.29 62.43 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.816 1.246 . . . . 0.0 111.788 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.27 -14.49 23.2 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 128.479 2.942 . . . . 0.0 113.513 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 149.4 42.61 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 123.14 1.448 . . . . 0.0 113.088 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -123.34 136.21 54.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.325 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -128.34 139.82 52.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m -127.73 131.63 49.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.688 0.795 . . . . 0.0 109.003 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.9 125.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.71 -85.85 0.09 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.615 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.05 33.84 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.726 -0.867 . . . . 0.0 110.909 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.608 HG21 ' HG3' ' C' ' 53' ' ' GLN . 11.0 p -103.83 129.05 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -74.51 166.23 23.87 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.972 0.891 . . . . 0.0 112.356 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -58.78 -25.9 63.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -67.91 -39.12 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.216 -0.927 . . . . 0.0 110.919 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.14 -6.34 12.03 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 124.782 1.182 . . . . 0.0 113.322 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.24 152.76 43.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.071 1.749 . . . . 0.0 112.15 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.38 166.49 30.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.884 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.406 HG22 HD13 ' C' ' 50' ' ' LEU . 21.6 p -123.37 -177.47 3.71 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.89 -166.87 39.84 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 119.322 -2.111 . . . . 0.0 112.703 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.512 ' HB ' HD11 ' C' ' 46' ' ' LEU . 59.0 p -139.69 136.89 34.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.257 1.027 . . . . 0.0 112.578 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -111.84 138.4 48.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.38 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.447 HD11 HD12 ' C' ' 46' ' ' LEU . 27.7 mt -130.42 127.62 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.405 ' O ' HG21 ' C' ' 44' ' ' ILE . 55.9 m -105.09 143.65 32.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.61 -13.08 18.72 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.8 143.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.179 0.992 . . . . 0.0 112.907 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.17 161.12 43.31 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.106 -0.996 . . . . 0.0 111.45 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -71.36 -28.81 64.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -140.09 75.38 29.26 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.914 2.486 . . . . 0.0 110.978 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.92 61.41 3.83 Favored 'Trans proline' 0 CA--C 1.551 1.373 1 C-N-CA 125.589 4.192 . . . . 0.0 115.134 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.7 13.56 38.65 Favored Glycine 0 N--CA 1.481 1.645 0 O-C-N 120.141 -1.599 . . . . 0.0 116.817 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -172.58 -29.43 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.21 1.404 . . . . 0.0 113.401 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.405 HG21 ' O ' ' C' ' 35' ' ' THR 0.325 48.8 mt 5.05 90.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.662 2.385 . . . . 0.0 116.33 -172.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.9 159.24 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.794 -2.457 . . . . 0.0 109.352 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.512 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.2 tt -46.76 128.02 10.32 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.624 1.97 . . . . 0.0 112.878 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -104.82 120.46 50.05 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.978 0.511 . . . . 0.0 111.682 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.89 143.0 83.57 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.949 2.432 . . . . 0.0 112.445 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.495 ' C ' HD12 ' C' ' 49' ' ' LEU . 0.6 OUTLIER -127.1 160.29 31.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.021 0.928 . . . . 0.0 112.78 177.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' B' ' 28' ' ' GLU . 14.9 tp -169.0 149.19 4.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.479 1.512 . . . . 0.0 112.466 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.26 -144.17 10.54 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 121.122 1.783 . . . . 0.0 109.765 -174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.722 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -147.99 139.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.745 -175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.608 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -125.77 138.94 53.88 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.613 1.165 . . . . 0.0 112.727 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -76.64 157.82 31.56 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.023 -1.673 . . . . 0.0 113.277 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -157.67 20.3 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.285 1.434 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -86.77 -53.73 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.926 1.29 . . . . 0.0 110.247 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.52 172.46 11.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.814 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.95 -29.31 25.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.857 0.863 . . . . 0.0 113.034 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -130.69 51.86 8.38 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 125.085 1.354 . . . . 0.0 112.726 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 175.72 10.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.935 2.423 . . . . 0.0 116.139 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.333 0.0 OUTLIER -100.77 170.78 8.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.202 1.477 . . . . 0.0 111.742 173.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' C' ' 6' ' ' LEU . 1.1 p90 -161.57 167.07 25.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.684 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.25 144.86 9.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -173.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.36 158.47 29.7 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -94.99 152.64 18.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.336 1.854 . . . . 0.0 108.718 173.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.85 117.8 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.702 ' HB2' HG21 ' B' ' 52' ' ' ILE . 7.3 t-20 -92.78 117.26 29.82 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.235 -0.916 . . . . 0.0 109.866 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.301 46.4 m95 -80.63 137.55 36.36 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 123.456 1.598 . . . . 0.0 114.123 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -92.78 -39.79 11.03 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -89.13 -15.47 33.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -151.22 130.4 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 129.307 3.043 . . . . 0.0 106.299 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -69.03 118.55 12.08 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 10.7 m -174.0 161.37 3.67 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.238 2.215 . . . . 0.0 108.968 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -142.56 140.58 31.8 Favored 'General case' 0 CA--C 1.483 -1.635 0 CA-C-O 123.347 1.546 . . . . 0.0 111.057 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.9 m -139.15 129.97 26.21 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 110.339 -3.119 . . . . 0.0 110.21 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.15 154.84 7.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.974 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.37 142.34 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.49 121.0 9.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.94 41.17 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 118.708 -1.71 . . . . 0.0 116.625 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -112.49 146.5 38.35 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 125.101 1.118 . . . . 0.0 111.805 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.63 135.13 39.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.312 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HB2' HD12 ' B' ' 106' ' ' ILE . 6.3 m-85 -123.54 165.9 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.055 0.942 . . . . 0.0 111.118 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.62 108.27 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.01 157.12 25.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -24.85 -48.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.634 2.374 . . . . 0.0 117.339 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -80.39 -3.38 49.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.905 2.082 . . . . 0.0 116.449 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.46 48.11 5.75 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 120.295 1.407 . . . . 0.0 111.963 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 135.62 54.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.198 1.799 . . . . 0.0 109.077 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -101.3 145.97 28.17 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.713 1.244 . . . . 0.0 109.729 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.2 m -150.13 157.07 6.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.934 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.49 115.39 26.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.79 ' HE2' HD11 ' B' ' 106' ' ' ILE . 4.3 mmtt -103.74 119.35 38.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.2 p -136.57 167.31 21.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 123.398 1.57 . . . . 0.0 113.889 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.423 ' HG3' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -117.83 166.11 12.86 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -141.23 160.15 40.71 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.121 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.792 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.9 tt -144.81 125.79 14.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.131 -1.849 . . . . 0.0 112.008 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.52 143.19 39.5 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.065 1.478 . . . . 0.0 112.218 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -126.66 114.19 17.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.516 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -66.75 175.35 2.44 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 126.083 2.114 . . . . 0.0 112.926 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.7 p -118.19 68.98 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.34 1.456 . . . . 0.0 107.675 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.8 171.53 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.889 -1.132 . . . . 0.0 111.539 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -106.7 -32.28 8.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -108.22 148.77 29.47 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.833 1.302 . . . . 0.0 111.588 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.789 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.9 tt -64.07 -29.04 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.888 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 5.56 6.11 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.706 1.146 . . . . 0.0 113.516 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -121.39 1.51 10.17 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.333 1.066 . . . . 0.0 113.694 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -33.07 73.73 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.035 0.922 . . . . 0.0 112.553 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.1 p-90 -46.7 -41.43 14.98 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -99.34 -6.57 27.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.318 1.047 . . . . 0.0 113.356 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.35 -0.17 21.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.792 ' CG2' HD21 ' C' ' 98' ' ' LEU . 5.9 m -109.9 138.38 46.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.599 0.76 . . . . 0.0 111.636 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.59 124.47 17.26 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 125.65 1.58 . . . . 0.0 111.01 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -99.57 158.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.245 1.418 . . . . 0.0 111.35 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.65 -178.84 38.34 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.809 0.718 . . . . 0.0 113.407 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 0.0 OUTLIER -124.41 157.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.733 -0.863 . . . . 0.0 111.911 176.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -148.39 155.59 41.44 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.967 0.889 . . . . 0.0 109.864 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -132.19 133.28 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -120.76 151.7 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 111.665 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.8 p -135.42 163.15 30.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.024 1.33 . . . . 0.0 109.876 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 115.94 5.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.86 -1.15 . . . . 0.0 111.732 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 tp . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.594 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 p -116.61 137.61 52.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.003 0.921 . . . . 0.0 109.823 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 p -139.77 133.09 29.94 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.196 -1.565 . . . . 0.0 114.348 -174.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 64' ' ' PHE . 42.1 mt -59.13 -32.01 69.47 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -52.35 116.18 2.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.774 1.273 . . . . 0.0 111.83 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.1 -114.47 1.25 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 125.94 1.733 . . . . 0.0 110.209 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -153.16 147.44 25.78 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -140.65 162.75 34.64 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.493 1.517 . . . . 0.0 111.35 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -138.63 147.94 43.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.29 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.28 146.99 38.46 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.709 0.803 . . . . 0.0 110.619 -175.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -56.67 -28.6 61.05 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 12' ' ' ASN . 32.6 tp -72.29 -15.62 61.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.053 1.741 . . . . 0.0 112.02 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.39 -14.29 25.42 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.048 2.261 . . . . 0.0 113.441 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.7 p -68.51 155.05 40.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.412 1.606 . . . . 0.0 113.134 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -127.02 138.28 53.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.608 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -124.09 136.03 53.96 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.56 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -126.79 130.51 50.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.9 mt -134.43 127.46 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.83 -89.59 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.077 0.861 . . . . 0.0 112.558 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.92 139.65 32.58 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.837 -0.801 . . . . 0.0 111.641 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.8 t -89.61 129.47 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.357 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.56 166.04 15.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.894 0.854 . . . . 0.0 111.589 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.1 p -57.15 -27.81 62.19 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -74.71 -32.83 62.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.698 0.681 . . . . 0.0 111.722 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.67 -7.43 26.05 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.959 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 9.6 pt-20 -66.3 144.27 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.772 1.286 . . . . 0.0 108.487 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 50' ' ' LEU . 20.8 p90 -158.18 145.82 18.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.802 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.57 162.01 14.34 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.02 -170.04 36.9 Favored Glycine 0 C--O 1.239 0.416 0 O-C-N 121.187 -0.946 . . . . 0.0 112.664 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' LEU . 46.9 p -140.15 139.03 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.407 1.098 . . . . 0.0 112.17 175.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -114.42 138.72 50.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 108.389 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 46' ' ' LEU . 41.4 mt -130.83 126.87 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG21 ' A' ' 44' ' ' ILE . 86.5 m -105.05 144.34 31.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.74 -21.96 17.82 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.5 m -132.98 143.26 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.48 1.112 . . . . 0.0 113.27 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.55 159.43 39.7 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.528 -0.732 . . . . 0.0 110.219 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.54 -23.72 58.84 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.95 -0.469 . . . . 0.0 110.909 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -146.43 68.72 12.34 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.221 2.208 . . . . 0.0 111.069 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' ILE . 39.0 Cg_endo -56.71 -79.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 125.08 3.853 . . . . 0.0 116.853 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.87 -48.65 0.01 OUTLIER Glycine 0 CA--C 1.546 1.996 0 C-N-CA 129.561 3.458 . . . . 0.0 120.565 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.84 -5.12 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.25 2.22 . . . . 0.0 113.118 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 35' ' ' THR 0.347 64.5 mt -8.89 85.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 124.316 2.007 . . . . 0.0 115.009 -172.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.2 151.13 21.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 111.63 -2.532 . . . . 0.0 108.465 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 32' ' ' THR . 3.3 tt -46.34 127.19 8.76 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.934 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.32 118.52 57.59 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 123.961 0.788 . . . . 0.0 111.252 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.92 144.07 69.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.727 2.284 . . . . 0.0 112.177 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.5 158.23 35.01 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.765 0.826 . . . . 0.0 111.267 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 29' ' ' PHE . 7.6 tp -159.89 148.97 17.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.319 1.847 . . . . 0.0 110.425 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.9 -157.22 28.95 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 121.062 1.756 . . . . 0.0 110.069 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.4 mt -141.7 134.94 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.45 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 136.61 53.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.543 1.137 . . . . 0.0 110.772 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -73.29 151.88 41.18 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.004 0.907 . . . . 0.0 109.746 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.9 26.46 1.37 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.619 -1.301 . . . . 0.0 111.633 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.47 -50.29 5.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 110.717 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 173.29 10.34 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.231 0.957 . . . . 0.0 112.987 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.7 m -83.93 -31.64 25.52 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.762 1.225 . . . . 0.0 113.366 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -128.51 54.94 15.09 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.243 1.417 . . . . 0.0 111.381 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.66 165.18 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.042 2.495 . . . . 0.0 117.553 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.3 p -81.11 164.27 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.115 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -158.78 163.47 36.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.215 -0.928 . . . . 0.0 113.021 175.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.89 140.1 6.12 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -159.68 157.55 29.76 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -95.84 151.55 19.3 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.302 1.441 . . . . 0.0 110.651 174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.44 118.13 48.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 24.8 t-20 -93.72 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 109.554 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.301 43.8 m95 -83.07 135.48 34.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.82 -44.02 9.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.953 2.101 . . . . 0.0 116.321 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -91.02 -9.56 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -152.79 126.8 9.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.507 2.323 . . . . 0.0 107.06 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -69.25 118.48 12.19 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.965 1.257 . . . . 0.0 110.503 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -177.23 164.23 2.16 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 126.329 1.851 . . . . 0.0 109.193 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -144.18 143.84 31.27 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.542 1.639 . . . . 0.0 111.549 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.31 125.17 21.12 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 110.33 -3.123 . . . . 0.0 109.691 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.67 152.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -126.33 142.17 51.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 118.14 7.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -174.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.1 -164.94 14.67 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.413 HE22 ' N ' ' D' ' 103' ' ' VAL . 14.6 tt0 -130.3 150.0 51.74 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.485 0.756 . . . . 0.0 112.216 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.5 t -94.86 124.93 39.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.7 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' HB2' HD12 ' D' ' 106' ' ' ILE . 5.0 m-85 -114.46 163.48 15.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.242 1.017 . . . . 0.0 111.966 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.87 110.72 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.16 161.22 9.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.249 0.619 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.37 -51.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -69.24 -33.46 73.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.8 42.44 0.73 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.906 1.241 . . . . 0.0 111.734 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -110.44 142.64 41.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.302 1.441 . . . . 0.0 109.85 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -101.58 140.33 36.01 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.856 1.262 . . . . 0.0 111.613 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 20.1 m -143.62 160.32 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.372 1.069 . . . . 0.0 108.681 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.69 119.25 33.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 119.51 39.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.531 HG22 ' HE1' ' A' ' 64' ' ' PHE . 4.4 p -137.7 172.27 13.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 123.131 1.443 . . . . 0.0 111.992 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.585 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.9 mmm -126.02 168.9 13.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.588 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -141.49 164.06 31.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.168 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.669 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -148.15 119.67 7.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.056 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 140.11 41.06 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.181 1.467 . . . . 0.0 112.11 -173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -120.16 120.97 37.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 110.804 -2.907 . . . . 0.0 111.237 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -88.7 163.52 15.73 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 125.496 1.748 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -113.81 70.85 0.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.419 ' N ' HE22 ' D' ' 82' ' ' GLN . 27.8 m -61.83 -167.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 111.001 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.44 -15.16 3.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.738 -1.851 . . . . 0.0 114.776 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.77 150.23 43.07 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.87 1.319 . . . . 0.0 110.315 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' D' ' 92' ' ' VAL . 16.6 tt -62.85 -28.38 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.708 174.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.82 6.89 10.58 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.244 -1.309 . . . . 0.0 113.472 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -121.08 -1.36 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.85 1.325 . . . . 0.0 113.632 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -59.08 -34.75 72.34 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.623 -1.298 . . . . 0.0 112.158 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.73 -39.56 18.07 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.724 1.21 . . . . 0.0 114.16 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.32 -7.65 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.285 1.434 . . . . 0.0 114.011 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 1.8 9.6 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.163 -0.961 . . . . 0.0 113.016 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.669 ' CG2' HD21 ' A' ' 98' ' ' LEU . 34.0 m -116.97 145.23 43.77 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.865 0.866 . . . . 0.0 111.537 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.52 129.05 18.06 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 125.759 1.624 . . . . 0.0 110.659 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.71 155.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 120.483 1.492 . . . . 0.0 109.367 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -175.31 28.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.542 1.067 . . . . 0.0 113.08 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 21.4 p90 -125.97 153.01 44.92 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.064 0.945 . . . . 0.0 110.782 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -144.85 152.97 41.1 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.695 1.198 . . . . 0.0 109.865 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.1 mt -135.06 122.17 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -110.6 149.18 30.78 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.521 0.677 . . . . 0.0 110.427 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.5 p -134.16 162.83 31.06 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.081 -1.012 . . . . 0.0 109.662 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -56.87 114.82 2.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.451 0.701 . . . . 0.0 109.928 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.417 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . 0.466 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 24.5 p -122.43 135.22 54.64 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.373 1.469 . . . . 0.0 110.236 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -139.91 134.4 31.55 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.389 -1.445 . . . . 0.0 114.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' D' ' 64' ' ' PHE . 43.1 mt -58.6 -32.94 69.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -51.5 117.32 2.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 123.35 1.547 . . . . 0.0 112.098 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.52 -116.72 1.75 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.687 1.613 . . . . 0.0 110.351 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -151.92 147.15 26.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -141.27 162.78 34.65 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.83 1.652 . . . . 0.0 111.927 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -139.73 148.08 41.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.938 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.54 HD22 ' H ' ' D' ' 14' ' ' LEU . 0.5 OUTLIER -113.05 146.98 38.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.781 0.832 . . . . 0.0 110.585 -176.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -57.9 -26.38 62.09 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.54 ' H ' HD22 ' D' ' 12' ' ' ASN . 35.1 tp -72.16 -16.91 61.98 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.451 1.5 . . . . 0.0 111.74 174.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.04 -13.74 23.99 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 127.136 2.303 . . . . 0.0 113.627 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -69.77 155.66 40.2 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.308 1.554 . . . . 0.0 112.841 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -127.81 138.35 52.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.044 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -124.11 136.64 54.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.261 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -126.67 131.25 51.45 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.2 127.12 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.03 -89.93 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.91 141.32 32.98 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.608 -0.937 . . . . 0.0 111.219 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -91.4 130.07 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.83 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 165.09 18.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.908 0.861 . . . . 0.0 111.885 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 28.7 p -57.37 -26.96 61.85 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -73.58 -31.97 63.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.849 0.75 . . . . 0.0 111.722 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.99 25.32 Favored Glycine 0 N--CA 1.462 0.389 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.344 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.3 156.81 38.77 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.582 1.191 . . . . 0.0 112.872 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . 0.421 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.1 p90 -160.35 160.25 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.389 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . 0.505 HG22 ' CD1' ' D' ' 50' ' ' LEU . 0.9 OUTLIER -120.45 156.98 30.33 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 173.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.78 -167.82 28.04 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 120.11 -1.619 . . . . 0.0 112.527 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.604 ' HB ' HD11 ' D' ' 46' ' ' LEU . 45.5 p -140.0 137.74 34.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 122.351 1.072 . . . . 0.0 112.474 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -114.62 139.14 49.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.476 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' D' ' 46' ' ' LEU . 44.3 mt -130.79 127.23 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.534 ' O ' HG21 ' D' ' 44' ' ' ILE . 86.7 m -105.1 144.17 32.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.64 -21.41 18.24 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.01 143.75 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 112.974 -174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.49 39.25 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.722 -0.611 . . . . 0.0 110.238 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.68 -23.46 58.63 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 121.984 -0.447 . . . . 0.0 110.935 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -146.6 68.7 12.12 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.263 2.225 . . . . 0.0 111.087 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' D' ' 44' ' ' ILE . 38.7 Cg_endo -56.79 -78.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 125.05 3.833 . . . . 0.0 116.89 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.66 -48.74 0.01 OUTLIER Glycine 0 CA--C 1.545 1.931 0 C-N-CA 129.651 3.501 . . . . 0.0 120.587 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.68 -5.15 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 127.176 2.19 . . . . 0.0 113.03 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.534 HG21 ' O ' ' D' ' 35' ' ' THR 0.345 64.9 mt -8.92 86.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 124.337 2.018 . . . . 0.0 115.068 -172.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.29 151.47 21.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.55 174.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.604 HD11 ' HB ' ' D' ' 32' ' ' THR . 3.5 tt -46.51 126.87 8.72 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.295 -2.23 . . . . 0.0 111.772 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.7 p -102.85 118.68 57.72 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 123.844 0.715 . . . . 0.0 111.381 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.84 144.15 67.88 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.66 2.24 . . . . 0.0 111.962 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.44 162.75 24.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.551 0.74 . . . . 0.0 111.516 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.505 ' CD1' HG22 ' D' ' 30' ' ' THR . 15.9 tp -164.22 149.02 10.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.894 1.678 . . . . 0.0 112.129 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -154.62 25.65 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 120.933 1.697 . . . . 0.0 110.498 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.2 mt -144.35 133.42 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.359 1.076 . . . . 0.0 110.929 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 136.71 54.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.28 1.432 . . . . 0.0 110.497 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -73.8 151.26 40.63 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.28 -0.887 . . . . 0.0 109.971 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -144.62 26.47 1.42 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.696 -1.252 . . . . 0.0 111.58 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.42 -49.28 6.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 111.289 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 172.8 12.6 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -80.01 -30.66 39.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.781 1.232 . . . . 0.0 113.11 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -133.29 57.68 28.8 Favored Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -71.76 164.25 36.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 N-CA-C 117.494 2.075 . . . . 0.0 117.494 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -81.21 164.1 22.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.944 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -158.35 163.56 37.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.871 0.844 . . . . 0.0 112.758 175.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.43 140.09 6.08 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -159.56 157.91 30.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -96.11 151.38 19.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.91 1.684 . . . . 0.0 110.648 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.47 118.74 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 52' ' ' ILE . 25.7 t-20 -94.93 113.29 25.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.966 0.906 . . . . 0.0 109.523 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.297 43.8 m95 -82.53 136.01 34.96 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -173.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -92.41 -43.25 9.32 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.899 2.08 . . . . 0.0 116.417 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -91.37 -9.72 43.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.77 127.41 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.422 2.289 . . . . 0.0 107.171 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -69.52 118.48 12.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.009 1.277 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -177.34 163.91 2.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.31 1.844 . . . . 0.0 109.039 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.5 t -144.0 143.78 31.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.893 1.806 . . . . 0.0 111.721 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 110.224 -3.171 . . . . 0.0 109.869 -172.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.1 153.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -127.12 141.97 51.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.36 118.37 7.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -164.95 14.61 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 116.401 1.32 . . . . 0.0 116.401 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.419 HE22 ' N ' ' A' ' 103' ' ' VAL . 14.5 tt0 -131.09 149.75 52.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.245 0.615 . . . . 0.0 112.024 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.466 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 37.9 t -97.25 122.28 40.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.211 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.7 m-85 -109.35 163.46 13.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.138 0.975 . . . . 0.0 112.008 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.79 107.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 160.84 5.36 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.251 0.548 . . . . 0.0 110.103 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.09 -49.97 0.14 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -25.87 61.06 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.83 51.51 1.17 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.881 0.764 . . . . 0.0 111.286 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -120.16 147.73 44.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 128.261 2.624 . . . . 0.0 105.346 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -113.7 137.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.804 1.242 . . . . 0.0 110.135 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 106' ' ' ILE . 26.0 m -139.71 161.86 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 110.05 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.01 120.05 36.64 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 118.41 36.7 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.534 HG22 ' HE1' ' D' ' 64' ' ' PHE . 3.9 p -137.11 171.84 13.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 123.303 1.525 . . . . 0.0 112.151 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.576 ' HG3' HG21 ' A' ' 113' ' ' THR . 88.5 mmm -125.95 168.88 13.29 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -141.07 163.72 32.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.312 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.66 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -148.11 120.1 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.84 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 140.33 40.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 123.23 1.49 . . . . 0.0 112.044 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.08 119.86 34.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 110.89 -2.868 . . . . 0.0 110.758 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -86.15 162.97 18.11 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 125.257 1.598 . . . . 0.0 112.044 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 3.8 t -112.83 73.17 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.413 ' N ' HE22 ' A' ' 82' ' ' GLN . 27.9 m -63.14 -166.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.452 0.701 . . . . 0.0 110.709 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.11 -14.54 3.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 119.907 -1.746 . . . . 0.0 114.569 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -123.46 149.49 45.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 123.086 1.422 . . . . 0.0 110.516 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 17.2 tt -62.01 -29.37 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.111 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.0 5.92 11.66 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.45 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -120.41 -1.77 10.13 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.01 1.405 . . . . 0.0 113.575 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.82 -34.99 70.26 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.652 -1.28 . . . . 0.0 112.745 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 62.7 p-90 -47.51 -39.8 17.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.079 1.352 . . . . 0.0 113.912 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -99.21 -6.8 27.49 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.322 1.449 . . . . 0.0 114.114 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.75 1.46 10.35 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.88 -1.137 . . . . 0.0 113.126 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.66 ' CG2' HD21 ' D' ' 98' ' ' LEU . 34.7 m -117.29 145.24 44.1 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.574 0.75 . . . . 0.0 111.604 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.17 129.05 18.42 Favored 'General case' 0 C--O 1.214 -0.81 0 C-N-CA 125.53 1.532 . . . . 0.0 110.681 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.74 155.15 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 120.531 1.514 . . . . 0.0 109.504 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.21 -175.53 29.24 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.628 1.109 . . . . 0.0 113.002 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 21.7 p90 -125.87 153.48 44.09 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.039 0.936 . . . . 0.0 110.68 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.33 153.24 41.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.675 1.19 . . . . 0.0 109.706 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 80.9 mt -135.37 123.93 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.52 149.51 32.57 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 111.064 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -133.56 164.93 26.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.939 0.896 . . . . 0.0 109.82 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -60.93 121.14 11.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.104 -0.997 . . . . 0.0 109.979 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 CA--C 1.55 0.954 0 O-C-N 121.765 -0.584 . . . . 0.0 110.14 174.886 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.41 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 26.0 p -117.59 134.94 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.322 1.849 . . . . 0.0 109.619 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -139.75 135.71 33.39 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.414 -1.429 . . . . 0.0 114.193 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' B' ' 64' ' ' PHE . 40.7 mt -60.46 -30.57 69.76 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -53.5 116.81 2.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.713 1.244 . . . . 0.0 111.582 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.65 -116.11 1.54 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.474 1.512 . . . . 0.0 110.369 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -152.68 145.3 24.22 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -139.63 162.15 35.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 111.553 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -141.51 145.57 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.607 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.463 HD22 ' H ' ' B' ' 14' ' ' LEU . 0.5 OUTLIER -109.21 148.85 30.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.062 0.945 . . . . 0.0 110.744 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -57.47 -28.91 63.8 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.463 ' H ' HD22 ' B' ' 12' ' ' ASN . 32.4 tp -72.18 -14.87 61.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.367 1.867 . . . . 0.0 111.91 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.78 -14.02 29.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 127.048 2.261 . . . . 0.0 113.461 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 54.1 p -69.35 155.83 39.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.233 1.516 . . . . 0.0 112.683 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -127.95 139.58 52.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.935 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -125.69 134.83 51.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.563 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -124.97 131.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.0 mt -135.01 127.83 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.6 -89.6 0.11 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.048 0.842 . . . . 0.0 112.52 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.4 140.5 32.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.714 -0.874 . . . . 0.0 111.554 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.3 t -90.96 129.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.402 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.73 165.8 16.55 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.576 0.703 . . . . 0.0 111.533 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 27.5 p -56.98 -27.42 61.37 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -74.89 -32.79 61.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.785 0.721 . . . . 0.0 111.877 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.62 -7.32 26.16 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.164 -1.353 . . . . 0.0 112.856 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 9.7 pt-20 -66.11 144.58 56.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.857 1.328 . . . . 0.0 108.464 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.415 ' O ' HD12 ' B' ' 50' ' ' LEU . 21.1 p90 -158.44 146.16 18.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.783 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.69 162.25 14.15 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.894 0.877 . . . . 0.0 108.76 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.84 36.86 Favored Glycine 0 C--O 1.238 0.372 0 O-C-N 121.245 -0.909 . . . . 0.0 112.608 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.6 ' HB ' HD11 ' B' ' 46' ' ' LEU . 43.9 p -140.17 139.24 35.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.335 1.064 . . . . 0.0 112.292 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -114.38 139.09 49.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.477 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.519 HD11 HD12 ' B' ' 46' ' ' LEU . 43.1 mt -131.2 127.1 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.535 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.5 m -105.0 145.47 30.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.45 -22.37 17.17 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -132.61 143.44 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.553 1.141 . . . . 0.0 113.093 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.62 159.5 39.68 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.387 -0.82 . . . . 0.0 110.083 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.46 -23.49 58.9 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.017 -0.427 . . . . 0.0 111.083 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.78 68.62 11.84 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 127.256 2.223 . . . . 0.0 110.945 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.436 ' HB3' HD11 ' B' ' 44' ' ' ILE . 38.4 Cg_endo -56.85 -78.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 125.083 3.856 . . . . 0.0 116.776 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.82 -48.46 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 C-N-CA 129.582 3.468 . . . . 0.0 120.568 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.98 -5.29 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.283 2.233 . . . . 0.0 113.114 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.535 HG21 ' O ' ' B' ' 35' ' ' THR 0.349 65.7 mt -8.58 85.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 124.354 2.026 . . . . 0.0 115.147 -172.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.89 151.11 21.21 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.501 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.6 HD11 ' HB ' ' B' ' 32' ' ' THR . 3.4 tt -46.34 127.3 8.86 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.777 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.46 118.72 56.98 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 123.951 0.782 . . . . 0.0 111.405 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.85 144.12 68.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.58 158.44 34.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.728 0.811 . . . . 0.0 111.22 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.415 HD12 ' O ' ' B' ' 29' ' ' PHE . 7.4 tp -160.03 148.94 17.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.409 1.884 . . . . 0.0 110.453 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.86 -157.28 29.01 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 121.018 1.735 . . . . 0.0 110.236 -174.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.4 mt -141.62 135.0 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.64 0.733 . . . . 0.0 111.491 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.56 136.71 53.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.723 1.209 . . . . 0.0 110.843 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -73.48 152.49 40.7 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.993 0.902 . . . . 0.0 109.756 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.86 25.82 1.42 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.537 -1.352 . . . . 0.0 111.773 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -93.23 -49.21 6.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.918 1.287 . . . . 0.0 111.238 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.23 172.53 12.69 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.557 1.161 . . . . 0.0 114.042 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.67 -28.6 36.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.492 1.117 . . . . 0.0 113.028 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -135.11 57.09 18.72 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.665 1.186 . . . . 0.0 111.52 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.77 163.95 37.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.598 2.865 . . . . 0.0 117.73 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 69.6 p -80.89 163.74 23.15 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.761 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -158.76 162.84 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.346 -0.846 . . . . 0.0 112.811 175.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.76 140.03 6.08 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -159.59 158.17 31.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.37 151.46 19.52 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.477 1.511 . . . . 0.0 110.632 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -127.38 118.06 48.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 52' ' ' ILE . 24.6 t-20 -93.74 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.01 0.924 . . . . 0.0 109.501 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.298 43.8 m95 -83.06 135.05 34.98 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.44 -43.86 9.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.179 2.192 . . . . 0.0 116.361 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -91.14 -9.66 44.71 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -152.74 126.32 8.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.479 2.312 . . . . 0.0 106.912 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.12 118.49 12.09 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.046 1.294 . . . . 0.0 110.515 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -177.48 163.57 1.98 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 109.176 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -143.63 144.25 31.82 Favored 'General case' 0 CA--C 1.482 -1.673 0 CA-C-O 123.376 1.56 . . . . 0.0 111.648 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 125.67 21.32 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 110.441 -3.072 . . . . 0.0 109.656 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.03 153.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -126.99 142.03 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 118.06 6.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.09 -165.01 14.76 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.433 HE22 ' H ' ' C' ' 103' ' ' VAL . 14.3 tt0 -130.83 149.61 52.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.928 1.016 . . . . 0.0 111.75 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.41 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 45.7 t -97.23 125.84 42.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.464 174.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.442 ' HB2' HD12 ' C' ' 106' ' ' ILE . 4.1 m-85 -113.07 165.44 12.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.267 1.027 . . . . 0.0 112.213 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 22.7 mt -130.56 110.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.91 162.08 4.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.258 0.623 . . . . 0.0 109.567 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -33.33 -48.94 0.26 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -13.44 60.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.64 43.45 4.22 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.225 0.92 . . . . 0.0 112.23 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 6.0 mtpt -113.36 142.67 45.59 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 127.389 2.276 . . . . 0.0 109.324 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -106.8 141.68 37.64 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.004 1.321 . . . . 0.0 111.271 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.8 m -144.55 160.37 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.589 1.156 . . . . 0.0 110.14 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.71 119.43 35.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 118.59 37.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.537 HG22 ' HE1' ' B' ' 64' ' ' PHE . 4.5 p -137.38 172.05 13.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.169 1.461 . . . . 0.0 112.189 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.588 ' HG3' HG21 ' C' ' 113' ' ' THR . 88.4 mmm -125.92 168.87 13.3 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.12 163.99 31.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.583 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -148.16 119.77 8.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.983 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 139.63 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 124.964 1.415 . . . . 0.0 112.176 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -119.38 120.35 36.63 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 110.684 -2.962 . . . . 0.0 110.676 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -87.79 163.35 16.5 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 125.319 1.637 . . . . 0.0 111.405 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -113.13 72.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.421 ' N ' HE22 ' C' ' 82' ' ' GLN . 27.2 m -63.58 -167.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.312 0.645 . . . . 0.0 110.269 174.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.03 -20.28 3.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.092 -1.63 . . . . 0.0 113.66 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -115.38 148.3 39.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.991 1.377 . . . . 0.0 110.96 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.469 ' CD1' HG21 ' C' ' 92' ' ' VAL . 16.9 tt -62.85 -28.4 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.516 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.75 5.83 15.31 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 118.003 -1.443 . . . . 0.0 113.831 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -121.27 -0.93 9.79 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.95 1.375 . . . . 0.0 113.432 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.5 -35.86 70.79 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.737 -1.227 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.41 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 62.9 p-90 -47.22 -40.25 15.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.195 1.398 . . . . 0.0 113.802 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -99.04 -7.07 27.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.241 1.416 . . . . 0.0 113.943 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.58 13.05 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.627 -1.295 . . . . 0.0 113.165 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.672 ' CG2' HD21 ' B' ' 98' ' ' LEU . 33.1 m -115.09 145.47 42.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.869 0.868 . . . . 0.0 111.757 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.78 129.86 18.51 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 125.876 1.671 . . . . 0.0 110.42 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.66 155.13 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 120.421 1.464 . . . . 0.0 109.353 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.68 -175.07 28.19 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.673 1.13 . . . . 0.0 113.517 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 21.1 p90 -126.29 152.84 45.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.13 0.972 . . . . 0.0 110.71 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -145.15 151.57 38.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.528 1.131 . . . . 0.0 110.304 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.86 119.74 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -108.69 152.28 25.03 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.933 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -136.91 162.15 34.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.23 1.012 . . . . 0.0 109.566 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -54.55 125.79 21.07 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.51 -0.744 . . . . 0.0 109.668 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.598 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 24.0 p -119.27 133.41 55.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.279 1.832 . . . . 0.0 109.228 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 78.9 p -139.83 133.21 30.01 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.243 -1.536 . . . . 0.0 114.148 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.629 HD21 ' CE2' ' C' ' 64' ' ' PHE . 40.8 mt -58.23 -32.82 68.68 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -51.76 116.3 2.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.903 1.335 . . . . 0.0 111.729 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.95 -114.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 125.66 1.6 . . . . 0.0 109.829 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -152.9 148.22 26.89 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -141.12 162.67 34.93 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.267 1.427 . . . . 0.0 112.315 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -135.45 147.3 48.89 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.859 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . 0.436 HD22 ' H ' ' C' ' 14' ' ' LEU . 0.4 OUTLIER -111.67 146.81 36.81 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.591 0.756 . . . . 0.0 110.475 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -57.1 -27.46 61.79 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.436 ' H ' HD22 ' C' ' 12' ' ' ASN . 34.9 tp -72.64 -16.25 61.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.126 1.77 . . . . 0.0 111.986 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.56 -13.81 25.15 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.128 2.299 . . . . 0.0 113.662 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 44.1 p -69.16 156.31 38.92 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.489 1.645 . . . . 0.0 113.128 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -128.86 138.93 52.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.848 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -124.08 136.87 54.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.26 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -126.68 130.72 50.96 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.97 126.87 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.83 -89.59 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.898 0.749 . . . . 0.0 112.63 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.42 32.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.619 -0.93 . . . . 0.0 111.206 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.33 130.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.08 165.33 18.29 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.589 0.709 . . . . 0.0 111.782 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 30.6 p -57.78 -26.76 62.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -73.65 -32.04 63.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.975 0.807 . . . . 0.0 111.733 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.08 -4.55 25.48 Favored Glycine 0 N--CA 1.463 0.462 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.392 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.73 156.49 39.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.432 1.116 . . . . 0.0 112.766 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . 0.417 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.0 p90 -159.81 159.93 33.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.258 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' CD1' ' C' ' 50' ' ' LEU . 1.0 OUTLIER -120.34 157.11 29.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 173.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.08 -167.33 27.6 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 120.054 -1.654 . . . . 0.0 112.627 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.581 ' HB ' HD11 ' C' ' 46' ' ' LEU . 54.0 p -139.79 138.14 35.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.514 1.149 . . . . 0.0 112.783 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.9 139.45 49.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.371 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.517 HD11 HD12 ' C' ' 46' ' ' LEU . 42.8 mt -131.16 127.06 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 174.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.542 ' O ' HG21 ' C' ' 44' ' ' ILE . 85.1 m -105.05 145.03 31.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.98 -20.12 18.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.49 142.89 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.548 1.139 . . . . 0.0 113.197 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.42 159.37 39.8 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.326 -0.859 . . . . 0.0 110.215 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.38 -23.42 58.99 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 110.99 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.71 68.88 12.07 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 127.239 2.216 . . . . 0.0 111.029 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.448 ' HB3' HD11 ' C' ' 44' ' ' ILE . 38.6 Cg_endo -56.92 -78.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 125.054 3.836 . . . . 0.0 116.86 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.51 -48.85 0.01 OUTLIER Glycine 0 CA--C 1.546 1.982 0 C-N-CA 129.65 3.5 . . . . 0.0 120.591 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.49 -5.08 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.307 2.243 . . . . 0.0 113.167 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.542 HG21 ' O ' ' C' ' 35' ' ' THR 0.345 65.6 mt -9.02 85.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 124.465 2.078 . . . . 0.0 115.301 -172.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.88 151.36 20.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.525 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.581 HD11 ' HB ' ' C' ' 32' ' ' THR . 3.4 tt -46.48 127.08 8.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 112.181 -2.282 . . . . 0.0 111.777 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.25 118.71 57.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 123.85 0.718 . . . . 0.0 111.376 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.74 144.29 66.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.755 2.303 . . . . 0.0 111.869 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.63 162.73 25.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.545 0.738 . . . . 0.0 111.702 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' C' ' 30' ' ' THR . 15.6 tp -164.46 148.97 9.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.778 1.631 . . . . 0.0 112.166 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.73 25.79 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 120.866 1.666 . . . . 0.0 110.488 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -143.76 135.18 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.209 1.004 . . . . 0.0 110.984 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.58 136.55 52.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.311 1.444 . . . . 0.0 110.34 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -73.72 151.44 40.7 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.889 0.852 . . . . 0.0 110.172 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -144.56 25.68 1.48 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.573 -1.329 . . . . 0.0 112.017 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -93.51 -49.96 5.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.28 1.432 . . . . 0.0 111.239 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.64 173.11 11.48 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.691 1.245 . . . . 0.0 113.659 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -83.0 -26.47 31.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.107 1.363 . . . . 0.0 113.46 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -134.91 55.74 14.77 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 125.438 1.495 . . . . 0.0 112.2 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.28 163.72 37.66 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.794 2.329 . . . . 0.0 117.878 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 68.2 p -80.86 164.18 22.84 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.033 173.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . 0.629 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.21 163.33 36.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.874 0.845 . . . . 0.0 113.118 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.74 140.81 6.53 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 117.816 1.886 . . . . 0.0 117.816 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -160.3 158.55 30.0 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -96.63 152.02 19.05 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.118 1.767 . . . . 0.0 110.709 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.34 118.12 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' B' ' 52' ' ' ILE . 26.1 t-20 -94.22 113.14 25.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.017 0.927 . . . . 0.0 109.447 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.295 43.6 m95 -82.46 135.43 35.13 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -172.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -91.56 -44.07 9.29 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.956 2.102 . . . . 0.0 116.226 -173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -90.89 -9.49 46.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.0 t -152.74 126.84 9.09 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 127.448 2.299 . . . . 0.0 107.065 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -69.19 118.48 12.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.0 1.273 . . . . 0.0 110.407 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -177.34 163.59 2.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.393 1.877 . . . . 0.0 109.142 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -143.69 143.89 31.62 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 124.067 1.889 . . . . 0.0 111.613 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.44 125.71 21.65 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 109.99 -3.277 . . . . 0.0 109.86 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.33 153.58 4.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.79 142.15 51.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.72 118.94 7.26 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -174.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.88 -164.29 14.16 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.421 HE22 ' N ' ' B' ' 103' ' ' VAL . 14.5 tt0 -132.06 149.46 52.41 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.541 0.789 . . . . 0.0 111.812 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.438 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 41.4 t -97.21 123.26 40.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.318 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.1 m-85 -112.34 164.71 12.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.264 1.025 . . . . 0.0 112.203 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -128.11 111.78 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.85 160.18 6.11 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -33.42 -47.74 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -10.06 59.13 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.07 5.79 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.524 1.056 . . . . 0.0 112.644 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -112.99 143.21 44.68 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 128.208 2.603 . . . . 0.0 108.959 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -109.45 143.93 38.38 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.489 1.495 . . . . 0.0 110.865 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.7 m -144.95 162.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.581 1.152 . . . . 0.0 109.606 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.63 121.02 39.16 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.84 119.07 38.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.532 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.7 p -137.31 172.54 12.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.083 1.42 . . . . 0.0 112.371 -174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.586 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.7 mmm -126.97 169.22 13.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -141.15 164.37 30.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.389 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -148.27 120.01 8.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.949 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.19 140.2 40.43 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 125.022 1.451 . . . . 0.0 112.231 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.25 120.74 36.98 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 111.208 -2.724 . . . . 0.0 111.129 -174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 38.4 t -88.56 163.18 15.99 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 125.176 1.548 . . . . 0.0 111.351 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -113.0 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . 0.433 ' H ' HE22 ' B' ' 82' ' ' GLN . 27.8 m -63.96 -165.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.439 0.695 . . . . 0.0 110.453 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.36 -15.65 3.19 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.074 -1.641 . . . . 0.0 114.054 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.58 148.89 43.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.13 1.443 . . . . 0.0 110.798 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.473 ' CD1' HG21 ' B' ' 92' ' ' VAL . 16.6 tt -62.18 -28.34 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.932 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.28 5.84 18.35 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-O 118.121 -1.377 . . . . 0.0 113.866 173.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.17 -1.43 9.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.587 1.194 . . . . 0.0 113.481 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.07 -35.71 71.76 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.738 -1.226 . . . . 0.0 112.581 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.42 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 62.7 p-90 -47.1 -39.8 13.98 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.018 1.327 . . . . 0.0 113.903 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.28 -7.21 26.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.16 2.04 9.89 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.537 -1.352 . . . . 0.0 113.09 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.683 ' CG2' HD21 ' C' ' 98' ' ' LEU . 35.8 m -116.96 145.08 43.87 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.977 0.911 . . . . 0.0 111.618 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.23 129.37 18.65 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 125.68 1.592 . . . . 0.0 110.62 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.66 155.08 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 120.558 1.526 . . . . 0.0 109.246 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -175.82 28.83 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.681 1.134 . . . . 0.0 113.441 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 21.1 p90 -125.45 152.95 44.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.541 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.61 152.66 40.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.75 1.22 . . . . 0.0 110.151 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.16 121.5 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -109.02 152.69 24.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -141.02 164.08 31.24 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.136 0.975 . . . . 0.0 110.676 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.39 114.38 2.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.097 0.959 . . . . 0.0 111.24 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.714 174.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 134.2 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.219 1.408 . . . . 0.0 111.273 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.43 127.54 13.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.022 1.329 . . . . 0.0 109.234 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -73.74 -27.7 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.77 116.1 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.86 1.264 . . . . 0.0 111.204 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.33 -123.52 2.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.411 1.482 . . . . 0.0 110.97 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -147.62 144.65 28.56 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -142.67 159.15 42.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.369 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -141.33 146.95 37.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 16' ' ' SER . 25.2 p30 -114.21 159.37 20.2 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -55.99 -26.06 46.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.146 2.578 . . . . 0.0 115.164 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -76.27 -11.97 60.0 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.608 1.163 . . . . 0.0 111.974 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.89 47.28 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 127.145 2.307 . . . . 0.0 112.931 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 12' ' ' ASN . 15.8 m -69.21 154.91 41.28 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.596 1.189 . . . . 0.0 111.598 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -128.99 150.56 50.35 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.736 -1.227 . . . . 0.0 110.273 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -134.47 145.4 48.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.339 0.59 . . . . 0.0 112.159 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -129.2 134.75 48.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.767 0.827 . . . . 0.0 109.231 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.31 125.05 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -78.68 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 O-C-N 124.335 1.022 . . . . 0.0 111.199 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.85 30.92 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.83 -0.806 . . . . 0.0 112.407 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.61 132.17 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.337 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 7.6 m-20 -76.52 168.73 19.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.941 0.877 . . . . 0.0 112.521 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 p -56.07 -27.4 53.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -75.64 -34.0 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.539 0.609 . . . . 0.0 112.272 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.65 -10.38 14.26 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.985 -1.453 . . . . 0.0 113.501 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 24' ' ' ASN . 10.1 pt-20 -62.56 140.02 58.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.358 2.263 . . . . 0.0 108.991 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.86 147.57 24.34 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 p -107.39 169.31 8.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.566 1.147 . . . . 0.0 109.78 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.04 -168.2 37.18 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.377 -1.452 . . . . 0.0 114.905 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.536 ' HB ' HD11 ' A' ' 46' ' ' LEU . 5.2 p -140.53 129.56 23.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.375 1.084 . . . . 0.0 111.975 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.29 137.79 48.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.12 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.5 mt -127.22 127.43 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 44' ' ' ILE 0.264 73.7 m -105.06 133.0 50.57 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 125.051 1.34 . . . . 0.0 112.986 -172.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.51 27.63 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.46 146.79 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.016 1.327 . . . . 0.0 112.092 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.02 161.69 42.23 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.817 -1.177 . . . . 0.0 111.407 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.98 -29.07 55.36 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 122.037 -0.414 . . . . 0.0 110.353 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -143.02 78.95 14.88 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 127.338 2.255 . . . . 0.0 110.215 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.15 21.28 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.336 1 C-N-CA 125.474 4.116 . . . . 0.0 117.415 -174.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.6 -7.13 5.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 119.289 2.476 . . . . 0.0 119.289 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.93 43.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.686 1.743 . . . . 0.0 111.38 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 35' ' ' THR . 71.5 mt -51.21 125.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.34 -1.475 . . . . 0.0 111.272 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.63 30.4 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.692 1.597 . . . . 0.0 110.389 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.3 tp -46.71 115.37 1.03 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.971 2.909 . . . . 0.0 110.738 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 t -102.76 119.36 55.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.493 0.717 . . . . 0.0 109.554 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -55.86 142.66 83.79 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.261 2.641 . . . . 0.0 111.431 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.54 154.81 47.42 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 124.017 0.823 . . . . 0.0 111.017 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -156.54 148.75 23.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.736 1.614 . . . . 0.0 110.574 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.21 -157.55 29.43 Favored Glycine 0 C--N 1.333 0.405 0 O-C-N 119.738 -1.851 . . . . 0.0 110.641 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.3 mt -142.7 142.01 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.681 0.792 . . . . 0.0 112.836 -174.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.44 136.91 47.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.0 151.12 44.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.671 1.225 . . . . 0.0 112.105 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -151.33 26.95 0.68 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.352 1.861 . . . . 0.0 110.019 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.41 -57.04 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.881 1.672 . . . . 0.0 110.065 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.26 7.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.301 0.64 . . . . 0.0 112.08 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 p -95.19 -17.95 21.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 117.329 -1.32 . . . . 0.0 113.754 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -131.6 45.4 1.71 Allowed Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.895 1.278 . . . . 0.0 112.364 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 171.38 17.28 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.7 2.266 . . . . 0.0 115.452 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.298 0.1 OUTLIER -98.81 163.81 12.47 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.747 1.737 . . . . 0.0 111.199 173.156 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -158.34 166.11 33.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.911 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.6 145.12 10.12 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 118.999 2.359 . . . . 0.0 118.999 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -161.41 153.65 19.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -90.15 149.18 22.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.548 1.939 . . . . 0.0 110.314 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -128.17 118.53 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' D' ' 52' ' ' ILE . 21.3 t30 -101.67 101.81 12.38 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.449 -0.782 . . . . 0.0 110.429 -174.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -58.69 129.43 42.08 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.49 -32.29 16.42 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -99.8 -11.96 20.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.35 138.01 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.944 2.098 . . . . 0.0 106.728 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -73.45 118.62 16.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.59 1.186 . . . . 0.0 111.254 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.67 159.77 2.37 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.591 1.556 . . . . 0.0 109.604 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -136.58 134.66 37.66 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.4 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.887 HG23 HD12 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -123.02 138.0 54.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 174.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.78 155.2 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -130.96 143.99 51.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.078 0.951 . . . . 0.0 108.844 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.47 118.98 8.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.32 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.73 176.68 44.83 Favored Glycine 0 C--O 1.215 -1.077 0 N-CA-C 118.196 2.038 . . . . 0.0 118.196 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' D' ' 103' ' ' VAL . 0.0 OUTLIER -101.71 150.5 23.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.47 115.14 27.21 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.445 1.716 . . . . 0.0 107.086 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB2' HD12 ' D' ' 106' ' ' ILE . 25.5 m-85 -105.64 159.21 16.14 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.761 1.164 . . . . 0.0 113.266 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 16.0 mt -120.02 109.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 113.519 -1.673 . . . . 0.0 106.9 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.86 161.41 4.91 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -22.71 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -10.31 48.88 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.689 0.796 . . . . 0.0 112.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.75 6.44 56.24 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.487 1.042 . . . . 0.0 114.851 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 19.6 mtpp -73.82 165.51 24.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.773 1.286 . . . . 0.0 110.153 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.62 143.42 49.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.738 1.615 . . . . 0.0 111.473 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.543 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.51 153.17 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.09 0.956 . . . . 0.0 110.891 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.5 mt -116.46 103.59 10.59 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' CD ' HG11 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -97.06 114.45 26.09 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -133.26 164.54 26.85 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.216 1.484 . . . . 0.0 112.227 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' D' ' 113' ' ' THR . 92.9 mmm -115.29 167.87 10.47 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -139.07 163.87 31.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 0.0 113.423 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD12 HD12 ' D' ' 98' ' ' LEU . 0.4 OUTLIER -142.91 124.66 15.02 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.05 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.887 HD12 HG23 ' A' ' 77' ' ' THR . 1.7 tp -107.15 131.97 53.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.634 1.683 . . . . 0.0 109.036 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.2 tpt85 -114.79 113.67 24.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 111.036 -2.802 . . . . 0.0 109.232 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.271 1.0 OUTLIER -68.26 165.98 17.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.447 . . . . 0.0 111.688 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.1 t -107.3 86.95 2.39 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 121.465 1.939 . . . . 0.0 107.775 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.527 ' H ' ' NE2' ' D' ' 82' ' ' GLN . 8.1 p -86.66 157.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 129.294 3.038 . . . . 0.0 110.96 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -96.84 -34.14 11.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.47 148.84 32.28 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.777 0.799 . . . . 0.0 112.685 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' D' ' 84' ' ' PHE . 4.6 tt -62.37 -29.58 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.851 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.63 5.26 38.92 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' A' ' 103' ' ' VAL . 4.7 m-20 -123.4 0.03 8.82 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.333 1.567 . . . . 0.0 113.6 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -28.8 69.32 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.49 -1.381 . . . . 0.0 113.77 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.681 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 62.5 p-90 -49.64 -44.39 47.45 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.946 0.898 . . . . 0.0 113.223 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.681 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -87.63 -12.72 44.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.252 -0.905 . . . . 0.0 113.223 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 -0.69 26.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.513 -0.742 . . . . 0.0 112.247 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.608 HG21 ' HG3' ' D' ' 96' ' ' MET . 35.2 m -110.22 139.84 44.96 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.348 1.059 . . . . 0.0 111.054 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.23 132.96 22.39 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.737 1.215 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -112.31 154.66 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 120.275 1.398 . . . . 0.0 110.961 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -174.45 27.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.938 0.78 . . . . 0.0 114.728 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 9.7 p90 -128.43 156.65 42.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.209 1.004 . . . . 0.0 112.209 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -152.16 150.23 29.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.243 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 94' ' ' LYS . 9.0 mt -126.66 121.13 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.67 149.49 34.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.6 p -138.8 165.02 28.1 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.62 117.0 2.79 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.649 0.78 . . . . 0.0 110.546 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.0 tt . . . . . 0 C--O 1.23 0.068 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 t -133.04 142.81 48.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.669 0.787 . . . . 0.0 110.964 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.02 135.88 33.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.155 1.782 . . . . 0.0 108.801 174.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.51 -24.78 60.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.045 1.293 . . . . 0.0 113.858 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 115.73 1.7 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.94 1.296 . . . . 0.0 111.08 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.91 -125.72 3.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.982 1.277 . . . . 0.0 110.382 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -147.48 145.81 29.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -143.51 159.85 41.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -140.26 149.21 42.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' D' ' 16' ' ' SER . 24.6 p30 -113.88 160.15 19.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -56.24 -26.07 50.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.127 2.571 . . . . 0.0 114.912 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' B' ' 110' ' ' TRP . 29.1 tp -76.48 -11.04 59.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.793 1.237 . . . . 0.0 112.074 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.17 -15.21 56.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.832 2.158 . . . . 0.0 112.994 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . 0.432 ' HB2' HD21 ' D' ' 12' ' ' ASN . 15.4 m -69.76 154.75 41.54 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.64 1.21 . . . . 0.0 111.643 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.02 151.23 49.94 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.576 -1.327 . . . . 0.0 110.677 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -134.3 146.78 50.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -130.27 134.85 47.53 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.662 0.785 . . . . 0.0 109.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.75 124.18 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.91 -75.86 0.39 Allowed Glycine 0 CA--C 1.527 0.827 0 O-C-N 124.339 1.024 . . . . 0.0 111.394 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.85 156.99 42.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.561 0.695 . . . . 0.0 111.931 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.5 131.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.052 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -77.99 168.57 19.69 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.833 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 61.8 p -57.08 -26.65 60.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -75.04 -30.2 60.99 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.253 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.02 -8.24 18.86 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 124.666 1.127 . . . . 0.0 114.154 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.49 147.72 51.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.51 2.324 . . . . 0.0 113.683 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . 0.501 ' O ' HD12 ' D' ' 50' ' ' LEU . 52.2 p90 -156.56 161.61 39.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.023 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . 0.414 HG22 HD13 ' D' ' 50' ' ' LEU . 3.0 p -119.2 172.72 7.39 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 173.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.4 -167.26 35.43 Favored Glycine 0 N--CA 1.467 0.756 0 O-C-N 119.349 -2.095 . . . . 0.0 114.143 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.531 ' HB ' HD11 ' D' ' 46' ' ' LEU . 5.0 p -139.52 129.24 24.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.482 1.134 . . . . 0.0 112.301 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -111.86 138.04 49.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.268 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 80.7 mt -127.16 127.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.424 ' O ' HG21 ' D' ' 44' ' ' ILE 0.264 90.5 m -105.1 133.82 49.23 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.816 1.246 . . . . 0.0 112.849 -172.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.65 -16.51 26.9 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 m -135.5 147.05 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.065 1.346 . . . . 0.0 112.167 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.4 161.04 42.71 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.806 -1.184 . . . . 0.0 111.74 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -76.22 -28.76 57.31 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.881 -0.512 . . . . 0.0 110.587 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -143.18 78.95 14.66 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.278 2.231 . . . . 0.0 110.311 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 21.09 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.316 1 C-N-CA 125.44 4.093 . . . . 0.0 117.403 -174.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.46 -7.04 5.17 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.15 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.136 1.774 . . . . 0.0 111.392 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.424 HG21 ' O ' ' D' ' 35' ' ' THR . 71.2 mt -51.05 126.31 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.303 -1.498 . . . . 0.0 111.288 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.73 164.66 31.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.606 1.562 . . . . 0.0 110.426 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.531 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.4 tp -46.55 115.36 1.01 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.918 2.887 . . . . 0.0 110.562 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.8 t -103.2 118.63 57.44 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 123.607 0.763 . . . . 0.0 109.221 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.89 141.71 85.26 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.015 2.476 . . . . 0.0 111.094 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . 0.41 ' C ' HD12 ' D' ' 49' ' ' LEU . 2.2 pp -129.76 162.18 29.02 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.199 0.999 . . . . 0.0 111.428 174.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.501 HD12 ' O ' ' D' ' 29' ' ' PHE . 18.7 tp -165.5 148.83 8.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.703 1.201 . . . . 0.0 112.104 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.72 25.77 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 121.227 1.83 . . . . 0.0 110.456 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.4 mt -145.19 141.83 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.878 0.987 . . . . 0.0 111.591 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 133.62 43.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.988 1.315 . . . . 0.0 114.515 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -67.31 147.31 53.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.443 1.116 . . . . 0.0 112.208 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -146.06 27.76 1.15 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.614 1.965 . . . . 0.0 110.127 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.12 -57.28 2.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.629 1.572 . . . . 0.0 110.133 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 175.31 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.527 0.731 . . . . 0.0 112.5 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 p -91.76 -20.59 21.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.673 1.189 . . . . 0.0 113.706 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -133.29 46.14 1.94 Allowed Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 125.227 1.411 . . . . 0.0 112.989 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.76 170.51 19.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.692 2.261 . . . . 0.0 116.006 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.296 0.0 OUTLIER -97.89 161.98 13.47 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 124.023 1.868 . . . . 0.0 111.465 173.092 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.09 166.37 33.48 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.369 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.86 145.52 10.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 118.656 2.223 . . . . 0.0 118.656 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -161.91 152.98 18.04 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -89.44 151.15 22.17 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.62 1.968 . . . . 0.0 110.268 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 70.9 t -130.28 119.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.451 ' CB ' HG21 ' A' ' 52' ' ' ILE . 21.3 t30 -103.0 102.11 12.14 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 110.426 -174.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -58.43 129.8 43.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 124.071 1.891 . . . . 0.0 115.216 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.22 -31.58 16.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.57 -11.95 19.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 138.34 18.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.999 2.12 . . . . 0.0 106.484 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.85 118.69 17.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 43.1 t -175.66 160.04 2.41 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.486 1.514 . . . . 0.0 109.558 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.39 134.71 38.08 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.594 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.893 HG23 HD12 ' D' ' 99' ' ' LEU . 0.9 OUTLIER -122.97 138.58 54.64 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.371 174.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.69 155.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -131.29 143.65 50.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.081 0.953 . . . . 0.0 108.657 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.61 118.25 8.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.444 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -170.86 176.05 44.4 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 118.185 2.034 . . . . 0.0 118.185 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -101.76 150.42 23.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.943 1.025 . . . . 0.0 113.491 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 12.6 p -97.51 118.41 33.95 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.193 -1.821 . . . . 0.0 106.633 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.653 ' HB2' HD12 ' A' ' 106' ' ' ILE . 20.4 m-85 -110.01 155.35 21.94 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.662 1.119 . . . . 0.0 113.849 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 10.4 mt -115.55 110.33 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.477 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -58.81 162.02 4.39 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -23.38 1.3 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -4.57 57.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.68 0.792 . . . . 0.0 112.692 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.86 61.85 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.035 1.302 . . . . 0.0 114.977 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 22.0 mtpp -77.32 165.92 23.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.927 1.363 . . . . 0.0 110.505 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -122.06 145.12 48.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.02 1.328 . . . . 0.0 111.212 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.534 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -144.5 154.19 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.381 1.072 . . . . 0.0 110.64 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.98 103.81 10.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.534 ' CD ' HG11 ' D' ' 92' ' ' VAL . 0.6 OUTLIER -96.85 114.27 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -133.05 164.59 26.68 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 123.003 1.383 . . . . 0.0 112.382 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.608 ' HG3' HG21 ' A' ' 113' ' ' THR . 92.3 mmm -115.19 167.86 10.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -139.06 164.0 30.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.412 1.101 . . . . 0.0 113.43 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.445 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.4 OUTLIER -143.1 124.95 15.09 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.922 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . 0.893 HD12 HG23 ' D' ' 77' ' ' THR . 1.9 tp -107.22 132.01 53.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 123.7 1.714 . . . . 0.0 108.964 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -114.7 113.6 24.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 111.067 -2.788 . . . . 0.0 108.985 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.266 1.0 OUTLIER -67.37 165.92 15.51 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 116.875 -1.536 . . . . 0.0 111.888 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 29.7 t -107.81 87.3 2.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 121.775 2.079 . . . . 0.0 107.611 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.56 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 8.0 p -88.09 154.86 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 129.215 3.006 . . . . 0.0 110.993 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -93.5 -33.06 13.93 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.83 150.35 35.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 84' ' ' PHE . 4.6 tt -62.96 -28.83 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.485 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.3 5.75 48.44 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.838 1.208 . . . . 0.0 115.606 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' D' ' 103' ' ' VAL . 4.3 m-20 -123.3 0.42 8.94 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.273 1.536 . . . . 0.0 113.374 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -29.37 69.34 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.387 -1.446 . . . . 0.0 114.226 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.675 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 62.4 p-90 -49.37 -44.75 45.15 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.973 0.909 . . . . 0.0 113.085 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . 0.675 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.0 OUTLIER -87.31 -12.64 45.9 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.04 0.936 . . . . 0.0 113.279 176.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.99 1.12 21.83 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.457 -0.777 . . . . 0.0 112.402 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 96' ' ' MET . 33.9 m -111.56 139.7 46.78 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.33 1.052 . . . . 0.0 111.118 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 114' ' ' ARG . 2.0 mpt_? -144.12 133.35 23.06 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.641 1.176 . . . . 0.0 110.942 175.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.33 154.74 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 120.4 1.455 . . . . 0.0 110.978 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -173.94 27.33 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.006 0.812 . . . . 0.0 114.744 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 10.0 p90 -128.67 156.39 43.53 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.282 1.033 . . . . 0.0 112.241 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -152.18 149.78 29.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.393 1.077 . . . . 0.0 112.144 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . 0.439 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.4 mt -126.47 123.4 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.675 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 148.39 40.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -139.74 167.29 22.44 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 120.74 7.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.675 1.19 . . . . 0.0 112.495 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 118.778 -0.63 . . . . 0.0 109.942 177.599 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tmmt? . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.33 144.0 51.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 111.533 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.06 134.97 32.12 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.827 1.651 . . . . 0.0 109.064 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -73.46 -25.8 60.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.978 1.263 . . . . 0.0 113.683 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.54 115.69 1.45 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 111.069 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.95 -125.6 3.14 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 125.252 1.406 . . . . 0.0 110.334 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -149.58 144.12 26.0 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -142.31 159.44 42.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.577 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 t -138.96 150.36 45.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.424 HD21 ' HB2' ' B' ' 16' ' ' SER . 24.6 p30 -114.84 158.89 21.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.825 1.298 . . . . 0.0 114.347 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -54.53 -26.45 31.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.054 2.542 . . . . 0.0 114.879 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.51 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.4 tp -75.98 -12.06 60.07 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.897 1.279 . . . . 0.0 112.302 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.16 -15.7 50.67 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.132 2.301 . . . . 0.0 112.991 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.424 ' HB2' HD21 ' B' ' 12' ' ' ASN . 15.5 m -69.81 155.26 40.82 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.718 1.247 . . . . 0.0 111.706 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 150.2 50.72 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.639 -1.288 . . . . 0.0 110.511 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -133.63 147.06 51.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.371 0.605 . . . . 0.0 112.626 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -130.67 134.49 46.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.651 0.78 . . . . 0.0 109.469 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 92.9 mt -132.35 125.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -78.89 0.22 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 124.506 1.129 . . . . 0.0 111.208 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.31 152.7 33.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.629 0.728 . . . . 0.0 112.305 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.64 131.94 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.362 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -76.93 168.4 20.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 0.0 112.472 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 62.8 p -55.79 -27.51 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.58 -33.33 60.59 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.596 0.634 . . . . 0.0 112.327 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.86 -10.05 15.87 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 117.961 -1.466 . . . . 0.0 113.682 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.12 139.89 58.82 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.453 2.301 . . . . 0.0 108.861 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.79 148.54 25.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.0 p -108.94 168.4 9.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.809 1.244 . . . . 0.0 109.633 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 -168.58 37.31 Favored Glycine 0 N--CA 1.466 0.692 0 O-C-N 120.27 -1.519 . . . . 0.0 114.983 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.524 ' HB ' HD11 ' B' ' 46' ' ' LEU . 5.8 p -140.5 130.03 24.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.394 1.092 . . . . 0.0 111.765 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -111.46 138.37 48.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.191 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 78.7 mt -127.66 127.77 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.412 ' O ' HG21 ' B' ' 44' ' ' ILE 0.263 82.4 m -105.16 134.02 48.97 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.792 1.237 . . . . 0.0 112.913 -172.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 -15.44 27.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 146.54 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.936 1.294 . . . . 0.0 111.972 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.31 42.7 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.735 -1.228 . . . . 0.0 111.489 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.48 -29.21 56.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.058 -0.401 . . . . 0.0 110.408 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -142.84 79.18 15.02 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.336 2.254 . . . . 0.0 110.292 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.17 20.55 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.377 1 C-N-CA 125.389 4.06 . . . . 0.0 117.406 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.67 -8.16 5.19 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.99 43.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.702 1.751 . . . . 0.0 111.335 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.412 HG21 ' O ' ' B' ' 35' ' ' THR . 70.3 mt -51.12 125.65 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.346 -1.471 . . . . 0.0 111.35 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.17 164.48 31.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.595 1.558 . . . . 0.0 110.449 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' B' ' 32' ' ' THR . 13.3 tp -46.49 115.41 1.02 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 129.005 2.922 . . . . 0.0 110.753 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.1 t -103.17 119.83 54.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.544 0.738 . . . . 0.0 109.268 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.03 142.55 85.45 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.363 2.708 . . . . 0.0 111.385 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.38 154.92 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.119 0.887 . . . . 0.0 110.89 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.73 148.72 22.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.621 1.568 . . . . 0.0 110.364 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.0 -158.07 29.97 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 121.25 1.841 . . . . 0.0 110.691 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.3 mt -142.64 141.95 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.571 0.748 . . . . 0.0 112.749 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.57 135.01 45.65 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -69.45 149.13 48.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.8 1.286 . . . . 0.0 112.249 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -148.8 27.1 0.89 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.475 1.91 . . . . 0.0 109.841 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.71 -56.55 2.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.522 1.529 . . . . 0.0 109.721 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.89 173.64 10.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.784 0.802 . . . . 0.0 112.88 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -88.85 -23.27 22.84 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 113.505 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -131.88 48.31 3.52 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.255 1.422 . . . . 0.0 113.315 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.82 171.64 17.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.328 2.019 . . . . 0.0 115.58 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.294 0.1 OUTLIER -98.14 163.07 12.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 123.775 1.75 . . . . 0.0 111.368 173.147 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -157.92 165.74 34.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.049 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 145.6 10.63 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 118.988 2.355 . . . . 0.0 118.988 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -161.59 153.94 19.91 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -89.92 149.46 22.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.651 1.98 . . . . 0.0 110.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -128.52 118.73 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' C' ' 52' ' ' ILE . 21.6 t30 -101.81 101.83 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.477 -0.764 . . . . 0.0 110.587 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.9 129.43 42.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 123.853 1.787 . . . . 0.0 115.311 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.62 -32.25 16.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -100.07 -11.92 20.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.5 t -152.46 138.0 17.74 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.807 2.043 . . . . 0.0 106.432 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.8 118.58 16.92 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.618 1.199 . . . . 0.0 111.406 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -175.34 159.99 2.56 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.624 1.57 . . . . 0.0 109.625 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.64 134.47 37.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.293 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.882 HG23 HD12 ' B' ' 99' ' ' LEU . 0.8 OUTLIER -122.83 137.67 54.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.45 174.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -109.04 155.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -131.69 144.61 51.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.88 118.49 7.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.705 0.628 . . . . 0.0 109.965 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' NE ' ' C' ' 100' ' ' ARG . . . -170.8 176.42 44.26 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 118.201 2.041 . . . . 0.0 118.201 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.562 ' NE2' ' H ' ' C' ' 103' ' ' VAL . 0.0 OUTLIER -101.77 150.33 23.26 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 125.021 1.071 . . . . 0.0 113.82 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 10.4 p -97.51 117.43 31.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.621 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.668 ' HB2' HD12 ' C' ' 106' ' ' ILE . 17.6 m-85 -108.81 155.15 21.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 119.804 1.184 . . . . 0.0 113.864 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.19 109.57 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.751 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -58.71 164.94 2.48 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.829 0.706 . . . . 0.0 109.594 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.98 -29.93 3.86 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -8.04 56.38 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.405 1.082 . . . . 0.0 113.27 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.95 10.71 58.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.764 1.173 . . . . 0.0 115.534 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -76.6 168.44 20.07 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.06 1.43 . . . . 0.0 108.895 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -124.58 145.06 49.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.192 1.36 . . . . 0.0 110.687 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.53 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.1 t -144.12 153.76 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.197 0.999 . . . . 0.0 111.453 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -117.57 103.32 9.95 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.53 ' CD ' HG11 ' B' ' 92' ' ' VAL . 0.6 OUTLIER -96.8 113.97 25.56 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 173.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -132.8 164.66 26.34 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.099 1.428 . . . . 0.0 112.385 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.623 ' HG3' HG21 ' C' ' 113' ' ' THR . 93.1 mmm -115.73 168.09 10.34 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -139.26 164.14 30.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.637 1.208 . . . . 0.0 113.419 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' C' ' 98' ' ' LEU . 0.4 OUTLIER -142.73 125.05 15.53 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.088 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 77' ' ' THR . 1.7 tp -107.2 131.55 54.05 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 125.412 1.695 . . . . 0.0 109.27 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.405 ' NE ' ' HA2' ' C' ' 81' ' ' GLY . 3.5 tpt85 -114.82 113.65 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 110.847 -2.888 . . . . 0.0 108.947 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.261 0.9 OUTLIER -69.02 164.4 22.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.318 1.447 . . . . 0.0 111.994 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.5 t -105.45 87.95 2.73 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 121.462 1.937 . . . . 0.0 107.703 173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.528 ' H ' ' NE2' ' C' ' 82' ' ' GLN . 7.5 p -88.04 156.04 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 129.215 3.006 . . . . 0.0 111.065 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -95.81 -33.31 12.3 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.28 148.46 34.13 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.64 0.733 . . . . 0.0 112.698 -174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' C' ' 84' ' ' PHE . 4.8 tt -62.4 -29.79 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.588 174.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.88 40.66 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.764 1.173 . . . . 0.0 115.888 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' B' ' 103' ' ' VAL . 4.5 m-20 -122.94 -0.36 9.01 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.319 1.559 . . . . 0.0 113.631 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -28.86 69.22 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.48 -1.387 . . . . 0.0 113.792 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.669 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 62.2 p-90 -49.44 -44.28 45.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.092 0.957 . . . . 0.0 113.311 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.669 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.0 OUTLIER -87.99 -12.56 44.12 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.139 -0.975 . . . . 0.0 113.294 176.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -0.54 25.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.424 0.69 . . . . 0.0 112.342 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' C' ' 96' ' ' MET . 35.5 m -110.1 139.85 44.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.289 1.036 . . . . 0.0 110.799 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' D' ' 114' ' ' ARG . 2.0 mpt_? -144.27 132.6 21.93 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.901 1.28 . . . . 0.0 111.167 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.82 154.59 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 120.213 1.37 . . . . 0.0 110.936 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.04 -174.7 28.08 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.008 0.813 . . . . 0.0 114.733 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 9.8 p90 -128.16 156.59 42.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.222 1.009 . . . . 0.0 112.272 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -152.6 148.88 27.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.299 1.04 . . . . 0.0 112.249 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.433 HD13 ' HE3' ' B' ' 94' ' ' LYS . 9.5 mt -125.31 122.74 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.424 175.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.9 148.68 38.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 28.3 p -140.35 167.78 21.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.32 123.47 16.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.888 -1.132 . . . . 0.0 113.016 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.204 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 45.3 t -132.08 143.63 50.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.828 0.851 . . . . 0.0 111.874 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 135.4 32.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.674 1.99 . . . . 0.0 109.216 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.2 mt -73.41 -24.7 60.31 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.605 1.548 . . . . 0.0 114.283 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -50.79 117.36 2.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.712 1.205 . . . . 0.0 111.237 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.98 -126.38 3.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.239 1.399 . . . . 0.0 110.295 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -147.02 143.42 28.38 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -141.43 158.58 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.682 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -139.07 148.8 43.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' C' ' 16' ' ' SER . 25.0 p30 -113.46 161.03 17.82 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.909 1.338 . . . . 0.0 114.499 175.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -57.69 -25.57 60.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.494 2.718 . . . . 0.0 114.899 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 110' ' ' TRP . 29.6 tp -77.06 -11.02 59.75 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 111.759 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.23 -16.27 53.51 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.945 2.212 . . . . 0.0 112.943 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . 0.434 ' HB2' HD21 ' C' ' 12' ' ' ASN . 15.4 m -69.29 154.58 41.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.598 1.189 . . . . 0.0 111.592 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.1 150.74 50.36 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.613 -1.305 . . . . 0.0 110.558 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.62 145.4 48.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.362 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -129.66 134.06 47.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.52 124.14 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.95 -74.75 0.48 Allowed Glycine 0 CA--C 1.528 0.866 0 O-C-N 124.26 0.975 . . . . 0.0 111.461 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.42 43.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.943 -0.74 . . . . 0.0 111.989 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.52 130.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.192 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -77.13 168.51 19.96 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.877 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 60.2 p -56.64 -26.99 57.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.12 -29.95 60.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.976 0.807 . . . . 0.0 112.395 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.83 -7.87 19.46 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 124.585 1.088 . . . . 0.0 114.339 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.47 148.12 49.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.599 2.36 . . . . 0.0 113.132 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . 0.49 ' O ' HD12 ' C' ' 50' ' ' LEU . 52.3 p90 -156.93 161.51 39.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.982 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.437 HG22 HD13 ' C' ' 50' ' ' LEU . 3.1 p -118.83 172.67 7.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.3 -167.58 35.84 Favored Glycine 0 N--CA 1.469 0.848 0 O-C-N 119.334 -2.104 . . . . 0.0 114.409 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.515 ' HB ' HD11 ' C' ' 46' ' ' LEU . 6.3 p -138.57 129.6 26.85 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.756 1.265 . . . . 0.0 112.446 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -112.05 137.64 49.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.302 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -127.31 127.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.261 90.3 m -105.03 134.46 48.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.842 1.257 . . . . 0.0 112.699 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.87 -15.73 26.07 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.88 146.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 161.19 42.71 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.795 -1.19 . . . . 0.0 111.566 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.51 -29.38 56.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.538 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -142.66 79.15 15.37 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.386 2.275 . . . . 0.0 110.377 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.28 21.04 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.386 1 C-N-CA 125.464 4.109 . . . . 0.0 117.356 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.24 -7.56 5.45 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.52 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.139 1.776 . . . . 0.0 111.439 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.12 126.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.418 -1.426 . . . . 0.0 111.379 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.4 164.67 30.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.614 1.565 . . . . 0.0 110.412 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.515 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -46.55 115.38 1.02 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 129.06 2.944 . . . . 0.0 110.545 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -102.96 119.06 56.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.547 0.739 . . . . 0.0 109.399 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.97 141.06 86.68 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.157 2.571 . . . . 0.0 111.278 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.404 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.4 pp -129.57 162.29 28.56 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.045 174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.49 HD12 ' O ' ' C' ' 29' ' ' PHE . 18.8 tp -165.36 148.82 8.19 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.991 1.717 . . . . 0.0 112.243 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.87 25.96 Favored Glycine 0 N--CA 1.448 -0.544 0 O-C-N 119.795 -1.816 . . . . 0.0 110.606 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.5 mt -145.49 142.25 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.838 0.964 . . . . 0.0 111.739 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 135.32 44.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.155 1.382 . . . . 0.0 114.384 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.88 149.58 47.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.482 1.134 . . . . 0.0 112.373 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -148.72 25.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.577 1.951 . . . . 0.0 110.065 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.88 -56.44 2.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.599 1.56 . . . . 0.0 110.347 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 173.92 8.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.773 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 3.9 p -92.25 -19.14 22.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.87 1.268 . . . . 0.0 113.674 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -133.61 46.31 1.98 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.924 1.29 . . . . 0.0 112.682 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.75 170.64 19.56 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.023 2.482 . . . . 0.0 116.19 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.292 0.0 OUTLIER -97.07 162.59 13.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 123.751 1.738 . . . . 0.0 111.282 173.088 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.55 166.11 33.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.267 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.87 145.71 10.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.95 153.49 18.6 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -89.65 150.99 22.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.765 2.026 . . . . 0.0 110.228 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 78.3 t -130.25 119.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.445 ' CB ' HG21 ' B' ' 52' ' ' ILE . 21.9 t30 -102.83 101.72 11.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -58.43 129.78 43.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.352 1.548 . . . . 0.0 115.137 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.06 -31.8 16.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.38 -11.98 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 32.4 t -152.4 138.09 17.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.827 2.051 . . . . 0.0 106.213 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -74.25 118.61 17.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.591 1.186 . . . . 0.0 111.253 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.03 159.83 2.68 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.557 1.543 . . . . 0.0 109.543 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -135.98 134.66 38.82 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.386 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.859 HG23 HD12 ' C' ' 99' ' ' LEU . 0.9 OUTLIER -123.24 138.53 54.61 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.408 0.623 . . . . 0.0 111.497 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.59 155.33 11.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -131.14 143.68 50.82 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.942 0.897 . . . . 0.0 108.77 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.35 118.45 8.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' B' ' 100' ' ' ARG . . . -170.26 176.64 43.86 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.528 ' NE2' ' H ' ' B' ' 103' ' ' VAL . 0.0 OUTLIER -101.67 150.35 23.2 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.928 1.016 . . . . 0.0 113.517 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 11.6 p -97.52 116.97 30.75 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 125.611 1.819 . . . . 0.0 107.34 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.665 ' HB2' HD12 ' B' ' 106' ' ' ILE . 17.5 m-85 -108.66 156.62 19.35 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.552 1.168 . . . . 0.0 113.604 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 9.7 mt -117.37 110.24 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.174 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -58.69 160.5 5.58 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -24.79 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -9.31 52.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.984 0.914 . . . . 0.0 113.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.18 14.97 49.88 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.673 1.13 . . . . 0.0 115.402 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -82.64 166.29 19.3 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.078 1.439 . . . . 0.0 109.075 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -122.39 145.37 48.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.605 1.548 . . . . 0.0 110.767 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.54 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.1 t -144.24 153.09 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.712 1.205 . . . . 0.0 111.106 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.25 103.65 10.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.54 ' CD ' HG11 ' C' ' 92' ' ' VAL . 0.5 OUTLIER -97.13 112.73 24.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 173.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.68 163.82 27.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.093 1.425 . . . . 0.0 112.383 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' B' ' 113' ' ' THR . 93.4 mmm -114.95 168.23 10.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -139.45 163.84 31.45 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.428 1.109 . . . . 0.0 113.376 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' B' ' 98' ' ' LEU . 0.4 OUTLIER -142.87 124.66 15.06 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.123 175.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . 0.859 HD12 HG23 ' C' ' 77' ' ' THR . 1.9 tp -107.2 131.95 53.59 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 123.769 1.747 . . . . 0.0 108.841 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . 0.41 ' NE ' ' HA2' ' B' ' 81' ' ' GLY . 3.2 tpt85 -114.84 113.57 24.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 110.942 -2.844 . . . . 0.0 109.05 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.19 164.83 19.61 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 116.867 -1.54 . . . . 0.0 111.912 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 88.12 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 121.742 2.065 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . 0.562 ' H ' ' NE2' ' B' ' 82' ' ' GLN . 6.6 p -88.45 155.82 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 129.265 3.026 . . . . 0.0 111.138 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -95.08 -32.77 12.95 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -114.02 149.35 35.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.573 0.701 . . . . 0.0 112.671 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' B' ' 84' ' ' PHE . 4.8 tt -62.53 -30.22 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.795 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.65 5.28 38.94 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.598 1.094 . . . . 0.0 115.777 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' C' ' 103' ' ' VAL . 4.6 m-20 -123.09 0.08 9.01 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.361 1.581 . . . . 0.0 113.735 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.92 69.17 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.365 -1.459 . . . . 0.0 113.806 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.676 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 62.5 p-90 -49.65 -44.24 47.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.87 0.868 . . . . 0.0 113.214 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . 0.676 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.0 OUTLIER -88.16 -12.6 43.49 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.097 -1.002 . . . . 0.0 113.347 176.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 1.48 18.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.708 0.803 . . . . 0.0 112.577 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.623 HG21 ' HG3' ' B' ' 96' ' ' MET . 33.9 m -112.68 139.61 48.15 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.436 1.094 . . . . 0.0 111.207 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -144.26 133.01 22.41 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.656 1.183 . . . . 0.0 110.94 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.13 154.79 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.364 1.438 . . . . 0.0 110.897 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.39 -174.29 27.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.908 0.766 . . . . 0.0 114.76 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 10.0 p90 -128.41 156.72 42.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.219 1.008 . . . . 0.0 112.294 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -152.23 148.67 27.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 112.298 173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' C' ' 94' ' ' LYS . 9.4 mt -124.94 122.2 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.522 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 148.87 37.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.843 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 45.6 p -138.84 167.43 22.04 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.69 122.54 13.05 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.4 -0.813 . . . . 0.0 111.735 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.309 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.14 154.67 51.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.72 1.208 . . . . 0.0 108.382 173.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.91 129.92 24.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.009 -1.057 . . . . 0.0 111.597 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.1 -25.17 67.98 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -54.56 120.25 6.41 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 123.355 1.55 . . . . 0.0 112.562 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.9 -110.92 1.04 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.979 2.228 . . . . 0.0 110.242 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HD2' HD13 ' A' ' 123' ' ' LEU . 18.4 ttmt -152.99 152.1 31.02 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.73 -0.865 . . . . 0.0 113.271 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -140.16 156.33 46.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.801 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.62 146.64 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.394 177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -116.72 143.33 45.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 111.238 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.04 -24.99 57.81 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.58 1.552 . . . . 0.0 113.825 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 37' ' ' VAL . 40.5 tp -67.31 -15.94 63.98 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 120.735 -1.228 . . . . 0.0 111.821 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.09 -9.46 42.98 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 127.645 2.545 . . . . 0.0 113.242 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.4 147.99 52.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.228 -1.16 . . . . 0.0 111.925 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -126.62 151.42 48.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.198 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.41 147.33 33.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -127.97 134.98 49.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.787 0.835 . . . . 0.0 110.291 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.67 121.01 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.13 -65.17 2.7 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.671 1.232 . . . . 0.0 113.291 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.68 137.71 4.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -84.45 137.67 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.76 163.5 27.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.826 0.451 . . . . 0.0 111.348 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -23.69 50.39 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -27.35 63.79 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.137 -0.977 . . . . 0.0 111.165 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.11 48.78 Favored Glycine 0 C--O 1.224 -0.512 0 CA-C-O 117.577 -1.68 . . . . 0.0 112.958 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -70.99 144.6 50.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.779 1.289 . . . . 0.0 108.547 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -156.03 155.77 33.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.682 0.753 . . . . 0.0 112.307 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.405 ' HB ' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -127.75 158.71 36.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.395 1.878 . . . . 0.0 108.267 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.32 -170.67 34.92 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.97 -1.081 . . . . 0.0 114.747 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.416 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 35.6 p -137.53 126.23 23.84 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.696 ' C ' HD12 ' A' ' 34' ' ' ILE . 1.4 t80 -126.52 133.14 51.21 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.05 -172.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 46' ' ' LEU . 1.4 mp -121.48 135.61 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 37' ' ' VAL . 50.1 m -115.77 131.0 57.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.36 3.86 50.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 35' ' ' THR . 26.9 m -141.34 162.28 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 128.116 2.566 . . . . 0.0 108.444 -175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.46 10.51 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.893 -1.754 . . . . 0.0 111.842 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.64 -24.69 61.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.287 0.235 . . . . 0.0 110.603 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.35 84.01 4.43 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 175.95 8.72 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.815 3.01 . . . . 0.0 112.905 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.51 -33.03 2.83 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.738 1.161 . . . . 0.0 111.981 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -132.77 20.71 4.2 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 35' ' ' THR . 42.4 mt -54.16 127.87 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 122.025 0.916 . . . . 0.0 109.233 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.0 177.12 8.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.655 1.982 . . . . 0.0 107.538 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.763 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -49.0 146.1 3.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.185 172.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -124.55 113.17 27.43 Favored Pre-proline 0 N--CA 1.426 -1.629 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.674 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.75 134.63 65.69 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.237 1.958 . . . . 0.0 109.668 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.32 151.26 46.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.429 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -143.3 149.13 37.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.853 2.461 . . . . 0.0 108.012 175.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.2 -160.79 34.57 Favored Glycine 0 N--CA 1.452 -0.267 0 O-C-N 120.75 -1.219 . . . . 0.0 111.019 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.8 mt -144.58 145.57 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 111.942 -174.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.662 -1.274 . . . . 0.0 113.108 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -86.81 141.85 28.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.654 1.216 . . . . 0.0 111.191 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HB2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -139.52 29.64 2.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.029 1.332 . . . . 0.0 112.138 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -93.06 -55.05 3.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.644 2.377 . . . . 0.0 111.405 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -179.9 5.9 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -81.77 -39.27 24.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.192 1.397 . . . . 0.0 112.888 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -132.61 46.4 2.13 Favored Pre-proline 0 CA--C 1.568 1.636 0 O-C-N 125.416 1.698 . . . . 0.0 111.473 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.55 177.02 5.84 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.359 2.039 . . . . 0.0 114.676 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.326 0.1 OUTLIER -100.95 169.62 8.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 122.54 1.162 . . . . 0.0 111.603 174.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -162.63 164.18 26.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.393 -173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.39 147.78 13.73 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.836 2.294 . . . . 0.0 118.836 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -161.0 150.5 17.0 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -89.1 147.84 24.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.906 1.682 . . . . 0.0 108.21 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.8 t -129.21 119.72 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.493 ' CB ' HG21 ' D' ' 52' ' ' ILE . 38.8 t30 -102.87 102.05 12.13 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.372 -173.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -69.18 125.36 26.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 121.249 1.84 . . . . 0.0 115.684 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -81.3 -37.35 28.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.435 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.08 -22.29 36.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.603 1.161 . . . . 0.0 113.65 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.43 124.07 7.84 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.59 1.556 . . . . 0.0 108.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -60.78 115.27 3.54 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.595 1.089 . . . . 0.0 111.722 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 p -172.52 158.78 4.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.974 2.109 . . . . 0.0 110.03 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -143.47 142.5 31.2 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-O 123.175 1.464 . . . . 0.0 110.427 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 128.74 20.67 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 109.965 -3.289 . . . . 0.0 109.838 -171.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.54 154.05 6.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.773 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -128.99 141.66 51.18 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -151.82 118.25 5.66 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.36 -175.44 34.34 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.658 -1.258 . . . . 0.0 115.388 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -126.97 147.2 50.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.235 1.017 . . . . 0.0 112.196 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.41 127.25 43.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.44 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.3 m-85 -120.13 166.34 13.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.531 0.681 . . . . 0.0 112.461 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 39.6 mt -127.33 109.03 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.552 -1.658 . . . . 0.0 107.098 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.97 162.34 4.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.392 0.677 . . . . 0.0 110.162 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.42 -32.3 1.32 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.32 -21.09 53.99 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.88 19.98 11.25 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.851 1.215 . . . . 0.0 114.572 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 mtpt -90.66 153.24 20.44 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.1 1.36 . . . . 0.0 111.559 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.14 134.92 43.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.634 1.574 . . . . 0.0 110.257 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -142.16 160.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 122.13 0.967 . . . . 0.0 108.819 174.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.1 mt -124.15 119.06 28.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -106.59 117.77 34.93 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.3 167.27 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.974 1.369 . . . . 0.0 112.554 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -119.36 170.49 9.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -140.55 159.06 43.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.446 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.435 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.5 tp -134.38 121.98 21.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.406 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER -107.46 135.89 48.18 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 124.961 1.413 . . . . 0.0 112.055 -176.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.98 113.9 23.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 111.857 -2.429 . . . . 0.0 110.167 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -69.82 166.8 18.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.384 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -112.41 85.44 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.44 -161.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.33 -13.64 1.02 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.709 -1.869 . . . . 0.0 114.281 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.06 151.1 49.06 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.298 1.047 . . . . 0.0 111.931 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.454 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.9 tt -59.27 -25.49 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.117 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.65 -1.87 19.05 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.193 1.378 . . . . 0.0 114.761 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.0 7.11 6.6 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.138 0.969 . . . . 0.0 112.346 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.57 -32.14 73.66 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 119.443 -2.036 . . . . 0.0 112.866 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.462 ' CD1' HD11 ' C' ' 14' ' ' LEU . 57.8 p-90 -47.67 -40.82 20.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.789 1.235 . . . . 0.0 114.036 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -95.19 -11.61 27.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.403 1.081 . . . . 0.0 113.503 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.17 -0.8 20.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.975 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.61 143.72 42.02 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.432 1.11 . . . . 0.0 111.056 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -142.06 153.78 44.45 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.471 1.509 . . . . 0.0 109.572 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.98 151.19 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.395 1.078 . . . . 0.0 109.903 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.44 -176.69 29.77 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 121.453 0.474 . . . . 0.0 112.104 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 33.6 p90 -124.92 152.03 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.507 0.723 . . . . 0.0 109.98 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -144.53 152.41 40.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.938 0.875 . . . . 0.0 109.301 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt -128.92 135.13 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.93 148.07 45.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -132.01 158.64 40.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.099 0.96 . . . . 0.0 110.655 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.05 118.8 6.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.646 0.779 . . . . 0.0 111.641 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 123' ' ' LEU . 4.2 tt . . . . . 0 C--O 1.238 0.496 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.771 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? . . . . . 0 C--O 1.225 -0.185 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . 0.428 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 22.1 p -143.67 143.54 31.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.633 1.973 . . . . 0.0 107.8 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.83 128.78 23.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.59 -1.319 . . . . 0.0 112.269 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.4 -25.59 68.35 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -53.0 119.27 4.47 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.204 1.478 . . . . 0.0 112.459 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.82 -110.69 1.02 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.841 2.162 . . . . 0.0 110.865 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -152.59 151.86 31.14 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -141.33 158.76 43.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.709 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -133.86 149.04 51.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.57 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -116.19 143.33 45.65 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.904 0.881 . . . . 0.0 110.737 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -58.74 -23.16 59.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.015 1.326 . . . . 0.0 113.475 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.48 HD21 HG21 ' D' ' 37' ' ' VAL . 42.4 tp -67.85 -15.94 63.86 Favored 'General case' 0 CA--C 1.555 1.16 0 O-C-N 120.543 -1.348 . . . . 0.0 111.398 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.34 -9.38 42.02 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.65 2.548 . . . . 0.0 113.372 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -66.42 148.25 52.14 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 121.213 -1.169 . . . . 0.0 111.792 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -127.02 151.16 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.196 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 147.35 33.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -127.53 135.96 51.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.761 0.824 . . . . 0.0 109.947 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.68 119.96 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.68 -64.39 3.34 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.58 1.175 . . . . 0.0 113.25 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.56 141.36 4.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.213 1.405 . . . . 0.0 110.214 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.17 136.36 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 122.505 0.322 . . . . 0.0 110.239 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.45 163.59 27.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.275 0.63 . . . . 0.0 111.186 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -21.98 54.05 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -25.45 62.37 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.161 -0.962 . . . . 0.0 111.221 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.89 51.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.248 1.404 . . . . 0.0 113.247 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 150.76 44.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.017 0.927 . . . . 0.0 110.42 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.52 166.34 33.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.347 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . 0.479 ' HB ' HD22 ' D' ' 50' ' ' LEU . 0.5 OUTLIER -134.28 160.82 36.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.444 1.898 . . . . 0.0 106.775 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.44 -170.78 35.91 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.418 -1.426 . . . . 0.0 114.599 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.414 ' HB ' ' HG ' ' D' ' 46' ' ' LEU . 35.2 p -138.22 126.62 23.21 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.408 0.623 . . . . 0.0 109.341 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . 0.691 ' C ' HD12 ' D' ' 34' ' ' ILE . 1.4 t80 -126.96 133.42 50.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.935 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.76 HD11 ' CD1' ' D' ' 46' ' ' LEU . 1.5 mp -121.46 136.28 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.69 HG22 ' O ' ' D' ' 37' ' ' VAL . 43.4 m -116.77 130.24 56.6 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 3.24 53.63 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.69 ' O ' HG22 ' D' ' 35' ' ' THR . 27.5 m -141.44 162.22 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 128.085 2.554 . . . . 0.0 108.141 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.38 10.2 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.015 -1.678 . . . . 0.0 111.738 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.52 -24.05 61.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.311 0.244 . . . . 0.0 110.652 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -154.14 83.43 4.21 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 127.277 2.231 . . . . 0.0 109.254 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.69 176.04 8.74 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.553 2.835 . . . . 0.0 112.805 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.02 -33.21 2.86 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.765 1.174 . . . . 0.0 112.33 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -132.59 20.62 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.93 1.292 . . . . 0.0 112.403 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.53 HG21 ' O ' ' D' ' 35' ' ' THR . 43.3 mt -54.18 127.7 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.236 1.017 . . . . 0.0 109.247 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.01 177.21 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.49 1.916 . . . . 0.0 107.273 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.76 ' CD1' HD11 ' D' ' 34' ' ' ILE . 0.8 OUTLIER -48.99 146.65 3.23 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.218 172.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -125.0 112.98 26.72 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 112.118 -2.31 . . . . 0.0 110.506 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -56.09 132.52 52.45 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.17 1.914 . . . . 0.0 109.263 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.32 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.274 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' D' ' 30' ' ' THR . 0.3 OUTLIER -148.42 149.22 31.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.866 2.466 . . . . 0.0 108.066 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.66 -160.24 32.58 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 121.287 -0.883 . . . . 0.0 112.781 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.493 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -144.94 145.06 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.384 1.074 . . . . 0.0 112.374 -174.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . 0.544 HE22 ' HB2' ' D' ' 57' ' ' LYS . 0.3 OUTLIER -132.01 150.97 52.01 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.626 -1.296 . . . . 0.0 112.843 175.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.38 141.66 28.47 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.696 0.76 . . . . 0.0 110.399 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . 0.544 ' HB2' HE22 ' D' ' 53' ' ' GLN . 1.0 OUTLIER -138.96 29.84 2.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.983 1.313 . . . . 0.0 112.517 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -92.93 -55.21 3.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.01 2.524 . . . . 0.0 111.399 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -78.95 -39.78 33.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.821 1.648 . . . . 0.0 113.037 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.34 50.14 4.7 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 125.244 1.417 . . . . 0.0 111.429 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 176.78 6.39 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.351 2.7 . . . . 0.0 115.223 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -102.23 168.79 9.13 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.732 1.253 . . . . 0.0 111.435 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -162.22 163.48 28.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.881 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.18 148.05 14.85 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 118.646 2.218 . . . . 0.0 118.646 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -161.63 149.86 15.3 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.93 149.09 23.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.259 1.823 . . . . 0.0 108.238 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.62 121.47 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.492 ' CB ' HG21 ' A' ' 52' ' ' ILE . 37.6 t30 -104.88 102.31 11.85 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.988 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -68.92 124.47 23.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -80.14 -36.81 34.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.623 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -82.6 -22.01 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 113.591 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 35.2 t -152.55 124.63 8.04 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.544 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -60.86 115.44 3.69 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.897 1.226 . . . . 0.0 111.509 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 9.4 p -172.74 158.94 4.14 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.129 2.172 . . . . 0.0 110.125 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -143.62 142.42 31.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 123.036 1.398 . . . . 0.0 110.296 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -141.8 128.54 20.42 Favored 'General case' 0 N--CA 1.402 -2.825 0 CA-C-N 110.173 -3.194 . . . . 0.0 109.971 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.95 154.41 5.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.773 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -129.65 141.35 50.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . 0.435 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -151.58 118.22 5.74 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.95 -175.25 34.66 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.49 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -127.61 144.91 51.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.704 0.885 . . . . 0.0 112.421 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.428 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 36.8 t -97.81 123.63 41.85 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.623 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.4 m-85 -115.69 167.26 11.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 118.45 0.568 . . . . 0.0 111.692 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 30.6 mt -126.21 107.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 O-C-N 125.293 1.62 . . . . 0.0 106.741 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -58.99 160.56 5.86 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -44.22 -31.74 1.08 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 118.193 2.664 . . . . 0.0 118.193 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -76.3 -21.94 55.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.26 1.85 29.67 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.111 1.339 . . . . 0.0 115.592 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -74.09 153.66 39.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.257 1.423 . . . . 0.0 112.578 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.38 135.44 42.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.265 1.826 . . . . 0.0 109.964 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.454 HG21 ' CD1' ' A' ' 106' ' ' ILE . 20.6 m -141.97 160.08 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.029 0.931 . . . . 0.0 109.663 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -122.69 118.64 28.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -106.76 117.74 34.84 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 167.95 20.41 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.05 1.405 . . . . 0.0 112.69 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -120.06 170.57 9.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 p-90 -140.57 159.51 42.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.561 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.437 HD23 ' OG1' ' A' ' 80' ' ' THR . 3.4 tp -134.93 121.86 21.12 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.526 175.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.37 136.01 47.89 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 125.061 1.476 . . . . 0.0 111.767 -176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -117.12 113.82 22.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.288 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 71.3 m -69.55 167.04 17.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.404 174.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 2.0 p -112.37 86.11 2.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.99 -160.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -140.36 -13.19 1.03 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 119.561 -1.962 . . . . 0.0 114.093 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.57 152.13 48.66 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.565 1.174 . . . . 0.0 112.356 174.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.0 tt -59.82 -24.87 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.982 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.93 -1.13 23.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.245 1.402 . . . . 0.0 114.935 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -127.12 6.34 6.49 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.119 0.968 . . . . 0.0 111.916 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.16 -31.79 73.15 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 119.327 -2.108 . . . . 0.0 113.067 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.456 ' CD1' HD11 ' B' ' 14' ' ' LEU . 58.1 p-90 -47.33 -41.61 19.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.343 1.057 . . . . 0.0 113.768 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -94.89 -11.47 28.65 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.403 1.081 . . . . 0.0 113.131 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.02 -1.13 21.35 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.311 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -111.21 143.8 41.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.318 1.056 . . . . 0.0 111.129 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -142.16 153.65 44.23 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.328 1.451 . . . . 0.0 109.486 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.88 151.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.464 1.106 . . . . 0.0 109.724 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.59 -177.23 30.5 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.505 0.503 . . . . 0.0 112.169 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 32.7 p90 -124.28 152.21 43.3 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.901 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -145.16 151.6 38.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.554 0.742 . . . . 0.0 109.46 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 59.7 mt -128.47 136.03 61.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -123.98 148.5 46.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.667 0.387 . . . . 0.0 111.061 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 12.7 p -132.24 161.63 32.96 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.694 1.198 . . . . 0.0 111.176 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -61.51 122.26 14.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.056 0.943 . . . . 0.0 111.784 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.282 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.2 p -143.11 144.21 32.14 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 124.967 1.417 . . . . 0.0 108.529 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.73 127.72 22.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.566 -0.709 . . . . 0.0 112.569 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.85 -25.3 67.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.61 119.49 5.36 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 123.042 1.401 . . . . 0.0 111.984 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.35 -111.2 1.06 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.01 2.243 . . . . 0.0 110.447 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.45 ' HD2' HD13 ' B' ' 123' ' ' LEU . 24.3 ttmt -153.65 152.56 30.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.34 158.18 43.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.884 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.1 146.88 45.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.683 1.193 . . . . 0.0 108.35 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -116.28 143.33 45.66 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 111.188 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -57.8 -24.15 55.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.204 1.401 . . . . 0.0 113.645 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.477 HD21 HG21 ' B' ' 37' ' ' VAL . 39.9 tp -68.18 -15.59 63.64 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.644 -1.285 . . . . 0.0 111.735 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.42 43.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.732 2.587 . . . . 0.0 113.418 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.61 147.7 52.92 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.196 -1.179 . . . . 0.0 111.633 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -127.1 152.01 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.12 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.96 147.38 33.86 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -126.89 135.39 50.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.99 120.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.23 -64.85 3.02 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.662 1.226 . . . . 0.0 113.201 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.51 139.8 3.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.241 1.416 . . . . 0.0 110.163 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -86.3 137.36 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.403 0.281 . . . . 0.0 110.576 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.26 163.37 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.678 0.391 . . . . 0.0 111.246 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -23.83 50.11 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -27.11 63.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.3 -0.875 . . . . 0.0 111.285 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.84 -2.12 48.5 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.218 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.18 144.51 51.93 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.524 1.162 . . . . 0.0 108.542 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.79 156.12 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 112.157 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.5 158.33 38.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.341 1.856 . . . . 0.0 108.201 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.33 -170.5 34.73 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 120.973 -1.079 . . . . 0.0 114.758 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 35.9 p -137.19 126.51 24.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.065 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.694 ' C ' HD12 ' B' ' 34' ' ' ILE . 1.5 t80 -126.74 133.31 50.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.72 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' B' ' 46' ' ' LEU . 1.5 mp -121.41 136.24 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.698 HG22 ' O ' ' B' ' 37' ' ' VAL . 42.7 m -116.39 130.54 56.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.29 2.7 53.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.302 1.049 . . . . 0.0 113.828 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.698 ' O ' HG22 ' B' ' 35' ' ' THR . 28.2 m -141.09 161.66 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.348 2.259 . . . . 0.0 108.373 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.61 166.67 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 119.971 -1.706 . . . . 0.0 111.909 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.0 -24.65 62.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 122.461 -0.149 . . . . 0.0 110.674 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.3 83.73 4.51 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.152 2.181 . . . . 0.0 109.22 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.54 175.92 8.82 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.842 3.028 . . . . 0.0 112.9 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.41 -33.21 2.81 Favored Glycine 0 N--CA 1.476 1.324 0 C-N-CA 124.715 1.15 . . . . 0.0 112.219 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -132.62 20.75 4.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.005 1.322 . . . . 0.0 112.359 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.514 HG21 ' O ' ' B' ' 35' ' ' THR . 43.9 mt -54.25 127.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.08 0.943 . . . . 0.0 109.141 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.19 176.46 8.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.758 2.023 . . . . 0.0 107.57 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.759 ' CD1' HD11 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -48.49 146.3 3.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.258 172.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -125.02 113.26 26.62 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 112.07 -2.332 . . . . 0.0 110.57 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -56.4 134.68 65.79 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.135 1.89 . . . . 0.0 109.65 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.04 151.22 45.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.486 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -143.32 149.19 37.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.821 2.449 . . . . 0.0 107.839 174.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 -161.28 35.11 Favored Glycine 0 N--CA 1.451 -0.326 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.498 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.8 mt -144.56 144.91 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.961 0.904 . . . . 0.0 111.799 -174.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.521 HE22 ' HB2' ' B' ' 57' ' ' LYS . 0.1 OUTLIER -133.18 148.26 52.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.301 1.04 . . . . 0.0 113.323 175.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -84.65 141.31 30.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.099 0.952 . . . . 0.0 111.069 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.521 ' HB2' HE22 ' B' ' 53' ' ' GLN . 0.9 OUTLIER -139.05 30.72 2.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.95 1.3 . . . . 0.0 112.222 178.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -93.33 -55.38 3.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.94 2.496 . . . . 0.0 111.72 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.97 179.51 6.17 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.0 m -82.98 -35.53 25.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.842 1.257 . . . . 0.0 113.264 174.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -135.04 49.01 3.29 Favored Pre-proline 0 CA--C 1.562 1.434 0 O-C-N 125.377 1.673 . . . . 0.0 111.4 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.44 177.5 5.98 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.079 2.52 . . . . 0.0 115.272 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.347 0.1 OUTLIER -102.13 168.06 9.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.027 1.394 . . . . 0.0 111.749 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -161.41 163.03 30.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.84 -173.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.66 147.26 13.02 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 118.81 2.284 . . . . 0.0 118.81 -173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.9 m -89.28 147.95 23.83 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.066 1.746 . . . . 0.0 108.338 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.34 119.8 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.489 ' CB ' HG21 ' C' ' 52' ' ' ILE . 37.8 t30 -102.67 102.09 12.26 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.352 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -69.07 125.64 27.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.278 1.854 . . . . 0.0 115.707 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.36 -37.46 28.21 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.514 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.83 -22.14 37.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.516 1.127 . . . . 0.0 113.647 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -152.42 124.79 8.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.722 1.609 . . . . 0.0 108.699 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.97 116.29 4.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.803 1.183 . . . . 0.0 111.173 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 9.2 p -173.01 158.79 3.83 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.059 2.143 . . . . 0.0 109.856 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -143.36 142.6 31.34 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-O 123.117 1.437 . . . . 0.0 110.531 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -142.12 128.46 19.97 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 110.084 -3.234 . . . . 0.0 109.927 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.33 153.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.741 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.11 142.29 50.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.44 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -152.29 118.61 5.59 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -174.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -162.72 -176.75 35.11 Favored Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -127.68 143.22 51.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.36 0.682 . . . . 0.0 112.169 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 49.9 t -97.52 124.84 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.07 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.402 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.01 168.27 10.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.239 1.019 . . . . 0.0 111.794 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 30.2 mt -124.79 109.54 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.286 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -58.62 157.33 9.36 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -42.31 -30.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.91 -19.38 54.79 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.81 8.57 27.88 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 125.073 1.32 . . . . 0.0 115.583 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 4.6 mtpp -87.48 152.94 21.82 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.931 1.366 . . . . 0.0 112.585 -176.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -100.96 134.83 43.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.565 1.546 . . . . 0.0 110.016 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 m -144.14 145.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 38.0 mt -118.89 92.42 3.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.47 1.129 . . . . 0.0 111.227 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -83.4 113.13 20.53 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.074 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.414 HG22 ' HA3' ' B' ' 81' ' ' GLY . 4.8 p -135.29 168.48 19.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.559 1.647 . . . . 0.0 112.801 -174.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -120.12 170.44 9.3 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 124.608 1.163 . . . . 0.0 107.901 172.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -141.11 159.05 43.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.427 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.5 tp -134.41 122.15 22.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.404 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . 0.262 0.4 OUTLIER -107.53 134.64 50.25 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 125.047 1.467 . . . . 0.0 112.216 -176.098 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 5.4 tpt180 -115.55 114.06 24.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 112.001 -2.363 . . . . 0.0 110.048 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.259 72.9 m -70.09 167.97 16.56 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.266 1.604 . . . . 0.0 111.465 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -113.29 85.38 2.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 -160.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -140.52 -13.21 1.0 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 119.569 -1.957 . . . . 0.0 114.223 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.17 151.17 49.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.509 1.147 . . . . 0.0 112.003 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' C' ' 84' ' ' PHE . 2.2 tt -58.57 -25.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.407 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.64 -2.36 28.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.038 1.304 . . . . 0.0 114.626 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.33 5.87 7.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.214 1.006 . . . . 0.0 112.137 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.5 -32.12 73.63 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 119.55 -1.969 . . . . 0.0 112.668 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.7 p-90 -48.0 -41.25 24.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.726 1.21 . . . . 0.0 113.718 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -94.37 -11.43 29.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.349 1.059 . . . . 0.0 113.494 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.1 -0.91 20.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.105 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -111.6 143.65 42.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.168 0.985 . . . . 0.0 111.244 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -142.38 153.48 43.82 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.316 1.446 . . . . 0.0 109.524 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.26 150.64 33.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.689 1.131 . . . . 0.0 109.517 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.99 -177.02 29.71 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.375 0.512 . . . . 0.0 112.184 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 34.9 p90 -124.42 151.77 44.09 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -144.17 151.22 39.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.998 0.904 . . . . 0.0 109.22 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.19 134.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -122.25 149.83 43.15 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.042 0.448 . . . . 0.0 111.038 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 5.3 p -130.86 159.82 36.24 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.94 1.296 . . . . 0.0 110.647 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -58.69 123.81 17.62 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.5 0.72 . . . . 0.0 111.495 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.45 HD13 ' HD2' ' B' ' 9' ' ' LYS . 2.7 tt . . . . . 0 CA--C 1.527 0.064 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.561 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? . . . . . 0 CA--C 1.515 -0.376 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 26.6 p -148.37 145.02 27.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.595 1.184 . . . . 0.0 109.788 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.74 127.92 22.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.53 -25.64 68.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.34 118.39 4.07 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.863 1.316 . . . . 0.0 112.08 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.55 -112.17 1.17 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.955 2.217 . . . . 0.0 110.667 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -150.58 151.77 33.09 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -142.0 157.44 44.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.577 -2.101 . . . . 0.0 111.226 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 147.95 50.58 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -115.87 143.41 45.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.929 0.892 . . . . 0.0 110.879 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.1 -24.21 52.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.332 1.453 . . . . 0.0 113.638 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.478 HD21 HG21 ' C' ' 37' ' ' VAL . 37.9 tp -67.85 -15.07 63.45 Favored 'General case' 0 CA--C 1.556 1.182 0 O-C-N 120.773 -1.204 . . . . 0.0 111.819 173.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.39 -9.35 45.37 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.723 2.582 . . . . 0.0 113.324 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -66.62 147.02 53.85 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.202 -1.175 . . . . 0.0 111.618 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -126.52 152.04 47.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.8 147.41 34.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -127.39 135.85 51.05 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.842 0.857 . . . . 0.0 110.22 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -128.31 119.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.51 -63.99 3.75 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.605 1.191 . . . . 0.0 113.308 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.23 143.16 4.22 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.51 1.524 . . . . 0.0 110.265 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.93 135.66 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.735 0.414 . . . . 0.0 110.274 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.7 163.38 28.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.337 0.655 . . . . 0.0 111.287 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -22.02 53.68 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -25.56 62.29 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.23 -0.919 . . . . 0.0 111.253 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.59 51.4 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.273 1.416 . . . . 0.0 113.225 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.1 150.37 43.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 110.333 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.14 166.32 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.795 0.807 . . . . 0.0 111.122 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.484 ' HB ' HD22 ' C' ' 50' ' ' LEU . 0.5 OUTLIER -134.49 160.72 37.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.529 1.932 . . . . 0.0 106.844 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.64 -170.9 36.2 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.327 -1.483 . . . . 0.0 114.822 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -137.61 126.63 24.27 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.565 0.698 . . . . 0.0 109.383 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.699 ' C ' HD12 ' C' ' 34' ' ' ILE . 1.6 t80 -126.73 133.45 50.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.466 -172.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.748 HD11 ' CD1' ' C' ' 46' ' ' LEU . 1.6 mp -121.49 136.29 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.687 HG22 ' O ' ' C' ' 37' ' ' VAL . 33.4 m -116.92 130.55 56.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -172.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.14 5.08 50.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.687 ' O ' HG22 ' C' ' 35' ' ' THR . 28.7 m -143.2 161.25 17.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.149 2.179 . . . . 0.0 108.261 -175.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.31 166.96 12.34 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.786 -1.821 . . . . 0.0 111.757 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.78 -23.72 61.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.162 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -153.41 84.08 4.39 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 127.211 2.205 . . . . 0.0 109.373 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.69 176.02 8.77 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.557 2.838 . . . . 0.0 112.805 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.04 -33.14 2.87 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.776 1.179 . . . . 0.0 112.284 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -132.64 20.57 4.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.026 1.33 . . . . 0.0 112.328 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.521 HG21 ' O ' ' C' ' 35' ' ' THR . 44.8 mt -54.11 127.82 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.249 1.023 . . . . 0.0 109.234 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.13 177.24 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.486 1.914 . . . . 0.0 107.296 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.748 ' CD1' HD11 ' C' ' 34' ' ' ILE . 1.0 OUTLIER -49.0 146.82 3.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.118 172.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -125.23 113.08 26.13 Favored Pre-proline 0 N--CA 1.426 -1.651 0 CA-C-N 112.042 -2.345 . . . . 0.0 110.398 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -56.01 132.25 50.84 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.03 1.82 . . . . 0.0 109.223 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.65 154.93 36.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.323 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' C' ' 30' ' ' THR . 0.3 OUTLIER -148.6 149.23 31.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.827 2.451 . . . . 0.0 108.142 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.72 -160.04 32.41 Favored Glycine 0 CA--C 1.517 0.186 0 O-C-N 121.383 -0.823 . . . . 0.0 112.71 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.489 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.36 144.95 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.319 1.047 . . . . 0.0 112.149 -174.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.516 HE22 ' HB2' ' C' ' 57' ' ' LYS . 0.4 OUTLIER -131.87 152.04 51.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.857 1.263 . . . . 0.0 112.909 175.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -88.93 140.87 29.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.05 0.929 . . . . 0.0 111.038 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . 0.516 ' HB2' HE22 ' C' ' 53' ' ' GLN . 0.9 OUTLIER -138.17 30.15 2.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.735 1.214 . . . . 0.0 112.237 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -93.37 -55.48 3.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.98 2.512 . . . . 0.0 111.714 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -179.76 5.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -83.94 -35.76 23.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.671 1.188 . . . . 0.0 112.95 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -134.34 48.06 2.87 Favored Pre-proline 0 CA--C 1.564 1.49 0 O-C-N 125.388 1.68 . . . . 0.0 111.823 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.09 176.42 6.28 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.148 2.565 . . . . 0.0 115.518 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.337 0.2 OUTLIER -101.05 169.91 8.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.674 1.226 . . . . 0.0 111.414 174.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.86 163.31 26.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.733 -173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 147.88 14.19 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -161.66 149.81 15.2 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.58 149.21 23.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.245 1.818 . . . . 0.0 108.221 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.63 121.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.498 ' CB ' HG21 ' B' ' 52' ' ' ILE . 39.8 t30 -104.32 102.19 11.88 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.198 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -68.44 124.35 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.854 1.661 . . . . 0.0 115.427 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -80.07 -37.55 33.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.641 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.78 -22.23 37.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 113.692 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.6 t -152.51 124.61 8.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.75 1.62 . . . . 0.0 108.66 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.68 116.52 4.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.587 1.085 . . . . 0.0 111.132 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 8.6 p -173.29 158.36 3.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.15 2.18 . . . . 0.0 110.02 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -142.69 142.01 31.93 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-O 123.181 1.467 . . . . 0.0 110.488 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.86 128.05 19.76 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 110.015 -3.266 . . . . 0.0 110.091 -171.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.66 154.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.785 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.47 141.99 50.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.433 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -152.27 118.69 5.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -174.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -163.07 -176.12 34.78 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -128.9 143.1 50.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 124.484 0.755 . . . . 0.0 112.319 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 49.0 t -97.56 122.69 40.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.527 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' B' ' 106' ' ' ILE . 3.5 m-85 -114.0 167.81 10.34 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.551 0.691 . . . . 0.0 111.638 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.71 108.34 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.082 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.56 160.93 4.98 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.05 -31.09 0.84 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -79.99 -15.08 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.03 5.6 40.72 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.884 1.23 . . . . 0.0 115.682 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 152.63 28.53 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.017 1.408 . . . . 0.0 112.543 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -100.72 135.96 41.33 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.496 1.518 . . . . 0.0 109.131 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.56 147.36 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.265 1.026 . . . . 0.0 111.36 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 40.7 mt -119.97 92.38 3.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.682 1.23 . . . . 0.0 111.772 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -83.59 112.57 20.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.903 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.418 HG22 ' HA3' ' C' ' 81' ' ' GLY . 4.5 p -134.36 168.95 17.98 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.607 1.194 . . . . 0.0 112.831 -174.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -120.94 170.7 9.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 38.9 p-90 -140.53 159.83 41.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.385 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.44 HD23 ' OG1' ' B' ' 80' ' ' THR . 3.3 tp -135.16 122.1 21.19 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.474 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.43 134.98 49.68 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.927 1.392 . . . . 0.0 111.863 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.16 114.09 23.98 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 111.974 -2.375 . . . . 0.0 110.078 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 71.4 m -69.74 168.09 15.74 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 125.299 1.624 . . . . 0.0 111.681 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -112.94 85.64 2.21 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.53 -160.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -141.45 -11.61 0.92 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 119.518 -1.989 . . . . 0.0 114.406 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.46 150.47 50.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.284 1.04 . . . . 0.0 111.723 174.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 84' ' ' PHE . 2.2 tt -58.13 -25.44 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.4 -2.81 28.97 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.97 1.272 . . . . 0.0 114.611 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.42 6.17 7.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.164 0.986 . . . . 0.0 112.309 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.47 -32.69 74.2 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.757 -1.84 . . . . 0.0 112.741 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.2 p-90 -48.28 -41.77 28.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.684 1.194 . . . . 0.0 113.697 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -93.93 -11.67 30.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.242 1.017 . . . . 0.0 113.329 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.61 -1.23 20.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.077 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.35 143.71 41.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.002 0.906 . . . . 0.0 111.373 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -142.56 153.33 43.45 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.463 1.505 . . . . 0.0 109.504 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.04 151.1 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 109.358 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.03 -177.77 30.47 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 121.813 0.674 . . . . 0.0 112.244 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 34.8 p90 -123.84 151.33 43.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.4 0.68 . . . . 0.0 109.419 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -144.18 151.4 39.46 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.995 0.902 . . . . 0.0 108.83 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.67 133.71 67.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -120.81 149.71 42.14 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.134 0.492 . . . . 0.0 111.093 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 33.2 p -134.6 163.48 29.64 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 110.907 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.48 123.76 20.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.062 0.945 . . . . 0.0 113.132 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.3 157.55 24.79 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 p -139.38 127.19 22.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.349 -0.844 . . . . 0.0 113.102 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.542 HD12 ' CD ' ' A' ' 53' ' ' GLN . 33.5 mt -69.39 -27.05 64.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.017 0.527 . . . . 0.0 111.777 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -62.91 120.77 11.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.67 24.86 1.49 Allowed Glycine 0 N--CA 1.476 1.309 0 N-CA-C 118.001 1.96 . . . . 0.0 118.001 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 tttt 69.3 145.96 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.894 2.478 . . . . 0.0 116.911 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -140.99 158.91 43.28 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.334 1.454 . . . . 0.0 112.538 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -132.45 142.85 49.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.853 1.261 . . . . 0.0 108.622 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.75 143.69 44.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.47 1.108 . . . . 0.0 110.128 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -57.06 -30.37 64.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.52 -11.73 61.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.311 1.444 . . . . 0.0 112.586 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.92 -11.19 37.88 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 127.503 2.477 . . . . 0.0 113.519 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -61.06 145.67 50.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 122.781 1.277 . . . . 0.0 112.326 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -122.81 139.99 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -132.71 145.27 50.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.94 0.876 . . . . 0.0 112.416 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 m -128.78 125.54 38.05 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.2 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.77 127.67 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.34 -88.86 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 O-C-N 125.647 1.842 . . . . 0.0 111.08 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.82 143.52 36.86 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.084 -0.657 . . . . 0.0 110.733 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.47 HG21 ' CG ' ' A' ' 53' ' ' GLN . 7.4 p -95.03 131.92 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.656 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -72.52 159.14 34.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.079 0.943 . . . . 0.0 112.919 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.0 m -54.47 -28.46 44.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.774 1.23 . . . . 0.0 114.212 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -71.11 -34.91 71.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.085 0.554 . . . . 0.0 112.472 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.81 -8.81 12.75 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.531 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 155.27 40.43 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.459 1.63 . . . . 0.0 108.271 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.47 166.12 32.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.975 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.5 148.04 52.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.24 26.34 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 122.554 1.086 . . . . 0.0 113.298 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.492 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -139.49 139.45 36.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.021 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.71 129.52 55.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.929 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -118.28 128.51 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 m -106.11 143.55 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.404 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 -15.63 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 15.9 m -135.03 142.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 113.154 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.56 168.91 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.39 -38.78 26.0 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.33 74.37 77.46 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.323 1.849 . . . . 0.0 109.227 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.64 6.5 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.165 3.243 . . . . 0.0 117.348 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.66 -21.29 0.8 Allowed Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.04 42.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.709 1.255 . . . . 0.0 111.945 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.59 134.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.835 0.826 . . . . 0.0 111.518 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 0.6 OUTLIER -152.48 171.82 17.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 0.0 111.22 176.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.2 tp -46.69 117.4 1.63 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 129.496 3.119 . . . . 0.0 112.438 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.7 m -111.79 114.05 52.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.899 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.18 145.15 66.88 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.324 2.683 . . . . 0.0 112.82 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.34 51.99 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.526 1.13 . . . . 0.0 111.864 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.75 149.85 39.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.188 2.995 . . . . 0.0 109.282 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.99 -155.33 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.3 mt -144.82 139.56 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.996 0.903 . . . . 0.0 112.637 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.542 ' CD ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -119.54 155.74 31.61 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.355 -0.841 . . . . 0.0 111.06 172.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.24 164.02 21.47 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.767 -1.208 . . . . 0.0 110.723 172.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.94 25.32 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.402 1.081 . . . . 0.0 112.924 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.84 -55.36 3.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.07 2.148 . . . . 0.0 110.454 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 173.19 12.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.711 1.243 . . . . 0.0 113.217 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -43.61 60.58 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.789 2.036 . . . . 0.0 112.176 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -131.41 53.75 12.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.952 1.301 . . . . 0.0 110.309 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.57 176.71 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.161 1.907 . . . . 0.0 116.272 -174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -88.34 161.85 16.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.504 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.37 164.48 29.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.249 -0.907 . . . . 0.0 112.46 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.84 149.47 15.7 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 120.397 2.919 . . . . 0.0 120.397 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -164.29 154.38 14.5 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -90.04 150.57 22.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.047 2.139 . . . . 0.0 109.332 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -129.97 120.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 59.4 t30 -95.59 106.01 18.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.653 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.12 131.88 46.72 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 121.234 1.834 . . . . 0.0 112.766 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.07 -38.22 12.33 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -90.38 -10.74 42.8 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -152.44 132.5 13.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 127.705 2.402 . . . . 0.0 106.847 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -69.85 118.49 12.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.546 1.066 . . . . 0.0 110.173 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -173.53 170.26 4.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.481 1.912 . . . . 0.0 109.769 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.89 137.95 31.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.979 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.446 ' CG2' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -114.29 165.99 12.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.327 1.06 . . . . 0.0 108.617 173.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 149.9 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.01 142.11 51.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.46 120.3 9.93 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 179.79 39.46 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 118.935 -1.602 . . . . 0.0 117.079 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.49 147.93 36.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 112.176 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.4 t -97.48 129.0 44.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.866 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' D' ' 106' ' ' ILE . 0.6 OUTLIER -124.1 169.18 11.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.729 1.252 . . . . 0.0 113.72 177.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.8 mt -131.49 107.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 112.642 -2.072 . . . . 0.0 106.85 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -58.86 157.28 9.96 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.46 -55.13 0.05 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.148 2.179 . . . . 0.0 116.449 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.93 -19.85 62.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.39 1.876 . . . . 0.0 115.976 -173.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.73 53.65 1.19 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -125.59 136.03 52.84 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 126.834 2.053 . . . . 0.0 108.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.34 142.65 32.43 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 111.094 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' D' ' 106' ' ' ILE . 15.1 m -147.23 166.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.188 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.34 122.34 33.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' D' ' 106' ' ' ILE . 1.5 mmmt -109.37 116.18 31.35 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.86 160.11 39.85 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.194 1.473 . . . . 0.0 112.15 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -108.25 167.75 9.8 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 172.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -141.32 160.81 39.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.649 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.3 tt -143.84 127.43 17.02 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.783 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' ' 77' ' ' THR . 1.0 OUTLIER -110.85 144.65 39.55 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 125.172 1.545 . . . . 0.0 110.818 -175.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.426 ' CZ ' ' HA2' ' D' ' 81' ' ' GLY . 2.3 tpt85 -128.27 116.01 19.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 112.209 -2.268 . . . . 0.0 112.115 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -89.43 158.68 17.64 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 113.396 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -103.68 80.76 1.82 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.7 m -66.8 -173.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.996 0.518 . . . . 0.0 109.658 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.16 -20.83 9.68 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.984 -1.698 . . . . 0.0 114.783 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -124.66 152.42 43.68 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.791 1.282 . . . . 0.0 111.459 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.582 HD11 ' HE2' ' D' ' 94' ' ' LYS . 10.3 tt -62.44 -27.5 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.181 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.99 23.62 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.291 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -120.08 -0.91 10.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.037 1.419 . . . . 0.0 113.937 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.76 -32.4 69.24 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.968 . . . . 0.0 112.947 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 60.1 p-90 -45.53 -44.6 12.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.609 1.164 . . . . 0.0 113.892 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -93.42 -12.86 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.86 0.864 . . . . 0.0 113.111 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.65 5.57 8.98 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.0 m -113.83 135.5 53.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.909 0.884 . . . . 0.0 111.824 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.67 126.49 22.29 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.61 154.92 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 120.524 1.511 . . . . 0.0 112.235 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.55 30.02 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.606 1.098 . . . . 0.0 113.177 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 24.4 p90 -129.28 153.67 47.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.771 0.828 . . . . 0.0 109.995 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -148.62 149.1 30.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.131 0.972 . . . . 0.0 109.716 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.32 130.63 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.39 -0.819 . . . . 0.0 109.28 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -118.52 153.86 33.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.255 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -137.51 165.1 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.202 1.001 . . . . 0.0 110.447 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -60.83 116.7 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 110.783 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.53 0.183 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 178.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 10.1 p -131.32 142.95 50.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 124.147 0.979 . . . . 0.0 108.388 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 21.1 p -132.63 127.47 35.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' D' ' 53' ' ' GLN . 28.7 mt -68.21 -26.56 65.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.292 1.037 . . . . 0.0 112.425 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 t -62.57 121.02 12.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.34 40.55 0.62 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 mttt 56.53 150.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 129.087 2.955 . . . . 0.0 118.371 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -142.55 161.97 36.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.567 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -131.76 148.17 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.305 1.442 . . . . 0.0 107.552 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.42 143.41 45.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 109.988 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -56.4 -28.86 60.57 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.23 -12.48 61.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.938 1.695 . . . . 0.0 113.018 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.8 -8.44 36.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.142 2.306 . . . . 0.0 113.775 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -63.59 147.0 52.64 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.827 1.313 . . . . 0.0 112.066 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -124.66 137.83 54.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -130.33 147.18 52.01 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.112 0.958 . . . . 0.0 113.121 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 14.6 m -131.31 125.25 32.28 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.14 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.94 126.55 73.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 -88.05 0.1 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 126.09 2.119 . . . . 0.0 111.073 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.36 142.59 35.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.246 0.618 . . . . 0.0 110.661 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.458 HG21 ' CG ' ' D' ' 53' ' ' GLN . 7.3 p -95.09 133.02 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.722 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -71.92 160.07 33.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.206 1.003 . . . . 0.0 113.316 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 15.8 m -53.76 -27.33 28.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.249 1.419 . . . . 0.0 114.455 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.99 -34.03 68.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.282 0.633 . . . . 0.0 112.625 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.74 -9.83 12.57 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.981 1.277 . . . . 0.0 113.432 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.3 157.42 37.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.907 1.354 . . . . 0.0 110.634 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.82 166.3 33.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.332 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -131.03 147.68 52.66 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.46 -168.67 24.73 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.859 1.255 . . . . 0.0 112.904 -174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' D' ' 46' ' ' LEU . 9.5 p -140.06 139.53 35.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.396 -1.402 . . . . 0.0 112.202 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -118.52 132.92 56.21 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.861 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 60.3 mt -121.47 129.31 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 55.1 m -107.36 143.42 35.68 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.538 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.63 -15.73 18.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.73 142.62 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.012 0.925 . . . . 0.0 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.35 169.19 22.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.216 -0.928 . . . . 0.0 110.967 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -38.77 25.35 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.15 74.41 77.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.573 1.949 . . . . 0.0 109.375 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.75 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.13 3.22 . . . . 0.0 117.332 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.52 -21.35 0.77 Allowed Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.531 2.172 . . . . 0.0 118.531 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.06 42.38 0.08 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 111.929 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -50.29 133.56 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.397 -0.815 . . . . 0.0 111.748 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . 0.259 0.6 OUTLIER -151.81 171.54 17.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 111.377 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' D' ' 32' ' ' THR . 12.3 tp -46.62 118.38 1.99 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.096 2.958 . . . . 0.0 112.116 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 69.6 m -113.08 112.52 49.86 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.256 1.022 . . . . 0.0 108.581 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -54.47 145.71 56.13 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.143 2.562 . . . . 0.0 112.593 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 143.96 51.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.43 1.092 . . . . 0.0 111.525 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -144.34 151.42 39.31 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 129.021 2.928 . . . . 0.0 109.446 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.55 -155.39 26.43 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -145.07 139.1 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.446 -0.877 . . . . 0.0 112.333 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . 0.522 ' CD ' HD12 ' D' ' 6' ' ' LEU . 0.0 OUTLIER -119.42 155.05 32.72 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.176 0.99 . . . . 0.0 110.79 173.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.15 163.98 22.7 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.43 -1.419 . . . . 0.0 110.81 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.16 26.43 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.231 1.013 . . . . 0.0 112.865 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.4 -56.69 2.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.019 2.128 . . . . 0.0 110.622 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.37 171.86 14.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.376 1.084 . . . . 0.0 113.356 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -43.82 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.2 1.4 . . . . 0.0 111.032 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -132.37 57.67 30.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 111.283 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.61 177.21 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 N-CA-C 116.767 1.795 . . . . 0.0 116.767 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -88.88 162.22 16.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.588 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.63 165.56 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.715 -1.241 . . . . 0.0 112.38 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.91 149.47 15.12 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.7 156.9 18.57 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -92.98 151.07 20.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.23 2.212 . . . . 0.0 108.967 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.41 121.97 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 53.5 t30 -97.77 106.73 19.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.414 -174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -67.16 131.7 46.32 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.807 1.639 . . . . 0.0 112.73 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.87 -38.13 12.5 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -90.42 -10.94 41.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.5 132.27 13.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.045 2.538 . . . . 0.0 107.068 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -69.54 118.61 12.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.298 0.954 . . . . 0.0 110.39 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 72.5 p -173.97 170.05 3.93 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 109.886 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -140.9 137.78 33.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.445 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.448 ' CG2' HD12 ' D' ' 99' ' ' LEU . 0.6 OUTLIER -114.25 165.53 12.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.205 1.002 . . . . 0.0 108.478 173.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.91 150.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.95 142.03 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.33 120.52 10.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 100' ' ' ARG . . . -165.46 -179.86 39.46 Favored Glycine 0 CA--C 1.497 -1.033 0 N-CA-C 117.274 1.67 . . . . 0.0 117.274 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.98 145.34 41.68 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.692 0.878 . . . . 0.0 112.236 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.485 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 28.1 t -97.76 125.25 42.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.439 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -120.19 169.84 9.87 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.456 1.122 . . . . 0.0 113.618 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.8 mt -130.6 107.24 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.056 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.15 155.31 14.25 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.477 0.711 . . . . 0.0 109.097 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -24.15 -56.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 127.091 2.157 . . . . 0.0 116.704 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.23 -17.83 63.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.43 47.89 1.62 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.501 1.046 . . . . 0.0 110.632 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -119.78 139.61 52.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.477 1.511 . . . . 0.0 110.025 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -101.39 143.69 31.12 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 111.108 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 106' ' ' ILE . 15.2 m -148.09 164.28 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.928 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' D' ' 83' ' ' CYS . 58.5 mt -124.34 120.52 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.582 ' HE2' HD11 ' A' ' 106' ' ' ILE . 1.7 mmmt -108.75 115.15 29.55 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 172.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -136.57 161.58 35.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 123.319 1.533 . . . . 0.0 111.667 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.418 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -110.01 168.53 9.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -142.11 161.28 38.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.306 173.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -144.29 127.06 16.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.808 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' D' ' 77' ' ' THR . 1.0 OUTLIER -110.62 144.71 39.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.554 1.159 . . . . 0.0 110.898 -176.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.11 114.59 17.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.011 -2.359 . . . . 0.0 112.13 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 85.7 p -86.97 158.6 19.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 124.813 1.32 . . . . 0.0 113.462 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -103.68 81.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.85 -173.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.039 0.535 . . . . 0.0 109.838 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -115.83 -21.0 9.79 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.119 -1.613 . . . . 0.0 114.789 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -123.85 151.3 43.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.486 1.136 . . . . 0.0 111.702 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.608 HD11 ' HE2' ' A' ' 94' ' ' LYS . 10.8 tt -61.93 -27.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.055 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.77 4.32 22.68 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.356 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -120.13 -0.19 10.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.905 1.353 . . . . 0.0 113.935 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -60.08 -31.38 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.358 -0.839 . . . . 0.0 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 60.4 p-90 -46.54 -44.21 17.66 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.53 1.132 . . . . 0.0 113.97 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -93.63 -12.79 28.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.011 0.924 . . . . 0.0 113.161 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.64 5.11 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' D' ' 98' ' ' LEU . 14.5 m -113.08 135.6 53.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.862 0.865 . . . . 0.0 111.726 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.57 126.25 22.14 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.611 -1.185 . . . . 0.0 110.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.91 154.82 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.298 1.408 . . . . 0.0 111.821 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.86 -175.87 30.27 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.687 1.137 . . . . 0.0 113.096 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.0 p90 -126.47 153.43 45.09 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.623 0.769 . . . . 0.0 109.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -148.08 148.24 30.43 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.036 0.934 . . . . 0.0 109.271 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 64.9 mt -128.2 131.5 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.031 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -117.74 156.76 27.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.222 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -137.53 160.95 37.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.591 1.156 . . . . 0.0 110.195 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.18 129.54 42.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.891 -0.506 . . . . 0.0 109.735 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.764 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.411 ' HG ' ' HB3' ' B' ' 83' ' ' CYS . 25.0 p -130.15 147.49 51.89 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.323 1.049 . . . . 0.0 108.275 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -137.64 127.46 25.5 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.53 HD12 ' CD ' ' B' ' 53' ' ' GLN . 28.5 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.549 0.74 . . . . 0.0 112.43 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.09 120.08 10.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.75 43.18 0.5 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt 53.6 148.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.388 3.075 . . . . 0.0 119.175 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -140.83 160.1 40.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.929 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 142.26 47.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.121 1.368 . . . . 0.0 108.514 175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.32 143.5 42.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.966 1.306 . . . . 0.0 110.041 -174.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -56.35 -29.36 61.27 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.9 -12.16 61.38 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.747 1.619 . . . . 0.0 112.836 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.45 -8.13 40.48 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 127.062 2.268 . . . . 0.0 113.635 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.9 t -64.43 145.04 56.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.787 1.294 . . . . 0.0 111.511 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -121.94 141.46 51.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -133.08 147.17 52.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.304 1.049 . . . . 0.0 112.795 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -129.58 125.26 35.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.544 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.56 127.44 75.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.05 -88.45 0.1 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 125.874 1.984 . . . . 0.0 110.987 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.98 145.13 37.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.202 -0.587 . . . . 0.0 110.824 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.462 HG21 ' CG ' ' B' ' 53' ' ' GLN . 7.3 p -97.02 131.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.729 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -72.79 159.54 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.029 0.919 . . . . 0.0 112.808 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -54.47 -27.87 40.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -71.84 -34.81 69.59 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.148 0.579 . . . . 0.0 112.448 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.82 -9.16 12.63 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.503 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 155.3 40.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.379 1.59 . . . . 0.0 108.225 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.39 166.12 32.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.882 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.14 147.92 52.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.54 26.77 Favored Glycine 0 C--O 1.236 0.24 0 O-C-N 121.623 -0.673 . . . . 0.0 112.81 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' B' ' 46' ' ' LEU . 10.7 p -139.89 138.53 35.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.836 -1.182 . . . . 0.0 112.092 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -117.14 132.39 56.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.811 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.13 129.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 45.2 m -107.14 143.56 35.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.742 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.44 -13.59 18.65 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -136.44 142.06 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.948 0.899 . . . . 0.0 112.806 -174.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.28 168.68 23.33 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.219 -0.926 . . . . 0.0 111.036 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -39.15 25.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -126.85 74.64 75.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.428 1.891 . . . . 0.0 109.321 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.82 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.175 3.25 . . . . 0.0 117.34 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.79 -20.96 0.75 Allowed Glycine 0 CA--C 1.537 1.433 0 N-CA-C 118.523 2.169 . . . . 0.0 118.523 -174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.2 42.34 0.08 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 111.861 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -50.06 134.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.336 -0.852 . . . . 0.0 111.454 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -152.3 171.85 17.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.425 1.49 . . . . 0.0 111.109 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.1 tp -46.69 119.34 2.41 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.469 3.108 . . . . 0.0 112.143 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 68.2 m -114.3 113.59 45.92 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.095 0.958 . . . . 0.0 108.579 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -55.28 144.76 69.9 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.622 2.881 . . . . 0.0 112.814 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.04 52.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.613 1.165 . . . . 0.0 111.892 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.41 150.7 40.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.167 2.987 . . . . 0.0 109.266 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.08 -155.43 26.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.2 mt -144.8 139.48 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.668 -0.766 . . . . 0.0 112.421 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.53 ' CD ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -118.78 155.15 31.66 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.255 1.022 . . . . 0.0 110.993 172.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.95 163.9 22.97 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.499 -1.375 . . . . 0.0 110.588 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.97 26.38 0.32 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 113.213 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -56.36 2.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.282 2.233 . . . . 0.0 111.022 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.75 171.83 14.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.955 0.883 . . . . 0.0 113.331 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -41.43 66.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.45 1.1 . . . . 0.0 110.91 173.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -132.87 57.9 31.71 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 125.383 1.473 . . . . 0.0 111.07 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.32 176.62 9.71 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.053 1.835 . . . . 0.0 116.654 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -87.71 163.79 16.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.718 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -163.44 164.44 24.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 149.14 15.03 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 119.941 2.736 . . . . 0.0 119.941 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -164.12 154.29 14.8 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -90.06 150.92 21.88 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.927 2.091 . . . . 0.0 109.133 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 74.1 t -130.28 120.72 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.5 ' HB2' HG21 ' C' ' 52' ' ' ILE . 56.2 t30 -95.76 105.91 17.97 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.612 -1.185 . . . . 0.0 110.793 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -67.1 132.14 47.24 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.165 1.802 . . . . 0.0 112.742 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.46 -38.2 12.1 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.58 -10.4 43.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -152.5 133.28 14.0 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.002 2.521 . . . . 0.0 107.265 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -70.66 118.47 13.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.273 0.942 . . . . 0.0 109.823 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 75.5 p -173.62 170.2 4.12 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.639 1.976 . . . . 0.0 109.928 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.76 137.9 31.92 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.142 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.447 ' CG2' HD12 ' B' ' 99' ' ' LEU . 0.6 OUTLIER -114.34 166.12 12.0 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 150.49 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -129.07 141.61 51.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.08 120.3 10.17 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.37 -179.35 38.47 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.915 -1.612 . . . . 0.0 117.106 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -114.31 145.7 41.44 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 125.178 1.163 . . . . 0.0 112.098 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.411 ' HB3' ' HG ' ' B' ' 4' ' ' CYS . 34.6 t -97.76 125.94 42.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.291 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.6 OUTLIER -120.7 170.89 9.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.76 1.267 . . . . 0.0 113.573 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 mt -131.63 110.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.49 -2.141 . . . . 0.0 106.506 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.5 156.55 19.22 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.59 -53.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -73.63 -8.96 58.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.435 1.894 . . . . 0.0 116.101 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.16 50.87 3.12 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 120.008 1.276 . . . . 0.0 110.684 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -122.87 135.97 54.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.434 1.894 . . . . 0.0 109.746 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -101.83 143.03 32.24 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.308 1.443 . . . . 0.0 112.066 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.525 HG21 ' CD1' ' C' ' 106' ' ' ILE . 15.3 m -148.56 161.95 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.803 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 mt -122.16 120.21 33.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.572 ' HE2' HD11 ' C' ' 106' ' ' ILE . 1.5 mmmt -108.24 114.47 28.37 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.05 161.06 36.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.306 1.527 . . . . 0.0 112.137 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -109.3 168.06 9.66 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -141.69 160.69 39.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.508 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -143.46 127.7 17.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.559 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' B' ' 77' ' ' THR . 1.0 OUTLIER -111.03 144.59 39.92 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 124.826 1.329 . . . . 0.0 110.987 -176.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.413 ' CZ ' ' HA2' ' C' ' 81' ' ' GLY . 2.5 tpt85 -128.23 116.91 20.61 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 112.125 -2.307 . . . . 0.0 112.279 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -90.71 158.66 16.77 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 124.73 1.269 . . . . 0.0 113.627 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.1 m -103.21 80.34 1.83 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -66.76 -174.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -115.66 -22.65 9.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 119.934 -1.729 . . . . 0.0 114.537 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -118.63 148.82 42.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.766 1.269 . . . . 0.0 110.734 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.534 HD11 ' HE2' ' C' ' 94' ' ' LYS . 10.7 tt -61.05 -28.23 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.77 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.95 4.05 25.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.221 -1.322 . . . . 0.0 115.457 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.83 -1.39 11.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.102 1.451 . . . . 0.0 113.815 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.77 -31.54 68.47 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.341 -0.85 . . . . 0.0 112.824 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 60.8 p-90 -46.43 -44.57 17.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 114.107 177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -92.88 -12.78 30.1 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.951 0.9 . . . . 0.0 113.263 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 4.95 10.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' B' ' 98' ' ' LEU . 16.2 m -113.12 135.08 54.19 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.915 0.886 . . . . 0.0 111.668 174.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.48 126.66 22.84 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.541 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.94 154.77 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 120.427 1.467 . . . . 0.0 112.041 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.94 -175.32 30.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.698 1.142 . . . . 0.0 113.056 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 24.2 p90 -128.21 154.63 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.678 0.791 . . . . 0.0 109.965 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -149.71 147.26 27.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.853 0.861 . . . . 0.0 109.831 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 129.54 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.399 -0.813 . . . . 0.0 109.146 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -116.86 155.41 29.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.437 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 32.8 p -137.31 160.42 39.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 110.458 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -59.65 128.58 37.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.79 0.836 . . . . 0.0 111.395 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.334 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.1 p -133.54 147.39 51.58 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.838 1.255 . . . . 0.0 108.453 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -137.21 127.51 26.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.519 HD12 ' CD ' ' C' ' 53' ' ' GLN . 30.3 mt -68.87 -26.76 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.959 0.904 . . . . 0.0 112.571 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -61.47 120.8 11.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.35 45.2 0.53 Allowed Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.938 1.535 . . . . 0.0 116.938 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt 52.87 149.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -141.83 161.02 38.99 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.427 -1.715 . . . . 0.0 112.139 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.05 144.35 49.97 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.271 1.428 . . . . 0.0 108.519 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.81 143.42 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.105 1.362 . . . . 0.0 109.476 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -55.75 -29.51 59.7 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.76 -12.23 61.43 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.77 1.628 . . . . 0.0 113.007 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.63 -9.09 40.77 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.284 2.373 . . . . 0.0 113.611 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.5 t -63.09 145.91 54.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.82 1.31 . . . . 0.0 111.804 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -122.36 141.09 51.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.17 147.24 52.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.999 0.904 . . . . 0.0 112.823 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.4 m -130.35 125.69 35.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.766 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.47 126.42 74.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.19 -88.71 0.08 OUTLIER Glycine 0 CA--C 1.526 0.77 0 O-C-N 126.036 2.085 . . . . 0.0 111.036 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.37 143.69 35.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.228 0.611 . . . . 0.0 110.862 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.454 HG21 ' CG ' ' C' ' 53' ' ' GLN . 7.3 p -96.16 132.74 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.739 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -71.77 160.04 33.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.247 1.023 . . . . 0.0 113.304 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 16.0 m -53.84 -27.23 28.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.151 1.381 . . . . 0.0 114.505 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.93 -34.17 68.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.231 0.612 . . . . 0.0 112.588 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.76 -9.88 12.52 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.967 1.27 . . . . 0.0 113.468 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.25 157.59 37.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.967 1.384 . . . . 0.0 110.563 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 166.3 33.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.326 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 148.04 52.66 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.65 -169.12 25.59 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 122.478 1.044 . . . . 0.0 112.746 -174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' C' ' 46' ' ' LEU . 10.2 p -139.66 138.96 36.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.686 -1.257 . . . . 0.0 112.032 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -117.19 135.09 54.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.854 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 60.6 mt -123.57 130.17 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 42.1 m -107.92 143.84 36.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.779 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.71 -13.5 18.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 16.6 m -136.74 141.43 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 112.737 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.84 168.36 23.95 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.204 -0.935 . . . . 0.0 110.992 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.62 -39.27 27.75 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.61 74.62 74.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.469 1.908 . . . . 0.0 109.291 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.8 6.8 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.147 3.232 . . . . 0.0 117.406 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.68 -21.28 0.8 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.14 42.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.732 1.266 . . . . 0.0 111.832 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 54.2 mt -49.95 134.62 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.382 -0.824 . . . . 0.0 111.518 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -152.85 171.6 18.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.222 1.409 . . . . 0.0 111.254 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' C' ' 32' ' ' THR . 12.3 tp -46.63 118.43 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 129.263 3.025 . . . . 0.0 112.136 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -113.5 112.79 48.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.542 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.5 145.69 56.6 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.173 2.582 . . . . 0.0 112.565 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.2 143.89 51.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.078 0.951 . . . . 0.0 111.329 175.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -143.93 151.53 39.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.339 3.056 . . . . 0.0 109.606 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.85 -155.66 26.72 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -144.87 139.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 114.484 -0.858 . . . . 0.0 112.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.519 ' CD ' HD12 ' C' ' 6' ' ' LEU . 0.0 OUTLIER -119.19 155.54 31.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.162 0.985 . . . . 0.0 110.739 173.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.85 163.6 22.2 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.392 -1.442 . . . . 0.0 110.886 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.74 25.09 0.33 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.113 0.965 . . . . 0.0 113.1 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.39 -57.52 2.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.191 2.196 . . . . 0.0 111.08 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.8 172.07 12.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -43.25 64.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.006 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -129.96 57.78 33.33 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 125.223 1.409 . . . . 0.0 111.054 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.37 176.83 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.976 1.784 . . . . 0.0 116.691 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 11.4 p -87.98 162.81 16.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.955 1.702 . . . . 0.0 109.637 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -162.02 165.33 27.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.174 -0.954 . . . . 0.0 112.665 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.64 149.38 15.06 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.14 155.4 15.9 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -91.6 150.78 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.985 2.114 . . . . 0.0 109.151 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.04 121.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.4 t30 -97.78 106.16 18.42 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.59 -174.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -66.58 131.69 46.56 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.779 1.627 . . . . 0.0 112.901 -173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.92 -37.99 12.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.56 -10.71 42.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 26.7 t -152.43 132.55 13.5 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.043 2.537 . . . . 0.0 107.216 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -70.24 118.53 13.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.303 0.956 . . . . 0.0 109.947 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 77.3 p -173.49 170.3 4.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.492 1.917 . . . . 0.0 110.026 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.82 137.88 31.81 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.019 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.441 ' CG2' HD12 ' C' ' 99' ' ' LEU . 0.6 OUTLIER -114.22 165.8 12.31 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.329 1.061 . . . . 0.0 108.578 173.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.42 150.89 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -128.95 142.0 51.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.35 120.3 10.0 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' CZ ' ' B' ' 100' ' ' ARG . . . -164.6 -179.73 38.85 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.79 144.83 42.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.084 0.945 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 34.2 t -97.85 123.13 41.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.549 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -117.89 170.42 8.83 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.585 1.183 . . . . 0.0 113.652 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -130.23 111.61 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.928 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.62 157.23 17.96 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -25.85 -53.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.195 2.198 . . . . 0.0 116.856 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.48 -8.61 56.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.78 47.16 4.31 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 120.399 1.454 . . . . 0.0 110.947 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -119.11 141.67 48.59 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.339 2.256 . . . . 0.0 108.209 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -108.41 145.49 34.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.598 1.159 . . . . 0.0 112.168 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' B' ' 106' ' ' ILE . 18.6 m -149.66 165.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.215 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 59.6 mt -124.3 121.59 35.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.534 ' HE2' HD11 ' B' ' 106' ' ' ILE . 1.4 mmmt -109.81 114.19 27.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -136.06 160.76 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.32 1.533 . . . . 0.0 112.033 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.42 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -109.04 168.16 9.57 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -141.6 161.1 38.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.278 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -144.08 127.09 16.45 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.265 -1.788 . . . . 0.0 110.505 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' C' ' 77' ' ' THR . 1.1 tt -110.5 144.65 39.0 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.577 1.173 . . . . 0.0 110.779 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -128.86 117.21 20.66 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 112.315 -2.22 . . . . 0.0 112.199 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -90.5 158.96 16.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 124.847 1.342 . . . . 0.0 113.848 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -103.07 80.01 1.81 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.84 -175.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.099 0.56 . . . . 0.0 109.924 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -114.47 -23.27 9.42 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.379 -1.451 . . . . 0.0 114.571 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -119.13 149.78 41.13 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.709 1.242 . . . . 0.0 110.455 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' B' ' 94' ' ' LYS . 11.5 tt -61.25 -29.06 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.295 174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.91 3.75 19.13 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.324 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.75 -1.19 11.13 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.963 1.381 . . . . 0.0 113.894 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -58.9 -31.74 68.89 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.273 -0.892 . . . . 0.0 112.74 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 61.0 p-90 -46.54 -44.19 17.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.765 1.226 . . . . 0.0 113.95 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -93.14 -12.88 29.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.979 0.912 . . . . 0.0 113.232 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.35 10.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' C' ' 98' ' ' LEU . 16.8 m -113.25 135.3 53.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.032 0.933 . . . . 0.0 111.449 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -138.82 125.36 20.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 117.597 -1.192 . . . . 0.0 110.552 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.53 154.85 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.211 1.368 . . . . 0.0 111.851 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.61 -175.47 30.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.714 1.149 . . . . 0.0 113.081 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.9 p90 -127.48 153.51 46.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.702 0.801 . . . . 0.0 109.81 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -148.63 147.2 28.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.165 0.986 . . . . 0.0 109.707 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -128.32 132.08 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -119.5 156.41 30.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.111 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 38.7 p -139.1 163.68 31.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.697 1.199 . . . . 0.0 110.662 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -60.79 124.66 21.08 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.419 -0.801 . . . . 0.0 111.517 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.667 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -138.76 153.94 48.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.009 0.818 . . . . 0.0 110.603 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -139.46 126.37 20.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.48 -31.41 72.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -66.3 101.38 0.73 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.75 -8.19 0.11 Allowed Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.1 tttt 75.63 139.09 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.041 2.536 . . . . 0.0 113.721 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -137.73 162.75 33.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.074 1.35 . . . . 0.0 111.617 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -141.05 148.47 40.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.661 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -108.88 151.99 25.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.796 0.838 . . . . 0.0 112.294 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.94 -25.76 66.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' C' ' 110' ' ' TRP . 27.4 tp -73.27 -15.98 61.4 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.346 1.858 . . . . 0.0 110.946 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.24 -6.34 34.28 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 127.192 2.329 . . . . 0.0 114.517 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 p -70.56 148.14 48.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.928 1.864 . . . . 0.0 112.219 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -119.11 139.09 52.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.868 -1.145 . . . . 0.0 109.433 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -127.8 136.16 51.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.692 0.758 . . . . 0.0 110.63 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.05 132.21 52.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.65 126.71 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -87.54 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 O-C-N 125.67 1.856 . . . . 0.0 110.611 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.88 29.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.193 -0.592 . . . . 0.0 111.5 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.49 126.55 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.045 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.19 159.3 29.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 112.277 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 t -53.07 -30.15 34.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -63.46 -39.59 94.86 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.006 -1.059 . . . . 0.0 110.97 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.56 -6.75 10.54 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 116.854 -2.081 . . . . 0.0 114.118 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.36 152.8 44.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.812 1.806 . . . . 0.0 109.705 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -152.03 145.27 24.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.304 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.53 155.67 22.91 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.834 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -169.16 30.96 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 122.928 1.293 . . . . 0.0 112.991 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.508 ' HB ' HD21 ' A' ' 46' ' ' LEU . 4.3 p -134.69 129.22 34.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.413 -1.394 . . . . 0.0 111.646 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -123.25 120.64 33.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.991 0.901 . . . . 0.0 111.607 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.99 132.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.488 ' O ' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -114.9 144.79 42.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.47 -13.99 21.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 143.11 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.572 1.149 . . . . 0.0 112.409 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.23 43.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.467 -1.396 . . . . 0.0 111.505 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.12 -25.82 63.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.54 83.71 14.71 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.568 1.947 . . . . 0.0 109.747 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.68 177.48 7.49 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.176 2.584 . . . . 0.0 110.47 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.11 -27.35 3.3 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 113.301 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -142.57 23.14 1.97 Allowed 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.72 1.608 . . . . 0.0 110.531 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 35' ' ' THR . 63.3 mt -57.21 105.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 123.182 1.468 . . . . 0.0 111.481 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 171.02 7.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.079 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -54.58 126.63 24.51 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 127.645 2.378 . . . . 0.0 111.62 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -104.09 119.54 53.92 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.646 174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -55.23 149.96 42.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.51 2.14 . . . . 0.0 111.562 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.22 149.46 47.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.324 1.05 . . . . 0.0 110.287 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -150.86 149.13 29.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.369 2.267 . . . . 0.0 109.159 177.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.33 -156.87 28.35 Favored Glycine 0 C--O 1.228 -0.236 0 O-C-N 120.355 -1.466 . . . . 0.0 111.058 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.555 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.4 mt -145.99 148.8 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 125.41 1.3 . . . . 0.0 111.704 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 152.81 50.76 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.515 -1.366 . . . . 0.0 112.997 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -101.19 147.12 26.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 14.12 1.77 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.391 1.477 . . . . 0.0 113.533 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -92.56 -42.35 9.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.823 1.649 . . . . 0.0 112.147 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.32 4.62 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.96 0.788 . . . . 0.0 112.64 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 t -70.12 -49.18 53.3 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.582 1.153 . . . . 0.0 112.538 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.34 65.33 72.25 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.07 0.948 . . . . 0.0 111.763 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.15 173.53 5.99 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.537 3.491 . . . . 0.0 116.921 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER -100.36 169.38 9.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 123.443 1.592 . . . . 0.0 110.725 173.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -162.17 162.5 28.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.071 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.87 143.17 8.45 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 118.579 2.192 . . . . 0.0 118.579 -172.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.16 152.33 20.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.514 ' HB ' HD12 ' D' ' 52' ' ' ILE . 1.8 m -89.81 152.23 21.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.032 1.733 . . . . 0.0 109.263 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.71 120.65 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.581 ' CB ' HG21 ' D' ' 52' ' ' ILE . 0.2 OUTLIER -104.45 117.97 35.46 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -82.29 136.31 35.06 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.065 -1.647 . . . . 0.0 114.55 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -97.08 -44.38 7.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.836 -1.074 . . . . 0.0 113.836 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -74.83 -19.28 60.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.368 0.667 . . . . 0.0 112.54 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.41 132.81 13.72 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.703 2.801 . . . . 0.0 107.34 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.45 118.88 20.32 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.284 1.402 . . . . 0.0 111.855 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 76.3 p -176.71 164.5 2.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.926 2.09 . . . . 0.0 107.379 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.6 135.67 17.66 Favored 'General case' 0 CA--C 1.47 -2.103 0 CA-C-O 122.202 1.001 . . . . 0.0 108.781 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -135.34 130.28 34.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 111.066 -2.788 . . . . 0.0 111.492 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.92 154.1 5.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 120.742 0.306 . . . . 0.0 110.212 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -127.99 144.2 51.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.419 HG23 HG13 ' D' ' 78' ' ' VAL . 0.0 OUTLIER -153.84 117.06 4.55 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -161.16 -177.72 34.51 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.451 HE22 HG22 ' D' ' 103' ' ' VAL . 9.7 tt0 -122.98 138.56 54.65 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.806 0.812 . . . . 0.0 111.178 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.6 t -97.97 112.76 24.57 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.154 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -112.01 168.58 9.48 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.793 1.282 . . . . 0.0 110.148 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.74 113.75 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 112.841 -1.981 . . . . 0.0 107.571 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.09 157.95 14.7 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -44.63 -28.63 0.62 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 118.156 2.651 . . . . 0.0 118.156 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -5.69 55.77 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.17 41.07 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.635 1.112 . . . . 0.0 113.416 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.27 144.53 25.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.522 2.329 . . . . 0.0 109.983 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.26 141.92 33.43 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.587 1.155 . . . . 0.0 109.616 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -146.6 160.66 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 125.121 1.513 . . . . 0.0 110.36 175.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 mt -124.43 118.17 26.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -106.39 113.2 26.58 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.6 p -132.86 165.1 25.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.58 1.657 . . . . 0.0 111.598 -173.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.56 168.52 10.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.037 173.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -141.54 158.08 44.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.272 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.68 127.26 28.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.867 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.5 137.24 45.89 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 124.788 1.305 . . . . 0.0 111.726 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.8 113.84 20.75 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.783 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 m -77.66 164.76 25.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 125.215 1.572 . . . . 0.0 111.755 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.6 m -108.61 85.16 2.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.01 178.2 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -116.25 6.43 13.83 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.35 144.88 33.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.427 174.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.2 tt -60.72 -31.11 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.166 174.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.14 6.67 13.11 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.366 1.46 . . . . 0.0 115.072 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -120.9 3.0 10.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.202 1.001 . . . . 0.0 112.831 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -33.41 75.37 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.966 -1.084 . . . . 0.0 113.196 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.41 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.6 p-90 -45.7 -41.04 10.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.12 0.968 . . . . 0.0 113.441 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -98.14 -9.02 26.47 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.242 1.017 . . . . 0.0 113.601 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.95 -0.8 19.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -112.58 141.76 45.96 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.568 0.699 . . . . 0.0 111.861 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -138.69 147.96 43.4 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.22 1.408 . . . . 0.0 109.898 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.75 149.51 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.955 1.707 . . . . 0.0 109.836 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.26 -175.26 27.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 123.799 0.714 . . . . 0.0 111.86 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 28.3 p90 -130.69 157.4 42.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.142 0.577 . . . . 0.0 110.282 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -148.81 145.94 27.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.042 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.6 mt -124.81 126.07 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.07 149.65 37.17 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.398 -0.814 . . . . 0.0 109.625 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 p -133.38 157.29 45.9 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.776 -0.578 . . . . 0.0 109.59 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 121.52 9.26 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.7 tt . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' D' ' 83' ' ' CYS . 25.3 p -150.14 145.46 26.32 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.508 1.13 . . . . 0.0 110.538 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -139.79 127.15 21.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.21 -27.98 68.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.84 101.2 1.04 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.42 -9.74 0.09 OUTLIER Glycine 0 N--CA 1.484 1.899 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -174.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 75.82 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.913 2.485 . . . . 0.0 113.649 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.18 162.73 32.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.846 1.307 . . . . 0.0 111.66 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -139.71 149.7 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.097 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.12 152.73 25.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.675 0.79 . . . . 0.0 111.584 -175.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.59 -26.66 67.21 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' B' ' 110' ' ' TRP . 27.0 tp -72.45 -16.04 61.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.5 1.92 . . . . 0.0 111.237 173.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.57 -5.59 35.32 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.194 2.33 . . . . 0.0 114.363 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 66.4 p -71.27 149.61 46.02 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.926 1.863 . . . . 0.0 112.252 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -121.99 139.05 54.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.914 -1.116 . . . . 0.0 109.808 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -127.37 136.76 52.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.88 0.848 . . . . 0.0 111.018 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.01 131.72 52.15 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 86.6 mt -127.64 126.74 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.84 -87.49 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 125.023 1.452 . . . . 0.0 110.704 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.61 139.33 31.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.287 -0.537 . . . . 0.0 111.328 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.06 125.46 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.908 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -65.26 159.1 24.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.172 0.589 . . . . 0.0 112.236 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 17.7 t -54.2 -28.58 41.74 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -63.37 -37.21 86.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.982 -1.074 . . . . 0.0 110.983 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.1 -4.87 15.95 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.484 1.516 . . . . 0.0 113.753 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.26 155.42 38.28 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.925 1.363 . . . . 0.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -152.51 154.53 35.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.698 1.237 . . . . 0.0 112.72 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.18 156.05 30.55 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.164 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.06 -168.62 30.45 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.844 1.247 . . . . 0.0 113.394 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.524 ' HB ' HD21 ' D' ' 46' ' ' LEU . 7.2 p -133.9 130.5 37.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.589 -1.306 . . . . 0.0 111.763 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -124.05 121.04 34.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.982 0.896 . . . . 0.0 111.515 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.3 133.45 66.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.456 ' O ' HG21 ' D' ' 44' ' ' ILE . 1.0 OUTLIER -114.99 145.72 41.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -173.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.6 -15.97 20.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 143.55 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.441 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.71 158.3 43.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.678 -1.264 . . . . 0.0 111.615 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.96 -26.06 63.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.98 83.42 14.05 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.384 1.874 . . . . 0.0 109.441 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.72 177.48 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.091 2.527 . . . . 0.0 110.546 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.9 -27.24 3.35 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 121.346 -0.847 . . . . 0.0 113.324 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 23.32 2.0 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.799 1.64 . . . . 0.0 110.687 -177.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.456 HG21 ' O ' ' D' ' 35' ' ' THR . 62.9 mt -57.21 106.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 123.195 1.474 . . . . 0.0 111.296 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.22 170.79 8.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.954 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' D' ' 32' ' ' THR . 0.4 OUTLIER -53.78 126.31 21.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 127.409 2.284 . . . . 0.0 111.628 176.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -104.53 119.87 52.35 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.015 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.97 150.4 38.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.354 2.036 . . . . 0.0 111.456 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.85 152.66 50.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 110.059 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -154.52 149.29 26.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.759 2.024 . . . . 0.0 109.691 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.26 -155.29 26.43 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 119.257 0.935 . . . . 0.0 113.948 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.1 mt -146.84 148.8 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.717 1.207 . . . . 0.0 111.838 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.04 152.34 49.97 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.482 -1.386 . . . . 0.0 112.794 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -100.2 146.97 26.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 16.17 1.84 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 113.335 -175.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -91.93 -42.12 10.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 174.39 5.34 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -71.8 -47.55 52.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 0.0 112.669 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.5 64.68 73.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 124.644 1.178 . . . . 0.0 112.673 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.43 173.61 8.5 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.654 3.569 . . . . 0.0 116.639 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.303 0.5 OUTLIER -99.15 168.62 9.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.533 1.635 . . . . 0.0 111.086 173.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.54 161.78 27.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.927 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.98 143.6 8.95 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.6 151.64 18.91 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 52' ' ' ILE . 1.7 m -89.16 154.0 20.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.357 1.863 . . . . 0.0 109.52 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.25 121.04 45.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.555 ' CB ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -104.84 117.25 33.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -174.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.83 135.16 35.46 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.24 -1.538 . . . . 0.0 114.676 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -95.62 -44.28 7.55 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -74.66 -19.59 60.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.455 0.702 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.39 132.19 13.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.553 2.741 . . . . 0.0 107.491 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -75.98 118.9 19.24 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.444 1.475 . . . . 0.0 112.107 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -176.59 164.12 2.47 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 127.004 2.122 . . . . 0.0 107.196 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.29 135.18 17.65 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-O 122.505 1.145 . . . . 0.0 108.897 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 4.9 m -135.02 130.16 35.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.576 -169.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.419 HG13 HG23 ' A' ' 80' ' ' THR . 4.2 m -103.38 154.58 5.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 120.623 0.249 . . . . 0.0 110.421 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -128.43 144.0 51.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.44 116.91 4.65 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -160.98 -177.0 33.71 Favored Glycine 0 CA--C 1.503 -0.707 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.73 137.98 54.31 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.66 0.859 . . . . 0.0 110.734 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' D' ' 4' ' ' CYS . 42.7 t -97.92 112.82 24.6 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.266 -1.35 . . . . 0.0 108.771 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.43 169.16 8.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.762 1.225 . . . . 0.0 110.031 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.08 110.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.916 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -60.19 157.3 13.55 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -43.59 -30.17 0.57 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.64 -0.76 48.64 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.76 43.35 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.511 -0.743 . . . . 0.0 113.13 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.85 146.14 23.99 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.748 2.019 . . . . 0.0 109.545 175.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -101.27 142.24 32.98 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.806 1.242 . . . . 0.0 108.795 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' A' ' 106' ' ' ILE . 21.9 m -146.26 159.13 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 125.07 1.481 . . . . 0.0 110.7 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 42.4 mt -121.64 117.01 25.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.17 112.28 25.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' D' ' 81' ' ' GLY . 2.2 p -132.27 165.62 23.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.613 1.673 . . . . 0.0 111.752 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.19 168.07 10.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 114.729 -1.123 . . . . 0.0 107.977 173.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -141.32 158.34 44.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.243 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.97 127.02 27.88 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.54 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 137.22 46.06 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.767 1.292 . . . . 0.0 111.46 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' D' ' 100' ' ' ARG . 6.2 tpt180 -120.72 113.83 20.78 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 113.131 -1.85 . . . . 0.0 110.855 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -77.58 164.9 24.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.829 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -109.25 84.82 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.451 HG22 HE22 ' A' ' 82' ' ' GLN . 33.4 m -74.24 -178.28 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -119.1 6.44 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.94 145.15 34.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.225 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 1.2 tt -60.34 -30.61 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.15 7.08 18.09 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.609 1.576 . . . . 0.0 115.207 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.63 3.21 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.25 1.025 . . . . 0.0 112.888 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.63 -33.04 74.73 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.119 -0.988 . . . . 0.0 112.655 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.42 ' CD1' HD11 ' B' ' 14' ' ' LEU . 56.5 p-90 -45.41 -41.38 9.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 113.636 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -98.3 -8.95 26.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.312 1.045 . . . . 0.0 113.672 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.64 -1.46 21.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 3.7 m -111.85 141.69 45.16 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.748 0.704 . . . . 0.0 111.895 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -138.35 148.05 44.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.335 1.454 . . . . 0.0 109.961 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.95 149.59 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 120.804 1.638 . . . . 0.0 109.83 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.51 -175.21 27.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.743 0.687 . . . . 0.0 111.877 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 29.1 p90 -130.77 156.78 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.125 0.57 . . . . 0.0 110.051 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -148.28 145.81 28.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.388 0.675 . . . . 0.0 109.922 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.3 mt -124.32 126.45 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -114.84 150.28 35.77 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.069 0.938 . . . . 0.0 110.076 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 61.9 p -133.64 158.81 42.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.683 0.793 . . . . 0.0 110.352 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 126.58 28.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.282 0.633 . . . . 0.0 109.381 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p -147.01 149.27 32.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 124.58 1.175 . . . . 0.0 111.207 -174.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.5 p -139.74 127.02 21.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.71 -28.16 67.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.43 101.97 1.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.36 -14.3 0.13 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 118.592 2.197 . . . . 0.0 118.592 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.4 ' HD3' ' CD2' ' B' ' 123' ' ' LEU . 4.9 tttt 80.7 143.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 128.502 2.721 . . . . 0.0 112.776 -176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -137.56 162.74 32.94 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 111.536 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.756 ' HB ' HD13 ' B' ' 123' ' ' LEU . 6.1 t -134.01 154.07 51.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.092 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -114.41 150.79 34.14 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.848 0.859 . . . . 0.0 111.409 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.05 -25.18 66.92 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' D' ' 110' ' ' TRP . 27.2 tp -73.77 -16.29 61.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.852 2.061 . . . . 0.0 111.011 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.07 -6.52 32.53 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.279 2.371 . . . . 0.0 114.603 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 45.4 p -71.49 147.15 48.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.776 1.788 . . . . 0.0 111.907 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.31 139.76 50.85 Favored 'General case' 0 CA--C 1.522 -0.103 0 O-C-N 120.829 -1.169 . . . . 0.0 109.823 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -127.96 135.17 49.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -123.85 130.7 53.03 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -126.12 126.83 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.88 -88.02 0.1 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 125.506 1.754 . . . . 0.0 110.678 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.55 141.22 32.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.069 -0.665 . . . . 0.0 111.966 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.61 126.14 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.256 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.9 158.93 29.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.879 0.472 . . . . 0.0 112.176 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -53.07 -30.05 33.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -63.5 -39.21 93.84 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.924 -1.11 . . . . 0.0 111.005 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.42 -7.22 10.54 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 116.882 -2.066 . . . . 0.0 114.159 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.04 152.74 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.73 1.765 . . . . 0.0 109.757 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -152.18 145.83 24.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.927 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.89 156.31 22.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.941 174.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.63 -169.11 30.75 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-O 122.588 1.104 . . . . 0.0 113.345 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.532 ' HB ' HD21 ' B' ' 46' ' ' LEU . 10.8 p -133.3 129.84 38.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.583 -1.309 . . . . 0.0 112.008 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -122.87 121.26 35.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 122.012 0.91 . . . . 0.0 111.066 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -121.07 132.62 70.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.436 ' O ' HG21 ' B' ' 44' ' ' ILE . 1.0 OUTLIER -114.6 146.93 40.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.69 -16.64 18.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.57 144.42 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 112.387 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.5 158.22 42.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.625 -1.297 . . . . 0.0 111.383 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.7 -26.57 64.42 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -140.71 83.44 14.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.689 1.996 . . . . 0.0 109.586 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.58 177.46 7.45 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.19 2.593 . . . . 0.0 110.532 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.98 -27.04 3.36 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.285 -0.885 . . . . 0.0 113.382 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -142.68 23.64 1.92 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.879 1.672 . . . . 0.0 110.666 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.436 HG21 ' O ' ' B' ' 35' ' ' THR . 64.4 mt -57.62 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.986 1.374 . . . . 0.0 111.35 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 170.03 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.944 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' B' ' 32' ' ' THR . 0.5 OUTLIER -52.21 126.24 18.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.397 2.279 . . . . 0.0 112.184 174.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.4 m -104.88 120.62 49.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.985 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -55.33 150.23 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.732 2.288 . . . . 0.0 111.818 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.23 149.61 47.28 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.985 0.914 . . . . 0.0 110.302 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' C' ' 50' ' ' LEU . 0.2 OUTLIER -150.74 149.34 29.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.342 2.257 . . . . 0.0 108.884 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.53 -156.94 28.36 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 120.246 1.385 . . . . 0.0 111.358 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.557 HG21 ' HB3' ' C' ' 69' ' ' ASN . 3.4 mt -146.4 148.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 125.21 1.182 . . . . 0.0 111.612 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 153.92 51.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.748 -1.22 . . . . 0.0 113.061 175.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -101.83 147.51 26.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 16.71 1.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.37 1.468 . . . . 0.0 113.394 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -92.85 -40.2 10.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.165 1.786 . . . . 0.0 111.899 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.55 174.31 8.44 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.087 0.867 . . . . 0.0 111.979 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -70.36 -50.15 41.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.126 1.37 . . . . 0.0 112.688 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.43 63.74 70.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.108 0.963 . . . . 0.0 112.107 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -66.73 172.95 8.71 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.446 3.43 . . . . 0.0 116.407 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.306 0.4 OUTLIER -98.9 167.85 10.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.662 1.22 . . . . 0.0 110.823 173.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.83 162.26 29.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.866 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.62 143.8 9.05 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -160.08 153.37 22.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.524 ' HB ' HD12 ' C' ' 52' ' ' ILE . 1.6 m -91.29 151.54 20.85 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.218 1.807 . . . . 0.0 109.485 173.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.67 120.82 51.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.569 ' CB ' HG21 ' C' ' 52' ' ' ILE . 0.1 OUTLIER -104.57 117.42 34.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -82.04 136.4 35.23 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.98 -1.7 . . . . 0.0 114.402 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -97.06 -44.22 7.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.896 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -75.12 -19.29 59.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.833 0.853 . . . . 0.0 112.495 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.44 133.35 14.1 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.832 2.853 . . . . 0.0 107.412 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -77.93 118.91 20.69 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.17 1.35 . . . . 0.0 111.895 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.6 p -176.69 164.32 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.957 2.103 . . . . 0.0 107.18 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.32 135.69 18.01 Favored 'General case' 0 CA--C 1.473 -1.991 0 CA-C-O 122.244 1.021 . . . . 0.0 108.668 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . 0.251 5.2 m -135.88 130.06 33.25 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.337 -169.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.94 154.87 5.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -129.16 143.82 50.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.402 HG23 HG13 ' C' ' 78' ' ' VAL . 0.0 OUTLIER -153.58 117.45 4.75 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -161.35 -177.71 34.68 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 115.951 1.14 . . . . 0.0 115.951 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.462 HE22 HG22 ' C' ' 103' ' ' VAL . 9.7 tt0 -123.22 138.28 54.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.374 0.691 . . . . 0.0 110.456 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.8 112.82 24.57 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.32 168.95 8.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.699 1.238 . . . . 0.0 109.973 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -123.24 109.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.497 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -58.66 158.26 8.14 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -43.56 -35.91 1.88 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.727 2.491 . . . . 0.0 117.727 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -20.51 61.44 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.92 19.73 12.53 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.734 1.159 . . . . 0.0 113.434 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 149.62 26.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.169 1.788 . . . . 0.0 109.097 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -101.36 145.45 28.9 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.401 1.481 . . . . 0.0 110.128 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' C' ' 106' ' ' ILE . 23.3 m -147.77 160.21 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.234 174.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 mt -121.86 117.24 26.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.41 111.37 23.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' B' ' 81' ' ' GLY . 2.0 p -130.93 166.33 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.127 1.917 . . . . 0.0 111.907 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -119.64 168.19 11.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.109 172.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -141.95 157.81 44.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.086 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -135.1 127.29 30.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 136.51 47.28 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 124.882 1.364 . . . . 0.0 111.583 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 6.3 tpt180 -120.15 113.88 21.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.871 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 23.2 m -78.15 164.91 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 124.925 1.391 . . . . 0.0 111.814 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 71.8 m -108.9 87.23 2.44 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 103.009 -2.959 . . . . 0.0 103.009 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.08 -174.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -122.5 7.49 9.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.57 145.68 31.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.293 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' C' ' 92' ' ' VAL . 1.2 tt -60.94 -30.72 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.114 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.14 17.03 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.279 1.419 . . . . 0.0 114.902 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.93 3.37 10.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.389 1.095 . . . . 0.0 112.86 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.17 -32.84 74.33 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.228 -0.92 . . . . 0.0 113.261 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' D' ' 14' ' ' LEU . 56.5 p-90 -45.29 -41.83 9.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.307 1.043 . . . . 0.0 113.694 175.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -97.29 -9.65 27.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -0.81 19.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.09 141.91 45.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.358 0.663 . . . . 0.0 111.545 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -138.4 148.37 44.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.624 1.57 . . . . 0.0 110.114 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.33 149.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 120.594 1.543 . . . . 0.0 109.727 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.69 27.36 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 124.04 0.828 . . . . 0.0 111.694 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 28.6 p90 -129.93 157.11 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.062 0.545 . . . . 0.0 110.096 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -148.68 145.0 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.81 129.1 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -116.88 149.79 39.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.752 0.786 . . . . 0.0 110.944 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 81.6 p -135.18 158.44 44.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.957 0.903 . . . . 0.0 110.014 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 129.53 41.67 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.218 -0.926 . . . . 0.0 110.762 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.756 HD13 ' HB ' ' B' ' 11' ' ' THR . 18.1 tp . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.705 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 23.8 p -147.88 147.43 29.74 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.815 0.697 . . . . 0.0 111.386 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.4 p -139.63 126.82 21.19 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -67.69 -29.1 68.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -67.58 102.14 1.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.31 0.11 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 73.2 140.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.637 2.375 . . . . 0.0 113.997 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -137.81 162.73 33.19 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.969 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.9 t -139.45 148.06 42.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.553 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -108.12 152.94 23.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.661 0.784 . . . . 0.0 111.553 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.0 -26.14 65.75 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.41 HD11 ' CD1' ' A' ' 110' ' ' TRP . 27.6 tp -72.41 -16.15 61.84 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.581 1.953 . . . . 0.0 110.956 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.4 -6.66 34.08 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 127.497 2.475 . . . . 0.0 114.451 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 73.2 p -70.67 148.45 48.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.87 1.835 . . . . 0.0 112.114 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.3 139.62 52.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 120.867 -1.146 . . . . 0.0 109.962 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -128.1 135.81 50.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.44 130.82 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.84 126.29 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.01 -87.64 0.09 OUTLIER Glycine 0 CA--C 1.526 0.74 0 O-C-N 125.41 1.694 . . . . 0.0 110.769 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.53 141.04 32.01 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.233 -0.569 . . . . 0.0 111.387 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.77 125.07 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.155 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -64.93 158.28 25.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.236 0.615 . . . . 0.0 112.252 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 17.6 t -53.74 -28.39 34.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -63.47 -37.15 86.2 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.805 -1.184 . . . . 0.0 111.005 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.31 -4.86 15.47 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.673 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 154.13 38.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.023 1.412 . . . . 0.0 111.287 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -151.71 154.39 36.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.934 0.873 . . . . 0.0 112.278 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -118.34 156.2 29.33 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.538 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -168.79 30.46 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 122.157 0.865 . . . . 0.0 113.52 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.5 ' HB ' HD21 ' C' ' 46' ' ' LEU . 7.2 p -133.45 130.08 38.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.778 -1.211 . . . . 0.0 112.018 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -125.09 120.96 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.627 1.203 . . . . 0.0 111.416 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -119.93 132.66 69.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.48 ' O ' HG21 ' C' ' 44' ' ' ILE . 0.8 OUTLIER -116.2 146.1 42.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -173.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.52 -13.89 22.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.468 ' H ' HG23 ' C' ' 35' ' ' THR . 27.8 m -134.34 144.44 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.737 1.215 . . . . 0.0 113.357 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.82 158.55 43.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.282 -1.511 . . . . 0.0 111.645 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.46 -26.01 63.44 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -140.84 83.09 14.66 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.552 1.941 . . . . 0.0 109.709 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.6 177.4 7.53 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.089 2.526 . . . . 0.0 110.605 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.27 -27.58 3.26 Favored Glycine 0 N--CA 1.476 1.348 0 O-C-N 121.345 -0.847 . . . . 0.0 113.412 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.99 23.12 2.07 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.893 1.677 . . . . 0.0 110.589 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.48 HG21 ' O ' ' C' ' 35' ' ' THR . 70.7 mt -56.95 106.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 122.946 1.355 . . . . 0.0 111.631 -174.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.1 t -113.63 169.56 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.005 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' C' ' 32' ' ' THR . 0.5 OUTLIER -52.36 126.89 20.54 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.507 2.323 . . . . 0.0 111.707 174.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.09 120.09 50.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.336 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.78 149.78 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.461 2.107 . . . . 0.0 111.432 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.66 153.05 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 109.917 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' B' ' 50' ' ' LEU . 0.3 OUTLIER -154.65 149.31 26.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.859 2.064 . . . . 0.0 109.72 -178.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.6 -155.64 26.96 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 119.207 0.912 . . . . 0.0 113.863 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.569 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.1 mt -146.41 148.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.846 -174.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 153.04 50.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.304 -1.497 . . . . 0.0 112.869 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -101.11 147.46 26.2 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 16.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.019 1.328 . . . . 0.0 113.493 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -92.95 -40.0 10.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.737 1.615 . . . . 0.0 112.06 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.57 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.825 0.85 . . . . 0.0 113.048 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 34.3 t -69.2 -48.47 61.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.429 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.61 64.82 69.61 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.241 1.017 . . . . 0.0 112.614 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -66.22 173.29 7.59 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.497 3.465 . . . . 0.0 116.931 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.305 0.5 OUTLIER -99.18 168.28 10.15 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.504 1.621 . . . . 0.0 111.13 173.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -162.24 162.0 28.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.937 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.63 143.83 9.08 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 118.075 1.99 . . . . 0.0 118.075 -172.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -160.42 152.42 20.18 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.5 ' HB ' HD12 ' B' ' 52' ' ' ILE . 1.7 m -90.01 154.36 19.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.367 1.867 . . . . 0.0 109.242 173.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -132.64 121.09 44.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.557 ' HB3' HG21 ' B' ' 52' ' ' ILE . 0.2 OUTLIER -105.29 115.83 30.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 117.972 0.351 . . . . 0.0 110.12 -174.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.02 135.88 36.47 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -96.38 -44.25 7.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.929 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -74.91 -19.67 60.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.789 0.836 . . . . 0.0 112.563 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -152.35 133.1 14.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.83 2.852 . . . . 0.0 107.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -77.78 118.93 20.6 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.39 1.45 . . . . 0.0 111.974 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 78.7 p -176.51 164.64 2.57 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 126.868 2.067 . . . . 0.0 107.201 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.64 135.45 17.45 Favored 'General case' 0 CA--C 1.475 -1.942 0 CA-C-O 122.593 1.187 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.0 m -135.55 130.07 34.0 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 110.761 -2.927 . . . . 0.0 111.706 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.402 HG13 HG23 ' B' ' 80' ' ' THR . 4.0 m -103.28 154.81 5.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.676 0.274 . . . . 0.0 110.328 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -128.87 144.0 51.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.81 116.88 4.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -160.45 -176.98 33.14 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.09 137.82 54.52 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.417 0.716 . . . . 0.0 110.575 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.88 112.85 24.61 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 117.232 -1.366 . . . . 0.0 108.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.17 168.94 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.123 1.369 . . . . 0.0 109.973 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -124.32 109.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.989 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.88 160.17 10.08 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -44.56 -31.92 1.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.02 -25.55 58.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.63 -3.74 19.66 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.909 1.242 . . . . 0.0 114.18 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 145.44 55.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.605 1.962 . . . . 0.0 111.684 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -101.14 140.75 35.0 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.668 1.987 . . . . 0.0 109.902 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.431 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.5 m -144.78 160.1 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.608 1.163 . . . . 0.0 110.954 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 mt -120.7 116.98 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -106.13 110.69 23.02 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.434 HG22 ' HA3' ' C' ' 81' ' ' GLY . 2.2 p -130.94 166.03 21.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 123.625 1.679 . . . . 0.0 112.029 -174.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -119.17 168.72 10.59 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -142.21 158.18 44.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.136 172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.66 127.27 28.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.609 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.58 137.31 45.84 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 124.704 1.253 . . . . 0.0 111.449 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.98 113.87 20.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.798 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -77.89 165.85 23.61 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.891 1.369 . . . . 0.0 111.985 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 69.5 m -109.89 87.24 2.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . 0.462 HG22 HE22 ' B' ' 82' ' ' GLN . 35.1 m -75.33 -172.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.284 -0.885 . . . . 0.0 108.658 174.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -124.88 7.86 8.08 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.94 145.98 30.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.031 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' B' ' 92' ' ' VAL . 1.2 tt -59.29 -31.22 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.559 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.03 6.22 14.64 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.187 1.375 . . . . 0.0 115.471 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -120.61 3.27 10.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.615 1.207 . . . . 0.0 113.089 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.51 -32.63 74.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.296 -0.877 . . . . 0.0 112.948 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.414 ' CD1' HD11 ' A' ' 14' ' ' LEU . 56.2 p-90 -45.64 -41.4 10.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -97.56 -9.83 26.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.159 0.984 . . . . 0.0 113.557 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -0.47 17.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.097 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.64 141.92 45.85 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.433 0.693 . . . . 0.0 111.547 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -138.65 148.02 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.522 1.529 . . . . 0.0 109.79 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.78 149.32 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 120.655 1.57 . . . . 0.0 109.664 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.69 -176.26 28.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.753 0.692 . . . . 0.0 111.572 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 28.7 p90 -129.7 156.71 43.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.069 0.548 . . . . 0.0 110.336 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -148.12 145.17 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.963 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.55 129.37 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.98 149.85 40.25 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.411 -0.806 . . . . 0.0 110.265 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.9 p -132.11 158.93 40.37 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.377 -0.827 . . . . 0.0 110.215 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 125.85 25.3 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 122.115 -0.366 . . . . 0.0 110.089 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.578 -177.101 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 pttt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.22 147.18 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.419 1.104 . . . . 0.0 109.152 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.425 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 69.6 m -139.27 126.71 21.6 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.764 -1.21 . . . . 0.0 111.568 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.08 -25.3 62.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.68 122.15 9.29 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.163 1.458 . . . . 0.0 110.598 174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.63 -118.02 2.38 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.805 2.145 . . . . 0.0 109.154 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -141.53 156.1 45.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.533 1.133 . . . . 0.0 113.37 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.68 160.85 39.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.901 -1.954 . . . . 0.0 111.201 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -139.86 142.24 36.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.84 147.29 31.11 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.713 0.805 . . . . 0.0 112.227 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' C' ' 110' ' ' TRP . 33.0 tp -72.92 -15.59 61.57 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.16 1.384 . . . . 0.0 111.8 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.76 -16.63 21.01 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.547 2.499 . . . . 0.0 113.593 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -61.28 146.57 47.46 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.517 1.151 . . . . 0.0 113.076 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -121.4 139.25 53.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.646 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -131.66 145.63 51.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 111.585 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -129.87 132.73 46.53 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.223 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.58 126.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.39 -95.03 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 O-C-N 124.22 0.95 . . . . 0.0 112.274 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.58 126.89 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.436 -1.038 . . . . 0.0 110.529 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.44 139.3 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.01 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.42 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 10.8 t-20 -75.14 166.44 23.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.108 0.963 . . . . 0.0 112.959 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.4 t -56.42 -34.51 66.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.982 1.313 . . . . 0.0 113.358 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -68.91 -35.59 77.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.593 -1.317 . . . . 0.0 111.54 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.68 -6.48 9.71 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.83 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 24' ' ' ASN . 8.3 pt-20 -67.19 142.62 56.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.439 1.496 . . . . 0.0 111.98 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -155.53 147.47 23.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.731 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 163.73 13.28 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.87 -166.87 29.54 Favored Glycine 0 C--O 1.238 0.378 0 O-C-N 121.335 -0.853 . . . . 0.0 111.895 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.571 ' HB ' HD11 ' A' ' 46' ' ' LEU . 33.7 p -140.01 128.65 23.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.937 -1.132 . . . . 0.0 111.788 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -103.82 137.57 41.65 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.231 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 46' ' ' LEU . 22.7 mt -128.64 126.17 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 37' ' ' VAL . 15.3 m -104.99 140.75 37.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.733 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.28 -2.42 33.76 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG21 HD21 ' A' ' 14' ' ' LEU . 30.4 m -138.54 163.43 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.616 1.966 . . . . 0.0 111.446 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.37 16.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.834 -1.791 . . . . 0.0 112.857 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -69.46 -47.04 65.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -124.86 79.41 64.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.18 2.992 . . . . 0.0 110.202 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.24 25.42 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 124.825 3.683 . . . . 0.0 116.591 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.36 0.75 63.02 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.107 -1.621 . . . . 0.0 115.799 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.76 30.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -49.03 131.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.034 -1.666 . . . . 0.0 112.399 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.17 165.26 27.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.886 2.074 . . . . 0.0 108.707 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 32' ' ' THR . 5.1 tt -49.24 131.04 19.91 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.78 1.632 . . . . 0.0 111.656 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 p -108.5 122.66 39.63 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.163 0.506 . . . . 0.0 112.206 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.56 145.36 89.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.151 2.567 . . . . 0.0 111.997 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -133.78 156.6 47.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.553 0.741 . . . . 0.0 112.45 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -158.86 149.06 19.51 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.448 2.299 . . . . 0.0 109.366 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.35 -153.76 23.5 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 120.461 1.482 . . . . 0.0 110.345 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.547 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.3 mt -146.39 138.17 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.493 1.117 . . . . 0.0 112.026 -174.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -122.19 141.27 51.64 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.899 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -57.06 -52.39 65.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.635 0.374 . . . . 0.0 111.152 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HE3' ' OG ' ' A' ' 5' ' ' SER . 16.7 tptm 52.58 -0.76 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.339 2.256 . . . . 0.0 116.363 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -75.08 -56.29 4.89 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.747 2.019 . . . . 0.0 113.408 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . . . -79.26 173.35 12.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.81 0.814 . . . . 0.0 110.933 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -73.42 -28.93 62.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.471 1.108 . . . . 0.0 113.749 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -141.81 46.47 0.82 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.296 1.439 . . . . 0.0 112.15 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 48.4 Cg_endo -82.39 -177.45 3.46 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.127 2.551 . . . . 0.0 114.245 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.3 p -84.91 167.77 15.64 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.143 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.86 159.38 15.89 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.484 1.114 . . . . 0.0 111.277 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.91 148.18 14.71 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.62 162.82 35.3 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.484 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.8 m -100.59 146.88 26.58 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 127.127 2.171 . . . . 0.0 109.413 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.34 117.0 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.541 ' HB2' HG21 ' D' ' 52' ' ' ILE . 53.3 t30 -98.65 106.56 18.84 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.893 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.329 52.4 m95 -67.93 158.87 31.75 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 121.56 1.982 . . . . 0.0 115.197 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -39.26 4.02 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -90.44 -11.99 38.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -152.42 143.6 23.19 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.076 2.55 . . . . 0.0 106.393 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.61 118.53 15.65 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.042 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -171.45 164.85 7.0 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.504 1.522 . . . . 0.0 111.644 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -146.99 138.76 24.33 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 123.867 1.794 . . . . 0.0 110.468 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.35 127.26 27.57 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 109.579 -3.464 . . . . 0.0 109.715 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.23 155.87 6.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.011 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.97 139.94 52.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.405 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -149.48 113.9 5.26 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -174.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.38 176.42 29.84 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.04 -1.076 . . . . 0.0 115.509 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 9.7 tt0 -118.05 146.69 43.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.178 -1.511 . . . . 0.0 108.934 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.8 t -97.09 129.61 44.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.368 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -125.72 167.87 14.55 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.867 1.318 . . . . 0.0 112.333 177.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.5 119.02 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 112.668 -2.06 . . . . 0.0 106.7 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -58.44 154.14 14.44 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.47 -23.58 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -7.34 58.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.554 1.142 . . . . 0.0 113.998 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.56 36.93 8.33 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.995 0.809 . . . . 0.0 113.981 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.73 151.91 35.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.868 1.267 . . . . 0.0 110.85 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -101.33 146.33 27.71 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 111.059 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.9 m -148.17 160.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.329 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.5 mt -121.43 115.64 23.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -105.71 110.65 23.03 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.427 HG22 ' HA3' ' A' ' 81' ' ' GLY . 6.2 p -126.02 166.61 16.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.886 1.327 . . . . 0.0 110.528 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.97 170.9 8.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -144.64 159.24 43.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.215 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.0 tp -137.72 123.24 19.66 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.451 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 137.79 44.96 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 125.569 1.793 . . . . 0.0 113.185 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -120.16 119.36 33.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.934 2.021 . . . . 0.0 111.762 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -86.25 160.11 19.26 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.309 1.006 . . . . 0.0 110.815 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m -103.43 82.17 2.01 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.16 -12.84 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.41 -29.47 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.3 137.12 51.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.025 1.284 . . . . 0.0 112.383 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.488 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.8 tt -62.5 -25.6 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.31 -3.76 33.42 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.628 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -124.69 3.16 8.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.396 1.078 . . . . 0.0 113.879 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -34.85 60.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.364 -0.835 . . . . 0.0 112.377 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.608 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 55.6 p-90 -49.95 -44.94 50.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.767 1.227 . . . . 0.0 113.542 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.608 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -89.58 -10.78 44.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.387 -0.82 . . . . 0.0 112.429 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.35 -0.05 24.17 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -118.61 146.25 44.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.19 0.596 . . . . 0.0 111.765 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.56 151.66 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.789 1.636 . . . . 0.0 110.498 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.32 148.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.224 1.375 . . . . 0.0 111.556 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.02 -176.8 27.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 122.55 1.083 . . . . 0.0 112.638 175.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -122.15 152.68 39.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.86 0.864 . . . . 0.0 108.812 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -149.63 132.82 16.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.104 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -124.95 121.32 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.585 -0.697 . . . . 0.0 110.725 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -110.38 151.55 27.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.776 -1.557 . . . . 0.0 110.396 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -133.54 160.25 38.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.281 1.032 . . . . 0.0 109.491 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -57.97 110.47 0.93 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 123' ' ' LEU . 7.0 tt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 N--CA 1.466 0.344 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 p -116.32 144.43 44.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.054 0.942 . . . . 0.0 108.763 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . 0.404 ' OG ' ' HE3' ' D' ' 57' ' ' LYS . 59.5 m -139.56 126.91 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.405 -1.434 . . . . 0.0 113.178 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.08 -26.99 64.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.5 121.38 7.59 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.009 1.385 . . . . 0.0 110.47 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.38 -117.9 2.25 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.844 2.164 . . . . 0.0 109.512 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -143.87 152.37 41.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.219 1.008 . . . . 0.0 113.337 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -142.16 158.05 44.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.255 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -136.46 144.95 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.661 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.12 146.58 35.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.553 0.741 . . . . 0.0 112.299 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.13 -23.3 67.38 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.56 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.8 tp -72.63 -14.69 61.66 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.027 1.331 . . . . 0.0 112.047 174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -14.55 31.61 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.564 2.507 . . . . 0.0 113.563 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.34 149.59 41.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.759 1.266 . . . . 0.0 113.059 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -125.12 142.18 51.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.028 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -133.02 143.87 49.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.407 0.622 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -128.38 131.93 48.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.224 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.72 127.14 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -95.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.451 1.094 . . . . 0.0 112.358 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -137.87 127.09 24.49 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.46 -1.024 . . . . 0.0 110.797 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.86 139.96 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.233 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.68 164.1 25.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.974 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.9 t -54.58 -34.22 61.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.178 1.391 . . . . 0.0 114.166 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -66.94 -35.66 80.47 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.288 -1.507 . . . . 0.0 111.545 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.1 -6.21 9.44 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 124.408 1.004 . . . . 0.0 114.313 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.12 147.56 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.17 162.86 40.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.577 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.72 168.15 14.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.14 -164.9 29.9 Favored Glycine 0 C--O 1.238 0.396 0 O-C-N 120.184 -1.573 . . . . 0.0 112.082 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.583 ' HB ' HD11 ' D' ' 46' ' ' LEU . 35.5 p -140.54 128.0 21.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.133 0.968 . . . . 0.0 112.058 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -104.71 138.45 40.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.86 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' D' ' 46' ' ' LEU . 21.7 mt -129.49 126.56 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.431 HG22 ' H ' ' D' ' 37' ' ' VAL . 16.4 m -105.06 141.15 37.14 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.703 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.08 -2.75 33.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.479 HG21 HD21 ' D' ' 14' ' ' LEU . 26.8 m -138.2 163.85 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.41 1.884 . . . . 0.0 111.142 -174.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.32 167.78 15.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.917 -1.74 . . . . 0.0 112.655 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -69.88 -46.56 65.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.284 1.034 . . . . 0.0 108.261 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -125.37 79.16 67.02 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.985 2.914 . . . . 0.0 110.121 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.85 24.47 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.937 3.758 . . . . 0.0 116.59 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.67 60.35 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.182 -1.574 . . . . 0.0 115.915 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.34 29.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' D' ' 72' ' ' PHE . 30.8 mt -48.99 131.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.019 -1.676 . . . . 0.0 112.417 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 164.89 28.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.877 2.071 . . . . 0.0 108.821 174.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' D' ' 32' ' ' THR . 5.1 tt -49.01 130.66 18.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.656 1.582 . . . . 0.0 111.456 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -107.98 122.73 39.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 121.388 0.613 . . . . 0.0 112.408 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.22 144.76 89.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.919 2.412 . . . . 0.0 111.582 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . 0.422 ' C ' HD12 ' D' ' 49' ' ' LEU . 2.0 pp -131.41 164.11 26.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.62 0.768 . . . . 0.0 112.305 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -165.52 149.03 8.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.226 1.811 . . . . 0.0 109.483 -174.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.48 -156.28 27.71 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 120.858 1.663 . . . . 0.0 112.952 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -146.13 137.11 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.246 1.018 . . . . 0.0 111.486 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -122.13 140.9 52.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.478 1.511 . . . . 0.0 108.578 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.14 -50.96 71.19 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.068 -0.395 . . . . 0.0 111.353 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . 0.404 ' HE3' ' OG ' ' D' ' 5' ' ' SER . 15.1 tptm 51.61 2.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.507 2.323 . . . . 0.0 116.156 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -78.81 -56.32 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.129 2.171 . . . . 0.0 113.568 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' D' ' 62' ' ' PRO . . . -79.65 173.62 12.4 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.467 1.104 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -74.03 -27.06 60.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.682 -1.151 . . . . 0.0 113.969 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -143.01 48.53 1.01 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 125.2 1.4 . . . . 0.0 112.754 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' D' ' 59' ' ' ALA . 45.4 Cg_endo -82.8 -177.65 3.49 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.221 2.614 . . . . 0.0 114.939 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -85.51 168.3 14.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.492 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.37 159.84 15.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 111.148 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.13 148.5 15.19 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -159.85 162.66 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . 0.506 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.8 m -100.6 149.6 23.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.238 2.215 . . . . 0.0 109.01 173.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -129.1 117.81 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 52' ' ' ILE . 51.2 t30 -100.17 107.45 19.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.746 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.336 50.9 m95 -68.68 158.24 34.55 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.102 1.774 . . . . 0.0 115.334 -172.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.35 4.26 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' D' ' 44' ' ' ILE . 47.0 p90 -91.09 -12.03 36.85 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -152.31 143.9 23.48 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.104 2.562 . . . . 0.0 106.305 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.84 118.53 15.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.101 0.864 . . . . 0.0 110.413 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 90.3 p -171.73 165.19 6.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.352 1.461 . . . . 0.0 111.903 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -146.9 139.2 24.75 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.459 1.6 . . . . 0.0 110.447 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.31 25.94 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 109.631 -3.44 . . . . 0.0 109.856 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.03 155.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.232 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.38 140.24 51.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -149.76 114.45 5.31 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -152.2 178.69 29.28 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.946 -1.121 . . . . 0.0 115.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 12.2 tt0 -120.08 144.91 47.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.456 -1.372 . . . . 0.0 109.17 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' D' ' 93' ' ' LEU . 41.4 t -97.31 128.74 44.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.542 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 0.4 OUTLIER -121.61 168.87 11.27 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.792 1.282 . . . . 0.0 111.299 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.28 118.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 112.823 -1.99 . . . . 0.0 106.994 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -58.67 154.87 13.65 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.38 -25.28 0.98 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -6.28 59.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.296 1.039 . . . . 0.0 113.746 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 27.25 20.88 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.544 1.545 . . . . 0.0 114.185 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -106.35 153.12 22.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 111.884 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -101.42 145.92 28.3 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 123.328 1.537 . . . . 0.0 110.871 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 106' ' ' ILE . 17.6 m -148.57 159.56 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.643 175.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' D' ' 83' ' ' CYS . 67.4 mt -119.2 115.28 23.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -105.9 109.84 21.92 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.412 HG22 ' HA3' ' D' ' 81' ' ' GLY . 6.6 p -125.25 167.33 15.02 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.941 1.353 . . . . 0.0 111.163 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.99 171.14 8.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 159.23 43.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.297 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.405 HD23 ' OG1' ' A' ' 80' ' ' THR . 2.9 tp -137.93 123.23 19.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.265 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.7 138.51 43.8 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 125.521 1.763 . . . . 0.0 113.005 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -120.97 117.77 28.14 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 125.898 1.999 . . . . 0.0 111.858 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -83.93 159.99 21.17 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 124.688 1.243 . . . . 0.0 110.977 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -104.22 82.97 2.01 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.0 -12.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 63.93 -28.22 0.09 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.71 136.5 53.32 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.93 1.241 . . . . 0.0 112.301 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.3 tt -62.09 -25.15 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.04 -4.09 33.34 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.546 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 4.7 m-20 -124.94 3.07 8.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.494 1.117 . . . . 0.0 113.769 -176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -52.97 -34.83 57.75 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.333 -0.854 . . . . 0.0 113.053 175.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.618 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 56.3 p-90 -49.72 -45.69 49.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.7 1.2 . . . . 0.0 113.287 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . 0.618 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.3 OUTLIER -89.06 -11.3 44.49 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.451 -0.781 . . . . 0.0 112.451 177.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.3 23.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 7.6 m -118.24 145.99 44.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.288 0.635 . . . . 0.0 111.884 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.77 151.86 40.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.85 1.66 . . . . 0.0 110.773 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.04 148.68 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 120.13 1.332 . . . . 0.0 111.675 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.21 -177.19 28.23 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 122.465 1.036 . . . . 0.0 112.912 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -120.96 152.88 38.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.778 0.831 . . . . 0.0 109.053 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -149.5 133.41 17.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.225 -174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 48.8 mt -126.09 122.63 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.259 1.028 . . . . 0.0 110.714 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -112.55 148.77 33.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.465 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 16.4 p -133.43 160.3 37.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.424 1.09 . . . . 0.0 109.844 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -55.88 115.62 2.49 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.132 0.573 . . . . 0.0 109.778 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . 0.505 HD23 ' C ' ' D' ' 123' ' ' LEU . 3.6 tt . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 120.142 0.02 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 p -116.46 144.43 44.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.207 1.003 . . . . 0.0 109.736 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.405 ' OG ' ' HE3' ' B' ' 57' ' ' LYS . 53.6 m -139.5 126.81 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.433 -1.417 . . . . 0.0 113.012 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.06 -27.77 62.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -53.17 116.62 2.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.764 1.226 . . . . 0.0 110.385 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.6 -121.14 2.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.974 1.749 . . . . 0.0 109.793 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -143.08 153.4 42.88 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.919 1.288 . . . . 0.0 113.224 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -143.31 160.23 40.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.707 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.444 ' HB ' HD12 ' B' ' 123' ' ' LEU . 14.3 t -138.28 145.14 40.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.677 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -112.11 146.17 38.48 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.478 0.711 . . . . 0.0 112.34 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.13 -24.38 67.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.593 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.6 tp -71.06 -14.4 62.31 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 112.029 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.96 -13.78 31.7 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.805 2.621 . . . . 0.0 113.738 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -63.64 149.47 46.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.842 1.306 . . . . 0.0 112.865 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -125.38 140.68 52.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.011 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -131.89 145.58 51.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.745 0.784 . . . . 0.0 112.408 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -129.22 133.63 47.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.015 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.03 127.56 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -93.75 0.07 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.922 0.764 . . . . 0.0 112.124 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.46 127.01 21.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.266 -1.138 . . . . 0.0 110.351 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.23 139.12 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.88 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' B' ' 28' ' ' GLU . 10.2 t-20 -75.36 167.07 22.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.781 0.832 . . . . 0.0 112.914 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -56.81 -34.37 67.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.01 1.324 . . . . 0.0 113.352 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -68.78 -36.19 77.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.281 -1.512 . . . . 0.0 111.476 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.77 -6.68 9.61 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.786 -1.563 . . . . 0.0 114.858 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' B' ' 24' ' ' ASN . 8.4 pt-20 -65.99 142.61 57.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.448 1.499 . . . . 0.0 112.45 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.75 147.94 23.56 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.553 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.32 163.09 14.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 174.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.26 -166.86 29.0 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 121.296 -0.877 . . . . 0.0 111.867 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.57 ' HB ' HD11 ' B' ' 46' ' ' LEU . 33.1 p -140.62 128.73 22.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.967 -1.117 . . . . 0.0 111.88 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -103.82 137.92 41.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.101 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.478 HD11 HD12 ' B' ' 46' ' ' LEU . 21.9 mt -129.25 126.17 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 37' ' ' VAL . 15.4 m -105.11 141.37 36.78 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.853 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.67 -2.27 33.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.485 HG21 HD21 ' B' ' 14' ' ' LEU . 26.9 m -138.5 163.29 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.534 1.933 . . . . 0.0 111.223 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.21 167.7 15.91 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.006 -1.684 . . . . 0.0 112.879 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -70.71 -44.86 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 108.493 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -126.61 79.04 72.02 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 129.035 2.934 . . . . 0.0 109.843 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.08 24.82 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.786 3.658 . . . . 0.0 116.602 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.84 0.63 61.32 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.157 -1.589 . . . . 0.0 115.877 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.45 29.96 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' B' ' 72' ' ' PHE . 30.5 mt -49.13 130.94 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 119.899 -1.75 . . . . 0.0 112.445 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.72 165.21 28.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.76 2.024 . . . . 0.0 108.59 174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' B' ' 32' ' ' THR . 5.1 tt -49.48 131.44 20.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.843 1.657 . . . . 0.0 111.806 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 7.3 p -109.54 122.61 38.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.183 0.516 . . . . 0.0 111.53 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.3 145.3 88.07 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.211 2.607 . . . . 0.0 111.92 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.83 156.21 48.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.587 0.755 . . . . 0.0 112.441 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -158.38 149.11 20.41 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.506 2.322 . . . . 0.0 109.483 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.11 -153.79 23.65 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 120.612 1.551 . . . . 0.0 110.254 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.3 mt -146.13 138.48 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.51 1.124 . . . . 0.0 112.086 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.73 140.59 52.71 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.082 -1.011 . . . . 0.0 108.681 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -56.47 -52.2 65.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.844 0.458 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' OG ' ' B' ' 5' ' ' SER . 16.0 tptm 52.87 0.28 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.488 2.315 . . . . 0.0 116.284 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -77.29 -56.3 4.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.137 2.175 . . . . 0.0 113.745 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' B' ' 62' ' ' PRO . . . -78.73 173.46 12.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 124.288 0.992 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -74.21 -26.26 60.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 117.206 -1.378 . . . . 0.0 113.903 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -143.67 48.74 0.98 Allowed Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 125.465 1.506 . . . . 0.0 112.709 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 59' ' ' ALA . 49.8 Cg_endo -82.93 -178.62 3.96 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.11 2.54 . . . . 0.0 114.848 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 70.4 p -84.54 167.77 16.02 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.24 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.84 159.83 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.452 1.101 . . . . 0.0 111.285 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.37 148.11 14.35 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -159.66 163.11 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.483 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.9 m -101.1 147.48 26.18 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.67 1.988 . . . . 0.0 109.303 173.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.58 117.05 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.545 ' HB2' HG21 ' C' ' 52' ' ' ILE . 42.9 t30 -98.45 107.03 19.39 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.662 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.331 52.5 m95 -68.31 158.77 32.72 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.594 1.997 . . . . 0.0 114.982 -173.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -38.89 4.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -174.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' B' ' 44' ' ' ILE . 47.5 p90 -90.96 -12.01 37.27 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -152.31 143.24 23.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.038 2.535 . . . . 0.0 106.433 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -72.9 118.39 15.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.081 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -170.92 164.94 7.75 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.742 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.61 138.92 24.94 Favored 'General case' 0 CA--C 1.48 -1.73 0 CA-C-O 123.473 1.606 . . . . 0.0 110.493 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.74 127.36 27.02 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 110.042 -3.254 . . . . 0.0 109.54 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -105.18 155.75 6.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.145 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.21 140.43 51.91 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.401 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -150.01 114.23 5.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.406 0.622 . . . . 0.0 109.327 -174.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -152.34 178.26 29.64 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 120.072 -1.061 . . . . 0.0 115.587 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.479 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 10.8 tt0 -119.83 144.91 47.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.301 -1.449 . . . . 0.0 109.157 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.419 ' SG ' HD23 ' B' ' 93' ' ' LEU . 49.7 t -97.21 128.73 44.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.724 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 0.4 OUTLIER -121.81 168.82 11.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.913 1.34 . . . . 0.0 110.977 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.3 118.94 57.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.636 -2.075 . . . . 0.0 106.627 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.31 153.56 15.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.48 -26.15 0.53 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.14 -9.44 59.19 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 31.37 10.58 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.521 1.057 . . . . 0.0 114.531 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.26 152.71 24.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.999 1.319 . . . . 0.0 110.85 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -101.43 146.05 28.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.495 1.518 . . . . 0.0 110.99 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' C' ' 106' ' ' ILE . 17.8 m -147.62 159.72 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.956 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 67.1 mt -119.44 115.27 23.73 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -105.88 110.65 23.01 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.402 HG22 ' HA3' ' B' ' 81' ' ' GLY . 7.2 p -126.56 167.11 16.1 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.007 1.384 . . . . 0.0 110.81 -174.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 170.85 8.92 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -144.72 158.97 43.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.494 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.408 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.1 tp -137.51 123.21 19.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.416 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.53 137.76 44.99 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 125.66 1.85 . . . . 0.0 113.299 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -120.93 117.1 26.46 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 125.937 2.023 . . . . 0.0 111.94 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 160.43 21.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.541 1.151 . . . . 0.0 111.137 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 3.6 m -104.33 83.35 2.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.46 -12.69 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 t30 64.07 -29.85 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.47 136.16 52.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.152 0.977 . . . . 0.0 112.515 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' C' ' 92' ' ' VAL . 2.5 tt -62.42 -26.58 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.12 -3.61 24.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.453 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 5.0 m-20 -124.64 3.34 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.53 1.132 . . . . 0.0 113.874 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -52.88 -35.76 58.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.226 -0.922 . . . . 0.0 112.306 175.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 54.9 p-90 -49.6 -45.24 47.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.378 1.071 . . . . 0.0 113.686 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.61 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -89.39 -11.04 44.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.621 0.768 . . . . 0.0 112.686 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.47 -0.32 25.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.427 -0.797 . . . . 0.0 113.078 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -118.02 146.19 44.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.769 0.713 . . . . 0.0 111.738 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.24 151.75 39.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.785 1.634 . . . . 0.0 110.415 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.19 148.37 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.01 -176.86 27.7 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 122.536 1.076 . . . . 0.0 112.79 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -121.52 153.43 37.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.565 -0.817 . . . . 0.0 108.985 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.1 133.72 16.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.015 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 51.8 mt -126.18 122.64 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.755 0.788 . . . . 0.0 110.637 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 12.4 m-85 -111.7 148.71 32.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.164 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 19.0 p -135.7 162.94 31.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.261 1.024 . . . . 0.0 110.189 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -59.93 115.83 3.69 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.526 -0.734 . . . . 0.0 111.062 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' B' ' 11' ' ' THR . 3.8 tt . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 p -116.41 141.84 47.64 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 122.112 0.958 . . . . 0.0 108.977 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . 0.419 ' OG ' ' HE3' ' C' ' 57' ' ' LYS . 65.0 m -139.39 126.54 21.21 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.368 -1.457 . . . . 0.0 113.026 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.55 -29.63 64.96 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -52.0 118.38 3.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.591 1.186 . . . . 0.0 110.243 174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.53 -122.53 2.94 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.315 1.912 . . . . 0.0 109.336 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -143.03 152.96 42.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.48 1.112 . . . . 0.0 113.113 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -143.59 155.85 44.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.091 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.409 ' HB ' HD12 ' C' ' 123' ' ' LEU . 9.9 t -133.43 145.14 49.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.395 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -109.42 147.43 32.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -65.06 -19.09 65.82 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.561 HD11 ' CD1' ' A' ' 110' ' ' TRP . 35.0 tp -75.36 -14.91 60.51 Favored 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.963 -1.086 . . . . 0.0 111.273 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.59 -14.07 32.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.222 2.344 . . . . 0.0 113.659 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 149.73 44.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.411 -1.052 . . . . 0.0 112.377 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -125.35 142.82 51.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.956 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -132.41 146.1 51.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 112.507 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -129.64 133.34 47.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.547 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.65 127.23 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.85 -93.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.135 0.897 . . . . 0.0 112.282 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.31 128.29 23.66 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.364 -1.08 . . . . 0.0 110.469 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.21 139.24 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.315 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -77.55 164.03 25.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.98 0.912 . . . . 0.0 112.584 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -54.35 -33.82 59.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.232 1.413 . . . . 0.0 114.217 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.26 -35.45 79.56 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.384 -1.447 . . . . 0.0 111.543 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.41 -6.26 9.24 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 124.369 0.985 . . . . 0.0 114.506 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.9 147.25 47.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -154.8 161.94 41.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.96 0.886 . . . . 0.0 110.728 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 167.72 14.1 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.31 30.28 Favored Glycine 0 C--O 1.238 0.344 0 O-C-N 120.391 -1.443 . . . . 0.0 112.096 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.573 ' HB ' HD11 ' C' ' 46' ' ' LEU . 33.9 p -140.33 129.0 22.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.155 0.978 . . . . 0.0 111.715 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -105.43 138.23 41.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.179 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.453 HD11 HD12 ' C' ' 46' ' ' LEU . 22.8 mt -129.22 126.64 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.438 HG22 ' H ' ' C' ' 37' ' ' VAL . 16.6 m -105.11 141.15 37.18 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.909 -173.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.39 -1.88 34.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.48 HG21 HD21 ' C' ' 14' ' ' LEU . 26.9 m -139.24 163.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.533 1.933 . . . . 0.0 111.31 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.24 167.46 16.07 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 119.894 -1.754 . . . . 0.0 112.871 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -70.16 -45.42 66.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.286 1.034 . . . . 0.0 108.463 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -126.33 78.85 71.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 129.002 2.921 . . . . 0.0 110.114 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.85 24.2 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.909 3.739 . . . . 0.0 116.591 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 0.65 59.7 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.224 -1.548 . . . . 0.0 115.885 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.38 30.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.09 131.4 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.965 -1.709 . . . . 0.0 112.462 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.3 165.44 27.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.775 2.03 . . . . 0.0 108.664 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' C' ' 32' ' ' THR . 5.3 tt -49.51 131.22 20.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.558 1.543 . . . . 0.0 111.65 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.1 p -109.02 123.04 38.06 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.33 144.61 90.77 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.01 2.473 . . . . 0.0 111.542 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.416 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.0 pp -131.15 164.32 25.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.788 0.835 . . . . 0.0 112.708 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -165.64 148.93 7.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.064 1.746 . . . . 0.0 109.656 -174.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.34 -156.17 27.55 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 120.898 1.681 . . . . 0.0 112.629 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.545 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -146.16 137.05 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 123.37 1.557 . . . . 0.0 112.006 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.02 141.65 51.13 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.086 -1.634 . . . . 0.0 108.38 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.15 -50.79 71.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.881 0.31 . . . . 0.0 111.345 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . 0.419 ' HE3' ' OG ' ' C' ' 5' ' ' SER . 16.4 tptm 51.85 2.79 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.351 2.26 . . . . 0.0 115.979 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -79.74 -56.73 4.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.598 1.959 . . . . 0.0 113.546 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' C' ' 62' ' ' PRO . . . -78.63 174.7 11.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.853 0.721 . . . . 0.0 111.339 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -75.73 -26.68 57.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.583 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.63 48.9 1.13 Allowed Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 125.216 1.407 . . . . 0.0 112.705 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' C' ' 59' ' ' ALA . 46.5 Cg_endo -83.12 -178.3 3.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.805 2.337 . . . . 0.0 115.007 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 82.4 p -84.63 168.1 15.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.619 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -166.08 160.29 16.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.457 1.103 . . . . 0.0 111.372 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.3 148.12 14.4 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 119.119 2.408 . . . . 0.0 119.119 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -159.76 162.17 34.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.502 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.8 m -100.25 150.1 22.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.007 2.123 . . . . 0.0 108.966 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 49.5 t -129.28 117.9 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.6 t30 -99.96 107.18 19.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.761 -174.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.337 51.3 m95 -67.79 158.11 33.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.247 1.84 . . . . 0.0 115.387 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.16 4.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.2 -12.08 36.38 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 8.3 t -152.32 143.86 23.45 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 128.155 2.582 . . . . 0.0 106.329 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.94 118.55 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.457 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p -171.83 165.13 6.51 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.573 1.549 . . . . 0.0 111.767 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.56 138.97 25.05 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 123.635 1.683 . . . . 0.0 110.606 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.52 26.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-N 109.785 -3.37 . . . . 0.0 109.712 -172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.05 155.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.145 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -128.31 140.06 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.408 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -150.08 115.02 5.34 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -153.13 177.87 30.52 Favored Glycine 0 CA--C 1.501 -0.792 0 C-N-CA 119.894 -1.146 . . . . 0.0 115.508 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 10.6 tt0 -119.22 145.27 46.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.545 -1.327 . . . . 0.0 108.917 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.443 ' SG ' HD23 ' C' ' 93' ' ' LEU . 49.9 t -97.27 129.23 44.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.404 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 0.3 OUTLIER -124.8 171.94 9.73 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.009 1.385 . . . . 0.0 111.649 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.81 115.76 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 112.363 -2.199 . . . . 0.0 106.604 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.82 152.42 19.22 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -45.27 -22.89 0.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.57 -10.5 55.82 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.46 43.06 6.3 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.731 1.158 . . . . 0.0 113.495 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -116.05 147.25 41.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.256 1.423 . . . . 0.0 108.382 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -101.26 141.19 34.51 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.969 1.707 . . . . 0.0 109.966 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.6 m -143.93 161.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.29 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . 0.443 HD23 ' SG ' ' C' ' 83' ' ' CYS . 62.7 mt -120.13 116.34 25.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -106.53 110.53 22.77 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 172.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' C' ' 81' ' ' GLY . 9.1 p -126.4 165.37 19.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.661 1.22 . . . . 0.0 110.935 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.16 170.66 8.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 172.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -144.37 159.44 42.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.487 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' B' ' 80' ' ' THR . 2.9 tp -137.79 123.14 19.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.436 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.63 138.41 43.91 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 125.295 1.622 . . . . 0.0 113.065 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -121.43 117.43 26.87 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 125.895 1.997 . . . . 0.0 111.823 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 15.7 m -83.53 159.76 21.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.729 1.268 . . . . 0.0 111.285 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -103.9 83.0 2.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.24 -12.56 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.48 -29.06 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.1 136.54 52.82 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.8 1.286 . . . . 0.0 112.436 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' B' ' 92' ' ' VAL . 2.3 tt -62.3 -25.21 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.574 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.61 -3.96 36.57 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.591 -1.116 . . . . 0.0 114.61 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 4.7 m-20 -124.29 2.72 8.49 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.455 1.102 . . . . 0.0 113.92 -177.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -52.86 -35.67 57.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.381 -0.824 . . . . 0.0 112.361 176.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.603 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 57.2 p-90 -49.67 -45.77 49.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.595 1.158 . . . . 0.0 113.311 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . 0.603 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.3 OUTLIER -88.88 -11.03 45.76 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.436 -0.79 . . . . 0.0 112.544 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -0.24 25.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -117.87 146.03 44.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.316 0.647 . . . . 0.0 111.65 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.61 152.06 40.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.745 1.618 . . . . 0.0 110.654 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.21 148.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 120.186 1.357 . . . . 0.0 111.802 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.96 -176.98 27.8 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-O 122.442 1.023 . . . . 0.0 112.809 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -121.55 153.49 37.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.719 0.808 . . . . 0.0 108.834 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.28 132.44 15.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.229 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 mt -124.8 118.04 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.903 0.858 . . . . 0.0 111.068 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 13.1 m-85 -105.59 150.71 25.15 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.564 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 3.9 p -136.53 159.83 40.61 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.514 1.126 . . . . 0.0 109.859 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -55.36 124.34 16.8 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.742 -0.599 . . . . 0.0 109.813 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.409 HD12 ' HB ' ' C' ' 11' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.916 174.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.04 133.5 53.64 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -139.54 128.53 23.62 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.811 -1.805 . . . . 0.0 110.695 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.8 mt -68.06 -23.22 64.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -51.58 113.63 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 112.004 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.95 -121.41 2.47 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.788 1.185 . . . . 0.0 110.954 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -151.88 146.28 25.54 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -143.34 163.24 33.58 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.223 1.409 . . . . 0.0 112.065 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.451 ' HB ' HD12 ' A' ' 123' ' ' LEU . 6.3 t -142.76 154.89 44.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.682 -1.151 . . . . 0.0 109.149 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 146.35 49.65 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.095 0.861 . . . . 0.0 112.515 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.24 -25.1 13.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.653 2.381 . . . . 0.0 115.012 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.07 -18.78 62.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.371 1.069 . . . . 0.0 112.848 174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.84 -15.76 21.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.828 2.633 . . . . 0.0 113.261 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.4 p -65.99 145.54 55.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 123.297 1.522 . . . . 0.0 113.086 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.98 144.93 46.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.737 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -141.8 147.34 37.11 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 173.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -137.44 135.23 36.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.428 0.691 . . . . 0.0 109.759 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.324 0.65 . . . . 0.0 109.903 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -92.68 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.57 32.25 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.701 -0.882 . . . . 0.0 112.235 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.67 129.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.244 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -70.31 165.84 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.228 0.33 . . . . 0.0 111.62 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -59.78 -24.11 63.82 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.429 -1.42 . . . . 0.0 114.822 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.37 -27.09 46.8 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.895 0.77 . . . . 0.0 112.027 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.27 -6.16 30.31 Favored Glycine 0 N--CA 1.468 0.805 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.539 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' D' ' 50' ' ' LEU . 10.0 pt-20 -63.78 138.62 58.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 162.58 38.94 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.395 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 50' ' ' LEU . 2.8 p -129.34 176.9 7.58 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.35 -166.0 37.75 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.566 -1.334 . . . . 0.0 114.095 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 46' ' ' LEU . 12.7 p -136.76 130.92 32.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.605 1.193 . . . . 0.0 111.781 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -114.52 141.28 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.658 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.4 mt -131.54 133.14 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 44' ' ' ILE . 2.7 m -107.69 140.56 40.54 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.731 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.33 -11.15 19.65 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.6 m -138.21 141.66 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 111.183 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.26 33.05 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.977 -0.452 . . . . 0.0 110.135 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -77.35 -34.75 55.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.75 83.84 40.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.764 1.626 . . . . 0.0 110.138 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.78 36.05 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.998 3.799 . . . . 0.0 115.075 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.29 -7.21 63.05 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 179.58 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.624 1.97 . . . . 0.0 110.858 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 35' ' ' THR . 63.4 mt -56.52 125.56 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 119.988 -1.695 . . . . 0.0 111.05 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.27 165.24 28.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 111.585 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.469 HD11 ' HB ' ' A' ' 32' ' ' THR . 10.3 tp -46.98 115.94 1.22 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 130.781 3.632 . . . . 0.0 113.028 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.6 p -105.9 122.99 40.61 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.456 0.702 . . . . 0.0 111.234 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.62 136.58 74.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.836 2.357 . . . . 0.0 111.318 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.69 155.03 37.27 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.07 0.856 . . . . 0.0 111.694 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 30' ' ' THR . 1.5 tp -162.37 149.01 13.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.92 1.688 . . . . 0.0 109.349 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.97 -150.01 20.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.296 1.407 . . . . 0.0 109.658 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -144.0 141.48 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.49 0.716 . . . . 0.0 111.271 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 137.53 51.91 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.333 -0.854 . . . . 0.0 110.599 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -68.52 155.07 40.65 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.397 -0.814 . . . . 0.0 111.843 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -146.2 13.98 1.28 Allowed 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.273 -1.517 . . . . 0.0 114.489 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -87.89 -49.11 7.3 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.825 0.739 . . . . 0.0 112.465 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.07 175.06 9.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -78.93 -38.56 36.91 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.798 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -136.31 52.0 5.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.591 1.156 . . . . 0.0 112.567 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.87 173.83 13.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.738 1.625 . . . . 0.0 113.834 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.331 0.6 OUTLIER -95.41 167.38 11.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.571 173.664 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.56 166.54 31.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.722 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.49 146.61 12.43 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -159.13 152.67 22.79 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.41 151.75 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.286 1.835 . . . . 0.0 109.287 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.16 118.44 40.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.645 ' HB2' HG21 ' D' ' 52' ' ' ILE . 1.9 t-20 -88.13 116.55 26.4 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.748 -0.595 . . . . 0.0 110.126 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.81 142.35 44.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.385 1.088 . . . . 0.0 110.573 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.69 -39.78 5.27 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.246 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.83 -13.12 54.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.268 1.427 . . . . 0.0 114.439 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.3 t -152.35 132.36 13.42 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.423 2.689 . . . . 0.0 106.06 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.02 117.67 16.09 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.081 1.309 . . . . 0.0 110.416 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -173.65 164.03 4.36 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 126.549 1.94 . . . . 0.0 110.057 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.86 142.6 38.6 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.19 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -132.38 152.07 51.6 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.462 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.79 150.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.748 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.42 143.95 51.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 127.38 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.61 178.47 45.51 Favored Glycine 0 C--O 1.217 -0.915 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -101.21 147.9 25.73 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.856 0.974 . . . . 0.0 112.835 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 21.7 p -97.74 120.53 38.29 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.754 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 82' ' ' GLN 0.299 2.7 m-85 -112.91 162.25 16.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -132.41 109.66 15.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -59.38 162.13 5.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.335 0.654 . . . . 0.0 109.448 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -21.67 2.27 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -8.18 54.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.562 0.745 . . . . 0.0 113.003 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.17 51.96 4.78 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -121.33 146.82 46.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.816 2.446 . . . . 0.0 104.938 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -112.41 150.19 31.47 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.857 1.263 . . . . 0.0 112.182 -172.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.689 HG11 ' HD3' ' A' ' 94' ' ' LYS . 1.7 t -148.14 161.33 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.786 1.279 . . . . 0.0 110.681 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.4 mt -125.51 110.49 13.94 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 101.241 -3.614 . . . . 0.0 101.241 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HD3' HG11 ' A' ' 92' ' ' VAL . 7.5 mmmt -102.71 122.35 44.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -138.84 163.76 31.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.477 1.608 . . . . 0.0 114.264 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.5 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.89 165.24 12.5 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -140.89 159.48 42.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.071 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.804 HD21 HG23 ' A' ' 113' ' ' THR . 1.2 tt -143.21 124.1 14.3 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.833 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 77' ' ' THR . 3.0 tp -107.69 141.7 38.81 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 125.692 1.87 . . . . 0.0 110.689 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.402 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.3 tpt85 -124.41 114.03 18.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 110.298 -3.137 . . . . 0.0 109.455 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.251 18.5 m -70.88 164.51 25.19 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.74 1.9 . . . . 0.0 113.094 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.408 ' HA ' ' OE1' ' D' ' 82' ' ' GLN . 58.4 m -101.44 84.36 2.59 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 112' ' ' ALA . 2.3 t -79.38 164.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 127.463 2.305 . . . . 0.0 109.296 174.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -114.59 -23.19 9.4 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.51 138.29 51.19 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.719 0.771 . . . . 0.0 111.113 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -59.77 -17.23 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.68 7.75 74.23 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.361 -1.8 . . . . 0.0 115.759 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.87 4.99 15.01 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.853 1.827 . . . . 0.0 112.704 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -62.27 -30.67 71.29 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.054 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CD1' HD11 ' C' ' 14' ' ' LEU . 54.7 p-90 -48.97 -40.12 29.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 113.21 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -96.92 -6.25 36.12 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 114.022 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 103' ' ' VAL . . . -78.94 7.0 7.92 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.804 HG23 HD21 ' A' ' 98' ' ' LEU . 19.2 m -122.1 140.46 52.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.757 0.789 . . . . 0.0 113.043 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 119.56 6.48 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.558 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.93 150.19 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.44 1.896 . . . . 0.0 111.51 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.41 -171.48 22.71 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.707 0.67 . . . . 0.0 112.768 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -131.38 157.31 43.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.071 -0.664 . . . . 0.0 111.448 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.409 HD21 HD22 ' A' ' 14' ' ' LEU . 7.1 m120 -147.69 160.13 43.03 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.363 1.065 . . . . 0.0 109.15 174.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.1 mt -138.71 119.03 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.74 148.44 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.529 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -134.98 165.31 25.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.66 124.4 20.9 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.893 0.877 . . . . 0.0 111.526 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 11' ' ' THR . 6.0 tt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.05 136.26 41.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -139.31 133.49 31.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.662 -1.274 . . . . 0.0 110.696 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.13 -23.2 63.94 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -51.02 114.38 1.16 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.1 1.429 . . . . 0.0 111.592 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.76 -120.54 2.42 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.67 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -152.81 149.74 28.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -147.0 163.21 36.96 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.56 1.544 . . . . 0.0 112.057 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.499 ' HB ' HD12 ' D' ' 123' ' ' LEU . 12.9 t -141.47 154.48 45.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.062 0.945 . . . . 0.0 108.935 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -123.08 145.83 48.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.855 0.862 . . . . 0.0 112.296 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.43 -24.57 13.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.527 2.331 . . . . 0.0 114.816 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' B' ' 110' ' ' TRP . 33.4 tp -70.81 -19.18 62.7 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.976 -1.078 . . . . 0.0 112.858 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.62 -15.69 19.51 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 127.796 2.617 . . . . 0.0 113.392 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -66.42 144.9 56.23 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 123.289 1.518 . . . . 0.0 112.991 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.87 146.07 45.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.698 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -141.99 147.59 37.18 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 18.9 m -136.24 135.25 38.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.517 0.727 . . . . 0.0 110.529 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 92.7 mt -136.94 128.34 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.339 0.656 . . . . 0.0 109.497 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.08 -90.61 0.06 OUTLIER Glycine 0 CA--C 1.533 1.194 0 O-C-N 123.573 0.546 . . . . 0.0 112.557 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.48 141.8 29.82 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.644 -0.915 . . . . 0.0 111.914 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.15 130.01 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.518 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -68.19 164.96 19.3 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.503 0.502 . . . . 0.0 111.795 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -60.47 -23.77 64.74 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.178 -1.576 . . . . 0.0 114.739 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -76.12 -24.77 54.96 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.877 0.762 . . . . 0.0 112.025 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.82 -5.45 32.59 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 124.093 0.854 . . . . 0.0 114.255 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.49 153.27 44.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.966 0.883 . . . . 0.0 112.167 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . 0.559 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -155.45 166.52 33.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.107 176.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . 0.433 HG22 HD13 ' D' ' 50' ' ' LEU . 15.9 p -127.09 -177.67 4.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.39 -165.99 39.22 Favored Glycine 0 N--CA 1.469 0.89 0 O-C-N 119.534 -1.979 . . . . 0.0 114.217 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.476 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.1 p -136.79 130.13 31.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.144 0.973 . . . . 0.0 112.325 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -114.59 141.38 47.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.74 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.9 133.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.45 ' O ' HG21 ' D' ' 44' ' ' ILE . 2.8 m -108.28 140.66 41.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.749 1.22 . . . . 0.0 111.861 -173.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.46 -11.93 18.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 18.3 m -137.84 141.08 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 124.093 0.957 . . . . 0.0 111.26 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.9 34.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.057 -0.402 . . . . 0.0 110.185 -174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.91 -34.55 57.69 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -134.92 83.82 39.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.641 1.576 . . . . 0.0 110.244 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 36.09 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 125.009 3.806 . . . . 0.0 115.197 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.12 63.32 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.77 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.538 1.935 . . . . 0.0 110.849 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.45 HG21 ' O ' ' D' ' 35' ' ' THR . 63.7 mt -56.21 125.84 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 119.989 -1.695 . . . . 0.0 111.254 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.79 165.91 27.45 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.988 1.315 . . . . 0.0 111.856 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' D' ' 32' ' ' THR . 10.9 tp -47.86 115.62 1.22 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.589 3.556 . . . . 0.0 112.782 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -105.69 122.69 41.79 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.469 0.708 . . . . 0.0 110.615 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.92 135.87 71.63 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.492 2.128 . . . . 0.0 110.837 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . 0.465 ' C ' HD12 ' D' ' 49' ' ' LEU . 1.2 pp -121.11 161.02 22.48 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.043 0.84 . . . . 0.0 111.246 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.559 HD12 ' O ' ' D' ' 29' ' ' PHE . 17.7 tp -169.05 149.33 4.25 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.668 1.587 . . . . 0.0 112.182 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.81 -146.96 13.51 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.0 mt -147.01 139.76 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.965 0.906 . . . . 0.0 110.296 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.79 53.37 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.157 -0.964 . . . . 0.0 110.871 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -70.57 153.52 42.81 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.766 -1.209 . . . . 0.0 111.304 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -143.91 17.23 1.78 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -93.31 -49.0 6.16 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.656 0.782 . . . . 0.0 112.642 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.7 177.25 5.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -81.58 -38.29 26.33 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.596 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.77 51.98 4.69 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.469 1.108 . . . . 0.0 111.875 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.71 175.21 11.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.707 1.605 . . . . 0.0 113.726 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.328 0.7 OUTLIER -96.47 165.91 11.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.018 1.389 . . . . 0.0 112.353 173.553 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.77 165.96 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.948 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 146.57 12.43 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -159.02 152.42 22.68 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.82 151.75 19.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.872 2.069 . . . . 0.0 109.034 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.87 119.45 45.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.672 ' HB2' HG21 ' A' ' 52' ' ' ILE . 1.7 t-20 -88.07 118.31 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.322 -0.861 . . . . 0.0 110.601 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -76.52 141.89 41.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.539 1.162 . . . . 0.0 110.498 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.55 -39.65 5.34 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.239 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.67 -13.3 54.48 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 114.268 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 43.2 t -152.34 133.32 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 128.554 2.741 . . . . 0.0 106.211 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -75.3 117.73 17.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.148 1.34 . . . . 0.0 110.347 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -173.72 164.02 4.31 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 109.72 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -138.88 142.59 38.57 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.073 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.753 HG23 HD12 ' D' ' 99' ' ' LEU . 0.0 OUTLIER -131.96 152.23 51.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.533 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.12 149.53 29.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.768 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.75 126.86 12.05 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -173.29 178.36 45.28 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.34 147.25 26.53 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 124.63 0.841 . . . . 0.0 112.337 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.83 115.7 28.59 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.445 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' D' ' 82' ' ' GLN 0.275 3.3 m-85 -110.15 162.95 14.09 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -132.74 112.21 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.71 161.95 11.56 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.671 0.788 . . . . 0.0 109.011 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -20.52 0.85 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.09 -2.22 55.71 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.81 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.33 51.57 6.03 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -173.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.23 138.9 54.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.91 2.084 . . . . 0.0 107.185 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -106.69 149.42 27.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.781 1.632 . . . . 0.0 112.261 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.675 HG11 ' HD3' ' D' ' 94' ' ' LYS . 1.8 t -150.53 161.64 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 122.729 1.252 . . . . 0.0 110.247 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 mt -125.9 111.27 14.61 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.675 ' HD3' HG11 ' D' ' 92' ' ' VAL . 6.8 mmmt -103.97 120.62 41.42 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -137.35 162.96 32.16 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.792 1.758 . . . . 0.0 114.101 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -112.45 164.8 12.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -140.54 159.72 41.58 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.887 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.807 HD21 HG23 ' D' ' 113' ' ' THR . 1.2 tt -143.45 124.01 14.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.85 175.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . 0.753 HD12 HG23 ' D' ' 77' ' ' THR . 3.1 tp -107.51 141.96 38.13 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 125.616 1.822 . . . . 0.0 110.693 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -124.2 114.13 19.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.216 -3.175 . . . . 0.0 109.417 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.263 19.2 m -71.45 163.93 26.78 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.682 1.864 . . . . 0.0 112.762 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . 0.407 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 55.2 m -100.25 85.7 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' D' ' 112' ' ' ALA . 2.3 t -80.89 164.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 127.048 2.139 . . . . 0.0 109.065 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.87 -23.84 8.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.44 137.96 51.18 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.601 0.715 . . . . 0.0 111.142 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.527 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.1 tt -59.06 -17.74 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 7.31 73.23 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.356 1.932 . . . . 0.0 116.016 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.49 4.66 15.31 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 119.967 1.884 . . . . 0.0 112.969 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -61.35 -31.17 71.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.972 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.487 ' CD1' HD11 ' B' ' 14' ' ' LEU . 55.1 p-90 -49.0 -39.58 27.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.117 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -97.72 -5.96 33.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.733 1.213 . . . . 0.0 114.057 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' D' ' 103' ' ' VAL . . . -78.89 6.74 8.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.807 HG23 HD21 ' D' ' 98' ' ' LEU . 18.3 m -121.65 140.18 52.6 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 122.076 0.941 . . . . 0.0 113.251 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.36 121.05 7.51 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.008 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 9.7 p -100.87 150.29 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.732 2.013 . . . . 0.0 111.418 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.42 -171.49 22.73 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.663 0.649 . . . . 0.0 112.502 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -131.67 157.19 44.38 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.02 -0.694 . . . . 0.0 111.517 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . 0.402 HD21 HD22 ' D' ' 14' ' ' LEU . 7.0 m120 -147.9 159.55 43.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.524 1.13 . . . . 0.0 109.095 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . 0.436 HD13 ' HE3' ' D' ' 94' ' ' LYS . 7.3 mt -137.83 118.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.61 146.5 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 14.7 p -132.89 163.57 28.84 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.158 0.98 . . . . 0.0 108.64 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.87 124.18 17.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.942 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . 0.499 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.301 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.38 138.78 51.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -139.49 133.32 30.74 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.524 -1.36 . . . . 0.0 111.16 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.45 -23.63 65.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -49.75 112.09 0.6 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.226 1.41 . . . . 0.0 112.308 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.57 -116.0 1.53 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.995 1.284 . . . . 0.0 111.907 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -153.39 147.87 26.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -145.24 163.36 34.67 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.674 1.589 . . . . 0.0 111.987 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -145.47 152.95 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.709 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.53 145.67 48.68 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.73 0.812 . . . . 0.0 112.537 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.63 -26.16 12.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.817 2.447 . . . . 0.0 114.834 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.6 tp -70.21 -19.85 63.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.316 1.046 . . . . 0.0 112.968 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.64 22.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 127.535 2.493 . . . . 0.0 113.574 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -67.83 145.57 54.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.338 1.569 . . . . 0.0 112.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 145.54 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.87 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -142.27 147.75 36.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -137.08 135.81 37.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.67 0.788 . . . . 0.0 109.994 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.1 mt -135.54 127.58 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.391 0.677 . . . . 0.0 110.337 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -75.92 0.57 Allowed Glycine 0 CA--C 1.532 1.1 0 O-C-N 123.922 0.764 . . . . 0.0 113.544 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.06 24.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.808 0.804 . . . . 0.0 112.084 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.89 130.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.91 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.4 166.79 20.95 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.24 0.337 . . . . 0.0 111.804 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 88.1 p -60.52 -24.69 65.55 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.451 -1.406 . . . . 0.0 114.771 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -78.24 -27.12 47.57 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.964 0.802 . . . . 0.0 111.849 173.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.66 30.37 Favored Glycine 0 N--CA 1.468 0.797 0 CA-C-O 117.82 -1.545 . . . . 0.0 113.571 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' C' ' 50' ' ' LEU . 10.0 pt-20 -64.17 138.9 58.67 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 173.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.84 162.21 39.71 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.43 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.416 HG22 HD13 ' B' ' 50' ' ' LEU . 2.5 p -129.0 177.27 7.24 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.48 -166.19 37.97 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 120.695 -1.253 . . . . 0.0 114.273 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.46 ' HB ' HD11 ' B' ' 46' ' ' LEU . 16.3 p -136.63 131.03 33.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.635 1.207 . . . . 0.0 111.696 175.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -114.36 141.36 47.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.095 -1.412 . . . . 0.0 108.39 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.92 134.51 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.462 ' O ' HG21 ' B' ' 44' ' ' ILE . 2.6 m -110.03 140.18 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.592 1.157 . . . . 0.0 111.611 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.13 -11.7 19.37 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 19.0 m -137.52 141.17 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.097 0.959 . . . . 0.0 111.325 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.24 32.97 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.999 -0.438 . . . . 0.0 110.21 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -77.14 -34.46 56.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -135.02 83.7 39.18 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.795 1.638 . . . . 0.0 110.244 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.62 36.19 0.26 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.849 3.699 . . . . 0.0 115.129 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.47 -6.98 63.29 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.72 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.591 1.956 . . . . 0.0 110.973 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.462 HG21 ' O ' ' B' ' 35' ' ' THR . 62.9 mt -56.58 125.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.137 -1.602 . . . . 0.0 110.922 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.25 165.74 27.5 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.007 1.323 . . . . 0.0 111.688 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' B' ' 32' ' ' THR . 10.1 tp -46.78 115.99 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.803 3.641 . . . . 0.0 112.995 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -106.19 123.17 39.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.519 0.728 . . . . 0.0 111.199 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 136.73 76.25 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.871 2.381 . . . . 0.0 111.329 174.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.87 155.59 36.34 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 124.023 0.827 . . . . 0.0 111.656 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.416 HD13 HG22 ' B' ' 30' ' ' THR . 1.5 tp -162.98 148.84 12.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.834 1.654 . . . . 0.0 109.364 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.19 -149.64 19.69 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.231 1.378 . . . . 0.0 109.672 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -144.64 140.72 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.511 0.725 . . . . 0.0 111.372 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 137.81 52.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.354 -0.841 . . . . 0.0 111.044 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -69.35 154.75 41.53 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.236 0.925 . . . . 0.0 111.152 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -145.22 16.45 1.52 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -92.24 -47.56 7.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.463 0.705 . . . . 0.0 112.685 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.11 175.28 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -76.74 -41.37 45.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.243 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -138.7 54.69 6.95 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.762 1.225 . . . . 0.0 111.843 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.63 174.54 12.68 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.711 1.608 . . . . 0.0 113.699 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.322 0.5 OUTLIER -96.21 166.57 11.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 123.057 1.408 . . . . 0.0 112.039 173.423 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.02 166.85 32.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.898 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.04 146.33 11.91 Favored Glycine 0 CA--C 1.544 1.901 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -158.92 153.46 24.35 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.23 -1.747 . . . . 0.0 115.66 -174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 151.94 19.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.273 1.829 . . . . 0.0 109.386 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.34 118.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' C' ' 52' ' ' ILE . 1.9 t-20 -88.34 116.62 26.68 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.866 -0.521 . . . . 0.0 110.039 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.67 143.09 44.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.517 1.151 . . . . 0.0 110.565 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -109.46 -39.72 5.1 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.226 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.79 -13.35 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.273 1.429 . . . . 0.0 114.408 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.5 t -152.31 132.52 13.58 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 128.408 2.683 . . . . 0.0 106.059 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -74.8 118.33 17.64 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.189 1.359 . . . . 0.0 110.394 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -174.44 163.81 3.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.661 1.985 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.33 142.33 39.72 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.089 173.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.766 HG23 HD12 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -131.71 152.32 50.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.648 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.53 150.2 29.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.788 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.67 143.01 51.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 127.34 12.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.83 178.54 44.8 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . 0.572 ' HB3' ' CE1' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.12 147.78 25.83 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.663 0.86 . . . . 0.0 112.704 178.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 6.8 p -97.9 115.85 28.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.267 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' B' ' 82' ' ' GLN 0.288 2.9 m-85 -110.24 161.56 15.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.39 112.09 18.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.45 162.76 12.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.642 0.777 . . . . 0.0 109.495 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -23.08 1.03 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.77 -4.66 56.5 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.774 0.83 . . . . 0.0 113.121 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 53.81 5.33 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 122.059 0.81 . . . . 0.0 111.346 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -122.96 140.66 52.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.245 2.618 . . . . 0.0 104.604 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -111.59 148.04 34.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.195 1.798 . . . . 0.0 112.08 -172.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.665 HG11 ' HD3' ' B' ' 94' ' ' LYS . 1.9 t -149.12 160.99 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 122.408 1.099 . . . . 0.0 110.546 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 mt -124.91 112.41 16.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 101.697 -3.445 . . . . 0.0 101.697 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.665 ' HD3' HG11 ' B' ' 92' ' ' VAL . 6.3 mmmt -104.96 120.08 40.57 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -137.28 162.8 32.54 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.663 1.697 . . . . 0.0 114.105 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.503 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -112.11 164.88 12.66 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -140.47 159.25 42.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.382 -1.735 . . . . 0.0 111.968 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.806 HD21 HG23 ' B' ' 113' ' ' THR . 1.2 tt -142.82 123.99 14.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.997 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.766 HD12 HG23 ' B' ' 77' ' ' THR . 3.1 tp -107.65 141.6 38.9 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 125.779 1.925 . . . . 0.0 110.826 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.9 tpt85 -123.89 114.09 19.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 110.069 -3.241 . . . . 0.0 109.338 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.264 21.6 m -71.48 164.69 25.35 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.639 1.837 . . . . 0.0 112.722 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.41 ' HA ' ' OE1' ' C' ' 82' ' ' GLN . 59.8 m -101.25 84.55 2.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' B' ' 112' ' ' ALA . 2.3 t -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 127.547 2.339 . . . . 0.0 109.295 175.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.87 -22.57 9.56 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.057 0.844 . . . . 0.0 113.246 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.48 137.56 51.93 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.757 0.789 . . . . 0.0 111.096 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.0 tt -59.76 -17.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.01 6.86 76.58 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.068 -1.962 . . . . 0.0 115.774 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.68 4.38 15.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.802 1.801 . . . . 0.0 112.798 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -30.55 70.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.485 ' CD1' HD11 ' D' ' 14' ' ' LEU . 54.8 p-90 -48.59 -41.15 29.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.269 1.028 . . . . 0.0 113.248 174.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -96.26 -6.22 38.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.577 1.151 . . . . 0.0 113.807 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' B' ' 103' ' ' VAL . . . -79.02 6.79 8.54 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.806 HG23 HD21 ' B' ' 98' ' ' LEU . 16.2 m -121.43 140.23 52.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.06 119.53 6.44 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.549 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -100.51 149.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.472 1.909 . . . . 0.0 111.255 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -171.77 22.8 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.594 0.616 . . . . 0.0 112.801 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -131.5 157.04 44.6 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.084 -0.656 . . . . 0.0 111.544 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . 0.415 HD21 HD22 ' B' ' 14' ' ' LEU . 6.8 m120 -147.71 159.89 43.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.705 1.202 . . . . 0.0 109.277 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.434 HD13 ' HE3' ' B' ' 94' ' ' LYS . 7.3 mt -138.75 119.33 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.44 147.37 34.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 15.0 p -134.85 164.95 26.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.818 0.847 . . . . 0.0 109.131 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -60.22 119.07 7.19 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.54 1.136 . . . . 0.0 111.627 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.441 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.68 138.28 45.78 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 15.4 m -139.35 131.1 27.45 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.568 -1.333 . . . . 0.0 110.95 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.74 -24.05 64.41 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -49.21 114.61 1.05 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.025 1.33 . . . . 0.0 111.747 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.23 -120.46 2.47 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.919 1.247 . . . . 0.0 110.675 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -151.29 147.57 27.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -145.33 163.16 35.38 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.295 1.438 . . . . 0.0 112.234 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -143.65 153.78 42.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.516 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.29 146.26 48.03 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.724 0.809 . . . . 0.0 112.599 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.1 -26.24 15.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.44 2.296 . . . . 0.0 114.74 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 110' ' ' TRP . 32.9 tp -70.19 -20.25 63.13 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.098 -1.001 . . . . 0.0 113.032 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 -13.21 21.94 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.471 2.462 . . . . 0.0 113.607 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 86.8 p -67.57 145.85 54.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.436 1.618 . . . . 0.0 112.852 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.63 144.9 46.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.628 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -141.75 147.44 37.38 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 35.3 m -137.86 136.38 37.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.512 0.725 . . . . 0.0 109.676 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.69 127.91 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.66 0.784 . . . . 0.0 110.721 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.01 -77.93 0.42 Allowed Glycine 0 CA--C 1.532 1.132 0 O-C-N 123.643 0.59 . . . . 0.0 113.909 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.39 145.13 22.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.051 0.925 . . . . 0.0 112.102 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.54 130.06 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.816 0.846 . . . . 0.0 109.776 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.06 164.89 19.17 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.579 0.55 . . . . 0.0 111.783 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 82.1 p -60.58 -25.15 65.99 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.223 -1.548 . . . . 0.0 114.598 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -74.76 -24.95 58.77 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.833 0.742 . . . . 0.0 111.928 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.58 -5.14 32.95 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.09 0.853 . . . . 0.0 114.286 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.0 152.92 44.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.172 0.986 . . . . 0.0 112.133 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . 0.558 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -155.05 166.49 33.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.117 176.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.454 HG22 HD13 ' C' ' 50' ' ' LEU . 15.2 p -127.04 -177.49 4.06 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.01 -165.6 38.92 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 119.486 -2.009 . . . . 0.0 113.947 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.471 ' HB ' HD11 ' C' ' 46' ' ' LEU . 11.3 p -136.67 130.48 32.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.453 1.12 . . . . 0.0 112.369 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.71 141.4 47.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.68 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 mt -130.69 134.19 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.449 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -109.97 140.42 43.98 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.447 1.099 . . . . 0.0 111.562 -173.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.35 18.84 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 18.9 m -136.92 140.92 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 123.772 0.829 . . . . 0.0 111.294 -175.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.86 165.4 35.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.01 -0.431 . . . . 0.0 110.131 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -76.58 -34.75 58.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -134.7 83.78 40.86 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.691 1.596 . . . . 0.0 110.154 173.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.89 36.21 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.917 3.745 . . . . 0.0 115.149 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.13 63.32 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 179.71 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.576 1.95 . . . . 0.0 110.883 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.449 HG21 ' O ' ' C' ' 35' ' ' THR . 63.9 mt -56.59 125.68 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.074 -1.641 . . . . 0.0 111.145 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.59 165.05 29.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.958 1.303 . . . . 0.0 111.806 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' C' ' 32' ' ' THR . 10.4 tp -47.28 115.55 1.14 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 130.766 3.626 . . . . 0.0 112.823 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 11.2 p -105.77 122.42 42.61 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.439 0.696 . . . . 0.0 110.74 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.6 135.29 68.63 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.559 2.173 . . . . 0.0 110.755 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.461 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.2 pp -120.8 161.07 22.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.72 0.808 . . . . 0.0 111.181 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.558 HD12 ' O ' ' C' ' 29' ' ' PHE . 17.9 tp -168.98 149.35 4.31 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.544 1.538 . . . . 0.0 112.257 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -147.16 13.92 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 120.185 1.357 . . . . 0.0 109.711 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -146.87 139.85 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.892 0.877 . . . . 0.0 110.24 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.82 53.37 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.86 154.09 42.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.685 -1.259 . . . . 0.0 111.148 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -144.63 14.67 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -89.78 -47.85 7.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.575 0.75 . . . . 0.0 112.389 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.61 172.23 13.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 31.2 t -74.85 -39.86 61.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.18 0.992 . . . . 0.0 112.617 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -138.45 53.47 5.73 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 112.866 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.1 176.04 10.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.461 1.44 . . . . 0.0 113.814 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.324 0.7 OUTLIER -97.29 166.0 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.071 1.415 . . . . 0.0 112.492 173.718 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -156.49 166.4 33.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.146 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.8 146.73 12.48 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -159.16 153.41 23.81 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -93.85 151.82 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.139 2.176 . . . . 0.0 109.002 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -130.9 119.71 45.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.684 ' HB2' HG21 ' B' ' 52' ' ' ILE . 1.6 t-20 -88.09 118.29 27.56 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.2 -0.938 . . . . 0.0 110.542 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.66 141.55 40.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.121 0.962 . . . . 0.0 110.214 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.94 -40.05 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.225 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.3 -13.12 55.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.326 1.451 . . . . 0.0 114.348 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 43.3 t -152.39 132.98 13.88 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 128.436 2.694 . . . . 0.0 106.175 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.61 117.96 17.02 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.093 1.315 . . . . 0.0 110.244 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 13.9 m -174.18 163.82 3.93 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.545 1.938 . . . . 0.0 109.871 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -139.0 142.48 38.3 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.291 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . 0.764 HG23 HD12 ' C' ' 99' ' ' LEU . 0.0 OUTLIER -132.01 152.2 51.29 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.679 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.13 149.89 29.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.182 -1.827 . . . . 0.0 107.889 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.06 143.6 51.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 127.07 11.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -174.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.96 178.4 44.98 Favored Glycine 0 CA--C 1.499 -0.943 0 N-CA-C 117.421 1.728 . . . . 0.0 117.421 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . 0.586 ' HB3' ' CE1' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.27 147.17 26.6 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.668 0.864 . . . . 0.0 112.125 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 4.4 p -97.8 115.62 28.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.205 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' C' ' 82' ' ' GLN 0.268 3.5 m-85 -110.67 162.57 14.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.15 112.74 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -62.74 163.48 9.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 0.0 109.416 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.19 -28.16 2.83 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.42 -7.39 58.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.188 0.995 . . . . 0.0 113.104 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.69 53.82 3.89 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -121.72 140.32 52.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.708 2.403 . . . . 0.0 106.012 174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -111.42 147.49 35.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.72 1.608 . . . . 0.0 112.251 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.679 HG11 ' HD3' ' C' ' 94' ' ' LYS . 1.8 t -150.11 161.11 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.583 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.48 112.94 17.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.679 ' HD3' HG11 ' C' ' 92' ' ' VAL . 6.6 mmmt -105.46 118.87 37.68 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 174.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.47 161.82 34.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 124.005 1.86 . . . . 0.0 114.043 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.496 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.21 165.66 11.74 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 172.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -140.91 159.49 42.1 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.037 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.828 HD21 HG23 ' C' ' 113' ' ' THR . 1.2 tt -143.27 124.03 14.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.868 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . 0.764 HD12 HG23 ' C' ' 77' ' ' THR . 3.1 tp -107.65 142.07 38.17 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 125.579 1.799 . . . . 0.0 110.68 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 -124.43 114.22 19.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 110.272 -3.149 . . . . 0.0 109.403 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.254 18.5 m -71.4 164.86 24.96 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 125.638 1.836 . . . . 0.0 112.897 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.4 m -102.4 82.58 2.19 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' C' ' 112' ' ' ALA . 2.3 t -77.2 165.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 127.905 2.482 . . . . 0.0 108.971 174.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -115.65 -23.5 8.7 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.6 139.49 50.05 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.986 0.898 . . . . 0.0 111.34 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.0 tt -60.36 -16.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.73 7.2 74.11 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 117.222 -1.877 . . . . 0.0 115.601 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -115.01 4.87 14.83 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.939 1.87 . . . . 0.0 112.725 174.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.8 -31.12 70.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.204 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.492 ' CD1' HD11 ' A' ' 14' ' ' LEU . 54.5 p-90 -49.3 -40.35 34.55 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 113.188 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -96.63 -5.61 38.59 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 113.927 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' C' ' 103' ' ' VAL . . . -79.51 7.2 8.6 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.828 HG23 HD21 ' C' ' 98' ' ' LEU . 18.0 m -122.03 140.67 52.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.767 0.794 . . . . 0.0 113.017 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.07 120.53 6.89 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.308 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -100.95 149.79 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.576 1.95 . . . . 0.0 111.303 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.5 -171.28 22.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.617 0.627 . . . . 0.0 112.653 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -132.06 156.95 45.39 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.106 -0.644 . . . . 0.0 111.569 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . 0.422 HD21 HD22 ' C' ' 14' ' ' LEU . 6.7 m120 -147.79 159.82 43.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.619 1.168 . . . . 0.0 109.256 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . 0.425 HD13 ' HE3' ' C' ' 94' ' ' LYS . 7.2 mt -138.56 119.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.21 147.29 34.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.2 p -135.34 164.62 27.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.716 0.806 . . . . 0.0 109.169 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -59.85 119.92 8.6 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.494 1.518 . . . . 0.0 113.175 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 mttt . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.4 131.7 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.477 1.511 . . . . 0.0 108.284 173.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.08 130.79 22.77 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.62 -26.6 60.86 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -45.39 109.73 0.19 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.866 1.666 . . . . 0.0 111.642 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.28 -125.98 2.93 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.231 0.92 . . . . 0.0 111.003 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -154.6 143.66 21.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -141.04 160.52 39.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.361 1.464 . . . . 0.0 110.983 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 2.9 t -136.59 151.65 49.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.58 1.152 . . . . 0.0 108.481 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.92 143.98 45.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 110.919 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -55.51 -23.06 24.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.451 1.901 . . . . 0.0 114.498 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.03 -18.56 62.57 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.577 -1.327 . . . . 0.0 111.305 174.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.81 -14.19 19.8 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 128.337 2.875 . . . . 0.0 113.487 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.2 p -71.05 144.7 50.29 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.988 -1.301 . . . . 0.0 112.332 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -120.48 141.77 49.88 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.209 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -130.88 143.52 50.79 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.146 0.974 . . . . 0.0 112.992 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.8 m -131.47 132.02 43.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.562 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.04 126.84 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.62 -89.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.775 0 O-C-N 125.125 1.516 . . . . 0.0 111.118 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.08 152.62 43.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.969 0.89 . . . . 0.0 111.815 176.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 53' ' ' GLN . 14.0 p -103.78 124.89 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.771 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.83 160.81 28.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.877 0.37 . . . . 0.0 111.961 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -53.97 -22.88 11.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.28 -36.53 77.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.317 0.647 . . . . 0.0 111.225 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -8.04 17.43 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 124.851 1.215 . . . . 0.0 112.534 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 155.33 40.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 108.789 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -159.82 163.84 34.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.515 177.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -129.16 162.7 27.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.52 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.81 -166.51 27.98 Favored Glycine 0 C--O 1.237 0.29 0 O-C-N 121.219 -0.926 . . . . 0.0 112.369 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.674 ' HB ' HD11 ' A' ' 46' ' ' LEU . 39.6 p -137.39 138.54 39.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 122.578 1.18 . . . . 0.0 111.732 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -114.51 140.66 48.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.234 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 46' ' ' LEU . 41.3 mt -133.57 126.48 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 44' ' ' ILE . 85.3 m -104.99 148.73 26.41 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.86 -18.22 15.83 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.6 m -132.97 138.44 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 111.511 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.1 18.99 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.179 -0.95 . . . . 0.0 112.44 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.25 -26.43 62.9 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.825 -0.547 . . . . 0.0 110.495 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -143.77 81.03 12.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.677 2.391 . . . . 0.0 110.346 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.66 33.43 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 124.94 3.76 . . . . 0.0 116.066 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.66 6.38 83.52 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 119.75 -1.844 . . . . 0.0 115.629 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -176.55 11.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 35' ' ' THR 0.257 59.5 mt -33.5 108.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -173.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -102.38 174.8 5.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.418 -2.173 . . . . 0.0 111.089 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.0 tt -71.69 137.14 47.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.379 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 p -114.12 125.9 28.73 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.189 0.596 . . . . 0.0 111.198 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -57.81 144.27 93.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.283 1.989 . . . . 0.0 112.131 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.66 144.24 51.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.153 0.981 . . . . 0.0 110.818 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.01 30.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.455 2.302 . . . . 0.0 108.621 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.11 -149.04 15.11 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 120.333 -1.479 . . . . 0.0 111.155 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.655 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.5 mp -145.12 138.39 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.872 0.869 . . . . 0.0 112.137 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.596 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.49 131.99 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.738 0.815 . . . . 0.0 110.817 173.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 62' ' ' PRO . 9.5 m-70 -64.4 156.1 30.38 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.794 -1.191 . . . . 0.0 111.273 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -146.75 13.34 1.16 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.798 1.239 . . . . 0.0 113.279 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -78.69 -58.14 3.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.109 2.564 . . . . 0.0 111.304 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.74 13.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.5 m -78.55 -29.2 46.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.062 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.53 58.98 33.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.933 1.293 . . . . 0.0 112.384 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 54' ' ' HIS . 55.2 Cg_endo -80.96 175.72 9.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.344 2.03 . . . . 0.0 116.001 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -88.92 160.05 17.36 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.572 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -161.09 156.69 24.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.156 -0.965 . . . . 0.0 113.145 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 149.39 17.2 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 119.7 2.64 . . . . 0.0 119.7 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.06 159.69 36.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.408 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.9 m -96.8 150.36 20.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.265 1.826 . . . . 0.0 108.398 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.93 125.98 63.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HB2' HG21 ' D' ' 52' ' ' ILE . 21.7 t-20 -104.04 112.4 25.38 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.495 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE1' ' HG1' ' A' ' 77' ' ' THR 0.355 56.4 m95 -74.47 154.89 38.52 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -173.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.86 -50.25 2.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.139 1.776 . . . . 0.0 115.396 -172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -75.58 -15.51 60.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.544 0.737 . . . . 0.0 112.934 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 t -149.26 145.02 26.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.186 2.594 . . . . 0.0 107.295 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.56 116.83 21.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.852 1.31 . . . . 0.0 110.216 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.2 p -168.42 172.06 8.61 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 126.194 1.798 . . . . 0.0 111.045 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.95 142.01 25.98 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.337 1.541 . . . . 0.0 110.711 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.422 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 1.7 m -138.77 132.04 30.04 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.644 -3.435 . . . . 0.0 109.848 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 m -109.54 157.46 9.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.78 137.28 43.26 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 119.96 10.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.48 0.712 . . . . 0.0 110.369 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.38 -173.21 24.62 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -124.0 145.67 49.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 124.968 1.04 . . . . 0.0 111.056 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.6 p -97.8 113.1 24.81 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.443 1.089 . . . . 0.0 112.095 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -102.65 166.94 10.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.883 0.473 . . . . 0.0 111.715 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.3 mt -126.47 110.54 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -58.7 160.73 5.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.218 1.007 . . . . 0.0 108.735 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -49.66 -25.27 2.74 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.79 -13.85 49.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.021 0.929 . . . . 0.0 113.276 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.22 58.24 2.0 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -130.12 148.26 51.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.388 2.675 . . . . 0.0 107.359 172.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -109.58 138.57 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 110.601 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.6 m -141.3 164.17 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 109.518 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 mt -123.31 118.53 27.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -107.57 115.87 30.93 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -133.02 169.43 16.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.886 1.803 . . . . 0.0 112.245 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.469 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -121.37 171.17 8.95 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.0 p-90 -146.38 162.75 37.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.13 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.794 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.7 tt -145.59 125.62 13.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.385 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.9 144.65 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 125.115 1.509 . . . . 0.0 114.588 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -128.64 123.5 33.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.035 -2.348 . . . . 0.0 113.755 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.88 156.24 18.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.674 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -103.08 64.15 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.589 -0.695 . . . . 0.0 109.84 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.12 153.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.139 1.376 . . . . 0.0 113.003 174.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.79 -29.76 32.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.13 144.69 43.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.728 1.252 . . . . 0.0 112.641 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.505 ' CD1' HG21 ' D' ' 92' ' ' VAL . 14.0 tt -65.25 -24.24 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.788 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.0 1.18 41.6 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-O 118.106 -1.386 . . . . 0.0 113.54 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.798 ' HB3' HG11 ' A' ' 103' ' ' VAL . 14.8 m-20 -121.35 6.28 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.804 1.242 . . . . 0.0 114.025 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -33.52 67.9 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 119.755 -1.841 . . . . 0.0 111.705 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 44.1 p-90 -45.67 -50.34 13.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.826 1.251 . . . . 0.0 113.981 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.83 -11.62 47.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.92 0.888 . . . . 0.0 113.342 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.68 -5.92 54.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.361 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.794 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.4 m -103.6 143.7 32.4 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 125.11 1.506 . . . . 0.0 112.174 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -144.05 129.91 19.37 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 124.694 1.198 . . . . 0.0 111.013 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.85 154.8 8.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 120.248 1.385 . . . . 0.0 110.524 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.78 -177.24 32.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.326 0.488 . . . . 0.0 113.259 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 22.8 p90 -125.1 152.58 44.18 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.9 -0.765 . . . . 0.0 111.096 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -148.13 144.04 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.77 128.13 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -115.45 152.75 32.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.975 0.417 . . . . 0.0 110.518 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.8 p -134.69 160.54 37.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.439 1.096 . . . . 0.0 110.054 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -56.81 122.09 11.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.818 0.847 . . . . 0.0 111.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 11' ' ' THR . 4.1 tt . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 83.2 mttt . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -116.31 135.31 53.99 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 2.2 t -139.6 136.84 34.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.774 1.23 . . . . 0.0 108.943 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 38.5 mt -73.63 -24.27 60.0 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -48.34 109.8 0.27 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.319 1.448 . . . . 0.0 112.07 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.48 -124.16 2.56 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 124.679 1.133 . . . . 0.0 110.813 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -151.72 144.28 24.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -142.28 157.49 44.77 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.111 1.365 . . . . 0.0 110.968 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -137.16 150.36 47.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 108.492 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -116.02 143.54 45.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.096 0.958 . . . . 0.0 111.042 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.62 -24.73 8.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.79 2.036 . . . . 0.0 114.975 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.4 tp -70.61 -18.53 62.88 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.282 -1.511 . . . . 0.0 111.643 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.29 -14.88 18.32 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 128.592 2.996 . . . . 0.0 113.543 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 82.5 p -71.34 144.11 50.02 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.011 -1.288 . . . . 0.0 112.455 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -118.73 142.98 47.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.631 0.773 . . . . 0.0 110.403 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -132.19 143.09 49.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.918 0.866 . . . . 0.0 112.538 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 20.5 m -131.44 132.03 44.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.163 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 70.3 mt -130.01 124.51 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -85.74 0.09 OUTLIER Glycine 0 CA--C 1.527 0.794 0 O-C-N 124.934 1.397 . . . . 0.0 111.224 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.32 155.82 44.55 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 122.045 0.926 . . . . 0.0 111.997 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' D' ' 53' ' ' GLN . 14.6 p -107.98 126.34 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.909 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -79.27 161.61 26.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.75 -23.2 16.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -69.63 -34.3 73.85 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.727 -0.608 . . . . 0.0 111.329 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.4 -6.27 18.93 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 124.918 1.247 . . . . 0.0 112.789 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.68 157.13 38.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 122.122 0.963 . . . . 0.0 111.783 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.06 166.53 32.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.482 1.134 . . . . 0.0 110.126 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -132.33 160.87 35.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.552 -1.658 . . . . 0.0 106.717 173.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.64 -166.65 28.97 Favored Glycine 0 C--O 1.24 0.488 0 CA-C-O 122.479 1.044 . . . . 0.0 112.333 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.662 ' HB ' HD11 ' D' ' 46' ' ' LEU . 40.0 p -137.84 140.33 40.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.502 -1.349 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -117.15 141.12 48.67 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.994 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.509 HD11 HD12 ' D' ' 46' ' ' LEU . 43.1 mt -133.31 126.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.465 ' O ' HG21 ' D' ' 44' ' ' ILE . 90.7 m -104.99 147.92 27.28 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.29 16.26 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.7 m -132.96 138.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.105 0.962 . . . . 0.0 111.37 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.67 170.37 18.3 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.286 -0.884 . . . . 0.0 112.229 -173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -71.59 -26.8 62.75 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.826 -0.546 . . . . 0.0 110.443 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.65 81.24 12.25 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.77 2.428 . . . . 0.0 110.241 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.43 32.56 0.12 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.79 3.66 . . . . 0.0 116.321 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.72 6.14 83.34 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 119.726 -1.859 . . . . 0.0 115.696 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.19 11.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.465 HG21 ' O ' ' D' ' 35' ' ' THR 0.257 59.6 mt -33.16 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -173.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -101.52 173.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.545 -2.116 . . . . 0.0 111.102 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.0 tt -69.79 138.06 52.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -114.83 125.61 28.84 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.281 0.633 . . . . 0.0 111.051 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -58.27 143.49 97.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.251 1.967 . . . . 0.0 112.062 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.76 151.02 48.79 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 110.741 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -157.34 149.16 22.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.774 2.03 . . . . 0.0 108.256 -175.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.73 -148.52 17.72 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 119.462 1.028 . . . . 0.0 112.676 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.669 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mp -144.26 138.71 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.167 0.987 . . . . 0.0 112.395 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -128.92 129.44 45.48 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.856 -1.153 . . . . 0.0 110.828 174.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' D' ' 62' ' ' PRO . 10.0 m-70 -62.65 155.32 26.55 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.762 -1.211 . . . . 0.0 111.835 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -146.43 12.52 1.19 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.862 1.265 . . . . 0.0 113.131 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -78.61 -58.17 3.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.35 2.66 . . . . 0.0 111.036 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.36 172.01 12.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.07 0.856 . . . . 0.0 112.603 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -83.39 -25.92 30.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.158 0.983 . . . . 0.0 112.428 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.53 55.33 15.74 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.168 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' D' ' 54' ' ' HIS . 57.7 Cg_endo -80.69 178.35 7.09 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.984 1.789 . . . . 0.0 115.703 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -89.96 157.07 18.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.5 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.934 -1.104 . . . . 0.0 112.883 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.59 149.19 16.29 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 119.925 2.73 . . . . 0.0 119.925 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.6 158.62 34.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . 0.438 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.2 m -94.98 151.61 19.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.336 1.854 . . . . 0.0 108.543 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.75 127.85 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.655 ' HB2' HG21 ' A' ' 52' ' ' ILE . 21.9 t-20 -105.73 112.35 25.38 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.332 -0.842 . . . . 0.0 111.288 -174.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.351 56.4 m95 -73.79 155.07 39.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.548 1.642 . . . . 0.0 115.353 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mmpm? -112.97 -49.4 2.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.022 1.729 . . . . 0.0 115.366 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.27 -15.63 59.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 45.7 t -149.52 144.69 26.43 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.228 2.611 . . . . 0.0 106.952 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -81.77 116.82 21.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.753 1.263 . . . . 0.0 110.115 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 92.9 p -168.67 171.35 8.8 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.231 1.813 . . . . 0.0 111.167 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.15 142.25 27.12 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.947 1.356 . . . . 0.0 110.994 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -139.01 131.85 29.24 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-N 109.906 -3.316 . . . . 0.0 110.098 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 m -109.12 156.8 9.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.941 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -133.71 137.29 45.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.58 119.76 10.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.554 0.741 . . . . 0.0 110.357 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.66 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -121.23 144.83 48.39 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.179 1.164 . . . . 0.0 110.551 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -97.65 113.07 24.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.427 1.08 . . . . 0.0 111.148 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -103.91 166.79 10.19 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.58 0.627 . . . . 0.0 111.868 -177.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.71 112.08 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -58.71 164.52 2.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.997 0.919 . . . . 0.0 109.795 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -51.83 -27.0 11.09 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -10.25 58.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.889 0.876 . . . . 0.0 113.099 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.49 39.39 6.32 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.833 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -113.94 147.24 38.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.608 1.563 . . . . 0.0 109.711 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -101.53 139.37 37.28 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.217 1.407 . . . . 0.0 110.647 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 106' ' ' ILE . 22.3 m -141.66 161.04 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.213 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.7 117.34 27.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 174.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -106.58 115.64 30.55 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -132.43 170.1 15.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.936 1.826 . . . . 0.0 111.89 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -121.79 171.23 9.04 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -146.15 162.65 37.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.105 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.8 tt -145.68 125.71 13.67 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.16 -1.382 . . . . 0.0 113.211 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . 0.402 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -110.08 144.67 38.33 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 125.218 1.574 . . . . 0.0 114.337 -174.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -128.55 123.57 33.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.774 -174.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.95 158.66 16.61 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.98 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -105.37 62.58 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.717 -0.614 . . . . 0.0 110.102 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' D' ' 108' ' ' ASP . 0.1 OUTLIER -48.75 152.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.268 1.427 . . . . 0.0 113.452 174.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -80.84 -29.69 35.83 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.44 144.7 43.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.772 1.272 . . . . 0.0 113.161 -174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 92' ' ' VAL . 12.1 tt -64.82 -24.58 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.991 174.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.21 1.07 43.8 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.054 -1.415 . . . . 0.0 113.72 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . 0.787 ' HB3' HG11 ' D' ' 103' ' ' VAL . 13.6 m-20 -121.06 5.41 10.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.506 1.122 . . . . 0.0 113.931 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -33.93 65.79 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.877 -1.764 . . . . 0.0 111.492 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.7 p-90 -45.59 -50.36 13.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.86 -11.69 47.07 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.292 -0.88 . . . . 0.0 113.231 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.64 -5.57 53.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.213 -172.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.781 ' CG2' HD21 ' D' ' 98' ' ' LEU . 15.2 m -103.34 143.86 32.12 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.981 1.425 . . . . 0.0 112.38 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -144.51 130.2 19.13 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.815 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.92 154.85 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 120.355 1.434 . . . . 0.0 110.733 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -177.64 33.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.402 0.525 . . . . 0.0 113.453 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.1 p90 -124.88 152.29 44.21 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.842 -0.799 . . . . 0.0 111.088 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.15 143.62 27.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.547 0.739 . . . . 0.0 109.061 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -127.55 131.52 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -120.25 151.5 39.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.446 0.641 . . . . 0.0 111.884 174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 36.8 p -131.07 163.8 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.548 1.139 . . . . 0.0 110.129 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -61.5 115.88 4.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.161 1.385 . . . . 0.0 111.781 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.464 0.258 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 174.688 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 51.2 t -117.96 134.56 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -139.61 136.48 34.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.464 1.106 . . . . 0.0 108.704 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 34.5 mt -73.63 -25.89 60.51 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -46.81 109.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.52 1.528 . . . . 0.0 111.705 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.29 -124.94 2.64 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.524 1.059 . . . . 0.0 111.164 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -153.52 142.26 20.99 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -140.42 158.5 43.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.573 1.549 . . . . 0.0 110.959 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t -137.2 151.19 48.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 108.783 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -117.76 143.67 46.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.148 0.979 . . . . 0.0 110.8 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -55.75 -22.99 26.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.441 1.896 . . . . 0.0 114.442 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.7 tp -70.86 -18.06 62.71 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.601 -1.312 . . . . 0.0 111.098 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.21 18.82 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.585 2.993 . . . . 0.0 113.52 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -70.8 145.08 50.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.798 1.299 . . . . 0.0 112.372 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -119.51 140.42 50.53 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.788 0.835 . . . . 0.0 110.321 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -130.54 140.61 50.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.806 0.813 . . . . 0.0 112.728 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.4 m -129.56 131.82 46.66 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.97 125.93 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.31 -88.27 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 125.0 1.437 . . . . 0.0 111.122 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 155.28 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.09 0.947 . . . . 0.0 112.087 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' B' ' 53' ' ' GLN . 15.0 p -107.17 124.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.899 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -77.81 161.3 27.76 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.896 0.379 . . . . 0.0 111.963 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m -54.39 -22.7 13.12 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -69.62 -36.28 76.02 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.241 0.616 . . . . 0.0 111.197 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -8.22 17.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.909 1.243 . . . . 0.0 112.554 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.53 154.5 40.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.579 1.18 . . . . 0.0 109.025 174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -159.39 163.56 35.41 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.314 177.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.56 162.94 26.1 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.436 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.01 -166.22 27.7 Favored Glycine 0 C--O 1.237 0.341 0 O-C-N 121.406 -0.809 . . . . 0.0 112.589 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.688 ' HB ' HD11 ' B' ' 46' ' ' LEU . 37.5 p -136.93 137.12 39.22 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 113.795 -1.202 . . . . 0.0 111.791 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.7 140.62 48.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.238 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.513 HD11 HD12 ' B' ' 46' ' ' LEU . 39.7 mt -133.79 126.77 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 174.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.439 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.0 m -104.95 149.33 25.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -173.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.78 15.38 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.8 m -133.34 138.6 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.77 1.228 . . . . 0.0 111.443 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.2 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.216 -0.928 . . . . 0.0 112.1 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -71.38 -26.84 62.96 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.948 -0.47 . . . . 0.0 110.296 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -143.51 81.15 12.47 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.604 2.362 . . . . 0.0 110.293 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -65.94 30.16 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.763 3.642 . . . . 0.0 116.242 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 6.73 76.74 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 119.829 -1.795 . . . . 0.0 116.176 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -176.76 11.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.439 HG21 ' O ' ' B' ' 35' ' ' THR 0.256 61.5 mt -33.66 109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -102.87 173.97 6.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.838 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.688 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.2 tt -70.94 137.86 49.55 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 171.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.2 p -114.85 126.33 28.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.184 0.593 . . . . 0.0 111.188 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -57.85 143.88 94.83 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.416 2.077 . . . . 0.0 112.134 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 144.49 51.13 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.209 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.07 30.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.565 2.346 . . . . 0.0 108.714 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.26 -149.41 15.88 Favored Glycine 0 CA--C 1.523 0.541 0 O-C-N 120.424 -1.422 . . . . 0.0 111.111 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.657 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.5 mp -144.08 139.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.891 0.877 . . . . 0.0 112.17 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -127.62 130.72 49.48 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.151 -0.968 . . . . 0.0 110.619 173.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . 0.429 ' HB2' ' HB2' ' B' ' 62' ' ' PRO . 10.0 m-70 -63.22 156.06 26.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.683 -1.261 . . . . 0.0 111.577 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -146.16 12.06 1.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.666 1.187 . . . . 0.0 113.106 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -77.56 -57.87 3.58 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.257 2.623 . . . . 0.0 110.861 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.7 171.84 11.31 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.602 1.189 . . . . 0.0 112.911 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 71.3 m -79.19 -29.68 43.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.002 0.921 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.29 56.55 19.03 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 111.631 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' B' ' 54' ' ' HIS . 58.7 Cg_endo -80.15 178.31 7.31 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 121.908 1.738 . . . . 0.0 115.773 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 p -90.02 156.64 18.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.36 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.68 156.54 31.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.224 -0.923 . . . . 0.0 112.742 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.98 149.77 17.89 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 120.07 2.788 . . . . 0.0 120.07 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -158.25 159.25 35.81 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.42 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.8 m -96.09 150.59 20.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.885 1.674 . . . . 0.0 108.478 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -129.02 125.72 63.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.652 ' HB2' HG21 ' C' ' 52' ' ' ILE . 22.0 t-20 -103.72 112.37 25.28 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.507 -174.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . 0.443 ' HE1' ' HG1' ' B' ' 77' ' ' THR 0.355 57.5 m95 -74.11 154.94 38.93 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -173.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.81 -49.42 2.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 115.438 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.42 -15.16 59.99 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -150.44 144.64 25.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.984 2.514 . . . . 0.0 107.278 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.62 116.95 21.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.691 1.234 . . . . 0.0 109.975 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -168.56 171.52 8.82 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.284 1.834 . . . . 0.0 111.208 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.89 142.03 26.07 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 123.202 1.477 . . . . 0.0 110.456 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . 0.443 ' HG1' ' HE1' ' B' ' 70' ' ' TRP . 1.7 m -138.51 132.73 31.66 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.629 -3.441 . . . . 0.0 109.577 -173.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.08 157.37 10.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.925 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.22 137.29 44.27 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.05 119.85 10.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.588 0.755 . . . . 0.0 110.018 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 -176.3 27.5 Favored Glycine 0 N--CA 1.463 0.492 0 N-CA-C 116.649 1.42 . . . . 0.0 116.649 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.06 144.56 48.48 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 124.874 0.984 . . . . 0.0 110.41 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 25.7 p -97.63 113.0 24.64 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.452 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.7 OUTLIER -104.14 166.45 10.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.779 0.718 . . . . 0.0 112.057 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.26 112.42 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -58.59 161.38 4.66 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.264 1.026 . . . . 0.0 108.999 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -48.79 -30.05 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -15.01 57.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.403 1.081 . . . . 0.0 113.221 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.48 54.09 2.47 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 31.8 mtpt -126.99 146.27 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.339 2.256 . . . . 0.0 108.407 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -106.27 138.32 42.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.932 1.693 . . . . 0.0 110.969 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.494 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.6 m -141.67 162.24 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.21 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.52 117.68 27.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -106.96 115.48 30.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -132.66 170.0 15.84 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 123.517 1.627 . . . . 0.0 111.952 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.463 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -121.8 170.88 9.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -145.84 162.83 36.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.215 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.7 tt -145.67 125.68 13.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.375 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 144.31 38.61 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 125.037 1.46 . . . . 0.0 114.625 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.26 123.93 35.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 112.023 -2.353 . . . . 0.0 113.777 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 156.55 17.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.137 0.975 . . . . 0.0 111.716 176.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -102.83 63.5 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.146 0.498 . . . . 0.0 109.75 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.817 HG11 ' HB3' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -49.61 151.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.855 1.262 . . . . 0.0 112.675 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.99 -30.73 39.74 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.05 144.92 42.33 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.49 1.138 . . . . 0.0 113.145 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.487 ' CD1' HG21 ' C' ' 92' ' ' VAL . 12.7 tt -65.74 -23.41 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.559 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.7 1.43 53.02 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 118.24 -1.311 . . . . 0.0 113.693 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.817 ' HB3' HG11 ' B' ' 103' ' ' VAL . 13.5 m-20 -121.14 5.63 10.31 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -33.71 66.67 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 119.878 -1.764 . . . . 0.0 111.699 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 44.4 p-90 -45.29 -50.22 12.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.024 1.329 . . . . 0.0 114.264 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.12 -11.41 47.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.82 -6.26 55.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.214 -1.374 . . . . 0.0 114.476 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.796 ' CG2' HD21 ' B' ' 98' ' ' LEU . 15.2 m -102.96 143.75 32.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 125.228 1.58 . . . . 0.0 112.148 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.9 mtt85 -144.34 129.38 18.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.626 1.17 . . . . 0.0 111.061 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.42 154.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.178 1.354 . . . . 0.0 110.867 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.92 -177.64 33.2 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.291 0.472 . . . . 0.0 113.579 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 23.9 p90 -125.13 152.25 44.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.683 -0.892 . . . . 0.0 110.97 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -148.27 143.42 26.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.62 0.768 . . . . 0.0 109.209 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.51 128.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.83 153.51 31.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.108 0.48 . . . . 0.0 111.43 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 42.2 p -136.14 160.74 37.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.285 1.034 . . . . 0.0 111.331 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -58.93 118.24 5.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.042 0.937 . . . . 0.0 111.735 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.632 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 118.528 -0.748 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 43.9 t -116.31 136.2 53.21 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -139.75 136.09 33.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.49 -26.15 60.77 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -46.54 109.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.256 1.422 . . . . 0.0 112.139 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.34 -126.9 3.32 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.389 0.995 . . . . 0.0 111.161 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -150.31 144.65 25.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -142.61 158.44 43.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.161 1.384 . . . . 0.0 111.034 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 148.82 45.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.705 1.202 . . . . 0.0 108.391 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -115.93 143.62 45.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.9 0.88 . . . . 0.0 110.769 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -53.45 -24.85 13.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.827 2.051 . . . . 0.0 114.549 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.442 HD11 ' CD1' ' A' ' 110' ' ' TRP . 31.3 tp -70.08 -18.39 63.26 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.192 -1.567 . . . . 0.0 111.565 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.42 -15.0 17.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 128.587 2.994 . . . . 0.0 113.452 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 87.9 p -71.66 144.73 49.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.574 1.187 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.89 142.67 49.47 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.4 -0.813 . . . . 0.0 110.681 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -131.3 144.12 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.28 1.038 . . . . 0.0 112.769 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 17.5 m -132.04 131.55 42.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.232 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 66.8 mt -128.66 124.64 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.53 -84.87 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 125.026 1.454 . . . . 0.0 111.102 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.86 157.42 44.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.068 0.937 . . . . 0.0 112.067 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' C' ' 53' ' ' GLN . 13.6 p -109.91 125.81 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.918 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -79.25 161.46 26.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.841 0.456 . . . . 0.0 112.01 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.64 -23.46 17.27 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -69.23 -34.54 74.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.203 0.601 . . . . 0.0 111.413 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.41 -6.35 18.87 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.994 1.283 . . . . 0.0 112.878 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.81 157.78 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.423 1.106 . . . . 0.0 112.07 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 166.35 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.205 174.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -132.08 160.34 36.24 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.06 -166.53 28.26 Favored Glycine 0 C--O 1.239 0.419 0 CA-C-O 122.439 1.021 . . . . 0.0 112.423 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.668 ' HB ' HD11 ' C' ' 46' ' ' LEU . 39.9 p -137.43 140.16 41.11 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.458 -1.371 . . . . 0.0 111.97 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.95 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' C' ' 46' ' ' LEU . 41.2 mt -133.48 126.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.454 ' O ' HG21 ' C' ' 44' ' ' ILE . 89.9 m -104.99 148.89 26.24 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.36 -18.17 15.53 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 17.1 m -133.07 138.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.83 1.252 . . . . 0.0 111.475 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 169.98 19.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.365 -0.834 . . . . 0.0 112.369 -173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.49 -25.53 62.3 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.836 -0.54 . . . . 0.0 110.534 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -145.09 81.2 10.68 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.621 2.369 . . . . 0.0 110.256 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.18 30.99 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 124.686 3.591 . . . . 0.0 116.243 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.35 6.49 79.68 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 119.816 -1.803 . . . . 0.0 116.1 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.46 10.51 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.454 HG21 ' O ' ' C' ' 35' ' ' THR 0.259 59.8 mt -32.64 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -173.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.66 173.59 6.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.042 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.668 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.0 tt -70.28 137.72 50.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.3 p -114.46 126.14 28.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.96 144.31 94.54 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.058 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 150.95 49.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.015 0.926 . . . . 0.0 110.57 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -157.28 149.23 22.5 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.95 2.1 . . . . 0.0 108.512 -175.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.62 -148.44 17.56 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.498 1.045 . . . . 0.0 112.419 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.652 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mp -144.58 138.67 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 124.29 1.036 . . . . 0.0 112.424 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.591 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -128.17 130.08 47.5 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.816 -1.178 . . . . 0.0 110.561 174.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' C' ' 62' ' ' PRO . 10.7 m-70 -62.12 156.26 22.08 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.716 -1.24 . . . . 0.0 111.868 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -147.57 12.87 1.04 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.835 1.254 . . . . 0.0 113.284 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -78.96 -58.16 3.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 128.22 2.608 . . . . 0.0 111.184 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.2 170.28 14.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.853 0.861 . . . . 0.0 112.622 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 73.9 m -81.22 -25.91 36.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.927 173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.93 56.4 16.79 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 125.228 1.411 . . . . 0.0 112.707 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' C' ' 54' ' ' HIS . 59.8 Cg_endo -81.38 178.95 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.103 1.869 . . . . 0.0 115.84 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -89.54 157.48 18.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.98 1.312 . . . . 0.0 112.728 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -158.75 156.12 29.24 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.232 -0.917 . . . . 0.0 112.862 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.03 149.64 17.59 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.63 158.95 34.81 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.446 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.4 m -95.27 151.36 19.31 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.272 1.829 . . . . 0.0 108.56 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.7 124.01 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.657 ' HB2' HG21 ' B' ' 52' ' ' ILE . 22.5 t-20 -102.12 112.47 25.15 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.956 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.354 55.4 m95 -73.91 154.87 39.21 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.98 -48.73 2.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.178 1.791 . . . . 0.0 115.529 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.67 -15.12 59.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -150.91 144.82 25.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.07 2.548 . . . . 0.0 107.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.8 117.17 22.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.607 1.094 . . . . 0.0 109.748 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 93.2 p -168.95 171.24 8.47 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.581 1.952 . . . . 0.0 110.942 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -147.59 142.27 26.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-O 123.039 1.399 . . . . 0.0 110.924 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.52 132.03 30.54 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 109.897 -3.319 . . . . 0.0 110.051 -172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -108.95 157.19 9.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.959 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -133.99 137.35 44.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.93 119.53 10.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 0.0 109.82 -174.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.24 -174.68 25.42 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.1 144.52 48.88 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.464 0.743 . . . . 0.0 110.781 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.69 113.0 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 124.139 0.899 . . . . 0.0 110.982 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -104.75 167.71 9.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.469 0.652 . . . . 0.0 111.557 -177.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.79 113.97 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -58.78 161.2 5.0 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.871 0.868 . . . . 0.0 109.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -51.31 -20.95 1.89 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.72 -11.04 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.535 0.734 . . . . 0.0 112.665 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.94 49.02 3.93 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -122.81 145.82 48.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.639 1.976 . . . . 0.0 109.409 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -102.9 139.17 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.857 1.263 . . . . 0.0 111.024 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.6 m -141.77 163.97 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.97 1.308 . . . . 0.0 109.433 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.52 119.02 28.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -108.14 115.41 30.07 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -132.59 170.06 15.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.978 1.847 . . . . 0.0 112.274 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.436 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -122.11 170.98 9.32 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 172.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -146.15 162.69 37.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.233 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.786 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.7 tt -145.64 125.67 13.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.194 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . 0.403 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -110.14 144.69 38.4 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.974 1.421 . . . . 0.0 114.333 -174.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.28 123.1 33.24 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 111.943 -2.389 . . . . 0.0 113.701 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.7 156.22 18.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.699 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -102.97 61.55 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.864 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' C' ' 108' ' ' ASP . 0.1 OUTLIER -48.06 151.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.144 1.377 . . . . 0.0 113.008 174.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -80.17 -31.05 38.89 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.89 145.15 42.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.534 1.159 . . . . 0.0 112.992 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.494 ' CD1' HG21 ' B' ' 92' ' ' VAL . 13.1 tt -64.84 -24.16 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.707 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 1.73 46.66 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.945 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . 0.794 ' HB3' HG11 ' C' ' 103' ' ' VAL . 13.2 m-20 -121.32 5.89 10.2 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -33.33 67.92 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 119.896 -1.752 . . . . 0.0 111.7 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.538 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 43.9 p-90 -45.59 -49.92 13.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.79 1.236 . . . . 0.0 114.299 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.33 -11.01 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.32 56.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.786 ' CG2' HD21 ' C' ' 98' ' ' LEU . 15.5 m -102.83 143.85 31.92 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 125.134 1.521 . . . . 0.0 112.265 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -144.54 130.03 18.93 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.64 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.25 154.18 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 120.417 1.462 . . . . 0.0 110.644 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -177.84 33.38 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.466 0.555 . . . . 0.0 113.442 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.8 p90 -124.76 152.43 43.84 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.665 -0.903 . . . . 0.0 111.135 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -148.14 143.71 27.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.666 0.787 . . . . 0.0 109.305 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.73 129.16 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.93 152.65 34.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.282 0.563 . . . . 0.0 111.612 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.2 p -135.18 161.86 34.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.447 1.099 . . . . 0.0 110.643 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -57.5 117.29 4.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.621 1.168 . . . . 0.0 112.505 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.466 0.374 0 O-C-N 121.655 -0.653 . . . . 0.0 109.817 176.391 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 154.03 31.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.014 0.926 . . . . 0.0 109.408 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.6 p -139.66 127.58 22.15 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.137 -0.977 . . . . 0.0 112.999 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.95 -31.56 72.85 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.594 1.543 . . . . 0.0 113.375 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -66.5 113.68 4.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.26 0.21 0.3 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 119.03 2.372 . . . . 0.0 119.03 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt 73.14 144.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 129.405 3.082 . . . . 0.0 114.362 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -140.27 161.97 36.4 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.321 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -141.44 147.17 37.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.434 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.42 143.42 40.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.729 0.812 . . . . 0.0 110.195 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -56.64 -23.87 44.35 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.478 1.911 . . . . 0.0 113.593 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' C' ' 110' ' ' TRP . 31.7 tp -71.61 -18.97 62.18 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.666 1.586 . . . . 0.0 111.499 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.45 -14.79 25.1 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 127.493 2.473 . . . . 0.0 113.582 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 p -67.99 140.3 56.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.361 1.581 . . . . 0.0 112.123 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.47 142.86 46.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -136.48 146.64 46.52 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.297 1.046 . . . . 0.0 112.843 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -134.2 132.17 39.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.313 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.0 mt -133.02 127.14 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.96 -84.52 0.19 Allowed Glycine 0 CA--C 1.526 0.762 0 O-C-N 125.187 1.554 . . . . 0.0 111.475 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 145.49 29.39 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.869 0.842 . . . . 0.0 112.238 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.57 128.9 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.718 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.14 161.88 20.93 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.519 0.676 . . . . 0.0 111.851 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 p -57.97 -20.9 41.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -78.22 -31.56 49.42 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.211 0.914 . . . . 0.0 111.532 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.29 -5.78 23.3 Favored Glycine 0 N--CA 1.466 0.655 0 CA-C-O 117.352 -1.805 . . . . 0.0 114.626 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 145.83 53.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.711 1.755 . . . . 0.0 109.056 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -155.1 140.2 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.05 12.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 -168.94 35.27 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.873 1.263 . . . . 0.0 111.304 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.664 ' HB ' HD11 ' A' ' 46' ' ' LEU . 43.3 p -133.0 130.26 39.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 123.339 1.543 . . . . 0.0 110.928 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -111.64 136.83 50.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.033 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD12 ' A' ' 46' ' ' LEU . 33.0 mt -132.6 130.27 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -108.5 145.98 33.91 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.32 -15.19 18.9 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.0 m -133.49 140.99 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.626 1.17 . . . . 0.0 112.937 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.47 162.53 38.1 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 120.76 -1.212 . . . . 0.0 111.0 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.95 -39.5 79.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.476 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -131.81 84.66 53.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 127.184 2.194 . . . . 0.0 108.082 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.11 175.56 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.423 2.082 . . . . 0.0 111.522 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.58 -31.96 3.29 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.608 1.099 . . . . 0.0 112.543 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.02 28.29 2.12 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.406 1.083 . . . . 0.0 112.164 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -58.25 134.11 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.796 0.807 . . . . 0.0 109.587 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 174.06 11.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.399 1.48 . . . . 0.0 108.984 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' HB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -53.28 132.48 39.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.112 1.765 . . . . 0.0 113.055 175.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -114.51 125.49 29.11 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.057 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' HE3' ' A' ' 71' ' ' LYS . 4.9 Cg_exo -58.51 146.96 88.78 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.235 1.957 . . . . 0.0 110.846 173.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.46 151.66 51.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.26 0.624 . . . . 0.0 110.871 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tp -156.75 149.05 23.21 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.003 1.721 . . . . 0.0 110.872 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.56 -154.26 25.0 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 121.541 1.973 . . . . 0.0 109.833 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.9 mt -146.7 140.94 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 112.132 -174.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.28 138.24 50.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.792 1.237 . . . . 0.0 110.766 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -70.52 155.56 40.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.837 0.827 . . . . 0.0 110.415 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -138.61 -5.6 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -77.67 -35.09 52.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.85 167.12 12.69 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 m -76.96 -37.99 54.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.298 1.439 . . . . 0.0 114.659 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -139.33 49.92 2.33 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 125.026 1.33 . . . . 0.0 111.877 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.76 -179.04 4.98 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.408 2.739 . . . . 0.0 115.35 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.5 p -87.44 161.31 17.91 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.892 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.51 155.75 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.487 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.82 19.92 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 119.715 2.646 . . . . 0.0 119.715 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -159.72 159.73 33.2 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -97.64 148.72 23.02 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.952 2.501 . . . . 0.0 108.685 173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.52 125.33 63.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 48.8 t30 -103.68 107.06 17.75 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.555 -174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -72.06 149.19 45.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 123.411 1.577 . . . . 0.0 114.731 -173.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HE3' ' HD3' ' A' ' 48' ' ' PRO . 27.9 mttt -108.54 -45.39 3.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -78.85 -17.23 55.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.287 1.035 . . . . 0.0 112.804 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 128.66 10.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 129.269 3.028 . . . . 0.0 105.397 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.12 119.01 11.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.332 0.969 . . . . 0.0 112.088 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 t -170.72 167.52 7.71 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.773 1.629 . . . . 0.0 110.919 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -146.13 140.9 27.02 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 124.001 1.857 . . . . 0.0 110.484 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.5 m -137.24 126.38 24.53 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-N 109.303 -3.589 . . . . 0.0 109.949 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -102.09 161.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.39 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -136.7 137.95 40.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.92 118.14 9.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.14 -179.41 26.84 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.058 -1.068 . . . . 0.0 115.535 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -121.57 148.89 43.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 125.223 1.19 . . . . 0.0 111.264 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.1 t -97.13 127.64 43.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 125.094 1.496 . . . . 0.0 109.911 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' D' ' 106' ' ' ILE . 7.7 m-85 -117.7 161.4 19.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.16 0.984 . . . . 0.0 113.517 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 28.1 mt -127.18 112.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.54 160.56 6.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.104 0.562 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -43.05 -37.26 1.89 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.12 -14.94 60.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.448 1.499 . . . . 0.0 114.773 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 46.82 4.15 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.587 0.613 . . . . 0.0 113.016 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 12.3 mtpt -115.79 160.23 20.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.966 2.106 . . . . 0.0 108.037 173.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -116.0 144.77 43.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.075 1.762 . . . . 0.0 111.713 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.72 159.36 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.601 1.191 . . . . 0.0 109.592 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 120' ' ' PHE . 24.8 mt -125.14 102.29 7.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' A' ' 92' ' ' VAL . 2.3 mmtt -96.23 121.42 37.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.4 p -134.01 162.86 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.627 1.204 . . . . 0.0 111.373 -174.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.421 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.38 168.16 9.85 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 171.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -142.11 163.8 31.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.786 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.7 OUTLIER -145.97 123.98 12.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.801 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.32 144.87 38.4 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 125.088 1.493 . . . . 0.0 114.025 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -124.52 114.89 20.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.983 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -73.7 162.59 29.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.889 0.876 . . . . 0.0 111.557 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.6 p -99.88 45.69 0.98 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.0 -1.063 . . . . 0.0 111.492 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -52.4 137.23 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.98 1.712 . . . . 0.0 113.145 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -20.58 61.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -174.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.62 150.93 51.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.16 1.457 . . . . 0.0 113.549 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' D' ' 84' ' ' PHE . 16.0 tt -64.15 -23.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.109 -0.994 . . . . 0.0 113.084 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.47 3.75 58.18 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.071 0.843 . . . . 0.0 113.552 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 103' ' ' VAL . 1.1 m-20 -122.7 -0.65 9.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.195 0.998 . . . . 0.0 112.451 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -31.76 69.18 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.208 -0.932 . . . . 0.0 112.85 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.7 p-90 -48.18 -41.61 27.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.096 1.358 . . . . 0.0 113.714 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 15.2 pttm -96.39 -8.59 32.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 -0.9 18.94 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.742 ' CG2' HD21 ' A' ' 98' ' ' LEU . 8.2 m -113.39 140.97 47.61 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.588 0.755 . . . . 0.0 112.632 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -144.21 131.67 20.97 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.787 1.235 . . . . 0.0 111.738 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.66 156.55 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 110.53 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -175.43 30.89 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.516 0.579 . . . . 0.0 113.225 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -125.14 153.15 43.45 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.795 -0.826 . . . . 0.0 112.112 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 132.13 14.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.746 0.784 . . . . 0.0 110.052 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.419 HD13 ' HE3' ' A' ' 94' ' ' LYS . 15.5 mt -118.93 138.45 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 21.0 m-85 -124.56 139.97 53.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.821 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.3 p -129.32 154.09 47.2 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -53.01 117.86 3.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.336 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 123' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 p -134.58 148.53 50.47 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.27 1.828 . . . . 0.0 107.732 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 65.3 p -139.29 131.12 27.57 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.285 -1.51 . . . . 0.0 114.148 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 50.7 mt -65.04 -31.88 73.33 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.259 1.391 . . . . 0.0 113.924 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -66.33 115.64 6.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.38 8.16 0.29 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 118.296 2.079 . . . . 0.0 118.296 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 66.55 148.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.272 2.629 . . . . 0.0 114.927 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -143.43 161.08 39.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.474 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -140.5 145.7 37.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.545 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -109.54 143.61 38.97 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.178 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.16 -23.34 46.77 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.405 1.882 . . . . 0.0 113.543 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.52 HD11 ' CD1' ' B' ' 110' ' ' TRP . 32.0 tp -72.4 -19.06 61.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.006 1.722 . . . . 0.0 111.27 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.47 -14.59 22.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.121 2.296 . . . . 0.0 113.622 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -67.52 138.34 56.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.458 1.629 . . . . 0.0 112.202 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.85 141.3 46.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -135.03 147.15 49.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.246 1.022 . . . . 0.0 113.179 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.1 m -134.49 131.96 38.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.068 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -133.13 126.32 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.08 -84.59 0.16 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 125.292 1.62 . . . . 0.0 111.583 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.05 29.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.713 0.757 . . . . 0.0 111.853 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.56 128.8 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.901 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.52 161.54 19.95 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.636 0.731 . . . . 0.0 111.595 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.8 p -58.2 -21.38 47.44 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -75.92 -30.3 58.68 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.176 0.898 . . . . 0.0 111.666 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.77 -4.21 25.98 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.778 1.18 . . . . 0.0 115.061 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.56 150.85 45.67 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.399 1.08 . . . . 0.0 110.926 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -156.46 162.84 39.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.164 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.86 171.97 12.17 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 173.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.21 -167.84 37.3 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 119.947 -1.721 . . . . 0.0 111.628 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' THR . . . . . 0.646 ' HB ' HD11 ' D' ' 46' ' ' LEU . 44.0 p -132.95 128.84 37.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.89 1.329 . . . . 0.0 110.823 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -111.65 136.06 51.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.12 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.412 HD11 HD12 ' D' ' 46' ' ' LEU . 30.6 mt -132.11 132.39 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' THR . . . . . 0.438 HG23 ' H ' ' D' ' 37' ' ' VAL . 1.0 OUTLIER -111.26 145.5 38.65 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 -15.41 19.2 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.438 ' H ' HG23 ' D' ' 35' ' ' THR . 18.6 m -133.55 140.7 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.324 1.05 . . . . 0.0 113.068 -174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.01 162.4 37.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.132 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.77 -38.85 80.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.628 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -131.89 84.5 53.75 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.987 2.115 . . . . 0.0 108.013 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 175.09 9.58 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.09 1.86 . . . . 0.0 111.417 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.23 -31.45 3.3 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.567 1.079 . . . . 0.0 112.502 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.37 28.13 2.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.341 1.056 . . . . 0.0 112.16 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.9 134.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.929 0.871 . . . . 0.0 109.608 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.18 174.08 11.19 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.314 1.445 . . . . 0.0 108.862 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.646 HD11 ' HB ' ' D' ' 32' ' ' THR . 0.9 OUTLIER -53.53 132.69 40.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 126.248 1.819 . . . . 0.0 113.093 175.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -114.67 125.67 28.83 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.067 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' D' ' 71' ' ' LYS . 4.8 Cg_exo -58.72 146.92 90.43 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.164 1.909 . . . . 0.0 110.748 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.13 157.41 43.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.441 0.697 . . . . 0.0 111.234 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.89 148.85 15.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.822 1.649 . . . . 0.0 110.381 -174.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -157.7 28.96 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 121.35 1.886 . . . . 0.0 111.999 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.6 mt -145.41 138.7 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.094 0.957 . . . . 0.0 111.903 -174.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.98 138.17 50.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.537 1.535 . . . . 0.0 110.733 174.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -71.09 154.94 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.408 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -136.8 -6.38 1.91 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -78.61 -35.91 44.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.25 168.57 13.8 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -74.82 -42.55 57.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.244 1.018 . . . . 0.0 113.556 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -137.45 53.07 6.06 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.07 1.348 . . . . 0.0 112.037 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.91 -179.73 5.48 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.264 1.976 . . . . 0.0 115.248 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 34.8 p -87.97 161.91 17.16 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.762 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -159.53 155.97 27.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.57 149.69 19.59 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 119.517 2.567 . . . . 0.0 119.517 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.13 158.07 29.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -96.47 149.22 21.97 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.827 2.451 . . . . 0.0 108.989 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.89 124.87 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 52' ' ' ILE . 44.5 t30 -104.23 107.31 18.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.053 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.7 149.6 45.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 123.381 1.562 . . . . 0.0 114.397 -173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' D' ' 48' ' ' PRO . 27.2 mttt -108.56 -45.06 3.93 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -173.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -79.22 -16.88 55.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.395 1.078 . . . . 0.0 112.917 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -152.26 129.25 11.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.299 3.04 . . . . 0.0 105.453 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.91 118.95 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.355 0.98 . . . . 0.0 111.584 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 45.5 t -170.5 167.54 8.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 110.776 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -145.9 141.06 27.44 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.832 1.777 . . . . 0.0 110.892 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.46 125.25 22.48 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 109.469 -3.514 . . . . 0.0 110.456 -172.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -101.04 161.06 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.355 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.29 138.38 39.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.26 118.16 9.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 109.223 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -151.23 -178.59 26.18 Favored Glycine 0 CA--C 1.5 -0.85 0 C-N-CA 120.006 -1.092 . . . . 0.0 115.816 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.26 145.58 48.09 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 125.09 1.112 . . . . 0.0 111.263 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' D' ' 93' ' ' LEU . 17.0 t -97.6 118.37 33.95 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.939 1.4 . . . . 0.0 110.653 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' A' ' 106' ' ' ILE . 8.9 m-85 -109.06 163.78 13.02 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 7.8 mt -127.94 113.64 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 174.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.31 154.99 26.18 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -36.51 -38.98 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -72.37 -29.68 64.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.655 1.582 . . . . 0.0 114.467 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.38 58.72 0.73 Allowed Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.122 1.344 . . . . 0.0 110.949 -173.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 19.2 mtpt -123.72 163.46 21.07 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.414 2.686 . . . . 0.0 107.31 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -124.81 145.74 49.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 121.77 2.077 . . . . 0.0 112.725 -172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' VAL . . . . . 0.554 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -145.16 159.48 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.679 1.191 . . . . 0.0 110.643 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' D' ' 120' ' ' PHE . 19.1 mt -123.22 104.15 8.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' LYS . . . . . 0.554 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.7 mmtt -98.29 119.05 36.29 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' THR . . . . . 0.401 HG22 ' HA3' ' D' ' 81' ' ' GLY . 1.9 p -133.19 161.93 33.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.534 1.159 . . . . 0.0 111.257 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.24 168.45 9.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -142.14 164.25 30.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.477 1.132 . . . . 0.0 111.727 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.7 OUTLIER -146.9 124.14 11.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.685 -1.598 . . . . 0.0 113.569 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.62 144.81 38.95 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 125.332 1.645 . . . . 0.0 114.078 -174.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -124.63 115.02 20.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.896 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 31.5 m -74.52 161.32 29.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.937 0.895 . . . . 0.0 111.844 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 58.8 p -99.0 45.55 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.85 -1.157 . . . . 0.0 111.356 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' D' ' 108' ' ' ASP . 0.3 OUTLIER -52.22 137.96 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 112.964 -174.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -19.74 60.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.04 151.75 50.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.862 1.315 . . . . 0.0 113.783 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.7 tt -63.89 -24.37 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.367 -0.833 . . . . 0.0 113.171 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.16 3.5 52.09 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.212 0.911 . . . . 0.0 113.6 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' ASP . . . . . 0.402 ' HB3' HG21 ' D' ' 103' ' ' VAL . 1.2 m-20 -122.9 -0.78 8.96 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.139 0.976 . . . . 0.0 112.454 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -31.85 68.46 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.408 -0.808 . . . . 0.0 112.747 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.1 p-90 -48.3 -41.68 28.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.255 1.422 . . . . 0.0 113.703 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' LYS . . . . . 0.405 ' HB3' ' CZ3' ' D' ' 110' ' ' TRP . 15.1 pttm -96.66 -8.6 31.16 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -1.46 20.87 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' THR . . . . . 0.746 ' CG2' HD21 ' D' ' 98' ' ' LEU . 8.5 m -112.95 140.83 47.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.531 0.733 . . . . 0.0 112.687 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -144.12 131.34 20.72 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.788 1.235 . . . . 0.0 111.658 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.49 156.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 110.492 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.24 -175.26 31.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.541 0.591 . . . . 0.0 113.434 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -125.06 152.59 44.1 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.734 -0.862 . . . . 0.0 112.004 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.34 12.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.851 0.834 . . . . 0.0 110.166 -175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' ILE . . . . . 0.412 HD13 ' HE3' ' D' ' 94' ' ' LYS . 16.4 mt -116.02 138.29 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' D' ' 93' ' ' LEU . 21.0 m-85 -125.08 141.88 51.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -130.36 154.32 47.8 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -52.83 112.94 0.93 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.246 1.018 . . . . 0.0 110.145 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' LEU . . . . . 0.57 HD23 ' C ' ' D' ' 123' ' ' LEU . 7.7 tt . . . . . 0 CA--C 1.51 -0.571 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.416 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.3 p -116.86 147.77 41.87 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.331 1.852 . . . . 0.0 109.54 -174.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -139.48 129.66 25.25 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.78 -33.22 75.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.13 1.332 . . . . 0.0 114.105 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -65.27 115.55 5.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.82 5.2 0.32 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 68.76 146.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 128.59 2.756 . . . . 0.0 115.483 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -141.97 159.14 42.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.411 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.407 ' HB ' HD12 ' B' ' 123' ' ' LEU . 13.7 t -136.45 143.82 44.09 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.591 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -108.97 143.54 38.11 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.611 0.764 . . . . 0.0 110.571 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -55.62 -25.09 36.9 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.194 1.798 . . . . 0.0 113.332 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' D' ' 110' ' ' TRP . 29.6 tp -71.13 -18.92 62.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.633 1.573 . . . . 0.0 111.846 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.94 -16.06 23.27 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.381 2.42 . . . . 0.0 113.414 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 61.5 p -67.29 141.11 57.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.019 1.39 . . . . 0.0 111.89 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.67 141.09 48.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -134.56 147.14 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.569 1.176 . . . . 0.0 112.505 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -134.76 131.17 37.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.57 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 93.9 mt -132.59 126.2 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -84.75 0.17 Allowed Glycine 0 CA--C 1.526 0.769 0 O-C-N 125.348 1.655 . . . . 0.0 111.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.23 146.54 30.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 112.265 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 28.2 t -89.94 128.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.497 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.28 162.18 17.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.527 0.68 . . . . 0.0 111.847 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.2 p -58.0 -20.92 42.24 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -78.35 -31.4 48.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.176 0.898 . . . . 0.0 111.719 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.97 -5.75 23.87 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-O 117.479 -1.734 . . . . 0.0 114.687 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.6 145.34 54.03 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.531 1.665 . . . . 0.0 108.914 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.76 140.1 17.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.18 12.04 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.43 -168.72 34.93 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-O 122.82 1.233 . . . . 0.0 111.132 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.654 ' HB ' HD11 ' B' ' 46' ' ' LEU . 41.7 p -133.59 131.1 39.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.32 -1.44 . . . . 0.0 110.789 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -112.25 137.06 50.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.898 -1.956 . . . . 0.0 108.116 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.42 HD11 HD12 ' B' ' 46' ' ' LEU . 27.0 mt -132.96 129.72 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.445 HG23 ' H ' ' B' ' 37' ' ' VAL . 1.0 OUTLIER -108.75 145.73 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -175.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.23 -14.75 19.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 35' ' ' THR . 18.4 m -133.93 140.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.559 1.143 . . . . 0.0 112.745 -174.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.36 162.85 37.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 110.862 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.48 -38.96 77.9 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.433 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -132.15 84.6 52.28 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.202 2.201 . . . . 0.0 107.995 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.01 175.49 9.06 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.375 2.05 . . . . 0.0 111.486 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.35 -31.41 3.44 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.584 1.088 . . . . 0.0 112.654 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -140.28 28.25 2.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.395 1.078 . . . . 0.0 112.15 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.03 134.41 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.92 0.867 . . . . 0.0 109.562 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.31 173.63 11.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.347 1.459 . . . . 0.0 109.039 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.654 HD11 ' HB ' ' B' ' 32' ' ' THR . 0.9 OUTLIER -52.97 132.93 38.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.15 1.78 . . . . 0.0 113.211 175.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -115.26 125.86 28.42 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.082 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' HE3' ' B' ' 71' ' ' LYS . 6.7 Cg_exo -58.42 146.51 89.9 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 0.0 110.811 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.4 151.48 51.5 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.289 0.635 . . . . 0.0 110.7 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 tp -156.78 149.08 23.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.028 1.731 . . . . 0.0 110.845 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.59 25.49 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 121.555 1.979 . . . . 0.0 109.511 -173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' C' ' 69' ' ' ASN . 4.0 mt -146.2 140.23 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.371 1.068 . . . . 0.0 112.403 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.35 137.35 49.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.465 1.106 . . . . 0.0 110.657 174.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -69.91 156.13 39.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 109.992 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -138.81 -5.66 1.51 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -79.15 -36.9 39.72 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.47 166.64 15.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.749 0.656 . . . . 0.0 112.524 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.7 m -79.41 -34.28 41.93 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -139.78 51.88 3.35 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 125.147 1.379 . . . . 0.0 112.351 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.3 -179.5 5.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.734 2.29 . . . . 0.0 115.806 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -87.23 161.55 17.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.941 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.84 155.67 26.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.575 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.68 19.44 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 119.705 2.642 . . . . 0.0 119.705 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -160.07 159.05 31.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -96.52 149.44 21.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.844 2.457 . . . . 0.0 108.783 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.88 125.74 63.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.606 ' HB2' HG21 ' C' ' 52' ' ' ILE . 48.5 t30 -104.05 106.63 17.2 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 118.223 -0.894 . . . . 0.0 112.373 -174.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -71.8 149.43 45.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.288 1.518 . . . . 0.0 114.591 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.503 ' HE3' ' HD3' ' B' ' 48' ' ' PRO . 28.2 mttt -108.58 -45.24 3.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -79.14 -16.97 55.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 112.857 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 129.17 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.242 3.017 . . . . 0.0 105.455 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.73 119.0 11.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.472 1.033 . . . . 0.0 111.791 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 39.4 t -170.43 167.38 8.25 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.993 1.717 . . . . 0.0 110.738 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -146.12 140.83 26.98 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-O 124.03 1.871 . . . . 0.0 110.453 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.52 126.18 23.78 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 109.335 -3.575 . . . . 0.0 110.052 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.8 161.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.328 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.91 138.58 40.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.3 119.43 10.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.668 0.787 . . . . 0.0 109.148 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.81 -178.84 27.85 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.202 -0.999 . . . . 0.0 115.579 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -121.51 145.9 47.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 125.211 1.183 . . . . 0.0 111.058 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . 0.456 ' SG ' HD23 ' B' ' 93' ' ' LEU . 17.2 t -97.36 121.94 39.83 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.651 1.219 . . . . 0.0 110.012 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.564 ' HB2' HD12 ' C' ' 106' ' ' ILE . 10.7 m-85 -111.98 163.57 14.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.916 1.286 . . . . 0.0 112.648 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 19.2 mt -128.08 119.09 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.13 163.63 5.98 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.362 0.601 . . . . 0.0 109.839 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -47.0 -36.84 8.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.85 -25.09 60.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.308 1.443 . . . . 0.0 113.444 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.06 11.37 22.51 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.02 -1.433 . . . . 0.0 115.785 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 9.5 mtpt -81.58 167.21 19.51 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.426 1.613 . . . . 0.0 111.143 174.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.77 148.19 43.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.065 1.757 . . . . 0.0 112.185 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.537 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.2 t -146.99 160.6 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 122.358 1.075 . . . . 0.0 110.61 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 18.6 mt -123.49 103.58 8.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' LYS . . . . . 0.537 ' CD ' HG11 ' B' ' 92' ' ' VAL . 2.0 mmtt -98.14 118.71 35.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -132.41 163.3 29.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.583 1.182 . . . . 0.0 111.534 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -113.15 168.45 9.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -142.57 164.0 31.31 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.184 0.992 . . . . 0.0 111.771 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -146.38 123.73 11.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.678 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.06 144.78 38.14 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 125.197 1.56 . . . . 0.0 114.173 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.4 115.4 20.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 111.822 -2.445 . . . . 0.0 114.298 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 38.4 m -75.81 161.33 29.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.156 0.982 . . . . 0.0 111.134 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.5 p -98.28 45.29 1.02 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 108' ' ' ASP . 0.3 OUTLIER -51.42 137.73 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.91 1.684 . . . . 0.0 112.979 -174.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -20.3 60.86 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -173.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.21 153.13 50.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.84 1.305 . . . . 0.0 113.666 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' C' ' 84' ' ' PHE . 16.0 tt -65.03 -22.81 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.76 2.78 58.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.363 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.406 ' HB3' HG21 ' B' ' 103' ' ' VAL . 1.5 m-20 -122.5 -0.79 9.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.558 1.143 . . . . 0.0 112.436 -174.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -32.07 67.05 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.28 -0.887 . . . . 0.0 112.892 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.52 ' CD1' HD11 ' D' ' 14' ' ' LEU . 57.0 p-90 -48.65 -41.52 31.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.076 1.35 . . . . 0.0 113.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 110' ' ' TRP . 14.8 pttm -96.65 -8.33 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.91 -1.21 18.7 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.745 ' CG2' HD21 ' B' ' 98' ' ' LEU . 8.2 m -113.15 140.97 47.46 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.772 0.829 . . . . 0.0 112.807 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -144.13 131.56 20.95 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.708 1.203 . . . . 0.0 111.547 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.54 156.73 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 123.976 0.91 . . . . 0.0 110.73 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.35 -175.91 31.85 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.509 0.576 . . . . 0.0 113.358 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 27.8 p90 -124.56 152.57 43.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.781 -0.834 . . . . 0.0 111.956 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.6 12.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.953 0.883 . . . . 0.0 110.072 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.411 HD13 ' HE3' ' B' ' 94' ' ' LYS . 15.2 mt -116.7 138.74 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 24.5 m-85 -125.19 142.41 51.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.851 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 26.9 p -132.29 158.86 40.76 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -57.55 119.68 6.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.455 1.102 . . . . 0.0 113.255 -173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.413 HD23 ' O ' ' B' ' 123' ' ' LEU . 8.7 tt . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' CYS . . . . . . . . . . . . 0.254 16.1 p -116.02 142.94 46.14 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 124.559 1.144 . . . . 0.0 108.343 -173.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 33.1 p -134.83 132.4 38.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.826 1.25 . . . . 0.0 113.858 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.31 -30.03 68.92 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -67.78 111.81 4.5 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.45 -10.32 0.29 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 118.597 2.199 . . . . 0.0 118.597 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt 81.19 146.48 0.08 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 130.513 3.525 . . . . 0.0 113.261 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -140.47 161.45 37.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.227 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -139.09 144.22 38.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.686 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -107.89 143.61 36.27 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.712 0.805 . . . . 0.0 110.275 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.08 -23.91 50.16 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.697 1.599 . . . . 0.0 113.276 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 110' ' ' TRP . 30.6 tp -71.14 -18.96 62.49 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.729 1.612 . . . . 0.0 111.415 174.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.9 -16.36 23.23 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.363 2.411 . . . . 0.0 113.537 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 51.7 p -66.55 141.04 57.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.215 1.508 . . . . 0.0 112.128 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.75 139.41 51.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.58 147.11 51.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.22 1.009 . . . . 0.0 113.021 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -134.85 131.9 37.96 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.891 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.99 125.6 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.99 -82.0 0.23 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 125.342 1.651 . . . . 0.0 111.379 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.72 151.11 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.681 0.753 . . . . 0.0 112.027 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.63 128.02 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.846 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -65.02 161.09 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.618 0.723 . . . . 0.0 111.675 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 11.7 p -58.03 -20.57 39.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -76.81 -29.91 56.18 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.313 0.96 . . . . 0.0 111.621 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.26 -3.69 26.76 Favored Glycine 0 N--CA 1.468 0.772 0 C-N-CA 124.761 1.172 . . . . 0.0 115.112 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.14 150.31 45.55 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.371 1.069 . . . . 0.0 110.797 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.86 162.73 40.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.041 174.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 172.4 11.62 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.37 -167.08 36.2 Favored Glycine 0 C--O 1.237 0.302 0 O-C-N 120.004 -1.685 . . . . 0.0 111.861 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' THR . . . . . 0.629 ' HB ' HD11 ' C' ' 46' ' ' LEU . 34.8 p -133.78 128.57 35.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 123.172 1.463 . . . . 0.0 111.1 174.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.02 137.21 50.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.14 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.411 HD11 HD12 ' C' ' 46' ' ' LEU . 25.7 mt -132.27 133.25 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' THR . . . . . 0.508 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.8 OUTLIER -114.92 146.96 40.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.91 -14.06 19.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.508 ' H ' HG23 ' C' ' 35' ' ' THR . 17.1 m -134.16 142.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.746 1.218 . . . . 0.0 112.609 -174.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.42 38.95 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.035 -1.041 . . . . 0.0 110.992 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.95 -39.01 79.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.362 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -132.12 84.69 52.16 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.089 2.156 . . . . 0.0 107.988 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 175.4 9.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.328 2.018 . . . . 0.0 111.506 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.83 -31.37 3.37 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.523 1.059 . . . . 0.0 112.58 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -140.19 28.6 2.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.486 1.114 . . . . 0.0 112.135 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.83 134.54 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.786 0.803 . . . . 0.0 109.462 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.97 174.66 10.65 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.273 1.429 . . . . 0.0 108.888 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' C' ' 32' ' ' THR . 1.0 OUTLIER -53.86 133.09 42.75 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.26 1.824 . . . . 0.0 112.963 174.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 49.0 m -115.37 125.75 28.51 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.153 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HE3' ' C' ' 71' ' ' LYS . 5.6 Cg_exo -58.04 146.7 86.43 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.142 1.895 . . . . 0.0 110.92 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.83 157.53 42.63 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.229 0.612 . . . . 0.0 111.187 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.513 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -161.3 148.89 15.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.835 1.654 . . . . 0.0 110.244 -174.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.83 -157.9 29.15 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 121.57 1.986 . . . . 0.0 111.875 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.6 mt -145.26 138.25 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.17 0.988 . . . . 0.0 111.933 -174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.17 139.29 51.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.687 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.46 154.64 40.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.486 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -137.28 -6.21 1.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -78.42 -37.2 44.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.31 165.8 16.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.344 0.592 . . . . 0.0 112.538 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 24.8 m -79.05 -34.26 43.95 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -140.2 52.74 3.7 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.897 1.279 . . . . 0.0 112.244 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.79 -179.09 5.11 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.851 2.367 . . . . 0.0 115.95 -174.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -86.5 162.38 18.1 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.792 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -160.22 156.49 26.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.736 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.4 148.98 17.96 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.64 158.77 32.16 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.91 149.78 21.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.825 2.45 . . . . 0.0 108.894 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.58 124.13 58.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' ASN . . . . . 0.587 ' HB2' HG21 ' B' ' 52' ' ' ILE . 44.0 t30 -103.53 107.66 18.59 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.231 -174.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -71.87 149.1 45.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.127 1.441 . . . . 0.0 114.557 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.452 ' HE3' ' HD3' ' C' ' 48' ' ' PRO . 26.5 mttt -108.21 -45.15 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.415 2.005 . . . . 0.0 116.415 -173.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -78.9 -16.93 56.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.204 1.002 . . . . 0.0 112.958 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -152.05 131.57 13.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 129.517 3.127 . . . . 0.0 105.032 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.41 119.04 13.98 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.163 0.892 . . . . 0.0 111.627 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 48.5 t -170.53 167.59 8.01 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.767 1.627 . . . . 0.0 110.819 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -145.81 141.14 27.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 123.927 1.823 . . . . 0.0 110.763 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.59 125.93 23.29 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 109.454 -3.521 . . . . 0.0 110.43 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -102.01 160.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.15 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -136.96 138.36 40.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.4 119.29 9.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.716 0.807 . . . . 0.0 108.875 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.51 -177.88 26.6 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 119.931 -1.128 . . . . 0.0 115.709 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -122.09 145.85 47.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.004 1.061 . . . . 0.0 111.191 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' C' ' 93' ' ' LEU . 14.6 t -97.4 121.73 39.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.803 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.575 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.8 m-85 -112.8 162.23 16.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.415 1.086 . . . . 0.0 113.276 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 27.5 mt -127.86 111.7 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -62.23 162.19 10.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.424 0.69 . . . . 0.0 110.052 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -42.97 -39.53 2.64 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.36 -25.55 63.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.051 1.34 . . . . 0.0 113.784 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.54 10.01 22.33 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.87 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 15.0 mtpp -78.77 164.24 24.7 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.333 1.566 . . . . 0.0 110.862 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.62 148.18 41.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.019 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.2 t -146.91 162.92 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.904 1.281 . . . . 0.0 110.425 176.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' C' ' 120' ' ' PHE . 19.4 mt -126.24 104.21 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.9 mmtt -98.79 118.26 35.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -131.96 163.13 29.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.462 1.125 . . . . 0.0 111.572 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' MET . . . . . 0.415 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -112.92 168.82 9.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -143.09 164.29 30.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.199 1.0 . . . . 0.0 111.832 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.747 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.7 OUTLIER -146.4 123.77 11.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.973 -1.467 . . . . 0.0 113.705 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.23 144.72 38.49 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.248 1.419 . . . . 0.0 114.068 -174.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.48 114.91 20.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 112.168 -2.287 . . . . 0.0 114.185 -174.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -74.86 161.32 29.66 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.852 0.861 . . . . 0.0 111.938 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 55.4 p -98.27 45.33 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.307 1.043 . . . . 0.0 111.48 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.31 136.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.744 1.618 . . . . 0.0 113.453 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -20.52 61.85 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -174.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.53 151.35 51.09 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.819 1.295 . . . . 0.0 113.597 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.9 tt -64.28 -21.92 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.56 3.27 64.06 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -122.81 -0.58 9.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.316 1.046 . . . . 0.0 112.621 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -31.55 68.51 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.72 0.808 . . . . 0.0 112.83 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' TRP . . . . . 0.524 ' CD1' HD11 ' A' ' 14' ' ' LEU . 57.4 p-90 -49.02 -41.16 33.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.009 1.323 . . . . 0.0 113.706 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' LYS . . . . . 0.406 ' HB3' ' CZ3' ' C' ' 110' ' ' TRP . 14.9 pttm -96.78 -8.54 30.93 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.01 18.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' THR . . . . . 0.747 ' CG2' HD21 ' C' ' 98' ' ' LEU . 8.3 m -113.41 140.44 48.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.52 0.728 . . . . 0.0 112.66 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -143.69 131.24 21.14 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.639 1.176 . . . . 0.0 111.645 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.37 156.49 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.034 0.933 . . . . 0.0 110.64 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.95 -175.8 31.33 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.352 0.501 . . . . 0.0 113.261 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 27.5 p90 -124.21 152.93 42.33 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.786 -0.832 . . . . 0.0 112.053 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.17 128.81 11.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.966 0.889 . . . . 0.0 110.132 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' ILE . . . . . 0.427 HD13 ' HE3' ' C' ' 94' ' ' LYS . 15.3 mt -115.37 140.87 34.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 25.2 m-85 -127.27 141.32 51.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.772 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 18.2 p -131.69 161.17 33.4 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -59.15 119.76 7.93 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.706 0.802 . . . . 0.0 112.546 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 172.332 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . 0.522 ' OE1' ' HA ' ' A' ' -3' ' ' GLN . 10.7 mm-40 . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 118.797 -0.621 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 18.5 p -86.87 -42.92 12.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.547 1.139 . . . . 0.0 111.972 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.63 137.11 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 142.9 101.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 129.702 3.201 . . . . 0.0 111.615 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 51.86 25.83 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -146.66 124.46 11.91 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.396 1.078 . . . . 0.0 113.228 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.31 136.97 52.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 122.564 1.173 . . . . 0.0 111.747 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.14 129.03 24.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.909 2.484 . . . . 0.0 107.564 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' A' ' 53' ' ' GLN . 3.8 mt -67.83 -31.25 70.97 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -53.44 116.53 2.5 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.731 0.777 . . . . 0.0 110.947 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.45 -128.85 4.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 10' ' ' TRP . 14.8 ttmt -146.23 152.34 39.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 55.9 m95 -138.35 162.73 33.66 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 110.879 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 14.7 t -141.3 144.64 34.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.54 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.632 HD22 ' H ' ' A' ' 14' ' ' LEU . 4.2 t30 -106.92 147.28 30.0 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.84 0.856 . . . . 0.0 111.591 -174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -27.79 58.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.868 1.267 . . . . 0.0 113.94 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 12' ' ' ASN . 35.1 tp -71.09 -15.99 62.55 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.425 1.49 . . . . 0.0 113.476 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.68 -9.81 44.77 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.871 2.177 . . . . 0.0 114.068 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -71.93 146.73 47.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.685 1.243 . . . . 0.0 110.839 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -122.72 148.36 45.41 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.15 -0.969 . . . . 0.0 111.711 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -135.06 139.81 45.05 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -126.4 132.68 51.48 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.76 126.71 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.77 -91.0 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.637 1.211 . . . . 0.0 111.97 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 134.61 30.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.519 -0.989 . . . . 0.0 110.387 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.01 133.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.959 0.787 . . . . 0.0 111.241 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.36 158.09 36.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.372 1.069 . . . . 0.0 110.874 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.6 m -57.65 -24.58 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.865 -1.147 . . . . 0.0 113.963 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.409 -0.807 . . . . 0.0 110.766 173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.31 -5.01 33.42 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.769 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.23 154.24 39.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.942 1.871 . . . . 0.0 111.608 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -155.04 154.22 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -116.83 156.28 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.604 1.162 . . . . 0.0 109.557 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.72 -176.57 38.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.651 1.139 . . . . 0.0 115.288 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.441 ' CG2' HD23 ' A' ' 46' ' ' LEU . 7.9 p -134.26 123.29 24.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.279 -1.461 . . . . 0.0 107.724 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' C ' HD12 ' A' ' 34' ' ' ILE . 62.2 t80 -124.38 132.14 53.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.169 -1.832 . . . . 0.0 113.76 -171.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 46' ' ' LEU . 2.4 mp -124.15 131.37 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.735 0.778 . . . . 0.0 108.965 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -106.92 138.27 43.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.087 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.32 24.63 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 30.3 m -137.81 136.96 45.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 124.083 0.953 . . . . 0.0 111.921 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.46 163.13 37.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.172 -0.955 . . . . 0.0 111.012 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.88 -27.13 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.25 80.47 10.13 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 127.281 2.232 . . . . 0.0 109.881 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.92 13.21 0.23 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.736 3.624 . . . . 0.0 117.986 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.31 -28.86 1.53 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.41 53.53 0.17 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.147 1.473 . . . . 0.0 112.28 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.55 130.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.756 -1.215 . . . . 0.0 111.096 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.09 172.32 11.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 128.272 2.629 . . . . 0.0 108.818 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.653 HD12 HG13 ' A' ' 34' ' ' ILE 0.289 5.5 mp -66.69 131.91 46.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.7 m -99.39 117.72 63.46 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.421 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.93 138.72 78.48 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.782 1.655 . . . . 0.0 110.525 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.53 148.49 46.24 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.165 0.916 . . . . 0.0 110.688 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 148.89 33.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.554 2.342 . . . . 0.0 108.64 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.49 -159.03 32.05 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.254 -1.529 . . . . 0.0 109.312 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.9 mt -145.48 146.65 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.717 0.892 . . . . 0.0 111.5 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' A' ' 6' ' ' LEU . 7.0 pt20 -132.29 154.35 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.28 1.038 . . . . 0.0 113.071 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -92.16 157.93 16.45 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.381 1.086 . . . . 0.0 109.098 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.13 23.53 0.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.726 1.61 . . . . 0.0 111.918 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.46 -52.34 4.55 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.465 2.306 . . . . 0.0 111.93 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.78 174.46 3.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 t -71.77 -44.84 63.33 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.446 -0.784 . . . . 0.0 111.773 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.59 69.08 81.52 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.688 1.195 . . . . 0.0 110.229 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.22 168.64 17.12 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.903 3.068 . . . . 0.0 118.08 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.5 p -86.06 157.45 20.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.365 174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -150.59 174.32 13.11 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 123.989 1.852 . . . . 0.0 112.533 174.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.82 149.62 9.38 Favored Glycine 0 N--CA 1.408 -3.186 0 CA-C-N 108.674 -3.875 . . . . 0.0 120.168 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.31 153.21 23.21 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.4 150.01 23.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.362 1.865 . . . . 0.0 109.985 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.84 117.01 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.538 ' CB ' HG21 ' D' ' 52' ' ' ILE . 39.8 t30 -101.99 110.86 22.94 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.87 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.331 50.5 m95 -70.08 154.79 41.5 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.156 1.931 . . . . 0.0 115.436 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 9.9 mmpt? -107.52 -44.18 4.35 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.332 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -91.8 -8.54 46.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 t -152.47 136.61 16.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.359 2.264 . . . . 0.0 107.728 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -72.52 112.35 8.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.658 1.572 . . . . 0.0 110.441 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.1 p -165.98 169.99 14.11 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.011 1.724 . . . . 0.0 111.562 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -148.14 141.62 25.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 122.855 1.312 . . . . 0.0 111.241 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m -137.11 124.06 21.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 110.945 -2.843 . . . . 0.0 110.198 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -101.3 154.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.426 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -127.23 142.31 51.51 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.163 0.985 . . . . 0.0 108.521 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.48 120.76 7.84 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -169.69 -166.12 28.17 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.552 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.85 146.15 50.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 124.671 0.865 . . . . 0.0 113.296 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 50.4 t -97.4 113.23 24.86 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.219 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' HD12 ' D' ' 106' ' ' ILE . 18.1 m-85 -103.77 169.64 8.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.298 1.839 . . . . 0.0 111.743 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -125.44 112.14 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.01 161.59 8.19 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.801 0.441 . . . . 0.0 110.535 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -30.36 -57.11 0.2 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.397 1.879 . . . . 0.0 115.975 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.26 -15.51 63.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.01 1.724 . . . . 0.0 115.022 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.94 27.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.702 1.144 . . . . 0.0 114.77 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -78.93 144.32 34.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.739 1.616 . . . . 0.0 111.79 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -101.42 141.73 33.86 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.728 1.211 . . . . 0.0 111.708 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.8 m -144.02 160.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.777 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -119.45 116.92 27.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -107.28 111.92 24.52 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 7.2 p -133.28 172.0 13.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.125 1.441 . . . . 0.0 111.563 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.513 ' HG3' HG21 ' D' ' 113' ' ' THR . 90.8 mmm -124.78 169.22 12.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.431 -1.258 . . . . 0.0 107.794 174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -139.94 162.03 36.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.045 1.402 . . . . 0.0 112.319 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -145.67 119.17 9.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.149 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.25 141.27 38.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 123.649 1.69 . . . . 0.0 110.42 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ARG . 10.4 tpt180 -125.62 113.91 18.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 110.172 -3.195 . . . . 0.0 109.746 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -77.09 156.94 31.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.982 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.87 82.87 2.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -65.8 173.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.684 1.194 . . . . 0.0 111.978 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.515 ' H ' HG12 ' A' ' 103' ' ' VAL . 4.6 p-10 -117.87 -7.58 10.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.96 148.1 39.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.869 1.319 . . . . 0.0 110.33 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' D' ' 92' ' ' VAL . 15.7 tt -63.3 -26.28 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.862 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.04 -2.83 33.38 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 117.912 -1.493 . . . . 0.0 115.219 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.55 3.67 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.843 1.321 . . . . 0.0 113.459 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -35.38 61.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.959 -1.088 . . . . 0.0 111.577 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.501 ' CD1' HD11 ' C' ' 14' ' ' LEU . 60.2 p-90 -50.13 -46.34 53.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.163 0.985 . . . . 0.0 113.402 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -14.71 42.65 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.372 -0.83 . . . . 0.0 112.728 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' A' ' 103' ' ' VAL . . . -73.81 -9.16 58.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' D' ' 96' ' ' MET . 61.9 m -95.24 155.97 16.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -154.05 124.15 6.87 Favored 'General case' 0 C--O 1.213 -0.836 0 C-N-CA 126.822 2.049 . . . . 0.0 111.156 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.37 156.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 121.792 2.087 . . . . 0.0 110.203 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.18 -177.56 31.4 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 124.397 1.061 . . . . 0.0 115.023 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 16.2 p90 -123.67 152.23 42.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.114 0.966 . . . . 0.0 110.984 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -150.4 148.2 28.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.899 0.88 . . . . 0.0 110.67 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.3 mt -132.27 122.94 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.082 -1.011 . . . . 0.0 109.294 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -113.87 153.94 28.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.013 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.0 p -135.73 164.27 28.28 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.307 1.043 . . . . 0.0 110.796 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -57.74 117.7 4.51 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.444 1.098 . . . . 0.0 110.41 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -67.0 133.68 50.42 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.228 -0.295 . . . . 0.0 110.606 177.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 76.78 31.3 0.56 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.9 t -58.73 159.72 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -96.42 -172.17 2.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.407 1.883 . . . . 0.0 111.161 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -94.54 118.32 31.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.667 0.787 . . . . 0.0 111.529 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.248 1.02 1 C-N-CA 131.838 4.055 . . . . 0.0 107.178 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.815 -1.088 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 10.1 t -149.38 62.73 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.539 1.638 . . . . 0.0 113.223 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.25 141.72 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.343 1.857 . . . . 0.0 108.128 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -153.21 5.19 0.34 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.925 1.69 . . . . 0.0 112.236 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 30.7 ttp85 -156.75 29.63 0.32 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.982 1.713 . . . . 0.0 111.715 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -152.41 125.81 8.75 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.822 -1.174 . . . . 0.0 112.594 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 131.36 56.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.752 1.263 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.77 127.58 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.908 2.083 . . . . 0.0 106.042 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.432 HD12 ' CD ' ' D' ' 53' ' ' GLN . 2.4 mt -73.22 -28.87 62.42 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 124.414 1.071 . . . . 0.0 112.755 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.5 t -53.5 115.84 2.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.93 0.892 . . . . 0.0 110.508 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.72 -132.63 5.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.482 1.515 . . . . 0.0 109.392 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . 0.489 ' HG2' ' H ' ' D' ' 10' ' ' TRP . 16.0 ttmt -144.24 152.51 40.93 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . 0.489 ' H ' ' HG2' ' D' ' 9' ' ' LYS . 55.6 m95 -139.94 162.72 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.544 1.938 . . . . 0.0 111.476 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.646 ' HB ' HD12 ' D' ' 123' ' ' LEU . 14.2 t -139.9 146.95 39.9 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.354 1.062 . . . . 0.0 109.102 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.666 HD22 ' H ' ' D' ' 14' ' ' LEU . 3.8 t30 -108.85 148.25 30.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.64 0.776 . . . . 0.0 111.546 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -25.37 59.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.692 1.197 . . . . 0.0 114.108 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.666 ' H ' HD22 ' D' ' 12' ' ' ASN . 34.9 tp -73.3 -15.85 61.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.596 1.559 . . . . 0.0 113.269 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.04 -12.84 45.14 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.479 1.99 . . . . 0.0 113.89 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -67.96 145.63 54.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.94 1.37 . . . . 0.0 111.166 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -120.95 149.31 42.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.182 -0.949 . . . . 0.0 111.692 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -135.31 142.46 45.84 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.912 -0.493 . . . . 0.0 112.209 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -128.59 132.35 48.19 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.871 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.01 127.6 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.577 1.173 . . . . 0.0 112.307 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.27 134.6 29.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.851 -0.794 . . . . 0.0 110.632 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.02 131.91 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.679 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.71 156.45 38.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.778 1.231 . . . . 0.0 110.275 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 72.8 m -57.29 -23.04 45.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.09 -28.15 68.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.501 -0.75 . . . . 0.0 110.841 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.74 -4.35 34.39 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 125.302 1.429 . . . . 0.0 112.771 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -76.85 158.98 30.43 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.843 1.322 . . . . 0.0 113.32 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -155.09 166.36 33.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.71 0.767 . . . . 0.0 112.05 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -128.61 160.07 33.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.552 1.141 . . . . 0.0 108.801 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.93 -175.48 39.52 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 119.974 -1.108 . . . . 0.0 115.465 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.459 ' CG2' HD23 ' D' ' 46' ' ' LEU . 8.7 p -134.75 124.03 24.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.084 1.354 . . . . 0.0 107.927 -174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . 0.581 ' C ' HD12 ' D' ' 34' ' ' ILE . 65.0 t80 -125.3 131.24 53.1 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.638 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.668 HG13 HD12 ' D' ' 46' ' ' LEU . 2.5 mp -123.37 129.67 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.926 0.87 . . . . 0.0 109.015 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.25 137.84 42.39 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.255 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.53 -6.92 26.65 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 31.1 m -138.4 136.87 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.056 0.931 . . . . 0.0 112.175 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.27 161.96 39.9 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.855 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.3 -25.45 54.84 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.715 -0.616 . . . . 0.0 110.555 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -146.85 79.81 9.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 127.277 2.231 . . . . 0.0 109.791 173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.91 13.13 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.834 3.689 . . . . 0.0 117.992 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.48 -28.64 1.57 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 118.241 2.056 . . . . 0.0 118.241 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -163.71 54.77 0.17 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.203 1.502 . . . . 0.0 112.076 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.68 130.54 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.76 -1.213 . . . . 0.0 111.068 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 173.06 10.95 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.274 2.629 . . . . 0.0 108.894 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.668 HD12 HG13 ' D' ' 34' ' ' ILE 0.296 5.4 mp -67.72 131.11 44.96 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 61.1 m -98.31 117.98 64.08 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.762 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.26 137.86 78.06 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.694 1.596 . . . . 0.0 110.264 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -121.9 155.67 34.97 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.446 1.091 . . . . 0.0 110.662 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.658 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -155.62 149.03 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.319 1.848 . . . . 0.0 109.026 -177.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.32 -157.42 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 O-C-N 121.158 -0.964 . . . . 0.0 111.021 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.538 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -145.56 147.06 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.03 0.919 . . . . 0.0 111.568 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . 0.432 ' CD ' HD12 ' D' ' 6' ' ' LEU . 5.7 pt20 -133.12 153.59 51.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.37 1.081 . . . . 0.0 112.969 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.37 157.55 17.56 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.389 1.09 . . . . 0.0 108.539 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 24.33 0.56 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.728 1.611 . . . . 0.0 111.358 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -93.48 -51.57 4.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.602 2.361 . . . . 0.0 111.318 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 172.26 8.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -69.11 -43.47 74.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 0.0 111.075 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.85 71.59 69.68 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.947 1.299 . . . . 0.0 110.851 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -69.86 169.29 19.38 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.076 3.184 . . . . 0.0 118.817 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 36.2 p -86.65 156.23 20.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.018 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' D' ' 83' ' ' CYS . 0.0 OUTLIER -152.62 173.99 14.52 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 123.981 1.848 . . . . 0.0 112.633 174.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.0 148.89 9.17 Favored Glycine 0 N--CA 1.412 -2.941 0 CA-C-N 109.213 -3.63 . . . . 0.0 119.748 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -159.59 153.09 22.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.55 151.3 23.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.601 1.96 . . . . 0.0 110.006 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.47 117.38 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.534 ' CB ' HG21 ' A' ' 52' ' ' ILE . 42.4 t30 -102.42 111.83 24.29 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.136 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.328 51.1 m95 -70.68 153.11 43.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 124.105 1.907 . . . . 0.0 115.61 -172.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' D' ' 71' ' ' LYS . 9.9 mmpt? -105.76 -43.46 4.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.188 -174.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -92.09 -8.65 45.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -152.58 136.51 16.32 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.204 2.202 . . . . 0.0 107.473 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.83 111.52 7.16 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.691 1.587 . . . . 0.0 110.368 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 93.0 p -165.07 170.73 14.72 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.778 1.631 . . . . 0.0 111.569 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 64' ' ' PHE . 4.9 t -148.35 142.21 25.74 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.519 1.152 . . . . 0.0 111.586 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.13 123.65 20.9 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 111.25 -2.705 . . . . 0.0 110.357 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 m -100.8 154.04 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -127.21 142.08 51.57 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.01 0.924 . . . . 0.0 108.719 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 119.96 7.24 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -167.79 -166.75 27.4 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.132 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -133.56 147.07 51.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 125.051 1.089 . . . . 0.0 112.819 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.448 ' HB2' ' CZ ' ' D' ' 64' ' ' PHE . 44.1 t -97.28 125.35 41.79 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-O 116.19 -1.862 . . . . 0.0 108.011 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.432 ' HB2' HD12 ' A' ' 106' ' ' ILE . 13.1 m-85 -114.51 172.03 7.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.921 1.689 . . . . 0.0 110.819 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mt -127.87 111.87 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.51 158.73 9.27 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -25.97 -55.16 0.06 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.212 2.205 . . . . 0.0 116.005 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -9.02 58.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.137 2.175 . . . . 0.0 116.001 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.8 51.1 3.51 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 120.082 1.31 . . . . 0.0 109.981 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -124.07 136.35 54.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.795 1.638 . . . . 0.0 109.119 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -101.06 139.82 36.22 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.903 1.335 . . . . 0.0 110.689 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 106' ' ' ILE . 19.9 m -144.3 161.05 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 113.203 -1.817 . . . . 0.0 109.704 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.73 116.78 25.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -106.78 111.13 23.52 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.432 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 6.3 p -133.07 172.18 12.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 123.51 1.624 . . . . 0.0 111.831 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' A' ' 113' ' ' THR . 90.4 mmm -124.92 169.06 12.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -139.26 162.22 35.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 123.56 1.648 . . . . 0.0 112.55 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -145.68 119.81 9.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.699 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.29 141.75 38.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.599 1.812 . . . . 0.0 110.442 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -126.0 113.87 17.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 109.999 -3.273 . . . . 0.0 109.895 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 2.6 t -77.84 158.19 29.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.286 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 56.6 m -105.22 77.62 1.32 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.68 0.752 . . . . 0.0 109.74 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.581 ' CG2' ' HB2' ' D' ' 112' ' ' ALA . 1.5 t -63.55 166.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.106 1.363 . . . . 0.0 112.595 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.405 ' H ' HG12 ' D' ' 103' ' ' VAL . 4.7 p-10 -112.44 -4.36 14.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.64 147.4 35.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.58 1.181 . . . . 0.0 110.373 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.482 ' CD1' HG21 ' A' ' 92' ' ' VAL . 16.0 tt -63.36 -26.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.854 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.49 -3.03 30.66 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 117.659 -1.634 . . . . 0.0 115.432 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.26 3.49 10.34 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.806 1.303 . . . . 0.0 113.636 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.96 60.71 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.819 -1.176 . . . . 0.0 111.816 174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.507 ' CD1' HD11 ' B' ' 14' ' ' LEU . 60.4 p-90 -49.46 -46.83 48.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 -15.65 41.82 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.29 -0.881 . . . . 0.0 112.789 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' D' ' 103' ' ' VAL . . . -73.51 -7.76 53.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.513 HG21 ' HG3' ' A' ' 96' ' ' MET . 57.2 m -96.54 154.88 17.02 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.021 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.19 124.3 7.47 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.627 1.971 . . . . 0.0 111.195 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.52 156.23 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 121.699 2.045 . . . . 0.0 110.047 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -178.6 31.68 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.834 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 15.6 p90 -122.51 152.62 40.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.168 0.987 . . . . 0.0 110.83 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -150.61 147.36 27.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.937 0.875 . . . . 0.0 110.837 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.64 120.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.239 -0.913 . . . . 0.0 108.985 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -110.46 154.31 23.8 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.067 0.855 . . . . 0.0 111.539 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -136.68 161.95 34.51 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.378 1.071 . . . . 0.0 110.055 174.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt-85 -56.66 128.26 35.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER -62.43 168.38 3.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.408 174.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -30.12 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.608 2.363 . . . . 0.0 114.944 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 15.6 p -79.08 143.9 35.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 122.417 1.103 . . . . 0.0 111.8 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -74.79 158.0 34.22 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.443 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -70.45 172.38 8.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.397 173.035 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 10.2 t -155.13 -43.7 0.08 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 120.493 1.497 . . . . 0.0 108.194 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 15.9 m -88.94 155.16 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.565 1.146 . . . . 0.0 108.07 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -89.09 -46.25 8.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.484 0.714 . . . . 0.0 112.734 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -172.59 89.31 0.09 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.851 2.06 . . . . 0.0 110.306 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -156.23 132.0 9.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.374 -0.829 . . . . 0.0 112.912 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 132.22 56.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.453 1.101 . . . . 0.0 111.391 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.27 127.64 19.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.847 2.059 . . . . 0.0 106.439 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.66 -30.82 64.6 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.84 117.3 2.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.929 0.892 . . . . 0.0 110.733 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.28 -130.49 4.83 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.755 1.645 . . . . 0.0 109.662 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' B' ' 10' ' ' TRP . 15.1 ttmt -145.25 152.83 40.58 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . 0.472 ' H ' ' HG2' ' B' ' 9' ' ' LYS . 58.0 m95 -138.76 162.73 33.99 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.753 2.021 . . . . 0.0 111.275 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -143.51 145.0 32.21 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.903 0.881 . . . . 0.0 109.195 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.62 HD22 ' H ' ' B' ' 14' ' ' LEU . 4.1 t30 -109.7 146.55 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.887 0.875 . . . . 0.0 111.83 -174.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -25.87 53.38 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.62 ' H ' HD22 ' B' ' 12' ' ' ASN . 35.0 tp -73.21 -16.54 61.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.479 1.512 . . . . 0.0 113.075 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 -12.94 29.98 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.964 2.221 . . . . 0.0 114.033 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -69.0 142.96 54.49 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.836 -1.391 . . . . 0.0 111.993 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.42 143.31 45.72 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.829 -1.169 . . . . 0.0 110.657 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -133.24 139.23 46.84 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.946 -0.471 . . . . 0.0 112.053 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -126.51 132.6 51.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.871 0.868 . . . . 0.0 108.74 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.9 mt -129.05 127.2 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.31 -91.06 0.07 OUTLIER Glycine 0 CA--C 1.528 0.9 0 O-C-N 124.87 1.356 . . . . 0.0 112.096 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.32 135.35 32.12 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.863 -0.787 . . . . 0.0 110.865 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.94 133.61 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.223 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -70.9 158.26 36.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.358 1.063 . . . . 0.0 110.993 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 64.7 m -57.87 -24.31 57.01 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.753 -1.217 . . . . 0.0 114.021 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -66.15 -29.25 69.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.453 -0.779 . . . . 0.0 110.729 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.19 34.63 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 117.918 -1.49 . . . . 0.0 112.933 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.85 154.15 39.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.798 1.799 . . . . 0.0 111.535 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.35 154.16 31.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -116.78 156.43 27.23 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 109.573 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.62 -176.18 38.1 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.691 1.162 . . . . 0.0 115.02 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.449 ' CG2' HD23 ' B' ' 46' ' ' LEU . 7.5 p -134.87 123.97 24.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 113.259 -1.471 . . . . 0.0 107.298 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.574 ' C ' HD12 ' B' ' 34' ' ' ILE . 64.9 t80 -124.72 131.29 53.47 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.724 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.649 HG13 HD12 ' B' ' 46' ' ' LEU . 2.4 mp -123.72 129.57 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 122.09 0.948 . . . . 0.0 108.597 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -105.02 141.23 36.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.251 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.97 21.6 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.96 136.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.201 1.0 . . . . 0.0 111.797 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.94 162.2 39.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.241 -0.912 . . . . 0.0 110.999 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.02 -27.45 60.1 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.445 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -146.09 80.36 10.33 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.214 2.205 . . . . 0.0 109.758 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.64 12.94 0.23 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.722 3.615 . . . . 0.0 118.073 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.0 -28.97 1.38 Allowed Glycine 0 CA--C 1.54 1.621 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -163.25 53.29 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.152 1.476 . . . . 0.0 112.361 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.74 130.54 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 120.782 -1.199 . . . . 0.0 111.358 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.95 173.5 10.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.049 2.54 . . . . 0.0 108.945 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.649 HD12 HG13 ' B' ' 34' ' ' ILE 0.292 5.4 mp -67.71 131.51 45.72 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.6 m -99.22 117.69 63.67 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.418 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -54.61 138.85 75.92 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.665 1.577 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.5 148.47 46.22 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.248 0.967 . . . . 0.0 110.641 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.66 148.85 33.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.402 2.281 . . . . 0.0 108.646 174.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.52 -159.09 32.12 Favored Glycine 0 N--CA 1.443 -0.898 0 O-C-N 120.319 -1.488 . . . . 0.0 109.464 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.9 mt -145.41 147.58 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.784 0.834 . . . . 0.0 111.473 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -133.15 153.99 51.02 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 122.409 1.099 . . . . 0.0 113.859 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -91.9 157.09 17.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.549 1.166 . . . . 0.0 108.892 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.38 25.09 0.47 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.018 1.727 . . . . 0.0 111.55 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -93.64 -52.16 4.6 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.601 2.36 . . . . 0.0 112.123 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.97 171.86 8.77 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.7 t -69.65 -42.22 74.51 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.747 0.819 . . . . 0.0 111.161 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 69.32 72.68 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.499 1.12 . . . . 0.0 110.931 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.88 169.14 18.44 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.003 3.136 . . . . 0.0 118.454 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -86.44 157.24 19.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.063 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' B' ' 83' ' ' CYS . 0.0 OUTLIER -153.21 174.28 14.47 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 124.18 1.943 . . . . 0.0 112.353 174.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.28 149.11 9.22 Favored Glycine 0 N--CA 1.411 -2.992 0 CA-C-N 109.065 -3.698 . . . . 0.0 120.046 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -159.12 153.48 23.99 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -88.47 149.94 23.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.984 1.714 . . . . 0.0 109.984 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 117.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 173.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.537 ' CB ' HG21 ' C' ' 52' ' ' ILE . 38.6 t30 -102.11 110.81 22.87 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.799 -174.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.334 49.9 m95 -70.08 155.54 40.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.958 1.837 . . . . 0.0 115.396 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' B' ' 71' ' ' LYS . 9.8 mmpt? -108.54 -44.26 4.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.355 -1.748 . . . . 0.0 114.143 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -91.18 -8.74 47.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.23 1.012 . . . . 0.0 113.691 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -152.38 137.05 16.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.31 2.244 . . . . 0.0 107.36 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.64 111.77 8.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.497 1.498 . . . . 0.0 110.715 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 93.3 p -165.31 169.92 15.28 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.077 1.751 . . . . 0.0 111.635 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.68 141.87 26.13 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.21 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.6 m -137.62 123.82 20.48 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.216 -173.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.95 154.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.536 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.24 141.93 51.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 108.676 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.62 119.86 7.3 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -168.55 -167.4 29.12 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.412 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -133.56 146.37 50.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.078 -1.061 . . . . 0.0 112.618 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' B' ' 64' ' ' PHE . 41.4 t -97.37 122.0 39.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.087 173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.451 ' HB2' HD12 ' C' ' 106' ' ' ILE . 12.2 m-85 -111.37 172.49 6.85 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.714 1.606 . . . . 0.0 110.669 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mt -128.41 113.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.97 162.47 6.96 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -30.12 -52.53 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.744 2.017 . . . . 0.0 115.772 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -78.35 -0.7 30.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.393 2.277 . . . . 0.0 116.978 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 50.94 6.87 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.439 -1.413 . . . . 0.0 110.505 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -119.91 141.89 49.2 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.514 2.326 . . . . 0.0 105.432 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -111.38 138.5 47.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.265 1.426 . . . . 0.0 110.99 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 20.6 m -144.3 161.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.686 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 15.8 mt -121.04 118.2 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -108.03 111.55 23.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 6.9 p -133.46 171.91 13.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.066 1.412 . . . . 0.0 111.971 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.519 ' HG3' HG21 ' C' ' 113' ' ' THR . 90.6 mmm -124.63 169.32 12.05 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -139.67 162.02 36.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.489 1.614 . . . . 0.0 112.644 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.47 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.9 OUTLIER -145.58 119.65 9.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.017 179.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 141.54 38.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 123.677 1.703 . . . . 0.0 110.578 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -126.26 114.0 17.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 110.121 -3.218 . . . . 0.0 110.162 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -78.23 156.65 29.64 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.616 1.198 . . . . 0.0 110.824 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -103.73 82.45 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' B' ' 112' ' ' ALA . 1.6 t -66.32 172.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.94 1.296 . . . . 0.0 111.815 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.498 ' H ' HG12 ' B' ' 103' ' ' VAL . 5.1 p-10 -119.2 -2.77 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 174.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.421 ' H ' HG12 ' B' ' 103' ' ' VAL . 0.8 OUTLIER -142.25 146.4 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.346 1.07 . . . . 0.0 111.06 174.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' C' ' 92' ' ' VAL . 14.8 tt -63.57 -26.88 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.958 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.63 -3.62 34.86 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.979 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.16 3.55 10.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.712 1.256 . . . . 0.0 113.271 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -36.13 62.12 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.041 -1.037 . . . . 0.0 111.575 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' D' ' 14' ' ' LEU . 59.0 p-90 -48.68 -46.79 40.9 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 -16.06 38.71 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.267 -0.895 . . . . 0.0 112.673 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . 0.579 ' HB2' ' CG2' ' B' ' 103' ' ' VAL . . . -72.25 -8.34 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.523 HG21 ' HG3' ' C' ' 96' ' ' MET . 57.6 m -96.38 156.65 16.25 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.697 0.399 . . . . 0.0 110.227 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ttm-85 -154.27 124.52 6.89 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 126.933 2.093 . . . . 0.0 111.366 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 p -105.63 156.18 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 121.832 2.105 . . . . 0.0 110.166 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.88 -178.0 31.52 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.232 0.958 . . . . 0.0 114.83 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 15.5 p90 -123.02 152.72 40.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.285 1.034 . . . . 0.0 110.691 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -150.61 146.25 26.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.008 0.908 . . . . 0.0 111.331 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.64 119.14 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.082 -1.011 . . . . 0.0 108.67 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.63 154.45 21.97 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.281 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 20.3 p -138.02 164.16 29.78 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.379 1.072 . . . . 0.0 109.645 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.99 123.72 16.14 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.87 156.6 11.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.039 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.89 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -78.85 -15.81 57.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.027 0.83 . . . . 0.0 111.28 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 57.37 -175.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.146 1.779 . . . . 0.0 111.621 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER -162.4 176.66 10.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.94 1.696 . . . . 0.0 110.145 172.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 C-N-CA 130.131 3.372 . . . . 0.0 111.86 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 7.4 p -91.97 175.46 6.87 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.404 1.881 . . . . 0.0 108.592 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 21.4 t 35.97 79.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 127.316 2.246 . . . . 0.0 114.955 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -172.04 -36.07 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.26 36.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.334 1.454 . . . . 0.0 112.625 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -154.64 125.88 7.31 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.491 -1.38 . . . . 0.0 112.943 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 131.49 56.92 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.924 1.345 . . . . 0.0 110.077 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -139.61 127.52 22.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.431 HD12 ' CD ' ' C' ' 53' ' ' GLN . 2.7 mt -73.41 -27.56 61.52 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.414 1.071 . . . . 0.0 112.844 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -53.61 117.28 3.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.861 0.838 . . . . 0.0 110.368 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.98 -130.27 4.79 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.719 1.628 . . . . 0.0 109.525 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . 0.433 ' HD2' HD13 ' C' ' 123' ' ' LEU . 19.7 ttmt -142.46 151.13 41.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.808 1.29 . . . . 0.0 113.288 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . 0.427 ' H ' ' HG2' ' C' ' 9' ' ' LYS . 50.0 m95 -136.18 162.69 32.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 112.469 -2.15 . . . . 0.0 110.816 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -142.84 142.51 31.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.65 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . 0.616 HD22 ' H ' ' C' ' 14' ' ' LEU . 4.2 t30 -108.36 148.06 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.918 0.887 . . . . 0.0 112.529 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -27.9 61.74 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.316 1.446 . . . . 0.0 114.365 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.616 ' H ' HD22 ' C' ' 12' ' ' ASN . 33.9 tp -72.34 -15.9 61.87 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.393 1.477 . . . . 0.0 113.176 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -14.34 29.51 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.153 2.311 . . . . 0.0 113.645 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.636 1.218 . . . . 0.0 111.29 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -118.49 144.48 45.98 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.264 -0.897 . . . . 0.0 111.061 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -133.79 141.46 47.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.998 0.428 . . . . 0.0 111.63 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 5.9 m -129.73 132.12 46.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.79 127.37 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.57 -89.91 0.08 OUTLIER Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.867 1.354 . . . . 0.0 112.18 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.41 135.12 30.05 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.605 -0.938 . . . . 0.0 110.649 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.71 131.67 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.807 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -72.46 156.37 39.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.791 1.237 . . . . 0.0 110.229 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -57.29 -23.05 46.0 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -66.05 -28.49 68.88 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.531 -0.731 . . . . 0.0 110.797 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.83 -3.94 34.11 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.167 1.365 . . . . 0.0 112.724 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -77.05 158.76 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.71 1.255 . . . . 0.0 113.316 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.02 166.32 33.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.485 0.659 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.7 160.16 33.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.709 1.203 . . . . 0.0 108.702 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.22 -175.5 39.72 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 119.961 -1.114 . . . . 0.0 115.435 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.443 ' CG2' HD23 ' C' ' 46' ' ' LEU . 9.0 p -134.7 123.96 24.5 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.811 1.244 . . . . 0.0 107.702 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.575 ' C ' HD12 ' C' ' 34' ' ' ILE . 65.4 t80 -125.09 130.56 52.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.612 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.657 HG13 HD12 ' C' ' 46' ' ' LEU . 2.3 mp -122.9 129.48 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 CA-C-O 121.932 0.872 . . . . 0.0 108.833 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -104.99 140.31 38.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.996 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.56 -6.39 22.87 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.64 136.93 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.025 0.93 . . . . 0.0 111.645 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.76 162.21 39.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.985 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.98 -27.49 60.18 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -145.78 80.42 10.57 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.989 2.116 . . . . 0.0 109.766 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.85 13.44 0.22 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.835 3.69 . . . . 0.0 118.044 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.71 -28.62 1.7 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.21 53.39 0.18 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.093 1.447 . . . . 0.0 112.037 -174.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 75.0 mt -56.84 130.31 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.914 -1.116 . . . . 0.0 111.087 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.53 172.27 11.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.109 2.564 . . . . 0.0 109.115 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.657 HD12 HG13 ' C' ' 34' ' ' ILE 0.299 5.4 mp -66.95 130.45 43.2 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 59.4 m -98.08 118.15 64.07 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.977 173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -55.0 138.65 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.643 1.562 . . . . 0.0 110.061 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -122.53 155.72 35.65 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.331 1.019 . . . . 0.0 110.852 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.655 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -155.38 149.08 25.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.014 1.726 . . . . 0.0 108.799 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.58 29.78 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 119.353 0.979 . . . . 0.0 111.033 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.42 147.0 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.057 0.932 . . . . 0.0 111.938 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.431 ' CD ' HD12 ' C' ' 6' ' ' LEU . 6.7 pt20 -133.57 154.0 51.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.221 1.008 . . . . 0.0 113.225 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -90.67 159.06 16.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.435 1.112 . . . . 0.0 108.765 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 25.05 0.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.689 1.596 . . . . 0.0 111.57 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -93.36 -51.87 4.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.831 2.453 . . . . 0.0 111.328 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 171.96 10.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -71.08 -41.95 70.01 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.665 0.745 . . . . 0.0 110.955 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.56 67.76 80.32 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.405 1.082 . . . . 0.0 111.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -69.69 170.23 16.99 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.902 3.068 . . . . 0.0 118.268 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 41.7 p -86.63 156.42 20.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.903 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' C' ' 83' ' ' CYS . 0.0 OUTLIER -153.58 173.7 15.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.728 1.728 . . . . 0.0 112.762 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.51 148.49 9.12 Favored Glycine 0 N--CA 1.412 -2.927 0 CA-C-N 109.351 -3.568 . . . . 0.0 119.528 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -159.47 153.18 22.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -172.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -87.85 150.94 23.22 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.333 1.853 . . . . 0.0 110.021 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.78 117.13 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' B' ' 52' ' ' ILE . 40.1 t30 -102.39 111.47 23.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.969 -174.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.33 49.9 m95 -70.45 154.7 41.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 124.199 1.952 . . . . 0.0 115.448 -172.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' C' ' 71' ' ' LYS . 9.9 mmpt? -107.54 -43.79 4.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.221 -1.809 . . . . 0.0 114.145 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -91.79 -8.42 46.77 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.57 136.7 16.48 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.286 2.235 . . . . 0.0 107.448 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -72.53 111.21 7.5 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.556 1.525 . . . . 0.0 110.829 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -165.1 170.07 15.45 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 125.879 1.672 . . . . 0.0 111.441 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -147.8 141.92 26.06 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 122.901 1.334 . . . . 0.0 111.264 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.6 m -137.04 124.36 21.91 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 110.88 -2.873 . . . . 0.0 110.387 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 m -101.81 154.31 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.555 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -127.19 142.32 51.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.102 0.961 . . . . 0.0 108.419 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.09 120.16 7.21 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -168.3 -167.31 28.75 Favored Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.11 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.58 146.67 51.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 125.171 1.159 . . . . 0.0 112.656 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 64' ' ' PHE . 44.7 t -97.23 125.56 41.85 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 115.66 -2.114 . . . . 0.0 108.009 174.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.433 ' HB2' HD12 ' B' ' 106' ' ' ILE . 13.8 m-85 -114.4 171.27 7.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.928 1.691 . . . . 0.0 110.614 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.03 110.77 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.26 157.67 13.04 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -23.45 -57.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.978 2.111 . . . . 0.0 116.53 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.0 -14.18 62.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.91 20.95 10.66 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.031 0.824 . . . . 0.0 113.68 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -91.09 142.28 27.93 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.849 1.325 . . . . 0.0 110.296 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -101.47 139.46 37.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.281 1.032 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.8 m -142.17 161.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.179 1.392 . . . . 0.0 110.057 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 14.8 mt -119.26 116.92 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -107.43 110.76 22.79 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.45 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 6.8 p -132.34 171.51 13.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 123.24 1.495 . . . . 0.0 111.862 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.523 ' HG3' HG21 ' B' ' 113' ' ' THR . 91.2 mmm -124.68 169.07 12.32 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -139.36 162.33 35.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 123.378 1.561 . . . . 0.0 112.658 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.477 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -145.76 119.48 9.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.069 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 141.74 38.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.465 1.602 . . . . 0.0 110.403 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -126.14 113.9 17.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 110.346 -3.116 . . . . 0.0 109.762 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -77.11 156.48 31.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.032 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 52.6 m -103.05 83.14 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' C' ' 112' ' ' ALA . 1.6 t -66.52 172.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.472 1.109 . . . . 0.0 111.715 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.499 ' H ' HG12 ' C' ' 103' ' ' VAL . 4.6 p-10 -118.04 -5.21 10.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.93 148.01 37.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.73 1.252 . . . . 0.0 110.202 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' B' ' 92' ' ' VAL . 15.5 tt -63.61 -25.73 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.02 -1.446 . . . . 0.0 112.909 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.15 -1.75 36.05 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.579 -1.123 . . . . 0.0 115.393 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . 0.404 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.6 OUTLIER -122.25 3.09 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.287 1.044 . . . . 0.0 113.54 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.91 60.52 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.2 -0.938 . . . . 0.0 111.556 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.503 ' CD1' HD11 ' A' ' 14' ' ' LEU . 60.1 p-90 -50.28 -46.35 55.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.137 0.975 . . . . 0.0 113.565 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -15.12 41.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.158 -0.964 . . . . 0.0 112.577 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . 0.578 ' HB2' ' CG2' ' C' ' 103' ' ' VAL . . . -73.54 -8.12 54.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.519 HG21 ' HG3' ' B' ' 96' ' ' MET . 62.2 m -96.63 155.12 16.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.675 0.39 . . . . 0.0 110.044 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttm-85 -153.04 124.02 7.43 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 126.931 2.092 . . . . 0.0 111.208 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 p -105.09 156.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 121.77 2.077 . . . . 0.0 110.091 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -177.54 31.46 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.206 0.941 . . . . 0.0 114.962 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 15.9 p90 -123.85 152.41 42.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.276 1.03 . . . . 0.0 110.908 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -150.43 147.0 27.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.936 0.895 . . . . 0.0 111.187 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.97 121.77 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -112.93 153.47 27.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.683 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.7 p -134.13 162.55 31.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.106 0.962 . . . . 0.0 110.317 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -55.5 121.77 9.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.948 0.899 . . . . 0.0 109.691 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.46 HD23 ' C ' ' C' ' 123' ' ' LEU . 5.4 tt -70.54 109.75 5.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.921 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.452 ' HB2' HD23 ' C' ' 123' ' ' LEU . 1.8 tmm_? 53.86 90.31 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.46 1.504 . . . . 0.0 111.598 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -94.51 -74.72 0.53 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 111.765 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -76.7 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.683 1.593 . . . . 0.0 109.885 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -156.77 -82.71 0.06 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.669 1.587 . . . . 0.0 112.301 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 114.136 -2.84 . . . . 0.0 114.861 -172.718 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 7.6 p -144.51 88.42 1.93 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.727 1.611 . . . . 0.0 109.36 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.73 142.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.237 0.615 . . . . 0.0 110.434 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -113.38 168.65 9.56 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.554 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.307 0.8 OUTLIER -154.47 73.56 0.91 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 0.0 111.37 -175.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.91 114.36 3.15 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.062 -1.024 . . . . 0.0 113.191 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -124.09 129.2 50.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.077 0.941 . . . . 0.0 110.963 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 p -139.61 127.5 22.11 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.248 -1.532 . . . . 0.0 114.279 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 64' ' ' PHE . 21.1 mt -55.51 -32.84 63.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -54.83 122.02 9.87 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.724 1.249 . . . . 0.0 110.932 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.25 -108.31 0.87 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.512 2.006 . . . . 0.0 111.696 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.12 144.0 20.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -140.76 162.79 34.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.327 1.851 . . . . 0.0 110.632 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 t -141.71 151.44 42.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.237 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 14' ' ' LEU . 4.6 t30 -116.42 146.31 42.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.376 1.071 . . . . 0.0 112.521 -173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.49 -23.67 64.69 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' H ' HD22 ' A' ' 12' ' ' ASN . 28.0 tp -71.58 -15.7 62.28 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.703 -1.248 . . . . 0.0 112.115 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.82 -14.35 24.34 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 128.382 2.896 . . . . 0.0 113.686 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p -63.31 144.27 57.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.456 1.128 . . . . 0.0 112.987 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' OD1' HD12 ' A' ' 34' ' ' ILE . 6.2 p30 -115.66 140.34 49.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -130.71 139.81 50.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.545 0.688 . . . . 0.0 111.084 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.7 m -129.0 131.52 47.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.21 127.02 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.51 -88.4 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.299 1.0 . . . . 0.0 111.553 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.24 42.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.863 0.839 . . . . 0.0 112.426 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 t -98.14 123.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.017 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.22 156.0 38.51 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 m -55.21 -22.01 16.14 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -72.32 -37.78 68.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.359 0.664 . . . . 0.0 111.237 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.31 -2.66 18.64 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 117.336 -1.813 . . . . 0.0 113.422 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HB2' HD21 ' D' ' 50' ' ' LEU . 9.7 pt-20 -69.26 137.44 53.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.928 1.691 . . . . 0.0 107.079 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.25 148.19 25.61 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.16 163.58 15.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.192 0.997 . . . . 0.0 109.374 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.35 -168.0 34.59 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 120.947 -1.095 . . . . 0.0 113.165 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.633 ' HB ' HD11 ' A' ' 46' ' ' LEU . 1.1 p -141.54 129.69 22.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.965 1.364 . . . . 0.0 110.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.64 141.02 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.019 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 46' ' ' LEU . 7.9 mt -131.93 128.75 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.375 1.083 . . . . 0.0 108.53 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 ' O ' HG21 ' A' ' 44' ' ' ILE . 35.3 m -105.65 133.76 49.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.615 -1.175 . . . . 0.0 113.073 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.26 -17.87 23.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.74 142.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.831 1.252 . . . . 0.0 111.83 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.98 153.81 40.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.028 -1.045 . . . . 0.0 111.268 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.54 -24.25 66.35 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -147.88 76.56 10.53 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 128.518 2.727 . . . . 0.0 112.053 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.03 169.56 18.97 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.169 2.579 . . . . 0.0 112.431 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.88 -29.55 1.55 Allowed Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.473 1.035 . . . . 0.0 113.078 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.06 2.89 3.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.559 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 35' ' ' THR . 54.9 mt -31.83 112.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.151 1.78 . . . . 0.0 114.354 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 157.78 41.59 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.556 1.543 . . . . 0.0 110.879 -176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.633 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.6 tp -46.72 115.51 1.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.021 2.928 . . . . 0.0 111.623 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 t -103.48 117.06 60.97 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.454 1.102 . . . . 0.0 109.933 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 144.22 82.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.27 2.647 . . . . 0.0 112.552 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.71 155.08 45.64 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.673 0.789 . . . . 0.0 111.863 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -159.75 147.61 17.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.164 1.785 . . . . 0.0 112.296 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.17 -151.55 21.91 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 120.786 1.63 . . . . 0.0 110.954 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.4 mp -141.24 137.86 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.886 0.874 . . . . 0.0 113.135 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -120.95 141.03 51.05 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.15 -50.47 71.72 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.503 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.92 14.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 127.395 2.278 . . . . 0.0 116.852 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.76 -47.08 6.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.515 2.726 . . . . 0.0 115.103 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.76 -174.11 2.46 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.319 1.012 . . . . 0.0 111.63 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -83.43 -36.72 24.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -124.41 56.67 12.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.667 1.187 . . . . 0.0 110.497 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.02 164.04 37.16 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.884 3.056 . . . . 0.0 116.309 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.5 p -82.21 167.79 18.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.95 1.3 . . . . 0.0 111.383 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -159.13 162.29 36.43 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.818 -1.176 . . . . 0.0 112.961 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.86 139.24 5.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 118.731 -1.7 . . . . 0.0 117.053 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -163.0 151.73 14.5 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 m -88.29 148.98 24.04 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.562 1.945 . . . . 0.0 110.549 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 t -126.02 117.72 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' HB2' HG21 ' D' ' 52' ' ' ILE . 9.7 t-20 -97.33 105.4 17.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.147 0.579 . . . . 0.0 112.376 -174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 32.4 m95 -74.76 147.99 40.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -110.7 -45.71 3.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.165 -1.38 . . . . 0.0 114.647 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -80.86 -11.3 59.61 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -152.53 133.24 13.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.789 2.436 . . . . 0.0 105.838 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.26 118.52 14.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.695 1.134 . . . . 0.0 111.2 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -178.52 167.15 1.82 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-O 123.625 1.679 . . . . 0.0 110.895 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 t -144.69 144.71 31.36 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.123 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.3 m -140.7 131.71 26.19 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 110.15 -3.205 . . . . 0.0 110.312 -172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.7 143.63 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.06 143.74 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 116.78 9.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HE ' ' D' ' 100' ' ' ARG . . . -151.98 -176.13 24.37 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 119.389 -1.386 . . . . 0.0 115.625 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -123.17 147.8 46.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.702 -1.249 . . . . 0.0 111.059 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 39.0 t -96.88 120.81 37.91 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.651 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' D' ' 106' ' ' ILE . 6.8 m-85 -115.24 166.9 11.34 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.731 1.213 . . . . 0.0 114.089 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.01 110.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -59.01 154.18 16.08 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -33.63 -41.97 0.1 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 126.619 1.968 . . . . 0.0 115.97 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -13.96 60.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 50.36 2.83 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.44 137.61 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.449 1.9 . . . . 0.0 109.492 174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -101.28 148.24 25.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.004 2.121 . . . . 0.0 112.164 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.6 t -152.09 155.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 113.156 -1.838 . . . . 0.0 109.606 -174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HE2' ' A' ' 64' ' ' PHE . 12.9 mt -122.04 105.92 10.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ3' HD11 ' D' ' 106' ' ' ILE . 3.0 mmtt -98.33 119.33 36.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 64' ' ' PHE . 8.9 p -130.35 162.5 28.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.346 1.546 . . . . 0.0 112.632 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.417 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -110.96 162.78 14.49 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -136.84 161.38 36.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.134 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -146.57 121.57 10.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.335 -1.757 . . . . 0.0 113.248 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.76 142.23 38.1 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.923 1.344 . . . . 0.0 112.241 -175.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.416 ' HE ' ' HA2' ' D' ' 81' ' ' GLY . 4.3 tpt85 -127.99 113.95 16.5 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 111.798 -2.455 . . . . 0.0 112.524 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.25 0.4 OUTLIER -71.95 165.68 23.71 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 125.269 1.606 . . . . 0.0 110.549 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -113.26 79.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.19 175.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 121.524 -0.735 . . . . 0.0 110.529 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -22.89 15.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.08 150.32 43.32 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 123.156 1.455 . . . . 0.0 112.678 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' D' ' 84' ' ' PHE . 17.4 tt -61.3 -27.57 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.141 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.87 9.32 24.85 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.959 0.79 . . . . 0.0 113.934 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -120.59 -0.41 10.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.328 1.051 . . . . 0.0 112.187 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -32.0 70.53 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.646 -1.284 . . . . 0.0 113.408 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.86 -44.91 59.67 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.911 1.684 . . . . 0.0 112.652 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -93.26 -10.63 34.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.332 1.053 . . . . 0.0 113.002 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.42 9.34 1.75 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.372 -0.83 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' A' ' 98' ' ' LEU . 20.9 m -117.45 139.3 51.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.853 0.861 . . . . 0.0 113.195 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.51 116.18 12.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 127.414 2.286 . . . . 0.0 111.281 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.68 152.91 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.725 1.148 . . . . 0.0 110.177 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.32 -174.24 31.97 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -127.56 154.66 44.91 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.705 -0.879 . . . . 0.0 112.195 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -146.71 152.63 39.15 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.815 1.246 . . . . 0.0 109.736 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.416 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.9 mt -136.46 119.01 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 12' ' ' ASN . 21.1 m-85 -109.68 149.38 29.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.331 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -134.74 163.32 30.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -56.82 119.91 7.0 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.845 0.858 . . . . 0.0 110.964 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 123' ' ' LEU . 10.4 tt -77.7 117.21 18.88 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.92 -171.05 0.42 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.661 1.184 . . . . 0.0 113.293 174.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -53.22 0.24 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.476 1.51 . . . . 0.0 111.485 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -100.58 153.46 19.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.374 1.07 . . . . 0.0 111.149 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? 70.05 101.52 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.087 2.155 . . . . 0.0 112.421 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 129.288 3.035 . . . . 0.0 110.866 174.253 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 116.944 -1.503 . . . . 0.0 107.808 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 11.7 m 51.74 85.72 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.52 13.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.423 1.089 . . . . 0.0 113.238 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -66.86 145.71 55.19 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.466 -1.396 . . . . 0.0 112.009 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -139.83 74.55 1.47 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.745 1.618 . . . . 0.0 110.79 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 125.49 10.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.872 -1.142 . . . . 0.0 112.698 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . 0.56 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 22.5 p -136.48 130.41 32.53 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.693 0.758 . . . . 0.0 111.501 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -139.77 129.51 24.57 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.4 -1.437 . . . . 0.0 114.56 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' D' ' 64' ' ' PHE . 20.7 mt -56.89 -32.16 65.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -55.58 119.71 6.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.968 1.366 . . . . 0.0 111.744 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.94 -116.5 1.99 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.203 1.859 . . . . 0.0 110.819 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.7 146.43 30.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -174.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . 0.425 ' CH2' HD21 ' D' ' 93' ' ' LEU . 38.2 m95 -141.57 161.92 36.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.232 1.413 . . . . 0.0 111.077 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.2 148.14 37.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.512 HD22 ' H ' ' D' ' 14' ' ' LEU . 5.0 t30 -113.03 147.64 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.362 1.065 . . . . 0.0 112.599 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.74 -23.47 64.96 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.512 ' H ' HD22 ' D' ' 12' ' ' ASN . 27.8 tp -73.08 -14.47 61.4 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.477 1.511 . . . . 0.0 112.257 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.11 -12.92 34.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.857 2.646 . . . . 0.0 113.913 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.47 148.68 50.09 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.584 1.192 . . . . 0.0 112.824 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . 0.426 ' OD1' HD12 ' D' ' 34' ' ' ILE . 5.8 p30 -121.66 143.08 49.54 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.58 0.752 . . . . 0.0 110.543 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -132.07 139.88 48.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.605 0.717 . . . . 0.0 111.849 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -127.74 132.78 49.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.74 123.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.42 -79.95 0.24 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.346 1.029 . . . . 0.0 111.78 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.24 42.09 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.848 -0.795 . . . . 0.0 112.084 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -100.53 125.25 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.616 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -69.46 156.7 38.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 20.1 m -55.88 -21.7 21.53 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -70.75 -35.73 72.78 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.688 0.676 . . . . 0.0 111.283 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.95 -1.39 21.27 Favored Glycine 0 N--CA 1.469 0.9 0 C-N-CA 124.52 1.057 . . . . 0.0 112.95 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.89 149.81 44.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 110.717 173.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . 0.604 ' O ' HD12 ' D' ' 50' ' ' LEU . 27.8 p90 -156.15 163.86 39.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.034 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.442 HG22 HD13 ' D' ' 50' ' ' LEU . 4.9 p -125.81 167.69 14.85 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.4 -166.49 33.12 Favored Glycine 0 N--CA 1.467 0.74 0 O-C-N 120.031 -1.668 . . . . 0.0 113.201 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.612 ' HB ' HD11 ' D' ' 46' ' ' LEU . 1.2 p -140.32 132.1 27.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.772 1.273 . . . . 0.0 111.539 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.5 139.1 50.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.463 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.556 HG12 HD12 ' D' ' 46' ' ' LEU . 7.8 mt -129.97 131.48 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.84 0.829 . . . . 0.0 108.789 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.583 ' O ' HG21 ' D' ' 44' ' ' ILE . 7.7 m -109.32 134.78 51.37 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 -19.22 21.55 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 28.3 m -131.38 141.54 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.892 1.277 . . . . 0.0 112.161 -174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.38 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.947 -1.096 . . . . 0.0 111.333 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.99 -24.08 66.7 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -147.91 76.72 10.45 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 128.536 2.734 . . . . 0.0 112.041 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.25 169.35 19.73 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.181 2.587 . . . . 0.0 112.517 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.87 -29.18 1.56 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.574 1.083 . . . . 0.0 113.123 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.29 2.87 3.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.736 -1.126 . . . . 0.0 113.533 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.583 HG21 ' O ' ' D' ' 35' ' ' THR . 50.8 mt -32.36 113.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 114.242 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.73 157.96 41.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.55 1.54 . . . . 0.0 110.747 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB ' ' D' ' 32' ' ' THR . 11.9 tp -47.48 115.36 1.1 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.712 2.805 . . . . 0.0 111.074 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.25 117.15 60.93 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.853 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.02 143.03 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.867 2.378 . . . . 0.0 112.272 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.412 ' C ' HD12 ' D' ' 49' ' ' LEU . 2.0 pp -128.48 163.76 24.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.87 0.868 . . . . 0.0 112.209 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.604 HD12 ' O ' ' D' ' 29' ' ' PHE . 27.6 tp -169.07 149.01 4.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.249 1.42 . . . . 0.0 113.842 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 -150.96 21.56 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 120.883 1.674 . . . . 0.0 111.315 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.8 mp -142.32 135.35 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.965 0.906 . . . . 0.0 111.705 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -120.16 140.18 51.5 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 110.113 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.21 -50.0 74.86 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.436 -0.79 . . . . 0.0 111.525 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.09 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.67 2.388 . . . . 0.0 116.634 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.94 -46.64 7.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.386 2.675 . . . . 0.0 115.053 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.25 -175.43 3.67 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.26 0.975 . . . . 0.0 112.512 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 40.8 t -81.67 -35.28 30.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.561 0.745 . . . . 0.0 111.576 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.29 58.56 31.44 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 125.041 1.336 . . . . 0.0 111.033 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.91 163.34 38.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.742 2.962 . . . . 0.0 117.317 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -81.63 168.08 18.53 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.197 1.399 . . . . 0.0 111.569 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -159.12 162.26 36.44 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.736 -1.227 . . . . 0.0 112.967 174.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.0 139.08 5.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 118.873 -1.632 . . . . 0.0 116.871 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.89 153.12 16.26 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -89.11 151.61 22.12 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 127.601 2.36 . . . . 0.0 110.325 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 32.1 t -129.25 119.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.546 ' HB2' HG21 ' A' ' 52' ' ' ILE . 10.0 t-20 -99.2 105.15 17.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.242 0.617 . . . . 0.0 112.004 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -74.34 147.27 42.38 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -110.1 -45.12 3.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.099 -1.409 . . . . 0.0 114.554 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.67 -11.16 59.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.55 132.91 13.68 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.881 2.473 . . . . 0.0 105.671 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.3 118.49 15.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.808 1.185 . . . . 0.0 111.193 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.79 166.55 1.68 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.94 1.696 . . . . 0.0 111.116 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 t -143.96 144.63 31.78 Favored 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.217 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.3 m -140.32 133.25 29.25 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 109.975 -3.284 . . . . 0.0 109.797 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.85 143.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.682 0.614 . . . . 0.0 109.548 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -116.3 143.91 44.92 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.7 116.55 8.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 100' ' ' ARG . . . -151.45 -175.72 23.53 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.669 -1.253 . . . . 0.0 115.757 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.42 147.41 47.15 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.438 -1.381 . . . . 0.0 110.776 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.56 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 5.6 t -97.16 123.61 40.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.872 1.358 . . . . 0.0 110.624 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.602 ' HB2' HD12 ' A' ' 106' ' ' ILE . 7.7 m-85 -116.65 163.02 16.75 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -130.16 110.4 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.96 157.44 9.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -36.22 -40.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.445 1.898 . . . . 0.0 115.578 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -78.2 -10.23 59.55 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.14 51.03 4.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.057 0.836 . . . . 0.0 111.633 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.5 147.08 46.78 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 129.107 2.963 . . . . 0.0 107.401 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -112.73 152.63 28.85 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 120.267 1.394 . . . . 0.0 111.279 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.509 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.4 t -153.37 158.3 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.516 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . 0.425 HD21 ' CH2' ' D' ' 10' ' ' TRP . 6.9 mt -121.17 108.13 13.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.509 ' CD ' HG11 ' D' ' 92' ' ' VAL . 2.8 mmtt -100.76 117.67 35.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.57 HG22 ' HE1' ' D' ' 64' ' ' PHE . 4.8 p -129.28 163.08 26.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.608 1.671 . . . . 0.0 112.88 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.12 162.54 14.8 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -136.55 161.51 35.68 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.879 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -146.59 121.94 10.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.298 -1.774 . . . . 0.0 113.05 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . 0.471 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 141.76 38.52 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.859 1.314 . . . . 0.0 112.556 -176.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.441 ' HE ' ' HA2' ' A' ' 81' ' ' GLY . 4.2 tpt85 -126.98 114.06 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 111.731 -2.486 . . . . 0.0 112.303 -174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.63 165.62 23.57 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 125.039 1.462 . . . . 0.0 110.557 173.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 8.3 t -113.53 77.11 1.02 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.82 176.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.23 -22.81 15.45 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.95 150.0 41.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 123.088 1.423 . . . . 0.0 112.914 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 84' ' ' PHE . 18.0 tt -62.57 -28.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.442 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 9.01 21.35 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.202 0.906 . . . . 0.0 113.961 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -119.45 -1.81 10.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.556 1.142 . . . . 0.0 111.878 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -31.45 70.27 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.394 -1.441 . . . . 0.0 113.279 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -50.62 -46.23 58.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.579 1.552 . . . . 0.0 112.52 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -91.73 -10.94 38.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.27 1.028 . . . . 0.0 112.832 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 8.75 2.08 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.605 -0.684 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' D' ' 98' ' ' LEU . 19.5 m -116.42 139.22 50.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.986 0.914 . . . . 0.0 113.28 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.54 116.21 12.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.4 2.28 . . . . 0.0 111.151 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.1 p -99.66 152.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.825 1.193 . . . . 0.0 110.394 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.51 -173.83 31.67 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -127.77 154.92 44.83 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.679 -0.895 . . . . 0.0 112.266 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -147.41 151.19 36.07 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.457 1.103 . . . . 0.0 109.746 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -135.69 119.18 24.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -111.12 151.72 27.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.566 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -137.4 167.64 21.22 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -61.69 125.61 24.41 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.586 -1.321 . . . . 0.0 113.246 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tt -84.65 95.83 9.02 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.87 140.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.712 2.005 . . . . 0.0 113.083 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 20.7 p -152.18 167.58 28.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.218 1.007 . . . . 0.0 111.991 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.8 148.92 44.07 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.858 0.463 . . . . 0.0 110.485 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm 91.92 109.49 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.459 3.103 . . . . 0.0 108.738 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.419 3.088 . . . . 0.0 106.661 -176.843 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' B' ' -3' ' ' GLN . 9.4 mm-40 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 5.1 m -148.22 146.05 28.51 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 108.781 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.43 105.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.457 1.103 . . . . 0.0 110.899 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.94 -18.73 0.05 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 24.3 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 128.434 2.694 . . . . 0.0 115.644 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.39 128.81 20.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.072 0.949 . . . . 0.0 111.647 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.656 ' HB2' ' HG ' ' B' ' 83' ' ' CYS . 24.9 p -139.68 127.96 22.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.623 0.769 . . . . 0.0 110.226 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -139.74 127.7 22.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.417 -1.427 . . . . 0.0 114.567 -174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.616 HD21 ' CE2' ' B' ' 64' ' ' PHE . 20.7 mt -55.62 -32.34 63.06 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -54.47 118.81 4.45 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.323 1.535 . . . . 0.0 111.732 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.14 -106.87 0.66 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.883 1.706 . . . . 0.0 111.302 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.27 146.58 21.51 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . 0.41 ' CH2' HD21 ' B' ' 93' ' ' LEU . 43.4 m95 -140.71 162.84 34.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.548 1.539 . . . . 0.0 110.578 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -139.36 152.22 46.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.479 HD22 ' H ' ' B' ' 14' ' ' LEU . 4.6 t30 -117.5 146.86 43.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 111.864 -174.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -60.89 -22.12 63.99 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.479 ' H ' HD22 ' B' ' 12' ' ' ASN . 26.7 tp -73.45 -14.19 61.2 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.959 1.304 . . . . 0.0 112.238 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.69 -13.32 35.39 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 128.069 2.747 . . . . 0.0 113.743 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 3.4 p -64.1 148.62 49.44 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.293 -1.122 . . . . 0.0 112.73 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.421 ' OD1' HD12 ' B' ' 34' ' ' ILE . 5.7 p30 -122.42 140.42 52.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.471 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -128.71 139.19 52.34 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.976 0.893 . . . . 0.0 111.793 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.93 131.93 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.016 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.39 126.71 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.4 -86.8 0.13 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.529 1.143 . . . . 0.0 111.531 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.36 154.15 42.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.916 0.865 . . . . 0.0 112.607 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.6 123.57 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.214 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -68.12 155.89 38.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.112 0.415 . . . . 0.0 109.916 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 20.3 m -54.99 -22.29 14.75 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -72.25 -37.42 69.11 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.636 0.653 . . . . 0.0 111.178 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -2.52 19.41 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-O 117.378 -1.79 . . . . 0.0 113.471 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.453 ' HB2' HD21 ' C' ' 50' ' ' LEU . 9.8 pt-20 -69.37 137.52 52.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.078 1.751 . . . . 0.0 107.112 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.4 ' O ' HD12 ' B' ' 50' ' ' LEU . 18.5 p90 -154.31 147.75 25.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -115.05 162.66 16.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.39 1.076 . . . . 0.0 109.62 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.36 -167.48 33.21 Favored Glycine 0 CA--C 1.523 0.538 0 O-C-N 120.972 -1.08 . . . . 0.0 113.407 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.607 ' HB ' HD11 ' B' ' 46' ' ' LEU . 1.3 p -140.66 131.6 26.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.785 1.279 . . . . 0.0 110.952 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -114.42 138.73 50.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.792 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.553 HG12 HD12 ' B' ' 46' ' ' LEU . 7.6 mt -129.97 132.45 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.582 ' O ' HG21 ' B' ' 44' ' ' ILE . 16.9 m -110.46 134.75 52.06 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.88 -18.77 21.63 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.59 141.71 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.88 1.272 . . . . 0.0 111.93 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.77 154.19 41.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.994 -1.066 . . . . 0.0 110.959 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.74 -24.55 66.24 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -148.12 76.61 10.29 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.577 2.751 . . . . 0.0 111.979 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.05 169.75 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.152 2.568 . . . . 0.0 112.566 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.82 -29.46 1.56 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.502 1.048 . . . . 0.0 113.158 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.02 2.73 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.512 1.125 . . . . 0.0 113.535 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.582 HG21 ' O ' ' B' ' 35' ' ' THR . 52.2 mt -31.9 113.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 126.164 1.786 . . . . 0.0 114.429 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.37 158.54 39.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.455 1.502 . . . . 0.0 110.84 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.607 HD11 ' HB ' ' B' ' 32' ' ' THR . 11.8 tp -48.62 115.41 1.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.672 2.789 . . . . 0.0 111.139 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -103.65 117.79 59.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.944 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.27 144.4 82.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.197 2.598 . . . . 0.0 112.782 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.49 155.51 44.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.831 0.852 . . . . 0.0 111.84 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' B' ' 29' ' ' PHE . 6.0 tp -160.37 147.65 16.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.183 1.793 . . . . 0.0 112.2 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.23 -151.53 21.87 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 120.789 1.631 . . . . 0.0 111.051 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.4 mp -141.15 137.95 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.855 0.862 . . . . 0.0 113.176 -174.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -121.0 141.1 51.05 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.098 -1.001 . . . . 0.0 110.706 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -61.81 -50.33 72.74 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.21 -0.931 . . . . 0.0 111.617 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 41.68 16.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 127.504 2.322 . . . . 0.0 116.907 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . 0.255 6.7 ptp180 -93.67 -46.19 7.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.948 2.499 . . . . 0.0 115.095 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 -175.33 4.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.318 1.011 . . . . 0.0 112.802 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -33.1 29.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.384 1.074 . . . . 0.0 111.45 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.03 57.51 30.59 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 124.849 1.26 . . . . 0.0 111.005 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.58 163.34 38.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.366 2.711 . . . . 0.0 117.078 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p -81.79 168.58 17.87 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.317 1.447 . . . . 0.0 111.654 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.616 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -159.92 161.97 34.4 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.783 -1.198 . . . . 0.0 113.134 174.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.81 139.28 5.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 118.83 -1.652 . . . . 0.0 117.065 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -163.43 151.86 13.79 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -87.57 150.89 23.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.513 1.925 . . . . 0.0 110.771 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 t -127.85 117.75 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.557 ' HB2' HG21 ' C' ' 52' ' ' ILE . 8.6 t-20 -97.63 104.24 16.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.254 0.622 . . . . 0.0 112.264 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.254 32.6 m95 -74.04 147.24 43.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -109.91 -46.05 3.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.461 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.89 -11.28 59.61 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -152.51 133.35 14.03 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.964 2.505 . . . . 0.0 106.055 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.46 118.58 15.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.028 1.285 . . . . 0.0 110.617 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -178.74 166.72 1.71 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.978 1.711 . . . . 0.0 110.952 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -144.38 144.79 31.59 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.273 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -140.53 132.95 28.46 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 110.341 -3.118 . . . . 0.0 110.043 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.05 143.33 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -115.04 143.85 44.55 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.719 0.637 . . . . 0.0 109.478 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.29 116.85 9.17 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HE ' ' C' ' 100' ' ' ARG . . . -152.0 -176.65 24.92 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.337 -1.411 . . . . 0.0 115.222 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -122.85 148.01 45.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.807 1.534 . . . . 0.0 110.426 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.656 ' HG ' ' HB2' ' B' ' 4' ' ' CYS . 5.1 t -97.04 124.54 41.06 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.255 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' C' ' 106' ' ' ILE . 7.9 m-85 -116.09 164.57 14.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.6 mt -131.75 107.91 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -59.29 154.74 15.85 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -35.11 -41.17 0.14 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -11.91 59.88 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.34 52.63 3.34 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 122.199 0.888 . . . . 0.0 111.863 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.16 148.18 45.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 129.135 2.974 . . . . 0.0 105.023 173.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -114.13 150.81 33.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.362 1.465 . . . . 0.0 110.326 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.506 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.5 t -150.77 159.93 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.439 1.095 . . . . 0.0 110.398 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.41 HD21 ' CH2' ' B' ' 10' ' ' TRP . 7.1 mt -121.9 108.6 13.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 172.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.508 ' CE ' HD11 ' C' ' 106' ' ' ILE . 2.6 mmtt -101.46 117.64 35.34 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 172.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.575 HG22 ' HE1' ' B' ' 64' ' ' PHE . 9.2 p -130.0 162.67 28.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.303 1.525 . . . . 0.0 112.463 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.405 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -111.22 163.03 14.35 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 170.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -137.04 161.42 36.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.075 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.77 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.59 121.6 10.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.303 -1.771 . . . . 0.0 113.203 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.485 ' N ' HD23 ' B' ' 98' ' ' LEU . 0.3 OUTLIER -107.69 142.34 37.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.947 1.356 . . . . 0.0 112.258 -175.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.437 ' HE ' ' HA2' ' C' ' 81' ' ' GLY . 4.0 tpt85 -128.0 113.98 16.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 111.504 -2.589 . . . . 0.0 112.28 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.23 165.61 24.07 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 125.147 1.53 . . . . 0.0 110.19 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.9 t -113.69 77.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -66.28 177.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -100.83 -22.45 14.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.88 148.72 43.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 123.047 1.404 . . . . 0.0 112.648 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' C' ' 84' ' ' PHE . 18.0 tt -62.24 -27.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.267 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.92 8.49 22.29 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.135 0.874 . . . . 0.0 113.782 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -120.89 -0.46 10.09 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.39 1.076 . . . . 0.0 112.535 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -31.78 69.86 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 120.785 -1.197 . . . . 0.0 113.466 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 66.0 p-90 -50.25 -46.56 54.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.628 1.571 . . . . 0.0 112.406 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.13 -10.39 39.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.045 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.03 2.03 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.575 -0.703 . . . . 0.0 111.845 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.77 ' CG2' HD21 ' B' ' 98' ' ' LEU . 21.5 m -116.45 139.13 50.78 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.948 0.899 . . . . 0.0 113.158 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -136.27 116.15 13.17 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.589 2.356 . . . . 0.0 111.163 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.7 152.69 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.699 1.136 . . . . 0.0 110.235 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.19 -174.39 32.02 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.787 -0.831 . . . . 0.0 112.133 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -147.32 150.7 35.26 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.697 1.199 . . . . 0.0 109.571 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.42 HD13 ' HE3' ' B' ' 94' ' ' LYS . 12.4 mt -135.24 119.8 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -110.39 152.11 26.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 124.171 0.92 . . . . 0.0 109.535 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -136.67 165.79 25.08 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -56.87 136.14 55.77 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.786 -1.196 . . . . 0.0 113.179 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.53 HD23 ' H ' ' B' ' 124' ' ' ARG . 0.4 OUTLIER -102.74 131.28 49.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.53 ' H ' HD23 ' B' ' 123' ' ' LEU . 0.1 OUTLIER 71.34 179.59 0.24 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 129.607 3.163 . . . . 0.0 109.919 -173.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m 98.04 160.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 128.499 2.72 . . . . 0.0 109.952 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 55.23 0.44 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.895 1.678 . . . . 0.0 110.213 174.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' B' ' 127' ' ' LYS . 4.1 mmpt? -141.75 18.97 2.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.582 2.353 . . . . 0.0 113.403 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.253 1.262 0 O-C-N 125.208 1.567 . . . . 0.0 108.791 173.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 117.203 -1.38 . . . . 0.0 107.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 44.6 m -109.01 118.34 36.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.452 1.023 . . . . 0.0 108.822 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 21.2 t -137.62 110.26 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.92 0.888 . . . . 0.0 108.869 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.02 -32.75 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . 0.342 3.7 ptp180 35.56 54.18 0.84 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.521 2.328 . . . . 0.0 116.045 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.78 132.44 19.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.372 1.069 . . . . 0.0 111.892 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . 0.596 ' HB2' ' HG ' ' C' ' 83' ' ' CYS . 25.1 p -143.09 125.95 16.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.726 0.81 . . . . 0.0 109.503 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -139.56 129.39 24.74 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.232 -1.543 . . . . 0.0 114.503 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' C' ' 64' ' ' PHE . 20.2 mt -56.38 -29.75 61.84 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -56.89 121.62 10.32 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 123.324 1.535 . . . . 0.0 111.643 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.13 -112.02 1.23 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.424 1.964 . . . . 0.0 110.582 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -149.12 147.73 28.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.744 0.818 . . . . 0.0 113.142 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . 0.413 ' CH2' HD21 ' C' ' 93' ' ' LEU . 39.3 m95 -141.86 162.51 35.3 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.293 1.437 . . . . 0.0 110.474 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -140.76 150.76 43.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . 0.504 HD22 ' H ' ' C' ' 14' ' ' LEU . 4.6 t30 -115.02 146.42 41.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.103 0.961 . . . . 0.0 112.669 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.89 -21.31 63.2 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.504 ' H ' HD22 ' C' ' 12' ' ' ASN . 29.8 tp -73.69 -16.21 61.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.297 1.439 . . . . 0.0 112.19 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.45 -13.58 27.92 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.869 2.652 . . . . 0.0 113.984 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 3.3 p -64.88 149.17 50.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.688 1.244 . . . . 0.0 112.981 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' C' ' 34' ' ' ILE . 5.9 p30 -122.05 142.75 50.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.688 0.795 . . . . 0.0 110.754 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -131.4 139.51 49.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.447 0.641 . . . . 0.0 112.202 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -126.93 132.76 50.79 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.93 123.22 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -77.14 0.43 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.148 0.905 . . . . 0.0 111.908 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.82 157.44 42.93 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.77 0.795 . . . . 0.0 112.176 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 t -101.77 125.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.815 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -69.83 156.58 38.83 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -55.89 -21.69 21.58 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -70.38 -36.11 73.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.251 0.62 . . . . 0.0 111.337 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.04 -0.98 21.16 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 124.614 1.102 . . . . 0.0 112.899 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.67 149.74 43.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.696 0.799 . . . . 0.0 110.73 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . 0.599 ' O ' HD12 ' C' ' 50' ' ' LEU . 27.9 p90 -156.21 163.74 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.835 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.468 HG22 HD13 ' C' ' 50' ' ' LEU . 4.7 p -125.76 168.38 13.87 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -175.99 -166.86 34.03 Favored Glycine 0 N--CA 1.465 0.633 0 O-C-N 120.073 -1.642 . . . . 0.0 113.212 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.605 ' HB ' HD11 ' C' ' 46' ' ' LEU . 1.2 p -140.64 132.24 27.14 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 123.024 1.393 . . . . 0.0 111.454 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -117.04 138.5 51.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.872 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.538 HG12 HD12 ' C' ' 46' ' ' LEU . 7.5 mt -129.36 131.16 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.561 ' O ' HG21 ' C' ' 44' ' ' ILE . 5.8 m -109.53 134.93 51.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.322 -173.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.63 -17.39 22.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.23 141.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.7 1.2 . . . . 0.0 112.099 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.66 154.51 41.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.39 -24.47 65.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -148.0 76.59 10.41 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 128.573 2.749 . . . . 0.0 111.965 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.11 169.39 19.48 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.231 2.62 . . . . 0.0 112.411 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.86 -29.33 1.56 Allowed Glycine 0 N--CA 1.474 1.206 0 C-N-CA 124.57 1.081 . . . . 0.0 113.138 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 2.93 3.32 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 117.656 -1.164 . . . . 0.0 113.529 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.561 HG21 ' O ' ' C' ' 35' ' ' THR . 52.4 mt -32.3 113.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.075 1.75 . . . . 0.0 114.311 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.03 158.1 41.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.72 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' C' ' 32' ' ' THR . 11.9 tp -47.56 115.42 1.13 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.764 2.826 . . . . 0.0 111.132 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.0 t -103.2 117.23 60.79 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.998 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.13 142.92 85.92 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.877 2.385 . . . . 0.0 112.269 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.418 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -128.66 163.62 24.68 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.865 0.866 . . . . 0.0 112.311 175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.599 HD12 ' O ' ' C' ' 29' ' ' PHE . 27.4 tp -169.26 148.93 4.02 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 113.936 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.63 -151.07 21.78 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 120.928 1.695 . . . . 0.0 111.414 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.8 mp -142.39 135.47 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.806 0.843 . . . . 0.0 111.543 -174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -119.73 140.68 50.32 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.765 1.226 . . . . 0.0 109.921 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.0 -50.34 72.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.487 -0.758 . . . . 0.0 111.388 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 42.68 15.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.64 2.376 . . . . 0.0 116.456 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -93.67 -45.83 7.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.281 2.633 . . . . 0.0 114.895 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -173.97 3.53 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 124.434 1.084 . . . . 0.0 112.765 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 48.4 t -81.02 -37.9 28.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.062 . . . . 0.0 111.027 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.28 58.47 30.77 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 125.111 1.364 . . . . 0.0 111.392 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.68 163.1 40.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.771 2.981 . . . . 0.0 116.953 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -81.5 167.9 18.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.636 1.574 . . . . 0.0 111.657 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.28 161.81 35.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.662 -1.274 . . . . 0.0 113.064 174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.49 139.21 5.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 118.78 -1.676 . . . . 0.0 116.608 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -162.73 153.72 17.27 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -89.73 151.72 21.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.616 2.366 . . . . 0.0 110.49 174.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 t -129.38 118.42 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' B' ' 52' ' ' ILE . 10.0 t-20 -98.53 104.89 16.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 111.976 -174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . 0.411 ' HE1' ' HG1' ' C' ' 77' ' ' THR . 32.9 m95 -74.33 147.05 42.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.47 -45.98 3.61 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.106 -1.406 . . . . 0.0 114.337 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -80.51 -11.3 59.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.2 t -152.56 133.22 13.9 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.915 2.486 . . . . 0.0 105.961 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.04 118.49 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.802 1.183 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -178.83 166.48 1.66 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.916 1.686 . . . . 0.0 111.085 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -144.02 144.8 31.82 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.102 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.411 ' HG1' ' HE1' ' C' ' 70' ' ' TRP . 1.2 m -140.4 132.89 28.58 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 109.971 -3.286 . . . . 0.0 109.972 -172.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 144.93 19.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -116.64 144.36 44.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.9 117.16 8.99 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HE ' ' B' ' 100' ' ' ARG . . . -151.78 -176.44 24.52 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 119.48 -1.343 . . . . 0.0 115.155 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -123.15 147.51 46.73 Favored 'General case' 0 N--CA 1.442 -0.867 0 O-C-N 125.795 1.527 . . . . 0.0 110.527 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.596 ' HG ' ' HB2' ' C' ' 4' ' ' CYS . 5.4 t -97.09 123.64 40.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.027 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' B' ' 106' ' ' ILE . 4.6 m-85 -116.51 164.65 14.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.09 111.55 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -60.89 154.75 21.38 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -34.7 -41.61 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.334 1.854 . . . . 0.0 115.849 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -13.88 60.96 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.55 46.26 4.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.478 1.037 . . . . 0.0 113.097 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.48 151.56 34.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.521 2.728 . . . . 0.0 106.172 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -115.25 150.05 36.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.865 1.666 . . . . 0.0 110.987 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.504 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -149.88 158.95 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.233 1.413 . . . . 0.0 110.762 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . 0.413 HD21 ' CH2' ' C' ' 10' ' ' TRP . 7.3 mt -121.67 109.91 15.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.682 -2.711 . . . . 0.0 103.682 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.504 ' CD ' HG11 ' C' ' 92' ' ' VAL . 2.9 mmtt -102.35 116.69 33.16 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.598 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.6 p -129.08 163.13 26.13 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.429 1.585 . . . . 0.0 112.741 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.413 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.5 162.88 14.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -136.96 161.6 35.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.952 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -146.85 121.65 9.92 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.142 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . 0.476 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -107.57 142.05 38.08 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.706 1.241 . . . . 0.0 112.319 -176.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.436 ' HE ' ' HA2' ' B' ' 81' ' ' GLY . 4.3 tpt85 -127.54 113.99 16.85 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 111.762 -2.472 . . . . 0.0 112.364 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.255 0.4 OUTLIER -71.79 165.96 23.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.583 173.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -114.22 79.53 1.27 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.53 177.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.59 -0.694 . . . . 0.0 110.52 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.43 -22.79 15.37 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.6 150.01 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.116 1.436 . . . . 0.0 113.134 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' B' ' 84' ' ' PHE . 17.5 tt -61.92 -27.25 41.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.145 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.17 9.06 28.21 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.256 0.932 . . . . 0.0 113.738 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -119.49 -1.39 10.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.48 1.112 . . . . 0.0 111.852 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.78 -31.58 70.94 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.385 -1.447 . . . . 0.0 113.142 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -50.44 -45.81 56.17 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.694 1.597 . . . . 0.0 112.523 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -92.86 -10.36 36.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.367 1.067 . . . . 0.0 113.026 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.77 9.41 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.779 -0.576 . . . . 0.0 111.851 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' C' ' 98' ' ' LEU . 22.2 m -116.93 139.56 50.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.887 0.875 . . . . 0.0 113.089 175.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -136.44 116.18 13.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.624 2.37 . . . . 0.0 111.3 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -99.7 152.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.832 1.196 . . . . 0.0 110.239 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.43 -174.18 32.02 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -127.28 155.33 43.68 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.703 -0.881 . . . . 0.0 112.227 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -147.62 151.23 35.86 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.505 1.122 . . . . 0.0 109.702 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . 0.431 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.5 mt -135.61 118.98 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -109.99 151.08 27.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.527 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.9 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -58.3 127.71 33.51 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.079 -1.013 . . . . 0.0 111.228 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -73.71 135.62 43.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -41.95 118.14 1.07 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.643 1.977 . . . . 0.0 112.029 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 6.4 t -149.85 -53.0 0.15 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.763 -1.21 . . . . 0.0 112.552 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.8 153.18 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.439 2.296 . . . . 0.0 106.712 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 73.67 172.68 0.29 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.426 1.49 . . . . 0.0 108.482 -173.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.344 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.2 m -77.3 169.73 17.81 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.756 1.222 . . . . 0.0 110.522 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.71 147.72 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 110.023 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -117.79 -61.4 1.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.786 0.834 . . . . 0.0 111.745 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 54.11 40.5 31.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.02 1.328 . . . . 0.0 113.889 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -149.19 113.84 5.34 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.939 1.296 . . . . 0.0 112.645 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 130.21 56.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -139.64 130.1 25.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 110.876 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.62 -27.99 61.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -65.02 110.93 2.65 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.22 5.25 0.23 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 118.738 2.255 . . . . 0.0 118.738 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt 68.86 143.92 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.733 2.413 . . . . 0.0 115.642 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -139.14 159.25 42.59 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.278 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 t -138.45 147.06 42.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.699 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 118' ' ' ASN . 39.6 t-20 -111.47 145.63 38.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.726 0.81 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.06 -25.02 57.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.453 1.501 . . . . 0.0 113.944 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.08 -16.39 61.03 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.344 1.858 . . . . 0.0 111.838 174.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.27 -9.69 28.84 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.443 2.449 . . . . 0.0 114.28 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -64.46 144.97 56.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.009 1.404 . . . . 0.0 112.121 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -122.97 134.05 54.35 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -128.12 136.59 51.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.911 0.862 . . . . 0.0 111.671 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -126.97 130.31 49.83 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.846 0.831 . . . . 0.0 109.252 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.59 131.02 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.72 -103.26 0.08 OUTLIER Glycine 0 CA--C 1.527 0.807 0 O-C-N 125.692 1.87 . . . . 0.0 110.569 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.48 138.58 52.35 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.596 0.758 . . . . 0.0 111.127 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.88 133.47 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.95 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -69.73 158.06 36.12 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.8 m -54.36 -29.02 46.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -67.68 -33.82 75.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.894 0.77 . . . . 0.0 111.323 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.73 -7.55 22.08 Favored Glycine 0 C--O 1.224 -0.507 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.624 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.76 151.63 45.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.097 1.448 . . . . 0.0 108.415 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -152.0 161.59 42.41 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.286 175.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.53 163.82 20.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.368 -1.742 . . . . 0.0 107.121 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.97 -168.13 35.17 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.508 1.06 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -138.19 146.15 42.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 112.776 -1.712 . . . . 0.0 111.746 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -126.06 141.02 52.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.347 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 46' ' ' LEU . 4.4 mp -126.33 145.54 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 44' ' ' ILE . 3.2 m -121.54 139.35 53.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 112.387 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.64 -15.14 17.86 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 27.2 m -135.48 140.37 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.709 1.203 . . . . 0.0 111.079 -176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.28 169.39 22.62 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.727 -1.233 . . . . 0.0 112.027 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' HH12 ' A' ' 114' ' ' ARG . 25.7 m-20 -70.65 -43.27 69.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 173.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -128.41 84.34 63.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.529 2.332 . . . . 0.0 107.588 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.76 36.96 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.262 3.308 . . . . 0.0 114.731 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.95 -3.31 90.64 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 119.845 -1.784 . . . . 0.0 115.999 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 -3.33 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.92 1.36 . . . . 0.0 114.342 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 35' ' ' THR . 28.1 mt -20.03 108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 164.87 24.87 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.019 1.727 . . . . 0.0 109.513 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 34' ' ' ILE . 4.5 tt -50.74 136.85 21.24 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.643 1.977 . . . . 0.0 114.025 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -119.95 125.94 27.12 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 113.176 -1.829 . . . . 0.0 111.937 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.29 141.99 98.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.596 2.198 . . . . 0.0 111.715 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 142.74 50.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.619 1.199 . . . . 0.0 109.701 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' D' ' 50' ' ' LEU . 0.1 OUTLIER -145.25 149.24 34.54 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.093 2.557 . . . . 0.0 109.073 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.03 -156.22 27.72 Favored Glycine 0 N--CA 1.452 -0.259 0 O-C-N 120.128 -1.608 . . . . 0.0 109.857 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.5 mt -146.96 146.86 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.244 1.017 . . . . 0.0 111.527 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.48 153.59 43.33 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.343 1.457 . . . . 0.0 112.537 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.5 153.52 40.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.195 -1.566 . . . . 0.0 112.28 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -139.53 20.8 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -93.42 -57.8 2.48 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.271 1.029 . . . . 0.0 112.944 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.79 20.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.185 0.594 . . . . 0.0 112.323 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -81.57 -20.28 40.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 45.28 0.78 Allowed Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.984 1.314 . . . . 0.0 113.253 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.38 -176.76 3.1 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 124.222 3.281 . . . . 0.0 115.568 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.289 2.8 t -97.02 164.33 12.57 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.884 1.326 . . . . 0.0 112.931 174.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -158.54 168.95 25.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.633 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.04 151.85 21.03 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 120.516 2.967 . . . . 0.0 120.516 -172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -163.52 153.73 15.55 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -92.67 149.88 21.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.601 1.561 . . . . 0.0 108.839 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.87 127.82 68.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' D' ' 52' ' ' ILE . 25.7 t-20 -104.32 110.53 22.79 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.434 -0.792 . . . . 0.0 110.935 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.676 ' HE1' ' HG1' ' A' ' 77' ' ' THR . 91.5 m95 -75.91 129.9 37.65 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.587 1.184 . . . . 0.0 112.329 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -90.93 -38.08 13.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.261 -1.336 . . . . 0.0 114.506 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -83.77 -19.7 34.62 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 117.28 5.09 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.28 118.94 6.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.959 1.254 . . . . 0.0 111.711 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -175.64 167.42 3.19 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 126.644 1.978 . . . . 0.0 110.42 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 t -139.79 141.77 36.74 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.676 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 2.4 m -141.09 122.97 15.39 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 111.349 -2.66 . . . . 0.0 109.902 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.04 156.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.386 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -132.41 141.87 49.04 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 121.43 9.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 95' ' ' THR . . . -171.57 173.52 44.95 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 34.4 tt0 -106.71 144.47 33.32 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.429 0.723 . . . . 0.0 111.508 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.0 p -97.65 121.48 39.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.503 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.8 m-85 -114.1 170.59 8.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.491 1.139 . . . . 0.0 111.665 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 65.9 mt -127.09 116.58 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -58.78 156.03 11.88 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -17.57 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -82.68 -12.9 57.26 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.29 41.94 5.67 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.831 1.205 . . . . 0.0 112.796 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -117.09 152.0 35.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.497 174.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -103.13 146.54 28.25 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.847 1.259 . . . . 0.0 110.207 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.47 HG21 ' CD1' ' D' ' 106' ' ' ILE . 27.7 m -147.75 164.68 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.052 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.92 118.38 26.15 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.7 mmmt -107.09 113.39 26.81 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.455 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 3.0 p -131.21 172.5 12.06 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.365 1.555 . . . . 0.0 111.346 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.8 mmm -127.8 170.3 12.92 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.706 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -139.76 164.0 31.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.749 1.261 . . . . 0.0 112.208 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.8 OUTLIER -141.72 121.67 13.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.326 174.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 138.3 43.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 124.193 1.949 . . . . 0.0 109.934 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.63 114.14 18.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 109.652 -3.431 . . . . 0.0 110.057 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -72.61 167.73 20.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.424 1.702 . . . . 0.0 112.207 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -114.97 87.96 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.05 -170.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.767 1.227 . . . . 0.0 108.428 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -121.61 -28.28 4.59 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.85 -1.156 . . . . 0.0 113.814 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.9 144.96 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.573 1.178 . . . . 0.0 110.986 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' D' ' 94' ' ' LYS . 14.3 tt -61.63 -20.69 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.144 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.86 2.95 47.39 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.295 -1.28 . . . . 0.0 114.387 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.45 7.51 8.34 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.567 1.184 . . . . 0.0 112.9 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.62 -36.07 75.6 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.517 -1.989 . . . . 0.0 111.463 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.402 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 58.9 p-90 -48.22 -45.67 34.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.487 1.115 . . . . 0.0 113.401 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.59 -12.47 36.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.656 1.183 . . . . 0.0 113.576 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.96 1.69 22.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' D' ' 96' ' ' MET . 27.0 m -111.66 140.26 46.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.966 0.906 . . . . 0.0 111.499 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.443 HH12 ' CG ' ' A' ' 39' ' ' ASP . 7.6 mtt180 -144.3 130.25 19.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.958 1.303 . . . . 0.0 111.433 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.41 151.45 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 121.038 1.745 . . . . 0.0 110.98 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.97 179.53 27.59 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -120.15 151.56 38.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.121 0.968 . . . . 0.0 110.706 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.427 ' CG ' HD21 ' A' ' 12' ' ' ASN . 6.3 m-20 -149.78 149.52 30.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.233 1.016 . . . . 0.0 110.777 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.9 mt -130.4 133.74 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.08 -1.012 . . . . 0.0 108.289 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -123.92 149.02 46.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.94 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.8 p -132.66 159.76 38.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.71 1.204 . . . . 0.0 110.866 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.24 125.58 24.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 111.122 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.24 113.35 19.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.24 174.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 58.47 83.43 0.12 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.483 1.113 . . . . 0.0 113.889 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.7 p -46.92 115.94 1.21 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.463 1.105 . . . . 0.0 112.008 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -91.67 -2.58 56.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.779 1.632 . . . . 0.0 112.799 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -119.95 137.59 53.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--O 1.247 0.963 0 C-N-CA 128.299 2.64 . . . . 0.0 107.722 174.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 117.566 -1.207 . . . . 0.0 107.864 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 7.0 m 65.68 148.66 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.944 1.698 . . . . 0.0 115.368 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 19.6 m -141.43 -174.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 119.88 -1.763 . . . . 0.0 111.959 -174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . 53.91 31.84 14.1 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.365 2.357 . . . . 0.0 117.365 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -52.31 128.28 24.77 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.978 2.511 . . . . 0.0 113.602 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -156.1 135.32 12.16 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.285 1.834 . . . . 0.0 112.482 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -149.16 136.5 20.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.992 1.269 . . . . 0.0 111.632 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 31.3 p -139.45 133.56 31.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.169 2.187 . . . . 0.0 111.549 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.72 -26.42 60.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -65.4 112.1 3.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -4.96 0.36 Allowed Glycine 0 N--CA 1.476 1.316 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 74.68 144.05 0.08 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.418 2.287 . . . . 0.0 114.007 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -139.41 162.16 35.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.134 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -142.49 148.8 38.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.09 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.412 HD21 ' CG ' ' D' ' 118' ' ' ASN . 38.2 t-20 -113.43 146.08 40.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.977 0.911 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -56.92 -25.39 57.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.967 1.307 . . . . 0.0 113.921 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.19 -15.62 61.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.362 1.865 . . . . 0.0 112.134 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.84 -8.37 31.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 127.304 2.383 . . . . 0.0 114.294 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -64.56 143.97 57.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.14 1.47 . . . . 0.0 112.512 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -121.4 132.07 54.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.901 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -126.74 137.67 53.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 111.969 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.6 m -128.75 130.39 47.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.244 1.021 . . . . 0.0 109.786 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.26 130.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.4 -97.09 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 125.825 1.953 . . . . 0.0 111.146 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.41 138.16 46.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 110.959 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.07 134.03 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.008 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -69.75 157.84 36.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.499 0.72 . . . . 0.0 111.793 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 64.4 m -54.51 -28.75 47.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -67.81 -32.87 73.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.794 0.724 . . . . 0.0 111.369 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.23 -6.07 23.34 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 124.777 1.179 . . . . 0.0 112.715 -174.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.16 156.99 38.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.456 1.128 . . . . 0.0 110.541 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.59 166.53 33.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 123.186 1.47 . . . . 0.0 110.891 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -129.75 164.72 23.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 112.0 -2.364 . . . . 0.0 105.905 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.13 -167.1 35.05 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 75.1 p -139.23 146.74 40.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.186 -1.507 . . . . 0.0 112.134 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -126.87 141.14 51.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.179 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.569 HD11 HD12 ' D' ' 46' ' ' LEU . 4.4 mp -125.89 144.77 34.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.471 ' O ' HG21 ' D' ' 44' ' ' ILE . 3.7 m -120.85 138.84 53.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.055 0.942 . . . . 0.0 112.522 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.76 -15.98 18.28 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.406 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 27.3 m -134.81 140.81 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.577 1.151 . . . . 0.0 111.337 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.66 169.06 23.65 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 120.477 -1.389 . . . . 0.0 111.905 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' D' ' 114' ' ' ARG . 31.2 m-20 -70.29 -43.26 70.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.059 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -128.4 83.93 64.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.522 2.329 . . . . 0.0 107.69 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.9 37.44 0.29 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.323 3.348 . . . . 0.0 114.684 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.5 -2.83 90.66 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 119.893 -1.754 . . . . 0.0 116.063 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 -3.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.828 1.314 . . . . 0.0 114.401 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.471 HG21 ' O ' ' D' ' 35' ' ' THR . 29.3 mt -19.53 107.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 164.35 25.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.994 1.717 . . . . 0.0 109.494 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.569 HD12 HD11 ' D' ' 34' ' ' ILE . 4.4 tt -49.99 136.19 19.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.664 1.986 . . . . 0.0 113.95 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -119.3 125.96 27.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 113.21 -1.813 . . . . 0.0 111.991 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.21 140.67 95.89 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.229 1.953 . . . . 0.0 111.269 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.45 149.78 41.84 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 124.892 1.37 . . . . 0.0 109.359 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.913 HD12 HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -154.87 149.34 26.27 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.074 2.15 . . . . 0.0 108.869 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.94 -154.2 25.33 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 120.898 -1.126 . . . . 0.0 111.347 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.3 mt -146.92 146.02 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.286 1.035 . . . . 0.0 112.033 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.79 153.81 41.9 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.457 1.503 . . . . 0.0 112.325 174.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -73.17 159.17 33.92 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 119.954 -1.716 . . . . 0.0 112.344 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -145.46 21.75 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -93.46 -58.07 2.4 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.039 0.936 . . . . 0.0 112.453 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.47 169.81 16.69 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.962 0.789 . . . . 0.0 111.983 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 26.1 m -90.41 -13.77 34.27 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -136.22 39.75 0.46 Allowed Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.724 1.209 . . . . 0.0 113.768 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.76 -176.99 3.57 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.792 2.328 . . . . 0.0 114.359 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.305 2.5 t -97.06 164.36 12.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.742 1.258 . . . . 0.0 112.074 174.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.57 168.35 27.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.391 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 151.61 20.51 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 120.742 3.057 . . . . 0.0 120.742 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -163.49 152.78 14.63 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -90.84 150.79 21.41 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.932 1.693 . . . . 0.0 108.776 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.09 128.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.607 ' HB2' HG21 ' A' ' 52' ' ' ILE . 25.4 t-20 -105.44 110.26 22.53 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.467 -0.771 . . . . 0.0 110.906 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -75.74 129.82 37.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.823 1.297 . . . . 0.0 112.608 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -91.51 -37.63 13.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.944 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -83.79 -19.54 34.85 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -152.42 119.01 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.38 119.05 7.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.304 1.411 . . . . 0.0 111.758 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -175.29 166.43 3.38 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 126.531 1.933 . . . . 0.0 110.384 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 141.59 38.07 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.195 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -141.11 123.34 15.68 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 111.364 -2.653 . . . . 0.0 109.947 -172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.05 156.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.649 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.54 141.92 49.82 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.21 121.26 9.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -174.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' D' ' 95' ' ' THR . . . -170.66 173.68 44.49 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 118.665 -1.731 . . . . 0.0 117.19 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 34.6 tt0 -106.63 144.51 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.99 0.9 . . . . 0.0 111.274 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 p -97.66 118.22 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.924 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.488 ' HB2' HD12 ' A' ' 106' ' ' ILE . 2.8 m-85 -112.27 170.56 8.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.901 0.858 . . . . 0.0 111.911 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 49.9 mt -128.97 114.81 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -58.61 155.85 11.75 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -29.62 2.63 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -72.07 -17.7 61.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.337 1.455 . . . . 0.0 113.833 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.89 54.38 2.64 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' D' ' 90' ' ' LYS . 0.2 OUTLIER -128.22 153.55 46.8 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 129.51 3.124 . . . . 0.0 108.794 173.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -109.54 146.96 33.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.523 1.154 . . . . 0.0 109.971 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 106' ' ' ILE . 23.3 m -148.44 164.03 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.34 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 73.4 mt -125.29 118.36 25.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.616 ' HE2' HD11 ' A' ' 106' ' ' ILE . 3.8 mmmt -106.76 112.94 26.15 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HA3' ' D' ' 81' ' ' GLY . 2.9 p -130.52 172.12 12.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.553 1.644 . . . . 0.0 111.155 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.667 ' HG3' HG21 ' A' ' 113' ' ' THR . 86.5 mmm -127.19 169.99 12.89 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.753 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -139.69 164.01 31.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.657 1.218 . . . . 0.0 111.913 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.418 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.8 OUTLIER -142.09 122.3 13.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.212 174.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 139.46 41.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 124.105 1.907 . . . . 0.0 110.11 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.84 114.58 18.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 109.717 -3.402 . . . . 0.0 110.626 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -73.08 167.83 20.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 125.492 1.745 . . . . 0.0 112.429 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -114.7 83.71 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.46 -172.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.904 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -119.05 -30.22 5.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.529 -1.357 . . . . 0.0 112.411 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -114.06 143.92 43.98 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 111.564 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.583 HD11 ' HE2' ' A' ' 94' ' ' LYS . 14.0 tt -61.61 -22.27 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.666 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.39 1.16 51.98 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 117.635 -1.647 . . . . 0.0 114.445 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.08 7.46 9.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.841 1.321 . . . . 0.0 113.002 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.06 -36.18 74.61 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.696 -1.877 . . . . 0.0 111.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.412 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 58.5 p-90 -48.25 -46.03 35.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.377 1.071 . . . . 0.0 113.201 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -90.32 -12.65 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.441 1.096 . . . . 0.0 113.508 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.28 1.0 23.12 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.667 HG21 ' HG3' ' A' ' 96' ' ' MET . 24.2 m -111.12 140.85 45.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.231 1.012 . . . . 0.0 111.669 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' D' ' 39' ' ' ASP . 7.3 mtt180 -144.75 130.95 19.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.61 152.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.085 1.766 . . . . 0.0 110.966 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.29 28.79 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -120.13 150.8 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.026 0.93 . . . . 0.0 110.407 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . 0.412 ' CG ' HD21 ' D' ' 12' ' ' ASN . 5.6 m-20 -149.18 148.07 29.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.768 0.794 . . . . 0.0 110.357 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -128.46 133.71 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -123.22 147.45 46.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.559 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 46.9 p -129.81 156.75 43.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.757 1.223 . . . . 0.0 110.009 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -57.75 127.79 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.761 0.825 . . . . 0.0 110.496 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -77.17 85.99 3.63 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -179.21 -92.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.66 1.984 . . . . 0.0 110.184 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 21.4 m 75.9 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.312 2.245 . . . . 0.0 107.703 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' D' ' 128' ' ' GLU . 1.9 mt-30 -151.89 -77.36 0.13 Allowed 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 22.1 tptp 77.19 -26.15 0.19 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 127.708 2.403 . . . . 0.0 113.644 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' D' ' 126' ' ' GLN . 2.2 pm0 . . . . . 0 C--O 1.261 1.709 1 C-N-CA 133.133 4.573 . . . . 0.0 109.77 174.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 2.8 m 17.86 73.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 129.173 2.989 . . . . 0.0 117.76 174.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.12 97.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.944 -1.098 . . . . 0.0 112.014 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.38 97.17 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . 0.301 14.3 ptm180 44.67 72.41 0.2 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.192 2.597 . . . . 0.0 117.324 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -147.31 125.81 12.44 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.295 1.038 . . . . 0.0 112.763 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 44.4 t -139.31 133.9 31.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 109.421 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.2 p -139.56 131.72 28.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.748 2.019 . . . . 0.0 110.081 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.45 -25.72 60.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -65.68 111.6 3.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -5.38 0.37 Allowed Glycine 0 N--CA 1.478 1.472 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt 75.34 144.32 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.657 2.383 . . . . 0.0 114.037 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -140.55 162.39 35.46 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.849 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.8 t -141.11 149.96 42.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.688 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -112.03 146.26 38.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.618 0.767 . . . . 0.0 110.512 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -57.26 -23.81 50.66 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.499 1.52 . . . . 0.0 113.626 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 24.5 tp -74.52 -16.17 60.84 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.511 1.924 . . . . 0.0 111.932 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.5 -7.68 32.19 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 127.421 2.439 . . . . 0.0 114.272 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -64.41 144.39 57.2 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.278 1.539 . . . . 0.0 113.14 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -122.85 132.26 54.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.177 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -126.49 136.64 52.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.887 0.851 . . . . 0.0 111.739 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.6 m -126.69 130.56 50.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.601 0.715 . . . . 0.0 109.607 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.04 130.14 72.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.61 -98.16 0.09 OUTLIER Glycine 0 CA--C 1.527 0.829 0 O-C-N 125.559 1.787 . . . . 0.0 111.229 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.16 138.21 46.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.709 0.804 . . . . 0.0 110.984 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 p -92.35 133.47 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.018 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' B' ' 28' ' ' GLU . 20.4 m-20 -69.27 158.02 35.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.237 0.615 . . . . 0.0 111.344 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 63.9 m -54.4 -29.02 47.46 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -67.76 -33.9 75.76 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.801 . . . . 0.0 111.39 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.83 21.63 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.697 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' B' ' 24' ' ' ASN . 15.0 pt-20 -69.52 151.72 45.68 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.116 1.458 . . . . 0.0 108.426 174.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.411 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.0 OUTLIER -151.99 161.27 42.9 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.107 175.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -123.3 163.71 20.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.111 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.93 -168.34 35.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-O 122.741 1.19 . . . . 0.0 110.976 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 77.8 p -137.96 146.97 43.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.505 -1.847 . . . . 0.0 111.73 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -126.61 141.13 51.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.228 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.59 HD11 HD12 ' B' ' 46' ' ' LEU . 4.5 mp -126.18 144.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.457 ' O ' HG21 ' B' ' 44' ' ' ILE . 3.3 m -120.89 139.42 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.941 0.896 . . . . 0.0 112.645 -173.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.09 -16.21 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.412 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 27.7 m -134.96 140.65 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.612 1.165 . . . . 0.0 111.116 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.72 169.11 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.844 -1.16 . . . . 0.0 112.103 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' CG ' HH12 ' B' ' 114' ' ' ARG . 27.9 m-20 -70.19 -43.39 70.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.987 173.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -128.72 83.95 64.63 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.651 2.381 . . . . 0.0 107.66 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.71 37.48 0.29 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.263 3.308 . . . . 0.0 114.753 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.69 -2.98 90.72 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 119.839 -1.788 . . . . 0.0 116.041 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.07 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.457 HG21 ' O ' ' B' ' 35' ' ' THR . 29.5 mt -19.7 107.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.73 24.78 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.98 1.712 . . . . 0.0 109.54 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.59 HD12 HD11 ' B' ' 34' ' ' ILE . 5.0 tt -50.77 137.21 20.73 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 126.556 1.942 . . . . 0.0 113.929 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -120.15 126.24 26.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.094 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.26 141.84 98.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.679 2.253 . . . . 0.0 111.813 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.74 143.13 50.02 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 124.562 1.163 . . . . 0.0 109.614 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' C' ' 50' ' ' LEU . 0.1 OUTLIER -145.32 149.25 34.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.978 2.511 . . . . 0.0 108.878 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.17 -155.95 27.39 Favored Glycine 0 N--CA 1.453 -0.222 0 O-C-N 120.337 -1.477 . . . . 0.0 109.853 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.623 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.5 mt -147.2 147.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.316 1.047 . . . . 0.0 111.618 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.62 154.0 42.94 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.048 1.339 . . . . 0.0 112.431 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -74.06 153.5 39.61 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 120.223 -1.548 . . . . 0.0 112.063 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -138.6 20.98 2.71 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -93.56 -57.07 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.791 0.836 . . . . 0.0 112.941 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 170.2 16.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.675 0.75 . . . . 0.0 112.972 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.8 m -80.77 -24.53 38.57 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.94 44.97 0.78 Allowed Pre-proline 0 CA--C 1.569 1.685 0 C-N-CA 125.319 1.448 . . . . 0.0 113.156 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.78 -176.23 3.07 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.201 2.6 . . . . 0.0 114.882 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.299 2.9 t -97.26 164.15 12.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.788 1.28 . . . . 0.0 112.508 174.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.56 168.61 26.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.893 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.44 151.53 20.32 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 120.825 3.09 . . . . 0.0 120.825 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -163.09 153.49 16.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -92.15 149.65 21.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.566 1.546 . . . . 0.0 108.849 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.61 128.18 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' C' ' 52' ' ' ILE . 25.8 t-20 -104.75 110.61 23.02 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.369 -0.832 . . . . 0.0 110.778 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -76.25 130.67 38.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 122.784 1.278 . . . . 0.0 112.645 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -92.41 -37.81 12.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.737 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -84.1 -19.49 34.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.5 117.32 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.96 118.93 6.84 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.897 1.226 . . . . 0.0 111.76 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -175.56 167.23 3.25 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 126.599 1.96 . . . . 0.0 110.27 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -139.38 142.14 37.55 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.249 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -141.15 123.32 15.63 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 111.462 -2.608 . . . . 0.0 109.588 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 m -99.17 156.53 3.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.512 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.29 141.85 49.14 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.55 121.34 9.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' B' ' 95' ' ' THR . . . -169.66 172.52 43.68 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 118.628 -1.748 . . . . 0.0 116.947 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 34.9 tt0 -105.02 144.85 31.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.654 0.74 . . . . 0.0 111.224 -176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 p -97.56 122.89 41.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.106 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.469 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.98 169.61 9.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.963 0.887 . . . . 0.0 111.778 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -126.37 116.38 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.91 155.55 13.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -21.26 0.8 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 118.104 2.631 . . . . 0.0 118.104 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -80.43 -12.23 59.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 47.5 4.79 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.259 0.933 . . . . 0.0 112.416 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.69 150.81 42.22 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.257 2.223 . . . . 0.0 110.462 174.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -103.44 145.75 29.53 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.967 1.307 . . . . 0.0 110.228 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 27.1 m -147.83 164.19 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.865 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.98 118.29 25.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.596 ' HE2' HD11 ' C' ' 106' ' ' ILE . 3.8 mmmt -106.77 113.47 26.98 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.445 ' HA ' ' HA3' ' B' ' 81' ' ' GLY . 3.0 p -130.85 172.69 11.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.543 1.64 . . . . 0.0 111.161 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.65 ' HG3' HG21 ' C' ' 113' ' ' THR . 87.7 mmm -127.63 170.12 13.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.554 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -139.82 163.36 32.84 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.573 1.178 . . . . 0.0 111.752 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -141.13 122.02 14.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.19 174.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 138.38 43.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 124.356 2.027 . . . . 0.0 110.108 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.71 114.11 18.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 109.475 -3.511 . . . . 0.0 109.922 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -73.08 167.94 20.09 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 125.508 1.755 . . . . 0.0 112.125 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 6.4 t -114.87 87.87 2.74 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.04 -171.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.838 1.255 . . . . 0.0 108.243 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.05 -30.52 4.35 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.823 -1.173 . . . . 0.0 112.226 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -112.76 143.2 44.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.255 1.026 . . . . 0.0 111.76 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.587 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.2 tt -60.37 -22.04 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.08 -0.963 . . . . 0.0 113.161 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.61 54.48 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 117.701 -1.611 . . . . 0.0 114.55 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -122.67 7.2 9.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.922 1.289 . . . . 0.0 113.118 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.68 -36.11 73.68 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 119.76 -1.837 . . . . 0.0 111.296 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.406 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 58.7 p-90 -48.27 -45.92 35.2 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.429 1.092 . . . . 0.0 113.479 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -90.36 -12.32 37.98 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.463 1.105 . . . . 0.0 113.345 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.61 1.1 23.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.656 HG21 ' HG3' ' C' ' 96' ' ' MET . 25.4 m -110.86 140.35 45.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.297 1.039 . . . . 0.0 111.938 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.438 HH12 ' CG ' ' B' ' 39' ' ' ASP . 7.5 mtt180 -144.6 130.7 19.47 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.658 1.183 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.39 152.25 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 121.111 1.778 . . . . 0.0 111.209 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.35 179.49 27.95 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -120.48 150.61 40.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.241 1.017 . . . . 0.0 110.344 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.41 148.27 29.26 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.033 0.921 . . . . 0.0 110.41 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 62.7 mt -129.58 133.31 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -122.88 148.01 45.91 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.985 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.7 p -131.28 159.15 38.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.768 1.227 . . . . 0.0 110.432 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 5.0 mmt-85 -59.14 134.52 57.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.731 0.812 . . . . 0.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 125.15 26.82 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.659 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 77.97 134.28 0.06 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.218 1.807 . . . . 0.0 111.228 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 14.2 m -57.41 109.0 0.61 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.019 0.928 . . . . 0.0 110.285 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -83.08 110.67 18.2 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.256 -0.903 . . . . 0.0 108.689 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 mttp 87.97 120.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.95 2.5 . . . . 0.0 109.528 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 127.602 2.361 . . . . 0.0 108.842 178.189 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.2 m 61.44 172.62 0.11 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.896 0.879 . . . . 0.0 111.177 -173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 6.4 p -169.56 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.315 1.446 . . . . 0.0 110.63 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -69.19 147.46 51.29 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -151.46 95.02 2.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.555 0.742 . . . . 0.0 112.09 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -154.76 125.89 7.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.059 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -141.58 135.92 30.54 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.921 1.237 . . . . 0.0 110.777 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 22.4 p -139.48 131.68 28.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.536 1.935 . . . . 0.0 110.844 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -73.54 -24.76 60.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -67.58 112.33 4.67 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.58 -3.22 0.43 Allowed Glycine 0 N--CA 1.481 1.636 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt 74.05 144.5 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.908 2.483 . . . . 0.0 114.446 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -139.54 162.55 34.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.121 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -142.81 147.38 35.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.449 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -110.68 145.92 37.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.826 0.85 . . . . 0.0 110.348 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -57.46 -23.39 49.54 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.627 1.571 . . . . 0.0 113.69 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.6 tp -75.04 -16.37 60.59 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.613 1.965 . . . . 0.0 111.895 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.07 -7.86 31.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 127.417 2.436 . . . . 0.0 114.364 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -65.1 145.25 56.54 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.285 1.543 . . . . 0.0 112.656 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -123.84 132.01 53.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.143 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 2.8 ptt? -125.93 137.9 53.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.859 0.838 . . . . 0.0 111.738 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 33.9 m -128.39 129.84 46.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.721 0.772 . . . . 0.0 109.438 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.9 129.73 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.76 -96.59 0.1 OUTLIER Glycine 0 CA--C 1.527 0.786 0 O-C-N 125.638 1.836 . . . . 0.0 111.179 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.92 45.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.758 0.823 . . . . 0.0 110.962 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.97 133.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.011 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -69.49 157.91 36.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.543 0.737 . . . . 0.0 111.831 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 64.3 m -54.58 -28.89 49.42 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -67.78 -32.88 73.77 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.834 0.743 . . . . 0.0 111.303 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.17 -6.06 23.44 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 124.761 1.172 . . . . 0.0 112.763 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.04 157.09 38.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.434 1.112 . . . . 0.0 110.426 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.6 166.55 33.01 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.95 1.357 . . . . 0.0 110.872 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -129.74 165.04 22.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 112.164 -2.289 . . . . 0.0 105.84 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.44 -167.03 35.11 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 122.448 1.027 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.404 ' HB ' HD11 ' C' ' 46' ' ' LEU . 70.2 p -139.01 147.36 42.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.972 -1.614 . . . . 0.0 112.187 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -127.48 141.26 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.587 HD11 HD12 ' C' ' 46' ' ' LEU . 4.3 mp -125.94 145.65 33.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.463 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -122.11 138.95 54.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.144 -173.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -13.45 18.65 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 27.7 m -136.63 140.16 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.672 1.189 . . . . 0.0 111.429 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.12 169.56 22.11 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.575 -1.328 . . . . 0.0 112.192 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . 0.447 ' CG ' HH12 ' C' ' 114' ' ' ARG . 30.2 m-20 -70.93 -42.9 69.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.142 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -128.31 84.57 62.84 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.685 2.394 . . . . 0.0 107.506 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.84 36.52 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.168 3.245 . . . . 0.0 114.675 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.88 -3.01 90.58 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 119.909 -1.744 . . . . 0.0 115.99 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.11 -4.11 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.83 1.315 . . . . 0.0 114.47 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.463 HG21 ' O ' ' C' ' 35' ' ' THR . 29.2 mt -19.33 108.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.77 164.09 26.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.073 1.749 . . . . 0.0 109.593 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.587 HD12 HD11 ' C' ' 34' ' ' ILE . 4.4 tt -49.98 136.57 18.44 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.652 1.981 . . . . 0.0 113.943 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 13.1 p -120.07 126.11 27.0 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.18 140.06 93.14 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.636 2.224 . . . . 0.0 111.377 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.09 149.48 42.12 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 124.772 1.295 . . . . 0.0 109.64 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -154.79 149.44 26.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.98 2.112 . . . . 0.0 108.601 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.95 -154.05 25.21 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 119.163 0.892 . . . . 0.0 111.543 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.3 mt -147.16 145.95 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.317 1.047 . . . . 0.0 111.923 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.98 153.29 43.01 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.349 1.459 . . . . 0.0 112.321 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -72.77 157.92 36.57 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.94 -1.725 . . . . 0.0 112.298 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -143.88 21.14 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -93.52 -57.26 2.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.931 0.892 . . . . 0.0 112.364 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.18 169.03 17.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.611 0.764 . . . . 0.0 112.179 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -85.38 -19.81 30.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 40.35 0.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 125.085 1.354 . . . . 0.0 113.335 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.95 -177.06 3.63 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.857 2.371 . . . . 0.0 114.531 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.308 2.3 t -96.57 164.09 12.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.711 1.243 . . . . 0.0 112.121 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -158.44 168.25 27.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.653 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.58 151.46 20.14 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 120.61 3.004 . . . . 0.0 120.61 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.19 153.21 15.73 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -91.53 150.44 21.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.996 1.719 . . . . 0.0 108.804 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.49 128.7 68.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.623 ' HB2' HG21 ' B' ' 52' ' ' ILE . 25.1 t-20 -105.46 110.62 23.03 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.817 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.47 130.95 39.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.736 1.255 . . . . 0.0 112.413 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -92.37 -38.35 12.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.964 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -82.94 -19.33 37.43 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 47.3 t -152.44 119.92 6.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.27 118.89 7.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.369 1.44 . . . . 0.0 111.35 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 6.4 m -175.56 166.38 3.22 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.695 1.998 . . . . 0.0 110.539 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -139.13 142.09 38.06 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 122.324 1.059 . . . . 0.0 111.397 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.4 m -141.25 124.19 16.25 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 111.284 -2.689 . . . . 0.0 109.831 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -100.17 155.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.421 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -131.43 141.76 49.88 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.44 121.46 9.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' C' ' 95' ' ' THR . . . -170.06 173.55 44.13 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.54 -1.791 . . . . 0.0 116.703 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 35.0 tt0 -105.81 144.89 31.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.379 1.085 . . . . 0.0 111.132 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 30.1 p -97.43 123.23 41.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.356 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.468 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.7 m-85 -117.76 170.43 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.733 0.778 . . . . 0.0 112.257 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 49.7 mt -127.28 115.77 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -58.85 154.95 14.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -19.16 0.51 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 176.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -82.31 -9.61 59.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.174 0.99 . . . . 0.0 113.247 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.83 49.75 5.24 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.193 0.901 . . . . 0.0 112.359 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 0.4 OUTLIER -124.31 152.88 42.55 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 127.716 2.406 . . . . 0.0 109.506 173.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -107.54 145.71 32.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.14 1.376 . . . . 0.0 110.005 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.448 HG21 ' CD1' ' B' ' 106' ' ' ILE . 25.9 m -148.15 165.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.178 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.89 118.63 25.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' B' ' 106' ' ' ILE . 3.7 mmmt -106.97 112.62 25.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' C' ' 81' ' ' GLY . 3.0 p -129.94 172.87 11.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.533 1.635 . . . . 0.0 111.374 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.656 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.0 mmm -128.31 170.56 12.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -140.43 163.6 32.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.741 1.257 . . . . 0.0 111.804 174.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.8 OUTLIER -141.39 122.2 14.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.389 174.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.08 139.17 41.93 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 124.122 1.915 . . . . 0.0 110.026 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.27 18.42 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 109.75 -3.386 . . . . 0.0 110.132 -173.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -72.35 168.25 18.77 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.342 1.651 . . . . 0.0 112.41 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -115.43 82.68 1.79 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.97 -172.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.791 1.237 . . . . 0.0 108.916 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -119.73 -28.52 5.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.661 -1.274 . . . . 0.0 112.847 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -116.55 143.28 45.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 122.419 1.104 . . . . 0.0 111.624 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.0 tt -61.79 -20.52 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.731 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.4 2.37 57.86 Favored Glycine 0 CA--C 1.539 1.555 0 CA-C-O 118.335 -1.259 . . . . 0.0 114.086 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -124.04 7.62 8.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.79 1.236 . . . . 0.0 112.994 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.8 -36.07 75.98 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 119.734 -1.853 . . . . 0.0 111.524 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 59.1 p-90 -48.1 -46.02 33.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.602 1.161 . . . . 0.0 113.248 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -90.22 -12.41 38.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.454 1.101 . . . . 0.0 113.763 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 1.36 23.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.65 HG21 ' HG3' ' B' ' 96' ' ' MET . 26.2 m -111.25 140.63 45.65 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.21 1.004 . . . . 0.0 111.385 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.447 HH12 ' CG ' ' C' ' 39' ' ' ASP . 7.4 mtt180 -144.81 130.93 19.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.911 1.284 . . . . 0.0 111.195 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.63 152.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.972 1.715 . . . . 0.0 111.145 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.12 28.3 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -119.9 150.72 40.02 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.146 0.978 . . . . 0.0 110.145 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.52 147.23 27.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.856 0.836 . . . . 0.0 110.406 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.56 132.78 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.87 147.74 45.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.569 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 63.3 p -131.54 158.09 41.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.831 1.252 . . . . 0.0 109.971 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -60.46 136.72 58.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.757 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.55 103.5 11.31 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -0.778 . . . . 0.0 111.387 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 65.27 82.1 0.19 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 117.317 2.339 . . . . 0.0 117.317 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 11.1 p -104.78 153.03 21.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.828 1.651 . . . . 0.0 112.396 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -143.45 132.23 22.63 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.165 2.586 . . . . 0.0 104.048 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.37 21.74 1.06 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.977 1.311 . . . . 0.0 112.865 -174.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.246 0.917 1 C-N-CA 133.662 4.785 . . . . 0.0 105.065 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 116.526 -1.702 . . . . 0.0 106.508 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 12.0 m 38.75 42.1 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.348 1.859 . . . . 0.0 115.215 -174.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.1 m -95.64 27.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.539 -1.35 . . . . 0.0 112.353 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -62.53 157.4 20.51 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.244 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -126.33 72.63 1.33 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.56 1.544 . . . . 0.0 108.94 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -157.36 155.81 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.111 0.965 . . . . 0.0 111.957 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -131.04 147.03 52.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.1 p -139.84 130.71 26.08 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.278 -1.514 . . . . 0.0 112.646 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.7 -27.45 68.71 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -50.49 118.43 3.04 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 123.575 1.655 . . . . 0.0 112.189 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.11 -119.12 2.58 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.84 2.162 . . . . 0.0 110.017 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -145.01 149.73 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.546 1.138 . . . . 0.0 113.273 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -145.83 159.18 43.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.296 1.438 . . . . 0.0 110.068 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -134.87 150.2 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -107.96 143.51 36.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.461 1.104 . . . . 0.0 111.265 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.3 -24.03 64.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.39 1.076 . . . . 0.0 112.632 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 HD21 ' A' ' 118' ' ' ASN . 50.0 tp -74.09 -14.34 60.97 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.983 1.313 . . . . 0.0 112.639 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.61 -14.29 32.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 127.049 2.262 . . . . 0.0 113.889 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.61 153.85 22.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.298 1.523 . . . . 0.0 112.741 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.52 146.81 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.149 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -141.29 147.12 37.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -129.89 134.04 47.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.339 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.18 123.72 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.93 -87.06 0.11 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 124.434 1.084 . . . . 0.0 111.567 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.5 42.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.06 0.933 . . . . 0.0 112.145 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.16 125.55 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 113.166 -1.834 . . . . 0.0 108.038 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -71.36 162.81 28.84 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.995 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -54.91 -23.67 19.93 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -74.75 -32.52 62.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.905 -1.122 . . . . 0.0 113.217 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 -5.4 26.4 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 117.603 -1.665 . . . . 0.0 112.586 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 0.0 OUTLIER -67.06 142.46 57.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.71 156.91 32.5 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 50' ' ' LEU . 1.5 p -125.2 168.61 13.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.622 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.52 -167.36 35.64 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.32 0.956 . . . . 0.0 113.838 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -138.61 133.63 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.758 -1.221 . . . . 0.0 111.308 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -113.65 131.92 55.96 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.59 129.24 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.251 61.2 m -104.66 142.65 34.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.638 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.24 -10.2 20.57 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -138.99 146.16 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.266 1.026 . . . . 0.0 112.647 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.1 26.4 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.319 -0.863 . . . . 0.0 110.881 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -31.14 63.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -141.1 69.73 28.27 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.454 1.902 . . . . 0.0 113.897 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.53 72.1 2.42 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 124.339 3.359 . . . . 0.0 114.183 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.69 2.28 13.64 Favored Glycine 0 N--CA 1.477 1.408 0 O-C-N 120.712 -1.242 . . . . 0.0 114.597 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.14 27.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.805 1.242 . . . . 0.0 112.623 -174.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.56 130.71 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.929 0.871 . . . . 0.0 110.76 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.25 0.5 OUTLIER -140.52 170.2 16.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.616 1.566 . . . . 0.0 110.055 177.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.1 tp -57.53 115.4 2.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.865 2.866 . . . . 0.0 111.0 174.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.2 m -100.55 120.09 56.97 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.23 142.38 87.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.434 2.089 . . . . 0.0 111.699 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.46 152.98 47.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.802 0.841 . . . . 0.0 111.624 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 30' ' ' THR . 1.1 tp -160.59 148.79 16.34 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 110.463 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.48 -152.01 22.66 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 120.883 1.674 . . . . 0.0 110.195 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -143.2 140.01 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.304 0.642 . . . . 0.0 111.279 -174.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.21 136.41 52.79 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.396 -0.815 . . . . 0.0 111.932 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -68.76 149.79 48.61 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.935 0.874 . . . . 0.0 111.321 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.3 23.98 1.15 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.995 1.318 . . . . 0.0 111.436 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -92.97 -58.2 2.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.361 1.864 . . . . 0.0 111.357 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.05 -178.15 3.21 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.616 1.197 . . . . 0.0 114.169 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -65.73 -57.81 7.15 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.215 1.006 . . . . 0.0 111.845 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -141.52 65.39 20.88 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.917 0.887 . . . . 0.0 110.129 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.34 -174.15 1.53 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.27 2.647 . . . . 0.0 114.546 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.275 4.5 t -96.15 160.72 14.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 123.158 1.456 . . . . 0.0 112.796 174.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.9 167.34 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.469 -173.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.55 147.37 12.91 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.19 156.91 27.38 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -92.9 149.68 21.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.661 1.984 . . . . 0.0 109.535 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.22 117.04 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 19.6 t-20 -92.36 105.5 17.68 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.752 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.266 42.9 m95 -74.3 130.96 40.7 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -89.47 -40.26 12.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -92.17 -9.46 42.28 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.42 128.37 10.31 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 128.187 2.595 . . . . 0.0 104.865 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.76 118.7 12.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.363 1.078 . . . . 0.0 110.739 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 m -177.07 159.65 1.68 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.001 1.721 . . . . 0.0 110.475 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.63 141.64 35.07 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.033 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 99' ' ' LEU . 1.8 m -140.57 126.68 19.65 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.553 -3.022 . . . . 0.0 108.558 -172.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.754 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -124.61 142.56 51.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 116.67 5.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.31 169.21 39.73 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 118.737 -1.697 . . . . 0.0 116.408 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 29.0 tt0 -101.84 148.13 25.68 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 122.274 1.035 . . . . 0.0 111.723 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 132.82 36.31 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.271 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' D' ' 106' ' ' ILE . 19.7 m-85 -121.62 158.09 29.37 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 174.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 110.18 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.81 158.58 7.94 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.547 1.139 . . . . 0.0 110.087 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -48.08 -33.77 8.65 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -75.33 -15.26 60.5 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.6 47.15 3.04 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.248 0.928 . . . . 0.0 111.729 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 4.9 mtpm? -119.8 154.18 34.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.431 1.492 . . . . 0.0 109.639 174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -109.03 151.82 25.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.814 1.645 . . . . 0.0 111.26 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.48 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.3 t -152.83 156.3 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.189 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 mt -123.42 104.11 8.89 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.48 ' CD ' HG11 ' A' ' 92' ' ' VAL . 1.2 mmtt -95.04 127.84 41.41 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -139.77 163.07 33.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.792 1.282 . . . . 0.0 112.768 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 19.9 mtp -121.34 160.47 23.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -133.51 162.57 31.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.154 -1.839 . . . . 0.0 113.057 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.81 126.55 23.81 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.508 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.409 HD12 HG21 ' A' ' 77' ' ' THR . 0.3 OUTLIER -107.3 140.79 39.64 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 125.14 1.525 . . . . 0.0 109.972 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.09 118.23 22.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.57 -173.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.8 p -84.99 172.07 11.61 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.7 m -110.71 70.89 0.73 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 0.0 107.7 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.46 169.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.048 1.339 . . . . 0.0 109.667 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.34 -11.1 14.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -135.36 152.76 51.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.064 1.412 . . . . 0.0 111.942 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -67.43 -20.77 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 113.939 -1.482 . . . . 0.0 113.376 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.83 4.3 45.83 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.674 -0.641 . . . . 0.0 114.401 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -125.75 1.64 7.45 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.25 -34.58 72.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.987 0.915 . . . . 0.0 113.028 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -48.32 -38.85 20.06 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -97.43 -12.92 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.04 1.336 . . . . 0.0 114.032 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.76 38.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.4 m -108.34 144.94 35.2 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-O 122.352 1.072 . . . . 0.0 109.583 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -141.0 151.84 44.44 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.524 1.529 . . . . 0.0 108.311 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.62 153.19 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.57 1.148 . . . . 0.0 109.411 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.38 32.22 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.141 0.877 . . . . 0.0 111.776 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 17.3 p90 -132.41 159.99 37.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.139 -0.624 . . . . 0.0 112.076 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.586 HD21 HD22 ' A' ' 14' ' ' LEU . 4.6 m120 -150.42 157.35 42.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.542 1.163 . . . . 0.0 109.784 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.4 HD13 ' HE3' ' A' ' 94' ' ' LYS . 8.6 mt -131.93 129.45 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.85 151.97 38.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 124.334 1.022 . . . . 0.0 108.772 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 p -139.84 164.77 29.09 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -57.04 129.62 42.51 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.496 0.718 . . . . 0.0 110.94 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.86 166.82 14.77 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 77.39 -51.96 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.5 m -103.12 84.73 2.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.783 1.233 . . . . 0.0 109.697 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -81.2 -41.69 21.93 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.351 0.596 . . . . 0.0 111.8 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -143.08 179.92 6.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.609 1.964 . . . . 0.0 110.132 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.272 2.27 2 C-N-CA 137.086 6.154 . . . . 0.0 98.551 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 116.507 -1.711 . . . . 0.0 107.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 14.9 t -71.22 -44.38 65.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.853 1.661 . . . . 0.0 112.646 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 11.7 t 60.26 -48.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 128.343 2.657 . . . . 0.0 113.839 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -74.74 139.58 43.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.051 1.341 . . . . 0.0 113.331 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ttm105 -70.18 96.29 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.271 1.829 . . . . 0.0 109.863 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -156.95 155.96 32.23 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.23 1.012 . . . . 0.0 111.516 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . 0.463 ' HG ' ' HB3' ' D' ' 83' ' ' CYS . 27.5 p -137.67 143.37 41.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.656 1.583 . . . . 0.0 108.888 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 85.2 p -139.98 131.95 27.77 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.346 -1.471 . . . . 0.0 113.552 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -63.31 -24.04 67.68 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -53.95 118.43 3.99 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.545 1.64 . . . . 0.0 112.092 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.46 -120.73 2.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.261 1.886 . . . . 0.0 109.554 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.559 1.144 . . . . 0.0 113.301 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -147.8 159.89 43.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -137.18 147.88 46.18 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -105.79 143.57 33.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.652 1.181 . . . . 0.0 111.945 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -58.79 -24.56 62.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.562 1.145 . . . . 0.0 112.92 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.634 HD22 HD21 ' D' ' 118' ' ' ASN . 45.4 tp -74.84 -13.81 60.61 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.694 1.197 . . . . 0.0 112.666 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -13.81 36.72 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.973 2.225 . . . . 0.0 113.619 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.2 152.27 25.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.298 1.523 . . . . 0.0 112.439 175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.95 146.44 50.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.854 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -141.19 147.29 38.14 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -129.76 134.95 47.9 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.035 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.08 123.62 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.86 0.12 Allowed Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.128 0.893 . . . . 0.0 111.757 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.09 151.63 38.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.747 -0.855 . . . . 0.0 111.969 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.66 126.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.59 -1.641 . . . . 0.0 108.596 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -70.87 162.8 28.62 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -56.52 -24.92 49.88 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -73.02 -30.95 64.14 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.825 -1.172 . . . . 0.0 112.52 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.11 -1.25 25.49 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.214 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.51 155.61 39.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.152 1.476 . . . . 0.0 112.417 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . 0.439 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -156.47 166.06 34.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.316 174.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.543 HG22 ' CD1' ' D' ' 50' ' ' LEU . 3.0 p -125.44 -179.92 4.83 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.81 -167.33 39.49 Favored Glycine 0 N--CA 1.469 0.878 0 O-C-N 119.46 -2.025 . . . . 0.0 113.755 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.5 p -137.92 132.31 32.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.101 0.953 . . . . 0.0 112.133 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -112.2 136.13 51.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 mt -125.78 129.53 72.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 70.4 m -104.74 143.33 33.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.736 -173.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.88 21.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -141.48 145.67 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.359 1.063 . . . . 0.0 112.504 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.05 167.99 26.67 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.111 -0.993 . . . . 0.0 110.896 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -30.98 63.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.9 69.7 29.45 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.448 1.899 . . . . 0.0 113.966 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.53 71.5 2.49 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.324 3.349 . . . . 0.0 114.266 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.17 14.49 Favored Glycine 0 N--CA 1.477 1.389 0 O-C-N 120.734 -1.229 . . . . 0.0 114.595 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.03 28.02 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.721 1.208 . . . . 0.0 112.626 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.69 130.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.946 0.879 . . . . 0.0 110.686 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.09 169.98 16.59 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.683 1.593 . . . . 0.0 109.753 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.3 tp -57.17 115.37 2.62 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.249 3.02 . . . . 0.0 111.151 174.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -100.93 119.48 58.08 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -56.12 141.17 87.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.365 2.044 . . . . 0.0 111.647 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -125.38 157.15 37.5 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.738 0.815 . . . . 0.0 111.777 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' D' ' 30' ' ' THR . 12.5 tp -163.67 149.04 10.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.538 1.535 . . . . 0.0 112.356 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -148.25 15.26 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 120.298 1.408 . . . . 0.0 110.729 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mt -146.42 139.49 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.179 0.992 . . . . 0.0 110.317 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.91 136.83 54.59 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.224 -0.922 . . . . 0.0 111.549 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -68.58 150.38 48.08 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.659 -1.276 . . . . 0.0 111.782 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -147.26 24.66 1.13 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 111.751 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 15.5 mmt-85 -93.12 -58.19 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.085 1.754 . . . . 0.0 111.448 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 179.89 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -63.68 -55.28 24.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.246 1.018 . . . . 0.0 111.431 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.07 67.83 15.5 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.516 0.726 . . . . 0.0 112.447 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.23 -173.59 1.65 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.166 2.577 . . . . 0.0 115.5 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.273 3.9 t -96.88 161.56 13.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 123.038 1.399 . . . . 0.0 112.997 174.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -151.46 167.99 26.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.352 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.84 147.53 13.1 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.994 2.358 . . . . 0.0 118.994 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.74 156.0 24.66 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.03 149.43 21.23 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.595 1.958 . . . . 0.0 109.594 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.62 117.73 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' A' ' 52' ' ' ILE . 19.6 t-20 -93.21 106.38 18.35 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.49 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.268 42.6 m95 -74.26 131.98 41.7 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -172.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -90.48 -39.47 12.59 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.83 -9.51 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.35 129.01 10.79 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.553 2.741 . . . . 0.0 105.374 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.28 118.82 12.65 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.07 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 4.7 m -177.03 159.99 1.73 Allowed 'General case' 0 C--O 1.244 0.779 0 C-N-CA 125.875 1.67 . . . . 0.0 110.34 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 3.0 t -140.64 141.29 35.1 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.065 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.413 HG21 HD12 ' D' ' 99' ' ' LEU . 1.8 m -140.5 126.26 19.27 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.834 -2.894 . . . . 0.0 108.845 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.12 151.5 5.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.808 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 142.28 51.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.84 116.42 5.83 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.2 168.98 39.56 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 118.605 -1.76 . . . . 0.0 116.388 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' D' ' 63' ' ' THR . 28.8 tt0 -101.89 148.31 25.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.782 0.801 . . . . 0.0 111.521 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' HG ' ' D' ' 4' ' ' CYS . 49.1 t -95.21 131.72 40.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.716 174.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.589 ' HB2' HD12 ' A' ' 106' ' ' ILE . 24.8 m-85 -117.59 159.93 22.09 Favored 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 123.685 0.794 . . . . 0.0 112.867 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -124.13 110.37 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.68 158.19 8.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.958 1.303 . . . . 0.0 109.678 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -47.52 -34.27 7.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -72.96 -18.23 61.4 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 36.4 4.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.705 1.145 . . . . 0.0 112.802 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.497 ' HB3' ' NZ ' ' D' ' 90' ' ' LYS . 8.4 mtpm? -109.14 157.14 19.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.727 1.211 . . . . 0.0 110.189 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -109.21 153.55 23.64 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 119.919 -1.738 . . . . 0.0 111.511 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.5 t -153.18 154.57 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.177 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 mt -118.9 106.44 12.48 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 172.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.1 mptt -97.7 125.94 42.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 172.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -138.78 162.91 33.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.75 1.262 . . . . 0.0 112.419 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 18.4 mtp -121.17 160.72 23.2 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -133.92 162.27 32.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.066 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -137.78 126.76 24.17 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.536 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . 0.413 HD12 HG21 ' D' ' 77' ' ' THR . 0.2 OUTLIER -107.24 142.06 37.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 125.074 1.484 . . . . 0.0 109.827 -177.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.82 117.85 20.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 111.801 -2.454 . . . . 0.0 111.729 -173.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -84.49 171.12 12.82 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 23.4 m -109.09 71.91 0.79 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.79 171.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.838 1.255 . . . . 0.0 109.613 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.64 -4.26 12.81 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.8 150.97 46.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.739 1.257 . . . . 0.0 110.807 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.4 tt -68.33 -21.5 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 114.378 -1.283 . . . . 0.0 113.183 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.38 3.99 44.38 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.943 0.783 . . . . 0.0 114.294 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.31 1.22 7.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.037 0.935 . . . . 0.0 113.423 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.5 -34.59 71.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 113.034 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -48.21 -39.48 21.23 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -96.78 -12.93 23.02 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.967 1.307 . . . . 0.0 114.189 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.29 -4.62 37.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 6.7 m -108.8 145.42 35.24 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.621 0.724 . . . . 0.0 109.369 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -141.2 151.7 44.0 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.936 1.694 . . . . 0.0 108.854 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.17 153.73 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 109.715 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.78 -176.24 32.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.687 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 18.4 p90 -132.51 160.01 37.76 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.162 -0.61 . . . . 0.0 111.881 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . 0.634 HD21 HD22 ' D' ' 14' ' ' LEU . 4.7 m120 -150.33 157.2 42.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.73 1.252 . . . . 0.0 109.866 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . 0.404 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.0 mt -133.02 130.33 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.66 152.52 41.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.19 0.931 . . . . 0.0 109.417 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 45.2 p -140.66 167.38 22.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -57.4 125.58 23.48 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.326 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.52 128.03 34.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 68.99 102.98 0.06 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.784 2.434 . . . . 0.0 114.266 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.69 -69.77 0.25 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.69 2.396 . . . . 0.0 106.906 174.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 116.64 -77.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 1 C-N-CA 132.106 4.162 . . . . 0.0 113.117 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -145.71 147.75 32.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.595 3.558 . . . . 0.0 103.271 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . 0.347 2.6 pt-20 . . . . . 0 CA--C 1.554 1.128 0 O-C-N 126.02 2.075 . . . . 0.0 113.227 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' B' ' -3' ' ' GLN . 2.6 tp-100 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 37.8 m -73.12 111.96 8.72 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.706 0.684 . . . . 0.0 110.423 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 21.2 t 73.03 86.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.946 2.098 . . . . 0.0 113.45 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.04 61.88 1.52 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.888 1.675 . . . . 0.0 110.268 174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -131.81 16.24 4.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.578 1.551 . . . . 0.0 113.363 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -157.2 155.97 31.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.851 2.061 . . . . 0.0 108.654 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.402 ' HG ' ' CB ' ' B' ' 83' ' ' CYS . 28.8 p -137.97 140.94 40.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.107 1.763 . . . . 0.0 107.479 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -139.86 131.17 26.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 119.839 -1.788 . . . . 0.0 113.463 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.56 -26.11 68.41 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -52.14 118.09 3.25 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.704 1.716 . . . . 0.0 112.433 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.44 -118.0 2.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.507 2.004 . . . . 0.0 110.306 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -144.75 148.52 34.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.502 1.121 . . . . 0.0 113.621 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -144.87 159.05 43.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.177 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -136.65 148.41 47.41 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -105.81 143.55 33.8 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.812 1.245 . . . . 0.0 112.215 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.89 -22.33 62.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.731 1.212 . . . . 0.0 112.918 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.62 HD22 HD21 ' B' ' 118' ' ' ASN . 50.2 tp -76.68 -14.5 59.96 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.838 1.255 . . . . 0.0 112.497 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 -12.83 34.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 126.707 2.099 . . . . 0.0 113.769 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 153.77 28.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.105 1.431 . . . . 0.0 112.554 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.45 147.56 50.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.628 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -142.03 146.87 36.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m -128.55 135.36 49.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.064 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.7 124.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.19 -86.41 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 O-C-N 124.362 1.039 . . . . 0.0 111.502 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.83 152.59 42.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 122.068 0.937 . . . . 0.0 112.11 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -99.84 125.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 113.124 -1.853 . . . . 0.0 108.288 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -71.38 162.83 28.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 110.94 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -55.09 -23.52 21.03 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -74.83 -31.82 61.78 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.849 -1.157 . . . . 0.0 113.304 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.78 -5.47 27.61 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.874 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.495 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 0.0 OUTLIER -67.03 142.77 57.08 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.15 156.73 31.41 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.413 HG22 HD13 ' B' ' 50' ' ' LEU . 1.3 p -125.01 168.87 12.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.556 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.35 -167.1 35.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 122.461 1.034 . . . . 0.0 113.778 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.521 ' HB ' HD11 ' B' ' 46' ' ' LEU . 12.3 p -138.56 132.33 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.606 -1.297 . . . . 0.0 111.15 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.11 136.36 50.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.222 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.9 mt -126.8 129.37 71.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . 0.252 63.7 m -104.67 143.2 33.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.925 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.44 -8.46 21.09 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 m -140.35 145.74 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.267 1.027 . . . . 0.0 112.601 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.94 167.78 27.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.216 -0.928 . . . . 0.0 111.0 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.94 -31.52 64.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -140.75 69.83 30.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 126.562 1.945 . . . . 0.0 113.902 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 71.36 2.48 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 124.426 3.417 . . . . 0.0 114.259 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.0 2.17 14.68 Favored Glycine 0 N--CA 1.476 1.366 0 O-C-N 120.753 -1.217 . . . . 0.0 114.571 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.11 27.9 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.594 1.157 . . . . 0.0 112.561 -174.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 86.4 mt -50.45 130.59 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.816 0.817 . . . . 0.0 110.658 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.59 170.42 15.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.636 1.574 . . . . 0.0 109.833 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.8 tp -57.61 115.4 2.75 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.133 2.973 . . . . 0.0 111.068 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m -100.9 119.97 56.79 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.06 142.53 85.68 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.622 2.215 . . . . 0.0 111.853 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.98 153.07 47.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.741 0.816 . . . . 0.0 111.725 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.413 HD13 HG22 ' B' ' 30' ' ' THR . 1.1 tp -160.64 148.77 16.24 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.426 1.49 . . . . 0.0 110.348 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.42 -152.38 23.12 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 120.857 1.662 . . . . 0.0 110.158 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -143.0 139.59 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.319 0.648 . . . . 0.0 111.358 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.78 136.36 53.05 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.508 -0.745 . . . . 0.0 112.081 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -69.25 150.93 46.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.988 0.899 . . . . 0.0 111.358 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -147.26 18.96 1.22 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.056 1.342 . . . . 0.0 111.865 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 mmt-85 -87.84 -58.19 2.66 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.315 1.846 . . . . 0.0 111.467 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 178.5 4.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.6 t -64.42 -53.37 49.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.602 1.161 . . . . 0.0 111.85 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -143.95 66.51 14.86 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.785 0.834 . . . . 0.0 113.057 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.83 -174.23 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.912 2.408 . . . . 0.0 115.316 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.262 4.2 t -96.35 161.27 14.0 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.689 173.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -151.49 168.48 24.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.207 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.41 147.16 12.27 Favored Glycine 0 CA--C 1.539 1.58 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -160.05 157.63 29.01 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -93.45 150.11 20.7 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.516 1.926 . . . . 0.0 109.575 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.51 117.12 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.51 ' HB2' HG21 ' C' ' 52' ' ' ILE . 20.1 t-20 -92.41 105.58 17.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.613 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.267 42.9 m95 -74.12 130.79 40.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -89.32 -40.34 12.85 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -91.9 -9.56 42.77 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -152.37 128.08 10.16 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.52 2.728 . . . . 0.0 105.326 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -69.08 118.88 12.54 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.823 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -177.08 159.95 1.71 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.958 1.703 . . . . 0.0 110.317 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -141.11 141.54 34.18 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -140.87 126.93 19.47 Favored 'General case' 0 N--CA 1.407 -2.625 0 CA-C-N 110.593 -3.003 . . . . 0.0 108.657 -172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.55 151.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.842 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -124.56 142.72 51.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.41 116.92 5.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.84 168.96 39.94 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 118.816 -1.659 . . . . 0.0 116.546 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' B' ' 63' ' ' THR . 28.8 tt0 -101.81 148.4 25.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.76 0.79 . . . . 0.0 111.356 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.402 ' CB ' ' HG ' ' B' ' 4' ' ' CYS . 49.8 t -95.2 133.04 39.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.133 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' C' ' 106' ' ' ILE . 18.1 m-85 -118.41 158.17 25.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 mt -121.97 108.43 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.14 158.62 8.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.126 0.97 . . . . 0.0 110.466 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -46.95 -32.15 3.65 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.05 -12.22 59.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.65 51.32 3.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.8 156.74 30.05 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 129.658 3.183 . . . . 0.0 108.548 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -118.02 155.31 30.53 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 119.948 -1.72 . . . . 0.0 111.465 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.493 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.4 t -155.54 155.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -120.12 107.07 12.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' B' ' 92' ' ' VAL . 1.0 OUTLIER -98.29 126.14 43.66 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 3.3 p -139.32 163.08 33.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.688 1.233 . . . . 0.0 112.551 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 19.7 mtp -120.79 160.68 22.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.82 162.63 31.48 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.133 -1.849 . . . . 0.0 113.175 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.73 126.38 23.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.568 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.24 141.0 39.23 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 125.05 1.468 . . . . 0.0 109.84 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 111.728 -2.487 . . . . 0.0 111.669 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -84.93 171.81 11.86 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 32.6 m -110.08 71.73 0.77 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.72 170.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.333 1.453 . . . . 0.0 110.012 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.39 -4.52 13.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.05 151.85 47.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.662 1.22 . . . . 0.0 111.067 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.7 tt -68.52 -22.29 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.072 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.73 4.53 36.19 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.753 0.692 . . . . 0.0 114.391 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.65 1.38 7.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.65 -34.38 71.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.294 1.038 . . . . 0.0 113.284 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -48.34 -39.51 22.3 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -96.44 -13.35 23.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.902 1.281 . . . . 0.0 114.125 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.06 -5.77 43.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.7 m -107.54 145.03 33.71 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 121.822 0.82 . . . . 0.0 109.279 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -140.61 151.31 44.56 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 125.966 1.706 . . . . 0.0 108.751 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.88 154.21 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 119.582 1.083 . . . . 0.0 109.656 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.84 -176.14 32.62 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.093 0.854 . . . . 0.0 111.739 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 17.9 p90 -132.73 160.08 37.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.137 -0.625 . . . . 0.0 112.087 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . 0.62 HD21 HD22 ' B' ' 14' ' ' LEU . 5.3 m120 -150.43 157.07 42.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.665 1.221 . . . . 0.0 110.02 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.65 130.0 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.9 153.36 39.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 124.285 0.991 . . . . 0.0 109.408 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 58.4 p -141.74 165.67 26.85 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -58.16 121.79 11.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.803 1.241 . . . . 0.0 111.872 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.29 149.63 47.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 38.0 15.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 9.7 t -59.59 171.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.454 0.702 . . . . 0.0 112.12 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.78 146.26 40.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.924 1.29 . . . . 0.0 107.827 174.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.42 -176.22 0.12 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.492 3.517 . . . . 0.0 109.147 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 O-C-N 125.814 1.946 . . . . 0.0 112.489 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 119.566 -0.254 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.8 p -139.05 -64.95 0.49 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.072 2.149 . . . . 0.0 109.583 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 13.4 m -138.23 21.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.917 1.687 . . . . 0.0 112.063 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 59.48 -81.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.795 2.438 . . . . 0.0 112.827 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.31 64.15 0.33 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.181 2.992 . . . . 0.0 108.5 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -157.17 155.93 31.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.218 1.007 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 p -133.72 143.63 48.61 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -140.04 129.22 23.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 119.581 -1.949 . . . . 0.0 114.248 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.07 -27.32 69.31 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -52.11 114.49 1.34 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 123.035 1.398 . . . . 0.0 111.915 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.96 -109.44 0.74 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.669 1.604 . . . . 0.0 110.979 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -152.0 144.26 23.98 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -140.87 160.48 39.97 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.256 1.022 . . . . 0.0 110.699 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -134.21 148.0 50.81 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -109.3 143.62 38.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.945 0.898 . . . . 0.0 111.859 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -59.6 -25.72 64.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.628 1.171 . . . . 0.0 112.969 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.64 HD22 HD21 ' C' ' 118' ' ' ASN . 48.9 tp -73.58 -14.2 61.15 Favored 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.838 -1.164 . . . . 0.0 112.357 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.28 -12.19 36.79 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.82 2.152 . . . . 0.0 113.685 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.86 155.01 28.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 123.393 1.568 . . . . 0.0 112.427 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.39 146.3 51.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.015 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -142.31 144.18 33.12 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.035 0.922 . . . . 0.0 113.348 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -127.52 134.11 49.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.246 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 95.9 mt -132.64 124.39 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.46 -85.71 0.1 Allowed Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.241 0.963 . . . . 0.0 111.701 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.6 152.33 39.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.846 -0.796 . . . . 0.0 112.283 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.98 126.23 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 113.474 -1.694 . . . . 0.0 108.652 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -71.29 163.23 28.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.541 0.686 . . . . 0.0 111.78 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -56.78 -24.82 53.15 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -73.04 -31.26 64.32 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.736 -1.228 . . . . 0.0 112.524 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.79 -2.26 24.51 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.257 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.44 155.47 40.08 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.016 1.408 . . . . 0.0 112.459 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . 0.448 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -156.89 166.08 34.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.43 174.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.539 HG22 ' CD1' ' C' ' 50' ' ' LEU . 3.0 p -125.66 -179.34 4.61 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 173.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.0 -166.91 39.22 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 119.208 -2.182 . . . . 0.0 113.222 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' C' ' 46' ' ' LEU . 12.4 p -137.13 131.94 33.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.797 0.808 . . . . 0.0 112.199 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -111.39 137.78 48.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.8 129.85 70.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.254 64.9 m -104.8 144.07 32.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.462 -173.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.97 -6.26 21.42 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -141.68 144.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 112.57 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.59 168.03 26.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 110.966 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -31.29 63.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 172.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -140.41 69.94 32.69 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 126.626 1.97 . . . . 0.0 113.977 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.53 71.56 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 124.405 3.403 . . . . 0.0 114.195 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.05 1.94 14.64 Favored Glycine 0 N--CA 1.477 1.409 0 O-C-N 120.686 -1.259 . . . . 0.0 114.616 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.91 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.583 1.153 . . . . 0.0 112.554 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -50.56 130.86 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.898 0.856 . . . . 0.0 110.612 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.15 169.93 16.68 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.773 1.629 . . . . 0.0 109.803 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -56.8 115.44 2.58 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 129.264 3.025 . . . . 0.0 111.153 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 57.0 m -100.98 119.47 58.04 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.88 141.75 85.13 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.174 1.916 . . . . 0.0 111.526 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.47 157.02 39.75 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.664 0.786 . . . . 0.0 111.805 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' C' ' 30' ' ' THR . 12.6 tp -164.19 148.98 10.09 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.521 1.528 . . . . 0.0 112.455 -176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.09 -147.97 14.74 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 120.357 1.435 . . . . 0.0 110.699 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mt -146.84 139.47 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 110.162 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.66 136.66 54.61 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 121.188 -0.945 . . . . 0.0 111.428 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -68.36 150.6 47.99 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 120.626 -1.296 . . . . 0.0 111.64 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -146.86 25.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.011 1.324 . . . . 0.0 111.717 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 mmt-85 -93.42 -58.2 2.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.173 1.789 . . . . 0.0 111.705 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.25 179.65 4.39 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.594 1.184 . . . . 0.0 113.992 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 37.5 t -63.71 -57.9 8.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.725 0.81 . . . . 0.0 110.795 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.75 66.64 27.63 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.606 0.763 . . . . 0.0 112.065 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -173.31 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.29 2.66 . . . . 0.0 115.245 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.276 4.0 t -96.54 161.51 13.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 123.055 1.407 . . . . 0.0 113.011 174.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -151.75 167.57 27.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.469 -173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.5 147.79 13.71 Favored Glycine 0 CA--C 1.542 1.771 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.68 156.54 25.64 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -93.57 150.05 20.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.546 1.938 . . . . 0.0 109.618 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.03 117.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.542 ' HB2' HG21 ' B' ' 52' ' ' ILE . 19.6 t-20 -92.74 107.14 18.99 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.347 -0.846 . . . . 0.0 110.42 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.268 43.1 m95 -75.3 131.8 40.56 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -89.95 -40.53 12.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -92.21 -9.23 43.0 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -152.37 127.79 9.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.605 2.762 . . . . 0.0 105.172 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.37 118.84 12.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.734 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 5.2 m -177.2 160.2 1.7 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 126.127 1.771 . . . . 0.0 110.424 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -140.98 141.57 34.38 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.054 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.408 HG23 ' HA ' ' C' ' 99' ' ' LEU . 1.8 m -140.43 127.32 20.63 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 110.642 -2.981 . . . . 0.0 108.824 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.13 151.19 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.69 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.8 142.42 51.12 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.5 117.16 5.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -173.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.28 169.0 39.61 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.257 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' C' ' 63' ' ' THR . 28.8 tt0 -101.75 148.66 25.01 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 111.354 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.48 132.67 41.8 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.107 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.583 ' HB2' HD12 ' B' ' 106' ' ' ILE . 19.1 m-85 -117.95 160.28 21.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.01 110.18 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 172.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.79 156.96 10.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 109.912 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -46.76 -34.9 5.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.62 -15.95 61.24 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.62 35.62 5.6 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.365 1.459 . . . . 0.0 113.232 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -104.47 163.04 12.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.16 1.384 . . . . 0.0 107.854 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -118.49 152.57 35.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.997 1.719 . . . . 0.0 111.182 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.481 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.5 t -153.34 156.04 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.229 1.411 . . . . 0.0 111.168 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 mt -119.91 108.67 14.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.481 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.0 OUTLIER -99.6 126.07 45.53 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 172.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -139.34 162.55 34.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.667 1.223 . . . . 0.0 112.677 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 18.9 mtp -120.3 160.98 21.91 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -133.86 162.76 31.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.995 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 tp -137.81 126.73 24.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.467 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . 0.408 ' HA ' HG23 ' C' ' 77' ' ' THR . 0.3 OUTLIER -107.21 141.22 38.84 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 124.881 1.363 . . . . 0.0 109.944 -177.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.42 118.92 22.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 111.615 -2.539 . . . . 0.0 111.771 -173.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 96.2 p -85.96 171.68 11.26 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -110.34 71.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.5 171.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.081 1.352 . . . . 0.0 109.529 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -114.07 -5.68 13.1 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.54 151.49 47.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.703 1.24 . . . . 0.0 110.98 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.3 tt -67.79 -22.11 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.932 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.5 3.84 38.84 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.85 -0.972 . . . . 0.0 114.33 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -125.58 1.27 7.57 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.289 1.036 . . . . 0.0 113.747 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.66 -34.39 71.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.148 0.979 . . . . 0.0 112.973 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.54 -39.0 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -96.95 -12.62 23.16 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.028 1.331 . . . . 0.0 114.237 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.57 -4.61 38.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 6.8 m -108.65 144.99 35.67 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 122.305 1.05 . . . . 0.0 109.672 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -141.31 151.68 43.81 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.547 1.539 . . . . 0.0 108.262 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.23 153.41 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.87 -175.88 32.37 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 123.998 0.808 . . . . 0.0 111.807 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 18.4 p90 -133.09 160.52 36.96 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.086 -0.656 . . . . 0.0 112.26 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . 0.64 HD21 HD22 ' C' ' 14' ' ' LEU . 4.9 m120 -150.65 157.56 43.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.719 1.247 . . . . 0.0 110.276 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . 0.413 HD13 ' HE3' ' C' ' 94' ' ' LYS . 8.8 mt -133.13 130.87 58.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -124.32 150.93 44.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -139.59 167.59 21.76 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.399 -0.813 . . . . 0.0 109.061 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -57.59 117.33 4.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.222 1.009 . . . . 0.0 111.572 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -77.97 114.34 16.74 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 81.68 81.52 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.647 2.379 . . . . 0.0 113.743 174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t -154.88 142.34 19.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 109.114 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -154.63 132.0 11.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.883 2.073 . . . . 0.0 107.42 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -142.81 14.18 1.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 . . . . . 0 C--O 1.255 1.37 0 C-N-CA 129.384 3.073 . . . . 0.0 110.558 -173.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 117.748 -1.12 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 11.8 t -80.75 39.41 0.48 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.447 1.476 . . . . 0.0 114.932 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.24 30.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 126.071 1.749 . . . . 0.0 109.809 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 61.77 -165.8 0.22 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.744 1.618 . . . . 0.0 113.594 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -145.05 106.9 4.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.263 2.225 . . . . 0.0 108.267 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.66 113.5 3.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.746 1.618 . . . . 0.0 110.076 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 t -116.33 123.44 47.64 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -141.11 134.78 30.16 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.892 -1.13 . . . . 0.0 112.232 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.65 -18.09 61.07 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -56.15 115.89 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.606 1.162 . . . . 0.0 111.317 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.91 -122.23 3.29 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.926 1.727 . . . . 0.0 111.269 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.45 143.6 26.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -140.35 162.68 34.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.28 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -137.77 146.31 43.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.359 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 14' ' ' LEU . 6.3 t30 -108.0 145.31 34.09 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.948 0.899 . . . . 0.0 110.581 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.81 -29.45 54.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.963 1.305 . . . . 0.0 114.248 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' H ' HD22 ' A' ' 12' ' ' ASN . 30.3 tp -70.99 -13.83 62.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.975 1.71 . . . . 0.0 113.402 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.38 22.95 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.31 2.386 . . . . 0.0 113.868 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.07 156.04 34.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.042 1.421 . . . . 0.0 113.578 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.29 136.14 51.54 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.407 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -130.1 143.26 50.69 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.393 -0.817 . . . . 0.0 112.09 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 m -132.07 133.08 43.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.514 0.726 . . . . 0.0 109.589 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.91 121.75 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -58.19 9.12 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.311 1.007 . . . . 0.0 112.425 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.32 153.27 3.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.164 1.386 . . . . 0.0 110.557 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.48 130.96 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 124.582 1.176 . . . . 0.0 111.293 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -75.1 168.85 19.18 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 m -55.62 -27.95 52.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -81.77 -35.77 29.24 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.059 0.845 . . . . 0.0 110.422 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.54 -6.02 9.2 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-O 117.151 -1.916 . . . . 0.0 114.489 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB2' HD21 ' D' ' 50' ' ' LEU . 1.4 pt-20 -67.9 141.81 56.26 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 119.7 1.75 . . . . 0.0 108.101 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.24 151.0 22.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.85 165.32 11.94 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.42 -165.45 32.09 Favored Glycine 0 C--O 1.237 0.322 0 O-C-N 120.683 -1.261 . . . . 0.0 111.707 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.1 p -141.36 143.35 33.94 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 122.227 1.013 . . . . 0.0 112.983 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -118.65 123.9 46.08 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.246 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 46' ' ' LEU . 2.8 mp -115.15 126.68 72.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.3 m -105.65 150.51 25.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.3 -11.88 14.82 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.39 146.98 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.363 1.465 . . . . 0.0 112.091 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.17 42.18 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.292 -1.505 . . . . 0.0 113.265 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -71.57 -21.54 61.87 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.693 0.397 . . . . 0.0 110.598 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -148.47 83.46 7.03 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.828 2.451 . . . . 0.0 109.944 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 28.33 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.545 3.497 . . . . 0.0 115.834 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.12 -5.67 49.17 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 0.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.003 -1.475 . . . . 0.0 114.165 -174.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -20.57 114.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.865 1.666 . . . . 0.0 115.451 -173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 168.18 18.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.351 2.26 . . . . 0.0 107.923 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 34' ' ' ILE . 6.8 tt -53.69 138.25 35.53 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.148 1.379 . . . . 0.0 112.856 174.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -115.55 121.56 34.32 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.22 144.82 89.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.435 2.757 . . . . 0.0 111.622 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.49 154.86 48.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 111.378 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.81 148.56 20.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.237 1.815 . . . . 0.0 109.916 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.25 -153.4 23.88 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 121.748 2.067 . . . . 0.0 111.775 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.9 mt -142.17 142.4 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.04 143.98 51.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.35 0.66 . . . . 0.0 111.816 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -79.35 151.43 31.0 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.603 1.192 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -145.94 25.46 1.28 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.43 1.492 . . . . 0.0 111.744 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -93.52 -50.22 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.219 2.208 . . . . 0.0 112.107 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.95 178.19 7.66 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.797 0.808 . . . . 0.0 112.81 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 p -77.82 -41.77 35.98 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.832 1.653 . . . . 0.0 113.676 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -131.66 56.46 24.26 Favored Pre-proline 0 CA--C 1.554 1.103 0 C-N-CA 125.367 1.467 . . . . 0.0 112.174 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.06 172.06 12.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.975 1.783 . . . . 0.0 115.71 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -94.51 174.08 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.229 173.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -166.69 165.34 16.54 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.252 -1.794 . . . . 0.0 113.592 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.68 148.32 13.67 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 118.589 2.195 . . . . 0.0 118.589 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -164.13 154.98 15.47 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 152.4 22.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.906 1.683 . . . . 0.0 110.326 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -133.23 116.91 26.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' D' ' 52' ' ' ILE . 29.3 t30 -99.49 110.13 22.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 110.874 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -76.95 136.81 38.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -38.34 12.54 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.545 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -86.54 -15.67 39.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -152.55 122.23 6.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.195 1.798 . . . . 0.0 107.145 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.65 118.48 5.71 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.175 1.352 . . . . 0.0 110.114 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.9 p -175.18 168.34 3.39 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.04 1.736 . . . . 0.0 110.616 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -147.78 145.33 28.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.254 1.502 . . . . 0.0 111.326 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -137.02 130.35 31.27 Favored 'General case' 0 N--CA 1.407 -2.621 0 CA-C-N 110.03 -3.259 . . . . 0.0 108.515 -173.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.35 140.79 31.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 O-C-N 123.874 0.734 . . . . 0.0 109.573 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -115.09 147.43 40.21 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.422 0.452 . . . . 0.0 110.561 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 118.25 10.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.39 -172.71 31.21 Favored Glycine 0 CA--C 1.502 -0.768 0 C-N-CA 119.493 -1.336 . . . . 0.0 115.749 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -123.3 149.9 44.24 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 125.101 1.118 . . . . 0.0 113.103 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.49 112.86 24.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.576 -2.556 . . . . 0.0 106.31 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' D' ' 106' ' ' ILE . 10.5 m-85 -108.41 155.97 19.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 118.893 0.77 . . . . 0.0 112.625 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -128.9 113.04 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.79 161.65 4.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.812 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -41.63 -48.29 4.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.553 1.541 . . . . 0.0 113.599 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.36 -29.97 70.26 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.23 24.53 5.38 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.124 1.345 . . . . 0.0 114.142 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -92.92 160.5 14.87 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.647 1.223 . . . . 0.0 108.128 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.01 147.67 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.363 1.465 . . . . 0.0 111.405 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' D' ' 106' ' ' ILE . 2.3 t -148.27 159.62 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.104 1.362 . . . . 0.0 110.088 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.1 mt -122.47 106.43 11.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CD ' HG11 ' A' ' 92' ' ' VAL . 3.9 mmtt -98.87 123.99 43.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -139.34 168.4 19.91 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.54 1.638 . . . . 0.0 113.652 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.555 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -118.71 163.15 17.26 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -136.9 162.23 33.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.632 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.758 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -145.52 120.82 10.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.78 -1.554 . . . . 0.0 111.676 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.74 137.57 45.52 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 125.152 1.532 . . . . 0.0 112.897 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -118.95 113.85 21.65 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 111.121 -2.763 . . . . 0.0 110.88 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.282 49.2 m -73.6 168.09 20.01 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.364 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 p -110.4 85.88 2.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.09 -164.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -131.49 -26.07 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.574 -1.329 . . . . 0.0 114.042 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.35 148.89 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.81 1.767 . . . . 0.0 111.916 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' D' ' 84' ' ' PHE . 19.5 tt -63.2 -22.49 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.343 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.86 2.69 54.04 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 117.969 -1.462 . . . . 0.0 113.634 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -120.36 1.9 10.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 112' ' ' ALA . 9.8 t70 -59.72 -27.84 66.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.606 -1.934 . . . . 0.0 112.395 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 43.7 p-90 -46.08 -49.49 16.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.302 1.041 . . . . 0.0 113.042 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -89.29 -11.42 43.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.93 0.892 . . . . 0.0 112.703 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -76.34 -3.03 34.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.237 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.758 ' CG2' HD21 ' A' ' 98' ' ' LEU . 1.9 m -107.72 138.46 43.92 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.746 0.819 . . . . 0.0 112.585 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' HH11 ' A' ' 114' ' ' ARG . 18.4 mtt85 -141.35 130.37 23.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 110.821 175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.45 158.25 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.933 1.242 . . . . 0.0 111.308 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.63 -177.51 36.54 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 14.7 p90 -126.69 155.56 42.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.913 -0.757 . . . . 0.0 111.858 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -148.13 155.73 41.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.539 1.161 . . . . 0.0 110.915 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 10.1 mt -139.32 120.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.06 153.92 27.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.466 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -142.14 165.99 25.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 123.5 14.84 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -71.17 112.12 7.06 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.287 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 66.56 87.46 0.12 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.019 1.728 . . . . 0.0 113.612 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t -138.68 40.25 2.19 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.317 1.447 . . . . 0.0 112.064 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 53.58 -161.4 0.12 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.816 1.246 . . . . 0.0 112.785 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -157.35 -9.92 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 127.628 2.371 . . . . 0.0 114.504 -174.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 127' ' ' LYS . 3.0 tt0 . . . . . 0 C--O 1.246 0.901 1 C-N-CA 134.004 4.921 . . . . 0.0 104.617 -173.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 117.952 -1.023 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 11.1 p -149.39 -83.49 0.1 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.071 1.348 . . . . 0.0 108.903 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.19 166.83 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.743 2.017 . . . . 0.0 108.751 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -121.19 178.63 4.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.936 1.294 . . . . 0.0 110.756 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -122.03 94.95 4.46 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.985 -1.072 . . . . 0.0 111.183 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 115.03 3.56 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.199 1.8 . . . . 0.0 108.422 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.25 123.49 47.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -143.02 136.26 28.23 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.41 -17.87 61.21 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -55.86 118.81 4.93 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.434 1.111 . . . . 0.0 111.704 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.2 -114.83 1.72 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 125.612 1.577 . . . . 0.0 111.239 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.83 141.37 21.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -139.18 162.8 34.08 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.559 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 12.4 t -142.52 147.92 36.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.92 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.52 HD22 ' H ' ' D' ' 14' ' ' LEU . 5.5 t30 -108.15 145.66 33.84 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.897 0.879 . . . . 0.0 110.487 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.63 -27.02 57.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.819 1.248 . . . . 0.0 113.9 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.52 ' H ' HD22 ' D' ' 12' ' ' ASN . 30.5 tp -71.41 -14.62 62.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.753 1.621 . . . . 0.0 113.384 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.14 -13.45 21.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.309 2.385 . . . . 0.0 113.975 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.39 154.55 41.08 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.094 1.447 . . . . 0.0 112.619 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.65 135.13 51.82 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.309 0.644 . . . . 0.0 110.764 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -128.77 144.42 51.16 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.472 -0.768 . . . . 0.0 111.987 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -133.77 131.48 39.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.964 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.81 122.3 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.64 -60.52 6.12 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 124.542 1.151 . . . . 0.0 112.24 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.1 156.08 8.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.538 1.135 . . . . 0.0 110.872 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.23 129.84 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.481 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -75.35 168.21 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.082 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -56.43 -26.8 54.72 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -80.16 -32.76 38.78 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.095 0.861 . . . . 0.0 110.606 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 -6.15 10.3 Favored Glycine 0 C--O 1.221 -0.703 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.486 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.59 149.77 46.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.218 1.407 . . . . 0.0 113.265 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . 0.484 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.0 p90 -160.17 165.56 31.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.57 0.748 . . . . 0.0 110.769 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -125.76 161.96 26.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -172.06 -165.26 28.93 Favored Glycine 0 N--CA 1.464 0.552 0 O-C-N 119.983 -1.698 . . . . 0.0 111.96 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . . . . . . . . . 70.6 p -139.89 141.43 36.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.464 1.126 . . . . 0.0 113.337 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -119.52 122.43 41.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.094 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.689 HD11 HD12 ' D' ' 46' ' ' LEU . 2.8 mp -113.75 127.23 71.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 58.2 m -105.6 150.87 25.02 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.79 -12.31 14.62 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -140.49 146.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.312 1.445 . . . . 0.0 111.935 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.88 161.59 41.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.362 -1.462 . . . . 0.0 113.353 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -72.09 -21.48 61.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.717 0.407 . . . . 0.0 110.747 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.27 83.29 7.23 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 127.857 2.463 . . . . 0.0 109.915 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.76 28.0 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 124.489 3.459 . . . . 0.0 115.951 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.91 -5.65 47.83 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 1.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.136 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -21.53 115.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 168.3 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.401 2.28 . . . . 0.0 107.894 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.689 HD12 HD11 ' D' ' 34' ' ' ILE . 6.8 tt -54.01 139.03 35.75 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.325 1.45 . . . . 0.0 112.837 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -116.8 121.59 32.65 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.87 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.21 143.34 93.68 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.452 2.768 . . . . 0.0 111.474 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.452 ' C ' HD12 ' D' ' 49' ' ' LEU . 1.9 pp -132.63 161.68 33.29 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.998 0.919 . . . . 0.0 111.885 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 28' ' ' GLU . 12.0 tp -166.78 148.4 6.19 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.231 1.412 . . . . 0.0 112.011 -175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 -152.91 23.54 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 121.171 1.805 . . . . 0.0 111.804 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -142.56 142.65 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.672 0.789 . . . . 0.0 112.689 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 144.6 51.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.851 1.26 . . . . 0.0 111.183 174.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.56 149.49 29.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.942 0.877 . . . . 0.0 109.522 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -143.46 24.53 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.573 1.549 . . . . 0.0 111.648 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.48 -49.68 5.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.748 2.019 . . . . 0.0 111.536 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.23 178.45 8.06 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.087 0.867 . . . . 0.0 112.371 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 13.2 p -77.39 -42.27 36.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.603 1.961 . . . . 0.0 113.907 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -131.28 54.06 13.5 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.237 1.415 . . . . 0.0 112.05 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.25 173.59 9.35 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.571 2.181 . . . . 0.0 115.989 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.67 6.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.72 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -166.7 164.27 16.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.868 -1.515 . . . . 0.0 113.724 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.7 147.84 13.31 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 118.158 2.023 . . . . 0.0 118.158 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -164.05 154.03 14.7 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.7 152.7 21.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.209 1.804 . . . . 0.0 110.06 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 43.5 t -133.59 116.91 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.457 ' HB2' HG21 ' A' ' 52' ' ' ILE . 26.5 t30 -100.11 110.06 22.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.428 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -76.44 138.62 40.45 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -172.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -37.72 11.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.152 -1.386 . . . . 0.0 114.688 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -87.23 -15.7 37.43 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -152.54 121.68 6.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 126.553 1.941 . . . . 0.0 107.277 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -57.98 118.49 5.44 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.957 1.253 . . . . 0.0 110.179 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 66.1 p -174.75 169.34 3.55 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.992 1.717 . . . . 0.0 110.65 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -148.09 145.71 28.53 Favored 'General case' 0 CA--C 1.479 -1.766 0 CA-C-O 123.501 1.619 . . . . 0.0 111.081 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.0 OUTLIER -136.77 130.22 31.61 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 109.847 -3.342 . . . . 0.0 108.459 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.69 141.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -115.09 147.73 39.82 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 0.0 110.562 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.29 117.92 9.81 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.66 -171.9 29.44 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 119.398 -1.382 . . . . 0.0 115.566 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.559 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 0.4 OUTLIER -127.31 149.95 49.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.528 1.156 . . . . 0.0 113.309 -174.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.63 112.63 24.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.83 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' A' ' 106' ' ' ILE . 11.9 m-85 -111.22 153.09 26.34 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 119.458 1.026 . . . . 0.0 113.066 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.75 109.94 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 163.16 3.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.475 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -41.63 -42.3 2.46 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -12.67 60.03 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.57 44.71 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.086 1.327 . . . . 0.0 114.898 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -67.76 159.51 30.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.254 1.527 . . . . 0.0 110.705 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -120.11 145.49 46.85 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.858 1.663 . . . . 0.0 111.892 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 106' ' ' ILE . 2.2 t -147.31 158.29 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.751 1.22 . . . . 0.0 110.706 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -121.57 106.65 11.57 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 172.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.502 ' CD ' HG11 ' D' ' 92' ' ' VAL . 4.2 mmtt -99.34 123.98 44.06 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -139.35 168.22 20.31 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 123.577 1.656 . . . . 0.0 113.677 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.537 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.39 16.77 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 171.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -137.0 162.45 33.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.254 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -145.82 121.07 10.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.611 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.14 44.49 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 125.062 1.477 . . . . 0.0 112.917 -174.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.45 113.85 21.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 111.177 -2.738 . . . . 0.0 110.943 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.284 49.8 m -73.42 168.3 19.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.279 1.612 . . . . 0.0 111.337 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.9 86.02 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.07 -165.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -130.77 -26.28 2.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 149.23 40.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.859 1.79 . . . . 0.0 111.93 176.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 84' ' ' PHE . 19.1 tt -63.39 -22.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.213 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.92 4.06 54.72 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.99 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . 0.482 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 6.7 m-20 -120.99 2.67 10.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' D' ' 112' ' ' ALA . 8.9 t70 -60.34 -27.86 67.7 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.587 -1.946 . . . . 0.0 112.046 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.482 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.3 p-90 -45.69 -49.46 14.53 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.347 1.059 . . . . 0.0 113.107 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -89.61 -11.32 42.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.039 0.936 . . . . 0.0 112.558 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' D' ' 109' ' ' ASP . . . -76.61 -2.62 33.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.695 0.398 . . . . 0.0 111.437 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.763 ' CG2' HD21 ' D' ' 98' ' ' LEU . 1.8 m -107.9 138.59 43.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.638 0.775 . . . . 0.0 112.78 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . 0.502 HH11 ' HG3' ' D' ' 114' ' ' ARG . 18.8 mtt85 -141.43 130.18 22.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.856 1.262 . . . . 0.0 111.032 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.32 158.26 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.891 1.223 . . . . 0.0 111.331 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.15 -177.9 36.48 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 14.7 p90 -126.07 155.33 41.74 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.913 -0.757 . . . . 0.0 111.477 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -148.03 154.69 40.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.072 0.939 . . . . 0.0 110.45 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . 0.456 HD13 ' HE3' ' D' ' 94' ' ' LYS . 11.2 mt -137.31 120.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -111.84 153.26 26.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.348 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 17.0 p -138.38 164.86 28.25 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 121.4 7.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.071 0.948 . . . . 0.0 110.956 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . 0.611 HD23 ' N ' ' D' ' 124' ' ' ARG . 3.5 tt -85.96 109.33 18.69 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . 0.611 ' N ' HD23 ' D' ' 123' ' ' LEU . 0.1 OUTLIER 178.58 169.09 0.85 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.232 1.813 . . . . 0.0 108.694 173.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 9.3 t 43.68 -154.89 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.959 1.704 . . . . 0.0 113.788 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -151.64 140.81 21.28 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.415 1.886 . . . . 0.0 105.971 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . 0.483 0.0 OUTLIER 62.54 -45.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.766 2.826 . . . . 0.0 115.167 -173.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.481 1.08 1 C-N-CA 136.225 5.81 . . . . 0.0 108.751 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 119.12 -0.467 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 13.4 p -111.94 -67.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.973 0.806 . . . . 0.0 110.079 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.84 150.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.825 1.25 . . . . 0.0 109.531 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.77 -168.12 0.24 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.276 1.43 . . . . 0.0 112.799 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -131.81 83.55 2.1 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 110.233 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.23 111.88 2.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.7 1.6 . . . . 0.0 108.978 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.51 123.35 48.3 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -173.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -142.91 135.48 27.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.396 1.078 . . . . 0.0 113.528 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.48 -17.83 61.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -55.94 115.87 2.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.46 1.104 . . . . 0.0 111.407 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.34 -119.72 2.7 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.953 1.739 . . . . 0.0 110.887 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.21 143.79 27.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -142.13 162.78 34.6 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.249 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -142.1 146.84 35.84 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.976 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.52 HD22 ' H ' ' B' ' 14' ' ' LEU . 6.6 t30 -107.08 146.25 31.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.15 0.98 . . . . 0.0 110.386 -174.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.8 -27.77 52.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.862 1.265 . . . . 0.0 114.329 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.52 ' H ' HD22 ' B' ' 12' ' ' ASN . 30.0 tp -72.14 -14.58 61.86 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.759 1.624 . . . . 0.0 113.225 175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.03 -12.28 24.47 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.257 2.36 . . . . 0.0 114.077 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.53 153.58 41.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.154 1.477 . . . . 0.0 113.74 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.8 134.05 52.9 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 174.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -128.06 145.21 51.07 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.544 -0.722 . . . . 0.0 112.408 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -133.33 133.28 42.32 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.43 0.692 . . . . 0.0 109.673 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -132.87 122.18 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.65 -58.85 7.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.226 0.954 . . . . 0.0 112.378 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.64 153.55 4.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.121 1.368 . . . . 0.0 110.626 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.52 131.4 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 124.492 1.12 . . . . 0.0 111.371 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -75.52 168.79 19.34 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -55.61 -27.89 52.13 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -81.83 -35.55 29.3 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.059 0.845 . . . . 0.0 110.44 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 -6.33 9.27 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 117.22 -1.878 . . . . 0.0 114.663 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.514 ' HB2' HD21 ' C' ' 50' ' ' LEU . 1.4 pt-20 -67.07 141.57 57.45 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.48 1.64 . . . . 0.0 108.461 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.22 151.13 22.63 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -110.95 165.19 12.07 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.15 -164.93 31.14 Favored Glycine 0 C--O 1.237 0.33 0 O-C-N 120.547 -1.346 . . . . 0.0 111.568 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -141.45 142.76 33.64 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.287 1.041 . . . . 0.0 113.011 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -117.58 125.26 50.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.229 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.687 HD11 HD12 ' B' ' 46' ' ' LEU . 2.8 mp -116.09 125.93 73.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 30.6 m -106.34 144.98 32.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.88 -13.42 16.96 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.8 146.8 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.182 1.393 . . . . 0.0 112.113 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.66 161.42 42.17 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.301 -1.499 . . . . 0.0 113.264 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.85 -21.52 61.66 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -148.31 83.05 7.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.858 2.463 . . . . 0.0 110.084 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.8 29.15 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 124.645 3.563 . . . . 0.0 115.895 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.88 -5.49 52.38 Favored Glycine 0 N--CA 1.478 1.434 0 N-CA-C 118.194 2.038 . . . . 0.0 118.194 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.92 2.37 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.163 1.482 . . . . 0.0 114.148 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -21.27 111.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.15 167.63 16.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.334 2.254 . . . . 0.0 108.181 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.687 HD12 HD11 ' B' ' 34' ' ' ILE . 6.9 tt -53.78 138.54 35.46 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.398 1.479 . . . . 0.0 112.846 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -115.55 121.82 33.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.056 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.42 144.75 90.89 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.426 2.751 . . . . 0.0 111.455 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.47 154.36 48.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.148 0.979 . . . . 0.0 111.287 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -156.87 148.79 22.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.066 1.746 . . . . 0.0 109.944 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.19 -153.5 24.05 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 121.933 2.151 . . . . 0.0 111.66 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.9 mt -142.39 142.43 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 143.45 50.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.192 0.597 . . . . 0.0 111.694 173.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -78.48 152.87 31.82 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.424 1.107 . . . . 0.0 109.549 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -147.29 25.45 1.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.568 1.547 . . . . 0.0 111.68 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -93.46 -49.21 6.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.985 2.114 . . . . 0.0 112.078 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 178.32 8.12 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.3 p -75.47 -43.06 51.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.042 1.737 . . . . 0.0 113.635 174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.2 54.21 13.37 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.25 1.42 . . . . 0.0 112.192 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -67.43 171.82 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.035 1.824 . . . . 0.0 115.79 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 174.58 7.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.129 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.77 164.61 16.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.529 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.4 147.8 12.98 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.43 154.75 16.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -88.38 150.72 23.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.22 1.808 . . . . 0.0 110.528 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.58 116.92 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.465 ' HB2' HG21 ' C' ' 52' ' ' ILE . 29.2 t30 -99.32 110.14 22.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.748 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -76.79 136.77 38.99 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.76 -37.93 12.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.667 -174.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -87.28 -15.11 39.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 21.8 t -152.58 122.66 7.07 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.42 1.888 . . . . 0.0 107.309 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.85 118.53 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.932 1.242 . . . . 0.0 110.078 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -174.92 168.98 3.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.19 1.796 . . . . 0.0 110.542 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.79 145.47 28.79 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.243 1.497 . . . . 0.0 111.181 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.1 m -137.31 130.21 30.46 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 110.095 -3.23 . . . . 0.0 108.588 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 m -113.47 140.84 31.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.892 0.745 . . . . 0.0 109.68 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -115.04 147.29 40.33 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 123.463 0.477 . . . . 0.0 110.452 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 117.99 10.21 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.55 -173.16 30.91 Favored Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 119.728 -1.225 . . . . 0.0 115.645 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.566 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 0.1 OUTLIER -124.77 149.92 46.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.579 1.18 . . . . 0.0 112.895 -175.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.44 112.66 24.4 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 111.358 -2.656 . . . . 0.0 105.488 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' C' ' 106' ' ' ILE . 11.5 m-85 -110.71 155.78 21.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 119.265 0.939 . . . . 0.0 112.666 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.34 117.99 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.95 162.79 10.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.195 0.998 . . . . 0.0 110.578 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -42.7 -44.85 4.5 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.595 1.558 . . . . 0.0 114.795 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -24.34 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.787 1.235 . . . . 0.0 113.541 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.46 5.45 26.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.446 1.498 . . . . 0.0 115.094 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -72.57 162.22 29.77 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 119.274 1.537 . . . . 0.0 110.809 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.45 142.51 51.26 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.527 1.531 . . . . 0.0 112.162 -173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' C' ' 106' ' ' ILE . 2.2 t -145.11 159.26 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 125.355 1.462 . . . . 0.0 110.701 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.4 107.18 11.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.506 ' CD ' HG11 ' B' ' 92' ' ' VAL . 3.8 mmtt -99.78 124.5 45.12 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 172.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 7.5 p -139.71 168.49 19.69 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.637 1.684 . . . . 0.0 113.662 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.563 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -118.85 163.18 17.27 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -136.96 162.83 32.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 0.0 111.647 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.771 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -146.19 121.06 9.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 138.33 44.18 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 125.198 1.561 . . . . 0.0 113.138 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -119.69 113.89 21.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.357 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.273 49.4 m -73.49 168.08 19.99 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.886 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.3 p -110.24 84.34 1.91 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.28 -167.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -127.2 -26.45 3.09 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.042 -1.036 . . . . 0.0 112.9 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.11 145.93 40.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 123.252 1.501 . . . . 0.0 112.521 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' C' ' 84' ' ' PHE . 19.3 tt -62.13 -23.77 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.851 175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.78 0.14 62.45 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 117.543 -1.698 . . . . 0.0 114.075 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 1.0 OUTLIER -117.55 1.07 12.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.808 1.304 . . . . 0.0 114.104 -178.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' B' ' 112' ' ' ALA . 9.7 t70 -59.59 -27.87 66.66 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 119.562 -1.961 . . . . 0.0 112.278 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.45 ' CD1' HD11 ' D' ' 14' ' ' LEU . 46.4 p-90 -46.38 -49.18 18.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.275 1.03 . . . . 0.0 113.157 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -88.86 -12.69 41.13 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.783 0.833 . . . . 0.0 112.367 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' B' ' 109' ' ' ASP . . . -75.26 -1.7 24.71 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.815 0.446 . . . . 0.0 111.577 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.771 ' CG2' HD21 ' B' ' 98' ' ' LEU . 1.9 m -109.13 137.7 46.62 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.614 0.765 . . . . 0.0 113.042 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.532 HH11 ' HG3' ' B' ' 114' ' ' ARG . 19.5 mtt85 -140.69 130.21 24.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.633 1.173 . . . . 0.0 110.676 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -104.88 158.88 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.044 1.293 . . . . 0.0 111.236 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.73 -177.33 36.47 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 14.4 p90 -126.87 156.03 42.03 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.819 -0.812 . . . . 0.0 111.937 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -148.46 155.34 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 122.554 1.168 . . . . 0.0 110.856 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.438 HD13 ' HE3' ' B' ' 94' ' ' LYS . 10.5 mt -138.26 119.83 17.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -111.21 152.52 27.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.467 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 21.5 p -139.13 164.2 30.41 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.57 128.99 31.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.291 1.036 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.16 150.56 47.96 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -11.08 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 129.643 3.177 . . . . 0.0 115.296 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 12.1 t -144.17 4.68 1.25 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 110.42 -176.44 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 131.197 3.799 . . . . 0.0 108.763 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.3 4.3 ptmm? -151.22 41.11 0.72 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' B' ' 128' ' ' GLU . 1.1 pm0 . . . . . 0 C--O 1.261 1.68 0 C-N-CA 127.528 2.331 . . . . 0.0 112.962 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 117.375 -1.298 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.4 m 50.7 35.25 11.41 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.574 1.15 . . . . 0.0 113.867 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 12.5 m -88.58 166.12 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.23 -51.44 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.543 0.737 . . . . 0.0 111.957 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.09 76.43 0.22 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.149 1.779 . . . . 0.0 111.094 174.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.56 115.46 3.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.619 1.168 . . . . 0.0 110.723 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 83' ' ' CYS . 0.1 OUTLIER -116.39 123.74 48.32 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -176.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -143.22 137.9 29.29 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.245 -1.535 . . . . 0.0 113.564 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.43 -18.95 61.08 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -56.29 115.91 2.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.387 1.075 . . . . 0.0 111.615 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.53 -119.63 2.5 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.838 1.685 . . . . 0.0 111.139 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 142.27 24.8 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -140.87 162.8 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.785 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -142.83 145.13 32.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.635 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . 0.502 HD22 ' H ' ' C' ' 14' ' ' LEU . 6.2 t30 -105.89 146.97 29.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.186 0.995 . . . . 0.0 110.582 -174.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.18 -26.48 64.83 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.502 ' H ' HD22 ' C' ' 12' ' ' ASN . 30.3 tp -71.44 -14.63 62.21 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.697 1.599 . . . . 0.0 112.983 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.69 -13.23 22.7 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.071 2.272 . . . . 0.0 113.99 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 154.3 37.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.958 1.379 . . . . 0.0 113.835 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 136.59 53.22 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -130.27 145.37 51.75 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.561 -0.712 . . . . 0.0 112.004 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -134.29 132.46 39.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.259 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.22 120.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.46 -56.9 12.85 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.535 1.147 . . . . 0.0 112.658 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.53 155.63 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.494 1.518 . . . . 0.0 110.648 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.41 129.72 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.611 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -75.18 167.93 20.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -56.38 -27.06 55.1 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -79.53 -33.77 41.7 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.083 0.856 . . . . 0.0 110.647 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.09 9.53 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 124.123 0.868 . . . . 0.0 114.373 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.02 149.96 46.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.218 1.407 . . . . 0.0 113.019 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . 0.477 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.2 p90 -160.22 166.05 30.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.55 0.74 . . . . 0.0 110.84 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.8 p -125.57 162.34 25.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.99 -165.55 29.32 Favored Glycine 0 N--CA 1.464 0.542 0 O-C-N 119.955 -1.716 . . . . 0.0 111.986 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 70.9 p -140.37 140.74 35.59 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 122.522 1.153 . . . . 0.0 113.116 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -118.63 124.87 48.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.906 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.694 HD11 HD12 ' C' ' 46' ' ' LEU . 2.9 mp -114.98 127.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 45.0 m -108.3 145.67 34.06 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.39 -11.6 17.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.91 146.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.102 1.361 . . . . 0.0 111.918 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.38 161.24 42.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.498 -1.376 . . . . 0.0 113.355 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.42 -22.54 61.84 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.603 0.361 . . . . 0.0 110.589 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -147.69 83.57 7.46 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.767 2.427 . . . . 0.0 110.111 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.82 28.27 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 124.548 3.499 . . . . 0.0 115.895 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.75 48.92 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.9 2.3 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.071 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 60.8 mt -22.0 112.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.46 168.21 16.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.449 2.3 . . . . 0.0 108.131 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.694 HD12 HD11 ' C' ' 34' ' ' ILE . 6.8 tt -53.96 139.1 35.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.463 1.505 . . . . 0.0 112.724 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -116.39 121.16 33.79 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.195 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.15 143.18 93.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.391 2.727 . . . . 0.0 111.56 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.454 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.9 pp -132.43 161.71 32.99 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.912 0.885 . . . . 0.0 111.694 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 28' ' ' GLU . 12.0 tp -166.56 148.73 6.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.131 1.373 . . . . 0.0 111.87 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.39 -153.04 23.73 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 121.563 1.983 . . . . 0.0 111.986 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -142.73 142.38 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 112.554 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 144.91 51.6 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.005 1.322 . . . . 0.0 111.01 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -80.72 151.13 29.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.771 0.796 . . . . 0.0 109.393 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -143.99 23.95 1.68 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.381 1.472 . . . . 0.0 111.686 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -93.36 -50.35 5.5 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.894 2.078 . . . . 0.0 111.84 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.36 178.18 7.88 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.822 0.701 . . . . 0.0 112.773 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 13.5 p -75.14 -42.48 56.14 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.751 1.62 . . . . 0.0 113.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -132.37 53.54 11.45 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -66.55 172.42 9.26 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 121.804 1.669 . . . . 0.0 115.716 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.89 174.52 7.12 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.138 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -166.73 164.24 16.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.558 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.8 147.58 12.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 118.151 2.02 . . . . 0.0 118.151 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -163.52 154.22 16.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -87.67 152.73 21.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.372 1.869 . . . . 0.0 110.136 174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.67 116.84 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.437 ' HB2' HG21 ' B' ' 52' ' ' ILE . 26.0 t30 -100.26 109.55 21.77 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.426 -173.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -76.23 138.66 40.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -37.69 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -87.31 -15.49 37.85 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 21.7 t -152.5 122.41 7.01 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.377 1.871 . . . . 0.0 107.236 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -58.32 118.57 5.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.002 1.274 . . . . 0.0 110.274 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 70.3 p -175.42 168.59 3.25 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.101 1.76 . . . . 0.0 110.553 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.2 t -147.84 146.01 28.94 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-O 123.489 1.614 . . . . 0.0 111.028 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -137.36 130.15 30.25 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 109.872 -3.331 . . . . 0.0 108.79 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -112.51 142.3 25.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -115.5 148.07 39.92 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.885 0.74 . . . . 0.0 110.597 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 117.91 9.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.64 -172.72 30.46 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.547 -1.311 . . . . 0.0 115.687 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.565 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 0.1 OUTLIER -125.86 149.64 48.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.606 1.193 . . . . 0.0 113.028 -174.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.407 ' HG ' ' HG ' ' C' ' 4' ' ' CYS . 0.5 OUTLIER -97.38 112.55 24.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.409 -2.632 . . . . 0.0 105.437 -175.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.7 m-85 -110.67 154.43 23.84 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 119.283 0.947 . . . . 0.0 112.72 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.84 115.34 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.99 162.09 11.96 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.806 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -42.82 -41.86 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.015 1.726 . . . . 0.0 115.577 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.35 -3.24 42.09 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.92 5.2 64.48 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.603 1.573 . . . . 0.0 115.19 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -71.72 162.27 29.71 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 1.242 . . . . 0.0 110.195 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -123.34 141.46 51.96 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.658 1.583 . . . . 0.0 111.235 -174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' B' ' 106' ' ' ILE . 2.4 t -143.15 159.44 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 125.368 1.467 . . . . 0.0 110.867 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.23 107.79 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 172.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.493 ' CD ' HG11 ' C' ' 92' ' ' VAL . 3.7 mmtt -100.56 123.97 45.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -138.92 168.1 20.58 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 123.645 1.688 . . . . 0.0 113.866 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.551 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -118.29 163.79 16.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -136.97 162.87 32.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.395 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -146.27 121.19 9.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.683 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.72 138.13 44.51 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 125.216 1.572 . . . . 0.0 113.044 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -119.78 113.93 21.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 111.372 -2.649 . . . . 0.0 111.12 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.279 50.2 m -73.49 168.1 19.95 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 125.365 1.666 . . . . 0.0 111.664 174.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.8 p -110.59 86.78 2.38 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.75 -165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -130.0 -25.42 2.52 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.947 -1.095 . . . . 0.0 113.251 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.03 147.16 39.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.366 1.555 . . . . 0.0 112.259 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' B' ' 84' ' ' PHE . 18.8 tt -62.93 -23.25 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.892 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.61 60.17 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.767 -1.574 . . . . 0.0 114.075 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . 0.44 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 0.5 OUTLIER -118.8 0.95 11.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.738 1.269 . . . . 0.0 113.833 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' C' ' 112' ' ' ALA . 9.0 t70 -59.4 -27.91 66.42 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 119.629 -1.92 . . . . 0.0 112.368 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.446 ' CD1' HD11 ' A' ' 14' ' ' LEU . 46.1 p-90 -46.1 -49.13 16.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.229 1.012 . . . . 0.0 113.379 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -89.06 -12.32 41.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.607 0.763 . . . . 0.0 112.67 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' C' ' 109' ' ' ASP . . . -75.57 -2.09 27.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.693 0.397 . . . . 0.0 111.409 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.769 ' CG2' HD21 ' C' ' 98' ' ' LEU . 2.0 m -108.55 138.71 44.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.55 0.74 . . . . 0.0 112.742 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.504 HH11 ' HG3' ' C' ' 114' ' ' ARG . 19.4 mtt85 -141.25 130.55 23.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.943 1.297 . . . . 0.0 110.831 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -105.17 158.68 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.272 . . . . 0.0 111.213 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.06 -177.45 36.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 13.4 p90 -126.68 155.82 42.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.851 -0.793 . . . . 0.0 111.861 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -148.47 154.58 40.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.386 1.089 . . . . 0.0 111.089 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . 0.444 HD13 ' HE3' ' C' ' 94' ' ' LYS . 11.0 mt -137.17 120.97 22.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.21 152.62 28.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.943 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.5 p -138.44 163.04 32.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.72 135.01 36.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.312 0.645 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.12 156.97 11.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.06 1.41 . . . . 0.0 111.186 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 84.61 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.679 3.192 . . . . 0.0 115.403 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -25.93 3.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -157.03 176.99 12.02 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.987 1.267 . . . . 0.0 110.68 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -136.96 141.23 42.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.567 1.547 . . . . 0.0 112.289 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.249 1.051 1 C-N-CA 137.845 6.458 . . . . 0.0 100.332 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 115.706 -2.092 . . . . 0.0 105.991 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 5.1 m -123.97 95.25 4.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.279 1.854 . . . . 0.0 110.263 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.04 145.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.618 0.723 . . . . 0.0 109.249 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -64.16 156.25 29.11 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.672 -0.643 . . . . 0.0 111.283 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.34 15.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -131.04 151.45 51.4 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.11 2.164 . . . . 0.0 109.617 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.28 150.09 38.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.367 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 p -139.33 127.44 22.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.205 1.002 . . . . 0.0 112.311 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD21 ' CE2' ' A' ' 64' ' ' PHE . 73.9 mt -69.24 -34.44 74.83 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -47.57 110.97 0.36 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.021 1.328 . . . . 0.0 111.077 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.38 -130.17 4.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 125.312 1.434 . . . . 0.0 109.584 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -146.14 144.87 30.24 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.073 0.949 . . . . 0.0 112.721 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -136.64 162.9 31.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.188 1.395 . . . . 0.0 111.391 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -140.62 150.95 44.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.11 0.964 . . . . 0.0 109.567 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.66 143.54 47.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.385 1.074 . . . . 0.0 110.348 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -60.52 -22.16 63.28 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.45 1.5 . . . . 0.0 113.338 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -72.52 -15.61 61.78 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.629 1.172 . . . . 0.0 111.094 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.76 -16.43 18.73 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.639 3.019 . . . . 0.0 113.395 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.42 148.87 40.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.065 1.412 . . . . 0.0 112.955 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.46 136.52 54.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.779 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -127.46 143.26 51.22 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.535 0.684 . . . . 0.0 112.154 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -131.34 130.98 43.39 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.979 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.59 126.03 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.52 -85.55 0.13 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.48 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.03 145.79 30.73 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.86 0.838 . . . . 0.0 111.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' A' ' 53' ' ' GLN . 11.2 p -100.17 129.65 50.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.16 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -75.65 168.96 19.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.995 0.902 . . . . 0.0 112.386 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -58.7 -26.34 63.77 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.89 -40.65 75.53 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.374 -0.829 . . . . 0.0 110.822 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.05 -7.34 12.89 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 117.558 -1.69 . . . . 0.0 112.694 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HB2' HD21 ' D' ' 50' ' ' LEU . 4.7 pt-20 -67.18 146.69 53.96 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.693 1.597 . . . . 0.0 107.469 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.79 166.05 34.67 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.229 175.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 p -124.75 177.76 5.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.8 -167.51 39.76 Favored Glycine 0 CA--C 1.521 0.439 0 O-C-N 120.372 -1.455 . . . . 0.0 112.262 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' HD11 ' A' ' 46' ' ' LEU . 49.4 p -139.8 137.73 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.93 1.347 . . . . 0.0 111.947 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -111.46 138.77 47.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.161 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 46' ' ' LEU . 27.5 mt -130.01 128.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 174.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 44' ' ' ILE . 49.6 m -105.15 144.09 32.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -172.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.6 -13.25 17.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.79 143.15 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.352 1.061 . . . . 0.0 112.715 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.49 43.84 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.407 -0.808 . . . . 0.0 111.74 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.77 -28.52 64.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.765 -0.584 . . . . 0.0 109.499 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -140.64 75.35 26.21 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.966 2.507 . . . . 0.0 110.836 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.14 61.06 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.365 1 C-N-CA 125.627 4.218 . . . . 0.0 115.028 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.44 13.41 39.56 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 120.163 -1.586 . . . . 0.0 116.795 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -172.32 -29.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.037 1.335 . . . . 0.0 113.298 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 35' ' ' THR 0.322 47.6 mt 4.48 91.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.449 2.3 . . . . 0.0 116.533 -172.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 159.13 18.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 111.563 -2.562 . . . . 0.0 109.337 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.525 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.2 tt -46.74 126.82 9.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.848 2.059 . . . . 0.0 113.131 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.8 p -103.8 120.25 51.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 122.966 0.506 . . . . 0.0 111.898 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 144.01 84.62 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.327 2.684 . . . . 0.0 112.872 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.38 154.67 44.71 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.916 0.886 . . . . 0.0 112.418 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -159.75 149.21 18.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.794 2.038 . . . . 0.0 110.112 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.8 -147.69 16.44 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 121.583 1.992 . . . . 0.0 109.961 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.7 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -145.74 141.06 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.688 0.795 . . . . 0.0 112.707 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.93 139.96 52.68 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.794 -1.191 . . . . 0.0 113.147 174.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -76.97 158.09 30.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.049 -1.657 . . . . 0.0 113.638 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -158.48 21.63 0.23 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.432 1.493 . . . . 0.0 112.51 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -87.23 -54.62 4.21 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.516 1.126 . . . . 0.0 109.999 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.33 173.11 10.69 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.748 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.38 -34.74 31.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.786 0.834 . . . . 0.0 112.504 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.22 47.6 2.86 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.993 1.317 . . . . 0.0 112.065 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.9 176.07 10.36 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.16 2.573 . . . . 0.0 115.341 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.329 0.0 OUTLIER -100.13 171.07 8.04 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 123.21 1.481 . . . . 0.0 112.194 173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' A' ' 6' ' ' LEU . 1.2 p90 -160.64 167.25 27.38 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.401 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.66 144.99 9.52 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 118.482 2.153 . . . . 0.0 118.482 -173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.25 158.57 30.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -95.35 152.41 18.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.583 1.553 . . . . 0.0 108.823 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.67 118.84 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.709 ' HB2' HG21 ' D' ' 52' ' ' ILE . 5.9 t-20 -92.83 116.21 28.82 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.231 -0.918 . . . . 0.0 109.956 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.314 46.2 m95 -80.49 134.64 35.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.413 1.577 . . . . 0.0 114.431 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -89.56 -40.63 12.5 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -88.78 -15.87 33.55 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -151.43 130.29 12.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 129.389 3.076 . . . . 0.0 106.102 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -68.67 118.62 11.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.032 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -173.85 161.76 3.84 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 127.342 2.257 . . . . 0.0 108.802 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -142.98 140.15 30.94 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 123.105 1.431 . . . . 0.0 111.151 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.8 m -139.08 129.29 25.39 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 110.34 -3.118 . . . . 0.0 110.555 -171.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -106.88 154.84 7.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.039 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.76 142.36 51.33 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.68 121.23 9.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.16 176.15 42.15 Favored Glycine 0 C--O 1.226 -0.372 0 C-N-CA 118.799 -1.667 . . . . 0.0 116.866 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -112.33 149.95 31.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.831 1.301 . . . . 0.0 112.929 -174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 19.6 t -97.18 130.37 44.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.945 -1.479 . . . . 0.0 109.806 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' D' ' 106' ' ' ILE . 3.8 m-85 -119.75 166.03 13.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.94 0.876 . . . . 0.0 111.749 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mt -128.77 109.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -59.57 159.65 8.11 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -28.45 -51.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -11.39 60.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.205 1.802 . . . . 0.0 115.706 -174.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.07 51.77 3.27 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 120.383 1.447 . . . . 0.0 110.235 -173.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.21 136.64 53.07 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.521 2.328 . . . . 0.0 107.755 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -101.34 144.09 30.59 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.628 1.171 . . . . 0.0 109.974 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.2 m -147.9 162.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.652 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.1 116.87 25.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.775 ' HE2' HD11 ' D' ' 106' ' ' ILE . 3.5 mmtt -104.92 120.51 41.62 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 p -137.25 166.91 22.64 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 123.358 1.551 . . . . 0.0 113.723 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.425 ' HG3' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -117.25 165.9 12.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 172.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -141.1 159.6 41.88 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.238 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.9 tt -144.42 126.17 15.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.913 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.18 143.64 40.0 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 125.379 1.674 . . . . 0.0 112.381 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.69 114.34 17.87 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 111.416 -2.629 . . . . 0.0 111.736 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.252 44.6 m -67.12 175.45 2.59 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 125.635 1.834 . . . . 0.0 113.083 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.4 p -117.93 67.49 0.76 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 107.948 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.63 167.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 120.921 -1.112 . . . . 0.0 111.709 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -102.78 -32.35 9.86 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -109.03 148.77 30.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.82 1.295 . . . . 0.0 111.407 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.806 HD11 ' HE2' ' D' ' 94' ' ' LYS . 15.0 tt -63.32 -30.78 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 113.426 -1.716 . . . . 0.0 109.979 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.88 5.75 3.32 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 117.801 -1.555 . . . . 0.0 113.726 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -121.41 1.92 10.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.809 1.305 . . . . 0.0 113.69 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -33.48 75.38 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.402 -0.811 . . . . 0.0 111.713 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.418 ' CD1' HD11 ' C' ' 14' ' ' LEU . 58.1 p-90 -46.88 -40.99 15.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -99.34 -6.72 27.38 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.359 1.063 . . . . 0.0 113.463 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.95 0.32 21.51 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.798 ' CG2' HD21 ' A' ' 98' ' ' LEU . 5.9 m -110.36 138.44 46.74 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.74 0.816 . . . . 0.0 112.072 176.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -140.59 124.79 17.55 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 125.184 1.394 . . . . 0.0 110.723 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.56 158.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.13 1.372 . . . . 0.0 111.317 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.02 -178.46 37.59 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.027 0.822 . . . . 0.0 113.326 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -124.98 156.74 37.6 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.755 -0.85 . . . . 0.0 111.705 175.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -147.7 157.91 43.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.416 1.103 . . . . 0.0 109.664 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.2 mt -133.37 138.36 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -125.72 149.14 48.75 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.285 1.041 . . . . 0.0 111.264 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 p -133.05 161.09 35.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.661 1.184 . . . . 0.0 110.352 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.09 113.16 2.96 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.614 0.765 . . . . 0.0 112.233 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -89.05 94.83 10.08 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 140.35 79.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 129.693 3.197 . . . . 0.0 111.663 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 t -161.74 172.09 16.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.586 1.155 . . . . 0.0 108.956 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -143.91 -59.59 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.37 0.0 OUTLIER 74.56 13.48 3.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.516 1.927 . . . . 0.0 114.965 174.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--O 1.261 1.68 1 C-N-CA 133.876 4.87 . . . . 0.0 105.763 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 116.692 -1.623 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 2.0 m -72.76 55.55 0.38 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.531 1.532 . . . . 0.0 112.405 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 31.0 m -94.91 157.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.732 1.213 . . . . 0.0 110.261 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -95.99 139.33 32.33 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.62 -0.675 . . . . 0.0 111.743 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -64.35 -1.56 1.75 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -133.03 147.29 52.23 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.953 1.701 . . . . 0.0 109.132 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.3 144.84 43.71 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.255 1.022 . . . . 0.0 109.62 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -139.7 127.85 22.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' D' ' 64' ' ' PHE . 80.5 mt -69.8 -33.01 71.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -48.83 113.46 0.79 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.511 1.124 . . . . 0.0 110.531 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.3 -132.5 5.85 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -147.23 143.67 28.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -136.09 162.55 32.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.221 1.408 . . . . 0.0 111.96 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.43 ' HB ' HD12 ' D' ' 123' ' ' LEU . 8.9 t -137.7 151.79 48.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.229 1.012 . . . . 0.0 109.231 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -119.89 143.79 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.232 1.013 . . . . 0.0 110.681 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -58.41 -25.31 62.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.462 1.505 . . . . 0.0 113.66 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' B' ' 110' ' ' TRP . 28.5 tp -70.25 -15.47 62.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.588 1.155 . . . . 0.0 111.711 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.23 -12.21 28.73 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 128.238 2.828 . . . . 0.0 113.515 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.65 149.65 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.265 1.507 . . . . 0.0 113.33 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -125.53 137.37 53.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.921 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -128.14 144.36 51.11 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -131.66 131.17 42.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.206 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 80.8 mt -131.13 124.52 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -86.42 0.08 OUTLIER Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.208 0.943 . . . . 0.0 111.733 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.24 145.28 31.22 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.803 -0.822 . . . . 0.0 110.676 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.61 HG21 ' HG3' ' D' ' 53' ' ' GLN . 11.3 p -99.72 130.37 48.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.053 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.99 166.7 23.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 112.382 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -26.02 63.98 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -67.89 -39.25 83.69 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.273 -0.892 . . . . 0.0 111.129 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.53 -6.55 11.53 Favored Glycine 0 C--O 1.221 -0.698 0 C-N-CA 124.728 1.156 . . . . 0.0 113.402 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.89 152.99 43.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.151 1.781 . . . . 0.0 112.258 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.38 30.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.252 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p -123.53 -177.13 3.63 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.71 -167.13 40.16 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 119.41 -2.056 . . . . 0.0 112.622 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' D' ' 46' ' ' LEU . 52.1 p -139.55 137.68 35.63 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.56 0.695 . . . . 0.0 112.346 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -112.83 138.71 49.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.377 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.437 HD11 HD12 ' D' ' 46' ' ' LEU . 31.2 mt -130.72 128.42 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.408 ' O ' HG21 ' D' ' 44' ' ' ILE . 54.6 m -105.74 144.82 31.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.1 -13.62 17.42 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.73 142.76 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.245 1.018 . . . . 0.0 112.607 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.55 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.153 -0.967 . . . . 0.0 111.474 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -70.5 -29.15 65.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.15 75.3 29.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 127.893 2.477 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.12 61.25 3.97 Favored 'Trans proline' 0 CA--C 1.551 1.358 1 C-N-CA 125.629 4.22 . . . . 0.0 115.13 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.61 13.58 38.96 Favored Glycine 0 N--CA 1.48 1.605 0 O-C-N 120.099 -1.626 . . . . 0.0 116.844 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -172.51 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.158 1.383 . . . . 0.0 113.401 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.408 HG21 ' O ' ' D' ' 35' ' ' THR 0.321 49.2 mt 4.55 91.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.627 2.371 . . . . 0.0 116.365 -172.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.58 159.31 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.584 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.1 tt -46.82 126.15 8.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.674 1.99 . . . . 0.0 112.88 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.03 120.53 52.02 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.158 0.583 . . . . 0.0 111.634 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.06 143.78 82.18 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.166 2.577 . . . . 0.0 112.438 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.498 ' C ' HD12 ' D' ' 49' ' ' LEU . 0.6 OUTLIER -127.75 160.33 32.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.953 0.901 . . . . 0.0 112.598 177.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 28' ' ' GLU . 15.3 tp -169.01 149.01 4.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 0.0 112.642 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 -144.1 10.45 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 121.091 1.769 . . . . 0.0 109.774 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.709 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.9 mt -147.53 139.37 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.769 0.827 . . . . 0.0 111.592 -175.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -125.36 138.45 54.05 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.163 1.385 . . . . 0.0 112.612 175.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -76.7 157.52 31.69 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 119.9 -1.75 . . . . 0.0 113.172 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -156.96 19.39 0.31 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.29 1.436 . . . . 0.0 112.5 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -84.96 -54.11 4.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.766 1.227 . . . . 0.0 110.085 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 172.67 11.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.911 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -31.77 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.28 1.032 . . . . 0.0 113.378 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -130.17 50.58 6.18 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 125.118 1.367 . . . . 0.0 112.589 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.24 175.96 10.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.989 2.46 . . . . 0.0 116.274 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.335 0.0 OUTLIER -100.82 170.17 8.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.104 1.431 . . . . 0.0 111.808 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.482 ' CE2' HD21 ' D' ' 6' ' ' LEU . 1.4 p90 -161.01 167.29 26.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.82 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.32 145.43 10.0 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 118.431 2.133 . . . . 0.0 118.431 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -160.88 158.69 28.68 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -95.02 152.42 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.569 1.948 . . . . 0.0 108.472 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.58 117.78 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.7 ' HB2' HG21 ' A' ' 52' ' ' ILE . 7.2 t-20 -92.85 117.21 29.78 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.407 -0.808 . . . . 0.0 109.927 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.3 46.3 m95 -80.46 137.39 36.47 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.543 1.64 . . . . 0.0 114.246 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -92.67 -39.45 11.28 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.3 -14.94 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -152.27 131.59 12.85 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 129.319 3.048 . . . . 0.0 106.241 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.4 118.64 12.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 10.8 m -173.53 161.82 4.09 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 127.222 2.209 . . . . 0.0 108.978 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.8 t -143.28 140.31 30.56 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.114 1.435 . . . . 0.0 110.842 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -139.05 128.79 24.74 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 110.509 -3.041 . . . . 0.0 110.451 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.12 154.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.038 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -127.64 141.8 51.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.1 121.69 10.44 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.78 174.46 42.15 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 118.748 -1.691 . . . . 0.0 116.786 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.51 146.65 38.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.021 1.071 . . . . 0.0 111.967 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 48.9 t -97.62 134.23 41.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.138 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' A' ' 106' ' ' ILE . 5.5 m-85 -122.31 164.93 17.05 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.203 1.001 . . . . 0.0 111.366 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.98 105.33 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -63.38 154.22 32.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -22.42 -51.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.072 2.549 . . . . 0.0 117.39 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -76.08 -7.2 54.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.253 1.821 . . . . 0.0 115.784 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.38 51.38 3.52 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.925 0.784 . . . . 0.0 111.231 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 135.96 54.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 108.784 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.29 144.6 29.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.17 0.986 . . . . 0.0 109.572 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 106' ' ' ILE . 25.1 m -148.51 159.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.818 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mt -117.72 117.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.806 ' HE2' HD11 ' A' ' 106' ' ' ILE . 4.0 mmtt -105.47 119.06 38.14 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -136.95 167.09 22.16 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.258 1.504 . . . . 0.0 113.639 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.421 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -117.13 166.51 12.15 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -141.58 160.09 40.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.101 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.776 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.9 tt -144.83 126.6 15.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.771 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.03 144.45 38.59 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 125.51 1.756 . . . . 0.0 112.082 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -127.45 114.36 17.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.677 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 42.5 m -67.01 175.33 2.58 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 125.803 1.939 . . . . 0.0 113.0 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 7.9 p -117.74 66.64 0.75 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.11 1.364 . . . . 0.0 108.251 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.69 167.47 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.988 -1.07 . . . . 0.0 111.999 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -101.52 -32.26 10.48 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.0 149.89 31.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 122.709 1.242 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.775 HD11 ' HE2' ' A' ' 94' ' ' LYS . 15.2 tt -62.96 -29.01 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.21 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.51 6.13 4.88 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.501 1.048 . . . . 0.0 113.586 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -122.2 2.26 9.77 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.509 1.155 . . . . 0.0 113.712 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.74 -34.02 76.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.312 -0.868 . . . . 0.0 112.14 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.2 p-90 -46.19 -41.43 12.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.28 1.032 . . . . 0.0 113.728 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -99.48 -6.79 26.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.215 1.006 . . . . 0.0 113.365 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.65 -0.21 22.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.776 ' CG2' HD21 ' D' ' 98' ' ' LEU . 5.7 m -109.33 138.8 45.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.477 0.711 . . . . 0.0 111.792 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -140.76 124.79 17.31 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 125.56 1.544 . . . . 0.0 111.247 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.6 158.89 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.08 1.352 . . . . 0.0 111.166 176.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.17 -179.53 38.43 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.939 0.781 . . . . 0.0 113.441 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 0.0 OUTLIER -123.77 156.37 36.19 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.759 -0.848 . . . . 0.0 111.571 176.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -147.72 157.36 43.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.09 0.948 . . . . 0.0 109.855 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.58 136.65 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -124.45 151.25 44.77 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 18.7 p -134.65 160.81 36.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.746 1.218 . . . . 0.0 110.186 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 129.43 41.36 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.53 -0.731 . . . . 0.0 110.855 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.3 OUTLIER -66.87 168.8 9.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.306 175.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' D' ' 124' ' ' ARG 0.31 0.0 OUTLIER -58.52 134.96 57.16 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.363 -0.836 . . . . 0.0 112.629 174.303 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -77.32 0.23 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.596 1.158 . . . . 0.0 109.044 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -111.72 131.52 55.25 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.909 1.684 . . . . 0.0 106.563 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.54 59.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.535 1.934 . . . . 0.0 110.35 -172.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 114.996 -2.43 . . . . 0.0 107.842 -172.305 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.6 t -152.78 29.76 0.52 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.81 1.291 . . . . 0.0 112.235 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 10.2 p -153.69 40.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.004 2.121 . . . . 0.0 109.529 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -169.14 153.32 5.42 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.491 -1.381 . . . . 0.0 111.501 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 65.24 -43.96 0.35 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 128.28 2.632 . . . . 0.0 116.669 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -138.13 155.84 48.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.219 2.208 . . . . 0.0 109.038 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.23 142.01 50.89 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 109.478 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -139.66 127.88 22.55 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' B' ' 64' ' ' PHE . 84.5 mt -69.23 -31.53 70.16 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -48.96 113.25 0.75 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.332 1.053 . . . . 0.0 111.028 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.32 -131.11 5.24 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.63 1.586 . . . . 0.0 109.452 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -146.38 143.21 28.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.46 1.104 . . . . 0.0 113.293 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . 0.421 ' CH2' HD21 ' B' ' 93' ' ' LEU . 45.3 m95 -135.56 162.75 31.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.297 1.439 . . . . 0.0 111.737 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -141.27 150.55 42.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.97 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -122.12 143.78 49.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.389 1.076 . . . . 0.0 111.025 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -58.88 -25.34 63.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.608 1.563 . . . . 0.0 113.458 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' D' ' 110' ' ' TRP . 28.9 tp -70.68 -15.63 62.73 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.371 1.081 . . . . 0.0 111.619 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.32 -13.98 23.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 128.415 2.912 . . . . 0.0 113.47 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 148.57 44.69 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 123.113 1.435 . . . . 0.0 113.252 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -122.7 136.08 54.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.671 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -131.05 131.19 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.4 mt -130.2 124.39 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.32 -84.34 0.11 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.537 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.79 32.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.76 -0.847 . . . . 0.0 110.85 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.588 HG21 ' HG3' ' B' ' 53' ' ' GLN . 10.9 p -102.66 130.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.294 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -75.94 168.77 19.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.942 0.877 . . . . 0.0 112.207 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 81.5 p -58.59 -26.08 63.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -70.1 -40.58 74.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.324 -0.86 . . . . 0.0 110.981 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.85 -7.17 13.32 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.523 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' C' ' 50' ' ' LEU . 4.2 pt-20 -67.33 146.75 53.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.649 1.58 . . . . 0.0 107.416 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.0 166.22 34.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.108 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.6 p -125.39 176.85 6.51 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.66 -167.54 39.46 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 120.321 -1.487 . . . . 0.0 112.302 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.529 ' HB ' HD11 ' B' ' 46' ' ' LEU . 48.5 p -139.76 137.52 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.607 1.194 . . . . 0.0 112.016 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -110.88 139.0 46.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.23 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' B' ' 46' ' ' LEU . 27.5 mt -130.59 128.02 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.406 ' O ' HG21 ' B' ' 44' ' ' ILE . 42.7 m -105.21 144.25 32.26 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.64 -13.72 17.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.24 143.46 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.328 1.051 . . . . 0.0 112.701 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.03 43.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.424 -0.798 . . . . 0.0 111.464 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -71.21 -28.82 64.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -140.24 75.66 27.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.926 2.49 . . . . 0.0 111.038 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.22 61.86 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.409 1 C-N-CA 125.583 4.188 . . . . 0.0 115.02 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.97 13.56 37.74 Favored Glycine 0 N--CA 1.481 1.659 0 O-C-N 120.269 -1.519 . . . . 0.0 116.862 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -172.36 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.174 1.39 . . . . 0.0 113.297 -174.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.406 HG21 ' O ' ' B' ' 35' ' ' THR 0.324 50.3 mt 5.35 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.616 2.366 . . . . 0.0 116.323 -172.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.63 159.19 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 111.607 -2.542 . . . . 0.0 109.32 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.5 tt -46.84 127.97 10.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.768 2.027 . . . . 0.0 112.926 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -104.96 120.65 49.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.083 0.553 . . . . 0.0 111.846 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.33 144.38 82.72 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.034 2.489 . . . . 0.0 112.947 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.47 154.37 45.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 112.633 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -159.97 149.14 17.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.531 1.932 . . . . 0.0 109.949 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.72 -147.22 15.32 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 121.389 1.904 . . . . 0.0 109.879 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -145.67 141.0 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.523 0.729 . . . . 0.0 112.655 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.588 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -126.94 136.84 52.84 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.978 -1.076 . . . . 0.0 113.363 174.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -74.01 158.32 34.55 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 119.96 -1.713 . . . . 0.0 113.557 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -159.58 23.93 0.19 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.483 1.513 . . . . 0.0 111.855 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -90.37 -53.08 4.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.677 1.191 . . . . 0.0 110.331 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.44 174.28 9.13 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.65 1.219 . . . . 0.0 113.36 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.27 -29.69 22.9 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -129.34 49.52 4.78 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.681 1.192 . . . . 0.0 112.627 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.59 175.1 10.65 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.901 2.401 . . . . 0.0 116.169 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.33 0.0 OUTLIER -101.03 169.83 8.68 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 123.048 1.404 . . . . 0.0 111.97 173.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' B' ' 6' ' ' LEU . 1.1 p90 -160.66 167.5 26.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.543 -173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.71 144.44 9.09 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.96 158.66 31.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.8 m -94.87 152.22 18.57 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.753 1.621 . . . . 0.0 108.802 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.55 118.23 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' C' ' 52' ' ' ILE . 7.6 t-20 -92.71 116.53 29.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.733 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.299 46.1 m95 -80.22 136.59 36.5 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 123.465 1.603 . . . . 0.0 114.326 -173.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -91.54 -39.83 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -89.29 -15.42 33.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -151.43 130.23 12.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.202 3.001 . . . . 0.0 105.904 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.66 118.57 11.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.0 m -173.58 161.61 4.02 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 127.253 2.221 . . . . 0.0 109.082 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 140.4 30.48 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.033 1.397 . . . . 0.0 110.694 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' B' ' 98' ' ' LEU . 1.9 m -139.33 129.41 25.15 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 110.549 -3.023 . . . . 0.0 110.558 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.44 155.46 7.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.092 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -128.48 142.22 51.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.41 121.18 9.89 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.18 175.05 41.76 Favored Glycine 0 CA--C 1.504 -0.629 0 C-N-CA 118.708 -1.711 . . . . 0.0 116.627 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -112.85 144.56 42.19 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.79 1.281 . . . . 0.0 112.083 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 t -97.84 127.22 43.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.873 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' C' ' 106' ' ' ILE . 5.2 m-85 -115.31 166.8 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.33 1.052 . . . . 0.0 111.561 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 mt -127.41 108.13 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -62.33 156.76 21.46 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -26.77 -48.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.336 2.254 . . . . 0.0 116.854 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.59 -2.25 41.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 49.26 5.77 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.651 1.114 . . . . 0.0 112.118 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.31 136.94 54.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.873 1.669 . . . . 0.0 108.043 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -101.26 144.23 30.37 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.357 1.063 . . . . 0.0 109.607 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' C' ' 106' ' ' ILE . 21.5 m -148.01 159.93 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.006 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.421 HD21 ' CH2' ' B' ' 10' ' ' TRP . 9.1 mt -118.08 118.42 31.85 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.789 ' HE2' HD11 ' C' ' 106' ' ' ILE . 4.2 mmtt -107.09 118.08 35.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -136.0 166.65 22.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 123.488 1.613 . . . . 0.0 113.712 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.428 ' HG3' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -116.83 165.75 12.95 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 p-90 -141.13 160.23 40.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.276 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.9 tt -144.92 126.76 15.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.956 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.38 143.16 41.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 125.37 1.669 . . . . 0.0 112.3 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -126.08 114.23 18.13 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 111.176 -2.738 . . . . 0.0 111.713 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 43.5 m -67.2 175.24 2.73 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 125.778 1.924 . . . . 0.0 112.911 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -117.7 67.66 0.75 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.082 1.353 . . . . 0.0 108.041 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.43 168.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 121.027 -1.046 . . . . 0.0 111.804 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -103.51 -31.35 10.0 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.09 148.63 30.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.838 1.304 . . . . 0.0 111.669 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.79 HD11 ' HE2' ' C' ' 94' ' ' LYS . 14.8 tt -64.42 -29.48 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.653 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.53 5.25 5.78 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 124.276 0.941 . . . . 0.0 113.254 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.92 1.24 10.41 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.387 1.075 . . . . 0.0 113.639 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.12 -32.88 73.51 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.057 0.932 . . . . 0.0 112.435 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.3 p-90 -46.93 -41.45 16.08 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -98.86 -6.67 28.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.456 1.103 . . . . 0.0 113.419 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.91 0.09 22.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.799 ' CG2' HD21 ' B' ' 98' ' ' LEU . 5.3 m -109.35 138.41 45.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.596 0.758 . . . . 0.0 112.124 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.98 123.49 15.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.404 1.482 . . . . 0.0 111.433 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -99.48 158.69 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.834 1.254 . . . . 0.0 111.062 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.35 -178.21 37.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.86 0.743 . . . . 0.0 113.462 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 0.0 OUTLIER -125.14 156.31 38.55 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.781 -0.835 . . . . 0.0 111.797 176.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -147.45 155.3 41.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.136 0.97 . . . . 0.0 110.003 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.72 132.07 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -119.9 152.38 37.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.118 0.961 . . . . 0.0 110.821 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 160.38 37.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.447 1.099 . . . . 0.0 109.476 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 122.32 13.78 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' B' ' 124' ' ' ARG . 6.4 tt -63.25 160.16 16.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.109 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.478 ' HB2' HD23 ' B' ' 123' ' ' LEU . 0.0 OUTLIER 77.79 -56.16 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.108 2.163 . . . . 0.0 113.489 172.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 19.5 p 55.44 146.11 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.574 2.749 . . . . 0.0 114.658 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -166.68 104.68 0.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.478 2.311 . . . . 0.0 105.037 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . 0.296 0.2 OUTLIER -141.97 21.78 2.11 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.901 1.28 . . . . 0.0 111.04 -174.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 129.546 3.138 . . . . 0.0 106.872 174.45 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 116.823 -1.56 . . . . 0.0 107.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.8 t -94.77 127.65 40.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.567 1.076 . . . . 0.0 110.738 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.39 17.7 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.692 1.197 . . . . 0.0 110.048 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 57.21 -133.2 1.32 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.994 1.718 . . . . 0.0 111.5 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 10.43 0.45 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.319 1.848 . . . . 0.0 112.059 173.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -128.89 143.7 50.97 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 124.847 1.259 . . . . 0.0 108.552 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 29.6 p -116.29 141.41 48.19 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.073 0.858 . . . . 0.0 108.865 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -139.64 127.69 22.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.994 -1.066 . . . . 0.0 113.07 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' C' ' 64' ' ' PHE . 84.0 mt -68.07 -31.7 71.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.7 t -48.27 113.85 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.964 1.306 . . . . 0.0 110.931 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -131.12 5.44 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 125.99 1.757 . . . . 0.0 109.111 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -145.47 146.97 31.69 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -136.59 162.65 32.54 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.993 1.317 . . . . 0.0 111.457 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -136.34 153.25 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.685 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -123.47 143.61 50.05 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.173 0.989 . . . . 0.0 111.093 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.9 -25.9 61.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.907 1.683 . . . . 0.0 113.353 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 110' ' ' TRP . 28.7 tp -71.25 -15.29 62.43 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.816 1.246 . . . . 0.0 111.788 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.27 -14.49 23.2 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 128.479 2.942 . . . . 0.0 113.513 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 149.4 42.61 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 123.14 1.448 . . . . 0.0 113.088 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -123.34 136.21 54.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.325 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.3 ptt? -128.34 139.82 52.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m -127.73 131.63 49.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.688 0.795 . . . . 0.0 109.003 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.9 125.4 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.71 -85.85 0.09 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.615 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.05 33.84 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.726 -0.867 . . . . 0.0 110.909 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.608 HG21 ' HG3' ' C' ' 53' ' ' GLN . 11.0 p -103.83 129.05 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -74.51 166.23 23.87 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.972 0.891 . . . . 0.0 112.356 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -58.78 -25.9 63.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -67.91 -39.12 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.216 -0.927 . . . . 0.0 110.919 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.14 -6.34 12.03 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 124.782 1.182 . . . . 0.0 113.322 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.24 152.76 43.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.071 1.749 . . . . 0.0 112.15 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.38 166.49 30.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.884 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.406 HG22 HD13 ' C' ' 50' ' ' LEU . 21.6 p -123.37 -177.47 3.71 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.89 -166.87 39.84 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 119.322 -2.111 . . . . 0.0 112.703 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.512 ' HB ' HD11 ' C' ' 46' ' ' LEU . 59.0 p -139.69 136.89 34.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.257 1.027 . . . . 0.0 112.578 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -111.84 138.4 48.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.38 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.447 HD11 HD12 ' C' ' 46' ' ' LEU . 27.7 mt -130.42 127.62 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.405 ' O ' HG21 ' C' ' 44' ' ' ILE . 55.9 m -105.09 143.65 32.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.61 -13.08 18.72 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.8 143.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.179 0.992 . . . . 0.0 112.907 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.17 161.12 43.31 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.106 -0.996 . . . . 0.0 111.45 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -71.36 -28.81 64.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -140.09 75.38 29.26 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.914 2.486 . . . . 0.0 110.978 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.92 61.41 3.83 Favored 'Trans proline' 0 CA--C 1.551 1.373 1 C-N-CA 125.589 4.192 . . . . 0.0 115.134 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.7 13.56 38.65 Favored Glycine 0 N--CA 1.481 1.645 0 O-C-N 120.141 -1.599 . . . . 0.0 116.817 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -172.58 -29.43 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.21 1.404 . . . . 0.0 113.401 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.405 HG21 ' O ' ' C' ' 35' ' ' THR 0.325 48.8 mt 5.05 90.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.662 2.385 . . . . 0.0 116.33 -172.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.9 159.24 17.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.794 -2.457 . . . . 0.0 109.352 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.512 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.2 tt -46.76 128.02 10.32 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.624 1.97 . . . . 0.0 112.878 174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -104.82 120.46 50.05 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.978 0.511 . . . . 0.0 111.682 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.89 143.0 83.57 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.949 2.432 . . . . 0.0 112.445 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.495 ' C ' HD12 ' C' ' 49' ' ' LEU . 0.6 OUTLIER -127.1 160.29 31.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.021 0.928 . . . . 0.0 112.78 177.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' B' ' 28' ' ' GLU . 14.9 tp -169.0 149.19 4.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.479 1.512 . . . . 0.0 112.466 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.26 -144.17 10.54 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 121.122 1.783 . . . . 0.0 109.765 -174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.722 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -147.99 139.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.745 -175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.608 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -125.77 138.94 53.88 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.613 1.165 . . . . 0.0 112.727 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -76.64 157.82 31.56 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.023 -1.673 . . . . 0.0 113.277 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -157.67 20.3 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.285 1.434 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -86.77 -53.73 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.926 1.29 . . . . 0.0 110.247 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.52 172.46 11.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.814 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.95 -29.31 25.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.857 0.863 . . . . 0.0 113.034 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -130.69 51.86 8.38 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 125.085 1.354 . . . . 0.0 112.726 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.37 175.72 10.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.935 2.423 . . . . 0.0 116.139 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.333 0.0 OUTLIER -100.77 170.78 8.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.202 1.477 . . . . 0.0 111.742 173.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' C' ' 6' ' ' LEU . 1.1 p90 -161.57 167.07 25.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.684 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.25 144.86 9.48 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -173.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.36 158.47 29.7 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -94.99 152.64 18.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.336 1.854 . . . . 0.0 108.718 173.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.85 117.8 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.702 ' HB2' HG21 ' B' ' 52' ' ' ILE . 7.3 t-20 -92.78 117.26 29.82 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.235 -0.916 . . . . 0.0 109.866 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.301 46.4 m95 -80.63 137.55 36.36 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 123.456 1.598 . . . . 0.0 114.123 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -92.78 -39.79 11.03 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -89.13 -15.47 33.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -151.22 130.4 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 129.307 3.043 . . . . 0.0 106.299 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -69.03 118.55 12.08 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 10.7 m -174.0 161.37 3.67 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.238 2.215 . . . . 0.0 108.968 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -142.56 140.58 31.8 Favored 'General case' 0 CA--C 1.483 -1.635 0 CA-C-O 123.347 1.546 . . . . 0.0 111.057 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' C' ' 98' ' ' LEU . 1.9 m -139.15 129.97 26.21 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 110.339 -3.119 . . . . 0.0 110.21 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.15 154.84 7.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.974 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.37 142.34 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.49 121.0 9.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.4 173.94 41.17 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 118.708 -1.71 . . . . 0.0 116.625 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -112.49 146.5 38.35 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 125.101 1.118 . . . . 0.0 111.805 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.63 135.13 39.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.312 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HB2' HD12 ' B' ' 106' ' ' ILE . 6.3 m-85 -123.54 165.9 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.055 0.942 . . . . 0.0 111.118 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.62 108.27 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.01 157.12 25.99 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -24.85 -48.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 127.634 2.374 . . . . 0.0 117.339 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -80.39 -3.38 49.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.905 2.082 . . . . 0.0 116.449 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.46 48.11 5.75 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 120.295 1.407 . . . . 0.0 111.963 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 135.62 54.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.198 1.799 . . . . 0.0 109.077 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -101.3 145.97 28.17 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.713 1.244 . . . . 0.0 109.729 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.2 m -150.13 157.07 6.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.934 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.49 115.39 26.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.79 ' HE2' HD11 ' B' ' 106' ' ' ILE . 4.3 mmtt -103.74 119.35 38.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 5.2 p -136.57 167.31 21.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 123.398 1.57 . . . . 0.0 113.889 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.423 ' HG3' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -117.83 166.11 12.86 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -141.23 160.15 40.71 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.121 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.792 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.9 tt -144.81 125.79 14.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.131 -1.849 . . . . 0.0 112.008 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.52 143.19 39.5 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.065 1.478 . . . . 0.0 112.218 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -126.66 114.19 17.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 111.523 -2.58 . . . . 0.0 111.516 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -66.75 175.35 2.44 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 126.083 2.114 . . . . 0.0 112.926 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 7.7 p -118.19 68.98 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.34 1.456 . . . . 0.0 107.675 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.8 171.53 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.889 -1.132 . . . . 0.0 111.539 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -106.7 -32.28 8.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -108.22 148.77 29.47 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.833 1.302 . . . . 0.0 111.588 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.789 HD11 ' HE2' ' B' ' 94' ' ' LYS . 14.9 tt -64.07 -29.04 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.888 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 5.56 6.11 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.706 1.146 . . . . 0.0 113.516 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -121.39 1.51 10.17 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.333 1.066 . . . . 0.0 113.694 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -33.07 73.73 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.035 0.922 . . . . 0.0 112.553 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.1 p-90 -46.7 -41.43 14.98 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -99.34 -6.57 27.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.318 1.047 . . . . 0.0 113.356 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.35 -0.17 21.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.792 ' CG2' HD21 ' C' ' 98' ' ' LEU . 5.9 m -109.9 138.38 46.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.599 0.76 . . . . 0.0 111.636 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -140.59 124.47 17.26 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 125.65 1.58 . . . . 0.0 111.01 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -99.57 158.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.245 1.418 . . . . 0.0 111.35 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.65 -178.84 38.34 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.809 0.718 . . . . 0.0 113.407 174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 0.0 OUTLIER -124.41 157.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.733 -0.863 . . . . 0.0 111.911 176.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -148.39 155.59 41.44 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.967 0.889 . . . . 0.0 109.864 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -132.19 133.28 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -120.76 151.7 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 111.665 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 17.8 p -135.42 163.15 30.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.024 1.33 . . . . 0.0 109.876 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 115.94 5.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.86 -1.15 . . . . 0.0 111.732 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 tp -71.87 145.64 48.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 61.99 68.49 0.68 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 54.8 p -63.37 156.04 27.07 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.092 -1.005 . . . . 0.0 109.706 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -43.79 -53.64 5.79 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.989 1.316 . . . . 0.0 113.297 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' C' ' 128' ' ' GLU . 17.7 tttm 63.51 168.38 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.793 2.037 . . . . 0.0 112.341 -174.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.496 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 5.3 mm-40 . . . . . 0 CA--C 1.551 0.983 1 C-N-CA 137.557 6.343 . . . . 0.0 102.29 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 116.708 -1.615 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 2.5 m -109.66 39.55 2.08 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 121.091 1.769 . . . . 0.0 113.476 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.67 -6.58 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.739 1.616 . . . . 0.0 113.31 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 54.93 -136.96 1.23 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.49 1.116 . . . . 0.0 111.587 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.316 0.2 OUTLIER -155.82 74.04 0.85 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.506 1.922 . . . . 0.0 111.158 -175.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -156.15 105.14 2.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.585 1.554 . . . . 0.0 111.29 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 p -116.61 137.61 52.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.003 0.921 . . . . 0.0 109.823 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 p -139.77 133.09 29.94 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.196 -1.565 . . . . 0.0 114.348 -174.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 64' ' ' PHE . 42.1 mt -59.13 -32.01 69.47 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -52.35 116.18 2.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.774 1.273 . . . . 0.0 111.83 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.1 -114.47 1.25 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 125.94 1.733 . . . . 0.0 110.209 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -153.16 147.44 25.78 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -140.65 162.75 34.64 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.493 1.517 . . . . 0.0 111.35 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -138.63 147.94 43.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.29 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.28 146.99 38.46 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.709 0.803 . . . . 0.0 110.619 -175.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -56.67 -28.6 61.05 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 12' ' ' ASN . 32.6 tp -72.29 -15.62 61.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.053 1.741 . . . . 0.0 112.02 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.39 -14.29 25.42 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.048 2.261 . . . . 0.0 113.441 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.7 p -68.51 155.05 40.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.412 1.606 . . . . 0.0 113.134 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -127.02 138.28 53.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.608 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -124.09 136.03 53.96 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.56 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -126.79 130.51 50.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.9 mt -134.43 127.46 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.83 -89.59 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.077 0.861 . . . . 0.0 112.558 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.92 139.65 32.58 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.837 -0.801 . . . . 0.0 111.641 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.8 t -89.61 129.47 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.357 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.56 166.04 15.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.894 0.854 . . . . 0.0 111.589 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.1 p -57.15 -27.81 62.19 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -74.71 -32.83 62.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.698 0.681 . . . . 0.0 111.722 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.67 -7.43 26.05 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.959 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' D' ' 50' ' ' LEU . 9.6 pt-20 -66.3 144.27 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.772 1.286 . . . . 0.0 108.487 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 50' ' ' LEU . 20.8 p90 -158.18 145.82 18.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.802 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.57 162.01 14.34 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.02 -170.04 36.9 Favored Glycine 0 C--O 1.239 0.416 0 O-C-N 121.187 -0.946 . . . . 0.0 112.664 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' LEU . 46.9 p -140.15 139.03 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.407 1.098 . . . . 0.0 112.17 175.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -114.42 138.72 50.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 108.389 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 46' ' ' LEU . 41.4 mt -130.83 126.87 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG21 ' A' ' 44' ' ' ILE . 86.5 m -105.05 144.34 31.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.74 -21.96 17.82 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.5 m -132.98 143.26 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.48 1.112 . . . . 0.0 113.27 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.55 159.43 39.7 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.528 -0.732 . . . . 0.0 110.219 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.54 -23.72 58.84 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.95 -0.469 . . . . 0.0 110.909 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -146.43 68.72 12.34 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.221 2.208 . . . . 0.0 111.069 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' ILE . 39.0 Cg_endo -56.71 -79.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 125.08 3.853 . . . . 0.0 116.853 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.87 -48.65 0.01 OUTLIER Glycine 0 CA--C 1.546 1.996 0 C-N-CA 129.561 3.458 . . . . 0.0 120.565 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -125.84 -5.12 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.25 2.22 . . . . 0.0 113.118 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 35' ' ' THR 0.347 64.5 mt -8.89 85.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 124.316 2.007 . . . . 0.0 115.009 -172.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.2 151.13 21.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 111.63 -2.532 . . . . 0.0 108.465 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.593 HD11 ' HB ' ' A' ' 32' ' ' THR . 3.3 tt -46.34 127.19 8.76 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.934 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.32 118.52 57.59 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 123.961 0.788 . . . . 0.0 111.252 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.92 144.07 69.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.727 2.284 . . . . 0.0 112.177 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.5 158.23 35.01 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.765 0.826 . . . . 0.0 111.267 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 29' ' ' PHE . 7.6 tp -159.89 148.97 17.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.319 1.847 . . . . 0.0 110.425 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.9 -157.22 28.95 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 121.062 1.756 . . . . 0.0 110.069 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.4 mt -141.7 134.94 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.45 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 136.61 53.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.543 1.137 . . . . 0.0 110.772 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -73.29 151.88 41.18 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.004 0.907 . . . . 0.0 109.746 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.9 26.46 1.37 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.619 -1.301 . . . . 0.0 111.633 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.47 -50.29 5.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 110.717 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 173.29 10.34 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.231 0.957 . . . . 0.0 112.987 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.7 m -83.93 -31.64 25.52 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.762 1.225 . . . . 0.0 113.366 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -128.51 54.94 15.09 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.243 1.417 . . . . 0.0 111.381 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.66 165.18 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.042 2.495 . . . . 0.0 117.553 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.3 p -81.11 164.27 22.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.115 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -158.78 163.47 36.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.215 -0.928 . . . . 0.0 113.021 175.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.89 140.1 6.12 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -159.68 157.55 29.76 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -95.84 151.55 19.3 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.302 1.441 . . . . 0.0 110.651 174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.44 118.13 48.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 24.8 t-20 -93.72 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 109.554 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.301 43.8 m95 -83.07 135.48 34.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.82 -44.02 9.19 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.953 2.101 . . . . 0.0 116.321 -173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -91.02 -9.56 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -152.79 126.8 9.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.507 2.323 . . . . 0.0 107.06 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -69.25 118.48 12.19 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.965 1.257 . . . . 0.0 110.503 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -177.23 164.23 2.16 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 126.329 1.851 . . . . 0.0 109.193 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -144.18 143.84 31.27 Favored 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.542 1.639 . . . . 0.0 111.549 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.31 125.17 21.12 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 110.33 -3.123 . . . . 0.0 109.691 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -100.67 152.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -126.33 142.17 51.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.54 118.14 7.01 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -174.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.1 -164.94 14.67 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.413 HE22 ' N ' ' D' ' 103' ' ' VAL . 14.6 tt0 -130.3 150.0 51.74 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.485 0.756 . . . . 0.0 112.216 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.5 t -94.86 124.93 39.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.7 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' HB2' HD12 ' D' ' 106' ' ' ILE . 5.0 m-85 -114.46 163.48 15.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.242 1.017 . . . . 0.0 111.966 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.87 110.72 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.16 161.22 9.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.249 0.619 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.37 -51.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -69.24 -33.46 73.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.8 42.44 0.73 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.906 1.241 . . . . 0.0 111.734 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 128' ' ' GLU . 3.4 mtpt -110.44 142.64 41.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.302 1.441 . . . . 0.0 109.85 175.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -101.58 140.33 36.01 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.856 1.262 . . . . 0.0 111.613 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 20.1 m -143.62 160.32 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.372 1.069 . . . . 0.0 108.681 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.69 119.25 33.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 119.51 39.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.531 HG22 ' HE1' ' A' ' 64' ' ' PHE . 4.4 p -137.7 172.27 13.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 123.131 1.443 . . . . 0.0 111.992 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.585 ' HG3' HG21 ' D' ' 113' ' ' THR . 87.9 mmm -126.02 168.9 13.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.588 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -141.49 164.06 31.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.168 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.669 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.2 tt -148.15 119.67 7.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.056 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.57 140.11 41.06 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.181 1.467 . . . . 0.0 112.11 -173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -120.16 120.97 37.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 110.804 -2.907 . . . . 0.0 111.237 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -88.7 163.52 15.73 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 125.496 1.748 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t -113.81 70.85 0.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' N ' HE22 ' D' ' 82' ' ' GLN . 27.8 m -61.83 -167.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 111.001 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.44 -15.16 3.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 119.738 -1.851 . . . . 0.0 114.776 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.77 150.23 43.07 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.87 1.319 . . . . 0.0 110.315 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' D' ' 92' ' ' VAL . 16.6 tt -62.85 -28.38 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.708 174.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.82 6.89 10.58 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.244 -1.309 . . . . 0.0 113.472 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -121.08 -1.36 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.85 1.325 . . . . 0.0 113.632 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -59.08 -34.75 72.34 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.623 -1.298 . . . . 0.0 112.158 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.73 -39.56 18.07 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.724 1.21 . . . . 0.0 114.16 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.32 -7.65 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.285 1.434 . . . . 0.0 114.011 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 1.8 9.6 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.163 -0.961 . . . . 0.0 113.016 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.669 ' CG2' HD21 ' A' ' 98' ' ' LEU . 34.0 m -116.97 145.23 43.77 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.865 0.866 . . . . 0.0 111.537 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.52 129.05 18.06 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 125.759 1.624 . . . . 0.0 110.659 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.71 155.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 120.483 1.492 . . . . 0.0 109.367 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -175.31 28.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.542 1.067 . . . . 0.0 113.08 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 21.4 p90 -125.97 153.01 44.92 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.064 0.945 . . . . 0.0 110.782 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -144.85 152.97 41.1 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.695 1.198 . . . . 0.0 109.865 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.1 mt -135.06 122.17 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -110.6 149.18 30.78 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.521 0.677 . . . . 0.0 110.427 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.5 p -134.16 162.83 31.06 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.081 -1.012 . . . . 0.0 109.662 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -56.87 114.82 2.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.451 0.701 . . . . 0.0 109.928 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -67.79 95.05 0.49 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 175.12 -45.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.679 2.392 . . . . 0.0 114.311 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 m 39.06 58.03 1.87 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.243 1.817 . . . . 0.0 113.166 -174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -140.62 131.33 25.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.436 1.094 . . . . 0.0 111.091 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt 88.04 94.24 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 129.97 3.308 . . . . 0.0 108.488 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 1.3 tp10 . . . . . 0 C--O 1.248 0.975 0 C-N-CA 127.693 2.397 . . . . 0.0 107.235 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . 0.514 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 8.2 tp60 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 117.61 -1.186 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 3.3 m -121.01 -33.38 3.74 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 5.0 t 52.0 80.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.157 1.783 . . . . 0.0 114.694 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.62 -30.42 0.27 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 52.89 64.12 1.98 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.537 1.535 . . . . 0.0 112.989 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -140.8 109.2 5.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.349 -0.844 . . . . 0.0 112.484 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . 0.466 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 24.5 p -122.43 135.22 54.64 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.373 1.469 . . . . 0.0 110.236 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -139.91 134.4 31.55 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.389 -1.445 . . . . 0.0 114.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' D' ' 64' ' ' PHE . 43.1 mt -58.6 -32.94 69.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -51.5 117.32 2.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 123.35 1.547 . . . . 0.0 112.098 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.52 -116.72 1.75 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.687 1.613 . . . . 0.0 110.351 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -151.92 147.15 26.24 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -141.27 162.78 34.65 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.83 1.652 . . . . 0.0 111.927 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -139.73 148.08 41.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.938 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.54 HD22 ' H ' ' D' ' 14' ' ' LEU . 0.5 OUTLIER -113.05 146.98 38.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.781 0.832 . . . . 0.0 110.585 -176.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -57.9 -26.38 62.09 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.54 ' H ' HD22 ' D' ' 12' ' ' ASN . 35.1 tp -72.16 -16.91 61.98 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.451 1.5 . . . . 0.0 111.74 174.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.04 -13.74 23.99 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 127.136 2.303 . . . . 0.0 113.627 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -69.77 155.66 40.2 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.308 1.554 . . . . 0.0 112.841 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -127.81 138.35 52.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.044 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -124.11 136.64 54.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.261 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -126.67 131.25 51.45 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.2 127.12 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.03 -89.93 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.91 141.32 32.98 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.608 -0.937 . . . . 0.0 111.219 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -91.4 130.07 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.83 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -67.92 165.09 18.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.908 0.861 . . . . 0.0 111.885 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 28.7 p -57.37 -26.96 61.85 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -73.58 -31.97 63.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.849 0.75 . . . . 0.0 111.722 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.99 25.32 Favored Glycine 0 N--CA 1.462 0.389 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.344 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.3 156.81 38.77 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.582 1.191 . . . . 0.0 112.872 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . 0.421 ' O ' HD12 ' D' ' 50' ' ' LEU . 31.1 p90 -160.35 160.25 32.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.389 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.505 HG22 ' CD1' ' D' ' 50' ' ' LEU . 0.9 OUTLIER -120.45 156.98 30.33 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 173.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.78 -167.82 28.04 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 120.11 -1.619 . . . . 0.0 112.527 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.604 ' HB ' HD11 ' D' ' 46' ' ' LEU . 45.5 p -140.0 137.74 34.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 122.351 1.072 . . . . 0.0 112.474 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -114.62 139.14 49.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.77 -1.559 . . . . 0.0 108.476 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' D' ' 46' ' ' LEU . 44.3 mt -130.79 127.23 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.534 ' O ' HG21 ' D' ' 44' ' ' ILE . 86.7 m -105.1 144.17 32.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.64 -21.41 18.24 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.41 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.01 143.75 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 112.974 -174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.49 39.25 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.722 -0.611 . . . . 0.0 110.238 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.68 -23.46 58.63 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 121.984 -0.447 . . . . 0.0 110.935 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -146.6 68.7 12.12 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.263 2.225 . . . . 0.0 111.087 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' D' ' 44' ' ' ILE . 38.7 Cg_endo -56.79 -78.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 125.05 3.833 . . . . 0.0 116.89 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.66 -48.74 0.01 OUTLIER Glycine 0 CA--C 1.545 1.931 0 C-N-CA 129.651 3.501 . . . . 0.0 120.587 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -125.68 -5.15 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 127.176 2.19 . . . . 0.0 113.03 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.534 HG21 ' O ' ' D' ' 35' ' ' THR 0.345 64.9 mt -8.92 86.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 124.337 2.018 . . . . 0.0 115.068 -172.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.29 151.47 21.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.55 174.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.604 HD11 ' HB ' ' D' ' 32' ' ' THR . 3.5 tt -46.51 126.87 8.72 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.295 -2.23 . . . . 0.0 111.772 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 4.7 p -102.85 118.68 57.72 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 123.844 0.715 . . . . 0.0 111.381 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.84 144.15 67.88 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.66 2.24 . . . . 0.0 111.962 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.44 162.75 24.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.551 0.74 . . . . 0.0 111.516 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.505 ' CD1' HG22 ' D' ' 30' ' ' THR . 15.9 tp -164.22 149.02 10.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.894 1.678 . . . . 0.0 112.129 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.19 -154.62 25.65 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 120.933 1.697 . . . . 0.0 110.498 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.2 mt -144.35 133.42 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.359 1.076 . . . . 0.0 110.929 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 136.71 54.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.28 1.432 . . . . 0.0 110.497 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -73.8 151.26 40.63 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.28 -0.887 . . . . 0.0 109.971 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -144.62 26.47 1.42 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.696 -1.252 . . . . 0.0 111.58 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -93.42 -49.28 6.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 111.289 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 172.8 12.6 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -80.01 -30.66 39.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.781 1.232 . . . . 0.0 113.11 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -133.29 57.68 28.8 Favored Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -71.76 164.25 36.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 N-CA-C 117.494 2.075 . . . . 0.0 117.494 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -81.21 164.1 22.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.944 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' D' ' 6' ' ' LEU . 0.1 OUTLIER -158.35 163.56 37.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.871 0.844 . . . . 0.0 112.758 175.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.43 140.09 6.08 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -159.56 157.91 30.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -96.11 151.38 19.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.91 1.684 . . . . 0.0 110.648 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.47 118.74 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 52' ' ' ILE . 25.7 t-20 -94.93 113.29 25.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.966 0.906 . . . . 0.0 109.523 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.297 43.8 m95 -82.53 136.01 34.96 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -173.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -92.41 -43.25 9.32 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.899 2.08 . . . . 0.0 116.417 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -91.37 -9.72 43.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.77 127.41 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.422 2.289 . . . . 0.0 107.171 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -69.52 118.48 12.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.009 1.277 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -177.34 163.91 2.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.31 1.844 . . . . 0.0 109.039 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.5 t -144.0 143.78 31.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.893 1.806 . . . . 0.0 111.721 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 110.224 -3.171 . . . . 0.0 109.869 -172.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.1 153.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -127.12 141.97 51.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.36 118.37 7.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -164.95 14.61 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 116.401 1.32 . . . . 0.0 116.401 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.419 HE22 ' N ' ' A' ' 103' ' ' VAL . 14.5 tt0 -131.09 149.75 52.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.245 0.615 . . . . 0.0 112.024 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.466 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 37.9 t -97.25 122.28 40.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.211 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.7 m-85 -109.35 163.46 13.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.138 0.975 . . . . 0.0 112.008 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.79 107.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 160.84 5.36 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.251 0.548 . . . . 0.0 110.103 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -31.09 -49.97 0.14 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -25.87 61.06 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.83 51.51 1.17 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.881 0.764 . . . . 0.0 111.286 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -120.16 147.73 44.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 128.261 2.624 . . . . 0.0 105.346 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -113.7 137.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.804 1.242 . . . . 0.0 110.135 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 106' ' ' ILE . 26.0 m -139.71 161.86 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 110.05 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.01 120.05 36.64 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 118.41 36.7 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.534 HG22 ' HE1' ' D' ' 64' ' ' PHE . 3.9 p -137.11 171.84 13.9 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 123.303 1.525 . . . . 0.0 112.151 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.576 ' HG3' HG21 ' A' ' 113' ' ' THR . 88.5 mmm -125.95 168.88 13.29 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -141.07 163.72 32.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.312 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.66 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.3 tt -148.11 120.1 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.84 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 140.33 40.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 123.23 1.49 . . . . 0.0 112.044 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.08 119.86 34.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 110.89 -2.868 . . . . 0.0 110.758 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -86.15 162.97 18.11 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 125.257 1.598 . . . . 0.0 112.044 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 3.8 t -112.83 73.17 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.413 ' N ' HE22 ' A' ' 82' ' ' GLN . 27.9 m -63.14 -166.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.452 0.701 . . . . 0.0 110.709 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.11 -14.54 3.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 119.907 -1.746 . . . . 0.0 114.569 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -123.46 149.49 45.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 123.086 1.422 . . . . 0.0 110.516 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 17.2 tt -62.01 -29.37 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.111 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.0 5.92 11.66 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.45 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -120.41 -1.77 10.13 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.01 1.405 . . . . 0.0 113.575 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -57.82 -34.99 70.26 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.652 -1.28 . . . . 0.0 112.745 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 62.7 p-90 -47.51 -39.8 17.02 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.079 1.352 . . . . 0.0 113.912 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -99.21 -6.8 27.49 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.322 1.449 . . . . 0.0 114.114 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.75 1.46 10.35 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.88 -1.137 . . . . 0.0 113.126 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.66 ' CG2' HD21 ' D' ' 98' ' ' LEU . 34.7 m -117.29 145.24 44.1 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.574 0.75 . . . . 0.0 111.604 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -144.17 129.05 18.42 Favored 'General case' 0 C--O 1.214 -0.81 0 C-N-CA 125.53 1.532 . . . . 0.0 110.681 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.74 155.15 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 120.531 1.514 . . . . 0.0 109.504 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.21 -175.53 29.24 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.628 1.109 . . . . 0.0 113.002 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 21.7 p90 -125.87 153.48 44.09 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.039 0.936 . . . . 0.0 110.68 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.33 153.24 41.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.675 1.19 . . . . 0.0 109.706 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 80.9 mt -135.37 123.93 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.52 149.51 32.57 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.214 0.53 . . . . 0.0 111.064 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -133.56 164.93 26.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.939 0.896 . . . . 0.0 109.82 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -60.93 121.14 11.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.104 -0.997 . . . . 0.0 109.979 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.08 147.5 47.15 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 121.765 -0.584 . . . . 0.0 110.14 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 72.63 -52.47 0.7 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.705 2.802 . . . . 0.0 115.194 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . 0.271 8.6 t 43.59 -162.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.819 1.248 . . . . 0.0 112.41 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -151.22 -49.25 0.12 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.782 2.033 . . . . 0.0 109.128 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -95.09 152.19 18.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 127.377 2.271 . . . . 0.0 110.371 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.134 -2.365 . . . . 0.0 110.892 174.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 2.9 m -138.79 165.99 25.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.319 1.448 . . . . 0.0 107.874 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.74 152.33 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.14 0.976 . . . . 0.0 110.203 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.19 150.98 44.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.534 1.133 . . . . 0.0 108.913 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -145.91 65.64 1.22 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.14 1.376 . . . . 0.0 110.09 -174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -151.99 105.38 3.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.645 0.778 . . . . 0.0 111.232 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.41 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 26.0 p -117.59 134.94 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.322 1.849 . . . . 0.0 109.619 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -139.75 135.71 33.39 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.414 -1.429 . . . . 0.0 114.193 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' B' ' 64' ' ' PHE . 40.7 mt -60.46 -30.57 69.76 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -53.5 116.81 2.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.713 1.244 . . . . 0.0 111.582 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.65 -116.11 1.54 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.474 1.512 . . . . 0.0 110.369 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -152.68 145.3 24.22 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -139.63 162.15 35.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.11 1.364 . . . . 0.0 111.553 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -141.51 145.57 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.607 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.463 HD22 ' H ' ' B' ' 14' ' ' LEU . 0.5 OUTLIER -109.21 148.85 30.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.062 0.945 . . . . 0.0 110.744 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -57.47 -28.91 63.8 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.463 ' H ' HD22 ' B' ' 12' ' ' ASN . 32.4 tp -72.18 -14.87 61.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.367 1.867 . . . . 0.0 111.91 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.78 -14.02 29.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 127.048 2.261 . . . . 0.0 113.461 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 54.1 p -69.35 155.83 39.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.233 1.516 . . . . 0.0 112.683 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -127.95 139.58 52.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.935 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -125.69 134.83 51.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.563 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -124.97 131.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.0 mt -135.01 127.83 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.6 -89.6 0.11 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.048 0.842 . . . . 0.0 112.52 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.4 140.5 32.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.714 -0.874 . . . . 0.0 111.554 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.3 t -90.96 129.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.402 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -67.73 165.8 16.55 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.576 0.703 . . . . 0.0 111.533 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 27.5 p -56.98 -27.42 61.37 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -74.89 -32.79 61.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.785 0.721 . . . . 0.0 111.877 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.62 -7.32 26.16 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.164 -1.353 . . . . 0.0 112.856 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' C' ' 50' ' ' LEU . 9.7 pt-20 -66.11 144.58 56.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.857 1.328 . . . . 0.0 108.464 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.415 ' O ' HD12 ' B' ' 50' ' ' LEU . 21.1 p90 -158.44 146.16 18.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.783 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.4 p -107.69 162.25 14.15 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.894 0.877 . . . . 0.0 108.76 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.84 36.86 Favored Glycine 0 C--O 1.238 0.372 0 O-C-N 121.245 -0.909 . . . . 0.0 112.608 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.6 ' HB ' HD11 ' B' ' 46' ' ' LEU . 43.9 p -140.17 139.24 35.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.335 1.064 . . . . 0.0 112.292 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -114.38 139.09 49.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.477 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.519 HD11 HD12 ' B' ' 46' ' ' LEU . 43.1 mt -131.2 127.1 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.535 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.5 m -105.0 145.47 30.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.45 -22.37 17.17 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -132.61 143.44 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.553 1.141 . . . . 0.0 113.093 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.62 159.5 39.68 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.387 -0.82 . . . . 0.0 110.083 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.46 -23.49 58.9 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.017 -0.427 . . . . 0.0 111.083 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.78 68.62 11.84 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 127.256 2.223 . . . . 0.0 110.945 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.436 ' HB3' HD11 ' B' ' 44' ' ' ILE . 38.4 Cg_endo -56.85 -78.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 125.083 3.856 . . . . 0.0 116.776 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.82 -48.46 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 C-N-CA 129.582 3.468 . . . . 0.0 120.568 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.98 -5.29 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.283 2.233 . . . . 0.0 113.114 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.535 HG21 ' O ' ' B' ' 35' ' ' THR 0.349 65.7 mt -8.58 85.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 124.354 2.026 . . . . 0.0 115.147 -172.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.89 151.11 21.21 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.501 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.6 HD11 ' HB ' ' B' ' 32' ' ' THR . 3.4 tt -46.34 127.3 8.86 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.777 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.9 p -103.46 118.72 56.98 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 123.951 0.782 . . . . 0.0 111.405 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.85 144.12 68.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.58 158.44 34.62 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.728 0.811 . . . . 0.0 111.22 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.415 HD12 ' O ' ' B' ' 29' ' ' PHE . 7.4 tp -160.03 148.94 17.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.409 1.884 . . . . 0.0 110.453 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.86 -157.28 29.01 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 121.018 1.735 . . . . 0.0 110.236 -174.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.4 mt -141.62 135.0 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.64 0.733 . . . . 0.0 111.491 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.56 136.71 53.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.723 1.209 . . . . 0.0 110.843 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -73.48 152.49 40.7 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.993 0.902 . . . . 0.0 109.756 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -144.86 25.82 1.42 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.537 -1.352 . . . . 0.0 111.773 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -93.23 -49.21 6.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.918 1.287 . . . . 0.0 111.238 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.23 172.53 12.69 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.557 1.161 . . . . 0.0 114.042 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.67 -28.6 36.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.492 1.117 . . . . 0.0 113.028 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -135.11 57.09 18.72 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.665 1.186 . . . . 0.0 111.52 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.77 163.95 37.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.598 2.865 . . . . 0.0 117.73 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 69.6 p -80.89 163.74 23.15 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.761 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' B' ' 6' ' ' LEU . 0.1 OUTLIER -158.76 162.84 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.346 -0.846 . . . . 0.0 112.811 175.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.76 140.03 6.08 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -159.59 158.17 31.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -96.37 151.46 19.52 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.477 1.511 . . . . 0.0 110.632 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -127.38 118.06 48.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 52' ' ' ILE . 24.6 t-20 -93.74 113.64 25.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.01 0.924 . . . . 0.0 109.501 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.298 43.8 m95 -83.06 135.05 34.98 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.44 -43.86 9.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.179 2.192 . . . . 0.0 116.361 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -91.14 -9.66 44.71 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -152.74 126.32 8.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.479 2.312 . . . . 0.0 106.912 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.12 118.49 12.09 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.046 1.294 . . . . 0.0 110.515 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -177.48 163.57 1.98 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.372 1.869 . . . . 0.0 109.176 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -143.63 144.25 31.82 Favored 'General case' 0 CA--C 1.482 -1.673 0 CA-C-O 123.376 1.56 . . . . 0.0 111.648 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 125.67 21.32 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 110.441 -3.072 . . . . 0.0 109.656 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.03 153.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -126.99 142.03 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 118.06 6.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.09 -165.01 14.76 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.433 HE22 ' H ' ' C' ' 103' ' ' VAL . 14.3 tt0 -130.83 149.61 52.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 124.928 1.016 . . . . 0.0 111.75 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.41 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 45.7 t -97.23 125.84 42.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.464 174.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.442 ' HB2' HD12 ' C' ' 106' ' ' ILE . 4.1 m-85 -113.07 165.44 12.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.267 1.027 . . . . 0.0 112.213 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 22.7 mt -130.56 110.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -58.91 162.08 4.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.258 0.623 . . . . 0.0 109.567 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -33.33 -48.94 0.26 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -13.44 60.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.64 43.45 4.22 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.225 0.92 . . . . 0.0 112.23 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 6.0 mtpt -113.36 142.67 45.59 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 127.389 2.276 . . . . 0.0 109.324 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -106.8 141.68 37.64 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.004 1.321 . . . . 0.0 111.271 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.8 m -144.55 160.37 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.589 1.156 . . . . 0.0 110.14 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.71 119.43 35.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 118.59 37.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.537 HG22 ' HE1' ' B' ' 64' ' ' PHE . 4.5 p -137.38 172.05 13.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.169 1.461 . . . . 0.0 112.189 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.588 ' HG3' HG21 ' C' ' 113' ' ' THR . 88.4 mmm -125.92 168.87 13.3 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.12 163.99 31.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.583 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -148.16 119.77 8.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.983 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 139.63 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 124.964 1.415 . . . . 0.0 112.176 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -119.38 120.35 36.63 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 110.684 -2.962 . . . . 0.0 110.676 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -87.79 163.35 16.5 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 125.319 1.637 . . . . 0.0 111.405 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -113.13 72.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.421 ' N ' HE22 ' C' ' 82' ' ' GLN . 27.2 m -63.58 -167.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.312 0.645 . . . . 0.0 110.269 174.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.03 -20.28 3.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.092 -1.63 . . . . 0.0 113.66 174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -115.38 148.3 39.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.991 1.377 . . . . 0.0 110.96 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.469 ' CD1' HG21 ' C' ' 92' ' ' VAL . 16.9 tt -62.85 -28.4 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 113.052 -1.885 . . . . 0.0 110.516 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.75 5.83 15.31 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 118.003 -1.443 . . . . 0.0 113.831 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -121.27 -0.93 9.79 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.95 1.375 . . . . 0.0 113.432 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.5 -35.86 70.79 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.737 -1.227 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.41 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 62.9 p-90 -47.22 -40.25 15.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.195 1.398 . . . . 0.0 113.802 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -99.04 -7.07 27.36 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.241 1.416 . . . . 0.0 113.943 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.58 13.05 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.627 -1.295 . . . . 0.0 113.165 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.672 ' CG2' HD21 ' B' ' 98' ' ' LEU . 33.1 m -115.09 145.47 42.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.869 0.868 . . . . 0.0 111.757 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.78 129.86 18.51 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 125.876 1.671 . . . . 0.0 110.42 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.66 155.13 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 120.421 1.464 . . . . 0.0 109.353 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.68 -175.07 28.19 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.673 1.13 . . . . 0.0 113.517 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 21.1 p90 -126.29 152.84 45.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.13 0.972 . . . . 0.0 110.71 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -145.15 151.57 38.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.528 1.131 . . . . 0.0 110.304 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.86 119.74 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -108.69 152.28 25.03 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.933 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -136.91 162.15 34.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.23 1.012 . . . . 0.0 109.566 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -54.55 125.79 21.07 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.51 -0.744 . . . . 0.0 109.668 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.36 83.18 0.56 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 72.52 167.0 0.31 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.823 2.449 . . . . 0.0 108.694 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 3.3 t -171.48 -57.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.196 0.999 . . . . 0.0 111.216 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 55.14 -167.92 0.09 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.871 1.268 . . . . 0.0 110.992 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 150.07 132.53 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 130.911 3.684 . . . . 0.0 107.859 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.019 0 O-C-N 126.856 2.597 . . . . 0.0 109.663 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 4.4 p -71.71 163.69 27.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.555 1.07 . . . . 0.0 111.868 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.11 -15.57 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 43.39 -132.23 0.63 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 126.092 1.757 . . . . 0.0 114.519 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . 0.354 0.0 OUTLIER 44.88 17.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 129.673 3.189 . . . . 0.0 117.496 -174.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -151.98 105.07 3.05 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.686 -1.259 . . . . 0.0 111.874 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 24.0 p -119.27 133.41 55.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.279 1.832 . . . . 0.0 109.228 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 78.9 p -139.83 133.21 30.01 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.243 -1.536 . . . . 0.0 114.148 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.629 HD21 ' CE2' ' C' ' 64' ' ' PHE . 40.8 mt -58.23 -32.82 68.68 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -51.76 116.3 2.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.903 1.335 . . . . 0.0 111.729 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.95 -114.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 125.66 1.6 . . . . 0.0 109.829 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -152.9 148.22 26.89 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -141.12 162.67 34.93 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.267 1.427 . . . . 0.0 112.315 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -135.45 147.3 48.89 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.859 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . 0.436 HD22 ' H ' ' C' ' 14' ' ' LEU . 0.4 OUTLIER -111.67 146.81 36.81 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.591 0.756 . . . . 0.0 110.475 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -57.1 -27.46 61.79 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.436 ' H ' HD22 ' C' ' 12' ' ' ASN . 34.9 tp -72.64 -16.25 61.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.126 1.77 . . . . 0.0 111.986 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.56 -13.81 25.15 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.128 2.299 . . . . 0.0 113.662 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 44.1 p -69.16 156.31 38.92 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.489 1.645 . . . . 0.0 113.128 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -128.86 138.93 52.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.848 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -124.08 136.87 54.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.26 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -126.68 130.72 50.96 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.97 126.87 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.83 -89.59 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.898 0.749 . . . . 0.0 112.63 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.42 32.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.619 -0.93 . . . . 0.0 111.206 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.33 130.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.08 165.33 18.29 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.589 0.709 . . . . 0.0 111.782 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 30.6 p -57.78 -26.76 62.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -73.65 -32.04 63.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.975 0.807 . . . . 0.0 111.733 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.08 -4.55 25.48 Favored Glycine 0 N--CA 1.463 0.462 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.392 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.73 156.49 39.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.432 1.116 . . . . 0.0 112.766 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . 0.417 ' O ' HD12 ' C' ' 50' ' ' LEU . 31.0 p90 -159.81 159.93 33.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.258 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.512 HG22 ' CD1' ' C' ' 50' ' ' LEU . 1.0 OUTLIER -120.34 157.11 29.93 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 173.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.08 -167.33 27.6 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 120.054 -1.654 . . . . 0.0 112.627 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.581 ' HB ' HD11 ' C' ' 46' ' ' LEU . 54.0 p -139.79 138.14 35.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.514 1.149 . . . . 0.0 112.783 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.9 139.45 49.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.371 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.517 HD11 HD12 ' C' ' 46' ' ' LEU . 42.8 mt -131.16 127.06 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 174.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.542 ' O ' HG21 ' C' ' 44' ' ' ILE . 85.1 m -105.05 145.03 31.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.98 -20.12 18.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.49 142.89 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.548 1.139 . . . . 0.0 113.197 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.42 159.37 39.8 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.326 -0.859 . . . . 0.0 110.215 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.38 -23.42 58.99 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 110.99 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -146.71 68.88 12.07 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 127.239 2.216 . . . . 0.0 111.029 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.448 ' HB3' HD11 ' C' ' 44' ' ' ILE . 38.6 Cg_endo -56.92 -78.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 125.054 3.836 . . . . 0.0 116.86 -173.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.51 -48.85 0.01 OUTLIER Glycine 0 CA--C 1.546 1.982 0 C-N-CA 129.65 3.5 . . . . 0.0 120.591 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -125.49 -5.08 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.307 2.243 . . . . 0.0 113.167 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.542 HG21 ' O ' ' C' ' 35' ' ' THR 0.345 65.6 mt -9.02 85.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 124.465 2.078 . . . . 0.0 115.301 -172.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.88 151.36 20.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.525 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.581 HD11 ' HB ' ' C' ' 32' ' ' THR . 3.4 tt -46.48 127.08 8.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 112.181 -2.282 . . . . 0.0 111.777 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -103.25 118.71 57.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 123.85 0.718 . . . . 0.0 111.376 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.74 144.29 66.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.755 2.303 . . . . 0.0 111.869 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.63 162.73 25.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.545 0.738 . . . . 0.0 111.702 175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' C' ' 30' ' ' THR . 15.6 tp -164.46 148.97 9.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.778 1.631 . . . . 0.0 112.166 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.73 25.79 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 120.866 1.666 . . . . 0.0 110.488 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -143.76 135.18 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.209 1.004 . . . . 0.0 110.984 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.58 136.55 52.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.311 1.444 . . . . 0.0 110.34 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -73.72 151.44 40.7 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.889 0.852 . . . . 0.0 110.172 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -144.56 25.68 1.48 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.573 -1.329 . . . . 0.0 112.017 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -93.51 -49.96 5.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.28 1.432 . . . . 0.0 111.239 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.64 173.11 11.48 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.691 1.245 . . . . 0.0 113.659 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -83.0 -26.47 31.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.107 1.363 . . . . 0.0 113.46 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -134.91 55.74 14.77 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 125.438 1.495 . . . . 0.0 112.2 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.28 163.72 37.66 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.794 2.329 . . . . 0.0 117.878 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 68.2 p -80.86 164.18 22.84 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.033 173.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.629 ' CE2' HD21 ' C' ' 6' ' ' LEU . 0.1 OUTLIER -159.21 163.33 36.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.874 0.845 . . . . 0.0 113.118 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.74 140.81 6.53 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 117.816 1.886 . . . . 0.0 117.816 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -160.3 158.55 30.0 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.7 m -96.63 152.02 19.05 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.118 1.767 . . . . 0.0 110.709 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 61.9 t -128.34 118.12 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' B' ' 52' ' ' ILE . 26.1 t-20 -94.22 113.14 25.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.017 0.927 . . . . 0.0 109.447 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.295 43.6 m95 -82.46 135.43 35.13 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -172.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -91.56 -44.07 9.29 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.956 2.102 . . . . 0.0 116.226 -173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -90.89 -9.49 46.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.0 t -152.74 126.84 9.09 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 127.448 2.299 . . . . 0.0 107.065 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -69.19 118.48 12.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.0 1.273 . . . . 0.0 110.407 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -177.34 163.59 2.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.393 1.877 . . . . 0.0 109.142 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -143.69 143.89 31.62 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 124.067 1.889 . . . . 0.0 111.613 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.44 125.71 21.65 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 109.99 -3.277 . . . . 0.0 109.86 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.33 153.58 4.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.79 142.15 51.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.72 118.94 7.26 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -174.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.88 -164.29 14.16 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.421 HE22 ' N ' ' B' ' 103' ' ' VAL . 14.5 tt0 -132.06 149.46 52.41 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.541 0.789 . . . . 0.0 111.812 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.438 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 41.4 t -97.21 123.26 40.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.318 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' B' ' 106' ' ' ILE . 2.1 m-85 -112.34 164.71 12.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.264 1.025 . . . . 0.0 112.203 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -128.11 111.78 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.85 160.18 6.11 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -33.42 -47.74 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -10.06 59.13 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.07 5.79 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.524 1.056 . . . . 0.0 112.644 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -112.99 143.21 44.68 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 128.208 2.603 . . . . 0.0 108.959 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -109.45 143.93 38.38 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.489 1.495 . . . . 0.0 110.865 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' B' ' 106' ' ' ILE . 22.7 m -144.95 162.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.581 1.152 . . . . 0.0 109.606 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.63 121.02 39.16 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.84 119.07 38.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.532 HG22 ' HE1' ' C' ' 64' ' ' PHE . 4.7 p -137.31 172.54 12.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.083 1.42 . . . . 0.0 112.371 -174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.586 ' HG3' HG21 ' B' ' 113' ' ' THR . 88.7 mmm -126.97 169.22 13.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -141.15 164.37 30.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.389 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.2 tt -148.27 120.01 8.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.949 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.19 140.2 40.43 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 125.022 1.451 . . . . 0.0 112.231 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -120.25 120.74 36.98 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 111.208 -2.724 . . . . 0.0 111.129 -174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 38.4 t -88.56 163.18 15.99 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 125.176 1.548 . . . . 0.0 111.351 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -113.0 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . 0.433 ' H ' HE22 ' B' ' 82' ' ' GLN . 27.8 m -63.96 -165.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.439 0.695 . . . . 0.0 110.453 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.36 -15.65 3.19 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.074 -1.641 . . . . 0.0 114.054 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.58 148.89 43.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.13 1.443 . . . . 0.0 110.798 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.473 ' CD1' HG21 ' B' ' 92' ' ' VAL . 16.6 tt -62.18 -28.34 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.932 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.28 5.84 18.35 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-O 118.121 -1.377 . . . . 0.0 113.866 173.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.17 -1.43 9.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.587 1.194 . . . . 0.0 113.481 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -58.07 -35.71 71.76 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.738 -1.226 . . . . 0.0 112.581 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.42 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 62.7 p-90 -47.1 -39.8 13.98 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.018 1.327 . . . . 0.0 113.903 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -99.28 -7.21 26.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.16 2.04 9.89 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.537 -1.352 . . . . 0.0 113.09 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.683 ' CG2' HD21 ' C' ' 98' ' ' LEU . 35.8 m -116.96 145.08 43.87 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.977 0.911 . . . . 0.0 111.618 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -144.23 129.37 18.65 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 125.68 1.592 . . . . 0.0 110.62 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.66 155.08 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 120.558 1.526 . . . . 0.0 109.246 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.47 -175.82 28.83 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.681 1.134 . . . . 0.0 113.441 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 21.1 p90 -125.45 152.95 44.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.541 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.61 152.66 40.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.75 1.22 . . . . 0.0 110.151 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.16 121.5 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -109.02 152.69 24.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -141.02 164.08 31.24 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.136 0.975 . . . . 0.0 110.676 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.39 114.38 2.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.097 0.959 . . . . 0.0 111.24 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.95 140.71 57.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.714 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . 0.325 0.0 OUTLIER 58.46 33.94 23.53 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 4.9 t -61.25 170.03 1.89 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.288 0.635 . . . . 0.0 112.646 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.01 125.92 54.6 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -149.53 110.42 4.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.931 1.292 . . . . 0.0 108.832 -173.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.312 21.8 pm0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.476 1.911 . . . . 0.0 115.081 -173.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 115.659 -2.115 . . . . 0.0 105.708 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 7.1 m 34.2 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.18 1.792 . . . . 0.0 113.267 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . 0.338 31.7 m 55.83 -140.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 117.175 -1.393 . . . . 0.0 110.115 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 164.01 -46.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.392 2.677 . . . . 0.0 112.681 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -149.26 96.75 2.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.868 1.267 . . . . 0.0 109.91 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -156.85 120.62 4.26 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.378 1.445 . . . . 0.0 114.492 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 134.2 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.219 1.408 . . . . 0.0 111.273 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.43 127.54 13.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.022 1.329 . . . . 0.0 109.234 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -73.74 -27.7 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.77 116.1 1.65 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.86 1.264 . . . . 0.0 111.204 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.33 -123.52 2.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.411 1.482 . . . . 0.0 110.97 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -147.62 144.65 28.56 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -142.67 159.15 42.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.369 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -141.33 146.95 37.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 16' ' ' SER . 25.2 p30 -114.21 159.37 20.2 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -55.99 -26.06 46.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.146 2.578 . . . . 0.0 115.164 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' C' ' 110' ' ' TRP . 30.1 tp -76.27 -11.97 60.0 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.608 1.163 . . . . 0.0 111.974 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.89 47.28 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 127.145 2.307 . . . . 0.0 112.931 176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 12' ' ' ASN . 15.8 m -69.21 154.91 41.28 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.596 1.189 . . . . 0.0 111.598 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -128.99 150.56 50.35 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.736 -1.227 . . . . 0.0 110.273 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -134.47 145.4 48.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.339 0.59 . . . . 0.0 112.159 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.6 m -129.2 134.75 48.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.767 0.827 . . . . 0.0 109.231 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.31 125.05 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -78.68 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 O-C-N 124.335 1.022 . . . . 0.0 111.199 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.85 30.92 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.83 -0.806 . . . . 0.0 112.407 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.61 132.17 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.337 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 7.6 m-20 -76.52 168.73 19.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.941 0.877 . . . . 0.0 112.521 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 p -56.07 -27.4 53.33 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -75.64 -34.0 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.539 0.609 . . . . 0.0 112.272 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.65 -10.38 14.26 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.985 -1.453 . . . . 0.0 113.501 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 24' ' ' ASN . 10.1 pt-20 -62.56 140.02 58.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.358 2.263 . . . . 0.0 108.991 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.86 147.57 24.34 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 p -107.39 169.31 8.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.566 1.147 . . . . 0.0 109.78 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.04 -168.2 37.18 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.377 -1.452 . . . . 0.0 114.905 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.536 ' HB ' HD11 ' A' ' 46' ' ' LEU . 5.2 p -140.53 129.56 23.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.375 1.084 . . . . 0.0 111.975 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -111.29 137.79 48.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.12 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.5 mt -127.22 127.43 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 44' ' ' ILE 0.264 73.7 m -105.06 133.0 50.57 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 125.051 1.34 . . . . 0.0 112.986 -172.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.51 27.63 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.46 146.79 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.016 1.327 . . . . 0.0 112.092 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.02 161.69 42.23 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.817 -1.177 . . . . 0.0 111.407 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.98 -29.07 55.36 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 122.037 -0.414 . . . . 0.0 110.353 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -143.02 78.95 14.88 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 127.338 2.255 . . . . 0.0 110.215 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.15 21.28 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.336 1 C-N-CA 125.474 4.116 . . . . 0.0 117.415 -174.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.6 -7.13 5.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 119.289 2.476 . . . . 0.0 119.289 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.93 43.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.686 1.743 . . . . 0.0 111.38 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 35' ' ' THR . 71.5 mt -51.21 125.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.34 -1.475 . . . . 0.0 111.272 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.63 30.4 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.692 1.597 . . . . 0.0 110.389 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 32' ' ' THR . 13.3 tp -46.71 115.37 1.03 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.971 2.909 . . . . 0.0 110.738 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 t -102.76 119.36 55.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.493 0.717 . . . . 0.0 109.554 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -55.86 142.66 83.79 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.261 2.641 . . . . 0.0 111.431 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.54 154.81 47.42 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 124.017 0.823 . . . . 0.0 111.017 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -156.54 148.75 23.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.736 1.614 . . . . 0.0 110.574 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.21 -157.55 29.43 Favored Glycine 0 C--N 1.333 0.405 0 O-C-N 119.738 -1.851 . . . . 0.0 110.641 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.3 mt -142.7 142.01 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.681 0.792 . . . . 0.0 112.836 -174.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.44 136.91 47.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.0 151.12 44.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.671 1.225 . . . . 0.0 112.105 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -151.33 26.95 0.68 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.352 1.861 . . . . 0.0 110.019 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.41 -57.04 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.881 1.672 . . . . 0.0 110.065 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.26 7.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.301 0.64 . . . . 0.0 112.08 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 p -95.19 -17.95 21.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 117.329 -1.32 . . . . 0.0 113.754 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -131.6 45.4 1.71 Allowed Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.895 1.278 . . . . 0.0 112.364 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 171.38 17.28 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.7 2.266 . . . . 0.0 115.452 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.298 0.1 OUTLIER -98.81 163.81 12.47 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.747 1.737 . . . . 0.0 111.199 173.156 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -158.34 166.11 33.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.911 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.6 145.12 10.12 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 118.999 2.359 . . . . 0.0 118.999 -173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -161.41 153.65 19.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -90.15 149.18 22.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.548 1.939 . . . . 0.0 110.314 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -128.17 118.53 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' D' ' 52' ' ' ILE . 21.3 t30 -101.67 101.81 12.38 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.449 -0.782 . . . . 0.0 110.429 -174.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -58.69 129.43 42.08 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.49 -32.29 16.42 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -99.8 -11.96 20.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -152.35 138.01 17.85 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.944 2.098 . . . . 0.0 106.728 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -73.45 118.62 16.62 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.59 1.186 . . . . 0.0 111.254 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.67 159.77 2.37 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.591 1.556 . . . . 0.0 109.604 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -136.58 134.66 37.66 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.4 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.887 HG23 HD12 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -123.02 138.0 54.8 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 174.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.78 155.2 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -130.96 143.99 51.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.078 0.951 . . . . 0.0 108.844 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.47 118.98 8.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.32 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.73 176.68 44.83 Favored Glycine 0 C--O 1.215 -1.077 0 N-CA-C 118.196 2.038 . . . . 0.0 118.196 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' D' ' 103' ' ' VAL . 0.0 OUTLIER -101.71 150.5 23.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.47 115.14 27.21 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 125.445 1.716 . . . . 0.0 107.086 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB2' HD12 ' D' ' 106' ' ' ILE . 25.5 m-85 -105.64 159.21 16.14 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.761 1.164 . . . . 0.0 113.266 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 16.0 mt -120.02 109.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 113.519 -1.673 . . . . 0.0 106.9 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.86 161.41 4.91 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -22.71 0.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -10.31 48.88 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.689 0.796 . . . . 0.0 112.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.75 6.44 56.24 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.487 1.042 . . . . 0.0 114.851 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 19.6 mtpp -73.82 165.51 24.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.773 1.286 . . . . 0.0 110.153 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.62 143.42 49.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.738 1.615 . . . . 0.0 111.473 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.543 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.51 153.17 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.09 0.956 . . . . 0.0 110.891 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.5 mt -116.46 103.59 10.59 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' CD ' HG11 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -97.06 114.45 26.09 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -133.26 164.54 26.85 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 123.216 1.484 . . . . 0.0 112.227 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' D' ' 113' ' ' THR . 92.9 mmm -115.29 167.87 10.47 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -139.07 163.87 31.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 0.0 113.423 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD12 HD12 ' D' ' 98' ' ' LEU . 0.4 OUTLIER -142.91 124.66 15.02 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.05 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.887 HD12 HG23 ' A' ' 77' ' ' THR . 1.7 tp -107.15 131.97 53.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 123.634 1.683 . . . . 0.0 109.036 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.2 tpt85 -114.79 113.67 24.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 111.036 -2.802 . . . . 0.0 109.232 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.271 1.0 OUTLIER -68.26 165.98 17.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.319 1.447 . . . . 0.0 111.688 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.1 t -107.3 86.95 2.39 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 121.465 1.939 . . . . 0.0 107.775 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.527 ' H ' ' NE2' ' D' ' 82' ' ' GLN . 8.1 p -86.66 157.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 129.294 3.038 . . . . 0.0 110.96 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -96.84 -34.14 11.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.47 148.84 32.28 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.777 0.799 . . . . 0.0 112.685 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' D' ' 84' ' ' PHE . 4.6 tt -62.37 -29.58 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.851 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.63 5.26 38.92 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' A' ' 103' ' ' VAL . 4.7 m-20 -123.4 0.03 8.82 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.333 1.567 . . . . 0.0 113.6 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -28.8 69.32 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.49 -1.381 . . . . 0.0 113.77 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.681 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 62.5 p-90 -49.64 -44.39 47.45 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.946 0.898 . . . . 0.0 113.223 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.681 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -87.63 -12.72 44.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.252 -0.905 . . . . 0.0 113.223 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 -0.69 26.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.513 -0.742 . . . . 0.0 112.247 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.608 HG21 ' HG3' ' D' ' 96' ' ' MET . 35.2 m -110.22 139.84 44.96 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.348 1.059 . . . . 0.0 111.054 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -144.23 132.96 22.39 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.737 1.215 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.7 p -112.31 154.66 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 120.275 1.398 . . . . 0.0 110.961 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.99 -174.45 27.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.938 0.78 . . . . 0.0 114.728 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 9.7 p90 -128.43 156.65 42.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.209 1.004 . . . . 0.0 112.209 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -152.16 150.23 29.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.243 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.43 HD13 ' HE3' ' A' ' 94' ' ' LYS . 9.0 mt -126.66 121.13 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.67 149.49 34.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.6 p -138.8 165.02 28.1 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.62 117.0 2.79 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.649 0.78 . . . . 0.0 110.546 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.0 tt -68.26 110.33 4.0 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.5 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.2 OUTLIER 177.09 -68.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.263 1.425 . . . . 0.0 110.115 174.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.7 t 38.63 29.37 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.015 2.526 . . . . 0.0 115.93 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -69.34 12.59 0.16 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm 69.46 5.47 5.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.6 1.96 . . . . 0.0 113.574 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 128.938 2.895 . . . . 0.0 110.354 173.209 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 63.73 8.27 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.666 1.575 . . . . 0.0 114.155 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.95 16.0 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.548 1.139 . . . . 0.0 113.763 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -62.71 -173.25 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.234 1.813 . . . . 0.0 113.769 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 58.78 20.83 8.32 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.61 -1.306 . . . . 0.0 113.707 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -156.75 123.07 4.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.207 -0.933 . . . . 0.0 113.019 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 t -133.04 142.81 48.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.669 0.787 . . . . 0.0 110.964 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.02 135.88 33.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.155 1.782 . . . . 0.0 108.801 174.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.51 -24.78 60.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.045 1.293 . . . . 0.0 113.858 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 115.73 1.7 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.94 1.296 . . . . 0.0 111.08 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.91 -125.72 3.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.982 1.277 . . . . 0.0 110.382 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -147.48 145.81 29.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -143.51 159.85 41.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -140.26 149.21 42.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' D' ' 16' ' ' SER . 24.6 p30 -113.88 160.15 19.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -56.24 -26.07 50.09 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.127 2.571 . . . . 0.0 114.912 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' B' ' 110' ' ' TRP . 29.1 tp -76.48 -11.04 59.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.793 1.237 . . . . 0.0 112.074 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.17 -15.21 56.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.832 2.158 . . . . 0.0 112.994 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . 0.432 ' HB2' HD21 ' D' ' 12' ' ' ASN . 15.4 m -69.76 154.75 41.54 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.64 1.21 . . . . 0.0 111.643 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.02 151.23 49.94 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.576 -1.327 . . . . 0.0 110.677 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -134.3 146.78 50.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -130.27 134.85 47.53 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.662 0.785 . . . . 0.0 109.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.75 124.18 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.91 -75.86 0.39 Allowed Glycine 0 CA--C 1.527 0.827 0 O-C-N 124.339 1.024 . . . . 0.0 111.394 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.85 156.99 42.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.561 0.695 . . . . 0.0 111.931 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.5 131.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.052 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -77.99 168.57 19.69 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.833 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 61.8 p -57.08 -26.65 60.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -75.04 -30.2 60.99 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.253 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.02 -8.24 18.86 Favored Glycine 0 N--CA 1.464 0.551 0 C-N-CA 124.666 1.127 . . . . 0.0 114.154 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.49 147.72 51.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.51 2.324 . . . . 0.0 113.683 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . 0.501 ' O ' HD12 ' D' ' 50' ' ' LEU . 52.2 p90 -156.56 161.61 39.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.023 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.414 HG22 HD13 ' D' ' 50' ' ' LEU . 3.0 p -119.2 172.72 7.39 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 173.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.4 -167.26 35.43 Favored Glycine 0 N--CA 1.467 0.756 0 O-C-N 119.349 -2.095 . . . . 0.0 114.143 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.531 ' HB ' HD11 ' D' ' 46' ' ' LEU . 5.0 p -139.52 129.24 24.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.482 1.134 . . . . 0.0 112.301 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -111.86 138.04 49.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.268 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 80.7 mt -127.16 127.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.424 ' O ' HG21 ' D' ' 44' ' ' ILE 0.264 90.5 m -105.1 133.82 49.23 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.816 1.246 . . . . 0.0 112.849 -172.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.65 -16.51 26.9 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 m -135.5 147.05 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.065 1.346 . . . . 0.0 112.167 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.4 161.04 42.71 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.806 -1.184 . . . . 0.0 111.74 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -76.22 -28.76 57.31 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.881 -0.512 . . . . 0.0 110.587 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -143.18 78.95 14.66 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.278 2.231 . . . . 0.0 110.311 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 21.09 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.316 1 C-N-CA 125.44 4.093 . . . . 0.0 117.403 -174.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.46 -7.04 5.17 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -176.15 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.136 1.774 . . . . 0.0 111.392 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.424 HG21 ' O ' ' D' ' 35' ' ' THR . 71.2 mt -51.05 126.31 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.303 -1.498 . . . . 0.0 111.288 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.73 164.66 31.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.606 1.562 . . . . 0.0 110.426 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.531 HD11 ' HB ' ' D' ' 32' ' ' THR . 13.4 tp -46.55 115.36 1.01 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.918 2.887 . . . . 0.0 110.562 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 3.8 t -103.2 118.63 57.44 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 123.607 0.763 . . . . 0.0 109.221 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.89 141.71 85.26 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.015 2.476 . . . . 0.0 111.094 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.41 ' C ' HD12 ' D' ' 49' ' ' LEU . 2.2 pp -129.76 162.18 29.02 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.199 0.999 . . . . 0.0 111.428 174.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.501 HD12 ' O ' ' D' ' 29' ' ' PHE . 18.7 tp -165.5 148.83 8.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.703 1.201 . . . . 0.0 112.104 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.72 25.77 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 121.227 1.83 . . . . 0.0 110.456 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.4 mt -145.19 141.83 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.878 0.987 . . . . 0.0 111.591 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 133.62 43.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.988 1.315 . . . . 0.0 114.515 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -67.31 147.31 53.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.443 1.116 . . . . 0.0 112.208 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -146.06 27.76 1.15 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.614 1.965 . . . . 0.0 110.127 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -93.12 -57.28 2.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.629 1.572 . . . . 0.0 110.133 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.55 175.31 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.527 0.731 . . . . 0.0 112.5 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.2 p -91.76 -20.59 21.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.673 1.189 . . . . 0.0 113.706 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -133.29 46.14 1.94 Allowed Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 125.227 1.411 . . . . 0.0 112.989 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.76 170.51 19.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.692 2.261 . . . . 0.0 116.006 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.296 0.0 OUTLIER -97.89 161.98 13.47 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 124.023 1.868 . . . . 0.0 111.465 173.092 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.09 166.37 33.48 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.369 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.86 145.52 10.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 118.656 2.223 . . . . 0.0 118.656 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -161.91 152.98 18.04 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -89.44 151.15 22.17 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.62 1.968 . . . . 0.0 110.268 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 70.9 t -130.28 119.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.451 ' CB ' HG21 ' A' ' 52' ' ' ILE . 21.3 t30 -103.0 102.11 12.14 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.356 -0.84 . . . . 0.0 110.426 -174.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -58.43 129.8 43.73 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 124.071 1.891 . . . . 0.0 115.216 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.22 -31.58 16.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.57 -11.95 19.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 138.34 18.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.999 2.12 . . . . 0.0 106.484 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.85 118.69 17.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 43.1 t -175.66 160.04 2.41 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.486 1.514 . . . . 0.0 109.558 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.39 134.71 38.08 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.594 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.893 HG23 HD12 ' D' ' 99' ' ' LEU . 0.9 OUTLIER -122.97 138.58 54.64 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.371 174.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -110.69 155.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -131.29 143.65 50.69 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.081 0.953 . . . . 0.0 108.657 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.61 118.25 8.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.444 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -170.86 176.05 44.4 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 118.185 2.034 . . . . 0.0 118.185 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -101.76 150.42 23.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.943 1.025 . . . . 0.0 113.491 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 12.6 p -97.51 118.41 33.95 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.193 -1.821 . . . . 0.0 106.633 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.653 ' HB2' HD12 ' A' ' 106' ' ' ILE . 20.4 m-85 -110.01 155.35 21.94 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 119.662 1.119 . . . . 0.0 113.849 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 10.4 mt -115.55 110.33 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.477 174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -58.81 162.02 4.39 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -23.38 1.3 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -4.57 57.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.68 0.792 . . . . 0.0 112.692 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.68 8.86 61.85 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.035 1.302 . . . . 0.0 114.977 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 22.0 mtpp -77.32 165.92 23.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.927 1.363 . . . . 0.0 110.505 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -122.06 145.12 48.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.02 1.328 . . . . 0.0 111.212 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.534 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -144.5 154.19 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.381 1.072 . . . . 0.0 110.64 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.98 103.81 10.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 172.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.534 ' CD ' HG11 ' D' ' 92' ' ' VAL . 0.6 OUTLIER -96.85 114.27 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -133.05 164.59 26.68 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 123.003 1.383 . . . . 0.0 112.382 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.608 ' HG3' HG21 ' A' ' 113' ' ' THR . 92.3 mmm -115.19 167.86 10.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -139.06 164.0 30.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.412 1.101 . . . . 0.0 113.43 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.445 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.4 OUTLIER -143.1 124.95 15.09 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.922 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . 0.893 HD12 HG23 ' D' ' 77' ' ' THR . 1.9 tp -107.22 132.01 53.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 123.7 1.714 . . . . 0.0 108.964 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -114.7 113.6 24.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 111.067 -2.788 . . . . 0.0 108.985 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.266 1.0 OUTLIER -67.37 165.92 15.51 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 116.875 -1.536 . . . . 0.0 111.888 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 29.7 t -107.81 87.3 2.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 121.775 2.079 . . . . 0.0 107.611 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.56 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 8.0 p -88.09 154.86 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 129.215 3.006 . . . . 0.0 110.993 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -93.5 -33.06 13.93 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.83 150.35 35.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -174.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 84' ' ' PHE . 4.6 tt -62.96 -28.83 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.485 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.3 5.75 48.44 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.838 1.208 . . . . 0.0 115.606 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' D' ' 103' ' ' VAL . 4.3 m-20 -123.3 0.42 8.94 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.273 1.536 . . . . 0.0 113.374 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -29.37 69.34 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.387 -1.446 . . . . 0.0 114.226 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.675 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 62.4 p-90 -49.37 -44.75 45.15 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.973 0.909 . . . . 0.0 113.085 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . 0.675 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.0 OUTLIER -87.31 -12.64 45.9 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.04 0.936 . . . . 0.0 113.279 176.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.99 1.12 21.83 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.457 -0.777 . . . . 0.0 112.402 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 96' ' ' MET . 33.9 m -111.56 139.7 46.78 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.33 1.052 . . . . 0.0 111.118 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 114' ' ' ARG . 2.0 mpt_? -144.12 133.35 23.06 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.641 1.176 . . . . 0.0 110.942 175.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.33 154.74 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 120.4 1.455 . . . . 0.0 110.978 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.27 -173.94 27.33 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.006 0.812 . . . . 0.0 114.744 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 10.0 p90 -128.67 156.39 43.53 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.282 1.033 . . . . 0.0 112.241 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -152.18 149.78 29.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.393 1.077 . . . . 0.0 112.144 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . 0.439 HD13 ' HE3' ' D' ' 94' ' ' LYS . 9.4 mt -126.47 123.4 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.675 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 148.39 40.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -139.74 167.29 22.44 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 120.74 7.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.675 1.19 . . . . 0.0 112.495 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.03 114.34 7.22 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.778 -0.63 . . . . 0.0 109.942 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 69.21 114.78 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.726 2.41 . . . . 0.0 113.076 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 20.1 p -144.21 -83.12 0.16 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.973 0.909 . . . . 0.0 109.917 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 61.93 -44.96 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.525 2.33 . . . . 0.0 114.76 -174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -139.08 102.13 4.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.059 1.744 . . . . 0.0 107.619 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.807 1.643 . . . . 0.0 108.937 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . 0.266 10.5 pm0 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.0 m -138.45 153.34 48.84 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.875 1.216 . . . . 0.0 110.408 -174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.61 37.36 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.166 1.386 . . . . 0.0 113.755 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -69.33 42.27 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.224 1.81 . . . . 0.0 114.907 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -144.46 43.98 1.4 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.495 1.918 . . . . 0.0 111.491 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tmmt? -156.65 120.54 4.33 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.156 -0.965 . . . . 0.0 113.409 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.33 144.0 51.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 111.533 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.06 134.97 32.12 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.827 1.651 . . . . 0.0 109.064 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -73.46 -25.8 60.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.978 1.263 . . . . 0.0 113.683 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -49.54 115.69 1.45 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 111.069 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.95 -125.6 3.14 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 125.252 1.406 . . . . 0.0 110.334 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -149.58 144.12 26.0 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -142.31 159.44 42.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.577 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 t -138.96 150.36 45.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.424 HD21 ' HB2' ' B' ' 16' ' ' SER . 24.6 p30 -114.84 158.89 21.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.825 1.298 . . . . 0.0 114.347 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -54.53 -26.45 31.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.054 2.542 . . . . 0.0 114.879 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.51 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.4 tp -75.98 -12.06 60.07 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.897 1.279 . . . . 0.0 112.302 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.16 -15.7 50.67 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.132 2.301 . . . . 0.0 112.991 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.424 ' HB2' HD21 ' B' ' 12' ' ' ASN . 15.5 m -69.81 155.26 40.82 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.718 1.247 . . . . 0.0 111.706 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 150.2 50.72 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.639 -1.288 . . . . 0.0 110.511 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -133.63 147.06 51.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.371 0.605 . . . . 0.0 112.626 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -130.67 134.49 46.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.651 0.78 . . . . 0.0 109.469 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 92.9 mt -132.35 125.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.33 -78.89 0.22 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 124.506 1.129 . . . . 0.0 111.208 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.31 152.7 33.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.629 0.728 . . . . 0.0 112.305 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.64 131.94 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.362 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -76.93 168.4 20.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 0.0 112.472 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 62.8 p -55.79 -27.51 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.58 -33.33 60.59 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.596 0.634 . . . . 0.0 112.327 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.86 -10.05 15.87 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 117.961 -1.466 . . . . 0.0 113.682 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.12 139.89 58.82 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.453 2.301 . . . . 0.0 108.861 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.79 148.54 25.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.0 p -108.94 168.4 9.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.809 1.244 . . . . 0.0 109.633 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 -168.58 37.31 Favored Glycine 0 N--CA 1.466 0.692 0 O-C-N 120.27 -1.519 . . . . 0.0 114.983 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.524 ' HB ' HD11 ' B' ' 46' ' ' LEU . 5.8 p -140.5 130.03 24.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.394 1.092 . . . . 0.0 111.765 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -111.46 138.37 48.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.191 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 78.7 mt -127.66 127.77 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.412 ' O ' HG21 ' B' ' 44' ' ' ILE 0.263 82.4 m -105.16 134.02 48.97 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.792 1.237 . . . . 0.0 112.913 -172.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.49 -15.44 27.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 146.54 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.936 1.294 . . . . 0.0 111.972 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.0 161.31 42.7 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.735 -1.228 . . . . 0.0 111.489 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.48 -29.21 56.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.058 -0.401 . . . . 0.0 110.408 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -142.84 79.18 15.02 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 127.336 2.254 . . . . 0.0 110.292 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.17 20.55 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.377 1 C-N-CA 125.389 4.06 . . . . 0.0 117.406 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.67 -8.16 5.19 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.99 43.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.702 1.751 . . . . 0.0 111.335 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.412 HG21 ' O ' ' B' ' 35' ' ' THR . 70.3 mt -51.12 125.65 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.346 -1.471 . . . . 0.0 111.35 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.17 164.48 31.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.595 1.558 . . . . 0.0 110.449 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' B' ' 32' ' ' THR . 13.3 tp -46.49 115.41 1.02 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 129.005 2.922 . . . . 0.0 110.753 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.1 t -103.17 119.83 54.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.544 0.738 . . . . 0.0 109.268 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.03 142.55 85.45 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.363 2.708 . . . . 0.0 111.385 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.38 154.92 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.119 0.887 . . . . 0.0 110.89 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.73 148.72 22.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.621 1.568 . . . . 0.0 110.364 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.0 -158.07 29.97 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 121.25 1.841 . . . . 0.0 110.691 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.3 mt -142.64 141.95 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.571 0.748 . . . . 0.0 112.749 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.57 135.01 45.65 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -69.45 149.13 48.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.8 1.286 . . . . 0.0 112.249 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -148.8 27.1 0.89 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.475 1.91 . . . . 0.0 109.841 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.71 -56.55 2.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.522 1.529 . . . . 0.0 109.721 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.89 173.64 10.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.784 0.802 . . . . 0.0 112.88 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -88.85 -23.27 22.84 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 113.505 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -131.88 48.31 3.52 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.255 1.422 . . . . 0.0 113.315 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.82 171.64 17.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.328 2.019 . . . . 0.0 115.58 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.294 0.1 OUTLIER -98.14 163.07 12.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 123.775 1.75 . . . . 0.0 111.368 173.147 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -157.92 165.74 34.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.049 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 145.6 10.63 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 118.988 2.355 . . . . 0.0 118.988 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -161.59 153.94 19.91 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -89.92 149.46 22.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.651 1.98 . . . . 0.0 110.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 66.8 t -128.52 118.73 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.453 ' CB ' HG21 ' C' ' 52' ' ' ILE . 21.6 t30 -101.81 101.83 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.477 -0.764 . . . . 0.0 110.587 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.9 129.43 42.11 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 123.853 1.787 . . . . 0.0 115.311 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -90.62 -32.25 16.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -100.07 -11.92 20.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.5 t -152.46 138.0 17.74 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.807 2.043 . . . . 0.0 106.432 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.8 118.58 16.92 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.618 1.199 . . . . 0.0 111.406 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -175.34 159.99 2.56 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.624 1.57 . . . . 0.0 109.625 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -136.64 134.47 37.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.293 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.882 HG23 HD12 ' B' ' 99' ' ' LEU . 0.8 OUTLIER -122.83 137.67 54.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.45 174.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.8 m -109.04 155.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -131.69 144.61 51.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.88 118.49 7.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.705 0.628 . . . . 0.0 109.965 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' NE ' ' C' ' 100' ' ' ARG . . . -170.8 176.42 44.26 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 118.201 2.041 . . . . 0.0 118.201 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.562 ' NE2' ' H ' ' C' ' 103' ' ' VAL . 0.0 OUTLIER -101.77 150.33 23.26 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 125.021 1.071 . . . . 0.0 113.82 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 10.4 p -97.51 117.43 31.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.621 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.668 ' HB2' HD12 ' C' ' 106' ' ' ILE . 17.6 m-85 -108.81 155.15 21.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 119.804 1.184 . . . . 0.0 113.864 176.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.19 109.57 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.751 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -58.71 164.94 2.48 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.829 0.706 . . . . 0.0 109.594 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.98 -29.93 3.86 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -8.04 56.38 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.405 1.082 . . . . 0.0 113.27 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.95 10.71 58.47 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.764 1.173 . . . . 0.0 115.534 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -76.6 168.44 20.07 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.06 1.43 . . . . 0.0 108.895 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -124.58 145.06 49.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.192 1.36 . . . . 0.0 110.687 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.53 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.1 t -144.12 153.76 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.197 0.999 . . . . 0.0 111.453 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -117.57 103.32 9.95 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.53 ' CD ' HG11 ' B' ' 92' ' ' VAL . 0.6 OUTLIER -96.8 113.97 25.56 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 173.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -132.8 164.66 26.34 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.099 1.428 . . . . 0.0 112.385 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.623 ' HG3' HG21 ' C' ' 113' ' ' THR . 93.1 mmm -115.73 168.09 10.34 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -139.26 164.14 30.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.637 1.208 . . . . 0.0 113.419 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' C' ' 98' ' ' LEU . 0.4 OUTLIER -142.73 125.05 15.53 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.088 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 77' ' ' THR . 1.7 tp -107.2 131.55 54.05 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 125.412 1.695 . . . . 0.0 109.27 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.405 ' NE ' ' HA2' ' C' ' 81' ' ' GLY . 3.5 tpt85 -114.82 113.65 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 110.847 -2.888 . . . . 0.0 108.947 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.261 0.9 OUTLIER -69.02 164.4 22.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.318 1.447 . . . . 0.0 111.994 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 22.5 t -105.45 87.95 2.73 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 121.462 1.937 . . . . 0.0 107.703 173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.528 ' H ' ' NE2' ' C' ' 82' ' ' GLN . 7.5 p -88.04 156.04 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 129.215 3.006 . . . . 0.0 111.065 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -95.81 -33.31 12.3 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.28 148.46 34.13 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.64 0.733 . . . . 0.0 112.698 -174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' C' ' 84' ' ' PHE . 4.8 tt -62.4 -29.79 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.588 174.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.88 40.66 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.764 1.173 . . . . 0.0 115.888 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' B' ' 103' ' ' VAL . 4.5 m-20 -122.94 -0.36 9.01 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.319 1.559 . . . . 0.0 113.631 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -28.86 69.22 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.48 -1.387 . . . . 0.0 113.792 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.669 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 62.2 p-90 -49.44 -44.28 45.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.092 0.957 . . . . 0.0 113.311 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.669 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.0 OUTLIER -87.99 -12.56 44.12 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.139 -0.975 . . . . 0.0 113.294 176.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -0.54 25.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.424 0.69 . . . . 0.0 112.342 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.607 HG21 ' HG3' ' C' ' 96' ' ' MET . 35.5 m -110.1 139.85 44.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.289 1.036 . . . . 0.0 110.799 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' D' ' 114' ' ' ARG . 2.0 mpt_? -144.27 132.6 21.93 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.901 1.28 . . . . 0.0 111.167 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.82 154.59 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 120.213 1.37 . . . . 0.0 110.936 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.04 -174.7 28.08 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.008 0.813 . . . . 0.0 114.733 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 9.8 p90 -128.16 156.59 42.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.222 1.009 . . . . 0.0 112.272 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -152.6 148.88 27.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.299 1.04 . . . . 0.0 112.249 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.433 HD13 ' HE3' ' B' ' 94' ' ' LYS . 9.5 mt -125.31 122.74 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.424 175.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.9 148.68 38.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 28.3 p -140.35 167.78 21.35 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.32 123.47 16.86 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.888 -1.132 . . . . 0.0 113.016 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.71 168.05 5.27 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.57 6.38 5.4 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 72.8 p -94.49 104.18 16.14 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.743 1.617 . . . . 0.0 108.928 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -79.34 -177.07 5.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.695 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 66.51 4.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.626 1.171 . . . . 0.0 108.51 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . 0.403 3.6 pm0 . . . . . 0 C--O 1.248 0.979 0 C-N-CA 130.403 3.481 . . . . 0.0 113.476 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 116.757 -1.592 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.7 38.28 5.61 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 173.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . 0.273 15.4 m 45.02 19.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.32 85.09 0.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.827 1.651 . . . . 0.0 112.428 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -158.59 55.73 0.44 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.908 1.283 . . . . 0.0 111.782 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -156.75 123.44 5.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 45.3 t -132.08 143.63 50.16 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.828 0.851 . . . . 0.0 111.874 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.07 135.4 32.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.674 1.99 . . . . 0.0 109.216 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.2 mt -73.41 -24.7 60.31 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.605 1.548 . . . . 0.0 114.283 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -50.79 117.36 2.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.712 1.205 . . . . 0.0 111.237 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.98 -126.38 3.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.239 1.399 . . . . 0.0 110.295 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -147.02 143.42 28.38 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -141.43 158.58 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.682 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -139.07 148.8 43.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' C' ' 16' ' ' SER . 25.0 p30 -113.46 161.03 17.82 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.909 1.338 . . . . 0.0 114.499 175.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -57.69 -25.57 60.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.494 2.718 . . . . 0.0 114.899 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 110' ' ' TRP . 29.6 tp -77.06 -11.02 59.75 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 111.759 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.23 -16.27 53.51 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.945 2.212 . . . . 0.0 112.943 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . 0.434 ' HB2' HD21 ' C' ' 12' ' ' ASN . 15.4 m -69.29 154.58 41.81 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.598 1.189 . . . . 0.0 111.592 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.1 150.74 50.36 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.613 -1.305 . . . . 0.0 110.558 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.62 145.4 48.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.362 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -129.66 134.06 47.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.52 124.14 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.95 -74.75 0.48 Allowed Glycine 0 CA--C 1.528 0.866 0 O-C-N 124.26 0.975 . . . . 0.0 111.461 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.42 43.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.943 -0.74 . . . . 0.0 111.989 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.52 130.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.192 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -77.13 168.51 19.96 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.877 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 60.2 p -56.64 -26.99 57.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.12 -29.95 60.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.976 0.807 . . . . 0.0 112.395 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.83 -7.87 19.46 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 124.585 1.088 . . . . 0.0 114.339 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.47 148.12 49.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.599 2.36 . . . . 0.0 113.132 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . 0.49 ' O ' HD12 ' C' ' 50' ' ' LEU . 52.3 p90 -156.93 161.51 39.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.982 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.437 HG22 HD13 ' C' ' 50' ' ' LEU . 3.1 p -118.83 172.67 7.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.3 -167.58 35.84 Favored Glycine 0 N--CA 1.469 0.848 0 O-C-N 119.334 -2.104 . . . . 0.0 114.409 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.515 ' HB ' HD11 ' C' ' 46' ' ' LEU . 6.3 p -138.57 129.6 26.85 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.756 1.265 . . . . 0.0 112.446 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -112.05 137.64 49.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.302 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -127.31 127.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . . . . . . . . 0.261 90.3 m -105.03 134.46 48.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.842 1.257 . . . . 0.0 112.699 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.87 -15.73 26.07 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.88 146.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 161.19 42.71 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.795 -1.19 . . . . 0.0 111.566 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.51 -29.38 56.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.538 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -142.66 79.15 15.37 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.386 2.275 . . . . 0.0 110.377 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.28 21.04 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.386 1 C-N-CA 125.464 4.109 . . . . 0.0 117.356 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.24 -7.56 5.45 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -175.52 43.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.139 1.776 . . . . 0.0 111.439 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.12 126.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.418 -1.426 . . . . 0.0 111.379 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.4 164.67 30.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.614 1.565 . . . . 0.0 110.412 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.515 HD11 ' HB ' ' C' ' 32' ' ' THR . 13.3 tp -46.55 115.38 1.02 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 129.06 2.944 . . . . 0.0 110.545 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -102.96 119.06 56.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.547 0.739 . . . . 0.0 109.399 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.97 141.06 86.68 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.157 2.571 . . . . 0.0 111.278 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.404 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.4 pp -129.57 162.29 28.56 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.045 174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.49 HD12 ' O ' ' C' ' 29' ' ' PHE . 18.8 tp -165.36 148.82 8.19 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.991 1.717 . . . . 0.0 112.243 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.91 -154.87 25.96 Favored Glycine 0 N--CA 1.448 -0.544 0 O-C-N 119.795 -1.816 . . . . 0.0 110.606 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.453 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.5 mt -145.49 142.25 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.838 0.964 . . . . 0.0 111.739 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 135.32 44.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.155 1.382 . . . . 0.0 114.384 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.88 149.58 47.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.482 1.134 . . . . 0.0 112.373 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -148.72 25.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.577 1.951 . . . . 0.0 110.065 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.88 -56.44 2.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.599 1.56 . . . . 0.0 110.347 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.37 173.92 8.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.773 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 3.9 p -92.25 -19.14 22.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.87 1.268 . . . . 0.0 113.674 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -133.61 46.31 1.98 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.924 1.29 . . . . 0.0 112.682 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.75 170.64 19.56 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.023 2.482 . . . . 0.0 116.19 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.292 0.0 OUTLIER -97.07 162.59 13.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 123.751 1.738 . . . . 0.0 111.282 173.088 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.55 166.11 33.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.267 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.87 145.71 10.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.95 153.49 18.6 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -89.65 150.99 22.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.765 2.026 . . . . 0.0 110.228 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 78.3 t -130.25 119.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.445 ' CB ' HG21 ' B' ' 52' ' ' ILE . 21.9 t30 -102.83 101.72 11.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -58.43 129.78 43.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.352 1.548 . . . . 0.0 115.137 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -91.06 -31.8 16.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.38 -11.98 19.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 32.4 t -152.4 138.09 17.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.827 2.051 . . . . 0.0 106.213 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -74.25 118.61 17.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.591 1.186 . . . . 0.0 111.253 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 47.1 t -175.03 159.83 2.68 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.557 1.543 . . . . 0.0 109.543 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -135.98 134.66 38.82 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.386 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.859 HG23 HD12 ' C' ' 99' ' ' LEU . 0.9 OUTLIER -123.24 138.53 54.61 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.408 0.623 . . . . 0.0 111.497 174.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.59 155.33 11.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -131.14 143.68 50.82 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.942 0.897 . . . . 0.0 108.77 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.35 118.45 8.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' B' ' 100' ' ' ARG . . . -170.26 176.64 43.86 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.528 ' NE2' ' H ' ' B' ' 103' ' ' VAL . 0.0 OUTLIER -101.67 150.35 23.2 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.928 1.016 . . . . 0.0 113.517 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 11.6 p -97.52 116.97 30.75 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 125.611 1.819 . . . . 0.0 107.34 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.665 ' HB2' HD12 ' B' ' 106' ' ' ILE . 17.5 m-85 -108.66 156.62 19.35 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.552 1.168 . . . . 0.0 113.604 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 9.7 mt -117.37 110.24 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.174 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -58.69 160.5 5.58 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -24.79 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.54 -9.31 52.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.984 0.914 . . . . 0.0 113.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.18 14.97 49.88 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.673 1.13 . . . . 0.0 115.402 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -82.64 166.29 19.3 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.078 1.439 . . . . 0.0 109.075 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -122.39 145.37 48.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 120.605 1.548 . . . . 0.0 110.767 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.54 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.1 t -144.24 153.09 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.712 1.205 . . . . 0.0 111.106 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.25 103.65 10.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.54 ' CD ' HG11 ' C' ' 92' ' ' VAL . 0.5 OUTLIER -97.13 112.73 24.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 173.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.68 163.82 27.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.093 1.425 . . . . 0.0 112.383 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.607 ' HG3' HG21 ' B' ' 113' ' ' THR . 93.4 mmm -114.95 168.23 10.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -139.45 163.84 31.45 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.428 1.109 . . . . 0.0 113.376 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.446 HD12 HD12 ' B' ' 98' ' ' LEU . 0.4 OUTLIER -142.87 124.66 15.06 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.123 175.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . 0.859 HD12 HG23 ' C' ' 77' ' ' THR . 1.9 tp -107.2 131.95 53.59 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 123.769 1.747 . . . . 0.0 108.841 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.41 ' NE ' ' HA2' ' B' ' 81' ' ' GLY . 3.2 tpt85 -114.84 113.57 24.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 110.942 -2.844 . . . . 0.0 109.05 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.19 164.83 19.61 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 116.867 -1.54 . . . . 0.0 111.912 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 88.12 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 121.742 2.065 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . 0.562 ' H ' ' NE2' ' B' ' 82' ' ' GLN . 6.6 p -88.45 155.82 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 129.265 3.026 . . . . 0.0 111.138 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -95.08 -32.77 12.95 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -114.02 149.35 35.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.573 0.701 . . . . 0.0 112.671 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' B' ' 84' ' ' PHE . 4.8 tt -62.53 -30.22 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.795 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.65 5.28 38.94 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.598 1.094 . . . . 0.0 115.777 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' C' ' 103' ' ' VAL . 4.6 m-20 -123.09 0.08 9.01 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.361 1.581 . . . . 0.0 113.735 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.92 69.17 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.365 -1.459 . . . . 0.0 113.806 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.676 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 62.5 p-90 -49.65 -44.24 47.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.87 0.868 . . . . 0.0 113.214 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . 0.676 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.0 OUTLIER -88.16 -12.6 43.49 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.097 -1.002 . . . . 0.0 113.347 176.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 1.48 18.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.708 0.803 . . . . 0.0 112.577 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.623 HG21 ' HG3' ' B' ' 96' ' ' MET . 33.9 m -112.68 139.61 48.15 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.436 1.094 . . . . 0.0 111.207 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -144.26 133.01 22.41 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.656 1.183 . . . . 0.0 110.94 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.13 154.79 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.364 1.438 . . . . 0.0 110.897 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.39 -174.29 27.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.908 0.766 . . . . 0.0 114.76 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 10.0 p90 -128.41 156.72 42.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.219 1.008 . . . . 0.0 112.294 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -152.23 148.67 27.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 112.298 173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . 0.442 HD13 ' HE3' ' C' ' 94' ' ' LYS . 9.4 mt -124.94 122.2 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.522 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 148.87 37.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.843 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 45.6 p -138.84 167.43 22.04 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.69 122.54 13.05 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.4 -0.813 . . . . 0.0 111.735 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -79.19 77.87 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 159.21 64.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 129.995 3.318 . . . . 0.0 112.784 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 1.8 p -144.2 161.74 38.11 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.196 -1.565 . . . . 0.0 110.746 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 -159.64 0.98 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.961 1.704 . . . . 0.0 109.193 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -170.39 160.09 7.4 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.153 3.381 . . . . 0.0 110.828 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 . . . . . 0 C--O 1.248 1.018 0 O-C-N 125.368 1.667 . . . . 0.0 108.899 171.573 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 1.4 m -71.15 55.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.576 1.951 . . . . 0.0 113.868 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 63.2 t 64.44 -47.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 128.236 2.614 . . . . 0.0 115.302 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 22.98 62.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.571 2.748 . . . . 0.0 116.208 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.51 52.66 1.18 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -156.8 144.91 19.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.866 1.266 . . . . 0.0 110.413 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -135.14 154.67 51.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.72 1.208 . . . . 0.0 108.382 173.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.91 129.92 24.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.009 -1.057 . . . . 0.0 111.597 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.1 -25.17 67.98 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -54.56 120.25 6.41 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 123.355 1.55 . . . . 0.0 112.562 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.9 -110.92 1.04 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.979 2.228 . . . . 0.0 110.242 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HD2' HD13 ' A' ' 123' ' ' LEU . 18.4 ttmt -152.99 152.1 31.02 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.73 -0.865 . . . . 0.0 113.271 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -140.16 156.33 46.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.059 -1.882 . . . . 0.0 110.801 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.62 146.64 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.394 177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -116.72 143.33 45.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 111.238 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.04 -24.99 57.81 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.58 1.552 . . . . 0.0 113.825 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 37' ' ' VAL . 40.5 tp -67.31 -15.94 63.98 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 120.735 -1.228 . . . . 0.0 111.821 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.09 -9.46 42.98 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 127.645 2.545 . . . . 0.0 113.242 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.4 147.99 52.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.228 -1.16 . . . . 0.0 111.925 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -126.62 151.42 48.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.198 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.41 147.33 33.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -127.97 134.98 49.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.787 0.835 . . . . 0.0 110.291 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.67 121.01 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.13 -65.17 2.7 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.671 1.232 . . . . 0.0 113.291 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.68 137.71 4.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -84.45 137.67 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.76 163.5 27.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.826 0.451 . . . . 0.0 111.348 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -23.69 50.39 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -27.35 63.79 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.137 -0.977 . . . . 0.0 111.165 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.11 48.78 Favored Glycine 0 C--O 1.224 -0.512 0 CA-C-O 117.577 -1.68 . . . . 0.0 112.958 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -70.99 144.6 50.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.779 1.289 . . . . 0.0 108.547 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -156.03 155.77 33.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.682 0.753 . . . . 0.0 112.307 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 ' HB ' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -127.75 158.71 36.93 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.395 1.878 . . . . 0.0 108.267 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.32 -170.67 34.92 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.97 -1.081 . . . . 0.0 114.747 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.416 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 35.6 p -137.53 126.23 23.84 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.696 ' C ' HD12 ' A' ' 34' ' ' ILE . 1.4 t80 -126.52 133.14 51.21 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.05 -172.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 46' ' ' LEU . 1.4 mp -121.48 135.61 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 37' ' ' VAL . 50.1 m -115.77 131.0 57.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.36 3.86 50.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 35' ' ' THR . 26.9 m -141.34 162.28 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 128.116 2.566 . . . . 0.0 108.444 -175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.46 10.51 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.893 -1.754 . . . . 0.0 111.842 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.64 -24.69 61.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.287 0.235 . . . . 0.0 110.603 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.35 84.01 4.43 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 175.95 8.72 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.815 3.01 . . . . 0.0 112.905 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.51 -33.03 2.83 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.738 1.161 . . . . 0.0 111.981 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -132.77 20.71 4.2 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.94 1.296 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 35' ' ' THR . 42.4 mt -54.16 127.87 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 122.025 0.916 . . . . 0.0 109.233 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.0 177.12 8.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.655 1.982 . . . . 0.0 107.538 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.763 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -49.0 146.1 3.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.185 172.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -124.55 113.17 27.43 Favored Pre-proline 0 N--CA 1.426 -1.629 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.674 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.75 134.63 65.69 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.237 1.958 . . . . 0.0 109.668 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.32 151.26 46.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.429 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -143.3 149.13 37.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.853 2.461 . . . . 0.0 108.012 175.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.2 -160.79 34.57 Favored Glycine 0 N--CA 1.452 -0.267 0 O-C-N 120.75 -1.219 . . . . 0.0 111.019 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.492 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.8 mt -144.58 145.57 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 111.942 -174.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.662 -1.274 . . . . 0.0 113.108 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -86.81 141.85 28.52 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.654 1.216 . . . . 0.0 111.191 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HB2' HE22 ' A' ' 53' ' ' GLN . 0.9 OUTLIER -139.52 29.64 2.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.029 1.332 . . . . 0.0 112.138 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -93.06 -55.05 3.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.644 2.377 . . . . 0.0 111.405 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -179.9 5.9 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -81.77 -39.27 24.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.192 1.397 . . . . 0.0 112.888 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -132.61 46.4 2.13 Favored Pre-proline 0 CA--C 1.568 1.636 0 O-C-N 125.416 1.698 . . . . 0.0 111.473 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.55 177.02 5.84 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.359 2.039 . . . . 0.0 114.676 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.326 0.1 OUTLIER -100.95 169.62 8.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 122.54 1.162 . . . . 0.0 111.603 174.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -162.63 164.18 26.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.393 -173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.39 147.78 13.73 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.836 2.294 . . . . 0.0 118.836 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -161.0 150.5 17.0 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -89.1 147.84 24.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.906 1.682 . . . . 0.0 108.21 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.8 t -129.21 119.72 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.493 ' CB ' HG21 ' D' ' 52' ' ' ILE . 38.8 t30 -102.87 102.05 12.13 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.372 -173.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -69.18 125.36 26.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 121.249 1.84 . . . . 0.0 115.684 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -81.3 -37.35 28.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.435 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.08 -22.29 36.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.603 1.161 . . . . 0.0 113.65 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -152.43 124.07 7.84 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.59 1.556 . . . . 0.0 108.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -60.78 115.27 3.54 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.595 1.089 . . . . 0.0 111.722 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 p -172.52 158.78 4.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.974 2.109 . . . . 0.0 110.03 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -143.47 142.5 31.2 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-O 123.175 1.464 . . . . 0.0 110.427 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.8 128.74 20.67 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 109.965 -3.289 . . . . 0.0 109.838 -171.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.54 154.05 6.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.773 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -128.99 141.66 51.18 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -151.82 118.25 5.66 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.36 -175.44 34.34 Favored Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 119.658 -1.258 . . . . 0.0 115.388 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -126.97 147.2 50.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.235 1.017 . . . . 0.0 112.196 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.41 127.25 43.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.44 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' D' ' 106' ' ' ILE . 2.3 m-85 -120.13 166.34 13.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.531 0.681 . . . . 0.0 112.461 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 39.6 mt -127.33 109.03 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.552 -1.658 . . . . 0.0 107.098 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.97 162.34 4.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.392 0.677 . . . . 0.0 110.162 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.42 -32.3 1.32 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.32 -21.09 53.99 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.88 19.98 11.25 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.851 1.215 . . . . 0.0 114.572 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 mtpt -90.66 153.24 20.44 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.1 1.36 . . . . 0.0 111.559 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.14 134.92 43.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.634 1.574 . . . . 0.0 110.257 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -142.16 160.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 122.13 0.967 . . . . 0.0 108.819 174.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.1 mt -124.15 119.06 28.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -106.59 117.77 34.93 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.3 167.27 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.974 1.369 . . . . 0.0 112.554 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -119.36 170.49 9.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -140.55 159.06 43.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.446 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.5 tp -134.38 121.98 21.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.406 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER -107.46 135.89 48.18 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 124.961 1.413 . . . . 0.0 112.055 -176.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.98 113.9 23.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 111.857 -2.429 . . . . 0.0 110.167 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -69.82 166.8 18.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.384 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -112.41 85.44 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.44 -161.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.33 -13.64 1.02 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.709 -1.869 . . . . 0.0 114.281 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.06 151.1 49.06 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.298 1.047 . . . . 0.0 111.931 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.454 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.9 tt -59.27 -25.49 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.117 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.65 -1.87 19.05 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.193 1.378 . . . . 0.0 114.761 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.0 7.11 6.6 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.138 0.969 . . . . 0.0 112.346 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.57 -32.14 73.66 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 119.443 -2.036 . . . . 0.0 112.866 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.462 ' CD1' HD11 ' C' ' 14' ' ' LEU . 57.8 p-90 -47.67 -40.82 20.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.789 1.235 . . . . 0.0 114.036 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -95.19 -11.61 27.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.403 1.081 . . . . 0.0 113.503 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.17 -0.8 20.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.975 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.61 143.72 42.02 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 122.432 1.11 . . . . 0.0 111.056 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -142.06 153.78 44.45 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.471 1.509 . . . . 0.0 109.572 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.98 151.19 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.395 1.078 . . . . 0.0 109.903 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.44 -176.69 29.77 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 121.453 0.474 . . . . 0.0 112.104 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 33.6 p90 -124.92 152.03 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.507 0.723 . . . . 0.0 109.98 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -144.53 152.41 40.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.938 0.875 . . . . 0.0 109.301 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.0 mt -128.92 135.13 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.93 148.07 45.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -132.01 158.64 40.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.099 0.96 . . . . 0.0 110.655 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.05 118.8 6.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.646 0.779 . . . . 0.0 111.641 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 123' ' ' LEU . 4.2 tt -77.55 78.19 4.07 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.771 174.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.67 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.8 m 65.65 116.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.873 2.069 . . . . 0.0 109.239 -172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -148.51 -94.65 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.88 -163.77 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.69 1.996 . . . . 0.0 109.724 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 . . . . . 0 C--O 1.253 1.277 0 CA-C-O 116.962 -1.494 . . . . 0.0 110.291 174.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.6 m 45.15 47.03 9.93 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.85 122.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.495 -1.378 . . . . 0.0 111.006 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -115.6 7.73 14.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.023 1.329 . . . . 0.0 113.658 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER 38.18 71.61 0.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 128.039 2.536 . . . . 0.0 113.439 -175.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -145.01 141.28 28.79 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.112 0.965 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . 0.428 ' CB ' ' HG ' ' D' ' 83' ' ' CYS . 22.1 p -143.67 143.54 31.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.633 1.973 . . . . 0.0 107.8 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.83 128.78 23.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.59 -1.319 . . . . 0.0 112.269 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.4 -25.59 68.35 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -53.0 119.27 4.47 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.204 1.478 . . . . 0.0 112.459 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.82 -110.69 1.02 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.841 2.162 . . . . 0.0 110.865 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -152.59 151.86 31.14 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -141.33 158.76 43.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.709 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -133.86 149.04 51.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.57 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -116.19 143.33 45.65 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.904 0.881 . . . . 0.0 110.737 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -58.74 -23.16 59.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.015 1.326 . . . . 0.0 113.475 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.48 HD21 HG21 ' D' ' 37' ' ' VAL . 42.4 tp -67.85 -15.94 63.86 Favored 'General case' 0 CA--C 1.555 1.16 0 O-C-N 120.543 -1.348 . . . . 0.0 111.398 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.34 -9.38 42.02 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.65 2.548 . . . . 0.0 113.372 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -66.42 148.25 52.14 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 121.213 -1.169 . . . . 0.0 111.792 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -127.02 151.16 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.196 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 147.35 33.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -127.53 135.96 51.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.761 0.824 . . . . 0.0 109.947 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.68 119.96 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.68 -64.39 3.34 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.58 1.175 . . . . 0.0 113.25 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.56 141.36 4.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.213 1.405 . . . . 0.0 110.214 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.17 136.36 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 122.505 0.322 . . . . 0.0 110.239 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.45 163.59 27.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.275 0.63 . . . . 0.0 111.186 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -21.98 54.05 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -25.45 62.37 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.161 -0.962 . . . . 0.0 111.221 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.89 51.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.248 1.404 . . . . 0.0 113.247 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.65 150.76 44.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.017 0.927 . . . . 0.0 110.42 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.52 166.34 33.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.347 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.479 ' HB ' HD22 ' D' ' 50' ' ' LEU . 0.5 OUTLIER -134.28 160.82 36.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.444 1.898 . . . . 0.0 106.775 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.44 -170.78 35.91 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.418 -1.426 . . . . 0.0 114.599 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.414 ' HB ' ' HG ' ' D' ' 46' ' ' LEU . 35.2 p -138.22 126.62 23.21 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.408 0.623 . . . . 0.0 109.341 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . 0.691 ' C ' HD12 ' D' ' 34' ' ' ILE . 1.4 t80 -126.96 133.42 50.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.935 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.76 HD11 ' CD1' ' D' ' 46' ' ' LEU . 1.5 mp -121.46 136.28 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.69 HG22 ' O ' ' D' ' 37' ' ' VAL . 43.4 m -116.77 130.24 56.6 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 3.24 53.63 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.69 ' O ' HG22 ' D' ' 35' ' ' THR . 27.5 m -141.44 162.22 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 128.085 2.554 . . . . 0.0 108.141 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.38 10.2 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.015 -1.678 . . . . 0.0 111.738 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.52 -24.05 61.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.311 0.244 . . . . 0.0 110.652 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -154.14 83.43 4.21 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 127.277 2.231 . . . . 0.0 109.254 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.69 176.04 8.74 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.553 2.835 . . . . 0.0 112.805 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.02 -33.21 2.86 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.765 1.174 . . . . 0.0 112.33 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -132.59 20.62 4.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.93 1.292 . . . . 0.0 112.403 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.53 HG21 ' O ' ' D' ' 35' ' ' THR . 43.3 mt -54.18 127.7 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.236 1.017 . . . . 0.0 109.247 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.01 177.21 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.49 1.916 . . . . 0.0 107.273 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.76 ' CD1' HD11 ' D' ' 34' ' ' ILE . 0.8 OUTLIER -48.99 146.65 3.23 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.218 172.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -125.0 112.98 26.72 Favored Pre-proline 0 N--CA 1.424 -1.728 0 CA-C-N 112.118 -2.31 . . . . 0.0 110.506 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -56.09 132.52 52.45 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.17 1.914 . . . . 0.0 109.263 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.32 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.274 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' D' ' 30' ' ' THR . 0.3 OUTLIER -148.42 149.22 31.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.866 2.466 . . . . 0.0 108.066 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.66 -160.24 32.58 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 121.287 -0.883 . . . . 0.0 112.781 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.493 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.6 mt -144.94 145.06 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.384 1.074 . . . . 0.0 112.374 -174.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . 0.544 HE22 ' HB2' ' D' ' 57' ' ' LYS . 0.3 OUTLIER -132.01 150.97 52.01 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.626 -1.296 . . . . 0.0 112.843 175.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.38 141.66 28.47 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.696 0.76 . . . . 0.0 110.399 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . 0.544 ' HB2' HE22 ' D' ' 53' ' ' GLN . 1.0 OUTLIER -138.96 29.84 2.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.983 1.313 . . . . 0.0 112.517 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -92.93 -55.21 3.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.01 2.524 . . . . 0.0 111.399 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.98 177.84 7.43 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -78.95 -39.78 33.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.821 1.648 . . . . 0.0 113.037 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.34 50.14 4.7 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 125.244 1.417 . . . . 0.0 111.429 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 176.78 6.39 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.351 2.7 . . . . 0.0 115.223 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -102.23 168.79 9.13 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.732 1.253 . . . . 0.0 111.435 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -162.22 163.48 28.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.881 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.18 148.05 14.85 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 118.646 2.218 . . . . 0.0 118.646 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -161.63 149.86 15.3 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.93 149.09 23.48 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.259 1.823 . . . . 0.0 108.238 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.62 121.47 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.492 ' CB ' HG21 ' A' ' 52' ' ' ILE . 37.6 t30 -104.88 102.31 11.85 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.988 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -68.92 124.47 23.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -80.14 -36.81 34.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.623 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -82.6 -22.01 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 113.591 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 35.2 t -152.55 124.63 8.04 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.544 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -60.86 115.44 3.69 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.897 1.226 . . . . 0.0 111.509 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 9.4 p -172.74 158.94 4.14 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.129 2.172 . . . . 0.0 110.125 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -143.62 142.42 31.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 123.036 1.398 . . . . 0.0 110.296 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -141.8 128.54 20.42 Favored 'General case' 0 N--CA 1.402 -2.825 0 CA-C-N 110.173 -3.194 . . . . 0.0 109.971 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.95 154.41 5.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.773 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -129.65 141.35 50.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . 0.435 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -151.58 118.22 5.74 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.95 -175.25 34.66 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.49 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -127.61 144.91 51.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.704 0.885 . . . . 0.0 112.421 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.428 ' HG ' ' CB ' ' D' ' 4' ' ' CYS . 36.8 t -97.81 123.63 41.85 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.623 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' A' ' 106' ' ' ILE . 3.4 m-85 -115.69 167.26 11.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 118.45 0.568 . . . . 0.0 111.692 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 30.6 mt -126.21 107.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 O-C-N 125.293 1.62 . . . . 0.0 106.741 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -58.99 160.56 5.86 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -44.22 -31.74 1.08 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 118.193 2.664 . . . . 0.0 118.193 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -76.3 -21.94 55.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.26 1.85 29.67 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.111 1.339 . . . . 0.0 115.592 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -74.09 153.66 39.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.257 1.423 . . . . 0.0 112.578 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.38 135.44 42.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.265 1.826 . . . . 0.0 109.964 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.454 HG21 ' CD1' ' A' ' 106' ' ' ILE . 20.6 m -141.97 160.08 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.029 0.931 . . . . 0.0 109.663 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -122.69 118.64 28.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -106.76 117.74 34.84 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 167.95 20.41 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.05 1.405 . . . . 0.0 112.69 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -120.06 170.57 9.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 40.1 p-90 -140.57 159.51 42.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.561 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.437 HD23 ' OG1' ' A' ' 80' ' ' THR . 3.4 tp -134.93 121.86 21.12 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.526 175.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.37 136.01 47.89 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 125.061 1.476 . . . . 0.0 111.767 -176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -117.12 113.82 22.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.288 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.25 71.3 m -69.55 167.04 17.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.404 174.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 2.0 p -112.37 86.11 2.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.99 -160.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -140.36 -13.19 1.03 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 119.561 -1.962 . . . . 0.0 114.093 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.57 152.13 48.66 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.565 1.174 . . . . 0.0 112.356 174.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.0 tt -59.82 -24.87 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.982 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.93 -1.13 23.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.245 1.402 . . . . 0.0 114.935 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -127.12 6.34 6.49 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.119 0.968 . . . . 0.0 111.916 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.16 -31.79 73.15 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 119.327 -2.108 . . . . 0.0 113.067 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.456 ' CD1' HD11 ' B' ' 14' ' ' LEU . 58.1 p-90 -47.33 -41.61 19.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.343 1.057 . . . . 0.0 113.768 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -94.89 -11.47 28.65 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.403 1.081 . . . . 0.0 113.131 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.02 -1.13 21.35 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.357 -0.83 . . . . 0.0 112.311 -174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -111.21 143.8 41.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.318 1.056 . . . . 0.0 111.129 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -142.16 153.65 44.23 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.328 1.451 . . . . 0.0 109.486 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.88 151.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 124.464 1.106 . . . . 0.0 109.724 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.59 -177.23 30.5 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.505 0.503 . . . . 0.0 112.169 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 32.7 p90 -124.28 152.21 43.3 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.901 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -145.16 151.6 38.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.554 0.742 . . . . 0.0 109.46 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 59.7 mt -128.47 136.03 61.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -123.98 148.5 46.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.667 0.387 . . . . 0.0 111.061 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 12.7 p -132.24 161.63 32.96 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.694 1.198 . . . . 0.0 111.176 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -61.51 122.26 14.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.056 0.943 . . . . 0.0 111.784 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 118.54 24.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.282 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.83 59.79 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 76.8 p -70.07 169.63 13.05 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.876 -1.14 . . . . 0.0 112.923 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -152.34 -44.56 0.1 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.198 2.199 . . . . 0.0 109.108 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.22 116.77 22.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.496 1.518 . . . . 0.0 107.868 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.247 0.948 0 C-N-CA 129.08 2.952 . . . . 0.0 108.634 -175.462 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.5 p -110.19 94.16 4.87 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.079 1.352 . . . . 0.0 110.42 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 13.9 p -53.2 -18.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.144 1.778 . . . . 0.0 115.641 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . 60.14 -168.64 0.16 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.71 1.204 . . . . 0.0 112.523 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . 0.259 22.2 ptt180 167.81 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 128.425 2.69 . . . . 0.0 113.559 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -154.3 141.68 19.64 Favored 'General case' 0 CA--C 1.513 -0.461 0 O-C-N 121.136 -0.977 . . . . 0.0 109.144 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.2 p -143.11 144.21 32.14 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 124.967 1.417 . . . . 0.0 108.529 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.73 127.72 22.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.566 -0.709 . . . . 0.0 112.569 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.85 -25.3 67.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.61 119.49 5.36 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 123.042 1.401 . . . . 0.0 111.984 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.35 -111.2 1.06 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.01 2.243 . . . . 0.0 110.447 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.45 ' HD2' HD13 ' B' ' 123' ' ' LEU . 24.3 ttmt -153.65 152.56 30.98 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.34 158.18 43.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.884 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.1 146.88 45.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.683 1.193 . . . . 0.0 108.35 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -116.28 143.33 45.66 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 111.188 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -57.8 -24.15 55.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.204 1.401 . . . . 0.0 113.645 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.477 HD21 HG21 ' B' ' 37' ' ' VAL . 39.9 tp -68.18 -15.59 63.64 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 120.644 -1.285 . . . . 0.0 111.735 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.42 43.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.732 2.587 . . . . 0.0 113.418 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -66.61 147.7 52.92 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.196 -1.179 . . . . 0.0 111.633 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -127.1 152.01 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.12 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.96 147.38 33.86 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -126.89 135.39 50.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.99 120.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.23 -64.85 3.02 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.662 1.226 . . . . 0.0 113.201 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.51 139.8 3.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.241 1.416 . . . . 0.0 110.163 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 m -86.3 137.36 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.403 0.281 . . . . 0.0 110.576 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.26 163.37 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.678 0.391 . . . . 0.0 111.246 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -23.83 50.11 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -27.11 63.71 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.3 -0.875 . . . . 0.0 111.285 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.84 -2.12 48.5 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.218 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.18 144.51 51.93 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.524 1.162 . . . . 0.0 108.542 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.79 156.12 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 112.157 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.5 158.33 38.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.341 1.856 . . . . 0.0 108.201 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.33 -170.5 34.73 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 120.973 -1.079 . . . . 0.0 114.758 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 35.9 p -137.19 126.51 24.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.065 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.694 ' C ' HD12 ' B' ' 34' ' ' ILE . 1.5 t80 -126.74 133.31 50.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.72 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' B' ' 46' ' ' LEU . 1.5 mp -121.41 136.24 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.698 HG22 ' O ' ' B' ' 37' ' ' VAL . 42.7 m -116.39 130.54 56.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.29 2.7 53.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.302 1.049 . . . . 0.0 113.828 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.698 ' O ' HG22 ' B' ' 35' ' ' THR . 28.2 m -141.09 161.66 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.348 2.259 . . . . 0.0 108.373 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.61 166.67 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 119.971 -1.706 . . . . 0.0 111.909 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.0 -24.65 62.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 122.461 -0.149 . . . . 0.0 110.674 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -153.3 83.73 4.51 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.152 2.181 . . . . 0.0 109.22 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.54 175.92 8.82 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.842 3.028 . . . . 0.0 112.9 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.41 -33.21 2.81 Favored Glycine 0 N--CA 1.476 1.324 0 C-N-CA 124.715 1.15 . . . . 0.0 112.219 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -132.62 20.75 4.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.005 1.322 . . . . 0.0 112.359 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.514 HG21 ' O ' ' B' ' 35' ' ' THR . 43.9 mt -54.25 127.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.08 0.943 . . . . 0.0 109.141 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.19 176.46 8.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.758 2.023 . . . . 0.0 107.57 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.759 ' CD1' HD11 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -48.49 146.3 3.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.258 172.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -125.02 113.26 26.62 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 112.07 -2.332 . . . . 0.0 110.57 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -56.4 134.68 65.79 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.135 1.89 . . . . 0.0 109.65 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.04 151.22 45.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.486 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -143.32 149.19 37.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.821 2.449 . . . . 0.0 107.839 174.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 -161.28 35.11 Favored Glycine 0 N--CA 1.451 -0.326 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.498 HG21 ' CB ' ' C' ' 69' ' ' ASN . 3.8 mt -144.56 144.91 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.961 0.904 . . . . 0.0 111.799 -174.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.521 HE22 ' HB2' ' B' ' 57' ' ' LYS . 0.1 OUTLIER -133.18 148.26 52.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.301 1.04 . . . . 0.0 113.323 175.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -84.65 141.31 30.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.099 0.952 . . . . 0.0 111.069 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.521 ' HB2' HE22 ' B' ' 53' ' ' GLN . 0.9 OUTLIER -139.05 30.72 2.21 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.95 1.3 . . . . 0.0 112.222 178.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -93.33 -55.38 3.32 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.94 2.496 . . . . 0.0 111.72 174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.97 179.51 6.17 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.0 m -82.98 -35.53 25.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.842 1.257 . . . . 0.0 113.264 174.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -135.04 49.01 3.29 Favored Pre-proline 0 CA--C 1.562 1.434 0 O-C-N 125.377 1.673 . . . . 0.0 111.4 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.44 177.5 5.98 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.079 2.52 . . . . 0.0 115.272 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.347 0.1 OUTLIER -102.13 168.06 9.61 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.027 1.394 . . . . 0.0 111.749 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -161.41 163.03 30.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.84 -173.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.66 147.26 13.02 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 118.81 2.284 . . . . 0.0 118.81 -173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.9 m -89.28 147.95 23.83 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.066 1.746 . . . . 0.0 108.338 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.34 119.8 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.489 ' CB ' HG21 ' C' ' 52' ' ' ILE . 37.8 t30 -102.67 102.09 12.26 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.352 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -69.07 125.64 27.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.278 1.854 . . . . 0.0 115.707 -172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.36 -37.46 28.21 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.514 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.83 -22.14 37.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.516 1.127 . . . . 0.0 113.647 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -152.42 124.79 8.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.722 1.609 . . . . 0.0 108.699 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.97 116.29 4.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.803 1.183 . . . . 0.0 111.173 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 9.2 p -173.01 158.79 3.83 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.059 2.143 . . . . 0.0 109.856 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -143.36 142.6 31.34 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-O 123.117 1.437 . . . . 0.0 110.531 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -142.12 128.46 19.97 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 110.084 -3.234 . . . . 0.0 109.927 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.33 153.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.741 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.11 142.29 50.93 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.44 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -152.29 118.61 5.59 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -174.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -162.72 -176.75 35.11 Favored Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -127.68 143.22 51.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.36 0.682 . . . . 0.0 112.169 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' B' ' 4' ' ' CYS . 49.9 t -97.52 124.84 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.07 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.402 ' HB2' HD12 ' C' ' 106' ' ' ILE . 2.9 m-85 -116.01 168.27 10.23 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.239 1.019 . . . . 0.0 111.794 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 30.2 mt -124.79 109.54 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.286 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -58.62 157.33 9.36 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -42.31 -30.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.91 -19.38 54.79 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.81 8.57 27.88 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 125.073 1.32 . . . . 0.0 115.583 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 4.6 mtpp -87.48 152.94 21.82 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.931 1.366 . . . . 0.0 112.585 -176.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -100.96 134.83 43.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.565 1.546 . . . . 0.0 110.016 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 m -144.14 145.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 38.0 mt -118.89 92.42 3.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.47 1.129 . . . . 0.0 111.227 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -83.4 113.13 20.53 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.074 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.414 HG22 ' HA3' ' B' ' 81' ' ' GLY . 4.8 p -135.29 168.48 19.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.559 1.647 . . . . 0.0 112.801 -174.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -120.12 170.44 9.3 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 124.608 1.163 . . . . 0.0 107.901 172.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -141.11 159.05 43.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.427 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.5 tp -134.41 122.15 22.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.404 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . 0.262 0.4 OUTLIER -107.53 134.64 50.25 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 125.047 1.467 . . . . 0.0 112.216 -176.098 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 5.4 tpt180 -115.55 114.06 24.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 112.001 -2.363 . . . . 0.0 110.048 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.259 72.9 m -70.09 167.97 16.56 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.266 1.604 . . . . 0.0 111.465 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -113.29 85.38 2.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 -160.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -140.52 -13.21 1.0 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 119.569 -1.957 . . . . 0.0 114.223 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.17 151.17 49.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.509 1.147 . . . . 0.0 112.003 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' C' ' 84' ' ' PHE . 2.2 tt -58.57 -25.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.407 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.64 -2.36 28.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.038 1.304 . . . . 0.0 114.626 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.33 5.87 7.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.214 1.006 . . . . 0.0 112.137 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.5 -32.12 73.63 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 119.55 -1.969 . . . . 0.0 112.668 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' D' ' 14' ' ' LEU . 58.7 p-90 -48.0 -41.25 24.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.726 1.21 . . . . 0.0 113.718 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -94.37 -11.43 29.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.349 1.059 . . . . 0.0 113.494 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.1 -0.91 20.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.105 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -111.6 143.65 42.12 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.168 0.985 . . . . 0.0 111.244 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -142.38 153.48 43.82 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 125.316 1.446 . . . . 0.0 109.524 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.26 150.64 33.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.689 1.131 . . . . 0.0 109.517 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.99 -177.02 29.71 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.375 0.512 . . . . 0.0 112.184 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 34.9 p90 -124.42 151.77 44.09 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -144.17 151.22 39.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.998 0.904 . . . . 0.0 109.22 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.19 134.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -122.25 149.83 43.15 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.042 0.448 . . . . 0.0 111.038 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 5.3 p -130.86 159.82 36.24 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.94 1.296 . . . . 0.0 110.647 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -58.69 123.81 17.62 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.5 0.72 . . . . 0.0 111.495 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' B' ' 124' ' ' ARG . 2.7 tt -74.4 102.86 4.56 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.561 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.607 ' HB2' HD23 ' B' ' 123' ' ' LEU . 0.0 OUTLIER 60.83 104.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.128 2.171 . . . . 0.0 113.405 173.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.93 169.93 15.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.42 -174.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -149.87 66.79 0.98 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.263 3.025 . . . . 0.0 105.111 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.76 93.74 2.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 129.412 3.085 . . . . 0.0 110.029 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.261 1.702 0 C-N-CA 129.697 3.199 . . . . 0.0 107.595 174.306 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 3.7 p -149.85 -64.97 0.21 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.454 1.502 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 m -158.29 154.79 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.51 2.324 . . . . 0.0 109.645 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -71.13 153.18 42.73 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.628 0.728 . . . . 0.0 109.9 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -158.0 29.75 0.26 Allowed 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.742 -1.224 . . . . 0.0 113.766 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -156.55 151.08 25.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.982 1.313 . . . . 0.0 107.591 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' C' ' 83' ' ' CYS . 26.6 p -148.37 145.02 27.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.595 1.184 . . . . 0.0 109.788 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.74 127.92 22.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.53 -25.64 68.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -54.34 118.39 4.07 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.863 1.316 . . . . 0.0 112.08 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.55 -112.17 1.17 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.955 2.217 . . . . 0.0 110.667 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -150.58 151.77 33.09 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -142.0 157.44 44.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 112.577 -2.101 . . . . 0.0 111.226 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 147.95 50.58 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -115.87 143.41 45.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.929 0.892 . . . . 0.0 110.879 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.1 -24.21 52.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.332 1.453 . . . . 0.0 113.638 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.478 HD21 HG21 ' C' ' 37' ' ' VAL . 37.9 tp -67.85 -15.07 63.45 Favored 'General case' 0 CA--C 1.556 1.182 0 O-C-N 120.773 -1.204 . . . . 0.0 111.819 173.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.39 -9.35 45.37 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.723 2.582 . . . . 0.0 113.324 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -66.62 147.02 53.85 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.202 -1.175 . . . . 0.0 111.618 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -126.52 152.04 47.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.8 147.41 34.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -127.39 135.85 51.05 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.842 0.857 . . . . 0.0 110.22 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -128.31 119.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.51 -63.99 3.75 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.605 1.191 . . . . 0.0 113.308 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.23 143.16 4.22 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.51 1.524 . . . . 0.0 110.265 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.93 135.66 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.735 0.414 . . . . 0.0 110.274 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.7 163.38 28.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.337 0.655 . . . . 0.0 111.287 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -22.02 53.68 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -25.56 62.29 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.23 -0.919 . . . . 0.0 111.253 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.59 51.4 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.273 1.416 . . . . 0.0 113.225 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.1 150.37 43.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 110.333 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.14 166.32 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.795 0.807 . . . . 0.0 111.122 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.484 ' HB ' HD22 ' C' ' 50' ' ' LEU . 0.5 OUTLIER -134.49 160.72 37.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.529 1.932 . . . . 0.0 106.844 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.64 -170.9 36.2 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.327 -1.483 . . . . 0.0 114.822 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -137.61 126.63 24.27 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.565 0.698 . . . . 0.0 109.383 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.699 ' C ' HD12 ' C' ' 34' ' ' ILE . 1.6 t80 -126.73 133.45 50.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.466 -172.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.748 HD11 ' CD1' ' C' ' 46' ' ' LEU . 1.6 mp -121.49 136.29 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.687 HG22 ' O ' ' C' ' 37' ' ' VAL . 33.4 m -116.92 130.55 56.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -172.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.14 5.08 50.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.687 ' O ' HG22 ' C' ' 35' ' ' THR . 28.7 m -143.2 161.25 17.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.149 2.179 . . . . 0.0 108.261 -175.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.31 166.96 12.34 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.786 -1.821 . . . . 0.0 111.757 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.78 -23.72 61.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.162 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -153.41 84.08 4.39 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 127.211 2.205 . . . . 0.0 109.373 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.69 176.02 8.77 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.557 2.838 . . . . 0.0 112.805 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.04 -33.14 2.87 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.776 1.179 . . . . 0.0 112.284 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -132.64 20.57 4.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.026 1.33 . . . . 0.0 112.328 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.521 HG21 ' O ' ' C' ' 35' ' ' THR . 44.8 mt -54.11 127.82 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.249 1.023 . . . . 0.0 109.234 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.13 177.24 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.486 1.914 . . . . 0.0 107.296 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.748 ' CD1' HD11 ' C' ' 34' ' ' ILE . 1.0 OUTLIER -49.0 146.82 3.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.118 172.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -125.23 113.08 26.13 Favored Pre-proline 0 N--CA 1.426 -1.651 0 CA-C-N 112.042 -2.345 . . . . 0.0 110.398 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -56.01 132.25 50.84 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.03 1.82 . . . . 0.0 109.223 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.65 154.93 36.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.323 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB ' ' C' ' 30' ' ' THR . 0.3 OUTLIER -148.6 149.23 31.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.827 2.451 . . . . 0.0 108.142 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.72 -160.04 32.41 Favored Glycine 0 CA--C 1.517 0.186 0 O-C-N 121.383 -0.823 . . . . 0.0 112.71 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.489 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.6 mt -145.36 144.95 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.319 1.047 . . . . 0.0 112.149 -174.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.516 HE22 ' HB2' ' C' ' 57' ' ' LYS . 0.4 OUTLIER -131.87 152.04 51.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.857 1.263 . . . . 0.0 112.909 175.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -88.93 140.87 29.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.05 0.929 . . . . 0.0 111.038 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . 0.516 ' HB2' HE22 ' C' ' 53' ' ' GLN . 0.9 OUTLIER -138.17 30.15 2.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.735 1.214 . . . . 0.0 112.237 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -93.37 -55.48 3.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.98 2.512 . . . . 0.0 111.714 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -179.76 5.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -83.94 -35.76 23.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.671 1.188 . . . . 0.0 112.95 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -134.34 48.06 2.87 Favored Pre-proline 0 CA--C 1.564 1.49 0 O-C-N 125.388 1.68 . . . . 0.0 111.823 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.09 176.42 6.28 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.148 2.565 . . . . 0.0 115.518 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.337 0.2 OUTLIER -101.05 169.91 8.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.674 1.226 . . . . 0.0 111.414 174.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.86 163.31 26.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.733 -173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 147.88 14.19 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 118.644 2.218 . . . . 0.0 118.644 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -161.66 149.81 15.2 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -88.58 149.21 23.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.245 1.818 . . . . 0.0 108.221 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.63 121.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.498 ' CB ' HG21 ' B' ' 52' ' ' ILE . 39.8 t30 -104.32 102.19 11.88 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.198 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -68.44 124.35 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.854 1.661 . . . . 0.0 115.427 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -80.07 -37.55 33.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.641 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -81.78 -22.23 37.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.694 1.198 . . . . 0.0 113.692 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 34.6 t -152.51 124.61 8.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.75 1.62 . . . . 0.0 108.66 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.68 116.52 4.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.587 1.085 . . . . 0.0 111.132 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 8.6 p -173.29 158.36 3.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.15 2.18 . . . . 0.0 110.02 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -142.69 142.01 31.93 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-O 123.181 1.467 . . . . 0.0 110.488 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -141.86 128.05 19.76 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 110.015 -3.266 . . . . 0.0 110.091 -171.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.66 154.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.785 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -129.47 141.99 50.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.433 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -152.27 118.69 5.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -174.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -163.07 -176.12 34.78 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -128.9 143.1 50.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 124.484 0.755 . . . . 0.0 112.319 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.489 ' HG ' ' CB ' ' C' ' 4' ' ' CYS . 49.0 t -97.56 122.69 40.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.527 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD12 ' B' ' 106' ' ' ILE . 3.5 m-85 -114.0 167.81 10.34 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.551 0.691 . . . . 0.0 111.638 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -125.71 108.34 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.082 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.56 160.93 4.98 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -44.05 -31.09 0.84 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -79.99 -15.08 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.03 5.6 40.72 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.884 1.23 . . . . 0.0 115.682 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 152.63 28.53 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.017 1.408 . . . . 0.0 112.543 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -100.72 135.96 41.33 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.496 1.518 . . . . 0.0 109.131 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.56 147.36 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.265 1.026 . . . . 0.0 111.36 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 40.7 mt -119.97 92.38 3.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.682 1.23 . . . . 0.0 111.772 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -83.59 112.57 20.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.903 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.418 HG22 ' HA3' ' C' ' 81' ' ' GLY . 4.5 p -134.36 168.95 17.98 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.607 1.194 . . . . 0.0 112.831 -174.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -120.94 170.7 9.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 38.9 p-90 -140.53 159.83 41.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.385 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.44 HD23 ' OG1' ' B' ' 80' ' ' THR . 3.3 tp -135.16 122.1 21.19 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.474 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.43 134.98 49.68 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.927 1.392 . . . . 0.0 111.863 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -116.16 114.09 23.98 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 111.974 -2.375 . . . . 0.0 110.078 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.26 71.4 m -69.74 168.09 15.74 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 125.299 1.624 . . . . 0.0 111.681 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 2.6 p -112.94 85.64 2.21 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.53 -160.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -141.45 -11.61 0.92 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 119.518 -1.989 . . . . 0.0 114.406 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.46 150.47 50.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.284 1.04 . . . . 0.0 111.723 174.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 84' ' ' PHE . 2.2 tt -58.13 -25.44 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.4 -2.81 28.97 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.97 1.272 . . . . 0.0 114.611 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.42 6.17 7.66 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.164 0.986 . . . . 0.0 112.309 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.47 -32.69 74.2 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.757 -1.84 . . . . 0.0 112.741 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.455 ' CD1' HD11 ' A' ' 14' ' ' LEU . 58.2 p-90 -48.28 -41.77 28.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.684 1.194 . . . . 0.0 113.697 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -93.93 -11.67 30.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.242 1.017 . . . . 0.0 113.329 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.61 -1.23 20.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.077 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -111.35 143.71 41.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.002 0.906 . . . . 0.0 111.373 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -142.56 153.33 43.45 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.463 1.505 . . . . 0.0 109.504 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.04 151.1 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 109.358 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.03 -177.77 30.47 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 121.813 0.674 . . . . 0.0 112.244 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 34.8 p90 -123.84 151.33 43.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.4 0.68 . . . . 0.0 109.419 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -144.18 151.4 39.46 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.995 0.902 . . . . 0.0 108.83 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.67 133.71 67.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -120.81 149.71 42.14 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.134 0.492 . . . . 0.0 111.093 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 33.2 p -134.6 163.48 29.64 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.042 1.337 . . . . 0.0 110.907 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.48 123.76 20.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.062 0.945 . . . . 0.0 113.132 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.84 81.84 8.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 64.46 106.15 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.999 2.12 . . . . 0.0 112.909 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -135.44 -173.26 3.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.709 1.604 . . . . 0.0 111.005 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.87 152.93 11.79 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.417 1.103 . . . . 0.0 109.516 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.48 10.26 21.35 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 129.271 3.028 . . . . 0.0 111.408 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.407 4.6 pt-20 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 128.784 2.834 . . . . 0.0 113.648 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . 0.272 6.9 pm0 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 116.756 -1.593 . . . . 0.0 108.889 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 9.2 m -130.8 96.95 4.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.526 1.512 . . . . 0.0 110.663 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.2 p -142.61 50.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 122.648 1.213 . . . . 0.0 113.843 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.09 -73.07 0.47 Allowed 'General case' 0 C--O 1.241 0.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.774 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 59.72 -38.04 0.08 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.633 3.173 . . . . 0.0 114.94 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -105.25 131.59 52.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.908 3.283 . . . . 0.0 106.973 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.3 157.55 24.79 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 p -139.38 127.19 22.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.349 -0.844 . . . . 0.0 113.102 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.542 HD12 ' CD ' ' A' ' 53' ' ' GLN . 33.5 mt -69.39 -27.05 64.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.017 0.527 . . . . 0.0 111.777 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -62.91 120.77 11.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.67 24.86 1.49 Allowed Glycine 0 N--CA 1.476 1.309 0 N-CA-C 118.001 1.96 . . . . 0.0 118.001 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 tttt 69.3 145.96 0.06 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.894 2.478 . . . . 0.0 116.911 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -140.99 158.91 43.28 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.334 1.454 . . . . 0.0 112.538 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 t -132.45 142.85 49.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.853 1.261 . . . . 0.0 108.622 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.75 143.69 44.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.47 1.108 . . . . 0.0 110.128 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -57.06 -30.37 64.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.52 -11.73 61.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.311 1.444 . . . . 0.0 112.586 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.92 -11.19 37.88 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 127.503 2.477 . . . . 0.0 113.519 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -61.06 145.67 50.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 122.781 1.277 . . . . 0.0 112.326 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -122.81 139.99 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -132.71 145.27 50.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.94 0.876 . . . . 0.0 112.416 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 m -128.78 125.54 38.05 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.2 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.77 127.67 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.34 -88.86 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 O-C-N 125.647 1.842 . . . . 0.0 111.08 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.82 143.52 36.86 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.084 -0.657 . . . . 0.0 110.733 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.47 HG21 ' CG ' ' A' ' 53' ' ' GLN . 7.4 p -95.03 131.92 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.656 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -72.52 159.14 34.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.079 0.943 . . . . 0.0 112.919 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.0 m -54.47 -28.46 44.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.774 1.23 . . . . 0.0 114.212 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -71.11 -34.91 71.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.085 0.554 . . . . 0.0 112.472 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.81 -8.81 12.75 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.531 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 155.27 40.43 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.459 1.63 . . . . 0.0 108.271 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.47 166.12 32.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.975 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.5 148.04 52.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.24 26.34 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 122.554 1.086 . . . . 0.0 113.298 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.492 ' HB ' HD11 ' A' ' 46' ' ' LEU . 10.9 p -139.49 139.45 36.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.021 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -118.71 129.52 55.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.929 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -118.28 128.51 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 m -106.11 143.55 34.08 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.404 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.52 -15.63 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 15.9 m -135.03 142.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 113.154 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.56 168.91 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.39 -38.78 26.0 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.33 74.37 77.46 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.323 1.849 . . . . 0.0 109.227 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.64 6.5 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.165 3.243 . . . . 0.0 117.348 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.66 -21.29 0.8 Allowed Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.04 42.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.709 1.255 . . . . 0.0 111.945 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.59 134.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.835 0.826 . . . . 0.0 111.518 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 0.6 OUTLIER -152.48 171.82 17.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 0.0 111.22 176.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 32' ' ' THR . 12.2 tp -46.69 117.4 1.63 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 129.496 3.119 . . . . 0.0 112.438 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.7 m -111.79 114.05 52.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.899 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.18 145.15 66.88 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.324 2.683 . . . . 0.0 112.82 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.34 51.99 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.526 1.13 . . . . 0.0 111.864 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.75 149.85 39.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.188 2.995 . . . . 0.0 109.282 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.99 -155.33 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.3 mt -144.82 139.56 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.996 0.903 . . . . 0.0 112.637 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.542 ' CD ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -119.54 155.74 31.61 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.355 -0.841 . . . . 0.0 111.06 172.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.24 164.02 21.47 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.767 -1.208 . . . . 0.0 110.723 172.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.94 25.32 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.402 1.081 . . . . 0.0 112.924 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.84 -55.36 3.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.07 2.148 . . . . 0.0 110.454 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 173.19 12.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.711 1.243 . . . . 0.0 113.217 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -43.61 60.58 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.789 2.036 . . . . 0.0 112.176 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -131.41 53.75 12.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.952 1.301 . . . . 0.0 110.309 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.57 176.71 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.161 1.907 . . . . 0.0 116.272 -174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -88.34 161.85 16.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.504 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.37 164.48 29.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.249 -0.907 . . . . 0.0 112.46 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.84 149.47 15.7 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 120.397 2.919 . . . . 0.0 120.397 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -164.29 154.38 14.5 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -90.04 150.57 22.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.047 2.139 . . . . 0.0 109.332 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -129.97 120.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' D' ' 52' ' ' ILE . 59.4 t30 -95.59 106.01 18.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.653 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.12 131.88 46.72 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 121.234 1.834 . . . . 0.0 112.766 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.07 -38.22 12.33 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -90.38 -10.74 42.8 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -152.44 132.5 13.44 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 127.705 2.402 . . . . 0.0 106.847 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -69.85 118.49 12.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.546 1.066 . . . . 0.0 110.173 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.1 p -173.53 170.26 4.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.481 1.912 . . . . 0.0 109.769 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.89 137.95 31.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.979 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.446 ' CG2' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -114.29 165.99 12.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.327 1.06 . . . . 0.0 108.617 173.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 149.9 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.01 142.11 51.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.46 120.3 9.93 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 179.79 39.46 Favored Glycine 0 CA--C 1.497 -1.058 0 C-N-CA 118.935 -1.602 . . . . 0.0 117.079 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.49 147.93 36.95 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.562 1.172 . . . . 0.0 112.176 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.4 t -97.48 129.0 44.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.866 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' D' ' 106' ' ' ILE . 0.6 OUTLIER -124.1 169.18 11.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.729 1.252 . . . . 0.0 113.72 177.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.8 mt -131.49 107.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 112.642 -2.072 . . . . 0.0 106.85 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -58.86 157.28 9.96 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.46 -55.13 0.05 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.148 2.179 . . . . 0.0 116.449 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.93 -19.85 62.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.39 1.876 . . . . 0.0 115.976 -173.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.73 53.65 1.19 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -125.59 136.03 52.84 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 126.834 2.053 . . . . 0.0 108.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.34 142.65 32.43 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 111.094 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' D' ' 106' ' ' ILE . 15.1 m -147.23 166.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.188 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.34 122.34 33.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' D' ' 106' ' ' ILE . 1.5 mmmt -109.37 116.18 31.35 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.86 160.11 39.85 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.194 1.473 . . . . 0.0 112.15 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -108.25 167.75 9.8 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 172.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -141.32 160.81 39.34 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.649 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.3 tt -143.84 127.43 17.02 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.783 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' ' 77' ' ' THR . 1.0 OUTLIER -110.85 144.65 39.55 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 125.172 1.545 . . . . 0.0 110.818 -175.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.426 ' CZ ' ' HA2' ' D' ' 81' ' ' GLY . 2.3 tpt85 -128.27 116.01 19.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 112.209 -2.268 . . . . 0.0 112.115 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -89.43 158.68 17.64 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 113.396 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -103.68 80.76 1.82 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.7 m -66.8 -173.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.996 0.518 . . . . 0.0 109.658 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.16 -20.83 9.68 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.984 -1.698 . . . . 0.0 114.783 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -124.66 152.42 43.68 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.791 1.282 . . . . 0.0 111.459 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.582 HD11 ' HE2' ' D' ' 94' ' ' LYS . 10.3 tt -62.44 -27.5 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.181 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.99 23.62 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.291 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -120.08 -0.91 10.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.037 1.419 . . . . 0.0 113.937 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.76 -32.4 69.24 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.968 . . . . 0.0 112.947 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' C' ' 37' ' ' VAL . 60.1 p-90 -45.53 -44.6 12.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.609 1.164 . . . . 0.0 113.892 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -93.42 -12.86 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.86 0.864 . . . . 0.0 113.111 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.65 5.57 8.98 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.0 m -113.83 135.5 53.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.909 0.884 . . . . 0.0 111.824 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.67 126.49 22.29 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.61 154.92 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 120.524 1.511 . . . . 0.0 112.235 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.55 30.02 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.606 1.098 . . . . 0.0 113.177 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 24.4 p90 -129.28 153.67 47.57 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.771 0.828 . . . . 0.0 109.995 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -148.62 149.1 30.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.131 0.972 . . . . 0.0 109.716 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.32 130.63 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.39 -0.819 . . . . 0.0 109.28 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -118.52 153.86 33.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.255 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -137.51 165.1 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.202 1.001 . . . . 0.0 110.447 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -60.83 116.7 4.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 110.783 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tp -76.63 104.44 7.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.543 0.0 OUTLIER 77.18 85.07 0.08 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 123.946 1.831 . . . . 0.0 109.417 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 t -136.45 0.04 2.47 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.389 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.255 3.4 pm0 27.49 -121.22 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.265 2.626 . . . . 0.0 117.428 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -170.25 77.77 0.09 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 130.148 3.379 . . . . 0.0 107.472 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.251 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 117.728 -1.13 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 3.3 t -155.63 -43.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 119.564 1.075 . . . . 0.0 112.868 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 7.4 m -68.61 64.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 127.111 2.164 . . . . 0.0 113.139 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.17 -146.81 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 70.35 -40.69 0.47 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.996 2.918 . . . . 0.0 113.582 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -106.96 135.08 49.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.961 2.504 . . . . 0.0 107.771 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' D' ' 83' ' ' CYS . 10.1 p -131.32 142.95 50.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 124.147 0.979 . . . . 0.0 108.388 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 21.1 p -132.63 127.47 35.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' D' ' 53' ' ' GLN . 28.7 mt -68.21 -26.56 65.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.292 1.037 . . . . 0.0 112.425 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 t -62.57 121.02 12.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.34 40.55 0.62 Allowed Glycine 0 CA--C 1.534 1.251 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 mttt 56.53 150.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 129.087 2.955 . . . . 0.0 118.371 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -142.55 161.97 36.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.567 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 1.2 t -131.76 148.17 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.305 1.442 . . . . 0.0 107.552 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.42 143.41 45.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 109.988 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -56.4 -28.86 60.57 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.23 -12.48 61.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.938 1.695 . . . . 0.0 113.018 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.8 -8.44 36.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 127.142 2.306 . . . . 0.0 113.775 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -63.59 147.0 52.64 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.827 1.313 . . . . 0.0 112.066 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -124.66 137.83 54.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -130.33 147.18 52.01 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.112 0.958 . . . . 0.0 113.121 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 14.6 m -131.31 125.25 32.28 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.14 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.94 126.55 73.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 -88.05 0.1 OUTLIER Glycine 0 CA--C 1.526 0.753 0 O-C-N 126.09 2.119 . . . . 0.0 111.073 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.36 142.59 35.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.246 0.618 . . . . 0.0 110.661 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.458 HG21 ' CG ' ' D' ' 53' ' ' GLN . 7.3 p -95.09 133.02 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.722 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -71.92 160.07 33.17 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.206 1.003 . . . . 0.0 113.316 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 15.8 m -53.76 -27.33 28.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.249 1.419 . . . . 0.0 114.455 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.99 -34.03 68.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.282 0.633 . . . . 0.0 112.625 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.74 -9.83 12.57 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.981 1.277 . . . . 0.0 113.432 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.3 157.42 37.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.907 1.354 . . . . 0.0 110.634 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.82 166.3 33.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.332 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -131.03 147.68 52.66 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.46 -168.67 24.73 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.859 1.255 . . . . 0.0 112.904 -174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' D' ' 46' ' ' LEU . 9.5 p -140.06 139.53 35.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.396 -1.402 . . . . 0.0 112.202 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -118.52 132.92 56.21 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.861 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 60.3 mt -121.47 129.31 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . . . . . . . . . 55.1 m -107.36 143.42 35.68 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.538 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.63 -15.73 18.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.2 m -134.73 142.62 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.012 0.925 . . . . 0.0 112.933 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.35 169.19 22.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.216 -0.928 . . . . 0.0 110.967 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -38.77 25.35 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.15 74.41 77.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.573 1.949 . . . . 0.0 109.375 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.75 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.13 3.22 . . . . 0.0 117.332 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.52 -21.35 0.77 Allowed Glycine 0 CA--C 1.536 1.401 0 N-CA-C 118.531 2.172 . . . . 0.0 118.531 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.06 42.38 0.08 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 111.929 -175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 54.9 mt -50.29 133.56 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.397 -0.815 . . . . 0.0 111.748 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . 0.259 0.6 OUTLIER -151.81 171.54 17.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 111.377 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' D' ' 32' ' ' THR . 12.3 tp -46.62 118.38 1.99 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.096 2.958 . . . . 0.0 112.116 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 69.6 m -113.08 112.52 49.86 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.256 1.022 . . . . 0.0 108.581 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -54.47 145.71 56.13 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.143 2.562 . . . . 0.0 112.593 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 143.96 51.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.43 1.092 . . . . 0.0 111.525 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -144.34 151.42 39.31 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 129.021 2.928 . . . . 0.0 109.446 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.55 -155.39 26.43 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -145.07 139.1 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.446 -0.877 . . . . 0.0 112.333 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . 0.522 ' CD ' HD12 ' D' ' 6' ' ' LEU . 0.0 OUTLIER -119.42 155.05 32.72 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.176 0.99 . . . . 0.0 110.79 173.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.15 163.98 22.7 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.43 -1.419 . . . . 0.0 110.81 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.16 26.43 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.231 1.013 . . . . 0.0 112.865 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.4 -56.69 2.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.019 2.128 . . . . 0.0 110.622 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.37 171.86 14.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.376 1.084 . . . . 0.0 113.356 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -43.82 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.2 1.4 . . . . 0.0 111.032 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -132.37 57.67 30.93 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 111.283 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.61 177.21 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 N-CA-C 116.767 1.795 . . . . 0.0 116.767 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -88.88 162.22 16.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.588 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.63 165.56 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.715 -1.241 . . . . 0.0 112.38 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.91 149.47 15.12 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.7 156.9 18.57 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -92.98 151.07 20.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.23 2.212 . . . . 0.0 108.967 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.41 121.97 52.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 53.5 t30 -97.77 106.73 19.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.414 -174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -67.16 131.7 46.32 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.807 1.639 . . . . 0.0 112.73 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.87 -38.13 12.5 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -90.42 -10.94 41.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -152.5 132.27 13.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.045 2.538 . . . . 0.0 107.068 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -69.54 118.61 12.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.298 0.954 . . . . 0.0 110.39 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 72.5 p -173.97 170.05 3.93 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 109.886 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -140.9 137.78 33.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.445 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.448 ' CG2' HD12 ' D' ' 99' ' ' LEU . 0.6 OUTLIER -114.25 165.53 12.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.205 1.002 . . . . 0.0 108.478 173.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.91 150.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.95 142.03 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.33 120.52 10.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 100' ' ' ARG . . . -165.46 -179.86 39.46 Favored Glycine 0 CA--C 1.497 -1.033 0 N-CA-C 117.274 1.67 . . . . 0.0 117.274 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.98 145.34 41.68 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.692 0.878 . . . . 0.0 112.236 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.485 ' HG ' ' HB2' ' D' ' 4' ' ' CYS . 28.1 t -97.76 125.25 42.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.439 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -120.19 169.84 9.87 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.456 1.122 . . . . 0.0 113.618 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.8 mt -130.6 107.24 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.056 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -59.15 155.31 14.25 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.477 0.711 . . . . 0.0 109.097 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -24.15 -56.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 127.091 2.157 . . . . 0.0 116.704 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.23 -17.83 63.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.43 47.89 1.62 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.501 1.046 . . . . 0.0 110.632 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -119.78 139.61 52.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.477 1.511 . . . . 0.0 110.025 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -101.39 143.69 31.12 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 111.108 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 106' ' ' ILE . 15.2 m -148.09 164.28 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.928 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' D' ' 83' ' ' CYS . 58.5 mt -124.34 120.52 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.582 ' HE2' HD11 ' A' ' 106' ' ' ILE . 1.7 mmmt -108.75 115.15 29.55 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 172.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -136.57 161.58 35.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 123.319 1.533 . . . . 0.0 111.667 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.418 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -110.01 168.53 9.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -142.11 161.28 38.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.306 173.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.783 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.2 tt -144.29 127.06 16.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.808 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' D' ' 77' ' ' THR . 1.0 OUTLIER -110.62 144.71 39.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 124.554 1.159 . . . . 0.0 110.898 -176.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -128.11 114.59 17.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.011 -2.359 . . . . 0.0 112.13 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 85.7 p -86.97 158.6 19.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 124.813 1.32 . . . . 0.0 113.462 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -103.68 81.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.85 -173.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.039 0.535 . . . . 0.0 109.838 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -115.83 -21.0 9.79 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.119 -1.613 . . . . 0.0 114.789 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -123.85 151.3 43.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.486 1.136 . . . . 0.0 111.702 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.608 HD11 ' HE2' ' A' ' 94' ' ' LYS . 10.8 tt -61.93 -27.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.055 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.77 4.32 22.68 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.356 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -120.13 -0.19 10.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.905 1.353 . . . . 0.0 113.935 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -60.08 -31.38 69.97 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.358 -0.839 . . . . 0.0 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' B' ' 37' ' ' VAL . 60.4 p-90 -46.54 -44.21 17.66 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.53 1.132 . . . . 0.0 113.97 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -93.63 -12.79 28.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.011 0.924 . . . . 0.0 113.161 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.64 5.11 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.783 ' CG2' HD21 ' D' ' 98' ' ' LEU . 14.5 m -113.08 135.6 53.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.862 0.865 . . . . 0.0 111.726 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.57 126.25 22.14 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.611 -1.185 . . . . 0.0 110.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.91 154.82 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.298 1.408 . . . . 0.0 111.821 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.86 -175.87 30.27 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.687 1.137 . . . . 0.0 113.096 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.0 p90 -126.47 153.43 45.09 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.623 0.769 . . . . 0.0 109.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -148.08 148.24 30.43 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.036 0.934 . . . . 0.0 109.271 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 64.9 mt -128.2 131.5 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.031 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -117.74 156.76 27.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.222 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -137.53 160.95 37.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.591 1.156 . . . . 0.0 110.195 174.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.18 129.54 42.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.891 -0.506 . . . . 0.0 109.735 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.02 -177.55 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.764 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 88.67 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.73 1.212 . . . . 0.0 110.177 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -169.14 1.69 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.93 2.092 . . . . 0.0 109.586 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -55.85 148.53 16.68 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.537 2.335 . . . . 0.0 105.039 173.197 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 117.291 -1.338 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' B' ' -1' ' ' VAL . 5.8 m -62.54 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.791 1.637 . . . . 0.0 111.583 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . 0.405 ' H ' ' HB ' ' B' ' -2' ' ' THR . 8.0 p -148.1 168.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.368 2.267 . . . . 0.0 108.077 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . 134.42 44.95 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 131.029 3.732 . . . . 0.0 109.085 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -150.78 -54.78 0.15 Allowed 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.532 -1.355 . . . . 0.0 113.45 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -109.9 136.83 48.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.291 1.836 . . . . 0.0 107.958 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.411 ' HG ' ' HB3' ' B' ' 83' ' ' CYS . 25.0 p -130.15 147.49 51.89 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.323 1.049 . . . . 0.0 108.275 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -137.64 127.46 25.5 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.53 HD12 ' CD ' ' B' ' 53' ' ' GLN . 28.5 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.549 0.74 . . . . 0.0 112.43 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.09 120.08 10.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.75 43.18 0.5 Allowed Glycine 0 CA--C 1.537 1.428 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt 53.6 148.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 129.388 3.075 . . . . 0.0 119.175 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -140.83 160.1 40.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.929 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 142.26 47.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.121 1.368 . . . . 0.0 108.514 175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.32 143.5 42.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.966 1.306 . . . . 0.0 110.041 -174.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -56.35 -29.36 61.27 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.9 -12.16 61.38 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.747 1.619 . . . . 0.0 112.836 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.45 -8.13 40.48 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 127.062 2.268 . . . . 0.0 113.635 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 2.9 t -64.43 145.04 56.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.787 1.294 . . . . 0.0 111.511 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -121.94 141.46 51.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -133.08 147.17 52.17 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.304 1.049 . . . . 0.0 112.795 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -129.58 125.26 35.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.544 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.56 127.44 75.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.05 -88.45 0.1 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 125.874 1.984 . . . . 0.0 110.987 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.98 145.13 37.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.202 -0.587 . . . . 0.0 110.824 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.462 HG21 ' CG ' ' B' ' 53' ' ' GLN . 7.3 p -97.02 131.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.729 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -72.79 159.54 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.029 0.919 . . . . 0.0 112.808 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -54.47 -27.87 40.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -71.84 -34.81 69.59 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.148 0.579 . . . . 0.0 112.448 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.82 -9.16 12.63 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.503 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 155.3 40.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.379 1.59 . . . . 0.0 108.225 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.39 166.12 32.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.882 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.14 147.92 52.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.18 -169.54 26.77 Favored Glycine 0 C--O 1.236 0.24 0 O-C-N 121.623 -0.673 . . . . 0.0 112.81 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.507 ' HB ' HD11 ' B' ' 46' ' ' LEU . 10.7 p -139.89 138.53 35.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.836 -1.182 . . . . 0.0 112.092 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -117.14 132.39 56.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.811 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.13 129.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 45.2 m -107.14 143.56 35.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.742 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.44 -13.59 18.65 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.6 m -136.44 142.06 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.948 0.899 . . . . 0.0 112.806 -174.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.28 168.68 23.33 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.219 -0.926 . . . . 0.0 111.036 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -39.15 25.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -126.85 74.64 75.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.428 1.891 . . . . 0.0 109.321 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.82 6.75 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.175 3.25 . . . . 0.0 117.34 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.79 -20.96 0.75 Allowed Glycine 0 CA--C 1.537 1.433 0 N-CA-C 118.523 2.169 . . . . 0.0 118.523 -174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.2 42.34 0.08 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.783 1.233 . . . . 0.0 111.861 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -50.06 134.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.336 -0.852 . . . . 0.0 111.454 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -152.3 171.85 17.35 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.425 1.49 . . . . 0.0 111.109 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.507 HD11 ' HB ' ' B' ' 32' ' ' THR . 12.1 tp -46.69 119.34 2.41 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.469 3.108 . . . . 0.0 112.143 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 68.2 m -114.3 113.59 45.92 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.095 0.958 . . . . 0.0 108.579 -175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -55.28 144.76 69.9 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.622 2.881 . . . . 0.0 112.814 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.1 141.04 52.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.613 1.165 . . . . 0.0 111.892 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.41 150.7 40.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.167 2.987 . . . . 0.0 109.266 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.08 -155.43 26.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' C' ' 69' ' ' ASN . 3.2 mt -144.8 139.48 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.668 -0.766 . . . . 0.0 112.421 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.53 ' CD ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -118.78 155.15 31.66 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.255 1.022 . . . . 0.0 110.993 172.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.95 163.9 22.97 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.499 -1.375 . . . . 0.0 110.588 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.97 26.38 0.32 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 113.213 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -56.36 2.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.282 2.233 . . . . 0.0 111.022 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.75 171.83 14.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.955 0.883 . . . . 0.0 113.331 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -41.43 66.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.45 1.1 . . . . 0.0 110.91 173.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -132.87 57.9 31.71 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 125.383 1.473 . . . . 0.0 111.07 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.32 176.62 9.71 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.053 1.835 . . . . 0.0 116.654 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -87.71 163.79 16.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.718 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -163.44 164.44 24.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.67 149.14 15.03 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 119.941 2.736 . . . . 0.0 119.941 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -164.12 154.29 14.8 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -90.06 150.92 21.88 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.927 2.091 . . . . 0.0 109.133 173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 74.1 t -130.28 120.72 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.5 ' HB2' HG21 ' C' ' 52' ' ' ILE . 56.2 t30 -95.76 105.91 17.97 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.612 -1.185 . . . . 0.0 110.793 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -67.1 132.14 47.24 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.165 1.802 . . . . 0.0 112.742 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -92.46 -38.2 12.1 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.58 -10.4 43.53 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -152.5 133.28 14.0 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.002 2.521 . . . . 0.0 107.265 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -70.66 118.47 13.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.273 0.942 . . . . 0.0 109.823 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 75.5 p -173.62 170.2 4.12 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.639 1.976 . . . . 0.0 109.928 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.76 137.9 31.92 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.142 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.447 ' CG2' HD12 ' B' ' 99' ' ' LEU . 0.6 OUTLIER -114.34 166.12 12.0 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.58 150.49 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -129.07 141.61 51.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.08 120.3 10.17 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.37 -179.35 38.47 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.915 -1.612 . . . . 0.0 117.106 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -114.31 145.7 41.44 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 125.178 1.163 . . . . 0.0 112.098 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.411 ' HB3' ' HG ' ' B' ' 4' ' ' CYS . 34.6 t -97.76 125.94 42.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.291 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.6 OUTLIER -120.7 170.89 9.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.76 1.267 . . . . 0.0 113.573 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 mt -131.63 110.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.49 -2.141 . . . . 0.0 106.506 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.5 156.55 19.22 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.59 -53.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -73.63 -8.96 58.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.435 1.894 . . . . 0.0 116.101 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.16 50.87 3.12 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 120.008 1.276 . . . . 0.0 110.684 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -122.87 135.97 54.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.434 1.894 . . . . 0.0 109.746 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -101.83 143.03 32.24 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.308 1.443 . . . . 0.0 112.066 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.525 HG21 ' CD1' ' C' ' 106' ' ' ILE . 15.3 m -148.56 161.95 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.803 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 mt -122.16 120.21 33.56 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.572 ' HE2' HD11 ' C' ' 106' ' ' ILE . 1.5 mmmt -108.24 114.47 28.37 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 171.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.5 p -136.05 161.06 36.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.306 1.527 . . . . 0.0 112.137 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -109.3 168.06 9.66 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -141.69 160.69 39.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.508 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.782 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.2 tt -143.46 127.7 17.69 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.559 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' B' ' 77' ' ' THR . 1.0 OUTLIER -111.03 144.59 39.92 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 124.826 1.329 . . . . 0.0 110.987 -176.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.413 ' CZ ' ' HA2' ' C' ' 81' ' ' GLY . 2.5 tpt85 -128.23 116.91 20.61 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 112.125 -2.307 . . . . 0.0 112.279 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -90.71 158.66 16.77 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 124.73 1.269 . . . . 0.0 113.627 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.1 m -103.21 80.34 1.83 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -66.76 -174.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -115.66 -22.65 9.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 119.934 -1.729 . . . . 0.0 114.537 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -118.63 148.82 42.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.766 1.269 . . . . 0.0 110.734 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.534 HD11 ' HE2' ' C' ' 94' ' ' LYS . 10.7 tt -61.05 -28.23 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.77 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.95 4.05 25.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.221 -1.322 . . . . 0.0 115.457 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.83 -1.39 11.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.102 1.451 . . . . 0.0 113.815 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.77 -31.54 68.47 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.341 -0.85 . . . . 0.0 112.824 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' D' ' 37' ' ' VAL . 60.8 p-90 -46.43 -44.57 17.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 114.107 177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -92.88 -12.78 30.1 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.951 0.9 . . . . 0.0 113.263 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 4.95 10.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.782 ' CG2' HD21 ' B' ' 98' ' ' LEU . 16.2 m -113.12 135.08 54.19 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.915 0.886 . . . . 0.0 111.668 174.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -138.48 126.66 22.84 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.541 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.94 154.77 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 120.427 1.467 . . . . 0.0 112.041 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.94 -175.32 30.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.698 1.142 . . . . 0.0 113.056 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 24.2 p90 -128.21 154.63 45.62 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.678 0.791 . . . . 0.0 109.965 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -149.71 147.26 27.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.853 0.861 . . . . 0.0 109.831 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 129.54 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.399 -0.813 . . . . 0.0 109.146 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -116.86 155.41 29.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.437 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 32.8 p -137.31 160.42 39.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 110.458 174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -59.65 128.58 37.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.79 0.836 . . . . 0.0 111.395 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -91.37 82.15 5.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . 0.303 0.0 OUTLIER 71.24 75.71 0.18 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 171.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 5.6 t -128.54 -22.33 3.34 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 129.136 2.974 . . . . 0.0 114.703 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . 0.488 ' HG2' ' H ' ' B' ' 127' ' ' LYS 0.314 3.5 pm0 50.04 -88.25 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.488 ' H ' ' HG2' ' B' ' 126' ' ' GLN . 26.0 mttm -133.99 127.43 32.31 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.691 2.396 . . . . 0.0 106.253 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 126.861 2.064 . . . . 0.0 107.809 -174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 118.206 -0.902 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 76.0 p -107.15 -11.13 15.69 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 24.5 m -129.74 -171.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.453 1.501 . . . . 0.0 111.009 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -160.77 -13.58 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -166.16 -33.86 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.716 1.607 . . . . 0.0 112.997 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -87.86 137.28 32.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.783 2.033 . . . . 0.0 109.259 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.1 p -133.54 147.39 51.58 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.838 1.255 . . . . 0.0 108.453 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -137.21 127.51 26.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.519 HD12 ' CD ' ' C' ' 53' ' ' GLN . 30.3 mt -68.87 -26.76 65.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.959 0.904 . . . . 0.0 112.571 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -61.47 120.8 11.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.35 45.2 0.53 Allowed Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.938 1.535 . . . . 0.0 116.938 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt 52.87 149.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -141.83 161.02 38.99 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.427 -1.715 . . . . 0.0 112.139 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.05 144.35 49.97 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.271 1.428 . . . . 0.0 108.519 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.81 143.42 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.105 1.362 . . . . 0.0 109.476 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -55.75 -29.51 59.7 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 tp -70.76 -12.23 61.43 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.77 1.628 . . . . 0.0 113.007 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.63 -9.09 40.77 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.284 2.373 . . . . 0.0 113.611 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 2.5 t -63.09 145.91 54.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.82 1.31 . . . . 0.0 111.804 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -122.36 141.09 51.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.17 147.24 52.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.999 0.904 . . . . 0.0 112.823 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 11.4 m -130.35 125.69 35.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.766 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.47 126.42 74.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.19 -88.71 0.08 OUTLIER Glycine 0 CA--C 1.526 0.77 0 O-C-N 126.036 2.085 . . . . 0.0 111.036 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.37 143.69 35.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.228 0.611 . . . . 0.0 110.862 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.454 HG21 ' CG ' ' C' ' 53' ' ' GLN . 7.3 p -96.16 132.74 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.739 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -71.77 160.04 33.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 122.247 1.023 . . . . 0.0 113.304 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 16.0 m -53.84 -27.23 28.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.151 1.381 . . . . 0.0 114.505 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -71.93 -34.17 68.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.231 0.612 . . . . 0.0 112.588 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.76 -9.88 12.52 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.967 1.27 . . . . 0.0 113.468 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.25 157.59 37.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.967 1.384 . . . . 0.0 110.563 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.93 166.3 33.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.326 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 148.04 52.66 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.65 -169.12 25.59 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 122.478 1.044 . . . . 0.0 112.746 -174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.501 ' HB ' HD11 ' C' ' 46' ' ' LEU . 10.2 p -139.66 138.96 36.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.686 -1.257 . . . . 0.0 112.032 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -117.19 135.09 54.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.854 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 60.6 mt -123.57 130.17 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . . . . . . . . . 42.1 m -107.92 143.84 36.0 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.779 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.71 -13.5 18.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 16.6 m -136.74 141.43 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 112.737 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.84 168.36 23.95 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.204 -0.935 . . . . 0.0 110.992 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.62 -39.27 27.75 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.61 74.62 74.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.469 1.908 . . . . 0.0 109.291 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.8 6.8 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.147 3.232 . . . . 0.0 117.406 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.68 -21.28 0.8 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.14 42.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.732 1.266 . . . . 0.0 111.832 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 54.2 mt -49.95 134.62 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.382 -0.824 . . . . 0.0 111.518 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -152.85 171.6 18.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.222 1.409 . . . . 0.0 111.254 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' C' ' 32' ' ' THR . 12.3 tp -46.63 118.43 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 129.263 3.025 . . . . 0.0 112.136 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -113.5 112.79 48.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.542 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.5 145.69 56.6 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.173 2.582 . . . . 0.0 112.565 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.2 143.89 51.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.078 0.951 . . . . 0.0 111.329 175.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -143.93 151.53 39.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.339 3.056 . . . . 0.0 109.606 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.85 -155.66 26.72 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.1 mt -144.87 139.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 114.484 -0.858 . . . . 0.0 112.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.519 ' CD ' HD12 ' C' ' 6' ' ' LEU . 0.0 OUTLIER -119.19 155.54 31.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.162 0.985 . . . . 0.0 110.739 173.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.85 163.6 22.2 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.392 -1.442 . . . . 0.0 110.886 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.74 25.09 0.33 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.113 0.965 . . . . 0.0 113.1 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.39 -57.52 2.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.191 2.196 . . . . 0.0 111.08 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.8 172.07 12.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -43.25 64.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.006 173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -129.96 57.78 33.33 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 125.223 1.409 . . . . 0.0 111.054 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.37 176.83 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.976 1.784 . . . . 0.0 116.691 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 11.4 p -87.98 162.81 16.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.955 1.702 . . . . 0.0 109.637 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -162.02 165.33 27.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.174 -0.954 . . . . 0.0 112.665 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.64 149.38 15.06 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.14 155.4 15.9 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -91.6 150.78 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.985 2.114 . . . . 0.0 109.151 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.04 121.88 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.4 t30 -97.78 106.16 18.42 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.59 -174.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -66.58 131.69 46.56 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.779 1.627 . . . . 0.0 112.901 -173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.92 -37.99 12.55 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.56 -10.71 42.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 26.7 t -152.43 132.55 13.5 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.043 2.537 . . . . 0.0 107.216 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -70.24 118.53 13.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.303 0.956 . . . . 0.0 109.947 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 77.3 p -173.49 170.3 4.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.492 1.917 . . . . 0.0 110.026 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -141.82 137.88 31.81 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.019 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.441 ' CG2' HD12 ' C' ' 99' ' ' LEU . 0.6 OUTLIER -114.22 165.8 12.31 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.329 1.061 . . . . 0.0 108.578 173.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.42 150.89 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -128.95 142.0 51.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.35 120.3 10.0 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' CZ ' ' B' ' 100' ' ' ARG . . . -164.6 -179.73 38.85 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.79 144.83 42.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.084 0.945 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 34.2 t -97.85 123.13 41.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.549 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -117.89 170.42 8.83 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.585 1.183 . . . . 0.0 113.652 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -130.23 111.61 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.928 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.62 157.23 17.96 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -25.85 -53.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.195 2.198 . . . . 0.0 116.856 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.48 -8.61 56.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.78 47.16 4.31 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 120.399 1.454 . . . . 0.0 110.947 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -119.11 141.67 48.59 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.339 2.256 . . . . 0.0 108.209 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -108.41 145.49 34.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.598 1.159 . . . . 0.0 112.168 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' B' ' 106' ' ' ILE . 18.6 m -149.66 165.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.215 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 59.6 mt -124.3 121.59 35.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.534 ' HE2' HD11 ' B' ' 106' ' ' ILE . 1.4 mmmt -109.81 114.19 27.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.6 p -136.06 160.76 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.32 1.533 . . . . 0.0 112.033 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.42 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -109.04 168.16 9.57 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -141.6 161.1 38.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.278 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.788 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.3 tt -144.08 127.09 16.45 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.265 -1.788 . . . . 0.0 110.505 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' C' ' 77' ' ' THR . 1.1 tt -110.5 144.65 39.0 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.577 1.173 . . . . 0.0 110.779 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -128.86 117.21 20.66 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 112.315 -2.22 . . . . 0.0 112.199 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -90.5 158.96 16.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 124.847 1.342 . . . . 0.0 113.848 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -103.07 80.01 1.81 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.84 -175.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.099 0.56 . . . . 0.0 109.924 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -114.47 -23.27 9.42 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.379 -1.451 . . . . 0.0 114.571 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -119.13 149.78 41.13 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.709 1.242 . . . . 0.0 110.455 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' B' ' 94' ' ' LYS . 11.5 tt -61.25 -29.06 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.295 174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.91 3.75 19.13 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.324 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.75 -1.19 11.13 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.963 1.381 . . . . 0.0 113.894 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -58.9 -31.74 68.89 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.273 -0.892 . . . . 0.0 112.74 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 37' ' ' VAL . 61.0 p-90 -46.54 -44.19 17.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.765 1.226 . . . . 0.0 113.95 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -93.14 -12.88 29.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.979 0.912 . . . . 0.0 113.232 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.35 10.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.788 ' CG2' HD21 ' C' ' 98' ' ' LEU . 16.8 m -113.25 135.3 53.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.032 0.933 . . . . 0.0 111.449 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -138.82 125.36 20.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 117.597 -1.192 . . . . 0.0 110.552 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.53 154.85 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.211 1.368 . . . . 0.0 111.851 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.61 -175.47 30.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.714 1.149 . . . . 0.0 113.081 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.9 p90 -127.48 153.51 46.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.702 0.801 . . . . 0.0 109.81 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -148.63 147.2 28.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.165 0.986 . . . . 0.0 109.707 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -128.32 132.08 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -119.5 156.41 30.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.111 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 38.7 p -139.1 163.68 31.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.697 1.199 . . . . 0.0 110.662 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -60.79 124.66 21.08 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.419 -0.801 . . . . 0.0 111.517 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.89 96.89 8.95 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 79.54 106.14 0.07 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.48 1.912 . . . . 0.0 113.466 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -73.01 43.35 0.12 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.699 -1.251 . . . . 0.0 112.961 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 46.47 -98.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.065 2.546 . . . . 0.0 114.182 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -157.08 172.03 19.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.493 2.717 . . . . 0.0 107.458 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.245 0.816 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 172.282 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 117.29 -1.338 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 13.7 p -61.31 -48.64 80.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.291 1.036 . . . . 0.0 112.404 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 4.6 t -75.91 59.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.202 1.401 . . . . 0.0 111.117 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -85.58 129.85 34.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.628 1.171 . . . . 0.0 108.985 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -162.88 30.71 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.66 152.44 27.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.392 2.277 . . . . 0.0 109.614 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -138.76 153.94 48.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.009 0.818 . . . . 0.0 110.603 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -139.46 126.37 20.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.48 -31.41 72.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -66.3 101.38 0.73 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.75 -8.19 0.11 Allowed Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.1 tttt 75.63 139.09 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.041 2.536 . . . . 0.0 113.721 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -137.73 162.75 33.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.074 1.35 . . . . 0.0 111.617 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -141.05 148.47 40.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.661 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -108.88 151.99 25.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.796 0.838 . . . . 0.0 112.294 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.94 -25.76 66.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' C' ' 110' ' ' TRP . 27.4 tp -73.27 -15.98 61.4 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.346 1.858 . . . . 0.0 110.946 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.24 -6.34 34.28 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 127.192 2.329 . . . . 0.0 114.517 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 p -70.56 148.14 48.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.928 1.864 . . . . 0.0 112.219 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -119.11 139.09 52.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.868 -1.145 . . . . 0.0 109.433 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -127.8 136.16 51.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.692 0.758 . . . . 0.0 110.63 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.05 132.21 52.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.65 126.71 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -87.54 0.1 Allowed Glycine 0 CA--C 1.526 0.721 0 O-C-N 125.67 1.856 . . . . 0.0 110.611 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.88 29.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.193 -0.592 . . . . 0.0 111.5 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.49 126.55 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.045 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.19 159.3 29.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 112.277 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 t -53.07 -30.15 34.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -63.46 -39.59 94.86 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.006 -1.059 . . . . 0.0 110.97 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.56 -6.75 10.54 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 116.854 -2.081 . . . . 0.0 114.118 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.36 152.8 44.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.812 1.806 . . . . 0.0 109.705 174.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -152.03 145.27 24.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.304 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.53 155.67 22.91 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.834 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -169.16 30.96 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 122.928 1.293 . . . . 0.0 112.991 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.508 ' HB ' HD21 ' A' ' 46' ' ' LEU . 4.3 p -134.69 129.22 34.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.413 -1.394 . . . . 0.0 111.646 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -123.25 120.64 33.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.991 0.901 . . . . 0.0 111.607 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.99 132.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.488 ' O ' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -114.9 144.79 42.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.47 -13.99 21.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.59 143.11 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.572 1.149 . . . . 0.0 112.409 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.23 43.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.467 -1.396 . . . . 0.0 111.505 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.12 -25.82 63.67 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.54 83.71 14.71 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.568 1.947 . . . . 0.0 109.747 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.68 177.48 7.49 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.176 2.584 . . . . 0.0 110.47 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.11 -27.35 3.3 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 113.301 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -142.57 23.14 1.97 Allowed 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.72 1.608 . . . . 0.0 110.531 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 35' ' ' THR . 63.3 mt -57.21 105.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 123.182 1.468 . . . . 0.0 111.481 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 171.02 7.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.722 -2.035 . . . . 0.0 108.079 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -54.58 126.63 24.51 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 127.645 2.378 . . . . 0.0 111.62 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 m -104.09 119.54 53.92 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.646 174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -55.23 149.96 42.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.51 2.14 . . . . 0.0 111.562 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.22 149.46 47.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.324 1.05 . . . . 0.0 110.287 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -150.86 149.13 29.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.369 2.267 . . . . 0.0 109.159 177.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.33 -156.87 28.35 Favored Glycine 0 C--O 1.228 -0.236 0 O-C-N 120.355 -1.466 . . . . 0.0 111.058 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.555 HG21 ' CB ' ' D' ' 69' ' ' ASN . 3.4 mt -145.99 148.8 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 125.41 1.3 . . . . 0.0 111.704 -174.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 152.81 50.76 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.515 -1.366 . . . . 0.0 112.997 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -101.19 147.12 26.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 14.12 1.77 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.391 1.477 . . . . 0.0 113.533 -174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -92.56 -42.35 9.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.823 1.649 . . . . 0.0 112.147 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.32 4.62 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.96 0.788 . . . . 0.0 112.64 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 t -70.12 -49.18 53.3 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.582 1.153 . . . . 0.0 112.538 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.34 65.33 72.25 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.07 0.948 . . . . 0.0 111.763 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -65.15 173.53 5.99 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.537 3.491 . . . . 0.0 116.921 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER -100.36 169.38 9.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 123.443 1.592 . . . . 0.0 110.725 173.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -162.17 162.5 28.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.071 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.87 143.17 8.45 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 118.579 2.192 . . . . 0.0 118.579 -172.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -160.16 152.33 20.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.514 ' HB ' HD12 ' D' ' 52' ' ' ILE . 1.8 m -89.81 152.23 21.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.032 1.733 . . . . 0.0 109.263 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.71 120.65 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.581 ' CB ' HG21 ' D' ' 52' ' ' ILE . 0.2 OUTLIER -104.45 117.97 35.46 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -82.29 136.31 35.06 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.065 -1.647 . . . . 0.0 114.55 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -97.08 -44.38 7.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.836 -1.074 . . . . 0.0 113.836 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -74.83 -19.28 60.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.368 0.667 . . . . 0.0 112.54 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.41 132.81 13.72 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.703 2.801 . . . . 0.0 107.34 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.45 118.88 20.32 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.284 1.402 . . . . 0.0 111.855 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 76.3 p -176.71 164.5 2.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.926 2.09 . . . . 0.0 107.379 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.6 135.67 17.66 Favored 'General case' 0 CA--C 1.47 -2.103 0 CA-C-O 122.202 1.001 . . . . 0.0 108.781 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -135.34 130.28 34.74 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 111.066 -2.788 . . . . 0.0 111.492 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.92 154.1 5.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 120.742 0.306 . . . . 0.0 110.212 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -127.99 144.2 51.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.419 HG23 HG13 ' D' ' 78' ' ' VAL . 0.0 OUTLIER -153.84 117.06 4.55 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -161.16 -177.72 34.51 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.451 HE22 HG22 ' D' ' 103' ' ' VAL . 9.7 tt0 -122.98 138.56 54.65 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.806 0.812 . . . . 0.0 111.178 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.6 t -97.97 112.76 24.57 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.154 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -112.01 168.58 9.48 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.793 1.282 . . . . 0.0 110.148 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.74 113.75 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 112.841 -1.981 . . . . 0.0 107.571 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.09 157.95 14.7 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -44.63 -28.63 0.62 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 118.156 2.651 . . . . 0.0 118.156 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -5.69 55.77 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.4 23.17 41.07 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.635 1.112 . . . . 0.0 113.416 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.27 144.53 25.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.522 2.329 . . . . 0.0 109.983 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -101.26 141.92 33.43 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.587 1.155 . . . . 0.0 109.616 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.4 m -146.6 160.66 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 125.121 1.513 . . . . 0.0 110.36 175.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 mt -124.43 118.17 26.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -106.39 113.2 26.58 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.6 p -132.86 165.1 25.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.58 1.657 . . . . 0.0 111.598 -173.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -117.56 168.52 10.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.037 173.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -141.54 158.08 44.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.66 -1.609 . . . . 0.0 112.272 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.68 127.26 28.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.867 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.5 137.24 45.89 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 124.788 1.305 . . . . 0.0 111.726 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.8 113.84 20.75 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.783 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.9 m -77.66 164.76 25.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 125.215 1.572 . . . . 0.0 111.755 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.6 m -108.61 85.16 2.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.01 178.2 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -116.25 6.43 13.83 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.35 144.88 33.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.427 174.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.2 tt -60.72 -31.11 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.166 174.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.14 6.67 13.11 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.366 1.46 . . . . 0.0 115.072 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -120.9 3.0 10.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.202 1.001 . . . . 0.0 112.831 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -33.41 75.37 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 120.966 -1.084 . . . . 0.0 113.196 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.41 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.6 p-90 -45.7 -41.04 10.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.12 0.968 . . . . 0.0 113.441 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -98.14 -9.02 26.47 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.242 1.017 . . . . 0.0 113.601 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.95 -0.8 19.9 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -112.58 141.76 45.96 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.568 0.699 . . . . 0.0 111.861 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -138.69 147.96 43.4 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.22 1.408 . . . . 0.0 109.898 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.75 149.51 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.955 1.707 . . . . 0.0 109.836 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.26 -175.26 27.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 123.799 0.714 . . . . 0.0 111.86 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 28.3 p90 -130.69 157.4 42.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.142 0.577 . . . . 0.0 110.282 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -148.81 145.94 27.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.042 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.6 mt -124.81 126.07 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.07 149.65 37.17 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.398 -0.814 . . . . 0.0 109.625 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 p -133.38 157.29 45.9 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.776 -0.578 . . . . 0.0 109.59 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 121.52 9.26 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.7 tt -75.1 82.81 2.29 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.46 -10.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.122 3.769 . . . . 0.0 112.037 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 t -67.93 4.34 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.87 159.65 33.27 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.487 1.515 . . . . 0.0 110.053 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -62.01 134.97 57.32 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.323 0.649 . . . . 0.0 109.754 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 126.66 1.984 . . . . 0.0 110.436 173.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.488 1.115 . . . . 0.0 111.156 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 53.4 t -145.92 142.51 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.157 1.783 . . . . 0.0 107.916 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.58 165.53 25.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 0.0 111.098 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.8 20.01 0.11 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.551 1.94 . . . . 0.0 113.349 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 155.94 32.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 128.144 2.577 . . . . 0.0 109.414 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' D' ' 83' ' ' CYS . 25.3 p -150.14 145.46 26.32 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.508 1.13 . . . . 0.0 110.538 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -139.79 127.15 21.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.21 -27.98 68.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.84 101.2 1.04 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.42 -9.74 0.09 OUTLIER Glycine 0 N--CA 1.484 1.899 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -174.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 75.82 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.913 2.485 . . . . 0.0 113.649 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.18 162.73 32.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.846 1.307 . . . . 0.0 111.66 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -139.71 149.7 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.097 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.12 152.73 25.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.675 0.79 . . . . 0.0 111.584 -175.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.59 -26.66 67.21 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.408 HD11 ' CD1' ' B' ' 110' ' ' TRP . 27.0 tp -72.45 -16.04 61.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.5 1.92 . . . . 0.0 111.237 173.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.57 -5.59 35.32 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.194 2.33 . . . . 0.0 114.363 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 66.4 p -71.27 149.61 46.02 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.926 1.863 . . . . 0.0 112.252 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -121.99 139.05 54.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.914 -1.116 . . . . 0.0 109.808 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -127.37 136.76 52.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.88 0.848 . . . . 0.0 111.018 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -126.01 131.72 52.15 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 86.6 mt -127.64 126.74 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.84 -87.49 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 125.023 1.452 . . . . 0.0 110.704 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.61 139.33 31.26 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.287 -0.537 . . . . 0.0 111.328 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.06 125.46 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.908 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -65.26 159.1 24.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.172 0.589 . . . . 0.0 112.236 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 17.7 t -54.2 -28.58 41.74 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -63.37 -37.21 86.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.982 -1.074 . . . . 0.0 110.983 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.1 -4.87 15.95 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.484 1.516 . . . . 0.0 113.753 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.26 155.42 38.28 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.925 1.363 . . . . 0.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -152.51 154.53 35.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.698 1.237 . . . . 0.0 112.72 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.18 156.05 30.55 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.164 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.06 -168.62 30.45 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.844 1.247 . . . . 0.0 113.394 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.524 ' HB ' HD21 ' D' ' 46' ' ' LEU . 7.2 p -133.9 130.5 37.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.589 -1.306 . . . . 0.0 111.763 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -124.05 121.04 34.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.982 0.896 . . . . 0.0 111.515 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.3 133.45 66.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.456 ' O ' HG21 ' D' ' 44' ' ' ILE . 1.0 OUTLIER -114.99 145.72 41.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -173.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.6 -15.97 20.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 143.55 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.441 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.71 158.3 43.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.678 -1.264 . . . . 0.0 111.615 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.96 -26.06 63.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -140.98 83.42 14.05 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.384 1.874 . . . . 0.0 109.441 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.72 177.48 7.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.091 2.527 . . . . 0.0 110.546 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.9 -27.24 3.35 Favored Glycine 0 N--CA 1.476 1.35 0 O-C-N 121.346 -0.847 . . . . 0.0 113.324 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 23.32 2.0 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.799 1.64 . . . . 0.0 110.687 -177.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.456 HG21 ' O ' ' D' ' 35' ' ' THR . 62.9 mt -57.21 106.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 123.195 1.474 . . . . 0.0 111.296 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.22 170.79 8.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 112.644 -2.071 . . . . 0.0 107.954 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' D' ' 32' ' ' THR . 0.4 OUTLIER -53.78 126.31 21.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 127.409 2.284 . . . . 0.0 111.628 176.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -104.53 119.87 52.35 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.015 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.97 150.4 38.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.354 2.036 . . . . 0.0 111.456 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.85 152.66 50.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 110.059 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -154.52 149.29 26.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.759 2.024 . . . . 0.0 109.691 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.26 -155.29 26.43 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 119.257 0.935 . . . . 0.0 113.948 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.581 HG21 ' CB ' ' A' ' 69' ' ' ASN . 3.1 mt -146.84 148.8 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.717 1.207 . . . . 0.0 111.838 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.04 152.34 49.97 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.482 -1.386 . . . . 0.0 112.794 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -100.2 146.97 26.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 16.17 1.84 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 113.335 -175.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -91.93 -42.12 10.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 174.39 5.34 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 123.939 0.774 . . . . 0.0 112.499 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -71.8 -47.55 52.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 0.0 112.669 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.5 64.68 73.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 124.644 1.178 . . . . 0.0 112.673 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.43 173.61 8.5 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.654 3.569 . . . . 0.0 116.639 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . 0.303 0.5 OUTLIER -99.15 168.62 9.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.533 1.635 . . . . 0.0 111.086 173.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.54 161.78 27.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.927 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.98 143.6 8.95 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.6 151.64 18.91 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 52' ' ' ILE . 1.7 m -89.16 154.0 20.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.357 1.863 . . . . 0.0 109.52 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.25 121.04 45.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.555 ' CB ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -104.84 117.25 33.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -174.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.83 135.16 35.46 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.24 -1.538 . . . . 0.0 114.676 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -95.62 -44.28 7.55 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -74.66 -19.59 60.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.455 0.702 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.39 132.19 13.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.553 2.741 . . . . 0.0 107.491 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -75.98 118.9 19.24 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.444 1.475 . . . . 0.0 112.107 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -176.59 164.12 2.47 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 127.004 2.122 . . . . 0.0 107.196 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.29 135.18 17.65 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-O 122.505 1.145 . . . . 0.0 108.897 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 4.9 m -135.02 130.16 35.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.576 -169.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.419 HG13 HG23 ' A' ' 80' ' ' THR . 4.2 m -103.38 154.58 5.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 120.623 0.249 . . . . 0.0 110.421 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -128.43 144.0 51.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.44 116.91 4.65 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -160.98 -177.0 33.71 Favored Glycine 0 CA--C 1.503 -0.707 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.73 137.98 54.31 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 124.66 0.859 . . . . 0.0 110.734 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' D' ' 4' ' ' CYS . 42.7 t -97.92 112.82 24.6 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.266 -1.35 . . . . 0.0 108.771 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.43 169.16 8.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.762 1.225 . . . . 0.0 110.031 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.08 110.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.916 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -60.19 157.3 13.55 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -43.59 -30.17 0.57 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.64 -0.76 48.64 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.76 43.35 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.511 -0.743 . . . . 0.0 113.13 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.85 146.14 23.99 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.748 2.019 . . . . 0.0 109.545 175.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -101.27 142.24 32.98 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.806 1.242 . . . . 0.0 108.795 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' A' ' 106' ' ' ILE . 21.9 m -146.26 159.13 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 125.07 1.481 . . . . 0.0 110.7 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 42.4 mt -121.64 117.01 25.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.17 112.28 25.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' D' ' 81' ' ' GLY . 2.2 p -132.27 165.62 23.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.613 1.673 . . . . 0.0 111.752 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' D' ' 117' ' ' TYR . 0.0 OUTLIER -118.19 168.07 10.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 114.729 -1.123 . . . . 0.0 107.977 173.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -141.32 158.34 44.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.243 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.97 127.02 27.88 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.54 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 137.22 46.06 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.767 1.292 . . . . 0.0 111.46 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' D' ' 100' ' ' ARG . 6.2 tpt180 -120.72 113.83 20.78 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 113.131 -1.85 . . . . 0.0 110.855 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -77.58 164.9 24.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.829 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -109.25 84.82 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.451 HG22 HE22 ' A' ' 82' ' ' GLN . 33.4 m -74.24 -178.28 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -119.1 6.44 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.94 145.15 34.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.225 174.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 92' ' ' VAL . 1.2 tt -60.34 -30.61 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.277 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.15 7.08 18.09 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.609 1.576 . . . . 0.0 115.207 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.63 3.21 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.25 1.025 . . . . 0.0 112.888 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.63 -33.04 74.73 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.119 -0.988 . . . . 0.0 112.655 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.42 ' CD1' HD11 ' B' ' 14' ' ' LEU . 56.5 p-90 -45.41 -41.38 9.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 113.636 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -98.3 -8.95 26.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.312 1.045 . . . . 0.0 113.672 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.64 -1.46 21.82 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 3.7 m -111.85 141.69 45.16 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.748 0.704 . . . . 0.0 111.895 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -138.35 148.05 44.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.335 1.454 . . . . 0.0 109.961 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.95 149.59 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 120.804 1.638 . . . . 0.0 109.83 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.51 -175.21 27.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.743 0.687 . . . . 0.0 111.877 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 29.1 p90 -130.77 156.78 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.125 0.57 . . . . 0.0 110.051 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -148.28 145.81 28.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.388 0.675 . . . . 0.0 109.922 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 60.3 mt -124.32 126.45 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -114.84 150.28 35.77 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.069 0.938 . . . . 0.0 110.076 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 61.9 p -133.64 158.81 42.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.683 0.793 . . . . 0.0 110.352 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 126.58 28.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.282 0.633 . . . . 0.0 109.381 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.15 140.55 58.88 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -57.74 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.287 1.835 . . . . 0.0 114.987 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m 54.26 -11.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 127.282 2.233 . . . . 0.0 116.383 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -99.42 130.92 45.72 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 119.02 -2.3 . . . . 0.0 109.748 174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.0 86.94 0.1 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.076 2.15 . . . . 0.0 107.981 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . 0.365 9.6 mm-40 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 128.313 2.645 . . . . 0.0 110.379 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 118.142 -0.932 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.0 t -153.86 96.43 1.98 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.347 1.459 . . . . 0.0 107.967 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 23.3 m 17.38 54.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 128.914 2.886 . . . . 0.0 117.262 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.2 -47.02 0.71 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 13.69 72.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 128.047 2.539 . . . . 0.0 114.054 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -141.52 153.53 44.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.148 1.779 . . . . 0.0 110.097 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p -147.01 149.27 32.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 124.58 1.175 . . . . 0.0 111.207 -174.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.5 p -139.74 127.02 21.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.71 -28.16 67.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.43 101.97 1.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.36 -14.3 0.13 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 118.592 2.197 . . . . 0.0 118.592 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.4 ' HD3' ' CD2' ' B' ' 123' ' ' LEU . 4.9 tttt 80.7 143.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 128.502 2.721 . . . . 0.0 112.776 -176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -137.56 162.74 32.94 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 111.536 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.756 ' HB ' HD13 ' B' ' 123' ' ' LEU . 6.1 t -134.01 154.07 51.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.092 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -114.41 150.79 34.14 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.848 0.859 . . . . 0.0 111.409 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.05 -25.18 66.92 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' D' ' 110' ' ' TRP . 27.2 tp -73.77 -16.29 61.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.852 2.061 . . . . 0.0 111.011 173.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.07 -6.52 32.53 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 127.279 2.371 . . . . 0.0 114.603 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 45.4 p -71.49 147.15 48.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.776 1.788 . . . . 0.0 111.907 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.31 139.76 50.85 Favored 'General case' 0 CA--C 1.522 -0.103 0 O-C-N 120.829 -1.169 . . . . 0.0 109.823 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -127.96 135.17 49.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -123.85 130.7 53.03 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.5 mt -126.12 126.83 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.88 -88.02 0.1 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 125.506 1.754 . . . . 0.0 110.678 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.55 141.22 32.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.069 -0.665 . . . . 0.0 111.966 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.61 126.14 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.256 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.9 158.93 29.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.879 0.472 . . . . 0.0 112.176 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -53.07 -30.05 33.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -63.5 -39.21 93.84 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.924 -1.11 . . . . 0.0 111.005 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.42 -7.22 10.54 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 116.882 -2.066 . . . . 0.0 114.159 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.04 152.74 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.73 1.765 . . . . 0.0 109.757 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -152.18 145.83 24.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.927 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.89 156.31 22.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.941 174.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.63 -169.11 30.75 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-O 122.588 1.104 . . . . 0.0 113.345 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.532 ' HB ' HD21 ' B' ' 46' ' ' LEU . 10.8 p -133.3 129.84 38.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.583 -1.309 . . . . 0.0 112.008 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -122.87 121.26 35.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 122.012 0.91 . . . . 0.0 111.066 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -121.07 132.62 70.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.436 ' O ' HG21 ' B' ' 44' ' ' ILE . 1.0 OUTLIER -114.6 146.93 40.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.69 -16.64 18.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.57 144.42 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 112.387 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.5 158.22 42.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.625 -1.297 . . . . 0.0 111.383 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.7 -26.57 64.42 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -140.71 83.44 14.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.689 1.996 . . . . 0.0 109.586 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.58 177.46 7.45 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.19 2.593 . . . . 0.0 110.532 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.98 -27.04 3.36 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.285 -0.885 . . . . 0.0 113.382 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -142.68 23.64 1.92 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.879 1.672 . . . . 0.0 110.666 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.436 HG21 ' O ' ' B' ' 35' ' ' THR . 64.4 mt -57.62 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.986 1.374 . . . . 0.0 111.35 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 170.03 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.944 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' B' ' 32' ' ' THR . 0.5 OUTLIER -52.21 126.24 18.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.397 2.279 . . . . 0.0 112.184 174.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.4 m -104.88 120.62 49.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.985 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -55.33 150.23 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.732 2.288 . . . . 0.0 111.818 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.23 149.61 47.28 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.985 0.914 . . . . 0.0 110.302 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' C' ' 50' ' ' LEU . 0.2 OUTLIER -150.74 149.34 29.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.342 2.257 . . . . 0.0 108.884 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.53 -156.94 28.36 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 120.246 1.385 . . . . 0.0 111.358 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.557 HG21 ' HB3' ' C' ' 69' ' ' ASN . 3.4 mt -146.4 148.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 125.21 1.182 . . . . 0.0 111.612 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 153.92 51.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.748 -1.22 . . . . 0.0 113.061 175.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -101.83 147.51 26.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 16.71 1.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.37 1.468 . . . . 0.0 113.394 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -92.85 -40.2 10.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.165 1.786 . . . . 0.0 111.899 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.55 174.31 8.44 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.087 0.867 . . . . 0.0 111.979 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -70.36 -50.15 41.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.126 1.37 . . . . 0.0 112.688 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.43 63.74 70.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.108 0.963 . . . . 0.0 112.107 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -66.73 172.95 8.71 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.446 3.43 . . . . 0.0 116.407 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . 0.306 0.4 OUTLIER -98.9 167.85 10.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.662 1.22 . . . . 0.0 110.823 173.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.83 162.26 29.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.016 -1.902 . . . . 0.0 111.866 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.62 143.8 9.05 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -160.08 153.37 22.06 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.524 ' HB ' HD12 ' C' ' 52' ' ' ILE . 1.6 m -91.29 151.54 20.85 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.218 1.807 . . . . 0.0 109.485 173.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.67 120.82 51.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.569 ' CB ' HG21 ' C' ' 52' ' ' ILE . 0.1 OUTLIER -104.57 117.42 34.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -82.04 136.4 35.23 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.98 -1.7 . . . . 0.0 114.402 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -97.06 -44.22 7.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.784 -1.098 . . . . 0.0 113.896 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -75.12 -19.29 59.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.833 0.853 . . . . 0.0 112.495 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -152.44 133.35 14.1 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.832 2.853 . . . . 0.0 107.412 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -77.93 118.91 20.69 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.17 1.35 . . . . 0.0 111.895 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.6 p -176.69 164.32 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.957 2.103 . . . . 0.0 107.18 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.32 135.69 18.01 Favored 'General case' 0 CA--C 1.473 -1.991 0 CA-C-O 122.244 1.021 . . . . 0.0 108.668 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . 0.251 5.2 m -135.88 130.06 33.25 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.337 -169.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.94 154.87 5.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -129.16 143.82 50.99 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.402 HG23 HG13 ' C' ' 78' ' ' VAL . 0.0 OUTLIER -153.58 117.45 4.75 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -161.35 -177.71 34.68 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 115.951 1.14 . . . . 0.0 115.951 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.462 HE22 HG22 ' C' ' 103' ' ' VAL . 9.7 tt0 -123.22 138.28 54.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.374 0.691 . . . . 0.0 110.456 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.8 112.82 24.57 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.32 168.95 8.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.699 1.238 . . . . 0.0 109.973 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -123.24 109.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.497 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -58.66 158.26 8.14 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -43.56 -35.91 1.88 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.727 2.491 . . . . 0.0 117.727 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -20.51 61.44 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.92 19.73 12.53 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.734 1.159 . . . . 0.0 113.434 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 149.62 26.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.169 1.788 . . . . 0.0 109.097 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -101.36 145.45 28.9 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.401 1.481 . . . . 0.0 110.128 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' C' ' 106' ' ' ILE . 23.3 m -147.77 160.21 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.234 174.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 mt -121.86 117.24 26.02 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -106.41 111.37 23.91 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' B' ' 81' ' ' GLY . 2.0 p -130.93 166.33 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.127 1.917 . . . . 0.0 111.907 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -119.64 168.19 11.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.109 172.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -141.95 157.81 44.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.086 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tp -135.1 127.29 30.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 136.51 47.28 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 124.882 1.364 . . . . 0.0 111.583 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' B' ' 100' ' ' ARG . 6.3 tpt180 -120.15 113.88 21.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.871 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 23.2 m -78.15 164.91 24.56 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 124.925 1.391 . . . . 0.0 111.814 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 71.8 m -108.9 87.23 2.44 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 103.009 -2.959 . . . . 0.0 103.009 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.08 -174.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -122.5 7.49 9.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.57 145.68 31.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.293 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' C' ' 92' ' ' VAL . 1.2 tt -60.94 -30.72 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.114 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.14 17.03 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.279 1.419 . . . . 0.0 114.902 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -120.93 3.37 10.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.389 1.095 . . . . 0.0 112.86 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.17 -32.84 74.33 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.228 -0.92 . . . . 0.0 113.261 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.408 ' CD1' HD11 ' D' ' 14' ' ' LEU . 56.5 p-90 -45.29 -41.83 9.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.307 1.043 . . . . 0.0 113.694 175.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -97.29 -9.65 27.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -0.81 19.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.09 141.91 45.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.358 0.663 . . . . 0.0 111.545 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -138.4 148.37 44.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.624 1.57 . . . . 0.0 110.114 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.33 149.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 120.594 1.543 . . . . 0.0 109.727 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.69 27.36 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 124.04 0.828 . . . . 0.0 111.694 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 28.6 p90 -129.93 157.11 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.062 0.545 . . . . 0.0 110.096 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -148.68 145.0 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.81 129.1 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -116.88 149.79 39.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.752 0.786 . . . . 0.0 110.944 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 81.6 p -135.18 158.44 44.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.957 0.903 . . . . 0.0 110.014 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.76 129.53 41.67 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.218 -0.926 . . . . 0.0 110.762 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.756 HD13 ' HB ' ' B' ' 11' ' ' THR . 18.1 tp -86.72 132.6 33.82 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.705 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 73.71 168.05 0.3 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.818 1.647 . . . . 0.0 110.416 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 9.8 t 174.19 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.458 1.903 . . . . 0.0 109.845 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 72.14 -174.17 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.894 1.677 . . . . 0.0 109.928 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -87.36 -51.43 5.95 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.826 0.739 . . . . 0.0 111.655 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.881 1 C-N-CA 134.46 5.104 . . . . 0.0 105.849 -174.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 117.922 -1.037 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.0 168.79 22.83 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.001 1.321 . . . . 0.0 109.431 -174.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . 0.267 17.1 m 43.98 31.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -116.84 -174.42 2.57 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.656 2.382 . . . . 0.0 109.906 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . 0.44 HH11 ' HB2' ' C' ' 2' ' ' ARG . 1.0 OUTLIER 81.88 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.756 2.022 . . . . 0.0 109.825 -174.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -154.21 152.15 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.426 1.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 23.8 p -147.88 147.43 29.74 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.815 0.697 . . . . 0.0 111.386 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 6.4 p -139.63 126.82 21.19 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -67.69 -29.1 68.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -67.58 102.14 1.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.31 0.11 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 73.2 140.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.637 2.375 . . . . 0.0 113.997 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -137.81 162.73 33.19 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.969 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.9 t -139.45 148.06 42.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.553 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -108.12 152.94 23.87 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.661 0.784 . . . . 0.0 111.553 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.0 -26.14 65.75 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.41 HD11 ' CD1' ' A' ' 110' ' ' TRP . 27.6 tp -72.41 -16.15 61.84 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.581 1.953 . . . . 0.0 110.956 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.4 -6.66 34.08 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 127.497 2.475 . . . . 0.0 114.451 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 73.2 p -70.67 148.45 48.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.87 1.835 . . . . 0.0 112.114 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.3 139.62 52.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 120.867 -1.146 . . . . 0.0 109.962 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -128.1 135.81 50.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.44 130.82 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.84 126.29 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.01 -87.64 0.09 OUTLIER Glycine 0 CA--C 1.526 0.74 0 O-C-N 125.41 1.694 . . . . 0.0 110.769 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.53 141.04 32.01 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.233 -0.569 . . . . 0.0 111.387 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.77 125.07 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.155 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -64.93 158.28 25.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.236 0.615 . . . . 0.0 112.252 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 17.6 t -53.74 -28.39 34.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -63.47 -37.15 86.2 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.805 -1.184 . . . . 0.0 111.005 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.31 -4.86 15.47 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.673 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 154.13 38.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.023 1.412 . . . . 0.0 111.287 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -151.71 154.39 36.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.934 0.873 . . . . 0.0 112.278 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -118.34 156.2 29.33 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.538 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -167.81 -168.79 30.46 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 122.157 0.865 . . . . 0.0 113.52 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.5 ' HB ' HD21 ' C' ' 46' ' ' LEU . 7.2 p -133.45 130.08 38.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.778 -1.211 . . . . 0.0 112.018 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -125.09 120.96 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.627 1.203 . . . . 0.0 111.416 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -119.93 132.66 69.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.48 ' O ' HG21 ' C' ' 44' ' ' ILE . 0.8 OUTLIER -116.2 146.1 42.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -173.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.52 -13.89 22.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.468 ' H ' HG23 ' C' ' 35' ' ' THR . 27.8 m -134.34 144.44 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.737 1.215 . . . . 0.0 113.357 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.82 158.55 43.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.282 -1.511 . . . . 0.0 111.645 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.46 -26.01 63.44 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -140.84 83.09 14.66 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.552 1.941 . . . . 0.0 109.709 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.6 177.4 7.53 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.089 2.526 . . . . 0.0 110.605 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.27 -27.58 3.26 Favored Glycine 0 N--CA 1.476 1.348 0 O-C-N 121.345 -0.847 . . . . 0.0 113.412 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.99 23.12 2.07 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.893 1.677 . . . . 0.0 110.589 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.48 HG21 ' O ' ' C' ' 35' ' ' THR . 70.7 mt -56.95 106.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 122.946 1.355 . . . . 0.0 111.631 -174.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.1 t -113.63 169.56 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.005 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' C' ' 32' ' ' THR . 0.5 OUTLIER -52.36 126.89 20.54 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.507 2.323 . . . . 0.0 111.707 174.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.09 120.09 50.97 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.336 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -54.78 149.78 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.461 2.107 . . . . 0.0 111.432 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -136.66 153.05 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 109.917 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' B' ' 50' ' ' LEU . 0.3 OUTLIER -154.65 149.31 26.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.859 2.064 . . . . 0.0 109.72 -178.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.6 -155.64 26.96 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 119.207 0.912 . . . . 0.0 113.863 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.569 HG21 ' CB ' ' B' ' 69' ' ' ASN . 3.1 mt -146.41 148.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.846 -174.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 153.04 50.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.304 -1.497 . . . . 0.0 112.869 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -101.11 147.46 26.2 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 16.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.019 1.328 . . . . 0.0 113.493 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -92.95 -40.0 10.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.737 1.615 . . . . 0.0 112.06 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.57 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.825 0.85 . . . . 0.0 113.048 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 34.3 t -69.2 -48.47 61.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.429 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.61 64.82 69.61 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 124.241 1.017 . . . . 0.0 112.614 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -66.22 173.29 7.59 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.497 3.465 . . . . 0.0 116.931 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . 0.305 0.5 OUTLIER -99.18 168.28 10.15 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.504 1.621 . . . . 0.0 111.13 173.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -162.24 162.0 28.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.937 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.63 143.83 9.08 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 118.075 1.99 . . . . 0.0 118.075 -172.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -160.42 152.42 20.18 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.5 ' HB ' HD12 ' B' ' 52' ' ' ILE . 1.7 m -90.01 154.36 19.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.367 1.867 . . . . 0.0 109.242 173.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -132.64 121.09 44.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.557 ' HB3' HG21 ' B' ' 52' ' ' ILE . 0.2 OUTLIER -105.29 115.83 30.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 117.972 0.351 . . . . 0.0 110.12 -174.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -80.02 135.88 36.47 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -96.38 -44.25 7.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.929 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -74.91 -19.67 60.04 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.789 0.836 . . . . 0.0 112.563 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -152.35 133.1 14.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.83 2.852 . . . . 0.0 107.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -77.78 118.93 20.6 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.39 1.45 . . . . 0.0 111.974 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 78.7 p -176.51 164.64 2.57 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 126.868 2.067 . . . . 0.0 107.201 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.64 135.45 17.45 Favored 'General case' 0 CA--C 1.475 -1.942 0 CA-C-O 122.593 1.187 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.0 m -135.55 130.07 34.0 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 110.761 -2.927 . . . . 0.0 111.706 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.402 HG13 HG23 ' B' ' 80' ' ' THR . 4.0 m -103.28 154.81 5.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 120.676 0.274 . . . . 0.0 110.328 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -128.87 144.0 51.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.81 116.88 4.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -160.45 -176.98 33.14 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -124.09 137.82 54.52 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.417 0.716 . . . . 0.0 110.575 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.88 112.85 24.61 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 117.232 -1.366 . . . . 0.0 108.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.17 168.94 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.123 1.369 . . . . 0.0 109.973 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -124.32 109.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.883 -1.962 . . . . 0.0 107.989 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.88 160.17 10.08 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -44.56 -31.92 1.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.02 -25.55 58.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.63 -3.74 19.66 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.909 1.242 . . . . 0.0 114.18 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 145.44 55.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.605 1.962 . . . . 0.0 111.684 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -101.14 140.75 35.0 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.668 1.987 . . . . 0.0 109.902 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.431 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.5 m -144.78 160.1 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.608 1.163 . . . . 0.0 110.954 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 mt -120.7 116.98 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -106.13 110.69 23.02 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.434 HG22 ' HA3' ' C' ' 81' ' ' GLY . 2.2 p -130.94 166.03 21.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 123.625 1.679 . . . . 0.0 112.029 -174.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' C' ' 117' ' ' TYR . 0.0 OUTLIER -119.17 168.72 10.59 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -142.21 158.18 44.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.136 172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -135.66 127.27 28.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.609 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.58 137.31 45.84 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 124.704 1.253 . . . . 0.0 111.449 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -120.98 113.87 20.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.798 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 24.6 m -77.89 165.85 23.61 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.891 1.369 . . . . 0.0 111.985 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 69.5 m -109.89 87.24 2.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . 0.462 HG22 HE22 ' B' ' 82' ' ' GLN . 35.1 m -75.33 -172.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.284 -0.885 . . . . 0.0 108.658 174.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -124.88 7.86 8.08 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.94 145.98 30.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.031 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' B' ' 92' ' ' VAL . 1.2 tt -59.29 -31.22 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.559 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.03 6.22 14.64 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.187 1.375 . . . . 0.0 115.471 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -120.61 3.27 10.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.615 1.207 . . . . 0.0 113.089 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.51 -32.63 74.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.296 -0.877 . . . . 0.0 112.948 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.414 ' CD1' HD11 ' A' ' 14' ' ' LEU . 56.2 p-90 -45.64 -41.4 10.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -97.56 -9.83 26.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.159 0.984 . . . . 0.0 113.557 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -0.47 17.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.097 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -112.64 141.92 45.85 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.433 0.693 . . . . 0.0 111.547 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -138.65 148.02 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.522 1.529 . . . . 0.0 109.79 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.78 149.32 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 120.655 1.57 . . . . 0.0 109.664 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.69 -176.26 28.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.753 0.692 . . . . 0.0 111.572 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 28.7 p90 -129.7 156.71 43.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.069 0.548 . . . . 0.0 110.336 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -148.12 145.17 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.963 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.55 129.37 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.98 149.85 40.25 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.411 -0.806 . . . . 0.0 110.265 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.9 p -132.11 158.93 40.37 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.377 -0.827 . . . . 0.0 110.215 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 125.85 25.3 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 122.115 -0.366 . . . . 0.0 110.089 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.46 104.44 0.79 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.578 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 84.42 44.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.885 2.074 . . . . 0.0 114.837 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 33.7 p -112.6 151.86 29.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.05 1.295 . . . . 0.0 114.4 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -155.81 -20.44 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -139.86 166.26 25.12 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.566 1.546 . . . . 0.0 110.42 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.398 0 C-N-CA 128.993 2.917 . . . . 0.0 113.808 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' -1' ' ' VAL . 1.0 OUTLIER 49.5 -153.66 0.12 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 117.683 -1.151 . . . . 0.0 110.944 -173.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' -2' ' ' THR . 11.5 t 56.88 -44.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 130.47 3.508 . . . . 0.0 118.372 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 59.53 -152.27 0.4 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.008 1.723 . . . . 0.0 112.75 -174.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.27 1.8 ptp180 161.89 66.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 130.665 3.586 . . . . 0.0 110.867 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -150.29 140.13 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.875 1.27 . . . . 0.0 112.316 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.22 147.18 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.419 1.104 . . . . 0.0 109.152 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.425 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 69.6 m -139.27 126.71 21.6 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.764 -1.21 . . . . 0.0 111.568 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.08 -25.3 62.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.68 122.15 9.29 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 123.163 1.458 . . . . 0.0 110.598 174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.63 -118.02 2.38 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.805 2.145 . . . . 0.0 109.154 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -141.53 156.1 45.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.533 1.133 . . . . 0.0 113.37 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.68 160.85 39.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 112.901 -1.954 . . . . 0.0 111.201 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -139.86 142.24 36.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.84 147.29 31.11 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.713 0.805 . . . . 0.0 112.227 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' C' ' 110' ' ' TRP . 33.0 tp -72.92 -15.59 61.57 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.16 1.384 . . . . 0.0 111.8 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.76 -16.63 21.01 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.547 2.499 . . . . 0.0 113.593 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 t -61.28 146.57 47.46 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.517 1.151 . . . . 0.0 113.076 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -121.4 139.25 53.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.646 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -131.66 145.63 51.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 111.585 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -129.87 132.73 46.53 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.223 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.58 126.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.39 -95.03 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 O-C-N 124.22 0.95 . . . . 0.0 112.274 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.58 126.89 22.95 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.436 -1.038 . . . . 0.0 110.529 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.44 139.3 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.01 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.42 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 10.8 t-20 -75.14 166.44 23.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.108 0.963 . . . . 0.0 112.959 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.4 t -56.42 -34.51 66.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.982 1.313 . . . . 0.0 113.358 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -68.91 -35.59 77.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.593 -1.317 . . . . 0.0 111.54 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.68 -6.48 9.71 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.83 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 24' ' ' ASN . 8.3 pt-20 -67.19 142.62 56.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.439 1.496 . . . . 0.0 111.98 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -155.53 147.47 23.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.731 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.95 163.73 13.28 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.87 -166.87 29.54 Favored Glycine 0 C--O 1.238 0.378 0 O-C-N 121.335 -0.853 . . . . 0.0 111.895 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.571 ' HB ' HD11 ' A' ' 46' ' ' LEU . 33.7 p -140.01 128.65 23.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.937 -1.132 . . . . 0.0 111.788 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -103.82 137.57 41.65 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.231 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 46' ' ' LEU . 22.7 mt -128.64 126.17 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 37' ' ' VAL . 15.3 m -104.99 140.75 37.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.733 -173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.28 -2.42 33.76 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG21 HD21 ' A' ' 14' ' ' LEU . 30.4 m -138.54 163.43 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.616 1.966 . . . . 0.0 111.446 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.37 16.11 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.834 -1.791 . . . . 0.0 112.857 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -69.46 -47.04 65.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -124.86 79.41 64.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.18 2.992 . . . . 0.0 110.202 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.24 25.42 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 124.825 3.683 . . . . 0.0 116.591 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.36 0.75 63.02 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.107 -1.621 . . . . 0.0 115.799 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.76 30.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -49.03 131.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.034 -1.666 . . . . 0.0 112.399 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.17 165.26 27.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.886 2.074 . . . . 0.0 108.707 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 32' ' ' THR . 5.1 tt -49.24 131.04 19.91 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.78 1.632 . . . . 0.0 111.656 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 p -108.5 122.66 39.63 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.163 0.506 . . . . 0.0 112.206 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.56 145.36 89.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.151 2.567 . . . . 0.0 111.997 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -133.78 156.6 47.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.553 0.741 . . . . 0.0 112.45 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -158.86 149.06 19.51 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.448 2.299 . . . . 0.0 109.366 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.35 -153.76 23.5 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 120.461 1.482 . . . . 0.0 110.345 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.547 HD11 ' HB2' ' D' ' 50' ' ' LEU . 3.3 mt -146.39 138.17 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.493 1.117 . . . . 0.0 112.026 -174.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -122.19 141.27 51.64 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.899 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -57.06 -52.39 65.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.635 0.374 . . . . 0.0 111.152 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HE3' ' OG ' ' A' ' 5' ' ' SER . 16.7 tptm 52.58 -0.76 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.339 2.256 . . . . 0.0 116.363 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -75.08 -56.29 4.89 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.747 2.019 . . . . 0.0 113.408 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . . . -79.26 173.35 12.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.81 0.814 . . . . 0.0 110.933 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -73.42 -28.93 62.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.471 1.108 . . . . 0.0 113.749 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -141.81 46.47 0.82 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.296 1.439 . . . . 0.0 112.15 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 48.4 Cg_endo -82.39 -177.45 3.46 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.127 2.551 . . . . 0.0 114.245 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.3 p -84.91 167.77 15.64 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.143 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.86 159.38 15.89 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.484 1.114 . . . . 0.0 111.277 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.91 148.18 14.71 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.62 162.82 35.3 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.484 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.8 m -100.59 146.88 26.58 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 127.127 2.171 . . . . 0.0 109.413 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.34 117.0 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.541 ' HB2' HG21 ' D' ' 52' ' ' ILE . 53.3 t30 -98.65 106.56 18.84 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.893 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . 0.329 52.4 m95 -67.93 158.87 31.75 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 121.56 1.982 . . . . 0.0 115.197 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -39.26 4.02 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -90.44 -11.99 38.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -152.42 143.6 23.19 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.076 2.55 . . . . 0.0 106.393 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.61 118.53 15.65 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.042 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -171.45 164.85 7.0 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 125.504 1.522 . . . . 0.0 111.644 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -146.99 138.76 24.33 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 123.867 1.794 . . . . 0.0 110.468 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.35 127.26 27.57 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 109.579 -3.464 . . . . 0.0 109.715 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.23 155.87 6.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.011 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.97 139.94 52.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.405 ' OG1' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -149.48 113.9 5.26 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -174.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.38 176.42 29.84 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.04 -1.076 . . . . 0.0 115.509 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 84' ' ' PHE . 9.7 tt0 -118.05 146.69 43.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 113.178 -1.511 . . . . 0.0 108.934 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.8 t -97.09 129.61 44.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.368 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -125.72 167.87 14.55 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.867 1.318 . . . . 0.0 112.333 177.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.5 119.02 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 112.668 -2.06 . . . . 0.0 106.7 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -58.44 154.14 14.44 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.47 -23.58 0.65 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -7.34 58.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.554 1.142 . . . . 0.0 113.998 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.56 36.93 8.33 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.995 0.809 . . . . 0.0 113.981 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.73 151.91 35.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.868 1.267 . . . . 0.0 110.85 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -101.33 146.33 27.71 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 111.059 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' D' ' 106' ' ' ILE . 17.9 m -148.17 160.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.329 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.5 mt -121.43 115.64 23.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.574 -2.009 . . . . 0.0 105.574 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -105.71 110.65 23.03 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.427 HG22 ' HA3' ' A' ' 81' ' ' GLY . 6.2 p -126.02 166.61 16.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.886 1.327 . . . . 0.0 110.528 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.97 170.9 8.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -144.64 159.24 43.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.215 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' D' ' 80' ' ' THR . 3.0 tp -137.72 123.24 19.66 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.451 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 137.79 44.96 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 125.569 1.793 . . . . 0.0 113.185 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -120.16 119.36 33.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.934 2.021 . . . . 0.0 111.762 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -86.25 160.11 19.26 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.309 1.006 . . . . 0.0 110.815 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 m -103.43 82.17 2.01 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.16 -12.84 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.41 -29.47 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.3 137.12 51.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.025 1.284 . . . . 0.0 112.383 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.488 ' CD1' HG21 ' D' ' 92' ' ' VAL . 1.8 tt -62.5 -25.6 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.31 -3.76 33.42 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.628 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 110' ' ' TRP . 4.8 m-20 -124.69 3.16 8.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.396 1.078 . . . . 0.0 113.879 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -34.85 60.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.364 -0.835 . . . . 0.0 112.377 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.608 ' CZ2' ' HE3' ' A' ' 111' ' ' LYS . 55.6 p-90 -49.95 -44.94 50.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.767 1.227 . . . . 0.0 113.542 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.608 ' HE3' ' CZ2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -89.58 -10.78 44.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.387 -0.82 . . . . 0.0 112.429 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.35 -0.05 24.17 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.2 m -118.61 146.25 44.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.19 0.596 . . . . 0.0 111.765 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.56 151.66 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.789 1.636 . . . . 0.0 110.498 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.32 148.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.224 1.375 . . . . 0.0 111.556 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.02 -176.8 27.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 122.55 1.083 . . . . 0.0 112.638 175.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -122.15 152.68 39.66 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.86 0.864 . . . . 0.0 108.812 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -149.63 132.82 16.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.104 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -124.95 121.32 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.585 -0.697 . . . . 0.0 110.725 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -110.38 151.55 27.33 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 113.776 -1.557 . . . . 0.0 110.396 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -133.54 160.25 38.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.281 1.032 . . . . 0.0 109.491 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -57.97 110.47 0.93 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 123' ' ' LEU . 7.0 tt -65.97 117.35 8.21 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.537 ' HB3' HH11 ' A' ' 124' ' ' ARG . 0.0 OUTLIER 177.54 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.3 t -141.75 164.71 29.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -104.6 150.81 24.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 109.365 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 159.81 43.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.96 1.704 . . . . 0.0 110.077 -173.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 176.087 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . 0.464 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 31.6 mm-40 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 116.368 -1.777 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 6.1 m 14.1 88.86 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 128.786 2.834 . . . . 0.0 116.65 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.68 140.28 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.405 1.082 . . . . 0.0 110.899 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -146.35 -58.98 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.725 0.81 . . . . 0.0 110.86 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 47.58 31.76 2.18 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.518 1.127 . . . . 0.0 113.545 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -152.56 144.97 24.04 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.479 1.512 . . . . 0.0 111.821 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 p -116.32 144.43 44.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.054 0.942 . . . . 0.0 108.763 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . 0.404 ' OG ' ' HE3' ' D' ' 57' ' ' LYS . 59.5 m -139.56 126.91 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.405 -1.434 . . . . 0.0 113.178 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.08 -26.99 64.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -53.5 121.38 7.59 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.009 1.385 . . . . 0.0 110.47 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.38 -117.9 2.25 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.844 2.164 . . . . 0.0 109.512 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -143.87 152.37 41.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.219 1.008 . . . . 0.0 113.337 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -142.16 158.05 44.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.255 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -136.46 144.95 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.661 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.12 146.58 35.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.553 0.741 . . . . 0.0 112.299 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.13 -23.3 67.38 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.56 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.8 tp -72.63 -14.69 61.66 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.027 1.331 . . . . 0.0 112.047 174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -14.55 31.61 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.564 2.507 . . . . 0.0 113.563 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -62.34 149.59 41.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.759 1.266 . . . . 0.0 113.059 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -125.12 142.18 51.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.028 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -133.02 143.87 49.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.407 0.622 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -128.38 131.93 48.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.224 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.72 127.14 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 -95.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.451 1.094 . . . . 0.0 112.358 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -137.87 127.09 24.49 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.46 -1.024 . . . . 0.0 110.797 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.86 139.96 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.233 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.68 164.1 25.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.974 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.9 t -54.58 -34.22 61.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.178 1.391 . . . . 0.0 114.166 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -66.94 -35.66 80.47 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.288 -1.507 . . . . 0.0 111.545 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.1 -6.21 9.44 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 124.408 1.004 . . . . 0.0 114.313 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.12 147.56 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.17 162.86 40.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.577 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.72 168.15 14.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.14 -164.9 29.9 Favored Glycine 0 C--O 1.238 0.396 0 O-C-N 120.184 -1.573 . . . . 0.0 112.082 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.583 ' HB ' HD11 ' D' ' 46' ' ' LEU . 35.5 p -140.54 128.0 21.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.133 0.968 . . . . 0.0 112.058 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -104.71 138.45 40.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.86 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.46 HD11 HD12 ' D' ' 46' ' ' LEU . 21.7 mt -129.49 126.56 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.431 HG22 ' H ' ' D' ' 37' ' ' VAL . 16.4 m -105.06 141.15 37.14 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.703 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.08 -2.75 33.49 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.479 HG21 HD21 ' D' ' 14' ' ' LEU . 26.8 m -138.2 163.85 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.41 1.884 . . . . 0.0 111.142 -174.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.32 167.78 15.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.917 -1.74 . . . . 0.0 112.655 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -69.88 -46.56 65.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.284 1.034 . . . . 0.0 108.261 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -125.37 79.16 67.02 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.985 2.914 . . . . 0.0 110.121 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.85 24.47 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.937 3.758 . . . . 0.0 116.59 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.67 60.35 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.182 -1.574 . . . . 0.0 115.915 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.34 29.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' D' ' 72' ' ' PHE . 30.8 mt -48.99 131.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.019 -1.676 . . . . 0.0 112.417 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 164.89 28.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.877 2.071 . . . . 0.0 108.821 174.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' D' ' 32' ' ' THR . 5.1 tt -49.01 130.66 18.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.656 1.582 . . . . 0.0 111.456 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -107.98 122.73 39.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 121.388 0.613 . . . . 0.0 112.408 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.22 144.76 89.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.919 2.412 . . . . 0.0 111.582 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.422 ' C ' HD12 ' D' ' 49' ' ' LEU . 2.0 pp -131.41 164.11 26.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.62 0.768 . . . . 0.0 112.305 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -165.52 149.03 8.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.226 1.811 . . . . 0.0 109.483 -174.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.48 -156.28 27.71 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 120.858 1.663 . . . . 0.0 112.952 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.1 mt -146.13 137.11 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.246 1.018 . . . . 0.0 111.486 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -122.13 140.9 52.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.478 1.511 . . . . 0.0 108.578 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.14 -50.96 71.19 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.068 -0.395 . . . . 0.0 111.353 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . 0.404 ' HE3' ' OG ' ' D' ' 5' ' ' SER . 15.1 tptm 51.61 2.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.507 2.323 . . . . 0.0 116.156 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -78.81 -56.32 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.129 2.171 . . . . 0.0 113.568 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' D' ' 62' ' ' PRO . . . -79.65 173.62 12.4 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.467 1.104 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -74.03 -27.06 60.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.682 -1.151 . . . . 0.0 113.969 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -143.01 48.53 1.01 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 125.2 1.4 . . . . 0.0 112.754 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' D' ' 59' ' ' ALA . 45.4 Cg_endo -82.8 -177.65 3.49 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.221 2.614 . . . . 0.0 114.939 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -85.51 168.3 14.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.492 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.37 159.84 15.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 111.148 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.13 148.5 15.19 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -159.85 162.66 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . 0.506 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.8 m -100.6 149.6 23.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.238 2.215 . . . . 0.0 109.01 173.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -129.1 117.81 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 52' ' ' ILE . 51.2 t30 -100.17 107.45 19.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.746 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.336 50.9 m95 -68.68 158.24 34.55 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.102 1.774 . . . . 0.0 115.334 -172.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.35 4.26 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' D' ' 44' ' ' ILE . 47.0 p90 -91.09 -12.03 36.85 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -152.31 143.9 23.48 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.104 2.562 . . . . 0.0 106.305 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.84 118.53 15.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.101 0.864 . . . . 0.0 110.413 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 90.3 p -171.73 165.19 6.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.352 1.461 . . . . 0.0 111.903 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 4.9 t -146.9 139.2 24.75 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.459 1.6 . . . . 0.0 110.447 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.31 25.94 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 109.631 -3.44 . . . . 0.0 109.856 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.03 155.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.232 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.38 140.24 51.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -149.76 114.45 5.31 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -152.2 178.69 29.28 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.946 -1.121 . . . . 0.0 115.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' CZ ' ' D' ' 84' ' ' PHE . 12.2 tt0 -120.08 144.91 47.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.456 -1.372 . . . . 0.0 109.17 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' D' ' 93' ' ' LEU . 41.4 t -97.31 128.74 44.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.542 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' D' ' 82' ' ' GLN . 0.4 OUTLIER -121.61 168.87 11.27 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.792 1.282 . . . . 0.0 111.299 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.28 118.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 112.823 -1.99 . . . . 0.0 106.994 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -58.67 154.87 13.65 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.38 -25.28 0.98 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -6.28 59.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.296 1.039 . . . . 0.0 113.746 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 27.25 20.88 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.544 1.545 . . . . 0.0 114.185 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -106.35 153.12 22.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 111.884 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -101.42 145.92 28.3 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 123.328 1.537 . . . . 0.0 110.871 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 106' ' ' ILE . 17.6 m -148.57 159.56 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.185 -1.825 . . . . 0.0 109.643 175.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' D' ' 83' ' ' CYS . 67.4 mt -119.2 115.28 23.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 173.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -105.9 109.84 21.92 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.412 HG22 ' HA3' ' D' ' 81' ' ' GLY . 6.6 p -125.25 167.33 15.02 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.941 1.353 . . . . 0.0 111.163 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.99 171.14 8.66 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 159.23 43.16 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.297 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.405 HD23 ' OG1' ' A' ' 80' ' ' THR . 2.9 tp -137.93 123.23 19.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.265 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.7 138.51 43.8 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 125.521 1.763 . . . . 0.0 113.005 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -120.97 117.77 28.14 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 125.898 1.999 . . . . 0.0 111.858 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -83.93 159.99 21.17 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 124.688 1.243 . . . . 0.0 110.977 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -104.22 82.97 2.01 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.0 -12.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 63.93 -28.22 0.09 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.71 136.5 53.32 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.93 1.241 . . . . 0.0 112.301 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 92' ' ' VAL . 2.3 tt -62.09 -25.15 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.04 -4.09 33.34 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.546 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' D' ' 110' ' ' TRP . 4.7 m-20 -124.94 3.07 8.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.494 1.117 . . . . 0.0 113.769 -176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -52.97 -34.83 57.75 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.333 -0.854 . . . . 0.0 113.053 175.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.618 ' CZ2' ' HE3' ' D' ' 111' ' ' LYS . 56.3 p-90 -49.72 -45.69 49.39 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.7 1.2 . . . . 0.0 113.287 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . 0.618 ' HE3' ' CZ2' ' D' ' 110' ' ' TRP . 0.3 OUTLIER -89.06 -11.3 44.49 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.451 -0.781 . . . . 0.0 112.451 177.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.3 23.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . . . . . . . . . 7.6 m -118.24 145.99 44.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.288 0.635 . . . . 0.0 111.884 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.77 151.86 40.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.85 1.66 . . . . 0.0 110.773 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.04 148.68 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 120.13 1.332 . . . . 0.0 111.675 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.21 -177.19 28.23 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 122.465 1.036 . . . . 0.0 112.912 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -120.96 152.88 38.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.778 0.831 . . . . 0.0 109.053 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -149.5 133.41 17.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.225 -174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 48.8 mt -126.09 122.63 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.259 1.028 . . . . 0.0 110.714 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -112.55 148.77 33.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.465 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 16.4 p -133.43 160.3 37.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.424 1.09 . . . . 0.0 109.844 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -55.88 115.62 2.49 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.132 0.573 . . . . 0.0 109.778 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . 0.505 HD23 ' C ' ' D' ' 123' ' ' LEU . 3.6 tt -80.01 98.6 7.27 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.6 139.7 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.908 0.483 . . . . 0.0 112.282 173.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . 0.532 HG22 ' H ' ' D' ' 126' ' ' GLN . 1.7 m 56.0 -160.75 0.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.427 1.079 . . . . 0.0 110.146 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . 0.532 ' H ' HG22 ' D' ' 125' ' ' THR . 0.0 OUTLIER -136.67 -177.42 4.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.023 1.329 . . . . 0.0 108.254 173.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.96 173.06 12.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.089 1.756 . . . . 0.0 109.591 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.556 0 C-N-CA 125.62 1.568 . . . . 0.0 114.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 6.6 t -69.97 51.44 0.11 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.771 1.628 . . . . 0.0 114.349 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.04 144.77 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.134 -1.603 . . . . 0.0 111.865 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.23 160.02 33.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -167.98 25.52 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.153 1.781 . . . . 0.0 112.323 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -154.69 142.45 19.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.145 1.378 . . . . 0.0 111.046 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 p -116.46 144.43 44.33 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.207 1.003 . . . . 0.0 109.736 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.405 ' OG ' ' HE3' ' B' ' 57' ' ' LYS . 53.6 m -139.5 126.81 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.433 -1.417 . . . . 0.0 113.012 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.06 -27.77 62.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -53.17 116.62 2.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.764 1.226 . . . . 0.0 110.385 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.6 -121.14 2.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.974 1.749 . . . . 0.0 109.793 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -143.08 153.4 42.88 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.919 1.288 . . . . 0.0 113.224 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -143.31 160.23 40.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.707 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.444 ' HB ' HD12 ' B' ' 123' ' ' LEU . 14.3 t -138.28 145.14 40.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.677 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -112.11 146.17 38.48 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.478 0.711 . . . . 0.0 112.34 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.13 -24.38 67.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.593 HD11 ' CD1' ' D' ' 110' ' ' TRP . 30.6 tp -71.06 -14.4 62.31 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 112.029 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.96 -13.78 31.7 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.805 2.621 . . . . 0.0 113.738 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -63.64 149.47 46.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.842 1.306 . . . . 0.0 112.865 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -125.38 140.68 52.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.011 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -131.89 145.58 51.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.745 0.784 . . . . 0.0 112.408 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -129.22 133.63 47.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.015 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.03 127.56 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -93.75 0.07 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.922 0.764 . . . . 0.0 112.124 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.46 127.01 21.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.266 -1.138 . . . . 0.0 110.351 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.23 139.12 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.88 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' B' ' 28' ' ' GLU . 10.2 t-20 -75.36 167.07 22.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.781 0.832 . . . . 0.0 112.914 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -56.81 -34.37 67.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.01 1.324 . . . . 0.0 113.352 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -68.78 -36.19 77.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.281 -1.512 . . . . 0.0 111.476 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.77 -6.68 9.61 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.786 -1.563 . . . . 0.0 114.858 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' B' ' 24' ' ' ASN . 8.4 pt-20 -65.99 142.61 57.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.448 1.499 . . . . 0.0 112.45 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.75 147.94 23.56 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.553 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.32 163.09 14.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 174.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.26 -166.86 29.0 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 121.296 -0.877 . . . . 0.0 111.867 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.57 ' HB ' HD11 ' B' ' 46' ' ' LEU . 33.1 p -140.62 128.73 22.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.967 -1.117 . . . . 0.0 111.88 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -103.82 137.92 41.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.101 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.478 HD11 HD12 ' B' ' 46' ' ' LEU . 21.9 mt -129.25 126.17 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 37' ' ' VAL . 15.4 m -105.11 141.37 36.78 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.853 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.67 -2.27 33.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.485 HG21 HD21 ' B' ' 14' ' ' LEU . 26.9 m -138.5 163.29 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.534 1.933 . . . . 0.0 111.223 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.21 167.7 15.91 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.006 -1.684 . . . . 0.0 112.879 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -70.71 -44.86 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 108.493 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -126.61 79.04 72.02 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 129.035 2.934 . . . . 0.0 109.843 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.08 24.82 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.786 3.658 . . . . 0.0 116.602 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.84 0.63 61.32 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.157 -1.589 . . . . 0.0 115.877 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.45 29.96 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' B' ' 72' ' ' PHE . 30.5 mt -49.13 130.94 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 119.899 -1.75 . . . . 0.0 112.445 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.72 165.21 28.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.76 2.024 . . . . 0.0 108.59 174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.57 HD11 ' HB ' ' B' ' 32' ' ' THR . 5.1 tt -49.48 131.44 20.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.843 1.657 . . . . 0.0 111.806 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 7.3 p -109.54 122.61 38.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.183 0.516 . . . . 0.0 111.53 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.3 145.3 88.07 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.211 2.607 . . . . 0.0 111.92 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.83 156.21 48.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.587 0.755 . . . . 0.0 112.441 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 tp -158.38 149.11 20.41 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.506 2.322 . . . . 0.0 109.483 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.11 -153.79 23.65 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 120.612 1.551 . . . . 0.0 110.254 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' C' ' 50' ' ' LEU . 3.3 mt -146.13 138.48 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.51 1.124 . . . . 0.0 112.086 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.73 140.59 52.71 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.082 -1.011 . . . . 0.0 108.681 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -56.47 -52.2 65.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.844 0.458 . . . . 0.0 111.165 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' OG ' ' B' ' 5' ' ' SER . 16.0 tptm 52.87 0.28 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.488 2.315 . . . . 0.0 116.284 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -77.29 -56.3 4.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.137 2.175 . . . . 0.0 113.745 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' B' ' 62' ' ' PRO . . . -78.73 173.46 12.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 124.288 0.992 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.5 p -74.21 -26.26 60.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 117.206 -1.378 . . . . 0.0 113.903 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -143.67 48.74 0.98 Allowed Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 125.465 1.506 . . . . 0.0 112.709 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 59' ' ' ALA . 49.8 Cg_endo -82.93 -178.62 3.96 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.11 2.54 . . . . 0.0 114.848 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 70.4 p -84.54 167.77 16.02 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.24 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.84 159.83 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.452 1.101 . . . . 0.0 111.285 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.37 148.11 14.35 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -159.66 163.11 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.483 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.9 m -101.1 147.48 26.18 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.67 1.988 . . . . 0.0 109.303 173.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.58 117.05 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.545 ' HB2' HG21 ' C' ' 52' ' ' ILE . 42.9 t30 -98.45 107.03 19.39 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.662 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . 0.331 52.5 m95 -68.31 158.77 32.72 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.594 1.997 . . . . 0.0 114.982 -173.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -38.89 4.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -174.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' B' ' 44' ' ' ILE . 47.5 p90 -90.96 -12.01 37.27 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -152.31 143.24 23.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.038 2.535 . . . . 0.0 106.433 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -72.9 118.39 15.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.081 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -170.92 164.94 7.75 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.742 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.61 138.92 24.94 Favored 'General case' 0 CA--C 1.48 -1.73 0 CA-C-O 123.473 1.606 . . . . 0.0 110.493 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.74 127.36 27.02 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 110.042 -3.254 . . . . 0.0 109.54 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -105.18 155.75 6.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.145 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -128.21 140.43 51.91 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.401 ' OG1' HD23 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -150.01 114.23 5.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.406 0.622 . . . . 0.0 109.327 -174.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' B' ' 95' ' ' THR . . . -152.34 178.26 29.64 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 120.072 -1.061 . . . . 0.0 115.587 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.479 ' HB3' ' CZ ' ' B' ' 84' ' ' PHE . 10.8 tt0 -119.83 144.91 47.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.301 -1.449 . . . . 0.0 109.157 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.419 ' SG ' HD23 ' B' ' 93' ' ' LEU . 49.7 t -97.21 128.73 44.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.724 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' B' ' 82' ' ' GLN . 0.4 OUTLIER -121.81 168.82 11.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.913 1.34 . . . . 0.0 110.977 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.3 118.94 57.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.636 -2.075 . . . . 0.0 106.627 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.31 153.56 15.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.48 -26.15 0.53 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.14 -9.44 59.19 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.41 31.37 10.58 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.521 1.057 . . . . 0.0 114.531 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.26 152.71 24.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.999 1.319 . . . . 0.0 110.85 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -101.43 146.05 28.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.495 1.518 . . . . 0.0 110.99 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' C' ' 106' ' ' ILE . 17.8 m -147.62 159.72 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.956 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 67.1 mt -119.44 115.27 23.73 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -105.88 110.65 23.01 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.402 HG22 ' HA3' ' B' ' 81' ' ' GLY . 7.2 p -126.56 167.11 16.1 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.007 1.384 . . . . 0.0 110.81 -174.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 170.85 8.92 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -144.72 158.97 43.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.494 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.408 HD23 ' OG1' ' C' ' 80' ' ' THR . 3.1 tp -137.51 123.21 19.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.416 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.53 137.76 44.99 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 125.66 1.85 . . . . 0.0 113.299 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -120.93 117.1 26.46 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 125.937 2.023 . . . . 0.0 111.94 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 160.43 21.37 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.541 1.151 . . . . 0.0 111.137 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 3.6 m -104.33 83.35 2.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.46 -12.69 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 t30 64.07 -29.85 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.47 136.16 52.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.152 0.977 . . . . 0.0 112.515 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' C' ' 92' ' ' VAL . 2.5 tt -62.42 -26.58 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.12 -3.61 24.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.453 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' B' ' 110' ' ' TRP . 5.0 m-20 -124.64 3.34 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.53 1.132 . . . . 0.0 113.874 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -52.88 -35.76 58.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.226 -0.922 . . . . 0.0 112.306 175.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.61 ' CZ2' ' HE3' ' B' ' 111' ' ' LYS . 54.9 p-90 -49.6 -45.24 47.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.378 1.071 . . . . 0.0 113.686 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.61 ' HE3' ' CZ2' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -89.39 -11.04 44.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.621 0.768 . . . . 0.0 112.686 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.47 -0.32 25.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.427 -0.797 . . . . 0.0 113.078 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -118.02 146.19 44.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.769 0.713 . . . . 0.0 111.738 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -144.24 151.75 39.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.785 1.634 . . . . 0.0 110.415 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.19 148.37 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 120.167 1.349 . . . . 0.0 111.817 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.01 -176.86 27.7 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 122.536 1.076 . . . . 0.0 112.79 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -121.52 153.43 37.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.565 -0.817 . . . . 0.0 108.985 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.1 133.72 16.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.015 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 51.8 mt -126.18 122.64 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.755 0.788 . . . . 0.0 110.637 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 12.4 m-85 -111.7 148.71 32.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.164 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 19.0 p -135.7 162.94 31.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.261 1.024 . . . . 0.0 110.189 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -59.93 115.83 3.69 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.526 -0.734 . . . . 0.0 111.062 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' B' ' 11' ' ' THR . 3.8 tt -61.82 159.13 14.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 25.9 5.58 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 119.795 1.179 . . . . 0.0 114.058 175.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 39.5 p -125.43 168.68 13.25 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.41 1.484 . . . . 0.0 111.763 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -145.05 -161.38 1.29 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.947 1.299 . . . . 0.0 111.381 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.87 78.16 1.68 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.506 1.522 . . . . 0.0 107.551 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 . . . . . 0 C--O 1.248 1.018 0 C-N-CA 126.379 1.872 . . . . 0.0 111.472 175.103 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 6.5 m -71.78 94.84 1.43 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.451 1.1 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 12.9 p -157.65 134.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.965 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.57 164.51 24.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.015 0.436 . . . . 0.0 111.93 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.84 -35.21 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -156.57 143.58 18.78 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.309 1.444 . . . . 0.0 110.518 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 p -116.41 141.84 47.64 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 122.112 0.958 . . . . 0.0 108.977 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.419 ' OG ' ' HE3' ' C' ' 57' ' ' LYS . 65.0 m -139.39 126.54 21.21 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.368 -1.457 . . . . 0.0 113.026 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.55 -29.63 64.96 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 2.2 t -52.0 118.38 3.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.591 1.186 . . . . 0.0 110.243 174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.53 -122.53 2.94 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.315 1.912 . . . . 0.0 109.336 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -143.03 152.96 42.47 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.48 1.112 . . . . 0.0 113.113 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -143.59 155.85 44.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.091 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.409 ' HB ' HD12 ' C' ' 123' ' ' LEU . 9.9 t -133.43 145.14 49.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.395 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -109.42 147.43 32.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -65.06 -19.09 65.82 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.561 HD11 ' CD1' ' A' ' 110' ' ' TRP . 35.0 tp -75.36 -14.91 60.51 Favored 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.963 -1.086 . . . . 0.0 111.273 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.59 -14.07 32.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.222 2.344 . . . . 0.0 113.659 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 149.73 44.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.411 -1.052 . . . . 0.0 112.377 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -125.35 142.82 51.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.956 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -132.41 146.1 51.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 112.507 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -129.64 133.34 47.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.547 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.65 127.23 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.85 -93.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.135 0.897 . . . . 0.0 112.282 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.31 128.29 23.66 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.364 -1.08 . . . . 0.0 110.469 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.21 139.24 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.315 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -77.55 164.03 25.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.98 0.912 . . . . 0.0 112.584 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -54.35 -33.82 59.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.232 1.413 . . . . 0.0 114.217 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.26 -35.45 79.56 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.384 -1.447 . . . . 0.0 111.543 174.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.41 -6.26 9.24 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 124.369 0.985 . . . . 0.0 114.506 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.9 147.25 47.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -154.8 161.94 41.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.96 0.886 . . . . 0.0 110.728 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 167.72 14.1 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.31 30.28 Favored Glycine 0 C--O 1.238 0.344 0 O-C-N 120.391 -1.443 . . . . 0.0 112.096 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.573 ' HB ' HD11 ' C' ' 46' ' ' LEU . 33.9 p -140.33 129.0 22.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.155 0.978 . . . . 0.0 111.715 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -105.43 138.23 41.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.179 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.453 HD11 HD12 ' C' ' 46' ' ' LEU . 22.8 mt -129.22 126.64 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.438 HG22 ' H ' ' C' ' 37' ' ' VAL . 16.6 m -105.11 141.15 37.18 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.909 -173.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.39 -1.88 34.84 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.48 HG21 HD21 ' C' ' 14' ' ' LEU . 26.9 m -139.24 163.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.533 1.933 . . . . 0.0 111.31 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -166.24 167.46 16.07 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 119.894 -1.754 . . . . 0.0 112.871 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -70.16 -45.42 66.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.286 1.034 . . . . 0.0 108.463 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -126.33 78.85 71.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 129.002 2.921 . . . . 0.0 110.114 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.85 24.2 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.909 3.739 . . . . 0.0 116.591 -176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 0.65 59.7 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.224 -1.548 . . . . 0.0 115.885 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -173.38 30.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.09 131.4 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 119.965 -1.709 . . . . 0.0 112.462 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.3 165.44 27.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.775 2.03 . . . . 0.0 108.664 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' C' ' 32' ' ' THR . 5.3 tt -49.51 131.22 20.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.558 1.543 . . . . 0.0 111.65 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.1 p -109.02 123.04 38.06 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.33 144.61 90.77 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.01 2.473 . . . . 0.0 111.542 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.416 ' C ' HD12 ' C' ' 49' ' ' LEU . 2.0 pp -131.15 164.32 25.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.788 0.835 . . . . 0.0 112.708 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -165.64 148.93 7.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.064 1.746 . . . . 0.0 109.656 -174.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.34 -156.17 27.55 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 120.898 1.681 . . . . 0.0 112.629 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.545 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.2 mt -146.16 137.05 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 123.37 1.557 . . . . 0.0 112.006 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -122.02 141.65 51.13 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.086 -1.634 . . . . 0.0 108.38 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -57.15 -50.79 71.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.881 0.31 . . . . 0.0 111.345 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . 0.419 ' HE3' ' OG ' ' C' ' 5' ' ' SER . 16.4 tptm 51.85 2.79 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.351 2.26 . . . . 0.0 115.979 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -79.74 -56.73 4.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.598 1.959 . . . . 0.0 113.546 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' C' ' 62' ' ' PRO . . . -78.63 174.7 11.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.853 0.721 . . . . 0.0 111.339 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 4.0 p -75.73 -26.68 57.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.583 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.63 48.9 1.13 Allowed Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 125.216 1.407 . . . . 0.0 112.705 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' C' ' 59' ' ' ALA . 46.5 Cg_endo -83.12 -178.3 3.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.805 2.337 . . . . 0.0 115.007 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 82.4 p -84.63 168.1 15.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.619 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -166.08 160.29 16.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.457 1.103 . . . . 0.0 111.372 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.3 148.12 14.4 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 119.119 2.408 . . . . 0.0 119.119 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -159.76 162.17 34.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.502 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.8 m -100.25 150.1 22.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.007 2.123 . . . . 0.0 108.966 173.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 49.5 t -129.28 117.9 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' B' ' 52' ' ' ILE . 51.6 t30 -99.96 107.18 19.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.761 -174.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.337 51.3 m95 -67.79 158.11 33.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.247 1.84 . . . . 0.0 115.387 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -38.16 4.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -91.2 -12.08 36.38 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 8.3 t -152.32 143.86 23.45 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 128.155 2.582 . . . . 0.0 106.329 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -72.94 118.55 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.457 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 89.6 p -171.83 165.13 6.51 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.573 1.549 . . . . 0.0 111.767 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -146.56 138.97 25.05 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 123.635 1.683 . . . . 0.0 110.606 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -136.36 126.52 26.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-N 109.785 -3.37 . . . . 0.0 109.712 -172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.05 155.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.145 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -128.31 140.06 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.408 ' OG1' HD23 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -150.08 115.02 5.34 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' C' ' 95' ' ' THR . . . -153.13 177.87 30.52 Favored Glycine 0 CA--C 1.501 -0.792 0 C-N-CA 119.894 -1.146 . . . . 0.0 115.508 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' C' ' 84' ' ' PHE . 10.6 tt0 -119.22 145.27 46.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.545 -1.327 . . . . 0.0 108.917 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.443 ' SG ' HD23 ' C' ' 93' ' ' LEU . 49.9 t -97.27 129.23 44.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.404 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' C' ' 82' ' ' GLN . 0.3 OUTLIER -124.8 171.94 9.73 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 123.009 1.385 . . . . 0.0 111.649 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.81 115.76 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 112.363 -2.199 . . . . 0.0 106.604 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.82 152.42 19.22 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -45.27 -22.89 0.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.57 -10.5 55.82 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.46 43.06 6.3 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.731 1.158 . . . . 0.0 113.495 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -116.05 147.25 41.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.256 1.423 . . . . 0.0 108.382 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -101.26 141.19 34.51 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.969 1.707 . . . . 0.0 109.966 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.451 HG21 ' CD1' ' B' ' 106' ' ' ILE . 20.6 m -143.93 161.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.29 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . 0.443 HD23 ' SG ' ' C' ' 83' ' ' CYS . 62.7 mt -120.13 116.34 25.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -106.53 110.53 22.77 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 172.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . 0.411 HG22 ' HA3' ' C' ' 81' ' ' GLY . 9.1 p -126.4 165.37 19.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.661 1.22 . . . . 0.0 110.935 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.16 170.66 8.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 172.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -144.37 159.44 42.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.487 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' B' ' 80' ' ' THR . 2.9 tp -137.79 123.14 19.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.436 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.63 138.41 43.91 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 125.295 1.622 . . . . 0.0 113.065 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -121.43 117.43 26.87 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 125.895 1.997 . . . . 0.0 111.823 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 15.7 m -83.53 159.76 21.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.729 1.268 . . . . 0.0 111.285 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -103.9 83.0 2.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.24 -12.56 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.48 -29.06 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.1 136.54 52.82 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.8 1.286 . . . . 0.0 112.436 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' B' ' 92' ' ' VAL . 2.3 tt -62.3 -25.21 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.574 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.61 -3.96 36.57 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.591 -1.116 . . . . 0.0 114.61 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' C' ' 110' ' ' TRP . 4.7 m-20 -124.29 2.72 8.49 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.455 1.102 . . . . 0.0 113.92 -177.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -52.86 -35.67 57.98 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.381 -0.824 . . . . 0.0 112.361 176.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.603 ' CZ2' ' HE3' ' C' ' 111' ' ' LYS . 57.2 p-90 -49.67 -45.77 49.06 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.595 1.158 . . . . 0.0 113.311 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . 0.603 ' HE3' ' CZ2' ' C' ' 110' ' ' TRP . 0.3 OUTLIER -88.88 -11.03 45.76 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.436 -0.79 . . . . 0.0 112.544 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -0.24 25.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 8.5 m -117.87 146.03 44.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.316 0.647 . . . . 0.0 111.65 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -143.61 152.06 40.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.745 1.618 . . . . 0.0 110.654 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.21 148.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 120.186 1.357 . . . . 0.0 111.802 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.96 -176.98 27.8 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-O 122.442 1.023 . . . . 0.0 112.809 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -121.55 153.49 37.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.719 0.808 . . . . 0.0 108.834 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -150.28 132.44 15.39 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.229 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 mt -124.8 118.04 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.903 0.858 . . . . 0.0 111.068 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 13.1 m-85 -105.59 150.71 25.15 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.564 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 3.9 p -136.53 159.83 40.61 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.514 1.126 . . . . 0.0 109.859 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -55.36 124.34 16.8 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.742 -0.599 . . . . 0.0 109.813 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.409 HD12 ' HB ' ' C' ' 11' ' ' THR . 0.3 OUTLIER -57.37 162.77 2.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.916 174.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . 0.315 18.1 ptt180 57.94 19.97 6.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 5.3 m -125.39 73.13 1.29 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.214 1.806 . . . . 0.0 107.461 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -55.29 142.09 33.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.6 0.714 . . . . 0.0 109.376 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.333 0.0 OUTLIER -126.71 74.93 1.52 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.299 1.84 . . . . 0.0 106.82 -174.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . 0.313 1.5 pm0 . . . . . 0 C--O 1.258 1.517 0 CA-C-N 110.76 -2.927 . . . . 0.0 114.99 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 3.3 t -117.53 162.76 17.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.4 1.88 . . . . 0.0 108.217 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.35 -23.74 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.272 1.029 . . . . 0.0 112.769 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 52.86 -161.12 0.11 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.486 1.514 . . . . 0.0 113.732 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -161.61 54.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.028 2.531 . . . . 0.0 110.0 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.29 151.73 25.16 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.82 -1.175 . . . . 0.0 109.408 173.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.04 133.5 53.64 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -139.54 128.53 23.62 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.811 -1.805 . . . . 0.0 110.695 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.8 mt -68.06 -23.22 64.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -51.58 113.63 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 112.004 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.95 -121.41 2.47 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.788 1.185 . . . . 0.0 110.954 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -151.88 146.28 25.54 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -143.34 163.24 33.58 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.223 1.409 . . . . 0.0 112.065 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.451 ' HB ' HD12 ' A' ' 123' ' ' LEU . 6.3 t -142.76 154.89 44.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.682 -1.151 . . . . 0.0 109.149 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 146.35 49.65 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.095 0.861 . . . . 0.0 112.515 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.24 -25.1 13.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.653 2.381 . . . . 0.0 115.012 -177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.07 -18.78 62.54 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.371 1.069 . . . . 0.0 112.848 174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.84 -15.76 21.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.828 2.633 . . . . 0.0 113.261 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.4 p -65.99 145.54 55.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 123.297 1.522 . . . . 0.0 113.086 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.98 144.93 46.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.737 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -141.8 147.34 37.11 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 173.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -137.44 135.23 36.68 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.428 0.691 . . . . 0.0 109.759 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.324 0.65 . . . . 0.0 109.903 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.21 -92.68 0.06 OUTLIER Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.42 141.57 32.25 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.701 -0.882 . . . . 0.0 112.235 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.67 129.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.244 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -70.31 165.84 21.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.228 0.33 . . . . 0.0 111.62 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -59.78 -24.11 63.82 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.429 -1.42 . . . . 0.0 114.822 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.37 -27.09 46.8 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.895 0.77 . . . . 0.0 112.027 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.27 -6.16 30.31 Favored Glycine 0 N--CA 1.468 0.805 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.539 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' D' ' 50' ' ' LEU . 10.0 pt-20 -63.78 138.62 58.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 162.58 38.94 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.395 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 50' ' ' LEU . 2.8 p -129.34 176.9 7.58 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.35 -166.0 37.75 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.566 -1.334 . . . . 0.0 114.095 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 46' ' ' LEU . 12.7 p -136.76 130.92 32.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.605 1.193 . . . . 0.0 111.781 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -114.52 141.28 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.658 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.4 mt -131.54 133.14 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 44' ' ' ILE . 2.7 m -107.69 140.56 40.54 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.673 1.189 . . . . 0.0 111.731 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.33 -11.15 19.65 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.6 m -138.21 141.66 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 111.183 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.26 33.05 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.977 -0.452 . . . . 0.0 110.135 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -77.35 -34.75 55.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.75 83.84 40.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.764 1.626 . . . . 0.0 110.138 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.78 36.05 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 124.998 3.799 . . . . 0.0 115.075 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.29 -7.21 63.05 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 179.58 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.624 1.97 . . . . 0.0 110.858 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 35' ' ' THR . 63.4 mt -56.52 125.56 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 119.988 -1.695 . . . . 0.0 111.05 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.27 165.24 28.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 111.585 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.469 HD11 ' HB ' ' A' ' 32' ' ' THR . 10.3 tp -46.98 115.94 1.22 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 130.781 3.632 . . . . 0.0 113.028 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.6 p -105.9 122.99 40.61 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.456 0.702 . . . . 0.0 111.234 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.62 136.58 74.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.836 2.357 . . . . 0.0 111.318 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.69 155.03 37.27 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.07 0.856 . . . . 0.0 111.694 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 30' ' ' THR . 1.5 tp -162.37 149.01 13.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.92 1.688 . . . . 0.0 109.349 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.97 -150.01 20.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.296 1.407 . . . . 0.0 109.658 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.8 mt -144.0 141.48 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.49 0.716 . . . . 0.0 111.271 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 137.53 51.91 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.333 -0.854 . . . . 0.0 110.599 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -68.52 155.07 40.65 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.397 -0.814 . . . . 0.0 111.843 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -146.2 13.98 1.28 Allowed 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.273 -1.517 . . . . 0.0 114.489 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -87.89 -49.11 7.3 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.825 0.739 . . . . 0.0 112.465 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.07 175.06 9.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.4 t -78.93 -38.56 36.91 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.798 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -136.31 52.0 5.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.591 1.156 . . . . 0.0 112.567 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.87 173.83 13.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.738 1.625 . . . . 0.0 113.834 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' GLN 0.331 0.6 OUTLIER -95.41 167.38 11.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.571 173.664 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.56 166.54 31.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.722 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.49 146.61 12.43 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -159.13 152.67 22.79 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.41 151.75 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.286 1.835 . . . . 0.0 109.287 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.16 118.44 40.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.645 ' HB2' HG21 ' D' ' 52' ' ' ILE . 1.9 t-20 -88.13 116.55 26.4 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.748 -0.595 . . . . 0.0 110.126 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.81 142.35 44.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.385 1.088 . . . . 0.0 110.573 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.69 -39.78 5.27 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.246 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.83 -13.12 54.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.268 1.427 . . . . 0.0 114.439 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.3 t -152.35 132.36 13.42 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.423 2.689 . . . . 0.0 106.06 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.02 117.67 16.09 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.081 1.309 . . . . 0.0 110.416 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -173.65 164.03 4.36 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 126.549 1.94 . . . . 0.0 110.057 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.86 142.6 38.6 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.19 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -132.38 152.07 51.6 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.462 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.79 150.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.748 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.42 143.95 51.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 127.38 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.61 178.47 45.51 Favored Glycine 0 C--O 1.217 -0.915 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -101.21 147.9 25.73 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.856 0.974 . . . . 0.0 112.835 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 21.7 p -97.74 120.53 38.29 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.754 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 82' ' ' GLN 0.299 2.7 m-85 -112.91 162.25 16.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -132.41 109.66 15.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -59.38 162.13 5.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.335 0.654 . . . . 0.0 109.448 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -21.67 2.27 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -8.18 54.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.562 0.745 . . . . 0.0 113.003 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.17 51.96 4.78 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -121.33 146.82 46.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.816 2.446 . . . . 0.0 104.938 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -112.41 150.19 31.47 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.857 1.263 . . . . 0.0 112.182 -172.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.689 HG11 ' HD3' ' A' ' 94' ' ' LYS . 1.7 t -148.14 161.33 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.786 1.279 . . . . 0.0 110.681 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.4 mt -125.51 110.49 13.94 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 101.241 -3.614 . . . . 0.0 101.241 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HD3' HG11 ' A' ' 92' ' ' VAL . 7.5 mmmt -102.71 122.35 44.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -138.84 163.76 31.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.477 1.608 . . . . 0.0 114.264 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.5 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.89 165.24 12.5 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 172.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -140.89 159.48 42.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.071 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.804 HD21 HG23 ' A' ' 113' ' ' THR . 1.2 tt -143.21 124.1 14.3 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.833 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 77' ' ' THR . 3.0 tp -107.69 141.7 38.81 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 125.692 1.87 . . . . 0.0 110.689 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.402 ' NE ' ' HA2' ' D' ' 81' ' ' GLY . 3.3 tpt85 -124.41 114.03 18.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 110.298 -3.137 . . . . 0.0 109.455 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.251 18.5 m -70.88 164.51 25.19 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.74 1.9 . . . . 0.0 113.094 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.408 ' HA ' ' OE1' ' D' ' 82' ' ' GLN . 58.4 m -101.44 84.36 2.59 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 112' ' ' ALA . 2.3 t -79.38 164.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 127.463 2.305 . . . . 0.0 109.296 174.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -114.59 -23.19 9.4 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.51 138.29 51.19 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.719 0.771 . . . . 0.0 111.113 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' D' ' 84' ' ' PHE . 14.8 tt -59.77 -17.23 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.68 7.75 74.23 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 117.361 -1.8 . . . . 0.0 115.759 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.87 4.99 15.01 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.853 1.827 . . . . 0.0 112.704 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -62.27 -30.67 71.29 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.054 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CD1' HD11 ' C' ' 14' ' ' LEU . 54.7 p-90 -48.97 -40.12 29.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 113.21 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -96.92 -6.25 36.12 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 114.022 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 103' ' ' VAL . . . -78.94 7.0 7.92 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.804 HG23 HD21 ' A' ' 98' ' ' LEU . 19.2 m -122.1 140.46 52.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.757 0.789 . . . . 0.0 113.043 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 119.56 6.48 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.558 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.93 150.19 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.44 1.896 . . . . 0.0 111.51 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.41 -171.48 22.71 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.707 0.67 . . . . 0.0 112.768 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -131.38 157.31 43.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.071 -0.664 . . . . 0.0 111.448 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.409 HD21 HD22 ' A' ' 14' ' ' LEU . 7.1 m120 -147.69 160.13 43.03 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.363 1.065 . . . . 0.0 109.15 174.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.443 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.1 mt -138.71 119.03 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.74 148.44 31.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.529 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -134.98 165.31 25.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.66 124.4 20.9 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.893 0.877 . . . . 0.0 111.526 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 11' ' ' THR . 6.0 tt -84.55 145.36 28.11 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.36 -44.34 0.5 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.89 2.476 . . . . 0.0 117.681 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . 0.277 0.2 OUTLIER 46.3 -156.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.639 1.976 . . . . 0.0 113.442 -176.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -148.49 13.97 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.721 2.808 . . . . 0.0 108.573 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -146.13 -2.73 0.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 114.748 -2.549 . . . . 0.0 116.183 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.256 1.409 0 C-N-CA 130.401 3.48 . . . . 0.0 106.581 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 1.8 m -68.91 59.14 0.1 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.892 2.077 . . . . 0.0 113.83 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 20.1 m -140.79 42.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.097 2.159 . . . . 0.0 109.968 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -65.01 165.58 10.77 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.419 1.104 . . . . 0.0 113.631 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . 0.308 4.9 ptm180 -134.16 54.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.982 1.313 . . . . 0.0 113.969 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 155.95 31.72 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.562 1.945 . . . . 0.0 109.162 173.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.05 136.26 41.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -139.31 133.49 31.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.662 -1.274 . . . . 0.0 110.696 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -69.13 -23.2 63.94 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -51.02 114.38 1.16 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.1 1.429 . . . . 0.0 111.592 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.76 -120.54 2.42 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.67 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -152.81 149.74 28.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -147.0 163.21 36.96 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.56 1.544 . . . . 0.0 112.057 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.499 ' HB ' HD12 ' D' ' 123' ' ' LEU . 12.9 t -141.47 154.48 45.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.062 0.945 . . . . 0.0 108.935 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -123.08 145.83 48.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.855 0.862 . . . . 0.0 112.296 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.43 -24.57 13.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.527 2.331 . . . . 0.0 114.816 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' B' ' 110' ' ' TRP . 33.4 tp -70.81 -19.18 62.7 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.976 -1.078 . . . . 0.0 112.858 174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.62 -15.69 19.51 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 127.796 2.617 . . . . 0.0 113.392 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -66.42 144.9 56.23 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 123.289 1.518 . . . . 0.0 112.991 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.87 146.07 45.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.698 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -141.99 147.59 37.18 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 18.9 m -136.24 135.25 38.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.517 0.727 . . . . 0.0 110.529 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 92.7 mt -136.94 128.34 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.339 0.656 . . . . 0.0 109.497 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.08 -90.61 0.06 OUTLIER Glycine 0 CA--C 1.533 1.194 0 O-C-N 123.573 0.546 . . . . 0.0 112.557 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.48 141.8 29.82 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.644 -0.915 . . . . 0.0 111.914 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.15 130.01 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.518 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -68.19 164.96 19.3 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.503 0.502 . . . . 0.0 111.795 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -60.47 -23.77 64.74 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.178 -1.576 . . . . 0.0 114.739 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -76.12 -24.77 54.96 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.877 0.762 . . . . 0.0 112.025 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.82 -5.45 32.59 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 124.093 0.854 . . . . 0.0 114.255 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.49 153.27 44.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.966 0.883 . . . . 0.0 112.167 173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . 0.559 ' O ' HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -155.45 166.52 33.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.107 176.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.433 HG22 HD13 ' D' ' 50' ' ' LEU . 15.9 p -127.09 -177.67 4.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.39 -165.99 39.22 Favored Glycine 0 N--CA 1.469 0.89 0 O-C-N 119.534 -1.979 . . . . 0.0 114.217 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.476 ' HB ' HD11 ' D' ' 46' ' ' LEU . 12.1 p -136.79 130.13 31.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.144 0.973 . . . . 0.0 112.325 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -114.59 141.38 47.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.74 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 mt -130.9 133.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.45 ' O ' HG21 ' D' ' 44' ' ' ILE . 2.8 m -108.28 140.66 41.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.749 1.22 . . . . 0.0 111.861 -173.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.46 -11.93 18.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 18.3 m -137.84 141.08 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 124.093 0.957 . . . . 0.0 111.26 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 165.9 34.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.057 -0.402 . . . . 0.0 110.185 -174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.91 -34.55 57.69 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -134.92 83.82 39.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.641 1.576 . . . . 0.0 110.244 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 36.09 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 125.009 3.806 . . . . 0.0 115.197 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.12 63.32 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.77 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.538 1.935 . . . . 0.0 110.849 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.45 HG21 ' O ' ' D' ' 35' ' ' THR . 63.7 mt -56.21 125.84 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 119.989 -1.695 . . . . 0.0 111.254 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.79 165.91 27.45 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.988 1.315 . . . . 0.0 111.856 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' D' ' 32' ' ' THR . 10.9 tp -47.86 115.62 1.22 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.589 3.556 . . . . 0.0 112.782 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -105.69 122.69 41.79 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.469 0.708 . . . . 0.0 110.615 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.92 135.87 71.63 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.492 2.128 . . . . 0.0 110.837 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.465 ' C ' HD12 ' D' ' 49' ' ' LEU . 1.2 pp -121.11 161.02 22.48 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.043 0.84 . . . . 0.0 111.246 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.559 HD12 ' O ' ' D' ' 29' ' ' PHE . 17.7 tp -169.05 149.33 4.25 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.668 1.587 . . . . 0.0 112.182 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.81 -146.96 13.51 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.645 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.0 mt -147.01 139.76 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.965 0.906 . . . . 0.0 110.296 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.79 53.37 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.157 -0.964 . . . . 0.0 110.871 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -70.57 153.52 42.81 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.766 -1.209 . . . . 0.0 111.304 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -143.91 17.23 1.78 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -93.31 -49.0 6.16 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.656 0.782 . . . . 0.0 112.642 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.7 177.25 5.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -81.58 -38.29 26.33 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.596 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.77 51.98 4.69 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.469 1.108 . . . . 0.0 111.875 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.71 175.21 11.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.707 1.605 . . . . 0.0 113.726 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' D' ' 82' ' ' GLN 0.328 0.7 OUTLIER -96.47 165.91 11.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.018 1.389 . . . . 0.0 112.353 173.553 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.77 165.96 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.948 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 146.57 12.43 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -159.02 152.42 22.68 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.82 151.75 19.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.872 2.069 . . . . 0.0 109.034 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.87 119.45 45.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.672 ' HB2' HG21 ' A' ' 52' ' ' ILE . 1.7 t-20 -88.07 118.31 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.322 -0.861 . . . . 0.0 110.601 175.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -76.52 141.89 41.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.539 1.162 . . . . 0.0 110.498 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -108.55 -39.65 5.34 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.239 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.67 -13.3 54.48 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 114.268 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 43.2 t -152.34 133.32 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 128.554 2.741 . . . . 0.0 106.211 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -75.3 117.73 17.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.148 1.34 . . . . 0.0 110.347 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -173.72 164.02 4.31 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 109.72 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.5 t -138.88 142.59 38.57 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.073 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.753 HG23 HD12 ' D' ' 99' ' ' LEU . 0.0 OUTLIER -131.96 152.23 51.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.533 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.12 149.53 29.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 113.165 -1.834 . . . . 0.0 107.768 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.75 126.86 12.05 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 100' ' ' ARG . . . -173.29 178.36 45.28 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' D' ' 84' ' ' PHE . 0.0 OUTLIER -101.34 147.25 26.53 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 124.63 0.841 . . . . 0.0 112.337 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.83 115.7 28.59 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.445 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' D' ' 82' ' ' GLN 0.275 3.3 m-85 -110.15 162.95 14.09 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -132.74 112.21 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.71 161.95 11.56 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.671 0.788 . . . . 0.0 109.011 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -20.52 0.85 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.09 -2.22 55.71 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.81 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.33 51.57 6.03 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -173.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.23 138.9 54.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.91 2.084 . . . . 0.0 107.185 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -106.69 149.42 27.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.781 1.632 . . . . 0.0 112.261 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.675 HG11 ' HD3' ' D' ' 94' ' ' LYS . 1.8 t -150.53 161.64 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 122.729 1.252 . . . . 0.0 110.247 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 mt -125.9 111.27 14.61 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 101.602 -3.481 . . . . 0.0 101.602 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.675 ' HD3' HG11 ' D' ' 92' ' ' VAL . 6.8 mmmt -103.97 120.62 41.42 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -137.35 162.96 32.16 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.792 1.758 . . . . 0.0 114.101 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -112.45 164.8 12.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -140.54 159.72 41.58 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.887 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.807 HD21 HG23 ' D' ' 113' ' ' THR . 1.2 tt -143.45 124.01 14.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.85 175.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . 0.753 HD12 HG23 ' D' ' 77' ' ' THR . 3.1 tp -107.51 141.96 38.13 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 125.616 1.822 . . . . 0.0 110.693 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -124.2 114.13 19.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 110.216 -3.175 . . . . 0.0 109.417 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . 0.263 19.2 m -71.45 163.93 26.78 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.682 1.864 . . . . 0.0 112.762 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . 0.407 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 55.2 m -100.25 85.7 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' D' ' 112' ' ' ALA . 2.3 t -80.89 164.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 127.048 2.139 . . . . 0.0 109.065 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.87 -23.84 8.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.44 137.96 51.18 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.601 0.715 . . . . 0.0 111.142 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.527 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.1 tt -59.06 -17.74 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 7.31 73.23 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.356 1.932 . . . . 0.0 116.016 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -114.49 4.66 15.31 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 119.967 1.884 . . . . 0.0 112.969 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -61.35 -31.17 71.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.972 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.487 ' CD1' HD11 ' B' ' 14' ' ' LEU . 55.1 p-90 -49.0 -39.58 27.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.117 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -97.72 -5.96 33.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.733 1.213 . . . . 0.0 114.057 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' D' ' 103' ' ' VAL . . . -78.89 6.74 8.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.807 HG23 HD21 ' D' ' 98' ' ' LEU . 18.3 m -121.65 140.18 52.6 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 122.076 0.941 . . . . 0.0 113.251 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.36 121.05 7.51 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.008 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 9.7 p -100.87 150.29 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.732 2.013 . . . . 0.0 111.418 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.42 -171.49 22.73 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.663 0.649 . . . . 0.0 112.502 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -131.67 157.19 44.38 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.02 -0.694 . . . . 0.0 111.517 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . 0.402 HD21 HD22 ' D' ' 14' ' ' LEU . 7.0 m120 -147.9 159.55 43.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.524 1.13 . . . . 0.0 109.095 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . 0.436 HD13 ' HE3' ' D' ' 94' ' ' LYS . 7.3 mt -137.83 118.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.61 146.5 34.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 14.7 p -132.89 163.57 28.84 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.158 0.98 . . . . 0.0 108.64 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.87 124.18 17.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.942 -174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . 0.499 HD12 ' HB ' ' D' ' 11' ' ' THR . 0.6 OUTLIER -73.34 142.11 47.07 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.634 -0.698 . . . . 0.0 109.301 174.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 115.45 149.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 1 C-N-CA 131.941 4.097 . . . . 0.0 107.804 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 17.5 p -70.98 -23.53 62.22 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 56.01 -83.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.71 2.004 . . . . 0.0 110.672 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . 0.302 6.6 mtpp 102.2 -9.79 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.278 1 C-N-CA 132.574 4.35 . . . . 0.0 115.093 174.306 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.774 2.83 . . . . 0.0 108.388 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.7 m -140.28 148.05 40.85 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.1 0.96 . . . . 0.0 108.411 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.31 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.22 1.008 . . . . 0.0 109.964 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -96.54 50.43 1.13 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.813 0.845 . . . . 0.0 110.855 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 46.35 62.34 2.34 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.597 1.959 . . . . 0.0 114.727 -174.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.65 155.86 32.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.238 1.815 . . . . 0.0 108.842 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.38 138.78 51.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -139.49 133.32 30.74 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.524 -1.36 . . . . 0.0 111.16 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.45 -23.63 65.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -49.75 112.09 0.6 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.226 1.41 . . . . 0.0 112.308 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.57 -116.0 1.53 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.995 1.284 . . . . 0.0 111.907 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -153.39 147.87 26.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -174.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -145.24 163.36 34.67 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.674 1.589 . . . . 0.0 111.987 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -145.47 152.95 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.709 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.53 145.67 48.68 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.73 0.812 . . . . 0.0 112.537 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.63 -26.16 12.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.817 2.447 . . . . 0.0 114.834 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.6 tp -70.21 -19.85 63.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.316 1.046 . . . . 0.0 112.968 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.56 -13.64 22.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 127.535 2.493 . . . . 0.0 113.574 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -67.83 145.57 54.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.338 1.569 . . . . 0.0 112.884 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 145.54 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.87 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -142.27 147.75 36.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -137.08 135.81 37.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.67 0.788 . . . . 0.0 109.994 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.1 mt -135.54 127.58 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.391 0.677 . . . . 0.0 110.337 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -75.92 0.57 Allowed Glycine 0 CA--C 1.532 1.1 0 O-C-N 123.922 0.764 . . . . 0.0 113.544 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.06 24.27 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 117.808 0.804 . . . . 0.0 112.084 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.89 130.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.91 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.4 166.79 20.95 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.24 0.337 . . . . 0.0 111.804 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 88.1 p -60.52 -24.69 65.55 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.451 -1.406 . . . . 0.0 114.771 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -78.24 -27.12 47.57 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.964 0.802 . . . . 0.0 111.849 173.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.66 30.37 Favored Glycine 0 N--CA 1.468 0.797 0 CA-C-O 117.82 -1.545 . . . . 0.0 113.571 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' C' ' 50' ' ' LEU . 10.0 pt-20 -64.17 138.9 58.67 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 173.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.84 162.21 39.71 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.43 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.416 HG22 HD13 ' B' ' 50' ' ' LEU . 2.5 p -129.0 177.27 7.24 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.48 -166.19 37.97 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 120.695 -1.253 . . . . 0.0 114.273 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.46 ' HB ' HD11 ' B' ' 46' ' ' LEU . 16.3 p -136.63 131.03 33.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.635 1.207 . . . . 0.0 111.696 175.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -114.36 141.36 47.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.095 -1.412 . . . . 0.0 108.39 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.92 134.51 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.462 ' O ' HG21 ' B' ' 44' ' ' ILE . 2.6 m -110.03 140.18 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.592 1.157 . . . . 0.0 111.611 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.13 -11.7 19.37 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 19.0 m -137.52 141.17 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.097 0.959 . . . . 0.0 111.325 -175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.24 32.97 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.999 -0.438 . . . . 0.0 110.21 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -77.14 -34.46 56.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -135.02 83.7 39.18 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.795 1.638 . . . . 0.0 110.244 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.62 36.19 0.26 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.849 3.699 . . . . 0.0 115.129 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.47 -6.98 63.29 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 179.72 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.591 1.956 . . . . 0.0 110.973 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.462 HG21 ' O ' ' B' ' 35' ' ' THR . 62.9 mt -56.58 125.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.137 -1.602 . . . . 0.0 110.922 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.25 165.74 27.5 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.007 1.323 . . . . 0.0 111.688 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' B' ' 32' ' ' THR . 10.1 tp -46.78 115.99 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.803 3.641 . . . . 0.0 112.995 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 10.9 p -106.19 123.17 39.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.519 0.728 . . . . 0.0 111.199 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.42 136.73 76.25 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.871 2.381 . . . . 0.0 111.329 174.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.87 155.59 36.34 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 124.023 0.827 . . . . 0.0 111.656 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.416 HD13 HG22 ' B' ' 30' ' ' THR . 1.5 tp -162.98 148.84 12.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.834 1.654 . . . . 0.0 109.364 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.19 -149.64 19.69 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.231 1.378 . . . . 0.0 109.672 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.8 mt -144.64 140.72 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.511 0.725 . . . . 0.0 111.372 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 137.81 52.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.354 -0.841 . . . . 0.0 111.044 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -69.35 154.75 41.53 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.236 0.925 . . . . 0.0 111.152 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -145.22 16.45 1.52 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -92.24 -47.56 7.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.463 0.705 . . . . 0.0 112.685 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.11 175.28 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -76.74 -41.37 45.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.243 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -138.7 54.69 6.95 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.762 1.225 . . . . 0.0 111.843 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.63 174.54 12.68 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.711 1.608 . . . . 0.0 113.699 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' B' ' 82' ' ' GLN 0.322 0.5 OUTLIER -96.21 166.57 11.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 123.057 1.408 . . . . 0.0 112.039 173.423 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.02 166.85 32.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.898 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.04 146.33 11.91 Favored Glycine 0 CA--C 1.544 1.901 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -158.92 153.46 24.35 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.23 -1.747 . . . . 0.0 115.66 -174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 151.94 19.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.273 1.829 . . . . 0.0 109.386 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.34 118.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' C' ' 52' ' ' ILE . 1.9 t-20 -88.34 116.62 26.68 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.866 -0.521 . . . . 0.0 110.039 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.67 143.09 44.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.517 1.151 . . . . 0.0 110.565 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -109.46 -39.72 5.1 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.226 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.79 -13.35 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.273 1.429 . . . . 0.0 114.408 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.5 t -152.31 132.52 13.58 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 128.408 2.683 . . . . 0.0 106.059 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -74.8 118.33 17.64 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.189 1.359 . . . . 0.0 110.394 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -174.44 163.81 3.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.661 1.985 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -138.33 142.33 39.72 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.089 173.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.766 HG23 HD12 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -131.71 152.32 50.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.648 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.53 150.2 29.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.014 -1.903 . . . . 0.0 107.788 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.67 143.01 51.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 127.34 12.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.83 178.54 44.8 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.572 ' HB3' ' CE1' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -101.12 147.78 25.83 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.663 0.86 . . . . 0.0 112.704 178.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 6.8 p -97.9 115.85 28.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.267 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' B' ' 82' ' ' GLN 0.288 2.9 m-85 -110.24 161.56 15.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.39 112.09 18.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.45 162.76 12.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.642 0.777 . . . . 0.0 109.495 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -23.08 1.03 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.77 -4.66 56.5 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.774 0.83 . . . . 0.0 113.121 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.53 53.81 5.33 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 122.059 0.81 . . . . 0.0 111.346 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -122.96 140.66 52.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.245 2.618 . . . . 0.0 104.604 173.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -111.59 148.04 34.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.195 1.798 . . . . 0.0 112.08 -172.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.665 HG11 ' HD3' ' B' ' 94' ' ' LYS . 1.9 t -149.12 160.99 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 122.408 1.099 . . . . 0.0 110.546 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 62.5 mt -124.91 112.41 16.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 101.697 -3.445 . . . . 0.0 101.697 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.665 ' HD3' HG11 ' B' ' 92' ' ' VAL . 6.3 mmmt -104.96 120.08 40.57 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -137.28 162.8 32.54 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.663 1.697 . . . . 0.0 114.105 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.503 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -112.11 164.88 12.66 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -140.47 159.25 42.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.382 -1.735 . . . . 0.0 111.968 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.806 HD21 HG23 ' B' ' 113' ' ' THR . 1.2 tt -142.82 123.99 14.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.997 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.766 HD12 HG23 ' B' ' 77' ' ' THR . 3.1 tp -107.65 141.6 38.9 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 125.779 1.925 . . . . 0.0 110.826 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 2.9 tpt85 -123.89 114.09 19.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 110.069 -3.241 . . . . 0.0 109.338 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . 0.264 21.6 m -71.48 164.69 25.35 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.639 1.837 . . . . 0.0 112.722 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.41 ' HA ' ' OE1' ' C' ' 82' ' ' GLN . 59.8 m -101.25 84.55 2.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' B' ' 112' ' ' ALA . 2.3 t -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 127.547 2.339 . . . . 0.0 109.295 175.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.87 -22.57 9.56 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.057 0.844 . . . . 0.0 113.246 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.48 137.56 51.93 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.757 0.789 . . . . 0.0 111.096 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' C' ' 84' ' ' PHE . 15.0 tt -59.76 -17.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.01 6.86 76.58 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.068 -1.962 . . . . 0.0 115.774 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.68 4.38 15.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.802 1.801 . . . . 0.0 112.798 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -30.55 70.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.485 ' CD1' HD11 ' D' ' 14' ' ' LEU . 54.8 p-90 -48.59 -41.15 29.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.269 1.028 . . . . 0.0 113.248 174.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -96.26 -6.22 38.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.577 1.151 . . . . 0.0 113.807 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' B' ' 103' ' ' VAL . . . -79.02 6.79 8.54 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.806 HG23 HD21 ' B' ' 98' ' ' LEU . 16.2 m -121.43 140.23 52.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.06 119.53 6.44 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.549 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -100.51 149.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.472 1.909 . . . . 0.0 111.255 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.08 -171.77 22.8 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.594 0.616 . . . . 0.0 112.801 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -131.5 157.04 44.6 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.084 -0.656 . . . . 0.0 111.544 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . 0.415 HD21 HD22 ' B' ' 14' ' ' LEU . 6.8 m120 -147.71 159.89 43.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.705 1.202 . . . . 0.0 109.277 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.434 HD13 ' HE3' ' B' ' 94' ' ' LYS . 7.3 mt -138.75 119.33 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.44 147.37 34.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 15.0 p -134.85 164.95 26.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.818 0.847 . . . . 0.0 109.131 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -60.22 119.07 7.19 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.54 1.136 . . . . 0.0 111.627 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt -76.81 129.09 35.78 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . 0.492 3.6 tmm_? 65.87 71.18 0.42 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 124.204 1.954 . . . . 0.0 114.02 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 12.5 t -72.75 -169.33 0.55 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.841 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -129.13 152.94 48.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.671 2.388 . . . . 0.0 104.889 173.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.85 164.63 0.18 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.3 1.44 . . . . 0.0 114.09 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.264 1.856 0 C-N-CA 125.684 1.594 . . . . 0.0 111.798 174.491 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 11.2 t -170.66 159.46 6.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.698 1.999 . . . . 0.0 107.981 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 37.9 t -135.8 126.72 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.142 0.883 . . . . 0.0 109.27 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.43 147.17 46.4 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.887 -0.508 . . . . 0.0 111.656 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -62.79 90.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.362 1.465 . . . . 0.0 113.813 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 155.82 31.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.887 2.075 . . . . 0.0 107.835 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.68 138.28 45.78 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 15.4 m -139.35 131.1 27.45 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.568 -1.333 . . . . 0.0 110.95 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.74 -24.05 64.41 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -49.21 114.61 1.05 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.025 1.33 . . . . 0.0 111.747 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.23 -120.46 2.47 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.919 1.247 . . . . 0.0 110.675 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -151.29 147.57 27.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -145.33 163.16 35.38 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.295 1.438 . . . . 0.0 112.234 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -143.65 153.78 42.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.516 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -123.29 146.26 48.03 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.724 0.809 . . . . 0.0 112.599 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.1 -26.24 15.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.44 2.296 . . . . 0.0 114.74 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 110' ' ' TRP . 32.9 tp -70.19 -20.25 63.13 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.098 -1.001 . . . . 0.0 113.032 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.03 -13.21 21.94 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.471 2.462 . . . . 0.0 113.607 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 86.8 p -67.57 145.85 54.48 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.436 1.618 . . . . 0.0 112.852 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.63 144.9 46.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.628 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -141.75 147.44 37.38 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 35.3 m -137.86 136.38 37.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.512 0.725 . . . . 0.0 109.676 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.69 127.91 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.66 0.784 . . . . 0.0 110.721 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.01 -77.93 0.42 Allowed Glycine 0 CA--C 1.532 1.132 0 O-C-N 123.643 0.59 . . . . 0.0 113.909 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.39 145.13 22.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.051 0.925 . . . . 0.0 112.102 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.54 130.06 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.816 0.846 . . . . 0.0 109.776 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.06 164.89 19.17 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.579 0.55 . . . . 0.0 111.783 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 82.1 p -60.58 -25.15 65.99 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.223 -1.548 . . . . 0.0 114.598 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -74.76 -24.95 58.77 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.833 0.742 . . . . 0.0 111.928 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.58 -5.14 32.95 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.09 0.853 . . . . 0.0 114.286 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.0 152.92 44.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.172 0.986 . . . . 0.0 112.133 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . 0.558 ' O ' HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -155.05 166.49 33.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.117 176.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.454 HG22 HD13 ' C' ' 50' ' ' LEU . 15.2 p -127.04 -177.49 4.06 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.01 -165.6 38.92 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 119.486 -2.009 . . . . 0.0 113.947 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.471 ' HB ' HD11 ' C' ' 46' ' ' LEU . 11.3 p -136.67 130.48 32.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.453 1.12 . . . . 0.0 112.369 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.71 141.4 47.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.68 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 mt -130.69 134.19 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.449 ' O ' HG21 ' C' ' 44' ' ' ILE . 2.9 m -109.97 140.42 43.98 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.447 1.099 . . . . 0.0 111.562 -173.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.35 18.84 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 18.9 m -136.92 140.92 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 123.772 0.829 . . . . 0.0 111.294 -175.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.86 165.4 35.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.01 -0.431 . . . . 0.0 110.131 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -76.58 -34.75 58.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -134.7 83.78 40.86 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.691 1.596 . . . . 0.0 110.154 173.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.89 36.21 0.27 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.917 3.745 . . . . 0.0 115.149 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -7.13 63.32 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 117.762 1.865 . . . . 0.0 117.762 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 179.71 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.576 1.95 . . . . 0.0 110.883 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.449 HG21 ' O ' ' C' ' 35' ' ' THR . 63.9 mt -56.59 125.68 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.074 -1.641 . . . . 0.0 111.145 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -145.59 165.05 29.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.958 1.303 . . . . 0.0 111.806 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' C' ' 32' ' ' THR . 10.4 tp -47.28 115.55 1.14 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 130.766 3.626 . . . . 0.0 112.823 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 11.2 p -105.77 122.42 42.61 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.439 0.696 . . . . 0.0 110.74 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.6 135.29 68.63 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.559 2.173 . . . . 0.0 110.755 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.461 ' C ' HD12 ' C' ' 49' ' ' LEU . 1.2 pp -120.8 161.07 22.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.72 0.808 . . . . 0.0 111.181 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.558 HD12 ' O ' ' C' ' 29' ' ' PHE . 17.9 tp -168.98 149.35 4.31 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.544 1.538 . . . . 0.0 112.257 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -147.16 13.92 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 120.185 1.357 . . . . 0.0 109.711 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.0 mt -146.87 139.85 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.892 0.877 . . . . 0.0 110.24 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.88 138.82 53.37 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.86 154.09 42.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.685 -1.259 . . . . 0.0 111.148 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -144.63 14.67 1.58 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -89.78 -47.85 7.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.575 0.75 . . . . 0.0 112.389 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.61 172.23 13.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 31.2 t -74.85 -39.86 61.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.18 0.992 . . . . 0.0 112.617 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -138.45 53.47 5.73 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.835 1.254 . . . . 0.0 112.866 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.1 176.04 10.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.461 1.44 . . . . 0.0 113.814 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' C' ' 82' ' ' GLN 0.324 0.7 OUTLIER -97.29 166.0 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 123.071 1.415 . . . . 0.0 112.492 173.718 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -156.49 166.4 33.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.146 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.8 146.73 12.48 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -159.16 153.41 23.81 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -93.85 151.82 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.139 2.176 . . . . 0.0 109.002 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -130.9 119.71 45.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.684 ' HB2' HG21 ' B' ' 52' ' ' ILE . 1.6 t-20 -88.09 118.29 27.56 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.2 -0.938 . . . . 0.0 110.542 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.66 141.55 40.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.121 0.962 . . . . 0.0 110.214 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -107.94 -40.05 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.225 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.3 -13.12 55.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.326 1.451 . . . . 0.0 114.348 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 43.3 t -152.39 132.98 13.88 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 128.436 2.694 . . . . 0.0 106.175 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.61 117.96 17.02 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.093 1.315 . . . . 0.0 110.244 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 13.9 m -174.18 163.82 3.93 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 126.545 1.938 . . . . 0.0 109.871 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.6 t -139.0 142.48 38.3 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.291 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . 0.764 HG23 HD12 ' C' ' 99' ' ' LEU . 0.0 OUTLIER -132.01 152.2 51.29 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.679 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.13 149.89 29.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.182 -1.827 . . . . 0.0 107.889 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.06 143.6 51.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.35 127.07 11.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -174.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.96 178.4 44.98 Favored Glycine 0 CA--C 1.499 -0.943 0 N-CA-C 117.421 1.728 . . . . 0.0 117.421 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . 0.586 ' HB3' ' CE1' ' C' ' 84' ' ' PHE . 0.0 OUTLIER -101.27 147.17 26.6 Favored 'General case' 0 C--O 1.238 0.468 0 O-C-N 124.668 0.864 . . . . 0.0 112.125 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 4.4 p -97.8 115.62 28.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.205 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' C' ' 82' ' ' GLN 0.268 3.5 m-85 -110.67 162.57 14.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -177.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.15 112.74 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -62.74 163.48 9.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 0.0 109.416 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.19 -28.16 2.83 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.42 -7.39 58.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.188 0.995 . . . . 0.0 113.104 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.69 53.82 3.89 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -121.72 140.32 52.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.708 2.403 . . . . 0.0 106.012 174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -111.42 147.49 35.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.72 1.608 . . . . 0.0 112.251 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.679 HG11 ' HD3' ' C' ' 94' ' ' LYS . 1.8 t -150.11 161.11 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.583 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 55.3 mt -124.48 112.94 17.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.679 ' HD3' HG11 ' C' ' 92' ' ' VAL . 6.6 mmmt -105.46 118.87 37.68 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 174.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 6.8 p -136.47 161.82 34.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 124.005 1.86 . . . . 0.0 114.043 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.496 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -111.21 165.66 11.74 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 172.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -140.91 159.49 42.1 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.037 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.828 HD21 HG23 ' C' ' 113' ' ' THR . 1.2 tt -143.27 124.03 14.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.868 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . 0.764 HD12 HG23 ' C' ' 77' ' ' THR . 3.1 tp -107.65 142.07 38.17 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 125.579 1.799 . . . . 0.0 110.68 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 -124.43 114.22 19.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 110.272 -3.149 . . . . 0.0 109.403 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . 0.254 18.5 m -71.4 164.86 24.96 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 125.638 1.836 . . . . 0.0 112.897 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.4 m -102.4 82.58 2.19 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' C' ' 112' ' ' ALA . 2.3 t -77.2 165.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 127.905 2.482 . . . . 0.0 108.971 174.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -115.65 -23.5 8.7 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.6 139.49 50.05 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.986 0.898 . . . . 0.0 111.34 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.0 tt -60.36 -16.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.73 7.2 74.11 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 117.222 -1.877 . . . . 0.0 115.601 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -115.01 4.87 14.83 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.939 1.87 . . . . 0.0 112.725 174.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.8 -31.12 70.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.204 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.492 ' CD1' HD11 ' A' ' 14' ' ' LEU . 54.5 p-90 -49.3 -40.35 34.55 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 113.188 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -96.63 -5.61 38.59 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 113.927 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' C' ' 103' ' ' VAL . . . -79.51 7.2 8.6 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.828 HG23 HD21 ' C' ' 98' ' ' LEU . 18.0 m -122.03 140.67 52.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.767 0.794 . . . . 0.0 113.017 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.07 120.53 6.89 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.308 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -100.95 149.79 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.576 1.95 . . . . 0.0 111.303 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.5 -171.28 22.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.617 0.627 . . . . 0.0 112.653 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -132.06 156.95 45.39 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.106 -0.644 . . . . 0.0 111.569 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . 0.422 HD21 HD22 ' C' ' 14' ' ' LEU . 6.7 m120 -147.79 159.82 43.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.619 1.168 . . . . 0.0 109.256 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . 0.425 HD13 ' HE3' ' C' ' 94' ' ' LYS . 7.2 mt -138.56 119.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -110.21 147.29 34.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 20.2 p -135.34 164.62 27.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.716 0.806 . . . . 0.0 109.169 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -59.85 119.92 8.6 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.494 1.518 . . . . 0.0 113.175 -174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 78.07 9.8 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.57 137.32 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 127.895 2.478 . . . . 0.0 111.751 -173.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 45.0 m -156.52 90.21 1.16 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.24 1.416 . . . . 0.0 107.462 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 57.58 -174.82 0.07 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . 0.289 6.7 tmtt? 60.21 81.21 0.18 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 C--O 1.261 1.676 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.075 172.664 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 3.7 t -178.37 146.8 0.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.567 1.947 . . . . 0.0 107.993 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.65 101.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.794 0.837 . . . . 0.0 110.326 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -70.77 26.63 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 48.87 99.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.982 2.513 . . . . 0.0 113.871 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.31 127.78 13.16 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.652 -1.28 . . . . 0.0 113.229 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.4 131.7 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.477 1.511 . . . . 0.0 108.284 173.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.08 130.79 22.77 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.62 -26.6 60.86 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 t -45.39 109.73 0.19 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.866 1.666 . . . . 0.0 111.642 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.28 -125.98 2.93 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.231 0.92 . . . . 0.0 111.003 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -154.6 143.66 21.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -141.04 160.52 39.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.361 1.464 . . . . 0.0 110.983 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.431 ' HB ' HD12 ' A' ' 123' ' ' LEU . 2.9 t -136.59 151.65 49.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.58 1.152 . . . . 0.0 108.481 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.92 143.98 45.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 110.919 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -55.51 -23.06 24.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.451 1.901 . . . . 0.0 114.498 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' C' ' 110' ' ' TRP . 32.4 tp -71.03 -18.56 62.57 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.577 -1.327 . . . . 0.0 111.305 174.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.81 -14.19 19.8 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 128.337 2.875 . . . . 0.0 113.487 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.2 p -71.05 144.7 50.29 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.988 -1.301 . . . . 0.0 112.332 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -120.48 141.77 49.88 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.209 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -130.88 143.52 50.79 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.146 0.974 . . . . 0.0 112.992 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.8 m -131.47 132.02 43.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.562 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.04 126.84 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.62 -89.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.775 0 O-C-N 125.125 1.516 . . . . 0.0 111.118 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.08 152.62 43.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.969 0.89 . . . . 0.0 111.815 176.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG21 ' HG3' ' A' ' 53' ' ' GLN . 14.0 p -103.78 124.89 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.771 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.83 160.81 28.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.877 0.37 . . . . 0.0 111.961 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -53.97 -22.88 11.39 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.28 -36.53 77.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.317 0.647 . . . . 0.0 111.225 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.64 -8.04 17.43 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 124.851 1.215 . . . . 0.0 112.534 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 155.33 40.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.484 1.135 . . . . 0.0 108.789 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -159.82 163.84 34.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.515 177.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -129.16 162.7 27.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.52 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.81 -166.51 27.98 Favored Glycine 0 C--O 1.237 0.29 0 O-C-N 121.219 -0.926 . . . . 0.0 112.369 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.674 ' HB ' HD11 ' A' ' 46' ' ' LEU . 39.6 p -137.39 138.54 39.98 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 122.578 1.18 . . . . 0.0 111.732 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -114.51 140.66 48.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.234 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 46' ' ' LEU . 41.3 mt -133.57 126.48 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 44' ' ' ILE . 85.3 m -104.99 148.73 26.41 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.86 -18.22 15.83 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 16.6 m -132.97 138.44 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 111.511 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.81 170.1 18.99 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.179 -0.95 . . . . 0.0 112.44 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.25 -26.43 62.9 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.825 -0.547 . . . . 0.0 110.495 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -143.77 81.03 12.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.677 2.391 . . . . 0.0 110.346 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.66 33.43 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 124.94 3.76 . . . . 0.0 116.066 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.66 6.38 83.52 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 119.75 -1.844 . . . . 0.0 115.629 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -176.55 11.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 35' ' ' THR 0.257 59.5 mt -33.5 108.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -173.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -102.38 174.8 5.75 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.418 -2.173 . . . . 0.0 111.089 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 32' ' ' THR . 2.0 tt -71.69 137.14 47.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.379 171.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 p -114.12 125.9 28.73 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.189 0.596 . . . . 0.0 111.198 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -57.81 144.27 93.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.283 1.989 . . . . 0.0 112.131 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.66 144.24 51.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.153 0.981 . . . . 0.0 110.818 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' D' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.01 30.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.455 2.302 . . . . 0.0 108.621 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.11 -149.04 15.11 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 120.333 -1.479 . . . . 0.0 111.155 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.655 HG21 ' HB2' ' D' ' 69' ' ' ASN . 2.5 mp -145.12 138.39 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.872 0.869 . . . . 0.0 112.137 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.596 ' HG3' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -126.49 131.99 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.738 0.815 . . . . 0.0 110.817 173.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 62' ' ' PRO . 9.5 m-70 -64.4 156.1 30.38 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.794 -1.191 . . . . 0.0 111.273 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -146.75 13.34 1.16 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.798 1.239 . . . . 0.0 113.279 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -78.69 -58.14 3.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.109 2.564 . . . . 0.0 111.304 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.74 13.27 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.5 m -78.55 -29.2 46.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.062 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.53 58.98 33.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.933 1.293 . . . . 0.0 112.384 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 54' ' ' HIS . 55.2 Cg_endo -80.96 175.72 9.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.344 2.03 . . . . 0.0 116.001 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -88.92 160.05 17.36 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.572 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -161.09 156.69 24.88 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.156 -0.965 . . . . 0.0 113.145 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.79 149.39 17.2 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 119.7 2.64 . . . . 0.0 119.7 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.06 159.69 36.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.408 ' HB ' HD12 ' D' ' 52' ' ' ILE . 2.9 m -96.8 150.36 20.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.265 1.826 . . . . 0.0 108.398 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.93 125.98 63.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HB2' HG21 ' D' ' 52' ' ' ILE . 21.7 t-20 -104.04 112.4 25.38 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.495 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE1' ' HG1' ' A' ' 77' ' ' THR 0.355 56.4 m95 -74.47 154.89 38.52 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -173.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.86 -50.25 2.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.139 1.776 . . . . 0.0 115.396 -172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -75.58 -15.51 60.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.544 0.737 . . . . 0.0 112.934 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 t -149.26 145.02 26.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.186 2.594 . . . . 0.0 107.295 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.56 116.83 21.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.852 1.31 . . . . 0.0 110.216 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.2 p -168.42 172.06 8.61 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 126.194 1.798 . . . . 0.0 111.045 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.95 142.01 25.98 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 123.337 1.541 . . . . 0.0 110.711 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.422 ' HG1' ' HE1' ' A' ' 70' ' ' TRP . 1.7 m -138.77 132.04 30.04 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.644 -3.435 . . . . 0.0 109.848 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 m -109.54 157.46 9.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.78 137.28 43.26 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 119.96 10.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.48 0.712 . . . . 0.0 110.369 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -156.38 -173.21 24.62 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -124.0 145.67 49.04 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 124.968 1.04 . . . . 0.0 111.056 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.6 p -97.8 113.1 24.81 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.443 1.089 . . . . 0.0 112.095 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -102.65 166.94 10.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.883 0.473 . . . . 0.0 111.715 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.3 mt -126.47 110.54 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -58.7 160.73 5.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.218 1.007 . . . . 0.0 108.735 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -49.66 -25.27 2.74 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.79 -13.85 49.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.021 0.929 . . . . 0.0 113.276 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.22 58.24 2.0 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -130.12 148.26 51.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.388 2.675 . . . . 0.0 107.359 172.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -109.58 138.57 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.417 1.487 . . . . 0.0 110.601 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' D' ' 106' ' ' ILE . 19.6 m -141.3 164.17 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 109.518 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 mt -123.31 118.53 27.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -107.57 115.87 30.93 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 p -133.02 169.43 16.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.886 1.803 . . . . 0.0 112.245 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.469 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -121.37 171.17 8.95 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.0 p-90 -146.38 162.75 37.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.13 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.794 HD21 ' CG2' ' A' ' 113' ' ' THR . 1.7 tt -145.59 125.62 13.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.385 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.9 144.65 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 125.115 1.509 . . . . 0.0 114.588 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -128.64 123.5 33.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.035 -2.348 . . . . 0.0 113.755 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.88 156.24 18.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.674 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -103.08 64.15 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.589 -0.695 . . . . 0.0 109.84 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -49.12 153.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.139 1.376 . . . . 0.0 113.003 174.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.79 -29.76 32.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.13 144.69 43.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.728 1.252 . . . . 0.0 112.641 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.505 ' CD1' HG21 ' D' ' 92' ' ' VAL . 14.0 tt -65.25 -24.24 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.788 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.0 1.18 41.6 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-O 118.106 -1.386 . . . . 0.0 113.54 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.798 ' HB3' HG11 ' A' ' 103' ' ' VAL . 14.8 m-20 -121.35 6.28 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.804 1.242 . . . . 0.0 114.025 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -33.52 67.9 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 119.755 -1.841 . . . . 0.0 111.705 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 108' ' ' ASP . 44.1 p-90 -45.67 -50.34 13.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.826 1.251 . . . . 0.0 113.981 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.83 -11.62 47.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.92 0.888 . . . . 0.0 113.342 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.68 -5.92 54.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.361 -172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.794 ' CG2' HD21 ' A' ' 98' ' ' LEU . 15.4 m -103.6 143.7 32.4 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 125.11 1.506 . . . . 0.0 112.174 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -144.05 129.91 19.37 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 124.694 1.198 . . . . 0.0 111.013 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.85 154.8 8.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 120.248 1.385 . . . . 0.0 110.524 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.78 -177.24 32.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 123.326 0.488 . . . . 0.0 113.259 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' MET . 22.8 p90 -125.1 152.58 44.18 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.9 -0.765 . . . . 0.0 111.096 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -148.13 144.04 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.77 128.13 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -115.45 152.75 32.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.975 0.417 . . . . 0.0 110.518 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.8 p -134.69 160.54 37.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.439 1.096 . . . . 0.0 110.054 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -56.81 122.09 11.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.818 0.847 . . . . 0.0 111.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 11' ' ' THR . 4.1 tt -78.43 152.84 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 101.27 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 129.784 3.233 . . . . 0.0 110.231 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -48.93 112.12 0.57 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.648 1.579 . . . . 0.0 110.031 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.99 -37.56 66.96 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.04 -37.8 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.963 2.105 . . . . 0.0 113.501 174.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . 0.282 5.4 tt0 . . . . . 0 C--O 1.246 0.918 0 O-C-N 128.549 3.656 . . . . 0.0 108.77 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 12.4 p -88.52 162.55 16.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.627 0.771 . . . . 0.0 109.757 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 12.0 p -167.21 -39.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.484 1.114 . . . . 0.0 112.639 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -64.18 135.35 56.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.736 0.814 . . . . 0.0 112.124 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -90.68 123.44 34.29 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.795 1.238 . . . . 0.0 110.192 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -156.58 117.36 3.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.81 1.244 . . . . 0.0 112.002 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 48.1 t -116.31 135.31 53.99 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 2.2 t -139.6 136.84 34.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.774 1.23 . . . . 0.0 108.943 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 38.5 mt -73.63 -24.27 60.0 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -48.34 109.8 0.27 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.319 1.448 . . . . 0.0 112.07 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.48 -124.16 2.56 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 124.679 1.133 . . . . 0.0 110.813 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -151.72 144.28 24.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -142.28 157.49 44.77 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.111 1.365 . . . . 0.0 110.968 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -137.16 150.36 47.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.238 1.015 . . . . 0.0 108.492 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -116.02 143.54 45.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.096 0.958 . . . . 0.0 111.042 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.62 -24.73 8.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.79 2.036 . . . . 0.0 114.975 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' B' ' 110' ' ' TRP . 31.4 tp -70.61 -18.53 62.88 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.282 -1.511 . . . . 0.0 111.643 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.29 -14.88 18.32 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 128.592 2.996 . . . . 0.0 113.543 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 82.5 p -71.34 144.11 50.02 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.011 -1.288 . . . . 0.0 112.455 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -118.73 142.98 47.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.631 0.773 . . . . 0.0 110.403 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -132.19 143.09 49.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.918 0.866 . . . . 0.0 112.538 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 20.5 m -131.44 132.03 44.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.163 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 70.3 mt -130.01 124.51 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.28 -85.74 0.09 OUTLIER Glycine 0 CA--C 1.527 0.794 0 O-C-N 124.934 1.397 . . . . 0.0 111.224 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.32 155.82 44.55 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 122.045 0.926 . . . . 0.0 111.997 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' D' ' 53' ' ' GLN . 14.6 p -107.98 126.34 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.909 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -79.27 161.61 26.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.75 -23.2 16.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -69.63 -34.3 73.85 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.727 -0.608 . . . . 0.0 111.329 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.4 -6.27 18.93 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 124.918 1.247 . . . . 0.0 112.789 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.68 157.13 38.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 122.122 0.963 . . . . 0.0 111.783 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.06 166.53 32.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.482 1.134 . . . . 0.0 110.126 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -132.33 160.87 35.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.552 -1.658 . . . . 0.0 106.717 173.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.64 -166.65 28.97 Favored Glycine 0 C--O 1.24 0.488 0 CA-C-O 122.479 1.044 . . . . 0.0 112.333 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.662 ' HB ' HD11 ' D' ' 46' ' ' LEU . 40.0 p -137.84 140.33 40.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.502 -1.349 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -117.15 141.12 48.67 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.994 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.509 HD11 HD12 ' D' ' 46' ' ' LEU . 43.1 mt -133.31 126.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.465 ' O ' HG21 ' D' ' 44' ' ' ILE . 90.7 m -104.99 147.92 27.28 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.29 16.26 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' CZ2' ' B' ' 110' ' ' TRP . 16.7 m -132.96 138.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.105 0.962 . . . . 0.0 111.37 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.67 170.37 18.3 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.286 -0.884 . . . . 0.0 112.229 -173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -71.59 -26.8 62.75 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.826 -0.546 . . . . 0.0 110.443 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.65 81.24 12.25 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.77 2.428 . . . . 0.0 110.241 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.43 32.56 0.12 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.79 3.66 . . . . 0.0 116.321 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.72 6.14 83.34 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 119.726 -1.859 . . . . 0.0 115.696 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.19 11.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.465 HG21 ' O ' ' D' ' 35' ' ' THR 0.257 59.6 mt -33.16 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -173.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -101.52 173.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.545 -2.116 . . . . 0.0 111.102 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' D' ' 32' ' ' THR . 2.0 tt -69.79 138.06 52.39 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -114.83 125.61 28.84 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.281 0.633 . . . . 0.0 111.051 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -58.27 143.49 97.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.251 1.967 . . . . 0.0 112.062 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.76 151.02 48.79 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 110.741 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -157.34 149.16 22.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.774 2.03 . . . . 0.0 108.256 -175.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.73 -148.52 17.72 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 119.462 1.028 . . . . 0.0 112.676 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.669 HG21 ' HB2' ' A' ' 69' ' ' ASN . 2.5 mp -144.26 138.71 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.167 0.987 . . . . 0.0 112.395 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . 0.568 ' HG3' HG21 ' D' ' 23' ' ' VAL . 0.0 OUTLIER -128.92 129.44 45.48 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.856 -1.153 . . . . 0.0 110.828 174.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' D' ' 62' ' ' PRO . 10.0 m-70 -62.65 155.32 26.55 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.762 -1.211 . . . . 0.0 111.835 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -146.43 12.52 1.19 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.862 1.265 . . . . 0.0 113.131 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -78.61 -58.17 3.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.35 2.66 . . . . 0.0 111.036 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.36 172.01 12.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.07 0.856 . . . . 0.0 112.603 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 74.5 m -83.39 -25.92 30.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.158 0.983 . . . . 0.0 112.428 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.53 55.33 15.74 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.168 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' D' ' 54' ' ' HIS . 57.7 Cg_endo -80.69 178.35 7.09 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.984 1.789 . . . . 0.0 115.703 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -89.96 157.07 18.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.5 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.934 -1.104 . . . . 0.0 112.883 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.59 149.19 16.29 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 119.925 2.73 . . . . 0.0 119.925 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.6 158.62 34.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . 0.438 ' HB ' HD12 ' A' ' 52' ' ' ILE . 2.2 m -94.98 151.61 19.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.336 1.854 . . . . 0.0 108.543 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.75 127.85 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.655 ' HB2' HG21 ' A' ' 52' ' ' ILE . 21.9 t-20 -105.73 112.35 25.38 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.332 -0.842 . . . . 0.0 111.288 -174.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . 0.351 56.4 m95 -73.79 155.07 39.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 123.548 1.642 . . . . 0.0 115.353 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mmpm? -112.97 -49.4 2.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.022 1.729 . . . . 0.0 115.366 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.27 -15.63 59.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 45.7 t -149.52 144.69 26.43 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.228 2.611 . . . . 0.0 106.952 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -81.77 116.82 21.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.753 1.263 . . . . 0.0 110.115 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 92.9 p -168.67 171.35 8.8 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 126.231 1.813 . . . . 0.0 111.167 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 1.4 t -147.15 142.25 27.12 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.947 1.356 . . . . 0.0 110.994 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -139.01 131.85 29.24 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-N 109.906 -3.316 . . . . 0.0 110.098 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 m -109.12 156.8 9.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.941 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -133.71 137.29 45.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.58 119.76 10.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.554 0.741 . . . . 0.0 110.357 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.66 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -121.23 144.83 48.39 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.179 1.164 . . . . 0.0 110.551 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -97.65 113.07 24.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.427 1.08 . . . . 0.0 111.148 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -103.91 166.79 10.19 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.58 0.627 . . . . 0.0 111.868 -177.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.71 112.08 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -58.71 164.52 2.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.997 0.919 . . . . 0.0 109.795 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -51.83 -27.0 11.09 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -10.25 58.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.889 0.876 . . . . 0.0 113.099 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.49 39.39 6.32 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.833 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -113.94 147.24 38.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.608 1.563 . . . . 0.0 109.711 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -101.53 139.37 37.28 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.217 1.407 . . . . 0.0 110.647 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.505 HG21 ' CD1' ' A' ' 106' ' ' ILE . 22.3 m -141.66 161.04 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.213 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.7 117.34 27.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 174.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -106.58 115.64 30.55 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . . . . . . . . . 5.0 p -132.43 170.1 15.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.936 1.826 . . . . 0.0 111.89 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -121.79 171.23 9.04 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -146.15 162.65 37.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.105 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' D' ' 113' ' ' THR . 1.8 tt -145.68 125.71 13.67 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.16 -1.382 . . . . 0.0 113.211 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . 0.402 ' N ' HD23 ' D' ' 98' ' ' LEU . 0.3 OUTLIER -110.08 144.67 38.33 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 125.218 1.574 . . . . 0.0 114.337 -174.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -128.55 123.57 33.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.774 -174.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.95 158.66 16.61 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.98 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 1.5 t -105.37 62.58 0.68 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.717 -0.614 . . . . 0.0 110.102 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' D' ' 108' ' ' ASP . 0.1 OUTLIER -48.75 152.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.268 1.427 . . . . 0.0 113.452 174.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -80.84 -29.69 35.83 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.44 144.7 43.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.772 1.272 . . . . 0.0 113.161 -174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 92' ' ' VAL . 12.1 tt -64.82 -24.58 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.991 174.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.21 1.07 43.8 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.054 -1.415 . . . . 0.0 113.72 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . 0.787 ' HB3' HG11 ' D' ' 103' ' ' VAL . 13.6 m-20 -121.06 5.41 10.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.506 1.122 . . . . 0.0 113.931 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -33.93 65.79 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.877 -1.764 . . . . 0.0 111.492 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' HA ' ' D' ' 108' ' ' ASP . 43.7 p-90 -45.59 -50.36 13.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -87.86 -11.69 47.07 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.292 -0.88 . . . . 0.0 113.231 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.64 -5.57 53.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 117.22 -1.371 . . . . 0.0 114.213 -172.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.781 ' CG2' HD21 ' D' ' 98' ' ' LEU . 15.2 m -103.34 143.86 32.12 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.981 1.425 . . . . 0.0 112.38 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -144.51 130.2 19.13 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.815 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.92 154.85 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 120.355 1.434 . . . . 0.0 110.733 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.19 -177.64 33.47 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.402 0.525 . . . . 0.0 113.453 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' D' ' 96' ' ' MET . 24.1 p90 -124.88 152.29 44.21 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.842 -0.799 . . . . 0.0 111.088 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.15 143.62 27.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.547 0.739 . . . . 0.0 109.061 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . . . . . . . . . 57.1 mt -127.55 131.52 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -120.25 151.5 39.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.446 0.641 . . . . 0.0 111.884 174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 36.8 p -131.07 163.8 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.548 1.139 . . . . 0.0 110.129 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -61.5 115.88 4.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.161 1.385 . . . . 0.0 111.781 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.45 84.19 7.27 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 176.77 -28.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.799 2.04 . . . . 0.0 114.857 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -62.28 140.9 58.49 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.347 1.059 . . . . 0.0 112.242 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.55 6.07 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.5 1.92 . . . . 0.0 114.804 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -140.61 8.71 2.18 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.56 1.544 . . . . 0.0 112.39 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.401 0 C-N-CA 127.682 2.393 . . . . 0.0 110.0 -174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . 0.282 1.8 pm0 . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.711 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 25.0 p -137.81 -167.6 2.17 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 121.524 1.966 . . . . 0.0 113.974 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.42 46.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 127.245 2.218 . . . . 0.0 112.361 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -116.38 -71.04 0.76 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.079 1.352 . . . . 0.0 110.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 25.37 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 128.584 2.754 . . . . 0.0 115.773 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.67 119.95 8.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.378 -0.826 . . . . 0.0 112.088 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 51.2 t -117.96 134.56 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -139.61 136.48 34.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.464 1.106 . . . . 0.0 108.704 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 34.5 mt -73.63 -25.89 60.51 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -46.81 109.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.52 1.528 . . . . 0.0 111.705 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.29 -124.94 2.64 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.524 1.059 . . . . 0.0 111.164 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -153.52 142.26 20.99 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -140.42 158.5 43.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.573 1.549 . . . . 0.0 110.959 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.0 t -137.2 151.19 48.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.266 1.026 . . . . 0.0 108.783 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -117.76 143.67 46.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.148 0.979 . . . . 0.0 110.8 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -55.75 -22.99 26.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.441 1.896 . . . . 0.0 114.442 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' D' ' 110' ' ' TRP . 32.7 tp -70.86 -18.06 62.71 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.601 -1.312 . . . . 0.0 111.098 173.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.21 18.82 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.585 2.993 . . . . 0.0 113.52 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 88.9 p -70.8 145.08 50.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.798 1.299 . . . . 0.0 112.372 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -119.51 140.42 50.53 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.788 0.835 . . . . 0.0 110.321 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -130.54 140.61 50.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.806 0.813 . . . . 0.0 112.728 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.4 m -129.56 131.82 46.66 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.97 125.93 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.31 -88.27 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 125.0 1.437 . . . . 0.0 111.122 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 155.28 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.09 0.947 . . . . 0.0 112.087 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' B' ' 53' ' ' GLN . 15.0 p -107.17 124.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.899 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -77.81 161.3 27.76 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.896 0.379 . . . . 0.0 111.963 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m -54.39 -22.7 13.12 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -69.62 -36.28 76.02 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.241 0.616 . . . . 0.0 111.197 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -8.22 17.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.909 1.243 . . . . 0.0 112.554 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.53 154.5 40.79 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.579 1.18 . . . . 0.0 109.025 174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -159.39 163.56 35.41 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.314 177.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -128.56 162.94 26.1 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.436 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.01 -166.22 27.7 Favored Glycine 0 C--O 1.237 0.341 0 O-C-N 121.406 -0.809 . . . . 0.0 112.589 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.688 ' HB ' HD11 ' B' ' 46' ' ' LEU . 37.5 p -136.93 137.12 39.22 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 113.795 -1.202 . . . . 0.0 111.791 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.7 140.62 48.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.238 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.513 HD11 HD12 ' B' ' 46' ' ' LEU . 39.7 mt -133.79 126.77 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 174.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.439 ' O ' HG21 ' B' ' 44' ' ' ILE . 86.0 m -104.95 149.33 25.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -173.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.78 15.38 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' D' ' 110' ' ' TRP . 16.8 m -133.34 138.6 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.77 1.228 . . . . 0.0 111.443 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.2 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.216 -0.928 . . . . 0.0 112.1 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -71.38 -26.84 62.96 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.948 -0.47 . . . . 0.0 110.296 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -143.51 81.15 12.47 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.604 2.362 . . . . 0.0 110.293 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -65.94 30.16 0.1 Allowed 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.763 3.642 . . . . 0.0 116.242 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.7 6.73 76.74 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 119.829 -1.795 . . . . 0.0 116.176 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -176.76 11.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.439 HG21 ' O ' ' B' ' 35' ' ' THR 0.256 61.5 mt -33.66 109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -102.87 173.97 6.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.537 -2.12 . . . . 0.0 110.838 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.688 HD11 ' HB ' ' B' ' 32' ' ' THR . 2.2 tt -70.94 137.86 49.55 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 171.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.2 p -114.85 126.33 28.0 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.184 0.593 . . . . 0.0 111.188 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -57.85 143.88 94.83 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.416 2.077 . . . . 0.0 112.134 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 144.49 51.13 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.209 0.943 . . . . 0.0 110.54 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' C' ' 50' ' ' LEU . 0.0 OUTLIER -148.88 149.07 30.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.565 2.346 . . . . 0.0 108.714 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.26 -149.41 15.88 Favored Glycine 0 CA--C 1.523 0.541 0 O-C-N 120.424 -1.422 . . . . 0.0 111.111 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.657 HG21 ' HB2' ' C' ' 69' ' ' ASN . 2.5 mp -144.08 139.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.891 0.877 . . . . 0.0 112.17 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -127.62 130.72 49.48 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.151 -0.968 . . . . 0.0 110.619 173.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . 0.429 ' HB2' ' HB2' ' B' ' 62' ' ' PRO . 10.0 m-70 -63.22 156.06 26.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.683 -1.261 . . . . 0.0 111.577 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -146.16 12.06 1.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.666 1.187 . . . . 0.0 113.106 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -77.56 -57.87 3.58 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.257 2.623 . . . . 0.0 110.861 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.7 171.84 11.31 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.602 1.189 . . . . 0.0 112.911 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 71.3 m -79.19 -29.68 43.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.002 0.921 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.29 56.55 19.03 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 111.631 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' B' ' 54' ' ' HIS . 58.7 Cg_endo -80.15 178.31 7.31 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 121.908 1.738 . . . . 0.0 115.773 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 p -90.02 156.64 18.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.36 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.68 156.54 31.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.224 -0.923 . . . . 0.0 112.742 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.98 149.77 17.89 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 120.07 2.788 . . . . 0.0 120.07 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -158.25 159.25 35.81 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.42 ' HB ' HD12 ' C' ' 52' ' ' ILE . 2.8 m -96.09 150.59 20.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.885 1.674 . . . . 0.0 108.478 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -129.02 125.72 63.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.652 ' HB2' HG21 ' C' ' 52' ' ' ILE . 22.0 t-20 -103.72 112.37 25.28 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.507 -174.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . 0.443 ' HE1' ' HG1' ' B' ' 77' ' ' THR 0.355 57.5 m95 -74.11 154.94 38.93 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -173.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.81 -49.42 2.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 115.438 -172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -76.42 -15.16 59.99 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -150.44 144.64 25.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.984 2.514 . . . . 0.0 107.278 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.62 116.95 21.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.691 1.234 . . . . 0.0 109.975 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -168.56 171.52 8.82 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.284 1.834 . . . . 0.0 111.208 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.3 t -147.89 142.03 26.07 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 123.202 1.477 . . . . 0.0 110.456 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . 0.443 ' HG1' ' HE1' ' B' ' 70' ' ' TRP . 1.7 m -138.51 132.73 31.66 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.629 -3.441 . . . . 0.0 109.577 -173.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.08 157.37 10.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.925 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.22 137.29 44.27 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.05 119.85 10.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.588 0.755 . . . . 0.0 110.018 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.48 -176.3 27.5 Favored Glycine 0 N--CA 1.463 0.492 0 N-CA-C 116.649 1.42 . . . . 0.0 116.649 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.06 144.56 48.48 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 124.874 0.984 . . . . 0.0 110.41 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 25.7 p -97.63 113.0 24.64 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.452 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' C' ' 106' ' ' ILE . 0.7 OUTLIER -104.14 166.45 10.4 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.779 0.718 . . . . 0.0 112.057 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.26 112.42 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -58.59 161.38 4.66 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.264 1.026 . . . . 0.0 108.999 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -48.79 -30.05 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -15.01 57.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.403 1.081 . . . . 0.0 113.221 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.48 54.09 2.47 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' B' ' 90' ' ' LYS . 31.8 mtpt -126.99 146.27 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.339 2.256 . . . . 0.0 108.407 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -106.27 138.32 42.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.932 1.693 . . . . 0.0 110.969 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.494 HG21 ' CD1' ' C' ' 106' ' ' ILE . 24.6 m -141.67 162.24 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.21 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.52 117.68 27.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -106.96 115.48 30.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 5.4 p -132.66 170.0 15.84 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 123.517 1.627 . . . . 0.0 111.952 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.463 ' SD ' HG21 ' C' ' 113' ' ' THR . 0.0 OUTLIER -121.8 170.88 9.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -145.84 162.83 36.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.215 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.796 HD21 ' CG2' ' B' ' 113' ' ' THR . 1.7 tt -145.67 125.68 13.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.133 -1.394 . . . . 0.0 113.375 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.92 144.31 38.61 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 125.037 1.46 . . . . 0.0 114.625 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.26 123.93 35.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 112.023 -2.353 . . . . 0.0 113.777 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 156.55 17.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.137 0.975 . . . . 0.0 111.716 176.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -102.83 63.5 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.146 0.498 . . . . 0.0 109.75 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.817 HG11 ' HB3' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -49.61 151.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.855 1.262 . . . . 0.0 112.675 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.99 -30.73 39.74 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.05 144.92 42.33 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.49 1.138 . . . . 0.0 113.145 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.487 ' CD1' HG21 ' C' ' 92' ' ' VAL . 12.7 tt -65.74 -23.41 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.559 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.7 1.43 53.02 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 118.24 -1.311 . . . . 0.0 113.693 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.817 ' HB3' HG11 ' B' ' 103' ' ' VAL . 13.5 m-20 -121.14 5.63 10.31 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -33.71 66.67 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 119.878 -1.764 . . . . 0.0 111.699 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CD1' ' HA ' ' B' ' 108' ' ' ASP . 44.4 p-90 -45.29 -50.22 12.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.024 1.329 . . . . 0.0 114.264 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.12 -11.41 47.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.82 -6.26 55.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.214 -1.374 . . . . 0.0 114.476 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.796 ' CG2' HD21 ' B' ' 98' ' ' LEU . 15.2 m -102.96 143.75 32.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 125.228 1.58 . . . . 0.0 112.148 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.9 mtt85 -144.34 129.38 18.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 124.626 1.17 . . . . 0.0 111.061 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.42 154.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.178 1.354 . . . . 0.0 110.867 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.92 -177.64 33.2 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.291 0.472 . . . . 0.0 113.579 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 23.9 p90 -125.13 152.25 44.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.683 -0.892 . . . . 0.0 110.97 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -148.27 143.42 26.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.62 0.768 . . . . 0.0 109.209 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.51 128.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.83 153.51 31.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.108 0.48 . . . . 0.0 111.43 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 42.2 p -136.14 160.74 37.72 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.285 1.034 . . . . 0.0 111.331 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -58.93 118.24 5.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.042 0.937 . . . . 0.0 111.735 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -81.0 139.54 35.72 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 67.64 47.27 1.21 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.064 1.346 . . . . 0.0 113.733 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -66.28 -24.68 66.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 55.55 -147.43 0.52 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.309 1.044 . . . . 0.0 111.07 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 tptp -148.05 5.53 0.76 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 117.094 -1.431 . . . . 0.0 113.49 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . 0.307 15.7 mt-10 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 128.875 2.87 . . . . 0.0 107.708 -170.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 1.3 m 67.56 -45.85 0.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.211 2.204 . . . . 0.0 115.617 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.9 -35.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.072 1.749 . . . . 0.0 114.423 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . 24.94 98.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.406 2.682 . . . . 0.0 116.951 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.59 60.51 1.58 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.726 1.21 . . . . 0.0 112.933 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -156.17 118.5 4.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.778 1.231 . . . . 0.0 111.388 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . . 43.9 t -116.31 136.2 53.21 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -139.75 136.09 33.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.49 -26.15 60.77 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -46.54 109.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.256 1.422 . . . . 0.0 112.139 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.34 -126.9 3.32 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.389 0.995 . . . . 0.0 111.161 -174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -150.31 144.65 25.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -142.61 158.44 43.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.161 1.384 . . . . 0.0 111.034 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 148.82 45.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.705 1.202 . . . . 0.0 108.391 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -115.93 143.62 45.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.9 0.88 . . . . 0.0 110.769 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -53.45 -24.85 13.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.827 2.051 . . . . 0.0 114.549 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.442 HD11 ' CD1' ' A' ' 110' ' ' TRP . 31.3 tp -70.08 -18.39 63.26 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.192 -1.567 . . . . 0.0 111.565 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.42 -15.0 17.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 128.587 2.994 . . . . 0.0 113.452 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 87.9 p -71.66 144.73 49.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.574 1.187 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.89 142.67 49.47 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.4 -0.813 . . . . 0.0 110.681 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -131.3 144.12 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.28 1.038 . . . . 0.0 112.769 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 17.5 m -132.04 131.55 42.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.232 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 66.8 mt -128.66 124.64 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.53 -84.87 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 125.026 1.454 . . . . 0.0 111.102 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.86 157.42 44.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.068 0.937 . . . . 0.0 112.067 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' C' ' 53' ' ' GLN . 13.6 p -109.91 125.81 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.918 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -79.25 161.46 26.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.841 0.456 . . . . 0.0 112.01 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 13.1 m -54.64 -23.46 17.27 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -69.23 -34.54 74.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.203 0.601 . . . . 0.0 111.413 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.41 -6.35 18.87 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.994 1.283 . . . . 0.0 112.878 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.81 157.78 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.423 1.106 . . . . 0.0 112.07 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 166.35 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.205 174.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -132.08 160.34 36.24 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.06 -166.53 28.26 Favored Glycine 0 C--O 1.239 0.419 0 CA-C-O 122.439 1.021 . . . . 0.0 112.423 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.668 ' HB ' HD11 ' C' ' 46' ' ' LEU . 39.9 p -137.43 140.16 41.11 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.458 -1.371 . . . . 0.0 111.97 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.95 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.512 HD11 HD12 ' C' ' 46' ' ' LEU . 41.2 mt -133.48 126.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.454 ' O ' HG21 ' C' ' 44' ' ' ILE . 89.9 m -104.99 148.89 26.24 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.36 -18.17 15.53 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.437 ' HB ' ' CZ2' ' A' ' 110' ' ' TRP . 17.1 m -133.07 138.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.83 1.252 . . . . 0.0 111.475 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 169.98 19.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.365 -0.834 . . . . 0.0 112.369 -173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -71.49 -25.53 62.3 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.836 -0.54 . . . . 0.0 110.534 173.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -145.09 81.2 10.68 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 127.621 2.369 . . . . 0.0 110.256 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.18 30.99 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 124.686 3.591 . . . . 0.0 116.243 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.35 6.49 79.68 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 119.816 -1.803 . . . . 0.0 116.1 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -176.46 10.51 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.454 HG21 ' O ' ' C' ' 35' ' ' THR 0.259 59.8 mt -32.64 108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -173.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.66 173.59 6.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.421 -2.172 . . . . 0.0 111.042 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.668 HD11 ' HB ' ' C' ' 32' ' ' THR . 2.0 tt -70.28 137.72 50.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 8.3 p -114.46 126.14 28.32 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.96 144.31 94.54 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.058 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 150.95 49.45 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.015 0.926 . . . . 0.0 110.57 174.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.756 HD12 HD12 ' B' ' 50' ' ' LEU . 0.1 OUTLIER -157.28 149.23 22.5 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.95 2.1 . . . . 0.0 108.512 -175.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.62 -148.44 17.56 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.498 1.045 . . . . 0.0 112.419 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.652 HG21 ' HB2' ' B' ' 69' ' ' ASN . 2.5 mp -144.58 138.67 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 124.29 1.036 . . . . 0.0 112.424 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.591 ' HG3' HG21 ' C' ' 23' ' ' VAL . 0.0 OUTLIER -128.17 130.08 47.5 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.816 -1.178 . . . . 0.0 110.561 174.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' C' ' 62' ' ' PRO . 10.7 m-70 -62.12 156.26 22.08 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.716 -1.24 . . . . 0.0 111.868 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -147.57 12.87 1.04 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.835 1.254 . . . . 0.0 113.284 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -78.96 -58.16 3.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 128.22 2.608 . . . . 0.0 111.184 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.2 170.28 14.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.853 0.861 . . . . 0.0 112.622 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 73.9 m -81.22 -25.91 36.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.927 173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.93 56.4 16.79 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 125.228 1.411 . . . . 0.0 112.707 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' C' ' 54' ' ' HIS . 59.8 Cg_endo -81.38 178.95 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.103 1.869 . . . . 0.0 115.84 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -89.54 157.48 18.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.98 1.312 . . . . 0.0 112.728 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -158.75 156.12 29.24 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.232 -0.917 . . . . 0.0 112.862 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.03 149.64 17.59 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.63 158.95 34.81 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.446 ' HB ' HD12 ' B' ' 52' ' ' ILE . 2.4 m -95.27 151.36 19.31 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.272 1.829 . . . . 0.0 108.56 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.7 124.01 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.657 ' HB2' HG21 ' B' ' 52' ' ' ILE . 22.5 t-20 -102.12 112.47 25.15 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.956 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . 0.354 55.4 m95 -73.91 154.87 39.21 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 mmpm? -112.98 -48.73 2.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.178 1.791 . . . . 0.0 115.529 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.67 -15.12 59.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -150.91 144.82 25.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.07 2.548 . . . . 0.0 107.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.8 117.17 22.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.607 1.094 . . . . 0.0 109.748 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 93.2 p -168.95 171.24 8.47 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.581 1.952 . . . . 0.0 110.942 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -147.59 142.27 26.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-O 123.039 1.399 . . . . 0.0 110.924 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -138.52 132.03 30.54 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 109.897 -3.319 . . . . 0.0 110.051 -172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -108.95 157.19 9.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.959 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -133.99 137.35 44.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.93 119.53 10.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 0.0 109.82 -174.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.24 -174.68 25.42 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.1 144.52 48.88 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.464 0.743 . . . . 0.0 110.781 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.69 113.0 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 124.139 0.899 . . . . 0.0 110.982 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HB2' HD12 ' B' ' 106' ' ' ILE . 0.6 OUTLIER -104.75 167.71 9.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.469 0.652 . . . . 0.0 111.557 -177.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.79 113.97 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 174.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -58.78 161.2 5.0 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.871 0.868 . . . . 0.0 109.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -51.31 -20.95 1.89 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.72 -11.04 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.535 0.734 . . . . 0.0 112.665 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.94 49.02 3.93 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -122.81 145.82 48.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.639 1.976 . . . . 0.0 109.409 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -102.9 139.17 38.83 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.857 1.263 . . . . 0.0 111.024 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' B' ' 106' ' ' ILE . 23.6 m -141.77 163.97 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.97 1.308 . . . . 0.0 109.433 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 57.6 mt -123.52 119.02 28.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -108.14 115.41 30.07 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -132.59 170.06 15.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.978 1.847 . . . . 0.0 112.274 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.436 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -122.11 170.98 9.32 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 172.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -146.15 162.69 37.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.233 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.786 HD21 ' CG2' ' C' ' 113' ' ' THR . 1.7 tt -145.64 125.67 13.67 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.194 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . 0.403 ' N ' HD23 ' C' ' 98' ' ' LEU . 0.3 OUTLIER -110.14 144.69 38.4 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.974 1.421 . . . . 0.0 114.333 -174.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -128.28 123.1 33.24 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 111.943 -2.389 . . . . 0.0 113.701 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.7 156.22 18.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.699 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -102.97 61.55 0.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.864 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' C' ' 108' ' ' ASP . 0.1 OUTLIER -48.06 151.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.144 1.377 . . . . 0.0 113.008 174.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -80.17 -31.05 38.89 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.89 145.15 42.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.534 1.159 . . . . 0.0 112.992 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.494 ' CD1' HG21 ' B' ' 92' ' ' VAL . 13.1 tt -64.84 -24.16 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.707 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 1.73 46.66 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.945 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . 0.794 ' HB3' HG11 ' C' ' 103' ' ' VAL . 13.2 m-20 -121.32 5.89 10.2 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -33.33 67.92 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 119.896 -1.752 . . . . 0.0 111.7 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.538 ' CD1' ' HA ' ' C' ' 108' ' ' ASP . 43.9 p-90 -45.59 -49.92 13.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.79 1.236 . . . . 0.0 114.299 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -88.33 -11.01 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.32 56.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.786 ' CG2' HD21 ' C' ' 98' ' ' LEU . 15.5 m -102.83 143.85 31.92 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 125.134 1.521 . . . . 0.0 112.265 176.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 30.2 mtt85 -144.54 130.03 18.93 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.64 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.25 154.18 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 120.417 1.462 . . . . 0.0 110.644 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -177.84 33.38 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.466 0.555 . . . . 0.0 113.442 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 23.8 p90 -124.76 152.43 43.84 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.665 -0.903 . . . . 0.0 111.135 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -148.14 143.71 27.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.666 0.787 . . . . 0.0 109.305 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.73 129.16 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.93 152.65 34.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.282 0.563 . . . . 0.0 111.612 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 66.2 p -135.18 161.86 34.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.447 1.099 . . . . 0.0 110.643 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -57.5 117.29 4.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.621 1.168 . . . . 0.0 112.505 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -86.12 106.54 17.32 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.655 -0.653 . . . . 0.0 109.817 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 80.99 142.07 0.07 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.101 2.56 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . . 8.9 t -156.43 -40.95 0.08 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.992 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 55.59 -82.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.195 1.798 . . . . 0.0 111.347 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? 62.59 66.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.435 2.294 . . . . 0.0 113.67 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.248 0.984 0 C-N-CA 129.852 3.261 . . . . 0.0 106.6 174.36 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' THR . . . . . . . . . . . . . 8.1 p -59.02 -48.33 81.99 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 113.32 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 51.12 -72.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 129.748 3.219 . . . . 0.0 114.619 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -167.82 73.62 0.12 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.914 2.085 . . . . 0.0 109.295 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.83 133.0 9.75 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.753 -0.592 . . . . 0.0 111.571 -176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 154.03 31.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.014 0.926 . . . . 0.0 109.408 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.6 p -139.66 127.58 22.15 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.137 -0.977 . . . . 0.0 112.999 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.95 -31.56 72.85 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.594 1.543 . . . . 0.0 113.375 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -66.5 113.68 4.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.26 0.21 0.3 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 119.03 2.372 . . . . 0.0 119.03 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt 73.14 144.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 129.405 3.082 . . . . 0.0 114.362 -174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -140.27 161.97 36.4 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.321 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -141.44 147.17 37.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.434 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.42 143.42 40.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.729 0.812 . . . . 0.0 110.195 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -56.64 -23.87 44.35 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.478 1.911 . . . . 0.0 113.593 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' C' ' 110' ' ' TRP . 31.7 tp -71.61 -18.97 62.18 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.666 1.586 . . . . 0.0 111.499 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.45 -14.79 25.1 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 127.493 2.473 . . . . 0.0 113.582 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 p -67.99 140.3 56.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.361 1.581 . . . . 0.0 112.123 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.47 142.86 46.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -136.48 146.64 46.52 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.297 1.046 . . . . 0.0 112.843 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -134.2 132.17 39.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.313 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.0 mt -133.02 127.14 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.96 -84.52 0.19 Allowed Glycine 0 CA--C 1.526 0.762 0 O-C-N 125.187 1.554 . . . . 0.0 111.475 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 145.49 29.39 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.869 0.842 . . . . 0.0 112.238 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.57 128.9 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.718 174.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.14 161.88 20.93 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.519 0.676 . . . . 0.0 111.851 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 p -57.97 -20.9 41.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -78.22 -31.56 49.42 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.211 0.914 . . . . 0.0 111.532 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.29 -5.78 23.3 Favored Glycine 0 N--CA 1.466 0.655 0 CA-C-O 117.352 -1.805 . . . . 0.0 114.626 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 145.83 53.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.711 1.755 . . . . 0.0 109.056 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -155.1 140.2 17.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.05 12.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 -168.94 35.27 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.873 1.263 . . . . 0.0 111.304 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.664 ' HB ' HD11 ' A' ' 46' ' ' LEU . 43.3 p -133.0 130.26 39.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 123.339 1.543 . . . . 0.0 110.928 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -111.64 136.83 50.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 112.784 -2.007 . . . . 0.0 108.033 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD12 ' A' ' 46' ' ' LEU . 33.0 mt -132.6 130.27 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -108.5 145.98 33.91 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.32 -15.19 18.9 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HB ' ' CZ2' ' C' ' 110' ' ' TRP . 19.0 m -133.49 140.99 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.626 1.17 . . . . 0.0 112.937 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.47 162.53 38.1 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 120.76 -1.212 . . . . 0.0 111.0 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.95 -39.5 79.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.476 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -131.81 84.66 53.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 127.184 2.194 . . . . 0.0 108.082 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.11 175.56 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.423 2.082 . . . . 0.0 111.522 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.58 -31.96 3.29 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.608 1.099 . . . . 0.0 112.543 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.02 28.29 2.12 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.406 1.083 . . . . 0.0 112.164 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.6 mt -58.25 134.11 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.796 0.807 . . . . 0.0 109.587 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.81 174.06 11.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.399 1.48 . . . . 0.0 108.984 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' HB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -53.28 132.48 39.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 126.112 1.765 . . . . 0.0 113.055 175.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -114.51 125.49 29.11 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.057 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD3' ' HE3' ' A' ' 71' ' ' LYS . 4.9 Cg_exo -58.51 146.96 88.78 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.235 1.957 . . . . 0.0 110.846 173.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.46 151.66 51.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.26 0.624 . . . . 0.0 110.871 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tp -156.75 149.05 23.21 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.003 1.721 . . . . 0.0 110.872 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.56 -154.26 25.0 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 121.541 1.973 . . . . 0.0 109.833 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' D' ' 69' ' ' ASN . 3.9 mt -146.7 140.94 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 112.132 -174.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.28 138.24 50.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.792 1.237 . . . . 0.0 110.766 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -70.52 155.56 40.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.837 0.827 . . . . 0.0 110.415 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -138.61 -5.6 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -77.67 -35.09 52.7 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.85 167.12 12.69 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 m -76.96 -37.99 54.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.298 1.439 . . . . 0.0 114.659 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -139.33 49.92 2.33 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 125.026 1.33 . . . . 0.0 111.877 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.76 -179.04 4.98 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.408 2.739 . . . . 0.0 115.35 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.5 p -87.44 161.31 17.91 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.892 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.51 155.75 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.487 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.82 19.92 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 119.715 2.646 . . . . 0.0 119.715 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -159.72 159.73 33.2 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -97.64 148.72 23.02 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.952 2.501 . . . . 0.0 108.685 173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.52 125.33 63.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.599 ' HB2' HG21 ' D' ' 52' ' ' ILE . 48.8 t30 -103.68 107.06 17.75 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.555 -174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -72.06 149.19 45.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 123.411 1.577 . . . . 0.0 114.731 -173.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HE3' ' HD3' ' A' ' 48' ' ' PRO . 27.9 mttt -108.54 -45.39 3.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -78.85 -17.23 55.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.287 1.035 . . . . 0.0 112.804 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 128.66 10.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 129.269 3.028 . . . . 0.0 105.397 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.12 119.01 11.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.332 0.969 . . . . 0.0 112.088 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 t -170.72 167.52 7.71 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.773 1.629 . . . . 0.0 110.919 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -146.13 140.9 27.02 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 124.001 1.857 . . . . 0.0 110.484 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 1.5 m -137.24 126.38 24.53 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-N 109.303 -3.589 . . . . 0.0 109.949 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 m -102.09 161.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.39 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -136.7 137.95 40.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.92 118.14 9.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -151.14 -179.41 26.84 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.058 -1.068 . . . . 0.0 115.535 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -121.57 148.89 43.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 125.223 1.19 . . . . 0.0 111.264 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.1 t -97.13 127.64 43.29 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 125.094 1.496 . . . . 0.0 109.911 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' HD12 ' D' ' 106' ' ' ILE . 7.7 m-85 -117.7 161.4 19.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.16 0.984 . . . . 0.0 113.517 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 28.1 mt -127.18 112.92 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.54 160.56 6.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.104 0.562 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -43.05 -37.26 1.89 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.12 -14.94 60.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.448 1.499 . . . . 0.0 114.773 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 46.82 4.15 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.587 0.613 . . . . 0.0 113.016 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 12.3 mtpt -115.79 160.23 20.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.966 2.106 . . . . 0.0 108.037 173.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -116.0 144.77 43.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.075 1.762 . . . . 0.0 111.713 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' A' ' 94' ' ' LYS . 2.2 t -143.72 159.36 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.601 1.191 . . . . 0.0 109.592 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 120' ' ' PHE . 24.8 mt -125.14 102.29 7.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' A' ' 92' ' ' VAL . 2.3 mmtt -96.23 121.42 37.99 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.408 HG22 ' HA3' ' A' ' 81' ' ' GLY . 2.4 p -134.01 162.86 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.627 1.204 . . . . 0.0 111.373 -174.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.421 ' SD ' HG21 ' D' ' 113' ' ' THR . 0.0 OUTLIER -112.38 168.16 9.85 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 171.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -142.11 163.8 31.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.786 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 113' ' ' THR . 0.7 OUTLIER -145.97 123.98 12.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.801 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.32 144.87 38.4 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 125.088 1.493 . . . . 0.0 114.025 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -124.52 114.89 20.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.983 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.1 m -73.7 162.59 29.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.889 0.876 . . . . 0.0 111.557 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.6 p -99.88 45.69 0.98 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.0 -1.063 . . . . 0.0 111.492 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -52.4 137.23 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.98 1.712 . . . . 0.0 113.145 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -20.58 61.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -174.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.62 150.93 51.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.16 1.457 . . . . 0.0 113.549 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' D' ' 84' ' ' PHE . 16.0 tt -64.15 -23.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.109 -0.994 . . . . 0.0 113.084 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.47 3.75 58.18 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.071 0.843 . . . . 0.0 113.552 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 103' ' ' VAL . 1.1 m-20 -122.7 -0.65 9.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.195 0.998 . . . . 0.0 112.451 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -31.76 69.18 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.208 -0.932 . . . . 0.0 112.85 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' C' ' 14' ' ' LEU . 56.7 p-90 -48.18 -41.61 27.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.096 1.358 . . . . 0.0 113.714 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HB3' ' CZ3' ' A' ' 110' ' ' TRP . 15.2 pttm -96.39 -8.59 32.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 -0.9 18.94 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.742 ' CG2' HD21 ' A' ' 98' ' ' LEU . 8.2 m -113.39 140.97 47.61 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.588 0.755 . . . . 0.0 112.632 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -144.21 131.67 20.97 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.787 1.235 . . . . 0.0 111.738 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.66 156.55 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 110.53 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.93 -175.43 30.89 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.516 0.579 . . . . 0.0 113.225 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -125.14 153.15 43.45 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.795 -0.826 . . . . 0.0 112.112 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 132.13 14.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.746 0.784 . . . . 0.0 110.052 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.419 HD13 ' HE3' ' A' ' 94' ' ' LYS . 15.5 mt -118.93 138.45 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 21.0 m-85 -124.56 139.97 53.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.821 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.3 p -129.32 154.09 47.2 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -53.01 117.86 3.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.336 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 124' ' ' ARG . 4.4 tt -85.35 123.09 30.41 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.734 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -159.8 -167.94 2.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.27 172.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -60.57 164.33 4.63 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.279 0.632 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -121.42 6.81 10.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.67 1.588 . . . . 0.0 111.101 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -131.51 84.0 2.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 128.138 2.575 . . . . 0.0 106.391 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.256 1.421 0 C-N-CA 129.216 3.007 . . . . 0.0 115.473 -178.687 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' -3' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' D' ' -3' ' ' GLN . 7.2 mm-40 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' -2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.56 -45.77 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.556 1.16 . . . . 0.0 110.191 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 21.3 m -65.19 148.4 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 111.812 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . -73.71 53.62 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.313 1.445 . . . . 0.0 112.528 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 29.45 61.76 0.15 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 129.065 2.946 . . . . 0.0 114.594 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 146.25 22.7 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 126.218 1.807 . . . . 0.0 109.227 -174.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 p -134.58 148.53 50.47 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.27 1.828 . . . . 0.0 107.732 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' SER . . . . . . . . . . . . . 65.3 p -139.29 131.12 27.57 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.285 -1.51 . . . . 0.0 114.148 -173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 50.7 mt -65.04 -31.88 73.33 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.259 1.391 . . . . 0.0 113.924 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -66.33 115.64 6.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.38 8.16 0.29 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 118.296 2.079 . . . . 0.0 118.296 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 66.55 148.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.272 2.629 . . . . 0.0 114.927 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -143.43 161.08 39.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.474 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -140.5 145.7 37.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.545 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -109.54 143.61 38.97 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.178 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.16 -23.34 46.77 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.405 1.882 . . . . 0.0 113.543 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.52 HD11 ' CD1' ' B' ' 110' ' ' TRP . 32.0 tp -72.4 -19.06 61.66 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.006 1.722 . . . . 0.0 111.27 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.47 -14.59 22.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.121 2.296 . . . . 0.0 113.622 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -67.52 138.34 56.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.458 1.629 . . . . 0.0 112.202 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.85 141.3 46.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -135.03 147.15 49.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.246 1.022 . . . . 0.0 113.179 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 7.1 m -134.49 131.96 38.67 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.068 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -133.13 126.32 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.08 -84.59 0.16 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 125.292 1.62 . . . . 0.0 111.583 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.05 29.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.713 0.757 . . . . 0.0 111.853 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.56 128.8 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.901 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.52 161.54 19.95 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.636 0.731 . . . . 0.0 111.595 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' SER . . . . . . . . . . . . . 13.8 p -58.2 -21.38 47.44 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -75.92 -30.3 58.68 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.176 0.898 . . . . 0.0 111.666 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.77 -4.21 25.98 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.778 1.18 . . . . 0.0 115.061 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.56 150.85 45.67 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.399 1.08 . . . . 0.0 110.926 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -156.46 162.84 39.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.164 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.86 171.97 12.17 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 173.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.21 -167.84 37.3 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 119.947 -1.721 . . . . 0.0 111.628 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' THR . . . . . 0.646 ' HB ' HD11 ' D' ' 46' ' ' LEU . 44.0 p -132.95 128.84 37.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.89 1.329 . . . . 0.0 110.823 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -111.65 136.06 51.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.12 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.412 HD11 HD12 ' D' ' 46' ' ' LEU . 30.6 mt -132.11 132.39 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' THR . . . . . 0.438 HG23 ' H ' ' D' ' 37' ' ' VAL . 1.0 OUTLIER -111.26 145.5 38.65 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 -15.41 19.2 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.438 ' H ' HG23 ' D' ' 35' ' ' THR . 18.6 m -133.55 140.7 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.324 1.05 . . . . 0.0 113.068 -174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.01 162.4 37.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.132 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.77 -38.85 80.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.628 173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -131.89 84.5 53.75 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.987 2.115 . . . . 0.0 108.013 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 175.09 9.58 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.09 1.86 . . . . 0.0 111.417 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.23 -31.45 3.3 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.567 1.079 . . . . 0.0 112.502 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.37 28.13 2.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.341 1.056 . . . . 0.0 112.16 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.9 134.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.929 0.871 . . . . 0.0 109.608 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.18 174.08 11.19 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.314 1.445 . . . . 0.0 108.862 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.646 HD11 ' HB ' ' D' ' 32' ' ' THR . 0.9 OUTLIER -53.53 132.69 40.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 126.248 1.819 . . . . 0.0 113.093 175.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -114.67 125.67 28.83 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.067 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' D' ' 71' ' ' LYS . 4.8 Cg_exo -58.72 146.92 90.43 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.164 1.909 . . . . 0.0 110.748 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.13 157.41 43.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.441 0.697 . . . . 0.0 111.234 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.89 148.85 15.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.822 1.649 . . . . 0.0 110.381 -174.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.89 -157.7 28.96 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 121.35 1.886 . . . . 0.0 111.999 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 69' ' ' ASN . 3.6 mt -145.41 138.7 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.094 0.957 . . . . 0.0 111.903 -174.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.98 138.17 50.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.537 1.535 . . . . 0.0 110.733 174.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -71.09 154.94 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.408 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -136.8 -6.38 1.91 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -78.61 -35.91 44.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.25 168.57 13.8 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -74.82 -42.55 57.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.244 1.018 . . . . 0.0 113.556 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -137.45 53.07 6.06 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.07 1.348 . . . . 0.0 112.037 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.91 -179.73 5.48 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.264 1.976 . . . . 0.0 115.248 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 34.8 p -87.97 161.91 17.16 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.762 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -159.53 155.97 27.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.57 149.69 19.59 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 119.517 2.567 . . . . 0.0 119.517 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.13 158.07 29.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -96.47 149.22 21.97 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.827 2.451 . . . . 0.0 108.989 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.89 124.87 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 52' ' ' ILE . 44.5 t30 -104.23 107.31 18.16 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.053 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.7 149.6 45.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 123.381 1.562 . . . . 0.0 114.397 -173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' D' ' 48' ' ' PRO . 27.2 mttt -108.56 -45.06 3.93 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -173.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -79.22 -16.88 55.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.395 1.078 . . . . 0.0 112.917 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -152.26 129.25 11.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.299 3.04 . . . . 0.0 105.453 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.91 118.95 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.355 0.98 . . . . 0.0 111.584 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 45.5 t -170.5 167.54 8.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 110.776 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -145.9 141.06 27.44 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 123.832 1.777 . . . . 0.0 110.892 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' D' ' 98' ' ' LEU . 1.5 m -137.46 125.25 22.48 Favored 'General case' 0 N--CA 1.409 -2.518 0 CA-C-N 109.469 -3.514 . . . . 0.0 110.456 -172.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 m -101.04 161.06 3.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.355 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.29 138.38 39.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.26 118.16 9.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 109.223 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' D' ' 95' ' ' THR . . . -151.23 -178.59 26.18 Favored Glycine 0 CA--C 1.5 -0.85 0 C-N-CA 120.006 -1.092 . . . . 0.0 115.816 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.26 145.58 48.09 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 125.09 1.112 . . . . 0.0 111.263 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' D' ' 93' ' ' LEU . 17.0 t -97.6 118.37 33.95 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.939 1.4 . . . . 0.0 110.653 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.578 ' HB2' HD12 ' A' ' 106' ' ' ILE . 8.9 m-85 -109.06 163.78 13.02 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' D' ' 90' ' ' LYS . 7.8 mt -127.94 113.64 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 174.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.31 154.99 26.18 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -36.51 -38.98 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -72.37 -29.68 64.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.655 1.582 . . . . 0.0 114.467 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.38 58.72 0.73 Allowed Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.122 1.344 . . . . 0.0 110.949 -173.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' D' ' 85' ' ' ILE . 19.2 mtpt -123.72 163.46 21.07 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.414 2.686 . . . . 0.0 107.31 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -124.81 145.74 49.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 121.77 2.077 . . . . 0.0 112.725 -172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . 0.554 HG11 ' CD ' ' D' ' 94' ' ' LYS . 2.2 t -145.16 159.48 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.679 1.191 . . . . 0.0 110.643 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' D' ' 120' ' ' PHE . 19.1 mt -123.22 104.15 8.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' LYS . . . . . 0.554 ' CD ' HG11 ' D' ' 92' ' ' VAL . 1.7 mmtt -98.29 119.05 36.29 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' THR . . . . . 0.401 HG22 ' HA3' ' D' ' 81' ' ' GLY . 1.9 p -133.19 161.93 33.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.534 1.159 . . . . 0.0 111.257 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -111.24 168.45 9.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -142.14 164.25 30.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.477 1.132 . . . . 0.0 111.727 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' D' ' 113' ' ' THR . 0.7 OUTLIER -146.9 124.14 11.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.685 -1.598 . . . . 0.0 113.569 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.62 144.81 38.95 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 125.332 1.645 . . . . 0.0 114.078 -174.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -124.63 115.02 20.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 111.896 -2.411 . . . . 0.0 113.896 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' SER . . . . . . . . . . . . . 31.5 m -74.52 161.32 29.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.937 0.895 . . . . 0.0 111.844 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 58.8 p -99.0 45.55 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.85 -1.157 . . . . 0.0 111.356 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' D' ' 108' ' ' ASP . 0.3 OUTLIER -52.22 137.96 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 112.964 -174.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -19.74 60.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.04 151.75 50.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.862 1.315 . . . . 0.0 113.783 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' A' ' 84' ' ' PHE . 15.7 tt -63.89 -24.37 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.367 -0.833 . . . . 0.0 113.171 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.16 3.5 52.09 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.212 0.911 . . . . 0.0 113.6 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . 0.402 ' HB3' HG21 ' D' ' 103' ' ' VAL . 1.2 m-20 -122.9 -0.78 8.96 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.139 0.976 . . . . 0.0 112.454 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -31.85 68.46 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.408 -0.808 . . . . 0.0 112.747 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' TRP . . . . . 0.522 ' CD1' HD11 ' B' ' 14' ' ' LEU . 57.1 p-90 -48.3 -41.68 28.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.255 1.422 . . . . 0.0 113.703 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . 0.405 ' HB3' ' CZ3' ' D' ' 110' ' ' TRP . 15.1 pttm -96.66 -8.6 31.16 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -1.46 20.87 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' THR . . . . . 0.746 ' CG2' HD21 ' D' ' 98' ' ' LEU . 8.5 m -112.95 140.83 47.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.531 0.733 . . . . 0.0 112.687 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -144.12 131.34 20.72 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.788 1.235 . . . . 0.0 111.658 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -107.49 156.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 110.492 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.24 -175.26 31.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.541 0.591 . . . . 0.0 113.434 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -125.06 152.59 44.1 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.734 -0.862 . . . . 0.0 112.004 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.34 12.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.851 0.834 . . . . 0.0 110.166 -175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' ILE . . . . . 0.412 HD13 ' HE3' ' D' ' 94' ' ' LYS . 16.4 mt -116.02 138.29 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' D' ' 93' ' ' LEU . 21.0 m-85 -125.08 141.88 51.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -130.36 154.32 47.8 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -52.83 112.94 0.93 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.246 1.018 . . . . 0.0 110.145 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' LEU . . . . . 0.57 HD23 ' C ' ' D' ' 123' ' ' LEU . 7.7 tt -72.47 116.6 13.12 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.36 -59.39 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.307 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' THR . . . . . . . . . . . . . 2.1 p 57.12 119.7 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.721 2.008 . . . . 0.0 113.12 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -157.51 118.72 3.61 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.14 -1.6 . . . . 0.0 107.256 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.76 164.86 35.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 128.062 2.545 . . . . 0.0 108.664 -174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.267 1.979 1 C-N-CA 133.609 4.764 . . . . 0.0 104.514 173.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' -3' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 117.112 -1.423 . . . . 0.0 108.024 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' -2' ' ' THR . . . . . . . . . . . . . 4.6 p -88.38 -62.86 1.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.604 1.162 . . . . 0.0 110.294 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.97 174.27 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.556 1.942 . . . . 0.0 109.11 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.98 158.23 37.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.575 1.15 . . . . 0.0 110.057 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -83.44 56.59 3.64 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.03 -1.044 . . . . 0.0 111.545 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 130.76 8.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.265 -0.897 . . . . 0.0 112.533 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.416 ' CB ' ' HG ' ' B' ' 83' ' ' CYS . 25.3 p -116.86 147.77 41.87 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.331 1.852 . . . . 0.0 109.54 -174.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -139.48 129.66 25.25 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.78 -33.22 75.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.13 1.332 . . . . 0.0 114.105 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -65.27 115.55 5.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.82 5.2 0.32 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 68.76 146.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 128.59 2.756 . . . . 0.0 115.483 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -141.97 159.14 42.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.411 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.407 ' HB ' HD12 ' B' ' 123' ' ' LEU . 13.7 t -136.45 143.82 44.09 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.591 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -108.97 143.54 38.11 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.611 0.764 . . . . 0.0 110.571 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -55.62 -25.09 36.9 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.194 1.798 . . . . 0.0 113.332 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' D' ' 110' ' ' TRP . 29.6 tp -71.13 -18.92 62.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.633 1.573 . . . . 0.0 111.846 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.94 -16.06 23.27 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.381 2.42 . . . . 0.0 113.414 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 61.5 p -67.29 141.11 57.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.019 1.39 . . . . 0.0 111.89 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.67 141.09 48.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -134.56 147.14 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.569 1.176 . . . . 0.0 112.505 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.4 m -134.76 131.17 37.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.57 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 93.9 mt -132.59 126.2 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.55 -84.75 0.17 Allowed Glycine 0 CA--C 1.526 0.769 0 O-C-N 125.348 1.655 . . . . 0.0 111.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.23 146.54 30.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 112.265 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 28.2 t -89.94 128.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.497 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.28 162.18 17.93 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.527 0.68 . . . . 0.0 111.847 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.2 p -58.0 -20.92 42.24 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -78.35 -31.4 48.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.176 0.898 . . . . 0.0 111.719 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.97 -5.75 23.87 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-O 117.479 -1.734 . . . . 0.0 114.687 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.6 145.34 54.03 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.531 1.665 . . . . 0.0 108.914 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.76 140.1 17.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.77 165.18 12.04 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.43 -168.72 34.93 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-O 122.82 1.233 . . . . 0.0 111.132 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.654 ' HB ' HD11 ' B' ' 46' ' ' LEU . 41.7 p -133.59 131.1 39.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.32 -1.44 . . . . 0.0 110.789 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -112.25 137.06 50.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.898 -1.956 . . . . 0.0 108.116 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.42 HD11 HD12 ' B' ' 46' ' ' LEU . 27.0 mt -132.96 129.72 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.445 HG23 ' H ' ' B' ' 37' ' ' VAL . 1.0 OUTLIER -108.75 145.73 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -175.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.23 -14.75 19.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 35' ' ' THR . 18.4 m -133.93 140.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.559 1.143 . . . . 0.0 112.745 -174.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.36 162.85 37.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.804 -1.185 . . . . 0.0 110.862 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.48 -38.96 77.9 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.433 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -132.15 84.6 52.28 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.202 2.201 . . . . 0.0 107.995 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.01 175.49 9.06 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.375 2.05 . . . . 0.0 111.486 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.35 -31.41 3.44 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.584 1.088 . . . . 0.0 112.654 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -140.28 28.25 2.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.395 1.078 . . . . 0.0 112.15 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.03 134.41 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.92 0.867 . . . . 0.0 109.562 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.31 173.63 11.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.347 1.459 . . . . 0.0 109.039 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.654 HD11 ' HB ' ' B' ' 32' ' ' THR . 0.9 OUTLIER -52.97 132.93 38.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 126.15 1.78 . . . . 0.0 113.211 175.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -115.26 125.86 28.42 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.082 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' HE3' ' B' ' 71' ' ' LYS . 6.7 Cg_exo -58.42 146.51 89.9 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 0.0 110.811 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.4 151.48 51.5 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.289 0.635 . . . . 0.0 110.7 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 tp -156.78 149.08 23.19 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.028 1.731 . . . . 0.0 110.845 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.59 25.49 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 121.555 1.979 . . . . 0.0 109.511 -173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' C' ' 69' ' ' ASN . 4.0 mt -146.2 140.23 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.371 1.068 . . . . 0.0 112.403 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.35 137.35 49.87 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.465 1.106 . . . . 0.0 110.657 174.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -69.91 156.13 39.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 109.992 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -138.81 -5.66 1.51 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -79.15 -36.9 39.72 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.47 166.64 15.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.749 0.656 . . . . 0.0 112.524 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.7 m -79.41 -34.28 41.93 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -139.78 51.88 3.35 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 125.147 1.379 . . . . 0.0 112.351 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.3 -179.5 5.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.734 2.29 . . . . 0.0 115.806 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 40.0 p -87.23 161.55 17.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.941 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.84 155.67 26.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.575 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.68 19.44 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 119.705 2.642 . . . . 0.0 119.705 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -160.07 159.05 31.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -96.52 149.44 21.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.844 2.457 . . . . 0.0 108.783 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.88 125.74 63.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.606 ' HB2' HG21 ' C' ' 52' ' ' ILE . 48.5 t30 -104.05 106.63 17.2 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 118.223 -0.894 . . . . 0.0 112.373 -174.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -71.8 149.43 45.31 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.288 1.518 . . . . 0.0 114.591 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.503 ' HE3' ' HD3' ' B' ' 48' ' ' PRO . 28.2 mttt -108.58 -45.24 3.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -173.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -79.14 -16.97 55.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 112.857 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.3 129.17 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.242 3.017 . . . . 0.0 105.455 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.73 119.0 11.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.472 1.033 . . . . 0.0 111.791 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 39.4 t -170.43 167.38 8.25 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.993 1.717 . . . . 0.0 110.738 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -146.12 140.83 26.98 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-O 124.03 1.871 . . . . 0.0 110.453 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.52 126.18 23.78 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 109.335 -3.575 . . . . 0.0 110.052 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.8 161.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.328 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.91 138.58 40.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.3 119.43 10.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.668 0.787 . . . . 0.0 109.148 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.81 -178.84 27.85 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.202 -0.999 . . . . 0.0 115.579 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -121.51 145.9 47.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 125.211 1.183 . . . . 0.0 111.058 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.456 ' SG ' HD23 ' B' ' 93' ' ' LEU . 17.2 t -97.36 121.94 39.83 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.651 1.219 . . . . 0.0 110.012 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.564 ' HB2' HD12 ' C' ' 106' ' ' ILE . 10.7 m-85 -111.98 163.57 14.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 124.916 1.286 . . . . 0.0 112.648 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' B' ' 90' ' ' LYS . 19.2 mt -128.08 119.09 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.13 163.63 5.98 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.362 0.601 . . . . 0.0 109.839 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -47.0 -36.84 8.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.85 -25.09 60.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.308 1.443 . . . . 0.0 113.444 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.06 11.37 22.51 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.02 -1.433 . . . . 0.0 115.785 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 85' ' ' ILE . 9.5 mtpt -81.58 167.21 19.51 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.426 1.613 . . . . 0.0 111.143 174.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.77 148.19 43.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.065 1.757 . . . . 0.0 112.185 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.537 HG11 ' CD ' ' B' ' 94' ' ' LYS . 2.2 t -146.99 160.6 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 122.358 1.075 . . . . 0.0 110.61 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' B' ' 120' ' ' PHE . 18.6 mt -123.49 103.58 8.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.537 ' CD ' HG11 ' B' ' 92' ' ' VAL . 2.0 mmtt -98.14 118.71 35.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -132.41 163.3 29.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.583 1.182 . . . . 0.0 111.534 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' B' ' 117' ' ' TYR . 0.0 OUTLIER -113.15 168.45 9.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -142.57 164.0 31.31 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.184 0.992 . . . . 0.0 111.771 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 113' ' ' THR . 0.8 OUTLIER -146.38 123.73 11.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.678 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.06 144.78 38.14 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 125.197 1.56 . . . . 0.0 114.173 -174.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.4 115.4 20.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 111.822 -2.445 . . . . 0.0 114.298 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 38.4 m -75.81 161.33 29.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.156 0.982 . . . . 0.0 111.134 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 58.5 p -98.28 45.29 1.02 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 108' ' ' ASP . 0.3 OUTLIER -51.42 137.73 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.91 1.684 . . . . 0.0 112.979 -174.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -20.3 60.86 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -173.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.21 153.13 50.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.84 1.305 . . . . 0.0 113.666 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' C' ' 84' ' ' PHE . 16.0 tt -65.03 -22.81 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.76 2.78 58.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.363 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.406 ' HB3' HG21 ' B' ' 103' ' ' VAL . 1.5 m-20 -122.5 -0.79 9.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.558 1.143 . . . . 0.0 112.436 -174.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -32.07 67.05 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.28 -0.887 . . . . 0.0 112.892 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.52 ' CD1' HD11 ' D' ' 14' ' ' LEU . 57.0 p-90 -48.65 -41.52 31.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.076 1.35 . . . . 0.0 113.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 110' ' ' TRP . 14.8 pttm -96.65 -8.33 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.91 -1.21 18.7 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.745 ' CG2' HD21 ' B' ' 98' ' ' LEU . 8.2 m -113.15 140.97 47.46 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.772 0.829 . . . . 0.0 112.807 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -144.13 131.56 20.95 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.708 1.203 . . . . 0.0 111.547 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.54 156.73 7.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 123.976 0.91 . . . . 0.0 110.73 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -160.35 -175.91 31.85 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.509 0.576 . . . . 0.0 113.358 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 96' ' ' MET . 27.8 p90 -124.56 152.57 43.32 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.781 -0.834 . . . . 0.0 111.956 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.84 129.6 12.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.953 0.883 . . . . 0.0 110.072 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.411 HD13 ' HE3' ' B' ' 94' ' ' LYS . 15.2 mt -116.7 138.74 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' B' ' 93' ' ' LEU . 24.5 m-85 -125.19 142.41 51.51 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.851 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 26.9 p -132.29 158.86 40.76 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -57.55 119.68 6.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.455 1.102 . . . . 0.0 113.255 -173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.413 HD23 ' O ' ' B' ' 123' ' ' LEU . 8.7 tt -93.85 89.06 5.98 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -178.52 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.341 1.456 . . . . 0.0 113.577 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -79.77 144.45 33.57 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.516 1.526 . . . . 0.0 110.498 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -90.16 -46.57 8.36 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -135.2 -54.45 0.8 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 111.129 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 C--O 1.263 1.769 1 C-N-CA 136.386 5.874 . . . . 0.0 105.411 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' -3' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' -2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.44 165.53 23.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.751 1.62 . . . . 0.0 108.276 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.48 141.17 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.391 0.676 . . . . 0.0 109.728 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . -137.44 137.28 38.59 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.788 0.835 . . . . 0.0 109.778 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -149.41 94.26 2.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.172 2.189 . . . . 0.0 107.135 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.66 124.22 5.42 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.51 1.124 . . . . 0.0 109.0 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' CYS . . . . . . . . . . . . 0.254 16.1 p -116.02 142.94 46.14 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 124.559 1.144 . . . . 0.0 108.343 -173.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 33.1 p -134.83 132.4 38.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.826 1.25 . . . . 0.0 113.858 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.31 -30.03 68.92 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -67.78 111.81 4.5 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.45 -10.32 0.29 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 118.597 2.199 . . . . 0.0 118.597 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt 81.19 146.48 0.08 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 130.513 3.525 . . . . 0.0 113.261 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -140.47 161.45 37.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.227 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -139.09 144.22 38.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.686 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -107.89 143.61 36.27 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.712 0.805 . . . . 0.0 110.275 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.08 -23.91 50.16 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.697 1.599 . . . . 0.0 113.276 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 110' ' ' TRP . 30.6 tp -71.14 -18.96 62.49 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.729 1.612 . . . . 0.0 111.415 174.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.9 -16.36 23.23 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.363 2.411 . . . . 0.0 113.537 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' SER . . . . . . . . . . . . . 51.7 p -66.55 141.04 57.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.215 1.508 . . . . 0.0 112.128 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.75 139.41 51.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -133.58 147.11 51.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.22 1.009 . . . . 0.0 113.021 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -134.85 131.9 37.96 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.891 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.99 125.6 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.99 -82.0 0.23 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 125.342 1.651 . . . . 0.0 111.379 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.72 151.11 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.681 0.753 . . . . 0.0 112.027 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.63 128.02 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.846 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -65.02 161.09 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.618 0.723 . . . . 0.0 111.675 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . . . . . . . . . 11.7 p -58.03 -20.57 39.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -76.81 -29.91 56.18 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.313 0.96 . . . . 0.0 111.621 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.26 -3.69 26.76 Favored Glycine 0 N--CA 1.468 0.772 0 C-N-CA 124.761 1.172 . . . . 0.0 115.112 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.14 150.31 45.55 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.371 1.069 . . . . 0.0 110.797 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.86 162.73 40.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.041 174.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.59 172.4 11.62 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.37 -167.08 36.2 Favored Glycine 0 C--O 1.237 0.302 0 O-C-N 120.004 -1.685 . . . . 0.0 111.861 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' THR . . . . . 0.629 ' HB ' HD11 ' C' ' 46' ' ' LEU . 34.8 p -133.78 128.57 35.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 123.172 1.463 . . . . 0.0 111.1 174.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.02 137.21 50.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.14 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.411 HD11 HD12 ' C' ' 46' ' ' LEU . 25.7 mt -132.27 133.25 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' THR . . . . . 0.508 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.8 OUTLIER -114.92 146.96 40.6 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.91 -14.06 19.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.508 ' H ' HG23 ' C' ' 35' ' ' THR . 17.1 m -134.16 142.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.746 1.218 . . . . 0.0 112.609 -174.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.42 38.95 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.035 -1.041 . . . . 0.0 110.992 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.95 -39.01 79.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.362 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -132.12 84.69 52.16 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.089 2.156 . . . . 0.0 107.988 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 175.4 9.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.328 2.018 . . . . 0.0 111.506 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.83 -31.37 3.37 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.523 1.059 . . . . 0.0 112.58 175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -140.19 28.6 2.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.486 1.114 . . . . 0.0 112.135 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.83 134.54 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.786 0.803 . . . . 0.0 109.462 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.97 174.66 10.65 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.273 1.429 . . . . 0.0 108.888 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' C' ' 32' ' ' THR . 1.0 OUTLIER -53.86 133.09 42.75 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.26 1.824 . . . . 0.0 112.963 174.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 49.0 m -115.37 125.75 28.51 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.153 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HE3' ' C' ' 71' ' ' LYS . 5.6 Cg_exo -58.04 146.7 86.43 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.142 1.895 . . . . 0.0 110.92 174.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.83 157.53 42.63 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.229 0.612 . . . . 0.0 111.187 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.513 ' HB2' HD11 ' B' ' 52' ' ' ILE . 0.0 OUTLIER -161.3 148.89 15.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.835 1.654 . . . . 0.0 110.244 -174.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.83 -157.9 29.15 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 121.57 1.986 . . . . 0.0 111.875 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' B' ' 69' ' ' ASN . 3.6 mt -145.26 138.25 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.17 0.988 . . . . 0.0 111.933 -174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.17 139.29 51.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.687 174.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -72.46 154.64 40.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.858 0.837 . . . . 0.0 110.486 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -137.28 -6.21 1.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -78.42 -37.2 44.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.31 165.8 16.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.344 0.592 . . . . 0.0 112.538 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' SER . . . . . . . . . . . . . 24.8 m -79.05 -34.26 43.95 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -140.2 52.74 3.7 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.897 1.279 . . . . 0.0 112.244 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.79 -179.09 5.11 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.851 2.367 . . . . 0.0 115.95 -174.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -86.5 162.38 18.1 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.792 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -160.22 156.49 26.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.736 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.4 148.98 17.96 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.64 158.77 32.16 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -96.91 149.78 21.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.825 2.45 . . . . 0.0 108.894 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.58 124.13 58.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' ASN . . . . . 0.587 ' HB2' HG21 ' B' ' 52' ' ' ILE . 44.0 t30 -103.53 107.66 18.59 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.231 -174.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -71.87 149.1 45.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.127 1.441 . . . . 0.0 114.557 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.452 ' HE3' ' HD3' ' C' ' 48' ' ' PRO . 26.5 mttt -108.21 -45.15 3.98 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.415 2.005 . . . . 0.0 116.415 -173.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -78.9 -16.93 56.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.204 1.002 . . . . 0.0 112.958 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -152.05 131.57 13.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 129.517 3.127 . . . . 0.0 105.032 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.41 119.04 13.98 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.163 0.892 . . . . 0.0 111.627 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' SER . . . . . . . . . . . . . 48.5 t -170.53 167.59 8.01 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.767 1.627 . . . . 0.0 110.819 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -145.81 141.14 27.64 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 123.927 1.823 . . . . 0.0 110.763 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -137.59 125.93 23.29 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 109.454 -3.521 . . . . 0.0 110.43 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 m -102.01 160.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.15 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -136.96 138.36 40.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.4 119.29 9.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.716 0.807 . . . . 0.0 108.875 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.51 -177.88 26.6 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 119.931 -1.128 . . . . 0.0 115.709 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -122.09 145.85 47.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.004 1.061 . . . . 0.0 111.191 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' C' ' 93' ' ' LEU . 14.6 t -97.4 121.73 39.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.803 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.575 ' HB2' HD12 ' B' ' 106' ' ' ILE . 12.8 m-85 -112.8 162.23 16.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.415 1.086 . . . . 0.0 113.276 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' C' ' 90' ' ' LYS . 27.5 mt -127.86 111.7 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -62.23 162.19 10.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.424 0.69 . . . . 0.0 110.052 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -42.97 -39.53 2.64 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.36 -25.55 63.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.051 1.34 . . . . 0.0 113.784 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.54 10.01 22.33 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.87 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' C' ' 85' ' ' ILE . 15.0 mtpp -78.77 164.24 24.7 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.333 1.566 . . . . 0.0 110.862 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.62 148.18 41.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.019 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' VAL . . . . . 0.541 HG11 ' CD ' ' C' ' 94' ' ' LYS . 2.2 t -146.91 162.92 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.904 1.281 . . . . 0.0 110.425 176.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' C' ' 120' ' ' PHE . 19.4 mt -126.24 104.21 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' LYS . . . . . 0.541 ' CD ' HG11 ' C' ' 92' ' ' VAL . 1.9 mmtt -98.79 118.26 35.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -131.96 163.13 29.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.462 1.125 . . . . 0.0 111.572 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.415 ' SD ' HG21 ' B' ' 113' ' ' THR . 0.0 OUTLIER -112.92 168.82 9.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -143.09 164.29 30.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.199 1.0 . . . . 0.0 111.832 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.747 HD21 ' CG2' ' C' ' 113' ' ' THR . 0.7 OUTLIER -146.4 123.77 11.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.973 -1.467 . . . . 0.0 113.705 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.23 144.72 38.49 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.248 1.419 . . . . 0.0 114.068 -174.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -124.48 114.91 20.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 112.168 -2.287 . . . . 0.0 114.185 -174.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -74.86 161.32 29.66 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.852 0.861 . . . . 0.0 111.938 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 55.4 p -98.27 45.33 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.307 1.043 . . . . 0.0 111.48 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -52.31 136.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.744 1.618 . . . . 0.0 113.453 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -20.52 61.85 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -174.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.53 151.35 51.09 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.819 1.295 . . . . 0.0 113.597 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' B' ' 84' ' ' PHE . 15.9 tt -64.28 -21.92 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.56 3.27 64.06 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -122.81 -0.58 9.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.316 1.046 . . . . 0.0 112.621 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -31.55 68.51 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.72 0.808 . . . . 0.0 112.83 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' TRP . . . . . 0.524 ' CD1' HD11 ' A' ' 14' ' ' LEU . 57.4 p-90 -49.02 -41.16 33.74 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.009 1.323 . . . . 0.0 113.706 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . 0.406 ' HB3' ' CZ3' ' C' ' 110' ' ' TRP . 14.9 pttm -96.78 -8.54 30.93 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.01 18.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . 0.747 ' CG2' HD21 ' C' ' 98' ' ' LEU . 8.3 m -113.41 140.44 48.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.52 0.728 . . . . 0.0 112.66 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -143.69 131.24 21.14 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.639 1.176 . . . . 0.0 111.645 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.37 156.49 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 124.034 0.933 . . . . 0.0 110.64 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.95 -175.8 31.33 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.352 0.501 . . . . 0.0 113.261 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' C' ' 96' ' ' MET . 27.5 p90 -124.21 152.93 42.33 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.786 -0.832 . . . . 0.0 112.053 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.17 128.81 11.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.966 0.889 . . . . 0.0 110.132 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' ILE . . . . . 0.427 HD13 ' HE3' ' C' ' 94' ' ' LYS . 15.3 mt -115.37 140.87 34.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' C' ' 93' ' ' LEU . 25.2 m-85 -127.27 141.32 51.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.772 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' THR . . . . . . . . . . . . . 18.2 p -131.69 161.17 33.4 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -59.15 119.76 7.93 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.706 0.802 . . . . 0.0 112.546 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' C' ' 124' ' ' ARG . 7.3 tt -84.66 162.95 19.53 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 172.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.414 ' HB2' HD23 ' C' ' 123' ' ' LEU . 0.0 OUTLIER 72.72 -178.26 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.753 0.821 . . . . 0.0 110.939 174.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' THR . . . . . . . . . . . . 0.256 5.8 t 53.41 -169.22 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.683 1.593 . . . . 0.0 112.762 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -70.58 172.33 8.74 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.384 -0.822 . . . . 0.0 109.393 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 0.44 5.06 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 115.864 -2.017 . . . . 0.0 115.829 -173.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.26 1.632 0 CA-C-O 117.024 -1.465 . . . . 0.0 109.727 -172.288 . . . . . . . . 0 0 . 1 stop_ save_